{"meta":{"query_hash":"e496dea6c581","filters":{"topic":"Pharmacogenetics and Drug Metabolism"},"cohort_total":1519,"direct_labels_cover":3,"predictions_cover":1519,"exported":1519,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e496dea6c581","api":"https://metacan.xera.ac/api/v1/cohort?topic=Pharmacogenetics+and+Drug+Metabolism"},"results":[{"id":"W1015548331","doi":"10.1016/j.bmc.2015.07.025","title":"A P450 fusion library of heme domains from Rhodococcus jostii RHA1 and its evaluation for the biotransformation of drug molecules","year":2015,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"FP7 People: Marie-Curie Actions; European Commission","keywords":"Rhodococcus; Chemistry; Biotransformation; Cytochrome P450; Biochemistry; Hydroxylation; Demethylation; Escherichia coli; Heme; Monooxygenase; Enzyme; Gene; Gene expression","score_opus":0.11187130459542524,"score_gpt":0.3972669808825699,"score_spread":0.2853956762871447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1015548331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886671,0.0008134305,0.0071654283,0.000112186186,0.000018688446,0.00012458934,0.0012339747,0.00013905163,0.0017254549],"genre_scores_gemma":[0.98427457,0.0010602009,0.007602116,0.00005084355,0.0000072815883,0.000051734776,0.002956041,0.000045699642,0.003951612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998313,0.000030826275,0.000013556894,0.000029098519,0.000066689165,0.000028399172],"domain_scores_gemma":[0.99991655,0.000018346876,0.00001858188,0.000013413507,0.00001789953,0.0000152042785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001634725,0.00035849217,0.00033221827,0.00030466964,0.00017245625,0.00020495958,0.00021762948,0.00026566282,0.0008683487],"category_scores_gemma":[0.00016253977,0.00013909614,0.000289451,0.0004340246,0.00012516015,0.0001343106,0.0001892612,0.00048431716,0.00042349784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007135936,0.000049152357,0.00007510065,0.000023019678,0.0000043009513,0.00005584872,0.000007278987,0.00016055413,0.9976738,0.000030172518,0.000028562217,0.001820896],"study_design_scores_gemma":[0.000010690542,0.00033784792,0.0009261912,0.0000028144138,0.000022589677,0.00025252945,0.00001676348,0.00056534226,0.99644876,0.000012217157,0.0013998087,0.0000043771333],"about_ca_topic_score_codex":0.0011775487,"about_ca_topic_score_gemma":0.0015488075,"teacher_disagreement_score":0.0011775487,"about_ca_system_score_codex":0.00019285573,"about_ca_system_score_gemma":0.00020768697,"threshold_uncertainty_score":0.002904892},"labels":[],"label_agreement":null},{"id":"W1125187349","doi":"10.1007/978-3-319-16009-2_5","title":"Regioselective Versatility of Monooxygenase Reactions Catalyzed by CYP2B6 and CYP3A4: Examples with Single Substrates","year":2015,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Hydroxylation; Monooxygenase; Regioselectivity; CYP2B6; Cytochrome P450; Substrate (aquarium); Enzyme; Stereochemistry; Organic chemistry; Biochemistry; Catalysis; CYP1A2","score_opus":0.2506256391629043,"score_gpt":0.5149566931814417,"score_spread":0.26433105401853735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1125187349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016229723,0.96070963,0.007312844,0.00047535627,0.00039558148,0.000055082153,0.00033482778,0.00012622315,0.0143606635],"genre_scores_gemma":[0.069191925,0.9160003,0.0057832813,0.0003774631,0.00037508004,0.0000706069,0.00039035975,0.000029065053,0.0077818288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981004,0.000033688906,0.000018823926,0.000055286615,0.00004970116,0.000032445456],"domain_scores_gemma":[0.9999083,0.00003672204,0.000018785566,0.000010732763,0.000017204182,0.000008235816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052870787,0.0008520156,0.00092741504,0.00096807047,0.0001920172,0.00057505275,0.0007313235,0.0004970602,0.003019598],"category_scores_gemma":[0.00033550715,0.00035585056,0.000655666,0.0011719972,0.00035545387,0.00097285205,0.0006524449,0.0011929708,0.0020103431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035572238,0.0002800836,0.00075865723,0.012534505,0.00031096773,0.001416715,0.00018869132,0.0018486559,0.08596369,0.013911438,0.014247353,0.86818355],"study_design_scores_gemma":[0.0000991621,0.0010555777,0.0027401098,0.000833323,0.0004217314,0.0067473226,0.0001102694,0.0010570897,0.10922977,0.007441315,0.87014276,0.000121583915],"about_ca_topic_score_codex":0.00025206534,"about_ca_topic_score_gemma":0.0006947546,"teacher_disagreement_score":0.003019598,"about_ca_system_score_codex":0.00024041241,"about_ca_system_score_gemma":0.00025983813,"threshold_uncertainty_score":0.010101557},"labels":[],"label_agreement":null},{"id":"W1167902140","doi":"10.1096/fasebj.29.1_supplement.616.14","title":"Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D Central Activation of Codeine to Morphine","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Morphine; Codeine; Nicotine; Pharmacology; Chemistry; Analgesic; Anesthesia; Medicine; Internal medicine","score_opus":0.1374100508209678,"score_gpt":0.410338380369313,"score_spread":0.2729283295483452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1167902140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917292,0.0020886334,0.0018472213,0.00022814715,0.00006218553,0.00008538841,0.00034385515,0.0001314622,0.0034839252],"genre_scores_gemma":[0.9899873,0.0017594987,0.0019790041,0.00011818451,0.00004023028,0.00011945328,0.0005734474,0.000025273299,0.005397577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998313,0.000031433792,0.000011455311,0.00002681474,0.000059585127,0.00003942658],"domain_scores_gemma":[0.9997538,0.00004097873,0.00006122274,0.000029230428,0.0000383424,0.000076354045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110109104,0.0004345342,0.00035567183,0.00019297014,0.00011170069,0.00025337393,0.00016705783,0.00025314454,0.0031769352],"category_scores_gemma":[0.00025121408,0.00015987275,0.0003283322,0.00009413431,0.00029691463,0.00026128796,0.00022558254,0.0011687102,0.0004375673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007132678,0.00015641749,0.00027089327,0.00006095101,0.000015078279,0.000050672475,0.000020463733,0.00003089987,0.99509263,0.000098548124,0.00009908027,0.0033911704],"study_design_scores_gemma":[0.00013956624,0.006043781,0.040694583,0.00003266279,0.00006179834,0.00038904106,0.000048098445,0.0013225321,0.948141,0.00009103549,0.0030223487,0.000013487439],"about_ca_topic_score_codex":0.0010245075,"about_ca_topic_score_gemma":0.0028545966,"teacher_disagreement_score":0.0031769352,"about_ca_system_score_codex":0.00035230845,"about_ca_system_score_gemma":0.0002963626,"threshold_uncertainty_score":0.010627866},"labels":[],"label_agreement":null},{"id":"W117007957","doi":"10.1096/fasebj.27.1_supplement.670.2","title":"Decreased Nuclear Receptor Activity Mediates Down‐ Regulation of Drug Metabolizing Enzymes in Chronic Kidney Disease Through Epigenetic Modulation.","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Chromatin immunoprecipitation; Pregnane X receptor; Nuclear receptor; Histone; Epigenetics; CYP3A; Internal medicine; Endocrinology; Messenger RNA; Kidney disease; Chemistry; Gene expression; Biology; Promoter; Medicine; Cytochrome P450; Transcription factor; Gene; Biochemistry; Metabolism","score_opus":0.048942508447225204,"score_gpt":0.35110058253044235,"score_spread":0.30215807408321715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W117007957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416,0.0072840406,0.006347509,0.00038700394,0.000042262112,0.000036814068,0.00026875618,0.000086354186,0.0013871937],"genre_scores_gemma":[0.9948127,0.0019528858,0.0014691576,0.000065030996,0.000022594588,0.000029489505,0.00017534074,0.0000062690688,0.0014664666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998847,0.000021037436,0.0000063713674,0.000028316066,0.00002826831,0.00003139697],"domain_scores_gemma":[0.9998796,0.000018951147,0.000047430785,0.000013342471,0.000019261264,0.000021285168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018286024,0.00026328827,0.00026793024,0.00014517641,0.00012937299,0.00018509263,0.00015093152,0.00019264309,0.0014710263],"category_scores_gemma":[0.00015034691,0.00012220348,0.00029500804,0.00010442223,0.00031938258,0.00017687968,0.00015910235,0.00030389568,0.00019189896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007306747,0.000082575934,0.006557489,0.00012841087,0.000039978742,0.00019919987,0.00003215754,0.000061265346,0.9857143,0.00024498452,0.000112798836,0.006096173],"study_design_scores_gemma":[0.00018531323,0.0020169145,0.42090198,0.000035479705,0.00024299567,0.0020227202,0.00021876453,0.0016280254,0.5655202,0.0004420541,0.0067612417,0.000024321535],"about_ca_topic_score_codex":0.0008374147,"about_ca_topic_score_gemma":0.0013673194,"teacher_disagreement_score":0.0014710263,"about_ca_system_score_codex":0.00024473024,"about_ca_system_score_gemma":0.00025208792,"threshold_uncertainty_score":0.004921019},"labels":[],"label_agreement":null},{"id":"W1186355623","doi":"10.1007/978-3-319-16009-2_8","title":"Use of Chemical Auxiliaries to Control P450 Enzymes for Predictable Oxidations at Unactivated C-H Bonds of Substrates","year":2015,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Oxidizing agent; Substrate (aquarium); Chemistry; Enzyme; Cytochrome P450; Selectivity; Combinatorial chemistry; Small molecule; Molecule; Stereochemistry; Biochemistry; Organic chemistry; Catalysis; Biology","score_opus":0.2972921616078985,"score_gpt":0.5411258675475317,"score_spread":0.24383370593963316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1186355623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.112774596,0.71992797,0.10296821,0.0012523034,0.0021221056,0.0005092131,0.0009626816,0.0011282475,0.058354788],"genre_scores_gemma":[0.39545795,0.5494148,0.0277578,0.0010239648,0.0008016764,0.0003852181,0.00087202125,0.00011958974,0.024167016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984455,0.000019739615,0.000012166096,0.000043791708,0.000050500126,0.000029185116],"domain_scores_gemma":[0.9999099,0.000030968906,0.000027211085,0.000010638539,0.000014156344,0.000007163086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003809631,0.0008451411,0.00045643272,0.0006877705,0.00017492972,0.0003437246,0.0005479598,0.00040957195,0.0025349823],"category_scores_gemma":[0.00032490355,0.00025265772,0.0006216831,0.0005104077,0.00038682306,0.0007236286,0.00057017413,0.0013486744,0.001275811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036273708,0.00036959982,0.00054101244,0.0077582537,0.00018726404,0.0008446241,0.00016181752,0.003105341,0.41145638,0.021503635,0.0072992365,0.5464101],"study_design_scores_gemma":[0.00015833453,0.0017928011,0.0021157444,0.0005440479,0.00025443325,0.0017118624,0.00005905328,0.0022822057,0.49334142,0.0041449256,0.49349484,0.00010039861],"about_ca_topic_score_codex":0.00024429173,"about_ca_topic_score_gemma":0.00053683226,"teacher_disagreement_score":0.0025349823,"about_ca_system_score_codex":0.00021216008,"about_ca_system_score_gemma":0.0002012362,"threshold_uncertainty_score":0.00848037},"labels":[],"label_agreement":null},{"id":"W120726635","doi":"10.1139/jpn.0260","title":"Chirality and drugs used to treat psychiatric disorders","year":2002,"lang":"en","type":"editorial","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Chirality (physics); Psychiatry; Medicine; Psychology; Physics","score_opus":0.054989534377641765,"score_gpt":0.41003581676261414,"score_spread":0.3550462823849724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W120726635","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084520056,0.047205966,0.0001642723,0.03316781,0.9175276,0.000017576285,0.000046074132,0.000049199225,0.0017370239],"genre_scores_gemma":[0.0009278065,0.020093033,0.00018723545,0.025691502,0.94593954,0.000022368891,0.000027711945,0.00002349721,0.0070873066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997512,0.00059468485,0.00047351405,0.00023435192,0.0010354458,0.00014995904],"domain_scores_gemma":[0.9898867,0.0048789834,0.0008904146,0.00033195157,0.0030210225,0.0009908107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004087037,0.0036000689,0.004758299,0.0037435011,0.0021378878,0.0039647133,0.0032344472,0.015556078,0.005270388],"category_scores_gemma":[0.012979204,0.0012721678,0.0023317647,0.0018647957,0.0022373525,0.0027265265,0.0013648428,0.020059861,0.004748888],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008395867,0.000022243525,0.000052373758,0.00050593115,0.000063809566,0.00039465306,0.000017143035,0.000036609843,0.00009631502,0.00028780857,0.9861827,0.0122565655],"study_design_scores_gemma":[0.0001417088,0.000056363948,0.00061664346,0.00059520215,0.00024492515,0.0013644344,0.00004221984,0.0001893523,0.00019409515,0.0006048708,0.99592483,0.000025383013],"about_ca_topic_score_codex":0.0024289582,"about_ca_topic_score_gemma":0.0075420635,"teacher_disagreement_score":0.015556078,"about_ca_system_score_codex":0.002173611,"about_ca_system_score_gemma":0.0017464395,"threshold_uncertainty_score":0.021614552},"labels":[],"label_agreement":null},{"id":"W125357068","doi":"10.2174/187569212800626430","title":"Editorials (Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?)","year":2012,"lang":"en","type":"article","venue":"Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Pharmacogenomics; Personalized medicine; Genomics; Primary care; Medicine; Point of care; Genomic medicine; Pharmacology; Computational biology; Bioinformatics; Family medicine; Genetics; Nursing; Biology; Genome; Gene","score_opus":0.14352934575995357,"score_gpt":0.4615633252755062,"score_spread":0.3180339795155526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W125357068","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043225766,0.0025291466,0.00012777897,0.03884986,0.95713633,0.000024677967,0.000056711793,0.00004667882,0.0011856275],"genre_scores_gemma":[0.00033742414,0.0012727684,0.00011244933,0.029787643,0.96496147,0.000023064205,0.000020034631,0.000018050067,0.003467018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99255264,0.0014333165,0.0013777821,0.00094634586,0.0031472924,0.00054280617],"domain_scores_gemma":[0.95800525,0.017943619,0.0030223208,0.0012916059,0.015544539,0.004192709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009751098,0.003918948,0.00393482,0.004553757,0.003997133,0.00668024,0.004175852,0.01831054,0.017017648],"category_scores_gemma":[0.037113648,0.0013726236,0.003954344,0.001879461,0.0038179834,0.004787836,0.0015388496,0.020195456,0.013139635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004050983,0.000020463156,0.000052391024,0.00022683301,0.000025235464,0.00012026109,0.0000099789395,0.000023865108,0.00005182724,0.0002478413,0.99501723,0.0041636396],"study_design_scores_gemma":[0.00014347679,0.000060170165,0.0011737946,0.0007629608,0.00014758283,0.00066394964,0.00007013464,0.0004032313,0.00021105012,0.0020938467,0.9942226,0.000047254955],"about_ca_topic_score_codex":0.0024139176,"about_ca_topic_score_gemma":0.0045515336,"teacher_disagreement_score":0.01831054,"about_ca_system_score_codex":0.003285638,"about_ca_system_score_gemma":0.0023632767,"threshold_uncertainty_score":0.056929648},"labels":[],"label_agreement":null},{"id":"W126253151","doi":"10.1096/fasebj.23.1_supplement.lb400","title":"Effect of altered lipid homeostasis on cytochrome P450 2A5 expression","year":2009,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Lipid metabolism; Cytochrome P450; Homeostasis; Chemistry; Drug metabolism; Biology; Biochemistry; Pharmacology; Endocrinology; Metabolism; Gene","score_opus":0.06080914244997124,"score_gpt":0.4159904782549048,"score_spread":0.3551813358049336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W126253151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983113,0.00060663576,0.00037990013,0.000096410346,0.000016071608,0.00000857967,0.00019868599,0.000023902683,0.00035862593],"genre_scores_gemma":[0.9972475,0.00040490794,0.00062083337,0.000056474662,0.000007823024,0.000014555036,0.0003688088,0.000008320755,0.0012706846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997569,0.00006426917,0.000018838798,0.000046907993,0.000042031657,0.00007102654],"domain_scores_gemma":[0.9997727,0.00005592497,0.000058672624,0.000034229575,0.000026727743,0.000051752144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018912212,0.00024471484,0.00027814973,0.00027801082,0.00018057952,0.00036285148,0.00011998833,0.0002976992,0.0014113433],"category_scores_gemma":[0.00020492288,0.00012985562,0.00020200053,0.00018212716,0.0002619979,0.00018407677,0.00016364,0.00044008074,0.00018390885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008720567,0.000051004397,0.00067841465,0.000016814767,0.0000070347983,0.000062850624,0.0000144770265,0.00003844496,0.9971143,0.000028726088,0.00002388878,0.0010919957],"study_design_scores_gemma":[0.00004474496,0.0013885448,0.020396095,0.000004950008,0.000041324703,0.00015568304,0.000058438123,0.0004860006,0.9761277,0.000043125296,0.0012469302,0.0000065104805],"about_ca_topic_score_codex":0.0012341653,"about_ca_topic_score_gemma":0.0024750342,"teacher_disagreement_score":0.0014113433,"about_ca_system_score_codex":0.00044424887,"about_ca_system_score_gemma":0.00019164059,"threshold_uncertainty_score":0.004721403},"labels":[],"label_agreement":null},{"id":"W137013804","doi":"10.1385/1-59259-957-5:003","title":"Pharmacogenomics: Historical Perspective and Current Status","year":2005,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Personalized medicine; Drug; Computational biology; Precision medicine; Genomics; Human genetics; Action (physics); Gene; Biology; Genetics; Bioinformatics; Medicine; Genome; Pharmacology","score_opus":0.3022909805118992,"score_gpt":0.5323538594758448,"score_spread":0.23006287896394562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W137013804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003252669,0.9970849,0.00017859781,0.0012265368,0.0003294711,0.000001928999,0.000006891652,0.0000061077612,0.0011330714],"genre_scores_gemma":[0.0005019772,0.997426,0.0002411572,0.0007347907,0.00074345473,0.000004290838,0.000011627746,0.0000026496573,0.0003340915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991309,0.00028405205,0.000114670256,0.00015814131,0.0002532582,0.00005895563],"domain_scores_gemma":[0.9953028,0.0032023638,0.0003321997,0.00015670438,0.00076672935,0.00023918776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003481672,0.0015759704,0.0023369752,0.006758916,0.0007857517,0.0039446237,0.0019288376,0.003578889,0.004520917],"category_scores_gemma":[0.004110216,0.00067607994,0.0007200488,0.010088753,0.0034774092,0.0068577286,0.0019780875,0.004595949,0.003346644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008675734,0.000089602014,0.00043321413,0.0120517565,0.00009059063,0.00051134336,0.0002500262,0.000624766,0.00040440154,0.033692323,0.060466386,0.89129883],"study_design_scores_gemma":[0.000010439686,0.000046890746,0.0006813659,0.005595043,0.000045488872,0.0019605316,0.00018006648,0.00013266144,0.00011018312,0.010248403,0.9809616,0.000027314298],"about_ca_topic_score_codex":0.0027044537,"about_ca_topic_score_gemma":0.0033514313,"teacher_disagreement_score":0.006758916,"about_ca_system_score_codex":0.0031975978,"about_ca_system_score_gemma":0.0027675761,"threshold_uncertainty_score":0.023200274},"labels":[],"label_agreement":null},{"id":"W1461815855","doi":"10.1016/j.abb.2015.09.002","title":"Kinetic analysis of electron flux in cytochrome P450 reductases reveals differences in rate-determining steps in plant and mammalian enzymes","year":2015,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Electron transfer; Chemistry; Electron transport chain; Flux (metallurgy); Hydride; Cytochrome c; Dehydrogenase; Cofactor; Enzyme; Photochemistry; Cytochrome; Reaction rate constant; Kinetics; Coenzyme Q – cytochrome c reductase; Stereochemistry; Biochemistry; Mitochondrion; Organic chemistry; Hydrogen; Physics","score_opus":0.06410435662737599,"score_gpt":0.35940323191205326,"score_spread":0.29529887528467724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1461815855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846613,0.0012890901,0.012418507,0.00010233457,0.000010607377,0.000023184732,0.00042656163,0.000060644987,0.0010078799],"genre_scores_gemma":[0.99580175,0.0004865634,0.0025453165,0.000011617428,0.0000025332226,0.000008026601,0.00050424406,0.000017507815,0.00062249444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999018,0.000025898631,0.0000075364433,0.000027762399,0.000020639252,0.000016418522],"domain_scores_gemma":[0.9997377,0.00014365788,0.000031936805,0.000025867677,0.000040062427,0.000020763133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033279872,0.00024261468,0.000280478,0.00019468593,0.00013893416,0.00031621434,0.000330933,0.00030718202,0.00065925234],"category_scores_gemma":[0.00049174106,0.00015945378,0.00029310753,0.00024188342,0.00020657429,0.00050218875,0.00008836981,0.0006104061,0.00022867361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017382246,0.000068352005,0.0035848764,0.00009429636,0.000051962932,0.00008300732,0.00008962742,0.002050491,0.9816275,0.002050944,0.000076286,0.008484415],"study_design_scores_gemma":[0.000028618157,0.000324444,0.020407693,0.000008080224,0.00005933774,0.00032888245,0.000074528194,0.021855712,0.9550102,0.00083704054,0.0010420476,0.000023422861],"about_ca_topic_score_codex":0.0017662168,"about_ca_topic_score_gemma":0.001170466,"teacher_disagreement_score":0.0017662168,"about_ca_system_score_codex":0.0005294073,"about_ca_system_score_gemma":0.00021461971,"threshold_uncertainty_score":0.0038411617},"labels":[],"label_agreement":null},{"id":"W1481769216","doi":"10.18433/j3ng6z","title":"Cranberry Juice Ingestion and Clinical Drug-Drug Interaction Potentials; Review of Case Studies and Perspectives","year":2013,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Grapefruit juice; In vivo; CRANBERRY JUICE; Pharmacodynamics; Bioavailability; Drug interaction; Chemistry; Pharmacokinetics; Drug; Medicine; Biology; Biotechnology; Internal medicine","score_opus":0.47715001903308973,"score_gpt":0.6240484845981872,"score_spread":0.14689846556509745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481769216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043421094,0.9868094,0.0008039299,0.0026896878,0.00039705558,0.000032736338,0.00009105836,0.000027016273,0.004807073],"genre_scores_gemma":[0.044822097,0.94858444,0.0014041037,0.0017283729,0.001940139,0.000041783205,0.00019181291,0.000013803024,0.0012734254],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99898285,0.0002521214,0.00029609745,0.00015467322,0.00021590189,0.00009835905],"domain_scores_gemma":[0.9979134,0.0010768616,0.0005342145,0.00007647108,0.00022661888,0.00017237363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008532164,0.00134759,0.0012848654,0.007817231,0.001189297,0.0015440307,0.00162156,0.0026083048,0.004675405],"category_scores_gemma":[0.0033528144,0.0005521575,0.0011502627,0.006411988,0.001574346,0.0029936044,0.0011901106,0.0024169935,0.0010176896],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022259366,0.0003784962,0.023684451,0.022091616,0.00045477558,0.33992755,0.0021341245,0.0006424508,0.0013156451,0.011858938,0.05932617,0.5379632],"study_design_scores_gemma":[0.000018874429,0.00005848383,0.008026323,0.009382681,0.00029148257,0.855543,0.0014203727,0.00022427828,0.00037676137,0.003914953,0.120652296,0.00009040868],"about_ca_topic_score_codex":0.0025076605,"about_ca_topic_score_gemma":0.003990841,"teacher_disagreement_score":0.007817231,"about_ca_system_score_codex":0.001264021,"about_ca_system_score_gemma":0.0012285695,"threshold_uncertainty_score":0.015640855},"labels":[],"label_agreement":null},{"id":"W1482946335","doi":"10.1038/sj.bjp.0706787","title":"Phenobarbital increases monkey<i>in vivo</i>nicotine disposition and induces liver and brain CYP2B6 protein","year":2006,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Phenobarbital; Nicotine; CYP2B6; Pharmacology; In vivo; Endocrinology; Internal medicine; Medicine; Chemistry; Biology; Metabolism; Cytochrome P450; CYP1A2","score_opus":0.025937868684479972,"score_gpt":0.34153468592392944,"score_spread":0.3155968172394495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482946335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421173,0.0011769058,0.001606369,0.00024802,0.000044047156,0.000056482422,0.00060585845,0.00021635785,0.0018340622],"genre_scores_gemma":[0.98529935,0.0018520606,0.0030504593,0.00022536993,0.000034550856,0.00013874036,0.0024113993,0.00015922141,0.00682877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998273,0.000030078629,0.000009818029,0.000045964836,0.000036253252,0.000050650222],"domain_scores_gemma":[0.9997532,0.000024995232,0.000091837464,0.00003362334,0.00003352562,0.00006281721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009459882,0.00057548645,0.0003783467,0.00026846313,0.0002002182,0.00034140813,0.0001574202,0.0002788175,0.002061],"category_scores_gemma":[0.00013712431,0.00019975503,0.00031368522,0.00016750334,0.00039675328,0.00022124946,0.00023159564,0.0006799653,0.00066489796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055240665,0.000058569098,0.0005047352,0.000026996966,0.000012804879,0.00003677092,0.000021756527,0.000018558867,0.997747,0.000025538433,0.00007324169,0.0009216757],"study_design_scores_gemma":[0.000039318358,0.0017964324,0.019254018,0.000008710328,0.00005312655,0.00026814747,0.000050315473,0.00038314407,0.97523206,0.000037414826,0.0028717206,0.0000056003037],"about_ca_topic_score_codex":0.0027423433,"about_ca_topic_score_gemma":0.0053370786,"teacher_disagreement_score":0.0027423433,"about_ca_system_score_codex":0.0005213656,"about_ca_system_score_gemma":0.0003259152,"threshold_uncertainty_score":0.0068947673},"labels":[],"label_agreement":null},{"id":"W1495793224","doi":"10.1111/j.1476-5381.2009.00168.x","title":"The hepoxilins and some analogues: a review of their biology","year":2009,"lang":"en","type":"review","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Chemistry; Inflammation; Biological activity; Pharmacology; Biochemistry; In vitro; Biology; Immunology; Biotechnology","score_opus":0.13116060194753823,"score_gpt":0.4822046214859074,"score_spread":0.35104401953836917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495793224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003849417,0.9974541,0.00023942877,0.00011750133,0.000190068,0.0000071727627,0.000024831195,0.0000113701,0.0015706107],"genre_scores_gemma":[0.0014063757,0.9960134,0.00050789886,0.00016281231,0.00022260555,0.0000128293195,0.000058784903,0.0000027605201,0.0016126416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988246,0.000016336708,0.000018438654,0.000025642345,0.00004541213,0.000011605814],"domain_scores_gemma":[0.9998677,0.00004959616,0.000025924983,0.0000061602245,0.000029313325,0.000021269494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032961997,0.0010353466,0.0012689849,0.0024973536,0.0002761213,0.0006920333,0.0009138537,0.00076256343,0.0041851266],"category_scores_gemma":[0.00035693764,0.00037645712,0.0003536897,0.0022387593,0.0004287834,0.001680245,0.000506444,0.0013993157,0.0037765384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012697792,0.00018367016,0.00016412714,0.011189068,0.00006286235,0.00048834796,0.00008439087,0.0006055958,0.0072895843,0.0032210515,0.025605096,0.95097923],"study_design_scores_gemma":[0.00002179383,0.00014781918,0.00063507643,0.0010299714,0.000043267788,0.0019663435,0.0000408669,0.000094937146,0.0011701018,0.0013235556,0.9935088,0.000017468266],"about_ca_topic_score_codex":0.0006956925,"about_ca_topic_score_gemma":0.0012293876,"teacher_disagreement_score":0.0041851266,"about_ca_system_score_codex":0.00047390175,"about_ca_system_score_gemma":0.0004443325,"threshold_uncertainty_score":0.014000714},"labels":[],"label_agreement":null},{"id":"W1499157913","doi":"10.1111/bcp.12308","title":"Characterizing variability in warfarin dose requirements in children using modelling and simulation","year":2013,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uppsala Universitet; Hospital for Sick Children; Vetenskapsrådet; Baxter International","keywords":"VKORC1; Warfarin; CYP2C9; Dosing; Medicine; Maintenance dose; Vitamin K epoxide reductase; Therapeutic index; Pharmacogenetics; Internal medicine; Genotype; Pharmacology; Biology; Drug; Atrial fibrillation","score_opus":0.25253721412720814,"score_gpt":0.5135829619349581,"score_spread":0.26104574780775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499157913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8849772,0.0003762033,0.10964334,0.00028046677,0.00002636057,0.00012638216,0.0015177766,0.00018811197,0.0028640914],"genre_scores_gemma":[0.97796315,0.00028303263,0.02008814,0.000040202405,0.000010951699,0.00012379835,0.0009526805,0.00002828463,0.00050985726],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99935585,0.0003132339,0.00005103265,0.000109860164,0.0001048336,0.00006518478],"domain_scores_gemma":[0.9950901,0.0038180035,0.0005863983,0.0002050628,0.00022295366,0.00007752414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015501812,0.00068455713,0.000702317,0.000708837,0.00031789648,0.00085311197,0.000951974,0.00093757856,0.00094127964],"category_scores_gemma":[0.007964635,0.00041174423,0.0014316222,0.0008200899,0.00040617795,0.0005335255,0.0006740331,0.00084722345,0.00013919923],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080305035,0.000023345992,0.028418483,0.00001997582,0.00007162778,0.000055689787,0.000063068874,0.9672145,0.00026407556,0.0004980982,0.00011855577,0.0031724111],"study_design_scores_gemma":[0.000021146281,0.00006958254,0.007272235,0.000013077788,0.000039612503,0.000060950064,0.000044092263,0.9908121,0.00030300114,0.00083019264,0.00051768735,0.000016187088],"about_ca_topic_score_codex":0.045538668,"about_ca_topic_score_gemma":0.02011595,"teacher_disagreement_score":0.045538668,"about_ca_system_score_codex":0.0014653975,"about_ca_system_score_gemma":0.0015559915,"threshold_uncertainty_score":0.090547204},"labels":[],"label_agreement":null},{"id":"W1502772866","doi":"10.18433/j3n30w","title":"Inhibition of Human Cytochrome P450 Metabolism by Blended Herbal Products and Vitamins","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Agriculture and Agri-Food Canada; Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Health Canada; Fondation pour la Recherche Médicale; Canadian Patient Safety Institute","keywords":"Cytochrome P450; Metabolism; Chemistry; Traditional medicine; Pharmacology; Biochemistry; Medicine","score_opus":0.18943000124686743,"score_gpt":0.45411292785520996,"score_spread":0.26468292660834253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502772866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428714,0.010373642,0.003265265,0.000103717415,0.000020288213,0.0000557615,0.00009816547,0.000035082045,0.0017608862],"genre_scores_gemma":[0.99432445,0.0017758631,0.0030756248,0.000053750842,0.000012673342,0.000015226252,0.00008879984,0.000006168629,0.0006474185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997476,0.00008913825,0.000030832893,0.00004730938,0.00006995734,0.000015139108],"domain_scores_gemma":[0.99979323,0.00007035892,0.00007358132,0.000032260406,0.000019196224,0.000011438075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023155568,0.00021344403,0.00021500066,0.00022195179,0.00013298195,0.00017739701,0.00013151686,0.00022883262,0.0010787428],"category_scores_gemma":[0.00046802752,0.00006889349,0.00023694163,0.00018822927,0.00018060052,0.00016374768,0.00020403186,0.00023548807,0.00018385188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001546723,0.00033048907,0.0116906585,0.0006140253,0.00013593305,0.001210831,0.000121722995,0.00019393768,0.9216386,0.00016633008,0.00013191339,0.062218923],"study_design_scores_gemma":[0.00010103249,0.008966699,0.03966195,0.00012761624,0.00024873402,0.009321296,0.0001404373,0.0012677355,0.9282607,0.00019081139,0.011699181,0.000013827381],"about_ca_topic_score_codex":0.00017248667,"about_ca_topic_score_gemma":0.00028996228,"teacher_disagreement_score":0.0010787428,"about_ca_system_score_codex":0.000110671106,"about_ca_system_score_gemma":0.000083146595,"threshold_uncertainty_score":0.0036088228},"labels":[],"label_agreement":null},{"id":"W1505082577","doi":"10.1002/9780470409107.ch8","title":"Nuclear Receptors and Drug–Drug Interactions with Prescription and Herbal Medicines","year":2008,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Pharmacology; Medical prescription; Medicine; Receptor; Internal medicine","score_opus":0.04598741843625072,"score_gpt":0.37146988967384537,"score_spread":0.32548247123759466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505082577","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003684483,0.633229,0.0048492206,0.009053724,0.003799861,0.0001322635,0.00215044,0.00029501217,0.34280598],"genre_scores_gemma":[0.008313867,0.58719784,0.0059825294,0.0034498987,0.0031346793,0.00009372518,0.0013651891,0.000058344376,0.39040396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999155,0.000014505864,0.0000062051136,0.000011021533,0.000044607,0.0000081617045],"domain_scores_gemma":[0.9999243,0.000036852776,0.000009681467,0.0000040546697,0.000018536397,0.000006519739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016946229,0.00039575563,0.00032524447,0.00084090943,0.00018667911,0.00045823335,0.00028532936,0.0004614431,0.05143191],"category_scores_gemma":[0.00023153955,0.00013906763,0.00032905012,0.00083181186,0.00020433948,0.00049592153,0.00034759342,0.00066668645,0.011249657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010454883,0.000109706656,0.00063712767,0.0018860392,0.000024675957,0.0005424959,0.00012122499,0.00044126966,0.007310681,0.011929847,0.2941817,0.68271065],"study_design_scores_gemma":[0.000007850456,0.000041658706,0.0021327161,0.00030574683,0.000012823973,0.0008930082,0.000031727348,0.00007371822,0.0010883535,0.0020310588,0.9933743,0.0000070791193],"about_ca_topic_score_codex":0.0016924186,"about_ca_topic_score_gemma":0.005311926,"teacher_disagreement_score":0.05143191,"about_ca_system_score_codex":0.00045187582,"about_ca_system_score_gemma":0.00045340022,"threshold_uncertainty_score":0.17205685},"labels":[],"label_agreement":null},{"id":"W1507721581","doi":"10.1016/j.phrs.2015.07.031","title":"3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease","year":2015,"lang":"en","type":"article","venue":"Pharmacological Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Pregnane X receptor; Inflammatory bowel disease; Pregnane; Medicine; Pharmacology; Receptor; Disease; Internal medicine; Chemistry; Stereochemistry; Nuclear receptor; Biochemistry","score_opus":0.3355986465387274,"score_gpt":0.5316364873347571,"score_spread":0.1960378407960297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507721581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957938,0.0020939051,0.0005812521,0.00015596744,0.000020090114,0.000012667365,0.0001703096,0.000011930273,0.0011601641],"genre_scores_gemma":[0.9976991,0.0008229705,0.00030152503,0.00006183178,0.000010256264,0.0000050314757,0.00012837625,0.0000032846835,0.00096768053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999026,0.00003450104,0.000006352557,0.0000130846065,0.00001528879,0.000028185044],"domain_scores_gemma":[0.99992037,0.000022904153,0.00002388096,0.000010402558,0.000008487802,0.000013987068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015812396,0.00015064768,0.0001580216,0.00017796882,0.00008369613,0.00025862706,0.00011164437,0.00024082833,0.0030883013],"category_scores_gemma":[0.00024238993,0.00009827271,0.00022780229,0.00012369239,0.00021822438,0.00017483567,0.00009155134,0.00022462616,0.00028571615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003034046,0.0000686689,0.0049363263,0.000047959013,0.000052603646,0.00029824232,0.000049874434,0.00024167121,0.97886056,0.0005485759,0.00008726721,0.011774194],"study_design_scores_gemma":[0.00055899646,0.0085813515,0.0993971,0.000032830176,0.00021958779,0.0030515208,0.0004779011,0.0010127095,0.8756936,0.0010628972,0.009871381,0.00004005712],"about_ca_topic_score_codex":0.0007992465,"about_ca_topic_score_gemma":0.0010764227,"teacher_disagreement_score":0.0030883013,"about_ca_system_score_codex":0.00021447652,"about_ca_system_score_gemma":0.00012193006,"threshold_uncertainty_score":0.010331392},"labels":[],"label_agreement":null},{"id":"W1508047865","doi":"","title":"Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Drug response; Drug; Personalized medicine; Affect (linguistics); Pharmacogenomics; Human genetics; Medicine; Genetics; Gene; Bioinformatics; Psychology; Pharmacology; Biology; Genotype","score_opus":0.12459068733492117,"score_gpt":0.4157381700249984,"score_spread":0.29114748269007723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508047865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013026321,0.44039965,0.33959466,0.09919434,0.0062437975,0.00074745965,0.014681029,0.0077551035,0.07835768],"genre_scores_gemma":[0.15216571,0.29105672,0.47972497,0.02510444,0.0074557597,0.0016750776,0.007678187,0.00086761144,0.034271523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997269,0.0014845657,0.00025813584,0.00018243663,0.0007561911,0.00004964382],"domain_scores_gemma":[0.99087864,0.0068883826,0.0008822739,0.0005088787,0.0005365207,0.0003053949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056543187,0.0013853526,0.002029202,0.006774155,0.0004537494,0.0022322915,0.0012145616,0.0018545425,0.010727539],"category_scores_gemma":[0.01576626,0.00065705663,0.0011251887,0.0037530826,0.0014400079,0.0023320897,0.0016742504,0.0023851297,0.0036178967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025316837,0.00015668925,0.023432422,0.0028478673,0.001115167,0.00082995475,0.00038844298,0.0010825229,0.0020521702,0.062867835,0.18043298,0.7245408],"study_design_scores_gemma":[0.00019618894,0.00039830556,0.03975751,0.0031012455,0.0010699704,0.008558772,0.00066367455,0.007076202,0.002401987,0.23437354,0.7022291,0.00017342897],"about_ca_topic_score_codex":0.0015508521,"about_ca_topic_score_gemma":0.0023516493,"teacher_disagreement_score":0.010727539,"about_ca_system_score_codex":0.0008116834,"about_ca_system_score_gemma":0.0014660682,"threshold_uncertainty_score":0.035887122},"labels":[],"label_agreement":null},{"id":"W1508284217","doi":"10.1111/j.1365-2125.2011.03905.x","title":"Impact of <i>CYP2D6</i>, <i>CYP3A5</i>, <i>CYP2C9</i> and <i>CYP2C19</i> polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Medical Research Council; Medical Research Council","keywords":"CYP2C19; Tamoxifen; CYP2D6; CYP2C9; Pharmacokinetics; Breast cancer; CYP3A5; Genotype; Pharmacogenetics; Pharmacology; Medicine; Metabolite; Internal medicine; Active metabolite; Pharmacogenomics; Oncology; Cancer; Biology; Genetics; Cytochrome P450; Gene; Metabolism","score_opus":0.12015916823421677,"score_gpt":0.4751685171169909,"score_spread":0.35500934888277413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508284217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933196,0.006941885,0.00016615422,0.0007501609,0.00005221961,0.000013537639,0.00055617,0.000012129276,0.0021756543],"genre_scores_gemma":[0.9976228,0.0011497973,0.00016478256,0.00026286612,0.000057798567,0.0000057103757,0.0003412476,0.000007873219,0.0003870734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963474,0.00013062259,0.000050685685,0.00007154211,0.00006772089,0.000044729448],"domain_scores_gemma":[0.9991436,0.00024020446,0.00032635016,0.000054767756,0.00011481999,0.00012020335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040475148,0.00016259262,0.00038872575,0.00017278067,0.0002180979,0.0005466064,0.00017864378,0.00027422764,0.0018379147],"category_scores_gemma":[0.0013762101,0.00010931422,0.0008731385,0.00053904456,0.00016213096,0.00024738756,0.00015769423,0.00047164218,0.00022776125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001676399,0.00010226579,0.96909785,0.00014112098,0.00082058494,0.00033280347,0.00012421039,0.00017856574,0.0016507624,0.00010833555,0.001021327,0.024745734],"study_design_scores_gemma":[0.00007635277,0.00047132466,0.99186534,0.000056994806,0.001276684,0.0011215145,0.0002008865,0.0005652127,0.0006851007,0.00021123295,0.0034537995,0.000015576254],"about_ca_topic_score_codex":0.0029282921,"about_ca_topic_score_gemma":0.004457554,"teacher_disagreement_score":0.0029282921,"about_ca_system_score_codex":0.00021686805,"about_ca_system_score_gemma":0.00036917994,"threshold_uncertainty_score":0.006148398},"labels":[],"label_agreement":null},{"id":"W1508488371","doi":"10.1111/cge.12392","title":"The emerging era of pharmacogenomics: current successes, future potential, and challenges","year":2014,"lang":"en","type":"review","venue":"Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Child and Family Research Institute; University of British Columbia","funders":"University of British Columbia; Child and Family Research Institute; Genome British Columbia; Michael Smith Health Research BC; C17 Council; Canadian Institutes of Health Research; Faculty of Medicine, University of British Columbia","keywords":"Pharmacogenomics; Medicine; Precision medicine; Drug; Clinical Practice; Diversity (politics); Drug response; Drug reaction; Bioinformatics; Intensive care medicine; Biology; Pharmacology; Family medicine; Political science; Pathology","score_opus":0.31150394762817457,"score_gpt":0.5519255687042839,"score_spread":0.24042162107610932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508488371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011067257,0.9953198,0.00046048246,0.0029584558,0.00029714018,0.0000036037893,0.000015854057,0.000015864432,0.00081816985],"genre_scores_gemma":[0.0006688621,0.9969982,0.0005321206,0.000875185,0.0005773366,0.0000046700798,0.000018370953,0.0000038239436,0.00032146033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989981,0.00032309335,0.00012117862,0.00013131555,0.00035368573,0.000072608535],"domain_scores_gemma":[0.9948613,0.0035212394,0.0003061572,0.00013913985,0.0009072847,0.00026494206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034768658,0.0009778478,0.002051211,0.0028886828,0.00043691523,0.0025394112,0.0014567204,0.002782921,0.0042545786],"category_scores_gemma":[0.0041212435,0.00038150043,0.00090096757,0.003894325,0.001843305,0.004060566,0.0014403866,0.00400204,0.001905555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005960359,0.00006720009,0.00048560632,0.011719229,0.00011989827,0.00029627717,0.00013471839,0.00040057808,0.0006987192,0.012447371,0.029486638,0.94408417],"study_design_scores_gemma":[0.00001495225,0.000092017995,0.0011504999,0.005759691,0.00011576974,0.0019295925,0.00024811426,0.00024819025,0.00033300958,0.013704806,0.97635853,0.00004484338],"about_ca_topic_score_codex":0.0015653013,"about_ca_topic_score_gemma":0.002252262,"teacher_disagreement_score":0.0042545786,"about_ca_system_score_codex":0.001409434,"about_ca_system_score_gemma":0.003012833,"threshold_uncertainty_score":0.018387675},"labels":[],"label_agreement":null},{"id":"W1508732282","doi":"10.1002/9781119959601.ch1","title":"Pharmacogenomics Principles: Introduction to Personalized Medicine","year":2012,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug response; Pharmacogenetics; Precision medicine; Medicine; Data science; Computational biology; Bioinformatics; Drug; Computer science; Pharmacology; Biology; Genetics; Gene; Genotype","score_opus":0.15670766884655996,"score_gpt":0.4495417510369221,"score_spread":0.29283408219036217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508732282","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010514694,0.3152348,0.3993121,0.14217253,0.009023372,0.0003145777,0.0007206667,0.0008208571,0.13134964],"genre_scores_gemma":[0.053836066,0.42874953,0.33488634,0.087680854,0.023751825,0.0013363507,0.0006063556,0.00061412476,0.068538606],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959383,0.002140757,0.00022275482,0.00042296076,0.001179161,0.00009607282],"domain_scores_gemma":[0.9948738,0.004148894,0.00013627493,0.00030149295,0.00041091096,0.00012854525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074147573,0.0015204765,0.0018719889,0.0028191148,0.0009312194,0.00474454,0.0020521423,0.004760237,0.00916278],"category_scores_gemma":[0.007276398,0.0006249472,0.0014753185,0.002292667,0.009042885,0.0039957417,0.0026037612,0.009115553,0.0043741264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038832106,0.00007390237,0.00047712727,0.0014329252,0.00012786145,0.0003112341,0.0006403624,0.0023035288,0.00046597884,0.72962445,0.06880177,0.19570208],"study_design_scores_gemma":[0.000015343396,0.00004614968,0.0004178063,0.00070177217,0.00002421279,0.00073900283,0.00012378512,0.00101193,0.00023582632,0.53962946,0.45701942,0.00003527721],"about_ca_topic_score_codex":0.0013776328,"about_ca_topic_score_gemma":0.0014082768,"teacher_disagreement_score":0.00916278,"about_ca_system_score_codex":0.0027395869,"about_ca_system_score_gemma":0.0027069552,"threshold_uncertainty_score":0.03921348},"labels":[],"label_agreement":null},{"id":"W1510956999","doi":"10.1023/a:1015341726183","title":"In Vitro Characterization of Hepatic Flavopiridol Metabolism Using Human Liver Microsomes and Recombinant UGT Enzymes","year":2002,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"In vitro; Microsome; Enzyme; Recombinant DNA; Biochemistry; Chemistry; Metabolism; Human liver; Liver enzyme; Pharmacology; Biology; Endocrinology; Gene","score_opus":0.41966555515645854,"score_gpt":0.5384143441943517,"score_spread":0.11874878903789321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510956999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97505885,0.0046440368,0.017197698,0.00021232708,0.00005691037,0.00009473133,0.0013657844,0.00017501765,0.0011945455],"genre_scores_gemma":[0.98701036,0.0015784017,0.0060759997,0.000047901423,0.000030343963,0.00004310629,0.0032459148,0.000045918536,0.0019219866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978536,0.00008691736,0.000019559644,0.00003164442,0.0000397455,0.000036874724],"domain_scores_gemma":[0.99979156,0.00009607218,0.000026467187,0.000039340885,0.000030497176,0.000016069673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004737457,0.0005100065,0.0004248753,0.00030737947,0.0002364537,0.00034023807,0.00020286236,0.00027247213,0.0008833867],"category_scores_gemma":[0.00059342076,0.00022881101,0.00042576625,0.00038848532,0.00023082145,0.000316865,0.00012944888,0.00057989074,0.00046047903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014148267,0.00014046862,0.0009967816,0.00008596499,0.00005713318,0.00017804003,0.00005054995,0.0007698107,0.9917024,0.0002487529,0.00013278505,0.0042225653],"study_design_scores_gemma":[0.000039277966,0.0004096017,0.0025919504,0.0000032489884,0.000056099834,0.0003068205,0.000020732783,0.0016548331,0.9937645,0.00006447606,0.0010812191,0.0000071196737],"about_ca_topic_score_codex":0.0035012534,"about_ca_topic_score_gemma":0.0034629316,"teacher_disagreement_score":0.0035012534,"about_ca_system_score_codex":0.0005158202,"about_ca_system_score_gemma":0.00033343196,"threshold_uncertainty_score":0.006961763},"labels":[],"label_agreement":null},{"id":"W1514900303","doi":"10.1186/bcr936","title":"Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview","year":2004,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Metabolic pathway; Enzyme; Chemistry; Breast cancer; Glucuronosyltransferase; Aromatase; Biochemistry; Metabolism; Glucuronic acid; Hydroxylation; Estrogen; Cancer; Biology; Internal medicine; Medicine; Endocrinology; Microsome","score_opus":0.3416129515924802,"score_gpt":0.5837350972914798,"score_spread":0.2421221456989996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514900303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010984973,0.9957867,0.0006605425,0.00015028402,0.00008414402,0.0000073730594,0.000044623182,0.000019635707,0.0021482043],"genre_scores_gemma":[0.0020037186,0.9956768,0.00059085776,0.0000938931,0.000078120036,0.000007409433,0.00006811035,0.0000017116407,0.0014794896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999019,0.000014412314,0.00001398529,0.000022727832,0.00003651471,0.000010539258],"domain_scores_gemma":[0.99993277,0.000021266864,0.000013378732,0.0000030548601,0.000021751392,0.000007815259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933879,0.00062366645,0.0010439721,0.0016275165,0.00015068302,0.0004721579,0.00039183476,0.00053725793,0.0019347003],"category_scores_gemma":[0.00017999213,0.0002096121,0.00029932542,0.0025174422,0.00016170114,0.0008028264,0.00024292577,0.00049397285,0.0019231846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011583599,0.00007946386,0.0005604388,0.008328739,0.00009717582,0.0005592658,0.000058443413,0.00049900636,0.010828699,0.0012199504,0.009287919,0.968365],"study_design_scores_gemma":[0.00002634703,0.0002569277,0.0040282174,0.0011309023,0.00021012026,0.0043976028,0.00008685127,0.00024178882,0.0056531266,0.0014669031,0.98247635,0.000024806799],"about_ca_topic_score_codex":0.00091456313,"about_ca_topic_score_gemma":0.0014976349,"teacher_disagreement_score":0.0019347003,"about_ca_system_score_codex":0.00042444436,"about_ca_system_score_gemma":0.0005444927,"threshold_uncertainty_score":0.00647223},"labels":[],"label_agreement":null},{"id":"W1519070625","doi":"10.1016/s0076-6879(05)00033-9","title":"Pregnane X Receptor‐Mediated Transcription","year":2005,"lang":"en","type":"article","venue":"Methods in enzymology on CD-ROM/Methods in enzymology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Pregnane X receptor; Nuclear receptor; Transcription factor; Xenobiotic; Cell biology; Drug metabolism; Constitutive androstane receptor; Gastrointestinal tract; Biology; Pregnane; Receptor; Reporter gene; Transcription (linguistics); Endogeny; Chemistry; Biochemistry; Pharmacology; Gene expression; Gene; Drug; Genetics; Enzyme","score_opus":0.16979546615555738,"score_gpt":0.5290633822734421,"score_spread":0.35926791611788467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519070625","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32036266,0.013507026,0.47580686,0.0055178925,0.0029649925,0.0015177475,0.018647188,0.01149157,0.15018411],"genre_scores_gemma":[0.6260452,0.005707596,0.111136876,0.0015596527,0.00034867943,0.0014478228,0.022231335,0.0013031996,0.23021968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881005,0.00015976347,0.00005437421,0.00039980674,0.00032331332,0.00025270117],"domain_scores_gemma":[0.99973387,0.00010299529,0.000016668491,0.00009005488,0.000020460246,0.000035946025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060706085,0.00085135794,0.000662891,0.0005605109,0.00078965595,0.0013709592,0.000897065,0.00061642466,0.017494077],"category_scores_gemma":[0.0006440289,0.0006343095,0.0011908574,0.0003930567,0.0011147255,0.00071454706,0.001338961,0.0026018857,0.009658775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022317613,0.00006602839,0.00027955126,0.0003228483,0.00002181973,0.00012605808,0.00020373703,0.00023490186,0.9454038,0.016004287,0.0033497019,0.03376404],"study_design_scores_gemma":[0.000044373697,0.00006904957,0.0008884416,0.000038504077,0.000011897729,0.000120330355,0.000038364902,0.00066631555,0.95672786,0.0026266614,0.038750626,0.000017711967],"about_ca_topic_score_codex":0.0010545789,"about_ca_topic_score_gemma":0.0017244361,"teacher_disagreement_score":0.017494077,"about_ca_system_score_codex":0.0014023561,"about_ca_system_score_gemma":0.0009400608,"threshold_uncertainty_score":0.058523536},"labels":[],"label_agreement":null},{"id":"W1520464148","doi":"10.1038/nrcardio.2015.64","title":"Genotype-based clinical trials in cardiovascular disease","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"National Institute of General Medical Sciences","keywords":"Pharmacogenomics; Clinical trial; Medicine; Randomized controlled trial; Intensive care medicine; Adverse effect; Pharmacogenetics; Population; Drug development; Disease; Psychological intervention; Clinical study design; Drug; Pharmacology; Internal medicine; Psychiatry; Genotype","score_opus":0.5735216600164936,"score_gpt":0.6214075842620781,"score_spread":0.047885924245584466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520464148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006970768,0.99654454,0.0005592787,0.00072197005,0.0003552394,0.000040558432,0.000070758295,0.00001159854,0.0009990322],"genre_scores_gemma":[0.012530882,0.9813215,0.0017840792,0.0027105683,0.000797036,0.00010624404,0.00018369006,0.000010388673,0.0005556776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998348,0.00093641534,0.00020732719,0.00017162572,0.00027717103,0.00005948419],"domain_scores_gemma":[0.99475586,0.004311607,0.0004783277,0.00009569301,0.0002461464,0.00011224023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004939961,0.0008452394,0.0039559654,0.0008663297,0.00014569437,0.0011160817,0.001531671,0.0014600521,0.0055761323],"category_scores_gemma":[0.006592988,0.00028788066,0.0017848908,0.0011380814,0.0005423628,0.00086327374,0.0006394644,0.0022276295,0.0006822441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031998775,0.00029745704,0.00061339466,0.03225574,0.0021973776,0.00019186104,0.000047363294,0.00075559714,0.0020473278,0.00443267,0.017313888,0.93664753],"study_design_scores_gemma":[0.017556323,0.008378318,0.012028748,0.05953981,0.015828012,0.0020930686,0.0002088403,0.0015350159,0.0026021635,0.027300233,0.8527465,0.00018299525],"about_ca_topic_score_codex":0.00035230725,"about_ca_topic_score_gemma":0.0013091674,"teacher_disagreement_score":0.0055761323,"about_ca_system_score_codex":0.00044362806,"about_ca_system_score_gemma":0.00085862936,"threshold_uncertainty_score":0.026125312},"labels":[],"label_agreement":null},{"id":"W1520559074","doi":"10.4212/cjhp.v54i1.610","title":"2001: A Pharmacogenomics Odyssey","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.11412947460189349,"score_gpt":0.4096154040626059,"score_spread":0.2954859294607124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520559074","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012316521,0.078400195,0.008229841,0.8853843,0.01296089,0.000016555869,0.0006364269,0.00027179814,0.012868352],"genre_scores_gemma":[0.043964148,0.21775994,0.024631329,0.5908195,0.0548188,0.0000646563,0.0013570093,0.00056987396,0.0660148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978537,0.00070689846,0.0001682219,0.00029533717,0.0008101122,0.00016575908],"domain_scores_gemma":[0.9888052,0.0034056967,0.0005495046,0.0008070934,0.0044493573,0.0019831683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010595718,0.0010152879,0.00076753914,0.0021914658,0.0014633294,0.0063796914,0.0010407026,0.0056166346,0.0076497067],"category_scores_gemma":[0.01539015,0.00055926084,0.0006430323,0.002856519,0.0034801287,0.0078837825,0.0028553975,0.008118256,0.003267072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001377786,0.000049599064,0.0014759399,0.00025326601,0.000044587185,0.0002667563,0.00032251803,0.0003884575,0.00085137424,0.0387049,0.7548472,0.20265761],"study_design_scores_gemma":[0.000024464922,0.000026049678,0.0029750888,0.00026756193,0.000028452323,0.00044769025,0.0002616966,0.00040026466,0.00029099526,0.03161732,0.9636284,0.00003200778],"about_ca_topic_score_codex":0.041638236,"about_ca_topic_score_gemma":0.064639516,"teacher_disagreement_score":0.041638236,"about_ca_system_score_codex":0.006848755,"about_ca_system_score_gemma":0.011037864,"threshold_uncertainty_score":0.082791746},"labels":[],"label_agreement":null},{"id":"W1521587409","doi":"10.4212/cjhp.v54i3.658","title":"Ethics and Pharmacogenomic Research","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Engineering ethics; Medicine; Pharmacology; Engineering","score_opus":0.31842451852268117,"score_gpt":0.5168916819269885,"score_spread":0.19846716340430737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521587409","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022969145,0.012042646,0.056064732,0.7376228,0.003478579,0.0005726612,0.0002691059,0.00005012039,0.16693021],"genre_scores_gemma":[0.7728181,0.0065359357,0.031328656,0.15424688,0.0073899482,0.0014434981,0.00020697483,0.0000952517,0.025934728],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.7439896,0.21880545,0.0070594116,0.0054579135,0.02091881,0.0037689137],"domain_scores_gemma":[0.5270109,0.38530836,0.014106366,0.03353268,0.03186218,0.008179483],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.16606343,0.00048851443,0.0013397863,0.0024152258,0.0050174613,0.00764051,0.0020013228,0.010076603,0.0032953671],"category_scores_gemma":[0.28609142,0.00073264015,0.0004907533,0.0025378005,0.04073688,0.004452825,0.003989242,0.009296595,0.0005581888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006761641,0.000060209928,0.0033316102,0.00012316031,0.000042000804,0.00037123117,0.0031657268,0.00036064303,0.00010782045,0.95561826,0.018278295,0.018473402],"study_design_scores_gemma":[0.000075311764,0.000039203354,0.0024315503,0.00045424528,0.000033416523,0.0007029586,0.0016263688,0.0011921105,0.00034923316,0.9198223,0.07324078,0.00003256554],"about_ca_topic_score_codex":0.009874893,"about_ca_topic_score_gemma":0.008664784,"teacher_disagreement_score":0.9899234,"about_ca_system_score_codex":0.006815845,"about_ca_system_score_gemma":0.025068698,"threshold_uncertainty_score":0.87823784},"labels":[],"label_agreement":null},{"id":"W1522657433","doi":"10.1111/bph.12284","title":"Indirect activation of the <scp>SV23</scp> and <scp>SV24</scp> splice variants of human constitutive androstane receptor: analysis with 3‐hydroxyflavone and its analogues","year":2013,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Galangin; Transactivation; Chemistry; Isorhamnetin; Proto-oncogene tyrosine-protein kinase Src; Pharmacology; Receptor; Biochemistry; Quercetin; Biology; Kaempferol; Transcription factor","score_opus":0.03708963950374107,"score_gpt":0.3400379426722101,"score_spread":0.30294830316846905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522657433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739575,0.0008217198,0.00091045996,0.00002432633,0.0000071114932,0.000016952868,0.00026645552,0.000012411041,0.00054483564],"genre_scores_gemma":[0.9960433,0.0005370668,0.0011985659,0.000025831561,0.000008251728,0.00002697203,0.0008837722,0.000008928877,0.0012673495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998733,0.000029031164,0.000010266418,0.00002767741,0.000036970934,0.000022805474],"domain_scores_gemma":[0.99990094,0.000023529914,0.000029051576,0.000013999888,0.000012844582,0.00001950985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016280454,0.0002500265,0.00012346143,0.00015464064,0.00011366635,0.00018569312,0.00015913647,0.00016516147,0.0013402369],"category_scores_gemma":[0.000099680205,0.00008725718,0.00038287966,0.00012728579,0.00020046002,0.00011315072,0.000078512654,0.00031217534,0.00041857178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012687748,0.000009255589,0.0002411372,0.000013221894,0.0000055199803,0.00002442123,0.000006498298,0.000020415018,0.99915206,0.000017625114,0.0000077118875,0.0003753307],"study_design_scores_gemma":[0.0000142111385,0.00029912338,0.006019453,0.0000020698778,0.000017195103,0.00039163968,0.000020351838,0.000289305,0.9922126,0.000014084593,0.0007170433,0.0000029955934],"about_ca_topic_score_codex":0.00055965944,"about_ca_topic_score_gemma":0.000746572,"teacher_disagreement_score":0.0013402369,"about_ca_system_score_codex":0.00022529537,"about_ca_system_score_gemma":0.00012689097,"threshold_uncertainty_score":0.004483521},"labels":[],"label_agreement":null},{"id":"W1522709944","doi":"10.1046/j.1432-1033.2003.03508.x","title":"Assessment of porcine and human 16‐ene‐synthase, a third activity of P450c17, in the formation of an androstenol precursor","year":2003,"lang":"en","type":"article","venue":"European Journal of Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Constitutive androstane receptor; Pregnenolone; Cytochrome P450; Lyase; Enzyme; Reductase; Dehydrogenase; Biochemistry; Steroid; CYP17A1; Chemistry; ATP synthase; Biology; Stereochemistry; Nuclear receptor; Gene","score_opus":0.06675817575336082,"score_gpt":0.4065634164008719,"score_spread":0.33980524064751105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522709944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887212,0.0028738459,0.0056282356,0.00010219682,0.000030469319,0.00006636997,0.0005366739,0.00003620558,0.002004708],"genre_scores_gemma":[0.9910156,0.0011530413,0.003064621,0.000053634285,0.000016626287,0.00005027579,0.0020313654,0.000019335263,0.0025954628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995577,0.0001533559,0.0000358202,0.00012302109,0.00008035915,0.00004975206],"domain_scores_gemma":[0.9997025,0.00011308595,0.00003920936,0.000036772923,0.00004322064,0.00006514649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006667633,0.00030574918,0.00022428267,0.00028329744,0.00014383475,0.0003886018,0.00011115137,0.0004066665,0.001500444],"category_scores_gemma":[0.00055356533,0.00019543192,0.0003119983,0.00024555813,0.00039146215,0.00020444822,0.000168724,0.0003602997,0.00063714053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006535904,0.00006498941,0.0031869435,0.000054531978,0.000034165263,0.000103284845,0.000049645543,0.0000786873,0.99288875,0.0001235354,0.00003905086,0.002722787],"study_design_scores_gemma":[0.00007037518,0.0017121325,0.02775131,0.000008440485,0.0001328781,0.0011984969,0.000087215085,0.001094765,0.9604721,0.00011339185,0.0073481887,0.000010621032],"about_ca_topic_score_codex":0.00068508124,"about_ca_topic_score_gemma":0.0003951898,"teacher_disagreement_score":0.001500444,"about_ca_system_score_codex":0.00019659685,"about_ca_system_score_gemma":0.00023871871,"threshold_uncertainty_score":0.0050195456},"labels":[],"label_agreement":null},{"id":"W1523241089","doi":"10.1002/9780470929353.ch16","title":"Discovery and Development of BILN 2061 and Follow‐Up BI 201335","year":2011,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Clinical trial; Cardiotoxicity; In vivo; Potency; Drug discovery; Computational biology; Medicine; In vitro; Biology; Bioinformatics; Internal medicine; Genetics; Chemotherapy","score_opus":0.13599458584910953,"score_gpt":0.4034073842049368,"score_spread":0.2674127983558273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523241089","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22139686,0.13881183,0.094122805,0.0055194786,0.0023460155,0.003083594,0.017110292,0.0035735946,0.5140356],"genre_scores_gemma":[0.3236915,0.124668285,0.08837919,0.003523197,0.00022854628,0.0013333575,0.022128114,0.0005748064,0.435473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998727,0.000012165535,0.0000072255143,0.000018366938,0.00006620303,0.000023389824],"domain_scores_gemma":[0.9999614,0.0000025248507,0.000006558984,0.0000031535242,0.000012626831,0.000013767015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003084251,0.0006673994,0.00029358576,0.00070013007,0.0002745892,0.00054534496,0.00044575622,0.00037316576,0.01159435],"category_scores_gemma":[0.00015154715,0.00022440995,0.00030174945,0.0003438085,0.0001404039,0.00043756794,0.00045225935,0.0009605007,0.007434278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083322986,0.00057548704,0.00033497906,0.0011343614,0.000034501456,0.000473116,0.00009540932,0.0013837583,0.5981113,0.012744457,0.040899705,0.34337977],"study_design_scores_gemma":[0.00010939369,0.0012497328,0.000848739,0.00013230048,0.000038389444,0.0009589356,0.000020052525,0.00096532266,0.39545465,0.00084621337,0.59934574,0.00003052482],"about_ca_topic_score_codex":0.0011037245,"about_ca_topic_score_gemma":0.0028104994,"teacher_disagreement_score":0.01159435,"about_ca_system_score_codex":0.0008029447,"about_ca_system_score_gemma":0.0007474611,"threshold_uncertainty_score":0.038787007},"labels":[],"label_agreement":null},{"id":"W1528478735","doi":"10.1139/jpn.0312","title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","year":2003,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Olanzapine; Quetiapine; Ziprasidone; CYP1A2; CYP2D6; Pharmacology; Risperidone; Cytochrome P450; CYP3A4; Clozapine; Sertindole; CYP2C19; Atypical antipsychotic; Medicine; Drug; Antipsychotic; Metabolism; Psychiatry; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.09750897274758721,"score_gpt":0.4072555498554237,"score_spread":0.3097465771078365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1528478735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72157675,0.20721115,0.022579322,0.0112834405,0.0005170001,0.00019175379,0.000529426,0.00044475764,0.03566645],"genre_scores_gemma":[0.9594607,0.031658,0.00338948,0.000682445,0.00059393723,0.000050433937,0.00015469726,0.000015398919,0.0039948616],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992849,0.00038105444,0.000039102146,0.00005329488,0.00018157197,0.00006012677],"domain_scores_gemma":[0.99854857,0.00085330865,0.0003492766,0.000056507586,0.00010761797,0.00008471596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064479513,0.0002353866,0.00038333895,0.00040746725,0.00022138155,0.00044897464,0.00010404285,0.00047078668,0.00295992],"category_scores_gemma":[0.0017505151,0.00011356527,0.00042602915,0.0003566395,0.00021124085,0.00024137796,0.00024821612,0.0006312546,0.0003848284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029883303,0.00053237524,0.26164243,0.0016216611,0.0013534989,0.021265948,0.00029545955,0.0022015336,0.09087591,0.0056472323,0.010433914,0.6011417],"study_design_scores_gemma":[0.00042283518,0.0055197137,0.69042283,0.00025151786,0.00091312884,0.103301525,0.000251439,0.0054839775,0.059503224,0.010498433,0.12333902,0.00009231716],"about_ca_topic_score_codex":0.0012296436,"about_ca_topic_score_gemma":0.0019054336,"teacher_disagreement_score":0.00295992,"about_ca_system_score_codex":0.00037713136,"about_ca_system_score_gemma":0.0003019284,"threshold_uncertainty_score":0.009901881},"labels":[],"label_agreement":null},{"id":"W1533588120","doi":"10.1111/j.1742-7843.2011.00807.x","title":"Distribution of <i>CYP2C</i> Polymorphisms in an Amerindian Population of Brazil","year":2011,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; CYP2C19; CYP2C9; SLCO1B1; CYP2C8; International HapMap Project; Pharmacogenetics; Genetics; Population; Haplotype; Allele; Gene; Demography; Genotype","score_opus":0.1955070297897911,"score_gpt":0.49072393867907893,"score_spread":0.29521690888928787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533588120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970745,0.0004843009,0.00023595402,0.00013409706,0.0000063417465,0.000026429112,0.00034929157,0.000008821377,0.0016803573],"genre_scores_gemma":[0.99908364,0.0002926369,0.00021665262,0.000056975045,0.0000052807272,0.000012675008,0.00017275772,0.000004362814,0.00015498194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974257,0.0000327014,0.00002292932,0.00011563145,0.00005235431,0.000033871704],"domain_scores_gemma":[0.99959594,0.00006274842,0.00014231353,0.000041938772,0.00008081119,0.00007626893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002903133,0.00024635802,0.00035068992,0.0009560562,0.00044807332,0.0004036535,0.0002877893,0.0002571172,0.0020619025],"category_scores_gemma":[0.00087659166,0.00024012993,0.0003131435,0.0011384642,0.00059578713,0.00017467135,0.00033075793,0.0002781105,0.00019826565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008000135,0.000048995527,0.98548174,0.000051986524,0.00008542388,0.00067377044,0.0023165944,0.000050185747,0.0044665127,0.00046308144,0.00022576492,0.0060558957],"study_design_scores_gemma":[0.000009896776,0.00009496298,0.9962787,0.000025951484,0.00004163668,0.0012737681,0.0010246363,0.0001309064,0.000088912704,0.00013658169,0.0008842403,0.000009863401],"about_ca_topic_score_codex":0.041352592,"about_ca_topic_score_gemma":0.03424546,"teacher_disagreement_score":0.041352592,"about_ca_system_score_codex":0.00043942698,"about_ca_system_score_gemma":0.0004770065,"threshold_uncertainty_score":0.08222377},"labels":[],"label_agreement":null},{"id":"W153956865","doi":"10.1007/978-1-4615-0667-6_34","title":"Hydrogen Peroxide Supports Hepatocyte P450 Catalysed Xenobiotic/Drug Metabolic Activation to form Cytotoxic Reactive Intermediates","year":2001,"lang":"en","type":"article","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hydrogen peroxide; Reactive intermediate; Chemistry; Xenobiotic; Drug metabolism; Drug; Cytotoxic T cell; Biochemistry; Combinatorial chemistry; Catalysis; Metabolism; Enzyme; Pharmacology; In vitro; Biology","score_opus":0.07447922132691032,"score_gpt":0.4584507806443641,"score_spread":0.3839715593174538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W153956865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96817666,0.0029170546,0.019106375,0.00083896116,0.00024263565,0.000093683026,0.00051585457,0.00044394992,0.0076647373],"genre_scores_gemma":[0.9959489,0.00038451093,0.0009911917,0.000053828953,0.00002711045,0.000011236621,0.00029737732,0.000016872318,0.0022689563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997967,0.00006698561,0.000009383297,0.000025710786,0.000044054206,0.000057141777],"domain_scores_gemma":[0.999616,0.000104553634,0.00005424652,0.000067889676,0.00009601466,0.00006119784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047419773,0.00037410346,0.00020055179,0.00026390728,0.00024925225,0.00044016988,0.00024888394,0.000423492,0.0055517433],"category_scores_gemma":[0.0004947086,0.000159104,0.0002701032,0.0001264378,0.00025857924,0.000600971,0.00034919466,0.0004920238,0.0012719678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014347635,0.000116012416,0.0015627623,0.00006279738,0.000028856686,0.00041233818,0.0000565579,0.00016117777,0.9881698,0.0015025578,0.00048006885,0.006012295],"study_design_scores_gemma":[0.000020303858,0.0004402099,0.0013826513,0.0000022544548,0.000010906932,0.00017466577,0.000031048683,0.0003540274,0.99580246,0.00030029268,0.0014770308,0.0000041430826],"about_ca_topic_score_codex":0.0006281065,"about_ca_topic_score_gemma":0.00058997754,"teacher_disagreement_score":0.0055517433,"about_ca_system_score_codex":0.00035746238,"about_ca_system_score_gemma":0.00035443975,"threshold_uncertainty_score":0.01857245},"labels":[],"label_agreement":null},{"id":"W1546874842","doi":"10.1111/jphp.12053","title":"Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"U.S. National Library of Medicine; Norges Idrettshøgskole; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Glucuronidation; CpG site; DNA methylation; Methylation; Epigenetics; Biology; Genotype; Bilirubin; Molecular biology; Biochemistry; DNA; Gene expression; Endocrinology; Enzyme; Gene","score_opus":0.17176134005573554,"score_gpt":0.4711815161530852,"score_spread":0.2994201760973496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546874842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716955,0.0013032339,0.0007978709,0.000046589,0.0000043854493,0.0000045206257,0.00030568286,0.000017081924,0.00035102922],"genre_scores_gemma":[0.9987374,0.00027507203,0.00041284735,0.00002344831,0.000006760446,0.000008368666,0.000295852,0.0000043466025,0.00023581799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998356,0.0000423277,0.000012219336,0.000060913535,0.000035422352,0.000013462361],"domain_scores_gemma":[0.9995704,0.00011736229,0.00016049894,0.000048601192,0.0000553327,0.000047795347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020658592,0.00013391608,0.00018165454,0.0004212969,0.00010671687,0.00014396635,0.00011483269,0.0001757357,0.0017800761],"category_scores_gemma":[0.00062022486,0.0001344577,0.00012397343,0.00025051806,0.00025853436,0.00008357977,0.00014526893,0.00014814554,0.00021569508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002380843,0.000059393995,0.40799835,0.00019021619,0.00021849612,0.00031672858,0.00025639494,0.00026216847,0.5705986,0.00009963465,0.00021652819,0.017402587],"study_design_scores_gemma":[0.000017909488,0.0002781817,0.97231776,0.000005976485,0.00005024656,0.00086518895,0.00004382838,0.00031254292,0.025526017,0.00008575739,0.0004919519,0.000004703939],"about_ca_topic_score_codex":0.00095713156,"about_ca_topic_score_gemma":0.0007107015,"teacher_disagreement_score":0.0017800761,"about_ca_system_score_codex":0.00010048693,"about_ca_system_score_gemma":0.00009039212,"threshold_uncertainty_score":0.0059549212},"labels":[],"label_agreement":null},{"id":"W1550316448","doi":"10.4212/cjhp.v56i4.516","title":"Pharmacogenetics of Psychotropic Drugs","year":2003,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacology; Biology; Genetics; Genotype","score_opus":0.07234523791836048,"score_gpt":0.4016761146159177,"score_spread":0.32933087669755723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550316448","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94811857,0.019555494,0.00459281,0.0031320448,0.00013927973,0.00007611025,0.0016521851,0.00012527093,0.022608293],"genre_scores_gemma":[0.99322754,0.002885909,0.0013728077,0.0005492644,0.00007127634,0.000014025563,0.00034582443,0.000018255525,0.0015152226],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924314,0.00025720024,0.00006519353,0.00010735116,0.0002544876,0.00007272733],"domain_scores_gemma":[0.9990994,0.00039372497,0.00023925124,0.00006477855,0.00013238362,0.000070423164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004354473,0.00024595505,0.00034891596,0.0010368974,0.00032034836,0.000654106,0.00025625087,0.00036731755,0.0014423556],"category_scores_gemma":[0.0017930118,0.000099818695,0.00036895773,0.0009204364,0.00029052678,0.00014840653,0.00019782416,0.00046159572,0.00021549794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001173591,0.0002183462,0.80723345,0.00016922214,0.0008899935,0.0021970905,0.0002700328,0.0012048571,0.033793304,0.0033393158,0.0025264684,0.14698425],"study_design_scores_gemma":[0.000032343065,0.00014315915,0.98237073,0.000049418602,0.0002163136,0.0028504655,0.000091181224,0.0014349206,0.0039291354,0.0016406933,0.007228282,0.000013392173],"about_ca_topic_score_codex":0.02262743,"about_ca_topic_score_gemma":0.023298476,"teacher_disagreement_score":0.02262743,"about_ca_system_score_codex":0.0010442706,"about_ca_system_score_gemma":0.00084098394,"threshold_uncertainty_score":0.044991493},"labels":[],"label_agreement":null},{"id":"W1557320473","doi":"10.1007/978-3-642-27841-9_4501-2","title":"Pharmacokinetics and Pharmacodynamics in Drug Development","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Pharmacology; Drug; Drug development; Medicine","score_opus":0.1605324733345047,"score_gpt":0.42770011563535176,"score_spread":0.26716764230084705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557320473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013559207,0.63023746,0.10194619,0.006083431,0.0058445395,0.00009518388,0.00041125843,0.000745665,0.25328034],"genre_scores_gemma":[0.014962759,0.43083164,0.0407273,0.0056619663,0.0044888747,0.00023234445,0.00044735495,0.00039106072,0.50225675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995554,0.00011293945,0.000019775107,0.00005016521,0.00024382221,0.00001791492],"domain_scores_gemma":[0.9996222,0.0002550366,0.000019597974,0.00002787528,0.000059361522,0.000015939635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079406955,0.0013521694,0.0012090367,0.0011624818,0.0002529713,0.0016147093,0.00087294047,0.0011869548,0.015222637],"category_scores_gemma":[0.0011879863,0.00044504594,0.00043505663,0.0012109287,0.000986761,0.0020043508,0.0010618687,0.0027558685,0.012876664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046894616,0.00008752249,0.000117040436,0.00095617404,0.000026858677,0.00012479782,0.00012812116,0.002657122,0.0025935064,0.080565244,0.13797483,0.774722],"study_design_scores_gemma":[0.000009592518,0.000056877467,0.00020911612,0.00045626532,0.000018463452,0.0006148967,0.000029675466,0.0014284675,0.0012794756,0.07123199,0.92464787,0.000017324872],"about_ca_topic_score_codex":0.00071050785,"about_ca_topic_score_gemma":0.0013473969,"teacher_disagreement_score":0.015222637,"about_ca_system_score_codex":0.00081314653,"about_ca_system_score_gemma":0.0009754902,"threshold_uncertainty_score":0.050924778},"labels":[],"label_agreement":null},{"id":"W1558516295","doi":"10.1023/a:1022531403741","title":"Reassessing Models of Hepatic Extraction","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Physics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Mitacs; Alberta Heritage Foundation for Medical Research","keywords":"IVIVC; Context (archaeology); Dispersion (optics); In vivo; Computer science; Biological system; Chemistry; Pharmacokinetics; Bioinformatics; Physics; Biology; Biopharmaceutics Classification System","score_opus":0.2862650852246321,"score_gpt":0.47788207886282735,"score_spread":0.19161699363819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558516295","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0531863,0.0013292765,0.89396363,0.005660335,0.000563842,0.000072110575,0.00057136314,0.0006849959,0.043968175],"genre_scores_gemma":[0.86506605,0.0019851993,0.09035384,0.0013868405,0.00053560757,0.00020747755,0.00038244046,0.0005931344,0.039489433],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999708,0.00011628287,0.000014411087,0.00005341139,0.00007861492,0.00002916961],"domain_scores_gemma":[0.9990287,0.00046655946,0.000115299,0.00022448749,0.000101897545,0.00006302308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007541444,0.0007747861,0.0008196778,0.00069886114,0.00043545247,0.0011287518,0.0018522199,0.0016169986,0.0039992123],"category_scores_gemma":[0.0030662578,0.0003384497,0.0010419452,0.00037586456,0.0012167733,0.002536602,0.0012938695,0.0013197063,0.0011812971],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001419997,0.00007952627,0.00058701966,0.00013154623,0.000049790993,0.0002305872,0.00013090824,0.19201021,0.015483081,0.77294457,0.003169247,0.015041517],"study_design_scores_gemma":[0.000031760144,0.000048097132,0.00019895784,0.000012372998,0.000023889028,0.00015700124,0.000030464476,0.6492703,0.0037457712,0.34040016,0.006052813,0.000028478242],"about_ca_topic_score_codex":0.0016430622,"about_ca_topic_score_gemma":0.00088437845,"teacher_disagreement_score":0.0039992123,"about_ca_system_score_codex":0.0008671114,"about_ca_system_score_gemma":0.000524147,"threshold_uncertainty_score":0.01337868},"labels":[],"label_agreement":null},{"id":"W156857027","doi":"10.1385/0-89603-519-0:141","title":"CYP2D6-Dependent Bufuralol 1 '-Hydroxylation Assayed by Reversed-Phase Ion-Pair High-Performance Liquid Chromatography with Fluorescence Detection","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Chromatography; Hydroxylation; Fluorescence; Chemistry; High-performance liquid chromatography; Phase (matter); Ion; Biochemistry; Organic chemistry; Enzyme; Physics; Optics","score_opus":0.06249636428874318,"score_gpt":0.3546729366023792,"score_spread":0.29217657231363603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W156857027","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39894426,0.02094407,0.53014004,0.0010122106,0.0006565602,0.0018906536,0.0072889486,0.009694595,0.029428763],"genre_scores_gemma":[0.43824068,0.020409534,0.48823446,0.0010622494,0.00031003729,0.0028412093,0.011734254,0.0008866294,0.036280923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992393,0.00013848198,0.000045007546,0.00014921426,0.00032252818,0.00010543687],"domain_scores_gemma":[0.99975914,0.000077606506,0.00003900548,0.000023960098,0.0000736701,0.00002661993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004850712,0.0013801437,0.00065491284,0.00060747005,0.00033355627,0.0005808798,0.0007298267,0.0005762802,0.0035116903],"category_scores_gemma":[0.00060292275,0.000498882,0.00044255963,0.00045958222,0.00031272403,0.0004438184,0.00027357272,0.0010677701,0.0044069802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008617089,0.000071191294,0.0001692806,0.00009011318,0.000012929659,0.000037807575,0.000021245678,0.00008222186,0.9913407,0.00015403754,0.00038940553,0.0075450125],"study_design_scores_gemma":[0.000021127316,0.00019268617,0.001311166,0.000011254681,0.000015578053,0.00020137105,0.000009412826,0.001472392,0.99053264,0.00004590016,0.0061705955,0.000015881986],"about_ca_topic_score_codex":0.0010002838,"about_ca_topic_score_gemma":0.0019997756,"teacher_disagreement_score":0.0035116903,"about_ca_system_score_codex":0.0004807523,"about_ca_system_score_gemma":0.00065212476,"threshold_uncertainty_score":0.011747777},"labels":[],"label_agreement":null},{"id":"W1578691566","doi":"10.1002/9780470285251.ch9","title":"Structure, Mechanism, and Regulation of Cytochromes P450","year":2007,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Mechanism (biology); SUPERFAMILY; Cytochrome P450 reductase; Cytochrome; Reading (process); Chemistry; Biology; Gene; Biochemistry; Cytochrome b; Enzyme; Political science; Philosophy","score_opus":0.0694987296364962,"score_gpt":0.42152029678911856,"score_spread":0.35202156715262234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578691566","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015613574,0.46207207,0.06905554,0.02133658,0.009220775,0.00034795367,0.0034663002,0.0013593924,0.41752777],"genre_scores_gemma":[0.041041486,0.32731062,0.022912214,0.002484285,0.0057466906,0.00016136609,0.0025833978,0.00018978045,0.5975702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998796,0.000014226574,0.0000070363553,0.000028465054,0.00006049337,0.000010056435],"domain_scores_gemma":[0.9999372,0.000017608476,0.0000075618073,0.0000075491903,0.000022456214,0.0000077878685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021089432,0.00040586098,0.00032909686,0.0005708193,0.00026358565,0.00072677806,0.0004179645,0.00057210337,0.025027167],"category_scores_gemma":[0.0002126583,0.00019938187,0.0002853816,0.00063310127,0.00037534215,0.0010407517,0.00027872395,0.0009334036,0.009527551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101320584,0.000108801316,0.00038285906,0.0014860417,0.000013677874,0.00039086098,0.0001076152,0.00082139246,0.06406077,0.07346902,0.13226348,0.72679424],"study_design_scores_gemma":[0.000011773201,0.00009008874,0.0025882067,0.0001503837,0.000009111977,0.0008986114,0.000048947288,0.00032311928,0.021900257,0.015842818,0.95812047,0.00001622475],"about_ca_topic_score_codex":0.00082278886,"about_ca_topic_score_gemma":0.0011407248,"teacher_disagreement_score":0.025027167,"about_ca_system_score_codex":0.0005468675,"about_ca_system_score_gemma":0.00040465174,"threshold_uncertainty_score":0.0837242},"labels":[],"label_agreement":null},{"id":"W1581862317","doi":"10.4212/cjhp.v58i1.285","title":"Warfarin Dosing after Initiation of Fenofibrate","year":2005,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Fenofibrate; Warfarin; Medicine; Dosing; Therapeutic index; Oral anticoagulant; Anticoagulant; Anticoagulant therapy; Drug; Intensive care medicine; Internal medicine; Pharmacology; Atrial fibrillation","score_opus":0.07397626367806759,"score_gpt":0.3879808281621054,"score_spread":0.3140045644840378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581862317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68246317,0.067141004,0.022516945,0.019716552,0.003849048,0.0007758565,0.0019692967,0.002037093,0.19953102],"genre_scores_gemma":[0.96672577,0.0066480427,0.005474192,0.005003976,0.001609665,0.00008325656,0.0008269946,0.000094211675,0.013533903],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9994369,0.00008219872,0.00010020689,0.00007838327,0.0002189275,0.00008331825],"domain_scores_gemma":[0.99911827,0.00017767317,0.00031297642,0.00008195542,0.00013636374,0.00017269008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026657546,0.00033116495,0.0003950911,0.000505373,0.0007177373,0.00065373175,0.00043994442,0.00068838365,0.0059794085],"category_scores_gemma":[0.0023132996,0.000078833524,0.00041129647,0.0003850084,0.00021846691,0.00031489876,0.000259939,0.0010729925,0.002042307],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004478755,0.00094197236,0.13315065,0.00054689724,0.00025330248,0.08772329,0.00081870577,0.0008265431,0.022985281,0.0028927636,0.035667792,0.70971406],"study_design_scores_gemma":[0.00047516642,0.0040037995,0.23813972,0.0010688086,0.00032994055,0.26328322,0.00035646782,0.002552282,0.045007776,0.0059370785,0.43870288,0.00014286228],"about_ca_topic_score_codex":0.0028896816,"about_ca_topic_score_gemma":0.0024882427,"teacher_disagreement_score":0.0059794085,"about_ca_system_score_codex":0.0009212756,"about_ca_system_score_gemma":0.00067662046,"threshold_uncertainty_score":0.02000314},"labels":[],"label_agreement":null},{"id":"W1589835327","doi":"10.1002/bdd.1847","title":"Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity","year":2013,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nebivolol; Bioavailability; Stereoselectivity; Pharmacokinetics; Chemistry; Pharmacology; First pass effect; Atenolol; Enantiomer; Oral administration; Internal medicine; Biochemistry; Medicine; Stereochemistry","score_opus":0.04616879704448408,"score_gpt":0.3783021071795566,"score_spread":0.3321333101350725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589835327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922369,0.0029575662,0.0024629913,0.00020250278,0.000057715486,0.00004814865,0.0007131722,0.0001433423,0.0011775829],"genre_scores_gemma":[0.985795,0.0042097336,0.003725492,0.00022668426,0.00007223525,0.00009377231,0.0011851891,0.000076122866,0.004615824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998443,0.000018770146,0.0000077774375,0.000035723984,0.000044110413,0.000049374048],"domain_scores_gemma":[0.9996761,0.000036901267,0.000104448794,0.00004634812,0.000046465135,0.000089840374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020859491,0.0005086098,0.0006327858,0.00041195095,0.00021709932,0.00043103902,0.00025338866,0.00043783456,0.0010632003],"category_scores_gemma":[0.00033739462,0.00028149356,0.00033699875,0.00021482198,0.0004081575,0.0004970829,0.00013565434,0.0013904917,0.0004624693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003983534,0.00036275692,0.0013266066,0.000084285886,0.000034516386,0.00012826228,0.00006538651,0.0003244298,0.98045087,0.00019291542,0.00020444833,0.012842037],"study_design_scores_gemma":[0.00032682435,0.009364166,0.023322335,0.000018930816,0.00015627145,0.0005444946,0.00011269495,0.0032327375,0.95815897,0.0002135776,0.0045027435,0.000046272988],"about_ca_topic_score_codex":0.0022070494,"about_ca_topic_score_gemma":0.0023852729,"teacher_disagreement_score":0.0022070494,"about_ca_system_score_codex":0.00051236455,"about_ca_system_score_gemma":0.0006271447,"threshold_uncertainty_score":0.004388392},"labels":[],"label_agreement":null},{"id":"W1589912390","doi":"10.1016/s0076-6879(02)57666-7","title":"Genotyping human CYP2A6 variants","year":2002,"lang":"en","type":"article","venue":"Methods in enzymology on CD-ROM/Methods in enzymology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Cotinine; Genotyping; Nicotine; Biology; Allele; Genotype; Genetics; Phenotype; Genetic variability; Cytochrome P450; Enzyme; Gene; Biochemistry; CYP3A4","score_opus":0.27073021257073043,"score_gpt":0.5537021702957196,"score_spread":0.2829719577249891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589912390","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8049399,0.008039965,0.14944358,0.0020133804,0.00057455915,0.0005537662,0.015898267,0.0024561828,0.01608032],"genre_scores_gemma":[0.9108156,0.0021334335,0.062151473,0.00084577437,0.00024000429,0.00037449424,0.010186845,0.00046143288,0.012791027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974584,0.0007847667,0.0001860003,0.0008050876,0.0006493695,0.00011646375],"domain_scores_gemma":[0.99897325,0.00043787045,0.00014887025,0.00022938011,0.00014233409,0.00006831219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011438319,0.0007880278,0.0008558505,0.001216775,0.00030694314,0.0006152018,0.0004970571,0.0014081092,0.003714622],"category_scores_gemma":[0.0029084478,0.0005249192,0.0005605021,0.001139077,0.0002661369,0.00019839822,0.0002817637,0.0006933857,0.0022270617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030635041,0.00037325174,0.19998057,0.0005171858,0.00094732206,0.0016606663,0.00045554969,0.0022349341,0.4728203,0.0024303386,0.011083043,0.30443326],"study_design_scores_gemma":[0.00075090607,0.0019500618,0.23138927,0.0001088808,0.000838899,0.017330227,0.00010865694,0.006998774,0.6746356,0.0032469926,0.06253687,0.00010486513],"about_ca_topic_score_codex":0.0007795833,"about_ca_topic_score_gemma":0.0011716466,"teacher_disagreement_score":0.003714622,"about_ca_system_score_codex":0.00023813655,"about_ca_system_score_gemma":0.00017203286,"threshold_uncertainty_score":0.012426674},"labels":[],"label_agreement":null},{"id":"W1593851516","doi":"","title":"Abstract 11847: Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Circulation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Medicine; Vitamin K antagonist; VKORC1; Meta-analysis; Genotype; Internal medicine; Algorithm; Randomized controlled trial; Warfarin; Gastroenterology; CYP2C9; Atrial fibrillation; Biology; Genetics","score_opus":0.18892035522802744,"score_gpt":0.4617229990521668,"score_spread":0.2728026438241393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593851516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033938717,0.99410146,0.00056404783,0.00036826608,0.00017994051,0.0003996345,0.0006334546,0.000037585367,0.00032168604],"genre_scores_gemma":[0.15118693,0.84075606,0.0029337932,0.001417424,0.00042046153,0.001693489,0.0010050882,0.000049390525,0.000537363],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9908503,0.004653915,0.0023657961,0.00080402463,0.0010628846,0.0002631858],"domain_scores_gemma":[0.98017853,0.014823284,0.0032531815,0.00040021722,0.001135989,0.00020874826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012715145,0.0025158357,0.017100396,0.0066511612,0.0005234722,0.00374436,0.0019993484,0.002273308,0.006362729],"category_scores_gemma":[0.03287764,0.0011801319,0.028159041,0.0074736667,0.00075205206,0.0019918033,0.0012185252,0.0019222274,0.00048449932],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001568307,0.00002817912,0.0023305635,0.5305191,0.44952515,0.00010508795,0.00007091253,0.00053765817,0.00020283375,0.00013285325,0.0012587071,0.013720643],"study_design_scores_gemma":[0.0010254987,0.00018258429,0.00345826,0.05326088,0.9393698,0.000084400075,0.000037925958,0.00027300257,0.00012816857,0.00024707633,0.0019063624,0.000026026411],"about_ca_topic_score_codex":0.006818027,"about_ca_topic_score_gemma":0.011479079,"teacher_disagreement_score":0.017100396,"about_ca_system_score_codex":0.0026252388,"about_ca_system_score_gemma":0.0036490054,"threshold_uncertainty_score":0.06724495},"labels":[],"label_agreement":null},{"id":"W1594081613","doi":"10.1002/9780470686263.ch4","title":"Physiologically Based Modeling of Pharmacokinetic Interactions in Chemical Mixtures","year":2010,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Chemistry; Computer science; Computational biology; Biochemical engineering; Data science; Pharmacology; Biology; Engineering","score_opus":0.11394734142969953,"score_gpt":0.4488184450313272,"score_spread":0.33487110360162764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594081613","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012401264,0.0043258476,0.926157,0.0009316007,0.00029881144,0.00016662574,0.0009421652,0.00094398996,0.05383262],"genre_scores_gemma":[0.4348601,0.018024396,0.3442805,0.0011763563,0.00078890455,0.0012831406,0.0020967908,0.0010014899,0.19648841],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996928,0.00006972991,0.0000150216465,0.000042430125,0.0001618649,0.000018237137],"domain_scores_gemma":[0.99979573,0.000111226895,0.000026719055,0.000012655394,0.000043839584,0.000009812805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034827008,0.0008039702,0.00094024744,0.0004301323,0.00041994784,0.0013577124,0.0013215389,0.0013067536,0.0064965584],"category_scores_gemma":[0.00088023924,0.00061801035,0.0009187992,0.00055922405,0.00043111833,0.0012813122,0.00067277683,0.0011945127,0.0025028607],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030945255,0.000043250842,0.00021121245,0.00011403036,0.0000281892,0.00007571224,0.000034631736,0.9290271,0.005568933,0.04355132,0.002813369,0.018501403],"study_design_scores_gemma":[0.00000815356,0.000011969137,0.000118246004,0.000011409089,0.000009623711,0.000040856386,0.000004103262,0.982634,0.0013064023,0.009182252,0.0066626356,0.000010277031],"about_ca_topic_score_codex":0.0058104983,"about_ca_topic_score_gemma":0.0031392972,"teacher_disagreement_score":0.0064965584,"about_ca_system_score_codex":0.0008767333,"about_ca_system_score_gemma":0.0011964457,"threshold_uncertainty_score":0.021733105},"labels":[],"label_agreement":null},{"id":"W1594588311","doi":"","title":"Lack of association of CYP11B2-344C/T polymorphism with essential hypertension: a meta-analysis.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Polymorphism (computer science); Essential hypertension; Internal medicine; Aldosterone synthase; Genetic model; Genotype; Genetics; Blood pressure; Gene; Biology","score_opus":0.3647916287318141,"score_gpt":0.4129102436769624,"score_spread":0.0481186149451483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594588311","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056375567,0.9369157,0.0031753744,0.0008208191,0.0005698117,0.00026069075,0.0012757584,0.00006891562,0.00053741684],"genre_scores_gemma":[0.83663553,0.15622754,0.0033193985,0.00086182053,0.0005441196,0.00052202697,0.0013630255,0.000048567807,0.00047790236],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894577,0.0050984034,0.0024953547,0.001538668,0.0010376831,0.00037214393],"domain_scores_gemma":[0.9822295,0.013435999,0.0022103246,0.0009852544,0.00087800453,0.00026102187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01631246,0.0021949385,0.010276675,0.0037578638,0.00065433705,0.0022301653,0.0018255572,0.0020065773,0.0025875582],"category_scores_gemma":[0.02610036,0.0011468448,0.040062245,0.0046429452,0.0005353264,0.001117765,0.00093303685,0.0014160223,0.00020863288],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050259223,0.00003231884,0.028038232,0.025666812,0.93349457,0.00026722587,0.0000419262,0.0005031708,0.0005581765,0.00008230489,0.0003612433,0.0059281876],"study_design_scores_gemma":[0.0006150708,0.00022607205,0.012225449,0.0012718221,0.9844518,0.00014518232,0.000020534497,0.00024601634,0.00014119825,0.00012059245,0.0005254436,0.000010783494],"about_ca_topic_score_codex":0.0041881204,"about_ca_topic_score_gemma":0.007201311,"teacher_disagreement_score":0.01631246,"about_ca_system_score_codex":0.0011337795,"about_ca_system_score_gemma":0.0015134816,"threshold_uncertainty_score":0.08626962},"labels":[],"label_agreement":null},{"id":"W1596914918","doi":"10.18433/j3dw3s","title":"Pharmacokinetics of a Cytochrome P450 2E1 Probe, Chlorzoxazone, and its 6-Hydroxy Metabolite in Poloxamer 407-Induced Hyperlipidemic Rats","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Catholic University of Korea; National Research Foundation","keywords":"Chlorzoxazone; CYP2E1; Pharmacokinetics; Chemistry; Metabolite; Pharmacology; Cytochrome P450; In vivo; Active metabolite; Metabolism; Biochemistry; Medicine; Biology","score_opus":0.16617667059064845,"score_gpt":0.46487871189829116,"score_spread":0.2987020413076427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596914918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977701,0.0004833595,0.0011587415,0.00006284712,0.000015681822,0.00002322296,0.00020727102,0.00006343499,0.0002153067],"genre_scores_gemma":[0.99509275,0.0006198403,0.0017330674,0.00007354326,0.000020096888,0.00006666619,0.00038677835,0.000024744644,0.0019825243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998368,0.000031114978,0.000010998826,0.000042571053,0.000047474416,0.00003105803],"domain_scores_gemma":[0.9997304,0.000030023126,0.00011575803,0.000029221721,0.00002912751,0.00006548861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019913375,0.00043788838,0.00047588153,0.00041665274,0.00015247961,0.00026858447,0.00012857483,0.00038766215,0.0007646297],"category_scores_gemma":[0.0002150181,0.00021892815,0.00028478634,0.00024159855,0.00038048162,0.00037616063,0.000101928366,0.0009040108,0.0001800117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005543426,0.00036657313,0.0015989178,0.000037792368,0.000028009847,0.000053716092,0.000044228276,0.00020106349,0.98775953,0.000041909847,0.00006887863,0.0042559486],"study_design_scores_gemma":[0.00027901647,0.014166868,0.013930541,0.0000058268597,0.000110004345,0.00016234472,0.00007762533,0.0021006104,0.96788245,0.00005812981,0.0012052677,0.000021391757],"about_ca_topic_score_codex":0.0011423951,"about_ca_topic_score_gemma":0.0012142354,"teacher_disagreement_score":0.0011423951,"about_ca_system_score_codex":0.00042246922,"about_ca_system_score_gemma":0.0003099999,"threshold_uncertainty_score":0.0030651689},"labels":[],"label_agreement":null},{"id":"W1599477728","doi":"10.18433/j3p599","title":"Antimicrobial and P450 Inhibitory Properties of Common Functional Foods","year":2014,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; Carleton University; University of Ottawa","funders":"Agriculture and Agri-Food Canada","keywords":"Apiaceae; Antimicrobial; Lamiaceae; Biology; Fabaceae; Traditional medicine; Botany; Microbiology; Medicine","score_opus":0.20349943375077628,"score_gpt":0.44450062773635757,"score_spread":0.24100119398558129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599477728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941842,0.0043530175,0.0005984044,0.00004577546,0.0000127784315,0.000020374278,0.0001561095,0.0000095291,0.0006197934],"genre_scores_gemma":[0.99691015,0.0012661071,0.0012147131,0.000045766217,0.000017415632,0.000015253594,0.00016812231,0.000003870268,0.00035854394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998273,0.000047871818,0.000012590197,0.000029590594,0.00005265614,0.000029968536],"domain_scores_gemma":[0.99969757,0.00007873775,0.000095474425,0.000019485615,0.000073763134,0.00003505759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026724322,0.0003901783,0.0002639757,0.0005015793,0.0001815155,0.0001693284,0.00012576407,0.00026957475,0.0013009376],"category_scores_gemma":[0.00037658997,0.0000821863,0.0003926112,0.00030120014,0.00019784097,0.00016070633,0.0001726769,0.0002975491,0.00013148275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009350085,0.00021827777,0.004297495,0.0003746238,0.000040689116,0.00015894925,0.000052644886,0.0001304167,0.9803242,0.000049386155,0.000049122496,0.013369254],"study_design_scores_gemma":[0.00006020042,0.010583897,0.075669505,0.00007999254,0.00016474327,0.0009839132,0.00016247293,0.00046395246,0.9090418,0.00008394795,0.0026912333,0.000014220359],"about_ca_topic_score_codex":0.0003757553,"about_ca_topic_score_gemma":0.00055476854,"teacher_disagreement_score":0.0013009376,"about_ca_system_score_codex":0.00013580396,"about_ca_system_score_gemma":0.00014113507,"threshold_uncertainty_score":0.004352033},"labels":[],"label_agreement":null},{"id":"W1599887186","doi":"10.18433/j3288c","title":"Reversible, Time-Dependent Inhibition of CYP3A-Mediated Metabolism of Midazolam and Tacrolimus by Telaprevir in Human Liver Microsomes","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health; University of Washington","keywords":"CYP3A; Telaprevir; Midazolam; Microsome; Pharmacology; Tacrolimus; CYP3A4; Chemistry; Non-competitive inhibition; IC50; Metabolite; Drug interaction; Cytochrome P450; Pharmacokinetics; Metabolism; Biochemistry; Biology; In vitro; Medicine; Enzyme; Internal medicine; Transplantation","score_opus":0.11859135691760876,"score_gpt":0.4371306430822569,"score_spread":0.31853928616464816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599887186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703382,0.004969974,0.020414632,0.00015084229,0.000057516565,0.00021430671,0.0008888393,0.0002522897,0.0027134386],"genre_scores_gemma":[0.98899275,0.0010732522,0.0064328867,0.00003375745,0.000022550683,0.000112755566,0.0010979394,0.000023209319,0.002210916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947387,0.0001749947,0.000043117387,0.00010888884,0.00014530626,0.000053723696],"domain_scores_gemma":[0.999853,0.000039986426,0.00003694643,0.00003625657,0.000025164923,0.000008650658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005533775,0.00036197653,0.0003000328,0.00013788282,0.00015631468,0.00025773916,0.00029790594,0.00022197908,0.0017378845],"category_scores_gemma":[0.0005054975,0.00020152902,0.00042487567,0.00017979625,0.00018069785,0.00026098322,0.00018135463,0.00044146876,0.00075155916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006274597,0.00008009566,0.00092266983,0.00012474957,0.0000513277,0.000080556514,0.000039716837,0.00033216208,0.99189657,0.00012417272,0.00009121991,0.0056292727],"study_design_scores_gemma":[0.000038080758,0.0010134474,0.004467876,0.0000055782416,0.000042776494,0.00025171656,0.000012941568,0.0018965994,0.9910074,0.000034637924,0.0012211541,0.00000778328],"about_ca_topic_score_codex":0.0010494096,"about_ca_topic_score_gemma":0.0012945333,"teacher_disagreement_score":0.0017378845,"about_ca_system_score_codex":0.00030742784,"about_ca_system_score_gemma":0.00035194555,"threshold_uncertainty_score":0.005813837},"labels":[],"label_agreement":null},{"id":"W1600350812","doi":"10.1046/j.1471-4159.2002.01069.x","title":"Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics","year":2002,"lang":"en","type":"article","venue":"Journal of Neurochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Dentate gyrus; Blot; Cerebellum; Human brain; Immunocytochemistry; CYP2D6; Hippocampus; Northern blot; Biology; Messenger RNA; Molecular biology; Endocrinology; Internal medicine; Neuroscience; Cytochrome P450; Medicine; Biochemistry; Gene; Metabolism","score_opus":0.1892853364846411,"score_gpt":0.4162120425284196,"score_spread":0.2269267060437785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600350812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984648,0.00064624473,0.00023602134,0.000030426108,0.0000030903143,0.0000023966747,0.0001751568,0.0000096707845,0.0004321868],"genre_scores_gemma":[0.9982468,0.00045549526,0.00029188555,0.0000144786045,0.000004325059,0.000004680176,0.0002467731,0.0000050979097,0.0007304077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999423,0.0000066348252,0.000004340316,0.000020546371,0.00001620022,0.000010060769],"domain_scores_gemma":[0.99992275,0.000007661479,0.0000311097,0.0000075929884,0.000016639426,0.000014168385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007296509,0.00011265366,0.00019056755,0.00048025715,0.00019178318,0.00022216605,0.000055315846,0.000120410696,0.0021182771],"category_scores_gemma":[0.00016340065,0.00010720533,0.000087850894,0.00028525782,0.00019466235,0.00008476011,0.00020203329,0.00016009973,0.0003854467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020872564,0.00009006796,0.23997046,0.00017659966,0.00011766137,0.0011878768,0.0008829457,0.000105147396,0.7303743,0.000160746,0.0004481104,0.024398835],"study_design_scores_gemma":[0.000010289022,0.00017061977,0.97592735,0.000008012869,0.00003041428,0.001828856,0.00026278134,0.00013913633,0.02021034,0.0001142562,0.0012930328,0.000004941616],"about_ca_topic_score_codex":0.0014671247,"about_ca_topic_score_gemma":0.0017436642,"teacher_disagreement_score":0.0021182771,"about_ca_system_score_codex":0.00015899207,"about_ca_system_score_gemma":0.00006428361,"threshold_uncertainty_score":0.007086396},"labels":[],"label_agreement":null},{"id":"W1601283237","doi":"10.1111/j.1360-0443.2010.03353.x","title":"Associations of<i>CYP2A6</i>genotype with smoking behaviors in southern China","year":2010,"lang":"en","type":"article","venue":"Addiction","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Odds ratio; Medicine; Confidence interval; Smoking cessation; Internal medicine; Demography; Genotype; Allele; Genetics; Biology; Cytochrome P450; Gene; Pathology","score_opus":0.04572874333085353,"score_gpt":0.38117364762121364,"score_spread":0.3354449042903601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601283237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99981016,0.00004352967,0.00002855538,0.000016092883,8.289972e-7,0.0000020574232,0.000027039376,0.000001135318,0.00007073297],"genre_scores_gemma":[0.99984324,0.000028405228,0.000026949241,0.000008313615,0.0000025039699,0.0000016356526,0.000048814225,5.4410157e-7,0.000039580456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997944,0.00005743575,0.000019082425,0.00005798938,0.00003863906,0.000032521497],"domain_scores_gemma":[0.99939835,0.000076018085,0.00026092862,0.000049867005,0.00006785406,0.00014697893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005080296,0.00028058927,0.00024704201,0.00052940124,0.00034142358,0.00025931172,0.0001948512,0.00026223608,0.00095105846],"category_scores_gemma":[0.0008872498,0.00018792837,0.0002782431,0.0006188414,0.00036684633,0.00013573845,0.00019443661,0.00022019594,0.00008356941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060172835,0.000009886089,0.9981667,0.000005103698,0.000030807107,0.00008726129,0.00008828753,0.000032058404,0.0007785659,0.000011492228,0.000019192523,0.00071047945],"study_design_scores_gemma":[0.000004866194,0.00003697234,0.9995975,0.0000013513925,0.000014153946,0.000105747,0.00004286813,0.000101767306,0.00004912461,0.000012722192,0.000031753123,0.0000011546666],"about_ca_topic_score_codex":0.018985597,"about_ca_topic_score_gemma":0.019162484,"teacher_disagreement_score":0.018985597,"about_ca_system_score_codex":0.00027352653,"about_ca_system_score_gemma":0.0003428686,"threshold_uncertainty_score":0.037750185},"labels":[],"label_agreement":null},{"id":"W1601862985","doi":"10.26443/mjm.v10i1.625","title":"Personalized Medicine and the Practice of Medicine in the 21st Century","year":2020,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Alternative medicine; Personalized medicine; Family medicine; Traditional medicine; Medical education; Bioinformatics; Pathology","score_opus":0.13826939995475213,"score_gpt":0.4482426661609605,"score_spread":0.30997326620620835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601862985","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006996154,0.14009151,0.002474619,0.7101773,0.038389113,0.00004007319,0.00021424663,0.00015883285,0.107754715],"genre_scores_gemma":[0.038939882,0.26725417,0.0061813756,0.54020226,0.0762341,0.00029170292,0.00033079658,0.00027935035,0.07028639],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9891317,0.004400523,0.0007297176,0.0012516284,0.003827462,0.0006588939],"domain_scores_gemma":[0.95571077,0.02190139,0.0036703993,0.0040536397,0.008033735,0.0066300663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012011509,0.00079025404,0.0019460883,0.0013112631,0.0031793432,0.009717846,0.0016618969,0.009429103,0.056061525],"category_scores_gemma":[0.038214765,0.00041713225,0.00065181067,0.0018175279,0.011795422,0.010242557,0.004726444,0.011767414,0.014219946],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016551981,0.000094163945,0.0011117229,0.0017043864,0.000053830947,0.00022949444,0.00053774944,0.00025277323,0.00060456234,0.122009255,0.65739423,0.21584234],"study_design_scores_gemma":[0.000025828062,0.000038061036,0.0014289656,0.0021022852,0.0000131422585,0.0002695903,0.0003324297,0.00012634453,0.00008338918,0.03780958,0.9577402,0.000030117262],"about_ca_topic_score_codex":0.012861229,"about_ca_topic_score_gemma":0.019348152,"teacher_disagreement_score":0.056061525,"about_ca_system_score_codex":0.00591874,"about_ca_system_score_gemma":0.017061783,"threshold_uncertainty_score":0.18754447},"labels":[],"label_agreement":null},{"id":"W1603258755","doi":"10.1002/ptr.3371","title":"The Effects of Commercial Preparations of Herbal Supplements Commonly Used by Women on the Biotransformation of Fluorogenic Substrates by Human Cytochromes P450","year":2011,"lang":"en","type":"article","venue":"Phytotherapy Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"CYP3A4; Traditional medicine; Black cohosh; CYP1A2; Pharmacology; Enzyme; Cytochrome P450; Chemistry; Biochemistry; Medicine","score_opus":0.2161939200423032,"score_gpt":0.492616864114315,"score_spread":0.2764229440720118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603258755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349266,0.0050369534,0.00028282485,0.00011623647,0.000036483423,0.00003328392,0.000105829866,0.000006457172,0.00088915473],"genre_scores_gemma":[0.99392986,0.003448161,0.000662015,0.00011636328,0.000033957655,0.00002728517,0.00013266373,0.0000060771113,0.0016434786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971086,0.00014978381,0.00001722958,0.000045170204,0.00004746246,0.00002948979],"domain_scores_gemma":[0.99962723,0.00022352746,0.000058332087,0.000021004618,0.00003863466,0.000031248237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027035645,0.0003802775,0.00028040286,0.00018515228,0.00020727883,0.00020375135,0.00011090479,0.0003718031,0.0028369885],"category_scores_gemma":[0.0009957701,0.00013847984,0.0002600203,0.0002057895,0.0002637322,0.00014414807,0.00020004016,0.00028856407,0.00022454801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035666626,0.0026626145,0.019529855,0.0012678624,0.00041451846,0.0010057715,0.0007196646,0.00023505099,0.82236904,0.00018352094,0.0004436965,0.11550183],"study_design_scores_gemma":[0.000644671,0.16351768,0.120961584,0.00015710996,0.0012459067,0.00212147,0.0016541622,0.0008664021,0.69391245,0.00021838595,0.0146588255,0.00004127224],"about_ca_topic_score_codex":0.0006377301,"about_ca_topic_score_gemma":0.0016259251,"teacher_disagreement_score":0.0028369885,"about_ca_system_score_codex":0.000119754695,"about_ca_system_score_gemma":0.00017355556,"threshold_uncertainty_score":0.009490728},"labels":[],"label_agreement":null},{"id":"W1603362850","doi":"10.1002/9780470921920.edm004","title":"Sex Differences in Drug Metabolism","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Drug metabolism; Cytochrome P450; Internal medicine; Endocrinology; Sexual dimorphism; Metabolism; Medicine","score_opus":0.04545445368411434,"score_gpt":0.37217458191443276,"score_spread":0.32672012823031843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603362850","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67514545,0.13422182,0.009714994,0.0066587226,0.0015498552,0.000248066,0.01201116,0.00042655994,0.16002335],"genre_scores_gemma":[0.93948585,0.01727637,0.0018725814,0.001627214,0.00029979023,0.00008312625,0.002238749,0.00007333543,0.037042946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996687,0.0000796326,0.00003704447,0.00007370278,0.00009838247,0.000042454925],"domain_scores_gemma":[0.99955016,0.000112446745,0.00012566565,0.0000523113,0.000099601966,0.000059769245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036415743,0.0002134253,0.0002406688,0.0003714538,0.00020708486,0.0004947188,0.00014113386,0.0002601351,0.0150473425],"category_scores_gemma":[0.0008804724,0.00008781974,0.00039069998,0.00034452672,0.00018555047,0.00020295946,0.0002849667,0.00037989885,0.0025060961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026723314,0.00038440988,0.18819693,0.0013574079,0.0006315261,0.0024909724,0.00048436926,0.000439466,0.13090684,0.014466748,0.019177083,0.6387919],"study_design_scores_gemma":[0.00018467428,0.0024142433,0.61010855,0.00031579388,0.00039083973,0.016962131,0.0003134755,0.0006184787,0.06909302,0.008276469,0.29125938,0.00006295822],"about_ca_topic_score_codex":0.0005705935,"about_ca_topic_score_gemma":0.0004900659,"teacher_disagreement_score":0.0150473425,"about_ca_system_score_codex":0.00028236932,"about_ca_system_score_gemma":0.00025189717,"threshold_uncertainty_score":0.050338387},"labels":[],"label_agreement":null},{"id":"W1603529942","doi":"10.18433/j3sg66","title":"The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ketoconazole; CYP1A2; In vivo; Chemistry; Isozyme; Cytochrome P450; CYP3A; Pharmacology; Microsome; CYP3A4; Gene isoform; Pharmacokinetics; Metabolism; Metabolite; Inhibitory postsynaptic potential; In vitro; Enzyme; Biochemistry; Endocrinology; Biology","score_opus":0.08183137636494679,"score_gpt":0.4338577602700514,"score_spread":0.3520263839051046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603529942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095356,0.005954351,0.0019359536,0.00007676578,0.000025789988,0.00001992928,0.00027423142,0.000041223248,0.0007182558],"genre_scores_gemma":[0.9939236,0.0022827517,0.0017609013,0.00004037718,0.000016567128,0.000027138221,0.00057573186,0.0000091426255,0.0013637966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970216,0.000094538016,0.000027117281,0.00006354444,0.000075863965,0.000036599482],"domain_scores_gemma":[0.9998379,0.000030150257,0.000045950597,0.000023258264,0.000037983555,0.00002470136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002907371,0.00036297258,0.0002347521,0.0003412472,0.00018061516,0.00032088513,0.000104441846,0.00027534473,0.0011085448],"category_scores_gemma":[0.00051812315,0.00019042005,0.0003824457,0.00030364946,0.00017654302,0.00017450057,0.00010827358,0.0003072236,0.00027228697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027079144,0.00020931277,0.012290849,0.00017640331,0.0001214293,0.0002293123,0.00008220636,0.00037286343,0.9653356,0.0001264447,0.0002244031,0.018123366],"study_design_scores_gemma":[0.00013251242,0.005439002,0.11861038,0.000020244066,0.0003276149,0.0030449808,0.00011900321,0.0023142765,0.8638668,0.00009761866,0.006001718,0.000025789297],"about_ca_topic_score_codex":0.0016862858,"about_ca_topic_score_gemma":0.0016716995,"teacher_disagreement_score":0.0016862858,"about_ca_system_score_codex":0.00024657208,"about_ca_system_score_gemma":0.00025625114,"threshold_uncertainty_score":0.0037084818},"labels":[],"label_agreement":null},{"id":"W1608447397","doi":"10.1002/9780470571224.pse048","title":"Cytochrome<scp>P</scp>450 Enzymes","year":2010,"lang":"en","type":"other","venue":"Pharmaceutical Sciences Encyclopedia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biotransformation; Cytochrome P450; Enzyme; Xenobiotic; Mixed Function Oxidase; Cytochrome; Biochemistry; Microsome; Function (biology); Chemistry; Oxidase test; Biology; Cell biology","score_opus":0.09840464064716335,"score_gpt":0.4422971645448059,"score_spread":0.3438925238976425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608447397","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024779364,0.07132713,0.016053973,0.0023541793,0.0011708144,0.00042151992,0.015354552,0.0023988034,0.86613977],"genre_scores_gemma":[0.08935589,0.07240399,0.012970005,0.00081207877,0.0006821239,0.00021028364,0.012387365,0.00024130485,0.810937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997553,0.000032772125,0.000019480907,0.000034460907,0.00012813504,0.000029843459],"domain_scores_gemma":[0.99984694,0.00002340743,0.000027589427,0.000019128742,0.000057359226,0.000025687323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020842114,0.0006393279,0.00031715786,0.0013982913,0.00026351956,0.0011039465,0.00036968422,0.00035409,0.07036605],"category_scores_gemma":[0.00035340036,0.00009065774,0.00023516185,0.0018912778,0.00024408872,0.00045531915,0.00049602817,0.0004335073,0.035337154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018899897,0.00016734515,0.0026871648,0.0013616416,0.00003681716,0.0010398424,0.00003900158,0.00032807016,0.032599095,0.011309218,0.12349329,0.82674944],"study_design_scores_gemma":[0.000017591437,0.00006117897,0.0076111536,0.0001533202,0.000016412681,0.0018799361,0.000024555831,0.00023436312,0.015300267,0.0019367678,0.97275484,0.000009545273],"about_ca_topic_score_codex":0.0018876285,"about_ca_topic_score_gemma":0.0019609465,"teacher_disagreement_score":0.07036605,"about_ca_system_score_codex":0.0005060847,"about_ca_system_score_gemma":0.000552619,"threshold_uncertainty_score":0.23539788},"labels":[],"label_agreement":null},{"id":"W1622313911","doi":"10.1002/hup.2383","title":"Positive perception of pharmacogenetic testing for psychotropic medications","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Perception; Psychology; Pharmacology; Biology; Genetics; Neuroscience; Genotype; Gene","score_opus":0.1763177381488729,"score_gpt":0.5428489992395906,"score_spread":0.36653126109071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1622313911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947813,0.00021496434,0.00015895617,0.001757141,0.000045357752,0.00002348464,0.00003029291,0.0000056650083,0.002982858],"genre_scores_gemma":[0.9983956,0.00022412455,0.00009384819,0.0006403654,0.000025096293,0.0000074437576,0.000015540763,0.0000016768919,0.00059632864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969216,0.0011695906,0.00018301286,0.00014718376,0.0012082973,0.00037032497],"domain_scores_gemma":[0.98201585,0.0059799035,0.005783448,0.00043174584,0.0023053482,0.0034836286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053707184,0.00022171428,0.00021776232,0.0005359327,0.0011543592,0.001331516,0.00032384225,0.0008403238,0.0042624483],"category_scores_gemma":[0.0144236935,0.00016494744,0.00032965516,0.00028220084,0.0023066993,0.0005321872,0.0011239889,0.0013507316,0.00026432503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003465055,0.00029677668,0.9267254,0.00021810687,0.00006757421,0.0008787142,0.03625686,0.00018837559,0.004682314,0.00041512234,0.0022898389,0.027634392],"study_design_scores_gemma":[0.00004703725,0.0009849898,0.91024333,0.00027415153,0.00007805468,0.0017742849,0.07442382,0.0005825098,0.0010241847,0.00031410833,0.010178861,0.00007469248],"about_ca_topic_score_codex":0.013398207,"about_ca_topic_score_gemma":0.011884208,"teacher_disagreement_score":0.013398207,"about_ca_system_score_codex":0.0016019066,"about_ca_system_score_gemma":0.0016706374,"threshold_uncertainty_score":0.028403401},"labels":[],"label_agreement":null},{"id":"W162868904","doi":"10.1007/978-3-319-10527-7_3","title":"Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amodiaquine; Mefloquine; Primaquine; Atovaquone; Sulfadoxine; Artemether; Artemisinin; Chloroquine; Proguanil; Artesunate; Pharmacology; Quinine; Malaria; Drug; Medicine; Pyrimethamine; Plasmodium falciparum; Immunology","score_opus":0.07299654881167561,"score_gpt":0.3629240715735569,"score_spread":0.2899275227618813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W162868904","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07238648,0.60769063,0.043916337,0.004724311,0.001350592,0.000112674454,0.0011304088,0.0005926003,0.26809594],"genre_scores_gemma":[0.45028007,0.34932056,0.03837577,0.0029018288,0.0018802371,0.0001105764,0.0013020197,0.00019425918,0.15563469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998005,0.000054444947,0.000008075033,0.000026510344,0.000099099285,0.00001146988],"domain_scores_gemma":[0.99970406,0.00023050634,0.00001893326,0.000007913042,0.000031582244,0.0000070115966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027214293,0.00042535714,0.00038339372,0.0006257882,0.00012090578,0.0005773011,0.0003593101,0.00045527122,0.005920283],"category_scores_gemma":[0.00069773116,0.00013017598,0.00047269242,0.0005507643,0.00016591692,0.0006177282,0.00037252813,0.0005163424,0.0015074988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038117656,0.00009867512,0.0032559827,0.0018955407,0.00020172942,0.0015402181,0.0001697299,0.0040635574,0.0928481,0.045595244,0.028023329,0.82192665],"study_design_scores_gemma":[0.000057579244,0.0011305893,0.014117332,0.00089821924,0.0005866326,0.020193234,0.00019560679,0.024260778,0.13283528,0.10123947,0.7043726,0.00011259114],"about_ca_topic_score_codex":0.00017820299,"about_ca_topic_score_gemma":0.00030845508,"teacher_disagreement_score":0.005920283,"about_ca_system_score_codex":0.00028963463,"about_ca_system_score_gemma":0.0001331559,"threshold_uncertainty_score":0.019805372},"labels":[],"label_agreement":null},{"id":"W1633107772","doi":"","title":"The Hurdled Race Toward Personalized Medicine: the Study of Pharmacogenomics. An interview with Dr. Stan Bardal","year":2013,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Human genome; Personalized medicine; Medicine; Drug response; Genome; Drug; Pharmacology; Bioinformatics; Genetics; Gene; Biology","score_opus":0.16514966518091748,"score_gpt":0.46528561356999615,"score_spread":0.30013594838907864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633107772","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027176083,0.013953981,0.00021915186,0.9815353,0.0033795019,0.00000966251,0.000014753913,0.00001076967,0.0006051058],"genre_scores_gemma":[0.008069296,0.023302348,0.0014304828,0.95452565,0.008702935,0.0000724014,0.000018295541,0.000032721164,0.0038458772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9841665,0.011834451,0.00047006563,0.0009351429,0.0018731902,0.0007206047],"domain_scores_gemma":[0.9566924,0.03057673,0.0012583849,0.0005721909,0.0036217629,0.0072784885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02577705,0.0010135865,0.0016977199,0.001726977,0.009413856,0.0063050245,0.0016654246,0.0136442585,0.0028949261],"category_scores_gemma":[0.035624597,0.001212731,0.0010802709,0.0014302091,0.013741925,0.014348477,0.005187599,0.055429522,0.001228367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030931096,0.000045931218,0.0005923264,0.00015899607,0.000020904692,0.00036758278,0.0063093696,0.00005991503,0.00019065668,0.0066302223,0.9644337,0.02115942],"study_design_scores_gemma":[0.00006664973,0.0001280972,0.0020943377,0.0009695028,0.00002626501,0.002572526,0.020408828,0.0003473453,0.00027594686,0.030899955,0.9420748,0.00013585333],"about_ca_topic_score_codex":0.0136075625,"about_ca_topic_score_gemma":0.028578212,"teacher_disagreement_score":0.02577705,"about_ca_system_score_codex":0.00900385,"about_ca_system_score_gemma":0.012533548,"threshold_uncertainty_score":0.13632375},"labels":[],"label_agreement":null},{"id":"W165664982","doi":"10.1096/fasebj.22.1_supplement.184.1","title":"Expression of the Human <i>UGT1</i> Locus in Transgenic Mice by WY‐14643 and Implications on Drug Metabolism Through Peroxisome Proliferator‐Activated Receptor (PPAR) α Activation","year":2008,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"U.S. Public Health Service","keywords":"Fibrate; Glucuronidation; Peroxisome proliferator-activated receptor; Genetically modified mouse; Drug metabolism; Glucuronosyltransferase; Receptor; Endocrinology; Lithocholic acid; Biology; Internal medicine; Peroxisome; Transgene; Chemistry; Metabolism; Biochemistry; Gene; Enzyme; Bile acid; Medicine; Microsome","score_opus":0.0687287760682565,"score_gpt":0.3657578713079008,"score_spread":0.29702909523964427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W165664982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97557336,0.0012862372,0.01636616,0.00066588196,0.00015123984,0.00020926727,0.002559662,0.00080688955,0.0023814447],"genre_scores_gemma":[0.962428,0.0022970398,0.017280577,0.0003155327,0.000054676904,0.0005117136,0.004535653,0.0005590293,0.012017723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996239,0.000076745695,0.000051686293,0.0001152995,0.000068135596,0.00006411297],"domain_scores_gemma":[0.9996761,0.000045756802,0.00015036682,0.00003384704,0.000020392074,0.00007355853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035069295,0.000791759,0.0004334515,0.00079783425,0.00038398246,0.00057507906,0.00035725458,0.0006717034,0.0023255697],"category_scores_gemma":[0.00018139543,0.0005788234,0.00070989534,0.00034299822,0.00067351427,0.00027767677,0.00031675413,0.0014414808,0.0008712964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024761513,0.000061579754,0.00019531877,0.00002451509,0.000010978443,0.00010322134,0.00002481417,0.00004594051,0.9980829,0.00030319986,0.000082845574,0.00081725424],"study_design_scores_gemma":[0.00011851255,0.00052437006,0.0031365452,0.000016262959,0.000058740523,0.0009926474,0.00003532327,0.0010727373,0.9881974,0.00013174623,0.0057024015,0.000013314619],"about_ca_topic_score_codex":0.0013012158,"about_ca_topic_score_gemma":0.0017826078,"teacher_disagreement_score":0.0023255697,"about_ca_system_score_codex":0.0005257978,"about_ca_system_score_gemma":0.00039615823,"threshold_uncertainty_score":0.007779777},"labels":[],"label_agreement":null},{"id":"W17089399","doi":"10.1007/978-3-642-37393-0_226-1","title":"Pharmacogenomics and Personalized Medicine: Bridging Genetic Knowledge and Clinical Practice","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Precision medicine; Bridging (networking); Medicine; Clinical Practice; Data science; Bioinformatics; Computer science; Pharmacology; Family medicine; Biology; Pathology","score_opus":0.14594088462330077,"score_gpt":0.4852945158635577,"score_spread":0.33935363124025697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W17089399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010433879,0.6665137,0.056106538,0.0701183,0.0065476815,0.00005738242,0.00034058077,0.00041534484,0.19885716],"genre_scores_gemma":[0.021760166,0.6346165,0.08955378,0.04545117,0.011236692,0.0002095284,0.0004503717,0.00043767487,0.19628415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931943,0.00026309327,0.000026915377,0.00007533207,0.00028623018,0.000028997049],"domain_scores_gemma":[0.997883,0.0017587394,0.00004435563,0.00006595489,0.00015826404,0.000089697365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019435652,0.0009001155,0.0010086433,0.0014427993,0.00047576657,0.0034856512,0.0012338767,0.0026626291,0.013755046],"category_scores_gemma":[0.003057013,0.00038045735,0.00040488,0.0016836814,0.003639848,0.004345616,0.0018230573,0.0046301754,0.0059845354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003037733,0.000072899646,0.00024548764,0.0010420262,0.00003294759,0.00016324791,0.00062962656,0.00089500437,0.0007400296,0.2586802,0.26581657,0.47165155],"study_design_scores_gemma":[0.000008554613,0.000017548356,0.00028848025,0.00093602523,0.000010488349,0.0005229739,0.0001880056,0.0004452998,0.00020267662,0.24219541,0.7551628,0.000021701195],"about_ca_topic_score_codex":0.0013180037,"about_ca_topic_score_gemma":0.0032983518,"teacher_disagreement_score":0.013755046,"about_ca_system_score_codex":0.001396679,"about_ca_system_score_gemma":0.0023626832,"threshold_uncertainty_score":0.046015263},"labels":[],"label_agreement":null},{"id":"W1740551684","doi":"10.1517/14656566.2015.1088829","title":"Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Personalized medicine; Precision medicine; Disease; Intensive care medicine; Bioinformatics; Internal medicine; Pathology","score_opus":0.20933489707651082,"score_gpt":0.5118279032799685,"score_spread":0.3024930062034577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740551684","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004204843,0.0525236,0.000330168,0.15076818,0.7941933,0.000042243526,0.000055400647,0.000059876456,0.0019851753],"genre_scores_gemma":[0.00064303447,0.037066724,0.0005162243,0.09275145,0.86458737,0.000047535133,0.000041012016,0.00003723298,0.0043093297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99194455,0.0024803104,0.0013567851,0.0007630715,0.003092502,0.00036289837],"domain_scores_gemma":[0.9635193,0.021156343,0.0022776662,0.0008624126,0.009681426,0.0025028156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0155684985,0.0018851534,0.004137362,0.0023151108,0.0019303838,0.006331973,0.0043909205,0.0226201,0.008376178],"category_scores_gemma":[0.04469054,0.0007972578,0.0022901206,0.0011351688,0.004451305,0.0065229037,0.0017784144,0.02458977,0.009153144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035544836,0.000014666972,0.000021584687,0.0009402841,0.000034061784,0.00011594627,0.000040729155,0.0000333043,0.000076817196,0.0014604555,0.9816689,0.015557792],"study_design_scores_gemma":[0.00005767992,0.000028633202,0.00015083753,0.0016985965,0.000060659113,0.0002768082,0.00005030649,0.00011060723,0.000075978205,0.0041932,0.9932761,0.000020631474],"about_ca_topic_score_codex":0.0011024299,"about_ca_topic_score_gemma":0.0024116084,"teacher_disagreement_score":0.0226201,"about_ca_system_score_codex":0.0034784572,"about_ca_system_score_gemma":0.0042379657,"threshold_uncertainty_score":0.082335055},"labels":[],"label_agreement":null},{"id":"W1748017913","doi":"10.1002/dta.1863","title":"Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements","year":2015,"lang":"en","type":"article","venue":"Drug Testing and Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"CYP3A4; Pharmacology; CYP2D6; Chemistry; Enzyme; Cytochrome P450; CYP1A2; Drug; Dietary supplement; In vivo; Biochemistry; Medicine; Biology; Food science; Biotechnology","score_opus":0.13737968176286192,"score_gpt":0.4142317591891828,"score_spread":0.2768520774263209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1748017913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98646784,0.008346751,0.0029682473,0.000099156285,0.00003548646,0.000072210896,0.0003686285,0.00004996029,0.001591713],"genre_scores_gemma":[0.9892407,0.0036802797,0.004336086,0.000055248987,0.00001934521,0.00006298468,0.0006162483,0.000011906264,0.0019772002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970204,0.00010417167,0.000034635534,0.00005982138,0.00007485657,0.000024381647],"domain_scores_gemma":[0.99987006,0.000037612088,0.000041110132,0.000013352401,0.000022626935,0.000015174732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022826192,0.00030883646,0.00037543484,0.00023270836,0.00013495801,0.00016322998,0.00016615773,0.00029828475,0.0010872745],"category_scores_gemma":[0.00028016744,0.00016419814,0.00036481643,0.00026706973,0.00016852544,0.00011473506,0.00016310022,0.00039013813,0.00024200014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030409388,0.00006156063,0.0004821319,0.00013114374,0.000024517856,0.0000479054,0.000015590384,0.0000724308,0.99538547,0.000018646653,0.000038002257,0.0034183771],"study_design_scores_gemma":[0.00003184538,0.0015162915,0.0048212926,0.0000110656665,0.000034405522,0.00016023258,0.000021376021,0.00032664352,0.9910678,0.000010756732,0.0019938443,0.000004373304],"about_ca_topic_score_codex":0.00065650954,"about_ca_topic_score_gemma":0.0020477509,"teacher_disagreement_score":0.0010872745,"about_ca_system_score_codex":0.0001866752,"about_ca_system_score_gemma":0.00016936859,"threshold_uncertainty_score":0.0036373138},"labels":[],"label_agreement":null},{"id":"W1765975574","doi":"10.1155/2007/976804","title":"<i>N</i>-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education of the People's Republic of China","keywords":"Sulfasalazine; Genotype; Medicine; Inflammatory bowel disease; Gastroenterology; Adverse effect; Internal medicine; Allele; Ulcerative colitis; Sulfapyridine; Arylamine N-acetyltransferase; Rash; Polymorphism (computer science); Disease; Biology; Gene; Genetics","score_opus":0.02099568495005241,"score_gpt":0.30343337229438405,"score_spread":0.28243768734433167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1765975574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935263,0.00039175604,0.00010245774,0.000020296746,0.0000037565223,0.0000029497826,0.000022562663,0.000002397516,0.00010119197],"genre_scores_gemma":[0.9997696,0.000061431514,0.000091266484,0.000011655789,0.0000059725635,0.0000016326819,0.000027559157,8.9767667e-7,0.000030082889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994498,0.0002547765,0.00007101427,0.000090889036,0.00008357566,0.00005000344],"domain_scores_gemma":[0.9976482,0.0007099597,0.0012472521,0.0000802598,0.00013142807,0.00018302228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006137693,0.000313728,0.00032902468,0.0004036283,0.00019721511,0.000276449,0.00015704898,0.00037685662,0.0010451224],"category_scores_gemma":[0.0021404997,0.00016707521,0.0003739364,0.00040509214,0.0002778762,0.00016342387,0.00016143863,0.00031143957,0.00011603193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005604874,0.000019264899,0.996216,0.000012746382,0.000063337335,0.00026119145,0.00002283123,0.000037703554,0.0014997883,0.0000059227923,0.00002039029,0.0012803209],"study_design_scores_gemma":[0.00002536437,0.0004383486,0.9961714,0.0000061765636,0.00009334346,0.002300068,0.000042041345,0.00029093339,0.0005060309,0.0000138416235,0.00010887259,0.0000034807576],"about_ca_topic_score_codex":0.0006585368,"about_ca_topic_score_gemma":0.00062536873,"teacher_disagreement_score":0.0010451224,"about_ca_system_score_codex":0.00012457826,"about_ca_system_score_gemma":0.00010710764,"threshold_uncertainty_score":0.0034962296},"labels":[],"label_agreement":null},{"id":"W1779232898","doi":"10.3109/00498254.2015.1060374","title":"Characterization of ligand-dependent activation of bovine and pig constitutive androstane (CAR) and pregnane X receptors (PXR) with interspecies comparisons","year":2015,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; Xenobiotic; Nuclear receptor; Receptor; Ligand (biochemistry); Biology; Biochemistry; Drug metabolism; Transporter; Steroid; Chemistry; Pharmacology; Metabolism; Enzyme; Gene; Transcription factor; Hormone","score_opus":0.08548819046845897,"score_gpt":0.3596491832988352,"score_spread":0.27416099283037626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1779232898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902164,0.0036100128,0.0029149891,0.00011694389,0.000023905894,0.00003736543,0.0007336512,0.000026402453,0.0023204065],"genre_scores_gemma":[0.9877791,0.0019095626,0.0037018068,0.00019550209,0.00003106249,0.000048117363,0.0041184607,0.00003234485,0.002184062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997075,0.00007459196,0.000025084495,0.00005746396,0.00007945256,0.000055858058],"domain_scores_gemma":[0.9996896,0.000115228584,0.00008459297,0.00003685109,0.00003120971,0.00004250333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003788231,0.00016007014,0.00024980967,0.00035258092,0.00009895768,0.00033036937,0.00021465184,0.0003294274,0.0015003469],"category_scores_gemma":[0.00050905993,0.00014751502,0.000323299,0.00025606723,0.00024806612,0.00017618517,0.0001508134,0.00029471848,0.00066950935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022268563,0.00002255177,0.0013723858,0.000037031186,0.000008144539,0.000085567204,0.000024755238,0.000045986966,0.99579996,0.000077435376,0.00003175709,0.0022716913],"study_design_scores_gemma":[0.0000811117,0.0038372027,0.19449407,0.00003496294,0.00015103177,0.006694933,0.00021628402,0.0021266206,0.76873356,0.00026501063,0.023330146,0.000035072113],"about_ca_topic_score_codex":0.00063322077,"about_ca_topic_score_gemma":0.00083221705,"teacher_disagreement_score":0.0015003469,"about_ca_system_score_codex":0.0002468798,"about_ca_system_score_gemma":0.00013697456,"threshold_uncertainty_score":0.0050191283},"labels":[],"label_agreement":null},{"id":"W1781334389","doi":"10.1007/978-1-60327-362-6_10","title":"Grapefruit and Other Fruit Juices Interactions with Medicines","year":2009,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; CYP3A4; Pharmacology; Drug; Pharmacokinetics; Adverse effect; Medicine; Pharmacokinetic interaction; Drug metabolism; Efflux; Drug interaction; Chemistry; Metabolism; Cytochrome P450; Internal medicine; Biochemistry","score_opus":0.22116545925945827,"score_gpt":0.43162243608362943,"score_spread":0.21045697682417117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781334389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009508231,0.7001937,0.0026084871,0.005588537,0.003257597,0.00008304828,0.00044745917,0.00026766316,0.27804518],"genre_scores_gemma":[0.032610126,0.4318019,0.00782121,0.0044823433,0.0030572903,0.00006153825,0.00044972508,0.00009730124,0.5196185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991345,0.000016505799,0.0000050630215,0.0000140202255,0.000044530403,0.000006377709],"domain_scores_gemma":[0.9999373,0.000037283688,0.0000060358752,0.00000216924,0.000011313425,0.000005787895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015639041,0.0005821876,0.00031206134,0.0006476652,0.0001953451,0.0006456212,0.00028840595,0.0006217103,0.01668199],"category_scores_gemma":[0.0002545051,0.00012353397,0.00035283415,0.0004373057,0.0001335618,0.00055127277,0.00035631665,0.0006359633,0.00417899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010968091,0.00012870999,0.00073440676,0.0019462125,0.000044166616,0.00082902855,0.00032623822,0.00039748516,0.008827311,0.009919504,0.16387324,0.81286395],"study_design_scores_gemma":[0.0000096498015,0.00015990475,0.0024201507,0.00061230775,0.00002733473,0.0029861953,0.000062015024,0.00020087734,0.0022208,0.0029187663,0.988368,0.000014034368],"about_ca_topic_score_codex":0.001172708,"about_ca_topic_score_gemma":0.0040215137,"teacher_disagreement_score":0.01668199,"about_ca_system_score_codex":0.00034008193,"about_ca_system_score_gemma":0.0002347295,"threshold_uncertainty_score":0.055806875},"labels":[],"label_agreement":null},{"id":"W1789580053","doi":"","title":"Lesion scoring and P450 Isoenzyme activity in liver of hepatocarcinogenesis rats treated with Strobilanthes Crispus","year":2008,"lang":"en","type":"article","venue":"Iranian Journal of Cancer Prevention","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glycyrrhizin; Hepatocellular carcinoma; 2-Acetylaminofluorene; Lesion; Liver cancer; Internal medicine; Gastroenterology; Carcinogen; Pathology; Microsome; Enzyme; Biochemistry; Chemistry","score_opus":0.15563776951044508,"score_gpt":0.4211681005919032,"score_spread":0.26553033108145807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1789580053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701273,0.0009033155,0.0011507254,0.000043058088,0.00001816973,0.000040116523,0.00018829503,0.000043155393,0.0006004681],"genre_scores_gemma":[0.9923625,0.0011556522,0.0021415593,0.000048731952,0.00000944912,0.000075514385,0.00044053723,0.000013010953,0.0037530647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998685,0.000016783388,0.000013100117,0.0000323211,0.000044171935,0.000025025878],"domain_scores_gemma":[0.9998275,0.000013257407,0.000056715988,0.00001934658,0.00002944394,0.0000537177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018740103,0.00050897524,0.00034942094,0.0007112771,0.00020286391,0.00015224933,0.00011435321,0.0003043303,0.001671136],"category_scores_gemma":[0.00013384905,0.00020260236,0.00031016188,0.00026368318,0.00021606022,0.00024900783,0.00017923977,0.00052080385,0.00023487321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000694014,0.00019479035,0.0014109745,0.0000442215,0.000013826443,0.000043980464,0.000030278456,0.000034539662,0.99587065,0.000015900274,0.000014714032,0.0016321585],"study_design_scores_gemma":[0.000058514193,0.0060462933,0.043314073,0.0000113343785,0.000082215585,0.00024266023,0.00013177,0.00053211267,0.94861615,0.000043781787,0.00091087807,0.0000103230905],"about_ca_topic_score_codex":0.0006963136,"about_ca_topic_score_gemma":0.0008306931,"teacher_disagreement_score":0.001671136,"about_ca_system_score_codex":0.00012655613,"about_ca_system_score_gemma":0.00016428505,"threshold_uncertainty_score":0.0055904984},"labels":[],"label_agreement":null},{"id":"W1811805154","doi":"","title":"Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP3A4; Flunitrazepam; Chemistry; CYP1A2; Mephenytoin; Microsome; Cytochrome P450; Ketoconazole; Pharmacology; Metabolite; Metabolism; Pharmacokinetics; Biochemistry; CYP2C19; Enzyme; Biology; Receptor; Benzodiazepine","score_opus":0.09584527878852,"score_gpt":0.37546103379237056,"score_spread":0.27961575500385055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1811805154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88098454,0.06468657,0.038199525,0.0012894085,0.00018286532,0.00043770557,0.0021363094,0.00041702378,0.011666128],"genre_scores_gemma":[0.97342706,0.0093992585,0.009819032,0.0001979838,0.00009113766,0.0000935632,0.0017407635,0.000024602325,0.0052066087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979407,0.00006598825,0.000015085333,0.00003762164,0.000053247637,0.000033879456],"domain_scores_gemma":[0.9998647,0.000028234768,0.000050483468,0.000012538197,0.00003170263,0.000012327541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027780997,0.0003780062,0.00025639482,0.00036366307,0.00019677632,0.0003037717,0.00014558717,0.0003008466,0.002002221],"category_scores_gemma":[0.0003562438,0.00017879068,0.0005389657,0.0003019071,0.00019609962,0.00017267097,0.00010891696,0.000379558,0.0005729849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010307909,0.000095558804,0.016914306,0.0003194182,0.00024709624,0.00071053416,0.00007499602,0.00059218233,0.91164696,0.00061406713,0.00087804545,0.06687604],"study_design_scores_gemma":[0.00022239097,0.0015932494,0.106651135,0.000025070192,0.00032542448,0.007071593,0.000052667456,0.004383195,0.84089047,0.00060290354,0.03815177,0.000030140487],"about_ca_topic_score_codex":0.0058861165,"about_ca_topic_score_gemma":0.0048029236,"teacher_disagreement_score":0.0058861165,"about_ca_system_score_codex":0.00046736858,"about_ca_system_score_gemma":0.0002965559,"threshold_uncertainty_score":0.01170367},"labels":[],"label_agreement":null},{"id":"W1817947240","doi":"10.3934/genet.2015.4.250","title":"Associations of CYP1A1 gene polymorphisms and risk of breast cancer in Indian women: a meta-analysis","year":2015,"lang":"en","type":"article","venue":"AIMS Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Meta-analysis; Breast cancer; Medicine; Oncology; Subgroup analysis; Internal medicine; Epidemiology; Case-control study; Demography; Publication bias; Gynecology; Cancer","score_opus":0.16305378488181962,"score_gpt":0.4273417605252685,"score_spread":0.26428797564344886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1817947240","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1342152,0.85867393,0.0028366575,0.00065419404,0.0004757804,0.00035741788,0.0016837086,0.00014910368,0.0009539309],"genre_scores_gemma":[0.82256925,0.17091249,0.0032507996,0.0005930761,0.0003854822,0.00048881694,0.0011686287,0.000050089377,0.0005814303],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99550784,0.00212921,0.00088480115,0.00074970274,0.0004915274,0.00023681858],"domain_scores_gemma":[0.992042,0.005335683,0.0010485962,0.0006142988,0.0007883752,0.00017107384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074216425,0.0021346929,0.008341741,0.0038954217,0.0006899294,0.0025063618,0.0016170001,0.0012409195,0.002762242],"category_scores_gemma":[0.012416275,0.0011552287,0.036324665,0.006543321,0.00045410744,0.00074927433,0.0008950569,0.0016836863,0.00025613583],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046837144,0.0000460356,0.04744472,0.026019903,0.91276205,0.00025263333,0.000061664396,0.0010308359,0.00065932167,0.00006916082,0.00050826115,0.006461732],"study_design_scores_gemma":[0.000367664,0.000155334,0.020762268,0.0011242903,0.9762976,0.0001293575,0.000028307559,0.00044893366,0.00017300624,0.000098529556,0.00039865787,0.000015896449],"about_ca_topic_score_codex":0.008623942,"about_ca_topic_score_gemma":0.012223995,"teacher_disagreement_score":0.008623942,"about_ca_system_score_codex":0.0012972238,"about_ca_system_score_gemma":0.0013903626,"threshold_uncertainty_score":0.039249837},"labels":[],"label_agreement":null},{"id":"W1829431903","doi":"10.1016/s0022-2275(20)33464-7","title":"Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis","year":2000,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Isotopomers; Biosynthesis; Deuterium; Chemistry; Cholesterol; Biochemistry; Physics; Organic chemistry; Enzyme; Nuclear physics; Molecule","score_opus":0.3802398926867185,"score_gpt":0.5481562739329916,"score_spread":0.16791638124627312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829431903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96883875,0.005172777,0.023961304,0.000071563685,0.000033628472,0.00004035497,0.00040908754,0.00008194612,0.0013905667],"genre_scores_gemma":[0.9758104,0.0017207261,0.02063646,0.00006669861,0.000023997902,0.00005848396,0.0004908002,0.000044739543,0.0011476476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995377,0.00017634044,0.000021826272,0.00012320367,0.00010489908,0.00003610872],"domain_scores_gemma":[0.99955887,0.00017235366,0.00008222561,0.000052588915,0.00008771522,0.000046274232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019767,0.00033210556,0.00036430306,0.0008605152,0.00021291558,0.0004952623,0.00021556555,0.00043513355,0.0007916877],"category_scores_gemma":[0.0010174055,0.00033095916,0.00016376737,0.0005194529,0.0002880185,0.00021671384,0.0002486484,0.00027429327,0.00028334014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028937894,0.00006429775,0.04835452,0.00014937988,0.000109017594,0.00015061296,0.00015614262,0.00020156798,0.9245854,0.00023848175,0.00013706445,0.022959646],"study_design_scores_gemma":[0.00020439406,0.0024192955,0.47557825,0.000042738204,0.00038645967,0.0030599304,0.000267402,0.008093265,0.5048515,0.0006268013,0.004391949,0.00007801914],"about_ca_topic_score_codex":0.0015652895,"about_ca_topic_score_gemma":0.0027513027,"teacher_disagreement_score":0.0015652895,"about_ca_system_score_codex":0.0002781781,"about_ca_system_score_gemma":0.0002790486,"threshold_uncertainty_score":0.005393088},"labels":[],"label_agreement":null},{"id":"W1838732593","doi":"10.1124/mol.58.4.747","title":"Duplications and Defects in the<i>CYP2A6</i>Gene: Identification, Genotyping, and In Vivo Effects on Smoking","year":2000,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse","keywords":"CYP2A6; Allele; Genotyping; Nicotine; Cotinine; Genotype; Genetics; Biology; Gene","score_opus":0.028214784637219735,"score_gpt":0.3774294290619727,"score_spread":0.349214644424753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1838732593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939645,0.00050939067,0.003180992,0.00021200911,0.00003163311,0.00005793619,0.0010408647,0.00011447029,0.0008881486],"genre_scores_gemma":[0.9949368,0.00039390454,0.0019513577,0.00013242746,0.000027560916,0.00006670216,0.0010272397,0.00015427818,0.0013097966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991836,0.00023757246,0.0001064768,0.00022400153,0.0001356455,0.000112712085],"domain_scores_gemma":[0.9985746,0.0005553943,0.00044167583,0.00017372119,0.000052008418,0.00020256928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031280128,0.0008605337,0.00064294285,0.0012334037,0.0003978245,0.0003028374,0.00052920374,0.001116623,0.003451153],"category_scores_gemma":[0.0011393694,0.0005256362,0.0010055931,0.00062446966,0.001103465,0.0002731273,0.00051666045,0.000945419,0.0006485583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002304892,0.00030745202,0.007184868,0.00007021232,0.00016807053,0.0032728706,0.00013731419,0.0007612741,0.97867304,0.0005181244,0.0003526868,0.0062491987],"study_design_scores_gemma":[0.00050580926,0.002976139,0.12918289,0.000050962983,0.00071324484,0.046997506,0.00031727744,0.003541007,0.81002384,0.000664745,0.004935857,0.00009074448],"about_ca_topic_score_codex":0.0022271983,"about_ca_topic_score_gemma":0.001794774,"teacher_disagreement_score":0.003451153,"about_ca_system_score_codex":0.0004333724,"about_ca_system_score_gemma":0.00031932566,"threshold_uncertainty_score":0.011545181},"labels":[],"label_agreement":null},{"id":"W1839698594","doi":"10.1111/j.1369-1600.2010.00287.x","title":"Pharmacogenetics of alcohol, nicotine and drug addiction treatments","year":2011,"lang":"en","type":"review","venue":"Addiction Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Addiction; Medicine; Drug; Pharmacotherapy; Naltrexone; Pharmacology; Nicotine; Psychiatry; Internal medicine; Opioid; Genetics; Biology; Gene; Genotype","score_opus":0.21330391609195812,"score_gpt":0.4835784193924277,"score_spread":0.27027450330046954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1839698594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23454097,0.59807193,0.0373001,0.031520262,0.0015501424,0.00045574404,0.005206004,0.00035534907,0.09099959],"genre_scores_gemma":[0.7593275,0.20361672,0.017313976,0.0053589665,0.0009666832,0.0003221509,0.0022660552,0.00009247665,0.010735452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984994,0.00076135626,0.0001221314,0.00018158347,0.00035621112,0.0000793349],"domain_scores_gemma":[0.9990038,0.00047173392,0.00024156911,0.00007784152,0.000154675,0.00005036103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011451402,0.00018284908,0.00062772987,0.0007688829,0.00019703466,0.00092376483,0.00029326853,0.00051316,0.002582562],"category_scores_gemma":[0.0029794783,0.0001237083,0.00056988397,0.0010974428,0.00039569227,0.00027639655,0.0003220012,0.00075490976,0.00053418806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005327441,0.00035056463,0.15284455,0.0029097092,0.0020740903,0.0010470449,0.00028985547,0.0021517081,0.013600038,0.030689461,0.014697092,0.7788131],"study_design_scores_gemma":[0.00015505918,0.00071397796,0.52320486,0.001936217,0.002430037,0.009219463,0.00040567745,0.0042346097,0.0103817545,0.056524877,0.39070433,0.000089226356],"about_ca_topic_score_codex":0.001506006,"about_ca_topic_score_gemma":0.0017905341,"teacher_disagreement_score":0.002582562,"about_ca_system_score_codex":0.00076210103,"about_ca_system_score_gemma":0.0009507209,"threshold_uncertainty_score":0.008639514},"labels":[],"label_agreement":null},{"id":"W1842977100","doi":"10.1002/9780470921920.edm119","title":"Current and Future Tools for Predicting Clinical Drug–Drug Interactions","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intertek (Canada)","funders":"","keywords":"Drug; Computer science; Drug development; Field (mathematics); Data science; Risk analysis (engineering); Computational biology; Medicine; Pharmacology; Biology; Mathematics","score_opus":0.07688309488247434,"score_gpt":0.4458639384986488,"score_spread":0.36898084361617445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842977100","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029300185,0.19524994,0.62862176,0.011238007,0.0016255094,0.0011739243,0.02572454,0.01952297,0.087543175],"genre_scores_gemma":[0.22189699,0.12206888,0.6030661,0.0024465835,0.0017597659,0.00094806444,0.023421103,0.0007602127,0.02363228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971539,0.0011248371,0.00027163205,0.00035473716,0.0010081148,0.00008676245],"domain_scores_gemma":[0.99418604,0.0031237865,0.000646555,0.00051704946,0.0013500137,0.00017653138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004906306,0.0018305262,0.0014914249,0.0057760417,0.0002739154,0.0037170348,0.0013484668,0.00083027134,0.018097159],"category_scores_gemma":[0.0110190725,0.00046281927,0.0010557496,0.0032969757,0.0004906551,0.0017613138,0.0011267312,0.0013212331,0.01092884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032789557,0.00024062158,0.019098483,0.0015993156,0.00035579444,0.0001785229,0.00005263762,0.0067012142,0.0044657467,0.009433609,0.02512632,0.9324199],"study_design_scores_gemma":[0.00030373968,0.0010611044,0.0467678,0.0033555445,0.0016240976,0.004774774,0.00041608844,0.23878245,0.036631983,0.09294617,0.572938,0.0003981985],"about_ca_topic_score_codex":0.0018253007,"about_ca_topic_score_gemma":0.001610582,"teacher_disagreement_score":0.018097159,"about_ca_system_score_codex":0.0006964858,"about_ca_system_score_gemma":0.0011835103,"threshold_uncertainty_score":0.060541034},"labels":[],"label_agreement":null},{"id":"W1861932861","doi":"10.1093/pch/15.9.571","title":"Baby boy blue – why is this newborn lethargic?","year":2010,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Children's Hospital of Western Ontario; University of Toronto","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.05129371163290666,"score_gpt":0.396338296081426,"score_spread":0.3450445844485194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861932861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43533954,0.050480485,0.0039042006,0.4178421,0.014689275,0.00023567602,0.00046259977,0.0006997446,0.0763464],"genre_scores_gemma":[0.867597,0.030869303,0.0038573723,0.071114324,0.0034781802,0.00005869765,0.00016378697,0.00014529444,0.02271594],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99957675,0.00007948022,0.00003951421,0.000071721035,0.00010418772,0.0001283067],"domain_scores_gemma":[0.99942446,0.00010749183,0.00009286581,0.00002243877,0.00009050287,0.00026224964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033288312,0.000593257,0.0006612827,0.0005540837,0.0018501141,0.0008926905,0.00061527715,0.0034445927,0.0038403943],"category_scores_gemma":[0.0029476604,0.00027489936,0.0003553522,0.000416076,0.001208658,0.0013889538,0.00068831054,0.0039251796,0.0013584205],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001090339,0.00007380192,0.015606356,0.00015972806,0.000025359132,0.9331717,0.0015640914,0.00008560095,0.001479123,0.0022050263,0.026880743,0.018639494],"study_design_scores_gemma":[0.0000130306635,0.00015838095,0.011322437,0.00041917592,0.000019133335,0.9545453,0.0037163077,0.00016748699,0.00047509416,0.002138298,0.026986785,0.000038664923],"about_ca_topic_score_codex":0.0072928183,"about_ca_topic_score_gemma":0.010701136,"teacher_disagreement_score":0.0072928183,"about_ca_system_score_codex":0.0009909185,"about_ca_system_score_gemma":0.00082706107,"threshold_uncertainty_score":0.014500737},"labels":[],"label_agreement":null},{"id":"W1867975073","doi":"10.1007/978-1-4614-3055-1_6","title":"Physiologically-Based Pharmacokinetic (PBPK) Models in Toxicity Testing and Risk Assessment","year":2012,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; In silico; Pharmacology; Biochemical engineering; Computational biology; Computer science; Chemistry; Medicine; Biology; Engineering","score_opus":0.34442742621845124,"score_gpt":0.558341622173602,"score_spread":0.2139141959551507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1867975073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080297765,0.95525587,0.039441947,0.0006877611,0.00033038566,0.00005196023,0.00025495526,0.00013782653,0.0030364117],"genre_scores_gemma":[0.008146973,0.9734797,0.015844764,0.0004099442,0.00034083505,0.00007932861,0.0002511325,0.000022328806,0.0014249414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936825,0.00017077658,0.00005971695,0.00010698917,0.0002694419,0.000024784738],"domain_scores_gemma":[0.9989742,0.0006735623,0.00011611776,0.000046138484,0.00016461848,0.000025446167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001826015,0.001969508,0.0034808943,0.0018685599,0.00025612264,0.0016824043,0.002233393,0.0019334473,0.0025749798],"category_scores_gemma":[0.0019927023,0.00062034605,0.001681181,0.0023629451,0.0008368056,0.001681816,0.0010065751,0.0027250564,0.002201843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001207183,0.00023997902,0.0004798013,0.012337329,0.00031475895,0.0003458804,0.000044056702,0.024423549,0.004443732,0.020231228,0.016701208,0.92031777],"study_design_scores_gemma":[0.000098154436,0.00050338526,0.0017004313,0.0050258953,0.0010090953,0.0028852138,0.000106569314,0.030553812,0.009070662,0.05290627,0.89591414,0.00022639996],"about_ca_topic_score_codex":0.0020914187,"about_ca_topic_score_gemma":0.0018804132,"teacher_disagreement_score":0.0034808943,"about_ca_system_score_codex":0.00092887285,"about_ca_system_score_gemma":0.0014413813,"threshold_uncertainty_score":0.009657025},"labels":[],"label_agreement":null},{"id":"W1877341189","doi":"10.1002/jps.24495","title":"Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug–Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Physiologically based pharmacokinetic modelling; CYP3A4; In vivo; Pharmacokinetics; Pharmacology; Drug-drug interaction; Chemistry; Drug; Drug metabolism; Medicine; Enzyme; Cytochrome P450; Biology; Biochemistry","score_opus":0.37766360271369076,"score_gpt":0.4895583486762489,"score_spread":0.11189474596255816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877341189","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09855224,0.0005601303,0.8979534,0.0002672433,0.000033585304,0.00007192626,0.00028655553,0.00052370224,0.0017511953],"genre_scores_gemma":[0.92556465,0.0005079872,0.0716089,0.000121319375,0.000022985812,0.00022837134,0.0002902501,0.00007266986,0.0015828849],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997451,0.000107256354,0.00001526791,0.000057031368,0.000058025686,0.000017356318],"domain_scores_gemma":[0.9993832,0.0004474881,0.00006408414,0.000027212758,0.000064991844,0.00001288749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055075466,0.00078348955,0.0010232315,0.0003081673,0.00025164726,0.0009418556,0.0007770938,0.0011213057,0.0007856423],"category_scores_gemma":[0.0017822048,0.0004110397,0.0009991736,0.00032612067,0.00024428847,0.0006243221,0.00029185467,0.0010266071,0.00034142943],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015476042,0.00009488478,0.0017765888,0.000088804154,0.00012158988,0.0001286551,0.000028739047,0.96040815,0.016607853,0.0015240439,0.00033259048,0.018733345],"study_design_scores_gemma":[0.000008747092,0.00004776126,0.00031963893,0.0000020446846,0.000022879263,0.000043221844,0.0000023144312,0.99758196,0.0014177408,0.00035522008,0.00019075777,0.000007668631],"about_ca_topic_score_codex":0.0057321843,"about_ca_topic_score_gemma":0.002676872,"teacher_disagreement_score":0.0057321843,"about_ca_system_score_codex":0.0006103168,"about_ca_system_score_gemma":0.0008455503,"threshold_uncertainty_score":0.0113976},"labels":[],"label_agreement":null},{"id":"W1884752701","doi":"10.1002/pbc.24932","title":"<i>VKORC1</i> and <i>CYP2C9</i> genotypes are predictors of warfarin‐related outcomes in children","year":2014,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; CYP2C9; Warfarin; Medicine; Dosing; Pharmacogenetics; Vitamin K epoxide reductase; Genotype; Cohort; Internal medicine; Atrial fibrillation; Genetics; Biology; Gene","score_opus":0.021630411946716905,"score_gpt":0.34129829576818566,"score_spread":0.31966788382146877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884752701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985429,0.00042202143,0.000118555676,0.00008927912,0.000005873677,0.000004868641,0.0005039042,0.000006615122,0.00030605422],"genre_scores_gemma":[0.99900407,0.00023723522,0.0002006682,0.00001752142,0.000010143812,0.000006386966,0.0004220694,0.000005586111,0.00009632454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951386,0.00011693993,0.00005649353,0.00011749619,0.000107645494,0.000087643704],"domain_scores_gemma":[0.9960855,0.00092548813,0.0023185702,0.00012334877,0.00018205216,0.0003650591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073527073,0.0004056598,0.00034335288,0.000605224,0.000277372,0.00055703765,0.00035864481,0.00044112044,0.002176259],"category_scores_gemma":[0.0031850971,0.00022329582,0.0006752785,0.0008817351,0.0004275499,0.0002917681,0.00032558758,0.00075019355,0.00026757695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045700024,0.0000046398827,0.99928635,0.000004130703,0.000016813077,0.000042549684,0.00001191154,0.000047539,0.0000829783,0.000009598715,0.000047448822,0.00040038937],"study_design_scores_gemma":[0.000005304824,0.000054472668,0.9989064,0.000009130893,0.00004156867,0.0005270499,0.000042023785,0.00015711643,0.00011030521,0.00002205431,0.00012216838,0.0000024548528],"about_ca_topic_score_codex":0.007694467,"about_ca_topic_score_gemma":0.0050828746,"teacher_disagreement_score":0.007694467,"about_ca_system_score_codex":0.00036183125,"about_ca_system_score_gemma":0.0005491794,"threshold_uncertainty_score":0.01529932},"labels":[],"label_agreement":null},{"id":"W1890529144","doi":"10.1111/jgh.12361","title":"Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short‐term remission in patients with ulcerative colitis treated with tacrolimus","year":2013,"lang":"en","type":"article","venue":"Journal of Gastroenterology and Hepatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Eisai Canada; Eisai","keywords":"CYP3A5; Ulcerative colitis; Pharmacokinetics; Gastroenterology; Medicine; Internal medicine; Tacrolimus; Trough level; Trough Concentration; CYP3A4; Pharmacology; Genotype; Cytochrome P450; Biology; Transplantation; Disease; Genetics; Metabolism","score_opus":0.02794258075012768,"score_gpt":0.33465730866329807,"score_spread":0.3067147279131704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1890529144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99947053,0.0003062214,0.000031759206,0.00002961159,0.0000026974194,0.0000018844426,0.000018389726,0.0000012371211,0.00013762509],"genre_scores_gemma":[0.9998288,0.000045050594,0.000028777986,0.000015044278,0.0000056962185,0.0000011548557,0.00003189415,7.200451e-7,0.000042783777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996332,0.0001272343,0.00005128469,0.00006582403,0.00006534705,0.000057233432],"domain_scores_gemma":[0.9988539,0.00039858738,0.00043875317,0.000053232176,0.000063630905,0.00019186304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040807,0.0001699667,0.0003540544,0.00024929908,0.00032653572,0.00035466856,0.000112929425,0.00033212928,0.0013069304],"category_scores_gemma":[0.0017183111,0.00013873306,0.0003504698,0.00028415903,0.00019368573,0.00023458674,0.00014414189,0.00041430484,0.00014024362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012383647,0.00009090122,0.99237084,0.0000107787555,0.00011702075,0.00024616986,0.000046454377,0.000067616704,0.0015245145,0.000011323079,0.000053343625,0.0042226054],"study_design_scores_gemma":[0.000023477573,0.0003126354,0.9985905,0.0000031279378,0.00005163591,0.0006410089,0.00003870912,0.00013809107,0.00011537005,0.000010601324,0.00007283525,0.0000020328682],"about_ca_topic_score_codex":0.0007761857,"about_ca_topic_score_gemma":0.0009807602,"teacher_disagreement_score":0.0013069304,"about_ca_system_score_codex":0.00018733546,"about_ca_system_score_gemma":0.000105247265,"threshold_uncertainty_score":0.0043720603},"labels":[],"label_agreement":null},{"id":"W1895335686","doi":"10.4212/cjhp.v55i3.578","title":"Formulary Considerations Related to Warfarin Interchangeability","year":2002,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Warfarin; Formulary; Medicine; Therapeutic index; Warfarin Sodium; Antithrombotic; Generic drug; Drug; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.15438704824613905,"score_gpt":0.40715268901986434,"score_spread":0.2527656407737253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895335686","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13937561,0.12386642,0.0442122,0.23729217,0.008763631,0.0015384746,0.0015421476,0.0011752308,0.4422341],"genre_scores_gemma":[0.7429064,0.040471237,0.07072901,0.085958965,0.012364568,0.0008260759,0.0016667277,0.0005711696,0.044505853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.979549,0.006001457,0.0023576461,0.00083616143,0.010370438,0.00088529935],"domain_scores_gemma":[0.9704071,0.014254724,0.0049263733,0.0019025382,0.0076619266,0.0008472406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015471663,0.0006148378,0.00067467126,0.003027615,0.0020344113,0.0036598828,0.0024795344,0.0031973897,0.010949554],"category_scores_gemma":[0.062437866,0.0003466275,0.0008725496,0.0017016901,0.0027445233,0.0026627888,0.0018252835,0.0023304017,0.0032715502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019199197,0.00029085283,0.021361876,0.0013307282,0.00011298381,0.011363976,0.0013697561,0.00107159,0.008835754,0.099416256,0.11861632,0.7343099],"study_design_scores_gemma":[0.00022487417,0.0011323424,0.0093541825,0.0017822351,0.00023306003,0.03634335,0.0007109682,0.0022738923,0.01393171,0.024599422,0.90935063,0.00006324004],"about_ca_topic_score_codex":0.007160114,"about_ca_topic_score_gemma":0.008513874,"teacher_disagreement_score":0.015471663,"about_ca_system_score_codex":0.0050619934,"about_ca_system_score_gemma":0.0034580003,"threshold_uncertainty_score":0.08182299},"labels":[],"label_agreement":null},{"id":"W1904768480","doi":"10.1111/j.1365-2125.2010.03772.x","title":"Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism","year":2010,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Repaglinide; Gemfibrozil; Glucuronidation; Chemistry; Pharmacology; Glucuronide; Microsome; Metabolite; Drug interaction; Nateglinide; Pharmacokinetics; Biochemistry; Endocrinology; Medicine; Enzyme; Metformin; Cholesterol","score_opus":0.07043696450870818,"score_gpt":0.4751353786480097,"score_spread":0.4046984141393015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904768480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6841349,0.27199998,0.016511047,0.009810532,0.0007132132,0.00041770338,0.0010996504,0.00045150722,0.014861396],"genre_scores_gemma":[0.9529401,0.03628792,0.0035780398,0.0014561471,0.00062025397,0.00008227667,0.00057157583,0.00005122471,0.0044123963],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912494,0.00035410785,0.00008948499,0.00012656456,0.00019808912,0.00010688461],"domain_scores_gemma":[0.99853015,0.00051337504,0.0006192618,0.000111585665,0.00015566497,0.00006991382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012180802,0.0007454147,0.0012268376,0.0005591252,0.00018756175,0.0010842765,0.0004472044,0.000983187,0.0057958295],"category_scores_gemma":[0.0017263573,0.00022603208,0.0013187897,0.00051372993,0.00031198343,0.0007992058,0.00033294436,0.0006244685,0.0006954448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010787385,0.0011325108,0.18192327,0.013835057,0.0077582216,0.018402122,0.00067619124,0.0032934775,0.227579,0.006403598,0.013927011,0.51428217],"study_design_scores_gemma":[0.0012944571,0.008542088,0.41238013,0.001155856,0.012041311,0.07649505,0.0007270244,0.030492054,0.2920161,0.009327686,0.15528758,0.00024064527],"about_ca_topic_score_codex":0.00064006285,"about_ca_topic_score_gemma":0.0009971904,"teacher_disagreement_score":0.0057958295,"about_ca_system_score_codex":0.00043297163,"about_ca_system_score_gemma":0.0004962367,"threshold_uncertainty_score":0.019389033},"labels":[],"label_agreement":null},{"id":"W1910111405","doi":"10.1002/pds.3571","title":"Validation of patient‐reported warfarin dose in a prospective incident cohort study","year":2014,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Warfarin; Medicine; Concordance; Dosing; Observational study; CYP2C9; Prospective cohort study; Internal medicine; Cohort study; Cohort; Population; Atrial fibrillation","score_opus":0.06433469346619204,"score_gpt":0.42044968127288473,"score_spread":0.3561149878066927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910111405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378503,0.0007884443,0.009531093,0.0002363315,0.00007320035,0.00060778734,0.003371728,0.000055105862,0.0015512662],"genre_scores_gemma":[0.9935488,0.00017256307,0.0032436368,0.0001898335,0.000034888348,0.00027536476,0.0022793375,0.000015230081,0.00024033275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95133895,0.030021338,0.0040778886,0.0043848413,0.009447676,0.00072921993],"domain_scores_gemma":[0.89063835,0.03948518,0.028150054,0.022291223,0.018028062,0.0014071597],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043470982,0.0006277969,0.0007124497,0.0013495699,0.0009833393,0.0015175178,0.0019060367,0.0009066473,0.00081753935],"category_scores_gemma":[0.10023871,0.0004003889,0.00098928,0.0021501868,0.0010257497,0.0005257983,0.0007328098,0.00079291983,0.00029218956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026000923,0.000042406053,0.99712485,0.000040767427,0.00032878562,0.00002544811,0.00019523832,0.00013181579,0.00021148643,0.00006015218,0.00015755535,0.0014214263],"study_design_scores_gemma":[0.000050050174,0.00018928267,0.99701416,0.00004403979,0.0001320582,0.00011010498,0.000072166884,0.0013334772,0.00029337255,0.000035256566,0.0007151547,0.000010855753],"about_ca_topic_score_codex":0.088969186,"about_ca_topic_score_gemma":0.06088832,"teacher_disagreement_score":0.956529,"about_ca_system_score_codex":0.0017052523,"about_ca_system_score_gemma":0.0029683516,"threshold_uncertainty_score":0.22989923},"labels":[],"label_agreement":null},{"id":"W1916407220","doi":"10.1002/bdd.1934","title":"Dealing with the complex drug–drug interactions: Towards mechanistic models","year":2014,"lang":"en","type":"review","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Drug; Pharmacokinetics; Pharmacology; Drug metabolism; Disposition; Transporter; Drug development; Medicine; Computational biology; Chemistry; Psychology; Biology","score_opus":0.22091946795104653,"score_gpt":0.4804788298779997,"score_spread":0.25955936192695317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1916407220","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010305322,0.08571241,0.8586677,0.016806629,0.0010194911,0.00047379418,0.0015678159,0.0006693342,0.024777405],"genre_scores_gemma":[0.20035477,0.3603005,0.40692756,0.010204597,0.0029260805,0.0024904674,0.0042076064,0.00038080607,0.012207592],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998314,0.0007474398,0.00013443701,0.00024208495,0.00047653465,0.00008545759],"domain_scores_gemma":[0.99721956,0.0017753646,0.00031819244,0.0001709454,0.0004355991,0.00008029375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035736046,0.0028262509,0.0021703648,0.001473059,0.0004890959,0.0024953494,0.0027501502,0.0027304331,0.0024512329],"category_scores_gemma":[0.0054888036,0.00095270626,0.0021941962,0.0010145584,0.0015796617,0.0053413706,0.002106529,0.0049937665,0.0017180411],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117866424,0.00037857585,0.0025330875,0.0061470116,0.0005712768,0.0006885813,0.00039451403,0.3890617,0.009528636,0.45667344,0.017795745,0.11610956],"study_design_scores_gemma":[0.000044529388,0.00036073555,0.00075638015,0.001028645,0.0003205034,0.00052180124,0.00017775196,0.36535865,0.002943971,0.46937785,0.15900117,0.00010792687],"about_ca_topic_score_codex":0.0031679992,"about_ca_topic_score_gemma":0.0018154113,"teacher_disagreement_score":0.0035736046,"about_ca_system_score_codex":0.0013223283,"about_ca_system_score_gemma":0.0025649653,"threshold_uncertainty_score":0.018899262},"labels":[],"label_agreement":null},{"id":"W1918770470","doi":"10.1111/bph.12997","title":"Differential activation of human constitutive androstane receptor and its<scp>SV23</scp>and<scp>SV24</scp>splice variants by rilpivirine and etravirine","year":2014,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Etravirine; Rilpivirine; Constitutive androstane receptor; Transactivation; Efavirenz; Chemistry; Pharmacology; Nevirapine; Biology; Nuclear receptor; Gene expression; Biochemistry; Reverse transcriptase; Virology; Gene; Transcription factor; Human immunodeficiency virus (HIV); RNA","score_opus":0.03422792534136944,"score_gpt":0.35901022668496707,"score_spread":0.32478230134359765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918770470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975412,0.0008386142,0.000481229,0.000031864904,0.000012832491,0.0000087194,0.00024447718,0.000011728079,0.00082933827],"genre_scores_gemma":[0.9975193,0.00038037173,0.00053755054,0.000020710206,0.000006944284,0.000013756609,0.00066186034,0.000007428087,0.00085211295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978334,0.00005233303,0.000019866031,0.000042043874,0.000061362145,0.00004095658],"domain_scores_gemma":[0.9999224,0.000021895186,0.0000155913,0.000013620701,0.0000107123615,0.000015746722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015472663,0.00015778583,0.00013856859,0.00010375048,0.00012525782,0.00029517824,0.00015289585,0.00013957857,0.0013639845],"category_scores_gemma":[0.00013052214,0.00009113568,0.0002655114,0.00012946271,0.00019635164,0.00012701591,0.00008005556,0.00030835453,0.0004039898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002361027,0.000023771505,0.000367385,0.0000192074,0.000008975615,0.000044222015,0.000013670421,0.00004940762,0.99835664,0.00011594144,0.000036687783,0.0007279463],"study_design_scores_gemma":[0.000024320614,0.00032704894,0.0072262343,0.0000029788166,0.000022625009,0.00071512535,0.000040946725,0.00077517267,0.9889129,0.00004079821,0.0019066372,0.000005224796],"about_ca_topic_score_codex":0.00046043383,"about_ca_topic_score_gemma":0.00055591954,"teacher_disagreement_score":0.0013639845,"about_ca_system_score_codex":0.00027192972,"about_ca_system_score_gemma":0.00012676713,"threshold_uncertainty_score":0.0045630336},"labels":[],"label_agreement":null},{"id":"W1919247819","doi":"10.1016/j.clpt.2005.12.124","title":"OV-A-3Genetic determinants of the hepatic expression of the phase II conjugating UGT1A3 enzyme","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Enzyme; Chemistry; Phase (matter); Biochemistry; Pharmacology; Medicine; Organic chemistry","score_opus":0.16431138991915625,"score_gpt":0.5032590767554878,"score_spread":0.3389476868363315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919247819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997247,0.00034860254,0.0011264951,0.000044483666,0.000015657452,0.00001662709,0.00054817204,0.00002383352,0.00062909606],"genre_scores_gemma":[0.9965204,0.00014216671,0.0008953633,0.000027871429,0.000012187674,0.00002212027,0.0011504018,0.000024973499,0.0012044604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998534,0.00002608621,0.000013279793,0.000046288747,0.000022416374,0.00003862203],"domain_scores_gemma":[0.9998307,0.000039780527,0.000054954533,0.000026717724,0.0000143798225,0.0000333905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001369517,0.00020354998,0.00015956267,0.00028534923,0.00012806752,0.00022424739,0.000108816785,0.00017153652,0.0048486665],"category_scores_gemma":[0.0002307037,0.00009369558,0.000248339,0.00019521794,0.00019831955,0.000081444115,0.00013290056,0.00035979014,0.00079355325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010078453,0.000107655746,0.0069981623,0.000020977253,0.000017380275,0.00013798641,0.000030576317,0.00004208613,0.9877862,0.00015991263,0.00008547801,0.0036057562],"study_design_scores_gemma":[0.00030787598,0.0028093823,0.28958488,0.00002397337,0.00019348472,0.0042240215,0.00017052428,0.0018825935,0.68817544,0.0006423042,0.011964398,0.000021154932],"about_ca_topic_score_codex":0.0006678995,"about_ca_topic_score_gemma":0.00044389116,"teacher_disagreement_score":0.0048486665,"about_ca_system_score_codex":0.00016437829,"about_ca_system_score_gemma":0.00013360118,"threshold_uncertainty_score":0.01622039},"labels":[],"label_agreement":null},{"id":"W1932022242","doi":"10.1016/s0022-3565(24)35325-x","title":"Potentiation of Oxygen-Induced Lung Injury in Rats by the Mechanism-Based Cytochrome P-450 Inhibitor, 1-Aminobenzotriazole","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Hyperoxia; Lung; Cytochrome P450; Microsome; Oxygen toxicity; Pharmacology; Cytochrome; Internal medicine; Chemistry; Endocrinology; Enzyme; Biology; Medicine; Biochemistry","score_opus":0.04850392889263474,"score_gpt":0.4055658496335674,"score_spread":0.3570619207409327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932022242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678016,0.0009152591,0.0008716165,0.00025761127,0.000106402964,0.00004950246,0.00026520435,0.00012343102,0.0006308901],"genre_scores_gemma":[0.9945498,0.0014947111,0.0006513163,0.00012250728,0.00006559081,0.000088129775,0.00050358387,0.000024156217,0.0025002235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972266,0.000037651833,0.000015870446,0.00004461835,0.00006160686,0.000117612],"domain_scores_gemma":[0.9992674,0.00008288942,0.00022071954,0.00010311211,0.00007677343,0.00024918542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002778799,0.0013210563,0.0008901474,0.00095323793,0.00054896146,0.0003267699,0.0005670989,0.00088758295,0.0024164566],"category_scores_gemma":[0.0004236775,0.000553175,0.0006360957,0.0003142923,0.0009800867,0.00072632905,0.00034661277,0.0020079557,0.00041491532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021383388,0.0025523608,0.0020291195,0.0001509381,0.00006889787,0.00054853666,0.00012675473,0.00030307664,0.963597,0.0003320961,0.00034477958,0.008563161],"study_design_scores_gemma":[0.00061529863,0.027851587,0.021215713,0.000026706715,0.00019532652,0.000480715,0.00018470529,0.0013513884,0.94680214,0.00028591516,0.0009536479,0.000036783953],"about_ca_topic_score_codex":0.0022442332,"about_ca_topic_score_gemma":0.0039303806,"teacher_disagreement_score":0.0024164566,"about_ca_system_score_codex":0.00054159923,"about_ca_system_score_gemma":0.00090881134,"threshold_uncertainty_score":0.00808388},"labels":[],"label_agreement":null},{"id":"W1933983447","doi":"10.1139/cjpp-2012-0334","title":"Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"In vivo; In vitro; Chemistry; Human plasma; Metabolic clearance rate; Plasma; Dispersion (optics); Distribution (mathematics); Pharmacokinetics; Chromatography; Biophysics; Biochemistry; Pharmacology; Biology; Mathematics","score_opus":0.06402301019181372,"score_gpt":0.3495859931400059,"score_spread":0.28556298294819216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933983447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8934105,0.0049425317,0.09940863,0.00016402674,0.00004490302,0.00010117758,0.00061141094,0.00044039742,0.00087644183],"genre_scores_gemma":[0.98079944,0.0011388207,0.016590022,0.00005669511,0.000011318008,0.00006138621,0.00053368625,0.000029817047,0.0007788136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967444,0.00015355136,0.000018141916,0.00006976907,0.000064160624,0.000019995352],"domain_scores_gemma":[0.999355,0.0003369294,0.00010462846,0.00006296255,0.00011243916,0.000028031433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077974534,0.00054746337,0.0006646978,0.00034666975,0.000090767506,0.0005006011,0.00021135209,0.0006203454,0.0005345517],"category_scores_gemma":[0.0018872613,0.00021080769,0.0005438998,0.00022533449,0.00019378807,0.00025406337,0.00024958875,0.00043271523,0.0004362061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005404639,0.00034177085,0.038123626,0.0005784057,0.00036605468,0.0010007287,0.00014959704,0.21832053,0.6657083,0.00048150672,0.000681062,0.06884376],"study_design_scores_gemma":[0.0001312909,0.002804081,0.016102074,0.000023114118,0.0002498862,0.0008425081,0.00006721773,0.46829385,0.509442,0.0004061185,0.001577972,0.00005989797],"about_ca_topic_score_codex":0.0021853433,"about_ca_topic_score_gemma":0.001511055,"teacher_disagreement_score":0.0021853433,"about_ca_system_score_codex":0.00040211322,"about_ca_system_score_gemma":0.00039064742,"threshold_uncertainty_score":0.004345238},"labels":[],"label_agreement":null},{"id":"W1947995207","doi":"10.4212/cjhp.v61i2.129","title":"Stockley’s Drug Interactions Pocket Companion, 2007","year":2008,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Drug; Pharmacology","score_opus":0.10031288708434959,"score_gpt":0.40080807988973066,"score_spread":0.30049519280538106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947995207","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002053625,0.07195346,0.003629231,0.09121232,0.034528077,0.00040698258,0.009211185,0.0028534487,0.78415173],"genre_scores_gemma":[0.0050258352,0.019308671,0.0020798796,0.012264258,0.009711195,0.00006155249,0.0019279863,0.00022890427,0.9493916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990133,0.00013993605,0.00007898503,0.00007389635,0.0006101655,0.000083777384],"domain_scores_gemma":[0.99625707,0.0008296881,0.00028610212,0.00021835712,0.0016088127,0.0008000543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011932065,0.00082916836,0.0011995016,0.002095449,0.0007114242,0.0024854797,0.0010432403,0.003253292,0.22907762],"category_scores_gemma":[0.005064309,0.0005414508,0.000774002,0.0011409199,0.00041948754,0.0015094846,0.0008926896,0.0034038918,0.114595816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053946584,0.000024164976,0.0001237422,0.00006756778,0.000006367033,0.0000871381,0.0000040067853,0.000026943457,0.00009221813,0.0002311985,0.90736336,0.0919193],"study_design_scores_gemma":[0.000044886518,0.000047084784,0.001153375,0.0001360492,0.0000151936265,0.00036645913,0.00000834765,0.00015217386,0.00013411047,0.00048725135,0.99744606,0.000009093837],"about_ca_topic_score_codex":0.006675571,"about_ca_topic_score_gemma":0.03582851,"teacher_disagreement_score":0.22907762,"about_ca_system_score_codex":0.0011548685,"about_ca_system_score_gemma":0.0025044673,"threshold_uncertainty_score":0.766341},"labels":[],"label_agreement":null},{"id":"W1958070321","doi":"10.1002/clc.22200","title":"Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization","year":2013,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Pharmacogenetics; Precision medicine; Personalized medicine; Pharmacogenomics; Intensive care medicine; Disease; Pharmacodynamics; Clinical pharmacology; Pharmacology; Bioinformatics; Internal medicine; Pharmacokinetics; Genotype; Pathology","score_opus":0.19093092557257357,"score_gpt":0.46416457451257137,"score_spread":0.2732336489399978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1958070321","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001456775,0.3305839,0.02680049,0.63240695,0.0035446049,0.000039241128,0.00017240937,0.0002058142,0.0047899033],"genre_scores_gemma":[0.07476757,0.6539514,0.063039914,0.16556758,0.038678944,0.00026757363,0.00027703523,0.00026951052,0.0031805425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97850066,0.012847435,0.0014311841,0.0016981912,0.0049943565,0.00052825245],"domain_scores_gemma":[0.83380127,0.14029135,0.0031731506,0.0070463573,0.012014628,0.0036732082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08421796,0.0017177379,0.0065885265,0.0027638937,0.0021446978,0.010105206,0.003807618,0.011085592,0.005374533],"category_scores_gemma":[0.088364966,0.0010592766,0.0018730788,0.002053253,0.018085945,0.027397003,0.0076440326,0.026212534,0.002913436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039573794,0.0002670816,0.0061694784,0.004149862,0.0007422635,0.0004885281,0.0011030833,0.0025184473,0.001209226,0.2734914,0.08241284,0.62705207],"study_design_scores_gemma":[0.00011629285,0.00039489396,0.0034279432,0.00616218,0.00035849944,0.0007510025,0.0013435661,0.0027782472,0.0003600852,0.7704618,0.21365872,0.00018656654],"about_ca_topic_score_codex":0.0037315413,"about_ca_topic_score_gemma":0.00303178,"teacher_disagreement_score":0.08421796,"about_ca_system_score_codex":0.0047890386,"about_ca_system_score_gemma":0.0123308785,"threshold_uncertainty_score":0.44539243},"labels":[],"label_agreement":null},{"id":"W1963797800","doi":"10.1002/jbt.20103","title":"Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR","year":2006,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"CYP1A2; Gene isoform; Cytochrome P450; Real-time polymerase chain reaction; Messenger RNA; Inducer; Molecular biology; Gene expression; Biology; CYP2E1; Chemistry; Biochemistry; Gene; Enzyme","score_opus":0.04918967283824594,"score_gpt":0.37894300831280103,"score_spread":0.3297533354745551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963797800","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35812175,0.008343332,0.61230266,0.00035337647,0.00055968954,0.0023202903,0.0088847,0.0028502033,0.006263956],"genre_scores_gemma":[0.2522437,0.00768349,0.6992754,0.00034506147,0.0003664059,0.007242609,0.01626844,0.00094855146,0.015626317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694175,0.0006429907,0.00035950632,0.00096371054,0.0007886769,0.00030332722],"domain_scores_gemma":[0.9979231,0.00082247617,0.00034851398,0.0002706697,0.000543853,0.00009132321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025408743,0.002486816,0.0011274328,0.002060292,0.00057340093,0.0008896454,0.0008488562,0.00087158533,0.0046974556],"category_scores_gemma":[0.0012671195,0.001006322,0.0012135971,0.0020293263,0.0010869623,0.00065012,0.00043172244,0.0021125185,0.0022814677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008931782,0.00006663496,0.00020132304,0.00012682786,0.000015284031,0.000023730758,0.00003995332,0.00009871997,0.99634403,0.00010914389,0.000055901604,0.0028290409],"study_design_scores_gemma":[0.00004922458,0.00074376,0.0021363574,0.000030057086,0.000108649576,0.00015193937,0.00003754815,0.0017529193,0.9899775,0.0002125327,0.0047732494,0.000026217229],"about_ca_topic_score_codex":0.0003657795,"about_ca_topic_score_gemma":0.00095224625,"teacher_disagreement_score":0.0046974556,"about_ca_system_score_codex":0.00052743766,"about_ca_system_score_gemma":0.000640112,"threshold_uncertainty_score":0.015714526},"labels":[],"label_agreement":null},{"id":"W1964281506","doi":"10.4155/bio.09.168","title":"Opinion: Microdosing: Safer Clinical Trials and Fewer Animal Tests","year":2010,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Dr Hadwen Trust for Humane Research","keywords":"SAFER; Clinical trial; Animal testing; Pharmacology; Medicine; Computer science; Biology; Internal medicine; Computer security","score_opus":0.36628675302535707,"score_gpt":0.5806299406802352,"score_spread":0.21434318765487814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964281506","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022086862,0.011914577,0.0017526427,0.8986021,0.0782109,0.00006625799,0.00026224542,0.00024271394,0.008727642],"genre_scores_gemma":[0.0032251414,0.027195232,0.0035264667,0.8423795,0.09195458,0.00012682193,0.00032263043,0.0002309706,0.031038668],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9850883,0.003248589,0.001308561,0.0012302961,0.008371233,0.0007530747],"domain_scores_gemma":[0.93096054,0.028878532,0.0049425606,0.0031607389,0.027818229,0.004239327],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020503325,0.0013846805,0.0015727855,0.001288034,0.0017716492,0.0087000225,0.003508788,0.027611658,0.05213883],"category_scores_gemma":[0.054213643,0.00089305884,0.0019696502,0.0015421779,0.006496525,0.012507126,0.0018235936,0.038307004,0.054151136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007883398,0.000029033254,0.00008436353,0.00029715087,0.000017360853,0.000067448156,0.00003670525,0.000031721367,0.00041229583,0.0036162545,0.9681769,0.0271519],"study_design_scores_gemma":[0.000055718006,0.000054549415,0.0002959518,0.00033637704,0.000026754426,0.00017409163,0.00011755142,0.00008907627,0.00041759064,0.0050472077,0.99334735,0.000037685626],"about_ca_topic_score_codex":0.0017278428,"about_ca_topic_score_gemma":0.0022994352,"teacher_disagreement_score":0.97949666,"about_ca_system_score_codex":0.002961781,"about_ca_system_score_gemma":0.004696727,"threshold_uncertainty_score":0.17442179},"labels":[],"label_agreement":null},{"id":"W1964371322","doi":"10.1139/y08-088","title":"Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidade de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Ketoconazole; Chemistry; Quinidine; Fluvoxamine; Pharmacology; Pharmacokinetics; Drug interaction; Metabolism; CYP3A4; CYP2D6; CYP3A; Citalopram; Endocrinology; Cytochrome P450; Receptor; Biochemistry; Medicine; Fluoxetine","score_opus":0.05422045697016994,"score_gpt":0.35323263445877995,"score_spread":0.29901217748861003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964371322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685115,0.0010024112,0.0005061761,0.00013890774,0.000051570358,0.000025650885,0.0004141464,0.00008735289,0.00092265854],"genre_scores_gemma":[0.9917971,0.0023468053,0.0016714943,0.00013721522,0.00004901816,0.000086709406,0.00066638977,0.000047809826,0.0031972926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996878,0.000056293487,0.000023303348,0.000065850116,0.00005403201,0.00011269897],"domain_scores_gemma":[0.99948716,0.00006147369,0.0001461179,0.00006498242,0.000058814494,0.0001814145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023518223,0.00084356504,0.00070912443,0.0006275851,0.00026169408,0.00033332137,0.0003025883,0.00043158463,0.001635521],"category_scores_gemma":[0.00034959422,0.0004876777,0.0006491721,0.00025774923,0.00050828,0.0005015865,0.00022309514,0.0010995059,0.0005913881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013220558,0.0011079619,0.0014525966,0.00007923213,0.00006897784,0.00030329073,0.000098660064,0.00028338068,0.9754321,0.00013767974,0.0003075024,0.007508107],"study_design_scores_gemma":[0.0004235261,0.014271907,0.016196437,0.000014546213,0.00019182067,0.00040954613,0.00015109961,0.0017497623,0.9643098,0.000105610045,0.0021222867,0.00005367944],"about_ca_topic_score_codex":0.0034769746,"about_ca_topic_score_gemma":0.004537245,"teacher_disagreement_score":0.0034769746,"about_ca_system_score_codex":0.00047159448,"about_ca_system_score_gemma":0.00065061834,"threshold_uncertainty_score":0.006913483},"labels":[],"label_agreement":null},{"id":"W1964571784","doi":"10.1016/s1040-0486(01)70007-5","title":"Drug interactions/P450","year":2001,"lang":"en","type":"article","venue":"Current Problems in Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Pharmacology","score_opus":0.15149489478162362,"score_gpt":0.4669930212480249,"score_spread":0.3154981264664013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964571784","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055246264,0.41000056,0.022034086,0.035916805,0.0054992894,0.00067564595,0.0061172135,0.0029403898,0.46156973],"genre_scores_gemma":[0.524909,0.23737326,0.012542707,0.017897336,0.011587593,0.00028100357,0.0052076075,0.0005370468,0.18966448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985324,0.00044926602,0.00013297563,0.0002407274,0.00052231946,0.00012225407],"domain_scores_gemma":[0.9988543,0.0003318194,0.00028576428,0.00016915302,0.00025495127,0.000104067345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011214232,0.00088220695,0.00075428706,0.0012904137,0.00058145064,0.0015842724,0.00051290134,0.0010061815,0.048050288],"category_scores_gemma":[0.0025282719,0.0002237677,0.0011202936,0.001194436,0.0005430839,0.0008613397,0.00062960107,0.0018284885,0.015498109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074408634,0.00040883105,0.015361462,0.0024978346,0.00053696596,0.006927054,0.0000808464,0.00020567545,0.0133431135,0.008159185,0.089528985,0.862206],"study_design_scores_gemma":[0.00021718767,0.0009124134,0.030238857,0.0005455103,0.0006207338,0.05362899,0.00010698781,0.00066441234,0.019479813,0.009191343,0.884358,0.00003560305],"about_ca_topic_score_codex":0.0010884808,"about_ca_topic_score_gemma":0.001576026,"teacher_disagreement_score":0.048050288,"about_ca_system_score_codex":0.0006053218,"about_ca_system_score_gemma":0.000682129,"threshold_uncertainty_score":0.16074419},"labels":[],"label_agreement":null},{"id":"W1964732626","doi":"10.1021/tx800177k","title":"Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash","year":2008,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chemistry; Quinone methide; Metabolite; Rash; Hydroxylation; Pharmacology; Stereochemistry; Metabolic pathway; Metabolism; Quinone; Biochemistry; Enzyme; Medicine; Dermatology","score_opus":0.4167828139448221,"score_gpt":0.529682845843989,"score_spread":0.11290003189916686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964732626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982656,0.0018952434,0.009662506,0.00018728871,0.000045344626,0.000121457924,0.0003811755,0.00013831617,0.0049127312],"genre_scores_gemma":[0.9922036,0.001243261,0.004228182,0.000069189184,0.000011481842,0.000032102304,0.000348625,0.000013197761,0.0018503498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999928,0.000015328833,0.0000049657815,0.000011256281,0.000024686207,0.000015769308],"domain_scores_gemma":[0.99992955,0.00001362259,0.000017190752,0.000014252872,0.000011776469,0.000013652959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079053265,0.00023472747,0.00012867246,0.00020797193,0.00011301313,0.00013779227,0.00011668456,0.0002527447,0.0013336786],"category_scores_gemma":[0.000167837,0.00011642437,0.00025154438,0.00008657243,0.00012644105,0.00010791663,0.000099632976,0.00032907864,0.00025901943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011076432,0.00002214845,0.0007724312,0.00002265177,0.000007932924,0.00030338645,0.000008180754,0.00005556926,0.9957632,0.00012382229,0.000024637367,0.002785243],"study_design_scores_gemma":[0.00002585378,0.0006310826,0.019350665,0.0000072166777,0.00003037573,0.0026785305,0.000026125226,0.0015377825,0.9729547,0.00018447134,0.0025648228,0.00000841535],"about_ca_topic_score_codex":0.000931518,"about_ca_topic_score_gemma":0.00079365727,"teacher_disagreement_score":0.0013336786,"about_ca_system_score_codex":0.00016704877,"about_ca_system_score_gemma":0.0001684236,"threshold_uncertainty_score":0.004461646},"labels":[],"label_agreement":null},{"id":"W1964983051","doi":"10.1124/dmd.31.2.202","title":"Comparison of the Formation of N-Alkylprotoporphyrin IX after Interaction of Porphyrinogenic Xenobiotics with Single cDNA-Expressed Human P450 Enzymes in Microsomes Prepared from Baculovirus-Infected Insect Cells and Human Lymphoblastoid Cell Lines+","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Microsome; Xenobiotic; CYP1A2; Cytochrome P450; Complementary DNA; Enzyme; Biochemistry; CYP3A4; Biology; CYP2B6; Isozyme; Molecular biology; Chemistry; Gene","score_opus":0.034886315928599025,"score_gpt":0.33663304785152715,"score_spread":0.3017467319229281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964983051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841953,0.0009921947,0.0064140926,0.000091163114,0.000059859824,0.000054055025,0.000750235,0.00015231594,0.0030665526],"genre_scores_gemma":[0.98720866,0.0004379481,0.0030505336,0.000030314302,0.000021596252,0.000049952818,0.0023509732,0.000053138407,0.006796914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952316,0.00015814605,0.000027034761,0.00010359364,0.000085314874,0.00010273895],"domain_scores_gemma":[0.9993623,0.0002715289,0.000098936616,0.000088315435,0.000100755184,0.000078208526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006005003,0.0006844867,0.0005395048,0.0005020036,0.00044179987,0.00042929134,0.00034202661,0.0005772328,0.0024522196],"category_scores_gemma":[0.00079695886,0.0004019507,0.0008301059,0.00041002277,0.00036357983,0.0004374532,0.00027745185,0.0006558907,0.0008749845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010899139,0.000055865512,0.0006152478,0.00006313288,0.00004317084,0.00015790935,0.00005372831,0.0003174955,0.9956201,0.0002729496,0.000087773864,0.0016226735],"study_design_scores_gemma":[0.000009823344,0.00024019869,0.0030117757,0.0000028556415,0.000022086933,0.00017850018,0.000024873607,0.0007532599,0.9952254,0.00003711062,0.0004883764,0.0000056729455],"about_ca_topic_score_codex":0.0024861915,"about_ca_topic_score_gemma":0.0015832952,"teacher_disagreement_score":0.0024861915,"about_ca_system_score_codex":0.0006485469,"about_ca_system_score_gemma":0.0004944222,"threshold_uncertainty_score":0.0082035065},"labels":[],"label_agreement":null},{"id":"W1965061440","doi":"10.1002/cbic.201200524","title":"Type II Ligands as Chemical Auxiliaries To Favor Enzymatic Transformations by P450 2E1","year":2012,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Biocatalysis; Enzyme; Combinatorial chemistry; Substrate (aquarium); Active site; Stereochemistry; Biochemistry; Catalysis; Biology; Reaction mechanism","score_opus":0.07344985078902708,"score_gpt":0.424801213434592,"score_spread":0.3513513626455649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965061440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9226659,0.0030898447,0.054227002,0.00086581707,0.00017985774,0.00021958527,0.000413379,0.00076155504,0.017577142],"genre_scores_gemma":[0.9789956,0.0013897773,0.013810856,0.0002826136,0.000048458613,0.000090215784,0.00020641304,0.000102629056,0.005073559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973565,0.000094917,0.000017423868,0.000056084144,0.00004316329,0.000052827098],"domain_scores_gemma":[0.99981374,0.000066687484,0.000050132494,0.00002175098,0.000022161417,0.00002553375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037623022,0.00039397817,0.00023393678,0.00015878513,0.00017700519,0.00038288586,0.00026879634,0.00034563013,0.0017252266],"category_scores_gemma":[0.00047263992,0.00022637758,0.00019263814,0.00018730116,0.00023808434,0.00050442776,0.00035870413,0.0007678783,0.0007364082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004049459,0.00009442146,0.00042759595,0.00016503902,0.000014492364,0.00024087464,0.00009129709,0.0017280186,0.98099226,0.0039813947,0.00082058384,0.01103904],"study_design_scores_gemma":[0.000037912774,0.00048367554,0.00026536998,0.0000074154987,0.000008522824,0.00014152417,0.000017020104,0.0030793825,0.98710537,0.0003047741,0.008534214,0.000014916765],"about_ca_topic_score_codex":0.00015618624,"about_ca_topic_score_gemma":0.00033946018,"teacher_disagreement_score":0.0017252266,"about_ca_system_score_codex":0.00018447296,"about_ca_system_score_gemma":0.00017730384,"threshold_uncertainty_score":0.005771458},"labels":[],"label_agreement":null},{"id":"W1965844669","doi":"10.1529/biophysj.105.069369","title":"Structural Motif-Based Homology Modeling of CYP27A1 and Site-Directed Mutational Analyses Affecting Vitamin D Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Biophysical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Homology modeling; Biochemistry; Hydroxylation; Active site; Binding site; Cytochrome P450; Stereochemistry; Site-directed mutagenesis; Chemistry; Docking (animal); Mutagenesis; CYP27A1; Biology; Protein structure; Enzyme; Mutation; Gene; Mutant","score_opus":0.0925468959742783,"score_gpt":0.42036459296474304,"score_spread":0.32781769699046476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965844669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709117,0.00031833808,0.025883099,0.00017881858,0.00003176883,0.000071430324,0.0005193613,0.00036712893,0.0017184716],"genre_scores_gemma":[0.9866223,0.0001546458,0.012210201,0.00001985906,0.0000043374866,0.000026789196,0.00040036617,0.000042443273,0.000519207],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99989426,0.000034309724,0.0000062741797,0.000016758293,0.000031115967,0.000017269133],"domain_scores_gemma":[0.99987507,0.00004604487,0.000026615453,0.0000092168975,0.000020140082,0.000022905257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619347,0.0004818093,0.0004246637,0.00023842958,0.00037416266,0.00031017105,0.00058689876,0.0004495845,0.0025158487],"category_scores_gemma":[0.00030735222,0.00015914542,0.00037285802,0.00024851022,0.00015744857,0.00016291838,0.00015925609,0.0006238748,0.00041338702],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018885379,0.0006827338,0.0036172941,0.00028265017,0.00010020125,0.0011959164,0.00020989096,0.18750855,0.77429026,0.009809265,0.0013326218,0.019082017],"study_design_scores_gemma":[0.00023223643,0.0005568778,0.002237328,0.000021346797,0.00011164525,0.0004890459,0.00015260883,0.6936207,0.29612237,0.0010489436,0.0053584506,0.000048527458],"about_ca_topic_score_codex":0.0023113096,"about_ca_topic_score_gemma":0.0022120913,"teacher_disagreement_score":0.0025158487,"about_ca_system_score_codex":0.0005327224,"about_ca_system_score_gemma":0.00045578557,"threshold_uncertainty_score":0.008416355},"labels":[],"label_agreement":null},{"id":"W1966988028","doi":"10.3109/03602532.2012.751992","title":"Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT","year":2013,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Chemistry; Glucuronosyltransferase; Receptor; Uridine diphosphate; Nuclear receptor; Biochemistry; Enzyme; Cell biology; Gene; Biology; Transcription factor","score_opus":0.12628961848727616,"score_gpt":0.42306576512738975,"score_spread":0.2967761466401136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966988028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010657875,0.995387,0.0007989913,0.0010664547,0.00020643607,0.0000022682968,0.000012037492,0.000012683655,0.0014483505],"genre_scores_gemma":[0.010546202,0.98452294,0.0007644716,0.0007551604,0.00048436158,0.000008977232,0.00004230787,0.0000062023437,0.0028694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997918,0.00006259854,0.000019188914,0.000045671237,0.0000544507,0.0000262445],"domain_scores_gemma":[0.9998734,0.000057855308,0.000021757072,0.0000058442542,0.000027053806,0.000014050999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037387706,0.000498125,0.00069710106,0.00058684364,0.00019152605,0.0009343718,0.0003404141,0.00087138393,0.001988659],"category_scores_gemma":[0.00028946126,0.00015811235,0.00029061487,0.00067857676,0.0008427343,0.0010800873,0.00046262145,0.0011765216,0.0010234275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038410598,0.00008591357,0.0007560052,0.008458431,0.000110569046,0.0010037931,0.00036136658,0.0006119509,0.047524735,0.035060566,0.021048803,0.88459384],"study_design_scores_gemma":[0.000023525783,0.00039741566,0.0024927089,0.0010917931,0.000100598474,0.004611133,0.00030385845,0.00029123103,0.011459852,0.014626535,0.9645573,0.000044015625],"about_ca_topic_score_codex":0.0005856351,"about_ca_topic_score_gemma":0.00089363975,"teacher_disagreement_score":0.001988659,"about_ca_system_score_codex":0.00060498406,"about_ca_system_score_gemma":0.0004725302,"threshold_uncertainty_score":0.006652713},"labels":[],"label_agreement":null},{"id":"W1967723196","doi":"10.1002/jps.10182","title":"The Influence of Lipids on Stereoselective Pharmacokinetics of Halofantrine: Important Implications in Food‐Effect Studies Involving Drugs That Bind to Lipoproteins","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Halofantrine; Bioavailability; Pharmacokinetics; Chemistry; Pharmacology; Volume of distribution; Enantiomer; Oral administration; Peanut oil; Free fraction; Distribution (mathematics); Stereochemistry; Medicine; Chloroquine","score_opus":0.18110921458844792,"score_gpt":0.47230847675474874,"score_spread":0.2911992621663008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967723196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278146,0.0011395322,0.0027932415,0.0005702578,0.000057672092,0.000044023236,0.000257875,0.00006117386,0.002294834],"genre_scores_gemma":[0.99728715,0.00071324874,0.0009504188,0.00017700216,0.000046771594,0.0000212753,0.00010830972,0.00004079748,0.000655122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99958724,0.00024154103,0.000019213148,0.000041807827,0.000060411872,0.000049857168],"domain_scores_gemma":[0.99777263,0.0013437646,0.00027156353,0.00030971086,0.000105793,0.00019657286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012392305,0.0005169324,0.000578509,0.00027016448,0.00035861132,0.00061498955,0.00028667582,0.0006718756,0.002787924],"category_scores_gemma":[0.0035106426,0.00046572732,0.00054712844,0.00016598069,0.0008560854,0.0008958529,0.0002728137,0.00093986234,0.00041410644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039645758,0.00035739175,0.013145226,0.00020273811,0.00042795288,0.0010358456,0.00045300994,0.0015137928,0.9051918,0.0022819156,0.00056863,0.03517596],"study_design_scores_gemma":[0.0011754306,0.0112576485,0.24952544,0.00003680274,0.0008076505,0.0025357225,0.00030453695,0.0065129325,0.72120625,0.0019839809,0.0045420467,0.00011154823],"about_ca_topic_score_codex":0.0020282953,"about_ca_topic_score_gemma":0.0019441628,"teacher_disagreement_score":0.002787924,"about_ca_system_score_codex":0.00038134077,"about_ca_system_score_gemma":0.0005418243,"threshold_uncertainty_score":0.009326518},"labels":[],"label_agreement":null},{"id":"W1967788840","doi":"10.1111/j.1365-2125.2006.02796.x","title":"The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Université Laval","funders":"","keywords":"Nebivolol; CYP2D6; Pharmacology; Tolerability; Medicine; Blood pressure; Atenolol; Adverse effect; Essential hypertension; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.08047983882801567,"score_gpt":0.4496756294067638,"score_spread":0.36919579057874813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967788840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932206,0.00025426364,0.000057706013,0.000024986977,0.000003248216,0.0000031207744,0.0000784789,0.0000016613,0.00025459603],"genre_scores_gemma":[0.9997656,0.000054626842,0.000033664088,0.000011584365,0.0000062373524,0.0000017138232,0.00006542518,0.0000010655252,0.00006017394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969864,0.00008405405,0.000043127333,0.00007473769,0.000058023765,0.00004136936],"domain_scores_gemma":[0.9990361,0.0003292889,0.0003448316,0.00005460812,0.000068757676,0.00016658864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028570718,0.0001694127,0.0003172162,0.00037971308,0.00024470573,0.00032074042,0.00013049302,0.00031187665,0.0015139111],"category_scores_gemma":[0.0014589645,0.00010169236,0.00024797674,0.0004333949,0.00016302933,0.00020635479,0.00014299291,0.00026533578,0.00020804052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004499005,0.000027691154,0.9961163,0.000007926289,0.000031935422,0.00027363963,0.000054294833,0.00001983994,0.000831054,0.000010093224,0.000037886555,0.0021395138],"study_design_scores_gemma":[0.000010423085,0.00016626723,0.9985359,0.000002419896,0.00001938031,0.00090799085,0.000056574863,0.000071485,0.00013127031,0.000013242641,0.00008358775,0.0000016133762],"about_ca_topic_score_codex":0.0005263007,"about_ca_topic_score_gemma":0.00065808033,"teacher_disagreement_score":0.0015139111,"about_ca_system_score_codex":0.00011571945,"about_ca_system_score_gemma":0.000072366594,"threshold_uncertainty_score":0.0050644875},"labels":[],"label_agreement":null},{"id":"W1968172143","doi":"10.1038/npp.2008.110","title":"Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme Inhibition","year":2008,"lang":"en","type":"article","venue":"Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Cytochrome P450; In vivo; Enzyme; Drug metabolism; Biochemistry; Prodrug; Pharmacology; Biology; Endogeny; Xenobiotic; Isozyme; Chemistry","score_opus":0.055646538220043444,"score_gpt":0.37160034617687415,"score_spread":0.3159538079568307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968172143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651054,0.0068046707,0.028315099,0.00061769347,0.00027533012,0.00018213628,0.0010404222,0.00043918102,0.005814947],"genre_scores_gemma":[0.9866262,0.0025725286,0.0063401237,0.000089636145,0.000070862465,0.000082723935,0.00085840793,0.00003947853,0.0033200285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998036,0.0000603757,0.0000113305805,0.00004589699,0.000044272176,0.00003459389],"domain_scores_gemma":[0.9998572,0.00003026717,0.000039775885,0.000034900717,0.00001606613,0.00002177108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041063846,0.00055518246,0.00042814904,0.00029013984,0.0001640673,0.00036192854,0.0003413533,0.00027407185,0.001802902],"category_scores_gemma":[0.00041610975,0.0002548822,0.0002967833,0.00024924107,0.00036827178,0.00032174253,0.00015233079,0.0010335625,0.0004410946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029683711,0.00036939437,0.0013039464,0.0001043073,0.000092476206,0.0001017938,0.000039961415,0.0002201165,0.9728299,0.0010121875,0.0006298344,0.020327788],"study_design_scores_gemma":[0.00017507568,0.0023232235,0.0055745984,0.000004982217,0.000078798555,0.0006162173,0.000015405916,0.001158344,0.98626244,0.00029643948,0.0034844633,0.000010094326],"about_ca_topic_score_codex":0.00077399536,"about_ca_topic_score_gemma":0.0012875054,"teacher_disagreement_score":0.001802902,"about_ca_system_score_codex":0.0002574771,"about_ca_system_score_gemma":0.00031476578,"threshold_uncertainty_score":0.006031275},"labels":[],"label_agreement":null},{"id":"W1968319279","doi":"10.1097/fpc.0000000000000031","title":"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Monooxygenase; Metabolite; Metabolism; Chemistry; Cotinine; Cytochrome P450; Drug metabolism; Biochemistry; Pharmacology; Biology; Internal medicine; CYP1A2; Medicine","score_opus":0.04835469404427228,"score_gpt":0.3456313863337212,"score_spread":0.2972766922894489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968319279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921274,0.00008590821,0.00024889913,0.000015505837,0.0000034811708,0.0000047111967,0.00014604423,0.00000576759,0.00027698444],"genre_scores_gemma":[0.99959034,0.00002546332,0.00011968321,0.000011085657,0.0000036101992,0.0000028096613,0.0001117132,0.0000047665585,0.00013061405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945647,0.0001773312,0.000048387457,0.00018790613,0.000068250534,0.00006167244],"domain_scores_gemma":[0.99934036,0.00020835348,0.0002746688,0.00009257188,0.000027149224,0.000056823512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040200015,0.0003283375,0.00028019308,0.0003714488,0.00022140838,0.00023721061,0.00020152383,0.00038753726,0.002545393],"category_scores_gemma":[0.0011702157,0.00016393392,0.0004919795,0.00040897654,0.00034483758,0.0001495796,0.00020406787,0.00028358013,0.00024085611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027958006,0.000115093244,0.9489225,0.000025427424,0.0004899486,0.0006713375,0.00010792621,0.00013840276,0.040143758,0.00015070559,0.00011207812,0.0063269394],"study_design_scores_gemma":[0.00001936699,0.00025861175,0.99679583,0.0000041757426,0.00008041593,0.000897499,0.00002377494,0.0002790604,0.0013751517,0.00008274877,0.00018022976,0.0000032086434],"about_ca_topic_score_codex":0.0018264506,"about_ca_topic_score_gemma":0.0016062052,"teacher_disagreement_score":0.002545393,"about_ca_system_score_codex":0.00013350222,"about_ca_system_score_gemma":0.00009252219,"threshold_uncertainty_score":0.008515179},"labels":[],"label_agreement":null},{"id":"W1968349511","doi":"10.2174/187231210791292717","title":"Assessment of Competitive and Mechanism-Based Inhibition by Clarithromycin: Use of Domperidone as a CYP3A Probe-Drug Substrate and Various Enzymatic Sources Including a New Cell-Based Assay with Freshly Isolated Human Hepatocytes","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Heart And Stroke Foundation Of Quebec; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Clarithromycin; CYP3A4; CYP3A; Microsome; Non-competitive inhibition; Pharmacology; Potency; Cytochrome P450; Drug metabolism; Biology; Chemistry; Drug; Biochemistry; Enzyme; In vitro; Antibiotics","score_opus":0.033419530124974436,"score_gpt":0.33336855677661625,"score_spread":0.2999490266516418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968349511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94494945,0.009323825,0.039299384,0.00016464922,0.00012885475,0.00030471527,0.00082898914,0.0003317092,0.0046684304],"genre_scores_gemma":[0.969175,0.0029359593,0.021659672,0.0000725832,0.00004265819,0.00026835676,0.001590426,0.00003969285,0.0042157434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886584,0.00038856012,0.00013239447,0.00020143743,0.00034670898,0.000065039465],"domain_scores_gemma":[0.99951553,0.00015597811,0.00006899152,0.000103244,0.00011556594,0.00004063658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080556725,0.00088698306,0.0006120662,0.000330341,0.00025096152,0.00042016685,0.00042133627,0.0005598192,0.0010813412],"category_scores_gemma":[0.00063847844,0.0003239429,0.00045156907,0.0004955414,0.0002770387,0.00035829828,0.00029574105,0.0006910313,0.0004612355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023830736,0.00008730602,0.0007605416,0.00007882133,0.00003690528,0.00005692245,0.00004170294,0.00009560649,0.99538463,0.000050511022,0.000033540684,0.0031352302],"study_design_scores_gemma":[0.00001636139,0.00067313045,0.005097679,0.0000031065213,0.000042797914,0.00019172154,0.000016643122,0.00091880636,0.9924412,0.000015825643,0.0005759919,0.0000068382096],"about_ca_topic_score_codex":0.0018451429,"about_ca_topic_score_gemma":0.0027178158,"teacher_disagreement_score":0.0018451429,"about_ca_system_score_codex":0.00036507333,"about_ca_system_score_gemma":0.000464412,"threshold_uncertainty_score":0.0042603016},"labels":[],"label_agreement":null},{"id":"W1968413239","doi":"10.1097/fpc.0b013e32801a3c10","title":"CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Alliance for Research on Schizophrenia and Depression","keywords":"Perphenazine; Internal medicine; Endocrinology; CYP2D6; Dopaminergic; Serotonergic; Pharmacology; Prolactin; Dopamine; Pharmacodynamics; Medicine; Antipsychotic; Serotonin; Pharmacokinetics; Schizophrenia (object-oriented programming); Cytochrome P450; Psychiatry; Receptor; Hormone","score_opus":0.03873708750571099,"score_gpt":0.3915192264568302,"score_spread":0.3527821389511192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968413239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821293,0.00084469863,0.00025675184,0.00010237682,0.000006574904,0.0000063941347,0.00014182957,0.0000063762873,0.00042204474],"genre_scores_gemma":[0.99951625,0.00016223344,0.00011663748,0.000025256857,0.0000088907655,0.0000022277336,0.000059038073,0.0000030599308,0.00010641457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998024,0.00006428975,0.00002242079,0.00005371948,0.00003542317,0.000021845946],"domain_scores_gemma":[0.9994288,0.00012711625,0.0002465809,0.000060554965,0.00006100454,0.000075846096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000535526,0.00028994514,0.0004173072,0.00033241662,0.0001946943,0.00032779362,0.00018707932,0.0002766937,0.001840489],"category_scores_gemma":[0.00068300945,0.0001327287,0.00040342,0.00076419435,0.0003014156,0.00018013704,0.00014098374,0.00031705384,0.00017466338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022170825,0.000068135145,0.97013086,0.00005693094,0.0003252856,0.0005941088,0.000268414,0.000098857825,0.017519843,0.000080089034,0.00013151026,0.008508795],"study_design_scores_gemma":[0.000014977908,0.00025275777,0.996917,0.0000057436646,0.00013648256,0.000904222,0.00016403354,0.00021814989,0.001064921,0.00004861954,0.0002687228,0.0000044901426],"about_ca_topic_score_codex":0.0038445867,"about_ca_topic_score_gemma":0.0032757279,"teacher_disagreement_score":0.0038445867,"about_ca_system_score_codex":0.00016282473,"about_ca_system_score_gemma":0.00016493392,"threshold_uncertainty_score":0.007644415},"labels":[],"label_agreement":null},{"id":"W1968595695","doi":"10.1007/s002280100298","title":"Study of the drug-drug interaction between simvastatin and cisapride in man","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Dalton Pharma Services (Canada); Université Laval; Université de Montréal","funders":"Medical Research Council; Heart And Stroke Foundation Of Quebec","keywords":"Simvastatin; Cisapride; Pharmacology; Drug interaction; Medicine; Concomitant; Pharmacokinetics; Drug; Internal medicine","score_opus":0.27510572726083704,"score_gpt":0.5407515798846579,"score_spread":0.2656458526238209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968595695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594396,0.0018728003,0.00059505267,0.000072032315,0.00001569321,0.00004014857,0.00015063105,0.000019699395,0.0012899438],"genre_scores_gemma":[0.9981918,0.00063906773,0.00036018182,0.00007408887,0.000024913223,0.000012902286,0.00011366747,0.000006587756,0.0005768889],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994462,0.00027797068,0.000026996637,0.000096246025,0.000106489344,0.00004603886],"domain_scores_gemma":[0.9990952,0.00046785732,0.00013188683,0.00008268519,0.000085165855,0.00013725313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061557215,0.00048288607,0.0008751633,0.00085358147,0.00077530055,0.00035263386,0.00033935808,0.0006395857,0.0012923441],"category_scores_gemma":[0.0020460803,0.0003773063,0.0005683567,0.00085843465,0.0006067797,0.00033729026,0.00026649158,0.0007296702,0.0003892341],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033568855,0.0023257085,0.81076103,0.0007184574,0.0023521157,0.008297161,0.0028041094,0.0017439094,0.072490424,0.001196364,0.0007506122,0.06299125],"study_design_scores_gemma":[0.0004946155,0.019503633,0.93030846,0.000020522994,0.0017971547,0.011359066,0.0010875898,0.0035863589,0.02460107,0.00081619655,0.00633598,0.0000893412],"about_ca_topic_score_codex":0.0038742404,"about_ca_topic_score_gemma":0.0027542296,"teacher_disagreement_score":0.0038742404,"about_ca_system_score_codex":0.00049693655,"about_ca_system_score_gemma":0.0005702888,"threshold_uncertainty_score":0.007703364},"labels":[],"label_agreement":null},{"id":"W1968996495","doi":"10.1097/ftd.0b013e31816b918f","title":"Herbal Supplements and Therapeutic Drug Monitoring: Focus on Digoxin Immunoassays and Interactions With St. John's Wort","year":2008,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacology; Carbamazepine; Medicine; Drug interaction; Drug; Ginseng; Digoxin; Pharmacokinetics; Therapeutic drug monitoring; Traditional medicine","score_opus":0.13787733445137268,"score_gpt":0.4444780486792382,"score_spread":0.3066007142278655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968996495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018208282,0.9523357,0.0075215837,0.014977856,0.0007630875,0.000047985686,0.00012645667,0.00014565766,0.005873389],"genre_scores_gemma":[0.12290215,0.8355716,0.017232725,0.011425532,0.0052353013,0.00006366266,0.00029314662,0.000074852156,0.0072010257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862874,0.00032150373,0.00014856551,0.00026939454,0.0005397474,0.000092050184],"domain_scores_gemma":[0.99767643,0.0010466697,0.0005116822,0.000071580456,0.0005595621,0.00013414859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015478728,0.0008834111,0.0010884077,0.00203036,0.00035403398,0.0018176247,0.00053281605,0.001678527,0.0021986428],"category_scores_gemma":[0.0020124384,0.00034877978,0.00080934016,0.0016459321,0.0008588294,0.002079273,0.00078429736,0.0018148801,0.000686244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042419147,0.0003354439,0.044623993,0.0062873545,0.00025095738,0.0054187025,0.00045407287,0.0005226317,0.028498609,0.0046377773,0.020476716,0.8880695],"study_design_scores_gemma":[0.00007774788,0.0018745854,0.12637968,0.0036922651,0.0008902089,0.07885401,0.001773721,0.005871083,0.039789367,0.011834397,0.7287013,0.00026161774],"about_ca_topic_score_codex":0.0025469577,"about_ca_topic_score_gemma":0.0031778852,"teacher_disagreement_score":0.0025469577,"about_ca_system_score_codex":0.0009298154,"about_ca_system_score_gemma":0.00092893123,"threshold_uncertainty_score":0.008186042},"labels":[],"label_agreement":null},{"id":"W1969752754","doi":"10.1124/dmd.108.023499","title":"Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Killam Trusts; National Institutes of Health; Michael Smith Health Research BC; GlaxoSmithKline","keywords":"Pregnane X receptor; Ginkgo biloba; CYP3A4; Pharmacology; Ginkgoales; Activator (genetics); Chemistry; Gene expression; Nuclear receptor; Receptor; Biology; Cytochrome P450; In vitro; Biochemistry; Transcription factor; Biological activity; Gene; Metabolism; Pharmacognosy","score_opus":0.05127372640614435,"score_gpt":0.36863628135205867,"score_spread":0.3173625549459143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969752754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905048,0.004007638,0.003330408,0.00045899136,0.00007614863,0.000035818044,0.0002480297,0.00005664771,0.0012814775],"genre_scores_gemma":[0.9951373,0.0013631779,0.0016642142,0.00011788223,0.000016356691,0.000011391661,0.00044976527,0.00001128468,0.001228637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999598,0.000007635736,0.0000025016889,0.000009899431,0.000008910485,0.000011143059],"domain_scores_gemma":[0.9999528,0.0000071828213,0.000012221305,0.000006355906,0.000007171282,0.000014250226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095777905,0.0002568242,0.00032781393,0.00028989319,0.00016844833,0.0003461178,0.00018227707,0.00026568232,0.0007442761],"category_scores_gemma":[0.00014918503,0.00011998673,0.0002763383,0.00017137223,0.0001975584,0.00020949921,0.00024634015,0.00049692305,0.00026531806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010017415,0.000039001377,0.0011767476,0.000044811735,0.000028212049,0.0006133254,0.00002055375,0.000105711224,0.9925228,0.00033811756,0.00008879876,0.004020165],"study_design_scores_gemma":[0.000355905,0.0012999062,0.034447256,0.000019266703,0.0002851936,0.0057131057,0.00012668563,0.003017285,0.937141,0.0013502261,0.016206153,0.000037933558],"about_ca_topic_score_codex":0.0004941169,"about_ca_topic_score_gemma":0.0006434056,"teacher_disagreement_score":0.0007442761,"about_ca_system_score_codex":0.0003124603,"about_ca_system_score_gemma":0.00020285074,"threshold_uncertainty_score":0.0024898648},"labels":[],"label_agreement":null},{"id":"W1970010625","doi":"10.1016/j.bmcl.2010.07.030","title":"Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study","year":2010,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Chemistry; CYP3A4; Renin inhibitor; Moiety; Stereochemistry; Renin–angiotensin system; Amide; Drug; Pharmacology; Biochemistry; Combinatorial chemistry; Cytochrome P450; Enzyme; Internal medicine","score_opus":0.12045615350016277,"score_gpt":0.3734272187967631,"score_spread":0.25297106529660035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970010625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959154,0.002086451,0.0032677904,0.00050853105,0.0000526717,0.000044736356,0.00006647275,0.000053407108,0.004328452],"genre_scores_gemma":[0.9971775,0.0008826135,0.00063823024,0.00011485345,0.00005003002,0.0000059353647,0.00003745204,0.000010201117,0.001083133],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998287,0.000039882474,0.000016772607,0.000035125475,0.000048296286,0.000031158528],"domain_scores_gemma":[0.9996704,0.00013513467,0.00007969564,0.00003951546,0.000024519102,0.000050663137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025166597,0.00021497648,0.00028583605,0.00022186336,0.0002638889,0.00030408142,0.00029524267,0.0006118343,0.0005888784],"category_scores_gemma":[0.0008873102,0.00008419123,0.00032160513,0.00019479066,0.00037379208,0.00024459796,0.00011057375,0.00082446844,0.00016507268],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047148815,0.0018784147,0.052638628,0.00032596564,0.00023624214,0.42204764,0.0010388361,0.002476461,0.3691475,0.0031845598,0.0017352741,0.14057562],"study_design_scores_gemma":[0.000263922,0.02076122,0.051989663,0.000024758996,0.0004737733,0.5994128,0.00034876133,0.007358081,0.2936615,0.0010862717,0.024554344,0.00006495292],"about_ca_topic_score_codex":0.0005596083,"about_ca_topic_score_gemma":0.0009483994,"teacher_disagreement_score":0.0006118343,"about_ca_system_score_codex":0.0002743388,"about_ca_system_score_gemma":0.00017629137,"threshold_uncertainty_score":0.001990497},"labels":[],"label_agreement":null},{"id":"W1970033257","doi":"10.1016/s0731-7085(00)00244-2","title":"Stability and enzymatic hydrolysis of quaternary ammonium-linked glucuronide metabolites of drugs with an aliphatic tertiary amine-implications for analysis","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Medical Research Council Canada","keywords":"Chemistry; Tertiary amine; Enzymatic hydrolysis; Ammonium; Hydrolysis; Organic chemistry; Enzyme; Amine gas treating; Chromatography","score_opus":0.0739053531599121,"score_gpt":0.41673094086368556,"score_spread":0.34282558770377347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970033257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928762,0.0012022402,0.0044384515,0.00006201053,0.000027615326,0.00002275078,0.0002605669,0.000021233562,0.0010890298],"genre_scores_gemma":[0.9963559,0.0004425024,0.001660125,0.000033796834,0.000016240245,0.000012497475,0.00048474452,0.000012681782,0.0009815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996418,0.000104895895,0.000033408392,0.00007010896,0.000087811626,0.00006202602],"domain_scores_gemma":[0.9994217,0.00012972114,0.0001843196,0.00006643389,0.00012646083,0.00007137954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068473496,0.00048373744,0.00020736977,0.00029686367,0.00019375427,0.00038508896,0.00024652248,0.0004779413,0.0008009777],"category_scores_gemma":[0.0012364144,0.00017286635,0.000547038,0.0002975633,0.0004093621,0.00043767787,0.00023130214,0.0005552327,0.0004687495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016157031,0.00006025701,0.0022981619,0.00003375206,0.000054355136,0.00007420516,0.00007133002,0.00037835428,0.99050456,0.00022892575,0.0000419654,0.004638427],"study_design_scores_gemma":[0.000011834654,0.0005727823,0.00782764,0.000004843971,0.000024858424,0.00021074999,0.000026387239,0.0011912452,0.9896646,0.00005754731,0.0003979554,0.0000095433725],"about_ca_topic_score_codex":0.0011469513,"about_ca_topic_score_gemma":0.0006849092,"teacher_disagreement_score":0.0011469513,"about_ca_system_score_codex":0.00039239865,"about_ca_system_score_gemma":0.0003857441,"threshold_uncertainty_score":0.0036212802},"labels":[],"label_agreement":null},{"id":"W1970064806","doi":"10.1038/sj.tpj.6500361","title":"Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine","year":2006,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Personalized medicine; Precision medicine; Medicine; Disease; Drug; Ethnic group; Drug response; Bioinformatics; Gene; Pharmacology; Genetics; Biology; Internal medicine; Genotype; Pathology; Political science","score_opus":0.09054567564092775,"score_gpt":0.4204349707298063,"score_spread":0.32988929508887854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970064806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055778427,0.48756066,0.02000099,0.47577158,0.0027535486,0.000025137326,0.00017361568,0.00019371277,0.007942916],"genre_scores_gemma":[0.1921417,0.57914495,0.037704542,0.14319384,0.042397104,0.00012009902,0.00031450842,0.00014835922,0.0048348242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931912,0.003628091,0.00042497134,0.0008173464,0.0015889024,0.00034959038],"domain_scores_gemma":[0.93192106,0.052176338,0.0028021599,0.0037605707,0.00673151,0.0026084261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03403753,0.00092327694,0.0033900798,0.0025111816,0.0015738687,0.009297263,0.0019715943,0.0085245,0.00441664],"category_scores_gemma":[0.02536046,0.00065944367,0.0010176717,0.0025911753,0.015481407,0.021610495,0.004284173,0.014386061,0.0010524658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006378126,0.00041326135,0.020613283,0.0026639912,0.00038367676,0.0006111173,0.0012184144,0.0016999636,0.0025536406,0.3695984,0.042907827,0.5566986],"study_design_scores_gemma":[0.00018223401,0.00038854717,0.016825277,0.0022750755,0.00030750065,0.002050735,0.0021502424,0.0037314638,0.0010592926,0.6184357,0.35231745,0.00027653415],"about_ca_topic_score_codex":0.001794346,"about_ca_topic_score_gemma":0.0022836875,"teacher_disagreement_score":0.03403753,"about_ca_system_score_codex":0.0037203406,"about_ca_system_score_gemma":0.0051927813,"threshold_uncertainty_score":0.18000984},"labels":[],"label_agreement":null},{"id":"W1970093780","doi":"10.2165/00129784-200404050-00002","title":"Interactions Between Grapefruit Juice and Cardiovascular Drugs","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; Felodipine; Medicine; Fluvastatin; Nisoldipine; Repaglinide; Nitrendipine; Verapamil; Oral administration; Cisapride; Pharmacokinetics; Chemistry; Nifedipine; Metformin; Endocrinology; Internal medicine; Simvastatin; Insulin; Calcium","score_opus":0.08993227723574834,"score_gpt":0.42836363717711545,"score_spread":0.3384313599413671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970093780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008998776,0.99738365,0.00019081208,0.00012777305,0.000090409936,0.000006554135,0.000027176602,0.000011193876,0.0012625735],"genre_scores_gemma":[0.004455768,0.9935296,0.00033839568,0.00016517383,0.00019205923,0.000009372712,0.00005196801,0.0000015163246,0.0012562252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985945,0.000031758267,0.000017290778,0.000025534919,0.000056325982,0.000009603597],"domain_scores_gemma":[0.9998388,0.00008224879,0.000035782166,0.0000054147704,0.000027729851,0.000009943798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031499064,0.0007089572,0.0013949656,0.0011021674,0.00014857587,0.0004933738,0.00058502227,0.00080226705,0.0026548342],"category_scores_gemma":[0.00041900613,0.00020298714,0.0005791423,0.0009950873,0.00016283839,0.0003783285,0.00027581136,0.0005507575,0.0009560429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024464156,0.00014631652,0.00090865244,0.008300794,0.00042684603,0.00056535774,0.000026704933,0.00037571441,0.003779717,0.00054113043,0.009819935,0.9748643],"study_design_scores_gemma":[0.0001887662,0.0008407072,0.013445308,0.0025096,0.0016187603,0.0060360837,0.00006836886,0.000427455,0.004964809,0.001298695,0.9685554,0.000046045367],"about_ca_topic_score_codex":0.0013676025,"about_ca_topic_score_gemma":0.0033663327,"teacher_disagreement_score":0.0026548342,"about_ca_system_score_codex":0.00027913693,"about_ca_system_score_gemma":0.000409903,"threshold_uncertainty_score":0.008881271},"labels":[],"label_agreement":null},{"id":"W1970461091","doi":"10.1002/humu.20698","title":"Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent","year":2008,"lang":"en","type":"article","venue":"Human Mutation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"CYP2A6; Nicotine; Biology; Allele; Cotinine; Population; Genetics; Genotype; Gene; Medicine; CYP1A2; In vitro","score_opus":0.09492972198041459,"score_gpt":0.39175397157669206,"score_spread":0.29682424959627746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970461091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996792,0.000041695715,0.00014859816,0.000010675533,0.0000021650303,0.0000040393743,0.000023325427,0.0000020560199,0.00008815803],"genre_scores_gemma":[0.9991166,0.000040561597,0.00031201242,0.000017614944,0.0000062801314,0.00000497724,0.000048006474,0.000003621002,0.00045021143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984515,0.00003609424,0.000008402993,0.000052400293,0.000023981796,0.0000339539],"domain_scores_gemma":[0.9998252,0.000030810566,0.000060110706,0.000016166083,0.000020967585,0.000046865815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018565434,0.00036505316,0.00023096168,0.00028947947,0.00043197174,0.00020335287,0.0001188988,0.00024859223,0.0018785417],"category_scores_gemma":[0.0005532288,0.0001414939,0.00015312797,0.00018293524,0.00020872043,0.00010774666,0.00013487015,0.00032249463,0.00019803082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041782837,0.00076499995,0.71875113,0.000048828264,0.00020177351,0.002293849,0.0015912197,0.00013110049,0.2460034,0.00045823542,0.00035128833,0.025225896],"study_design_scores_gemma":[0.00007609883,0.0016813091,0.985388,0.000008719563,0.000103304395,0.0050079264,0.00033527857,0.000456063,0.0056701936,0.00013281369,0.0011267684,0.000013527759],"about_ca_topic_score_codex":0.0021469665,"about_ca_topic_score_gemma":0.0013341316,"teacher_disagreement_score":0.0021469665,"about_ca_system_score_codex":0.000108972534,"about_ca_system_score_gemma":0.00008394687,"threshold_uncertainty_score":0.0062842965},"labels":[],"label_agreement":null},{"id":"W1970801600","doi":"10.2174/1568026043387728","title":"Preface [Hot Topic: Pharmacogenomics (Guest Editor: Amadeo M. Parissenti)]","year":2004,"lang":"en","type":"article","venue":"Current Topics in Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.09419277259503857,"score_gpt":0.4482717134690607,"score_spread":0.35407894087402214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970801600","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010562216,0.009511786,0.00044509664,0.053581476,0.93389475,0.00003846434,0.00016664785,0.00007954013,0.0021766683],"genre_scores_gemma":[0.0011340556,0.009964814,0.00050147035,0.040496297,0.9311671,0.00004447285,0.0002118048,0.00008032046,0.016399695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998708,0.00028909015,0.00027721547,0.00020440079,0.00045314795,0.00006826572],"domain_scores_gemma":[0.97841346,0.0063000848,0.0010539478,0.00047162198,0.011215809,0.0025450299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030370855,0.0018410935,0.002728529,0.0032411935,0.0013871276,0.0030838137,0.0023318501,0.004629672,0.029968675],"category_scores_gemma":[0.018605474,0.00053507346,0.0013764395,0.0018162896,0.00086780527,0.0028241635,0.00096408685,0.008231253,0.028170116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028832063,0.0000085491,0.000057270106,0.00018166672,0.00000859442,0.00016893345,0.000008933895,0.00002647081,0.00007130929,0.00011247847,0.9886164,0.01071047],"study_design_scores_gemma":[0.000040128867,0.000055257817,0.0013155628,0.00042795713,0.000036593716,0.0011769698,0.00004504067,0.0002702894,0.00021566001,0.0010935671,0.9952918,0.0000311706],"about_ca_topic_score_codex":0.0017507268,"about_ca_topic_score_gemma":0.0024438228,"teacher_disagreement_score":0.029968675,"about_ca_system_score_codex":0.0009621511,"about_ca_system_score_gemma":0.0011066466,"threshold_uncertainty_score":0.10025519},"labels":[],"label_agreement":null},{"id":"W1970977102","doi":"10.1002/jps.23502","title":"Toward a new paradigm for the efficient in vitro–in vivo extrapolation of metabolic clearance in humans from hepatocyte data","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In vivo; Hepatocyte; In vitro; Extrapolation; Metabolic clearance rate; Chemistry; Cell biology; Biology; Computational biology; Pharmacology; Biochemistry; Pharmacokinetics; Genetics; Mathematics","score_opus":0.3159447964285114,"score_gpt":0.4846943504884899,"score_spread":0.1687495540599785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970977102","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019701157,0.0050420314,0.9658726,0.003894064,0.0004117404,0.00025968414,0.00074671116,0.00074785645,0.003324123],"genre_scores_gemma":[0.33090317,0.009009538,0.6462247,0.005630169,0.00093913416,0.0011889488,0.0021227265,0.0012143555,0.0027672532],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98325205,0.011914982,0.0008921705,0.0015834232,0.002161958,0.00019530517],"domain_scores_gemma":[0.9802367,0.008220953,0.001468059,0.0065439222,0.0030919437,0.00043848442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031152708,0.0012922006,0.0028371923,0.0018496987,0.0007722173,0.0064854696,0.0027441408,0.0017103187,0.0021370659],"category_scores_gemma":[0.0291888,0.0011327923,0.0011638873,0.0012036568,0.0020868191,0.0041541187,0.0025829414,0.0077142725,0.002022721],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037268475,0.0016349636,0.021617116,0.0019534444,0.0012630646,0.0008127419,0.0014048546,0.01444572,0.5191932,0.0966413,0.013730974,0.32357576],"study_design_scores_gemma":[0.0005663376,0.008489064,0.020176396,0.0008839099,0.0014232969,0.0086962385,0.0010904847,0.11899599,0.5304702,0.14769912,0.16104312,0.00046589726],"about_ca_topic_score_codex":0.0015636926,"about_ca_topic_score_gemma":0.0015528972,"teacher_disagreement_score":0.031152708,"about_ca_system_score_codex":0.0012065007,"about_ca_system_score_gemma":0.0026318769,"threshold_uncertainty_score":0.16475326},"labels":[],"label_agreement":null},{"id":"W1971839077","doi":"10.1016/j.jss.2010.06.040","title":"Drug Metabolism in Hemorrhagic Shock: Pharmacokinetics of Selective Markers of Cytochrome-P450 2C9, 2D6, and 3A4 Enzyme Activities in a Porcine Model","year":2010,"lang":"en","type":"article","venue":"Journal of Surgical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Office of Naval Research; Naval Group; University of Minnesota","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Hemorrhagic shock; Drug metabolism; CYP2C9; CYP3A4; Drug; Medicine; Chemistry; Enzyme; Shock (circulatory); Biochemistry; Internal medicine","score_opus":0.10067116599379468,"score_gpt":0.46486015174310136,"score_spread":0.3641889857493067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971839077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747413,0.00036246603,0.0014716559,0.00007815282,0.000021330776,0.000032544198,0.00018680835,0.000029071918,0.00034387177],"genre_scores_gemma":[0.99774075,0.00042586136,0.0007551014,0.000055851135,0.000019343115,0.00004303909,0.00035548623,0.000016623617,0.00058789836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997999,0.000066593646,0.0000092467535,0.000052735206,0.00003431231,0.000037142727],"domain_scores_gemma":[0.9996263,0.000089245834,0.00009718136,0.000062229876,0.0000182171,0.00010669844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040146074,0.000426763,0.00055912975,0.0003200974,0.0002255806,0.00051921204,0.0002716786,0.0005165514,0.0008622315],"category_scores_gemma":[0.0005451257,0.000279782,0.00041922648,0.00038016983,0.000658608,0.0007514428,0.00017710397,0.0013743241,0.00018213358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10907051,0.006066242,0.0190115,0.0001692411,0.0002483497,0.00062340836,0.00050736516,0.0037246225,0.81733906,0.00063215516,0.0010049026,0.041602653],"study_design_scores_gemma":[0.002708517,0.16965456,0.10209522,0.00003521267,0.00068789383,0.0016919775,0.0005454467,0.021471001,0.69652987,0.0006292817,0.003831502,0.000119484175],"about_ca_topic_score_codex":0.0010493641,"about_ca_topic_score_gemma":0.0011273377,"teacher_disagreement_score":0.0010493641,"about_ca_system_score_codex":0.0004982508,"about_ca_system_score_gemma":0.0003477507,"threshold_uncertainty_score":0.0036150813},"labels":[],"label_agreement":null},{"id":"W1972310204","doi":"10.1016/j.jchromb.2005.07.016","title":"Assessment of 3-nitrobenzanthrone reductase activity in mammalian tissues by normal-phase HPLC with fluorescence detection","year":2005,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Carleton University","funders":"Health Canada; National Institutes of Health; Cancer Research Institute","keywords":"Chemistry; Chromatography; Fluorescence; High-performance liquid chromatography","score_opus":0.03501206374497128,"score_gpt":0.4152515355554261,"score_spread":0.3802394718104548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972310204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62659407,0.0070540346,0.35117078,0.00054148457,0.0002153774,0.0002831978,0.0015272349,0.0027652278,0.009848568],"genre_scores_gemma":[0.74858165,0.0046328646,0.21892723,0.00045783725,0.000098546996,0.0008255292,0.005858914,0.00040801745,0.020209476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957305,0.00012071118,0.000023265191,0.00011081412,0.00010660712,0.000065528395],"domain_scores_gemma":[0.9995048,0.00014684454,0.000047623183,0.00008818141,0.00015237762,0.000060058388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073004054,0.0008520891,0.00042216064,0.00072540797,0.00054764556,0.00033024148,0.0006099319,0.0006198945,0.0013339282],"category_scores_gemma":[0.00043646857,0.00045039735,0.0004188105,0.0005660858,0.00054332515,0.0005633767,0.00028927394,0.0010561554,0.0011787383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001348539,0.000029138793,0.00035304358,0.000031227366,0.000009599703,0.000028611003,0.000029064193,0.000051952255,0.99688196,0.0001250439,0.000060868464,0.0022645465],"study_design_scores_gemma":[0.000010192728,0.00023080611,0.0025793838,0.000003913677,0.000027171016,0.00016334592,0.000015275158,0.00075458863,0.99488753,0.00009993109,0.0012218205,0.0000060872376],"about_ca_topic_score_codex":0.003128634,"about_ca_topic_score_gemma":0.0052265604,"teacher_disagreement_score":0.003128634,"about_ca_system_score_codex":0.00050337636,"about_ca_system_score_gemma":0.0008045929,"threshold_uncertainty_score":0.006220877},"labels":[],"label_agreement":null},{"id":"W1972504152","doi":"10.1006/jmbi.1999.3374","title":"Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4 1 1Edited by J. Karn","year":2000,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pseudogene; Biology; Gene; Genetics; Exon; Gene cluster; Homology (biology); Tandem exon duplication; Promoter; Genome; Gene expression","score_opus":0.03060425396471708,"score_gpt":0.36310026061990214,"score_spread":0.3324960066551851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972504152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738801,0.0054394165,0.009826904,0.00064284686,0.0001257972,0.00019208984,0.007409612,0.00008955261,0.002393631],"genre_scores_gemma":[0.88029385,0.0042181183,0.03300132,0.0005044548,0.00011409373,0.0002455245,0.06839376,0.00015426932,0.013074563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.000014654193,0.000009402066,0.000036316444,0.000027141174,0.000018122248],"domain_scores_gemma":[0.99989915,0.000032321845,0.0000115195,0.000014910097,0.000011797603,0.000030244579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104168226,0.0003766334,0.00030793913,0.00045435707,0.00020976445,0.00027353253,0.00024393329,0.0003296542,0.0015344343],"category_scores_gemma":[0.0002937518,0.00028180022,0.00042995173,0.00030271037,0.00024520484,0.00012855731,0.00031440498,0.00042649586,0.0012209552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018448304,0.000040508774,0.001319546,0.00007226989,0.000017770899,0.0003012374,0.000036808007,0.00015495447,0.9931901,0.0002381823,0.0002341627,0.0042099697],"study_design_scores_gemma":[0.00039410495,0.0010674945,0.114352144,0.00010447862,0.00019182613,0.004512112,0.00013683448,0.0037877846,0.82882965,0.00068098184,0.045900274,0.000042363605],"about_ca_topic_score_codex":0.0020126998,"about_ca_topic_score_gemma":0.002575363,"teacher_disagreement_score":0.0020126998,"about_ca_system_score_codex":0.00026206186,"about_ca_system_score_gemma":0.00037102838,"threshold_uncertainty_score":0.0051332116},"labels":[],"label_agreement":null},{"id":"W1972812665","doi":"10.1016/j.bcp.2013.04.014","title":"First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo","year":2013,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health; National Institutes of Health; Ontario Ministry of Research and Innovation; National Institute on Drug Abuse; Ontario Ministry of Research, Innovation and Science","keywords":"Opiate; In vivo; Neuroscience; Pharmacology; Chemistry; Medicine; Anesthesia; Psychology; Biology; Internal medicine; Receptor","score_opus":0.0615965428876762,"score_gpt":0.3782378347088845,"score_spread":0.3166412918212083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972812665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343336,0.006994435,0.045654923,0.0021972025,0.0009126301,0.00021918165,0.0020015547,0.0005201561,0.007166233],"genre_scores_gemma":[0.97617143,0.0032915757,0.012218397,0.00053841196,0.0002083184,0.00011221355,0.0010316911,0.00008493798,0.00634306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998734,0.000028758144,0.000007234773,0.00003200612,0.000035315617,0.000023281214],"domain_scores_gemma":[0.9998204,0.000049394577,0.000023545103,0.00004230389,0.000036680583,0.000027609804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021181344,0.00045016946,0.00039428665,0.0002146025,0.00023051923,0.00029205365,0.00017205188,0.00040373145,0.0015473976],"category_scores_gemma":[0.0003847901,0.00020450517,0.0003428279,0.000127839,0.00037496234,0.00020948645,0.00027277184,0.0013981808,0.00026335052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012796747,0.00014757246,0.0009226011,0.00008430361,0.000047391084,0.00016873775,0.00002228659,0.0001031793,0.98341227,0.0005977768,0.00076975237,0.012444506],"study_design_scores_gemma":[0.00009971839,0.00175193,0.019337902,0.0000074884206,0.000092197966,0.0010487388,0.000036543242,0.00086692424,0.9693591,0.00038702498,0.006992429,0.000019882016],"about_ca_topic_score_codex":0.0011924987,"about_ca_topic_score_gemma":0.0023998397,"teacher_disagreement_score":0.0015473976,"about_ca_system_score_codex":0.0003817198,"about_ca_system_score_gemma":0.00036225663,"threshold_uncertainty_score":0.005176544},"labels":[],"label_agreement":null},{"id":"W1973165085","doi":"10.1080/15376520490429382","title":"Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments","year":2004,"lang":"en","type":"article","venue":"Toxicology Mechanisms and Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Physiologically based pharmacokinetic modelling; In silico; Pharmacokinetics; Pharmacology; Pharmacodynamics; Risk assessment; Computational biology; Medicine; Chemistry; Biology; Computer science; Biochemistry","score_opus":0.1472903305135723,"score_gpt":0.5406335177628201,"score_spread":0.39334318724924777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973165085","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012162686,0.0034524035,0.9729547,0.0013418521,0.00023924852,0.00046790953,0.0007060643,0.00041167793,0.008263356],"genre_scores_gemma":[0.3165769,0.0077388845,0.6685365,0.0008773856,0.00049303035,0.00075413747,0.000838371,0.000341453,0.0038433457],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97193605,0.015664807,0.0018524035,0.0011004095,0.009211921,0.00023444806],"domain_scores_gemma":[0.95807886,0.026115375,0.00408249,0.004726862,0.0066209706,0.0003754159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03774276,0.0025478955,0.0020951878,0.0041274833,0.00045581555,0.0061195665,0.0020630213,0.0015744976,0.0023644532],"category_scores_gemma":[0.062736586,0.0008048582,0.0018839128,0.001704526,0.0012144714,0.004033985,0.0024120882,0.0034618734,0.0008038059],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045033608,0.00043074499,0.011658883,0.0021097932,0.0017373763,0.0003117396,0.00034782224,0.27406666,0.011657677,0.112575635,0.0055251108,0.5791283],"study_design_scores_gemma":[0.00017902945,0.002061146,0.009972132,0.001595761,0.0016983493,0.0010904475,0.00035483716,0.52322876,0.022025483,0.34266382,0.09464045,0.00048975635],"about_ca_topic_score_codex":0.0014024255,"about_ca_topic_score_gemma":0.001413466,"teacher_disagreement_score":0.03774276,"about_ca_system_score_codex":0.0015101683,"about_ca_system_score_gemma":0.0024020094,"threshold_uncertainty_score":0.19960523},"labels":[],"label_agreement":null},{"id":"W1973438638","doi":"10.1006/bbrc.2000.2795","title":"Isolation and Characterization of the Human UGT2B7 Gene","year":2000,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Medical Research Council Canada","keywords":"Gene; Biology; UGT2B7; Promoter; Exon; Molecular biology; Genetics; Biochemistry; Gene expression; Glucuronidation; Enzyme; Microsome","score_opus":0.20915214843550145,"score_gpt":0.491323296417168,"score_spread":0.28217114798166654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973438638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92255723,0.007139334,0.048845038,0.0021933266,0.00032899523,0.0005452803,0.011306005,0.0003473439,0.0067375647],"genre_scores_gemma":[0.8813985,0.0058908775,0.041005615,0.0008823764,0.00024748346,0.00037712615,0.059841186,0.0003556523,0.010001153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998424,0.000031074676,0.000013428857,0.000037203223,0.000048654165,0.000027199983],"domain_scores_gemma":[0.9997968,0.0000754645,0.000019760031,0.000033429318,0.00003212641,0.0000423839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016868381,0.0003536855,0.0004382638,0.00073628436,0.0002574042,0.0004208973,0.00033793674,0.0004265611,0.0012401928],"category_scores_gemma":[0.00051686587,0.00033196152,0.0005441025,0.00041673557,0.00038160465,0.00013949141,0.00026898758,0.00070316717,0.0015924551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018129783,0.00005419751,0.0011503842,0.00010005727,0.000035752466,0.00050389644,0.0000667795,0.00039201393,0.987992,0.0009357567,0.00061694864,0.007970941],"study_design_scores_gemma":[0.0001985713,0.0005558972,0.02406717,0.000057469555,0.00018608986,0.0032773453,0.0001538995,0.004724137,0.9057214,0.0012264433,0.059796494,0.000034963847],"about_ca_topic_score_codex":0.0016903639,"about_ca_topic_score_gemma":0.0017811364,"teacher_disagreement_score":0.0016903639,"about_ca_system_score_codex":0.0002757422,"about_ca_system_score_gemma":0.00045508074,"threshold_uncertainty_score":0.004148841},"labels":[],"label_agreement":null},{"id":"W1974750430","doi":"10.1016/s0924-977x(02)00005-6","title":"Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes","year":2002,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nefazodone; CYP3A4; Enzyme; Microsome; Cytochrome P450; Metabolism; Drug metabolism; CYP2B6; Chemistry; Metabolic pathway; Pharmacology; Biochemistry; Biology; Receptor; Fluoxetine","score_opus":0.05361579510543714,"score_gpt":0.3455406473337206,"score_spread":0.29192485222828346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974750430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887611,0.0032059497,0.005765324,0.00028668513,0.00004492403,0.000033865577,0.00077102735,0.00007422057,0.0010569121],"genre_scores_gemma":[0.9913038,0.0008564295,0.0029005413,0.00002497022,0.000010854253,0.000019854093,0.001964432,0.000016931488,0.0029021848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997962,0.00007611126,0.0000163599,0.000037706275,0.000035887188,0.00003782282],"domain_scores_gemma":[0.9999112,0.00003432968,0.000018012468,0.000015319192,0.000013964255,0.0000072402577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000292235,0.00021427048,0.000302717,0.00023340518,0.00020564946,0.0004462265,0.00024045527,0.00026755832,0.0012601616],"category_scores_gemma":[0.0004747814,0.00021008069,0.0003750948,0.00036517778,0.00033692308,0.00023214724,0.0001351941,0.00043294686,0.00037021644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031328101,0.00012325942,0.0022923634,0.0001363608,0.0000818319,0.0002374834,0.00012019427,0.0017210757,0.98212343,0.0019151908,0.00031070507,0.0078052906],"study_design_scores_gemma":[0.0001459308,0.00042354243,0.007673548,0.0000092529135,0.000079272366,0.00057051936,0.00008425777,0.0060061584,0.97882724,0.00029944483,0.005863353,0.000017506309],"about_ca_topic_score_codex":0.009220663,"about_ca_topic_score_gemma":0.008921948,"teacher_disagreement_score":0.009220663,"about_ca_system_score_codex":0.0011861636,"about_ca_system_score_gemma":0.0004880762,"threshold_uncertainty_score":0.018333972},"labels":[],"label_agreement":null},{"id":"W1974807717","doi":"10.1016/j.bmc.2014.09.026","title":"Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α,17β-diol derivatives","year":2014,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Androstane; Bioavailability; Cytotoxicity; Stereochemistry; CYP3A4; In vivo; Pharmacokinetics; IC50; Pharmacology; Cell growth; Cell culture; In vitro; Biochemistry; Enzyme; Cytochrome P450","score_opus":0.049740435153245215,"score_gpt":0.3665065988968841,"score_spread":0.31676616374363886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974807717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96707416,0.008637746,0.007970155,0.0004383458,0.00013522006,0.00019344808,0.0021565882,0.00011983889,0.013274569],"genre_scores_gemma":[0.9792078,0.0061705783,0.003975599,0.0001359035,0.000031632295,0.00007252535,0.0010808781,0.000029262064,0.009295884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990606,0.000017485403,0.000013227734,0.000015384117,0.000020985806,0.00002679895],"domain_scores_gemma":[0.9999187,0.00001735405,0.00001668595,0.000013830065,0.00001816529,0.000015342495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017873972,0.00024003767,0.00018648039,0.00027061047,0.00020839233,0.00015881148,0.0002569898,0.00014999407,0.0025143705],"category_scores_gemma":[0.0001307289,0.00013432968,0.00022153085,0.00029378792,0.00013877949,0.00016099775,0.00010458157,0.00035300304,0.00077161373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005112939,0.00012841336,0.00022269708,0.00012969543,0.000011005801,0.00024924983,0.000049965238,0.0012177781,0.98475987,0.0008708037,0.00029690238,0.011552382],"study_design_scores_gemma":[0.000054441698,0.0008321096,0.00062237465,0.0000067643155,0.000016998614,0.00018571735,0.00001668341,0.00028786313,0.99142456,0.00008066975,0.0064638043,0.000007935786],"about_ca_topic_score_codex":0.00085904554,"about_ca_topic_score_gemma":0.0014923321,"teacher_disagreement_score":0.0025143705,"about_ca_system_score_codex":0.00032720258,"about_ca_system_score_gemma":0.00035005226,"threshold_uncertainty_score":0.0084114075},"labels":[],"label_agreement":null},{"id":"W1975032319","doi":"10.1016/s0006-2952(00)00249-5","title":"Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene","year":2000,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylcholanthrene; Cytochrome P450; Transcription (linguistics); Gene expression; Biology; In vivo; Messenger RNA; Enzyme inducer; Gene; Carcinogen; Molecular biology; Internal medicine; Chemistry; Endocrinology; Enzyme; Metabolism; Biochemistry; Genetics; Medicine","score_opus":0.055565309597907016,"score_gpt":0.4018804836958368,"score_spread":0.3463151740979298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975032319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147207,0.0011182539,0.0033648277,0.0004174352,0.000114627524,0.000048642924,0.00086338574,0.000185017,0.0024157958],"genre_scores_gemma":[0.9929686,0.00037925335,0.00078529224,0.000067202476,0.000020628371,0.000032866512,0.0007239558,0.000041032712,0.0049811355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995932,0.00007451013,0.00003494215,0.00008693837,0.00007697841,0.00013347373],"domain_scores_gemma":[0.9995074,0.00018425946,0.00007795834,0.00009974123,0.000048086255,0.00008254231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002584974,0.00054778776,0.00037535522,0.00054804445,0.00038770595,0.0006471336,0.0002612588,0.00040827,0.0026975705],"category_scores_gemma":[0.00038150224,0.00034458996,0.00067683647,0.00032480757,0.00063604506,0.00023370047,0.00038908218,0.00083753833,0.00071584136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003665469,0.00004713637,0.00024856787,0.000015840362,0.0000058151245,0.00007412863,0.000023013547,0.00008736995,0.99814177,0.00020064782,0.000052183215,0.0007369481],"study_design_scores_gemma":[0.000016412429,0.00013725509,0.0030005937,0.000003185757,0.000008423566,0.0001062883,0.00004242583,0.0005174151,0.9951592,0.00004216196,0.0009617562,0.000004916118],"about_ca_topic_score_codex":0.0029043383,"about_ca_topic_score_gemma":0.0038499632,"teacher_disagreement_score":0.0029043383,"about_ca_system_score_codex":0.0007381366,"about_ca_system_score_gemma":0.0005785606,"threshold_uncertainty_score":0.009024203},"labels":[],"label_agreement":null},{"id":"W1975781755","doi":"10.1021/bi000779p","title":"N-Glycosylation and Residue 96 Are Involved in the Functional Properties of UDP-Glucuronosyltransferase Enzymes<sup>,</sup>","year":2000,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glycosylation; Biochemistry; Enzyme; Chemistry; Asparagine; Biology","score_opus":0.08207284842191288,"score_gpt":0.33037291651102374,"score_spread":0.24830006808911087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975781755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890505,0.0034529727,0.004450691,0.00015079549,0.000053212163,0.000018071478,0.00040854703,0.00006157009,0.0023535632],"genre_scores_gemma":[0.98845905,0.0012262688,0.00447583,0.00010814556,0.000023640849,0.000025089372,0.002445692,0.000040820774,0.0031953948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998368,0.000036822225,0.000018710633,0.000045759793,0.000038753216,0.000023140316],"domain_scores_gemma":[0.9998362,0.000018079352,0.000058480207,0.00002896825,0.000020405107,0.000037783306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017556184,0.0004697373,0.00021836278,0.00011847812,0.00016008371,0.00047089154,0.00026739103,0.0003393922,0.00161774],"category_scores_gemma":[0.00027084173,0.00013125325,0.0004210815,0.00026115347,0.00028783293,0.00030814882,0.00020381837,0.00031833746,0.00085143297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065595016,0.00002505473,0.0027237816,0.00010165781,0.000023770253,0.00031287348,0.00002367853,0.0001858754,0.98672897,0.0003766988,0.00015295425,0.008688689],"study_design_scores_gemma":[0.000026359083,0.0002054055,0.02630265,0.000016188798,0.000040675506,0.0018561478,0.00003695623,0.001319756,0.9600209,0.0002655011,0.009897959,0.000011496261],"about_ca_topic_score_codex":0.00079114013,"about_ca_topic_score_gemma":0.0005408726,"teacher_disagreement_score":0.00161774,"about_ca_system_score_codex":0.00038706153,"about_ca_system_score_gemma":0.0001834444,"threshold_uncertainty_score":0.0054118633},"labels":[],"label_agreement":null},{"id":"W1976009585","doi":"10.1111/j.1365-2885.2007.00893.x","title":"Comparative oxidative metabolic profiles of clomipramine in cats, rats and dogs: preliminary results from an <i>in vitro</i> study","year":2007,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Université de Montréal","keywords":"Microsome; Clomipramine; CATS; Internal medicine; Endocrinology; Nicotinamide adenine dinucleotide phosphate; Metabolism; Chemistry; In vitro; Pharmacology; Biology; Biochemistry; Medicine; Oxidase test; Enzyme","score_opus":0.1446500564530649,"score_gpt":0.4667937058876791,"score_spread":0.3221436494346142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976009585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681455,0.0009840876,0.0010918477,0.000055648474,0.000006628589,0.00003337767,0.00038239852,0.000015407979,0.00061617163],"genre_scores_gemma":[0.9929095,0.0013338323,0.0028579622,0.00006871997,0.000011565505,0.000034947854,0.0013779536,0.000013364488,0.0013920726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998975,0.000025192287,0.0000093663075,0.00002353154,0.000021972182,0.000022438839],"domain_scores_gemma":[0.99980956,0.00003311384,0.000058647984,0.000023853143,0.00004256713,0.00003229344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002533754,0.00025066093,0.00025656453,0.00035263572,0.00027200597,0.00024951927,0.00011073413,0.00026855248,0.0012426055],"category_scores_gemma":[0.00038071585,0.00015603665,0.00021085571,0.0001842664,0.00024531566,0.00025218047,0.000106061605,0.00025018773,0.00031570648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035178692,0.00015063887,0.025489971,0.00013630635,0.00007210431,0.00060033746,0.0002901896,0.00017220093,0.9582956,0.00016998986,0.00017042847,0.010934469],"study_design_scores_gemma":[0.00007626329,0.007807693,0.18242131,0.000013534593,0.00029397954,0.003476109,0.00049404666,0.001225068,0.7989324,0.00013598554,0.005095428,0.000028137421],"about_ca_topic_score_codex":0.0027560783,"about_ca_topic_score_gemma":0.0068697874,"teacher_disagreement_score":0.0027560783,"about_ca_system_score_codex":0.000333159,"about_ca_system_score_gemma":0.00021413057,"threshold_uncertainty_score":0.005480051},"labels":[],"label_agreement":null},{"id":"W1976967080","doi":"10.3109/00498254.2010.529178","title":"The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat","year":2010,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ketoconazole; Pharmacokinetics; Pharmacology; Enantiomer; Lipoprotein; Medicine; Endocrinology; Biology; Internal medicine; Chemistry; Cholesterol; Antifungal; Microbiology; Stereochemistry","score_opus":0.05158699698607702,"score_gpt":0.397180062483188,"score_spread":0.345593065497111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976967080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963947,0.00097306015,0.0012877092,0.00015707494,0.000050628765,0.000022563583,0.00028940086,0.0001118627,0.0007129938],"genre_scores_gemma":[0.9944106,0.0011970532,0.0016165121,0.00016206519,0.000032220323,0.000051742372,0.0004040816,0.00003487401,0.0020909186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974376,0.000057468726,0.000020629614,0.00006466061,0.000046830948,0.00006660979],"domain_scores_gemma":[0.99959403,0.000050522634,0.00013556515,0.000064938075,0.000039772698,0.000115102695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027641183,0.00050468725,0.00042624527,0.0005030466,0.00019369478,0.00046031576,0.0002172275,0.00044674956,0.001172484],"category_scores_gemma":[0.00027255036,0.0003455873,0.00037274623,0.00026767747,0.0004379606,0.0004900168,0.00020614162,0.001236412,0.00041783406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011482191,0.00071691873,0.0015198954,0.00005935481,0.00004012759,0.00017525641,0.000054649612,0.0001459235,0.975663,0.00016110463,0.00017320568,0.009808397],"study_design_scores_gemma":[0.00026629237,0.008559205,0.013109577,0.000007894482,0.000116676514,0.00026175866,0.000076995886,0.0010952275,0.97473323,0.000109292945,0.0016351807,0.000028578197],"about_ca_topic_score_codex":0.0015264468,"about_ca_topic_score_gemma":0.0016562539,"teacher_disagreement_score":0.0015264468,"about_ca_system_score_codex":0.0005515802,"about_ca_system_score_gemma":0.0004392651,"threshold_uncertainty_score":0.0040020347},"labels":[],"label_agreement":null},{"id":"W1976992742","doi":"10.1016/j.jpba.2009.07.004","title":"Validation of a new HPLC method for determination of midazolam and its metabolites: Application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbits","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Chemistry; Chromatography; Midazolam; Pharmacokinetics; High-performance liquid chromatography; Analyte; Coefficient of variation; CYP3A; Correlation coefficient; Calibration curve; Extraction (chemistry); Cytochrome P450; Detection limit; Enzyme; Pharmacology; Biochemistry","score_opus":0.09434307390800653,"score_gpt":0.4639736425141439,"score_spread":0.3696305686061374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976992742","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.450604,0.0074502137,0.53145105,0.0010008703,0.0007069348,0.0021020626,0.0012712842,0.0022252125,0.0031883998],"genre_scores_gemma":[0.66948944,0.0038689836,0.31585935,0.0014041545,0.00024358534,0.0016499258,0.0013983708,0.0002720401,0.0058140894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974305,0.0007091938,0.00019221866,0.00046795834,0.0011016708,0.00009845594],"domain_scores_gemma":[0.99796754,0.00055019016,0.0003232785,0.0001952178,0.00077096536,0.00019288016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026494067,0.000849278,0.0007602706,0.0010938258,0.00072163605,0.00071104936,0.00078524114,0.0013553048,0.0007104604],"category_scores_gemma":[0.003284706,0.0006239866,0.0005849021,0.000550742,0.0008528433,0.0005934742,0.0005849869,0.0012503243,0.00088043674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005418636,0.00030276788,0.00248223,0.00015862759,0.000106938925,0.000089004,0.00014180745,0.00033875508,0.9646132,0.00023769261,0.0002919362,0.030695291],"study_design_scores_gemma":[0.00028073197,0.0040402687,0.015840575,0.000055665325,0.00037340034,0.0021393995,0.00007908093,0.0071398546,0.9607657,0.00021959344,0.008983826,0.00008197573],"about_ca_topic_score_codex":0.0027672155,"about_ca_topic_score_gemma":0.0044593,"teacher_disagreement_score":0.0027672155,"about_ca_system_score_codex":0.00061452,"about_ca_system_score_gemma":0.0016686518,"threshold_uncertainty_score":0.0140116215},"labels":[],"label_agreement":null},{"id":"W1977032972","doi":"10.1007/s12160-011-9318-5","title":"Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers","year":2011,"lang":"en","type":"article","venue":"Annals of Behavioral Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institutes of Health; Canadian Institutes of Health Research; Sun Yat-sen University","keywords":"CYP2A6; Abdominal obesity; Obesity; Medicine; Genotype; Cigarette smoking; Abdominal fat; Health psychology; Environmental health; Consumption (sociology); Risk factor; Demography; Internal medicine; Public health; Biology; Genetics; Gene; Pathology; Metabolic syndrome","score_opus":0.42569123688865657,"score_gpt":0.5116186034948406,"score_spread":0.085927366606184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977032972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963033,0.00012938865,0.000025667508,0.000020789848,0.0000024378096,0.0000036131541,0.000038753824,0.0000011367777,0.00014785795],"genre_scores_gemma":[0.9997818,0.000048827987,0.000025097368,0.000009755302,0.0000053479425,0.0000028701577,0.000035373927,6.881024e-7,0.00009030017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972254,0.00007581285,0.00003371453,0.000056336852,0.00006882974,0.000042694173],"domain_scores_gemma":[0.9983575,0.0005095581,0.00061409856,0.00011313409,0.00013395192,0.00027165844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006107844,0.00022550169,0.00025132333,0.00077323645,0.00034237892,0.00037902055,0.00022167599,0.00039426392,0.0021046023],"category_scores_gemma":[0.0015979199,0.00033372294,0.0004465907,0.0005421925,0.00028352495,0.00022059144,0.00020766261,0.0004589453,0.00016504059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001464474,0.000027191352,0.99885046,0.000003870651,0.000050433082,0.000046966317,0.000041622156,0.000011393219,0.00029170883,0.000006386885,0.000016058482,0.0005074484],"study_design_scores_gemma":[0.0000032121122,0.000051637522,0.9995983,0.0000013544374,0.000031114527,0.000118136246,0.000039578987,0.00009046641,0.00003611742,0.0000072668267,0.000021347925,0.0000015352193],"about_ca_topic_score_codex":0.005414511,"about_ca_topic_score_gemma":0.0065501193,"teacher_disagreement_score":0.005414511,"about_ca_system_score_codex":0.00019589366,"about_ca_system_score_gemma":0.00019977217,"threshold_uncertainty_score":0.01076597},"labels":[],"label_agreement":null},{"id":"W1977079922","doi":"10.1006/abbi.2000.2115","title":"The Human Cytochrome P450 1A1 mRNA Is Rapidly Degraded In HepG2 Cells","year":2000,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council Canada","keywords":"Messenger RNA; CYP1A2; Glyceraldehyde 3-phosphate dehydrogenase; Cytochrome P450; Biology; Molecular biology; P-bodies; Gene expression; Cell biology; Gene; Biochemistry; Enzyme; Translation (biology)","score_opus":0.03520420764586936,"score_gpt":0.3557035254223258,"score_spread":0.32049931777645646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977079922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699014,0.0072345412,0.009530056,0.00071380875,0.00043751387,0.000077277495,0.004553107,0.0005194595,0.0070328624],"genre_scores_gemma":[0.9572019,0.0025718033,0.004856153,0.0002154542,0.00015182709,0.00011112855,0.012134549,0.0001745081,0.022582605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996811,0.000060597235,0.000032463617,0.00006987049,0.00009611738,0.00005986105],"domain_scores_gemma":[0.9996805,0.00010929842,0.000033580684,0.00006479671,0.000072462295,0.000039324583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023943082,0.00038660405,0.00047314525,0.0005746027,0.0005221454,0.00066422793,0.00014260785,0.0002599199,0.002893136],"category_scores_gemma":[0.00033196784,0.00035765464,0.00044763403,0.00041107263,0.00032824738,0.0003327175,0.00025453907,0.0007844162,0.00225806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030675507,0.000023527658,0.00037626523,0.00003977518,0.000007898581,0.00013659263,0.000057365305,0.000045872377,0.9974451,0.00008953308,0.00018851167,0.0012828398],"study_design_scores_gemma":[0.000026725838,0.00027843544,0.009213076,0.000006798746,0.000025705298,0.0006071732,0.000119183256,0.0008419658,0.9827488,0.00008501866,0.006032919,0.000014340825],"about_ca_topic_score_codex":0.0039912737,"about_ca_topic_score_gemma":0.0030099368,"teacher_disagreement_score":0.0039912737,"about_ca_system_score_codex":0.0004249816,"about_ca_system_score_gemma":0.00045779502,"threshold_uncertainty_score":0.009678543},"labels":[],"label_agreement":null},{"id":"W1978042645","doi":"10.1111/j.1349-7006.2011.02143.x","title":"Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Prostate cancer; CYP3A4; Xenobiotic; Steroid; Cancer research; Cancer; Gene; Clinical significance; Receptor; Oncology; Medicine; Biology; Internal medicine; Cytochrome P450; Genetics; Hormone; Biochemistry; Metabolism; Enzyme","score_opus":0.2063154794774133,"score_gpt":0.48248698710334703,"score_spread":0.27617150762593373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978042645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336595,0.0123955775,0.00084923353,0.00024281851,0.000028792585,0.000026141422,0.00030029728,0.000058895777,0.0027322543],"genre_scores_gemma":[0.9984497,0.0007606404,0.00019769602,0.00003122155,0.00002870564,0.0000057798247,0.00017378679,0.000003984515,0.0003485631],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967,0.00007674462,0.00002266975,0.00006329732,0.00012408932,0.00004323069],"domain_scores_gemma":[0.9995333,0.000082449886,0.00017441013,0.000031362626,0.00008024767,0.0000982364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036303644,0.00017019,0.00027685624,0.0008014135,0.00032537873,0.00037149363,0.00017619727,0.00025502077,0.0012970095],"category_scores_gemma":[0.00072905753,0.00012636343,0.00027684253,0.0009631173,0.00037839648,0.00012589402,0.00019581692,0.00042153432,0.00020494378],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011930873,0.00006596685,0.9207117,0.00013848986,0.00012907568,0.0033840574,0.00010705853,0.00017287263,0.052993335,0.00015075745,0.0004436634,0.020510016],"study_design_scores_gemma":[0.0000113364695,0.00016873943,0.9890794,0.0000050262693,0.000078438345,0.0057486254,0.000052742536,0.00028966073,0.003207777,0.00006825965,0.0012843331,0.000005667038],"about_ca_topic_score_codex":0.0013941554,"about_ca_topic_score_gemma":0.0013750853,"teacher_disagreement_score":0.0013941554,"about_ca_system_score_codex":0.00028364122,"about_ca_system_score_gemma":0.00028909827,"threshold_uncertainty_score":0.0043388605},"labels":[],"label_agreement":null},{"id":"W1978118879","doi":"10.1016/j.toxlet.2005.08.006","title":"Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes","year":2005,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Ligue Contre le Cancer","keywords":"p38 mitogen-activated protein kinases; Kinase; MAPK/ERK pathway; Enhancer; Protein kinase A; Molecular biology; Cell biology; Mitogen-activated protein kinase; Biology; Signal transduction; Chemistry; Gene expression; Gene; Biochemistry","score_opus":0.05281194561271687,"score_gpt":0.37646414984549437,"score_spread":0.3236522042327775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978118879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536044,0.00524204,0.0048457347,0.0003764922,0.000114217924,0.000051950097,0.0012772955,0.000084704,0.002647182],"genre_scores_gemma":[0.9881373,0.0022342731,0.0035495656,0.00009279122,0.000049906528,0.000087059205,0.0017813543,0.00002832875,0.00403927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997856,0.000055722907,0.000022595828,0.000031289153,0.0000438998,0.000060888768],"domain_scores_gemma":[0.99977475,0.00009116065,0.000021101407,0.00003813574,0.000033514767,0.00004139832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028132857,0.0003153019,0.00033866093,0.00041073305,0.00036131128,0.00040958755,0.00014891854,0.0002047184,0.0017631945],"category_scores_gemma":[0.00019489934,0.00027173897,0.00047329703,0.00026477853,0.0002472661,0.00032018806,0.00024137383,0.00068883057,0.0007480847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032675447,0.00003235493,0.00019064166,0.000030603216,0.0000046024206,0.000060453876,0.00002208132,0.00004033669,0.99856573,0.000091353955,0.000044202603,0.000590911],"study_design_scores_gemma":[0.000026431197,0.00022758154,0.007332186,0.0000056539498,0.000017199927,0.00017340855,0.000061019877,0.0006485978,0.99014646,0.000055116874,0.0013022751,0.0000039700917],"about_ca_topic_score_codex":0.0015315389,"about_ca_topic_score_gemma":0.0031573572,"teacher_disagreement_score":0.0017631945,"about_ca_system_score_codex":0.00044733827,"about_ca_system_score_gemma":0.0002969523,"threshold_uncertainty_score":0.0058984756},"labels":[],"label_agreement":null},{"id":"W1978188597","doi":"10.1007/s00253-012-4654-3","title":"Heterologous expression of CYP102A5 variant from Bacillus cereus CYPPB-1: Validation of model for predicting drug metabolism of human P450 probe substrates","year":2013,"lang":"en","type":"article","venue":"Applied Microbiology and Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Council of Scientific and Industrial Research, India","keywords":"Bacillus cereus; In silico; Biochemistry; Chemistry; Drug metabolism; Docking (animal); Homology modeling; Biology; Metabolism; Enzyme; Bacteria; Genetics","score_opus":0.04365088839581922,"score_gpt":0.32288330347463606,"score_spread":0.27923241507881685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978188597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852835,0.00028585832,0.012592968,0.00010188889,0.0000176361,0.000014142344,0.0007682038,0.00016274642,0.00077303953],"genre_scores_gemma":[0.9882023,0.00022783846,0.009309614,0.000010300375,0.000002752159,0.000010513855,0.0016142114,0.000031476284,0.0005909649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990106,0.000019723419,0.0000075448797,0.000029445036,0.000029068236,0.000013210069],"domain_scores_gemma":[0.9999449,0.00001776289,0.000012501819,0.000005341444,0.000011071878,0.000008323433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012388019,0.000427545,0.000368674,0.00013312428,0.00016250862,0.00042695567,0.00030016617,0.00037222618,0.0005567672],"category_scores_gemma":[0.00028959123,0.00011517188,0.00028733307,0.00027620848,0.00010019453,0.00013594958,0.00012565739,0.00044111226,0.00025232238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006590534,0.00015251711,0.003269244,0.00015741316,0.00004083818,0.00028877816,0.000044957917,0.047703974,0.93797636,0.0007588819,0.00028126285,0.0086667165],"study_design_scores_gemma":[0.000049147147,0.0004178396,0.0030500987,0.000010079854,0.000044915476,0.0002818625,0.00006479762,0.2665251,0.7270437,0.00025202497,0.0022438224,0.00001671583],"about_ca_topic_score_codex":0.0048108003,"about_ca_topic_score_gemma":0.0025320877,"teacher_disagreement_score":0.0048108003,"about_ca_system_score_codex":0.0004611012,"about_ca_system_score_gemma":0.00028616353,"threshold_uncertainty_score":0.009565592},"labels":[],"label_agreement":null},{"id":"W1978196851","doi":"10.1002/jcb.10177","title":"Displacement of histamine from liver cells and cell components by ligands for cytochromes P450","year":2002,"lang":"en","type":"article","venue":"Journal of Cellular Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Histamine; Displacement (psychology); Chemistry; Cell; Cell biology; Pharmacology; Biochemistry; Biology; Psychology","score_opus":0.05369761102648932,"score_gpt":0.32754899030868406,"score_spread":0.2738513792821947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978196851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97865844,0.005361572,0.008173507,0.0003377374,0.0000737928,0.00008540194,0.00029845044,0.0000764494,0.0069345464],"genre_scores_gemma":[0.99248487,0.0010644714,0.0028138587,0.00011751971,0.000035446967,0.000052510568,0.00034947472,0.000015413701,0.0030664294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998429,0.000039850496,0.000008749885,0.00003129545,0.000035681373,0.00004158975],"domain_scores_gemma":[0.9999125,0.000034660472,0.00001359496,0.000014979765,0.000009568187,0.000014781896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018961614,0.00031260122,0.00019325757,0.00008131126,0.00016630102,0.0002507611,0.00017553539,0.00025661982,0.001944643],"category_scores_gemma":[0.00015636551,0.000119505894,0.00018188039,0.000100105426,0.00023792253,0.00020487364,0.00025434064,0.00049315306,0.00052030274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015874342,0.000010217386,0.00012019252,0.00002832082,0.0000028220243,0.00004787375,0.00002116819,0.000011860731,0.99778336,0.0001562786,0.000033997887,0.0016250876],"study_design_scores_gemma":[0.000040585222,0.00048218234,0.005263004,0.00000588878,0.000008578868,0.00020425628,0.000038632257,0.0003396283,0.9907578,0.00006654753,0.0027896941,0.0000030452939],"about_ca_topic_score_codex":0.0007683724,"about_ca_topic_score_gemma":0.0012948187,"teacher_disagreement_score":0.001944643,"about_ca_system_score_codex":0.0003040907,"about_ca_system_score_gemma":0.00018967074,"threshold_uncertainty_score":0.0065054297},"labels":[],"label_agreement":null},{"id":"W1978862031","doi":"10.1007/s11095-006-9217-9","title":"The Evolving Role of Drug Metabolism in Drug Discovery and Development","year":2007,"lang":"en","type":"review","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"ADME; Drug metabolism; Drug discovery; Pharmacology; Pharmacogenomics; Drug; Computational biology; Drug development; Pharmacogenetics; Biology; Bioinformatics; Genetics","score_opus":0.3889439312688324,"score_gpt":0.5860510311367881,"score_spread":0.19710709986795572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978862031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015368148,0.99653167,0.0010807002,0.0008516147,0.00030309637,0.0000036468884,0.000010751623,0.000013596888,0.001051262],"genre_scores_gemma":[0.0008432314,0.99664813,0.0009947426,0.0004820061,0.00055545603,0.000005103219,0.000013179153,0.0000026753787,0.00045547218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992873,0.00022115186,0.00007380377,0.000109918656,0.00026562985,0.000042193926],"domain_scores_gemma":[0.9978229,0.0014987702,0.0001744168,0.00006511609,0.0003376753,0.0001012149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022023586,0.0011555766,0.002783494,0.0018886486,0.00035624413,0.0020817788,0.0013340903,0.002198785,0.0027297644],"category_scores_gemma":[0.0017914412,0.00045257914,0.00061535486,0.0035134528,0.0015484057,0.0029206893,0.0010528408,0.0031371657,0.0020379808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007662228,0.00006264658,0.0002588721,0.007427754,0.000067368856,0.00021968578,0.00004549107,0.0005339584,0.0021415886,0.009487557,0.0146778375,0.9650007],"study_design_scores_gemma":[0.00003226045,0.00016364986,0.000912384,0.0020277018,0.00013317294,0.0017352463,0.000090545036,0.0004388792,0.0013209861,0.011846129,0.9812633,0.000035698853],"about_ca_topic_score_codex":0.0013591794,"about_ca_topic_score_gemma":0.0022990075,"teacher_disagreement_score":0.002783494,"about_ca_system_score_codex":0.0013055631,"about_ca_system_score_gemma":0.0019717568,"threshold_uncertainty_score":0.011647344},"labels":[],"label_agreement":null},{"id":"W1979401973","doi":"10.1016/j.tox.2009.10.025","title":"Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: Its regulation by aryl hydrocarbon receptor agonists","year":2009,"lang":"en","type":"article","venue":"Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Aryl hydrocarbon receptor; Messenger RNA; CYP1B1; Internal medicine; Gene expression; Cytochrome P450; Endocrinology; Molecular biology; Biochemistry; Biology; Gene; Enzyme; Medicine","score_opus":0.05629017069368933,"score_gpt":0.37886978297206236,"score_spread":0.32257961227837306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979401973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994948,0.0006778354,0.0032618495,0.00014171301,0.000025054132,0.000014698745,0.00054652145,0.00005079923,0.00033346782],"genre_scores_gemma":[0.9930072,0.0006345836,0.002044275,0.0000680068,0.000025027543,0.00003680421,0.0009902552,0.00004814588,0.003145663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998666,0.000019932668,0.000008475836,0.00003396732,0.000036223882,0.000034784345],"domain_scores_gemma":[0.9995634,0.000049644754,0.00011443088,0.000044406814,0.000068930305,0.00015933417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016285935,0.00046968315,0.0004227363,0.0007899164,0.0002690835,0.0002967536,0.00017592212,0.00026609097,0.0012064684],"category_scores_gemma":[0.0002914645,0.00030272192,0.0003709861,0.00028051704,0.00035381905,0.00024689696,0.00012521149,0.0007592783,0.000310556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012345288,0.00009876931,0.0044506704,0.000029022845,0.000028637347,0.00010583524,0.000037110447,0.00010118584,0.99001044,0.00016056155,0.00007645101,0.0036668254],"study_design_scores_gemma":[0.000046016226,0.0011546022,0.0528946,0.000007117165,0.00011440245,0.0005785376,0.00010006319,0.001100522,0.94205123,0.00019144871,0.0017438029,0.000017598462],"about_ca_topic_score_codex":0.0016844303,"about_ca_topic_score_gemma":0.0024879482,"teacher_disagreement_score":0.0016844303,"about_ca_system_score_codex":0.00031077163,"about_ca_system_score_gemma":0.00036352404,"threshold_uncertainty_score":0.0040360093},"labels":[],"label_agreement":null},{"id":"W1979729122","doi":"10.1016/s0024-3205(01)01241-3","title":"L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","year":2001,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Novartis Pharma","keywords":"In vivo; Cytochrome P450; Pharmacology; Chemistry; Cytochrome; Medicine; Biochemistry; Biology; Enzyme","score_opus":0.0739610474471642,"score_gpt":0.3999660705482856,"score_spread":0.3260050231011214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979729122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866572,0.002979999,0.0062083164,0.00076218264,0.00039008344,0.00008948173,0.0004375334,0.00051081,0.0019643605],"genre_scores_gemma":[0.99213153,0.0011857616,0.0021136915,0.00015952736,0.00021835478,0.00008514083,0.0006473851,0.000076587334,0.0033820579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938905,0.00018466561,0.00006138564,0.00006424025,0.00009634705,0.00020425771],"domain_scores_gemma":[0.99825436,0.0003704459,0.00042718262,0.00027771626,0.00012688141,0.00054337975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000686667,0.0012694226,0.0014521318,0.0006194719,0.00054156233,0.0006768587,0.00061095064,0.001002246,0.0032093541],"category_scores_gemma":[0.0010144197,0.0005148977,0.00077266817,0.00034227208,0.0014679345,0.0009886412,0.00042703832,0.0029111332,0.0010404731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009894769,0.0009585675,0.0005107781,0.00016357149,0.000040081628,0.00043440989,0.0000868233,0.0002227151,0.9829798,0.00038738508,0.00029417608,0.0040269135],"study_design_scores_gemma":[0.0004041542,0.0057130903,0.004262778,0.000016801965,0.000061240746,0.0006203101,0.00006502328,0.00093573943,0.98666024,0.0001436631,0.0010989043,0.000018076558],"about_ca_topic_score_codex":0.0005173418,"about_ca_topic_score_gemma":0.000822792,"teacher_disagreement_score":0.0032093541,"about_ca_system_score_codex":0.00036649275,"about_ca_system_score_gemma":0.0009381022,"threshold_uncertainty_score":0.010736346},"labels":[],"label_agreement":null},{"id":"W1979836228","doi":"10.1023/b:pham.0000041458.81836.c4","title":"Tamoxifen Alters Hepatic Cytochrome P450 Enzyme Expression and Circulating Growth Hormone Levels in Intact Male Rats","year":2004,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council Canada","keywords":"Endocrinology; Internal medicine; Tamoxifen; Triiodothyronine; Testosterone (patch); Cytochrome P450; Hormone; Biology; Medicine; Chemistry; Metabolism; Cancer; Breast cancer","score_opus":0.3261665139244788,"score_gpt":0.5312953775401043,"score_spread":0.20512886361562543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979836228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956536,0.0004850468,0.0016342681,0.00021962202,0.00008184439,0.000019944331,0.0009557056,0.00018975513,0.0007600894],"genre_scores_gemma":[0.98022985,0.0009899619,0.002499054,0.00018728906,0.00005637468,0.00011826443,0.0015242547,0.00017644856,0.014218488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995378,0.000042751628,0.000027324872,0.0001475582,0.0000933761,0.00015117071],"domain_scores_gemma":[0.999215,0.00010019802,0.00027874167,0.00010786998,0.00006509876,0.00023298514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001837702,0.00073860376,0.0006383872,0.0014583777,0.00038194313,0.00052972935,0.0004320269,0.0006561242,0.0038125955],"category_scores_gemma":[0.00035377083,0.00053302915,0.00045357793,0.00046174842,0.00113361,0.0008580883,0.0002722556,0.0014173607,0.0010389275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041145473,0.00036295276,0.0009052232,0.000017723527,0.000016109363,0.00011941343,0.000059830032,0.000057763067,0.9916013,0.00012566707,0.000118001066,0.0025014663],"study_design_scores_gemma":[0.00020456943,0.0030785545,0.015746618,0.000009477289,0.000120821154,0.00026639973,0.00026267208,0.0008205963,0.97771865,0.00020253677,0.0015371868,0.000031849944],"about_ca_topic_score_codex":0.0028348297,"about_ca_topic_score_gemma":0.0053114216,"teacher_disagreement_score":0.0038125955,"about_ca_system_score_codex":0.00080289075,"about_ca_system_score_gemma":0.00045588982,"threshold_uncertainty_score":0.012754381},"labels":[],"label_agreement":null},{"id":"W1979838277","doi":"10.1016/j.resmic.2008.08.006","title":"Characterization of a mycothiol ligase mutant of Rhodococcus jostii RHA1","year":2008,"lang":"en","type":"article","venue":"Research in Microbiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Biology; Mutant; Rhodococcus; Biochemistry; DNA ligase; Rhodococcus rhodochrous; Microbiology; Enzyme; Gene","score_opus":0.2825787198897924,"score_gpt":0.5010948488247937,"score_spread":0.21851612893500133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979838277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915936,0.00043436745,0.0040056775,0.00032300001,0.000058721394,0.00008121401,0.0019567772,0.00019477602,0.0013517861],"genre_scores_gemma":[0.9862584,0.00029686515,0.0054822075,0.000073383126,0.000012442474,0.000059256105,0.0029674754,0.00017168689,0.004678304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970394,0.00004114586,0.000049565628,0.00004767307,0.00011110653,0.000046525096],"domain_scores_gemma":[0.9996369,0.00008418587,0.00011292593,0.00005456702,0.00005471062,0.000056709774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001489059,0.0005620948,0.0006294817,0.00036162505,0.00021809978,0.00047374345,0.0005822609,0.00053852814,0.001288577],"category_scores_gemma":[0.00041463753,0.00025504193,0.0005548243,0.00040696183,0.00024291557,0.0002428262,0.00039663227,0.000859477,0.0011625256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005921982,0.00003506511,0.00022555441,0.000028612894,0.0000062085373,0.00018881755,0.000020780857,0.00007139617,0.9984836,0.00003991605,0.000022803248,0.0008180207],"study_design_scores_gemma":[0.0000106442385,0.00012885187,0.004804195,0.000005231207,0.000020876492,0.0011273414,0.00011373415,0.00078333606,0.9916156,0.000025248059,0.001351325,0.000013527116],"about_ca_topic_score_codex":0.004601388,"about_ca_topic_score_gemma":0.0027186743,"teacher_disagreement_score":0.004601388,"about_ca_system_score_codex":0.00041903387,"about_ca_system_score_gemma":0.00040442075,"threshold_uncertainty_score":0.009149194},"labels":[],"label_agreement":null},{"id":"W1979845492","doi":"10.1038/446975a","title":"When good drugs go bad","year":2007,"lang":"en","type":"article","venue":"Nature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":282,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Drug reaction; Business; Adverse effect; Scale (ratio); Medicine; Drug; Geography; Psychiatry; Pharmacology","score_opus":0.0409152139193354,"score_gpt":0.4231492329399157,"score_spread":0.3822340190205803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979845492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010398108,0.039576456,0.002292982,0.77637386,0.019286733,0.000052652496,0.00073654804,0.0003357863,0.15094687],"genre_scores_gemma":[0.268483,0.047090195,0.004194066,0.57077795,0.015892113,0.00015599458,0.00066590036,0.00048573338,0.092255004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99102974,0.0028300476,0.0004648715,0.0006823394,0.003953004,0.0010399915],"domain_scores_gemma":[0.98845196,0.003777748,0.0015893526,0.0011483931,0.0025515298,0.0024810638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067376746,0.0006203904,0.0014910422,0.0018960753,0.0032026966,0.007783154,0.001036105,0.007577281,0.030575307],"category_scores_gemma":[0.021172535,0.0005764277,0.00086119317,0.0011665601,0.009313021,0.0073277783,0.0033256775,0.00994573,0.0108161885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064099266,0.00021967066,0.013501928,0.0006425153,0.00029631116,0.0010740146,0.00094946206,0.00027855282,0.002224326,0.10169113,0.67786413,0.20061702],"study_design_scores_gemma":[0.000113817456,0.0002461582,0.007273789,0.0006852049,0.00014019158,0.0014867708,0.0019453088,0.000245311,0.0021010067,0.19145958,0.7941816,0.00012136412],"about_ca_topic_score_codex":0.0026029614,"about_ca_topic_score_gemma":0.005681918,"teacher_disagreement_score":0.030575307,"about_ca_system_score_codex":0.0030061489,"about_ca_system_score_gemma":0.004042696,"threshold_uncertainty_score":0.10228461},"labels":[],"label_agreement":null},{"id":"W1979995329","doi":"10.1016/s0960-0760(01)00057-7","title":"Comparative biosynthetic pathway of androstenol and androgens","year":2001,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; Cytochrome P450; Biology; Nuclear receptor; Biochemistry; Dehydrogenase; Pheromone; Androgen receptor; Enzyme; Gene; Transcription factor; Genetics","score_opus":0.05564122880844084,"score_gpt":0.39505953266151783,"score_spread":0.339418303853077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979995329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499587,0.014481754,0.0058807116,0.0007269907,0.00010797834,0.000057462817,0.0022569413,0.00014994568,0.026379436],"genre_scores_gemma":[0.9734572,0.0057525975,0.004276311,0.00018850039,0.000044257813,0.000023854634,0.0030264144,0.000055690216,0.013175221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998153,0.00003821148,0.000012306705,0.000047703394,0.000043392494,0.0000431501],"domain_scores_gemma":[0.99965966,0.00007715397,0.00003534735,0.00004199588,0.00010440684,0.00008143847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002082265,0.00032133667,0.0002622303,0.0013373316,0.00060479034,0.00096067,0.00042071714,0.00045941866,0.0039136335],"category_scores_gemma":[0.00028868433,0.00036955578,0.00046489257,0.0007429623,0.00043484682,0.00068706524,0.0003334523,0.00073141133,0.0012423884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002791574,0.00004558958,0.0028099346,0.0001275048,0.000035897727,0.0009834173,0.00016260296,0.00040743052,0.96562785,0.0071989186,0.00016868397,0.019640643],"study_design_scores_gemma":[0.00010719615,0.0010184323,0.054290406,0.00006453072,0.00014431657,0.0032963112,0.0005873377,0.0008221174,0.90577805,0.0038053277,0.030026052,0.00005984029],"about_ca_topic_score_codex":0.0033853562,"about_ca_topic_score_gemma":0.003744572,"teacher_disagreement_score":0.0039136335,"about_ca_system_score_codex":0.0011006492,"about_ca_system_score_gemma":0.0009725124,"threshold_uncertainty_score":0.013092458},"labels":[],"label_agreement":null},{"id":"W1980440732","doi":"10.1124/jpet.104.076141","title":"The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice","year":2005,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Inflammation; Pregnane; Gene; Receptor; Biology; Pharmacology; Internal medicine; Endocrinology; Nuclear receptor; Immunology; Medicine; Genetics; Transcription factor","score_opus":0.05142888166797033,"score_gpt":0.39064532776775296,"score_spread":0.33921644609978263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980440732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918623,0.0018952799,0.0033333376,0.0005546299,0.00005511937,0.000032585747,0.0009060947,0.0001661004,0.0011946053],"genre_scores_gemma":[0.989031,0.0012698942,0.0024243346,0.00027486077,0.000032290245,0.00011605143,0.00065230514,0.00013542049,0.006063806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993881,0.000112416936,0.000041998246,0.00015028164,0.00011609255,0.00019113593],"domain_scores_gemma":[0.9993697,0.00007051413,0.00025812144,0.00009136248,0.00003190925,0.0001783551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040724143,0.0006469526,0.00051350624,0.0016671298,0.00034406997,0.00085501425,0.00037728978,0.000841444,0.002000938],"category_scores_gemma":[0.00030301703,0.0007188147,0.0007384792,0.00039969347,0.0012362377,0.00059850333,0.00041379037,0.001721532,0.0005898915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018810508,0.00008803721,0.00069247297,0.000028157308,0.000010305661,0.00015403652,0.000045769422,0.00011226355,0.9952539,0.00039873944,0.0000536979,0.0012814605],"study_design_scores_gemma":[0.00026358714,0.001422492,0.022066008,0.00003169364,0.00011831832,0.0008456559,0.00029826947,0.001328434,0.97045094,0.0008219391,0.0023202782,0.00003244173],"about_ca_topic_score_codex":0.0007266267,"about_ca_topic_score_gemma":0.0011152709,"teacher_disagreement_score":0.002000938,"about_ca_system_score_codex":0.00065017614,"about_ca_system_score_gemma":0.0004307712,"threshold_uncertainty_score":0.0066937804},"labels":[],"label_agreement":null},{"id":"W1981252527","doi":"10.1139/y00-130","title":"Effect of<i>trans</i>-resveratrol on 7-benzyloxy-4-trifluoromethylcoumarin<i>O</i>-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CYP3A4; Recombinant DNA; Alkylation; Chemistry; Resveratrol; Stereochemistry; Pharmacology; Catalysis; Biology; Biochemistry; Enzyme; Cytochrome P450; Gene","score_opus":0.02938001970215018,"score_gpt":0.3681678513950691,"score_spread":0.33878783169291893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981252527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993683,0.0029329932,0.00101067,0.000086106535,0.00006561675,0.000026868032,0.0001850794,0.00005442399,0.0019553187],"genre_scores_gemma":[0.9947771,0.0015911589,0.0013198336,0.00008623177,0.000025439498,0.000017404376,0.00048873475,0.000015430805,0.0016785638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998499,0.00006447258,0.000014105702,0.000023144348,0.000019296358,0.000029128547],"domain_scores_gemma":[0.99989355,0.000035268233,0.000021870077,0.000012709113,0.00001785084,0.000018814317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017965795,0.00040789106,0.00032251675,0.00009731862,0.00009688185,0.00016552898,0.00022495344,0.0002613156,0.0010256481],"category_scores_gemma":[0.0001925542,0.00014070346,0.00046728348,0.00009873438,0.00014192954,0.00016001519,0.000105342144,0.00038741445,0.00042908083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010032894,0.00011347273,0.00015341898,0.00008735666,0.000037391477,0.000054264732,0.00003313096,0.00011520934,0.99589074,0.000039307688,0.00008496349,0.00238739],"study_design_scores_gemma":[0.000026243928,0.0013226168,0.0014529098,0.000005335735,0.000041351566,0.00009627869,0.000019153174,0.00054227904,0.9954716,0.000008617696,0.0010083196,0.0000052898513],"about_ca_topic_score_codex":0.001333758,"about_ca_topic_score_gemma":0.0017426576,"teacher_disagreement_score":0.001333758,"about_ca_system_score_codex":0.0001469973,"about_ca_system_score_gemma":0.0001536538,"threshold_uncertainty_score":0.0034311414},"labels":[],"label_agreement":null},{"id":"W1981397813","doi":"10.2217/pme.14.66","title":"Fast And Frugal Trees: Translating Population-Based Pharmacogenomics to Medication Prioritization","year":2015,"lang":"en","type":"article","venue":"Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Alberta","funders":"","keywords":"Pharmacogenomics; Prioritization; Population; Medicine; Pharmacogenetics; Computer science; Pharmacology; Biology; Genetics; Management science; Engineering; Environmental health; Gene","score_opus":0.1442892469105504,"score_gpt":0.4509678658964886,"score_spread":0.3066786189859382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981397813","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010704808,0.0004511354,0.976253,0.0018495173,0.0001779494,0.00039087332,0.0026892025,0.0049993293,0.002484234],"genre_scores_gemma":[0.0969237,0.00043056763,0.89731723,0.00066595525,0.000121550875,0.0005221662,0.002991392,0.00041659258,0.00061083026],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954171,0.0029502641,0.00034022628,0.00058848684,0.0005763238,0.00012761698],"domain_scores_gemma":[0.9655209,0.030009577,0.0009898223,0.0010710824,0.002052251,0.00035637192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007919222,0.0014401363,0.001217266,0.002717402,0.0010191527,0.0027084965,0.0014421956,0.0013504789,0.0062008193],"category_scores_gemma":[0.055257056,0.00074332417,0.0023732348,0.0023884894,0.00067760673,0.0019563185,0.0018740686,0.0030592112,0.0018543571],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005046383,0.00038848026,0.008008766,0.0010870715,0.0004922998,0.0006659663,0.0014530001,0.28047195,0.00152542,0.025272205,0.035326883,0.6448034],"study_design_scores_gemma":[0.00016846201,0.00016324643,0.0011844845,0.00043190958,0.0002034739,0.00017216217,0.00038473195,0.82845026,0.0015219122,0.15008058,0.017160522,0.00007829468],"about_ca_topic_score_codex":0.014097427,"about_ca_topic_score_gemma":0.01982759,"teacher_disagreement_score":0.014097427,"about_ca_system_score_codex":0.001803314,"about_ca_system_score_gemma":0.0037737817,"threshold_uncertainty_score":0.041881323},"labels":[],"label_agreement":null},{"id":"W1982052181","doi":"10.1124/dmd.108.022483","title":"Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Chemistry; Pharmacokinetics; Area under the curve; Oral administration; Metabolism; Pharmacology; Active metabolite; Enterocyte; Small intestine; Biochemistry; Biology","score_opus":0.05574559710314367,"score_gpt":0.3849257242669349,"score_spread":0.3291801271637912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982052181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673291,0.00023007551,0.01548618,0.0014180512,0.000018526347,0.0000504503,0.00012425038,0.000022069886,0.015321232],"genre_scores_gemma":[0.99783546,0.000067572044,0.0010515467,0.00006692897,0.000008950916,0.000007704091,0.000023224615,0.0000026446571,0.0009359681],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996443,0.00014328091,0.0000111089885,0.000102537895,0.000047082784,0.000051706375],"domain_scores_gemma":[0.99756026,0.0017666803,0.00021894404,0.00020878662,0.00013895577,0.00010647751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095148664,0.0002065091,0.00036855342,0.0004797518,0.00042336946,0.000966794,0.0005016111,0.00061955664,0.009677096],"category_scores_gemma":[0.006290012,0.00016788198,0.00047857684,0.00038474772,0.0010498161,0.0012336322,0.0009492279,0.0007366023,0.000306966],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061569354,0.0016563393,0.33540404,0.00027016533,0.0002467278,0.0045443205,0.0019215356,0.021856815,0.030453544,0.46689028,0.001496686,0.12910275],"study_design_scores_gemma":[0.0006077373,0.004979948,0.36848506,0.000066656954,0.0005877564,0.0065422957,0.005118898,0.17319506,0.01310832,0.4217588,0.005476562,0.000072882125],"about_ca_topic_score_codex":0.0014516789,"about_ca_topic_score_gemma":0.00075991097,"teacher_disagreement_score":0.009677096,"about_ca_system_score_codex":0.0006097564,"about_ca_system_score_gemma":0.00043321066,"threshold_uncertainty_score":0.03237307},"labels":[],"label_agreement":null},{"id":"W1982264959","doi":"10.1097/fpc.0b013e3283331637","title":"A pharmacogenetics study of the human glucuronosyltransferase UGT1A4","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Biology; Genetics; Coding region; Promoter; Linkage disequilibrium; Gene; Genetic variation; Haplotype; Allele; Gene expression","score_opus":0.0951563878583701,"score_gpt":0.42852828229794054,"score_spread":0.33337189443957044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982264959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927569,0.0032136727,0.0021595587,0.0004916935,0.000024171542,0.000034449473,0.00015568407,0.000015694006,0.0011483612],"genre_scores_gemma":[0.99678683,0.000883797,0.001611005,0.00016379016,0.000067950896,0.000015697911,0.00013645836,0.000006404656,0.0003280613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959534,0.00016826949,0.00002275875,0.000116939096,0.00006812657,0.00002851341],"domain_scores_gemma":[0.99939644,0.00030383584,0.0001191712,0.00003885569,0.00006956049,0.00007213142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009670398,0.00039823848,0.00037121924,0.00049901416,0.00025871905,0.00031549888,0.00020005486,0.00038416206,0.00108445],"category_scores_gemma":[0.001367794,0.00011649512,0.00043865605,0.00083037216,0.0002565371,0.0001281021,0.00016651554,0.00044930514,0.00015779847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004213504,0.00054290856,0.8243684,0.000246938,0.001728259,0.0028255326,0.00029681317,0.0027552142,0.06921031,0.0010304883,0.0008164092,0.09196528],"study_design_scores_gemma":[0.00033584784,0.00399071,0.9435887,0.00006198221,0.0020678607,0.007438504,0.00012199023,0.005667741,0.02487415,0.0011804196,0.010646969,0.000025150446],"about_ca_topic_score_codex":0.0016746034,"about_ca_topic_score_gemma":0.0006136724,"teacher_disagreement_score":0.0016746034,"about_ca_system_score_codex":0.0004348603,"about_ca_system_score_gemma":0.00049220206,"threshold_uncertainty_score":0.0051142573},"labels":[],"label_agreement":null},{"id":"W1983101272","doi":"10.1111/j.1399-0004.2006.0627a.x","title":"Pharmacogenetics of antidepressants: serotonin 2A receptor genotype strongly associated with treatment outcome","year":2006,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Citation; Medicine; Pharmacogenomics; Genotype; Psychiatry; Psychology; Family medicine; Library science; Genetics; Pharmacology; Biology; Computer science; Gene","score_opus":0.22834278485750384,"score_gpt":0.49838857943981363,"score_spread":0.2700457945823098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983101272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772733,0.0004354698,0.00015137931,0.00036841488,0.000016198686,0.000005225941,0.00017796556,0.000006707356,0.0011113025],"genre_scores_gemma":[0.9995845,0.000056102297,0.00005259784,0.000056848938,0.000017502933,0.0000020154696,0.000084176965,0.0000031850961,0.00014293293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906486,0.00038666558,0.00009285914,0.00016909288,0.000117127536,0.00016945657],"domain_scores_gemma":[0.9966125,0.0011067189,0.0012785064,0.00021966314,0.00018900838,0.0005936887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068078976,0.00043321832,0.00070307235,0.00065640855,0.0005806523,0.0006032783,0.00037740706,0.0010855198,0.004008233],"category_scores_gemma":[0.00348145,0.00019431837,0.00078360905,0.000929528,0.0004394739,0.00033718016,0.0003029064,0.00095949863,0.00034010093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009718394,0.00007636439,0.99246395,0.000009663501,0.00025355464,0.0007897096,0.000060297898,0.00008732665,0.0026631919,0.0000616008,0.00015841915,0.0024039324],"study_design_scores_gemma":[0.000027468945,0.0001575652,0.99714154,0.000007495768,0.0002254298,0.0013930884,0.000073416275,0.00036360035,0.00028884597,0.00017646853,0.00013764396,0.000007290467],"about_ca_topic_score_codex":0.0027384742,"about_ca_topic_score_gemma":0.0028372137,"teacher_disagreement_score":0.004008233,"about_ca_system_score_codex":0.00028567505,"about_ca_system_score_gemma":0.00048531702,"threshold_uncertainty_score":0.013408899},"labels":[],"label_agreement":null},{"id":"W1983119579","doi":"10.1124/dmd.31.6.768","title":"INTERACTION OF BUPRENORPHINE AND ITS METABOLITE NORBUPRENORPHINE WITH CYTOCHROMES P450 IN VITRO","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institute on Drug Abuse","keywords":"Chemistry; Pharmacology; CYP2A6; Metabolite; Dextrorphan; CYP3A4; Dextromethorphan; Microsome; Buprenorphine; Cytochrome P450; Biochemistry; Opioid; In vitro; Metabolism; Biology","score_opus":0.03156261028565863,"score_gpt":0.34412999770526287,"score_spread":0.3125673874196042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983119579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881022,0.006494528,0.0015247645,0.0002135801,0.000096514545,0.00007729776,0.00067848497,0.00005172036,0.0027609037],"genre_scores_gemma":[0.9920374,0.0028115776,0.0014670374,0.00005972235,0.00006338003,0.00004073293,0.0014881034,0.000014289552,0.0020177478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884915,0.0005947164,0.00008222845,0.00012417109,0.00019443854,0.00015524405],"domain_scores_gemma":[0.9989986,0.00063398544,0.00008549336,0.000097901095,0.00013000872,0.000053970405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007457549,0.0004817595,0.0007873695,0.00028751369,0.0004825541,0.00049291406,0.00045993022,0.0005631845,0.0026159126],"category_scores_gemma":[0.0014614057,0.00051262963,0.0006212436,0.0004229266,0.00024535193,0.0003721854,0.0002623451,0.00076043536,0.00080868904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008389586,0.0014093512,0.00788858,0.00076244224,0.0005181636,0.00096079905,0.00031433426,0.0023562666,0.95424354,0.0006016341,0.0011679736,0.02138735],"study_design_scores_gemma":[0.0003329872,0.0071976497,0.027450358,0.000043522305,0.000264901,0.0015100754,0.00016941897,0.008077588,0.9509339,0.00014797703,0.0038298315,0.00004181645],"about_ca_topic_score_codex":0.0043753143,"about_ca_topic_score_gemma":0.0045182803,"teacher_disagreement_score":0.0043753143,"about_ca_system_score_codex":0.00038989887,"about_ca_system_score_gemma":0.00052836834,"threshold_uncertainty_score":0.008751035},"labels":[],"label_agreement":null},{"id":"W1983986186","doi":"10.1016/j.tips.2011.08.005","title":"Cytochrome P450 enzymes in the brain: emerging evidence of biological significance","year":2011,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Cytochrome P450; Drug metabolism; Biology; Central nervous system; Endogeny; Metabolism; Enzyme; Neuroscience; Pharmacology; Drug; Biochemistry","score_opus":0.6210428183400608,"score_gpt":0.5809706546204215,"score_spread":0.04007216371963929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983986186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000188114,0.9987375,0.00017583922,0.00022836744,0.000066933026,0.0000020955174,0.000017442382,0.0000060184766,0.0005775677],"genre_scores_gemma":[0.00088627904,0.9983677,0.00018073188,0.00008662369,0.00012080455,0.0000021368453,0.000021170288,7.352652e-7,0.00033376177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999859,0.000019714013,0.000016820724,0.000037947248,0.000053193737,0.000013405049],"domain_scores_gemma":[0.9995622,0.00019185888,0.00008336208,0.000013510402,0.000107676155,0.000041342344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055214466,0.00077763275,0.0015366839,0.00148746,0.00017311773,0.0009781753,0.00075003336,0.0008727234,0.0030640604],"category_scores_gemma":[0.0005965198,0.00020897931,0.00033993917,0.0026508411,0.00047318154,0.00108647,0.0004975361,0.0014055885,0.0018016857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008944809,0.000046591213,0.000372392,0.0075412765,0.00007481804,0.00027660234,0.000029238849,0.0002075235,0.002603628,0.0013295274,0.011415421,0.9760134],"study_design_scores_gemma":[0.000054051212,0.00021998982,0.004963103,0.0029912011,0.00037277376,0.004194991,0.00012713736,0.00020295192,0.0017003168,0.003703596,0.9814228,0.000047013695],"about_ca_topic_score_codex":0.0013946826,"about_ca_topic_score_gemma":0.002963825,"teacher_disagreement_score":0.0030640604,"about_ca_system_score_codex":0.00040642606,"about_ca_system_score_gemma":0.0010733053,"threshold_uncertainty_score":0.01025033},"labels":[],"label_agreement":null},{"id":"W1984061511","doi":"10.1002/bdd.517","title":"Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics","year":2006,"lang":"en","type":"review","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Enantiomer; Bioequivalence; Pharmacology; Pharmacodynamics; Chemistry; Drug; Stereoselectivity; In vivo; Distribution (mathematics); Medicine; Stereochemistry; Biology; Biochemistry; Mathematics","score_opus":0.12001963851674498,"score_gpt":0.4615586697855712,"score_spread":0.34153903126882623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984061511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012287077,0.99682,0.0006304696,0.00060554204,0.0004653837,0.0000046172327,0.000019993211,0.000016360864,0.0013146808],"genre_scores_gemma":[0.0007384661,0.99637103,0.0008005228,0.0005608955,0.00052462233,0.000007901136,0.00003649907,0.0000039338665,0.00095613796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993691,0.00015085976,0.00012428335,0.00009340308,0.00022765744,0.000034711808],"domain_scores_gemma":[0.99868053,0.0006770504,0.00015431119,0.000058253674,0.00036398583,0.00006591198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015920306,0.0014155088,0.003261276,0.0032047294,0.00028185072,0.0016693693,0.0015697089,0.0017070554,0.00378622],"category_scores_gemma":[0.0016587568,0.00047305215,0.0010736126,0.0037204376,0.0009032683,0.0031134114,0.00094107474,0.002932062,0.0032431155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080335696,0.00007824366,0.00026123016,0.008717036,0.00014084531,0.00038306692,0.00007414775,0.0005589072,0.00090040383,0.0045658415,0.03345774,0.95078224],"study_design_scores_gemma":[0.00002017385,0.00011089704,0.00067817,0.002308986,0.00015707701,0.002103558,0.000052906948,0.00021173622,0.00031503354,0.0024709234,0.99153835,0.0000322022],"about_ca_topic_score_codex":0.001825108,"about_ca_topic_score_gemma":0.0029564842,"teacher_disagreement_score":0.00378622,"about_ca_system_score_codex":0.0010780077,"about_ca_system_score_gemma":0.0014121856,"threshold_uncertainty_score":0.012666106},"labels":[],"label_agreement":null},{"id":"W1984122156","doi":"10.1007/s00213-015-3898-x","title":"Exploring the role of drug-metabolising enzymes in antidepressant side effects","year":2015,"lang":"en","type":"article","venue":"Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Medical Research Council; H. Lundbeck A/S; Lundbeckfonden; European Commission; National Institute for Health and Care Research; Canada Research Chairs; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Antidepressant; Drug; Pharmacology; Medicine; Psychology; Psychiatry; Anxiety","score_opus":0.14755125303168887,"score_gpt":0.42150140560046895,"score_spread":0.2739501525687801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984122156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980475,0.013121906,0.0025176583,0.0009868393,0.000019409374,0.00007844771,0.0006632397,0.000017690243,0.002119741],"genre_scores_gemma":[0.9969344,0.0016355824,0.00083348976,0.00013490861,0.000030875686,0.000021681786,0.00022133566,0.0000030630313,0.00018457396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897194,0.00062669045,0.00007098188,0.00013312555,0.00013491091,0.00006239963],"domain_scores_gemma":[0.9939604,0.003583034,0.0017037175,0.00028179112,0.00027629864,0.00019478063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029983276,0.00046831468,0.00036776988,0.00056640146,0.0001984162,0.000586426,0.0004090877,0.0006176402,0.0017926439],"category_scores_gemma":[0.0057901284,0.00018045232,0.0007301686,0.0009929381,0.00046735763,0.00039953578,0.00034468688,0.0005541682,0.00026279947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009627096,0.000084567335,0.97424555,0.00017893226,0.00041593576,0.00016955675,0.000047867154,0.0003214757,0.001539231,0.00009802089,0.00014409663,0.021791985],"study_design_scores_gemma":[0.00006323917,0.00068288925,0.9956703,0.000049043872,0.0003665219,0.00044800178,0.000032635013,0.0010095963,0.00060190895,0.00040697365,0.000663382,0.0000054306997],"about_ca_topic_score_codex":0.0016551906,"about_ca_topic_score_gemma":0.0018789663,"teacher_disagreement_score":0.0029983276,"about_ca_system_score_codex":0.00024747674,"about_ca_system_score_gemma":0.0004119614,"threshold_uncertainty_score":0.015856862},"labels":[],"label_agreement":null},{"id":"W1984441096","doi":"10.1016/s0163-7258(01)00165-6","title":"Alteration of drug biotransformation and elimination during infection and inflammation","year":2001,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Inflammation; Mediator; Cytochrome P450; Biotransformation; Endogeny; Signal transduction; Biology; Drug; Drug metabolism; Immunology; Pharmacology; Cell biology; Enzyme; Endocrinology; Biochemistry","score_opus":0.14086341103683375,"score_gpt":0.46719198610173945,"score_spread":0.3263285750649057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984441096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026531122,0.99216616,0.0019532817,0.0001886884,0.0001303025,0.000013920251,0.000061307306,0.0000356424,0.0027975067],"genre_scores_gemma":[0.009751444,0.9851542,0.0015094492,0.00016801625,0.000115449555,0.00002124138,0.0001023044,0.0000045295865,0.0031733373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998944,0.000019279703,0.000013041419,0.000021189178,0.000040180745,0.000011961056],"domain_scores_gemma":[0.9998803,0.000049987877,0.000025199328,0.000007913622,0.000030038913,0.0000065736376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026880248,0.00056929496,0.0010709445,0.00068004703,0.00012041299,0.0004908445,0.0004330571,0.00054587127,0.001456649],"category_scores_gemma":[0.00027957506,0.00017196217,0.0002645966,0.0008930826,0.00023270215,0.0005549235,0.00021357738,0.0005708718,0.0011752829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022858729,0.00008481931,0.0005408187,0.0033685663,0.000054353924,0.0003724391,0.000022268143,0.0004121149,0.018863054,0.0009524552,0.0031253584,0.97197527],"study_design_scores_gemma":[0.000086318774,0.0011495053,0.013194448,0.0013705264,0.0003746639,0.011589591,0.00010803645,0.0006436645,0.05304435,0.002981381,0.91540134,0.00005624546],"about_ca_topic_score_codex":0.00064523215,"about_ca_topic_score_gemma":0.0011779272,"teacher_disagreement_score":0.001456649,"about_ca_system_score_codex":0.00031511078,"about_ca_system_score_gemma":0.0005304959,"threshold_uncertainty_score":0.0048729777},"labels":[],"label_agreement":null},{"id":"W1985406339","doi":"10.1124/dmd.109.029991","title":"Down-Regulation of Liver Drug-Metabolizing Enzymes in a Murine Model of Chronic Renal Failure","year":2009,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"CYP1A2; Cytochrome P450; Drug metabolism; CYP3A; Endocrinology; Internal medicine; Messenger RNA; Biology; Isozyme; Gene expression; Enzyme; Metabolism; Gene; Medicine; Biochemistry","score_opus":0.031937619041561345,"score_gpt":0.33781999480115205,"score_spread":0.3058823757595907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985406339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947495,0.0007415202,0.0028589498,0.00035528681,0.00010636143,0.00007312067,0.00051098206,0.00014624628,0.00045806865],"genre_scores_gemma":[0.9936572,0.00066981814,0.002671669,0.00014627418,0.000037533082,0.00014315976,0.0005251835,0.00004925202,0.0020999268],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995371,0.000099411634,0.000043580996,0.00010659718,0.00010806695,0.00010527815],"domain_scores_gemma":[0.9991334,0.00015608719,0.00032291654,0.0001287688,0.000051075327,0.00020778079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889842,0.00086012465,0.000773508,0.0010730731,0.0003748042,0.0005754999,0.0006253953,0.0009854067,0.0014482298],"category_scores_gemma":[0.00042790815,0.0004426571,0.00077528344,0.00039541646,0.0011484534,0.0005958135,0.0002789201,0.0016996526,0.0003356231],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038439834,0.0010198221,0.0009271349,0.00008380312,0.00004351751,0.00038195436,0.000044360157,0.0007620627,0.9899003,0.000520306,0.00019817014,0.0022745652],"study_design_scores_gemma":[0.00072684884,0.009107469,0.007626538,0.000028302551,0.00016604297,0.0011836165,0.00011879351,0.005108532,0.9729102,0.0004336626,0.0025467174,0.00004321167],"about_ca_topic_score_codex":0.0008968235,"about_ca_topic_score_gemma":0.0013638247,"teacher_disagreement_score":0.0014482298,"about_ca_system_score_codex":0.00063037773,"about_ca_system_score_gemma":0.00056843634,"threshold_uncertainty_score":0.0048448443},"labels":[],"label_agreement":null},{"id":"W1985410301","doi":"10.1016/j.pharmthera.2004.10.013","title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","year":2005,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":546,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Glucuronidation; Diflunisal; Glucuronosyltransferase; Temazepam; Enzyme; Drug; Chemistry; Pharmacology; CYP2B6; Drug metabolism; Xenobiotic; Biochemistry; Cytochrome P450; Biology; Microsome; CYP1A2; Receptor","score_opus":0.3361456151830802,"score_gpt":0.5765719802520972,"score_spread":0.240426365069017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985410301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031278146,0.99784386,0.00029252277,0.00018402087,0.000109960616,0.000005661019,0.000022442053,0.000010722592,0.001218017],"genre_scores_gemma":[0.002241009,0.99536884,0.00046107336,0.00017858176,0.00016409118,0.000008256427,0.000059349397,0.000001520652,0.0015172986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985754,0.00003193518,0.000021935271,0.000020197354,0.000056309116,0.000012160223],"domain_scores_gemma":[0.9997925,0.00008343052,0.000050942792,0.0000074117615,0.00004928714,0.00001641366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000495002,0.00084000285,0.0014536025,0.0014941188,0.00014046177,0.0006016796,0.0005320832,0.00072754343,0.0034579802],"category_scores_gemma":[0.00058332045,0.0002229276,0.00037404516,0.0022629662,0.0002632973,0.0005441982,0.0004321033,0.00082835613,0.0018295994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108589615,0.00006311521,0.00034668093,0.0033348408,0.00009061225,0.0002683009,0.000014822163,0.0002702861,0.0010519107,0.00083500956,0.012687462,0.98092836],"study_design_scores_gemma":[0.00010290332,0.00027875198,0.0027038539,0.0019184707,0.00042300994,0.003483116,0.00005250492,0.0002980547,0.0018484653,0.001901063,0.98696625,0.000023552795],"about_ca_topic_score_codex":0.0011949696,"about_ca_topic_score_gemma":0.0026748308,"teacher_disagreement_score":0.0034579802,"about_ca_system_score_codex":0.0004023249,"about_ca_system_score_gemma":0.0009450701,"threshold_uncertainty_score":0.011568129},"labels":[],"label_agreement":null},{"id":"W1985851151","doi":"10.1016/j.bcp.2005.10.040","title":"The 21-aminosteroid U74389G prevents the down-regulation and decrease in activity of CYP1A1, 1A2 and 3A6 induced by an inflammatory reaction","year":2005,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck Canada","keywords":"Chemistry; Pharmacology; Internal medicine; Endocrinology; Medicine","score_opus":0.04714237804707585,"score_gpt":0.3874188025204056,"score_spread":0.3402764244733298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985851151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951109,0.0018464365,0.0005388565,0.0003040999,0.00014817099,0.000036807058,0.00030999395,0.0002203238,0.0014843149],"genre_scores_gemma":[0.9960251,0.0008714622,0.0006821414,0.00009718308,0.000079284866,0.00003831787,0.0004384441,0.000018177821,0.0017498271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974364,0.000049360227,0.000024791918,0.000024765974,0.000047616944,0.000109717956],"domain_scores_gemma":[0.99977416,0.000031590782,0.00006644831,0.000031369163,0.000015644762,0.000080775055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016111461,0.0006156957,0.0010054293,0.0005001318,0.0003588904,0.00021803657,0.00042182757,0.0005636603,0.0042012464],"category_scores_gemma":[0.0003475268,0.00026849,0.00035324928,0.0003058795,0.0004799432,0.00025268758,0.00021987768,0.001101396,0.0007948955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086143585,0.0010351515,0.0006504788,0.00011201049,0.00006532617,0.0006315709,0.000033598822,0.00023853425,0.9685866,0.00026544926,0.0011150588,0.018651774],"study_design_scores_gemma":[0.00072661374,0.008924284,0.008995418,0.00001284816,0.00006903327,0.00081533025,0.000054717097,0.00066793594,0.9753356,0.00015760364,0.0042207646,0.000019837129],"about_ca_topic_score_codex":0.0009695044,"about_ca_topic_score_gemma":0.0014647605,"teacher_disagreement_score":0.0042012464,"about_ca_system_score_codex":0.0002757769,"about_ca_system_score_gemma":0.0004487729,"threshold_uncertainty_score":0.014054537},"labels":[],"label_agreement":null},{"id":"W1985978909","doi":"10.1016/j.tiv.2014.03.004","title":"Modulation of trichloroethylene in vitro metabolism by different drugs in human","year":2014,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Mefenamic acid; Chemistry; Naproxen; Microsome; Salicylic acid; Metabolite; Pharmacology; Glucuronidation; Acetaminophen; Carbamazepine; Metabolism; Ibuprofen; Biochemistry; In vitro; Chromatography","score_opus":0.044262208007041226,"score_gpt":0.38232666997655274,"score_spread":0.3380644619695115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985978909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135965,0.0034905206,0.0021240222,0.000111039066,0.000032514647,0.000044267974,0.00051307445,0.000035261113,0.002289672],"genre_scores_gemma":[0.99491125,0.0015195226,0.0008126638,0.000046211655,0.000012290392,0.00003203269,0.00074719806,0.000014197174,0.0019045982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948895,0.0002526591,0.000037502283,0.000081817496,0.00007978991,0.00005917857],"domain_scores_gemma":[0.99972826,0.00011305986,0.000039464267,0.000050856997,0.000043016098,0.000025350084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003325681,0.00031294415,0.00030111,0.00025043616,0.00022774018,0.00033651444,0.00019760209,0.0003616395,0.0016843596],"category_scores_gemma":[0.00075346883,0.00021303518,0.00031742224,0.00036430705,0.00031870793,0.00018013119,0.00015831072,0.00038194546,0.00046577948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00457161,0.00014757746,0.005436548,0.00008052908,0.00007021815,0.00037137925,0.00012720432,0.00032116173,0.98108494,0.00009690095,0.00017682984,0.007515039],"study_design_scores_gemma":[0.000041547522,0.0026905586,0.02229751,0.0000053883396,0.00007294655,0.0007838328,0.000118337666,0.00061734155,0.971621,0.000047716625,0.0016919433,0.000011816878],"about_ca_topic_score_codex":0.004485882,"about_ca_topic_score_gemma":0.006033488,"teacher_disagreement_score":0.004485882,"about_ca_system_score_codex":0.0004774716,"about_ca_system_score_gemma":0.00033170558,"threshold_uncertainty_score":0.008919537},"labels":[],"label_agreement":null},{"id":"W1986311009","doi":"10.1016/j.clpt.2004.12.026","title":"Effect of St. John's Wort administration on CYP2C8 mediated rosiglitazone metabolism","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Pharmacokinetics; CYP2C8; Pharmacology; Medicine; Internal medicine; Metabolism; Receptor; CYP3A4; Cytochrome P450","score_opus":0.13527301971220893,"score_gpt":0.516411642202892,"score_spread":0.3811386224906831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986311009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999223,0.00039720265,0.00014136957,0.00001798979,0.0000101249825,0.000022424643,0.000037417576,0.00000539023,0.00014513214],"genre_scores_gemma":[0.9985972,0.0002972731,0.00055997923,0.00003432206,0.000025021747,0.000031900185,0.00006604542,0.0000045941024,0.00038365144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947196,0.00023682811,0.00004171726,0.0000934192,0.00009882007,0.000057348327],"domain_scores_gemma":[0.99931395,0.00019611344,0.0002800411,0.00006502138,0.00003590849,0.00010893726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062484,0.00038938588,0.0008353955,0.0002222103,0.00017465238,0.00030865308,0.00015702532,0.00028916032,0.0016423701],"category_scores_gemma":[0.000738189,0.0001993509,0.000515629,0.00016694893,0.00041067548,0.00013936087,0.00013572602,0.00039138045,0.00019211226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18517426,0.007432916,0.10702758,0.0006866444,0.001204416,0.00058876444,0.00021490027,0.0011263593,0.57546514,0.00016208323,0.0004005763,0.12051635],"study_design_scores_gemma":[0.0054667876,0.3077981,0.5146555,0.000043973057,0.0010786066,0.0015466528,0.00017253145,0.0031847265,0.16328552,0.00013649144,0.0025823952,0.000048809747],"about_ca_topic_score_codex":0.00044329197,"about_ca_topic_score_gemma":0.0008222156,"teacher_disagreement_score":0.0016423701,"about_ca_system_score_codex":0.00021984983,"about_ca_system_score_gemma":0.00029161794,"threshold_uncertainty_score":0.0054942966},"labels":[],"label_agreement":null},{"id":"W1986577071","doi":"10.1097/fjc.0b013e3182163b82","title":"Pharmacogenomics of Cardiovascular Drugs and Adverse Effects in Pediatrics","year":2011,"lang":"en","type":"review","venue":"Journal of Cardiovascular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Medicine; Adverse effect; Intensive care medicine; Pediatrics; Pharmacology","score_opus":0.08207730166137694,"score_gpt":0.39963533610348984,"score_spread":0.3175580344421129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986577071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002782393,0.9977452,0.00049537816,0.000391222,0.000065278145,0.000006102551,0.000042468833,0.000011629659,0.00096444675],"genre_scores_gemma":[0.001863043,0.996603,0.0006579514,0.00018422073,0.00012562043,0.000007834755,0.000063934946,0.0000022363058,0.0004921321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996555,0.000093897994,0.00005199489,0.000055562887,0.00012117466,0.000021849923],"domain_scores_gemma":[0.9992901,0.00041006142,0.00011006571,0.000021088323,0.00014044109,0.000028208748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071075704,0.0007495761,0.0017212377,0.0020361634,0.00016357431,0.0007864285,0.00055765704,0.0009890175,0.0017394307],"category_scores_gemma":[0.0012157671,0.00024881607,0.00076473167,0.002428524,0.0002838969,0.0006823218,0.00040937698,0.0010136999,0.0010840885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004475934,0.00005333115,0.001099739,0.0067821257,0.00020553982,0.00042940187,0.000034715093,0.00047039648,0.0011112215,0.0014565667,0.011749768,0.97656244],"study_design_scores_gemma":[0.000046770656,0.00022477767,0.015186978,0.0066336584,0.00074691814,0.011954668,0.0001217659,0.00066567544,0.002887853,0.005771436,0.95569706,0.00006243035],"about_ca_topic_score_codex":0.0017433348,"about_ca_topic_score_gemma":0.0023872184,"teacher_disagreement_score":0.0020361634,"about_ca_system_score_codex":0.000565363,"about_ca_system_score_gemma":0.0011676791,"threshold_uncertainty_score":0.0058190227},"labels":[],"label_agreement":null},{"id":"W1987148753","doi":"10.1177/0091270005284389","title":"Use of Omeprazole as a CYP3A Probe Drug: Effect of Sex and Menstrual Cycle Phase on CYP3A Activity in Healthy Caucasian Adults","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Luteal phase; Omeprazole; Follicular phase; Menstrual cycle; CYP3A; Medicine; Endocrinology; Internal medicine; Metabolism; Hormone","score_opus":0.1143286373631692,"score_gpt":0.5257836796528554,"score_spread":0.4114550422896862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987148753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988182,0.0007801536,0.00007087471,0.000018379054,0.0000051642733,0.000009187544,0.000075767755,0.000003347445,0.00021889008],"genre_scores_gemma":[0.99936813,0.00020846938,0.000118364784,0.00004498318,0.0000136570625,0.000011064415,0.0001248532,0.000002899109,0.00010750731],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993364,0.0002684274,0.000073227435,0.00013865891,0.00013435872,0.00004880586],"domain_scores_gemma":[0.9988895,0.00033014454,0.0004264442,0.00008335008,0.00010447306,0.00016613398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007387094,0.00027215254,0.0005885291,0.00030648228,0.00026172254,0.0002906246,0.0001322306,0.00042132242,0.00054264173],"category_scores_gemma":[0.0020288783,0.00021099005,0.00039838033,0.00039650867,0.00026634402,0.00025008494,0.00020041685,0.00027903717,0.00016738678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044857254,0.0002582605,0.9777565,0.000040478106,0.000332459,0.00028915337,0.00020863971,0.0000672733,0.007146794,0.000016569556,0.00009841684,0.009299738],"study_design_scores_gemma":[0.00002339284,0.0012281755,0.9978296,0.0000020139855,0.00006161453,0.00031752684,0.0000406748,0.00010861354,0.00024440963,0.000007357529,0.00013366778,0.0000028942181],"about_ca_topic_score_codex":0.0010414068,"about_ca_topic_score_gemma":0.0015347447,"teacher_disagreement_score":0.0010414068,"about_ca_system_score_codex":0.00016660639,"about_ca_system_score_gemma":0.00013229252,"threshold_uncertainty_score":0.003906727},"labels":[],"label_agreement":null},{"id":"W1987843098","doi":"10.1038/sj.tpj.6500364","title":"Pharmacogenomics and regulatory decision making: an international perspective","year":2006,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Pharmacogenomics; Perspective (graphical); Regulatory science; Clinical decision making; Medicine; Computer science; Family medicine; Pharmacology; Artificial intelligence; Pathology","score_opus":0.07374768435680266,"score_gpt":0.44596075582684136,"score_spread":0.3722130714700387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987843098","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012824697,0.23002192,0.018611703,0.68113256,0.009282689,0.00001988682,0.000081199025,0.00005992805,0.059507627],"genre_scores_gemma":[0.2582794,0.41373926,0.022721276,0.19215174,0.09816614,0.00016404515,0.00015803715,0.0001707564,0.014449332],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.984608,0.008943134,0.0010803519,0.0013770579,0.002964276,0.001027239],"domain_scores_gemma":[0.92750156,0.056092385,0.002910051,0.0016231488,0.008147042,0.0037258386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045540575,0.0024840992,0.0034092763,0.005831678,0.0032980838,0.026546663,0.003667798,0.029431336,0.019879084],"category_scores_gemma":[0.040948313,0.0010494586,0.0016293344,0.0059818067,0.027447656,0.028061561,0.0057390095,0.018536936,0.0019518287],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017897875,0.00019551019,0.00073351397,0.0008001925,0.00016638386,0.00044914006,0.00071218325,0.0056029093,0.00027584482,0.8396202,0.05686129,0.09440402],"study_design_scores_gemma":[0.0000812587,0.00014838082,0.00092772476,0.0023528293,0.00011389182,0.00046805502,0.0017566858,0.00391802,0.00026003207,0.79792887,0.19192767,0.00011649033],"about_ca_topic_score_codex":0.0063263974,"about_ca_topic_score_gemma":0.005282529,"teacher_disagreement_score":0.045540575,"about_ca_system_score_codex":0.0126861995,"about_ca_system_score_gemma":0.012665867,"threshold_uncertainty_score":0.24084443},"labels":[],"label_agreement":null},{"id":"W1988144987","doi":"10.1007/s002280000116","title":"Genotype and phenotype of cytochrome P 450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome","year":2000,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Genotype; CYP2D6; Dextromethorphan; Phenotype; Biology; Immunology; Virology; Internal medicine; Medicine; Genetics; Pharmacology; Gene","score_opus":0.05406232218643753,"score_gpt":0.40537479072086907,"score_spread":0.35131246853443154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988144987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914587,0.00020966942,0.00004161247,0.000037373426,0.000008670323,0.0000045925076,0.00013542324,0.0000030513936,0.00041380626],"genre_scores_gemma":[0.9995295,0.00008829955,0.000047711233,0.000036702342,0.000014162476,0.000005289214,0.00013934352,0.000002067615,0.00013686568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965656,0.00009860558,0.000049422295,0.00007102456,0.000051805975,0.00007252092],"domain_scores_gemma":[0.9987558,0.00054049667,0.00030194575,0.000044584463,0.0000678943,0.00028934036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027411967,0.00069803046,0.0006818352,0.001264511,0.000668115,0.00061586883,0.0004024037,0.0011343776,0.0027213087],"category_scores_gemma":[0.0030107084,0.0003312205,0.00037879153,0.0009512048,0.0005016785,0.00049762573,0.0003246503,0.0006358293,0.0003118377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090286304,0.00008005138,0.9918249,0.000012799942,0.000049072387,0.0031929852,0.00019287263,0.000108509776,0.0022265422,0.000050202292,0.000081666316,0.0012775119],"study_design_scores_gemma":[0.0000512938,0.0006102663,0.98248786,0.0000100597035,0.00007802045,0.015108239,0.00048162814,0.00044511646,0.00039765448,0.00012026673,0.00019404951,0.000015592606],"about_ca_topic_score_codex":0.0018552903,"about_ca_topic_score_gemma":0.0014514233,"teacher_disagreement_score":0.0027213087,"about_ca_system_score_codex":0.00025257366,"about_ca_system_score_gemma":0.00019477987,"threshold_uncertainty_score":0.009103715},"labels":[],"label_agreement":null},{"id":"W1988257729","doi":"10.1016/j.bmc.2014.06.034","title":"Controlling substrate specificity and product regio- and stereo-selectivities of P450 enzymes without mutagenesis","year":2014,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Substrate (aquarium); Protein engineering; Directed evolution; Combinatorial chemistry; Molecular engineering; Enzyme; Mutagenesis; Selectivity; Covalent bond; Substrate specificity; Stereochemistry; Stereoselectivity; Saturated mutagenesis; Small molecule; Natural product; Biochemistry; Organic chemistry; Mutation; Catalysis; Gene","score_opus":0.12670602946013323,"score_gpt":0.42012914460428574,"score_spread":0.29342311514415254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988257729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031912297,0.9290356,0.02536581,0.0003669899,0.0003107752,0.000085002386,0.0002952153,0.00030571382,0.012322525],"genre_scores_gemma":[0.12467059,0.8501872,0.011938808,0.00035379236,0.00017440978,0.00008104908,0.0006937003,0.000052553172,0.011847945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999856,0.00002181878,0.000010411276,0.000037593916,0.000051676405,0.000022429007],"domain_scores_gemma":[0.99993396,0.000027678298,0.0000133467875,0.000008262193,0.000013212872,0.000003484411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034619268,0.00068346167,0.000595849,0.00045563412,0.00009182894,0.0003347072,0.0006070345,0.00033535942,0.0012698711],"category_scores_gemma":[0.0002228785,0.00020274265,0.0003644245,0.00058129133,0.00022851104,0.00043517543,0.00030320688,0.000702242,0.00089367677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001262267,0.00007624567,0.0003271113,0.0043275324,0.000082044906,0.00024170564,0.000039153587,0.0014415303,0.21449524,0.004335629,0.0032432915,0.77126426],"study_design_scores_gemma":[0.0000628719,0.0006063442,0.0022435323,0.00047159372,0.00030311715,0.0019046924,0.00004037975,0.0017319786,0.4208556,0.0027759864,0.568947,0.000056949953],"about_ca_topic_score_codex":0.00034682316,"about_ca_topic_score_gemma":0.000521609,"teacher_disagreement_score":0.0012698711,"about_ca_system_score_codex":0.0001917468,"about_ca_system_score_gemma":0.00020858237,"threshold_uncertainty_score":0.0042481422},"labels":[],"label_agreement":null},{"id":"W1988416386","doi":"10.1016/j.ijcard.2015.02.025","title":"Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice","year":2015,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacogenomics; Current (fluid); State (computer science); Intensive care medicine; Pharmacology","score_opus":0.20496760891612423,"score_gpt":0.5668869890262286,"score_spread":0.3619193801101044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988416386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042979154,0.9938122,0.0009305799,0.0032620323,0.00023500534,0.000014467513,0.00004913977,0.000019762378,0.0012470623],"genre_scores_gemma":[0.0045824144,0.99118924,0.0021245778,0.0013182352,0.0004975551,0.000015272593,0.000059526068,0.0000050417007,0.00020819562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979442,0.0006132376,0.0003264689,0.000396655,0.00061078626,0.0001087311],"domain_scores_gemma":[0.9825348,0.01293354,0.0012887398,0.00033785694,0.002237046,0.0006680076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009502057,0.0007216116,0.0021239845,0.0024064197,0.00027030284,0.002669892,0.0017523075,0.002287246,0.0037565182],"category_scores_gemma":[0.015305443,0.0004047428,0.0009398015,0.0029642447,0.0014082151,0.002450685,0.0013391039,0.0031019626,0.0009170085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011469302,0.00010189477,0.0014118972,0.016230011,0.00014800979,0.00012651234,0.00011446596,0.00061488425,0.000385268,0.0042477404,0.009147375,0.9673573],"study_design_scores_gemma":[0.00015144762,0.00046088872,0.01129434,0.05582169,0.0011960338,0.002103393,0.00069725123,0.001558407,0.001257531,0.016851362,0.90848875,0.0001189378],"about_ca_topic_score_codex":0.0023041253,"about_ca_topic_score_gemma":0.0037575194,"teacher_disagreement_score":0.009502057,"about_ca_system_score_codex":0.0014158572,"about_ca_system_score_gemma":0.0065849507,"threshold_uncertainty_score":0.05025226},"labels":[],"label_agreement":null},{"id":"W1988463445","doi":"10.1007/s00228-002-0487-9","title":"Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression","year":2002,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP3A4; Chemistry; Microsome; Population; Internal medicine; Biology; Molecular biology; Endocrinology; Enzyme; Cytochrome P450; Biochemistry","score_opus":0.17140802209131079,"score_gpt":0.4408356935308331,"score_spread":0.2694276714395223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988463445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6736622,0.00076039135,0.311439,0.00046230428,0.000052001986,0.00014641398,0.0030437799,0.0010476782,0.0093862815],"genre_scores_gemma":[0.9696191,0.00032781175,0.01908208,0.00008975277,0.0000065256345,0.00015932889,0.0016895969,0.00014361697,0.008882353],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997538,0.000091210386,0.000007209884,0.000078444325,0.000041063508,0.000028333807],"domain_scores_gemma":[0.9995272,0.0003225765,0.0000424912,0.000031929198,0.00006581116,0.000010009555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040153347,0.000470205,0.0003275106,0.00022044069,0.00017900766,0.00043155398,0.0003319748,0.00047398146,0.0014958497],"category_scores_gemma":[0.0011759879,0.00021923627,0.00074300123,0.00029109683,0.00019115243,0.00019334584,0.00010777512,0.00044920004,0.00072803826],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031406066,0.00009169729,0.00445001,0.00009471641,0.00005926184,0.00015960462,0.000060779075,0.95274943,0.02706658,0.0027371396,0.0008998071,0.011316923],"study_design_scores_gemma":[0.000020504569,0.00016123464,0.0031238405,0.0000066210864,0.000027216054,0.00019752225,0.000024893816,0.9759188,0.016419856,0.0017018174,0.0023810626,0.000016478367],"about_ca_topic_score_codex":0.006439783,"about_ca_topic_score_gemma":0.004238026,"teacher_disagreement_score":0.006439783,"about_ca_system_score_codex":0.00072472217,"about_ca_system_score_gemma":0.00054200436,"threshold_uncertainty_score":0.012804568},"labels":[],"label_agreement":null},{"id":"W1988551553","doi":"10.1016/j.vascn.2003.10.005","title":"Evaluation of a real-time polymerase chain reaction method for the quantification of CYP1B1 gene expression in MCF-7 human breast carcinoma cells","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CYP1B1; Amplicon; Molecular biology; Complementary DNA; Melting curve analysis; Real-time polymerase chain reaction; Agarose gel electrophoresis; SYBR Green I; Biology; Gene expression; MCF-7; Messenger RNA; Polymerase chain reaction; Breast carcinoma; Chemistry; Gene; Breast cancer; Cancer; Cytochrome P450; Biochemistry; Enzyme; Genetics; Human breast","score_opus":0.24174978708953548,"score_gpt":0.5317668371579236,"score_spread":0.2900170500683881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988551553","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12622531,0.00297789,0.8587021,0.00092247705,0.000969363,0.0024171167,0.0026841143,0.0021957553,0.0029058822],"genre_scores_gemma":[0.09561685,0.002035081,0.88258886,0.00067932525,0.00022751161,0.007091766,0.005229933,0.0005306014,0.0060001235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98836774,0.004048701,0.0009272731,0.0028742433,0.0030588547,0.00072321034],"domain_scores_gemma":[0.9940513,0.0035425518,0.00046092633,0.0005723168,0.0011863792,0.00018642173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075608864,0.0037848048,0.002813331,0.0031953203,0.0011598002,0.0015643025,0.002560374,0.002215268,0.0033644552],"category_scores_gemma":[0.0045651454,0.0027301216,0.002240834,0.0021644023,0.0032035643,0.0012650603,0.00084721495,0.0043363706,0.0032877405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031905735,0.00020299213,0.00046517636,0.0002461347,0.000041861156,0.000064752894,0.0001830713,0.000374273,0.99324787,0.00046907878,0.00019207438,0.0041935486],"study_design_scores_gemma":[0.00012986735,0.0011172713,0.0016162015,0.00006796291,0.00017853102,0.0002668107,0.00008446569,0.008350799,0.9843881,0.0003010145,0.0034384262,0.000060445673],"about_ca_topic_score_codex":0.0016220687,"about_ca_topic_score_gemma":0.003915071,"teacher_disagreement_score":0.0075608864,"about_ca_system_score_codex":0.0015068372,"about_ca_system_score_gemma":0.0019427883,"threshold_uncertainty_score":0.039986312},"labels":[],"label_agreement":null},{"id":"W1989040972","doi":"10.1124/jpet.110.175927","title":"Differential Effect of Meclizine on the Activity of Human Pregnane X Receptor and Constitutive Androstane Receptor","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Constitutive androstane receptor; Coactivator; CYP3A4; Agonist; Reporter gene; Receptor; Pharmacology; Nuclear receptor; Inverse agonist; CYP2B6; Biology; Transfection; Chemistry; Gene expression; Endocrinology; Cytochrome P450; Gene; Transcription factor; Biochemistry","score_opus":0.059989985206199775,"score_gpt":0.43189578480434937,"score_spread":0.3719057995981496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989040972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771273,0.0009478711,0.00015028918,0.00012371039,0.000053371525,0.000008764255,0.00020405812,0.000019928746,0.00077930355],"genre_scores_gemma":[0.9966966,0.00066988525,0.00020416388,0.00006514154,0.000022353785,0.000013193477,0.00035695333,0.0000065412682,0.0019652506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.00005435967,0.000019539531,0.000023861514,0.0000243089,0.000076129836],"domain_scores_gemma":[0.9997702,0.000098597615,0.0000239467,0.000029913857,0.000021671625,0.000055683802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018589474,0.00022501116,0.00046100345,0.00015160641,0.00013507246,0.00030174223,0.00022412108,0.00030409766,0.0028700666],"category_scores_gemma":[0.0006270174,0.00022573766,0.0002693284,0.00016028991,0.00037644905,0.00027998746,0.00014436926,0.0006196644,0.00029277656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017855506,0.00037627798,0.0012941738,0.000116511525,0.00010080953,0.00023893552,0.00008089967,0.00032780712,0.97162986,0.00047383175,0.0003828702,0.0071226824],"study_design_scores_gemma":[0.0009824648,0.008379054,0.023230229,0.000015949508,0.0002393192,0.00081350986,0.00014801635,0.0025112843,0.95959175,0.00016704528,0.0038880443,0.00003327998],"about_ca_topic_score_codex":0.0017529908,"about_ca_topic_score_gemma":0.0027684884,"teacher_disagreement_score":0.0028700666,"about_ca_system_score_codex":0.00028486727,"about_ca_system_score_gemma":0.0003719341,"threshold_uncertainty_score":0.009601295},"labels":[],"label_agreement":null},{"id":"W1989226681","doi":"10.1517/17425255.2011.586630","title":"The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Université de Montréal","funders":"","keywords":"Hypoxia (environmental); Pharmacology; Cytochrome P450; Gene isoform; Biology; Drug; Drug action; Cell biology; Chemistry; Biochemistry; Enzyme; Gene","score_opus":0.1443570859063354,"score_gpt":0.4785649180725097,"score_spread":0.33420783216617433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989226681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006578715,0.99593985,0.00040037773,0.00079143053,0.0002830142,0.000007140112,0.00006070432,0.000013254877,0.001846323],"genre_scores_gemma":[0.004432728,0.99220216,0.00032668634,0.00036036345,0.00042515653,0.000012996637,0.000098966455,0.0000031964926,0.0021376908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985147,0.000031313215,0.000014290302,0.00003154572,0.000056128363,0.000015243243],"domain_scores_gemma":[0.9998431,0.00005423836,0.000036821613,0.000004823321,0.000050960043,0.000009925556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002642051,0.0004944387,0.0007957159,0.0005904608,0.0001401336,0.0005079391,0.0003864786,0.0007847748,0.0036308717],"category_scores_gemma":[0.00037451668,0.00012550662,0.0003046493,0.0007905293,0.00025940966,0.0005817394,0.00025878023,0.000754341,0.0020687042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001348878,0.000043874297,0.00046531647,0.012635863,0.00008508052,0.00042876162,0.000051605723,0.0002836069,0.0113131665,0.0024078223,0.029148526,0.94300145],"study_design_scores_gemma":[0.000032067135,0.00029818353,0.00512891,0.0023332054,0.00018528962,0.0056186407,0.000091926166,0.00021642624,0.006840441,0.0027122193,0.9765094,0.000033343495],"about_ca_topic_score_codex":0.00088628026,"about_ca_topic_score_gemma":0.0011799616,"teacher_disagreement_score":0.0036308717,"about_ca_system_score_codex":0.00037686556,"about_ca_system_score_gemma":0.0005590541,"threshold_uncertainty_score":0.012146473},"labels":[],"label_agreement":null},{"id":"W1989512634","doi":"10.1038/sj.clpt.6100033","title":"Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Gene duplication; Gene; Locus (genetics); Genetics; Biology; CYP2D6; Allele; Polymerase chain reaction; Copy-number variation; Genotype; Genome","score_opus":0.20364432140957647,"score_gpt":0.5107263157474201,"score_spread":0.30708199433784367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989512634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990097,0.00017914645,0.0005506403,0.00001226663,6.845516e-7,0.000007034821,0.00008501478,0.000002638999,0.00015263571],"genre_scores_gemma":[0.99911827,0.00008225358,0.00055907475,0.0000075148114,0.0000024639496,0.0000054085367,0.00014374354,0.0000016021885,0.00007950363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981004,0.00004444294,0.000018037617,0.00006229251,0.000046268826,0.00001902374],"domain_scores_gemma":[0.999728,0.00008679062,0.00010230025,0.000019233526,0.000026387654,0.000037370424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023601607,0.00009791062,0.0001610587,0.00047107154,0.00008240949,0.00015027181,0.00009623328,0.00011993479,0.00057225575],"category_scores_gemma":[0.0005442055,0.000063843996,0.000105025596,0.00033930843,0.0001596817,0.00009519634,0.00013469627,0.00015153992,0.000113305236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053231296,0.000078359,0.45334202,0.000056520395,0.00007621451,0.0015694714,0.00024729155,0.00039828173,0.5178943,0.00028116326,0.000119114695,0.025405036],"study_design_scores_gemma":[0.000028553315,0.00031632552,0.94335884,0.0000071840723,0.00004167296,0.012573528,0.00013951461,0.0012264805,0.04079471,0.00021276256,0.0012884,0.000012025184],"about_ca_topic_score_codex":0.0004099026,"about_ca_topic_score_gemma":0.0004492097,"teacher_disagreement_score":0.00057225575,"about_ca_system_score_codex":0.00011722366,"about_ca_system_score_gemma":0.00008302419,"threshold_uncertainty_score":0.0019144416},"labels":[],"label_agreement":null},{"id":"W1990239543","doi":"10.1097/00004714-200002000-00008","title":"Cytochrome P450 2D6 and Treatment of Codeine Dependence","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Toronto Public Health","funders":"National Institute on Drug Abuse","keywords":"Codeine; Opiate; Morphine; CYP2D6; Fluoxetine; Pharmacology; Opioid; Medicine; Cytochrome P450; Anesthesia; Internal medicine; Serotonin; Receptor; Metabolism","score_opus":0.21482331721826947,"score_gpt":0.5619404381075592,"score_spread":0.34711712088928975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990239543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518942,0.039284904,0.0011555253,0.0015545625,0.00009705962,0.00018660657,0.00015209221,0.000071354036,0.0056037125],"genre_scores_gemma":[0.99136144,0.0063342946,0.00089916465,0.00015177962,0.00007938449,0.000052518404,0.00015631263,0.0000038548496,0.0009612489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996735,0.00019101848,0.000024906438,0.000024769572,0.00006294239,0.000022922402],"domain_scores_gemma":[0.9997439,0.000075268465,0.000085757114,0.000014211112,0.00003113028,0.000049678347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041564115,0.00016940024,0.000403834,0.0001829293,0.00015643635,0.00016438958,0.00018430858,0.00026368166,0.0014254317],"category_scores_gemma":[0.0010485972,0.000050225415,0.0001288806,0.00020833492,0.00023595396,0.00011173979,0.0001136812,0.00040513714,0.00021295881],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016575076,0.0064839805,0.089647494,0.0010012296,0.0003495036,0.0011139072,0.0002578564,0.00068381045,0.05036591,0.0005455078,0.0047545047,0.8282212],"study_design_scores_gemma":[0.0078673735,0.06234292,0.8489961,0.00024503804,0.0003473614,0.0083063785,0.00035269614,0.0026057872,0.020981016,0.0015698586,0.0463353,0.000050056427],"about_ca_topic_score_codex":0.00065853517,"about_ca_topic_score_gemma":0.0019205998,"teacher_disagreement_score":0.0014254317,"about_ca_system_score_codex":0.00024504008,"about_ca_system_score_gemma":0.00018361081,"threshold_uncertainty_score":0.00476861},"labels":[],"label_agreement":null},{"id":"W1990643506","doi":"10.1515/labm.2001.25.11-12.477","title":"Arzneimittelnebenwirkungen vermeiden: Möglichkeiten der pharmakogenetischen Diagnostik. Prevention of Adverse Drug Reactions: Potential of Pharmacogenetic Diagnostics","year":2001,"lang":"de","type":"article","venue":"LaboratoriumsMedizin","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lockheed Martin (Canada)","funders":"","keywords":"Medicine; Pharmacogenetics; Drug reaction; Gynecology; Drug; Pharmacology; Genotype; Biology; Genetics","score_opus":0.04177313621223318,"score_gpt":0.38162602412996494,"score_spread":0.33985288791773177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990643506","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1730805,0.54124135,0.04670731,0.1637867,0.0031834824,0.0008534802,0.0011987464,0.00058636186,0.069362015],"genre_scores_gemma":[0.83445156,0.11359941,0.03403196,0.007242566,0.0027016264,0.00033622875,0.00025397795,0.000038506834,0.0073442026],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9956672,0.0027412942,0.0003447011,0.00015249613,0.0010228069,0.000071556984],"domain_scores_gemma":[0.9855114,0.009299717,0.0029256332,0.00033768555,0.0013834931,0.00054202805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055851326,0.00087963016,0.0017951115,0.0013720342,0.00049604115,0.0016283605,0.0005154976,0.002447252,0.0055681425],"category_scores_gemma":[0.019667609,0.0003232121,0.00069657044,0.0007729465,0.0010116936,0.0015988027,0.00049368804,0.0016791743,0.0010046551],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036806322,0.0007831674,0.074014924,0.0042423415,0.00044994729,0.004924361,0.00035959587,0.0014992438,0.009539835,0.0068704206,0.019628135,0.87400734],"study_design_scores_gemma":[0.0028153323,0.017253539,0.3869942,0.012390192,0.0041142586,0.11848364,0.0023861874,0.014185957,0.055314247,0.09507647,0.29026932,0.0007166452],"about_ca_topic_score_codex":0.0003794891,"about_ca_topic_score_gemma":0.00085244357,"teacher_disagreement_score":0.0055851326,"about_ca_system_score_codex":0.0005348305,"about_ca_system_score_gemma":0.0010235611,"threshold_uncertainty_score":0.02953738},"labels":[],"label_agreement":null},{"id":"W1991072079","doi":"10.1002/jps.21802","title":"Physiologically Based Predictions of the Impact of Inhibition of Intestinal and Hepatic Metabolism on Human Pharmacokinetics of CYP3A Substrates","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Ketoconazole; Pharmacology; Triazolam; CYP3A; Chemistry; Midazolam; Oral administration; First pass effect; Medicine; Cytochrome P450; Metabolism","score_opus":0.1606504098242696,"score_gpt":0.4841378396146311,"score_spread":0.3234874297903615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991072079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84200317,0.0022513203,0.14049815,0.0013252284,0.00008779543,0.000083972714,0.0014293365,0.0002748464,0.012046124],"genre_scores_gemma":[0.99707186,0.00026001874,0.0018209233,0.000108319495,0.000011934426,0.00003114417,0.00018460769,0.000016755865,0.0004944972],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997168,0.0001535955,0.000010104418,0.000045012308,0.000042149146,0.00003220427],"domain_scores_gemma":[0.99809426,0.0016459933,0.00011135542,0.00005074217,0.00006748124,0.000030159483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070846383,0.00053610624,0.0006058236,0.00018639506,0.00013402083,0.0010587521,0.00048408643,0.0007869622,0.0011976104],"category_scores_gemma":[0.00383496,0.0003365374,0.0006922886,0.0001259496,0.00030503643,0.00046758892,0.00023440653,0.00089209905,0.00039292927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059424137,0.00009124483,0.004527835,0.00008303889,0.00008291868,0.00017850446,0.000036895297,0.9736771,0.01140703,0.0020640504,0.000389742,0.006867268],"study_design_scores_gemma":[0.000087131615,0.00045205766,0.0052444884,0.000013117498,0.00009876329,0.00016628909,0.000040479525,0.9814006,0.007978653,0.00392868,0.0005627253,0.000026983442],"about_ca_topic_score_codex":0.0039716396,"about_ca_topic_score_gemma":0.0017568475,"teacher_disagreement_score":0.0039716396,"about_ca_system_score_codex":0.0006378915,"about_ca_system_score_gemma":0.000592597,"threshold_uncertainty_score":0.007897019},"labels":[],"label_agreement":null},{"id":"W1991279188","doi":"10.1097/01.pra.0000341891.43501.6b","title":"Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System","year":2008,"lang":"en","type":"review","venue":"Journal of Psychiatric Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"CYP2D6; Desipramine; Concomitant; Venlafaxine; Pharmacology; Paroxetine; Duloxetine; Area under the curve; Medicine; Internal medicine; Chemistry; Cytochrome P450; Metabolism; Antidepressant","score_opus":0.11581923016131854,"score_gpt":0.4986463035760674,"score_spread":0.38282707341474886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991279188","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8983296,0.09132938,0.0014231813,0.0005732497,0.00013181349,0.0000834338,0.00060381973,0.000063470296,0.0074621295],"genre_scores_gemma":[0.98502874,0.012220999,0.0005940443,0.00016178988,0.00004227127,0.00002197598,0.00024705514,0.000007152494,0.0016760527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999496,0.00029169922,0.00004874508,0.000052575375,0.000077938406,0.0000330555],"domain_scores_gemma":[0.99936,0.0003586341,0.00017002295,0.000027129105,0.000052868174,0.000031367657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335413,0.00024259987,0.00033077874,0.00017643768,0.00010956552,0.0002907016,0.0001477032,0.00023103632,0.002274208],"category_scores_gemma":[0.001208422,0.000089354275,0.00044001825,0.00022040769,0.00010778571,0.0001387582,0.00012894956,0.00025736223,0.00020659003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03550515,0.0009882448,0.11110072,0.004364929,0.0052735093,0.0021663203,0.00031483226,0.0044928123,0.2687139,0.0013257682,0.0046499055,0.561104],"study_design_scores_gemma":[0.003545846,0.05231937,0.5273601,0.00061222364,0.0038623437,0.010316898,0.00031546628,0.004811495,0.2844745,0.00088029646,0.11143969,0.0000617529],"about_ca_topic_score_codex":0.00070081966,"about_ca_topic_score_gemma":0.0012356285,"teacher_disagreement_score":0.002274208,"about_ca_system_score_codex":0.00033527534,"about_ca_system_score_gemma":0.00013810757,"threshold_uncertainty_score":0.0076079965},"labels":[],"label_agreement":null},{"id":"W1991435125","doi":"10.1038/tpj.2009.64","title":"Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines","year":2009,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Glucuronidation; Exon; Alternative splicing; Gene isoform; Gene knockdown; Biology; RNA splicing; Gene; Gene expression; Endogeny; Biochemistry; Cell biology; RNA; Molecular biology; Enzyme","score_opus":0.08082405094282673,"score_gpt":0.4104322238664293,"score_spread":0.32960817292360256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991435125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567693,0.0006840315,0.0018233614,0.00013010183,0.000037223646,0.000017081733,0.00043282783,0.00006133607,0.0011370471],"genre_scores_gemma":[0.99519324,0.0003794949,0.0011992248,0.00004026066,0.000013505259,0.00001890432,0.0012264261,0.000047017344,0.0018818745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969256,0.00008561086,0.00003190124,0.00004899925,0.00009428671,0.00004660223],"domain_scores_gemma":[0.99958116,0.00015248214,0.00006504248,0.00009650767,0.00006963508,0.00003516014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022944306,0.0003091664,0.00030894126,0.00033116777,0.00024027193,0.00056198816,0.00020729071,0.00027333363,0.0022140003],"category_scores_gemma":[0.00039710177,0.00024117276,0.00036304473,0.00030495907,0.0002993899,0.00019960919,0.00022139611,0.00062301976,0.00078470295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012778933,0.00002615086,0.0007416168,0.000012708657,0.000007004853,0.000079050136,0.00003474544,0.000061890845,0.9976878,0.0002741966,0.00010424999,0.0008428232],"study_design_scores_gemma":[0.000023056353,0.00022220527,0.01184256,0.000003728627,0.000027494338,0.0007648851,0.000090562884,0.0017454296,0.98218507,0.0001423825,0.00294548,0.0000070187325],"about_ca_topic_score_codex":0.0013915786,"about_ca_topic_score_gemma":0.0014444373,"teacher_disagreement_score":0.0022140003,"about_ca_system_score_codex":0.0003915286,"about_ca_system_score_gemma":0.00027259244,"threshold_uncertainty_score":0.0074065924},"labels":[],"label_agreement":null},{"id":"W1991546902","doi":"10.1097/fpc.0b013e32833bba25","title":"Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; Child and Family Research Institute","funders":"","keywords":"Biology; Locus (genetics); Genetic variation; Genetics; Allele; Population; Genetic diversity; Confounding; Evolutionary biology; Gene; Demography","score_opus":0.0648848010729666,"score_gpt":0.3244512909148713,"score_spread":0.25956648984190467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991546902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726284,0.00092639646,0.0011208248,0.00012078806,0.000004788148,0.0000047062917,0.00009798353,0.0000052211426,0.00045650415],"genre_scores_gemma":[0.99929905,0.00020126953,0.0003125966,0.000022533564,0.000008514567,0.000002313977,0.000051916708,0.0000030655392,0.00009872564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956244,0.000194067,0.000022811695,0.00014550953,0.000041365383,0.00003386095],"domain_scores_gemma":[0.9995479,0.00020921319,0.00011667846,0.000041069226,0.00003079615,0.000054366184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071082276,0.00018310921,0.00024367667,0.0005757536,0.00028681115,0.000377691,0.00018815554,0.00041788383,0.0013174126],"category_scores_gemma":[0.0010773742,0.00012865601,0.0002543855,0.0006553281,0.00051495316,0.00032455433,0.00027937815,0.00033022638,0.00014203448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049850706,0.000056813242,0.9309561,0.000052125466,0.00040615626,0.0004491883,0.0005235607,0.0008864169,0.04225832,0.0005791473,0.000093060975,0.023240447],"study_design_scores_gemma":[0.000009805403,0.00009462262,0.9956974,0.000008962146,0.000067989815,0.0005584868,0.00015424733,0.0010871731,0.0013827974,0.00043582622,0.0004928542,0.000009838825],"about_ca_topic_score_codex":0.00091117877,"about_ca_topic_score_gemma":0.0012478973,"teacher_disagreement_score":0.0013174126,"about_ca_system_score_codex":0.00015727092,"about_ca_system_score_gemma":0.00010580726,"threshold_uncertainty_score":0.0044071674},"labels":[],"label_agreement":null},{"id":"W1991715552","doi":"10.1111/j.1365-2125.2005.02519.x","title":"Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition","year":2005,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"National Center for Research Resources; National Institute of General Medical Sciences","keywords":"Grapefruit juice; Ciclosporin; Crossover study; Chemistry; Pharmacokinetics; CYP3A4; Orange juice; Fluorescence polarization immunoassay; Oral administration; Daucus carota; Pharmacology; Food science; Medicine; Internal medicine; Chromatography; Transplantation; Biochemistry; Cytochrome P450; Botany; Metabolism; Biology","score_opus":0.1507275346383384,"score_gpt":0.5474249559089603,"score_spread":0.3966974212706219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991715552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759287,0.0016271569,0.00012979508,0.00006456933,0.000013345898,0.00003222792,0.000047044225,0.000011326753,0.00048162698],"genre_scores_gemma":[0.9988194,0.0003871262,0.00021642252,0.00008164566,0.00001392033,0.000008041808,0.000041919142,0.0000038705384,0.0004275932],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975485,0.00009804251,0.000014696654,0.00006131168,0.000050191444,0.000021020887],"domain_scores_gemma":[0.9997507,0.000104212406,0.00006547619,0.00001909825,0.000019892834,0.000040736013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004010851,0.0003345014,0.00035050724,0.00016474625,0.0002778542,0.0003841051,0.00010762559,0.0003181982,0.0023836417],"category_scores_gemma":[0.0007095693,0.00010174493,0.00032960394,0.00013107354,0.00027987137,0.00021006128,0.00014543343,0.000338899,0.00017198102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084121235,0.0028870841,0.19445859,0.0016814014,0.0015129115,0.0068023126,0.0005448133,0.00047881063,0.5487328,0.00024711902,0.00078812847,0.15774487],"study_design_scores_gemma":[0.0010320907,0.059489813,0.7591684,0.0001238679,0.0013697315,0.013638873,0.00044526785,0.0013364331,0.15559086,0.00017672243,0.00758751,0.0000404415],"about_ca_topic_score_codex":0.0007284509,"about_ca_topic_score_gemma":0.0009982625,"teacher_disagreement_score":0.0023836417,"about_ca_system_score_codex":0.00038504513,"about_ca_system_score_gemma":0.00011933179,"threshold_uncertainty_score":0.007974088},"labels":[],"label_agreement":null},{"id":"W1991720659","doi":"10.1002/rcm.4507","title":"Improved detection of reactive metabolites with a bromine‐containing glutathione analog using mass defect and isotope pattern matching","year":2010,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Glutathione; Chromatography; Metabolite; Mass spectrometry; Electrospray ionization; Electrospray; Liquid chromatography–mass spectrometry; Adduct; Tandem mass spectrometry; Biochemistry; Organic chemistry; Enzyme","score_opus":0.057041847258660475,"score_gpt":0.38388406912848116,"score_spread":0.3268422218698207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991720659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88385427,0.0026169333,0.110726506,0.00019276707,0.00006904844,0.00018271263,0.00037658724,0.0008210774,0.0011600588],"genre_scores_gemma":[0.8616298,0.0016756231,0.1335933,0.00023574353,0.000025396495,0.00015203367,0.0007457903,0.00007732176,0.0018650128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922943,0.00021748504,0.00004186179,0.00021720293,0.0002418731,0.00005215864],"domain_scores_gemma":[0.9995889,0.000083091814,0.0001408156,0.000060651942,0.00009851986,0.000027979337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068090047,0.0006691735,0.00045004886,0.00091120356,0.00014365067,0.000293754,0.0005699967,0.000815968,0.00066738506],"category_scores_gemma":[0.0008955943,0.00031181274,0.00039016845,0.00049284665,0.00035488605,0.00041113535,0.00039255468,0.0005023322,0.00030796672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011784271,0.0000140849925,0.00041032635,0.000032853288,0.00001066936,0.000036385085,0.00000939416,0.0000442161,0.99608624,0.000022859083,0.000014474119,0.003200648],"study_design_scores_gemma":[0.000012263424,0.00034056915,0.0024236746,0.0000029053997,0.000029270943,0.00045851365,0.000008467271,0.0015727445,0.9945732,0.00003015233,0.0005376742,0.000010540302],"about_ca_topic_score_codex":0.0005777491,"about_ca_topic_score_gemma":0.00095173775,"teacher_disagreement_score":0.00091120356,"about_ca_system_score_codex":0.00029828332,"about_ca_system_score_gemma":0.00023605634,"threshold_uncertainty_score":0.003600955},"labels":[],"label_agreement":null},{"id":"W1991738315","doi":"10.1002/hep.21481","title":"The role of chrysin and the Ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice","year":2007,"lang":"en","type":"article","venue":"Hepatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; U.S. Public Health Service; Karolinska Institutet; Virginia Commonwealth University","keywords":"Chrysin; Pharmacology; Receptor; Chemistry; Agonist; Endocrinology; Biology; Biochemistry; Flavonoid","score_opus":0.03975550666566725,"score_gpt":0.37205727623956386,"score_spread":0.3323017695738966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991738315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546904,0.0028636514,0.0079040555,0.00044815658,0.00004820706,0.000057674624,0.0009943561,0.00023871454,0.0019761897],"genre_scores_gemma":[0.99250585,0.0009084838,0.0024170962,0.00005509657,0.000015005816,0.000040910374,0.0007924163,0.000035728975,0.0032292805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998435,0.000033152883,0.000009908516,0.000034245415,0.00004532914,0.000033961423],"domain_scores_gemma":[0.99980325,0.000057486835,0.00006295692,0.000022848895,0.00001440048,0.000039138886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000226516,0.0003506381,0.0001563339,0.00046931836,0.0001852775,0.00025629657,0.00021632305,0.0005047125,0.0021668],"category_scores_gemma":[0.0001486225,0.00019084592,0.00030988525,0.00019241912,0.00041204345,0.00022269475,0.0001659723,0.00054044515,0.0005574535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019038076,0.000019577878,0.00015101922,0.000016908116,0.000003466812,0.000036375925,0.0000098390265,0.000032518135,0.9989573,0.00006856571,0.000027083977,0.00048693473],"study_design_scores_gemma":[0.000022459522,0.00027736044,0.0027055314,0.0000023683046,0.000018945995,0.00027924008,0.000015451491,0.0004583508,0.99475396,0.00004566035,0.0014175571,0.0000031120328],"about_ca_topic_score_codex":0.0010934466,"about_ca_topic_score_gemma":0.001358335,"teacher_disagreement_score":0.0021668,"about_ca_system_score_codex":0.000546188,"about_ca_system_score_gemma":0.0002120321,"threshold_uncertainty_score":0.0072486997},"labels":[],"label_agreement":null},{"id":"W19917450","doi":"10.5588/ijtld.11.0404","title":"&lt;I&gt;UGT1A1&lt;/I&gt; polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications [Short communication]","year":2012,"lang":"en","type":"article","venue":"The International Journal of Tuberculosis and Lung Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Taipei Medical University","keywords":"Medicine; Tuberculosis; Incidence (geometry); Drug; Internal medicine; Pharmacology; Pathology","score_opus":0.02793072421740166,"score_gpt":0.34330120234629374,"score_spread":0.3153704781288921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19917450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975616,0.00062086695,0.00036290352,0.00021029904,0.000016069253,0.000005916962,0.0005079241,0.00001566662,0.00069880276],"genre_scores_gemma":[0.9986681,0.0001481099,0.00031097984,0.00005191303,0.000026785941,0.0000042397764,0.00028256825,0.0000059832414,0.0005012661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998503,0.00005448027,0.000015858866,0.0000381312,0.000019675903,0.000021518545],"domain_scores_gemma":[0.9991615,0.00022281049,0.00043257908,0.000036561938,0.000045090088,0.000101387806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002285108,0.00024955257,0.00028599854,0.00034783458,0.0001545158,0.00028044003,0.0001628727,0.00029413798,0.004238243],"category_scores_gemma":[0.00090866495,0.00010992813,0.00031347174,0.0005341496,0.00017086318,0.0001327006,0.00010150682,0.00033870566,0.00037249617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015643684,0.00009130146,0.97791183,0.00005442285,0.00025969042,0.00074029196,0.00004875466,0.00027392595,0.008808734,0.00013004304,0.00077219977,0.009344416],"study_design_scores_gemma":[0.000052567684,0.0005120889,0.9899777,0.000017507584,0.00027990135,0.0027080127,0.000042606713,0.0011224888,0.003906292,0.0001617396,0.001210519,0.00000867713],"about_ca_topic_score_codex":0.0011420969,"about_ca_topic_score_gemma":0.001106682,"teacher_disagreement_score":0.004238243,"about_ca_system_score_codex":0.00012339481,"about_ca_system_score_gemma":0.00012844813,"threshold_uncertainty_score":0.014178336},"labels":[],"label_agreement":null},{"id":"W1991912173","doi":"10.1016/s0006-2952(01)00744-4","title":"Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain22Abbreviations: CYP, cytochrome P450; C8 xanthate, potassium octylxanthate; NCO, nicotine C-oxidation; NDMA, N-nitrosodimethylamine; NMA, N-nitroso-N-methylaniline; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; and SSC, saline-sodium citrate buffer.","year":2001,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research; Medical Research Council Canada","keywords":"Nicotine; Chemistry; Microsome; Endocrinology; Internal medicine; Ethanol; Cytochrome P450; Toxicity; Saline; Pharmacology; Metabolism; Biochemistry; Biology; Enzyme; Medicine","score_opus":0.04710211895602214,"score_gpt":0.3553460143880339,"score_spread":0.3082438954320118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991912173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801675,0.005286144,0.0049481993,0.00025129784,0.00010036496,0.00006805562,0.0018061206,0.00026113752,0.0071110534],"genre_scores_gemma":[0.95621365,0.0029155912,0.0034735934,0.00008842829,0.00003957391,0.00011747682,0.006437766,0.00013981244,0.03057405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998074,0.000036060574,0.000013382516,0.0000402896,0.000046910456,0.00005593102],"domain_scores_gemma":[0.9998221,0.000022209353,0.00003415678,0.000042704854,0.00003361357,0.00004525621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013411377,0.00063680485,0.00027048407,0.00061085285,0.00028597424,0.0002532218,0.00018176838,0.00020209899,0.005177824],"category_scores_gemma":[0.0001792625,0.00032584718,0.0004621505,0.00042175033,0.00027675254,0.00022276973,0.00028208463,0.0005336313,0.0015868738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035877773,0.000051812633,0.0004547667,0.00003969041,0.00001898307,0.00012754995,0.000038566723,0.000025255216,0.99627763,0.00017217446,0.00011543449,0.0023192428],"study_design_scores_gemma":[0.000016873777,0.00028359648,0.015678095,0.000009651982,0.000039496732,0.00034832253,0.00003076921,0.00021861409,0.98064536,0.000059719387,0.002663454,0.0000060940793],"about_ca_topic_score_codex":0.0049386485,"about_ca_topic_score_gemma":0.010114869,"teacher_disagreement_score":0.005177824,"about_ca_system_score_codex":0.0006361339,"about_ca_system_score_gemma":0.00040425346,"threshold_uncertainty_score":0.017321527},"labels":[],"label_agreement":null},{"id":"W1992234430","doi":"10.1097/ftd.0b013e3182557325","title":"Is There a Role for Therapeutic Drug Monitoring With Codeine?","year":2012,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Codeine; Analgesic; Prodrug; Pharmacogenetics; Morphine; Drug; Pharmacology; CYP2D6; Medicine; Therapeutic drug monitoring; Adverse effect; Pharmacogenomics; Cytochrome P450; Chemistry; Internal medicine; Genotype; Metabolism","score_opus":0.2301740048227166,"score_gpt":0.47048771687925633,"score_spread":0.24031371205653973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992234430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012253078,0.9953413,0.00040812115,0.0022674121,0.00030809754,0.0000058068613,0.000011982386,0.000013131732,0.0015216103],"genre_scores_gemma":[0.001016122,0.99513346,0.0008460827,0.0016712139,0.00044680983,0.000010204954,0.000025356314,0.0000041009944,0.00084668683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956936,0.00012974588,0.00005752197,0.000055736524,0.00016187794,0.00002564664],"domain_scores_gemma":[0.9992569,0.00037583953,0.00011404123,0.000029556513,0.00016953747,0.00005413872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010465627,0.00054507813,0.0016584299,0.0010764243,0.00026970945,0.0010980614,0.0010216053,0.0018474548,0.0037453864],"category_scores_gemma":[0.0014951662,0.00019780229,0.0006135043,0.0011700969,0.000779813,0.0022470423,0.00063472317,0.0028507067,0.0027699354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066668246,0.00005339393,0.00018235568,0.009482981,0.000068478796,0.00039147245,0.000079747704,0.0001165647,0.0015820931,0.0054274146,0.024394525,0.95815426],"study_design_scores_gemma":[0.00002613172,0.000094277755,0.0005554572,0.0030861674,0.00008154042,0.0037692261,0.00009541491,0.00008528827,0.0004682158,0.0033114685,0.9884043,0.00002245668],"about_ca_topic_score_codex":0.0007777161,"about_ca_topic_score_gemma":0.0013845072,"teacher_disagreement_score":0.0037453864,"about_ca_system_score_codex":0.00066739775,"about_ca_system_score_gemma":0.0014151805,"threshold_uncertainty_score":0.012529552},"labels":[],"label_agreement":null},{"id":"W1992259971","doi":"10.1038/sj.clpt.6100434","title":"Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep Saint-Jean-sur-Richelieu; Institut universitaire de cardiologie et de pneumologie de Québec; Montreal Heart Institute; Bausch Health (Canada); Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Vitamin K epoxide reductase; CYP2C9; Medicine; Internal medicine; Pharmacology; Genotype; Losartan; Biology; Genetics; Gene; Atrial fibrillation; Cytochrome P450; Renin–angiotensin system","score_opus":0.24618215903103102,"score_gpt":0.5471762856085234,"score_spread":0.30099412657749236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992259971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996996,0.00005775909,0.000096608885,0.00001532384,0.0000012821185,0.0000024043302,0.000040617713,0.000002830363,0.00008360037],"genre_scores_gemma":[0.99969923,0.00002187448,0.00016118998,0.000013616985,0.0000039652864,0.0000024347967,0.000068030924,0.0000014343658,0.000028334476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991818,0.00030506655,0.00010491895,0.00018710837,0.00015534744,0.000065705266],"domain_scores_gemma":[0.9983791,0.00068669824,0.0005104458,0.0001427622,0.00010215617,0.00017882074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059701945,0.00035765176,0.00062053825,0.0005038086,0.00023864227,0.0004972386,0.0002306703,0.00035793724,0.0003720385],"category_scores_gemma":[0.003084796,0.00024863752,0.00034716638,0.00061037677,0.00027307495,0.00025704884,0.00031805047,0.00044578494,0.00011835019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054951967,0.000039866285,0.9943157,0.0000053233416,0.00006911096,0.00017473029,0.000043401447,0.00023490096,0.0014433676,0.00001024388,0.000039115635,0.0030748032],"study_design_scores_gemma":[0.000024254965,0.00042856348,0.9962126,0.0000028875143,0.0000741211,0.0006382171,0.00005845739,0.0016992266,0.0007435806,0.000047109243,0.00006362602,0.000007363294],"about_ca_topic_score_codex":0.0013128676,"about_ca_topic_score_gemma":0.0024481602,"teacher_disagreement_score":0.0013128676,"about_ca_system_score_codex":0.00027546054,"about_ca_system_score_gemma":0.00021853192,"threshold_uncertainty_score":0.0031573772},"labels":[],"label_agreement":null},{"id":"W1992320105","doi":"10.1097/00004714-200104000-00009","title":"Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"Diphenhydramine; Venlafaxine; Pharmacology; CYP2D6; Antihistamine; Venlafaxine Hydrochloride; Drug interaction; Concomitant; Pharmacokinetics; Oral administration; Diphenhydramine hydrochloride; Medicine; Chemistry; Endocrinology; Internal medicine; Antidepressant; Histamine; Cytochrome P450; Metabolism","score_opus":0.19000529920427853,"score_gpt":0.5480024974528064,"score_spread":0.3579971982485278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992320105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870205,0.00047316658,0.00023277718,0.000019428377,0.00000613075,0.000009633945,0.000049177917,0.0000062933264,0.00050148653],"genre_scores_gemma":[0.9992736,0.00016278586,0.00013959073,0.00003377844,0.000007552193,0.0000050639624,0.000045809404,0.0000016686853,0.00033019972],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988127,0.000046830508,0.000008891341,0.000027866872,0.00002003985,0.00001507083],"domain_scores_gemma":[0.99991405,0.00002366006,0.00002645824,0.000012790305,0.0000046714795,0.00001832686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016741983,0.00014879393,0.0002461331,0.00012560576,0.0001211583,0.00019033744,0.000056910463,0.00016791752,0.0011459291],"category_scores_gemma":[0.0003622325,0.00009881011,0.00014957317,0.00008105347,0.00013792819,0.000106613836,0.00007489542,0.00020543934,0.00012118903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032715604,0.002640958,0.33465225,0.00019316345,0.00045874348,0.0029859662,0.000401676,0.00046733633,0.5021408,0.00043368575,0.0010772918,0.121832445],"study_design_scores_gemma":[0.00037516875,0.020352345,0.9423691,0.00000990648,0.00013911551,0.004279597,0.00008434557,0.0007606392,0.02773572,0.00014041897,0.0037419149,0.000011655445],"about_ca_topic_score_codex":0.00034418693,"about_ca_topic_score_gemma":0.00042843077,"teacher_disagreement_score":0.0011459291,"about_ca_system_score_codex":0.000117369964,"about_ca_system_score_gemma":0.00004935501,"threshold_uncertainty_score":0.0038335323},"labels":[],"label_agreement":null},{"id":"W1992520141","doi":"10.1080/13651500410005559","title":"High-dose venlafaxine treatment in a depressed patient with a genetic CYP2D6 deficiency","year":2004,"lang":"en","type":"article","venue":"International Journal of Psychiatry in Clinical Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ven; CYP2D6; Venlafaxine; Metabolite; Pharmacogenetics; Lithium (medication); Depression (economics); Antidepressant; Genotyping; Internal medicine; Nortriptyline; Medicine; Venlafaxine Hydrochloride; Psychology; Pharmacology; Psychiatry; Genotype; Metabolism; Anxiety; Cytochrome P450; Biology; Genetics","score_opus":0.09506915189284447,"score_gpt":0.5073594227501658,"score_spread":0.4122902708573213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992520141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961695,0.0009034217,0.00030206647,0.0007311149,0.000037089754,0.00002653437,0.00006163674,0.000016599464,0.0017520854],"genre_scores_gemma":[0.99873453,0.00030618068,0.00020379426,0.00031418793,0.000037315916,0.0000054454854,0.00003441699,0.000002038858,0.00036217168],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99988854,0.000028251925,0.00001616028,0.00002206566,0.000019815518,0.000025099424],"domain_scores_gemma":[0.999816,0.00005760666,0.000037502963,0.00000888581,0.000011190141,0.000068743146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014542484,0.0003725182,0.00047145315,0.0003041939,0.0007797658,0.00032569593,0.00019188195,0.0010205387,0.000765417],"category_scores_gemma":[0.00082263286,0.000225003,0.00030702096,0.00026813417,0.0002818126,0.00020620707,0.00017168511,0.000754653,0.00019792984],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032055145,0.0011222862,0.24162626,0.00020525626,0.00021569587,0.68822306,0.0015269853,0.00073144294,0.025543274,0.00054994255,0.0016503966,0.035399884],"study_design_scores_gemma":[0.0005697558,0.005091703,0.25671083,0.000055687993,0.0002657534,0.7250628,0.00078986934,0.0023024443,0.004969728,0.0006225647,0.0035055103,0.00005347806],"about_ca_topic_score_codex":0.0012341024,"about_ca_topic_score_gemma":0.0020148389,"teacher_disagreement_score":0.0012341024,"about_ca_system_score_codex":0.00033907447,"about_ca_system_score_gemma":0.0002566886,"threshold_uncertainty_score":0.002560556},"labels":[],"label_agreement":null},{"id":"W1992617863","doi":"10.1016/j.tiv.2007.07.002","title":"Constitutive expression and inducibility of CYP1A1 in the H9c2 rat cardiomyoblast cells","year":2007,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inducer; In vitro; Cell culture; Embryonic stem cell; Cell biology; Messenger RNA; Gene expression; Biology; RNA; Molecular biology; Gene; Chemistry; Biochemistry; Genetics","score_opus":0.07969788146826398,"score_gpt":0.4170768668416165,"score_spread":0.33737898537335254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992617863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845978,0.0024500322,0.0069851526,0.00028487123,0.00014212457,0.00005083251,0.002478409,0.00016593479,0.0028447541],"genre_scores_gemma":[0.9856828,0.0011715282,0.0042959726,0.000071601346,0.000051433024,0.000061459665,0.0034995526,0.00006217357,0.005103538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995497,0.000074835385,0.000062889536,0.00011052677,0.00012817173,0.00007375524],"domain_scores_gemma":[0.99958295,0.00013651658,0.00006845331,0.000109928835,0.00004555539,0.00005674134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035516513,0.00029663282,0.00030884412,0.00031292415,0.0002838233,0.0004475144,0.00023257993,0.0002465667,0.0012800229],"category_scores_gemma":[0.00021771064,0.00024244863,0.00039052864,0.0003018743,0.00029719473,0.00023907518,0.00024207469,0.0008944712,0.0006001373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006503506,0.000016898011,0.00020275479,0.00001754493,0.0000037532573,0.000045159708,0.000020550517,0.000030598727,0.99910694,0.00011611702,0.000037449252,0.00033719934],"study_design_scores_gemma":[0.000009608724,0.00011490013,0.0032598253,0.000003572119,0.000012482555,0.0001713085,0.000032043685,0.0003519114,0.993958,0.000027272807,0.002055307,0.0000037841598],"about_ca_topic_score_codex":0.0011492393,"about_ca_topic_score_gemma":0.0014936499,"teacher_disagreement_score":0.0012800229,"about_ca_system_score_codex":0.00039505906,"about_ca_system_score_gemma":0.00029325174,"threshold_uncertainty_score":0.0042820573},"labels":[],"label_agreement":null},{"id":"W1992854159","doi":"10.1007/s10822-010-9336-6","title":"Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism","year":2010,"lang":"en","type":"article","venue":"Journal of Computer-Aided Molecular Design","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Docking (animal); Homology modeling; Ligand (biochemistry); Homology (biology); Chemistry; Stereochemistry; Binding site; Cytochrome P450; Crystallography; Enzyme; Receptor; Biochemistry; Amino acid; Medicine","score_opus":0.13860884713725702,"score_gpt":0.4108136456716016,"score_spread":0.2722047985343446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992854159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68523544,0.001000605,0.29802135,0.0008520567,0.00009758273,0.00014048145,0.0017589642,0.0015588216,0.011334555],"genre_scores_gemma":[0.9475363,0.0004168698,0.049484003,0.000046603855,0.000011850534,0.00005771219,0.0011165029,0.00005631033,0.00127382],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99994075,0.000018593748,0.0000030826282,0.000010438248,0.00001913437,0.000007971768],"domain_scores_gemma":[0.99992347,0.00003799072,0.000008343075,0.0000058429755,0.000016149535,0.000008207963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001229315,0.0004187739,0.00055745087,0.00031739258,0.0003674429,0.00048434996,0.0004162006,0.00068932737,0.0023004757],"category_scores_gemma":[0.00041896477,0.00024014917,0.000541986,0.00030541123,0.0001625128,0.0002743053,0.00016802274,0.00036072073,0.00044602086],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003114182,0.000084067884,0.0020111504,0.00015187592,0.000042698626,0.00083071867,0.000052865995,0.950149,0.021335483,0.0065072323,0.0009518852,0.017571678],"study_design_scores_gemma":[0.00007236882,0.00008340092,0.0002929445,0.000006626742,0.000022885046,0.00010558107,0.00001947602,0.99173295,0.0041627735,0.0022545897,0.0012384601,0.000007928919],"about_ca_topic_score_codex":0.0060907197,"about_ca_topic_score_gemma":0.004150534,"teacher_disagreement_score":0.0060907197,"about_ca_system_score_codex":0.0004494583,"about_ca_system_score_gemma":0.00076431385,"threshold_uncertainty_score":0.012110531},"labels":[],"label_agreement":null},{"id":"W1992917631","doi":"10.5414/cp201845","title":"Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations","year":2013,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Cmax; Pharmacology; Carbamazepine; Medicine; Population","score_opus":0.3202860587396284,"score_gpt":0.5351534356356845,"score_spread":0.21486737689605612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992917631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466729,0.002674649,0.038644493,0.0011206153,0.000103567494,0.0004997989,0.0007274333,0.00030829737,0.009248291],"genre_scores_gemma":[0.99236333,0.00037883464,0.005837598,0.0005390229,0.00003393998,0.0001407212,0.00035373593,0.00003294417,0.00031988297],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945979,0.0031417818,0.00037763437,0.0005853134,0.0011753357,0.00012199647],"domain_scores_gemma":[0.99333835,0.0042541246,0.0012543716,0.00072165206,0.00036205535,0.00006945817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007246558,0.00027841533,0.0009207236,0.0002497611,0.00022076143,0.0013592811,0.00050864235,0.0009862046,0.003380426],"category_scores_gemma":[0.022769356,0.00019851972,0.00066901755,0.00027687367,0.00048943073,0.0006964314,0.00035097805,0.00081939,0.00068341865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031758424,0.0023017537,0.12882966,0.0026420765,0.004350231,0.0020380004,0.0015077358,0.025253156,0.14167455,0.023638941,0.0060025197,0.63000286],"study_design_scores_gemma":[0.013668002,0.09584614,0.38964486,0.0007906073,0.007251537,0.02262496,0.00160135,0.14461716,0.17445616,0.07739925,0.07181601,0.0002840038],"about_ca_topic_score_codex":0.00020089898,"about_ca_topic_score_gemma":0.00013740914,"teacher_disagreement_score":0.007246558,"about_ca_system_score_codex":0.00036507318,"about_ca_system_score_gemma":0.00049878046,"threshold_uncertainty_score":0.03832388},"labels":[],"label_agreement":null},{"id":"W1993351059","doi":"10.1167/tvst.2.6.1","title":"Translating Drugs From Animals to Humans: Do We Need to Prove Efficacy?","year":2013,"lang":"en","type":"article","venue":"Translational Vision Science & Technology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Allergan; Fidelity Biosciences; Akebia Therapeutics; Astellas Pharma; Concert Pharmaceuticals; Astellas Pharma Global Development; Shire; Aerie Pharmaceuticals; Santen; Innovent Biologics; Astex Pharmaceuticals; Wells Fargo; Valeant Pharmaceuticals International; Omeros Corporation; Alexion Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Medicine; Clinical trial; Drug development; Food and drug administration; Publication; Drug; Drug approval; Pharmacology; Family medicine; Pathology; Business","score_opus":0.07029417089914052,"score_gpt":0.44588606372034995,"score_spread":0.3755918928212094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993351059","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018434889,0.2990161,0.017499942,0.59569967,0.058822535,0.0004626672,0.00047437428,0.0005770478,0.025604257],"genre_scores_gemma":[0.037524145,0.37454808,0.04529855,0.46041927,0.06251917,0.0013180316,0.0007621586,0.0012414915,0.016369218],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93361425,0.035969395,0.006497984,0.0031295293,0.019143999,0.0016448493],"domain_scores_gemma":[0.78661805,0.1402585,0.013740516,0.021039067,0.032486558,0.005857311],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11875842,0.0018431232,0.006694709,0.002393961,0.0018777229,0.013507099,0.0042327773,0.01336247,0.018724408],"category_scores_gemma":[0.19855742,0.0012490519,0.002606188,0.0019666015,0.023195645,0.032489575,0.0057491427,0.025507664,0.016622264],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017162028,0.000619035,0.0018557657,0.013168354,0.00073686783,0.0007829695,0.0019189039,0.0003826278,0.0049387957,0.13914223,0.34702408,0.4877142],"study_design_scores_gemma":[0.00046530535,0.0019587146,0.0011204063,0.007816276,0.00040150736,0.0015152375,0.0013258717,0.0003510474,0.004403215,0.105324,0.87514144,0.00017700675],"about_ca_topic_score_codex":0.0021004695,"about_ca_topic_score_gemma":0.00179562,"teacher_disagreement_score":0.88124156,"about_ca_system_score_codex":0.004960946,"about_ca_system_score_gemma":0.011782067,"threshold_uncertainty_score":0.628062},"labels":[],"label_agreement":null},{"id":"W1994315871","doi":"10.1359/jbmr.060902","title":"CYP1A1: Ethnic and Population Differences in Allelic Frequencies and Interpretation of Bone Biology Studies","year":2006,"lang":"en","type":"letter","venue":"Journal of Bone and Mineral Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise","funders":"","keywords":"Allele frequency; Allele; Genotype; Osteoporosis; Genetics; Breast cancer; Population; Internal medicine; Demography; Medicine; Biology; Oncology; Endocrinology; Cancer; Gene","score_opus":0.3653082482145677,"score_gpt":0.540954819672869,"score_spread":0.17564657145830126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994315871","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027437296,0.019115249,0.0020970642,0.37526834,0.59931254,0.00005061031,0.00028178675,0.00018661041,0.0009440587],"genre_scores_gemma":[0.01689023,0.006157886,0.0016270065,0.17933542,0.792798,0.00007132374,0.00012363319,0.00018778781,0.0028087122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833904,0.0069683283,0.0033679656,0.0019932082,0.0036570898,0.00062303536],"domain_scores_gemma":[0.92180794,0.041110575,0.006812845,0.0023946487,0.025530986,0.0023429913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022296693,0.0016107323,0.0027214629,0.0020965762,0.0013198811,0.003787859,0.0049521783,0.0075856578,0.0029666233],"category_scores_gemma":[0.10421682,0.0009598836,0.0012101906,0.0020684425,0.002534881,0.0020843213,0.0011158431,0.008343417,0.0028901896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034638928,0.0000498797,0.004335709,0.0010055352,0.00033489612,0.0019286043,0.00022451527,0.00011915254,0.0003690637,0.0005943959,0.9575091,0.033182688],"study_design_scores_gemma":[0.00031975502,0.00027730587,0.020262124,0.0025198627,0.00077437237,0.009963034,0.00045640633,0.0023775268,0.0020733518,0.0037250142,0.9570056,0.00024562035],"about_ca_topic_score_codex":0.0019544526,"about_ca_topic_score_gemma":0.0034258757,"teacher_disagreement_score":0.022296693,"about_ca_system_score_codex":0.0021241382,"about_ca_system_score_gemma":0.0014524485,"threshold_uncertainty_score":0.1179176},"labels":[],"label_agreement":null},{"id":"W1994438706","doi":"10.2165/00003088-200241080-00001","title":"Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Propafenone; Mexiletine; Flecainide; Stereoselectivity; Chemistry; Pharmacology; Debrisoquine; Verapamil; Pharmacokinetics; Quinidine; Disopyramide; Procainamide; Antiarrhythmic agent; Enantiomer; CYP2D6; Metabolism; Medicine; Internal medicine; Stereochemistry; Cytochrome P450; Biochemistry; Calcium","score_opus":0.29272726509544517,"score_gpt":0.5554188054718815,"score_spread":0.2626915403764363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994438706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047765,0.9907754,0.0010258446,0.00028118383,0.00010256709,0.000007864162,0.000061826766,0.00001756226,0.0029512136],"genre_scores_gemma":[0.019180594,0.97753567,0.0008298266,0.00027128163,0.00021102947,0.000007583543,0.00008622953,0.0000053035556,0.0018725503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974006,0.000069367146,0.00003124348,0.00004832923,0.00009370769,0.000017380597],"domain_scores_gemma":[0.999597,0.00021505821,0.00008236751,0.000014105577,0.000078454694,0.000013147192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844585,0.00044843188,0.0011511846,0.0004782063,0.00008194746,0.00050530845,0.00059438276,0.00040540815,0.0020312953],"category_scores_gemma":[0.00064624334,0.00015823361,0.00032299708,0.0006178702,0.00026287316,0.0005364065,0.00020845055,0.000568861,0.0008701066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039084558,0.00006715426,0.00086329854,0.0052578603,0.000113518756,0.0003438849,0.00003072427,0.00063015183,0.016263884,0.0019531809,0.0033856363,0.9706999],"study_design_scores_gemma":[0.00022348562,0.0016310697,0.016052043,0.0015262249,0.0010184706,0.010514093,0.00012179406,0.0009474179,0.046767432,0.0063414085,0.91477937,0.00007723884],"about_ca_topic_score_codex":0.0008179725,"about_ca_topic_score_gemma":0.0014802451,"teacher_disagreement_score":0.0020312953,"about_ca_system_score_codex":0.00032075116,"about_ca_system_score_gemma":0.0005927735,"threshold_uncertainty_score":0.0067953467},"labels":[],"label_agreement":null},{"id":"W1994627863","doi":"10.1007/s10928-010-9185-x","title":"Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion","year":2010,"lang":"en","type":"review","venue":"Journal of Pharmacokinetics and Pharmacodynamics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pharmacokinetics; Excretion; Metabolism; Absorption (acoustics); Physiologically based pharmacokinetic modelling; Pharmacology; Chemistry; Metabolic clearance rate; Medicine; Biochemistry; Physics","score_opus":0.13243371621155753,"score_gpt":0.4536219995116794,"score_spread":0.3211882833001219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994627863","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033159624,0.3172792,0.66967684,0.0011265582,0.00064183504,0.00009600097,0.00058628427,0.0010657217,0.006211556],"genre_scores_gemma":[0.111475036,0.6371146,0.23069832,0.0010635849,0.00129641,0.0004966717,0.0018800785,0.00042548956,0.015549897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995783,0.00012809681,0.000029297938,0.000065878376,0.00018017269,0.000018292947],"domain_scores_gemma":[0.99965775,0.00019282359,0.00003477758,0.000025468169,0.000080618825,0.000008525994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089477893,0.0020192934,0.0033083854,0.0007263809,0.00023343255,0.0013617908,0.0023895793,0.0015768319,0.0016797227],"category_scores_gemma":[0.0010357274,0.0005443806,0.0020771646,0.00095962296,0.00045099517,0.0011994255,0.0005602169,0.001898413,0.002868997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013081322,0.00022065567,0.000621926,0.0049933926,0.0006452914,0.00044769037,0.00007843664,0.2246828,0.015553908,0.03520013,0.018646933,0.698778],"study_design_scores_gemma":[0.000085825646,0.00028137467,0.0011808693,0.0012106571,0.0008478801,0.002225041,0.00006340752,0.58812195,0.01843969,0.061050516,0.32630906,0.00018377978],"about_ca_topic_score_codex":0.0034374618,"about_ca_topic_score_gemma":0.0018920125,"teacher_disagreement_score":0.0034374618,"about_ca_system_score_codex":0.0009238423,"about_ca_system_score_gemma":0.0012774658,"threshold_uncertainty_score":0.006834924},"labels":[],"label_agreement":null},{"id":"W1994925836","doi":"10.1089/gtmb.2011.0327","title":"The AmpliChip <sup>®</sup> CYP450 Test and Response to Treatment in Schizophrenia and Obsessive Compulsive Disorder: A Pilot Study and Focus on Cases with Abnormal CYP2D6 Drug Metabolism","year":2012,"lang":"en","type":"article","venue":"Genetic Testing and Molecular Biomarkers","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"CYP2D6; CYP2C19; Genotyping; Pharmacogenetics; Medicine; Schizophrenia (object-oriented programming); Analysis of variance; Drug; Internal medicine; Prospective cohort study; Psychiatry; Pharmacology; Genotype; Biology; Genetics; Cytochrome P450","score_opus":0.04705397687062119,"score_gpt":0.34476096420026775,"score_spread":0.29770698732964657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994925836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996561,0.000068969646,0.00009850196,0.0000136315475,9.298953e-7,0.0000123146065,0.000034084573,0.0000026817593,0.000112689806],"genre_scores_gemma":[0.99957377,0.000028829341,0.00022872176,0.000014911601,0.000004280557,0.00001209751,0.00007091892,0.0000020037844,0.00006449628],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994155,0.00028352856,0.000054795462,0.000096074706,0.00008325729,0.00006681679],"domain_scores_gemma":[0.9984145,0.0007501695,0.0003811,0.000103694576,0.00009938127,0.00025113995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006781879,0.00039279167,0.00028034137,0.00065404305,0.00023956464,0.00019037993,0.00026424264,0.00041296816,0.001390115],"category_scores_gemma":[0.0016781698,0.00016483707,0.0003157733,0.00038698924,0.0003320106,0.00016362751,0.0003279246,0.0003252178,0.00023725402],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001459624,0.00038080366,0.98348063,0.000020478918,0.00004876657,0.0019390023,0.00015336853,0.00008643138,0.0050110673,0.00001584793,0.00007011566,0.007333864],"study_design_scores_gemma":[0.00008658279,0.002883077,0.9855804,0.0000035895748,0.00004996759,0.008829251,0.00014072645,0.0005348821,0.0017136513,0.00002810827,0.00014225527,0.000007391844],"about_ca_topic_score_codex":0.0014969913,"about_ca_topic_score_gemma":0.0013829409,"teacher_disagreement_score":0.0014969913,"about_ca_system_score_codex":0.00025336622,"about_ca_system_score_gemma":0.00017168773,"threshold_uncertainty_score":0.0046504736},"labels":[],"label_agreement":null},{"id":"W1995164644","doi":"10.1016/s0028-3908(03)00136-9","title":"Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain","year":2003,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Nicotine; CYP2B6; Hippocampus; Hippocampal formation; Cerebellum; Genotype; Medicine; Putamen; Internal medicine; Pharmacology; Biology; Endocrinology; Genetics","score_opus":0.10946275119032528,"score_gpt":0.42519202655195837,"score_spread":0.3157292753616331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995164644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972071,0.0014072906,0.00025080921,0.00009760874,0.000010044383,0.000003532554,0.00035795572,0.000011814245,0.00065396744],"genre_scores_gemma":[0.99850684,0.00044132586,0.00016346133,0.000039773568,0.000013300198,0.000003365027,0.00025846044,0.000011327447,0.00056211255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998776,0.000036155736,0.000010650873,0.000034868226,0.000024675122,0.000016156218],"domain_scores_gemma":[0.9997923,0.00006164406,0.00006171411,0.00002280789,0.000030402936,0.000031100248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013220639,0.00018070405,0.00033555177,0.00053757423,0.0002342372,0.00040766518,0.00013275287,0.00035440832,0.002345519],"category_scores_gemma":[0.0005651806,0.00020671537,0.00021545419,0.00057558686,0.00022331327,0.00020506985,0.000117427946,0.00032479424,0.00025525625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007064162,0.00028618835,0.7562806,0.00016790949,0.0012053128,0.0012464849,0.00042775608,0.00030860727,0.20222041,0.00038684515,0.00067150214,0.0297342],"study_design_scores_gemma":[0.00002984128,0.00015920594,0.98980963,0.000004017584,0.00014087414,0.0013734158,0.00007019683,0.00020973619,0.007451031,0.00028334794,0.0004626183,0.000006090852],"about_ca_topic_score_codex":0.0031189986,"about_ca_topic_score_gemma":0.0041706227,"teacher_disagreement_score":0.0031189986,"about_ca_system_score_codex":0.00022287297,"about_ca_system_score_gemma":0.00011172647,"threshold_uncertainty_score":0.007846594},"labels":[],"label_agreement":null},{"id":"W1995307921","doi":"10.1016/j.jmb.2010.01.075","title":"Structural Basis of Human CYP51 Inhibition by Antifungal Azoles","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Structural Genomics Consortium; University of Toronto","funders":"Knut och Alice Wallenbergs Stiftelse; Ontario Ministry of Research and Innovation; Stiftelsen för Strategisk Forskning; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Ontario Genomics Institute; Canadian Institutes of Health Research; Genome Canada; Ontario Innovation Trust; Wellcome Trust; GlaxoSmithKline","keywords":"Azole; Sterol; Ergosterol; Lanosterol; Active site; Ketoconazole; Demethylase; Chemistry; Ligand (biochemistry); Econazole; Biochemistry; Enzyme; Stereochemistry; Binding site; Biology; Receptor; Antifungal; Cholesterol; Gene","score_opus":0.04465020308208338,"score_gpt":0.43135881597979575,"score_spread":0.38670861289771236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995307921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809006,0.0029361234,0.0065829144,0.000760461,0.000118977936,0.00006653175,0.00065860536,0.00018674888,0.007789151],"genre_scores_gemma":[0.99786854,0.00040993033,0.00061027915,0.000069177826,0.000012726363,0.000006885455,0.00028283033,0.00000598221,0.00073356903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998666,0.0000436053,0.000010812871,0.000021735274,0.000027693937,0.000029570992],"domain_scores_gemma":[0.9999306,0.000021555295,0.000019808755,0.000009264859,0.000007777264,0.000011024959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016364812,0.0003911285,0.00036301548,0.000172577,0.00031834294,0.00027413404,0.00045503431,0.00043773671,0.004208208],"category_scores_gemma":[0.00023442485,0.00017900288,0.00035574983,0.000099605895,0.00025858096,0.00012382149,0.00015994182,0.0004406258,0.0007566639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016136965,0.00014178836,0.0020912988,0.00013203795,0.00008793225,0.0020688907,0.00005885896,0.0076027904,0.9651191,0.0070696906,0.0010916084,0.012922302],"study_design_scores_gemma":[0.0002243592,0.00085769815,0.006037795,0.000029400993,0.00010901887,0.0025508874,0.000045877194,0.012637767,0.96763325,0.001000099,0.008842955,0.000030944255],"about_ca_topic_score_codex":0.0012284892,"about_ca_topic_score_gemma":0.0009644281,"teacher_disagreement_score":0.004208208,"about_ca_system_score_codex":0.00041347038,"about_ca_system_score_gemma":0.00032038684,"threshold_uncertainty_score":0.014077842},"labels":[],"label_agreement":null},{"id":"W1995565483","doi":"10.1097/01213011-200502000-00007","title":"Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2A6; Cotinine; Zygosity; Nicotine; Pharmacogenetics; Metabolite; Heritability; Genotype; Genetic variation; Biology; Drug metabolism; Pharmacokinetics; Pharmacology; Genetics; Metabolism; Internal medicine; Medicine; Endocrinology; Gene; CYP1A2; Cytochrome P450","score_opus":0.052108970261283416,"score_gpt":0.4206246086507744,"score_spread":0.368515638389491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995565483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95314294,0.0023708502,0.041776735,0.00031818758,0.00007582691,0.000061723964,0.00047215837,0.00007310613,0.0017085006],"genre_scores_gemma":[0.99209106,0.00028143075,0.006959333,0.00006358653,0.000030978073,0.000029561399,0.00019457605,0.000046319554,0.00030315766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9811396,0.014305947,0.0005522408,0.0019478664,0.0017539861,0.0003003618],"domain_scores_gemma":[0.9670156,0.026120054,0.0014183989,0.0041716504,0.0009049401,0.0003693536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014120663,0.0008837639,0.0014194159,0.0007662347,0.0006612946,0.0008017833,0.0008300949,0.0007016604,0.00096250506],"category_scores_gemma":[0.05606059,0.00037402342,0.0016082673,0.0013971739,0.00071747025,0.000678355,0.0009947148,0.0012792898,0.00022672709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013960496,0.000074212505,0.94876176,0.00007909303,0.003710482,0.0010414618,0.00038480695,0.004412067,0.008390114,0.0012139059,0.00032287423,0.03021318],"study_design_scores_gemma":[0.000044117234,0.00044982994,0.9664437,0.00002594426,0.0019824763,0.0022562637,0.00012863634,0.023597246,0.0022467892,0.0020158056,0.00076546567,0.000043706663],"about_ca_topic_score_codex":0.009951939,"about_ca_topic_score_gemma":0.009929005,"teacher_disagreement_score":0.014120663,"about_ca_system_score_codex":0.00032505134,"about_ca_system_score_gemma":0.0004635376,"threshold_uncertainty_score":0.07467812},"labels":[],"label_agreement":null},{"id":"W1996069708","doi":"10.1038/jhg.2010.73","title":"Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements","year":2010,"lang":"en","type":"article","venue":"Journal of Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"VKORC1; Pharmacogenomics; Allele frequency; Single-nucleotide polymorphism; Biology; Genetics; Allele; SNP; 1000 Genomes Project; CYP2C9; Warfarin; Evolutionary biology; Medicine; Genotype; Gene; Internal medicine","score_opus":0.10880308868572869,"score_gpt":0.40596740656787644,"score_spread":0.29716431788214775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996069708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979519,0.00014900639,0.00043020133,0.00004262018,0.000004564093,0.000007417516,0.00045071234,0.000013052182,0.00095057365],"genre_scores_gemma":[0.9987626,0.00006126677,0.00028942482,0.000014928132,0.0000073666138,0.00000708908,0.00038904054,0.000010398503,0.00045797072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885416,0.0003653858,0.0002117076,0.00034058708,0.00011756621,0.00011060545],"domain_scores_gemma":[0.99757975,0.0011614033,0.00062897656,0.00024367354,0.00018978743,0.00019643984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006514396,0.00046044786,0.000527162,0.0021214152,0.00036792192,0.00053518516,0.00048419007,0.00070523244,0.008639496],"category_scores_gemma":[0.0024919608,0.0002513454,0.0006930557,0.0017787961,0.00033536964,0.0002597403,0.0003393212,0.00056922744,0.00085317984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004341383,0.00021271988,0.9173905,0.00007762792,0.0009863261,0.0017637066,0.000570676,0.00045000936,0.05248167,0.0006550397,0.00040883152,0.02066153],"study_design_scores_gemma":[0.00006499372,0.00036507478,0.99199593,0.000013160288,0.00027849505,0.0035150158,0.00019220493,0.00061235647,0.0019566603,0.0003304657,0.00065505103,0.000020647725],"about_ca_topic_score_codex":0.0011731671,"about_ca_topic_score_gemma":0.0007325012,"teacher_disagreement_score":0.008639496,"about_ca_system_score_codex":0.00014895078,"about_ca_system_score_gemma":0.00013388148,"threshold_uncertainty_score":0.028901935},"labels":[],"label_agreement":null},{"id":"W1996237457","doi":"10.1089/omi.2014.0029","title":"Bernard Lerer: Recipient of the 2014 Inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics)","year":2014,"lang":"en","type":"article","venue":"OMICS A Journal of Integrative Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Personalized medicine; Pharmacogenetics; Precision medicine; Sociology; History; Medicine; Bioinformatics; Biology; Genetics","score_opus":0.11148479628998831,"score_gpt":0.48257665518281617,"score_spread":0.37109185889282786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996237457","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033858088,0.057947636,0.004928766,0.5255318,0.35468137,0.00013613964,0.00038771515,0.00037681457,0.05262397],"genre_scores_gemma":[0.060800124,0.06467025,0.004814,0.11302208,0.16324721,0.00021949211,0.0006898144,0.0010222718,0.59151477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955842,0.00091993046,0.00014989365,0.000791637,0.001955143,0.000599147],"domain_scores_gemma":[0.98898906,0.0008404241,0.00056917965,0.00017556138,0.002592467,0.0068333982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065037855,0.0009148372,0.0011754228,0.0012060875,0.0025394594,0.0078354,0.001082111,0.003806083,0.026354302],"category_scores_gemma":[0.013647565,0.00032044304,0.0004536726,0.0007371855,0.0025051653,0.003174357,0.0033968494,0.0064645465,0.023996273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083561274,0.000027624785,0.0005927719,0.0001180028,0.0000090579,0.0001807409,0.0002140193,0.00006507585,0.00032751553,0.008896392,0.95706517,0.03242008],"study_design_scores_gemma":[0.000014781581,0.000048560345,0.00051377167,0.00010299568,0.000005039824,0.0004775281,0.00020142895,0.00007956263,0.00041112138,0.002411015,0.99570423,0.000029954248],"about_ca_topic_score_codex":0.0012872583,"about_ca_topic_score_gemma":0.001490348,"teacher_disagreement_score":0.026354302,"about_ca_system_score_codex":0.002030437,"about_ca_system_score_gemma":0.004265252,"threshold_uncertainty_score":0.08816397},"labels":[],"label_agreement":null},{"id":"W1996603307","doi":"10.1517/17425255.2015.1028355","title":"Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Uridine diphosphate; Allosteric regulation; Biochemistry; Glycosylation; Enzyme; Ribosome; Uridine; Chemistry; Function (biology); Phosphorylation; Biology; Cell biology; RNA; Gene","score_opus":0.2114949152708257,"score_gpt":0.4791306733333917,"score_spread":0.267635758062566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996603307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008424997,0.99218494,0.001085279,0.0008885489,0.0005293949,0.000013430526,0.00009841799,0.000036631976,0.004320824],"genre_scores_gemma":[0.0059569506,0.98893905,0.0006968543,0.0005727545,0.00032064787,0.000016694616,0.00022382865,0.000008256234,0.003264946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.000027437067,0.000016764618,0.000043861244,0.000068535286,0.000021895943],"domain_scores_gemma":[0.9998549,0.000040194336,0.000031544685,0.0000047658427,0.000052793916,0.000015658043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031725675,0.00061093376,0.00073084247,0.0007535474,0.00013946243,0.00084388175,0.000469541,0.0008782056,0.0033714462],"category_scores_gemma":[0.00037684117,0.00016092086,0.0003732652,0.00078658655,0.00029793885,0.0007196259,0.0004622637,0.0009808232,0.0023639705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112907765,0.00004245937,0.000333472,0.01345088,0.00009981508,0.0005773392,0.00010038691,0.00072735397,0.025723495,0.010047867,0.037949357,0.91083467],"study_design_scores_gemma":[0.000010843885,0.00006636752,0.00086253753,0.0010565456,0.00006303223,0.0011601626,0.000038374947,0.00019407614,0.007460122,0.0021567864,0.9869127,0.000018444274],"about_ca_topic_score_codex":0.00053466816,"about_ca_topic_score_gemma":0.00068623095,"teacher_disagreement_score":0.0033714462,"about_ca_system_score_codex":0.0006136371,"about_ca_system_score_gemma":0.00067842903,"threshold_uncertainty_score":0.011278629},"labels":[],"label_agreement":null},{"id":"W1997075839","doi":"10.1016/j.jmb.2008.03.065","title":"Structural Analysis of CYP2R1 in Complex with Vitamin D3","year":2008,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Structural Genomics Consortium; University of Toronto","funders":"Wellcome Trust","keywords":"Stereochemistry; Active site; Chemistry; Vitamin; Rickets; Vitamin D and neurology; Enzyme; Biology; Biochemistry; Endocrinology","score_opus":0.105146290333826,"score_gpt":0.44204101325358064,"score_spread":0.33689472291975464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997075839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891722,0.0028991676,0.0022986934,0.0010331677,0.000102720376,0.000028632265,0.0012839576,0.00015206909,0.0030294177],"genre_scores_gemma":[0.9926392,0.00097123964,0.002024774,0.0001620897,0.000033221157,0.000011915411,0.0019047275,0.000034704954,0.0022181354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999796,0.000042489497,0.000009081007,0.000042117605,0.00006332123,0.000047046116],"domain_scores_gemma":[0.9998099,0.000061317274,0.00005126417,0.000009946375,0.000025196065,0.000042464322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025758514,0.00065714994,0.0007093773,0.00029062154,0.00071342196,0.0004755915,0.0011200091,0.00076447334,0.0051403134],"category_scores_gemma":[0.000414751,0.00028988795,0.00057772844,0.00033633626,0.00026339898,0.00025749428,0.00023946256,0.0011299563,0.0006523165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046144887,0.00057232473,0.008375461,0.000724276,0.00045154244,0.005262604,0.0007348585,0.021508984,0.93080664,0.0059241853,0.006824522,0.014200124],"study_design_scores_gemma":[0.0007541702,0.001251647,0.0283577,0.00009450617,0.0005820544,0.006751234,0.0008799103,0.11831122,0.79589325,0.0012043568,0.045686845,0.00023307845],"about_ca_topic_score_codex":0.007397634,"about_ca_topic_score_gemma":0.006641261,"teacher_disagreement_score":0.007397634,"about_ca_system_score_codex":0.0013232745,"about_ca_system_score_gemma":0.0005171401,"threshold_uncertainty_score":0.01719606},"labels":[],"label_agreement":null},{"id":"W1997849419","doi":"10.1191/096032700678827717","title":"In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms","year":2000,"lang":"en","type":"article","venue":"Human & Experimental Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Cytochrome P450; Cilostazol; CYP2D6; In vitro; Metabolism; Drug metabolism; Gene isoform; Pharmacology; Chemistry; Biochemistry; Medicine; Aspirin","score_opus":0.07079417858071473,"score_gpt":0.4295074177035331,"score_spread":0.3587132391228184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997849419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746757,0.009116663,0.009342698,0.00025699858,0.00010991405,0.00026121232,0.0032295801,0.00023539925,0.002771826],"genre_scores_gemma":[0.9773079,0.003606059,0.00678653,0.00012279725,0.00013060709,0.00024803763,0.00941803,0.00006189166,0.0023181767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925774,0.00031623605,0.00007912214,0.00010402394,0.00012691147,0.00011606523],"domain_scores_gemma":[0.99963844,0.00016229691,0.00005866485,0.00005320422,0.000058247744,0.000029202762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006479291,0.00058967114,0.00054111704,0.0003139488,0.00034895822,0.0004425875,0.00024065157,0.00032218423,0.0016509813],"category_scores_gemma":[0.00093030103,0.00023826235,0.00042742645,0.0007291221,0.00026191724,0.00022087428,0.00018742855,0.00044436194,0.0007858284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00348003,0.00042057814,0.0053206133,0.00035992076,0.00015895609,0.0003179669,0.0001460219,0.0011161284,0.97500235,0.00016348889,0.0007585808,0.012755269],"study_design_scores_gemma":[0.00018903599,0.0042491336,0.024304066,0.000022641427,0.00026622295,0.0009228654,0.00005025975,0.0034989775,0.96160626,0.00011567192,0.0047450257,0.000029843364],"about_ca_topic_score_codex":0.0037951658,"about_ca_topic_score_gemma":0.0038572815,"teacher_disagreement_score":0.0037951658,"about_ca_system_score_codex":0.000507077,"about_ca_system_score_gemma":0.00033520916,"threshold_uncertainty_score":0.0075461864},"labels":[],"label_agreement":null},{"id":"W1997979175","doi":"10.1080/004982500406408","title":"Identification of enzymes responsible for rifalazil metabolism in human liver microsomes","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Microsome; Hydroxylation; CYP3A4; Enzyme; Biochemistry; Metabolism; Chemistry; Cytochrome P450; Biotransformation; Microsoma; Metabolite; Drug metabolism","score_opus":0.07261191469656943,"score_gpt":0.42408075111964194,"score_spread":0.35146883642307253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997979175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9191021,0.029985411,0.039255623,0.0007766202,0.00013530179,0.00053731975,0.004874675,0.00074512,0.0045878184],"genre_scores_gemma":[0.92633426,0.012435113,0.026143963,0.00021408917,0.00015621704,0.00036323312,0.024604138,0.00009682619,0.009651987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998117,0.000047855236,0.000018425993,0.000048996633,0.000035616686,0.00003737234],"domain_scores_gemma":[0.99985456,0.00003585504,0.000026928146,0.000018399513,0.000043791682,0.000020497091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020521734,0.00066070305,0.00046827804,0.00043396873,0.00017301989,0.00025049967,0.00016430464,0.0002687948,0.0014081219],"category_scores_gemma":[0.00030737979,0.00026026907,0.0004115151,0.0003366967,0.000120407596,0.00022528956,0.00014380828,0.0003195251,0.0019456272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004493483,0.00003434504,0.0020210312,0.00010619046,0.00003529046,0.00013744648,0.00003111801,0.000060749724,0.990212,0.0000652426,0.00015840179,0.006688764],"study_design_scores_gemma":[0.0001110407,0.00069008576,0.049359206,0.00002117239,0.00021572843,0.0012544357,0.000054416254,0.0012916172,0.93725294,0.0001313757,0.009599212,0.000018755783],"about_ca_topic_score_codex":0.0018037587,"about_ca_topic_score_gemma":0.0017423101,"teacher_disagreement_score":0.0018037587,"about_ca_system_score_codex":0.00024643153,"about_ca_system_score_gemma":0.0003433417,"threshold_uncertainty_score":0.0047106743},"labels":[],"label_agreement":null},{"id":"W1998221260","doi":"10.1517/14622416.5.5.513","title":"Pharmacogenomic Data Submissions to the FDA: Clinical Pharmacology Case Studies","year":2004,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Medicine; Pharmacology; Library science; Biology; Computer science; Genetics","score_opus":0.5619068180930767,"score_gpt":0.6062603981433838,"score_spread":0.044353580050307095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998221260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7572537,0.0040626707,0.020226296,0.09705537,0.0017480821,0.0023205539,0.006495437,0.0006948058,0.110143036],"genre_scores_gemma":[0.96398014,0.0018621265,0.007847535,0.012313305,0.00068630755,0.00028848456,0.002008397,0.0002242646,0.0107895015],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.989281,0.0033958082,0.0019157007,0.00082583126,0.0038991875,0.00068255165],"domain_scores_gemma":[0.9223013,0.054164145,0.009406942,0.004196202,0.0075931423,0.002338229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0111103505,0.0006343098,0.00047504666,0.002612793,0.0031028648,0.0025076545,0.001407825,0.0048987763,0.007123074],"category_scores_gemma":[0.070279635,0.0004964718,0.0009086382,0.0030963158,0.0014420857,0.0011419969,0.0015652671,0.002748652,0.0012220803],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037622154,0.0042800484,0.2051496,0.0013544756,0.00040739888,0.46538958,0.008117501,0.0035349636,0.0056920014,0.01751049,0.12839451,0.15640727],"study_design_scores_gemma":[0.00089155644,0.003056767,0.09858487,0.0010922682,0.00077874697,0.47369972,0.0055702087,0.008030072,0.025345694,0.009526892,0.37308407,0.00033925084],"about_ca_topic_score_codex":0.004343879,"about_ca_topic_score_gemma":0.0043605664,"teacher_disagreement_score":0.0111103505,"about_ca_system_score_codex":0.0017747317,"about_ca_system_score_gemma":0.0033537226,"threshold_uncertainty_score":0.05875784},"labels":[],"label_agreement":null},{"id":"W1998664238","doi":"10.1016/j.clinbiochem.2006.01.023","title":"Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort","year":2006,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"CYP2C9; Warfarin; Genotype; Genotyping; Internal medicine; Allele frequency; Allele; Gastroenterology; Genotype frequency; Medicine; Restriction fragment length polymorphism; Cohort; Anticoagulant; Biology; Genetics; Gene; Atrial fibrillation","score_opus":0.08773732555880336,"score_gpt":0.4538236815173983,"score_spread":0.36608635595859496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998664238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994413,0.000056799345,0.000067678026,0.000034647543,0.00000470355,0.000004871809,0.000121635625,0.0000048256375,0.00026349197],"genre_scores_gemma":[0.99947864,0.000031113002,0.00006535096,0.000032732358,0.000013944777,0.000007694327,0.00014482578,0.000005949113,0.00021981221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892324,0.00030583955,0.000095439245,0.00038494894,0.00013799171,0.00015251816],"domain_scores_gemma":[0.9981736,0.00058299256,0.0003859108,0.00024007037,0.00017051713,0.00044696094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005750306,0.0004978784,0.0008664878,0.0016604189,0.0015043175,0.0010376178,0.0006802123,0.0010563305,0.0043071005],"category_scores_gemma":[0.003375743,0.0007968754,0.00055835565,0.0014737115,0.00072151946,0.0005301918,0.0004736012,0.0010172097,0.00066737586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005068639,0.00015928166,0.9942331,0.0000058027854,0.000089206726,0.0011620645,0.00030101815,0.00004313159,0.0021284372,0.000044139775,0.00022000792,0.0011070635],"study_design_scores_gemma":[0.000049444036,0.0002282896,0.99558276,0.0000026942787,0.000081911334,0.003091371,0.00033243705,0.00026955456,0.00014758362,0.000034539593,0.00016826073,0.00001120369],"about_ca_topic_score_codex":0.005519352,"about_ca_topic_score_gemma":0.0037262253,"teacher_disagreement_score":0.005519352,"about_ca_system_score_codex":0.00029107463,"about_ca_system_score_gemma":0.00034276515,"threshold_uncertainty_score":0.014408648},"labels":[],"label_agreement":null},{"id":"W2000070385","doi":"10.1002/jps.21607","title":"The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (±)-halofantrine","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Adipose tissue; Chemistry; Biodistribution; Internal medicine; Endocrinology; Chylomicron; Kidney; Microsome; Hyperlipidemia; Lipoprotein; Pharmacokinetics; Spleen; Enantiomer; Triglyceride; Pharmacology; Very low-density lipoprotein; Cholesterol; Biochemistry; In vitro; Biology; Medicine","score_opus":0.06516465357576305,"score_gpt":0.42667827674217795,"score_spread":0.3615136231664149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000070385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819946,0.0002616788,0.0003278624,0.00012873029,0.00005448086,0.00002172098,0.0002688007,0.00005042805,0.0006868487],"genre_scores_gemma":[0.99388075,0.0004477537,0.00049502205,0.000117823576,0.000069212154,0.0000650294,0.00043556848,0.000043065553,0.0044457866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999613,0.000101564496,0.00003451441,0.00006928343,0.000034062046,0.00014758433],"domain_scores_gemma":[0.99843115,0.00058707746,0.00023662912,0.0002806312,0.000091125345,0.00037332237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005173309,0.00095505285,0.0007188894,0.00061742804,0.00044155022,0.0004935636,0.00050138426,0.0008034307,0.004482125],"category_scores_gemma":[0.0009135237,0.0005885474,0.00054915325,0.00041776735,0.0012330313,0.0009877242,0.00034262092,0.0015288797,0.0005754124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19277298,0.0037347544,0.0019496641,0.000107734464,0.00012773022,0.00040271925,0.0002161443,0.00039635316,0.79148275,0.00062988646,0.0003736833,0.007805558],"study_design_scores_gemma":[0.0013491049,0.015686566,0.008530534,0.000012994881,0.00018529549,0.00028473427,0.00015740603,0.0014281772,0.97088146,0.00025472304,0.0011781295,0.00005077048],"about_ca_topic_score_codex":0.0023428446,"about_ca_topic_score_gemma":0.002454118,"teacher_disagreement_score":0.004482125,"about_ca_system_score_codex":0.00066384726,"about_ca_system_score_gemma":0.0007067955,"threshold_uncertainty_score":0.014994204},"labels":[],"label_agreement":null},{"id":"W2000172206","doi":"10.1196/annals.1423.020","title":"Genotypic Approaches to Therapy in Children","year":2007,"lang":"en","type":"article","venue":"Annals of the New York Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Child and Family Research Institute; University of British Columbia","funders":"Health Canada","keywords":"Pharmacogenomics; Medicine; Drug reaction; Dosing; Drug; Incidence (geometry); Pharmacotherapy; Pharmacogenetics; Precision medicine; Genomics; Intensive care medicine; Pediatrics; Bioinformatics; Genotype; Pharmacology; Internal medicine; Genetics; Biology; Genome; Pathology","score_opus":0.46781501088935706,"score_gpt":0.47042429044790346,"score_spread":0.0026092795585463957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000172206","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27814233,0.13631842,0.051325537,0.118601136,0.0031262985,0.00072085403,0.0029650505,0.0014015842,0.40739876],"genre_scores_gemma":[0.8078361,0.08299156,0.044083375,0.02782902,0.0010852882,0.00071049,0.0012406171,0.00018371565,0.034039833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994393,0.0002909928,0.000026339183,0.00006176933,0.00012133519,0.000060264778],"domain_scores_gemma":[0.9997125,0.00009343847,0.000056912257,0.00004220979,0.00004655279,0.00004825044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000676871,0.0003543784,0.00028814372,0.00040600623,0.000474431,0.0006384769,0.00042116857,0.0007250361,0.004732907],"category_scores_gemma":[0.0018251123,0.000085368156,0.000248478,0.0004348232,0.0006446725,0.00029668826,0.0009005526,0.00084373663,0.00095032336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004480421,0.00047785454,0.060511127,0.00048247122,0.00011799282,0.00623255,0.0007508278,0.0017891959,0.008216667,0.066554956,0.056659102,0.79775923],"study_design_scores_gemma":[0.00029135428,0.0008727127,0.06467997,0.00085500453,0.0002474637,0.034952432,0.0008976261,0.0014956641,0.0081978105,0.039447952,0.84800637,0.000055739758],"about_ca_topic_score_codex":0.0034614394,"about_ca_topic_score_gemma":0.0038009936,"teacher_disagreement_score":0.004732907,"about_ca_system_score_codex":0.0010731468,"about_ca_system_score_gemma":0.0016443392,"threshold_uncertainty_score":0.01583314},"labels":[],"label_agreement":null},{"id":"W2001064598","doi":"10.1016/j.phymed.2006.12.004","title":"In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato","year":2007,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; University of Ottawa","funders":"","keywords":"Aglycone; Hypericin; Pharmacology; Chemistry; CYP3A4; Biochemistry; Cytochrome P450; In vitro; In vivo; Drug metabolism; Metabolism; Biology; Glycoside","score_opus":0.09117782702004557,"score_gpt":0.45052397743014594,"score_spread":0.3593461504101004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001064598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945088,0.0026293804,0.0016323626,0.00004496221,0.000025750182,0.000038061524,0.00025260306,0.000014659772,0.0008534151],"genre_scores_gemma":[0.99562436,0.0015009874,0.0011324268,0.000020769208,0.000012075827,0.000025466972,0.00029765998,0.000007758939,0.0013785729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998894,0.00004777076,0.000008935079,0.00002089288,0.000017721548,0.000015241539],"domain_scores_gemma":[0.9998596,0.00006434691,0.000026451677,0.000013297162,0.00002412158,0.000012185764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019506703,0.00027903795,0.00024261953,0.0001493191,0.00017282697,0.0001309616,0.000121269135,0.00018813401,0.0015023821],"category_scores_gemma":[0.0002921932,0.00016279181,0.00034432346,0.00019315846,0.00012473506,0.00018294796,0.00009788718,0.00039945598,0.0002031994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023108197,0.0002639153,0.00062768476,0.00013976153,0.000052984804,0.00014991622,0.00007211893,0.00041013962,0.99058354,0.000088504996,0.000058635294,0.0052418527],"study_design_scores_gemma":[0.00006393518,0.0054222546,0.0041521545,0.000008939714,0.00010200398,0.00024616614,0.000047973088,0.00075178524,0.9883541,0.00003257763,0.00081236876,0.0000056680847],"about_ca_topic_score_codex":0.00070196035,"about_ca_topic_score_gemma":0.0009876136,"teacher_disagreement_score":0.0015023821,"about_ca_system_score_codex":0.000111759815,"about_ca_system_score_gemma":0.00015188697,"threshold_uncertainty_score":0.005025983},"labels":[],"label_agreement":null},{"id":"W2001314811","doi":"10.1038/nchembio0709-436","title":"Open access chemical and clinical probes to support drug discovery","year":2009,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Drug discovery; Pharmaceutical industry; Productivity; Data science; Business; Drug industry; Computational biology; Computer science; Biology; Biotechnology; Bioinformatics; Economics","score_opus":0.134351923613858,"score_gpt":0.5619974727123195,"score_spread":0.4276455490984615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001314811","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06539757,0.11720635,0.17473441,0.107407086,0.01776757,0.000954799,0.006098953,0.003537249,0.50689614],"genre_scores_gemma":[0.62662333,0.064506814,0.08209369,0.031222992,0.011772157,0.00090508885,0.0031865966,0.00048797348,0.1792013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990113,0.00034181934,0.00004015889,0.000114592905,0.00039166765,0.00010049604],"domain_scores_gemma":[0.9979315,0.00076002604,0.0002714889,0.00029885606,0.00033297352,0.000405142],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.0019252653,0.00044863363,0.0004261963,0.0008980108,0.00034340736,0.0016435863,0.00070094224,0.0018585915,0.033190135],"category_scores_gemma":[0.0035974158,0.00024722275,0.0004069316,0.00045633334,0.0013941169,0.0017343675,0.001756539,0.0023997256,0.006804702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011062943,0.0004890605,0.0017229316,0.00092257065,0.000089805115,0.0011516538,0.00015282731,0.00075249426,0.1789853,0.21878877,0.08551397,0.5103243],"study_design_scores_gemma":[0.0003668565,0.0013818281,0.0018919043,0.00015542305,0.000077063574,0.0025525584,0.000100568046,0.0013430458,0.093688145,0.086408235,0.8119775,0.000056934485],"about_ca_topic_score_codex":0.00020408402,"about_ca_topic_score_gemma":0.0002544231,"teacher_disagreement_score":0.99929905,"about_ca_system_score_codex":0.00056485884,"about_ca_system_score_gemma":0.0010955031,"threshold_uncertainty_score":0.11103207},"labels":[{"model":"gemma","categories":["open_science"],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["open_science","scholarly_communication"],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2001637088","doi":"10.1159/000064040","title":"Presence on human chromosome 10 of omeprazole-sensitivity gene whose product mediates CYP1A1 induction","year":2002,"lang":"en","type":"article","venue":"Cytogenetic and Genome Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Biology; Molecular biology; Cell culture; Gene expression; Fluorescence in situ hybridization; Signal transduction; Locus (genetics); Gene; In situ hybridization; Gene product; Chromosome; Cell biology; Genetics","score_opus":0.3781055115440178,"score_gpt":0.49505363337501984,"score_spread":0.11694812183100206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001637088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833585,0.0013822032,0.004737575,0.0001762344,0.000029697527,0.000040163588,0.0011853996,0.00013357904,0.0039792815],"genre_scores_gemma":[0.99105763,0.0006594601,0.002197431,0.000059605925,0.000011052876,0.000031750616,0.0025150522,0.000016551336,0.003451459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989593,0.000018487604,0.0000061262194,0.000036556863,0.00002299271,0.000019971021],"domain_scores_gemma":[0.99984014,0.00006584218,0.000037809154,0.000018359211,0.000012944351,0.0000248183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057410587,0.0003535053,0.00018093958,0.0003360821,0.00013986781,0.0001731463,0.00012999636,0.00024183937,0.004876718],"category_scores_gemma":[0.0002234545,0.00016892249,0.00021165679,0.0001966951,0.00022100532,0.00008531509,0.0001706585,0.0003132444,0.0016111188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003007708,0.000028904036,0.0031837544,0.000056360463,0.000015316702,0.00090392085,0.000046555266,0.00008893701,0.98958266,0.000284839,0.000111989255,0.005396021],"study_design_scores_gemma":[0.00009279339,0.0006837316,0.16573209,0.000043460455,0.000108641136,0.009859721,0.00013441977,0.0011414174,0.8014732,0.0003831215,0.020324184,0.000023280549],"about_ca_topic_score_codex":0.0011317929,"about_ca_topic_score_gemma":0.0011914065,"teacher_disagreement_score":0.004876718,"about_ca_system_score_codex":0.00026992554,"about_ca_system_score_gemma":0.00020567887,"threshold_uncertainty_score":0.016314209},"labels":[],"label_agreement":null},{"id":"W2001989326","doi":"10.1080/03602530500251220","title":"“Phase I and Phase II” Drug Metabolism: Terminology that we Should Phase Out?","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Phase (matter); Drug metabolism; Drug; Terminology; Chemistry; Pharmacology; Medicine; Philosophy","score_opus":0.21912137132643994,"score_gpt":0.4792411872007885,"score_spread":0.26011981587434857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001989326","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027395482,0.749425,0.037681825,0.117180295,0.06638006,0.00024657228,0.00034844744,0.00027039,0.025727827],"genre_scores_gemma":[0.06745581,0.5434372,0.04584435,0.2344919,0.07491831,0.0012322172,0.0010169578,0.0008255663,0.03077765],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99283314,0.003634929,0.0007493825,0.0010668333,0.0011963054,0.0005193472],"domain_scores_gemma":[0.9945952,0.00265689,0.00082932616,0.00049299997,0.0010150265,0.00041047847],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008896731,0.0019994618,0.0026159212,0.002558548,0.001695102,0.0069415197,0.0037466218,0.00448225,0.002999307],"category_scores_gemma":[0.008817233,0.0006179918,0.0018769089,0.0040982356,0.01960337,0.011507298,0.0034472684,0.013191769,0.0031316234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004032995,0.000175657,0.0013166909,0.00387854,0.00013879263,0.00038498195,0.004456086,0.0005069402,0.0021661527,0.49227366,0.31460175,0.1796975],"study_design_scores_gemma":[0.000029942175,0.00018150572,0.0006132674,0.0013165125,0.000040867755,0.00080263906,0.000669273,0.00024145604,0.00051020796,0.117832944,0.8777212,0.0000401699],"about_ca_topic_score_codex":0.0029504546,"about_ca_topic_score_gemma":0.0022367288,"teacher_disagreement_score":0.9911033,"about_ca_system_score_codex":0.0038613637,"about_ca_system_score_gemma":0.00476892,"threshold_uncertainty_score":0.047050953},"labels":[],"label_agreement":null},{"id":"W2002040298","doi":"10.1038/nrg1559","title":"Pharmacogenetics and geographical ancestry: implications for drug development and global health","year":2005,"lang":"en","type":"review","venue":"Nature Reviews Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University of Toronto","funders":"Hospital for Sick Children; Drugs for Neglected Diseases initiative; Ontario Genomics; Genome Canada; McGill University","keywords":"Pharmacogenetics; Nexus (standard); Personalized medicine; Genomics; Precision medicine; Biology; Developing country; Genotyping; Data science; Biotechnology; Genome; Bioinformatics; Genetics; Computer science; Genotype; Ecology","score_opus":0.2425314229493519,"score_gpt":0.5693222252738795,"score_spread":0.3267908023245276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002040298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001551966,0.99582016,0.0005545812,0.0021267135,0.0003658639,0.0000022694094,0.000023463537,0.000010064601,0.00094160764],"genre_scores_gemma":[0.0010018194,0.9969754,0.00045548752,0.0006240325,0.0004950057,0.0000040167874,0.000024689483,0.0000018567616,0.0004177029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996475,0.000119325,0.00003465095,0.00007234694,0.00010223719,0.000023862496],"domain_scores_gemma":[0.9986745,0.00092774857,0.00010694734,0.00003153315,0.00018662693,0.00007265115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017808423,0.0010707985,0.0031690353,0.0018304503,0.00034807326,0.00184685,0.0012762224,0.0022161452,0.0044863056],"category_scores_gemma":[0.002002464,0.00036129923,0.00055145274,0.003615905,0.0015840386,0.0022981076,0.0010336259,0.0023537322,0.0013367172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105101986,0.00005127995,0.0013227002,0.0049610366,0.00023544568,0.00047807087,0.00012330056,0.00054195366,0.0010500245,0.011286804,0.038546544,0.9412976],"study_design_scores_gemma":[0.000050034498,0.00007303418,0.005431888,0.004181233,0.00031185555,0.0029057004,0.00040020252,0.00030309786,0.00035606732,0.026582705,0.9593364,0.000067895286],"about_ca_topic_score_codex":0.0036874341,"about_ca_topic_score_gemma":0.0077266307,"teacher_disagreement_score":0.0044863056,"about_ca_system_score_codex":0.0009961146,"about_ca_system_score_gemma":0.0015593612,"threshold_uncertainty_score":0.0150081515},"labels":[],"label_agreement":null},{"id":"W2002225487","doi":"10.1023/b:cemn.0000012725.31108.4a","title":"Inhibitory Effects of the Monoamine Oxidase Inhibitor Tranylcypromine on the Cytochrome P450 Enzymes CYP2C19, CYP2C9, and CYP2D6","year":2004,"lang":"en","type":"article","venue":"Cellular and Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Tranylcypromine; Monoamine oxidase inhibitor; Pharmacology; CYP2C9; CYP2C19; Monoamine oxidase; CYP3A4; CYP2D6; Cytochrome P450; Non-competitive inhibition; Dextromethorphan; Enzyme; CYP1A2; Chemistry; Selegiline; Biochemistry; Biology; Internal medicine; Medicine","score_opus":0.02254054429114349,"score_gpt":0.3001204972931966,"score_spread":0.2775799530020531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002225487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609966,0.006620084,0.00056133926,0.00028713545,0.00015377124,0.00003860119,0.0005938593,0.000105753075,0.0055397316],"genre_scores_gemma":[0.99176425,0.0039557926,0.00035941537,0.000073299576,0.0000729431,0.000016093873,0.00078785495,0.00001622386,0.002954107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998473,0.000049046525,0.000014684421,0.00001877851,0.00002097573,0.000049231632],"domain_scores_gemma":[0.99975437,0.00008004771,0.00005719666,0.000026394266,0.000025314848,0.000056710272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015208551,0.00044490746,0.00045788125,0.00021724905,0.00025117362,0.00026526724,0.0002227194,0.0003060131,0.004651007],"category_scores_gemma":[0.0005932726,0.00022117986,0.00035796384,0.00022542472,0.00021432951,0.0002522168,0.00015486818,0.00056794623,0.0005740216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017472748,0.0007967385,0.0024449467,0.00033437664,0.00027608222,0.00042215007,0.00014509022,0.00072811404,0.92315173,0.0006261287,0.002841902,0.050759785],"study_design_scores_gemma":[0.000723064,0.013510991,0.039158605,0.000029999179,0.00032334696,0.00149873,0.000097699,0.0025727067,0.93521225,0.0001424355,0.006699559,0.000030632662],"about_ca_topic_score_codex":0.0027388625,"about_ca_topic_score_gemma":0.006608321,"teacher_disagreement_score":0.004651007,"about_ca_system_score_codex":0.00030677931,"about_ca_system_score_gemma":0.00029286786,"threshold_uncertainty_score":0.0155591965},"labels":[],"label_agreement":null},{"id":"W2002367289","doi":"10.1016/s0960-0760(02)00044-4","title":"Structural specificity of steroids in stimulating DNA synthesis and protooncogene expression in primary rat hepatocyte cultures","year":2002,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"Flinders University","keywords":"DNA synthesis; Stimulation; Anabolism; Mechanism of action; Steroid; Biology; Pregnenolone; Hepatocyte; Endocrinology; Internal medicine; DNA; Steroid hormone; Biochemistry; Chemistry; Hormone; In vitro","score_opus":0.046627104563193,"score_gpt":0.3605423213105825,"score_spread":0.3139152167473895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002367289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697853,0.0034585984,0.004104871,0.00011202589,0.000056477056,0.00005277073,0.00055761915,0.00011313389,0.00456592],"genre_scores_gemma":[0.9903998,0.0014004519,0.0026891138,0.00006110421,0.000030804753,0.000037705646,0.0011308463,0.000055477703,0.004194594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996191,0.00011450057,0.00004475205,0.000051435167,0.00008418438,0.00008596158],"domain_scores_gemma":[0.99925405,0.00045634792,0.00004078196,0.00007188842,0.0000767601,0.00010024427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045535888,0.0002412137,0.0004069205,0.000525178,0.00024848038,0.00045523993,0.00024448909,0.00021457161,0.0019982127],"category_scores_gemma":[0.00034298154,0.00034821616,0.0003809106,0.00035542133,0.00036196355,0.00019079224,0.00028104815,0.0005074822,0.00077680877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023717151,0.000020143298,0.00012915529,0.000023585302,0.0000026979465,0.00002553455,0.000020616599,0.00004669084,0.99882716,0.000082872815,0.000016097789,0.00056823966],"study_design_scores_gemma":[0.000008745074,0.00017998375,0.0011807975,0.000002250741,0.000006153328,0.000047358593,0.000018482364,0.00010932111,0.99784946,0.000016993446,0.00057841395,0.0000019533863],"about_ca_topic_score_codex":0.0019185672,"about_ca_topic_score_gemma":0.0052751326,"teacher_disagreement_score":0.0019982127,"about_ca_system_score_codex":0.00044877565,"about_ca_system_score_gemma":0.00039354368,"threshold_uncertainty_score":0.0066847205},"labels":[],"label_agreement":null},{"id":"W2002417408","doi":"10.2174/138920009790820138","title":"Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes","year":2009,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Cytochrome P450; Aryl hydrocarbon receptor; Constitutive androstane receptor; Biology; Enzyme; Function (biology); Gene; Biochemistry; Receptor; Isozyme; Nuclear receptor; Cell biology; Transcription factor","score_opus":0.1498512899212153,"score_gpt":0.4583765530236701,"score_spread":0.30852526310245476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002417408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023511904,0.9945273,0.00083458476,0.00008862716,0.000059513484,0.0000049952027,0.000067075285,0.000019323359,0.0020474023],"genre_scores_gemma":[0.009803006,0.98666465,0.0011109909,0.0001000279,0.000101014724,0.000011641941,0.00021157619,0.0000046928276,0.0019924708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998735,0.000018936578,0.000017130631,0.000031016963,0.00004904833,0.000010356053],"domain_scores_gemma":[0.99988556,0.00004046179,0.000031809202,0.000005517267,0.00002772808,0.000008880666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021695593,0.00043814437,0.0006970203,0.0010901236,0.00008480659,0.00044518933,0.00033177578,0.0003039939,0.0016899598],"category_scores_gemma":[0.00023592831,0.00012424325,0.0002784506,0.001455862,0.00014360466,0.00046673903,0.00016997707,0.00039307162,0.0012672655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117744894,0.00006783739,0.0011224138,0.009211093,0.000103518025,0.0005570047,0.000052753923,0.0004912164,0.046157964,0.0017534647,0.005949066,0.93441594],"study_design_scores_gemma":[0.000022548946,0.00034437986,0.011716393,0.0010776897,0.0003394188,0.007195597,0.00006635573,0.00022832604,0.024627352,0.0013262,0.9530264,0.000029242878],"about_ca_topic_score_codex":0.00044483386,"about_ca_topic_score_gemma":0.0005416535,"teacher_disagreement_score":0.0016899598,"about_ca_system_score_codex":0.00024742482,"about_ca_system_score_gemma":0.00029977207,"threshold_uncertainty_score":0.0056535006},"labels":[],"label_agreement":null},{"id":"W2002702566","doi":"10.1016/j.amjopharm.2011.09.006","title":"Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based Software","year":2011,"lang":"en","type":"article","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Drug; CYP2D6; Prospective cohort study; Internal medicine; Drug interaction; Pharmacology; Cytochrome P450","score_opus":0.0715310687299459,"score_gpt":0.3993760881135736,"score_spread":0.3278450193836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002702566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5950253,0.0031249262,0.368666,0.0012624301,0.00016797043,0.0005806229,0.0062515484,0.019504517,0.0054166685],"genre_scores_gemma":[0.8699762,0.00066618255,0.1254788,0.00032238624,0.00011127736,0.00015692518,0.00213721,0.00021785864,0.0009331559],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880743,0.00036052894,0.00018118984,0.00028147182,0.00033376194,0.000035661218],"domain_scores_gemma":[0.9916074,0.005926906,0.0010839318,0.0003880874,0.0008149302,0.00017868499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023030776,0.0007444584,0.0010102807,0.0025071285,0.00017859337,0.00096036616,0.00061168475,0.00054958183,0.0012123147],"category_scores_gemma":[0.010186933,0.00028692273,0.0008037909,0.0009158663,0.00012523287,0.00085198274,0.00042162475,0.00063741417,0.0003854274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023706383,0.0011616455,0.39004594,0.0003643148,0.0016039263,0.00035306945,0.00012457123,0.023450566,0.00903072,0.00072632724,0.0051362608,0.565632],"study_design_scores_gemma":[0.00046950893,0.0014585872,0.14639474,0.00008638288,0.0012451484,0.0015436107,0.00007262245,0.814962,0.023676204,0.004536982,0.005434305,0.00011989439],"about_ca_topic_score_codex":0.0022512518,"about_ca_topic_score_gemma":0.0026165075,"teacher_disagreement_score":0.0025071285,"about_ca_system_score_codex":0.00028264918,"about_ca_system_score_gemma":0.00043953088,"threshold_uncertainty_score":0.012179971},"labels":[],"label_agreement":null},{"id":"W2003017820","doi":"10.1067/mcp.2000.106464","title":"Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Metoprolol; Pharmacology; Diphenhydramine; Antihistamine; CYP2D6; Drug interaction; Debrisoquine; Medicine; Pharmacokinetics; Chemistry; In vivo; Histamine; Endocrinology; Internal medicine; Cytochrome P450; Biology; Metabolism","score_opus":0.15374140742723044,"score_gpt":0.46811064952311976,"score_spread":0.31436924209588935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003017820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996006,0.00019459148,0.00007380058,0.000008821732,0.000002886091,0.000006398293,0.00001832363,0.0000021282465,0.00009242729],"genre_scores_gemma":[0.9995757,0.000056665485,0.00010148848,0.000015723408,0.000007618898,0.000006271104,0.00003238808,9.294144e-7,0.00020317498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996904,0.00015522049,0.000016134534,0.00005299622,0.000043130596,0.00004215732],"domain_scores_gemma":[0.999691,0.00015254124,0.00006244591,0.000019892443,0.0000119686065,0.000062264306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035902383,0.00027321975,0.00044912015,0.00016125185,0.00021198943,0.00023214922,0.00009530052,0.0002778526,0.0012560771],"category_scores_gemma":[0.0006620034,0.0002278301,0.00025711305,0.0001325477,0.00025117505,0.00013358639,0.0001527475,0.000311638,0.00012287419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08337685,0.0028385944,0.7688841,0.00012976557,0.000490931,0.0016954629,0.00040532375,0.0003188983,0.10399809,0.000119726596,0.00018034455,0.037561852],"study_design_scores_gemma":[0.0009461266,0.028543126,0.9588052,0.0000029538762,0.00031755847,0.0010887882,0.00009367854,0.0006577897,0.009027865,0.000052343534,0.00045518222,0.000009397934],"about_ca_topic_score_codex":0.0006026734,"about_ca_topic_score_gemma":0.0009471844,"teacher_disagreement_score":0.0012560771,"about_ca_system_score_codex":0.00018997047,"about_ca_system_score_gemma":0.00012013121,"threshold_uncertainty_score":0.0042020082},"labels":[],"label_agreement":null},{"id":"W2003227063","doi":"10.1097/fpc.0b013e3283527c1c","title":"CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people","year":2012,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Nicotine; CYP2B6; Population; Medicine; Nicotine replacement therapy; Genotype; Demography; Physiology; Metabolism; Pharmacology; Internal medicine; Genetics; Biology; Environmental health; Gene; Cytochrome P450","score_opus":0.042490101905294606,"score_gpt":0.34686930900466045,"score_spread":0.30437920709936583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003227063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945706,0.00017729781,0.000038177543,0.000015160495,0.0000027626459,0.000002045455,0.00007179422,0.0000013058329,0.00023446651],"genre_scores_gemma":[0.9996203,0.000075522024,0.00006500051,0.0000061664177,0.00000384683,0.0000021759377,0.000049811388,6.2858595e-7,0.00017661187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999871,0.000031347558,0.000016485703,0.000036143912,0.000031563668,0.000013478227],"domain_scores_gemma":[0.999814,0.000032841002,0.00007135281,0.000012606755,0.000027472259,0.00004181978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022276228,0.0001481348,0.00014000766,0.00030848949,0.00034074674,0.00024958278,0.00009999704,0.0002082942,0.0015753807],"category_scores_gemma":[0.0004835148,0.00011063301,0.00017104346,0.00045730107,0.00013413308,0.00010683162,0.0001243881,0.00018781246,0.00012237257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015864782,0.00003445509,0.9967451,0.000010505424,0.00006351068,0.00011255491,0.00016764732,0.00004425902,0.0008647186,0.000021264466,0.000057619978,0.0017196416],"study_design_scores_gemma":[0.0000038561348,0.00004387326,0.99930215,0.0000032998591,0.000022323484,0.00022474604,0.00011977519,0.0001001015,0.000056431007,0.000020118006,0.00010209968,0.0000012931422],"about_ca_topic_score_codex":0.011493491,"about_ca_topic_score_gemma":0.00858394,"teacher_disagreement_score":0.011493491,"about_ca_system_score_codex":0.000102807106,"about_ca_system_score_gemma":0.00009027565,"threshold_uncertainty_score":0.022853196},"labels":[],"label_agreement":null},{"id":"W2003392791","doi":"10.2310/6650.2007.06042","title":"Asymmetry in Scientific Method and Limits to Cross-Disciplinary Dialogue: Toward a Shared Language and Science Policy in Pharmacogenomics and Human Disease Genetics","year":2007,"lang":"en","type":"article","venue":"Journal of Investigative Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacogenomics; Observational study; Medical genetics; Engineering ethics; Genetics; Biology; Medicine; Engineering; Pathology","score_opus":0.1830591389252305,"score_gpt":0.5265354442479359,"score_spread":0.34347630532270534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003392791","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010349107,0.005689667,0.06873506,0.9006257,0.0015641603,0.00014955935,0.000030908614,0.00008603226,0.012769836],"genre_scores_gemma":[0.61809707,0.0044496804,0.103558324,0.26336387,0.0049919677,0.0019124227,0.00008507558,0.00027136135,0.003270294],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.35164112,0.5308365,0.025182402,0.025182022,0.05756382,0.009594119],"domain_scores_gemma":[0.2797924,0.6149386,0.023303047,0.042293318,0.028583974,0.011088661],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6209054,0.0013344346,0.0047845994,0.0069947485,0.020689536,0.04797744,0.012676517,0.04602789,0.0022440315],"category_scores_gemma":[0.4951291,0.0023138677,0.0029921231,0.004392545,0.20091332,0.05840036,0.044961825,0.053329065,0.00079130376],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003411794,0.000045577624,0.0005600811,0.00012814137,0.000030089743,0.00010284181,0.014792347,0.0005177614,0.00015521885,0.97290355,0.0029620195,0.007768159],"study_design_scores_gemma":[0.00004997412,0.000028706923,0.00023495525,0.00043093064,0.000018035349,0.00005293624,0.003033166,0.00079037383,0.00018086808,0.9801879,0.014943057,0.000049007587],"about_ca_topic_score_codex":0.0058139535,"about_ca_topic_score_gemma":0.003367547,"teacher_disagreement_score":0.3790946,"about_ca_system_score_codex":0.030520039,"about_ca_system_score_gemma":0.076554574,"threshold_uncertainty_score":0.4674912},"labels":[],"label_agreement":null},{"id":"W2003705423","doi":"10.1016/j.lfs.2004.03.032","title":"The comparative interaction of human and bovine serum albumins with CYP2C9 in human liver microsomes","year":2004,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Microsome; Bovine serum albumin; Chemistry; Biochemistry; Human liver; Biology; Enzyme","score_opus":0.1651852111968331,"score_gpt":0.4732791834806386,"score_spread":0.3080939722838055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003705423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891451,0.0037991786,0.0045878245,0.00020591872,0.000054520846,0.000027062148,0.00028816317,0.00008526164,0.001807075],"genre_scores_gemma":[0.9958982,0.00059120444,0.00088341173,0.000048891212,0.000020934765,0.000011908448,0.0005340731,0.000025516769,0.0019858782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998928,0.000556209,0.00005498037,0.000112093214,0.00016978987,0.00017883498],"domain_scores_gemma":[0.9991394,0.00043430377,0.0001189066,0.00007864473,0.00015844774,0.00007033893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093227305,0.00048220076,0.0006124883,0.00043745947,0.00037136915,0.00064066437,0.0003596996,0.00059458334,0.0018220709],"category_scores_gemma":[0.002067548,0.00031060903,0.0008437081,0.0005998585,0.0004191208,0.0004527095,0.00021659031,0.0004617845,0.0007117674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012876996,0.00019291615,0.006547765,0.00033603972,0.00043274782,0.000512509,0.00037227807,0.0019452875,0.964369,0.00092050555,0.0004611183,0.01103296],"study_design_scores_gemma":[0.00009361452,0.002255568,0.024874061,0.000016628834,0.00023456354,0.0009944963,0.00016262267,0.0060439575,0.9618514,0.00014478271,0.0032965941,0.00003181076],"about_ca_topic_score_codex":0.006072927,"about_ca_topic_score_gemma":0.004135576,"teacher_disagreement_score":0.006072927,"about_ca_system_score_codex":0.0006921095,"about_ca_system_score_gemma":0.00045139343,"threshold_uncertainty_score":0.012075186},"labels":[],"label_agreement":null},{"id":"W2003959180","doi":"10.4155/tde.10.59","title":"An Innovative Software Solution for Personalized Pharmacotherapy","year":2010,"lang":"en","type":"article","venue":"Therapeutic Delivery","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Drug; Polypharmacy; Medicine; Drug metabolism; Pharmacology; Pharmacotherapy; Prodrug; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.12050780089051928,"score_gpt":0.45457124555016315,"score_spread":0.3340634446596439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003959180","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025108892,0.0014765761,0.86720705,0.0031991343,0.0009391836,0.0004318409,0.0017359776,0.09845907,0.024040338],"genre_scores_gemma":[0.06937147,0.0034325605,0.841637,0.005696989,0.0009241532,0.0013110124,0.006162767,0.00751761,0.063946515],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99879104,0.000287284,0.000110745794,0.00019724204,0.0005338874,0.00007984774],"domain_scores_gemma":[0.99856657,0.0006352788,0.000097536395,0.00029595094,0.00026414613,0.00014062166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016291405,0.001405814,0.0007963238,0.0009282226,0.00038814323,0.0024017834,0.0021019883,0.0020177057,0.03731599],"category_scores_gemma":[0.005458581,0.000636604,0.0013663053,0.0006090544,0.00051168835,0.0020907063,0.0028849067,0.0023931523,0.018019482],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061224704,0.00019657615,0.0011021178,0.000652881,0.00017712188,0.00070286205,0.00031424838,0.01870871,0.008578776,0.03219978,0.2095594,0.7271953],"study_design_scores_gemma":[0.0003188349,0.00024552463,0.00073671615,0.00031186445,0.00014662875,0.0013042345,0.00007621885,0.13815156,0.00847903,0.06573145,0.7843654,0.00013252907],"about_ca_topic_score_codex":0.0009152731,"about_ca_topic_score_gemma":0.0007394626,"teacher_disagreement_score":0.03731599,"about_ca_system_score_codex":0.00048462223,"about_ca_system_score_gemma":0.0010122721,"threshold_uncertainty_score":0.12483442},"labels":[],"label_agreement":null},{"id":"W2004256112","doi":"10.1097/01213011-200503000-00008","title":"Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method","year":2005,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Alcohol Abuse and Alcoholism; University of Toronto","keywords":"CYP2A6; Haplotype; Allele; Genetics; Single-nucleotide polymorphism; Biology; Allele frequency; SNP; Genotype; Gene","score_opus":0.1199717370528832,"score_gpt":0.45728655851368316,"score_spread":0.33731482146079994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004256112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740484,0.0006681782,0.0207938,0.00012718204,0.000021404734,0.00018776166,0.0021223687,0.000105897634,0.0019251241],"genre_scores_gemma":[0.9728617,0.00036047597,0.022835642,0.00009614787,0.000014904083,0.00014138619,0.0015603163,0.000026973064,0.0021024325],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991091,0.00017483546,0.000046919016,0.0003038632,0.00028545552,0.00007982168],"domain_scores_gemma":[0.9996099,0.00007117625,0.000108248416,0.00006388369,0.0001006498,0.000046186207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005824887,0.00034302144,0.00033404093,0.0007881461,0.00045155417,0.00027988205,0.00032278927,0.000277935,0.0010951177],"category_scores_gemma":[0.0008257688,0.00012743092,0.0002328091,0.0007995428,0.00030648464,0.00007670904,0.0002791207,0.0003415916,0.00024282504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010387473,0.00022126595,0.41980767,0.00015697739,0.00064571475,0.00065240543,0.0015044047,0.0010349349,0.49014854,0.00076272024,0.0013995472,0.082627036],"study_design_scores_gemma":[0.00007690845,0.00032275927,0.920229,0.000016417333,0.0003070772,0.0023078183,0.00022013902,0.0026483263,0.0656245,0.00019383099,0.0079937745,0.000059334594],"about_ca_topic_score_codex":0.028862024,"about_ca_topic_score_gemma":0.060068518,"teacher_disagreement_score":0.028862024,"about_ca_system_score_codex":0.00039392823,"about_ca_system_score_gemma":0.00046319907,"threshold_uncertainty_score":0.057388067},"labels":[],"label_agreement":null},{"id":"W2005113813","doi":"10.1016/j.bmc.2012.05.042","title":"Functional characterization of recombinant hyoscyamine 6β-hydroxylase from Atropa belladonna","year":2012,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyoscyamine; Atropa belladonna; Tropane; Chemistry; Datura; Scopolamine; Stereochemistry; Biochemistry; Solanaceae; Biology; Botany; Pharmacology","score_opus":0.08144738520202573,"score_gpt":0.3575645116783777,"score_spread":0.276117126476352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005113813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928289,0.001208533,0.0039459076,0.00012744062,0.000027881651,0.000030321005,0.0008121734,0.000035978726,0.0009827566],"genre_scores_gemma":[0.98527145,0.0009513117,0.004334809,0.00005589556,0.000017483297,0.000023338456,0.00440966,0.000041216692,0.004894914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999027,0.000009899412,0.00001296169,0.000028366741,0.00002376626,0.0000222492],"domain_scores_gemma":[0.9998543,0.000037762235,0.000032731703,0.000026708316,0.000025792724,0.00002268734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017098492,0.00037573525,0.00030305862,0.00018613433,0.00017854314,0.00039577228,0.00024510926,0.0002350056,0.00082627416],"category_scores_gemma":[0.00019062895,0.00013781065,0.00035089208,0.00019742169,0.00020771884,0.00020057496,0.00015860642,0.00054142915,0.0005220362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003411447,0.000011236516,0.00008228235,0.000013253267,0.000004342193,0.000030868036,0.0000126488285,0.000023719384,0.99926656,0.00003540027,0.000007316267,0.00047834436],"study_design_scores_gemma":[0.0000110796855,0.000086929496,0.0048038196,0.0000042573442,0.0000355483,0.0002761502,0.00004123553,0.0005977213,0.99176884,0.00003614735,0.0023327891,0.000005398108],"about_ca_topic_score_codex":0.0025472268,"about_ca_topic_score_gemma":0.001481027,"teacher_disagreement_score":0.0025472268,"about_ca_system_score_codex":0.00034203232,"about_ca_system_score_gemma":0.00020958534,"threshold_uncertainty_score":0.0050647855},"labels":[],"label_agreement":null},{"id":"W2005328285","doi":"10.2165/00003088-200038010-00003","title":"Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":907,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Pharmacology; Drug interaction; Ritonavir; CYP3A4; Ketoconazole; Triazolam; Pharmacokinetics; Dextromethorphan; Medicine; Chemistry; Benzodiazepine; Cytochrome P450; Internal medicine","score_opus":0.2913135195647739,"score_gpt":0.5702358397399223,"score_spread":0.2789223201751484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005328285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009235396,0.9967535,0.00031696184,0.00034151322,0.00012427554,0.000006368896,0.000031584765,0.000009129462,0.0014930211],"genre_scores_gemma":[0.005165634,0.9926918,0.00034993247,0.00028818598,0.00017987292,0.000009081524,0.00005288113,0.0000025485251,0.0012600381],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99983335,0.000039629544,0.000019303621,0.00003077675,0.000064940985,0.00001193255],"domain_scores_gemma":[0.9997737,0.00011558168,0.000045419358,0.0000074085756,0.00004475598,0.000013077805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369055,0.0007019108,0.0013975479,0.00081068627,0.00010624999,0.0006558798,0.00059747114,0.00066579145,0.0022756918],"category_scores_gemma":[0.0006437697,0.00015759999,0.0004038146,0.0009584287,0.00027129037,0.00051580573,0.00022487924,0.0010340061,0.0011676318],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035470494,0.000099972916,0.00037375453,0.004265027,0.000103324404,0.00046359946,0.000027132586,0.00040791594,0.0034439682,0.0010863654,0.009118813,0.9802555],"study_design_scores_gemma":[0.00028480662,0.0010400058,0.007894665,0.0022883483,0.0007026892,0.006921462,0.00010194469,0.0004744657,0.006458286,0.0039476096,0.9698343,0.000051437404],"about_ca_topic_score_codex":0.0006273223,"about_ca_topic_score_gemma":0.0014244865,"teacher_disagreement_score":0.0022756918,"about_ca_system_score_codex":0.00039883135,"about_ca_system_score_gemma":0.00057081436,"threshold_uncertainty_score":0.0076130033},"labels":[],"label_agreement":null},{"id":"W2005384924","doi":"10.1053/jlts.2003.50216","title":"Pharmacogenomics in liver transplantation","year":2003,"lang":"en","type":"review","venue":"Liver Transplantation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenomics; Medicine; Library science; Citation; Liver transplantation; Transplantation; Internal medicine; Pharmacology; Computer science","score_opus":0.17056409262798156,"score_gpt":0.446579544662701,"score_spread":0.27601545203471944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005384924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112516085,0.9983911,0.00044859154,0.0003009258,0.00014269682,0.0000030553497,0.000010398461,0.000008152116,0.0005824876],"genre_scores_gemma":[0.00073093036,0.99775726,0.0004723323,0.0002674081,0.00032112576,0.000004213806,0.000020742367,0.0000013420668,0.00042464404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972445,0.00008800636,0.00004055764,0.000043778593,0.00008765949,0.000015477764],"domain_scores_gemma":[0.99919444,0.0004827175,0.00010851013,0.000026527217,0.0001504689,0.000037357106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012333157,0.0011375849,0.0022666492,0.002423837,0.00019454064,0.0010875848,0.0007449456,0.0013231402,0.002010082],"category_scores_gemma":[0.0012436623,0.00034159957,0.00064602715,0.0033075318,0.00055570924,0.0010180537,0.00057714974,0.0015319363,0.0012015118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001009764,0.000094457195,0.00047673433,0.00636787,0.00018452384,0.00045581153,0.00002234024,0.0006937512,0.0011551151,0.0020593419,0.017717652,0.9706715],"study_design_scores_gemma":[0.000103448,0.00023918157,0.0044879704,0.0052589816,0.0006236289,0.004876073,0.00008203148,0.00069336256,0.0014690913,0.0067084576,0.9754087,0.000049214636],"about_ca_topic_score_codex":0.0017495655,"about_ca_topic_score_gemma":0.0034857607,"teacher_disagreement_score":0.002423837,"about_ca_system_score_codex":0.00064820115,"about_ca_system_score_gemma":0.0013433415,"threshold_uncertainty_score":0.0067243576},"labels":[],"label_agreement":null},{"id":"W2005685849","doi":"10.1002/jps.22675","title":"Effect of hyperlipidemia on ketoconazole–midazolam drug–drug interaction in rat","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ketoconazole; Pharmacokinetics; Midazolam; CYP3A; Pharmacology; Hyperlipidemia; Chemistry; Drug interaction; Volume of distribution; Jugular vein; Free fraction; Drug; Medicine; Endocrinology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.15947094308959447,"score_gpt":0.4887370155521109,"score_spread":0.32926607246251643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005685849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969182,0.0010010264,0.00044422274,0.00023046126,0.00010760191,0.000029745715,0.00035680755,0.000069696915,0.0008423148],"genre_scores_gemma":[0.9929669,0.0014034105,0.00093141384,0.00016230627,0.00009202641,0.000072277835,0.00053554,0.000023644661,0.0038124956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996119,0.00009530905,0.000034120112,0.00007566939,0.00006374367,0.000119282515],"domain_scores_gemma":[0.9993523,0.00016249497,0.00013123588,0.00007792498,0.00007862383,0.00019744081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000334854,0.0007207573,0.00092974585,0.00073690416,0.0005307978,0.0004003927,0.0003995596,0.0007656092,0.0028263074],"category_scores_gemma":[0.0005434922,0.00056784204,0.00089114584,0.00043603897,0.0007155733,0.0008155214,0.00033365106,0.0017363739,0.00054452533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0727172,0.0045007495,0.0042156777,0.00023857999,0.00024423987,0.000781894,0.00024123765,0.0004216168,0.8965671,0.0003759423,0.00076576055,0.018929983],"study_design_scores_gemma":[0.0010994138,0.024562348,0.022320906,0.00002015699,0.00049200165,0.0004772442,0.0002814906,0.002564637,0.9456014,0.0002101821,0.002265473,0.000104675695],"about_ca_topic_score_codex":0.0036904505,"about_ca_topic_score_gemma":0.0060633644,"teacher_disagreement_score":0.0036904505,"about_ca_system_score_codex":0.0006884427,"about_ca_system_score_gemma":0.0008443531,"threshold_uncertainty_score":0.009454906},"labels":[],"label_agreement":null},{"id":"W2005818996","doi":"10.1038/clpt.2008.50","title":"Mice as Clinically Relevant Models for the Study of Cytochrome P450-dependent Metabolism","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Research Nova Scotia","keywords":"Drug metabolism; Cytochrome P450; Biology; Computational biology; Drug; Xenobiotic; Drug discovery; Function (biology); Gene; Metabolism; Drug development; Pharmacology; Bioinformatics; Genetics; Biochemistry; Enzyme","score_opus":0.46419484390673466,"score_gpt":0.5847167342678442,"score_spread":0.12052189036110955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005818996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010815802,0.99057734,0.0026125587,0.00040307804,0.0003283886,0.000039990657,0.00012338704,0.00006969607,0.004763902],"genre_scores_gemma":[0.0037142253,0.9891283,0.0035073357,0.00050301047,0.00017802388,0.00008214499,0.0002481295,0.000014821287,0.0026239299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960715,0.00009938722,0.000039969385,0.00006360363,0.00016629805,0.000023579198],"domain_scores_gemma":[0.9996822,0.00014382522,0.00005811812,0.000020570882,0.00006595457,0.000029397239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010349937,0.000927838,0.0017355897,0.0014027028,0.00016902061,0.0008685088,0.0010740776,0.0011531174,0.0028682223],"category_scores_gemma":[0.0005029982,0.0002456251,0.00035275458,0.0010825146,0.00049854134,0.0009015052,0.00048701777,0.0019677829,0.0026662531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020621349,0.00027099557,0.00041147645,0.01114726,0.00010186446,0.0007463378,0.000084818355,0.0004519663,0.07478181,0.01398553,0.02932847,0.8684833],"study_design_scores_gemma":[0.00005597592,0.00035408212,0.0010481521,0.0013902822,0.0001472519,0.0030601376,0.000043028507,0.00013606554,0.012187047,0.0034172637,0.97813123,0.000029493242],"about_ca_topic_score_codex":0.00032117462,"about_ca_topic_score_gemma":0.00057786255,"teacher_disagreement_score":0.0028682223,"about_ca_system_score_codex":0.00041393476,"about_ca_system_score_gemma":0.00047752832,"threshold_uncertainty_score":0.009595215},"labels":[],"label_agreement":null},{"id":"W2006615927","doi":"10.1124/dmd.105.005488","title":"HUMAN CYP2D6 AND MOUSE CYP2DS: ORGAN DISTRIBUTION IN A HUMANIZED MOUSE MODEL","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs","funders":"Canadian Institutes of Health Research","keywords":"Genetically modified mouse; Biology; Transgene; Humanized mouse; Kidney; CYP2D6; Cytochrome P450; Molecular biology; Enzyme; In vivo; Biochemistry; Gene; Endocrinology; Genetics","score_opus":0.04104609317897825,"score_gpt":0.3710906995961201,"score_spread":0.3300446064171419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006615927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95147794,0.0036352414,0.035706926,0.00069642044,0.00017458612,0.00029370337,0.003919611,0.00094294274,0.0031527912],"genre_scores_gemma":[0.9567594,0.003529719,0.0169401,0.00033200253,0.00008366653,0.0006103265,0.0043804385,0.00045012843,0.016914165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924076,0.00015230628,0.000049249844,0.00027833448,0.00018294175,0.000096435884],"domain_scores_gemma":[0.999471,0.0000738617,0.00016417657,0.00013113313,0.00004369014,0.00011611005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009895806,0.0013852471,0.00097004947,0.0024521179,0.00042845812,0.00091344403,0.00070995995,0.0010549,0.0026468125],"category_scores_gemma":[0.0003292161,0.0007779203,0.0010111213,0.00090899144,0.0009939455,0.0011175197,0.0003551492,0.002587412,0.0010391071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058401288,0.0011325071,0.0013501338,0.00007703046,0.00008528405,0.00031379893,0.00009188223,0.00069776434,0.98178035,0.0010711954,0.00072109356,0.0068388116],"study_design_scores_gemma":[0.00053349213,0.0062506935,0.0061775283,0.000019524847,0.00036002463,0.002245788,0.00012276089,0.004859751,0.9684552,0.00057872594,0.010350057,0.000046446377],"about_ca_topic_score_codex":0.0013987907,"about_ca_topic_score_gemma":0.0017006674,"teacher_disagreement_score":0.0026468125,"about_ca_system_score_codex":0.0008520631,"about_ca_system_score_gemma":0.0005369577,"threshold_uncertainty_score":0.008854449},"labels":[],"label_agreement":null},{"id":"W2006793732","doi":"10.1067/mcp.2002.126409","title":"Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Felodipine; Ascorbyl palmitate; Chemistry; Bioavailability; Grapefruit juice; Pharmacokinetics; Pharmacology; Nifedipine; Food science; Chromatography; Ascorbic acid; Calcium; Endocrinology; Medicine","score_opus":0.2868937453360573,"score_gpt":0.5101501110644951,"score_spread":0.22325636572843782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006793732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468344,0.0031264971,0.0016133628,0.000050440794,0.000020196521,0.000063241234,0.00009431312,0.000025830708,0.00032266547],"genre_scores_gemma":[0.994286,0.0019747787,0.0025795556,0.000045367302,0.000025980275,0.00006187395,0.00024112266,0.000009810319,0.0007755559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981135,0.00008589035,0.000013256827,0.00003950973,0.000029668732,0.000020381942],"domain_scores_gemma":[0.9997924,0.000058146426,0.00006909796,0.000022433142,0.000023740511,0.000034216635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034184897,0.0005450711,0.00034666102,0.00018226387,0.00014349516,0.00021946486,0.00020507004,0.00028730076,0.0011480483],"category_scores_gemma":[0.0004068862,0.00014421187,0.00030061035,0.00015175348,0.00025333164,0.00026447704,0.0001065046,0.00037215595,0.00015842836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0174286,0.00086177303,0.0018146025,0.0002563434,0.00019841999,0.00012985512,0.000053655946,0.00030969584,0.95727646,0.00007854247,0.00008476122,0.021507256],"study_design_scores_gemma":[0.000734774,0.033829596,0.006035754,0.000013117526,0.00027285496,0.00040303572,0.000027555008,0.00079041946,0.9557245,0.00003449244,0.0021247861,0.000009133785],"about_ca_topic_score_codex":0.00054133445,"about_ca_topic_score_gemma":0.00074030703,"teacher_disagreement_score":0.0011480483,"about_ca_system_score_codex":0.0002276247,"about_ca_system_score_gemma":0.00022025852,"threshold_uncertainty_score":0.0038405657},"labels":[],"label_agreement":null},{"id":"W2006820999","doi":"10.1038/sj.bjp.0703486","title":"Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine‐induced inflammation: the role of cytokines","year":2000,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytochrome P450; Turpentine; Inflammation; Incubation; Chemistry; Antibody; Endocrinology; Internal medicine; Blood proteins; Pharmacology; Metabolism; Immunology; Biology; Biochemistry; Medicine","score_opus":0.01902833250098119,"score_gpt":0.315713561138266,"score_spread":0.2966852286372848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006820999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941816,0.0038554552,0.0009510577,0.00012660609,0.000031430194,0.00003622226,0.000081549224,0.000023512395,0.00071258756],"genre_scores_gemma":[0.99762064,0.0009597143,0.00053722056,0.0001401598,0.000037178088,0.00002492508,0.00024899005,0.0000048225556,0.00042618834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996841,0.00012836172,0.000032732187,0.000048631668,0.00006486266,0.000041328498],"domain_scores_gemma":[0.99980575,0.000037941176,0.000069719375,0.000028803597,0.000026104404,0.000031736578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037948295,0.0004965466,0.0003204284,0.0002344756,0.000123505,0.00027157218,0.000085450985,0.00041122292,0.000902435],"category_scores_gemma":[0.0005513637,0.00011578721,0.00029822302,0.00011143366,0.00027950684,0.00013699388,0.00016244293,0.00042405858,0.00035681907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026669074,0.00017710007,0.013746201,0.00017334288,0.00006662606,0.00044165834,0.00015701738,0.000044217588,0.9721672,0.00008137196,0.00013133563,0.010147032],"study_design_scores_gemma":[0.00044816703,0.011913229,0.24454811,0.000078028075,0.0002778858,0.009159062,0.00027092075,0.0010509216,0.7249176,0.00018947471,0.0071267616,0.000019844278],"about_ca_topic_score_codex":0.00023152346,"about_ca_topic_score_gemma":0.000204566,"teacher_disagreement_score":0.000902435,"about_ca_system_score_codex":0.00013461524,"about_ca_system_score_gemma":0.00012102239,"threshold_uncertainty_score":0.0030189753},"labels":[],"label_agreement":null},{"id":"W2006946795","doi":"10.1371/journal.pone.0083898","title":"A Large-Scale Allosteric Transition in Cytochrome P450 3A4 Revealed by Luminescence Resonance Energy Transfer (LRET)","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Allosteric regulation; Chemistry; Förster resonance energy transfer; Biophysics; Allosteric enzyme; Stereochemistry; Biochemistry; Enzyme; Fluorescence; Biology","score_opus":0.06415620133064288,"score_gpt":0.3189187530538429,"score_spread":0.2547625517232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006946795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959545,0.00012956781,0.003406474,0.00004596696,0.000005567445,0.000009258598,0.000021647136,0.00004600411,0.00038098375],"genre_scores_gemma":[0.99831474,0.000056222656,0.0012512591,0.000018361892,0.0000019712375,0.000009033243,0.00003077036,0.0000056768195,0.00031191486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986446,0.00004096127,0.0000054323714,0.0000374401,0.000029995326,0.000021650922],"domain_scores_gemma":[0.999877,0.000043253913,0.000035999576,0.000018231438,0.000010092332,0.000015423951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022383877,0.00023105637,0.0001785847,0.000068069414,0.000111618065,0.0001788918,0.00019343308,0.00022962535,0.0007216395],"category_scores_gemma":[0.0002558466,0.00010861929,0.00020941894,0.00007028041,0.00028731828,0.00017023578,0.00021484103,0.00061685016,0.00019708522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008074363,0.000016778458,0.00016742374,0.000010058193,0.000002633169,0.00002550903,0.0000117210175,0.000064796346,0.9988649,0.000072209754,0.0000080185555,0.00067523913],"study_design_scores_gemma":[0.000013008573,0.00022457162,0.0013123817,9.623186e-7,0.0000056028894,0.00009137809,0.000013055292,0.00097692,0.997027,0.000044304692,0.0002884038,0.0000025633753],"about_ca_topic_score_codex":0.00012197635,"about_ca_topic_score_gemma":0.00010903042,"teacher_disagreement_score":0.0007216395,"about_ca_system_score_codex":0.00017925292,"about_ca_system_score_gemma":0.00007191538,"threshold_uncertainty_score":0.0024141073},"labels":[],"label_agreement":null},{"id":"W2007404873","doi":"10.1177/0269881110370504","title":"<i>CYP2D6</i> genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics","year":2010,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fluvoxamine; CYP2D6; Pharmacology; Pharmacogenetics; Genotype; Serotonin reuptake inhibitor; Psychology; Reuptake inhibitor; Internal medicine; Antidepressant; Medicine; Cytochrome P450; Serotonin; Psychiatry; Fluoxetine; Anxiety; Biology; Genetics; Metabolism","score_opus":0.04800565763787678,"score_gpt":0.4051272772895266,"score_spread":0.3571216196516498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007404873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404645,0.0016350158,0.0032296618,0.00030782446,0.000031393298,0.00006893493,0.000116803225,0.000013278342,0.0005506085],"genre_scores_gemma":[0.9972029,0.00019057802,0.0021989737,0.00011849135,0.000024332874,0.000045511722,0.000096074706,0.000009027729,0.000114108945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99125165,0.006305536,0.0006153685,0.0011088892,0.0005373393,0.00018114744],"domain_scores_gemma":[0.99278367,0.0036976174,0.0014497986,0.0012667486,0.00046309564,0.0003391371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009010741,0.00045808055,0.0010540908,0.00041062536,0.0005431866,0.0007354922,0.0006331861,0.00070805487,0.0009228895],"category_scores_gemma":[0.012151863,0.00038438954,0.0011041216,0.0008898498,0.0009396515,0.00047429043,0.00041111006,0.0006882344,0.00014074211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015020189,0.0000748796,0.98639387,0.0000608955,0.0010504047,0.00010347614,0.00035015462,0.0001517464,0.002105544,0.00015236982,0.00014998495,0.007904534],"study_design_scores_gemma":[0.000098880824,0.00045541668,0.99615425,0.000016832479,0.0005963498,0.00021035352,0.00012998359,0.0011467845,0.0004019652,0.00033956364,0.00043353342,0.000016018053],"about_ca_topic_score_codex":0.0048930985,"about_ca_topic_score_gemma":0.007066927,"teacher_disagreement_score":0.009010741,"about_ca_system_score_codex":0.0003978048,"about_ca_system_score_gemma":0.0005187525,"threshold_uncertainty_score":0.047653973},"labels":[],"label_agreement":null},{"id":"W2007411634","doi":"10.1016/s0958-1669(00)00142-7","title":"Enzymatic hydroxylation reactions","year":2000,"lang":"en","type":"review","venue":"Current Opinion in Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Hydroxylation; Regioselectivity; Stereoselectivity; Enzyme; Chemistry; Cytochrome P450; Substrate (aquarium); Context (archaeology); Biocatalysis; Stereochemistry; Biochemistry; Biology; Catalysis; Reaction mechanism","score_opus":0.33006365873134347,"score_gpt":0.5400877479652982,"score_spread":0.21002408923395477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007411634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03334137,0.63580763,0.15010421,0.0038088197,0.010748429,0.0005609176,0.0014329174,0.0015493474,0.16264632],"genre_scores_gemma":[0.20514847,0.5931503,0.028787417,0.0030642818,0.0034264468,0.0004449925,0.00319954,0.0001789702,0.16259953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994155,0.0001033917,0.000050693812,0.00017008962,0.00014288712,0.00011756768],"domain_scores_gemma":[0.99981517,0.000041180505,0.00003551241,0.000034509474,0.000050301285,0.000023388655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007976868,0.0019350788,0.0009309585,0.00095246255,0.00044027166,0.00081447064,0.0013209751,0.0012573956,0.008756101],"category_scores_gemma":[0.00047916773,0.0004257896,0.00073914276,0.0010940405,0.00071472995,0.0017294168,0.0014043609,0.0020680272,0.014192093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027928056,0.00032995472,0.00053477444,0.0066294256,0.00017176499,0.0013190652,0.00018986595,0.0012701619,0.15036131,0.022073664,0.033609107,0.7832316],"study_design_scores_gemma":[0.000038419643,0.00040859976,0.0006541684,0.00018133855,0.00007238564,0.0023088267,0.000055835197,0.0005287482,0.2855129,0.0053533693,0.70482767,0.000057649915],"about_ca_topic_score_codex":0.00058778917,"about_ca_topic_score_gemma":0.0007542813,"teacher_disagreement_score":0.008756101,"about_ca_system_score_codex":0.0006777295,"about_ca_system_score_gemma":0.00075796543,"threshold_uncertainty_score":0.029292047},"labels":[],"label_agreement":null},{"id":"W2007600177","doi":"10.1016/s0300-483x(02)00292-5","title":"Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis","year":2002,"lang":"en","type":"review","venue":"Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mutagenesis; Biotransformation; Enzyme; Mutagen; Biology; Xenobiotic; Biochemistry; Bacteria; Function (biology); Metabolite; Carcinogen; Computational biology; Chemistry; Genetics; Mutation; Gene","score_opus":0.27410794615285267,"score_gpt":0.45363944452622457,"score_spread":0.1795314983733719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007600177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061982294,0.9940182,0.003528635,0.00013816125,0.00022682408,0.000016915856,0.000039340783,0.000043658383,0.0013684861],"genre_scores_gemma":[0.0025211647,0.9919303,0.0033489012,0.00013735554,0.00009553073,0.000019490468,0.000108610555,0.000007764249,0.001830805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995801,0.00005772372,0.000041276107,0.00007623412,0.00021840433,0.000026316602],"domain_scores_gemma":[0.9996284,0.0001723785,0.00007021454,0.000028041402,0.000078206605,0.000022814986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008120957,0.0014202319,0.0021278518,0.0026603306,0.00024393189,0.00091057946,0.0014589076,0.001275868,0.0015468113],"category_scores_gemma":[0.00064155,0.0005250178,0.0005610687,0.0035109012,0.0010598247,0.0010525224,0.00061632745,0.0019262597,0.002615996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013440366,0.00015115216,0.00020242737,0.0072444724,0.00006501946,0.00041608507,0.0000534447,0.0008877307,0.047420558,0.0054940917,0.007366831,0.93056375],"study_design_scores_gemma":[0.000057376703,0.000261187,0.0010620872,0.0009749091,0.00018449166,0.0033751617,0.000039681458,0.00032149506,0.04812398,0.002985355,0.9425646,0.000049780334],"about_ca_topic_score_codex":0.0013546022,"about_ca_topic_score_gemma":0.0014709773,"teacher_disagreement_score":0.0026603306,"about_ca_system_score_codex":0.00076556724,"about_ca_system_score_gemma":0.0009004428,"threshold_uncertainty_score":0.005554557},"labels":[],"label_agreement":null},{"id":"W2007657277","doi":"10.1074/jbc.275.12.8895","title":"Identification and Functional Characterization of a Conserved, Nuclear Factor 1-like Element in the Proximal Promoter Region ofCYP1A2 Gene Specifically Expressed in the Liver and Olfactory Mucosa","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Institute on Deafness and Other Communication Disorders; University of Illinois at Urbana-Champaign; National Institutes of Health; National Institute of Environmental Health Sciences; University of Illinois at Chicago","keywords":"Gene; Identification (biology); Biology; Olfactory mucosa; Computational biology; Promoter; Genetics; Molecular biology; Olfactory system; Gene expression; Neuroscience","score_opus":0.1284334063191823,"score_gpt":0.32703745739549883,"score_spread":0.19860405107631654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007657277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934151,0.0009968918,0.0037123966,0.00008128346,0.000018694163,0.000027744647,0.0009314696,0.000032613272,0.00078373373],"genre_scores_gemma":[0.9854944,0.00052963104,0.005563093,0.000068664405,0.000026631025,0.000052384792,0.0054476606,0.000028630162,0.0027889442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998987,0.000010401409,0.0000057659104,0.00003826908,0.000025441628,0.000021511481],"domain_scores_gemma":[0.9998448,0.000029832128,0.000039384006,0.000014177161,0.0000253189,0.000046524947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117128126,0.0003262373,0.00021119455,0.00023228097,0.00020561533,0.00017592314,0.00014878102,0.0001957023,0.0014480422],"category_scores_gemma":[0.00016344053,0.00015218895,0.0003931457,0.00015170156,0.00021403647,0.0000938535,0.00011834298,0.00037244556,0.00055902585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005301469,0.000014527632,0.00047298838,0.00002819009,0.0000023057735,0.00003731348,0.000019310406,0.000018931763,0.9987797,0.000040067956,0.000011954994,0.0005218058],"study_design_scores_gemma":[0.000055744607,0.00034795955,0.114777006,0.000037774415,0.000046010562,0.0013622622,0.00012627101,0.0017331935,0.8748826,0.00014467645,0.0064721364,0.000014426923],"about_ca_topic_score_codex":0.0012990698,"about_ca_topic_score_gemma":0.0017349933,"teacher_disagreement_score":0.0014480422,"about_ca_system_score_codex":0.000276239,"about_ca_system_score_gemma":0.00027326014,"threshold_uncertainty_score":0.0048441887},"labels":[],"label_agreement":null},{"id":"W2008263103","doi":"10.1097/fpc.0000000000000008","title":"Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues","year":2013,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Exon; UGT2B7; Biology; Promoter; Alternative splicing; Glucuronidation; Molecular biology; Kidney; Gene expression; Gene; Genetics; Enzyme; Biochemistry","score_opus":0.05437189203628639,"score_gpt":0.40985482682499225,"score_spread":0.35548293478870585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98516756,0.0022092254,0.010323413,0.00008209337,0.000016859885,0.000040642804,0.0007357781,0.00010919128,0.0013151797],"genre_scores_gemma":[0.9815307,0.001305027,0.011456207,0.000052527823,0.000027713657,0.0000828736,0.0037134236,0.000050074716,0.0017813278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996222,0.000045793884,0.000022332038,0.00012998334,0.00013851497,0.000041213967],"domain_scores_gemma":[0.9997099,0.00006293057,0.00009959613,0.00002575879,0.000060621234,0.000041056694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022976704,0.0002644831,0.00023143471,0.00049681525,0.00017740193,0.00047311612,0.0001481259,0.00023802304,0.0010641366],"category_scores_gemma":[0.00038205672,0.0002388863,0.00025934956,0.00034489774,0.00029265686,0.00010934998,0.00027425482,0.0002740337,0.00064863963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024829383,0.000020147592,0.0049839607,0.00007512658,0.000017616032,0.0002179425,0.00010977299,0.00010222595,0.9878493,0.00029600546,0.00009643869,0.0059830826],"study_design_scores_gemma":[0.00007786757,0.0005129946,0.08442292,0.00006254055,0.00011799067,0.0061677205,0.00022041773,0.0030541227,0.891662,0.0004452694,0.013228993,0.000027064838],"about_ca_topic_score_codex":0.00068763294,"about_ca_topic_score_gemma":0.0008738417,"teacher_disagreement_score":0.0010641366,"about_ca_system_score_codex":0.00028385225,"about_ca_system_score_gemma":0.00031786558,"threshold_uncertainty_score":0.003559947},"labels":[],"label_agreement":null},{"id":"W2008423993","doi":"10.1177/0091270003261078","title":"Effects of St. John's Wort (<i>Hypericum perforatum</i>) on Tacrolimus Pharmacokinetics in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pharmacokinetics; Hypericum perforatum; Tacrolimus; Pharmacology; CYP3A; Volume of distribution; Medicine; Pharmacokinetic interaction; Oral administration; Dosing; Drug interaction; Chemistry; Transplantation; Metabolism; Internal medicine; Cytochrome P450","score_opus":0.09962250996604795,"score_gpt":0.4859302468162513,"score_spread":0.38630773685020336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008423993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825174,0.0008773692,0.00015072602,0.00003410027,0.000023237073,0.00003390367,0.0000743307,0.000021614536,0.00053296617],"genre_scores_gemma":[0.9986369,0.0003716643,0.00026970546,0.000095824325,0.000036644502,0.000026696513,0.00011728008,0.0000060538237,0.0004391149],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975413,0.000098825636,0.000015003497,0.000059639136,0.000035903136,0.000036507085],"domain_scores_gemma":[0.9997316,0.00007416517,0.00005049384,0.000017978364,0.00002557991,0.000100089426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024946383,0.00038117435,0.00043993333,0.000097377466,0.00022093812,0.00028910933,0.00009412409,0.00037790296,0.00090898067],"category_scores_gemma":[0.0006324388,0.00017781294,0.00024610892,0.000105465275,0.00028849256,0.00018052082,0.00013614807,0.0003352312,0.00030940818],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19098379,0.011799263,0.07984664,0.00063353206,0.000772419,0.0020745457,0.0006232398,0.00064247486,0.5531252,0.00011691626,0.002063356,0.15731862],"study_design_scores_gemma":[0.0052725193,0.36226144,0.5471344,0.000049970502,0.00087197364,0.0047219372,0.00035183242,0.0023038893,0.071304336,0.00014777022,0.005516412,0.000063533065],"about_ca_topic_score_codex":0.0007594418,"about_ca_topic_score_gemma":0.0008396215,"teacher_disagreement_score":0.00090898067,"about_ca_system_score_codex":0.00015508985,"about_ca_system_score_gemma":0.00018015869,"threshold_uncertainty_score":0.0030407906},"labels":[],"label_agreement":null},{"id":"W2008616614","doi":"10.2165/00003088-200342150-00004","title":"Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Pharmacology; Pharmacokinetics; Enantiomer; Primaquine; Mefloquine; Plasmodium falciparum; Chloroquine; Stereochemistry; Medicine; Biochemistry; Malaria","score_opus":0.2544438096591189,"score_gpt":0.5451954329062285,"score_spread":0.2907516232471096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008616614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015161658,0.9943644,0.0012486964,0.00022739613,0.000092854,0.000008202472,0.000040707095,0.00001972153,0.002481932],"genre_scores_gemma":[0.008016915,0.98840094,0.0010748021,0.00021805258,0.00019447207,0.000009123937,0.00007769974,0.000004873107,0.0020031976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971145,0.00006240766,0.000034782563,0.00005756923,0.00011375143,0.000020081976],"domain_scores_gemma":[0.99959916,0.00018611635,0.00009515454,0.000017446162,0.00008206699,0.0000200256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000993839,0.0005922537,0.0014538448,0.0010434306,0.00014805698,0.0006676885,0.00082491,0.00057731674,0.00203646],"category_scores_gemma":[0.0006331384,0.0002804574,0.00036279354,0.0014236512,0.0005934929,0.00073490053,0.00037475541,0.0009507522,0.0013055879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017345042,0.00005967564,0.0005815003,0.005283405,0.00006921722,0.0002986227,0.000041147592,0.00062667206,0.008718279,0.0037466667,0.0045480146,0.9758533],"study_design_scores_gemma":[0.00008979534,0.00050805375,0.006232726,0.0010997187,0.00031970724,0.007677889,0.00009099047,0.00060130283,0.019593263,0.006286225,0.957434,0.00006639138],"about_ca_topic_score_codex":0.0017267385,"about_ca_topic_score_gemma":0.002860292,"teacher_disagreement_score":0.00203646,"about_ca_system_score_codex":0.0006711304,"about_ca_system_score_gemma":0.0009348499,"threshold_uncertainty_score":0.006812632},"labels":[],"label_agreement":null},{"id":"W2008730180","doi":"10.1080/00498250400015301","title":"Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone","year":2004,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; AstraZeneca (Canada); Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec","keywords":"CYP3A4; Domperidone; Cytochrome P450; Metabolite; Chemistry; Microsome; Enzyme; Metabolism; Biochemistry; Drug metabolism; Pharmacology; Biology; Endocrinology; Dopamine","score_opus":0.06427480296366353,"score_gpt":0.3887474671002587,"score_spread":0.32447266413659515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008730180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607748,0.011883664,0.023823135,0.00021695663,0.00003257363,0.00016793657,0.0009360347,0.00015995014,0.0020051464],"genre_scores_gemma":[0.9773563,0.0033520928,0.016121795,0.0000738451,0.000032571592,0.0000547841,0.0010790288,0.000012093502,0.0019173527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998554,0.00004528967,0.000014196686,0.000030180703,0.000028522514,0.000026411637],"domain_scores_gemma":[0.9998041,0.000058166574,0.00004894554,0.000017036775,0.00005179213,0.000019947069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002793193,0.00033601306,0.0003094412,0.00022732149,0.00014250127,0.00020743681,0.00009005305,0.00022906838,0.00081661704],"category_scores_gemma":[0.00037702388,0.0001186915,0.00026947298,0.00021125235,0.00012734444,0.00016614902,0.00008568394,0.00026857425,0.00047726434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033071614,0.000038115108,0.0060424246,0.0001197509,0.000027828542,0.00025158224,0.00002745933,0.000115034556,0.9811412,0.00008122131,0.00008583574,0.011738801],"study_design_scores_gemma":[0.000035044253,0.0011089571,0.08982362,0.000018265737,0.00012242219,0.0017128972,0.000048158516,0.0014719574,0.9001437,0.00019750546,0.0053071734,0.0000102748],"about_ca_topic_score_codex":0.0013612729,"about_ca_topic_score_gemma":0.0013769908,"teacher_disagreement_score":0.0013612729,"about_ca_system_score_codex":0.00019647037,"about_ca_system_score_gemma":0.00024689978,"threshold_uncertainty_score":0.0027318597},"labels":[],"label_agreement":null},{"id":"W2008837673","doi":"10.1016/j.bcp.2014.09.005","title":"Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole","year":2014,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; Institute of Aging; Universidad de Extremadura; Federación Española de Enfermedades Raras","keywords":"Metamizole; CYP2C19; Metabolite; Pharmacogenetics; Phenacetin; Allele; Biology; Pharmacology; Genotype; Genetics; Analgesic; Endocrinology; Gene","score_opus":0.08188882132745803,"score_gpt":0.3732399314390883,"score_spread":0.2913511101116303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008837673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827933,0.00034556634,0.00029388015,0.00009501331,0.000009838952,0.000004346885,0.00031165464,0.000008638318,0.00065176166],"genre_scores_gemma":[0.9989717,0.00011536765,0.00011190159,0.000041978623,0.0000063718057,0.0000021952853,0.00013554019,0.000009549791,0.00060527155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998667,0.000031619875,0.000012094065,0.000035561894,0.000030035782,0.00002398627],"domain_scores_gemma":[0.99974424,0.00006887561,0.0001009478,0.00002650023,0.000017920082,0.000041533647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001510176,0.00024572603,0.00029946613,0.0002707271,0.00012491073,0.00026600473,0.00014407867,0.00030341538,0.002805827],"category_scores_gemma":[0.00063152023,0.00015359081,0.0003358214,0.00024944934,0.00016574663,0.0002035428,0.000101666286,0.00027842674,0.0003230673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009343204,0.000286687,0.7829762,0.000047503127,0.00045089185,0.0016667995,0.00018217364,0.00027767674,0.17894356,0.00040253924,0.0005622174,0.02486062],"study_design_scores_gemma":[0.00007835817,0.0009153227,0.981822,0.000010887169,0.0002538679,0.0032862567,0.00012722184,0.0007039651,0.011279882,0.00034186168,0.0011655621,0.000014772361],"about_ca_topic_score_codex":0.00093268184,"about_ca_topic_score_gemma":0.0011146984,"teacher_disagreement_score":0.002805827,"about_ca_system_score_codex":0.0001795355,"about_ca_system_score_gemma":0.00014421598,"threshold_uncertainty_score":0.00938642},"labels":[],"label_agreement":null},{"id":"W2009145411","doi":"10.1080/10256010208033314","title":"[<sup>13</sup>C]Aminopyrine and [<sup>13</sup>C]Caffeine Breath Test: Influence of Gender, Cigarette Smoking and Oral Contraceptives Intake","year":2002,"lang":"en","type":"article","venue":"Isotopes in Environmental and Health Studies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Breath test; Medicine; Caffeine; CYP1A2; Cigarette smoking; Physiology; Oral dose; Internal medicine; Cytochrome P450; Oral administration; Metabolism","score_opus":0.10628741146972744,"score_gpt":0.39087320827697264,"score_spread":0.2845857968072452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009145411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998547,0.00062341784,0.00031381214,0.000029450235,0.0000060736566,0.000013246338,0.0001398502,0.0000067250153,0.0003204966],"genre_scores_gemma":[0.99837166,0.00023240432,0.0005724574,0.00005347522,0.000009571509,0.000017118444,0.00021896273,0.000006135576,0.0005183172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995727,0.0001760937,0.00003039707,0.00007015976,0.00011478115,0.000035938756],"domain_scores_gemma":[0.99911493,0.00043139595,0.00021048213,0.000056920893,0.00007071041,0.00011550564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046982736,0.000251018,0.00028208006,0.00031000611,0.00022635752,0.00026637016,0.00015750743,0.0002960988,0.0013812167],"category_scores_gemma":[0.0016647221,0.00024968063,0.00015958124,0.0002714399,0.00028312084,0.000114320275,0.0001425975,0.00019535498,0.00020529758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067867697,0.00027060305,0.92876405,0.000046198755,0.00019094908,0.00079191575,0.00023273399,0.0001022383,0.0444925,0.000028546498,0.00018462926,0.018108798],"study_design_scores_gemma":[0.000033134886,0.001833605,0.98444897,0.000003982077,0.00008100751,0.0018621328,0.00011431944,0.00025842353,0.010886125,0.000032153403,0.00043880957,0.0000072871794],"about_ca_topic_score_codex":0.0015236179,"about_ca_topic_score_gemma":0.003152993,"teacher_disagreement_score":0.0015236179,"about_ca_system_score_codex":0.00015064697,"about_ca_system_score_gemma":0.00018529853,"threshold_uncertainty_score":0.0046206117},"labels":[],"label_agreement":null},{"id":"W2009236753","doi":"10.1177/00912700222011418","title":"Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Midazolam; Reproducibility; Mean squared error; CYP3A; Sampling (signal processing); Linear regression; Pharmacokinetics; Mathematics; Statistics; Medicine; Anesthesia; Pharmacology; Internal medicine; Computer science","score_opus":0.17446470495559757,"score_gpt":0.48976398802201493,"score_spread":0.31529928306641736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009236753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.652538,0.001351004,0.34395605,0.00025914586,0.000034618035,0.0002891677,0.0003552156,0.0007389292,0.0004777528],"genre_scores_gemma":[0.91878814,0.00034085306,0.079688124,0.00011522865,0.00001636211,0.00024962603,0.00047125772,0.00003653529,0.00029392412],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971986,0.0016869663,0.000201788,0.00036042568,0.000495492,0.00005687742],"domain_scores_gemma":[0.9926771,0.00493712,0.0008455209,0.000617301,0.0007979822,0.0001250137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005636983,0.0009052951,0.0010803677,0.0007284529,0.00020140877,0.00049595296,0.00069673377,0.0006444987,0.00046623347],"category_scores_gemma":[0.017268354,0.00044774075,0.0008124138,0.00044875682,0.0002327434,0.00041327058,0.00048237244,0.000628548,0.00025221054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060927407,0.0011861508,0.33316958,0.00038171836,0.0010469168,0.00040646532,0.0003531294,0.26507458,0.057827387,0.0007115063,0.0012639022,0.33248585],"study_design_scores_gemma":[0.0001784596,0.0022989637,0.06647864,0.000039784154,0.0002652903,0.00042407142,0.000035060842,0.9146444,0.014402472,0.0005125904,0.0006666078,0.00005373835],"about_ca_topic_score_codex":0.0036186066,"about_ca_topic_score_gemma":0.0030522398,"teacher_disagreement_score":0.005636983,"about_ca_system_score_codex":0.00045127512,"about_ca_system_score_gemma":0.0007463863,"threshold_uncertainty_score":0.02981162},"labels":[],"label_agreement":null},{"id":"W2009830490","doi":"10.2165/00002018-200124020-00001","title":"What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Pharmacogenetics; Medicine; Drug; Drug development; Pharmacology; Precision medicine; Bioinformatics; Computational biology; Intensive care medicine; Genetics; Gene; Biology; Genotype","score_opus":0.09356849628257248,"score_gpt":0.4601029387777244,"score_spread":0.36653444249515194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009830490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012729524,0.9929964,0.0009792267,0.0044439235,0.0005818332,0.0000070958217,0.000014892521,0.000011919005,0.0008373869],"genre_scores_gemma":[0.0011177426,0.99289614,0.0018328024,0.0026400022,0.001009847,0.000012054893,0.000015824853,0.000004009912,0.0004716503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980469,0.0007711402,0.00018841522,0.00024111752,0.0006604029,0.00009198857],"domain_scores_gemma":[0.98978746,0.0066282754,0.0007541058,0.00025380682,0.0022309977,0.00034535374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009300078,0.0016394655,0.005290721,0.002350995,0.00044616053,0.0035256995,0.002296386,0.0047070137,0.0026010964],"category_scores_gemma":[0.007698058,0.0005796338,0.0015303451,0.0030932173,0.0024158233,0.0059257494,0.00091319863,0.0050125523,0.0023230265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001454576,0.000103508195,0.00072187703,0.0065580606,0.00023493124,0.00020198793,0.00006667166,0.0004491494,0.00069773116,0.0066365898,0.016041037,0.9681429],"study_design_scores_gemma":[0.00015945813,0.0004883026,0.0040716166,0.015190917,0.0006611083,0.0027060474,0.00039153517,0.00094655383,0.0010202692,0.027735734,0.94648534,0.00014320601],"about_ca_topic_score_codex":0.003922153,"about_ca_topic_score_gemma":0.0058572115,"teacher_disagreement_score":0.009300078,"about_ca_system_score_codex":0.0016430841,"about_ca_system_score_gemma":0.0032808993,"threshold_uncertainty_score":0.049184144},"labels":[],"label_agreement":null},{"id":"W2010082382","doi":"10.1139/cjc-2012-0537","title":"Modification of the anticancer drug tamoxifen to avoid CYP2D6 polymorphism","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Göteborgs Universitet","keywords":"Prodrug; Chemistry; CYP2D6; Tamoxifen; Drug; CYP3A; Adduct; Stereochemistry; Pharmacology; Cytochrome P450; Breast cancer; Combinatorial chemistry; Biochemistry; Enzyme; Cancer; Genetics; Organic chemistry","score_opus":0.05366901459742366,"score_gpt":0.354078313607545,"score_spread":0.3004092990101213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93205595,0.0050766757,0.04825531,0.0005136285,0.000116042334,0.0001339567,0.00054863293,0.00019050018,0.013109255],"genre_scores_gemma":[0.98589617,0.0014362107,0.0103716105,0.000085598964,0.000013626718,0.000038789374,0.00024804883,0.000022822764,0.0018869723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999198,0.000019292516,0.0000033094489,0.000015615036,0.0000287895,0.000013122446],"domain_scores_gemma":[0.9999578,0.000010447778,0.000013326207,0.000009047516,0.000006306927,0.000003042417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103757804,0.00019739439,0.00022389488,0.00010865938,0.0001518525,0.00015243585,0.00032945815,0.00036087338,0.0024734677],"category_scores_gemma":[0.0003125398,0.00009730516,0.0003561392,0.00012563498,0.00014111892,0.00016945455,0.00019463229,0.00026433083,0.00045737802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010187656,0.00023867087,0.005903897,0.00082916295,0.00021559422,0.001422318,0.00014508252,0.06420088,0.81876093,0.027989388,0.0017338406,0.07754142],"study_design_scores_gemma":[0.00044674223,0.005595812,0.0087205935,0.000061770625,0.0003273043,0.0026401025,0.00012251482,0.11600016,0.79110426,0.013042728,0.06184484,0.00009306233],"about_ca_topic_score_codex":0.0006262011,"about_ca_topic_score_gemma":0.000710275,"teacher_disagreement_score":0.0024734677,"about_ca_system_score_codex":0.00014820712,"about_ca_system_score_gemma":0.00016337434,"threshold_uncertainty_score":0.008274615},"labels":[],"label_agreement":null},{"id":"W2010152279","doi":"10.1002/jps.23090","title":"Advancing Prediction of Tissue Distribution and Volume of Distribution of Highly Lipophilic Compounds from a Simplified Tissue-Composition-Based Model as a Mechanistic Animal Alternative Method","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lipophilicity; Partition coefficient; Physiologically based pharmacokinetic modelling; Chemistry; Distribution (mathematics); Octanol; Volume of distribution; Volume (thermodynamics); Chromatography; Distribution Volume; Composition (language); Pharmacokinetics; Biological system; Thermodynamics; Stereochemistry; Pharmacology; Mathematics","score_opus":0.08519529832141709,"score_gpt":0.45123076288169545,"score_spread":0.36603546456027836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010152279","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07580419,0.00035879726,0.921314,0.0001437539,0.000014939509,0.00005523222,0.00021314164,0.00026995584,0.0018259098],"genre_scores_gemma":[0.91732293,0.00086304365,0.07819845,0.00010436935,0.000024374507,0.00021520781,0.0003011419,0.00012093646,0.0028495735],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999145,0.000025021447,0.0000034830314,0.000020598221,0.00002646138,0.0000099167455],"domain_scores_gemma":[0.9997496,0.00014284084,0.00004837424,0.000021066815,0.000025293633,0.00001285043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029851234,0.0005144358,0.0006098258,0.00027901988,0.00016589779,0.00060002715,0.00070419523,0.0008070298,0.0006407202],"category_scores_gemma":[0.0007646231,0.0003664112,0.00060378277,0.00018379334,0.00035877168,0.0005535603,0.00039256777,0.00065324194,0.0002976995],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070662754,0.000045835557,0.0007640419,0.00007674818,0.000040291925,0.00009453431,0.000017057453,0.927669,0.059657782,0.0036088855,0.0001642128,0.0077911085],"study_design_scores_gemma":[0.000003825752,0.000023005092,0.00020867071,0.0000025552708,0.000012026289,0.00003161855,0.0000025308584,0.9934104,0.00496735,0.0010454438,0.00028856297,0.0000039981887],"about_ca_topic_score_codex":0.0031897088,"about_ca_topic_score_gemma":0.002193646,"teacher_disagreement_score":0.0031897088,"about_ca_system_score_codex":0.0005778827,"about_ca_system_score_gemma":0.0007516841,"threshold_uncertainty_score":0.006342292},"labels":[],"label_agreement":null},{"id":"W2010642193","doi":"10.1159/000139121","title":"Effect of Acute and Chronic Moderate Hypoxia on Diltiazem Kinetics and Metabolism in the Dog","year":2008,"lang":"en","type":"article","venue":"Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Diltiazem; Hypoxia (environmental); Metabolite; Chemistry; Medicine; Internal medicine; Pharmacology; Anesthesia; Endocrinology; Oxygen; Calcium","score_opus":0.05352348994147575,"score_gpt":0.40642327329426214,"score_spread":0.3528997833527864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010642193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990427,0.000501113,0.00016693836,0.000028689647,0.000007095641,0.000009351225,0.000046026456,0.0000053795984,0.0001926671],"genre_scores_gemma":[0.99876803,0.0003551149,0.0002600855,0.000061769,0.000021113237,0.000018148818,0.00016496243,0.0000035255503,0.00034733373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998355,0.00003347234,0.000012500546,0.0000345942,0.000043171054,0.00004076745],"domain_scores_gemma":[0.9997476,0.000053884614,0.00008615698,0.000022070042,0.000020627549,0.00006964269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017356499,0.00014879733,0.0003462843,0.00012458231,0.00010610804,0.00024182923,0.00013766736,0.00026219507,0.00076312973],"category_scores_gemma":[0.00029416516,0.00012616189,0.0001624067,0.00008021657,0.0003257894,0.00020677844,0.0001474506,0.00031082024,0.00013360384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04427257,0.0012217523,0.050623085,0.00016726906,0.00014160232,0.0007974119,0.00020135038,0.00061411364,0.8685242,0.00011498745,0.0004312719,0.032890428],"study_design_scores_gemma":[0.001199577,0.13478144,0.43433964,0.00003148379,0.00040505096,0.004033118,0.00056886626,0.0040276716,0.41151527,0.0001864173,0.00886608,0.000045332676],"about_ca_topic_score_codex":0.0008178817,"about_ca_topic_score_gemma":0.0015425641,"teacher_disagreement_score":0.0008178817,"about_ca_system_score_codex":0.0003308191,"about_ca_system_score_gemma":0.00015367928,"threshold_uncertainty_score":0.002552867},"labels":[],"label_agreement":null},{"id":"W2010953472","doi":"10.1124/dmd.30.12.1478","title":"Microsomal N-Glucuronidation of Nicotine and Cotinine: Human Hepatic Interindividual, Human Intertissue, and Interspecies Hepatic Variation","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Microsome; Nicotine; Cotinine; Microsoma; Chemistry; Internal medicine; Duodenum; Drug metabolism; Endocrinology; Jejunum; Metabolism; Biochemistry; Biology; Enzyme; Medicine","score_opus":0.049332615267348986,"score_gpt":0.3639251113968429,"score_spread":0.3145924961294939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010953472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919827,0.0019942734,0.0059397384,0.00005979249,0.00003211382,0.000026048416,0.00053428643,0.000099258104,0.0021162415],"genre_scores_gemma":[0.99748516,0.0003429326,0.0007746157,0.00002403315,0.000007608462,0.0000142717045,0.00039811124,0.000051670133,0.00090157206],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991897,0.00031463252,0.000046034944,0.00029075035,0.00011154963,0.000047392045],"domain_scores_gemma":[0.9984475,0.000559742,0.00021507288,0.0004444627,0.00022324768,0.00010999776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009592962,0.0002733795,0.0004314476,0.0007859845,0.0004181263,0.00060151337,0.0001574286,0.0003557103,0.001336035],"category_scores_gemma":[0.0018858362,0.00034010608,0.0003560109,0.0007669079,0.0005737774,0.00029966174,0.00034262106,0.0003582414,0.0004389905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01038098,0.000300807,0.6079203,0.0002945405,0.0028378086,0.0010030889,0.0041388,0.0025784546,0.26437175,0.0030998162,0.001383174,0.10169052],"study_design_scores_gemma":[0.000039088074,0.0004628238,0.9650509,0.0000132364785,0.00024388173,0.0017126851,0.00026157452,0.0017562497,0.027743934,0.00048454327,0.002205431,0.000025761829],"about_ca_topic_score_codex":0.006326313,"about_ca_topic_score_gemma":0.0075566834,"teacher_disagreement_score":0.006326313,"about_ca_system_score_codex":0.00040641654,"about_ca_system_score_gemma":0.00023691745,"threshold_uncertainty_score":0.012578964},"labels":[],"label_agreement":null},{"id":"W2011586410","doi":"10.1067/mcp.2002.126174","title":"Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CYP2C19; Omeprazole; Menstrual cycle; Medicine; Internal medicine; Endocrinology; Cytochrome P450; Physiology; Hormone; Metabolism","score_opus":0.18530976811129077,"score_gpt":0.5257971988813166,"score_spread":0.34048743077002586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011586410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688005,0.0020538424,0.00019650772,0.000087579894,0.00002584298,0.000024962648,0.00014424701,0.000005912948,0.0005811508],"genre_scores_gemma":[0.99864465,0.0005481911,0.00027676122,0.000061141116,0.00002901336,0.000016779733,0.00012079865,0.000006595983,0.00029590804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992322,0.00039829858,0.00005240539,0.00009567548,0.0001692162,0.000052222393],"domain_scores_gemma":[0.99777526,0.001096997,0.00071322086,0.000114513365,0.00014345015,0.00015661855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009006724,0.00023806523,0.00032260965,0.00028945794,0.00013626495,0.00024985516,0.00014491004,0.00018462114,0.0014674865],"category_scores_gemma":[0.0028330442,0.00009179348,0.00029746685,0.00033885083,0.00017841159,0.00013754678,0.00015410513,0.00021526794,0.00016608123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008188118,0.00022061648,0.94269675,0.000096587326,0.00038599133,0.00029461447,0.00011044703,0.00008577572,0.021383688,0.00002705728,0.0002317173,0.026278649],"study_design_scores_gemma":[0.000043409953,0.0025860355,0.99350667,0.000010417236,0.00014753199,0.00047403597,0.000043632586,0.0001957436,0.0024228068,0.000013353322,0.00055286626,0.000003606829],"about_ca_topic_score_codex":0.00038419117,"about_ca_topic_score_gemma":0.0006649094,"teacher_disagreement_score":0.0014674865,"about_ca_system_score_codex":0.00013426822,"about_ca_system_score_gemma":0.00009208341,"threshold_uncertainty_score":0.004909277},"labels":[],"label_agreement":null},{"id":"W2012012982","doi":"10.1093/chrsci/49.2.108","title":"Determination of Pharmacokinetics of Flurbiprofen in Pakistani Population Using Modified HPLC Method","year":2011,"lang":"en","type":"article","venue":"Journal of Chromatographic Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flurbiprofen; Pharmacokinetics; Chemistry; Disposition; Pharmacology; Population; Chromatography; Medicine; Psychology","score_opus":0.20000171334017872,"score_gpt":0.4842981408414823,"score_spread":0.2842964275013036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012012982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874527,0.0018424719,0.0070011592,0.00016861428,0.000032727916,0.00014326986,0.0010205617,0.00008243678,0.0022561308],"genre_scores_gemma":[0.99038917,0.0013522484,0.0062199836,0.00019100717,0.00003984853,0.0001187685,0.0005900748,0.000008388085,0.0010904976],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965525,0.000072141294,0.000024153478,0.00009436856,0.00012002612,0.000034052868],"domain_scores_gemma":[0.9998004,0.000042577012,0.000068753536,0.000018142455,0.000054209046,0.000015955726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041735495,0.00032622143,0.0003336485,0.00040608,0.00031033732,0.00025269674,0.00019329591,0.0003434108,0.0010280042],"category_scores_gemma":[0.00076328794,0.00018212108,0.00016636049,0.00052962935,0.00021231327,0.00017516206,0.00009628706,0.0004514373,0.00025504167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025037583,0.0010284609,0.6347345,0.0004746292,0.0005144517,0.0024220059,0.0015774241,0.0014615804,0.22123082,0.00044504105,0.0028361212,0.13077123],"study_design_scores_gemma":[0.00015550361,0.0037650864,0.9389359,0.000042287335,0.00022445801,0.010409577,0.00041865365,0.0038348965,0.03565707,0.00022270635,0.0062595713,0.000074310214],"about_ca_topic_score_codex":0.0029718347,"about_ca_topic_score_gemma":0.0025613557,"teacher_disagreement_score":0.0029718347,"about_ca_system_score_codex":0.00019781642,"about_ca_system_score_gemma":0.00023441056,"threshold_uncertainty_score":0.0059090853},"labels":[],"label_agreement":null},{"id":"W2012225071","doi":"10.2174/1389200043335531","title":"Cytochrome P450 and Liver Diseases","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Alcoholic liver disease; Cytochrome P450; Drug metabolism; Liver disease; Pharmacology; Pathogenesis; Liver injury; Steatohepatitis; Acetaminophen; Fatty liver; Metabolite; Cirrhosis; Chemistry; Biology; Biochemistry; Medicine; Immunology; Metabolism; Internal medicine; Disease; Drug","score_opus":0.17439992346561517,"score_gpt":0.48166391284223137,"score_spread":0.3072639893766162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012225071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010970583,0.8938164,0.0037967395,0.020245021,0.004035242,0.0001518685,0.0030778137,0.00027966555,0.06362674],"genre_scores_gemma":[0.23801246,0.68319166,0.0065899054,0.00996443,0.011975097,0.00036161896,0.005818453,0.00013395223,0.04395239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979887,0.00083223986,0.00021424341,0.00029905114,0.00048056504,0.00018528194],"domain_scores_gemma":[0.99762386,0.0008962269,0.00060605205,0.00014414554,0.00051611,0.00021352674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013517953,0.0005821746,0.00086630124,0.0011124293,0.000532512,0.0014294193,0.00046314628,0.0011913015,0.017981721],"category_scores_gemma":[0.0047484078,0.0001261401,0.00050471275,0.002985536,0.00073193747,0.0006677051,0.0007305479,0.0018279622,0.00718128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050647097,0.00019945031,0.04173651,0.006176044,0.00043579206,0.002417773,0.00042619635,0.000369176,0.0010573565,0.020763583,0.23776932,0.6881424],"study_design_scores_gemma":[0.00007345749,0.00018757349,0.040215902,0.0026328391,0.00022460187,0.010203618,0.00021721398,0.00023624765,0.0003612606,0.015869992,0.92974013,0.00003720544],"about_ca_topic_score_codex":0.002090198,"about_ca_topic_score_gemma":0.0011489203,"teacher_disagreement_score":0.017981721,"about_ca_system_score_codex":0.00068846176,"about_ca_system_score_gemma":0.0010359657,"threshold_uncertainty_score":0.060154796},"labels":[],"label_agreement":null},{"id":"W2013199340","doi":"10.1016/j.msard.2012.11.003","title":"The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Multiple sclerosis; Drug; Drug reaction; Adverse effect; Intensive care medicine; Pharmacology; Immunology","score_opus":0.0915563427425296,"score_gpt":0.3518274075304867,"score_spread":0.2602710647879571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013199340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014683799,0.9990914,0.00017656757,0.00018133575,0.00006362527,0.0000028314046,0.000013914099,0.0000042129427,0.00031929722],"genre_scores_gemma":[0.0011528999,0.9979917,0.0003120013,0.00017005557,0.00014117153,0.0000038853746,0.000022028169,9.1442337e-7,0.00020538594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997366,0.00006675284,0.000041078194,0.000040844632,0.00009617086,0.00001843452],"domain_scores_gemma":[0.99934226,0.0004003602,0.00010521688,0.000015803776,0.0001056577,0.000030706244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009433114,0.00073293486,0.0019199911,0.0018572437,0.00016324554,0.00081576,0.00080062007,0.0010172112,0.0024529602],"category_scores_gemma":[0.0010501617,0.00019641717,0.0007810743,0.0017763883,0.0003679428,0.0007329265,0.000605057,0.0014102578,0.00073804054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010805617,0.00010109126,0.00042009354,0.0107015725,0.00024372975,0.0002508192,0.000025554658,0.00028468276,0.00127323,0.001468042,0.006702195,0.9784209],"study_design_scores_gemma":[0.00019685319,0.00052947365,0.006867429,0.009142414,0.0013867593,0.0035728926,0.00011477199,0.00051904656,0.0020495688,0.00628821,0.9692574,0.000075243464],"about_ca_topic_score_codex":0.0011647235,"about_ca_topic_score_gemma":0.0023285232,"teacher_disagreement_score":0.0024529602,"about_ca_system_score_codex":0.00035612326,"about_ca_system_score_gemma":0.0009771246,"threshold_uncertainty_score":0.00820601},"labels":[],"label_agreement":null},{"id":"W2013249805","doi":"10.4088/jcp.08r04856blu","title":"Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6","year":2009,"lang":"en","type":"review","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tamoxifen; CYP2D6; Bupropion; Venlafaxine; Antidepressant; Paroxetine; Breast cancer; Medicine; Pharmacology; Fluoxetine; Oncology; Internal medicine; Psychiatry; Cytochrome P450; Cancer; Metabolism; Receptor","score_opus":0.41565225308262443,"score_gpt":0.6227604105954995,"score_spread":0.20710815751287504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013249805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015193785,0.969535,0.00087087374,0.0049461345,0.00021242669,0.00015112819,0.0025267936,0.000025440746,0.0065383874],"genre_scores_gemma":[0.10882384,0.88033897,0.002653111,0.0026765629,0.0010368614,0.0001874361,0.0021765449,0.00000824031,0.0020984774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974564,0.00086545484,0.0007676937,0.00022843805,0.00062020496,0.00006190683],"domain_scores_gemma":[0.991388,0.0053224745,0.0026145023,0.0000738835,0.0005605226,0.000040505594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018839309,0.00044906794,0.0012902914,0.0029810045,0.00024507838,0.0011261533,0.0004953137,0.0012596984,0.0091718715],"category_scores_gemma":[0.008529817,0.000208382,0.0015698508,0.005383485,0.00028115025,0.0010726398,0.0003338862,0.0004576733,0.001147876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014625282,0.00015925869,0.042565886,0.2655766,0.004808763,0.00523731,0.00041690157,0.0005855206,0.0056873052,0.0018685748,0.029639602,0.64199173],"study_design_scores_gemma":[0.002355648,0.0032628886,0.22514844,0.1359416,0.03414458,0.038240016,0.0011473019,0.0013442105,0.013017463,0.00460983,0.5406153,0.00017279785],"about_ca_topic_score_codex":0.0015110824,"about_ca_topic_score_gemma":0.0037302368,"teacher_disagreement_score":0.0091718715,"about_ca_system_score_codex":0.000705336,"about_ca_system_score_gemma":0.00091533817,"threshold_uncertainty_score":0.030682981},"labels":[],"label_agreement":null},{"id":"W2013380575","doi":"10.1371/journal.pone.0015666","title":"Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism","year":2010,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Microsome; Verapamil; Messenger RNA; Pharmacology; Drug metabolism; CYP2C9; Biology; Drug; Cytochrome P450; Heart failure; Internal medicine; Endocrinology; Medicine; Metabolism; Enzyme; Biochemistry; Gene; Calcium","score_opus":0.14834241397453862,"score_gpt":0.38685983842399435,"score_spread":0.23851742444945573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013380575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954326,0.0013119073,0.0014437899,0.00003203114,0.0000075200937,0.000020498483,0.000850521,0.000018541208,0.0008826986],"genre_scores_gemma":[0.99486697,0.00051809504,0.0016102277,0.000028297727,0.00003157442,0.000043179098,0.002063558,0.000011375434,0.0008267147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997799,0.0000431822,0.000017822616,0.00008370091,0.00004271271,0.00003264606],"domain_scores_gemma":[0.99966717,0.00011295434,0.000080270205,0.000035984132,0.00007513963,0.000028344703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023959867,0.00015462766,0.00016767833,0.00039034328,0.00014073955,0.00033119463,0.00006700242,0.00016608708,0.0015831089],"category_scores_gemma":[0.00045219145,0.00009934485,0.00014024536,0.00027258828,0.00018230872,0.00009392262,0.000091007925,0.00022432311,0.00042118205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008610421,0.00007230966,0.087399274,0.00008814645,0.00007426924,0.00023585436,0.00019364212,0.0001110449,0.8984952,0.00008257061,0.00015874639,0.012227931],"study_design_scores_gemma":[0.000044727276,0.0010988301,0.74973714,0.0000146849825,0.00015970595,0.0019950846,0.00015643156,0.00071077596,0.24343726,0.00012544577,0.0025083378,0.000011616909],"about_ca_topic_score_codex":0.0003670816,"about_ca_topic_score_gemma":0.00039726574,"teacher_disagreement_score":0.0015831089,"about_ca_system_score_codex":0.000120038,"about_ca_system_score_gemma":0.00009467237,"threshold_uncertainty_score":0.005295992},"labels":[],"label_agreement":null},{"id":"W2013899794","doi":"10.1016/s0149-2918(02)80102-3","title":"An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme a reductase inhibitors on health care utilization: A Canadian population-based study","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Toronto Metropolitan University; University of Toronto; Bristol-Myers Squibb (Canada); PharmIdeas (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Statin; Medical prescription; Atorvastatin; Drug; Drug interaction; Health care; Pharmacology; Population; Adverse effect; Internal medicine; Environmental health","score_opus":0.19452395590427193,"score_gpt":0.5057903588286968,"score_spread":0.31126640292442487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013899794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347645,0.0011437519,0.00017574849,0.00033445706,0.000016106276,0.000100168654,0.0028434936,0.000010111379,0.0018996664],"genre_scores_gemma":[0.9967752,0.00075190637,0.0003156135,0.00020035687,0.000014950805,0.00003492388,0.0013029006,0.000008501409,0.0005956936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995706,0.00067142077,0.00030567404,0.0006179955,0.001875907,0.00082299346],"domain_scores_gemma":[0.9924839,0.000839498,0.0013999621,0.0004055801,0.0034773964,0.0013936093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030874882,0.0010114493,0.0011118116,0.003142174,0.004621656,0.0015951571,0.0023860035,0.0014559549,0.0020597668],"category_scores_gemma":[0.007879953,0.0009954172,0.0026209634,0.010879238,0.0013163842,0.0008044894,0.001164651,0.0017875386,0.00021614924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022165652,0.00008995219,0.9965978,0.00002734078,0.0003195996,0.0000968546,0.00039586058,0.00007011753,0.00012761053,0.000084380175,0.00034907297,0.001619795],"study_design_scores_gemma":[0.000027126316,0.000078800185,0.9987876,0.000007701697,0.00014968144,0.000078920435,0.0003093239,0.0001532962,0.00002743257,0.000012444787,0.00035422298,0.000013476919],"about_ca_topic_score_codex":0.9876386,"about_ca_topic_score_gemma":0.988766,"teacher_disagreement_score":0.025151994,"about_ca_system_score_codex":0.025151994,"about_ca_system_score_gemma":0.027501939,"threshold_uncertainty_score":0.18249136},"labels":[],"label_agreement":null},{"id":"W2014023051","doi":"10.2217/pgs.10.124","title":"Pharmacogenomic Testing for Angiotensin-Converting Enzyme Inhibitors: Getting Ready for Prime Time","year":2010,"lang":"en","type":"letter","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Pharmacogenomics; Pharmacology; Angiotensin-converting enzyme; Prime (order theory); Chemistry; Medicine; Internal medicine; Mathematics","score_opus":0.15434368504479087,"score_gpt":0.4108588781251313,"score_spread":0.25651519308034043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014023051","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007375984,0.0006954892,0.00028675812,0.98708135,0.00801731,0.00001131412,0.000033869554,0.000036814174,0.003099414],"genre_scores_gemma":[0.0076960335,0.0009440719,0.0008313951,0.9569935,0.025558865,0.000028467775,0.000038208407,0.000021686139,0.007887745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654776,0.0010255495,0.0003761645,0.00037090623,0.0010945408,0.0005852234],"domain_scores_gemma":[0.99217975,0.0037892135,0.00045206465,0.00021328052,0.0012740426,0.0020916269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028628963,0.00086999557,0.0012882095,0.00064808445,0.0026642417,0.0033279508,0.0013218637,0.057951804,0.0058888686],"category_scores_gemma":[0.017311724,0.000603301,0.0011727348,0.00048532974,0.0018009492,0.003795155,0.0014362768,0.034441493,0.00413972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014177455,0.000109327346,0.0021544963,0.000050187067,0.000019515215,0.0057978444,0.00010149819,0.000110113375,0.00080756634,0.0021225144,0.9679497,0.02063547],"study_design_scores_gemma":[0.000523854,0.00064683135,0.007528409,0.0005469556,0.00011222741,0.019148584,0.0007869948,0.002502626,0.0013275144,0.021566495,0.9451526,0.00015680573],"about_ca_topic_score_codex":0.0064469115,"about_ca_topic_score_gemma":0.014919807,"teacher_disagreement_score":0.057951804,"about_ca_system_score_codex":0.0037782663,"about_ca_system_score_gemma":0.005027164,"threshold_uncertainty_score":0.027413368},"labels":[],"label_agreement":null},{"id":"W2014144507","doi":"10.1038/clpt.2011.18","title":"Pharmacogenetic Testing: Time for Clinical Practice Guidelines","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute; BC Children's Hospital","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Clinical Practice; Drug; Medicine; Genetic testing; Drug reaction; Pharmacology; Drug response; Adverse effect; Intensive care medicine; Medical physics; Internal medicine; Family medicine; Biology; Gene; Genetics; Genotype","score_opus":0.806811082690761,"score_gpt":0.6867118532933741,"score_spread":0.12009922939738682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014144507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031922333,0.6216845,0.026624287,0.3155518,0.015339555,0.00058003224,0.00050998124,0.00077432167,0.018616218],"genre_scores_gemma":[0.004927537,0.7254023,0.13258691,0.107849225,0.012273297,0.0012254103,0.0022155207,0.00022166314,0.013298101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894069,0.004593222,0.0016892646,0.00059886003,0.0034563192,0.00025553993],"domain_scores_gemma":[0.9601239,0.017893145,0.0022617695,0.0018482503,0.015591527,0.0022814663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0273432,0.0022103975,0.0036419425,0.0044113505,0.0008265029,0.0037734106,0.0053773024,0.009674921,0.010333837],"category_scores_gemma":[0.04092758,0.0011184126,0.001784055,0.003984234,0.002203698,0.008437537,0.0032978097,0.013294238,0.011699921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035787278,0.0001777728,0.00019228496,0.003897683,0.00005091023,0.00038946304,0.00015785014,0.00068062946,0.00037869113,0.014415721,0.42683017,0.552793],"study_design_scores_gemma":[0.00006075428,0.000047117395,0.00060861936,0.014204367,0.000050582043,0.0009037511,0.0001996122,0.0005041856,0.00014552707,0.023203572,0.9600288,0.00004316134],"about_ca_topic_score_codex":0.0041827643,"about_ca_topic_score_gemma":0.005358137,"teacher_disagreement_score":0.0273432,"about_ca_system_score_codex":0.0036978319,"about_ca_system_score_gemma":0.012281475,"threshold_uncertainty_score":0.14460641},"labels":[],"label_agreement":null},{"id":"W2014305717","doi":"10.1371/journal.pone.0061897","title":"Water Oxidation by a Cytochrome P450: Mechanism and Function of the Reaction","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Chemistry; Borneol; Camphor; Hydrogen peroxide; Catalysis; Monooxygenase; Redox; Cytochrome; Catalytic cycle; Reaction mechanism; Biocatalysis; Photochemistry; Cytochrome P450; Medicinal chemistry; Organic chemistry; Enzyme","score_opus":0.08968631440100855,"score_gpt":0.3215443455690774,"score_spread":0.23185803116806886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014305717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77626383,0.044749327,0.16043322,0.0049967063,0.00060239,0.0004944548,0.0005887904,0.00094621634,0.01092513],"genre_scores_gemma":[0.9829338,0.0041737584,0.009243971,0.00015727019,0.000113352035,0.000049043934,0.0001936171,0.000023566457,0.003111577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997956,0.000036115212,0.000008850295,0.0000744128,0.000043127653,0.00004191752],"domain_scores_gemma":[0.99989045,0.00002033187,0.000021641761,0.000013063302,0.000027348464,0.00002711189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027510282,0.00083340344,0.0003361755,0.000245545,0.00034310055,0.00051462854,0.00050226634,0.00090519676,0.0012066064],"category_scores_gemma":[0.00028536527,0.00023519881,0.00038109912,0.00019605791,0.0006066866,0.0010199473,0.00033676444,0.0007692559,0.00080672256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017810745,0.000088110486,0.0019601437,0.00037000896,0.000032671753,0.0007799902,0.00009037821,0.00041861483,0.97618777,0.0033133845,0.0004928066,0.016088],"study_design_scores_gemma":[0.000033139535,0.00037274518,0.0048529506,0.000015903737,0.000033282126,0.0016899906,0.000079145255,0.0046607456,0.97672105,0.0024564536,0.009057703,0.000026814727],"about_ca_topic_score_codex":0.00068603543,"about_ca_topic_score_gemma":0.00031009418,"teacher_disagreement_score":0.0012066064,"about_ca_system_score_codex":0.00041722707,"about_ca_system_score_gemma":0.00021555877,"threshold_uncertainty_score":0.004036486},"labels":[],"label_agreement":null},{"id":"W2014467774","doi":"10.1071/rd11159","title":"Ontogenesis of phase I hepatic drug metabolic enzymes in sheep","year":2011,"lang":"en","type":"article","venue":"Reproduction Fertility and Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"U.S. National Library of Medicine; Canadian Institutes of Health Research","keywords":"Biology; CYP3A4; Fetus; Endocrinology; Internal medicine; Cytochrome P450; Messenger RNA; Enzyme; Drug metabolism; CYP2A6; CYP3A; Complementary DNA; Ontogeny; Metabolism; Gene; Biochemistry; Pregnancy; Genetics; Medicine","score_opus":0.17477960085153482,"score_gpt":0.4065292542753175,"score_spread":0.23174965342378268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014467774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742604,0.0045758667,0.0022254754,0.00008987459,0.000028408967,0.000042138403,0.00088625,0.00006169356,0.004664241],"genre_scores_gemma":[0.98192924,0.0034536375,0.002095668,0.000112116504,0.000026948537,0.00012635808,0.0012760193,0.00005370182,0.010926374],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998703,0.000015876527,0.000009873089,0.000059689257,0.00002785296,0.00001628134],"domain_scores_gemma":[0.999629,0.00007823507,0.00012424267,0.000026548121,0.000060203372,0.000081723374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012294487,0.00018053183,0.00030550736,0.00072669284,0.00016851773,0.00040478716,0.00014302538,0.00034623494,0.0015790865],"category_scores_gemma":[0.00040342828,0.0002518338,0.00023403807,0.0001487247,0.0002886835,0.00023884691,0.00025188012,0.0005175716,0.00087316177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070613343,0.00004757191,0.016963365,0.00011915325,0.000020007321,0.0006749938,0.0003885501,0.00011503629,0.9557659,0.00044640028,0.00027739443,0.024475433],"study_design_scores_gemma":[0.000049526167,0.0019868165,0.7780424,0.00012733287,0.00008132627,0.0036443402,0.00092700886,0.00082421856,0.19326721,0.0009029258,0.020102767,0.00004409282],"about_ca_topic_score_codex":0.0009810532,"about_ca_topic_score_gemma":0.0012826548,"teacher_disagreement_score":0.0015790865,"about_ca_system_score_codex":0.00030165535,"about_ca_system_score_gemma":0.00015646545,"threshold_uncertainty_score":0.0052825212},"labels":[],"label_agreement":null},{"id":"W2014927292","doi":"10.1182/blood-2011-08-372722","title":"VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Dosing; Medicine; Vitamin K epoxide reductase; Pharmacogenomics; Maintenance dose; Cohort; Internal medicine; Pharmacology; Genotype; Biology; Atrial fibrillation; Genetics","score_opus":0.055999133099533804,"score_gpt":0.32894300954047917,"score_spread":0.27294387644094537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014927292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814315,0.0063816016,0.0070085907,0.00068275083,0.000052281837,0.000042265212,0.0023079722,0.000069107125,0.0020239116],"genre_scores_gemma":[0.99251515,0.0012796372,0.0031026197,0.00019362425,0.000051621388,0.000035651945,0.0023327763,0.000035755045,0.00045322883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975739,0.000872056,0.00028965579,0.0005387132,0.00055455364,0.00017111104],"domain_scores_gemma":[0.9942239,0.0023710013,0.0020143823,0.00076346286,0.00044117923,0.0001861187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002426778,0.00062027335,0.00093711686,0.00081430725,0.0002779162,0.0008221779,0.0006996151,0.00051872234,0.001835037],"category_scores_gemma":[0.007059339,0.00028302855,0.00094512594,0.0016586186,0.00039879754,0.00048970117,0.00033535797,0.0007750065,0.00034836275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015232331,0.000011920852,0.9916785,0.000020419482,0.00033713024,0.000095167976,0.00005640705,0.00018912953,0.0003205056,0.00008997992,0.0003063248,0.0067423414],"study_design_scores_gemma":[0.0000129748105,0.000063311694,0.99696237,0.000020750187,0.00016498707,0.00055653194,0.00005950227,0.00067320175,0.00026257138,0.00014648722,0.0010691463,0.000008082454],"about_ca_topic_score_codex":0.009432056,"about_ca_topic_score_gemma":0.006632766,"teacher_disagreement_score":0.009432056,"about_ca_system_score_codex":0.00044418557,"about_ca_system_score_gemma":0.00052703486,"threshold_uncertainty_score":0.018754303},"labels":[],"label_agreement":null},{"id":"W2016290546","doi":"10.1111/j.1365-2710.2007.00870.x","title":"Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Pharmacy and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Universitaire de la Francophonie","keywords":"CYP2C9; CYP2C19; Acenocoumarol; Pharmacogenetics; CYP3A5; CYP1A2; CYP3A4; Pharmacology; VKORC1; Genetics; Medicine; Gene; Biology; Cytochrome P450; Warfarin; Genotype; Biochemistry; Internal medicine; Microsome; Enzyme; In vitro","score_opus":0.31704571967649586,"score_gpt":0.5557127096929809,"score_spread":0.23866699001648506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016290546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901175,0.00046182485,0.00012417068,0.00002406881,0.000002559304,0.000004259322,0.00010366769,0.0000024440342,0.00026538293],"genre_scores_gemma":[0.99970716,0.000057329555,0.00006490952,0.00000951096,0.0000041432863,0.0000026977393,0.00008238577,0.0000012751423,0.000070603164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996728,0.00009570305,0.000038712176,0.000084141866,0.00006618185,0.000042473523],"domain_scores_gemma":[0.99940133,0.00017428004,0.00028295943,0.0000340818,0.000038836726,0.00006849989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023258125,0.00015395149,0.00036317247,0.00046541065,0.00020902892,0.00032411373,0.00013762052,0.0002702263,0.002288414],"category_scores_gemma":[0.0009898768,0.0000939943,0.0002774836,0.0007156221,0.00019151071,0.00011873723,0.000103192906,0.00028942648,0.000197741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030598778,0.00003207793,0.99538475,0.000011963452,0.00007371338,0.00017727006,0.000044556018,0.0001054545,0.0012486187,0.00002825158,0.000044243192,0.0025430582],"study_design_scores_gemma":[0.00000821341,0.00010571287,0.9983518,0.0000031051363,0.000031346714,0.0008703054,0.000034464618,0.00017717812,0.00025374364,0.00002285451,0.00013944933,0.0000018552371],"about_ca_topic_score_codex":0.0015342509,"about_ca_topic_score_gemma":0.001216728,"teacher_disagreement_score":0.002288414,"about_ca_system_score_codex":0.00019297014,"about_ca_system_score_gemma":0.0001394668,"threshold_uncertainty_score":0.0076554418},"labels":[],"label_agreement":null},{"id":"W2016361130","doi":"10.1124/dmd.30.10.1063","title":"Metabolic Activation of 4-Hydroxyanisole by Isolated Rat Hepatocytes","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cytotoxicity; Glutathione; Chemistry; Metabolite; Biochemistry; Pharmacology; Butylated hydroxyanisole; Buthionine sulfoximine; Toxicity; Antioxidant; Biology; Enzyme; In vitro","score_opus":0.037251659351443506,"score_gpt":0.33387947819396474,"score_spread":0.2966278188425212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016361130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083066,0.0017800718,0.004708418,0.00014866002,0.00011514329,0.00005626533,0.00054446666,0.00010764157,0.0017086634],"genre_scores_gemma":[0.99558926,0.00050179876,0.001485707,0.000033236167,0.000030647254,0.00003158945,0.0007032367,0.000023675608,0.0016008479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996846,0.00010962226,0.00002148572,0.00004934366,0.000055981563,0.00007906781],"domain_scores_gemma":[0.9998148,0.0000701439,0.000021731825,0.000042781587,0.000028801553,0.000021757456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031256187,0.0005805599,0.00056193327,0.00046547365,0.00033258047,0.00037732537,0.00033510083,0.00033661228,0.0019863462],"category_scores_gemma":[0.00025319378,0.0002676795,0.00075941184,0.00044088712,0.00040034554,0.0003543514,0.00032851848,0.000553449,0.0005935794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046844906,0.000080538724,0.00089078856,0.00007356179,0.000046089448,0.00023815501,0.000063244566,0.0005403952,0.98923486,0.00019755703,0.00008565816,0.0038646369],"study_design_scores_gemma":[0.000040712566,0.0005704544,0.0017316535,0.0000021248409,0.000025463964,0.00010285158,0.00003358318,0.0007508762,0.9962913,0.000052468666,0.0003920111,0.0000064979035],"about_ca_topic_score_codex":0.0026238507,"about_ca_topic_score_gemma":0.0039164657,"teacher_disagreement_score":0.0026238507,"about_ca_system_score_codex":0.0005509518,"about_ca_system_score_gemma":0.0005473402,"threshold_uncertainty_score":0.006645024},"labels":[],"label_agreement":null},{"id":"W2016448468","doi":"10.1007/s00204-014-1218-6","title":"Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic","year":2014,"lang":"en","type":"article","venue":"Archives of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Monooxygenase; Ex vivo; Esterase; Cytochrome P450; Human skin; Chemistry; Glutathione; Isozyme; Enzyme; In vivo; Xenobiotic; Biochemistry; Pharmacology; In vitro; Biology; Genetics","score_opus":0.10955456522387487,"score_gpt":0.4296709575214729,"score_spread":0.32011639229759803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016448468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848873,0.0010981546,0.0072683855,0.00003269047,0.000035672467,0.00003554634,0.00051583204,0.00006770014,0.002457206],"genre_scores_gemma":[0.9906784,0.00085948454,0.003453213,0.000026724536,0.0000057761863,0.000027713824,0.00079950964,0.000026910311,0.0041221827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998661,0.000029468,0.0000116208175,0.000036737125,0.0000335039,0.000022624065],"domain_scores_gemma":[0.99984837,0.000038255366,0.000022050745,0.000037683832,0.000028978577,0.000024613932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022343449,0.00031985244,0.00018982436,0.00030938722,0.00011573236,0.00036750862,0.00013400128,0.00020706569,0.002725093],"category_scores_gemma":[0.00015660365,0.00015142697,0.00039604265,0.0002101504,0.00021544495,0.00030679832,0.00014739831,0.00045976083,0.0004331867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082002324,0.00009438766,0.0011991435,0.00004313957,0.000023500814,0.00019103194,0.00003518462,0.00018473157,0.9944693,0.00012006574,0.000031307343,0.0027882599],"study_design_scores_gemma":[0.00001610281,0.0007441671,0.010149055,0.0000057017232,0.00007190528,0.00071232504,0.00011724313,0.0010883398,0.98584497,0.000058435668,0.0011856708,0.0000061165892],"about_ca_topic_score_codex":0.0005195192,"about_ca_topic_score_gemma":0.0005500391,"teacher_disagreement_score":0.002725093,"about_ca_system_score_codex":0.00010122236,"about_ca_system_score_gemma":0.00015848955,"threshold_uncertainty_score":0.009116352},"labels":[],"label_agreement":null},{"id":"W2016545633","doi":"10.1097/fpc.0b013e3282f3606e","title":"A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"CYP2A6; Pharmacogenetics; Allele; In vivo; Genetics; Allele frequency; Biology; Population; Descent (aeronautics); Enzyme; In vitro; Gene; Medicine; Genotype; Geography; Environmental health; Biochemistry","score_opus":0.0661402791490691,"score_gpt":0.34489303013547035,"score_spread":0.27875275098640123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016545633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889994,0.000260936,0.0005192714,0.000039348102,0.0000092286555,0.000009385884,0.00010493998,0.000016927863,0.00013993752],"genre_scores_gemma":[0.9977029,0.00023500065,0.001149711,0.000046253812,0.00001412266,0.000015915677,0.0002375106,0.000014323871,0.00058426405],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997725,0.00006019594,0.000013851945,0.00007172591,0.00005619902,0.000025478987],"domain_scores_gemma":[0.9997112,0.000045367517,0.00014349358,0.000021007525,0.000021922402,0.000056973768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029529168,0.00041763118,0.00034325075,0.00020369209,0.00018186512,0.00018896548,0.0001469826,0.0003236046,0.0020746754],"category_scores_gemma":[0.00049699954,0.0000921471,0.00025450584,0.00021339317,0.00020005122,0.000066445034,0.000100169396,0.00038523547,0.00026729086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014052159,0.00031624944,0.062351767,0.000075851196,0.0001982861,0.0007435889,0.0000951545,0.0001196105,0.9244725,0.00008952349,0.00022956272,0.009902664],"study_design_scores_gemma":[0.0002648547,0.0050008344,0.71324885,0.000040680865,0.0004725384,0.018839521,0.00014161774,0.0018707177,0.255208,0.0001535678,0.004726811,0.000031991312],"about_ca_topic_score_codex":0.0011206367,"about_ca_topic_score_gemma":0.0010442466,"teacher_disagreement_score":0.0020746754,"about_ca_system_score_codex":0.0001474357,"about_ca_system_score_gemma":0.00014641508,"threshold_uncertainty_score":0.0069405437},"labels":[],"label_agreement":null},{"id":"W2016959089","doi":"10.1124/dmd.112.048835","title":"The Role of Cytochrome P450–Dependent Metabolism in the Regulation of Mouse Hepatic Growth Hormone Signaling Components and Target Genes by 3-Methylcholanthrene","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Biology; Internal medicine; Endocrinology; Aryl hydrocarbon receptor; Cytochrome P450; Wild type; CYP1A2; CYP1B1; Protein kinase B; Signal transduction; Growth hormone receptor; Gene; Hormone; Metabolism; Cell biology; Transcription factor; Biochemistry","score_opus":0.022962910056862552,"score_gpt":0.31610187990290517,"score_spread":0.2931389698460426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016959089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927563,0.0013418923,0.0038425298,0.00019236143,0.000021590755,0.000019362782,0.0006890245,0.00012898435,0.001007985],"genre_scores_gemma":[0.9943632,0.0006114856,0.0015233149,0.000047868474,0.0000084521735,0.00003491964,0.0004771454,0.000058482015,0.002875288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997708,0.00004951546,0.000018120474,0.00005346617,0.000056500132,0.000051653824],"domain_scores_gemma":[0.99966216,0.000076939534,0.00010587533,0.00006086093,0.000025237932,0.000069002235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021159282,0.0004948787,0.00023907884,0.00092443405,0.00026055434,0.00051373465,0.00025807112,0.00032839825,0.0011650637],"category_scores_gemma":[0.00021737647,0.00043437455,0.00047514518,0.00031087772,0.00047777093,0.00029611008,0.00021641959,0.0006575919,0.00032113638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005009769,0.000024529052,0.001123893,0.000009879293,0.0000087026965,0.00006675762,0.000020136431,0.00008474618,0.99685293,0.00021453352,0.000024373125,0.0010686275],"study_design_scores_gemma":[0.000023194529,0.0001238265,0.02130851,0.00000394843,0.000032844066,0.00019375882,0.000037306112,0.00085586664,0.9763885,0.0001662287,0.0008581388,0.000007914333],"about_ca_topic_score_codex":0.0022117125,"about_ca_topic_score_gemma":0.003182178,"teacher_disagreement_score":0.0022117125,"about_ca_system_score_codex":0.00055256265,"about_ca_system_score_gemma":0.00031561046,"threshold_uncertainty_score":0.0043976307},"labels":[],"label_agreement":null},{"id":"W2017109689","doi":"10.1517/17425255.2011.585968","title":"Have physiologically-based pharmacokinetic models delivered?","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Heartland Health Research Alliance; U.S. Environmental Protection Agency","keywords":"Physiologically based pharmacokinetic modelling; In silico; Pharmacokinetics; Drug development; Drug; Human health; Computational biology; Computer science; Biochemical engineering; Pharmacology; Risk analysis (engineering); Medicine; Biology; Engineering","score_opus":0.2037785665111753,"score_gpt":0.41993476547632874,"score_spread":0.21615619896515345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017109689","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023786865,0.09119985,0.29692575,0.5470275,0.011114883,0.0002866186,0.0010690525,0.0009114803,0.02767802],"genre_scores_gemma":[0.47601226,0.15264179,0.19727446,0.14107567,0.00850197,0.0007507479,0.0015257125,0.00074481533,0.021472557],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99025947,0.0046090353,0.000689243,0.0013921678,0.0026671805,0.00038286095],"domain_scores_gemma":[0.982557,0.007789297,0.0018573535,0.002206211,0.0050248457,0.0005652871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019281436,0.0012261051,0.0025080196,0.00091234903,0.0008026046,0.007044174,0.0021361662,0.006912608,0.0061203474],"category_scores_gemma":[0.050722998,0.0010894571,0.0016662492,0.001063673,0.003829572,0.014735536,0.002345154,0.010195244,0.0060529015],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068756903,0.000428211,0.009239489,0.0031422768,0.00043748203,0.0006276995,0.0021393397,0.03598046,0.008456554,0.44967282,0.052618995,0.43656915],"study_design_scores_gemma":[0.00016067954,0.00095030805,0.00310625,0.0017826536,0.00029685022,0.0011976381,0.0020774063,0.044936847,0.008909954,0.54029864,0.3959104,0.0003724254],"about_ca_topic_score_codex":0.006392593,"about_ca_topic_score_gemma":0.0025905948,"teacher_disagreement_score":0.019281436,"about_ca_system_score_codex":0.005970111,"about_ca_system_score_gemma":0.0061591123,"threshold_uncertainty_score":0.10197115},"labels":[],"label_agreement":null},{"id":"W2017394346","doi":"10.1016/s0009-2797(00)00246-5","title":"Cytochrome P450 2E1 metabolically activates propargyl alcohol: propiolaldehyde-induced hepatocyte cytotoxicity","year":2001,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chemistry; Alcohol dehydrogenase; Glutathione; Cytotoxicity; Biochemistry; Catalase; Pharmacology; Hepatocyte; Alcohol; Enzyme; Biology; In vitro","score_opus":0.2703021651535082,"score_gpt":0.47003989163839943,"score_spread":0.19973772648489124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017394346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924252,0.0007556004,0.0037231136,0.00018933314,0.00006564736,0.000057527715,0.00030305365,0.00009692783,0.0023835402],"genre_scores_gemma":[0.9965926,0.0003764003,0.0005366528,0.00003349985,0.0000130875405,0.00002410613,0.0003593098,0.000011253281,0.002053038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976486,0.00008453441,0.000014080471,0.000022436781,0.000045494948,0.000068632195],"domain_scores_gemma":[0.99982387,0.000054604192,0.00003322408,0.000030720217,0.000032913915,0.000024686131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002828616,0.00048183548,0.00022743898,0.00035388616,0.00020781433,0.00027751797,0.00016549947,0.00030474024,0.004070447],"category_scores_gemma":[0.00031325634,0.00021291495,0.0003502524,0.00028314273,0.00021827618,0.00026062017,0.00026475833,0.00046974243,0.00088077073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024165595,0.00023485767,0.0013849172,0.000085249514,0.000036841804,0.00060224155,0.000038423317,0.0002878085,0.99011034,0.00036149746,0.00021812764,0.0042232005],"study_design_scores_gemma":[0.0000314653,0.0005591799,0.0019433411,0.0000022408487,0.0000151504955,0.00025990262,0.00002031537,0.00035770622,0.9960194,0.000051852585,0.0007360814,0.0000032034945],"about_ca_topic_score_codex":0.0009309203,"about_ca_topic_score_gemma":0.0011353699,"teacher_disagreement_score":0.004070447,"about_ca_system_score_codex":0.0004503703,"about_ca_system_score_gemma":0.00034754124,"threshold_uncertainty_score":0.013617039},"labels":[],"label_agreement":null},{"id":"W2017568512","doi":"10.1021/ac202787n","title":"Functional Screening of Cytochrome P450 Activity and Uncoupling by Capillary Electrophoresis","year":2011,"lang":"en","type":"letter","venue":"Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Chemistry; Cytochrome P450; Xenobiotic; Substrate (aquarium); Biochemistry; Monooxygenase; Cytochrome; Capillary electrophoresis; Metabolism; Enzyme; Chromatography; Biology","score_opus":0.09038373432684911,"score_gpt":0.3632725842239597,"score_spread":0.2728888498971106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017568512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89660305,0.0124577535,0.073861085,0.0034970718,0.0003587489,0.00036967432,0.00085542083,0.0007240316,0.011273173],"genre_scores_gemma":[0.9235884,0.0063123805,0.05942355,0.0012061972,0.00013411691,0.00048718508,0.0017475561,0.00009415125,0.007006533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989925,0.00025635568,0.000055061424,0.00014603807,0.00045614602,0.00009400976],"domain_scores_gemma":[0.9988991,0.0005402142,0.00013464144,0.00010376509,0.0002832834,0.00003898419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007192231,0.0006432468,0.00037110975,0.0003745497,0.00020522496,0.00032640997,0.00054536655,0.0010643456,0.00083422975],"category_scores_gemma":[0.0017161482,0.00017298062,0.00017975167,0.0003546113,0.00032894345,0.00024075761,0.00020117038,0.00067832397,0.0006554058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007933742,0.00003767638,0.0007063722,0.00007808105,0.00000806515,0.00018583062,0.000030200807,0.00007217943,0.9873591,0.00029364746,0.00044769212,0.0107016545],"study_design_scores_gemma":[0.000014092353,0.0003824415,0.0042953864,0.000008021131,0.000016417722,0.0008979101,0.000018871182,0.0018516473,0.9870459,0.0001835482,0.0052740225,0.000011700723],"about_ca_topic_score_codex":0.00064810726,"about_ca_topic_score_gemma":0.0008785488,"teacher_disagreement_score":0.0010643456,"about_ca_system_score_codex":0.0004756151,"about_ca_system_score_gemma":0.0001959101,"threshold_uncertainty_score":0.0038036704},"labels":[],"label_agreement":null},{"id":"W2018457102","doi":"10.1007/s11606-010-1515-6","title":"Personalized Medicine: Understanding Probabilities and Managing Expectations","year":2010,"lang":"en","type":"review","venue":"Journal of General Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Stylized fact; Personalized medicine; Medicine; Creativity; Precision medicine; Health care; Set (abstract data type); Engineering ethics; Data science; Management science; Computer science; Bioinformatics; Psychology; Pathology","score_opus":0.3094777700488312,"score_gpt":0.5173109236552946,"score_spread":0.20783315360646343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018457102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011517616,0.6652365,0.21521951,0.08250702,0.0017926275,0.00015233614,0.00047688858,0.00041471422,0.022682838],"genre_scores_gemma":[0.22491604,0.64428324,0.110539064,0.010638324,0.00477029,0.00023671548,0.0003711191,0.000058368718,0.0041868105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755955,0.0014129112,0.00016934138,0.00018489131,0.00062454224,0.000048734513],"domain_scores_gemma":[0.98930335,0.009168102,0.0006511604,0.00018497834,0.00055691734,0.00013554384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004401162,0.0008223499,0.0012814142,0.0012587875,0.0002945741,0.0021746557,0.001080079,0.0015349685,0.0024015582],"category_scores_gemma":[0.019485889,0.00037436406,0.0006625367,0.0009829983,0.0012834838,0.0036763146,0.0010131134,0.002854009,0.0005383429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005020365,0.000089688736,0.0033169552,0.0021910253,0.00019423288,0.00015430577,0.00037130387,0.00507317,0.00023988402,0.02989063,0.015875543,0.9425529],"study_design_scores_gemma":[0.000074390504,0.00020989601,0.01609357,0.0076836618,0.00068288494,0.0030972084,0.0011933635,0.024774728,0.0015332972,0.67292625,0.27150753,0.00022319588],"about_ca_topic_score_codex":0.0020666567,"about_ca_topic_score_gemma":0.0026695644,"teacher_disagreement_score":0.004401162,"about_ca_system_score_codex":0.0016642214,"about_ca_system_score_gemma":0.0022768064,"threshold_uncertainty_score":0.023275852},"labels":[],"label_agreement":null},{"id":"W2018954315","doi":"10.1182/blood-2011-03-345173","title":"Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Pharmacogenetics; CYP2C9; Vitamin K epoxide reductase; Medicine; Regimen; Maintenance dose; Internal medicine; Pharmacology; Dosing; Therapeutic index; Atrial fibrillation; Genotype; Biology; Genetics; Drug; Cytochrome P450","score_opus":0.28632132103989605,"score_gpt":0.4536510918270174,"score_spread":0.16732977078712136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018954315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976525,0.00018613871,0.0009824798,0.000037949794,0.000012286315,0.00019208514,0.00023728373,0.000021802565,0.00067750027],"genre_scores_gemma":[0.9977957,0.000067930916,0.0014762122,0.000047647372,0.000014009171,0.0001295138,0.0003583281,0.000006534675,0.00010421326],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99776924,0.0009146247,0.00025589575,0.00042863836,0.00050939556,0.00012227906],"domain_scores_gemma":[0.9948059,0.0011474831,0.0020937987,0.00066950044,0.0006935342,0.0005897889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031477998,0.0003618723,0.00053035707,0.0004107659,0.0003082437,0.00073272956,0.0003830907,0.0004061201,0.0004638559],"category_scores_gemma":[0.008717167,0.00021666178,0.000435246,0.0005807572,0.00015448236,0.00040061335,0.00037819005,0.00046726322,0.0002455614],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056620114,0.0006648827,0.9723982,0.00003291483,0.00009359384,0.00008390281,0.00013996336,0.00039947592,0.0014670511,0.00004731963,0.00019150766,0.018819187],"study_design_scores_gemma":[0.00031196701,0.0075333123,0.98778963,0.000020508396,0.00014585139,0.00022866718,0.00007180971,0.0022435335,0.0011675652,0.00003794665,0.00043578658,0.000013384681],"about_ca_topic_score_codex":0.00093356776,"about_ca_topic_score_gemma":0.0012516052,"teacher_disagreement_score":0.0031477998,"about_ca_system_score_codex":0.00049722224,"about_ca_system_score_gemma":0.0009103757,"threshold_uncertainty_score":0.016647339},"labels":[],"label_agreement":null},{"id":"W2019013686","doi":"10.1016/j.clinbiochem.2012.01.002","title":"Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic","year":2012,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"Sunnybrook Research Institute","keywords":"VKORC1; Warfarin; Genotyping; CYP2C9; Pharmacogenetics; Single-nucleotide polymorphism; Vitamin K epoxide reductase; Medicine; Population; Allele frequency; Anticoagulant; Internal medicine; Genotype; Biology; Genetics; Gene; Atrial fibrillation","score_opus":0.18982417356238343,"score_gpt":0.4939509925637549,"score_spread":0.3041268190013715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019013686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987858,0.00018813585,0.00028057513,0.00013830022,0.000010295586,0.000012613358,0.00006763066,0.00000716391,0.0005094581],"genre_scores_gemma":[0.9992687,0.000045718964,0.00046133058,0.000040710784,0.000012816424,0.0000059437866,0.000049060705,0.000008789459,0.00010681764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972988,0.0013362058,0.0002957294,0.00048206965,0.00047280014,0.00011449656],"domain_scores_gemma":[0.9962127,0.0023126733,0.000695425,0.00017088832,0.00026151957,0.00034683518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020607705,0.00086578913,0.000853769,0.0011041358,0.0005895759,0.00085788476,0.0004626351,0.0008890938,0.0014831185],"category_scores_gemma":[0.008995923,0.00017791893,0.00069404184,0.0009804594,0.0005472797,0.00045033253,0.000382336,0.00066307175,0.00026475076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01251808,0.0007554348,0.93872225,0.000045787416,0.000701903,0.0027160258,0.00073086243,0.0014590293,0.02031108,0.0003500525,0.0002508576,0.021438673],"study_design_scores_gemma":[0.0005012424,0.0053183236,0.9758606,0.000028009734,0.0009245673,0.0044014975,0.00046475691,0.0070010154,0.0043373248,0.00039620957,0.0007187468,0.000047712005],"about_ca_topic_score_codex":0.0022094776,"about_ca_topic_score_gemma":0.0023610506,"teacher_disagreement_score":0.0022094776,"about_ca_system_score_codex":0.00053488096,"about_ca_system_score_gemma":0.00053490314,"threshold_uncertainty_score":0.0108985305},"labels":[],"label_agreement":null},{"id":"W2019329705","doi":"10.1155/2013/943014","title":"Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs","year":2013,"lang":"en","type":"review","venue":"Pain Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacogenomics; Medicine; Adverse effect; Pharmacoeconomics; Opioid; Intensive care medicine; Chronic pain; Precision medicine; Health care; Pharmacogenetics; Psychiatry; Pharmacology; Internal medicine","score_opus":0.4528503072247933,"score_gpt":0.5662816994102443,"score_spread":0.11343139218545101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019329705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009731731,0.9994098,0.000037526068,0.0001592128,0.00003846385,0.0000056659082,0.000020277455,0.0000017445111,0.00022990289],"genre_scores_gemma":[0.0010538392,0.99855334,0.00012017565,0.000097023825,0.00007281345,0.000009655975,0.000016547909,5.9702234e-7,0.00007603665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896574,0.00027136007,0.0002426011,0.00008484403,0.00039714796,0.000038303777],"domain_scores_gemma":[0.9978066,0.0014345048,0.0004291555,0.000029132741,0.00026891337,0.00003160683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015523806,0.0008794897,0.0029229857,0.0043474236,0.00022935116,0.0013992031,0.000853621,0.0012375154,0.003209107],"category_scores_gemma":[0.0035680518,0.00031006697,0.001672076,0.0060627037,0.00030744044,0.001074274,0.0004177771,0.00089102186,0.0006323767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012587423,0.00008368982,0.0007756514,0.13054127,0.0012951969,0.0002649935,0.000056636596,0.0002915472,0.0007065758,0.0017812977,0.01216783,0.85190934],"study_design_scores_gemma":[0.0003065428,0.00060541497,0.019477498,0.20844224,0.0120188445,0.0071940725,0.00035892864,0.00081493513,0.0018553118,0.0062331893,0.74256027,0.0001327391],"about_ca_topic_score_codex":0.0017781969,"about_ca_topic_score_gemma":0.0032093343,"teacher_disagreement_score":0.0043474236,"about_ca_system_score_codex":0.0011267188,"about_ca_system_score_gemma":0.0022880621,"threshold_uncertainty_score":0.010735571},"labels":[],"label_agreement":null},{"id":"W2019742973","doi":"10.1111/j.1365-2125.2004.02162.x","title":"A convenient five‐drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study","year":2004,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Chlorzoxazone; Pharmacology; Metoprolol; Tolbutamide; CYP1A2; CYP2D6; Paraxanthine; Theophylline; Debrisoquine; Caffeine; Dapsone; Chemistry; Dextromethorphan; Xanthine oxidase; CYP2C9; Drug interaction; Medicine; Drug; CYP2E1; Cytochrome P450; Internal medicine; Endocrinology; Metabolism; Biochemistry; Enzyme; Diabetes mellitus","score_opus":0.2111626489578926,"score_gpt":0.5403817289466539,"score_spread":0.3292190799887613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019742973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904309,0.00039309709,0.0077892006,0.000081808736,0.00004512039,0.0008880386,0.00014033643,0.000046772766,0.00018478624],"genre_scores_gemma":[0.9678054,0.0009026539,0.027415643,0.00019044706,0.00008819264,0.0013325838,0.000958065,0.000034563753,0.0012724878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989176,0.00043369192,0.00006512582,0.00020721572,0.00028732722,0.00008905712],"domain_scores_gemma":[0.99930084,0.0001476796,0.00013053289,0.000107995766,0.00008262337,0.0002302908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012016463,0.000758575,0.0007887592,0.000400596,0.0003239855,0.00046133046,0.00068543974,0.000703614,0.0016628372],"category_scores_gemma":[0.0009643188,0.00041436314,0.0004927628,0.00028281115,0.00059983705,0.00045173653,0.00044418345,0.00096111035,0.00037601116],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00588794,0.008302036,0.002435597,0.000109158485,0.00008545296,0.00008270252,0.00008492342,0.000181389,0.972097,0.000031296986,0.0001259492,0.010576679],"study_design_scores_gemma":[0.00395769,0.5116082,0.035879977,0.00003288436,0.0005574968,0.0012133976,0.00017029517,0.0024438258,0.44040155,0.000080836486,0.0035885107,0.00006533901],"about_ca_topic_score_codex":0.00039857844,"about_ca_topic_score_gemma":0.000871913,"teacher_disagreement_score":0.0016628372,"about_ca_system_score_codex":0.00019867878,"about_ca_system_score_gemma":0.0005479614,"threshold_uncertainty_score":0.0063549876},"labels":[],"label_agreement":null},{"id":"W2019791623","doi":"10.1016/s0196-9781(01)00364-3","title":"Recognition and oxidative metabolism of cyclodipeptides by hepatic cytochrome P450","year":2001,"lang":"en","type":"article","venue":"Peptides","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Cytochrome P450; Metabolism; Biochemistry; Chemistry; Amino acid; Drug metabolism; Peptide; Biology","score_opus":0.10694778888943761,"score_gpt":0.39257723358628976,"score_spread":0.28562944469685214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019791623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951851,0.0011721995,0.002187493,0.00010794402,0.0000132640325,0.00001790758,0.00012876696,0.000012507694,0.0011748301],"genre_scores_gemma":[0.9984407,0.0004072361,0.0004703881,0.00002929886,0.000015779402,0.000007786099,0.0001556939,0.0000035759379,0.00046956298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981755,0.00007229641,0.000007782572,0.000036313693,0.000025184532,0.00004099777],"domain_scores_gemma":[0.9996586,0.00008586191,0.00013029389,0.000034216235,0.000035526497,0.00005561719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002234773,0.00023460083,0.00018061,0.00030933562,0.00020699129,0.00033120252,0.000115585884,0.00023291612,0.0017891192],"category_scores_gemma":[0.0005847636,0.0001605201,0.00019615964,0.00021523162,0.0002404156,0.00025176702,0.00019507504,0.00038396305,0.00028636333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003959464,0.00021620466,0.05894714,0.00010979993,0.00011383464,0.0012899425,0.0001690039,0.00030781294,0.9012607,0.00088371517,0.00024309539,0.032499366],"study_design_scores_gemma":[0.00009835119,0.001680908,0.2359845,0.00001757053,0.000070483155,0.0035062162,0.00017672848,0.0016958235,0.7547518,0.00067992136,0.0013186139,0.00001914235],"about_ca_topic_score_codex":0.000991604,"about_ca_topic_score_gemma":0.0008423224,"teacher_disagreement_score":0.0017891192,"about_ca_system_score_codex":0.0002572857,"about_ca_system_score_gemma":0.00011772742,"threshold_uncertainty_score":0.0059852004},"labels":[],"label_agreement":null},{"id":"W2020003713","doi":"10.1111/bcpt.12071","title":"Enantiomer Selective Glucuronidation of the Non‐Steroidal Pure Anti‐Androgen Bicalutamide by Human Liver and Kidney: Role of the Human <scp>UDP</scp>‐Glucuronosyltransferase (<scp>UGT</scp>)1A9 Enzyme","year":2013,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Bicalutamide; Glucuronidation; Chemistry; Microsome; Glucuronosyltransferase; UGT2B7; Enantiomer; Pharmacology; Enzyme; Biochemistry; Internal medicine; Androgen receptor; Prostate cancer; Medicine; Stereochemistry; Cancer","score_opus":0.042002983008611466,"score_gpt":0.3787265330817431,"score_spread":0.3367235500731316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020003713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841685,0.0065538343,0.0032985893,0.000089385976,0.00001853846,0.000027422248,0.0004175235,0.0000586712,0.0011192947],"genre_scores_gemma":[0.9935508,0.0015955154,0.0020962695,0.000047034973,0.000008004326,0.000011827484,0.000780739,0.000018050125,0.0018917153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998423,0.00004952117,0.000009521249,0.000040352024,0.00003002958,0.000028204691],"domain_scores_gemma":[0.99994254,0.000009972496,0.000014864375,0.000008334955,0.000014757085,0.0000094605075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015265359,0.00026492498,0.00027336567,0.00017521332,0.000115442366,0.0002788098,0.0001063033,0.00020980206,0.00088246004],"category_scores_gemma":[0.00019043367,0.00016444523,0.00028762745,0.00023192445,0.00015104697,0.00014753372,0.00011189984,0.00017083531,0.00033937168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001421542,0.00003793797,0.0028931089,0.000116625706,0.00005646383,0.00019093744,0.000076215816,0.00015481473,0.98775196,0.00009973747,0.0000988515,0.007101701],"study_design_scores_gemma":[0.00004504151,0.00047929958,0.033815794,0.000009265113,0.000113855785,0.0012710752,0.00007699255,0.0015440221,0.9596494,0.00005432136,0.002921182,0.000019783622],"about_ca_topic_score_codex":0.0034146106,"about_ca_topic_score_gemma":0.0038293297,"teacher_disagreement_score":0.0034146106,"about_ca_system_score_codex":0.00023791457,"about_ca_system_score_gemma":0.00030867572,"threshold_uncertainty_score":0.006789446},"labels":[],"label_agreement":null},{"id":"W2021086919","doi":"10.1002/cbic.200600006","title":"Replacement of Natural Cofactors by Selected Hydrogen Peroxide Donors or Organic Peroxides Results in Improved Activity for CYP3A4 and CYP2D6","year":2006,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Arizona; Vanderbilt University","keywords":"Cofactor; Hydrogen peroxide; Chemistry; Natural product; Dioxygenase; Organic synthesis; Cumene hydroperoxide; Cumene; Enzyme; Stereochemistry; Biochemistry; Organic chemistry; Combinatorial chemistry; Catalysis","score_opus":0.035926567750434624,"score_gpt":0.36059240399073716,"score_spread":0.32466583624030254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021086919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698074,0.0024964258,0.022238102,0.00023383823,0.000107430205,0.000051078252,0.0008847222,0.00042959957,0.0037514514],"genre_scores_gemma":[0.98273575,0.0011514708,0.011720766,0.000047140118,0.000016137978,0.000023818926,0.0013750058,0.00007845743,0.0028514867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997645,0.000054817996,0.000020057641,0.00006951461,0.00006277774,0.00002831774],"domain_scores_gemma":[0.99970394,0.00005712896,0.000093053604,0.00006913633,0.00003242061,0.000044266584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031713882,0.0003548776,0.0002988509,0.00013007883,0.000111479356,0.00028814646,0.00024283475,0.00019442418,0.0022801394],"category_scores_gemma":[0.0004939283,0.00013001534,0.0002114083,0.00021293282,0.00020625447,0.0001929006,0.00017539854,0.00038815156,0.001015215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013610414,0.000028193217,0.00045037406,0.00004548469,0.00001061738,0.00005533768,0.00000840601,0.00005985205,0.99470204,0.00014095292,0.00011030483,0.004252265],"study_design_scores_gemma":[0.000010673991,0.00012843117,0.0009146416,0.0000014177733,0.00000928893,0.00022663061,0.0000049642076,0.00015116751,0.9950722,0.000043376724,0.00343402,0.0000031444656],"about_ca_topic_score_codex":0.00035452135,"about_ca_topic_score_gemma":0.00056437583,"teacher_disagreement_score":0.0022801394,"about_ca_system_score_codex":0.0002520694,"about_ca_system_score_gemma":0.00021922559,"threshold_uncertainty_score":0.007627845},"labels":[],"label_agreement":null},{"id":"W2021635654","doi":"10.1038/clpt.2013.2","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Doxepin; Nortriptyline; Desipramine; Tricyclic; CYP2D6; Pharmacology; Pharmacogenetics; Clomipramine; CYP2C19; Dosing; Active metabolite; Medicine; Imipramine; Pharmacokinetics; Amitriptyline; Genotype; Chemistry; Internal medicine; Antidepressant; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.2465648872691833,"score_gpt":0.5759832517471809,"score_spread":0.3294183644779976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021635654","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02730071,0.055654857,0.21595381,0.27995884,0.009587639,0.016658539,0.022942185,0.005860328,0.36608306],"genre_scores_gemma":[0.12275723,0.04551492,0.50303036,0.15122238,0.005668949,0.028515087,0.049124975,0.0018086239,0.09235746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.972386,0.011563876,0.0071186977,0.0008401446,0.0071286196,0.00096261606],"domain_scores_gemma":[0.94702965,0.015704172,0.0062711644,0.0021890486,0.026985874,0.0018200176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018548682,0.00090154,0.0019433754,0.0024906844,0.0011115215,0.0019154934,0.00453594,0.006701755,0.0065886667],"category_scores_gemma":[0.036987055,0.00079764647,0.0030851082,0.0029768746,0.0007369782,0.0012557774,0.001661238,0.006450461,0.0065963212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052766106,0.00083232915,0.0129487645,0.0015792506,0.0001993081,0.0014487533,0.00054741063,0.0024222217,0.0031643307,0.0063860333,0.6565062,0.31343767],"study_design_scores_gemma":[0.0008679144,0.0007424302,0.055250507,0.007559663,0.00037852855,0.0038992953,0.00046308595,0.0038196538,0.004435182,0.006507307,0.91591966,0.00015684718],"about_ca_topic_score_codex":0.012480809,"about_ca_topic_score_gemma":0.01627866,"teacher_disagreement_score":0.018548682,"about_ca_system_score_codex":0.0017993785,"about_ca_system_score_gemma":0.008742095,"threshold_uncertainty_score":0.09809595},"labels":[],"label_agreement":null},{"id":"W2021644601","doi":"10.1016/s0887-2333(00)00016-3","title":"Evidence for the catalysis of Dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver","year":2000,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Dextromethorphan; CYP2B6; CYP2E1; Molecular biology; Cytochrome P450; Complementary DNA; Enzyme; Quinidine; Polyclonal antibodies; Biochemistry; Biology; Demethylation; Chemistry; CYP1A2; Pharmacology; Antibody; Gene expression; Gene","score_opus":0.1784145241042837,"score_gpt":0.4493209677791409,"score_spread":0.27090644367485717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021644601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758045,0.004215155,0.014232642,0.0006477631,0.00013305165,0.000053904863,0.0008511953,0.00008562447,0.0039761],"genre_scores_gemma":[0.9908496,0.0011025976,0.0038397994,0.00023440804,0.00003754773,0.00002686662,0.0014719856,0.000020393933,0.0024168608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987864,0.00004154113,0.000012022199,0.0000320265,0.000018616032,0.000017177916],"domain_scores_gemma":[0.9995983,0.00015783867,0.00006915131,0.00009523507,0.00004383222,0.000035687004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027413614,0.00028860313,0.00026470306,0.00030671907,0.00017812331,0.00027765613,0.00021802742,0.00052795955,0.0020136253],"category_scores_gemma":[0.00039507696,0.00020759668,0.00042799197,0.00015144199,0.00039751938,0.0003199528,0.0001850815,0.00053394877,0.0007483506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083207403,0.000031638825,0.0032902951,0.000106409374,0.000021723694,0.00042698177,0.000048228863,0.00006545065,0.99191177,0.00029315214,0.000085678315,0.0028864236],"study_design_scores_gemma":[0.00004130163,0.0007562523,0.027266238,0.000020939093,0.00005924745,0.0027652974,0.000102598635,0.0007199129,0.96467763,0.00034745663,0.0032321864,0.0000109753655],"about_ca_topic_score_codex":0.00070617674,"about_ca_topic_score_gemma":0.0004937963,"teacher_disagreement_score":0.0020136253,"about_ca_system_score_codex":0.00019590526,"about_ca_system_score_gemma":0.00013276035,"threshold_uncertainty_score":0.006736219},"labels":[],"label_agreement":null},{"id":"W2021889472","doi":"10.1038/nbt0806-942","title":"Shifting emphasis from pharmacogenomics to theragnostics","year":2006,"lang":"en","type":"review","venue":"Nature Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"NIH Clinical Center; Université de Montréal; Office of Research and Development; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Pharmacogenomics; Downstream (manufacturing); Biomarker; Upstream (networking); Emphasis (telecommunications); Computational biology; Data science; Engineering ethics; Biology; Bioinformatics; Computer science; Business; Genetics; Engineering; Marketing","score_opus":0.12268277317795143,"score_gpt":0.49455684904083375,"score_spread":0.37187407586288235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021889472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014180475,0.99172956,0.0017592751,0.0026048662,0.0009926136,0.000005938454,0.000012433966,0.000030724364,0.0027228899],"genre_scores_gemma":[0.0012116237,0.9900031,0.001956384,0.0027906704,0.0014469449,0.000012153999,0.000027001804,0.000009173628,0.0025429744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930763,0.00021565802,0.00006652335,0.00011075153,0.00025662244,0.00004291087],"domain_scores_gemma":[0.99839056,0.0010333671,0.00010077237,0.00007369465,0.00030405962,0.000097540214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002745001,0.0014167359,0.002867291,0.0031192359,0.000353657,0.0020081075,0.0014521657,0.0029422154,0.0037966336],"category_scores_gemma":[0.0020725983,0.0004575274,0.0006668793,0.00342853,0.002051126,0.0032629303,0.0014747938,0.005025726,0.0032612975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081722595,0.0001034865,0.00014637104,0.006012982,0.0000683974,0.00027978473,0.00007641248,0.00046431256,0.0021794646,0.022806715,0.038342576,0.92943776],"study_design_scores_gemma":[0.000036979585,0.00007790847,0.00040356314,0.0017344956,0.000056554134,0.0012678935,0.000074199124,0.00018366036,0.0006601469,0.010759699,0.98472506,0.000019832045],"about_ca_topic_score_codex":0.00095238275,"about_ca_topic_score_gemma":0.0019043357,"teacher_disagreement_score":0.0037966336,"about_ca_system_score_codex":0.0014851204,"about_ca_system_score_gemma":0.0017746042,"threshold_uncertainty_score":0.0145171285},"labels":[],"label_agreement":null},{"id":"W2022348635","doi":"10.1016/j.cbi.2007.05.004","title":"Differential inhibition of hepatic microsomal alkoxyresorufin O-dealkylation activities by tetrachlorobiphenyls","year":2007,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microsome; Cytochrome P450; In vitro; Phenobarbital; Chemistry; Microsoma; Enzyme; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine","score_opus":0.08753881808618443,"score_gpt":0.4184558594168284,"score_spread":0.330917041330644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022348635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950847,0.0009937255,0.0023544587,0.0000838719,0.000029637824,0.000013401,0.0002596711,0.0000953408,0.0010851596],"genre_scores_gemma":[0.9967505,0.00046301942,0.0005138566,0.000027144592,0.000010062089,0.000013125126,0.00039950127,0.000015387339,0.0018074282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975973,0.00006144051,0.000020351657,0.00003106002,0.00004104414,0.00008638487],"domain_scores_gemma":[0.9997894,0.000059863196,0.00003871824,0.00003303092,0.0000357099,0.000043251363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024710537,0.00044081002,0.0003009404,0.00031128523,0.00016776964,0.00030068198,0.00018293837,0.00026383155,0.0017619914],"category_scores_gemma":[0.0003303769,0.0002384669,0.00033268385,0.00026809404,0.00021317578,0.00021430053,0.00018073352,0.0003536693,0.00045521458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011775547,0.00004257727,0.00043449365,0.00002118764,0.000015879192,0.000033380013,0.000012156761,0.0001543903,0.99633515,0.00011134844,0.000037472648,0.0016244245],"study_design_scores_gemma":[0.0000129652735,0.0003106074,0.0023132835,0.00000114947,0.000012936731,0.000046200967,0.0000087421595,0.00041105083,0.9966229,0.000020654628,0.00023708567,0.0000024365884],"about_ca_topic_score_codex":0.0021045303,"about_ca_topic_score_gemma":0.0030640778,"teacher_disagreement_score":0.0021045303,"about_ca_system_score_codex":0.00040089953,"about_ca_system_score_gemma":0.00029165132,"threshold_uncertainty_score":0.005894482},"labels":[],"label_agreement":null},{"id":"W2022811284","doi":"10.1177/0091270004268910","title":"Lack of Weight‐Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Omeprazole; CYP2C19; Proton-pump inhibitor; Medicine; Interquartile range; Coefficient of variation; Pharmacology; Internal medicine; Chemistry; Metabolism; Chromatography","score_opus":0.34318280028713016,"score_gpt":0.5652223211458592,"score_spread":0.22203952085872908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022811284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96282387,0.0009988936,0.03236621,0.00018652492,0.00008052223,0.0003224116,0.000603159,0.00016767139,0.0024506445],"genre_scores_gemma":[0.9906557,0.000110871464,0.0073608146,0.00021541526,0.00003938173,0.00018303949,0.000620028,0.00013488495,0.00067982037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99243873,0.0032011648,0.00033979028,0.0011713144,0.0026635902,0.00018542042],"domain_scores_gemma":[0.990987,0.0030817203,0.0018911313,0.0030604207,0.00077449874,0.00020520527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054912586,0.0005633281,0.0007161658,0.00061570626,0.00036474565,0.0006006025,0.00042525292,0.0007515817,0.00073296804],"category_scores_gemma":[0.011683623,0.00049297704,0.0006147871,0.00054915063,0.0006048474,0.00045106804,0.00040401443,0.0009885451,0.00041104405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033701025,0.00060614944,0.29287896,0.00013985635,0.00085502694,0.00040996092,0.0005524851,0.0014636712,0.6576877,0.00044276222,0.0007522128,0.040841065],"study_design_scores_gemma":[0.000074167605,0.005074855,0.87509245,0.000012591387,0.00026200432,0.0018694762,0.00005406177,0.0062545543,0.10898553,0.00027712388,0.002012196,0.00003106135],"about_ca_topic_score_codex":0.0006968786,"about_ca_topic_score_gemma":0.0014884803,"teacher_disagreement_score":0.0054912586,"about_ca_system_score_codex":0.00024336252,"about_ca_system_score_gemma":0.00020700964,"threshold_uncertainty_score":0.029040873},"labels":[],"label_agreement":null},{"id":"W2023792717","doi":"10.1517/17425250902865586","title":"Characterization and expression of extrahepatic CYP2S1","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Context (archaeology); Gene expression; Isozyme; Enzyme; Gene; Biochemistry; Genetics; Biology","score_opus":0.1341981640508461,"score_gpt":0.46143677831385393,"score_spread":0.3272386142630078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023792717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010673494,0.9787445,0.0035781353,0.0006771632,0.00023206491,0.000029675284,0.00037719993,0.000040829364,0.0056468653],"genre_scores_gemma":[0.07138155,0.91154414,0.0045698374,0.0004455424,0.0006156928,0.00006614159,0.0017108419,0.000021793448,0.009644411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981993,0.000031451782,0.000015195054,0.00004949372,0.000066734916,0.00001731554],"domain_scores_gemma":[0.99979526,0.000051678737,0.000038894636,0.000013883712,0.00008860861,0.000011844626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039303323,0.0004803968,0.0006885828,0.0008497038,0.000075303265,0.00041414198,0.0003549806,0.00041245806,0.0018879215],"category_scores_gemma":[0.0003642753,0.00013182183,0.00036492632,0.0008499192,0.00021664401,0.00037004778,0.00016867544,0.00054221257,0.0016832231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003875359,0.00005993999,0.003431013,0.009965615,0.00016476009,0.00080749736,0.000057742323,0.0006775532,0.10971101,0.0023530698,0.011344695,0.8610395],"study_design_scores_gemma":[0.00007665362,0.0005758459,0.020639146,0.001132981,0.0004466478,0.0090977615,0.00006895159,0.0010229156,0.14885426,0.0018344099,0.81619626,0.000054091208],"about_ca_topic_score_codex":0.0007548465,"about_ca_topic_score_gemma":0.00062382274,"teacher_disagreement_score":0.0018879215,"about_ca_system_score_codex":0.0003510465,"about_ca_system_score_gemma":0.00041796252,"threshold_uncertainty_score":0.006315708},"labels":[],"label_agreement":null},{"id":"W2024278415","doi":"10.1097/fpc.0000000000000061","title":"Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Willingness to pay; Cancer; Genetic testing; Oncology; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.16242019437257235,"score_gpt":0.4190787767134464,"score_spread":0.256658582340874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024278415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969259,0.00021452937,0.00015224339,0.0007804796,0.0000058737364,0.000017436283,0.000046608988,0.0000029175878,0.0018541171],"genre_scores_gemma":[0.9995704,0.00007231991,0.00008988075,0.00015920815,0.000004294482,0.000007894228,0.000022028851,8.229653e-7,0.00007315397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603456,0.0022002968,0.0002751351,0.00017610996,0.000887363,0.00042663366],"domain_scores_gemma":[0.97642696,0.014512361,0.005590731,0.0005032207,0.001338328,0.0016283218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048023495,0.00018394779,0.00027711582,0.0006994678,0.00048183248,0.0017970633,0.0003280437,0.0010228193,0.0042647016],"category_scores_gemma":[0.026806664,0.00014948734,0.00069817883,0.00044749628,0.0008708664,0.0008985213,0.000731722,0.0011828775,0.00029161823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003809762,0.00029886572,0.96745425,0.000077828794,0.00015189085,0.00044592845,0.007108107,0.0008076154,0.0005022457,0.00042607597,0.0007924831,0.021553826],"study_design_scores_gemma":[0.000104911895,0.0018025563,0.9389798,0.0002106156,0.00016056596,0.0039521907,0.04147786,0.0063247927,0.00069073384,0.0020299705,0.0041455314,0.000120445315],"about_ca_topic_score_codex":0.0015610133,"about_ca_topic_score_gemma":0.0010639537,"teacher_disagreement_score":0.0048023495,"about_ca_system_score_codex":0.0006937988,"about_ca_system_score_gemma":0.0006790157,"threshold_uncertainty_score":0.02539754},"labels":[],"label_agreement":null},{"id":"W2024912502","doi":"10.1038/mp.2011.38","title":"Genetic variation in CYP3A43 explains racial difference in olanzapine clearance","year":2011,"lang":"en","type":"article","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"NHLBI Division of Intramural Research; National Institutes of Health; National Institute of Mental Health; Eli Lilly and Company","keywords":"Olanzapine; Antipsychotic; Medicine; Atypical antipsychotic; Pharmacology; Internal medicine; Genotype; Drug; Adverse effect; Pharmacogenetics; Discontinuation; Psychiatry; Schizophrenia (object-oriented programming); Biology; Genetics","score_opus":0.06587998474827186,"score_gpt":0.37139545662018325,"score_spread":0.3055154718719114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024912502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886,0.00016452308,0.0002791592,0.000090312984,0.000016261089,0.0000037697039,0.00012078242,0.00000811771,0.0004570079],"genre_scores_gemma":[0.9994287,0.000041543983,0.00016790481,0.000041557258,0.0000091152515,0.0000021922674,0.000056679637,0.000020773408,0.00023147344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993724,0.00021719174,0.00006541442,0.00018665568,0.0000833759,0.00007499014],"domain_scores_gemma":[0.998841,0.0004147549,0.00038806736,0.00017586332,0.000083464234,0.0000969344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077387074,0.00036320483,0.0004591956,0.0005511049,0.00044743717,0.0005958831,0.00033533608,0.00056068995,0.004214095],"category_scores_gemma":[0.0024669159,0.00034598913,0.00084963697,0.0005342789,0.00031139326,0.0003157224,0.0002765634,0.0005670586,0.00035561607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055367444,0.00033668504,0.8848921,0.0000572421,0.0017376423,0.0019635565,0.0009393879,0.0004645753,0.086474374,0.0011873328,0.000906747,0.015503665],"study_design_scores_gemma":[0.000052339135,0.00013228325,0.9941037,0.000010305459,0.0002627134,0.0011936293,0.00012610634,0.0009142783,0.0024818531,0.0002536132,0.0004554581,0.0000138152645],"about_ca_topic_score_codex":0.0052244705,"about_ca_topic_score_gemma":0.0028842925,"teacher_disagreement_score":0.0052244705,"about_ca_system_score_codex":0.00033883489,"about_ca_system_score_gemma":0.00022913501,"threshold_uncertainty_score":0.014097571},"labels":[],"label_agreement":null},{"id":"W2025416272","doi":"10.1097/01.jcp.0000227355.54074.14","title":"Phenotype-genotype Relationship and Clinical Effects of Citalopram in Chinese Patients","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hong Kong Government; H. Lundbeck A/S","keywords":"CYP2C19; Citalopram; Pharmacokinetics; Genotype; Chinese population; Population; Pharmacology; Medicine; Internal medicine; Adverse effect; Gastroenterology; Biology; Genetics; Metabolism; Gene; Antidepressant","score_opus":0.08347896920586216,"score_gpt":0.521271239930772,"score_spread":0.4377922707249098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025416272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965966,0.000075958604,0.000030582447,0.000020502166,0.0000016114748,0.000005255829,0.000031592226,0.0000013168525,0.00017341692],"genre_scores_gemma":[0.9997439,0.000051740975,0.000035515433,0.00001716052,0.0000054346483,0.0000046631185,0.000050936716,8.094325e-7,0.00008986652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997161,0.000053243788,0.00003512936,0.000085135434,0.000053553413,0.000056799192],"domain_scores_gemma":[0.99956065,0.00009012845,0.00015511141,0.00003476972,0.000037653306,0.000121652236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024192841,0.0003514959,0.00037381807,0.0006593133,0.0007489424,0.00026797137,0.00021084123,0.0003739389,0.001664383],"category_scores_gemma":[0.0010797463,0.0002337321,0.0002825228,0.00083411054,0.00035178103,0.00021425127,0.00023204499,0.00029060518,0.0001342695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030106318,0.000039075727,0.9946833,0.000010675754,0.000042467585,0.0011517665,0.0002291707,0.00005377716,0.001566639,0.000045051525,0.000060871927,0.0018162138],"study_design_scores_gemma":[0.000016489832,0.00013522468,0.99796057,0.0000020478299,0.000029883357,0.0013357466,0.00011298832,0.00015521293,0.0001099025,0.00004123431,0.000095934105,0.0000047304934],"about_ca_topic_score_codex":0.008546682,"about_ca_topic_score_gemma":0.0074566444,"teacher_disagreement_score":0.008546682,"about_ca_system_score_codex":0.00040443827,"about_ca_system_score_gemma":0.00035212224,"threshold_uncertainty_score":0.01699388},"labels":[],"label_agreement":null},{"id":"W2026046906","doi":"10.1038/sj.bjp.0704951","title":"Down‐regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators","year":2002,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Kidney Foundation of Canada; American Society of Nephrology","keywords":"Internal medicine; Endocrinology; Cytochrome P450; Messenger RNA; CYP3A; Incubation; Biology; Gene isoform; Chemistry; Metabolism; Medicine; Biochemistry; Gene","score_opus":0.03132249171432585,"score_gpt":0.34717265378749074,"score_spread":0.3158501620731649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026046906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899484,0.00905261,0.00051405345,0.00007524036,0.000018106557,0.000013655859,0.00007837291,0.000011812111,0.0002878023],"genre_scores_gemma":[0.9965083,0.0025052712,0.000449498,0.000040527186,0.00003518898,0.00001712934,0.0001364007,0.0000021982669,0.00030558908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994373,0.000015610169,0.000006206591,0.000009146236,0.000014881087,0.000010391151],"domain_scores_gemma":[0.99985635,0.000025826079,0.000049237904,0.00001251999,0.00001820276,0.000037806127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001617468,0.00029743707,0.00038284954,0.00014592949,0.00013801435,0.00013587183,0.00010600469,0.00024914605,0.00075699855],"category_scores_gemma":[0.0001687105,0.00007338013,0.00020899327,0.000113153634,0.00025096512,0.0001547371,0.00013860757,0.0003659518,0.00006673733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035321973,0.00016440959,0.011550413,0.00032288188,0.00005868912,0.0006365447,0.00005670681,0.00007630357,0.9749238,0.000047089045,0.00010003665,0.008530991],"study_design_scores_gemma":[0.00019917364,0.005927916,0.6690827,0.000039940478,0.0002878516,0.0024395923,0.00015728324,0.0005845091,0.31837976,0.00013674663,0.0027436505,0.000020934769],"about_ca_topic_score_codex":0.0004080079,"about_ca_topic_score_gemma":0.0006485698,"teacher_disagreement_score":0.00075699855,"about_ca_system_score_codex":0.00012655818,"about_ca_system_score_gemma":0.000106536194,"threshold_uncertainty_score":0.0025324225},"labels":[],"label_agreement":null},{"id":"W2026270252","doi":"10.1111/j.1538-7836.2009.03483.x","title":"Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram","year":2009,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Warfarin; Nomogram; VKORC1; Medicine; Dosing; Maintenance dose; CYP2C9; Internal medicine; Atrial fibrillation","score_opus":0.0854572687441948,"score_gpt":0.39443852602649526,"score_spread":0.30898125728230047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026270252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584633,0.0006600594,0.0010592208,0.0003041555,0.000051813917,0.000034829904,0.00026832463,0.00003637514,0.0017389585],"genre_scores_gemma":[0.998434,0.00016133471,0.0008252247,0.000098259654,0.00003855639,0.000017843475,0.00031784037,0.0000033613787,0.00010349624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993693,0.0002255008,0.00012374856,0.00007859069,0.00015112503,0.000051679337],"domain_scores_gemma":[0.99737656,0.0012905071,0.000619303,0.00015251544,0.00028949132,0.0002715829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059426,0.00050939317,0.00092087325,0.0010765765,0.00021872306,0.000685317,0.00030648432,0.00064322416,0.000556455],"category_scores_gemma":[0.004954237,0.00016125155,0.0007258609,0.0006493878,0.00022974405,0.0004282205,0.00024344583,0.0006388528,0.00021690837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016185278,0.00009929559,0.9874865,0.000021109461,0.00020247744,0.00015066762,0.00003579475,0.0010129039,0.00072640495,0.000058147398,0.0004825405,0.008105631],"study_design_scores_gemma":[0.00029793286,0.0023661398,0.9664149,0.000043078602,0.00047579265,0.0015332745,0.00015362912,0.026119877,0.0015019752,0.00035581124,0.000706386,0.00003115758],"about_ca_topic_score_codex":0.00094354467,"about_ca_topic_score_gemma":0.0012018615,"teacher_disagreement_score":0.0010765765,"about_ca_system_score_codex":0.00031681213,"about_ca_system_score_gemma":0.00043353954,"threshold_uncertainty_score":0.0056028366},"labels":[],"label_agreement":null},{"id":"W2026704167","doi":"10.4212/cjhp.v63i5.950","title":"Interaction between Methadone and Ciprofloxacin","year":2010,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"CYP3A4; CYP1A2; CYP2D6; Pharmacology; Methadone; Drug interaction; Cytochrome P450; Medicine; Metabolite; Isozyme; Chemistry; Pharmacokinetics; Internal medicine; Enzyme; Metabolism; Biochemistry","score_opus":0.08319447041285404,"score_gpt":0.417700975120298,"score_spread":0.334506504707444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026704167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658196,0.015185797,0.0008503902,0.0021211645,0.00016307694,0.00023441552,0.00026003912,0.000043698274,0.015321811],"genre_scores_gemma":[0.99298453,0.0024903847,0.000806783,0.00051680865,0.000059987535,0.000032775577,0.000090419744,0.0000040971286,0.003014282],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999529,0.00016233658,0.00005013576,0.000046209523,0.00014649016,0.00006584235],"domain_scores_gemma":[0.9994684,0.00021129644,0.00015270505,0.000017322332,0.00006235645,0.00008795479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002087511,0.00015803638,0.00032864444,0.0001455998,0.00042749575,0.00027477776,0.00014880016,0.00058897294,0.0029076433],"category_scores_gemma":[0.001714103,0.000087651984,0.0004146674,0.00013169204,0.00012313106,0.0001611564,0.00025369012,0.00044093316,0.00023741674],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011248573,0.002304505,0.41325212,0.0016261551,0.00092498545,0.08402019,0.0010349826,0.0011506795,0.107358,0.0012384468,0.00737276,0.36846864],"study_design_scores_gemma":[0.0008659825,0.01197278,0.77296156,0.00039070335,0.00069872243,0.09480851,0.0007966442,0.0035842855,0.020607907,0.00041845776,0.09279871,0.000095709125],"about_ca_topic_score_codex":0.0041515236,"about_ca_topic_score_gemma":0.011391222,"teacher_disagreement_score":0.0041515236,"about_ca_system_score_codex":0.0006835564,"about_ca_system_score_gemma":0.00046141096,"threshold_uncertainty_score":0.009727001},"labels":[],"label_agreement":null},{"id":"W2027139914","doi":"10.1039/b607001a","title":"Progress towards the easier use of P450 enzymes","year":2006,"lang":"en","type":"review","venue":"Molecular BioSystems","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Canada; Centre National de la Recherche Scientifique","keywords":"Cytochrome P450; Cofactor; Enzyme; Substrate (aquarium); Chemistry; Protein engineering; Biochemistry; Heme; Mutagenesis; Hydroxylation; Hemeprotein; Combinatorial chemistry; Biology; Gene; Mutation","score_opus":0.28224781355110473,"score_gpt":0.4799072877840047,"score_spread":0.19765947423289998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027139914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011890203,0.9076076,0.054140624,0.0016136789,0.00066077214,0.00008640981,0.00022328366,0.00046076003,0.023316648],"genre_scores_gemma":[0.04953872,0.88896894,0.040692773,0.0012400032,0.00072267896,0.0001488893,0.0008780349,0.00012009384,0.017689893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904186,0.00020230179,0.00006363232,0.00025485404,0.00037395078,0.00006342233],"domain_scores_gemma":[0.9996525,0.00011420646,0.000050949166,0.00005483392,0.00010011597,0.000027357604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011260331,0.00097639963,0.0012534944,0.0014386222,0.00024322428,0.0010891614,0.0010619295,0.0011775078,0.004023527],"category_scores_gemma":[0.000768133,0.00036652546,0.00074658194,0.0014720057,0.000530227,0.0013063169,0.0010197822,0.0018464151,0.00661289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118918804,0.00021480866,0.00048857945,0.0059736054,0.00009152783,0.00040430675,0.0001148234,0.0006080273,0.11445031,0.0103299385,0.007960081,0.859245],"study_design_scores_gemma":[0.000031407108,0.00038307838,0.001284497,0.00043754326,0.00010762439,0.002198231,0.00004886341,0.00045103757,0.089049056,0.0029681793,0.9030101,0.000030428997],"about_ca_topic_score_codex":0.00044759098,"about_ca_topic_score_gemma":0.00035838317,"teacher_disagreement_score":0.004023527,"about_ca_system_score_codex":0.0005430218,"about_ca_system_score_gemma":0.000646422,"threshold_uncertainty_score":0.01346004},"labels":[],"label_agreement":null},{"id":"W2027851095","doi":"10.1038/clpt.2011.280","title":"Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; CYP2D6; Odds ratio; Pharmacogenetics; Catechol-O-methyl transferase; Depression (economics); Opioid; Genotype; Clinical pharmacology; Pharmacology; Breastfeeding; Internal medicine; Bioinformatics; Pediatrics; Biology; Genetics; Receptor; Morphine; Gene; Cytochrome P450","score_opus":0.25220514093363794,"score_gpt":0.47173391498590633,"score_spread":0.2195287740522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027851095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992292,0.0002392595,0.00025472007,0.000028238677,0.0000024970184,0.0000037266045,0.000067018176,0.0000035540218,0.00017180867],"genre_scores_gemma":[0.9991811,0.00018670644,0.00044107123,0.000009806856,0.000002957887,0.0000051614716,0.000084920204,0.0000014724059,0.000086675005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995117,0.00022746748,0.00003410085,0.00008493688,0.00009886387,0.000042851785],"domain_scores_gemma":[0.99889636,0.0004918807,0.00039450877,0.000051899104,0.000082851526,0.00008248666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006825949,0.00044752867,0.00042893132,0.00054352585,0.00015529849,0.00035023937,0.00021346052,0.00038608973,0.00060413417],"category_scores_gemma":[0.0031748763,0.00019920345,0.00033406354,0.00047927757,0.00014300423,0.0002062759,0.0003367516,0.00041621388,0.0001478207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016401162,0.000013816638,0.9961481,0.000005212209,0.00003161683,0.00015312049,0.00003307385,0.00007149663,0.0005039833,0.0000109957255,0.000026161175,0.0028384163],"study_design_scores_gemma":[0.000010437126,0.00026921218,0.9951416,0.000012465542,0.00006996728,0.001066232,0.00011881003,0.0026048874,0.0005017382,0.000059695703,0.00014023027,0.000004700377],"about_ca_topic_score_codex":0.0023504773,"about_ca_topic_score_gemma":0.0019126986,"teacher_disagreement_score":0.0023504773,"about_ca_system_score_codex":0.00020624758,"about_ca_system_score_gemma":0.00018152018,"threshold_uncertainty_score":0.0046735406},"labels":[],"label_agreement":null},{"id":"W2027884629","doi":"10.1159/000242572","title":"Indomethacin Metabolism in Liver Microsomes during Postnatal Development in the Rat","year":2009,"lang":"en","type":"article","venue":"Biology of the Neonate","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Phenobarbital; Metabolism; Endocrinology; Internal medicine; Microsome; Monooxygenase; Enzyme; Chemistry; Drug metabolism; Cytochrome P450; Biology; Biochemistry; Medicine","score_opus":0.0605789463448444,"score_gpt":0.37981095174788804,"score_spread":0.31923200540304364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027884629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615306,0.0021697609,0.0007173744,0.000045779238,0.000010021333,0.000008906039,0.0003350917,0.000033630055,0.0005264399],"genre_scores_gemma":[0.9933122,0.002497143,0.001325126,0.0000247765,0.000008277367,0.000027399961,0.0010038499,0.0000138138375,0.001787405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999336,0.000009509087,0.000005254403,0.000017384458,0.000013392198,0.000020941363],"domain_scores_gemma":[0.9998474,0.00002904487,0.000055387,0.000016164207,0.000021290512,0.000030655676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010085585,0.00032811504,0.0002495716,0.00041161184,0.00012453503,0.00017167594,0.00014695148,0.00015879754,0.0007002552],"category_scores_gemma":[0.00020978966,0.00018755387,0.00017194396,0.00020195375,0.00021861923,0.00030121912,0.00013181855,0.00034448467,0.00030321264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001069946,0.000035885692,0.0050358833,0.000047434707,0.000011862952,0.00028226714,0.00009383791,0.000046935314,0.9873854,0.00008738501,0.000032413776,0.0058707935],"study_design_scores_gemma":[0.000015908256,0.00083849364,0.0518712,0.000008136649,0.000058118487,0.00043878192,0.00011454249,0.00021088515,0.9450745,0.000072465155,0.0012876228,0.000009235599],"about_ca_topic_score_codex":0.001451317,"about_ca_topic_score_gemma":0.0023006517,"teacher_disagreement_score":0.001451317,"about_ca_system_score_codex":0.00025838404,"about_ca_system_score_gemma":0.00027671084,"threshold_uncertainty_score":0.0028857589},"labels":[],"label_agreement":null},{"id":"W2028021793","doi":"10.1002/jbt.10023","title":"Acute sodium arsenite treatment induces <i>Cyp2a5</i> but not <i>Cyp1a1</i> in the C57Bl/6 mouse in a tissue (kidney) selective manner","year":2002,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Chemistry; Monooxygenase; Kidney; Cytochrome P450; Sodium arsenite; Heme oxygenase; Glutathione; Heme; Enzyme; Messenger RNA; Bilirubin; Internal medicine; Endocrinology; Biochemistry; Biology; Gene; Medicine","score_opus":0.0485822596568027,"score_gpt":0.3632461314711738,"score_spread":0.3146638718143711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028021793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917447,0.001299181,0.003574527,0.00016589568,0.000058929516,0.00005197561,0.00085468654,0.00054208026,0.0017080605],"genre_scores_gemma":[0.98693174,0.0010553385,0.001911806,0.00016006653,0.000027960925,0.000076871984,0.0014564587,0.00012359784,0.008256205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970144,0.000028272078,0.000023560291,0.00009727304,0.000072275056,0.00007716375],"domain_scores_gemma":[0.99965835,0.000023080385,0.0001437025,0.00003794824,0.000037116362,0.00009980397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012432656,0.0008629,0.0004401468,0.00061903393,0.00019327343,0.00045073344,0.0002585711,0.0004646571,0.0018404567],"category_scores_gemma":[0.000099087985,0.00038455523,0.0006028242,0.0002853234,0.00050991005,0.00026625083,0.0002622936,0.00093866675,0.0005188032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022049077,0.000036816306,0.00022396086,0.000021965492,0.000011841836,0.000033878943,0.000008607111,0.000024257235,0.99893266,0.000031356965,0.000035946752,0.00041819195],"study_design_scores_gemma":[0.000028655686,0.0011265842,0.009889795,0.000005706872,0.000054693963,0.00025761774,0.000037873226,0.00036552708,0.9868688,0.00006262231,0.0012925403,0.000009531279],"about_ca_topic_score_codex":0.0017133068,"about_ca_topic_score_gemma":0.0035167665,"teacher_disagreement_score":0.0018404567,"about_ca_system_score_codex":0.00047336402,"about_ca_system_score_gemma":0.00024935542,"threshold_uncertainty_score":0.0061569214},"labels":[],"label_agreement":null},{"id":"W2028166816","doi":"10.1097/00004714-200112000-00011","title":"Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C → A Polymorphism in Intron 1 of the CYP1A2 Gene: Effect of Grapefruit Juice and Low-Dose Fluvoxamine","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clozapine; Fluvoxamine; CYP1A2; Pharmacology; Atypical antipsychotic; Antipsychotic; Metabolite; Cytochrome P450; CYP2D6; Medicine; Pharmacokinetics; Chemistry; Internal medicine; Schizophrenia (object-oriented programming); Fluoxetine; Metabolism; Psychiatry; Receptor","score_opus":0.0458833678902309,"score_gpt":0.4533985987353348,"score_spread":0.4075152308451039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028166816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920493,0.000168172,0.00008108028,0.00008587493,0.000006090946,0.000007658272,0.000040403913,0.000008995158,0.0003967198],"genre_scores_gemma":[0.99954456,0.000049889473,0.00008402218,0.000046577647,0.000011773934,0.0000034923507,0.000057315585,0.0000039117476,0.00019841854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999603,0.00013408835,0.0000507852,0.00009411539,0.00006060423,0.000057392503],"domain_scores_gemma":[0.99912757,0.00025274535,0.00032318546,0.00007143246,0.00004837536,0.00017682136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031702424,0.00059072307,0.0004899468,0.0004895495,0.00052170735,0.00039950912,0.0002231211,0.0009505783,0.0027041412],"category_scores_gemma":[0.001705423,0.00029773384,0.0005846563,0.00042571776,0.0003550143,0.00021125235,0.00014566146,0.00086014345,0.00031533738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008489011,0.0013920815,0.8982809,0.00005133462,0.00045330022,0.022852462,0.00039915764,0.00022328066,0.053576156,0.00017977123,0.0004834755,0.013619091],"study_design_scores_gemma":[0.000201606,0.0020489637,0.94412214,0.0000096961085,0.00022703539,0.04979378,0.00010355276,0.0006950026,0.0021780697,0.000087262895,0.00050782127,0.00002514111],"about_ca_topic_score_codex":0.0018361799,"about_ca_topic_score_gemma":0.002674369,"teacher_disagreement_score":0.0027041412,"about_ca_system_score_codex":0.0003329091,"about_ca_system_score_gemma":0.00018926877,"threshold_uncertainty_score":0.009046257},"labels":[],"label_agreement":null},{"id":"W2028825845","doi":"10.1002/rcm.3092","title":"Investigating the <i>in vitro</i> metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Metabolite; Chromatography; Mass spectrometry; Tandem mass spectrometry; Metabolism; Drug metabolism; In vitro; Designer drug; Biochemistry; Drug; Pharmacology","score_opus":0.07958362151495889,"score_gpt":0.39506622960449916,"score_spread":0.31548260808954026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028825845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600884,0.00835925,0.027174586,0.00017055964,0.00004377365,0.00018017094,0.0014490286,0.00020084882,0.0023334173],"genre_scores_gemma":[0.969003,0.004757186,0.020855047,0.00026854314,0.000039464037,0.00019223565,0.0018940736,0.000049119695,0.0029412515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981576,0.000043013584,0.0000139068425,0.000053439668,0.00004768232,0.000026161963],"domain_scores_gemma":[0.99977034,0.000046363366,0.00008534207,0.000024938372,0.00005048001,0.000022483064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032785238,0.0005487417,0.00027237734,0.00029144005,0.0001698951,0.00028705545,0.00020780166,0.00057264726,0.0007552476],"category_scores_gemma":[0.00040004493,0.00014078802,0.00033585518,0.00022405098,0.00024071996,0.00026810094,0.00014829352,0.00035552555,0.00045157224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012414857,0.000020500453,0.0008465088,0.000050312818,0.000019545167,0.00008856724,0.000014813017,0.00008229702,0.99675,0.00002728262,0.000026324988,0.0019497639],"study_design_scores_gemma":[0.0000054635902,0.00034155828,0.0045540063,0.0000034599038,0.000026455658,0.00023185497,0.000011952828,0.0004020152,0.99337363,0.000024276707,0.0010203044,0.0000050508556],"about_ca_topic_score_codex":0.00083352375,"about_ca_topic_score_gemma":0.0008112148,"teacher_disagreement_score":0.00083352375,"about_ca_system_score_codex":0.00023754964,"about_ca_system_score_gemma":0.00026995334,"threshold_uncertainty_score":0.0025265813},"labels":[],"label_agreement":null},{"id":"W2028902084","doi":"10.1136/jech-2014-204489","title":"Risk of overdose and death following codeine prescription among immigrants","year":2014,"lang":"en","type":"article","venue":"Journal of Epidemiology & Community Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Codeine; Medical prescription; Immigration; Emergency medicine; Medical emergency; Psychiatry; Anesthesia; Pharmacology","score_opus":0.1801273029800061,"score_gpt":0.48633813327460407,"score_spread":0.30621083029459795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028902084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997999,0.00034456726,0.00005424737,0.00012947226,0.000011113955,0.000011760258,0.00081415847,0.0000050271406,0.0006306349],"genre_scores_gemma":[0.9987326,0.00024362175,0.000056966815,0.000050216884,0.0000144698415,0.0000049796754,0.0006885959,0.000001716514,0.00020684254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970883,0.000050989904,0.000025433816,0.00006715478,0.000056739496,0.00009092248],"domain_scores_gemma":[0.9986386,0.00011523452,0.00069618697,0.00006973003,0.0002056118,0.00027464665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034530458,0.00023500247,0.00022556234,0.00050298736,0.000538895,0.00058450614,0.0003023859,0.00042394554,0.002271439],"category_scores_gemma":[0.0021624372,0.00017454683,0.0007581074,0.00066017493,0.00024403683,0.00018328127,0.0005598555,0.00065516884,0.00017227333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000994816,0.000008980563,0.9987708,0.0000072989046,0.00004446925,0.000045522764,0.000026789618,0.000027384067,0.000038305247,0.000011203224,0.00014468815,0.0007750554],"study_design_scores_gemma":[0.000007946631,0.000039861403,0.9992499,0.000014522388,0.000034378114,0.00015253006,0.00012321472,0.0002062561,0.000021841872,0.000021719648,0.00012351872,0.000004289503],"about_ca_topic_score_codex":0.13132186,"about_ca_topic_score_gemma":0.13789323,"teacher_disagreement_score":0.13132186,"about_ca_system_score_codex":0.0009173904,"about_ca_system_score_gemma":0.0011879117,"threshold_uncertainty_score":0.26111495},"labels":[],"label_agreement":null},{"id":"W2029744552","doi":"10.1016/s0040-4039(02)01206-6","title":"An efficient approach to the synthesis of LTB4 and ω-substituted LTB4 metabolites","year":2002,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); McGill University","funders":"National Institutes of Health","keywords":"Chemistry; Synthon; Metabolite; Aldehyde dehydrogenase; Aldehyde; Total synthesis; Cytosol; Catalysis; Organic chemistry; Biochemistry; Enzyme","score_opus":0.08084426649477261,"score_gpt":0.35883641360099305,"score_spread":0.27799214710622044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029744552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.543511,0.008000651,0.3977028,0.0022235787,0.0008109638,0.0008890944,0.0016391178,0.0011701656,0.044052597],"genre_scores_gemma":[0.8992849,0.005024092,0.07974787,0.00056443416,0.00012758237,0.00038954275,0.00094046525,0.00016356472,0.013757468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961793,0.00010595661,0.00003949357,0.000057190544,0.00006574148,0.0001136522],"domain_scores_gemma":[0.999846,0.000031508265,0.00003005966,0.000032748416,0.000027981194,0.00003172082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005466721,0.0007578048,0.0004508819,0.0004980042,0.00043182555,0.00032949494,0.00065111805,0.00073416316,0.0033611131],"category_scores_gemma":[0.0003840348,0.0002911157,0.0005299061,0.00040695156,0.00036616938,0.0004020461,0.00073272816,0.0011727689,0.0019033145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048717388,0.0003013906,0.00034955717,0.00050415605,0.00011269676,0.00163752,0.0003020703,0.0024366037,0.9180244,0.008229222,0.0024089608,0.065206125],"study_design_scores_gemma":[0.00018870819,0.001597357,0.00070735515,0.000038522376,0.00009445524,0.0010683398,0.000054803993,0.0024189837,0.963434,0.0022103088,0.028113157,0.00007410675],"about_ca_topic_score_codex":0.0010110409,"about_ca_topic_score_gemma":0.0014504712,"teacher_disagreement_score":0.0033611131,"about_ca_system_score_codex":0.0005383347,"about_ca_system_score_gemma":0.0009902135,"threshold_uncertainty_score":0.011243999},"labels":[],"label_agreement":null},{"id":"W2030018298","doi":"10.1097/fpc.0b013e3283349e84","title":"Cytochrome P450 2C9-CYP2C9","year":2010,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences; National Institutes of Health; Mashhad University of Medical Sciences","keywords":"CYP2C9; Cytochrome P450; Biology; Biochemistry; Metabolism","score_opus":0.21651714893957597,"score_gpt":0.504793880293876,"score_spread":0.2882767313543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030018298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047577536,0.9700586,0.002949658,0.0026903972,0.0020417357,0.00015570711,0.0010488062,0.00020498314,0.020374343],"genre_scores_gemma":[0.003623256,0.9657024,0.001939402,0.000978051,0.0015270057,0.000075993106,0.0012818414,0.000020621215,0.024851456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958855,0.000069494025,0.00003785545,0.00008818426,0.00018175867,0.000034157336],"domain_scores_gemma":[0.9996321,0.00010128313,0.000070125534,0.000022205726,0.00013132485,0.000043020453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044931308,0.0010924522,0.0015837476,0.0022146462,0.00026845108,0.0009221429,0.00096291135,0.0011203447,0.030259537],"category_scores_gemma":[0.0011054997,0.00026884733,0.0006332962,0.003039781,0.00038712833,0.0010559658,0.00050121057,0.0012591832,0.030646153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008795502,0.00006145417,0.00029392948,0.0053901,0.000055268705,0.00038413508,0.00001170375,0.00018493086,0.0020499225,0.0012634856,0.14611691,0.84410024],"study_design_scores_gemma":[0.0000557579,0.00007174732,0.0009881807,0.0011190339,0.00007381891,0.0026622675,0.0000107377255,0.000081425766,0.0013460204,0.0011896039,0.9923878,0.000013671282],"about_ca_topic_score_codex":0.0016285846,"about_ca_topic_score_gemma":0.0023479324,"teacher_disagreement_score":0.030259537,"about_ca_system_score_codex":0.00049185526,"about_ca_system_score_gemma":0.0009445489,"threshold_uncertainty_score":0.1012283},"labels":[],"label_agreement":null},{"id":"W2030065493","doi":"10.1177/1091581810388307","title":"Effects in Rats of Maternal Exposure to Raspberry Leaf and Its Constituents on the Activity of Cytochrome P450 Enzymes in the Offspring","year":2010,"lang":"en","type":"article","venue":"International Journal of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; McMaster University","keywords":"Offspring; Biotransformation; Kaempferol; Cytochrome P450; Biology; Ellagic acid; Quercetin; Weaning; CYP1B1; Enzyme; Physiology; Internal medicine; Endocrinology; Pregnancy; Biochemistry; Antioxidant; Medicine; Polyphenol","score_opus":0.05433120400376857,"score_gpt":0.4061784750775488,"score_spread":0.3518472710737802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030065493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986499,0.00041028592,0.00034156375,0.00007542064,0.00001786186,0.000008197127,0.00012530999,0.000029502467,0.00034191995],"genre_scores_gemma":[0.9935389,0.00095225754,0.0008564823,0.00012381864,0.000019009529,0.0000551575,0.00029839395,0.000023783858,0.0041321325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979633,0.000036236677,0.000010859885,0.00006681848,0.000043839773,0.00004591312],"domain_scores_gemma":[0.999579,0.000057165307,0.00014158848,0.000058898313,0.000035619738,0.00012776458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015707234,0.00049913925,0.00043369268,0.00050794124,0.00030157084,0.0002300757,0.00018125055,0.0004013077,0.0018011883],"category_scores_gemma":[0.00028971912,0.00030182512,0.00025656747,0.00013344787,0.00046679936,0.0002646415,0.00028287913,0.0010897362,0.00023741649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005146294,0.00078899827,0.008485865,0.000063635154,0.000045507488,0.0006863119,0.00023816539,0.000058505208,0.9737317,0.00013766903,0.00013505908,0.0104823075],"study_design_scores_gemma":[0.00016726449,0.021196075,0.132777,0.000029816621,0.00021858318,0.0014362467,0.0005542391,0.00051105284,0.8397684,0.0003006554,0.0029977432,0.0000429642],"about_ca_topic_score_codex":0.0011640032,"about_ca_topic_score_gemma":0.0021111309,"teacher_disagreement_score":0.0018011883,"about_ca_system_score_codex":0.00035111813,"about_ca_system_score_gemma":0.00028344145,"threshold_uncertainty_score":0.0060256124},"labels":[],"label_agreement":null},{"id":"W2030646690","doi":"10.1592/phco.22.8.673.33210","title":"The Association of St. John's Wort with Elevated Thyroid‐Stimulating Hormone","year":2002,"lang":"en","type":"letter","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Citation; Library science; Computer science","score_opus":0.05185567973223974,"score_gpt":0.3753069574817535,"score_spread":0.32345127774951377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030646690","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03850696,0.006649207,0.00081354316,0.89521176,0.024100464,0.00006303178,0.00023398074,0.000088582645,0.034332484],"genre_scores_gemma":[0.3608382,0.009996266,0.0009884265,0.51579756,0.082069956,0.00007249194,0.000160058,0.000058744296,0.03001829],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99907136,0.00023293654,0.00012717115,0.00014151375,0.00024209236,0.00018481302],"domain_scores_gemma":[0.9974879,0.0015054686,0.0002543278,0.00011066757,0.00033040746,0.00031118136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007519607,0.0004870447,0.0007008494,0.00053232495,0.0013533088,0.00075936044,0.0006577712,0.014291825,0.0039616944],"category_scores_gemma":[0.009595666,0.0003630939,0.0009532879,0.0005654856,0.0013469389,0.0011914116,0.0004706407,0.010693878,0.0016069326],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005827925,0.0002455685,0.030686827,0.00024095704,0.00011004745,0.5281616,0.00049002556,0.00038783942,0.0017040663,0.0062750224,0.39935464,0.03176067],"study_design_scores_gemma":[0.00041675454,0.00056660804,0.038002465,0.0005386345,0.00018352087,0.7068489,0.00080896175,0.002489488,0.0011554555,0.011153366,0.23770542,0.0001303718],"about_ca_topic_score_codex":0.009015942,"about_ca_topic_score_gemma":0.01505132,"teacher_disagreement_score":0.014291825,"about_ca_system_score_codex":0.0017814619,"about_ca_system_score_gemma":0.0014441713,"threshold_uncertainty_score":0.017926931},"labels":[],"label_agreement":null},{"id":"W2031575997","doi":"10.1007/s00228-013-1592-7","title":"Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates","year":2013,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Beef Cattle Research Council; GlaxoSmithKline","keywords":"Omeprazole; Pharmacology; CYP2C19; Pharmacokinetics; CYP3A4; Rosuvastatin; Chemistry; Pioglitazone; Oral administration; In vivo; Medicine; Cytochrome P450; Endocrinology; Enzyme; Type 2 diabetes; Biology; Biochemistry; Diabetes mellitus","score_opus":0.1660924149876682,"score_gpt":0.4554010342335258,"score_spread":0.2893086192458576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031575997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985525,0.00067414495,0.00027013363,0.000028774573,0.000012316907,0.00004115573,0.00006464636,0.000016172458,0.00034019357],"genre_scores_gemma":[0.99859697,0.00036319104,0.0003732539,0.00004050522,0.000019538127,0.000020618412,0.00012309087,0.0000060471884,0.00045691873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959415,0.00021042269,0.000020214191,0.00006749068,0.00006931206,0.00003829561],"domain_scores_gemma":[0.9995515,0.00016828906,0.0001279591,0.00005052559,0.000031925432,0.00006979843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003479019,0.00040959497,0.0006179555,0.00012585093,0.00015685085,0.00036782457,0.0001531826,0.00037379385,0.0015104365],"category_scores_gemma":[0.0007503483,0.000247153,0.00034518066,0.00014402455,0.0003798847,0.00036963826,0.00011961967,0.00066874665,0.00021734623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0567927,0.0032646437,0.009303103,0.00020563799,0.00027121574,0.00026801124,0.00016009835,0.00066374306,0.9007226,0.00006852341,0.00024880274,0.028030798],"study_design_scores_gemma":[0.0037046126,0.38912502,0.14299646,0.000024299497,0.00058767624,0.0012023551,0.00017524904,0.005123709,0.4544085,0.00009618321,0.0025105565,0.000045346984],"about_ca_topic_score_codex":0.0009079255,"about_ca_topic_score_gemma":0.0016452741,"teacher_disagreement_score":0.0015104365,"about_ca_system_score_codex":0.00028095357,"about_ca_system_score_gemma":0.00021374035,"threshold_uncertainty_score":0.005052924},"labels":[],"label_agreement":null},{"id":"W2031623172","doi":"10.1139/bcb-2014-0088","title":"Cytochrome P450 expression in mouse brain: specific isoenzymes involved in Phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria","year":2014,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Secretaría de Ciencia y Técnica, Universidad de Buenos Aires; Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Microsome; CYP2E1; Mitochondrion; Cytochrome P450; Chemistry; Pharmacology; Biochemistry; Biology; Enzyme","score_opus":0.053806717972345756,"score_gpt":0.360197004842612,"score_spread":0.30639028687026626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031623172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96404105,0.0058836997,0.022145009,0.0003489501,0.00007692721,0.00013897236,0.0036890672,0.00046531248,0.0032111048],"genre_scores_gemma":[0.9628299,0.004719389,0.014805603,0.00013418606,0.00003166179,0.00039521858,0.004152112,0.0001498998,0.012782084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997092,0.00003089373,0.00002575828,0.000116637304,0.00005969763,0.00005782501],"domain_scores_gemma":[0.99983656,0.00001256195,0.00005909029,0.00002231426,0.000035142974,0.000034302804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020702207,0.00037143606,0.00021810643,0.000997897,0.00022642832,0.0003301735,0.00017224441,0.00035159627,0.002141979],"category_scores_gemma":[0.000103317165,0.00024364436,0.00032289085,0.0005046531,0.00029920074,0.0002829622,0.0001415387,0.0007290342,0.00065674237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001549792,0.000030873354,0.0005625193,0.000034898316,0.0000072435814,0.000053334345,0.000028707533,0.000016586322,0.9976902,0.00007673454,0.00005596966,0.0012879303],"study_design_scores_gemma":[0.000022527654,0.00042323227,0.018532764,0.000016675562,0.000055070068,0.0005785415,0.00007611462,0.00039338434,0.97659814,0.00015917433,0.0031376737,0.0000065969634],"about_ca_topic_score_codex":0.0005724115,"about_ca_topic_score_gemma":0.0008288922,"teacher_disagreement_score":0.002141979,"about_ca_system_score_codex":0.00024478228,"about_ca_system_score_gemma":0.00015599365,"threshold_uncertainty_score":0.0071656704},"labels":[],"label_agreement":null},{"id":"W2031652509","doi":"10.1002/jps.23288","title":"Comparative Assessment of In Vitro–In Vivo Extrapolation Methods used for Predicting Hepatic Metabolic Clearance of Drugs","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Genentech","keywords":"In vivo; Pharmacology; Chemistry; Drug; Pharmacokinetics; Medicine; Biology","score_opus":0.2504778167021015,"score_gpt":0.5828243398569454,"score_spread":0.33234652315484386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031652509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73103654,0.007917501,0.25413707,0.00022232746,0.00022317677,0.00027027927,0.0013791369,0.0009868597,0.0038270217],"genre_scores_gemma":[0.92307204,0.0024825267,0.07148556,0.000089084904,0.0000473511,0.00018310302,0.001112848,0.00016065837,0.0013668495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99652773,0.0020547023,0.00024797357,0.00027938603,0.00080202665,0.000088254696],"domain_scores_gemma":[0.9882238,0.007210172,0.0009582129,0.0009323094,0.0025169186,0.00015858836],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0058301026,0.0011995668,0.0009809695,0.001185984,0.0003008489,0.0011919774,0.00081477995,0.001010515,0.0007089468],"category_scores_gemma":[0.015294106,0.00043567872,0.0009534868,0.00092686247,0.00029768955,0.00060857716,0.0005658929,0.0010700607,0.00053263886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020858685,0.0014195812,0.06035246,0.0014197107,0.0013158519,0.00035623251,0.00060589716,0.083952725,0.5410956,0.0012492089,0.0011644823,0.28620952],"study_design_scores_gemma":[0.00014586211,0.007847523,0.04938905,0.0001395356,0.0011957675,0.0010437083,0.00024877256,0.27408233,0.6612281,0.000713372,0.0038038637,0.00016210788],"about_ca_topic_score_codex":0.001925432,"about_ca_topic_score_gemma":0.0019149218,"teacher_disagreement_score":0.9941699,"about_ca_system_score_codex":0.00062082894,"about_ca_system_score_gemma":0.0006406384,"threshold_uncertainty_score":0.030832946},"labels":[],"label_agreement":null},{"id":"W2032334516","doi":"10.1007/s10552-012-0088-6","title":"CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment","year":2012,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"CYP2C9; Colorectal adenoma; Medicine; Internal medicine; Aspirin; Relative risk; Gastroenterology; Adenoma; Genotype; Allele; Endocrinology; Confidence interval; Colorectal cancer; Genetics; Biology; Cytochrome P450; Cancer; Metabolism","score_opus":0.08161629301114395,"score_gpt":0.39518510890856806,"score_spread":0.31356881589742414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032334516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961085,0.0012887262,0.00024994442,0.0002850143,0.000057200814,0.000008451784,0.00055581244,0.000035730856,0.0014106233],"genre_scores_gemma":[0.99890685,0.00014812834,0.00012709347,0.000042223663,0.000041285457,0.0000029271628,0.00015246127,0.000011822088,0.0005672018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993303,0.00020488443,0.00007074211,0.00018695601,0.000104397724,0.00010273813],"domain_scores_gemma":[0.99609417,0.0011437545,0.0015726744,0.0005415269,0.00023784216,0.00041008097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004989925,0.0005580117,0.00079136674,0.00076004496,0.00044763382,0.0007485931,0.00045519395,0.0010662453,0.0056505185],"category_scores_gemma":[0.0039389604,0.0005723068,0.0019142877,0.0013485517,0.00030112438,0.00039436162,0.00033512354,0.0011185197,0.00049962575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024453169,0.00013362407,0.9854637,0.00005045712,0.002002865,0.00048291724,0.000083150546,0.00014558125,0.004300087,0.00008260612,0.0003521998,0.0044575334],"study_design_scores_gemma":[0.00004459527,0.00010353445,0.99798274,0.00000597367,0.000574222,0.00037921956,0.00002496358,0.00030835802,0.00030359763,0.0000696566,0.00019559386,0.000007532431],"about_ca_topic_score_codex":0.005531415,"about_ca_topic_score_gemma":0.006554949,"teacher_disagreement_score":0.0056505185,"about_ca_system_score_codex":0.00022738284,"about_ca_system_score_gemma":0.0002836369,"threshold_uncertainty_score":0.018902898},"labels":[],"label_agreement":null},{"id":"W2032586769","doi":"10.1002/jps.1074","title":"Enantiomeric drug development: Issues, considerations, and regulatory requirements","year":2001,"lang":"en","type":"review","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Enantiomer; Pharmacology; Medicine; Drug development; Pharmacodynamics; Pharmacokinetics; Chemistry; Drug; Stereochemistry","score_opus":0.37898506675273774,"score_gpt":0.5552674945783355,"score_spread":0.17628242782559772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032586769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040807197,0.98458165,0.0016812682,0.0052753,0.0006067042,0.000017026414,0.00003178272,0.00003477339,0.0073634507],"genre_scores_gemma":[0.0026828412,0.98814195,0.002912973,0.0022554083,0.0008495619,0.000025581596,0.000046166424,0.000008782293,0.003076761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983889,0.00039014124,0.00022125455,0.00015018608,0.000763858,0.00008568108],"domain_scores_gemma":[0.99554515,0.0027112775,0.00048372988,0.00015167137,0.0009022853,0.00020588725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060975184,0.0011003935,0.002948636,0.0022223906,0.0006246027,0.003126428,0.0024470214,0.0040784907,0.0055728494],"category_scores_gemma":[0.004117556,0.00054334896,0.0006387639,0.0027683277,0.0020271924,0.0039627557,0.0012018227,0.0042850883,0.0034217741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009757916,0.00012685692,0.00020984077,0.00406325,0.000026603084,0.0005135949,0.00007899353,0.00060964015,0.0018777144,0.020029832,0.033911638,0.93845457],"study_design_scores_gemma":[0.000047613747,0.0001871455,0.00053936493,0.0023791702,0.00005157153,0.003470258,0.0001410146,0.0003300246,0.0011168602,0.008925433,0.9827843,0.000027160586],"about_ca_topic_score_codex":0.001601379,"about_ca_topic_score_gemma":0.004991947,"teacher_disagreement_score":0.0060975184,"about_ca_system_score_codex":0.0012022898,"about_ca_system_score_gemma":0.003057347,"threshold_uncertainty_score":0.032247186},"labels":[],"label_agreement":null},{"id":"W2032878259","doi":"10.1016/j.amjopharm.2006.03.001","title":"Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review","year":2006,"lang":"en","type":"review","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"China Aerospace Science and Technology Corporation; Heart and Stroke Foundation of Canada","keywords":"Warfarin; Azathioprine; Discontinuation; Medicine; Drug interaction; Anticoagulant; Gastroenterology; Internal medicine; Pharmacology; Pharmacokinetics; Atrial fibrillation","score_opus":0.06018615349957545,"score_gpt":0.43892958919414293,"score_spread":0.3787434356945675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032878259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017665247,0.99639004,0.00016511722,0.00032931843,0.00008552862,0.000005657236,0.000023547103,0.0000059381655,0.001228157],"genre_scores_gemma":[0.010210894,0.98851043,0.00036736368,0.00029498152,0.00026150348,0.000005333515,0.000047598845,0.0000019013462,0.00030004748],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9995968,0.000050676514,0.00015128,0.00006540951,0.000106431165,0.00002935674],"domain_scores_gemma":[0.9989526,0.0005841705,0.00026486584,0.000035421726,0.00012137712,0.000041551768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041981493,0.000760255,0.0016824252,0.0039694505,0.00032925786,0.0012282588,0.0011963511,0.0016819366,0.0022949073],"category_scores_gemma":[0.0014781224,0.0003250216,0.00079260365,0.0036677856,0.0006548773,0.0016702581,0.00046483648,0.00088807056,0.0010120465],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003165909,0.00021951225,0.008860195,0.03579246,0.00075719197,0.15919131,0.00050177297,0.00035275196,0.0045532254,0.0018497736,0.015370204,0.772235],"study_design_scores_gemma":[0.000096103664,0.00021629594,0.019387918,0.014725928,0.0026812074,0.6403302,0.00093060784,0.00026998433,0.0027649256,0.0022185086,0.3162753,0.00010307783],"about_ca_topic_score_codex":0.0011793566,"about_ca_topic_score_gemma":0.0019182703,"teacher_disagreement_score":0.0039694505,"about_ca_system_score_codex":0.00045786967,"about_ca_system_score_gemma":0.0010969505,"threshold_uncertainty_score":0.0076771975},"labels":[],"label_agreement":null},{"id":"W2033334346","doi":"10.1016/j.vascn.2006.07.002","title":"Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine","year":2006,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CYP3A; Fluorescence; Substrate (aquarium); Chemistry; Biology; Biochemistry; Cytochrome P450; Enzyme; Ecology; Physics","score_opus":0.3033270995124598,"score_gpt":0.5003424430822251,"score_spread":0.1970153435697653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033334346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5354375,0.0072047273,0.4442972,0.0009173367,0.00031375804,0.00030380947,0.0010016448,0.0010960508,0.009427852],"genre_scores_gemma":[0.67869014,0.0042310883,0.30089518,0.0004802026,0.00008560999,0.00057497097,0.0018967631,0.000332659,0.012813322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950004,0.00011202431,0.000019962676,0.00017860306,0.00008559152,0.000103751496],"domain_scores_gemma":[0.9995122,0.0001790203,0.00006849266,0.00007496044,0.00009293404,0.00007238539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007575535,0.0008123647,0.000533733,0.00067932217,0.0007132908,0.00054241135,0.0006525332,0.0011863308,0.0016016505],"category_scores_gemma":[0.000549934,0.00060763763,0.00046807525,0.0006195348,0.00050490233,0.00066160946,0.0005028824,0.0016268286,0.0006955615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009895545,0.000015602322,0.00011630838,0.00005100323,0.000008276316,0.000028483926,0.000019549794,0.00006741499,0.9976603,0.00023260333,0.000058453028,0.0016430401],"study_design_scores_gemma":[0.000013981696,0.00014189063,0.0007795018,0.0000066702587,0.000019606627,0.00016383818,0.000015867288,0.00097226695,0.99620456,0.000068019835,0.0016069048,0.0000067892256],"about_ca_topic_score_codex":0.0018932762,"about_ca_topic_score_gemma":0.0043593408,"teacher_disagreement_score":0.0018932762,"about_ca_system_score_codex":0.0005932466,"about_ca_system_score_gemma":0.00076219696,"threshold_uncertainty_score":0.0053579807},"labels":[],"label_agreement":null},{"id":"W2033719606","doi":"10.1002/jat.1172","title":"4‐Aminobiphenyl <i>N</i>‐glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP‐glucuronosyltransferase isoforms","year":2006,"lang":"en","type":"article","venue":"Journal of Applied Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"U.S. Public Health Service","keywords":"Glucuronidation; Microsome; Gene isoform; Chemistry; Biochemistry; Isozyme; Enzyme; Gene","score_opus":0.019494362091555875,"score_gpt":0.3024328709927072,"score_spread":0.28293850890115135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033719606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595632,0.006176895,0.030503549,0.00025056594,0.00004914818,0.00018577202,0.00081933907,0.00027925742,0.0021722915],"genre_scores_gemma":[0.96039724,0.005032229,0.027383626,0.000093142946,0.000031111565,0.00017655175,0.0024651869,0.00016191692,0.0042589265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963117,0.00013576077,0.0000340768,0.0000735501,0.000064454536,0.000060949766],"domain_scores_gemma":[0.99984014,0.000031460277,0.00004612597,0.000016129688,0.00004357642,0.000022546432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050667697,0.0006066256,0.00053631264,0.00018554709,0.00015199825,0.00031653166,0.00016451268,0.00028519472,0.0005402358],"category_scores_gemma":[0.0004045972,0.00021547492,0.00038441631,0.000441814,0.0001772256,0.00024745715,0.00021882256,0.00042954736,0.0006042398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001997818,0.000024590589,0.00031148642,0.000064604144,0.000016106062,0.000032428758,0.000016018594,0.00023306439,0.9966935,0.000047289792,0.000042675856,0.0023183574],"study_design_scores_gemma":[0.000009482598,0.0002169213,0.0017818788,0.0000044331564,0.000024902132,0.00007817453,0.000010629693,0.00081422296,0.9956695,0.00001734807,0.0013655131,0.000006904338],"about_ca_topic_score_codex":0.0016472068,"about_ca_topic_score_gemma":0.0019769997,"teacher_disagreement_score":0.0016472068,"about_ca_system_score_codex":0.00043258487,"about_ca_system_score_gemma":0.00035635487,"threshold_uncertainty_score":0.0032752752},"labels":[],"label_agreement":null},{"id":"W2033806536","doi":"10.3109/10408363.2014.950407","title":"Is personalized medicine a dream or a reality?","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"U.S. Public Health Service","keywords":"Pharmacogenomics; VKORC1; Personalized medicine; Medicine; Warfarin; Precision medicine; Pharmacogenetics; Drug; CYP2C9; Intensive care medicine; Bioinformatics; Pharmacology; Internal medicine; Biology; Genetics; Gene; Cytochrome P450; Atrial fibrillation; Pathology","score_opus":0.7021953646493445,"score_gpt":0.6928524729234234,"score_spread":0.009342891725921065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033806536","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044745658,0.07844412,0.008790217,0.89966,0.007176522,0.000022243543,0.00018649669,0.00019694709,0.0050760396],"genre_scores_gemma":[0.050695367,0.25274518,0.033645816,0.6154833,0.03896019,0.00022239565,0.0005584509,0.0003469869,0.0073423265],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.977523,0.012473612,0.0011038996,0.0026919092,0.00481969,0.001387843],"domain_scores_gemma":[0.93118167,0.049962927,0.0021688095,0.005720759,0.0053035775,0.005662212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04154207,0.0015305971,0.003911885,0.0023651246,0.0049646283,0.016764846,0.0034153324,0.016863529,0.012131959],"category_scores_gemma":[0.049857926,0.00076563767,0.0019362395,0.0025532248,0.029198654,0.029912839,0.009988449,0.037297882,0.0058324244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018602649,0.00013742599,0.0013991614,0.0025080119,0.00038982136,0.00048647547,0.0025889908,0.0008485206,0.00074348843,0.4211242,0.36949545,0.20009243],"study_design_scores_gemma":[0.000034627465,0.00007869155,0.0006283931,0.00214973,0.000076895274,0.00055311195,0.0015677393,0.0004108372,0.00020144344,0.47766462,0.51654065,0.0000932757],"about_ca_topic_score_codex":0.0022817783,"about_ca_topic_score_gemma":0.0021036642,"teacher_disagreement_score":0.04154207,"about_ca_system_score_codex":0.0066990703,"about_ca_system_score_gemma":0.010553731,"threshold_uncertainty_score":0.21969807},"labels":[],"label_agreement":null},{"id":"W2034105674","doi":"10.7326/0003-4819-155-10-201111150-00003","title":"Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios","year":2011,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Warfarin; Internal medicine; Anesthesia; Surgery; Atrial fibrillation","score_opus":0.18559471097793345,"score_gpt":0.4508698301658539,"score_spread":0.26527511918792046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034105674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544525,0.0028500364,0.00020377383,0.0002560529,0.00009835044,0.00033578958,0.00009421997,0.000014582063,0.00070185546],"genre_scores_gemma":[0.99747366,0.0008519634,0.00063814776,0.00020921913,0.000107761705,0.00035972815,0.00010087656,0.0000025114746,0.00025608114],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979195,0.0012219426,0.00025002373,0.00021640597,0.00024812933,0.00014392256],"domain_scores_gemma":[0.9958366,0.0014536122,0.001658026,0.0002148532,0.00022931634,0.0006075288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00297545,0.00042605004,0.001626447,0.000304442,0.00037403248,0.0005502517,0.00044627453,0.00070985034,0.0021250087],"category_scores_gemma":[0.006158543,0.0002810838,0.0011026994,0.00038267806,0.00055545766,0.0005451483,0.00024790512,0.0010389378,0.00023614324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9185885,0.0059892917,0.019399893,0.0004864437,0.0009169831,0.00005552022,0.00011957273,0.00029812372,0.0011850996,0.000066502194,0.0006483711,0.052245762],"study_design_scores_gemma":[0.5543651,0.32347533,0.1163486,0.00017183166,0.0016025647,0.00020052194,0.00010924399,0.0015023006,0.0007925024,0.00022292523,0.0011596613,0.000049460057],"about_ca_topic_score_codex":0.0024870702,"about_ca_topic_score_gemma":0.006268191,"teacher_disagreement_score":0.00297545,"about_ca_system_score_codex":0.0010458416,"about_ca_system_score_gemma":0.0016552907,"threshold_uncertainty_score":0.015735865},"labels":[],"label_agreement":null},{"id":"W2034687446","doi":"10.1097/ftd.0b013e31824a1e21","title":"Suspected Opioid Overdose Case Resolved by CYP2D6 Genotyping","year":2012,"lang":"en","type":"article","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"CYP2D6; Genotyping; Opiate; Medicine; Pharmacogenetics; Opioid; Anesthesia; Drug overdose; Opioid overdose; Pharmacology; (+)-Naloxone; Genotype; Poison control; Internal medicine; Emergency medicine; Cytochrome P450; Biology; Genetics; Receptor","score_opus":0.10790998077482065,"score_gpt":0.4240395855465061,"score_spread":0.31612960477168545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034687446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97101146,0.0034505327,0.0025891273,0.010333474,0.0005521404,0.0001812134,0.00035014108,0.00012331922,0.011408665],"genre_scores_gemma":[0.99377984,0.0013383261,0.0007052998,0.0019186493,0.00064354105,0.000013378576,0.0001366313,0.000016581675,0.0014477726],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963105,0.000041132225,0.000051700765,0.0000932185,0.00006881148,0.000114138886],"domain_scores_gemma":[0.9993537,0.00016197888,0.0001249105,0.00003725255,0.000080101745,0.00024198579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023531815,0.0011437808,0.0009970118,0.0011330243,0.0018248161,0.0007755554,0.00079924345,0.0036954086,0.0021706242],"category_scores_gemma":[0.0019669414,0.00056118955,0.0009586379,0.0006929537,0.00072433794,0.0010424819,0.00070986117,0.0030148476,0.00049813115],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056530298,0.000054639302,0.01256496,0.000012064459,0.0000064656574,0.9856607,0.000087959896,0.00004308521,0.00042981197,0.00006885233,0.00023328525,0.00078167714],"study_design_scores_gemma":[0.000027144077,0.00017967104,0.019150715,0.000022736376,0.000033037217,0.9783558,0.00022580763,0.00036759974,0.0005736425,0.00019242078,0.0008550318,0.000016333084],"about_ca_topic_score_codex":0.0032570749,"about_ca_topic_score_gemma":0.0037314508,"teacher_disagreement_score":0.0036954086,"about_ca_system_score_codex":0.00090685766,"about_ca_system_score_gemma":0.00083504844,"threshold_uncertainty_score":0.007261455},"labels":[],"label_agreement":null},{"id":"W2034832094","doi":"10.1002/iub.241","title":"Cytochrome P450 enzymes and the heart","year":2009,"lang":"en","type":"review","venue":"IUBMB Life","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Biology; Enzyme; Monooxygenase; Disease; Isozyme; Pharmacology; Bioinformatics; Biochemistry; Internal medicine; Medicine","score_opus":0.21103047640168152,"score_gpt":0.5038105398568771,"score_spread":0.2927800634551956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034832094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023291679,0.99715245,0.00018066083,0.00022780026,0.00013877849,0.0000041124194,0.000014216486,0.000010067922,0.0020388877],"genre_scores_gemma":[0.0019769543,0.9943597,0.00028802504,0.00016830437,0.0002666343,0.000007987285,0.00003939906,0.0000016949825,0.002891456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998363,0.00003410854,0.000016589694,0.000031923388,0.00006393638,0.00001717075],"domain_scores_gemma":[0.9998888,0.00003940727,0.00001997406,0.0000050964386,0.00003344311,0.000013221678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024220766,0.0005982521,0.00089646725,0.0011285191,0.0002755585,0.00069251435,0.00048380755,0.00082693616,0.004522389],"category_scores_gemma":[0.00034880903,0.00017717913,0.00031830592,0.001587851,0.00031669738,0.00074464676,0.0004219229,0.0010863148,0.004509311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005934335,0.0000660551,0.00031056322,0.005304398,0.000046167486,0.00056972203,0.000051136387,0.00024937614,0.0032328102,0.002274269,0.026824106,0.96101195],"study_design_scores_gemma":[0.00002166286,0.000097691765,0.0022438196,0.0011745243,0.000061480656,0.0039602714,0.000050534807,0.00008373609,0.0009816554,0.0027799357,0.9885296,0.000014978788],"about_ca_topic_score_codex":0.0009942595,"about_ca_topic_score_gemma":0.0013412718,"teacher_disagreement_score":0.004522389,"about_ca_system_score_codex":0.00041433825,"about_ca_system_score_gemma":0.0006657826,"threshold_uncertainty_score":0.015128851},"labels":[],"label_agreement":null},{"id":"W2034897616","doi":"10.1007/s10549-013-2511-4","title":"CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Tamoxifen; CYP2D6; Breast cancer; Pharmacogenetics; Medicine; Oncology; Internal medicine; Pharmacogenomics; Pharmacology; CYP3A5; Selective estrogen receptor modulator; Genotype; Prospective cohort study; Cancer; Bioinformatics; Biology; Genetics; Cytochrome P450","score_opus":0.16394551591650738,"score_gpt":0.4609639978878481,"score_spread":0.29701848197134073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034897616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381787,0.0026221867,0.0012513135,0.00024323016,0.000042787324,0.00001750312,0.0007018948,0.000028450282,0.0012747735],"genre_scores_gemma":[0.99827003,0.00029044176,0.00046350935,0.000068412955,0.000022876298,0.0000075723965,0.00029433324,0.000011510671,0.0005713013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995666,0.00013426415,0.000046782563,0.00010861372,0.00009488086,0.000048871745],"domain_scores_gemma":[0.99899083,0.00029145423,0.0003768494,0.00013255911,0.00014322251,0.00006511004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004102167,0.0002144947,0.00046120695,0.0004827487,0.000220908,0.00054564344,0.00025413264,0.00044473997,0.0013478224],"category_scores_gemma":[0.0015927189,0.00021313065,0.0005219255,0.0007355129,0.00015824779,0.00020289235,0.00016188133,0.00042446723,0.00017527767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021847973,0.000100845675,0.94985086,0.000062217034,0.000687938,0.00023915846,0.00012836755,0.0003769208,0.023815678,0.00011318019,0.00038282233,0.022057075],"study_design_scores_gemma":[0.000011079498,0.0001186657,0.99641174,0.0000056921363,0.00011668912,0.00029047282,0.00006623557,0.00045543603,0.0018277897,0.00006902349,0.00062180654,0.0000053901313],"about_ca_topic_score_codex":0.005113923,"about_ca_topic_score_gemma":0.007702401,"teacher_disagreement_score":0.005113923,"about_ca_system_score_codex":0.00036568588,"about_ca_system_score_gemma":0.00025872374,"threshold_uncertainty_score":0.010168314},"labels":[],"label_agreement":null},{"id":"W2035212715","doi":"10.1111/j.1365-2125.2007.02984.x","title":"Exposure–response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets","year":2007,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Carbamazepine; Pharmacology; Toxicity; Medicine; Pharmacokinetics; Internal medicine; Epilepsy","score_opus":0.2179767613148042,"score_gpt":0.518435792513046,"score_spread":0.30045903119824174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035212715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92139274,0.0055974307,0.06255517,0.00074939156,0.000118139564,0.0011571929,0.0024362535,0.00041100706,0.005582744],"genre_scores_gemma":[0.9924614,0.0005393729,0.004735779,0.0002750959,0.0000371383,0.00023626866,0.000578756,0.0000669221,0.001069301],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98762065,0.007885367,0.00084393646,0.0013750625,0.0020632085,0.00021186583],"domain_scores_gemma":[0.9719044,0.021566262,0.0026686706,0.0030138325,0.000680387,0.000166464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012577502,0.0006132062,0.0016121938,0.00049117795,0.00014898276,0.0010099236,0.00050115323,0.0011942232,0.004139329],"category_scores_gemma":[0.019418258,0.00033075447,0.0030671456,0.0006982334,0.0003918544,0.0007115388,0.0004619633,0.0013935666,0.0007179453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07078309,0.0053227297,0.16346702,0.004857701,0.02262132,0.000870723,0.0014477604,0.048995193,0.26850626,0.0030016678,0.0035864825,0.40654013],"study_design_scores_gemma":[0.0014617305,0.079530574,0.6934588,0.00026867088,0.00833066,0.0033291716,0.0005346043,0.10729936,0.078733616,0.006867183,0.019879404,0.00030634872],"about_ca_topic_score_codex":0.00044683449,"about_ca_topic_score_gemma":0.00034670482,"teacher_disagreement_score":0.012577502,"about_ca_system_score_codex":0.00043867342,"about_ca_system_score_gemma":0.00038236222,"threshold_uncertainty_score":0.066516995},"labels":[],"label_agreement":null},{"id":"W2035714354","doi":"10.1016/j.bcp.2008.08.015","title":"The CYP2B2 5′ flank contains a complex glucocorticoid response unit","year":2008,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Glucocorticoid receptor; Glucocorticoid; Hormone response element; Basal (medicine); Dexamethasone; Biology; Flank; Immediate early gene; Gene; Endocrinology; Gene expression; Genetics; Anatomy; Estrogen receptor","score_opus":0.20684548059427788,"score_gpt":0.4588772604516215,"score_spread":0.25203177985734365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035714354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6995477,0.00897082,0.22420852,0.0024335585,0.0018574502,0.00090223714,0.016144821,0.008830608,0.037104264],"genre_scores_gemma":[0.8850535,0.0007106119,0.07134853,0.00097323844,0.00034933805,0.0003069192,0.009317498,0.0005399288,0.031400498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994968,0.00009662983,0.000031955093,0.00017566758,0.00012126317,0.00007763788],"domain_scores_gemma":[0.99940324,0.00012252756,0.00011491535,0.00014826642,0.00007796411,0.00013306446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031766927,0.0005920553,0.00083846063,0.0004968572,0.0005257542,0.00096327334,0.00055910205,0.0010609885,0.013143816],"category_scores_gemma":[0.0005190569,0.00055975304,0.0012331089,0.00053537084,0.00051500765,0.00033780772,0.00066033076,0.0011125697,0.013991037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014335734,0.00008510899,0.0013558175,0.00014601921,0.00005934753,0.00039214708,0.00004550767,0.0007910137,0.9694288,0.0024017503,0.0025013865,0.021359412],"study_design_scores_gemma":[0.0002155787,0.00064330816,0.014394153,0.000029058085,0.000068148096,0.0018711848,0.000042629843,0.0021589256,0.8674233,0.00084068446,0.11223142,0.00008151445],"about_ca_topic_score_codex":0.0022860668,"about_ca_topic_score_gemma":0.0013966397,"teacher_disagreement_score":0.013143816,"about_ca_system_score_codex":0.000652154,"about_ca_system_score_gemma":0.0006627593,"threshold_uncertainty_score":0.043970406},"labels":[],"label_agreement":null},{"id":"W2035815658","doi":"10.1016/j.ympev.2011.10.016","title":"Phylogenetic and functional analyses of the cytochrome P450 family 4","year":2011,"lang":"en","type":"article","venue":"Molecular Phylogenetics and Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Subfamily; Phylogenetic tree; Evolutionary biology; Gene; Functional divergence; Phylogenetics; Genetics; In silico; Pseudogene; Gene family; Genome","score_opus":0.1551532149022495,"score_gpt":0.38175850900779207,"score_spread":0.22660529410554256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035815658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879871,0.002587388,0.0041905274,0.00038387475,0.000018456465,0.000014953859,0.00045618965,0.00003605095,0.0043255226],"genre_scores_gemma":[0.9936441,0.0010085792,0.002686627,0.00008713632,0.00003747708,0.000008574184,0.0010632271,0.000019118961,0.0014452499],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99969816,0.000102772516,0.00001151781,0.00006429967,0.00005610558,0.000067091714],"domain_scores_gemma":[0.99943167,0.00017372376,0.00013590594,0.00004176498,0.00013737584,0.00007950628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048160728,0.00026788682,0.00027353593,0.0017835475,0.0007816357,0.0004584184,0.0003366622,0.00039178136,0.0016230505],"category_scores_gemma":[0.0008127475,0.00014653464,0.0003993492,0.0011682193,0.00036326976,0.00032140684,0.00036376933,0.0007817619,0.0005422705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025639667,0.00027832724,0.12749985,0.0003414836,0.00035241884,0.0014988281,0.001288512,0.0069259787,0.69175965,0.011185637,0.0011522433,0.1551531],"study_design_scores_gemma":[0.00011174204,0.00062407734,0.8688491,0.00008496437,0.0003070254,0.0044201203,0.0008433248,0.024179028,0.040138364,0.0055742147,0.054792486,0.00007555986],"about_ca_topic_score_codex":0.0023644115,"about_ca_topic_score_gemma":0.001590991,"teacher_disagreement_score":0.0023644115,"about_ca_system_score_codex":0.0005463173,"about_ca_system_score_gemma":0.00024391679,"threshold_uncertainty_score":0.005429685},"labels":[],"label_agreement":null},{"id":"W2036131177","doi":"10.1016/s0378-4274(01)00264-8","title":"Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and α-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat","year":2001,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Debrisoquine; Globulin; Hydroxylation; Hamster; Microsome; Albumin; Chemistry; Human serum albumin; Biochemistry; Blood proteins; Serum albumin; Cytochrome P450; Biology; Metabolism; Endocrinology; In vitro; Enzyme; CYP2D6","score_opus":0.03984320214840741,"score_gpt":0.3447167022005488,"score_spread":0.30487350005214137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036131177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958331,0.0018650476,0.001639948,0.000071239185,0.000024619509,0.000011923782,0.00010928202,0.000036126057,0.0004088471],"genre_scores_gemma":[0.9972308,0.00067053904,0.00065888,0.000033333796,0.000021456868,0.000012075879,0.000355774,0.000012208674,0.00100505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998029,0.00009019424,0.000010486914,0.000028381173,0.000021021939,0.000047081456],"domain_scores_gemma":[0.9997943,0.000079709396,0.000042525502,0.000027905615,0.00002600459,0.000029606297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028524478,0.0005161104,0.0003118829,0.00018713891,0.0001900944,0.00021799601,0.00019539056,0.0003277283,0.0008419445],"category_scores_gemma":[0.00040955146,0.00019441363,0.00033631446,0.00023493414,0.0002330103,0.00020812268,0.00017502898,0.00032903033,0.00035119493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044104336,0.00017648673,0.0023455052,0.00013530793,0.000096523494,0.00021739917,0.00011602055,0.00032527227,0.9859788,0.00020369641,0.00018790159,0.005806632],"study_design_scores_gemma":[0.00005774068,0.0013269704,0.010300205,0.000005314146,0.00005002327,0.00027042144,0.000027106165,0.0008949016,0.9856009,0.000060268096,0.0013988779,0.00000736549],"about_ca_topic_score_codex":0.0012070156,"about_ca_topic_score_gemma":0.0009160239,"teacher_disagreement_score":0.0012070156,"about_ca_system_score_codex":0.00028544743,"about_ca_system_score_gemma":0.00014164779,"threshold_uncertainty_score":0.0028166175},"labels":[],"label_agreement":null},{"id":"W2036181656","doi":"10.1016/j.ejps.2008.11.002","title":"Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo","year":2008,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Chemistry; In vivo; Polysorbate; Pharmacology; Microsome; Hydroxylation; Pharmacokinetics; Midazolam; Cytochrome P450; Metabolite; Chromatography; First pass effect; In vitro; Biochemistry; Metabolism; Pulmonary surfactant; Enzyme; Medicine; Biology","score_opus":0.148289908046269,"score_gpt":0.4161611932189839,"score_spread":0.26787128517271497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036181656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483138,0.026904603,0.017497387,0.00051040406,0.00025890826,0.00016225659,0.0003679128,0.00019115108,0.0057936697],"genre_scores_gemma":[0.9800571,0.008247372,0.0034795494,0.00021876901,0.00008088296,0.00005550518,0.0006389132,0.000048745627,0.0071731736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995334,0.00016610764,0.000042997013,0.000041650255,0.0001580194,0.000057796486],"domain_scores_gemma":[0.99927896,0.00023849023,0.00021741867,0.000048654536,0.00012822663,0.00008831885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041139507,0.0005701067,0.00037897372,0.00034361138,0.00019470413,0.00035149071,0.00020143931,0.00035975876,0.0023054532],"category_scores_gemma":[0.00075242406,0.00024185344,0.00036601757,0.00028369747,0.00020091028,0.00034254545,0.0002370754,0.00062724337,0.00047015076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085876224,0.00011708188,0.00042411953,0.00017165909,0.00005322388,0.00015101551,0.000028397713,0.0001400688,0.9898477,0.00020659766,0.00026759956,0.0077336673],"study_design_scores_gemma":[0.000041530562,0.00091389637,0.0011050899,0.00001023008,0.000037819562,0.00036569225,0.000016840368,0.00032441888,0.9935549,0.000067896464,0.0035563956,0.0000052843207],"about_ca_topic_score_codex":0.00074085186,"about_ca_topic_score_gemma":0.0016475989,"teacher_disagreement_score":0.0023054532,"about_ca_system_score_codex":0.00024817875,"about_ca_system_score_gemma":0.00034425748,"threshold_uncertainty_score":0.0077124834},"labels":[],"label_agreement":null},{"id":"W2036206840","doi":"10.1016/j.cbi.2003.09.003","title":"Spectral interactions of tetrachlorobiphenyls with hepatic microsomal cytochrome P450 enzymes","year":2003,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Microsome; Cytochrome P450; Cytochrome; Enzyme; Chemistry; Biochemistry","score_opus":0.11657548732323841,"score_gpt":0.4197559361963263,"score_spread":0.30318044887308787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036206840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987387,0.002644169,0.004925473,0.00029917614,0.000054840908,0.000023776896,0.00030552348,0.000106594205,0.0042534177],"genre_scores_gemma":[0.9973687,0.0005528231,0.00044603398,0.00007181124,0.000023827062,0.000007351255,0.0002142923,0.000009633194,0.0013056428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999681,0.00016286776,0.000010887189,0.000030458434,0.00005973706,0.000055172142],"domain_scores_gemma":[0.9994547,0.00024487416,0.00009541929,0.00003714761,0.00010241477,0.000065413944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040349425,0.00031556204,0.00025843084,0.00041607444,0.00031723708,0.00033669383,0.0001700004,0.00041115767,0.0036040926],"category_scores_gemma":[0.0008262293,0.00023903485,0.00030720778,0.00040288694,0.00016803348,0.00017330272,0.00019269728,0.00032374007,0.00062134425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041605597,0.00018104611,0.01603355,0.000113681715,0.0001709319,0.00039126145,0.00007505351,0.0009894673,0.96303946,0.000505898,0.00045495285,0.0138841225],"study_design_scores_gemma":[0.000090806985,0.0016855943,0.06346122,0.0000134725115,0.00015075674,0.000940171,0.00012420097,0.0032723548,0.9279692,0.0005478903,0.0017284487,0.000015795787],"about_ca_topic_score_codex":0.0025541368,"about_ca_topic_score_gemma":0.0027456197,"teacher_disagreement_score":0.0036040926,"about_ca_system_score_codex":0.00056551525,"about_ca_system_score_gemma":0.00025492886,"threshold_uncertainty_score":0.012056887},"labels":[],"label_agreement":null},{"id":"W2037050175","doi":"10.1080/07357900802574660","title":"Pharmacology and Pharmacogenetics of Chemotherapeutic Agents","year":2009,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Chemotherapeutic drugs; Medicine; Drug; Pharmacology; Precision medicine; Clinical pharmacology; Drug response; Intensive care medicine; Chemotherapy; Bioinformatics; Internal medicine; Biology; Pathology; Genotype","score_opus":0.3330410630973113,"score_gpt":0.5339622308067224,"score_spread":0.20092116770941115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037050175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032101257,0.9814516,0.004312682,0.0014344964,0.0001909699,0.000034892753,0.0001328309,0.000048198075,0.009184205],"genre_scores_gemma":[0.018141916,0.9756875,0.0025009369,0.0004783454,0.00023019854,0.000043571228,0.00012996882,0.0000067002484,0.0027808677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996345,0.000112495276,0.000037923754,0.000059637856,0.00013427222,0.000021167536],"domain_scores_gemma":[0.999665,0.00015297576,0.00007051593,0.000018658564,0.00007765428,0.000015124913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004834602,0.00046042458,0.001075658,0.0011297787,0.00018361711,0.0007800641,0.0005115699,0.0006094011,0.0016890977],"category_scores_gemma":[0.00083196093,0.00022807789,0.0004466671,0.0013678409,0.0004350365,0.00049305736,0.0004032485,0.001018032,0.0012447401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013666524,0.00014184412,0.003175092,0.006346815,0.00017646003,0.0011858332,0.00009320667,0.0018813439,0.018881936,0.010708381,0.011116036,0.9461563],"study_design_scores_gemma":[0.000048817794,0.00037321632,0.0120096,0.0016907308,0.00028982083,0.012100538,0.00010445028,0.0011677853,0.02104633,0.013048319,0.9380579,0.00006249157],"about_ca_topic_score_codex":0.0009360135,"about_ca_topic_score_gemma":0.0013076258,"teacher_disagreement_score":0.0016890977,"about_ca_system_score_codex":0.000604112,"about_ca_system_score_gemma":0.00081188645,"threshold_uncertainty_score":0.0056506395},"labels":[],"label_agreement":null},{"id":"W2037171637","doi":"10.1182/blood-2008-01-134247","title":"A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":486,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of Washington; National Institute of Neurological Disorders and Stroke; University of Florida","keywords":"VKORC1; Warfarin; CYP2C9; Single-nucleotide polymorphism; Vitamin K epoxide reductase; Biology; Population; Genetics; Medicine; Internal medicine; Genotype; Gene","score_opus":0.06018353544277637,"score_gpt":0.3613729850026524,"score_spread":0.30118944955987603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037171637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942888,0.0025494164,0.00091514597,0.00043287306,0.000026912376,0.00001161162,0.0007597278,0.00004101108,0.00097440294],"genre_scores_gemma":[0.997815,0.00042443362,0.00080416776,0.00022228541,0.00005291966,0.000008450592,0.0004501868,0.00000969635,0.00021284644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850607,0.00043006905,0.0001063908,0.00067477644,0.0001951861,0.000087539054],"domain_scores_gemma":[0.9966182,0.0016883834,0.0009110699,0.00036002477,0.00015903295,0.00026322526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010431932,0.00045097864,0.00060680776,0.0007381257,0.00045914022,0.00075345836,0.00051576615,0.001067556,0.0031848336],"category_scores_gemma":[0.003320196,0.00021983533,0.0007246462,0.001753308,0.00068597466,0.00025916813,0.00031056552,0.00087289925,0.00025897496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011074677,0.00008849502,0.97506773,0.000079138044,0.0015577782,0.00077077316,0.00010530323,0.00015947512,0.007655364,0.00024831117,0.00075080653,0.012409469],"study_design_scores_gemma":[0.00005425665,0.00019175521,0.9961176,0.00001123741,0.00073343917,0.001292338,0.000042958134,0.00027484438,0.00042452093,0.0001884395,0.00066143565,0.000007222143],"about_ca_topic_score_codex":0.003497685,"about_ca_topic_score_gemma":0.003566762,"teacher_disagreement_score":0.003497685,"about_ca_system_score_codex":0.0002289018,"about_ca_system_score_gemma":0.00036279685,"threshold_uncertainty_score":0.01065433},"labels":[],"label_agreement":null},{"id":"W2037431844","doi":"10.1080/00498250310001657559","title":"Role of individual human cytochrome P450 enzymes in the<i>in vitro</i>metabolism of hydromorphone","year":2004,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ketoconazole; Microsome; CYP3A; CYP3A4; Hydromorphone; CYP1A2; Chemistry; Cytochrome P450; Demethylation; Pharmacology; Drug metabolism; Metabolism; Biochemistry; Biology; Enzyme; Microbiology","score_opus":0.05461144811330217,"score_gpt":0.3783237289665465,"score_spread":0.3237122808532443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037431844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96728927,0.012898227,0.015496415,0.0002255497,0.000044013057,0.00007881678,0.00085836643,0.00020206229,0.0029072883],"genre_scores_gemma":[0.9908285,0.0025054333,0.004542109,0.000068082205,0.000025111096,0.000024494753,0.0009374482,0.000017337938,0.0010515254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998056,0.000072831026,0.000017409458,0.000044563832,0.000036395777,0.000023298717],"domain_scores_gemma":[0.9997569,0.00006822054,0.000073976524,0.00003759958,0.00003481451,0.000028497274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002909129,0.00029990243,0.00022130599,0.00014017877,0.00012195227,0.0002877816,0.00013410559,0.00017441723,0.000933976],"category_scores_gemma":[0.00042663363,0.00012981452,0.00023179466,0.00011677861,0.00015951262,0.00015846734,0.00011720835,0.00019613084,0.0005224486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057071174,0.000036168258,0.007866935,0.000121670164,0.000058069974,0.00025663,0.000038404978,0.0002442484,0.9756217,0.00011302932,0.00018714067,0.014885322],"study_design_scores_gemma":[0.000026078622,0.0008112728,0.061436202,0.000013735497,0.00011768728,0.0021302062,0.000034395525,0.0014176276,0.92913747,0.0001737712,0.004690141,0.000011454635],"about_ca_topic_score_codex":0.000973241,"about_ca_topic_score_gemma":0.0009140587,"teacher_disagreement_score":0.000973241,"about_ca_system_score_codex":0.00021176216,"about_ca_system_score_gemma":0.00012063238,"threshold_uncertainty_score":0.0031244755},"labels":[],"label_agreement":null},{"id":"W2037469925","doi":"10.3109/00498254.2013.791410","title":"Potential role of CYP2D6 in the central nervous system","year":2013,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2D6; Biology; Endocrinology; Serotonin; Human brain; Internal medicine; Pharmacology; In vivo; Central nervous system; Cytochrome P450; Metabolism; Biochemistry; Genetics; Neuroscience; Medicine; Receptor","score_opus":0.03128201951289982,"score_gpt":0.34641311599089253,"score_spread":0.3151310964779927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037469925","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5539976,0.392005,0.023253988,0.006648626,0.0012011754,0.00016658986,0.0028262874,0.0003767274,0.019524075],"genre_scores_gemma":[0.9211704,0.061160397,0.0043213973,0.0008077891,0.0006465928,0.00009150919,0.0018607014,0.000031153944,0.009910127],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989533,0.000031563563,0.000007268958,0.000030435982,0.00001743789,0.000017928976],"domain_scores_gemma":[0.99982315,0.000033803175,0.000047845788,0.000014397607,0.000038027323,0.00004287311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024040574,0.00034358207,0.00033981958,0.00032835972,0.00019392374,0.0005427079,0.0002593906,0.00050149777,0.0028992735],"category_scores_gemma":[0.00024781816,0.000095100804,0.00032060195,0.0002740899,0.00022606162,0.0001640454,0.0001857668,0.00034459357,0.000599745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045993887,0.00058021327,0.082612395,0.002830725,0.001117644,0.014812486,0.00031514408,0.0014089633,0.674831,0.010859517,0.013526748,0.19250573],"study_design_scores_gemma":[0.00058939634,0.0047019487,0.35900685,0.0004538096,0.0010981994,0.03866511,0.0005365184,0.00558757,0.29948428,0.010271271,0.27949563,0.00010942486],"about_ca_topic_score_codex":0.00055020297,"about_ca_topic_score_gemma":0.0006164514,"teacher_disagreement_score":0.0028992735,"about_ca_system_score_codex":0.00026877815,"about_ca_system_score_gemma":0.00013843706,"threshold_uncertainty_score":0.009698987},"labels":[],"label_agreement":null},{"id":"W2037845030","doi":"10.1177/0091270005280851","title":"Effect of a Triphasic Oral Contraceptive on Drug‐Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacology; CYP2C19; Dextromethorphan; Medicine; CYP3A; CYP1A2; Drug; CYP2C9; Bioequivalence; Pharmacokinetics; Crossover study; Drug metabolism; Dextrorphan; Mephenytoin; Paraxanthine; Active metabolite; Oral administration; Internal medicine; Cytochrome P450; Metabolism; Placebo","score_opus":0.14238138566770764,"score_gpt":0.5159168353209036,"score_spread":0.37353544965319596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037845030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785584,0.0009964682,0.0003178136,0.00004561794,0.000022411054,0.000078351724,0.00017001962,0.000015358051,0.00049815426],"genre_scores_gemma":[0.9937494,0.0014372389,0.0024832515,0.00012379244,0.0000444022,0.00012134101,0.0005637827,0.000012108675,0.001464686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887484,0.00053486635,0.00008217662,0.00016691588,0.0002546331,0.00008662992],"domain_scores_gemma":[0.9985973,0.00033903262,0.0006500534,0.00012676846,0.00010189494,0.00018488412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008490979,0.00044290294,0.00067122345,0.00035730636,0.00015488679,0.00027814417,0.0002877517,0.0003650723,0.0027551306],"category_scores_gemma":[0.0018698855,0.00030810357,0.00044378728,0.00032229238,0.00032835914,0.00020931633,0.00026493004,0.00049535814,0.00023047836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1997185,0.010055617,0.021402221,0.0006842536,0.0012590234,0.0002971753,0.00030115555,0.0011532423,0.5510014,0.00023466146,0.001186443,0.21270633],"study_design_scores_gemma":[0.01236725,0.5638212,0.13632844,0.00012143221,0.0018845279,0.0013188792,0.0002069728,0.0024017717,0.26778942,0.00012046148,0.013491996,0.00014769443],"about_ca_topic_score_codex":0.0011278518,"about_ca_topic_score_gemma":0.0037361977,"teacher_disagreement_score":0.0027551306,"about_ca_system_score_codex":0.0003881723,"about_ca_system_score_gemma":0.0006229197,"threshold_uncertainty_score":0.009216845},"labels":[],"label_agreement":null},{"id":"W2038539486","doi":"10.1038/sj.bjp.0704933","title":"Hypoxia‐induced down‐regulation of CYP1A1/1A2 and up‐regulation of CYP3A6 involves serum mediators","year":2002,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal","funders":"","keywords":"Hypoxia (environmental); Messenger RNA; Cytochrome P450; Internal medicine; Endocrinology; Erythropoietin; Chemistry; Isozyme; Enzyme; Biology; Molecular biology; Metabolism; Biochemistry; Medicine; Oxygen; Gene","score_opus":0.07424612824752516,"score_gpt":0.3677138819621633,"score_spread":0.2934677537146382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038539486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986842,0.007675332,0.0027787702,0.00033854027,0.00005480243,0.000057182362,0.00034322529,0.00007474348,0.0018353864],"genre_scores_gemma":[0.99249965,0.0026684704,0.0013117321,0.00012456308,0.000045160203,0.000054833818,0.00040036195,0.000016132326,0.002879003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998565,0.000033772852,0.000011485945,0.000033874912,0.000028052722,0.00003644403],"domain_scores_gemma":[0.99981695,0.00001837208,0.000080566024,0.000020138796,0.000030288391,0.000033674423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015460968,0.00032199355,0.00026087376,0.00016778053,0.00018879476,0.00020529582,0.000078971585,0.00020414998,0.0019882075],"category_scores_gemma":[0.00013081332,0.00012404981,0.0003980417,0.00012782072,0.00025969572,0.00014660103,0.00017348409,0.0003742053,0.00032768582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038997864,0.000018750776,0.0013824545,0.000041636216,0.000011502394,0.000077832105,0.000020933729,0.000018309604,0.99601597,0.000043011183,0.000056789922,0.001922797],"study_design_scores_gemma":[0.0000487456,0.0010638868,0.1162801,0.00001206315,0.00006792221,0.0010807422,0.000059926217,0.0004653603,0.875932,0.00010408358,0.004878286,0.000006966079],"about_ca_topic_score_codex":0.0006279833,"about_ca_topic_score_gemma":0.00081892597,"teacher_disagreement_score":0.0019882075,"about_ca_system_score_codex":0.00023472814,"about_ca_system_score_gemma":0.00014876215,"threshold_uncertainty_score":0.0066512227},"labels":[],"label_agreement":null},{"id":"W2038865244","doi":"10.1074/jbc.m109.073908","title":"The Human UGT1A3 Enzyme Conjugates Norursodeoxycholic Acid into a C23-ester Glucuronide in the Liver","year":2009,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronide; Conjugate; Chemistry; Glucuronates; Enzyme; Biochemistry; Human liver; Metabolism; Glucuronic acid","score_opus":0.1014905172757326,"score_gpt":0.4177579687733212,"score_spread":0.3162674514975886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038865244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903922,0.0050542615,0.0028579368,0.000117084295,0.0000165307,0.00003314779,0.00053168135,0.00009419218,0.0009030088],"genre_scores_gemma":[0.99469584,0.0014093335,0.0014759973,0.00003495848,0.000007485517,0.000016020827,0.0011682643,0.000011865226,0.001180303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998671,0.000039477425,0.000009918308,0.000034352302,0.00003511329,0.000013999228],"domain_scores_gemma":[0.99991477,0.000012156315,0.0000317296,0.0000127616095,0.000010372483,0.000018289089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012176973,0.00030115133,0.00026261262,0.00024746187,0.00012492348,0.00029137923,0.00010159815,0.0001700296,0.0007260328],"category_scores_gemma":[0.00022929301,0.00012236627,0.00027432753,0.00029388792,0.0002254903,0.00008051867,0.00012730158,0.000241699,0.00036424404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066408614,0.00003759743,0.013042419,0.00007522681,0.00006242395,0.0001801095,0.000029570425,0.00018273084,0.9693793,0.00009867051,0.00013864067,0.016109232],"study_design_scores_gemma":[0.00004676233,0.0011100605,0.12694,0.000009986781,0.0001005477,0.002842862,0.000055512042,0.0011789039,0.8609297,0.00012364019,0.0066496944,0.000012260987],"about_ca_topic_score_codex":0.0012712482,"about_ca_topic_score_gemma":0.0015083934,"teacher_disagreement_score":0.0012712482,"about_ca_system_score_codex":0.000265717,"about_ca_system_score_gemma":0.00017645517,"threshold_uncertainty_score":0.0025277138},"labels":[],"label_agreement":null},{"id":"W2039139292","doi":"10.1016/j.beem.2008.01.001","title":"Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate","year":2008,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Dihydrotestosterone; LNCaP; Androsterone; Androgen receptor; Androgen; Glucuronidation; Chemistry; Endocrinology; Prostate; Small interfering RNA; Internal medicine; Testosterone (patch); Biology; Prostate cancer; Enzyme; Biochemistry; RNA; Gene; Microsome; Hormone; Medicine; Steroid; Cancer","score_opus":0.5109476191605136,"score_gpt":0.6453303354420363,"score_spread":0.13438271628152276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039139292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032305028,0.9984982,0.00019756502,0.0001333812,0.00008475589,0.0000039524402,0.000020950863,0.000008588424,0.00072957197],"genre_scores_gemma":[0.00094211526,0.99808025,0.000173032,0.000092081704,0.000080272286,0.000003326267,0.000036997244,0.0000010111277,0.00059092254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987614,0.00001687162,0.000015963617,0.000022135826,0.000057893387,0.000010908065],"domain_scores_gemma":[0.9998579,0.00005590398,0.000033608234,0.0000050877343,0.000034121083,0.000013375944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044966166,0.0007270489,0.0012201883,0.0014824902,0.00012361398,0.0006539944,0.0006587458,0.00059243914,0.002092215],"category_scores_gemma":[0.00034731286,0.00027709917,0.00036604775,0.0018406757,0.00029106438,0.0005775281,0.0004190225,0.0008587234,0.002014456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010089382,0.000049402417,0.00028859396,0.0059986576,0.0000700377,0.00028728822,0.000023095103,0.00035327522,0.0032746673,0.0011860414,0.010779115,0.977589],"study_design_scores_gemma":[0.00007931182,0.000204308,0.0025831375,0.0019224845,0.00023619861,0.0031183006,0.00006213815,0.00018566563,0.0033147663,0.0016771983,0.9865841,0.000032404558],"about_ca_topic_score_codex":0.0011759895,"about_ca_topic_score_gemma":0.0023137575,"teacher_disagreement_score":0.002092215,"about_ca_system_score_codex":0.00041557063,"about_ca_system_score_gemma":0.0008410087,"threshold_uncertainty_score":0.006999135},"labels":[],"label_agreement":null},{"id":"W2039185379","doi":"10.1038/clpt.2014.126","title":"Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Glucuronosyltransferase; Uridine; Pharmacogenomics; Clinical pharmacology; Uridine diphosphate; Pharmacology; Drug metabolism; Xenobiotic; Pharmacogenetics; Drug; Chemistry; Computational biology; Enzyme; Biochemistry; Biology; RNA; Gene; Microsome","score_opus":0.2620271041099431,"score_gpt":0.5475852774856149,"score_spread":0.2855581733756718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039185379","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91066015,0.05303916,0.017302435,0.004015157,0.000103035425,0.00014226539,0.0037498008,0.00013907866,0.010849002],"genre_scores_gemma":[0.9895465,0.004788333,0.002717899,0.00068935595,0.00008805329,0.00003127498,0.0009334576,0.00002609342,0.0011791989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989454,0.0005519797,0.0000442866,0.00019538766,0.00022005098,0.000042876178],"domain_scores_gemma":[0.9990522,0.00048433366,0.00019774385,0.000080647165,0.00013953558,0.000045544064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001693504,0.00021634325,0.00046653685,0.0005933984,0.000113485476,0.00087929075,0.00018041051,0.0005127256,0.001113279],"category_scores_gemma":[0.002938448,0.0001221124,0.00025683618,0.00095595635,0.00033512898,0.00017058285,0.0002078932,0.00039656047,0.000284703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045676366,0.00041687742,0.3968137,0.00047981244,0.000999644,0.0014109815,0.0002626694,0.003564526,0.11452566,0.004478637,0.0036179256,0.46886197],"study_design_scores_gemma":[0.00019623945,0.0026640743,0.87282115,0.00010248568,0.0010922105,0.0058346074,0.00019029087,0.007825171,0.06947675,0.006828875,0.032923024,0.000045144152],"about_ca_topic_score_codex":0.0007337557,"about_ca_topic_score_gemma":0.00052315526,"teacher_disagreement_score":0.001693504,"about_ca_system_score_codex":0.00039266737,"about_ca_system_score_gemma":0.00050472165,"threshold_uncertainty_score":0.008956194},"labels":[],"label_agreement":null},{"id":"W2039970150","doi":"10.1016/j.ijpharm.2008.05.019","title":"The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat","year":2008,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Amiodarone; Hyperlipidemia; Endocrinology; Poloxamer 407; Internal medicine; Chemistry; Microsome; Cytochrome P450; Kidney; Intraperitoneal injection; Metabolism; Distribution (mathematics); Spleen; Drug metabolism; Thyroid; Saline; Pharmacology; Biology; Medicine; Biochemistry; Enzyme; Poloxamer","score_opus":0.1187817189469937,"score_gpt":0.47096799285012336,"score_spread":0.3521862739031297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039970150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969003,0.00076397014,0.0007948045,0.0001655377,0.00006057448,0.000013548243,0.00036576542,0.000058853693,0.0008765149],"genre_scores_gemma":[0.99089164,0.0016423862,0.0010690151,0.00017075053,0.00006431437,0.0000556403,0.00089260936,0.00006921813,0.0051444317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996877,0.00004520156,0.000026925936,0.00006124824,0.00005397818,0.00012500491],"domain_scores_gemma":[0.9993144,0.0001430016,0.00016102563,0.00012278922,0.000064963766,0.00019381341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029479884,0.00061216095,0.0005568049,0.0009799219,0.00043331023,0.00065120554,0.00042133025,0.0006170713,0.0023540861],"category_scores_gemma":[0.00035709504,0.0005068072,0.0006065478,0.0006171539,0.0009421827,0.00086851214,0.00031894806,0.0016148946,0.00056102214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033205885,0.001468535,0.0033291108,0.00009019056,0.00008001125,0.00051192835,0.0001331177,0.00027381265,0.951482,0.00050351245,0.0002118667,0.008710101],"study_design_scores_gemma":[0.0002590158,0.0043126997,0.01357894,0.000011226031,0.00019659645,0.0003594007,0.00022288771,0.0010478521,0.9785355,0.00029318497,0.0011380295,0.0000446978],"about_ca_topic_score_codex":0.0032008777,"about_ca_topic_score_gemma":0.003969032,"teacher_disagreement_score":0.0032008777,"about_ca_system_score_codex":0.0007372104,"about_ca_system_score_gemma":0.00085592794,"threshold_uncertainty_score":0.007875204},"labels":[],"label_agreement":null},{"id":"W2040208101","doi":"10.1016/j.drudis.2008.07.007","title":"Challenges for drug studies in children: CYP3A phenotyping as example","year":2008,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Western University; SickKids Foundation","funders":"","keywords":"ADME; Disposition; Drug; CYP3A; Pharmacology; In vivo; Drug metabolism; Computational biology; Medicine; Biology; Psychology; Biotechnology; Metabolism; Cytochrome P450; Internal medicine","score_opus":0.3458736567710027,"score_gpt":0.5051877439248266,"score_spread":0.1593140871538239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040208101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012901211,0.99178785,0.0012077632,0.005297607,0.00046479653,0.0000061069727,0.000030543484,0.00002643316,0.0010498604],"genre_scores_gemma":[0.0012339216,0.989608,0.0031313857,0.0038452253,0.0011926604,0.000015359,0.000055094046,0.000012183364,0.0009061669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985285,0.0005892056,0.00016965755,0.00022580475,0.0004293292,0.000057548725],"domain_scores_gemma":[0.9878221,0.009295274,0.00048482924,0.00024082825,0.0016518098,0.0005051783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00576044,0.001272075,0.0044052545,0.0022960934,0.000432272,0.0018918214,0.001539992,0.0033313865,0.003550056],"category_scores_gemma":[0.006750301,0.00043390915,0.0012539427,0.0024918055,0.0013159184,0.0031793583,0.0011519843,0.0060265,0.0025086245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108027016,0.00008229336,0.00086403236,0.0051824544,0.00011857637,0.0010202206,0.00008975137,0.00036205642,0.0008821774,0.006647467,0.080654524,0.90398836],"study_design_scores_gemma":[0.00008985609,0.00017556178,0.0023915998,0.0059918636,0.00021074752,0.008335296,0.00022926877,0.00031757983,0.00054208405,0.010899707,0.97075933,0.00005722112],"about_ca_topic_score_codex":0.0029695046,"about_ca_topic_score_gemma":0.0055046366,"teacher_disagreement_score":0.00576044,"about_ca_system_score_codex":0.0014320401,"about_ca_system_score_gemma":0.0030425075,"threshold_uncertainty_score":0.03046453},"labels":[],"label_agreement":null},{"id":"W2040475315","doi":"10.1097/01213011-200506000-00001","title":"Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes","year":2005,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Aryl hydrocarbon receptor; Biology; Nuclear receptor; Receptor; Drug metabolism; Gene; Xenobiotic; Single-nucleotide polymorphism; Transcription factor; Phenotype; Genetics; Function (biology); Enzyme; Cell biology; Biochemistry; Genotype","score_opus":0.13710172867479412,"score_gpt":0.43579132939100107,"score_spread":0.298689600716207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040475315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025746558,0.9976464,0.00020840597,0.00021594932,0.000079446494,0.0000039030087,0.000027131264,0.000010323185,0.0015509365],"genre_scores_gemma":[0.0014624735,0.9969164,0.0002627203,0.000113177506,0.00007595401,0.000005707753,0.000054710752,0.0000011907799,0.0011076397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999846,0.000028783805,0.000017490993,0.000037701466,0.000056222398,0.0000137716115],"domain_scores_gemma":[0.9997843,0.0000839611,0.000044066437,0.000007907717,0.00006130552,0.000018505049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045912556,0.0006786463,0.0012235262,0.001381514,0.00014728043,0.000515166,0.00064303074,0.0005954777,0.0036456594],"category_scores_gemma":[0.0005056226,0.00017760132,0.00027016603,0.0017178571,0.0003349948,0.00061343214,0.00025576563,0.0006246378,0.0036045725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007432944,0.00003262976,0.00048568033,0.0054749153,0.00006402357,0.00027351457,0.000029835091,0.0003173085,0.0030692157,0.0018144994,0.01731438,0.9710497],"study_design_scores_gemma":[0.00003471408,0.000095407624,0.0030776847,0.0014438353,0.00010149369,0.002951782,0.00006224696,0.0000810274,0.0014768195,0.0021070621,0.9885484,0.000019513769],"about_ca_topic_score_codex":0.0010151834,"about_ca_topic_score_gemma":0.001737218,"teacher_disagreement_score":0.0036456594,"about_ca_system_score_codex":0.00048707926,"about_ca_system_score_gemma":0.0005828959,"threshold_uncertainty_score":0.012195945},"labels":[],"label_agreement":null},{"id":"W2040477888","doi":"10.1016/j.jep.2013.10.029","title":"In vitro inhibition of metabolism but not transport of gliclazide and repaglinide by Cree medicinal plant extracts","year":2013,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Repaglinide; Gliclazide; Pharmacognosy; Traditional medicine; In vitro; Pharmacology; Medicine; Metabolism; Chemistry; Medicinal plants; Biological activity; Diabetes mellitus; Metformin; Biochemistry; Endocrinology","score_opus":0.06335815634570247,"score_gpt":0.39389301044759367,"score_spread":0.3305348541018912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040477888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166846,0.0027233388,0.0017098921,0.00024610097,0.0000669848,0.000053760596,0.00077765,0.00009988191,0.0026539774],"genre_scores_gemma":[0.9912723,0.001991687,0.001609836,0.00007917255,0.000037887112,0.00004209673,0.0017274076,0.000035777564,0.0032037848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997563,0.00008368424,0.000022393686,0.000030445017,0.000032017146,0.00007508392],"domain_scores_gemma":[0.9997577,0.00010135799,0.00003679474,0.000045012515,0.00003344013,0.000025595022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026965726,0.0006199855,0.0006214444,0.0003849649,0.00021713224,0.0002957619,0.00045971392,0.00034500164,0.0032256255],"category_scores_gemma":[0.00038064166,0.0003494236,0.00069771917,0.00031806476,0.00029343466,0.00038742568,0.0002522762,0.00092535757,0.0008333931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003977372,0.0004359894,0.00030601103,0.00016526078,0.000069015885,0.00020121127,0.00010854193,0.0002733883,0.9886995,0.00016656694,0.00029073402,0.0053063906],"study_design_scores_gemma":[0.00031401185,0.0032316777,0.003941153,0.000015316993,0.00012469069,0.0002685796,0.000056316836,0.0013059624,0.98918355,0.000050179067,0.0014947901,0.000013829269],"about_ca_topic_score_codex":0.003423869,"about_ca_topic_score_gemma":0.0027464267,"teacher_disagreement_score":0.003423869,"about_ca_system_score_codex":0.00032089153,"about_ca_system_score_gemma":0.00039151928,"threshold_uncertainty_score":0.010790765},"labels":[],"label_agreement":null},{"id":"W2040550914","doi":"10.1038/sj.clpt.6100087","title":"The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; National Institute on Drug Abuse; Wellcome Trust","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Addiction; Clinical pharmacology; Pharmacology; Medicine; Drug; Disease; Informatics; Bioinformatics; Computational biology; Biology; Psychiatry; Genetics; Genotype; Internal medicine; Gene","score_opus":0.7589401969495758,"score_gpt":0.7016421437167268,"score_spread":0.05729805323284898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040550914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023403714,0.9887291,0.001976816,0.004196243,0.0005064614,0.000025573518,0.000120759345,0.00007260248,0.00413843],"genre_scores_gemma":[0.0016053584,0.9912888,0.0031943542,0.0014629235,0.0006054563,0.000048707454,0.00020053361,0.000010746035,0.001583081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878234,0.0005497104,0.000105745436,0.00015082714,0.00034881773,0.000062555024],"domain_scores_gemma":[0.99772805,0.0014690658,0.00022623761,0.00006606299,0.00036309395,0.0001475016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030488407,0.0010535135,0.0018968469,0.003764357,0.00024457744,0.0017380385,0.0017217302,0.002088177,0.005136028],"category_scores_gemma":[0.0035995971,0.0004199184,0.0005925701,0.0047575296,0.0006904148,0.001688249,0.0011353694,0.0021452785,0.004444593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065270375,0.000036336194,0.0003692839,0.003851654,0.00011324862,0.00019580692,0.00004268103,0.00048038308,0.0004438584,0.004763514,0.039278064,0.9503599],"study_design_scores_gemma":[0.00006817211,0.0001312649,0.0024034039,0.006794834,0.00020720721,0.0014949042,0.00008174912,0.0006161747,0.0008438697,0.014958547,0.9723591,0.000040862305],"about_ca_topic_score_codex":0.002390316,"about_ca_topic_score_gemma":0.003505407,"teacher_disagreement_score":0.005136028,"about_ca_system_score_codex":0.0017690582,"about_ca_system_score_gemma":0.0028305089,"threshold_uncertainty_score":0.017181754},"labels":[],"label_agreement":null},{"id":"W2040999980","doi":"10.1016/s0960-0760(01)00062-0","title":"Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens","year":2001,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medical Council of Canada; Wilfrid Laurier University; Université Laval","funders":"Medical Research Council","keywords":"Complementary DNA; Glucuronidation; Biology; Glucuronosyltransferase; Enzyme; Molecular biology; Biochemistry; Isozyme; Western blot; Hydroxysteroid; Microsome; cDNA library; Polyclonal antibodies; clone (Java method); Gene; Antibody; Dehydrogenase; Genetics","score_opus":0.026587815379358122,"score_gpt":0.34540920112175333,"score_spread":0.3188213857423952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040999980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725519,0.0037801093,0.0121533675,0.00065422273,0.0001249048,0.00010368123,0.004005793,0.00022053912,0.006405504],"genre_scores_gemma":[0.91411257,0.0047429274,0.016001526,0.00036708795,0.00011785285,0.00012959783,0.03252081,0.00024210056,0.031765494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998784,0.000016548644,0.000008727661,0.000027221879,0.000025107596,0.000043938137],"domain_scores_gemma":[0.9998252,0.0000404961,0.000024808629,0.000020004853,0.00003544834,0.000054161763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016829307,0.0004069077,0.00043143137,0.00042970793,0.00040377222,0.00060691906,0.0002835793,0.00029615947,0.0016277598],"category_scores_gemma":[0.00026055434,0.0002940401,0.00044634513,0.00041652645,0.00027791513,0.00021640328,0.00024170085,0.0006782535,0.0016211392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008360462,0.000011524762,0.0002170409,0.000022412352,0.000004006661,0.00007764217,0.000025522952,0.00004733329,0.99754554,0.00027540405,0.00009679953,0.0015931436],"study_design_scores_gemma":[0.00002881227,0.00022050797,0.012590902,0.000020487581,0.000067139044,0.0012315648,0.00016545929,0.0019037395,0.94486415,0.00034793714,0.038539004,0.000020223612],"about_ca_topic_score_codex":0.0031088945,"about_ca_topic_score_gemma":0.0030938687,"teacher_disagreement_score":0.0031088945,"about_ca_system_score_codex":0.0006178304,"about_ca_system_score_gemma":0.00058443483,"threshold_uncertainty_score":0.0061815977},"labels":[],"label_agreement":null},{"id":"W2041631632","doi":"10.1097/fpc.0b013e3283498ecf","title":"Genetic epidemiology of induced CYP3A4 activity","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"CYP3A4; Pharmacogenetics; Genetic variation; Population; Biology; Drug metabolism; Heritability; Genetic variability; Twin study; Pharmacology; Genetics; Cytochrome P450; Drug; Medicine; Metabolism; Environmental health; Biochemistry; Gene; Genotype","score_opus":0.3375756093859221,"score_gpt":0.4534916952181803,"score_spread":0.11591608583225815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041631632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974317,0.00057049387,0.0012648742,0.00005735567,0.000006315942,0.000013314759,0.00029968825,0.000012009934,0.0003442952],"genre_scores_gemma":[0.9990125,0.00017582155,0.000547232,0.000009949195,0.000008258154,0.000007000614,0.00016380339,0.0000046439227,0.00007090608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980153,0.000890741,0.0001507609,0.00058027194,0.00026454416,0.000098409706],"domain_scores_gemma":[0.9979752,0.00067792373,0.0007371583,0.00025351156,0.00019508046,0.00016120121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012380495,0.00034370396,0.0004507964,0.0008788991,0.00042261824,0.00039785696,0.0003881771,0.00050228066,0.0015339945],"category_scores_gemma":[0.0035305377,0.00022861935,0.00042129893,0.0012357144,0.0006073224,0.00020124426,0.0005682327,0.00046078087,0.00015411762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029209195,0.000039329545,0.9917679,0.000022242059,0.00022735415,0.00024130393,0.00010847488,0.00024494083,0.0033263569,0.0003259239,0.000068241185,0.0033357171],"study_design_scores_gemma":[0.000007844419,0.00018240517,0.997001,0.00001025072,0.00010769832,0.0010604191,0.0000709473,0.0006547074,0.00046700845,0.00024939058,0.00018222503,0.0000061410283],"about_ca_topic_score_codex":0.0034236396,"about_ca_topic_score_gemma":0.0018252261,"teacher_disagreement_score":0.0034236396,"about_ca_system_score_codex":0.00024952498,"about_ca_system_score_gemma":0.00021616758,"threshold_uncertainty_score":0.006807387},"labels":[],"label_agreement":null},{"id":"W2041804792","doi":"10.1038/sj.tpj.6500171","title":"Pharmacogenomics of human UDP-glucuronosyltransferase enzymes","year":2003,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":423,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glucuronidation; Pharmacogenomics; Glucuronosyltransferase; Enzyme; Glycosyltransferase; Biotransformation; Drug; Xenobiotic; Biochemistry; Chemistry; Pharmacology; Biology; Microsome","score_opus":0.3297373214886679,"score_gpt":0.531695184887113,"score_spread":0.20195786339844507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041804792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014867886,0.99431217,0.0025148392,0.0002491565,0.000107918575,0.000010528035,0.00007069021,0.00002652534,0.0012213952],"genre_scores_gemma":[0.0056579346,0.9906991,0.0017988477,0.00021152975,0.00020135802,0.000013887371,0.00022164048,0.000003964485,0.0011915851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997626,0.000051521205,0.000024286857,0.000049078866,0.000096429954,0.000016110283],"domain_scores_gemma":[0.99971706,0.00012315893,0.00005702955,0.000015352105,0.00007418319,0.000013230102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000772501,0.0011051771,0.0021364307,0.0016536722,0.000121430676,0.00077899074,0.0007049768,0.0008388774,0.00090626255],"category_scores_gemma":[0.00059382024,0.00027922637,0.0006242171,0.0022447617,0.00028837952,0.0005119548,0.00034175755,0.00074664206,0.0010266276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013715062,0.00007749528,0.0009790433,0.00395215,0.00021084092,0.00064388727,0.000020774058,0.0009924226,0.013515526,0.0013871116,0.0060248524,0.97205883],"study_design_scores_gemma":[0.00014411827,0.0005774181,0.011467194,0.0019460534,0.001042158,0.010772216,0.00007697326,0.0014849412,0.03824441,0.0058545466,0.9283049,0.00008496016],"about_ca_topic_score_codex":0.001068266,"about_ca_topic_score_gemma":0.001616383,"teacher_disagreement_score":0.0021364307,"about_ca_system_score_codex":0.0005494281,"about_ca_system_score_gemma":0.00087066233,"threshold_uncertainty_score":0.0040854216},"labels":[],"label_agreement":null},{"id":"W2042345206","doi":"10.1111/j.1365-2125.2006.02806.x","title":"Warfarin: almost 60 years old and still causing problems","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Pharmacology; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.14617076145120667,"score_gpt":0.4785994965935348,"score_spread":0.3324287351423281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042345206","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022820204,0.5315703,0.0015744881,0.41560537,0.026400818,0.000028076423,0.00048712333,0.00032091432,0.021730958],"genre_scores_gemma":[0.019751567,0.61517686,0.002608353,0.27550316,0.053992663,0.000053526444,0.0009687263,0.0002263533,0.03171882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733526,0.00042608287,0.00044044413,0.00041062525,0.00110991,0.0002776959],"domain_scores_gemma":[0.99388474,0.0018708621,0.0006504526,0.00033635975,0.0015945174,0.0016630447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035992397,0.0009161203,0.0018516409,0.001321077,0.002388345,0.0040364997,0.00087030313,0.006496318,0.023258625],"category_scores_gemma":[0.014010278,0.0003396826,0.00086715724,0.001790097,0.0030575085,0.007690132,0.0022916093,0.009595647,0.01412029],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030419033,0.00009410695,0.0030548822,0.0012308958,0.00008982918,0.0019569835,0.0007358805,0.00009130993,0.0005875697,0.013591277,0.53159034,0.44667268],"study_design_scores_gemma":[0.000020537738,0.00007230407,0.0012497678,0.0013596416,0.000038704537,0.0038212216,0.0005669164,0.000039628852,0.00009120665,0.009459512,0.9832493,0.00003124978],"about_ca_topic_score_codex":0.003851878,"about_ca_topic_score_gemma":0.0039925757,"teacher_disagreement_score":0.023258625,"about_ca_system_score_codex":0.0015111313,"about_ca_system_score_gemma":0.0027797008,"threshold_uncertainty_score":0.07780784},"labels":[],"label_agreement":null},{"id":"W2042719175","doi":"10.1139/y08-017","title":"Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Universidade Estadual Paulista; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Verapamil; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Inhalation; Enantiomer; Chromatography; Stereochemistry; Biochemistry; Anesthesia; Medicine; Calcium; Organic chemistry","score_opus":0.056903496862475,"score_gpt":0.3522992351570084,"score_spread":0.2953957382945334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042719175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834824,0.00044144917,0.0007474779,0.000053270724,0.000020153948,0.0000125820325,0.00008611142,0.00002523148,0.0002655068],"genre_scores_gemma":[0.9962625,0.0010174671,0.0007951414,0.0000614675,0.000018168546,0.000039489063,0.00024938656,0.000017280789,0.0015391003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997962,0.00003639922,0.000012536609,0.000037250782,0.00005067183,0.00006696073],"domain_scores_gemma":[0.99966323,0.000033615313,0.00013210537,0.000049809256,0.000045284334,0.00007593744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013012919,0.00049738126,0.000494418,0.00023498657,0.00015338416,0.00029613436,0.00016545404,0.00024752368,0.0010477604],"category_scores_gemma":[0.00024395212,0.00024167872,0.00040947416,0.00013399821,0.00033281394,0.00024978683,0.00019503766,0.00070294173,0.00018383487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020052502,0.00011058265,0.0014773624,0.00002786095,0.00002197472,0.00016254364,0.00003348844,0.000046761837,0.9935575,0.00003105654,0.00003372114,0.0024918774],"study_design_scores_gemma":[0.000054018485,0.00450361,0.025989292,0.0000074803193,0.00007090357,0.0003973052,0.0001433572,0.00073671865,0.96726,0.000063056745,0.00075937563,0.000014938803],"about_ca_topic_score_codex":0.0010441432,"about_ca_topic_score_gemma":0.0017612526,"teacher_disagreement_score":0.0010477604,"about_ca_system_score_codex":0.00021643919,"about_ca_system_score_gemma":0.00031746065,"threshold_uncertainty_score":0.0035051107},"labels":[],"label_agreement":null},{"id":"W2042929001","doi":"10.1002/jbt.20156","title":"Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat","year":2007,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Ontogeny; CYP2E1; CYP1A2; Weaning; Biology; Internal medicine; Messenger RNA; Endocrinology; Immunohistochemistry; Cytochrome P450; Andrology; Metabolism; Immunology; Biochemistry; Gene; Medicine","score_opus":0.036159059703389326,"score_gpt":0.38982959232492276,"score_spread":0.3536705326215334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042929001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841458,0.005360263,0.004562169,0.00009154456,0.000024824127,0.000033707696,0.0013984629,0.00014917976,0.004233983],"genre_scores_gemma":[0.9786582,0.0051537016,0.004250039,0.00008018851,0.000020489424,0.0000972985,0.0017351696,0.000094106654,0.009910789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998872,0.00001272236,0.000006830739,0.00004067775,0.00003168651,0.000020911591],"domain_scores_gemma":[0.9997087,0.000040763527,0.000084553125,0.000035380857,0.00006236014,0.00006824789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017906654,0.00025681907,0.00024035967,0.0011291443,0.00020302799,0.00034967935,0.00016141415,0.00017001257,0.0018870967],"category_scores_gemma":[0.00020133908,0.000223059,0.00029328113,0.00030007688,0.00023168577,0.0003140054,0.00025807653,0.00039345853,0.00059720554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007448245,0.00006650708,0.025202159,0.00009623264,0.000041061958,0.0004338039,0.00020727477,0.00018961233,0.92929167,0.00041772975,0.0002088132,0.04310032],"study_design_scores_gemma":[0.000027178314,0.0013498679,0.5456405,0.000042392836,0.00011919405,0.0023113214,0.00029074482,0.0005435033,0.43322027,0.0003269275,0.016088525,0.000039552928],"about_ca_topic_score_codex":0.0016386579,"about_ca_topic_score_gemma":0.0025947418,"teacher_disagreement_score":0.0018870967,"about_ca_system_score_codex":0.0002828686,"about_ca_system_score_gemma":0.0002699513,"threshold_uncertainty_score":0.0063129067},"labels":[],"label_agreement":null},{"id":"W2043208032","doi":"10.1002/chir.20334","title":"The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: Evidence of tissue‐specific enantioselectivity in microsomal metabolism","year":2006,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microsome; Chemistry; Cytochrome P450; In vivo; Metabolite; Enantiomer; Halofantrine; Metabolism; Pharmacokinetics; Pharmacology; Stereoselectivity; Biochemistry; Drug metabolism; Enzyme; Stereochemistry; Biology; Genetics","score_opus":0.09011752858820486,"score_gpt":0.42653340339910306,"score_spread":0.3364158748108982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043208032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948932,0.001412291,0.0022836584,0.00010351922,0.000021025591,0.000024367046,0.00031800315,0.00006700839,0.00087700965],"genre_scores_gemma":[0.9956808,0.0012871517,0.0011027373,0.00004647102,0.000013952306,0.000025190599,0.00043980576,0.00001417451,0.0013896467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989164,0.000027687633,0.000008071558,0.000023161323,0.00001766375,0.00003176005],"domain_scores_gemma":[0.9998029,0.000026980273,0.00006274519,0.000040684718,0.000024369416,0.000042490108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023797108,0.00053917634,0.00031641548,0.00048690382,0.00017279005,0.00024456534,0.00015647722,0.00032157786,0.001416137],"category_scores_gemma":[0.00026892012,0.0003445944,0.0004320996,0.0001743745,0.00029425212,0.0003116249,0.00013527431,0.00044894937,0.00036001523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020561342,0.00011084594,0.002171926,0.00004751801,0.00003057102,0.00020938473,0.00004157603,0.00014775588,0.98831123,0.00015380865,0.00007456236,0.006644699],"study_design_scores_gemma":[0.000060831004,0.0025047434,0.023557022,0.0000051767033,0.000059232087,0.00065296283,0.00003673012,0.0005255109,0.9713577,0.0000970042,0.0011283025,0.000014732549],"about_ca_topic_score_codex":0.0015570037,"about_ca_topic_score_gemma":0.001718793,"teacher_disagreement_score":0.0015570037,"about_ca_system_score_codex":0.00025421043,"about_ca_system_score_gemma":0.00030017417,"threshold_uncertainty_score":0.0047374964},"labels":[],"label_agreement":null},{"id":"W2043547585","doi":"10.3109/1547691x.2012.707699","title":"Changes in gene expression induced by aromatic amine drugs: Testing the danger hypothesis","year":2012,"lang":"en","type":"article","venue":"Journal of Immunotoxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Aromatic amine; Pharmacology; Chemistry; Gene expression; Drug; Enzyme; Glutathione; Biochemistry; Gene; Biology","score_opus":0.14222412686599273,"score_gpt":0.3913642409011099,"score_spread":0.24914011403511716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043547585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961676,0.0010049758,0.001815014,0.00008420921,0.000020890882,0.000025275438,0.00039576687,0.000013468988,0.0004727602],"genre_scores_gemma":[0.9949149,0.00074629457,0.0028209607,0.00013044686,0.000018549443,0.00010780948,0.00052102417,0.000004849102,0.00073525007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965644,0.000097556185,0.000028503517,0.00009127825,0.00006307772,0.00006317326],"domain_scores_gemma":[0.9996138,0.00013974521,0.000106972504,0.000039858845,0.00004724448,0.000052462216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004888125,0.000319922,0.0002976643,0.0004009366,0.00016401647,0.00021786596,0.00014282123,0.00034112117,0.00084043114],"category_scores_gemma":[0.00031303277,0.00010303116,0.00037450079,0.00038632556,0.00038824335,0.00029329536,0.00024345049,0.00033809477,0.00013503061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071577076,0.000059387738,0.007243479,0.00008730972,0.000037291178,0.00007844895,0.00005930861,0.00008731139,0.9896812,0.000078659614,0.000018686003,0.0018532379],"study_design_scores_gemma":[0.000050573697,0.0035880904,0.30904126,0.000019123436,0.00013917605,0.0006293701,0.00038139167,0.0023465008,0.6815919,0.00033629205,0.0018528788,0.000023427932],"about_ca_topic_score_codex":0.00044718944,"about_ca_topic_score_gemma":0.00059553987,"teacher_disagreement_score":0.00084043114,"about_ca_system_score_codex":0.00019843265,"about_ca_system_score_gemma":0.00013552609,"threshold_uncertainty_score":0.0028114915},"labels":[],"label_agreement":null},{"id":"W2043875467","doi":"10.2174/1389200043335577","title":"Effect of Hypoxia on Cytochrome P450 Activity and Expression","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CYP1A2; CYP2B6; Hypoxia (environmental); Pharmacology; Cytochrome P450; In vivo; Ex vivo; Biology; Chemistry; Endocrinology; Internal medicine; In vitro; Biochemistry; Medicine; Oxygen; Metabolism","score_opus":0.11755886781772057,"score_gpt":0.4857253257161715,"score_spread":0.3681664578984509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043875467","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419479,0.04630209,0.0031621605,0.00081340515,0.000269849,0.000055660046,0.0011738401,0.0001247909,0.006150304],"genre_scores_gemma":[0.98676234,0.00761501,0.0007809673,0.00020519733,0.00009525141,0.000041268784,0.00081356073,0.00001683036,0.003669523],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998117,0.000039412276,0.000012424208,0.000049189242,0.000037336504,0.00004999532],"domain_scores_gemma":[0.9998305,0.000030907555,0.000048886,0.000014781347,0.000040013827,0.000034941047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014521407,0.00018748845,0.00021622075,0.00016687873,0.00016167045,0.00029479098,0.00008199631,0.00019234612,0.0022292105],"category_scores_gemma":[0.00027036754,0.000082313905,0.00023033118,0.00016393172,0.00014815232,0.00016789671,0.0001525241,0.00029578392,0.000316637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025728093,0.00015000453,0.017142285,0.00039527417,0.00014263265,0.0005021064,0.00015997744,0.00018763125,0.9319753,0.00034557597,0.0012595039,0.0451669],"study_design_scores_gemma":[0.000078096265,0.0026221366,0.32658473,0.00007091013,0.0002518088,0.0019894587,0.00025877994,0.001085523,0.63525385,0.0004253143,0.031354494,0.000025032345],"about_ca_topic_score_codex":0.0014747363,"about_ca_topic_score_gemma":0.00079194986,"teacher_disagreement_score":0.0022292105,"about_ca_system_score_codex":0.00026689513,"about_ca_system_score_gemma":0.00016923316,"threshold_uncertainty_score":0.007457435},"labels":[],"label_agreement":null},{"id":"W2044335128","doi":"10.3109/03602532.2011.596204","title":"The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition","year":2011,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Cytochrome P450; Pharmacokinetics; Drug; Pharmacology; Xenobiotic; Polycyclic aromatic hydrocarbon; Disposition; Enzyme; Physiologically based pharmacokinetic modelling; Drug metabolism; Toxicokinetics; Biochemistry; Environmental chemistry; Metabolism; Biology","score_opus":0.28624432840596054,"score_gpt":0.47608183658350767,"score_spread":0.18983750817754713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044335128","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7885612,0.16382942,0.014563121,0.002891679,0.00092554156,0.00016979058,0.002058247,0.0003082556,0.026692634],"genre_scores_gemma":[0.94905424,0.04176806,0.0017482723,0.00061899493,0.00032853984,0.000056410598,0.0006167991,0.000022460423,0.005786072],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996798,0.00007810828,0.000024860605,0.00007672664,0.000095516356,0.000044868444],"domain_scores_gemma":[0.9995184,0.00010974356,0.00021196317,0.000044721044,0.00006723733,0.00004800738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028682756,0.00028711732,0.00023186897,0.00038642925,0.00024654812,0.0006221336,0.00016255016,0.00049820286,0.002188238],"category_scores_gemma":[0.0009247344,0.00014496215,0.00037958915,0.0004255879,0.00031565953,0.00033359445,0.000280301,0.0005992996,0.00051210925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019462426,0.0007873921,0.16301496,0.0012813574,0.0007313428,0.0038417873,0.00037183732,0.0013550957,0.53366995,0.006657165,0.0038579677,0.28248486],"study_design_scores_gemma":[0.000092680784,0.0028900264,0.66851485,0.00021665124,0.00051441445,0.01264097,0.00037568665,0.001529228,0.21831648,0.0059945364,0.08882396,0.00009053365],"about_ca_topic_score_codex":0.001369992,"about_ca_topic_score_gemma":0.001148704,"teacher_disagreement_score":0.002188238,"about_ca_system_score_codex":0.0003549561,"about_ca_system_score_gemma":0.00033867854,"threshold_uncertainty_score":0.007320404},"labels":[],"label_agreement":null},{"id":"W2044432552","doi":"10.1542/peds.2013-1416","title":"Public Perceptions of Pharmacogenetics","year":2014,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Medicine; Perception; Family medicine; Genetic testing; Exploratory analysis; Psychology; Data science; Genotype; Internal medicine; Genetics; Computer science","score_opus":0.14413060833045402,"score_gpt":0.42333091163757447,"score_spread":0.2792003033071204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044432552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528701,0.0026226712,0.00059346436,0.025719984,0.000119513694,0.000023898818,0.000121526646,0.000020772724,0.017908225],"genre_scores_gemma":[0.99709725,0.0008713946,0.00009422336,0.0014842662,0.000052029227,0.0000065023664,0.000026251211,0.0000031756078,0.00036483546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942953,0.0030767329,0.00026283847,0.0002753523,0.0015154937,0.0005743094],"domain_scores_gemma":[0.97748375,0.012313596,0.005384726,0.00057709194,0.0019242837,0.0023164898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072134235,0.00017514786,0.00027122494,0.0005693435,0.0010914099,0.0024705927,0.00028341956,0.001361184,0.0046385247],"category_scores_gemma":[0.020179017,0.00019434467,0.00034793408,0.00045964713,0.0021751078,0.001581661,0.0018719683,0.0021808168,0.00024421277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006673937,0.00043655923,0.69859844,0.000727751,0.00016056478,0.0028366423,0.12041529,0.0006848441,0.003655501,0.009145304,0.010691296,0.15198044],"study_design_scores_gemma":[0.000089968125,0.0014480744,0.67333376,0.0016105565,0.00024022088,0.0044581397,0.23715572,0.0010292989,0.001767804,0.005962721,0.07277882,0.00012495306],"about_ca_topic_score_codex":0.0046406523,"about_ca_topic_score_gemma":0.0022960727,"teacher_disagreement_score":0.0072134235,"about_ca_system_score_codex":0.001991811,"about_ca_system_score_gemma":0.001574808,"threshold_uncertainty_score":0.0381487},"labels":[],"label_agreement":null},{"id":"W2044708845","doi":"10.1016/j.jbiotec.2007.05.009","title":"Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6","year":2007,"lang":"en","type":"article","venue":"Journal of Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Canada; Vanderbilt University","keywords":"Trehalose; Sorbitol; Mannitol; Enzyme; Chemistry; Sugar; Biochemistry; Sucrose; Anhydrous; CYP3A4; Enzyme assay; Chromatography; Cytochrome P450; Organic chemistry","score_opus":0.07037182869266764,"score_gpt":0.42333223103471435,"score_spread":0.35296040234204673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044708845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931584,0.0013615997,0.0028081266,0.00017386506,0.00009725138,0.000055207925,0.00049724017,0.000102797116,0.0017455555],"genre_scores_gemma":[0.9904688,0.00072544685,0.0017407894,0.00007393124,0.000027538492,0.000027525888,0.0016245984,0.000027128255,0.005284275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999907,0.000024499332,0.0000059054532,0.000012485307,0.000016569633,0.000033428096],"domain_scores_gemma":[0.999943,0.000015076648,0.0000108536915,0.000008674551,0.000007762244,0.0000146684715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013606735,0.00044093927,0.00023757141,0.0001350641,0.0001373587,0.00023584938,0.00019794116,0.00018281021,0.0034465168],"category_scores_gemma":[0.00020905265,0.00012129863,0.0003059895,0.00018662466,0.00017365935,0.0001075669,0.00020238689,0.0005800157,0.0004964333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013012694,0.0001834155,0.00042386088,0.0000736064,0.000037651018,0.000104543775,0.000032687447,0.00029346265,0.99074334,0.00042655203,0.00034956704,0.006030063],"study_design_scores_gemma":[0.00006793331,0.00045781472,0.0015220905,0.0000033610368,0.000018414265,0.0001238224,0.00001259594,0.0007086037,0.9947448,0.000031423595,0.0023057172,0.000003513171],"about_ca_topic_score_codex":0.001687602,"about_ca_topic_score_gemma":0.0021265147,"teacher_disagreement_score":0.0034465168,"about_ca_system_score_codex":0.0002502364,"about_ca_system_score_gemma":0.0003408595,"threshold_uncertainty_score":0.011529744},"labels":[],"label_agreement":null},{"id":"W2045041505","doi":"10.1007/s00239-010-9402-7","title":"Phylogenetic and Functional Analysis of the Vertebrate Cytochrome P450 2 Family","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Vertebrate; Phylogenetic tree; Phylogenetics; Genetics; Evolutionary biology; Gene","score_opus":0.03655027407068639,"score_gpt":0.3525491873309859,"score_spread":0.3159989132602995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045041505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877523,0.0029665618,0.003624132,0.000297879,0.00001890833,0.000015854968,0.00036035906,0.000033137465,0.0049307253],"genre_scores_gemma":[0.9927614,0.0011845076,0.002925077,0.00012611454,0.000039139723,0.0000103630855,0.0010205896,0.000021164618,0.0019116082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998292,0.000038025013,0.00000641808,0.000054237964,0.00003750174,0.00003451598],"domain_scores_gemma":[0.99969065,0.00006326146,0.00007857008,0.000031285137,0.000073417476,0.00006283072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002596383,0.00023705687,0.0002101424,0.0012046226,0.0006762317,0.00037714414,0.00027304608,0.00042703183,0.0013765503],"category_scores_gemma":[0.00033554266,0.00015304376,0.00027691934,0.00068764435,0.00032970324,0.00026062017,0.000309366,0.0006648397,0.00048086958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013324029,0.00015023108,0.08824796,0.00022531803,0.000198873,0.0013220253,0.00109908,0.0022636207,0.80761063,0.005591829,0.0009371136,0.09102075],"study_design_scores_gemma":[0.000050399645,0.00040812485,0.927362,0.00007936746,0.00016043484,0.0039006812,0.00046284747,0.0096144015,0.020554624,0.0018836213,0.03548247,0.0000409908],"about_ca_topic_score_codex":0.0028897584,"about_ca_topic_score_gemma":0.003400524,"teacher_disagreement_score":0.0028897584,"about_ca_system_score_codex":0.00042628119,"about_ca_system_score_gemma":0.00025865395,"threshold_uncertainty_score":0.0057458878},"labels":[],"label_agreement":null},{"id":"W2045367654","doi":"10.1002/bdd.236","title":"Dose staggering as a strategy to reduce drug–drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: a computer simulation study","year":2000,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Drug; Pharmacology; Drug interaction; Absorption (acoustics); Pharmacokinetics; First pass effect; Medicine; Chemistry; Materials science","score_opus":0.0503995315314563,"score_gpt":0.40593889976541686,"score_spread":0.35553936823396054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045367654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93614894,0.0004146589,0.059333708,0.00021755899,0.000024694205,0.00011678592,0.00019252395,0.00022003913,0.003331136],"genre_scores_gemma":[0.985416,0.00031616443,0.013151044,0.000039358347,0.000004318604,0.000087391636,0.00006708592,0.000022981421,0.00089561165],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999881,0.000047887774,0.000006638608,0.00001662712,0.000025603404,0.000022130593],"domain_scores_gemma":[0.9992755,0.00052498555,0.0000901575,0.00003237465,0.000050180723,0.000026843878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031548322,0.00042520792,0.0007005212,0.0002701529,0.00015880754,0.00047115554,0.0005216532,0.00068356784,0.0010817354],"category_scores_gemma":[0.0011861686,0.00023542679,0.0005830272,0.00025830496,0.00028340254,0.00038106515,0.00021606621,0.0004846049,0.000106511616],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019895246,0.00010290087,0.0010049575,0.00005768881,0.000028234634,0.0000865853,0.000030094217,0.98439807,0.009558676,0.0007860502,0.000084047904,0.0036638111],"study_design_scores_gemma":[0.00005893888,0.00039232452,0.00042228066,0.0000035197586,0.000035238718,0.000034119472,0.000011613437,0.99166965,0.0066662673,0.0002721574,0.00042446115,0.000009343574],"about_ca_topic_score_codex":0.0052461377,"about_ca_topic_score_gemma":0.0021575482,"teacher_disagreement_score":0.0052461377,"about_ca_system_score_codex":0.00045608415,"about_ca_system_score_gemma":0.0007209126,"threshold_uncertainty_score":0.01043117},"labels":[],"label_agreement":null},{"id":"W2045397804","doi":"10.1016/s1056-8719(00)00112-x","title":"Fluorometric screening for metabolism-based drug–drug interactions","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Drug; Drug metabolism; Drug discovery; Chemistry; High-throughput screening; Computational biology; Pharmacology; Chromatography; Biochemistry; Biology","score_opus":0.23344236357453158,"score_gpt":0.5384354334319789,"score_spread":0.3049930698574473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045397804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7110144,0.018555347,0.235637,0.0016450441,0.00055636343,0.0018267785,0.003446441,0.0022485538,0.025070213],"genre_scores_gemma":[0.89156127,0.004578334,0.09022325,0.00075591845,0.000102200625,0.00087492354,0.0019319379,0.00006940108,0.009902763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996687,0.0016058665,0.000101860845,0.00041117432,0.0009883036,0.0002058951],"domain_scores_gemma":[0.99862623,0.0007466813,0.00022597786,0.00012484266,0.0002044131,0.00007191489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025334829,0.0010923049,0.0010366525,0.0016887182,0.00059748365,0.00062495435,0.0011041631,0.0018539389,0.00339907],"category_scores_gemma":[0.0032388065,0.00080951786,0.00081361464,0.0013725256,0.00074127835,0.0005529198,0.0006560464,0.0015577874,0.0010021948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017153013,0.00049057323,0.0056191017,0.0002968714,0.00025169857,0.00017086383,0.00007790569,0.0008763655,0.956281,0.0007085946,0.0009903586,0.032521307],"study_design_scores_gemma":[0.00016502535,0.0026806593,0.009640283,0.000022037359,0.00019782527,0.00062903494,0.000030396448,0.0049944823,0.9776313,0.0002138995,0.003762474,0.000032606615],"about_ca_topic_score_codex":0.0016531841,"about_ca_topic_score_gemma":0.0023461708,"teacher_disagreement_score":0.00339907,"about_ca_system_score_codex":0.0009839124,"about_ca_system_score_gemma":0.0010514596,"threshold_uncertainty_score":0.0133984685},"labels":[],"label_agreement":null},{"id":"W2045537064","doi":"10.1517/17425250903234709","title":"Glucocorticoids and phenobarbital induce murine<i>CYP2B</i>genes by independent mechanisms","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Phenobarbital; Biology; Gene; Glucocorticoid; Inducer; Glucocorticoid receptor; Nuclear receptor; Cell biology; Transcription factor; Genetics; Pharmacology; Immunology","score_opus":0.10458827221336382,"score_gpt":0.4432972763190783,"score_spread":0.3387090041057145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045537064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001951306,0.98791724,0.0017935698,0.000685424,0.00039381132,0.000024103421,0.00014310575,0.00007086417,0.007020546],"genre_scores_gemma":[0.007439738,0.98685724,0.0010420013,0.00051154254,0.00027074086,0.000030193862,0.00020306658,0.000007941315,0.0036374552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987745,0.00002207514,0.00001265999,0.000029915213,0.00004501439,0.00001282872],"domain_scores_gemma":[0.99990594,0.00002554675,0.000027006145,0.0000053853664,0.000027372318,0.000008627569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018154114,0.00060920883,0.00067498937,0.0004704231,0.00007663951,0.00034339348,0.00036795947,0.0005400229,0.0029953297],"category_scores_gemma":[0.00015073619,0.00013962795,0.00032288686,0.00059852534,0.00019686697,0.00037617373,0.0001959828,0.0005533775,0.0036150825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014241853,0.000044694134,0.00044979792,0.009830034,0.00007709415,0.0003943809,0.000035529843,0.00033599048,0.072434,0.0030198281,0.019392127,0.8938441],"study_design_scores_gemma":[0.000049936196,0.00024364231,0.0030787443,0.0009788731,0.00011003385,0.0025507433,0.00004375179,0.00012438871,0.028362438,0.0015457368,0.9628889,0.00002282211],"about_ca_topic_score_codex":0.0004811436,"about_ca_topic_score_gemma":0.0008389254,"teacher_disagreement_score":0.0029953297,"about_ca_system_score_codex":0.00027652358,"about_ca_system_score_gemma":0.00029896776,"threshold_uncertainty_score":0.010020435},"labels":[],"label_agreement":null},{"id":"W2045715230","doi":"10.1002/rcm.2813","title":"Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry","year":2006,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Chemistry; Chromatography; Active metabolite; Metabolite; Bioanalysis; Analyte; Mass spectrometry; Tandem mass spectrometry; Liquid chromatography–mass spectrometry; Triple quadrupole mass spectrometer; Electrospray ionization; Selected reaction monitoring; Biochemistry","score_opus":0.04002299090569218,"score_gpt":0.3751251071828876,"score_spread":0.33510211627719544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045715230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75317407,0.038243055,0.19590974,0.000997448,0.0006116348,0.0013112519,0.002749763,0.0025710666,0.0044319774],"genre_scores_gemma":[0.8232457,0.010351245,0.1549402,0.002128019,0.0003791962,0.0026785613,0.0019057547,0.00016951837,0.0042017326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682766,0.0007798164,0.00029138167,0.0007021568,0.0012232794,0.00017566756],"domain_scores_gemma":[0.9986506,0.00040507413,0.0002930942,0.00008301929,0.0004513093,0.00011690112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024037356,0.0015413851,0.0011558298,0.0013242302,0.0006751521,0.0010377038,0.000722844,0.0016100453,0.0005839649],"category_scores_gemma":[0.003459361,0.0006132839,0.00067050994,0.0009460318,0.00088347046,0.00071818236,0.00056939916,0.0013323443,0.0005704968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022474963,0.00035245568,0.0053824014,0.00049059343,0.00021704797,0.00041907013,0.0003265786,0.0008474831,0.9411108,0.00049877586,0.0006820312,0.04742533],"study_design_scores_gemma":[0.0004941637,0.0036202546,0.025257397,0.00011528171,0.00028775728,0.0037789363,0.00013539055,0.01363877,0.9427011,0.0008144551,0.0089971265,0.0001593095],"about_ca_topic_score_codex":0.0008010448,"about_ca_topic_score_gemma":0.0010361741,"teacher_disagreement_score":0.0024037356,"about_ca_system_score_codex":0.00048805945,"about_ca_system_score_gemma":0.0012661839,"threshold_uncertainty_score":0.0127123},"labels":[],"label_agreement":null},{"id":"W2046215289","doi":"10.1021/bi002607y","title":"Isolation and Characterization of the UGT2B28 cDNA Encoding a Novel Human Steroid Conjugating UDP-Glucuronosyltransferase","year":2001,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Complementary DNA; Glucuronidation; Subcellular localization; Biology; Gene isoform; Biochemistry; Gene; Molecular biology; Hydroxysteroid; Enzyme; Microsome; Dehydrogenase","score_opus":0.0710527033254991,"score_gpt":0.374405378057015,"score_spread":0.30335267473151595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046215289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97632,0.003176134,0.011864198,0.0006878324,0.00014247076,0.00019105499,0.005185485,0.0001349537,0.0022977688],"genre_scores_gemma":[0.89674044,0.0044413717,0.027252844,0.00053644355,0.00020629875,0.00024538426,0.05060314,0.00020743845,0.01976664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999163,0.000007503048,0.0000058262517,0.00003299009,0.000022049404,0.000015286843],"domain_scores_gemma":[0.99988604,0.000016461569,0.000012193713,0.000014116708,0.000026346182,0.0000448866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007421709,0.00035754417,0.00041882385,0.00023593911,0.00014777997,0.00029535842,0.00019852085,0.00029382296,0.00160487],"category_scores_gemma":[0.00018772761,0.00018276088,0.00038839088,0.00021691808,0.00017127357,0.00012901143,0.00018267847,0.0005677736,0.0019142622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008294748,0.000046528567,0.00064447173,0.000044153767,0.000009838657,0.00033925925,0.000027482005,0.000094877636,0.9946232,0.00010816782,0.0002636043,0.0037155573],"study_design_scores_gemma":[0.0003809771,0.0014871731,0.06353822,0.000059530452,0.0001942428,0.012144091,0.00020869939,0.010844523,0.80599576,0.0006236094,0.10447031,0.00005286151],"about_ca_topic_score_codex":0.00080593576,"about_ca_topic_score_gemma":0.00044650858,"teacher_disagreement_score":0.00160487,"about_ca_system_score_codex":0.00020466394,"about_ca_system_score_gemma":0.00027561816,"threshold_uncertainty_score":0.0053688884},"labels":[],"label_agreement":null},{"id":"W2046405322","doi":"10.1016/j.fct.2006.10.023","title":"Effect of testicular steroids on catalytic activities of cytochrome P450 enzymes in porcine liver microsomes","year":2006,"lang":"en","type":"article","venue":"Food and Chemical Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Microsome; CYP2E1; Internal medicine; Testosterone (patch); Endocrinology; Microsoma; Cytochrome P450; Skatole; Chemistry; Enzyme; Metabolism; Biochemistry; Biology; Medicine","score_opus":0.026498577257160955,"score_gpt":0.35022376348022416,"score_spread":0.32372518622306323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046405322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468166,0.0013577971,0.0007664954,0.00011579679,0.00007149828,0.00001817324,0.0003584957,0.000037479058,0.0025925431],"genre_scores_gemma":[0.9963135,0.00070914684,0.00027792857,0.000058780974,0.00004240906,0.0000064970327,0.0006493341,0.000021582775,0.001920829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995326,0.00021369426,0.00003369623,0.000058971233,0.0000538111,0.000107196945],"domain_scores_gemma":[0.998629,0.00084651675,0.00010146848,0.00015943866,0.000099262696,0.00016441477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003846839,0.0003925897,0.0003564617,0.0002750716,0.00028270629,0.00041573448,0.00032177658,0.00036533063,0.0034254638],"category_scores_gemma":[0.0012149788,0.00029207708,0.00039295646,0.00048761655,0.0005147593,0.00039640264,0.00019108882,0.0007350704,0.0007655837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02140614,0.0005670242,0.0066546015,0.0002996606,0.00020218991,0.00077535264,0.0005549644,0.0015763411,0.95026976,0.0006509089,0.0005287884,0.016514251],"study_design_scores_gemma":[0.000095823416,0.003020614,0.0080046095,0.000009111695,0.000094167466,0.00016994722,0.00012463807,0.0010538661,0.9860183,0.000064580214,0.0013306644,0.000013673293],"about_ca_topic_score_codex":0.0046383617,"about_ca_topic_score_gemma":0.0053213416,"teacher_disagreement_score":0.0046383617,"about_ca_system_score_codex":0.00037638037,"about_ca_system_score_gemma":0.00043148774,"threshold_uncertainty_score":0.011459291},"labels":[],"label_agreement":null},{"id":"W2046420852","doi":"10.1016/s0165-1781(00)00213-4","title":"Effect of venlafaxine on imipramine metabolism","year":2000,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of Mental Health","keywords":"Venlafaxine; Imipramine; CYP2D6; Desipramine; Pharmacology; Cytochrome P450; Venlafaxine Hydrochloride; Metabolism; Drug interaction; Volume of distribution; Internal medicine; Endocrinology; Pharmacokinetics; Reuptake inhibitor; Drug metabolism; Medicine; Chemistry; Drug; Antidepressant","score_opus":0.13876486953812592,"score_gpt":0.542203822319702,"score_spread":0.40343895278157604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046420852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644727,0.0010101086,0.00017869954,0.00022608059,0.00011621949,0.000032037966,0.00032656727,0.000032728327,0.0016303095],"genre_scores_gemma":[0.995786,0.00058062683,0.00036568547,0.00010479347,0.00013833055,0.000019598538,0.00036359185,0.000016025346,0.0026253583],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994436,0.00029917734,0.00003516013,0.000044720044,0.000039019244,0.00013835753],"domain_scores_gemma":[0.99817824,0.0010682748,0.0001128512,0.0001658065,0.0001024136,0.00037238252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061055913,0.000537604,0.0016473258,0.00020541291,0.00031948887,0.00057371805,0.0004892286,0.0010993184,0.005103763],"category_scores_gemma":[0.0033341676,0.00030658636,0.00051914377,0.00027113318,0.00061722007,0.0007047397,0.00023567428,0.0010249971,0.0005045386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6856214,0.002914293,0.0062608733,0.00035517884,0.00094458176,0.001235826,0.0002686819,0.0020413992,0.25074238,0.00090317585,0.0011214117,0.0475908],"study_design_scores_gemma":[0.028734257,0.14935577,0.11011949,0.00013053083,0.0016718282,0.0024943447,0.00067821366,0.0103347255,0.683117,0.000882185,0.012320166,0.00016147702],"about_ca_topic_score_codex":0.002945052,"about_ca_topic_score_gemma":0.0031830447,"teacher_disagreement_score":0.005103763,"about_ca_system_score_codex":0.00039425507,"about_ca_system_score_gemma":0.0007032587,"threshold_uncertainty_score":0.01707381},"labels":[],"label_agreement":null},{"id":"W2046515541","doi":"10.1016/j.thromres.2003.12.014","title":"The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100","year":2003,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"In vivo; Chemistry; Medicine; Biochemistry; Biology","score_opus":0.19169147956414898,"score_gpt":0.45380072141703626,"score_spread":0.2621092418528873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046515541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561746,0.005677123,0.004053832,0.00021267436,0.000089141824,0.00006904262,0.00040964416,0.00020453612,0.0036664782],"genre_scores_gemma":[0.99376947,0.001717822,0.0019449468,0.00008066476,0.000060226772,0.00002651142,0.0006822502,0.000028294155,0.0016898098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977297,0.00008778832,0.00001507052,0.000022184766,0.00005213806,0.0000499869],"domain_scores_gemma":[0.99977833,0.000100196674,0.000029831768,0.000028666478,0.000011802829,0.000051238403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032757837,0.00038667704,0.00045832884,0.00026771167,0.00016408294,0.00031909527,0.00032830655,0.0003008859,0.0018880266],"category_scores_gemma":[0.00042610918,0.00017714367,0.00025321913,0.00023381793,0.00030535852,0.00015550772,0.00013486874,0.00080213515,0.0004711546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002843485,0.00024254674,0.00045625216,0.000085906635,0.000041950847,0.00024698925,0.000037699578,0.00020307484,0.9870178,0.00014137998,0.00041614045,0.008266676],"study_design_scores_gemma":[0.00022921775,0.0030316084,0.004944844,0.0000053252093,0.000037389626,0.00075755565,0.000013071592,0.0011122286,0.9886988,0.000051012164,0.0011138156,0.000005067954],"about_ca_topic_score_codex":0.0010399083,"about_ca_topic_score_gemma":0.0013575061,"teacher_disagreement_score":0.0018880266,"about_ca_system_score_codex":0.00023623354,"about_ca_system_score_gemma":0.00026838688,"threshold_uncertainty_score":0.0063161254},"labels":[],"label_agreement":null},{"id":"W2047398257","doi":"10.1016/j.clpt.2005.06.005","title":"Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient","year":2005,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical pharmacology; Associate editor; Internal medicine; Family medicine; Oncology; Pharmacology; Library science","score_opus":0.13295563203773855,"score_gpt":0.48423952665964093,"score_spread":0.35128389462190235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047398257","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4046192,0.005383877,0.0011120816,0.5569245,0.005614469,0.000048598657,0.000889443,0.00020536226,0.025202455],"genre_scores_gemma":[0.795347,0.0051334514,0.0016284221,0.1720855,0.013758412,0.000051206596,0.0003944109,0.00009735141,0.011504297],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99958855,0.000108219174,0.00006433174,0.000064109234,0.00009268392,0.000082084276],"domain_scores_gemma":[0.99872416,0.0006866853,0.00018051351,0.000029091783,0.000121706325,0.00025791756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745938,0.00042029427,0.0010143033,0.00028500528,0.0007075516,0.00076601934,0.0004075972,0.0058678165,0.0025587257],"category_scores_gemma":[0.004079151,0.0002722488,0.00072994287,0.0004889714,0.0005512604,0.00059479504,0.00022520195,0.00498466,0.00061192416],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012207559,0.00033046445,0.16121477,0.00016172194,0.00020669034,0.5814129,0.00089279364,0.00095876417,0.0042867255,0.0028211912,0.19483487,0.0516584],"study_design_scores_gemma":[0.00075616967,0.002108972,0.18997292,0.00038391995,0.00067449996,0.6617491,0.0017932269,0.0054295897,0.0046856524,0.004201225,0.12810631,0.00013844046],"about_ca_topic_score_codex":0.0059224195,"about_ca_topic_score_gemma":0.01035931,"teacher_disagreement_score":0.0059224195,"about_ca_system_score_codex":0.0016032609,"about_ca_system_score_gemma":0.0012495304,"threshold_uncertainty_score":0.011775851},"labels":[],"label_agreement":null},{"id":"W2047667596","doi":"10.1016/j.clpt.2003.11.301","title":"Evaluation of herbal products as potential inhibitors of MDR1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Pharmacology; Black cohosh; Verapamil; Traditional medicine; Digoxin; Valerian; Phytochemical; Chemistry; Kava; Phytotherapy; Ginseng; Medicine","score_opus":0.2840747636108134,"score_gpt":0.5431562213857632,"score_spread":0.25908145777494984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047667596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96590906,0.026470251,0.0016385604,0.00035170803,0.0001391239,0.0005992788,0.0009828776,0.00007173864,0.0038374714],"genre_scores_gemma":[0.95437,0.03160962,0.006507226,0.00029494718,0.0001463468,0.000399259,0.0013945607,0.000025695677,0.0052523543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998031,0.000058750047,0.000021063403,0.000026223805,0.000061869774,0.000029007762],"domain_scores_gemma":[0.999826,0.000050654886,0.000031274907,0.000010041387,0.000050837192,0.000031217038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035744262,0.00042552463,0.00071385043,0.0007090366,0.00030485707,0.00040261302,0.00032097963,0.00033089038,0.0028322672],"category_scores_gemma":[0.0003443663,0.00019469447,0.000523616,0.0006267623,0.00017184824,0.00031575194,0.00024863702,0.00066725595,0.0002526011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039520264,0.005251572,0.0018278492,0.0025785335,0.00027657862,0.00063036324,0.00018321817,0.000576349,0.9296388,0.0004154246,0.0006799319,0.053989373],"study_design_scores_gemma":[0.0018850247,0.11196163,0.029752426,0.00040778963,0.0017526975,0.0013779185,0.00046521454,0.0025679779,0.80153185,0.00034881505,0.047855612,0.00009308009],"about_ca_topic_score_codex":0.00042707476,"about_ca_topic_score_gemma":0.0013101902,"teacher_disagreement_score":0.0028322672,"about_ca_system_score_codex":0.00016539883,"about_ca_system_score_gemma":0.00030013124,"threshold_uncertainty_score":0.009474874},"labels":[],"label_agreement":null},{"id":"W2048088066","doi":"10.1371/journal.pone.0107728","title":"The Cytochrome P450 Superfamily Complement (CYPome) in the Annelid Capitella teleta","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Cytochrome P450; Annelid; Phylogenetics; Pseudogene; Xenobiotic; Phylogenetic tree; Demethylase; Genetics; Hox gene; Gene; Biochemistry; Genome; Enzyme; Zoology; Epigenetics; Gene expression","score_opus":0.21364250109640043,"score_gpt":0.39352596601146383,"score_spread":0.1798834649150634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048088066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912059,0.0009409994,0.0011787558,0.000048615628,0.000013130108,0.000019066518,0.0046812133,0.00008370463,0.0018286759],"genre_scores_gemma":[0.97244304,0.00079327193,0.0055532916,0.00007971734,0.000021795357,0.000051406936,0.017447315,0.000039699433,0.0035703862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999892,0.0000055246423,0.000006623605,0.00005514328,0.000025749407,0.000014949317],"domain_scores_gemma":[0.99983954,0.000020523266,0.0000577501,0.000015422109,0.000035212794,0.0000315362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052847205,0.00023119124,0.00019401178,0.0011344829,0.00045613063,0.0002925963,0.00012026519,0.00029190863,0.0015221257],"category_scores_gemma":[0.00017282466,0.00012605319,0.00037579774,0.00069365336,0.00019879587,0.00017318806,0.00028861497,0.00026843857,0.0004324647],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051141944,0.000025839476,0.045336213,0.00026082067,0.000034945773,0.0004905901,0.00026442163,0.0002895097,0.93133575,0.00021731324,0.00061086053,0.02062234],"study_design_scores_gemma":[0.000019760204,0.00023296903,0.9300744,0.00004882914,0.00009174327,0.0027167094,0.00034867058,0.0014452435,0.045552958,0.000159591,0.019278705,0.000030354522],"about_ca_topic_score_codex":0.0045542587,"about_ca_topic_score_gemma":0.004726139,"teacher_disagreement_score":0.0045542587,"about_ca_system_score_codex":0.00031590398,"about_ca_system_score_gemma":0.0002641303,"threshold_uncertainty_score":0.009055555},"labels":[],"label_agreement":null},{"id":"W2048391139","doi":"10.1006/bbrc.2001.6209","title":"An in Vivo Pilot Study Characterizing the New CYP2A6*7, *8, and *10 Alleles","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canada Research Chairs; Centre for Addiction and Mental Health","keywords":"Allele; CYP2A6; Genotyping; Genetics; Biology; In vivo; Homology (biology); Genotype; Gene; In vitro","score_opus":0.3966348491509826,"score_gpt":0.5169513918226329,"score_spread":0.12031654267165032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048391139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914643,0.00024452864,0.0058904374,0.00039979522,0.00020855131,0.00035284733,0.0005682233,0.00008361411,0.0007876122],"genre_scores_gemma":[0.9835581,0.00051960145,0.004841819,0.0006426899,0.00019847433,0.00054629525,0.0020793942,0.00011733819,0.0074961814],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99952066,0.00016869073,0.0000228974,0.00013529457,0.000053737946,0.000098720506],"domain_scores_gemma":[0.99914277,0.00025959962,0.00010488233,0.00012122448,0.00007152709,0.00029986442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010039791,0.001009509,0.0007113476,0.0002781378,0.00038037248,0.00040713119,0.0004462226,0.00078509934,0.003254752],"category_scores_gemma":[0.0006763648,0.00031355873,0.00066484546,0.00020320753,0.0008003139,0.00048024917,0.00016678472,0.0029236763,0.00065656396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014471261,0.012254708,0.0011000249,0.00004608203,0.000085071464,0.00028310623,0.00009578781,0.00027184447,0.96360105,0.00021745793,0.00075245753,0.006821101],"study_design_scores_gemma":[0.010966818,0.41189334,0.012321485,0.000013933077,0.00057627686,0.003572691,0.00025981656,0.0029507736,0.55056864,0.00062934216,0.0061855703,0.00006132191],"about_ca_topic_score_codex":0.0007843725,"about_ca_topic_score_gemma":0.00091032713,"teacher_disagreement_score":0.003254752,"about_ca_system_score_codex":0.00023988371,"about_ca_system_score_gemma":0.00034079546,"threshold_uncertainty_score":0.010888219},"labels":[],"label_agreement":null},{"id":"W2048902326","doi":"10.1210/endo.141.7.7583","title":"Distribution of Uridine Diphosphate-Glucuronosyltransferase (UGT) Expression and Activity in Cynomolgus Monkey Tissues: Evidence for Differential Expression of Steroid-Conjugating UGT Enzymes in Steroid Target Tissues*","year":2000,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Medical Council of Canada","funders":"","keywords":"Glucuronidation; Glucuronosyltransferase; Steroid; Chemistry; Hydroxysteroid; Androsterone; Biochemistry; Enzyme; Sulfotransferase; Uridine diphosphate; Microsome; Biology; Internal medicine; Endocrinology; Hormone; Dehydrogenase; Medicine","score_opus":0.0831781560007816,"score_gpt":0.4067591959740246,"score_spread":0.323581039973243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048902326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858283,0.0059411298,0.0037381202,0.00010460343,0.000014213962,0.000023365455,0.000894925,0.000082240374,0.0033731319],"genre_scores_gemma":[0.99065816,0.002231169,0.0031365717,0.0001039667,0.000019423434,0.00005180111,0.0013011562,0.000050064395,0.0024477632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998722,0.000023683608,0.000007724331,0.00004692929,0.000024273357,0.000025141992],"domain_scores_gemma":[0.9998349,0.000031429347,0.00004163696,0.00002536256,0.000029026396,0.000037603448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015191363,0.00019356095,0.00030810386,0.00079160917,0.0002730294,0.0004892752,0.0000819734,0.00025987407,0.001264899],"category_scores_gemma":[0.00019271437,0.00017212654,0.00021394546,0.0004993953,0.00027686998,0.00016434334,0.00019098171,0.00025294238,0.00037568706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027947896,0.000010907277,0.009896964,0.000043437925,0.000035082827,0.0001851741,0.000085372376,0.000027029826,0.98443675,0.00009210782,0.000056873243,0.004850828],"study_design_scores_gemma":[0.00003158429,0.0006645662,0.5877641,0.000027843602,0.00022674532,0.0035012644,0.00033357358,0.001222309,0.3955972,0.0004648434,0.01013873,0.000027250275],"about_ca_topic_score_codex":0.0022593916,"about_ca_topic_score_gemma":0.0030452425,"teacher_disagreement_score":0.0022593916,"about_ca_system_score_codex":0.00028046008,"about_ca_system_score_gemma":0.00022290081,"threshold_uncertainty_score":0.0044924617},"labels":[],"label_agreement":null},{"id":"W2048985510","doi":"10.1016/j.pharmthera.2013.04.004","title":"Functional genomics of pain in analgesic drug development and therapy","year":2013,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Drug repositioning; Analgesic; Drug development; Pharmacogenomics; Drug discovery; Computational biology; Functional genomics; Repurposing; Bioinformatics; Chronic pain; Medicine; Genomics; Neuroscience; Biology; Drug; Pharmacology; Gene; Genetics; Genome","score_opus":0.2564023176093579,"score_gpt":0.44987072339124473,"score_spread":0.19346840578188684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048985510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013264713,0.9927208,0.0019622932,0.0007471801,0.00020526927,0.000009487663,0.00007126009,0.000026312957,0.002930912],"genre_scores_gemma":[0.00720115,0.98919094,0.0014169645,0.00033306165,0.0002369309,0.000010348597,0.00011940205,0.0000038690355,0.0014873741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999076,0.000016365328,0.000007119605,0.000017735278,0.00003733941,0.000013843952],"domain_scores_gemma":[0.99992156,0.000036870395,0.000013763855,0.000002954946,0.000018021505,0.0000068941886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028452364,0.0005109568,0.0008250999,0.0006648901,0.0001176842,0.0006306112,0.0004852474,0.00050256326,0.0019400767],"category_scores_gemma":[0.00028398028,0.00018073541,0.00033401034,0.00078212254,0.0003589051,0.0004436082,0.00040523426,0.0008195001,0.00076831016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080248574,0.00006683199,0.0004916297,0.0041523213,0.00008373341,0.00025138946,0.00002838943,0.0008956581,0.016445482,0.008456143,0.009257719,0.9597906],"study_design_scores_gemma":[0.000035488454,0.00016498259,0.0059717703,0.002113004,0.00028567942,0.00222013,0.00009281041,0.000820326,0.0084549785,0.0131102605,0.96668595,0.000044592543],"about_ca_topic_score_codex":0.00092653587,"about_ca_topic_score_gemma":0.0015374201,"teacher_disagreement_score":0.0019400767,"about_ca_system_score_codex":0.00047630267,"about_ca_system_score_gemma":0.0008975887,"threshold_uncertainty_score":0.006490171},"labels":[],"label_agreement":null},{"id":"W2049217578","doi":"10.2174/1570160053175027","title":"Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions","year":2005,"lang":"en","type":"article","venue":"Current Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Pharmacogenomics; Regulatory science; Drug development; Personalized medicine; Precision medicine; Drug; Medicine; Biomarker; Bioinformatics; Computational biology; Biology; Genetics; Pharmacology","score_opus":0.058876441371449754,"score_gpt":0.4508847345390754,"score_spread":0.39200829316762564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049217578","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012590685,0.021982515,0.77285945,0.175502,0.0029191517,0.00023078223,0.0002957769,0.00036408805,0.01325556],"genre_scores_gemma":[0.49352098,0.021610556,0.4316811,0.0358922,0.010484339,0.001288356,0.00030397475,0.00028190037,0.0049365317],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.922916,0.05431296,0.003815428,0.009887025,0.0077143316,0.0013543208],"domain_scores_gemma":[0.71223134,0.23713052,0.014902272,0.02214573,0.011409136,0.002181043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.123905025,0.0013717061,0.0035666095,0.002302878,0.0018926285,0.011956789,0.0043321517,0.0062835007,0.003978699],"category_scores_gemma":[0.20246732,0.0012399649,0.0023121785,0.0020513204,0.022899421,0.012147387,0.005324399,0.010618293,0.0010689761],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003964606,0.00011999741,0.010044007,0.00086542236,0.0005334741,0.00042550178,0.0020903824,0.012156676,0.0012592067,0.8390907,0.006817693,0.12620042],"study_design_scores_gemma":[0.000057732377,0.00012804703,0.005176008,0.0002955865,0.00012053618,0.0003712269,0.00033246825,0.022392502,0.0008218175,0.9552837,0.0148845,0.00013599177],"about_ca_topic_score_codex":0.0024917994,"about_ca_topic_score_gemma":0.0016712691,"teacher_disagreement_score":0.123905025,"about_ca_system_score_codex":0.004290159,"about_ca_system_score_gemma":0.0070744255,"threshold_uncertainty_score":0.65528023},"labels":[],"label_agreement":null},{"id":"W2049258047","doi":"10.1016/j.mrfmmm.2003.08.002","title":"Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5","year":2003,"lang":"en","type":"article","venue":"Mutation research. Fundamental and molecular mechanisms of mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health and Welfare; Korea University; University of Calgary","keywords":"Naringenin; CYP1A2; Chemistry; Quinoline; Biochemistry; Mutagenesis; Mutagen; Cytochrome b5; Quercetin; Cytochrome P450; Enzyme; Mutant; Carcinogen; Antioxidant; Flavonoid; Gene; Organic chemistry","score_opus":0.06792987090676106,"score_gpt":0.405054574289843,"score_spread":0.3371247033830819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049258047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962268,0.001229988,0.00043789597,0.00010215598,0.00004431805,0.0000241292,0.00044374575,0.00004269185,0.001448319],"genre_scores_gemma":[0.9964929,0.00042530426,0.0004617726,0.000050474802,0.00001155215,0.00001967352,0.00050051376,0.000010278869,0.0020274722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986184,0.00003630152,0.000010439275,0.00001972321,0.000022062188,0.000049578797],"domain_scores_gemma":[0.99977976,0.00007597773,0.000037826852,0.00002379672,0.000029338433,0.000053414915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013319032,0.00028209054,0.00023350691,0.00013550023,0.00008641168,0.00017407213,0.00023803324,0.00033107025,0.0026323486],"category_scores_gemma":[0.0002712053,0.00018879978,0.0002457033,0.00010558511,0.00020675734,0.00018390449,0.00012777124,0.00042400637,0.00047646888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002406114,0.00008044798,0.00014156313,0.000029771572,0.000007386803,0.00004636847,0.000022379409,0.0001342525,0.9954087,0.00012183852,0.000102936836,0.0014981993],"study_design_scores_gemma":[0.0001472677,0.0024184028,0.008463625,0.000009505673,0.00002482629,0.00012343036,0.000060612798,0.00096682715,0.9867127,0.00009811555,0.0009612323,0.0000135238215],"about_ca_topic_score_codex":0.0016663658,"about_ca_topic_score_gemma":0.0022506702,"teacher_disagreement_score":0.0026323486,"about_ca_system_score_codex":0.0003128633,"about_ca_system_score_gemma":0.0002259517,"threshold_uncertainty_score":0.008806109},"labels":[],"label_agreement":null},{"id":"W2049540056","doi":"10.1038/nbt0703-747","title":"Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare","year":2003,"lang":"en","type":"article","venue":"Nature Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"","keywords":"Pharmacogenomics; Drug; Business; Drug approval; Health care; Pharmacology; Biotechnology; Risk analysis (engineering); Medicine; Economics; Biology; Economic growth","score_opus":0.04512963305399814,"score_gpt":0.40116465542716306,"score_spread":0.3560350223731649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049540056","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014033257,0.016829824,0.032744985,0.6625685,0.004779652,0.00038131687,0.0007110623,0.00025631196,0.26769513],"genre_scores_gemma":[0.5677848,0.013093541,0.051425047,0.28190756,0.018892637,0.001180812,0.0004827518,0.00034195004,0.064890966],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9723159,0.014321929,0.0011762165,0.0016660986,0.008583349,0.0019364664],"domain_scores_gemma":[0.85207564,0.12624183,0.003412258,0.0033459207,0.010776093,0.004148319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043281093,0.0013236254,0.00228063,0.0032997348,0.0033724941,0.014255421,0.0042659775,0.044776823,0.023677614],"category_scores_gemma":[0.121119685,0.0013972484,0.0028177411,0.0018052936,0.013219109,0.012614842,0.0037316459,0.017253138,0.0027366518],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005442845,0.00024332166,0.0014179547,0.0003170291,0.0001206286,0.0006670975,0.00026505574,0.005795054,0.0011488654,0.8712318,0.067943335,0.050305635],"study_design_scores_gemma":[0.00039720873,0.00044289316,0.005416447,0.0017604899,0.00027880704,0.0014830736,0.00088858395,0.012412841,0.0013545502,0.6681672,0.3070996,0.0002983915],"about_ca_topic_score_codex":0.010301973,"about_ca_topic_score_gemma":0.013883318,"teacher_disagreement_score":0.044776823,"about_ca_system_score_codex":0.009624363,"about_ca_system_score_gemma":0.020031583,"threshold_uncertainty_score":0.22889501},"labels":[],"label_agreement":null},{"id":"W2050349526","doi":"10.1016/s0378-4347(00)00325-x","title":"Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine","year":2000,"lang":"en","type":"article","venue":"Journal of Chromatography B Biomedical Sciences and Applications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chromatography; Caffeine; Chemistry; Urine; CYP1A2; Extraction (chemistry); High-performance liquid chromatography; Xanthine oxidase; Acetic acid; Enzyme; Cytochrome P450; Biochemistry","score_opus":0.038831079446932565,"score_gpt":0.4165151362868271,"score_spread":0.3776840568398946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050349526","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40286508,0.037037358,0.533395,0.0017621566,0.0017447274,0.0034023356,0.0033937397,0.0062585985,0.010140918],"genre_scores_gemma":[0.62536424,0.0097665405,0.34074506,0.003416144,0.0004975312,0.0029260768,0.0026092562,0.00024723302,0.014427797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980438,0.00038719465,0.000101627535,0.0003830598,0.0009708068,0.00011348945],"domain_scores_gemma":[0.998582,0.00048670123,0.00015737112,0.00006861038,0.00048442805,0.00022094099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011136719,0.0008790361,0.001049658,0.002740255,0.0017489443,0.00052782317,0.0011922438,0.0019609635,0.0022185566],"category_scores_gemma":[0.0020047543,0.0007861838,0.0006435515,0.0010554307,0.0006164611,0.00048570134,0.0008401709,0.0016648823,0.0022267946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013966477,0.00081060315,0.005676748,0.00034660866,0.00026689447,0.0004059338,0.0001170028,0.0003275147,0.9162766,0.00038749774,0.0019385292,0.072049595],"study_design_scores_gemma":[0.0005934308,0.0052763396,0.046181045,0.00019800403,0.0007554873,0.008903701,0.00016783562,0.014090052,0.8937655,0.0004843474,0.029217042,0.00036722003],"about_ca_topic_score_codex":0.0035347003,"about_ca_topic_score_gemma":0.009533272,"teacher_disagreement_score":0.0035347003,"about_ca_system_score_codex":0.0005844454,"about_ca_system_score_gemma":0.0020297389,"threshold_uncertainty_score":0.0074217916},"labels":[],"label_agreement":null},{"id":"W2050415328","doi":"10.2174/1389200053586082","title":"Accelerated Cytotoxicity Mechanism Screening Using Drug Metabolising Enzyme Modulators","year":2005,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytotoxicity; Enzyme; Pharmacology; Biochemistry; Cytochrome P450; Glutathione; Chemistry; In vivo; Drug; Metabolic pathway; Mechanism of action; In vitro; Biology","score_opus":0.342628587452192,"score_gpt":0.5038157467382227,"score_spread":0.16118715928603072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050415328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055656065,0.9800071,0.0033465326,0.00019853782,0.00012464459,0.00008701229,0.000099546916,0.00008788026,0.010483087],"genre_scores_gemma":[0.016949305,0.97129357,0.0045345803,0.00020659716,0.00012408633,0.00008054993,0.00019283676,0.0000073990786,0.006611043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997906,0.000035907942,0.000021343685,0.000040111492,0.00009486158,0.000017186907],"domain_scores_gemma":[0.99983144,0.00005251659,0.00003453328,0.000008216575,0.000060489536,0.0000127410285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039705238,0.0008641309,0.0012967348,0.0025938842,0.0001630043,0.00048720208,0.00069840706,0.0005991143,0.0024196163],"category_scores_gemma":[0.0002615484,0.0002578129,0.00045209427,0.0016124976,0.00019714364,0.00069843367,0.00024654294,0.0005044677,0.002418032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012519071,0.00020007233,0.0005661598,0.006981473,0.00009377192,0.0005513182,0.000041615607,0.0008811801,0.07096282,0.002041971,0.004874209,0.9126802],"study_design_scores_gemma":[0.00013616771,0.0018224433,0.005391442,0.001421942,0.00035826385,0.007130009,0.00009513285,0.0009952947,0.11219018,0.0016620151,0.8687269,0.00007008892],"about_ca_topic_score_codex":0.0006503339,"about_ca_topic_score_gemma":0.0013313188,"teacher_disagreement_score":0.0025938842,"about_ca_system_score_codex":0.00045454683,"about_ca_system_score_gemma":0.0004925905,"threshold_uncertainty_score":0.00809443},"labels":[],"label_agreement":null},{"id":"W2050440877","doi":"10.1053/j.ajkd.2014.09.015","title":"Effect of CKD and Dialysis Modality on Exposure to Drugs Cleared by Nonrenal Mechanisms","year":2014,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research; Lawson Health Research Institute; American Society of Nephrology","keywords":"Medicine; Clearance; Dialysis; Modality (human–computer interaction); Kidney disease; Metabolic clearance rate; Renal function; Intensive care medicine; Internal medicine; Pharmacology; Urology; Pharmacokinetics","score_opus":0.01281538090334569,"score_gpt":0.3623033779102713,"score_spread":0.3494879970069256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050440877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905951,0.004262774,0.0002237961,0.00028468185,0.000078211386,0.000021315594,0.00085183425,0.00003393344,0.0036483628],"genre_scores_gemma":[0.9973935,0.0004977697,0.00011472331,0.00007868014,0.000072783194,0.000009158336,0.00024259934,0.000014573335,0.0015762598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986143,0.00045725662,0.000113215014,0.00030347417,0.00019022249,0.00032150612],"domain_scores_gemma":[0.9895215,0.0062937257,0.0014790108,0.0007813811,0.00053690525,0.0013874953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019723854,0.00046718327,0.0015451837,0.00040006818,0.00048136883,0.0010712771,0.00066910905,0.001134799,0.008051953],"category_scores_gemma":[0.009105782,0.000345639,0.0034095952,0.00063407834,0.0005209759,0.0014541189,0.00087615364,0.0017551156,0.00045540926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12537739,0.0015994621,0.8391036,0.0003107878,0.006317172,0.00040994538,0.00028966588,0.0014546035,0.002995867,0.00039148386,0.0008166893,0.020933287],"study_design_scores_gemma":[0.00026645735,0.0051961597,0.98688775,0.000043948676,0.003117577,0.00026847242,0.00020516783,0.0015731049,0.0005329254,0.00040553694,0.0014536006,0.000049325343],"about_ca_topic_score_codex":0.008864532,"about_ca_topic_score_gemma":0.00820615,"teacher_disagreement_score":0.008864532,"about_ca_system_score_codex":0.00074569776,"about_ca_system_score_gemma":0.0018170297,"threshold_uncertainty_score":0.026936471},"labels":[],"label_agreement":null},{"id":"W2050603486","doi":"10.1002/phar.1398","title":"Pharmacogenomic Testing for Neuropsychiatric Drugs: Current Status of Drug Labeling, Guidelines for Using Genetic Information, and Test Options","year":2014,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Drug; Dosing; Carbamazepine; Intensive care medicine; Genetic testing; Personalized medicine; Pharmacogenetics; Pharmacology; Psychiatry; Epilepsy; Bioinformatics; Internal medicine","score_opus":0.24175570729423315,"score_gpt":0.5158485495858426,"score_spread":0.27409284229160946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050603486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051442627,0.9897815,0.0018153808,0.003090055,0.00026392055,0.000027241475,0.00015245122,0.000044139964,0.004310902],"genre_scores_gemma":[0.0040620873,0.9868412,0.0050985785,0.002057689,0.00036664857,0.000042562915,0.0003214137,0.000017008133,0.0011927445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974152,0.0007521675,0.0003986138,0.00027124677,0.0010522285,0.000110505745],"domain_scores_gemma":[0.99408853,0.00397925,0.00055394263,0.00016663477,0.001088813,0.00012284252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053442596,0.00071792403,0.0017780699,0.003863868,0.00032886257,0.0014206716,0.00173083,0.0021597133,0.0032305014],"category_scores_gemma":[0.0063829413,0.00031399043,0.0009499666,0.0030280782,0.0013349043,0.0018095751,0.00092783524,0.0023826,0.001781551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006383956,0.000049897284,0.0005352597,0.006216815,0.00005112023,0.00024263706,0.00006857331,0.00017581809,0.0010878807,0.004681073,0.01668363,0.97014356],"study_design_scores_gemma":[0.000035269415,0.0001271226,0.0024176678,0.009669223,0.0002265417,0.003553987,0.0001562915,0.00020417443,0.0024558138,0.0073139686,0.9737847,0.00005526836],"about_ca_topic_score_codex":0.0022648748,"about_ca_topic_score_gemma":0.0032467425,"teacher_disagreement_score":0.0053442596,"about_ca_system_score_codex":0.0009630045,"about_ca_system_score_gemma":0.002528819,"threshold_uncertainty_score":0.02826345},"labels":[],"label_agreement":null},{"id":"W2050701148","doi":"10.1038/clpt.2011.334","title":"PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"","keywords":"Pharmacogenomics; Pharmacodynamics; Clinical pharmacology; Pharmaceutical industry; Drug development; Pharmacology; Drug; Medicine; Pharmacokinetics","score_opus":0.47578842760430606,"score_gpt":0.5873528190965384,"score_spread":0.1115643914922323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050701148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8093011,0.018791687,0.039166078,0.07315783,0.00062815816,0.002140996,0.023472568,0.0015951621,0.031746447],"genre_scores_gemma":[0.92684907,0.01270891,0.027236253,0.01818013,0.0007086713,0.0013656303,0.010035911,0.00017043344,0.0027449934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95031226,0.023687365,0.008926786,0.0023594848,0.013252453,0.0014616421],"domain_scores_gemma":[0.80928904,0.07557716,0.042134963,0.013738224,0.05305508,0.006205554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.063988134,0.0003688366,0.0009892955,0.005166091,0.00055273913,0.0025034975,0.0010657137,0.0012190035,0.0025923674],"category_scores_gemma":[0.114008814,0.00032674344,0.0009121382,0.006127042,0.00079431175,0.003341374,0.0021315718,0.0011367383,0.0014122315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028398406,0.00024061142,0.6891804,0.000995815,0.00022718614,0.00019734135,0.0010709763,0.00041139117,0.0018414481,0.0010701079,0.019031072,0.2854496],"study_design_scores_gemma":[0.000033557793,0.0010736277,0.9162489,0.0005587621,0.00012187341,0.0009472807,0.0026871657,0.0012734126,0.0016996632,0.0009584697,0.07432076,0.00007645534],"about_ca_topic_score_codex":0.0029267026,"about_ca_topic_score_gemma":0.0023756442,"teacher_disagreement_score":0.063988134,"about_ca_system_score_codex":0.0012013968,"about_ca_system_score_gemma":0.003045923,"threshold_uncertainty_score":0.33840567},"labels":[],"label_agreement":null},{"id":"W2051347512","doi":"10.1016/s0006-291x(02)02469-5","title":"Identification of the novel splicing variants for the hPXR in human livers","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Alternative splicing; Biology; RNA splicing; Pregnane X receptor; CYP3A4; Gene; Gene expression; Molecular biology; Messenger RNA; Genetics; RNA; Transcription factor; Nuclear receptor; Biochemistry; Metabolism; Cytochrome P450","score_opus":0.38998610452843224,"score_gpt":0.5215106350060051,"score_spread":0.1315245304775729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051347512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950623,0.00044918575,0.0035410128,0.00009489463,0.000020900166,0.000013347409,0.00023007391,0.000040085382,0.0005482624],"genre_scores_gemma":[0.9978795,0.00015360488,0.001017817,0.00003142306,0.000030007637,0.0000083940595,0.00030201674,0.00002174539,0.00055556133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998031,0.0000293272,0.000033631626,0.00006816568,0.00003431844,0.000031422413],"domain_scores_gemma":[0.9995196,0.00015470985,0.00009911983,0.00009897229,0.00005372077,0.00007385564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026389444,0.00034067951,0.0003955139,0.00071973464,0.00020846646,0.00041902412,0.00023203105,0.00035554622,0.002439422],"category_scores_gemma":[0.00064458285,0.0003017169,0.00047627182,0.00032328235,0.0004423251,0.00020408558,0.00028521375,0.0005060184,0.0006038662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026440783,0.0000691144,0.05114526,0.00010461282,0.0001542325,0.012588799,0.00038831442,0.00036175974,0.917451,0.0006717109,0.00022283097,0.014198237],"study_design_scores_gemma":[0.00024465664,0.0016394326,0.44274125,0.000033401662,0.0005143362,0.12507007,0.0007937284,0.0035400838,0.41840982,0.0023838107,0.0045669097,0.00006251862],"about_ca_topic_score_codex":0.0003861626,"about_ca_topic_score_gemma":0.0002737269,"teacher_disagreement_score":0.002439422,"about_ca_system_score_codex":0.00010151593,"about_ca_system_score_gemma":0.000099521974,"threshold_uncertainty_score":0.008160651},"labels":[],"label_agreement":null},{"id":"W2051366695","doi":"10.1159/000064194","title":"Ethical, Social and Legal Implications of Pharmacogenomics: A Critical Review","year":2001,"lang":"en","type":"review","venue":"Public Health Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international","keywords":"Pharmacogenomics; Bioethics; Multidisciplinary approach; Engineering ethics; Medicine; Psychology; Political science; Sociology; Social science; Pharmacology; Law; Engineering","score_opus":0.5366961779633526,"score_gpt":0.5952239631420325,"score_spread":0.05852778517867996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051366695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008556606,0.896014,0.0033466362,0.08845144,0.0076774983,0.00017393251,0.000022435941,0.000013944708,0.0034446195],"genre_scores_gemma":[0.018224485,0.9466938,0.007796169,0.019537088,0.0055210437,0.00037239687,0.000026234882,0.000010327227,0.0018183843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97754365,0.015733538,0.0018177053,0.000623041,0.0038640718,0.00041797056],"domain_scores_gemma":[0.919616,0.06350521,0.0030854812,0.0007302839,0.012461068,0.0006020675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028593015,0.0009790736,0.0014801705,0.0053469776,0.0020646967,0.0040791687,0.0021680642,0.0068315277,0.001257086],"category_scores_gemma":[0.045685504,0.0004812374,0.00094694935,0.003524038,0.006149086,0.0052873297,0.001670254,0.004388983,0.00047631946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012338051,0.00011886329,0.0010275019,0.03481139,0.00027960818,0.004110384,0.008317977,0.0011451647,0.0009907376,0.07447495,0.22872858,0.6458715],"study_design_scores_gemma":[0.00004209891,0.00012434907,0.0013240114,0.049676433,0.00017809699,0.004482827,0.011007238,0.0005742417,0.0010933855,0.06680061,0.8645917,0.000104979976],"about_ca_topic_score_codex":0.002365156,"about_ca_topic_score_gemma":0.0037785494,"teacher_disagreement_score":0.028593015,"about_ca_system_score_codex":0.0052456027,"about_ca_system_score_gemma":0.015753256,"threshold_uncertainty_score":0.15121615},"labels":[],"label_agreement":null},{"id":"W2052268395","doi":"10.3109/03602530903219220","title":"Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential","year":2009,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Glucuronidation; Nuclear receptor; Chemistry; Pregnane X receptor; Glucuronosyltransferase; Endogeny; Biochemistry; Transcription factor; Enzyme; Transporter; Bilirubin; Aryl hydrocarbon receptor; Drug metabolism; Enterohepatic circulation; Receptor; Metabolism; Pharmacology; Gene; Biology; Endocrinology; Microsome","score_opus":0.14883391734934248,"score_gpt":0.41339755002485434,"score_spread":0.26456363267551186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052268395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009711345,0.9960322,0.0006930617,0.00020724711,0.00009005155,0.0000060801294,0.000023872666,0.000015230904,0.0019611209],"genre_scores_gemma":[0.003706703,0.9938141,0.0006713963,0.00015852215,0.00008251895,0.000011725964,0.0000450729,0.000002906762,0.0015069732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992204,0.000014596243,0.000009381502,0.000015548916,0.000028508804,0.000009903484],"domain_scores_gemma":[0.9999379,0.000023334755,0.000011606357,0.0000028057748,0.00001693056,0.0000074178315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023927266,0.00054459856,0.000856269,0.00081376627,0.0001264659,0.0004476443,0.00039431316,0.0005829917,0.001876783],"category_scores_gemma":[0.00013676978,0.00016444741,0.00024463225,0.0008529453,0.00025320562,0.00051575387,0.00027981665,0.00073344074,0.0015498875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011515595,0.00010769705,0.00020975187,0.0058433716,0.00005806884,0.00041551274,0.000057624642,0.00055412983,0.029680833,0.0034785878,0.008241591,0.9512376],"study_design_scores_gemma":[0.00004470126,0.00029867064,0.0020065655,0.00097474514,0.0000980196,0.0033017637,0.00007603171,0.00029874896,0.012516231,0.002693151,0.9776625,0.000028946533],"about_ca_topic_score_codex":0.00041905107,"about_ca_topic_score_gemma":0.000870168,"teacher_disagreement_score":0.001876783,"about_ca_system_score_codex":0.00033615035,"about_ca_system_score_gemma":0.00036439355,"threshold_uncertainty_score":0.0062784553},"labels":[],"label_agreement":null},{"id":"W2052300490","doi":"10.1097/fpc.0b013e3283498147","title":"Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants","year":2011,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"UGT2B7; Exon; Alternative splicing; Biology; Glucuronidation; RNA splicing; Gene isoform; Exon skipping; Messenger RNA; Locus (genetics); Genetics; Gene; Molecular biology; RNA","score_opus":0.10904525793029503,"score_gpt":0.34436475449878223,"score_spread":0.23531949656848722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052300490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887056,0.0026012314,0.0064979736,0.00009901396,0.0000159679,0.000024821356,0.00065131334,0.00008935548,0.001314725],"genre_scores_gemma":[0.9886458,0.0011890944,0.0049042543,0.0000685557,0.000035082918,0.000052335596,0.0036475542,0.000051604067,0.001405707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996941,0.00004155906,0.000015060538,0.00011769997,0.00008750682,0.00004413766],"domain_scores_gemma":[0.99972314,0.00007244563,0.0000717061,0.000025446261,0.00006443171,0.00004278599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020783019,0.00029264542,0.00035952614,0.0005604559,0.00019975599,0.00055216305,0.0001407005,0.0002897984,0.0010294626],"category_scores_gemma":[0.0002591748,0.00017652282,0.0004592805,0.00045316646,0.0003633444,0.00011789626,0.00024477782,0.00030165247,0.0006730462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000124056,0.000012187584,0.0068955277,0.00005101586,0.000024981771,0.00017586269,0.00005890291,0.000088023844,0.98851776,0.00016986516,0.00004743298,0.0038343375],"study_design_scores_gemma":[0.00005071615,0.0004760935,0.21788466,0.00007474068,0.00017957011,0.0036773204,0.00027746276,0.0030225918,0.7635903,0.00082257,0.009910905,0.000033093722],"about_ca_topic_score_codex":0.00054729014,"about_ca_topic_score_gemma":0.0008637065,"teacher_disagreement_score":0.0010294626,"about_ca_system_score_codex":0.00024609882,"about_ca_system_score_gemma":0.00021960384,"threshold_uncertainty_score":0.0034438968},"labels":[],"label_agreement":null},{"id":"W2052642028","doi":"10.1271/bbb.90199","title":"Comparison of Two Vectors for Functional Expression of a Bacterial Cytochrome P450 Gene in<i>Escherichia coli</i>Using<i>CYP153</i>Genes","year":2009,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Bioconversion; Escherichia coli; Reductase; Cytochrome P450; Octane; Chemistry; Cytochrome; Cyclohexane; Ferredoxin; Monooxygenase; Biochemistry; Stereochemistry; Gene; Biology; Enzyme; Organic chemistry; Fermentation","score_opus":0.09079325676693505,"score_gpt":0.42080295504922166,"score_spread":0.3300096982822866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052642028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766162,0.00083120575,0.019930588,0.00013696797,0.00005171437,0.000120651435,0.0009301013,0.00019930396,0.0011832746],"genre_scores_gemma":[0.9531403,0.00076683547,0.03494819,0.00011510932,0.000013336096,0.00015025948,0.007931511,0.00020735353,0.002727211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920875,0.00015287256,0.00018189385,0.00014715834,0.00021915637,0.000090139],"domain_scores_gemma":[0.99952674,0.00013796057,0.00012199222,0.00006578715,0.000077574936,0.00006997638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048044603,0.0006933041,0.0006030978,0.00038074306,0.00014326042,0.0006169045,0.00039097134,0.00045035165,0.00069777673],"category_scores_gemma":[0.0005334312,0.0003179777,0.0006773782,0.00037947338,0.0002424126,0.00026399837,0.000318241,0.00068236404,0.0004957119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011773783,0.000044066168,0.00026528706,0.000039875747,0.000013345293,0.000023932624,0.000014373172,0.000066562934,0.99780935,0.00007012662,0.000022979655,0.0015124702],"study_design_scores_gemma":[0.000011868974,0.00023008486,0.0020851966,0.0000057702664,0.000035361834,0.00017309644,0.000017419992,0.00054532057,0.995665,0.0000122375395,0.0012120506,0.0000065278145],"about_ca_topic_score_codex":0.00081592595,"about_ca_topic_score_gemma":0.00081355375,"teacher_disagreement_score":0.00081592595,"about_ca_system_score_codex":0.0005266369,"about_ca_system_score_gemma":0.00023110308,"threshold_uncertainty_score":0.0038210154},"labels":[],"label_agreement":null},{"id":"W2053450751","doi":"10.1067/mjd.2002.126823","title":"Drug interactions: Proteins, pumps, and P-450s","year":2002,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Computational biology; Drug; Pharmacology; Biology","score_opus":0.1446874382603087,"score_gpt":0.4860916144772223,"score_spread":0.34140417621691366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053450751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019167282,0.99796826,0.00027814604,0.00030358226,0.00026107978,0.000006273051,0.000015956697,0.00001658142,0.00095841393],"genre_scores_gemma":[0.0010918602,0.99605066,0.0003577077,0.00030976158,0.0005265816,0.00000731566,0.000029802595,0.0000016141273,0.0016247437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997086,0.00005050183,0.000033516295,0.000050419105,0.00013658426,0.000020367743],"domain_scores_gemma":[0.9995933,0.0001766669,0.00008826369,0.000010537472,0.00009948086,0.000031721334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004613463,0.0014405224,0.0023731207,0.0022686978,0.00033844827,0.0009668501,0.0009944253,0.001362197,0.0041887746],"category_scores_gemma":[0.00059611624,0.00032142736,0.0005714853,0.0027369498,0.0004985385,0.0012179851,0.00045911002,0.0015170107,0.003144689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010401993,0.00013336186,0.00040442622,0.0077339513,0.00013054516,0.00055974163,0.000029249733,0.0003641864,0.002273926,0.0011764513,0.040523198,0.94656706],"study_design_scores_gemma":[0.000055794044,0.0002306291,0.0026775436,0.0017726383,0.00025278758,0.0069737304,0.00006567835,0.00033977945,0.0012695341,0.0021735416,0.98415655,0.00003190058],"about_ca_topic_score_codex":0.0013002172,"about_ca_topic_score_gemma":0.0036123765,"teacher_disagreement_score":0.0041887746,"about_ca_system_score_codex":0.0005357075,"about_ca_system_score_gemma":0.00072191696,"threshold_uncertainty_score":0.014012873},"labels":[],"label_agreement":null},{"id":"W2053667925","doi":"10.1016/j.taap.2005.12.001","title":"Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene","year":2006,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; CYP2E1; Toluene; Chemistry; Physiology; Internal medicine; Metabolism; Biochemistry; Medicine; Cytochrome P450; Organic chemistry","score_opus":0.16526360397405881,"score_gpt":0.3903623144458353,"score_spread":0.2250987104717765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053667925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96641713,0.000084592284,0.032393906,0.00018993625,0.000006892171,0.0000449972,0.00024470635,0.00008270366,0.000535164],"genre_scores_gemma":[0.9857756,0.000053062173,0.0130614955,0.000026079426,0.000004343397,0.000036753936,0.00022533763,0.000034869023,0.0007824806],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998665,0.00094727543,0.000035821708,0.00020015311,0.00007548971,0.00007627336],"domain_scores_gemma":[0.9758601,0.022405732,0.0004945528,0.0005860953,0.0004811911,0.00017239487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045338175,0.00062356447,0.0008382589,0.00031948186,0.0004019511,0.00079762365,0.001090792,0.0012542964,0.0011343873],"category_scores_gemma":[0.014847326,0.00043763762,0.0010006354,0.000537654,0.00042004592,0.000712355,0.00064407923,0.0012310816,0.00013371218],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761056,0.0005269565,0.09707137,0.000046345824,0.0005071562,0.0014750523,0.0005800097,0.8704782,0.0015323979,0.0035886408,0.0005191112,0.022598594],"study_design_scores_gemma":[0.00004600647,0.0002492595,0.013548632,0.000003572613,0.0001068189,0.00019377704,0.00014293731,0.98302275,0.000687168,0.0017252509,0.0002513767,0.000022499107],"about_ca_topic_score_codex":0.030667333,"about_ca_topic_score_gemma":0.02255961,"teacher_disagreement_score":0.030667333,"about_ca_system_score_codex":0.0009954874,"about_ca_system_score_gemma":0.00097099453,"threshold_uncertainty_score":0.060977638},"labels":[],"label_agreement":null},{"id":"W2053768822","doi":"10.1080/03602530600569828","title":"Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)","year":2006,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Pregnane X receptor; Constitutive androstane receptor; Pregnane; Nuclear receptor; Pharmacology; Receptor; Chemistry; Biology; Transcription factor; Biochemistry; Gene; Stereochemistry","score_opus":0.07311730853590803,"score_gpt":0.4081307594694231,"score_spread":0.3350134509335151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053768822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078359945,0.99194616,0.0006161556,0.00015689543,0.00012708665,0.000012537189,0.00003621123,0.000021170119,0.0063001164],"genre_scores_gemma":[0.0025607971,0.99181753,0.00079541386,0.00015666998,0.000106715204,0.000017695522,0.00006640375,0.0000032865203,0.0044754157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987555,0.0000252995,0.000013591749,0.00002202316,0.0000544817,0.000009045323],"domain_scores_gemma":[0.9999306,0.000024122672,0.000013975985,0.0000037353748,0.00001954121,0.000007964703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002197599,0.0006845154,0.00096854934,0.0014899487,0.0002022077,0.0005978713,0.00049371365,0.0006282317,0.0041917632],"category_scores_gemma":[0.000187563,0.00020008403,0.00027803998,0.0015364235,0.00026795425,0.0007623044,0.0004048912,0.0006547734,0.004227904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075928496,0.00011179268,0.00022248729,0.006946505,0.000052217893,0.00047722214,0.00006453328,0.0003909148,0.015418597,0.005052664,0.013102164,0.958085],"study_design_scores_gemma":[0.000017356275,0.00013559448,0.0009777376,0.00071969745,0.000049303108,0.0027470207,0.000044529286,0.000091628106,0.003949159,0.0014167901,0.9898372,0.000013992613],"about_ca_topic_score_codex":0.0005071773,"about_ca_topic_score_gemma":0.0011733634,"teacher_disagreement_score":0.0041917632,"about_ca_system_score_codex":0.00030988405,"about_ca_system_score_gemma":0.0004550237,"threshold_uncertainty_score":0.014022827},"labels":[],"label_agreement":null},{"id":"W2054186041","doi":"10.1002/jps.22554","title":"PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Predictability; Computer science; Predictive modelling; Data mining; Medicine; Medical physics; Pharmacology; Statistics; Machine learning; Mathematics","score_opus":0.33954721024789325,"score_gpt":0.45141002523332635,"score_spread":0.1118628149854331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054186041","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06922665,0.0036468767,0.10864071,0.0039753215,0.0006894959,0.0014697319,0.7787175,0.025339976,0.0082938],"genre_scores_gemma":[0.09178638,0.00090616563,0.10077375,0.0011038663,0.00019976163,0.0013340813,0.8008811,0.0008467076,0.0021681099],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99581367,0.0017125334,0.0003540145,0.00089531124,0.00106705,0.00015742081],"domain_scores_gemma":[0.9809622,0.010524096,0.00071253954,0.0053404677,0.001953366,0.0005074145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009890856,0.0020077492,0.0017652637,0.0024411713,0.0008806444,0.0021831268,0.006144667,0.002698847,0.006589207],"category_scores_gemma":[0.039047312,0.0007874041,0.0032255289,0.0026273408,0.0006465443,0.00211422,0.0025261142,0.0033778322,0.0036983956],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028610164,0.0020502878,0.021602463,0.0034758335,0.0023828275,0.00047326018,0.00015936114,0.1397219,0.0038710877,0.010937181,0.5732403,0.23922446],"study_design_scores_gemma":[0.0025035895,0.0012800542,0.028510153,0.0007548582,0.0012318416,0.0015841259,0.00020180998,0.62561667,0.016019462,0.02786279,0.29412088,0.0003138227],"about_ca_topic_score_codex":0.012415258,"about_ca_topic_score_gemma":0.014579928,"teacher_disagreement_score":0.012415258,"about_ca_system_score_codex":0.0014784808,"about_ca_system_score_gemma":0.0031539176,"threshold_uncertainty_score":0.05230844},"labels":[],"label_agreement":null},{"id":"W2055248098","doi":"10.1038/jhh.2011.111","title":"Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers","year":2012,"lang":"en","type":"article","venue":"Journal of Human Hypertension","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service; National Institutes of Health","keywords":"CYP2A6; Medicine; Odds ratio; Confounding; Confidence interval; Internal medicine; Genotype; Genotyping; Logistic regression; Demography; Genetics; Biology; CYP1A2","score_opus":0.12018983475754252,"score_gpt":0.40614691093053135,"score_spread":0.2859570761729888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055248098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920756,0.00024547856,0.000061021277,0.00005351759,0.000012704732,0.0000039263696,0.00011460055,0.0000044348626,0.000296813],"genre_scores_gemma":[0.99936455,0.000103239814,0.000049239225,0.00002489005,0.00002404924,0.0000036862,0.00009709496,0.0000026174043,0.00033071387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996362,0.00008779439,0.00005880077,0.00009108162,0.00006533391,0.00006087897],"domain_scores_gemma":[0.9988433,0.00031148916,0.0003486039,0.00010664426,0.00010955132,0.00028033133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044165525,0.0004573887,0.00059572293,0.0011744071,0.0006430185,0.00052192376,0.00044207115,0.0006251262,0.0029517019],"category_scores_gemma":[0.0009265486,0.0005514756,0.0011947738,0.0015051679,0.00038311095,0.00034434462,0.00025888166,0.0008124765,0.00029996017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004244282,0.00009715642,0.9963569,0.000017084207,0.00028159455,0.0002893576,0.00013149813,0.00002189868,0.0013088353,0.000024533943,0.00005651551,0.0009901032],"study_design_scores_gemma":[0.000010349442,0.000069702044,0.9992009,0.0000018140802,0.00014023154,0.00019041974,0.00008857807,0.00016269255,0.00006878988,0.000013861662,0.000048149002,0.000004493031],"about_ca_topic_score_codex":0.012651773,"about_ca_topic_score_gemma":0.013516862,"teacher_disagreement_score":0.012651773,"about_ca_system_score_codex":0.00030309762,"about_ca_system_score_gemma":0.0003870728,"threshold_uncertainty_score":0.02515626},"labels":[],"label_agreement":null},{"id":"W2055589832","doi":"10.1097/01.fpc.0000114754.08559.27","title":"Identification of common polymorphisms in the promoter of the UGT1A9 gene","year":2004,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; National Institute on Drug Abuse; National Institute of Mental Health; National Institute on Aging","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Haplotype; Gene; Genetic variation; Phenotype; Glucuronidation; Allele; Molecular biology; Genotype; Microsome","score_opus":0.08665500048623402,"score_gpt":0.41731882350763433,"score_spread":0.3306638230214003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055589832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973067,0.0003224445,0.0015938722,0.00004568258,0.000008910929,0.00001706952,0.00041551626,0.000018362342,0.0002715224],"genre_scores_gemma":[0.99815804,0.000103654595,0.0009752504,0.000017411909,0.000012527687,0.000012830657,0.00042725727,0.000006554034,0.00028656248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996886,0.00005529746,0.000034567154,0.00013674132,0.00005399986,0.000030856347],"domain_scores_gemma":[0.999419,0.00017811776,0.00025090258,0.000040513438,0.00004276563,0.00006869055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025024568,0.00043229776,0.00026558732,0.00044761892,0.00015013575,0.00019355855,0.00017383181,0.00027693174,0.0026093295],"category_scores_gemma":[0.00064139656,0.00016308857,0.00036949434,0.00044168512,0.00019962803,0.00007615111,0.00015602208,0.00033285678,0.00043156033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029024112,0.0003068934,0.70127225,0.00017390966,0.0005385618,0.0034201518,0.00036911754,0.00058655563,0.269269,0.0003394847,0.0003228788,0.020498851],"study_design_scores_gemma":[0.00017270523,0.0012992793,0.9407139,0.00006286016,0.00060464174,0.012001777,0.00013690593,0.0022216802,0.039683264,0.00030456285,0.0027721443,0.000026269421],"about_ca_topic_score_codex":0.00076501846,"about_ca_topic_score_gemma":0.00072740513,"teacher_disagreement_score":0.0026093295,"about_ca_system_score_codex":0.00011955114,"about_ca_system_score_gemma":0.00015996347,"threshold_uncertainty_score":0.0087291},"labels":[],"label_agreement":null},{"id":"W2055769396","doi":"10.1007/s10552-013-0185-1","title":"Risk of prostate cancer death in long-term users of warfarin: a population-based case–control study","year":2013,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; Saskatchewan Cancer Agency; Health Research Board","keywords":"Medicine; Prostate cancer; Warfarin; Cancer; Internal medicine; Population; Rate ratio; Cancer registry; Prostate; Confidence interval; Gynecology; Atrial fibrillation","score_opus":0.05894535400512411,"score_gpt":0.4138610440469393,"score_spread":0.35491569004181517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055769396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889,0.00037443708,0.00014358493,0.000027754413,0.000010594879,0.000009835361,0.00024214239,0.0000073808033,0.00029439694],"genre_scores_gemma":[0.99921834,0.00013645714,0.000091172675,0.000025475747,0.000021011652,0.000009477768,0.00025619363,0.0000035750115,0.00023838323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883634,0.00036459818,0.00012026957,0.00036400722,0.0001642201,0.00015060788],"domain_scores_gemma":[0.9980896,0.00044251804,0.00055510184,0.00035007895,0.00021687945,0.00034578962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010933809,0.00056014425,0.00089048425,0.0012493655,0.0009639128,0.0013015232,0.0009326245,0.0012910019,0.0020538394],"category_scores_gemma":[0.0023670844,0.0011454206,0.0015456532,0.0017508427,0.00069276715,0.00084574457,0.000506465,0.0013420008,0.00035300254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019583192,0.00033525136,0.9948644,0.000017797664,0.00072103605,0.00025084932,0.000111663845,0.000060135953,0.0007597393,0.000035366367,0.000095822346,0.00078958436],"study_design_scores_gemma":[0.0000988676,0.00041206955,0.9981976,0.0000035205474,0.0003033976,0.000409726,0.00012254524,0.00025682113,0.00006045632,0.000024439447,0.00009952384,0.00001099987],"about_ca_topic_score_codex":0.01206671,"about_ca_topic_score_gemma":0.0091913575,"teacher_disagreement_score":0.01206671,"about_ca_system_score_codex":0.0005896737,"about_ca_system_score_gemma":0.00038703182,"threshold_uncertainty_score":0.023992956},"labels":[],"label_agreement":null},{"id":"W2055924792","doi":"10.1371/journal.pone.0112640","title":"Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Financiadora de Estudos e Projetos; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Instituto Nacional de Medicina Genómica; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Governo Brasil","keywords":"Pharmacogenomics; Ancestry-informative marker; Biology; Genetic variation; Genetics; Population; Pharmacogenetics; Population genetics; Genetic marker; Evolutionary biology; Allele frequency; Genotype; Gene; Medicine; Environmental health","score_opus":0.2503122258489838,"score_gpt":0.37414523644722825,"score_spread":0.12383301059824442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055924792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886656,0.00013720039,0.00034461726,0.000031160325,0.0000011642712,0.000009454754,0.0001352112,0.0000024860133,0.00047217723],"genre_scores_gemma":[0.9987942,0.00021050328,0.00058184704,0.000018120929,0.0000028485028,0.000015811462,0.00022763413,0.0000025596644,0.00014650355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995278,0.00014769284,0.000029900246,0.00015912531,0.0000699854,0.000065593886],"domain_scores_gemma":[0.9994417,0.00012130945,0.00023917097,0.0000788454,0.00008410749,0.000034872675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008743819,0.0002306439,0.0003065586,0.00096688274,0.00041426223,0.00047649565,0.00020247781,0.0002051479,0.0009835421],"category_scores_gemma":[0.0025076007,0.00018998786,0.00028209484,0.00090863643,0.0003864038,0.00011004538,0.00045961488,0.00024219796,0.00007584275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003533204,0.00005864603,0.96538025,0.00003560907,0.00019265269,0.00021259366,0.002602551,0.00017207956,0.01307358,0.00056795194,0.000087692875,0.01726302],"study_design_scores_gemma":[0.00001164165,0.00007066189,0.99747473,0.0000142434765,0.00006579488,0.00024588013,0.0005721981,0.00023653166,0.00040220981,0.00010097696,0.00079916004,0.000005860258],"about_ca_topic_score_codex":0.019934768,"about_ca_topic_score_gemma":0.020817744,"teacher_disagreement_score":0.019934768,"about_ca_system_score_codex":0.00034680928,"about_ca_system_score_gemma":0.00021252513,"threshold_uncertainty_score":0.039637506},"labels":[],"label_agreement":null},{"id":"W2055932556","doi":"10.1016/j.abb.2014.02.009","title":"Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase","year":2014,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Histidine; Electron transfer; Stereochemistry; Reductase; Hydroquinone; Residue (chemistry); Hydride; Cofactor; Proton-coupled electron transfer; Cytochrome P450 reductase; Enzyme; Biochemistry; Photochemistry; Coenzyme Q – cytochrome c reductase; Cytochrome c; Organic chemistry; Hydrogen; Mitochondrion","score_opus":0.028644775766320622,"score_gpt":0.3573881565029165,"score_spread":0.32874338073659587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055932556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987723,0.00013291529,0.00070471613,0.000037070455,0.00000876851,0.0000034827838,0.00003533882,0.0000138025025,0.00029146994],"genre_scores_gemma":[0.9992385,0.000030843275,0.00017151462,0.000008349358,0.0000016097239,9.609205e-7,0.000036068657,0.0000054071597,0.0005066835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998667,0.000042256663,0.000010734907,0.000029192388,0.000017799654,0.00003334187],"domain_scores_gemma":[0.99978167,0.00007571668,0.000028400851,0.00002114918,0.00003077311,0.00006238943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019702865,0.0001551113,0.0001895621,0.00012807595,0.00025204202,0.00026064826,0.00029180123,0.0003302519,0.0024642327],"category_scores_gemma":[0.00042234015,0.00013851469,0.00015833232,0.00009294674,0.0002627812,0.00029620042,0.00017561775,0.0003435036,0.0004085832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001425927,0.000036503083,0.00082832854,0.000019656194,0.000011859567,0.00014199832,0.000042404812,0.000096811076,0.9955545,0.00033986932,0.000036098423,0.0014660107],"study_design_scores_gemma":[0.00005608145,0.00026986573,0.016614217,0.0000044938406,0.000034658602,0.00037226322,0.00009436209,0.0018249966,0.979838,0.00022531659,0.00065334013,0.000012381415],"about_ca_topic_score_codex":0.0018482455,"about_ca_topic_score_gemma":0.0014172993,"teacher_disagreement_score":0.0024642327,"about_ca_system_score_codex":0.0004088998,"about_ca_system_score_gemma":0.00018777324,"threshold_uncertainty_score":0.00824368},"labels":[],"label_agreement":null},{"id":"W2056001419","doi":"10.1038/sj.bjp.0705146","title":"Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics","year":2003,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; Karolinska Institutet; Centre for Addiction and Mental Health","keywords":"Nicotine; CYP2E1; Endocrinology; Internal medicine; Ethanol; Cerebellum; Hippocampal formation; Dentate gyrus; Immunostaining; Chemistry; Pharmacology; Medicine; Anesthesia; Biochemistry; Immunohistochemistry; Cytochrome P450","score_opus":0.06577666156730935,"score_gpt":0.40384728455645724,"score_spread":0.3380706229891479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056001419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081296,0.0046450202,0.001259664,0.00022975258,0.00006191738,0.000025241652,0.0011170077,0.00014481983,0.001703503],"genre_scores_gemma":[0.9811078,0.004973704,0.0016448074,0.00014731176,0.00004664594,0.000083991195,0.0027397932,0.000043591222,0.00921233],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985933,0.000013295814,0.000006904089,0.000039154784,0.000054326567,0.00002696852],"domain_scores_gemma":[0.9997464,0.000011495288,0.000094375995,0.000024783667,0.000049094222,0.00007382106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009201538,0.00037173307,0.00038612416,0.0009395284,0.00028099562,0.00025668906,0.00011805646,0.00027242512,0.002315527],"category_scores_gemma":[0.00014754906,0.00026159355,0.00034407046,0.00046047373,0.00028221158,0.00018224685,0.00026160278,0.00053922593,0.00054885185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015145649,0.00017538422,0.027433133,0.00010135467,0.00014396613,0.00037884887,0.00010743704,0.000028496584,0.95611924,0.000109800174,0.00041206472,0.013475753],"study_design_scores_gemma":[0.00003548147,0.00090579933,0.7704826,0.000017665245,0.000169349,0.0019209094,0.00021138851,0.00022685078,0.22122872,0.00019925094,0.004582833,0.000019310342],"about_ca_topic_score_codex":0.0024647391,"about_ca_topic_score_gemma":0.004027471,"teacher_disagreement_score":0.0024647391,"about_ca_system_score_codex":0.00029312793,"about_ca_system_score_gemma":0.00024900498,"threshold_uncertainty_score":0.0077462196},"labels":[],"label_agreement":null},{"id":"W2056290988","doi":"10.1016/j.jep.2010.01.039","title":"In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily","year":2010,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa","funders":"","keywords":"Medicinal plants; Biology; CYP3A4; CYP3A; Traditional medicine; Zingiberaceae; Subfamily; Cytochrome P450; Botany; Enzyme; Biochemistry; Medicine; Rhizome; Gene","score_opus":0.06937977054827237,"score_gpt":0.44300267839867324,"score_spread":0.37362290785040086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056290988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359787,0.003979864,0.0002823745,0.00011856057,0.00004953344,0.000016277154,0.0003255055,0.000010943556,0.0016191361],"genre_scores_gemma":[0.99396,0.0027697145,0.00035250548,0.00004981042,0.000034551238,0.000011575931,0.00047888944,0.0000039359024,0.0023388062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999212,0.000029222,0.0000055727564,0.000009788611,0.000009783021,0.000024437746],"domain_scores_gemma":[0.9998623,0.00007499048,0.000015921327,0.00001038845,0.000014601162,0.00002165829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001384723,0.00035783983,0.00019942352,0.00017136097,0.00026122294,0.00013209159,0.00013522609,0.00016672573,0.0046235872],"category_scores_gemma":[0.00027070593,0.00012682794,0.00021819462,0.00025445584,0.00020643251,0.00011525956,0.00015310972,0.00036646498,0.00034098074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006857319,0.0006510893,0.002105868,0.000451541,0.00007874264,0.00037453437,0.00029895647,0.000409468,0.973942,0.0002522837,0.00050980534,0.01406844],"study_design_scores_gemma":[0.00032661497,0.008953736,0.025712295,0.000052768108,0.00022286295,0.00068685383,0.00026258596,0.0007598162,0.9588427,0.00011690114,0.004049616,0.000013241702],"about_ca_topic_score_codex":0.0018928852,"about_ca_topic_score_gemma":0.002939637,"teacher_disagreement_score":0.0046235872,"about_ca_system_score_codex":0.000113327704,"about_ca_system_score_gemma":0.00019611756,"threshold_uncertainty_score":0.015467465},"labels":[],"label_agreement":null},{"id":"W2056297313","doi":"10.1586/erp.12.15","title":"Personalized medicine policy challenges: measuring clinical utility at point of care","year":2012,"lang":"en","type":"review","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Personalized medicine; Pharmacogenomics; Precision medicine; Relevance (law); Point of care; Tipping point (physics); Medicine; Scale (ratio); MEDLINE; Data science; Computer science; Bioinformatics; Nursing; Pharmacology","score_opus":0.5349782942177395,"score_gpt":0.68611998141965,"score_spread":0.15114168720191057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056297313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006056227,0.66903335,0.06581813,0.22395937,0.0027958907,0.0008088747,0.0017088436,0.00015703333,0.029662272],"genre_scores_gemma":[0.25804323,0.56033754,0.11665755,0.050064553,0.0077240556,0.0032600267,0.0015248919,0.00013394895,0.002254232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.83229715,0.13540553,0.007958757,0.005151081,0.018296968,0.0008905164],"domain_scores_gemma":[0.6181079,0.33514974,0.015812078,0.008900858,0.020554913,0.0014744363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1239487,0.0017702121,0.006026623,0.005748603,0.0009721942,0.009833751,0.005999408,0.0070537026,0.0057890415],"category_scores_gemma":[0.25009245,0.00092939386,0.0021515777,0.008435765,0.006551032,0.011786104,0.0038673237,0.0072611994,0.0015661408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022659049,0.00021068714,0.008446432,0.013707995,0.0019129489,0.00015096008,0.0007964485,0.006068753,0.00019058792,0.12014775,0.036304675,0.81183624],"study_design_scores_gemma":[0.00031069532,0.00051943277,0.019336917,0.044645958,0.0022391195,0.0010427993,0.002975795,0.01135523,0.0011883972,0.66288286,0.25316733,0.00033546568],"about_ca_topic_score_codex":0.0050466857,"about_ca_topic_score_gemma":0.0033878009,"teacher_disagreement_score":0.1239487,"about_ca_system_score_codex":0.007821523,"about_ca_system_score_gemma":0.014191826,"threshold_uncertainty_score":0.65551126},"labels":[],"label_agreement":null},{"id":"W2056362627","doi":"10.1097/00008571-200206000-00009","title":"Novel detection assay by PCR???RFLP and frequency of the CYP3A5 SNPs, CYP3A5 *3 and *6, in a Japanese population","year":2002,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP3A5; Single-nucleotide polymorphism; Biology; Restriction fragment length polymorphism; Allele frequency; Genetics; Pharmacogenetics; Polymerase chain reaction; Allele; Molecular biology; Polymorphism (computer science); Gene; Genotype","score_opus":0.07970406418178103,"score_gpt":0.36744934008213714,"score_spread":0.28774527590035615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056362627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97875494,0.0012687142,0.018971123,0.000084256695,0.000025706326,0.00004294252,0.00020201261,0.00006611933,0.00058419426],"genre_scores_gemma":[0.97492313,0.00041101608,0.023473348,0.000070538204,0.000033177486,0.000049756498,0.00039302476,0.000011313074,0.0006347518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909985,0.00018979008,0.00006920258,0.00036755542,0.00022026263,0.000053425854],"domain_scores_gemma":[0.99927205,0.00023670465,0.00017596,0.00007729171,0.0001700795,0.000067865156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096252566,0.00040451254,0.00031213308,0.00084293704,0.00022598683,0.00032833315,0.00030304998,0.0005065589,0.00061303994],"category_scores_gemma":[0.0012619675,0.00028751613,0.0002533377,0.00033003566,0.0003737046,0.00016484021,0.00016969594,0.00044573756,0.0002636075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005276674,0.0002499941,0.2908702,0.0001832952,0.00013305283,0.00053756003,0.00085099094,0.00024727808,0.65208125,0.00027089697,0.00023339955,0.05381448],"study_design_scores_gemma":[0.00012537514,0.0022253091,0.83544385,0.000046192792,0.0007682333,0.01106246,0.0005743944,0.005280129,0.1385447,0.00045753134,0.0054000625,0.00007186263],"about_ca_topic_score_codex":0.0015159501,"about_ca_topic_score_gemma":0.0019499116,"teacher_disagreement_score":0.0015159501,"about_ca_system_score_codex":0.00017263804,"about_ca_system_score_gemma":0.00013509218,"threshold_uncertainty_score":0.005090356},"labels":[],"label_agreement":null},{"id":"W2056370575","doi":"10.1271/bbb.70.307","title":"Hydroxylation of Testosterone by Bacterial Cytochromes P450 Using the<i>Escherichia coli</i>Expression System","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Hydroxylation; Escherichia coli; Cytochrome P450; Testosterone (patch); Bacteria; Cytochrome; Chemistry; Biochemistry; Biology; Enzyme; Gene; Endocrinology; Genetics","score_opus":0.030320790401659102,"score_gpt":0.3293990592002817,"score_spread":0.2990782687986226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056370575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741314,0.0014666766,0.020145781,0.0002576283,0.000046415815,0.00008220401,0.001140499,0.0002101875,0.0025190879],"genre_scores_gemma":[0.96396595,0.0017665847,0.024278142,0.000084271895,0.000020267964,0.00003959912,0.0045726234,0.000066998655,0.005205542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965584,0.00008700412,0.000028779265,0.00004511081,0.00012112826,0.00006218462],"domain_scores_gemma":[0.99989426,0.00002376683,0.000026487985,0.000013897632,0.000024591527,0.000017014181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026196468,0.00033516058,0.00022820185,0.00017773244,0.00019409986,0.0003715129,0.00016959889,0.00015863925,0.0007402132],"category_scores_gemma":[0.00024973706,0.00014676426,0.00020513868,0.00034656716,0.00016182702,0.000116280695,0.0001548707,0.00046189173,0.0006406011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001028776,0.000038215632,0.00059122534,0.000035655754,0.0000063458015,0.000030196963,0.000015516029,0.00016676149,0.99604636,0.00011084085,0.00009306847,0.0027629281],"study_design_scores_gemma":[0.000012233971,0.00015708887,0.0019497806,0.000005431443,0.000014723584,0.000121906975,0.00001671194,0.0008624642,0.99356127,0.000024549878,0.0032697574,0.0000041468356],"about_ca_topic_score_codex":0.0019192612,"about_ca_topic_score_gemma":0.0019961835,"teacher_disagreement_score":0.0019192612,"about_ca_system_score_codex":0.0004051379,"about_ca_system_score_gemma":0.00028556449,"threshold_uncertainty_score":0.0038161874},"labels":[],"label_agreement":null},{"id":"W2056697662","doi":"10.1016/j.vascn.2007.06.001","title":"H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"In vitro; Cell culture; Heart cells; Cytochrome P450; Messenger RNA; Gene expression; CYP1B1; Biology; Cell; Enzyme; Cell biology; Molecular biology; Gene; Biochemistry; Myocyte; Genetics","score_opus":0.28450714162708074,"score_gpt":0.5519377379896758,"score_spread":0.2674305963625951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056697662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8228008,0.02531323,0.09307034,0.0025097807,0.002321387,0.00035635036,0.03006128,0.001251189,0.022315595],"genre_scores_gemma":[0.8692584,0.016937412,0.05786113,0.0007345731,0.0008301231,0.00041384457,0.028158378,0.0005405783,0.02526561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996245,0.000059191563,0.000045887107,0.00008971485,0.00011324527,0.00006750199],"domain_scores_gemma":[0.99961436,0.00012493855,0.000045884975,0.00008022157,0.0000560498,0.00007859167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048340834,0.00095757894,0.0010547021,0.0011114278,0.0008093787,0.0007465763,0.00085254916,0.0007443229,0.0033445517],"category_scores_gemma":[0.00026486715,0.0003599222,0.0006979027,0.00057501224,0.00032828056,0.0006309734,0.00037608427,0.0017755649,0.0019228497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038323118,0.00028368845,0.0013553685,0.00013365716,0.000038621918,0.0005966474,0.000036938585,0.00026782887,0.99148226,0.0006827044,0.0013399761,0.0033991004],"study_design_scores_gemma":[0.00009269971,0.001070921,0.011801164,0.000027937616,0.00017865133,0.0020031228,0.00012216388,0.003185801,0.9536045,0.00052469654,0.027340077,0.000048300695],"about_ca_topic_score_codex":0.0037085493,"about_ca_topic_score_gemma":0.006641437,"teacher_disagreement_score":0.0037085493,"about_ca_system_score_codex":0.00038714142,"about_ca_system_score_gemma":0.00037797267,"threshold_uncertainty_score":0.011188686},"labels":[],"label_agreement":null},{"id":"W2056759774","doi":"10.1023/b:agen.0000011799.47529.fd","title":"Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker","year":2003,"lang":"en","type":"article","venue":"Angiogenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; University of Toronto; Hospital for Sick Children","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Angiogenesis; In vivo; Cancer research; Pathology; Cell culture; Matrigel; Endothelial stem cell; Carcinoma; Biology; In vitro; Medicine","score_opus":0.03898224097341798,"score_gpt":0.3417008093245264,"score_spread":0.30271856835110844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056759774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926131,0.0019415977,0.0028007813,0.00014721877,0.0000579942,0.000027018721,0.00050400966,0.000057345227,0.001850861],"genre_scores_gemma":[0.9947594,0.0006060257,0.001053904,0.000029986617,0.000013316344,0.0000259257,0.0006957166,0.000022426982,0.00279342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952495,0.00013080906,0.000047612564,0.00005856155,0.00011413483,0.00012391026],"domain_scores_gemma":[0.99950016,0.00025195215,0.00006473333,0.00008151957,0.00004372993,0.000057877518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003410137,0.00026939926,0.00045937116,0.00036474236,0.00023835347,0.0003362364,0.00023118837,0.0005174882,0.0014328709],"category_scores_gemma":[0.00043418532,0.00024566232,0.0002906775,0.0003054686,0.00023896489,0.00040476653,0.00016564708,0.0007818498,0.00036750248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001326658,0.00004309583,0.00012389668,0.000016632712,0.0000040323084,0.00003920479,0.000021409252,0.00011323237,0.99900657,0.00009375207,0.00002965237,0.00037588552],"study_design_scores_gemma":[0.000008955194,0.00048785924,0.0040536453,0.000002654925,0.000010490092,0.00019915402,0.000025513946,0.0012223328,0.99337876,0.000051061743,0.00055508676,0.000004353713],"about_ca_topic_score_codex":0.0031210452,"about_ca_topic_score_gemma":0.002496146,"teacher_disagreement_score":0.0031210452,"about_ca_system_score_codex":0.00043705502,"about_ca_system_score_gemma":0.00020726479,"threshold_uncertainty_score":0.0062057376},"labels":[],"label_agreement":null},{"id":"W2056894910","doi":"10.1016/s0944-7113(00)80044-6","title":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures","year":2000,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":350,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Matricaria chamomilla; Hypericum perforatum; Hypericin; Traditional medicine; IC50; Chemistry; Glycyrrhiza; CYP3A4; Pharmacology; Metabolite; Cytochrome P450; In vitro; Biology; Biochemistry; Medicine; Enzyme","score_opus":0.08005555040464424,"score_gpt":0.4554864010696971,"score_spread":0.3754308506650529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056894910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888986,0.0056632604,0.0023303851,0.00012090679,0.00012632147,0.00012427398,0.0006258903,0.000064349275,0.0020460663],"genre_scores_gemma":[0.9868195,0.004117019,0.002726826,0.000082777,0.00007423734,0.0000898391,0.00140717,0.000016960303,0.00466559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997509,0.00009534767,0.000025498417,0.00004058564,0.00005339738,0.000034230525],"domain_scores_gemma":[0.99974805,0.00011464592,0.00003758792,0.000028075236,0.000047021615,0.00002460027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003831672,0.00067993527,0.00046454323,0.00030590428,0.00037032535,0.00018442162,0.00036575837,0.00030360694,0.0028981888],"category_scores_gemma":[0.0003553617,0.00026140307,0.000614159,0.00044285803,0.00021933495,0.00018602044,0.00017236944,0.00048201092,0.00033736505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003610287,0.0010096204,0.00082332117,0.00027534354,0.00010694127,0.00018096535,0.00007860825,0.00044726327,0.9849488,0.00008034356,0.00022457693,0.008213889],"study_design_scores_gemma":[0.00016494167,0.008663414,0.0040831477,0.000011229623,0.00017049277,0.00018277549,0.000038166287,0.00057209295,0.98481226,0.000020514784,0.0012727545,0.000008151895],"about_ca_topic_score_codex":0.0022293483,"about_ca_topic_score_gemma":0.004655095,"teacher_disagreement_score":0.0028981888,"about_ca_system_score_codex":0.00023855011,"about_ca_system_score_gemma":0.00033868224,"threshold_uncertainty_score":0.009695411},"labels":[],"label_agreement":null},{"id":"W2057186028","doi":"10.1182/blood-2010-05-283861","title":"In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; CYP2C9; Dosing; Vitamin K epoxide reductase; Medicine; Warfarin; Phenprocoumon; Internal medicine; Genotype; Gastroenterology; Biology; Genetics; Cytochrome P450; Atrial fibrillation","score_opus":0.055102093488590756,"score_gpt":0.40129211118856173,"score_spread":0.346190017699971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057186028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699046,0.010717841,0.0026944377,0.0012041375,0.00019683999,0.000042058553,0.0017038046,0.000063142914,0.006387391],"genre_scores_gemma":[0.9932989,0.0029017662,0.0011376106,0.00033215844,0.00014722007,0.000019802794,0.000822363,0.000037254173,0.0013029802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998946,0.00038304864,0.00010793035,0.00021467645,0.0002306703,0.00011768707],"domain_scores_gemma":[0.9961832,0.0016346284,0.001421961,0.0002638959,0.00021077854,0.0002855246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088094024,0.00052672805,0.00096188893,0.00040575824,0.0004361325,0.0008777355,0.00026686178,0.00040645647,0.0091029],"category_scores_gemma":[0.0048932103,0.00023986792,0.0013831734,0.0010813959,0.0003303366,0.0006650168,0.00043801803,0.0011310762,0.00091240765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028764084,0.000047688703,0.98449945,0.00006368467,0.00017461562,0.000385093,0.00009969054,0.0001581125,0.00037371172,0.0001445916,0.00048896467,0.013276825],"study_design_scores_gemma":[0.000015645473,0.00031215308,0.9926191,0.00006949623,0.00026476753,0.002495383,0.00020772609,0.00035022435,0.00023056114,0.0002301308,0.0031927852,0.000012191473],"about_ca_topic_score_codex":0.0029438622,"about_ca_topic_score_gemma":0.002946059,"teacher_disagreement_score":0.0091029,"about_ca_system_score_codex":0.0004069176,"about_ca_system_score_gemma":0.00078643893,"threshold_uncertainty_score":0.030452251},"labels":[],"label_agreement":null},{"id":"W2057828133","doi":"10.1124/dmd.30.10.1070","title":"Quaternary Ammonium-Linked Glucuronidation of 1-Substituted Imidazoles by Liver Microsomes: Interspecies Differences and Structure-Metabolism Relationships","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Microsome; Chemistry; Metabolite; Stereochemistry; Enzyme kinetics; Metabolism; Substrate (aquarium); Enzyme; Chromatography; Biochemistry; Active site; Biology","score_opus":0.06322874557579293,"score_gpt":0.3213998346208855,"score_spread":0.25817108904509256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057828133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231905,0.0013732456,0.0048682997,0.000075960255,0.000024937723,0.00002633451,0.00024323956,0.000053413325,0.001015417],"genre_scores_gemma":[0.9936906,0.0009335334,0.002626503,0.000038621623,0.000017888176,0.000017450082,0.0008586955,0.00003618777,0.0017804101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998074,0.00008838317,0.000013087629,0.000029626939,0.000020229614,0.000041182313],"domain_scores_gemma":[0.9997111,0.00008609979,0.0000779239,0.000036173584,0.000050106795,0.00003857251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050797977,0.00044523814,0.00048293947,0.00033627474,0.0002510975,0.00033738595,0.00022127331,0.00031680247,0.0010123835],"category_scores_gemma":[0.00074008584,0.00023907839,0.00032816976,0.0004278753,0.00024480213,0.00046388945,0.00017457863,0.00040140122,0.00045158862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004463414,0.00011291576,0.003045619,0.000120364304,0.00010121037,0.00018667044,0.00025474076,0.0006711525,0.9763802,0.000727427,0.00015352677,0.013782646],"study_design_scores_gemma":[0.000028222536,0.0008209417,0.011325047,0.000009027504,0.00007403051,0.00031804328,0.00005190741,0.0016804718,0.9848625,0.00010708456,0.0007050069,0.000017624163],"about_ca_topic_score_codex":0.0027872995,"about_ca_topic_score_gemma":0.0040998864,"teacher_disagreement_score":0.0027872995,"about_ca_system_score_codex":0.0005164618,"about_ca_system_score_gemma":0.0006074906,"threshold_uncertainty_score":0.005542159},"labels":[],"label_agreement":null},{"id":"W2058186699","doi":"10.1042/bj20011594","title":"Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones","year":2002,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronosyltransferase; Biology; Glucuronidation; Androsterone; Dihydrotestosterone; Complementary DNA; Androgen; Molecular biology; Biochemistry; Enzyme; Gene; Microsome; Hormone; Steroid","score_opus":0.056607082899957605,"score_gpt":0.31737335058461297,"score_spread":0.2607662676846554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058186699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773286,0.0035052304,0.013593717,0.00034581198,0.000068755515,0.00012816428,0.0031902615,0.00016947625,0.0016699976],"genre_scores_gemma":[0.9337807,0.003652858,0.027499052,0.0003478362,0.00011669808,0.00017230828,0.027358618,0.00019961137,0.006872389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.0000128484735,0.0000071945806,0.00003575865,0.000029893828,0.000023258925],"domain_scores_gemma":[0.999818,0.000022806345,0.00004034555,0.000022873914,0.000026635542,0.00006928998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012351724,0.00044584763,0.0004140571,0.00038808348,0.00026995645,0.0003273105,0.0001919341,0.0003158618,0.0009810312],"category_scores_gemma":[0.00023859288,0.00018389887,0.0005385569,0.0003327216,0.00020305102,0.0001734161,0.0002347286,0.00040002185,0.0010715903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010786124,0.000018213012,0.0014076636,0.00004108579,0.000012583772,0.00023239266,0.000030017985,0.000059090402,0.9946069,0.00008834538,0.00008561381,0.0033101223],"study_design_scores_gemma":[0.00013193536,0.0012335263,0.120268114,0.00005247651,0.00027128597,0.009135689,0.00022373679,0.006993666,0.7976023,0.0005972349,0.06343461,0.00005543803],"about_ca_topic_score_codex":0.0019160315,"about_ca_topic_score_gemma":0.0017266473,"teacher_disagreement_score":0.0019160315,"about_ca_system_score_codex":0.00031245343,"about_ca_system_score_gemma":0.00037009383,"threshold_uncertainty_score":0.0038098097},"labels":[],"label_agreement":null},{"id":"W2058631507","doi":"10.1016/j.bbrc.2009.05.033","title":"Purification, characterization, and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica","year":2009,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"New Energy and Industrial Technology Development Organization","keywords":"Hydroxylation; Enzyme; Directed evolution; Biochemistry; Biology; Bioconversion; Cytochrome P450; Mutant; Chemistry; Gene","score_opus":0.1358445377548713,"score_gpt":0.4552206927658562,"score_spread":0.31937615501098493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058631507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928324,0.0008189265,0.0045079784,0.00030073174,0.000029659877,0.000037025064,0.00072903064,0.00003897476,0.0007052475],"genre_scores_gemma":[0.9841546,0.0009910384,0.0077517442,0.00010806039,0.000017511107,0.000022660322,0.003875462,0.000054287073,0.0030247278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983203,0.000026560121,0.000020122934,0.000036521495,0.00005621625,0.00002848958],"domain_scores_gemma":[0.9996815,0.00008879368,0.000056237594,0.000050729454,0.00006947305,0.000053294065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025256161,0.0004248617,0.00034781653,0.00027203656,0.00019918845,0.00049258367,0.0003192407,0.00032905827,0.00020666845],"category_scores_gemma":[0.00044746939,0.00018428259,0.00034994096,0.00041863203,0.00023231196,0.00019476372,0.00027665624,0.00069161964,0.0003146485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007876841,0.00004577263,0.00063091645,0.0000305394,0.000009317597,0.0001058976,0.000058563688,0.00018322555,0.99674666,0.00005017159,0.000032794283,0.0020273747],"study_design_scores_gemma":[0.000032161908,0.00020345842,0.013662471,0.000011052768,0.000069401445,0.0008917278,0.00021206951,0.0018710706,0.9785701,0.00011765751,0.0043381043,0.000020727202],"about_ca_topic_score_codex":0.0071693836,"about_ca_topic_score_gemma":0.003151776,"teacher_disagreement_score":0.0071693836,"about_ca_system_score_codex":0.00037699225,"about_ca_system_score_gemma":0.00046133445,"threshold_uncertainty_score":0.014255345},"labels":[],"label_agreement":null},{"id":"W2058632265","doi":"10.2217/pgs.13.130","title":"Sunny Outlook for Personalized Medicine: Tamoxifen and Beyond","year":2013,"lang":"en","type":"editorial","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Tamoxifen; Medicine; MEDLINE; Breast cancer; Oncology; Internal medicine; Family medicine; Pharmacology; Library science; Cancer; Political science; Computer science","score_opus":0.08553001355217504,"score_gpt":0.44312988380152535,"score_spread":0.3575998702493503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058632265","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018963865,0.027141327,0.00014678006,0.07096809,0.9006729,0.000009017758,0.000028375975,0.00004392011,0.00097063323],"genre_scores_gemma":[0.00024193522,0.010237971,0.00011974469,0.046930324,0.9380433,0.000012364816,0.000012901273,0.000019913246,0.004381535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930514,0.0017576328,0.00079164526,0.0007124199,0.003223126,0.00046372466],"domain_scores_gemma":[0.9656546,0.017795581,0.0019010314,0.0008961601,0.009937517,0.0038150344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106199905,0.0035961322,0.0040668184,0.0036297922,0.003291723,0.009292599,0.0042624585,0.024424685,0.014280168],"category_scores_gemma":[0.03156624,0.0011613661,0.0030966778,0.0017164006,0.004218373,0.0078014736,0.002833132,0.027514331,0.007839386],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019271756,0.000008754515,0.000012456411,0.00016709161,0.000016842501,0.00006355154,0.000010328639,0.000015113266,0.000028292226,0.00044932103,0.9941017,0.0051073185],"study_design_scores_gemma":[0.00006751759,0.00002978114,0.00016785036,0.000677711,0.000069386406,0.00030909613,0.00005906369,0.00013116092,0.00005395343,0.0033222488,0.9950783,0.000033872362],"about_ca_topic_score_codex":0.002476114,"about_ca_topic_score_gemma":0.008037365,"teacher_disagreement_score":0.024424685,"about_ca_system_score_codex":0.004296494,"about_ca_system_score_gemma":0.0053466302,"threshold_uncertainty_score":0.056164503},"labels":[],"label_agreement":null},{"id":"W2059006559","doi":"10.1016/s0304-4165(02)00488-9","title":"Molecular dynamics of substrate complexes with hamster cytochrome P450c17 (CYP17): mechanistic approach to understanding substrate binding and activities","year":2003,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - General Subjects","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; University of California, San Francisco; U.S. Public Health Service; National Institutes of Health","keywords":"Substrate (aquarium); Hamster; Chemistry; Stereochemistry; Cytochrome P450; Molecular dynamics; Cytochrome; Hydrogen bond; Heme; CYP17A1; Active site; Pregnenolone; Enzyme; Biochemistry; Computational chemistry; Biology; Steroid; Molecule; Organic chemistry","score_opus":0.08158662111929803,"score_gpt":0.3425933926486129,"score_spread":0.26100677152931484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059006559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850552,0.00045922928,0.0072369277,0.0008920882,0.00004884968,0.00003799732,0.00031082463,0.00010494399,0.0058539035],"genre_scores_gemma":[0.99622357,0.0004006664,0.0014857266,0.000094949035,0.000013960844,0.00004698176,0.00042808172,0.000064827094,0.0012411048],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99982697,0.000025875612,0.000005079626,0.000036486006,0.00004015812,0.00006541609],"domain_scores_gemma":[0.9995952,0.00018431467,0.000058581754,0.00003395574,0.000056268473,0.000071609174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033912895,0.00046374623,0.00061162235,0.00021341616,0.0009596115,0.000778705,0.0011455815,0.0006457514,0.005747595],"category_scores_gemma":[0.0013671389,0.00051842624,0.00044356103,0.00036534944,0.00077248627,0.0014311527,0.00045438542,0.0017702492,0.0004302549],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001957106,0.0011969786,0.027267277,0.0005914955,0.00049464725,0.0017326187,0.0019165953,0.69177777,0.17920513,0.06320914,0.0107912645,0.019859925],"study_design_scores_gemma":[0.00016787626,0.0003500911,0.00862327,0.000025165726,0.00006520332,0.00014477526,0.00044742163,0.955624,0.027456205,0.0045432276,0.0024904225,0.00006234966],"about_ca_topic_score_codex":0.0075708716,"about_ca_topic_score_gemma":0.0054172208,"teacher_disagreement_score":0.0075708716,"about_ca_system_score_codex":0.001984789,"about_ca_system_score_gemma":0.00084209937,"threshold_uncertainty_score":0.019227564},"labels":[],"label_agreement":null},{"id":"W2059096370","doi":"10.1002/jps.23602","title":"Hepatocyte Composition-Based Model as a Mechanistic Tool for Predicting the Cell Suspension: Aqueous Phase Partition Coefficient of Drugs in In Vitro Metabolic Studies","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hepatocyte; Composition (language); Chemistry; Microsome; In vitro; Partition coefficient; Chromatography; Biochemistry","score_opus":0.1445566727357377,"score_gpt":0.4741265744938992,"score_spread":0.32956990175816153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059096370","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33579046,0.0008353149,0.6573032,0.0002497155,0.00006395631,0.00008727422,0.000556857,0.00039441723,0.004718825],"genre_scores_gemma":[0.96809065,0.0007125128,0.028176036,0.00007519821,0.000016595703,0.00010517245,0.00028544647,0.00006157162,0.0024768182],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999213,0.000021403694,0.000005477378,0.00001668157,0.000023890985,0.000011246635],"domain_scores_gemma":[0.9998785,0.000055552555,0.000022266344,0.000010409684,0.000025966734,0.0000072578223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019521681,0.0005435961,0.0004497011,0.00028016127,0.0002445278,0.00047002305,0.0005230533,0.00083450286,0.00075996167],"category_scores_gemma":[0.00048049644,0.00021302197,0.0005945199,0.00023434575,0.00019993415,0.00055681524,0.00034314065,0.0005252854,0.00044859733],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018463547,0.00012629048,0.0031071543,0.00015398856,0.00007965451,0.00027821996,0.000048369326,0.73000497,0.2486937,0.003918641,0.00034455193,0.013059843],"study_design_scores_gemma":[0.0000070087003,0.000039837545,0.00046060586,0.0000028355919,0.000026753441,0.000053146494,0.000008633914,0.97698444,0.021363128,0.00058827637,0.00045779152,0.000007658334],"about_ca_topic_score_codex":0.0050388216,"about_ca_topic_score_gemma":0.0031550094,"teacher_disagreement_score":0.0050388216,"about_ca_system_score_codex":0.00045971634,"about_ca_system_score_gemma":0.0005635185,"threshold_uncertainty_score":0.010019004},"labels":[],"label_agreement":null},{"id":"W2059224128","doi":"10.1073/pnas.1413481111","title":"Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes","year":2014,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Drug metabolism; Drug; Cytochrome P450; Induced pluripotent stem cell; Biology; Human liver; Drug response; Hepatocyte; Drug development; Pharmacology; Computational biology; Metabolism; Gene; Biochemistry; Enzyme; In vitro; Embryonic stem cell","score_opus":0.17007588872682827,"score_gpt":0.39676754904985845,"score_spread":0.22669166032303018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059224128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520465,0.0005480482,0.020372,0.000047001427,0.000024290737,0.0001878598,0.0016777761,0.000118480675,0.0018198831],"genre_scores_gemma":[0.9882692,0.0002850883,0.007968024,0.00010850451,0.000013372981,0.00017276943,0.002459038,0.000039347266,0.00068455527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930227,0.00018298475,0.000089913556,0.00015275688,0.00022850225,0.00004355119],"domain_scores_gemma":[0.9990706,0.00040950303,0.000114214774,0.00021289509,0.00013564325,0.000057193258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012235,0.00028442196,0.0004160794,0.00063166476,0.00014891499,0.00053519354,0.00017698648,0.00033290722,0.0011444908],"category_scores_gemma":[0.0013028453,0.00014560285,0.00034940228,0.00040776705,0.00024363158,0.000158709,0.00030127342,0.00048118667,0.00034376886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011533438,0.00035283485,0.11748432,0.000109040346,0.00030613932,0.00039186285,0.00027564712,0.005219499,0.8328806,0.0003399097,0.00043348776,0.041053325],"study_design_scores_gemma":[0.000047810143,0.0015123138,0.33045852,0.000025480946,0.00046283574,0.001277426,0.00024223421,0.023660328,0.6369919,0.0007545958,0.004503159,0.00006326305],"about_ca_topic_score_codex":0.0005255059,"about_ca_topic_score_gemma":0.0004604316,"teacher_disagreement_score":0.0012235,"about_ca_system_score_codex":0.00013939023,"about_ca_system_score_gemma":0.00012364192,"threshold_uncertainty_score":0.006470561},"labels":[],"label_agreement":null},{"id":"W2059431105","doi":"10.1034/j.1601-183x.2002.103083.x","title":"Werner Kalow, Urs A. Meyer and Rachel F. Tyndale (eds): Pharmacogenomics","year":2002,"lang":"en","type":"article","venue":"Genes Brain & Behavior","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacokinetics; Drug; Pharmacology; Clinical pharmacology; Pharmacodynamics; Medicine; Genetics; Biology; Genotype; Gene","score_opus":0.1360126646776427,"score_gpt":0.41513188181996974,"score_spread":0.279119217142327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059431105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022330132,0.9760498,0.0024011286,0.0055583916,0.0034160444,0.00003081186,0.00024904718,0.00025113532,0.011820274],"genre_scores_gemma":[0.0010616451,0.9514018,0.0041838484,0.0013982957,0.0028280355,0.000050066537,0.00036364055,0.000091824426,0.03862078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899405,0.00017712057,0.00009544855,0.00021224044,0.00045471167,0.0000664806],"domain_scores_gemma":[0.998216,0.0009119911,0.00024755273,0.00008396069,0.00029596666,0.00024464674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021739823,0.0032075255,0.002860556,0.003325989,0.0005867478,0.0040735817,0.0012062439,0.00350607,0.05611944],"category_scores_gemma":[0.0026839506,0.0015080501,0.0009790694,0.0052651437,0.0011925646,0.006106909,0.0012908845,0.005445469,0.058423385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007417637,0.000058364625,0.00030656712,0.0023180903,0.000065742,0.00010372717,0.000129094,0.00047938657,0.0008859991,0.003267113,0.5364367,0.45587504],"study_design_scores_gemma":[0.000020963691,0.0000455204,0.00096172193,0.0016932635,0.0000480349,0.00095301186,0.000099643454,0.0003219946,0.00035916554,0.0064893425,0.9889671,0.000040173607],"about_ca_topic_score_codex":0.0039901193,"about_ca_topic_score_gemma":0.0067837765,"teacher_disagreement_score":0.05611944,"about_ca_system_score_codex":0.0016113879,"about_ca_system_score_gemma":0.0019172343,"threshold_uncertainty_score":0.18773824},"labels":[],"label_agreement":null},{"id":"W2059623829","doi":"10.1007/bf03261913","title":"Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System","year":2012,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Ketoconazole; Medicine; Buprenorphine; Cmax; Pharmacokinetics; Placebo; Crossover study; Pharmacology; Confidence interval; Transdermal; Area under the curve; Anesthesia; Internal medicine; Opioid","score_opus":0.10642077970965888,"score_gpt":0.43825656655936307,"score_spread":0.33183578684970416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059623829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991999,0.00021109649,0.00015192678,0.000044644166,0.000030304618,0.000014317592,0.000055052846,0.000020513815,0.0002722751],"genre_scores_gemma":[0.9993856,0.000086094085,0.00011170682,0.00003030629,0.000016932992,0.0000039757633,0.000059711663,0.0000069085945,0.00029877393],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999607,0.00014914296,0.000031848078,0.000046504745,0.00007430934,0.000091213704],"domain_scores_gemma":[0.99862003,0.0006803475,0.00023134043,0.00015295102,0.00009179227,0.00022355984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047144256,0.00029676463,0.00072033604,0.00016694654,0.00023960027,0.0005303141,0.00024178794,0.00046364454,0.001550991],"category_scores_gemma":[0.0030947425,0.00020208705,0.00045694356,0.00023201335,0.00050789793,0.0006198546,0.00012376884,0.0011653512,0.00025867464],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5091217,0.0053779604,0.020933669,0.00016503046,0.0004491239,0.0013657962,0.0006016135,0.0016543474,0.3686666,0.00019544565,0.0007249322,0.09074381],"study_design_scores_gemma":[0.005811643,0.20001708,0.35495463,0.000034340563,0.001149774,0.0035653242,0.00057833595,0.01772391,0.41268855,0.00019590068,0.0031457366,0.00013479294],"about_ca_topic_score_codex":0.002706439,"about_ca_topic_score_gemma":0.0033064303,"teacher_disagreement_score":0.002706439,"about_ca_system_score_codex":0.00039873543,"about_ca_system_score_gemma":0.00056236703,"threshold_uncertainty_score":0.0053814054},"labels":[],"label_agreement":null},{"id":"W2060079516","doi":"10.1097/fpc.0b013e328336ef1c","title":"Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation","year":2010,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Exon; Biology; Glucuronidation; Alternative splicing; Gene; RNA splicing; Gene isoform; Molecular biology; Genetics; Biochemistry; Enzyme; RNA; Microsome","score_opus":0.0675290214685342,"score_gpt":0.38030536502945145,"score_spread":0.3127763435609172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060079516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329764,0.000656764,0.004704585,0.000054409786,0.000022636901,0.000012156047,0.00032463597,0.000059432194,0.0008677036],"genre_scores_gemma":[0.99559313,0.00043291523,0.0020228443,0.000031016174,0.0000126710465,0.000018841905,0.0006260357,0.000031362455,0.0012311214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987197,0.000017662187,0.0000106238695,0.000049636878,0.000028869394,0.000021254458],"domain_scores_gemma":[0.9998005,0.000039397586,0.00007382815,0.000022476966,0.000025665588,0.000038243033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013809808,0.00033865162,0.00017535457,0.00017955931,0.00011044929,0.0002592675,0.00014033754,0.00022106389,0.0015177925],"category_scores_gemma":[0.0001860756,0.00012732465,0.00027960198,0.00015481473,0.0002697231,0.00009611717,0.00020854558,0.00032598575,0.00038434265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060901348,0.0000056591084,0.0016896533,0.00001782623,0.000006228078,0.0001175755,0.000018110699,0.00003306835,0.9966247,0.00006247277,0.00002600153,0.0013377785],"study_design_scores_gemma":[0.000019786054,0.00023205698,0.05077085,0.000013047686,0.000064111584,0.0014359814,0.00006670213,0.0011703937,0.9436394,0.0001537772,0.002426071,0.000007799008],"about_ca_topic_score_codex":0.00031913663,"about_ca_topic_score_gemma":0.00030284375,"teacher_disagreement_score":0.0015177925,"about_ca_system_score_codex":0.00018796779,"about_ca_system_score_gemma":0.00012927101,"threshold_uncertainty_score":0.005077541},"labels":[],"label_agreement":null},{"id":"W2060134307","doi":"10.1016/s0169-409x(02)00065-0","title":"CYP2A6 genetic variation and potential consequences","year":2002,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Variation (astronomy); Genetic variation; CYP2A6; Biology; Genetics; Gene","score_opus":0.14631540495016146,"score_gpt":0.43780734581757985,"score_spread":0.29149194086741836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060134307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026908747,0.99273735,0.001285345,0.0007293843,0.00020964419,0.0000050236085,0.000050111707,0.000017739401,0.0022745566],"genre_scores_gemma":[0.014320059,0.9809537,0.0012387792,0.0005369503,0.0005808339,0.0000110562905,0.000113394046,0.000004964794,0.0022402103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986625,0.000032657885,0.000014919564,0.000039458428,0.00003687982,0.000009915473],"domain_scores_gemma":[0.9998035,0.00013160678,0.000025518468,0.000007007427,0.000023884913,0.000008542588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031650087,0.0005348919,0.0011418876,0.00070916,0.00011785827,0.00045535716,0.00045197684,0.0007021751,0.00244065],"category_scores_gemma":[0.0004576323,0.00014022557,0.00035879476,0.00095685944,0.00032202853,0.0003511163,0.00018871934,0.00060471543,0.000721809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023840892,0.00007056736,0.0025488108,0.002288335,0.0001580695,0.0025430904,0.000040535873,0.00031307433,0.0048452253,0.0021100307,0.008771314,0.9760724],"study_design_scores_gemma":[0.00020259568,0.00062289974,0.03265771,0.0022711311,0.0013865787,0.048488427,0.00021112997,0.00072149525,0.0086456,0.010609202,0.89409673,0.00008638239],"about_ca_topic_score_codex":0.000745067,"about_ca_topic_score_gemma":0.0010412565,"teacher_disagreement_score":0.00244065,"about_ca_system_score_codex":0.00021197891,"about_ca_system_score_gemma":0.00031277203,"threshold_uncertainty_score":0.008164823},"labels":[],"label_agreement":null},{"id":"W2060234882","doi":"10.1177/0269881114523861","title":"Association of tardive dyskinesia with variation in <i>CYP2D6</i> : Is there a role for active metabolites?","year":2014,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Mental Health; Wellcome Trust","keywords":"Tardive dyskinesia; CYP2D6; Dyskinesia; Odds ratio; Antipsychotic; Parkinsonism; Schizophrenia (object-oriented programming); Internal medicine; Medicine; Genotype; Chlorpromazine; Psychology; Psychosis; Psychiatry; Biology; Genetics; Disease; Gene; Parkinson's disease; Cytochrome P450","score_opus":0.028681409567631027,"score_gpt":0.3901963718726726,"score_spread":0.36151496230504154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060234882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993168,0.00022344972,0.000104346254,0.0000532919,0.0000037719747,0.0000041137982,0.000092380615,0.0000035594828,0.00019831922],"genre_scores_gemma":[0.9996668,0.000045324417,0.00009130584,0.000029623874,0.000011749281,0.000002537057,0.00008940688,0.0000026005923,0.000060702507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995154,0.00013401266,0.00008001438,0.00014249585,0.000072797666,0.000055168788],"domain_scores_gemma":[0.997133,0.0007447423,0.0015865804,0.00011659643,0.00016875172,0.00025036308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054695323,0.00029910574,0.00042159058,0.00046859847,0.00025752228,0.00043933862,0.00027211438,0.0004759557,0.0030312382],"category_scores_gemma":[0.00208123,0.0001667561,0.00031650058,0.0005552756,0.00042027482,0.00020586269,0.00023953676,0.0004982233,0.00028594537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003853239,0.000018777904,0.9964084,0.000012413473,0.000064554624,0.00024456173,0.000031571362,0.000022993398,0.0013825304,0.000011338645,0.000040375264,0.0013771077],"study_design_scores_gemma":[0.000012627131,0.00014705262,0.99813193,0.000003064512,0.000031804844,0.0013227544,0.000028775514,0.000077781886,0.00015750104,0.000017077322,0.0000669774,0.0000026809055],"about_ca_topic_score_codex":0.0014793688,"about_ca_topic_score_gemma":0.0017583342,"teacher_disagreement_score":0.0030312382,"about_ca_system_score_codex":0.00020745322,"about_ca_system_score_gemma":0.00011761891,"threshold_uncertainty_score":0.010140479},"labels":[],"label_agreement":null},{"id":"W2060473854","doi":"10.1006/abbi.2000.2059","title":"Failure of Ah Receptor to Mediate Induction of Cytochromes P450 in the CYP1 Family in the Human Hepatoma Line SK-Hep-1","year":2000,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Texas A and M University","keywords":"Receptor; Cytochrome P450; Aryl hydrocarbon receptor; Ligand (biochemistry); Cytosol; Cell culture; Molecular biology; Hep G2; Enzyme inducer; Chemistry; Isozyme; Messenger RNA; Carcinogen; Biochemistry; Biology; In vitro; Enzyme; Gene; Transcription factor","score_opus":0.044752677732869325,"score_gpt":0.36777943593409745,"score_spread":0.3230267582012281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060473854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965701,0.00045200737,0.0012956999,0.00011984001,0.000027558233,0.000014133612,0.00039542114,0.000066063076,0.0010591064],"genre_scores_gemma":[0.9962734,0.0001747047,0.0002842501,0.000032671163,0.000009188113,0.000015687447,0.0010676861,0.000027760387,0.002114763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966514,0.000082445426,0.000029374263,0.000052000905,0.000068955735,0.00010205294],"domain_scores_gemma":[0.9994456,0.0002341586,0.00006153577,0.0001457293,0.000042699325,0.00007035505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026200965,0.000261427,0.0003371506,0.00023614436,0.00019601044,0.00031576215,0.00018111113,0.0003471649,0.0035090465],"category_scores_gemma":[0.00037154765,0.0001949434,0.00042436528,0.00016168095,0.0002668997,0.00027519854,0.00019791021,0.000758609,0.0013407066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018500512,0.00004177144,0.00035497296,0.000018025035,0.0000064777782,0.00014654691,0.000021419166,0.000051779913,0.99826884,0.00013630511,0.000076261,0.00069255126],"study_design_scores_gemma":[0.000025987636,0.0006087659,0.008179055,0.000003625529,0.000017437194,0.0014887488,0.00007245065,0.00047113415,0.9874164,0.00006801839,0.0016414255,0.000006858911],"about_ca_topic_score_codex":0.0011093968,"about_ca_topic_score_gemma":0.000783032,"teacher_disagreement_score":0.0035090465,"about_ca_system_score_codex":0.00026503438,"about_ca_system_score_gemma":0.0001823574,"threshold_uncertainty_score":0.011738896},"labels":[],"label_agreement":null},{"id":"W2060516957","doi":"10.1515/dmdi.2011.012","title":"Comparing pharmacokinetics and metabolism of diltiazem in normotensive Sprague Dawley and Wistar Kyoto rats vs. spontaneously hypertensive rats in vivo","year":2011,"lang":"en","type":"article","venue":"Drug metabolism and drug interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Nova Scotia Health Research Foundation","keywords":"Pharmacokinetics; Diltiazem; Chemistry; In vivo; Pharmacology; Metabolism; Desmethyl; Endocrinology; Internal medicine; Calcium; Metabolite; Medicine; Biochemistry; Biology","score_opus":0.07032727981593452,"score_gpt":0.34779390708357394,"score_spread":0.27746662726763943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060516957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638546,0.0010947306,0.0017722445,0.000043315456,0.00002160044,0.00002735407,0.00023291195,0.000057284527,0.00036507516],"genre_scores_gemma":[0.9911981,0.0017800384,0.004147946,0.00007449786,0.000027497337,0.000083682186,0.0005593713,0.000027375721,0.00210149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998927,0.000016625174,0.000007753834,0.00002793765,0.000030703908,0.000024255343],"domain_scores_gemma":[0.999826,0.000032967488,0.000056360954,0.000016627997,0.000024985658,0.000043073305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021765106,0.0003060694,0.00039005556,0.00029751845,0.00010934528,0.00019931878,0.000112803406,0.00022603617,0.0009030053],"category_scores_gemma":[0.00024206175,0.00015664473,0.00021288695,0.00016047848,0.00018890208,0.00026684272,0.00007520603,0.0004612995,0.00023122254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004002827,0.0002477717,0.0019349875,0.000060345854,0.000031257256,0.00006355032,0.000041643303,0.00017791268,0.9875777,0.00005118,0.00008098837,0.005729719],"study_design_scores_gemma":[0.0003904612,0.019248303,0.050324198,0.000009310614,0.00022703793,0.0004622283,0.00014160461,0.0038288222,0.9231859,0.000112641195,0.0020365848,0.000032961678],"about_ca_topic_score_codex":0.0018479985,"about_ca_topic_score_gemma":0.0024058816,"teacher_disagreement_score":0.0018479985,"about_ca_system_score_codex":0.00027591418,"about_ca_system_score_gemma":0.00026003193,"threshold_uncertainty_score":0.0036744475},"labels":[],"label_agreement":null},{"id":"W2060570337","doi":"10.1089/thy.2010.1642","title":"The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology","year":2010,"lang":"en","type":"review","venue":"Thyroid","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hospital for Sick Children; SickKids Foundation; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Pharmacogenomics; Drug; Safety pharmacology; Medicine; Pharmacology; Intensive care medicine","score_opus":0.142553412410372,"score_gpt":0.45637777616507913,"score_spread":0.3138243637547071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060570337","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024019072,0.012033956,0.06530867,0.7238787,0.0042250855,0.0014253464,0.0041349684,0.0017400029,0.1848514],"genre_scores_gemma":[0.18802962,0.06504721,0.36748576,0.2308776,0.007932865,0.0040722783,0.01635197,0.00094895734,0.11925365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96673065,0.016023902,0.00080747594,0.002117327,0.01231447,0.0020062274],"domain_scores_gemma":[0.9402005,0.008980057,0.0022874984,0.004211285,0.033189446,0.011131241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032442365,0.0018456965,0.0015655385,0.0054741167,0.006599577,0.011633784,0.0063141165,0.006691897,0.019340357],"category_scores_gemma":[0.056193423,0.0008731309,0.0015739189,0.0087162405,0.0070031257,0.007014758,0.0062568733,0.0072783893,0.005085248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016270122,0.0001585429,0.0078546805,0.0004736716,0.00018884608,0.00028443793,0.0003940749,0.0059303558,0.00023715958,0.31686282,0.52758485,0.1398679],"study_design_scores_gemma":[0.00027772874,0.00014155064,0.0048885113,0.0010974421,0.00016151182,0.00019991655,0.0005281339,0.014736326,0.00021695872,0.16076748,0.8168452,0.00013912532],"about_ca_topic_score_codex":0.69385695,"about_ca_topic_score_gemma":0.6790799,"teacher_disagreement_score":0.95115477,"about_ca_system_score_codex":0.048845258,"about_ca_system_score_gemma":0.18264042,"threshold_uncertainty_score":0.61589193},"labels":[],"label_agreement":null},{"id":"W2060688925","doi":"10.2174/1389200043489045","title":"Expression of Cytochrome P450 in Lung Tumor","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Lung cancer; Drug; Drug metabolism; Enzyme; Lung; Pharmacology; Cancer research; Metabolism; Biology; Medicine; Pathology; Internal medicine; Biochemistry","score_opus":0.1495398489201582,"score_gpt":0.4884367072325,"score_spread":0.3388968583123418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060688925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011472893,0.9941802,0.0005583787,0.000226334,0.00011180947,0.00000731407,0.00003516594,0.000016714155,0.0037167354],"genre_scores_gemma":[0.006052482,0.9900918,0.00046267826,0.00013059429,0.00013022305,0.0000075678504,0.00007450013,0.000002301529,0.0030478449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998872,0.000017471673,0.000012419662,0.000026948937,0.000045290246,0.000010612944],"domain_scores_gemma":[0.9999056,0.000030720737,0.000018840632,0.0000046953173,0.00003324797,0.000006899281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017190888,0.00039450903,0.00068501884,0.001240568,0.00014209544,0.0004676199,0.0003512887,0.000545325,0.0022510537],"category_scores_gemma":[0.00025546123,0.00014215235,0.00031613326,0.0014569659,0.0002036084,0.0005402309,0.00020132352,0.00054493116,0.0019236396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006167181,0.000045274715,0.0008931757,0.006277412,0.000053629963,0.0010852945,0.000046163055,0.00027513207,0.012718065,0.0014518566,0.011993134,0.9650993],"study_design_scores_gemma":[0.000019628387,0.00019381521,0.0077512525,0.0015188581,0.00019930047,0.016000412,0.00007966945,0.00022770511,0.010323686,0.0020573642,0.9616042,0.000024181349],"about_ca_topic_score_codex":0.0011606717,"about_ca_topic_score_gemma":0.001360501,"teacher_disagreement_score":0.0022510537,"about_ca_system_score_codex":0.0003908253,"about_ca_system_score_gemma":0.00039709554,"threshold_uncertainty_score":0.00753057},"labels":[],"label_agreement":null},{"id":"W2060938572","doi":"10.1111/j.1749-6632.2000.tb06685.x","title":"Mimicking Gene Defects to Treat Drug Dependence","year":2000,"lang":"en","type":"review","venue":"Annals of the New York Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dextromethorphan; CYP2A6; Codeine; Nicotine; Pharmacology; Population; CYP2D6; Debrisoquine; Drug; Pharmacogenetics; Cytochrome P450; Genetics; Biology; Genotype; Medicine; Gene; CYP1A2; Enzyme; Internal medicine; Morphine; Biochemistry","score_opus":0.3805598074305748,"score_gpt":0.5164229025892486,"score_spread":0.13586309515867379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060938572","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63385594,0.13983262,0.09150069,0.014358002,0.0047186534,0.0018716321,0.0044407956,0.005478329,0.10394327],"genre_scores_gemma":[0.8721594,0.044383258,0.02515222,0.007852926,0.0005074533,0.00074177235,0.0036412217,0.00038480002,0.045176912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998535,0.00003196973,0.000012004688,0.000031797746,0.000043000116,0.000027633214],"domain_scores_gemma":[0.9998671,0.000028991088,0.000029723573,0.000017988208,0.000022219421,0.000034026027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021766912,0.0004197221,0.00030173536,0.00039465216,0.00021011595,0.0002457148,0.0004419755,0.00068377174,0.0048684566],"category_scores_gemma":[0.0003887648,0.00008053771,0.00039007436,0.00023093435,0.00033528716,0.0001750677,0.00035301226,0.0010573554,0.0014492114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016578694,0.0018037508,0.0052346117,0.0015146367,0.0002062295,0.008532438,0.00022031371,0.0009938754,0.46528253,0.017723938,0.028401194,0.46842864],"study_design_scores_gemma":[0.0011227311,0.006212806,0.0186587,0.00058812794,0.00043753273,0.04105885,0.00016075985,0.0018970913,0.2100071,0.0066843177,0.7130997,0.00007230193],"about_ca_topic_score_codex":0.00046314168,"about_ca_topic_score_gemma":0.00074080244,"teacher_disagreement_score":0.0048684566,"about_ca_system_score_codex":0.0002889693,"about_ca_system_score_gemma":0.00024658337,"threshold_uncertainty_score":0.016286552},"labels":[],"label_agreement":null},{"id":"W2061164760","doi":"10.2217/14622416.10.2.255","title":"Call for Nominations – Pacific Rim Association for Clinical Pharmacogenetics – Werner Kalow Best Paper Award in Clinical Pharmacogenetics","year":2009,"lang":"en","type":"letter","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenetics; Bioethics; Medicine; Political science; Biology; Law; Genetics; Genotype","score_opus":0.2528882958559432,"score_gpt":0.5262328410658247,"score_spread":0.2733445452098815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061164760","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021906302,0.0007976776,0.00021792532,0.9243694,0.06415625,0.000059197326,0.00009269354,0.00008041628,0.010007377],"genre_scores_gemma":[0.002233886,0.0007269678,0.0005514027,0.86578286,0.05036845,0.00009764995,0.00011580835,0.000072073046,0.080050975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910227,0.0015712978,0.0007145311,0.0012570951,0.0033663786,0.0020680078],"domain_scores_gemma":[0.9817045,0.0043784613,0.0009224431,0.0008266176,0.0043283645,0.007839582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00804103,0.002019725,0.0033319502,0.0016808569,0.006764722,0.009901704,0.0026947907,0.10387541,0.037145413],"category_scores_gemma":[0.0307722,0.0017115624,0.0026817545,0.0009788834,0.0038595872,0.0038611507,0.0046878904,0.04897025,0.037103415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028641081,0.000022096301,0.00013937899,0.00000938008,0.000008567303,0.0002790914,0.000009610785,0.000021826754,0.000045526453,0.0004954343,0.996608,0.0023324485],"study_design_scores_gemma":[0.00024841004,0.00008471917,0.0016292062,0.00015168026,0.000038292554,0.00078074174,0.00017294417,0.00042435018,0.00011910039,0.0038608997,0.9924117,0.00007803423],"about_ca_topic_score_codex":0.010252076,"about_ca_topic_score_gemma":0.03280239,"teacher_disagreement_score":0.10387541,"about_ca_system_score_codex":0.006189886,"about_ca_system_score_gemma":0.013933943,"threshold_uncertainty_score":0.12426376},"labels":[],"label_agreement":null},{"id":"W2061209675","doi":"10.2217/14622416.8.10.1385","title":"Genetic Variability in<i>CYP2A6</i>and the Pharmacokinetics of Nicotine","year":2007,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"CYP2A6; Nicotine; Pharmacokinetics; Pharmacology; Biology; Genetics; Neuroscience","score_opus":0.18209797631604696,"score_gpt":0.4837606931305429,"score_spread":0.3016627168144959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061209675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003742919,0.99645656,0.0003470751,0.00034802672,0.00013645191,0.0000070358187,0.000031370742,0.0000132521445,0.0022859483],"genre_scores_gemma":[0.0011511231,0.9964755,0.0003463957,0.0001378885,0.00016644796,0.000007511127,0.00005239011,0.000001919729,0.0016608429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982905,0.00003076682,0.00001959231,0.000037988764,0.00006956027,0.000012995948],"domain_scores_gemma":[0.9998116,0.000082883635,0.000029380919,0.0000060327225,0.000052991425,0.000016986054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045548065,0.00064538437,0.001116646,0.001176821,0.00018314502,0.0005903317,0.00060266163,0.00091610546,0.0038288478],"category_scores_gemma":[0.00049962936,0.00021758425,0.0003901071,0.0015525549,0.00026601765,0.00080119097,0.00031888057,0.0008408814,0.004049583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006162735,0.000057740246,0.00046860523,0.0035663499,0.00006116817,0.0002074699,0.000021751646,0.00022213398,0.0015956566,0.0012412607,0.013822465,0.97867364],"study_design_scores_gemma":[0.00002329986,0.00012756296,0.004645983,0.0013336536,0.00010595239,0.0036668077,0.000044611086,0.0001379261,0.0012376657,0.0015834862,0.987071,0.000022072258],"about_ca_topic_score_codex":0.0012894634,"about_ca_topic_score_gemma":0.001633722,"teacher_disagreement_score":0.0038288478,"about_ca_system_score_codex":0.00041438604,"about_ca_system_score_gemma":0.00060560834,"threshold_uncertainty_score":0.0128088},"labels":[],"label_agreement":null},{"id":"W2061459550","doi":"10.1007/s40262-013-0065-6","title":"The Integration of Allometry and Virtual Populations to Predict Clearance and Clearance Variability in Pediatric Populations over the Age of 6 Years","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"","keywords":"Allometry; Biology; Pharmacotherapy; Medicine; Demography; Ecology; Internal medicine","score_opus":0.16065767397032374,"score_gpt":0.47878067063202867,"score_spread":0.31812299666170496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061459550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585674,0.00087060523,0.03715361,0.00023106768,0.00007044304,0.000062089624,0.0011590912,0.00056859263,0.0013171856],"genre_scores_gemma":[0.9928349,0.00015581424,0.005958506,0.000058582667,0.000026533715,0.000034627355,0.0006691656,0.00007068334,0.00019125531],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976375,0.0012797121,0.00011909256,0.0005378076,0.00031157339,0.00011433332],"domain_scores_gemma":[0.98999363,0.005517458,0.0019346148,0.0013193161,0.00086575723,0.000369136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005549954,0.0007215075,0.0012936082,0.0016796412,0.00033976563,0.0018761838,0.0008648958,0.0008516533,0.0009999893],"category_scores_gemma":[0.02214505,0.00033503887,0.0010682275,0.0011809134,0.00039553238,0.0016947654,0.0010951802,0.0011632754,0.00049807824],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00124912,0.00019049666,0.90318024,0.00004864797,0.00077277736,0.00018196135,0.00026569644,0.024589023,0.0013223696,0.0009888144,0.0012373278,0.06597353],"study_design_scores_gemma":[0.000091217895,0.0017533726,0.43052396,0.000052082665,0.0005801783,0.0022423293,0.0003877561,0.5521409,0.0026044252,0.006912992,0.0026194416,0.00009142518],"about_ca_topic_score_codex":0.0030460216,"about_ca_topic_score_gemma":0.0019879208,"teacher_disagreement_score":0.005549954,"about_ca_system_score_codex":0.0005397098,"about_ca_system_score_gemma":0.000800286,"threshold_uncertainty_score":0.029351294},"labels":[],"label_agreement":null},{"id":"W2062052463","doi":"10.1096/fj.14-258780","title":"Decreased nuclear receptor activity and epigenetic modulation associates with down‐regulation of hepatic drug‐metabolizing enzymes in chronic kidney disease","year":2014,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Pregnane X receptor; Nuclear receptor; Chromatin immunoprecipitation; Acetylation; Epigenetics; Histone; Kidney disease; Internal medicine; Biology; Endocrinology; Receptor; Promoter; Molecular biology; Gene expression; Medicine; Transcription factor; Gene; Biochemistry","score_opus":0.028374229501594614,"score_gpt":0.32485170535872704,"score_spread":0.2964774758571324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062052463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975776,0.0010120397,0.0007542705,0.00007016438,0.000012726998,0.00000507465,0.00012993402,0.00001855768,0.00041971408],"genre_scores_gemma":[0.99761117,0.00045186616,0.00035262763,0.000038625894,0.0000111501095,0.000015224035,0.00023782873,0.000004934749,0.001276547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999027,0.000011968059,0.000007596233,0.000029167502,0.000024924244,0.000023592804],"domain_scores_gemma":[0.9998758,0.000010474165,0.000049825358,0.000011273676,0.000019555368,0.000033103657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097822616,0.00015715578,0.00029450527,0.0002642789,0.00014815584,0.0001688246,0.000081535574,0.00014538477,0.0017453433],"category_scores_gemma":[0.00014004958,0.00015207217,0.0002922236,0.00017041052,0.00020226091,0.00009017336,0.0001457758,0.00033939886,0.00018168469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017800959,0.00015742697,0.052820385,0.00007429235,0.00010121109,0.0002798547,0.00012571657,0.00007665584,0.9367302,0.00013834496,0.0001707697,0.0075451885],"study_design_scores_gemma":[0.00004786735,0.00039015265,0.934823,0.0000081611015,0.000076377,0.0008941379,0.00012623616,0.00035851795,0.061791185,0.00012786496,0.0013458227,0.00001071681],"about_ca_topic_score_codex":0.00091896637,"about_ca_topic_score_gemma":0.0011763597,"teacher_disagreement_score":0.0017453433,"about_ca_system_score_codex":0.00013878016,"about_ca_system_score_gemma":0.00016162546,"threshold_uncertainty_score":0.005838752},"labels":[],"label_agreement":null},{"id":"W2062795545","doi":"10.1139/y07-121","title":"Adventures in drug disposition: pas seulement pâté de foie","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Disposition; Drug; Medicine; Pharmacology; Intervention (counseling); Pharmacotherapy; Psychology; Internal medicine; Psychiatry","score_opus":0.04436017988986066,"score_gpt":0.3900812560260888,"score_spread":0.34572107613622816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062795545","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70259917,0.069328055,0.021873344,0.09776273,0.008693217,0.00011363694,0.00078815746,0.00064425095,0.09819741],"genre_scores_gemma":[0.9065512,0.01615729,0.010368735,0.0073000905,0.0024545765,0.000046566285,0.00021981541,0.00017939237,0.056722414],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9991242,0.00026331344,0.000045255943,0.00023748177,0.00022279964,0.00010683929],"domain_scores_gemma":[0.9972785,0.00080709584,0.0005398639,0.00036031727,0.0003651561,0.0006490355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012917737,0.000490736,0.0005490059,0.000564647,0.0013700018,0.0025984736,0.0004650829,0.0016908556,0.008848007],"category_scores_gemma":[0.0062439097,0.0003568512,0.0005228629,0.00037887495,0.0021171435,0.0029305846,0.001454594,0.0037531094,0.0026094164],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004670969,0.002209703,0.20101936,0.0012532033,0.00061231287,0.010903919,0.011809504,0.00057281647,0.060852468,0.056799065,0.057199467,0.5920973],"study_design_scores_gemma":[0.00015540786,0.003419257,0.3765656,0.0008838848,0.00035915803,0.047964092,0.0059330435,0.0015753343,0.024505576,0.04281637,0.49549568,0.00032662004],"about_ca_topic_score_codex":0.0018560791,"about_ca_topic_score_gemma":0.0020745974,"teacher_disagreement_score":0.008848007,"about_ca_system_score_codex":0.00091702904,"about_ca_system_score_gemma":0.0005769099,"threshold_uncertainty_score":0.029599547},"labels":[],"label_agreement":null},{"id":"W2063035659","doi":"10.2165/00003088-200140110-00001","title":"Pharmacogenetics","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Therapeutic drug monitoring; Drug; Pharmacology; CYP2D6; CYP2C19; Pharmacogenomics; Intensive care medicine; Bioinformatics; Internal medicine; Biology; Cytochrome P450; Genotype; Genetics","score_opus":0.5455348796245921,"score_gpt":0.6286190238947967,"score_spread":0.08308414427020461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063035659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087586505,0.9202786,0.017068708,0.003663772,0.0021285682,0.00011874403,0.0003480266,0.00028593157,0.05523177],"genre_scores_gemma":[0.012320496,0.91159,0.0144041125,0.0056120036,0.0032085972,0.00016439098,0.0009348746,0.000058974027,0.051706523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994362,0.0001769512,0.000055104054,0.00010686204,0.00018905845,0.000035780446],"domain_scores_gemma":[0.99953926,0.00020048792,0.000054999742,0.000058737012,0.0001147192,0.000031727424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009365946,0.0011096838,0.0012066225,0.0016188495,0.0002167058,0.0011307029,0.00081766746,0.0010011914,0.011201246],"category_scores_gemma":[0.0017683147,0.00024173563,0.00057451834,0.0017252194,0.0005606491,0.0007608732,0.00090625783,0.0017435157,0.007564515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006560859,0.000068357345,0.0004314238,0.0016068574,0.0000546139,0.00035895986,0.000024870671,0.00026518496,0.0012693463,0.007218333,0.051657278,0.9369792],"study_design_scores_gemma":[0.000031769752,0.00006268146,0.00087158306,0.0010329735,0.00007679241,0.003792643,0.000018693418,0.00018071389,0.0010858831,0.005108869,0.98772556,0.000011911396],"about_ca_topic_score_codex":0.0009985361,"about_ca_topic_score_gemma":0.001224526,"teacher_disagreement_score":0.011201246,"about_ca_system_score_codex":0.0005391036,"about_ca_system_score_gemma":0.0012531142,"threshold_uncertainty_score":0.03747183},"labels":[],"label_agreement":null},{"id":"W2063194647","doi":"10.1038/clpt.2009.17","title":"Pharmacogenetics of Pharmacoecology: Which Route to Personalized Medicine?","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Miller; Clinical pharmacology; Pharmacy; Library science; Medicine; Citation; Family medicine; Pharmacology; Computer science; Biology","score_opus":0.20988326001252208,"score_gpt":0.5630251880812913,"score_spread":0.3531419280687692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063194647","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002262125,0.021688849,0.0002024167,0.058130838,0.9189041,0.000009668325,0.000031341297,0.000033853623,0.0009763354],"genre_scores_gemma":[0.00034903007,0.012337233,0.00018745108,0.029507697,0.9542163,0.00001170332,0.000015089917,0.000016465778,0.0033590314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950177,0.0015908048,0.0008067182,0.0004806919,0.0018718386,0.00023220037],"domain_scores_gemma":[0.96988636,0.016454749,0.0015612246,0.00069225824,0.009337263,0.0020681878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009273159,0.0030929646,0.0052595423,0.002839666,0.0020011093,0.0060254633,0.003255563,0.016927231,0.0079248175],"category_scores_gemma":[0.030274011,0.0012562273,0.002649926,0.0014064654,0.0029687888,0.004148213,0.0012864212,0.026155164,0.0057956814],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034281038,0.0000118978205,0.000031804168,0.0003128403,0.000049045506,0.00012509192,0.00000862963,0.00003142548,0.00003736241,0.000446469,0.9909999,0.007911253],"study_design_scores_gemma":[0.00013977893,0.000044509794,0.0005363085,0.001383956,0.00024243294,0.00078883686,0.00005170948,0.00037051298,0.00014366787,0.0033517492,0.99290127,0.000045170207],"about_ca_topic_score_codex":0.0023650122,"about_ca_topic_score_gemma":0.007079884,"teacher_disagreement_score":0.016927231,"about_ca_system_score_codex":0.0028391152,"about_ca_system_score_gemma":0.0032994305,"threshold_uncertainty_score":0.049041748},"labels":[],"label_agreement":null},{"id":"W2063459644","doi":"10.1021/bi801595t","title":"Reaction of<i>Mycobacterium tuberculosis</i>Cytochrome P450 Enzymes with Nitric Oxide","year":2009,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Ferrous; Heme; Chemistry; Ferric; Biochemistry; Enzyme; Cytochrome; Hemeprotein; Nitric oxide; Sodium dithionite; Cytochrome P450; Inorganic chemistry; Organic chemistry","score_opus":0.03568531832195848,"score_gpt":0.3573246010325339,"score_spread":0.3216392827105754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063459644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906577,0.0021544353,0.005604581,0.00009334988,0.000041261515,0.00003667608,0.000057488494,0.000029566021,0.001324881],"genre_scores_gemma":[0.9935069,0.0008004381,0.00430939,0.00004726135,0.000018495284,0.000024853567,0.00013191042,0.0000056920253,0.0011550919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974996,0.00009538705,0.000009977223,0.00005345312,0.00005094689,0.000040273644],"domain_scores_gemma":[0.99986887,0.000050082075,0.000028700479,0.000016939874,0.000020697507,0.0000146592165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033959595,0.0002994824,0.00020394746,0.000053975047,0.00012986491,0.00015216036,0.00024401656,0.00026364872,0.00038333252],"category_scores_gemma":[0.0003572406,0.00009377334,0.00015569483,0.00006070944,0.00017605351,0.0001070276,0.00014411812,0.0002241074,0.00013490269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015542237,0.000020259042,0.00072008424,0.00005612681,0.00001340445,0.00005624078,0.000019536124,0.00009989629,0.9969465,0.0001296939,0.00003908229,0.0017437758],"study_design_scores_gemma":[0.000007059872,0.00031903264,0.0019858733,0.0000045806732,0.000010017351,0.00014341963,0.000011476322,0.0008893093,0.9953726,0.000048321726,0.0012052543,0.000003239664],"about_ca_topic_score_codex":0.00067181926,"about_ca_topic_score_gemma":0.0007471916,"teacher_disagreement_score":0.00067181926,"about_ca_system_score_codex":0.00020656541,"about_ca_system_score_gemma":0.00012013693,"threshold_uncertainty_score":0.0017960072},"labels":[],"label_agreement":null},{"id":"W2063523494","doi":"10.1016/s0960-0760(01)00172-8","title":"Comparison of the hamster and human adrenal P450c17 (17α-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling","year":2002,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of California, San Francisco","keywords":"Pregnenolone; Hamster; CYP17A1; Mutant; Mutagenesis; Hydroxylation; Chinese hamster ovary cell; Cytochrome P450; Biology; Biochemistry; Site-directed mutagenesis; Lyase; Enzyme; Molecular biology; Mutation; Chemistry; Steroid; Gene; Receptor; Hormone","score_opus":0.08079557702632102,"score_gpt":0.4054192553344981,"score_spread":0.32462367830817707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063523494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98116744,0.0023093678,0.011685329,0.00019176387,0.00007379518,0.000060748476,0.0014002669,0.0001512219,0.00296004],"genre_scores_gemma":[0.9832575,0.0015994826,0.01040845,0.000061697196,0.000012358445,0.000028405551,0.0027689012,0.00005609183,0.0018071396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983406,0.000032788714,0.000014382792,0.0000319928,0.000063713516,0.000022890385],"domain_scores_gemma":[0.99987173,0.00004140179,0.000025900372,0.000010748842,0.000026437521,0.000023717772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030815383,0.00046725207,0.0005997307,0.00028706176,0.00030155847,0.00047539256,0.00038884117,0.00044937863,0.002044918],"category_scores_gemma":[0.00040977134,0.00019093418,0.00063141884,0.00033804725,0.00017069138,0.00016633495,0.0001461325,0.00046655087,0.0004849126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001496726,0.00022621645,0.0050229398,0.00035700307,0.0002287342,0.0011661906,0.00012100425,0.016416319,0.95541865,0.0037601697,0.00064377586,0.015142412],"study_design_scores_gemma":[0.00024390974,0.000804749,0.009403424,0.00004037279,0.00037489837,0.00158082,0.00012811628,0.052286677,0.9120842,0.0006560764,0.022350213,0.000046612557],"about_ca_topic_score_codex":0.00600392,"about_ca_topic_score_gemma":0.0058379536,"teacher_disagreement_score":0.00600392,"about_ca_system_score_codex":0.00071288546,"about_ca_system_score_gemma":0.0005616626,"threshold_uncertainty_score":0.011937916},"labels":[],"label_agreement":null},{"id":"W2063753138","doi":"10.1016/s0024-3205(03)00093-6","title":"Interaction of serum proteins with CYP isoforms in human liver microsomes: inhibitory effects of human and bovine albumin, alpha-globulins, alpha-1-acid glycoproteins and gamma-globulins on CYP2C19 and CYP2D6","year":2003,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Alpha (finance); Albumin; Glycoprotein; Alpha globulin; Globulin; Gamma globulin; Biochemistry; Microsome; Serum albumin; Chemistry; Gene isoform; Pharmacology; Biology; In vitro; Endocrinology; Immunology; Medicine; Antibody; Gene","score_opus":0.04460263588564069,"score_gpt":0.36977810509180953,"score_spread":0.32517546920616885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063753138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903161,0.005514988,0.0026551434,0.00023970961,0.00009155021,0.0000430246,0.00031372654,0.000066485016,0.0007592788],"genre_scores_gemma":[0.99277604,0.0017569084,0.0022701602,0.0001162731,0.000057964236,0.000039874725,0.0013082452,0.000029569597,0.0016449605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948967,0.000276523,0.00003744113,0.000048497077,0.00005793014,0.00008997632],"domain_scores_gemma":[0.9997106,0.00012462104,0.000043178632,0.000032978143,0.000050513205,0.00003804575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076648593,0.0007196626,0.00060179515,0.00024308378,0.0002955818,0.00034513357,0.00025147313,0.00037742217,0.0014220381],"category_scores_gemma":[0.0009598964,0.0002504832,0.0006241885,0.0004945594,0.00027793212,0.00021215624,0.0002663313,0.00044411913,0.0004585375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007196514,0.00039335666,0.0031426696,0.0003837787,0.0002498973,0.00028485464,0.00022396697,0.0009778003,0.97547853,0.00025683278,0.00076002505,0.010651817],"study_design_scores_gemma":[0.00016032938,0.0013157023,0.008664282,0.000018004142,0.00011299692,0.00039041266,0.00005125529,0.0019562296,0.98475283,0.00004923808,0.0025167388,0.000011949208],"about_ca_topic_score_codex":0.003787623,"about_ca_topic_score_gemma":0.004293827,"teacher_disagreement_score":0.003787623,"about_ca_system_score_codex":0.00052978867,"about_ca_system_score_gemma":0.00043828075,"threshold_uncertainty_score":0.007531166},"labels":[],"label_agreement":null},{"id":"W2063970227","doi":"10.1067/mcp.2001.116714","title":"Pharmacogenetics, pharmacogenomics, and pharmacobiology","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical pharmacology; Medicine; Pharmacology; Biopharmaceutics; Biology; Pharmacognosy; Genotype; Genetics; Gene","score_opus":0.5125665708794018,"score_gpt":0.6075484237968155,"score_spread":0.09498185291741368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063970227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011975774,0.9897467,0.0013470362,0.0015599598,0.00051017944,0.000010611864,0.000019452349,0.000035917074,0.0066503845],"genre_scores_gemma":[0.0009088663,0.99197537,0.0015180289,0.0007808396,0.00080114935,0.00001403148,0.00004004076,0.0000040061436,0.003957682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960715,0.00010792764,0.000030816896,0.000056615252,0.00017107074,0.000026370477],"domain_scores_gemma":[0.9992405,0.00041960922,0.00006083288,0.000036836078,0.00018078707,0.000061382954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001378734,0.001185841,0.0017382477,0.0026788036,0.00033053473,0.0016780165,0.00094077893,0.0014235332,0.00897789],"category_scores_gemma":[0.0012380235,0.00035919226,0.0003498199,0.0033661104,0.0014173554,0.0020370376,0.0007971218,0.0022728746,0.008353523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003192453,0.000050820046,0.00020415115,0.0022610365,0.000038569786,0.00015448144,0.000034618406,0.00027285295,0.0010900954,0.006816343,0.038644753,0.95040035],"study_design_scores_gemma":[0.000015117365,0.000048804897,0.0008937352,0.0015321573,0.00003616355,0.0020059636,0.000060580693,0.00016425033,0.00045326632,0.013867264,0.98090726,0.000015469193],"about_ca_topic_score_codex":0.0011267832,"about_ca_topic_score_gemma":0.0028901868,"teacher_disagreement_score":0.00897789,"about_ca_system_score_codex":0.0010575862,"about_ca_system_score_gemma":0.0011922113,"threshold_uncertainty_score":0.030034006},"labels":[],"label_agreement":null},{"id":"W2063972278","doi":"10.1016/s0009-9236(03)00051-1","title":"Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Grapefruit juice; Chemistry; Felodipine; Lime; Wine; Citrus paradisi; Food science; Metabolite; Pharmacokinetics; Pharmacology; Biochemistry; Botany; Medicine; Endocrinology","score_opus":0.1754512454019363,"score_gpt":0.5006417785127449,"score_spread":0.32519053311080864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063972278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183357,0.0074272705,0.00017685574,0.00005248292,0.000038730745,0.000040471896,0.00006128869,0.0000119944725,0.00035729865],"genre_scores_gemma":[0.99636924,0.00233646,0.00044641644,0.00006311239,0.000041166673,0.000016657414,0.00014621938,0.0000046077475,0.0005760726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964404,0.0001792561,0.000020749072,0.00007014415,0.000054336273,0.000031469743],"domain_scores_gemma":[0.99962854,0.00012775265,0.00009964911,0.000018540353,0.000029417395,0.000096109674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005508124,0.00044261385,0.00060821883,0.00027601232,0.00014259738,0.000563406,0.00017217103,0.00038845383,0.0012406069],"category_scores_gemma":[0.00089504494,0.00016802916,0.0005338773,0.00022440139,0.00026204536,0.00044162344,0.00018488643,0.00033177232,0.00011587149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34058228,0.0062553775,0.03373293,0.0015013027,0.003380411,0.000516234,0.00033591094,0.0011720307,0.4367362,0.0003012778,0.00074025855,0.17474583],"study_design_scores_gemma":[0.013053681,0.37975088,0.3275309,0.00014353558,0.0057066423,0.0019536063,0.0003745376,0.0072403657,0.2510442,0.0003602702,0.012707043,0.00013428341],"about_ca_topic_score_codex":0.0011540597,"about_ca_topic_score_gemma":0.0020246771,"teacher_disagreement_score":0.0012406069,"about_ca_system_score_codex":0.00047249172,"about_ca_system_score_gemma":0.00019200842,"threshold_uncertainty_score":0.0041502714},"labels":[],"label_agreement":null},{"id":"W2064377262","doi":"10.3109/00498254.2012.751141","title":"A simplified approach to predict CYP3A-mediated drug–drug interactions at early drug discovery: validation with clinical data","year":2012,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Drug; Drug discovery; Drug-drug interaction; Pharmacology; Drug metabolism; Computational biology; Medicine; Bioinformatics; Biology","score_opus":0.1967283429259725,"score_gpt":0.46054134951206044,"score_spread":0.263813006586088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064377262","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23158315,0.0072459765,0.7502577,0.0014379346,0.00009408445,0.0011496354,0.003456529,0.0020988071,0.0026762893],"genre_scores_gemma":[0.7774624,0.0030228887,0.213658,0.0006748209,0.00010617603,0.00059309194,0.0032229587,0.00013304687,0.0011265082],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99546033,0.0026751417,0.00026916928,0.00033737265,0.001180522,0.0000774801],"domain_scores_gemma":[0.99054986,0.006475571,0.0011357991,0.0006256593,0.001012251,0.00020085824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075760325,0.0015758639,0.0020220282,0.0019402152,0.00033470016,0.0016033922,0.001024522,0.00093173137,0.002179991],"category_scores_gemma":[0.027223663,0.00051758933,0.0011410406,0.00097126514,0.00051125616,0.0008918632,0.0011960196,0.0012459157,0.0010689491],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003399754,0.0007178798,0.063927144,0.0016664643,0.0017487654,0.0009836856,0.00020412289,0.51558316,0.030966474,0.0021526301,0.0037737559,0.37487623],"study_design_scores_gemma":[0.00032575012,0.0031920392,0.04027134,0.00011609906,0.0008140752,0.0013778462,0.000051619907,0.9343381,0.009022583,0.0030758218,0.0073089516,0.000105730476],"about_ca_topic_score_codex":0.0060070194,"about_ca_topic_score_gemma":0.0059369453,"teacher_disagreement_score":0.0075760325,"about_ca_system_score_codex":0.0011779896,"about_ca_system_score_gemma":0.0020007903,"threshold_uncertainty_score":0.04006636},"labels":[],"label_agreement":null},{"id":"W2064835492","doi":"10.1016/j.bcp.2004.03.035","title":"Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Liver Foundation","keywords":"CYP1A2; Pharmacology; Metabolite; Microsome; Metabolism; Chemistry; Drug interaction; CYP2E1; Drug metabolism; Biochemistry; Pharmacokinetics; Cytochrome P450; Biology; Enzyme","score_opus":0.055181212763018496,"score_gpt":0.4263006129790119,"score_spread":0.3711194002159934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064835492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400313,0.03182621,0.008894822,0.006357288,0.00016303083,0.00012461799,0.00036372207,0.00016539318,0.012073669],"genre_scores_gemma":[0.9931009,0.0029354503,0.0014539129,0.0003206649,0.00011465619,0.000018754541,0.00009166671,0.000023347306,0.001940736],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903154,0.0006016478,0.000043063876,0.00006155957,0.00019183513,0.000070273265],"domain_scores_gemma":[0.9988091,0.0006452268,0.00029465626,0.00006462178,0.00008194748,0.00010450839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007571295,0.00050880504,0.0008313543,0.0005075282,0.0003602011,0.0007580843,0.0002061078,0.0010498516,0.002878809],"category_scores_gemma":[0.0025632128,0.0002640719,0.0004941626,0.00033257512,0.00031171585,0.00037959276,0.00024394724,0.0009297919,0.00044491317],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02546733,0.0010021445,0.3252303,0.0009959454,0.0020626117,0.024868557,0.0003453808,0.0071634217,0.23302944,0.004452899,0.007403894,0.36797822],"study_design_scores_gemma":[0.001589414,0.009509089,0.69815946,0.00015740932,0.0018288861,0.0782827,0.00025902857,0.016544346,0.15503371,0.002653128,0.035838414,0.00014450037],"about_ca_topic_score_codex":0.0013232171,"about_ca_topic_score_gemma":0.0018885578,"teacher_disagreement_score":0.002878809,"about_ca_system_score_codex":0.0005766398,"about_ca_system_score_gemma":0.00042835175,"threshold_uncertainty_score":0.0096306205},"labels":[],"label_agreement":null},{"id":"W2066629394","doi":"10.1191/0748233704th203oa","title":"Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose","year":2004,"lang":"en","type":"review","venue":"Toxicology and Industrial Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"","keywords":"Context (archaeology); Physiologically based pharmacokinetic modelling; CYP2E1; Chemistry; Solvent; Biochemical engineering; Toxicology; Pharmacokinetics; Environmental chemistry; Pharmacology; Organic chemistry; Cytochrome P450; Biology; Enzyme","score_opus":0.33566057100426483,"score_gpt":0.506782810509422,"score_spread":0.17112223950515715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066629394","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2317577,0.09378096,0.22719945,0.0561429,0.0025154834,0.000334853,0.0033063558,0.00057528936,0.384387],"genre_scores_gemma":[0.93426764,0.01887987,0.027013242,0.0038317225,0.0011646373,0.0003418295,0.0006555842,0.00008360961,0.01376187],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927428,0.0029418159,0.00059189973,0.0008764086,0.002474005,0.0003730351],"domain_scores_gemma":[0.99056774,0.00613742,0.0011768795,0.00056885876,0.0014007295,0.0001483958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062283687,0.0005780173,0.0007274224,0.0018399906,0.0010548392,0.0035788657,0.0023603837,0.0032538397,0.00218007],"category_scores_gemma":[0.01401377,0.00027250382,0.0006990966,0.001164759,0.0030317989,0.0016064813,0.003156511,0.0018617661,0.0006587533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084165536,0.00044664543,0.07140067,0.0019869402,0.00023694379,0.005933294,0.008317399,0.066634014,0.023853196,0.62886786,0.030914735,0.16056658],"study_design_scores_gemma":[0.000029865041,0.001413749,0.0896736,0.003921904,0.00043288822,0.008642524,0.013693256,0.028319778,0.019637477,0.46482122,0.36906,0.0003537156],"about_ca_topic_score_codex":0.0113161225,"about_ca_topic_score_gemma":0.011206438,"teacher_disagreement_score":0.0113161225,"about_ca_system_score_codex":0.0023411692,"about_ca_system_score_gemma":0.002135458,"threshold_uncertainty_score":0.032939196},"labels":[],"label_agreement":null},{"id":"W2066735702","doi":"10.1002/cbic.200700128","title":"CYP3A4 Activity in the Presence of Organic Cosolvents, Ionic Liquids, or Water‐Immiscible Organic Solvents","year":2007,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chemistry; Ionic liquid; Solvent; Hydroxylation; Aqueous solution; Organic chemistry; Toluene; Enzyme; Catalysis","score_opus":0.08851109300882451,"score_gpt":0.4086276546446671,"score_spread":0.32011656163584257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066735702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773485,0.0050422293,0.0041880175,0.00008920308,0.000024562005,0.000035125347,0.0005229358,0.00007977116,0.002283186],"genre_scores_gemma":[0.9860633,0.0040735705,0.0054268497,0.00007781484,0.000022025091,0.00005948267,0.0015559705,0.0000341944,0.0026869134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965596,0.00011166663,0.00003076158,0.0000689993,0.000085491476,0.000047224894],"domain_scores_gemma":[0.99978715,0.00007885257,0.000048190166,0.000015803816,0.00004841104,0.000021618447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033310565,0.00046045842,0.00026857323,0.0002527758,0.00014739101,0.0003006092,0.00014595495,0.00023399478,0.0006462815],"category_scores_gemma":[0.00050821586,0.00013874735,0.00022537679,0.000506501,0.00018766086,0.0002269105,0.00015996347,0.0003302176,0.00030579173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102736834,0.00001711389,0.00064269424,0.00004546458,0.000012608912,0.000019771745,0.000017258284,0.0000697064,0.9964855,0.000018916793,0.000023319748,0.0025449737],"study_design_scores_gemma":[0.0000036819142,0.00018963359,0.0024783942,0.0000036146548,0.000021601954,0.0000674869,0.00001425269,0.00016287867,0.99615425,0.000011368123,0.00088920764,0.0000035291573],"about_ca_topic_score_codex":0.0007493136,"about_ca_topic_score_gemma":0.00083394913,"teacher_disagreement_score":0.0007493136,"about_ca_system_score_codex":0.00016805575,"about_ca_system_score_gemma":0.00021193,"threshold_uncertainty_score":0.0021620393},"labels":[],"label_agreement":null},{"id":"W2067166101","doi":"10.1021/ac070221o","title":"High-Throughput Cytochrome P450 Inhibition Assays Using Laser Diode Thermal Desorption-Atmospheric Pressure Chemical Ionization-Tandem Mass Spectrometry","year":2007,"lang":"en","type":"article","venue":"Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phytronix (Canada)","funders":"","keywords":"Chemistry; Mass spectrometry; Atmospheric-pressure chemical ionization; Tandem mass spectrometry; Ambient ionization; Desorption electrospray ionization; Chemical ionization; Analytical Chemistry (journal); Tandem; Thermal desorption; Atmospheric pressure; Chromatography; Laser; Ionization; Desorption; Environmental chemistry; Organic chemistry; Adsorption","score_opus":0.04601591275015205,"score_gpt":0.36826010205148413,"score_spread":0.3222441893013321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067166101","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12646139,0.010949653,0.83756185,0.0005745941,0.0003315443,0.0017158701,0.005271057,0.01022058,0.0069134603],"genre_scores_gemma":[0.20292525,0.0116411615,0.76117855,0.00086950825,0.00033978967,0.003834409,0.009157394,0.00050903606,0.009544854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940627,0.0010004545,0.00039030367,0.0009084453,0.0034423245,0.0001957385],"domain_scores_gemma":[0.9980944,0.0005671103,0.00036904792,0.0002014964,0.00068262767,0.0000853458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002670395,0.0017917755,0.0013929689,0.0020241202,0.0007347962,0.0013168838,0.0016251333,0.0010876677,0.0017674126],"category_scores_gemma":[0.0021864541,0.0009078766,0.0012452791,0.001500517,0.00046857414,0.0011702981,0.001036617,0.001807277,0.003193304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016410279,0.00018678926,0.00144744,0.00025921228,0.00011558611,0.000068376976,0.000040826217,0.00046208678,0.97134566,0.00016677465,0.0007762331,0.02496706],"study_design_scores_gemma":[0.0000628317,0.00046357827,0.0059703663,0.000023335915,0.00011230429,0.00071398256,0.000017249986,0.007196466,0.97718436,0.00017540318,0.008010003,0.000070157024],"about_ca_topic_score_codex":0.0007818535,"about_ca_topic_score_gemma":0.0024657748,"teacher_disagreement_score":0.002670395,"about_ca_system_score_codex":0.00076098385,"about_ca_system_score_gemma":0.0009248644,"threshold_uncertainty_score":0.014122546},"labels":[],"label_agreement":null},{"id":"W2067493036","doi":"10.1097/01.jcp.0000085407.08426.e1","title":"Pharmacokinetic and Pharmacodynamic Evaluation of the Inhibition of Alprazolam by Citalopram and Fluoxetine","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"H. Lundbeck A/S","keywords":"Citalopram; Alprazolam; Serotonin reuptake inhibitor; Pharmacology; Fluoxetine; Reuptake inhibitor; Serotonin Uptake Inhibitors; Antidepressant; Pharmacokinetics; Drug interaction; CYP3A; Pharmacodynamics; CYP3A4; Chemistry; Cytochrome P450; Medicine; Serotonin; Internal medicine; Metabolism; Psychiatry; Receptor","score_opus":0.14907782224679142,"score_gpt":0.5354392699966413,"score_spread":0.3863614477498498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067493036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935993,0.0024661296,0.002231736,0.000108052234,0.000028576598,0.00010733772,0.00031713376,0.00005055987,0.001091187],"genre_scores_gemma":[0.99691075,0.0008828214,0.0012041889,0.000054168995,0.000035343863,0.00008173223,0.00030947255,0.000012720043,0.0005089175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994481,0.00024064574,0.000035355853,0.00006850101,0.00014410357,0.000063262334],"domain_scores_gemma":[0.9994467,0.00018315666,0.0001743985,0.00004161905,0.00006375519,0.00009032433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003758481,0.00034061974,0.00056461577,0.00023506634,0.0001832589,0.00040338194,0.0002748121,0.0004830801,0.00092268246],"category_scores_gemma":[0.0017914906,0.00025152232,0.00042900434,0.000324854,0.00030635725,0.00028532144,0.00012034148,0.0006982111,0.00028913136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026228106,0.00083864527,0.006597761,0.00021755602,0.0003776249,0.0004475678,0.00020613217,0.0025607732,0.9205853,0.00028917385,0.00053715846,0.041114174],"study_design_scores_gemma":[0.002976771,0.07629703,0.16272475,0.00003346034,0.00094288675,0.0041176905,0.00022221908,0.023019644,0.71994567,0.00027197812,0.009300732,0.00014714366],"about_ca_topic_score_codex":0.001716398,"about_ca_topic_score_gemma":0.0018104203,"teacher_disagreement_score":0.001716398,"about_ca_system_score_codex":0.00050365616,"about_ca_system_score_gemma":0.0004515447,"threshold_uncertainty_score":0.0036543012},"labels":[],"label_agreement":null},{"id":"W2067571642","doi":"10.1177/0091270008326716","title":"The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Desipramine; Paroxetine; Pharmacokinetics; CYP2D6; Pharmacology; Medicine; Cytochrome P450; Internal medicine; Antidepressant","score_opus":0.1405376604974933,"score_gpt":0.4776603833222849,"score_spread":0.3371227228247916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067571642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979479,0.0013141716,0.00010840825,0.000053840886,0.000020418434,0.000051946437,0.00012423485,0.000009125334,0.0003699165],"genre_scores_gemma":[0.9983304,0.0005319289,0.00032954905,0.00013203344,0.000048337457,0.00005451202,0.00018400492,0.000002890354,0.00038642355],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992126,0.0004448771,0.000055959084,0.00012608638,0.00010006828,0.000060326085],"domain_scores_gemma":[0.99918944,0.00030009728,0.00018719297,0.000045606823,0.00005435752,0.00022330259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009949052,0.00042557126,0.0008705242,0.00017408808,0.00018800255,0.00025076134,0.00015434717,0.0007392643,0.0010634952],"category_scores_gemma":[0.0020579405,0.00032898985,0.00046053654,0.00014610603,0.00029953237,0.00034334618,0.00015934829,0.0005345418,0.00022692347],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66143715,0.011532548,0.13647613,0.00043675082,0.0021653732,0.00065754016,0.0006531917,0.00058395416,0.06182968,0.00014696119,0.001024462,0.12305629],"study_design_scores_gemma":[0.028555254,0.33146653,0.6283804,0.000021110181,0.00087512785,0.0010318845,0.00016049712,0.0009302278,0.0061957226,0.00016195101,0.0021886148,0.00003261894],"about_ca_topic_score_codex":0.0006738363,"about_ca_topic_score_gemma":0.0010248657,"teacher_disagreement_score":0.0010634952,"about_ca_system_score_codex":0.0002698262,"about_ca_system_score_gemma":0.00016644648,"threshold_uncertainty_score":0.0052616},"labels":[],"label_agreement":null},{"id":"W2067981076","doi":"10.1016/s0009-9236(03)90530-3","title":"Domperidone As A Substrate Marker Drug for CYP3A4 and CYP3A5","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Domperidone; CYP3A4; Drug; Pharmacology; Medicine; Clinical pharmacology; Internal medicine; Cytochrome P450","score_opus":0.21800424138292177,"score_gpt":0.527010602900353,"score_spread":0.3090063615174312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067981076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91871655,0.032610256,0.029309915,0.0015549537,0.0008158829,0.00029276265,0.0015851961,0.0013141606,0.013800204],"genre_scores_gemma":[0.9752622,0.002819998,0.017372923,0.00033706066,0.00008654767,0.000053523447,0.0006141446,0.00006657004,0.003387042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986859,0.00081386266,0.000055007895,0.00014314274,0.00023294907,0.000069124704],"domain_scores_gemma":[0.9994735,0.00015898062,0.00010510753,0.00005784309,0.000100079815,0.000104519386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007734811,0.0005055416,0.0010471067,0.0006245134,0.00056302483,0.00086164346,0.0002784042,0.00088597706,0.0011612268],"category_scores_gemma":[0.0017202719,0.00038013846,0.0003573457,0.00052844087,0.00035725677,0.0005013826,0.00038711558,0.0007924137,0.0006050276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042321704,0.0008139972,0.06644198,0.0009050401,0.00046928172,0.002529921,0.0003819533,0.0019786283,0.6202586,0.0036661031,0.009701092,0.25053167],"study_design_scores_gemma":[0.001469525,0.012079841,0.09281712,0.00009863567,0.0008037586,0.014752943,0.00018402052,0.021556057,0.81442034,0.0012682845,0.0404146,0.00013489615],"about_ca_topic_score_codex":0.0018414757,"about_ca_topic_score_gemma":0.005112667,"teacher_disagreement_score":0.0018414757,"about_ca_system_score_codex":0.00075294904,"about_ca_system_score_gemma":0.00068712654,"threshold_uncertainty_score":0.0054631233},"labels":[],"label_agreement":null},{"id":"W2067982635","doi":"10.1111/j.1365-2885.2007.00821.x","title":"Reply to Robert Meyer","year":2007,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe","funders":"","keywords":"Pascal (unit); Citation; SAINT; Computer science; Library science; Information retrieval; World Wide Web; Programming language; Computer security","score_opus":0.13197839668232822,"score_gpt":0.4709440028894807,"score_spread":0.33896560620715244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067982635","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100309575,0.004334539,0.00005285212,0.93815726,0.05627983,0.000005919594,0.000019145422,0.00002032168,0.0010298075],"genre_scores_gemma":[0.0009396862,0.0008387869,0.00004517084,0.9690581,0.025594832,0.000013502746,0.000006211527,0.000014299344,0.0034893923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916328,0.0018488851,0.00072017114,0.0017549095,0.002652556,0.0013906149],"domain_scores_gemma":[0.97498864,0.012094515,0.0020577405,0.0011381509,0.0054189535,0.0043020616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008241487,0.0015872878,0.002530395,0.0014086445,0.0061695236,0.009308728,0.003992155,0.071992666,0.0099715125],"category_scores_gemma":[0.07182748,0.0013872174,0.002132076,0.0010657259,0.006926423,0.005515611,0.005297695,0.08079806,0.009700951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017632468,0.000004991979,0.00009181135,0.000037241745,0.00001635487,0.00021663037,0.00013426624,0.000017079481,0.00005909611,0.0012781979,0.99578214,0.0023446481],"study_design_scores_gemma":[0.00003429967,0.000020331205,0.00047089127,0.0003301876,0.0000317893,0.00053670903,0.0005774402,0.000048528025,0.0001144615,0.0028289903,0.99495417,0.000052337167],"about_ca_topic_score_codex":0.007407774,"about_ca_topic_score_gemma":0.011099213,"teacher_disagreement_score":0.071992666,"about_ca_system_score_codex":0.0059826663,"about_ca_system_score_gemma":0.0076298774,"threshold_uncertainty_score":0.043585658},"labels":[],"label_agreement":null},{"id":"W2068075375","doi":"10.1016/j.clpt.2003.10.006","title":"A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; UGT2B7; Morphine; Glucuronosyltransferase; Glucuronide; Chemistry; Uridine; Internal medicine; Glucuronidation; Biology; Pharmacology; Genotype; Biochemistry; Medicine; In vitro; Gene; Metabolism; RNA","score_opus":0.20729445862948895,"score_gpt":0.47151952957898674,"score_spread":0.26422507094949776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068075375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988188,0.00018188912,0.0006728258,0.000042840908,0.0000062341264,0.0000060540606,0.000092661314,0.000008264793,0.00017041496],"genre_scores_gemma":[0.9991466,0.00004970035,0.00047682907,0.000022017137,0.00001042928,0.000004979839,0.0001471611,0.0000053773883,0.00013688736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999835,0.000046410827,0.000015223495,0.000041809497,0.000035810874,0.000025771351],"domain_scores_gemma":[0.9995703,0.00016645566,0.00013207142,0.000028453263,0.00003210171,0.000070640024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013423365,0.00026752107,0.00023068415,0.0002929494,0.00012562025,0.00015623466,0.00012487918,0.00021759856,0.00091953663],"category_scores_gemma":[0.00049208006,0.000095643656,0.00026840324,0.00025426596,0.00019438379,0.000055493427,0.00013693029,0.00027262833,0.00016617546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017072344,0.0002748073,0.33373895,0.00007608429,0.00016947022,0.0051191915,0.00029921933,0.0004140872,0.6431017,0.0005476293,0.00022347835,0.014328116],"study_design_scores_gemma":[0.0002624381,0.002145666,0.87188077,0.000038169645,0.00032012493,0.03011283,0.0002314597,0.0047215815,0.08699088,0.00059838645,0.0026596882,0.000037929854],"about_ca_topic_score_codex":0.0006032343,"about_ca_topic_score_gemma":0.0006542946,"teacher_disagreement_score":0.00091953663,"about_ca_system_score_codex":0.00015670001,"about_ca_system_score_gemma":0.00013250273,"threshold_uncertainty_score":0.0030761957},"labels":[],"label_agreement":null},{"id":"W2068149117","doi":"10.1111/bcp.12475","title":"Genotype‐guided drug prescribing: a systematic review and meta‐analysis of randomized control trials","year":2014,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Medicine; Warfarin; Dosing; Adverse effect; Pharmacogenetics; Odds ratio; Internal medicine; Randomized controlled trial; Meta-analysis; Drug; Inclusion and exclusion criteria; Genotype; Pharmacology; Biology; Pathology","score_opus":0.4100241303029413,"score_gpt":0.5830695597088381,"score_spread":0.1730454294058968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068149117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024848508,0.9957469,0.00052214955,0.000185371,0.00011081946,0.00041605165,0.0003337652,0.000021853406,0.00017817215],"genre_scores_gemma":[0.09985149,0.8924166,0.0036903094,0.0008560235,0.00024407,0.0019429445,0.0007101542,0.000035226865,0.00025315545],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97956985,0.011767937,0.0050163576,0.0014848817,0.0017661495,0.00039474736],"domain_scores_gemma":[0.95916605,0.031489942,0.0062622437,0.00093613536,0.001819836,0.00032578423],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020613464,0.0033648117,0.023761716,0.008140649,0.000696838,0.003205709,0.0027847597,0.0024660043,0.0041388907],"category_scores_gemma":[0.051177356,0.0016636463,0.031664953,0.009184303,0.0009864494,0.002089145,0.0014122576,0.0021567252,0.0003644985],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029306062,0.000032921846,0.002102508,0.51062965,0.4691204,0.00011548683,0.00006954171,0.0005419107,0.00015966194,0.0001466106,0.0006967757,0.013453817],"study_design_scores_gemma":[0.0014767874,0.00031300553,0.0023679738,0.04681333,0.9466198,0.00010260046,0.000039195358,0.0002276625,0.00012782346,0.00027106743,0.0016127024,0.000027992057],"about_ca_topic_score_codex":0.005977385,"about_ca_topic_score_gemma":0.013379353,"teacher_disagreement_score":0.9793865,"about_ca_system_score_codex":0.0035796699,"about_ca_system_score_gemma":0.004592388,"threshold_uncertainty_score":0.1090157},"labels":[],"label_agreement":null},{"id":"W2068288884","doi":"10.1081/dmr-46136","title":"Regulation of Cytochrome P450 by Posttranslational Modification","year":2005,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cytochrome P450; Biology; Biochemistry; Post-translational regulation; Enzyme; Aryl hydrocarbon receptor; Phosphorylation; Gene; Transcription factor","score_opus":0.2543033041153936,"score_gpt":0.5029916058813573,"score_spread":0.24868830176596368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068288884","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82337743,0.07351683,0.072558254,0.0023520135,0.0018283048,0.00037707205,0.0016864027,0.0012587237,0.023044921],"genre_scores_gemma":[0.9682491,0.012167058,0.009320577,0.00046033858,0.00028507068,0.000107058004,0.0009829148,0.000112309084,0.00831567],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954236,0.00010111971,0.00003394653,0.00013150969,0.00010564964,0.000085424785],"domain_scores_gemma":[0.99972874,0.00003589141,0.000073254996,0.000046260473,0.00008512402,0.00003075493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004410433,0.00039755407,0.0002617632,0.00030609887,0.00026413208,0.00055214774,0.00027789132,0.00033525168,0.001974974],"category_scores_gemma":[0.00042874922,0.00015805839,0.00051465386,0.00034683506,0.00030102534,0.00044288862,0.0003162032,0.0007188274,0.0012214041],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027203216,0.000076784214,0.0015402664,0.00021131766,0.000036743993,0.000282557,0.0000707082,0.00014981179,0.9757464,0.0014960499,0.00095810764,0.01915914],"study_design_scores_gemma":[0.000027950678,0.00029164576,0.01358508,0.000021071495,0.000041875548,0.00062293577,0.000042718577,0.0011647854,0.95170224,0.0007727501,0.031708777,0.000018224],"about_ca_topic_score_codex":0.0005574105,"about_ca_topic_score_gemma":0.00042407063,"teacher_disagreement_score":0.001974974,"about_ca_system_score_codex":0.0003689275,"about_ca_system_score_gemma":0.00018060415,"threshold_uncertainty_score":0.0066069365},"labels":[],"label_agreement":null},{"id":"W2068626136","doi":"10.1016/j.jchromb.2007.02.044","title":"An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies","year":2007,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec","keywords":"Domperidone; Chemistry; Chromatography; High-performance liquid chromatography; Metabolite; Drug metabolism; Detection limit; Quantitative analysis (chemistry); Coefficient of variation; Metabolism; Biochemistry","score_opus":0.034578492918093555,"score_gpt":0.39452528455408464,"score_spread":0.3599467916359911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068626136","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1037065,0.005331065,0.881623,0.00058269134,0.0004504607,0.00072439964,0.0013209464,0.0037448553,0.0025159905],"genre_scores_gemma":[0.21808721,0.002970951,0.76718765,0.0011321651,0.00020093271,0.0008163814,0.0025288353,0.00025106338,0.0068247314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854183,0.00034968936,0.00009392398,0.00034095842,0.0005199711,0.00015366184],"domain_scores_gemma":[0.9990146,0.00033746558,0.000085288375,0.00010016512,0.00034184623,0.00012066698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012138584,0.0016241851,0.0013317246,0.0012123937,0.0006592699,0.00053776545,0.0013843686,0.0018950205,0.0017188968],"category_scores_gemma":[0.0013459674,0.00091168255,0.0007964544,0.0006510293,0.000470253,0.00071211945,0.0006585151,0.002166329,0.0020392712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013133978,0.00009526057,0.00033756462,0.000076580596,0.000024827843,0.000047475212,0.000013571905,0.00012672124,0.98231447,0.00012758632,0.00037447884,0.016330076],"study_design_scores_gemma":[0.000066201545,0.0006004068,0.0030038222,0.000014515668,0.00010576071,0.0015594172,0.000011039969,0.00463779,0.9826634,0.00014351461,0.007126122,0.00006793848],"about_ca_topic_score_codex":0.0021626644,"about_ca_topic_score_gemma":0.0054609296,"teacher_disagreement_score":0.0021626644,"about_ca_system_score_codex":0.0006936134,"about_ca_system_score_gemma":0.0014506971,"threshold_uncertainty_score":0.006419599},"labels":[],"label_agreement":null},{"id":"W2068732634","doi":"10.1002/prp2.82","title":"Modulation of<scp>CYP</scp>3a expression and activity in mice models of type 1 and type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Type 2 diabetes; Modulation (music); Type (biology); Pharmacology; Expression (computer science); Diabetes mellitus; Computational biology; Chemistry; Medicine; Computer science; Biology; Endocrinology; Physics","score_opus":0.15960501819051987,"score_gpt":0.4788953691973568,"score_spread":0.31929035100683695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068732634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98100543,0.0032024437,0.00773164,0.0006480908,0.00024214719,0.0002235441,0.00370917,0.0005447626,0.0026926354],"genre_scores_gemma":[0.9656512,0.004339619,0.01004967,0.0005547923,0.00010174204,0.0010498103,0.0048427866,0.00023957096,0.013170757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993242,0.000105285144,0.000077413635,0.00018955719,0.00016532872,0.00013813745],"domain_scores_gemma":[0.9995827,0.00003003003,0.0001460306,0.000050929673,0.0000469013,0.00014327579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004964491,0.0008742299,0.0008824689,0.001289574,0.00044122874,0.0006222795,0.00043665874,0.0008269125,0.0026424723],"category_scores_gemma":[0.00016944823,0.00048320656,0.0009623877,0.0009664136,0.000654701,0.00041620157,0.0002678881,0.0024603514,0.000708368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028969308,0.00060793373,0.0008793497,0.00012707086,0.000048768947,0.00015005586,0.000050178933,0.00016075553,0.99198663,0.00016340187,0.00024085106,0.0026881373],"study_design_scores_gemma":[0.0005942546,0.006272224,0.022568554,0.000039572475,0.00025686808,0.0007746702,0.00018120614,0.0022341844,0.95671433,0.00022391682,0.01008933,0.000050872186],"about_ca_topic_score_codex":0.0011950663,"about_ca_topic_score_gemma":0.0018999757,"teacher_disagreement_score":0.0026424723,"about_ca_system_score_codex":0.00061549176,"about_ca_system_score_gemma":0.00047015928,"threshold_uncertainty_score":0.008839965},"labels":[],"label_agreement":null},{"id":"W2068747617","doi":"10.1097/01.fpc.0000054090.48725.a2","title":"CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Nicotine; Allele; Genotype; Ethnic group; Allele frequency; Genotype frequency; Demography; CYP2E1; Medicine; Genetics; Biology; Internal medicine; Gene; Sociology","score_opus":0.07037701125279835,"score_gpt":0.3376240692111136,"score_spread":0.26724705795831527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068747617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657637,0.0013797588,0.00013476989,0.0002643137,0.000012004866,0.000014409948,0.0006116807,0.000008860736,0.0009978191],"genre_scores_gemma":[0.9984731,0.00024157252,0.00019090978,0.000042850716,0.0000114937275,0.0000046352493,0.0003703313,0.0000028581405,0.00066214515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980813,0.000023291177,0.000011185977,0.00005213308,0.00006166326,0.00004367308],"domain_scores_gemma":[0.9996222,0.000056334156,0.00014633081,0.000015430494,0.00008120485,0.000078454344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029483932,0.000317768,0.0002074908,0.0003604263,0.00040499636,0.00023347509,0.00033225914,0.00033686575,0.0025641492],"category_scores_gemma":[0.0007367149,0.00011091621,0.0002416361,0.0008471576,0.00024423745,0.00007940398,0.00013593455,0.00040610533,0.00018098581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039149876,0.00007988448,0.99217063,0.000032151944,0.00016956715,0.00020616363,0.000045701578,0.00004728167,0.0015184435,0.000050470033,0.00036270515,0.0049255597],"study_design_scores_gemma":[0.000011177939,0.000033850258,0.998922,0.0000064883684,0.00007047999,0.00035324725,0.000019487848,0.000116157426,0.00012334931,0.000014664677,0.0003274386,0.0000016300598],"about_ca_topic_score_codex":0.1290869,"about_ca_topic_score_gemma":0.12869838,"teacher_disagreement_score":0.1290869,"about_ca_system_score_codex":0.0006344703,"about_ca_system_score_gemma":0.0008333237,"threshold_uncertainty_score":0.25667107},"labels":[],"label_agreement":null},{"id":"W2068880530","doi":"10.1111/jth.12072","title":"The VKORC1 and CYP2C9 genotypes are associated with over‐anticoagulation during initiation of warfarin therapy in children","year":2012,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children; Newcastle upon Tyne Hospitals NHS Foundation Trust","keywords":"VKORC1; Warfarin; CYP2C9; Medicine; Internal medicine; Genotype; Therapeutic index; Vitamin K epoxide reductase; Scopus; Gastroenterology; Pharmacology; MEDLINE; Biology; Genetics; Atrial fibrillation; Cytochrome P450","score_opus":0.13027643020196125,"score_gpt":0.39682358600366285,"score_spread":0.26654715580170163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068880530","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.833765,0.0064428537,0.001112972,0.13412489,0.0034574992,0.000054223492,0.0011529318,0.00013558425,0.019754088],"genre_scores_gemma":[0.9659818,0.0031760975,0.0011096321,0.021759037,0.004418017,0.000026827383,0.00027555964,0.000044503406,0.0032085082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987985,0.00021961422,0.00022458393,0.00018769737,0.00029501188,0.0002745903],"domain_scores_gemma":[0.9964557,0.0017334736,0.0009015031,0.000109204855,0.0003192254,0.0004809493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047394444,0.00072305516,0.001013361,0.00085234124,0.0006656364,0.00079716585,0.0006080687,0.004121057,0.0020976],"category_scores_gemma":[0.006384523,0.00045629783,0.0010633421,0.0009958736,0.0008923222,0.00068030757,0.0003816852,0.003673006,0.0004249563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005186032,0.00014027928,0.5539856,0.00023273643,0.00019311151,0.40132722,0.000897608,0.00038114723,0.0032929908,0.0013809399,0.023381287,0.0142685305],"study_design_scores_gemma":[0.00014297957,0.0004071202,0.29321456,0.00035661933,0.00040689023,0.68314314,0.001167475,0.0013769376,0.0015987477,0.0009611868,0.017145304,0.00007912688],"about_ca_topic_score_codex":0.0061876513,"about_ca_topic_score_gemma":0.006093272,"teacher_disagreement_score":0.0061876513,"about_ca_system_score_codex":0.00082170404,"about_ca_system_score_gemma":0.0011929349,"threshold_uncertainty_score":0.012303233},"labels":[],"label_agreement":null},{"id":"W2069734969","doi":"10.1016/j.bcp.2004.04.002","title":"Signal transduction pathways implicated in the decrease in CYP1A1, 1A2 and 3A6 activity produced by serum from rabbits and humans with an inflammatory reaction","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck Canada","keywords":"Protein kinase A; Kinase; Turpentine; Protein kinase C; Signal transduction; Phosphorylation; Biochemistry; Molecular biology; Biology; Inflammation; Chemistry; Immunology","score_opus":0.04896893482873117,"score_gpt":0.352325636948419,"score_spread":0.30335670211968785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069734969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894895,0.003172497,0.004637612,0.00032623997,0.00007552978,0.000051875377,0.00018706179,0.00006934156,0.0019903434],"genre_scores_gemma":[0.99709177,0.0008088347,0.00096710713,0.00008791266,0.00003305773,0.00003190661,0.00020101505,0.0000073733568,0.00077107333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968505,0.0001175995,0.000031861506,0.000039864542,0.000047367543,0.00007840984],"domain_scores_gemma":[0.99971884,0.000053330732,0.00010349274,0.000046258338,0.000031754527,0.00004642982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045620996,0.00068222714,0.00037390503,0.00047858685,0.0003014294,0.00030373663,0.00013285925,0.0005269031,0.0023182693],"category_scores_gemma":[0.00047962193,0.00021860837,0.00057616073,0.00018658586,0.0005355916,0.00022397516,0.00020680111,0.0008169662,0.00061722007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042088344,0.00010059015,0.0025621224,0.00009259608,0.000030155325,0.0007345576,0.000099524776,0.000039816798,0.9887892,0.00031496104,0.00008439609,0.0029431481],"study_design_scores_gemma":[0.00024030794,0.0026851364,0.04866779,0.000023361416,0.00014201525,0.0035214168,0.00012730833,0.00079222664,0.9416575,0.00038609453,0.0017445907,0.000012173585],"about_ca_topic_score_codex":0.00036322494,"about_ca_topic_score_gemma":0.0002591995,"teacher_disagreement_score":0.0023182693,"about_ca_system_score_codex":0.00024088597,"about_ca_system_score_gemma":0.00017774497,"threshold_uncertainty_score":0.007755339},"labels":[],"label_agreement":null},{"id":"W2070001149","doi":"10.1097/fpc.0b013e3282f1f118","title":"Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Exon; Alternative splicing; Gene isoform; Biology; Gene; Genetics; Exon skipping; Glucuronidation; Locus (genetics); RNA splicing; Microsome; RNA","score_opus":0.08133985469911617,"score_gpt":0.37645900795841075,"score_spread":0.2951191532592946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070001149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949763,0.00028535904,0.0036839037,0.000029086752,0.000007681877,0.00002201244,0.00024398907,0.00008603667,0.0006656132],"genre_scores_gemma":[0.9936935,0.00028452728,0.0033550826,0.0000329726,0.000021917198,0.00004194421,0.0016522171,0.000044880893,0.00087307766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997801,0.000030383986,0.00001685485,0.00009094882,0.00004720415,0.000034563334],"domain_scores_gemma":[0.9997092,0.000057301902,0.00013325136,0.000032220614,0.000017355826,0.000050675833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342037,0.000544576,0.00025915183,0.0005831556,0.00018123223,0.00029445166,0.00028189563,0.00026199865,0.0013995944],"category_scores_gemma":[0.0002013024,0.0001959839,0.0005590544,0.0003963626,0.0002531308,0.00009176618,0.00031387157,0.00049009296,0.00044914676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001683783,0.000026257763,0.0044941516,0.000027270211,0.000028560271,0.00045895547,0.00003745151,0.000106352774,0.9907141,0.00014418706,0.000044215234,0.0037500765],"study_design_scores_gemma":[0.0001191069,0.0010330059,0.18313627,0.000045907324,0.000416611,0.020741846,0.00010730109,0.0042679766,0.7811074,0.00056396984,0.008402714,0.000057832898],"about_ca_topic_score_codex":0.00027158644,"about_ca_topic_score_gemma":0.00029059825,"teacher_disagreement_score":0.0013995944,"about_ca_system_score_codex":0.0002626111,"about_ca_system_score_gemma":0.00015537108,"threshold_uncertainty_score":0.0046821237},"labels":[],"label_agreement":null},{"id":"W2070312848","doi":"10.1016/s0378-4274(02)00285-0","title":"The interaction of human and bovine serum proteins with CYP3A in human liver microsomes: inhibition of testosterone 6β-hydroxylation by albumin, α-globulins, α1-acid glycoprotein and γ-globulins","year":2002,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Globulin; CYP3A; Hydroxylation; Albumin; Chemistry; Bovine serum albumin; Microsome; Biochemistry; Serum albumin; Glycoprotein; Biology; Endocrinology; Enzyme","score_opus":0.04280737593280513,"score_gpt":0.3327666058703122,"score_spread":0.28995922993750706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070312848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318635,0.003907829,0.0017720584,0.00016803925,0.000050090784,0.00001720492,0.00016355987,0.000042694737,0.0006921355],"genre_scores_gemma":[0.9962063,0.0011119519,0.0008695903,0.00004716671,0.000022101325,0.0000100311345,0.0004774687,0.000013704648,0.0012416728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967575,0.00015548102,0.000021002594,0.000038875445,0.00004560292,0.0000632532],"domain_scores_gemma":[0.99979156,0.00009897779,0.0000339582,0.000024149882,0.000024729916,0.000026664495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047617193,0.0005317656,0.0003922618,0.0002460913,0.00028895363,0.00033323557,0.00032347316,0.0005121141,0.0010545097],"category_scores_gemma":[0.0006462895,0.00027803704,0.0005052981,0.00046549542,0.00036013487,0.0002631781,0.00015448044,0.00045764385,0.00042725762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068908664,0.00023511334,0.002213182,0.00021095734,0.00017201703,0.0003464876,0.00025864417,0.0009409522,0.9812432,0.00048685598,0.00044719697,0.0065544],"study_design_scores_gemma":[0.00009780967,0.0010851332,0.0048964974,0.0000080088475,0.000070689995,0.00039053563,0.00005123597,0.0017340131,0.9896387,0.000055946042,0.0019613625,0.000010096651],"about_ca_topic_score_codex":0.005242625,"about_ca_topic_score_gemma":0.0040048556,"teacher_disagreement_score":0.005242625,"about_ca_system_score_codex":0.00060028746,"about_ca_system_score_gemma":0.0003198235,"threshold_uncertainty_score":0.010424197},"labels":[],"label_agreement":null},{"id":"W2070771447","doi":"10.1007/s00702-014-1298-8","title":"Genetic variation in CYP3A43 is associated with response to antipsychotic medication","year":2014,"lang":"en","type":"review","venue":"Journal of Neural Transmission","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Les Laboratories Pierre Fabre; Eli Lilly and Company","keywords":"Single-nucleotide polymorphism; Antipsychotic; Minor allele frequency; Brief Psychiatric Rating Scale; SNP; Internal medicine; Olanzapine; Missense mutation; Medicine; Psychology; Schizophrenia (object-oriented programming); Genotype; Psychiatry; Genetics; Psychosis; Biology; Mutation; Gene","score_opus":0.1399189130807576,"score_gpt":0.4713257361115055,"score_spread":0.3314068230307479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070771447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063244076,0.9909285,0.00048014382,0.00059170666,0.00016827683,0.000005656257,0.00008709257,0.000013295534,0.0014008682],"genre_scores_gemma":[0.03783093,0.9584476,0.0011478254,0.0005262183,0.0005208476,0.000014117994,0.0002084264,0.0000056984545,0.0012984425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99988246,0.000028353239,0.000019165083,0.000027324053,0.000034169956,0.0000083914865],"domain_scores_gemma":[0.9997094,0.00016708914,0.00007409071,0.00000675792,0.00003133765,0.000011276532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025757556,0.0003807117,0.0007501742,0.0005947018,0.000074436946,0.00032059953,0.0003331787,0.00042423158,0.0014856474],"category_scores_gemma":[0.000639147,0.00010076933,0.00042239533,0.0009964359,0.00019998828,0.00017531376,0.00020733815,0.00045299437,0.0002773109],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003515681,0.00007615406,0.013014679,0.004740357,0.00090481475,0.0008620294,0.00003747804,0.00028403947,0.0037941718,0.00079589273,0.0074989465,0.9676399],"study_design_scores_gemma":[0.00031410204,0.00076916744,0.23543271,0.0072738566,0.006525335,0.018175287,0.00028607473,0.0009471051,0.0052809813,0.0064765485,0.7183862,0.00013279551],"about_ca_topic_score_codex":0.0009922808,"about_ca_topic_score_gemma":0.0015686137,"teacher_disagreement_score":0.0014856474,"about_ca_system_score_codex":0.00014394932,"about_ca_system_score_gemma":0.0002820362,"threshold_uncertainty_score":0.0049699545},"labels":[],"label_agreement":null},{"id":"W2070840005","doi":"10.1016/j.ejpb.2008.03.019","title":"Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration","year":2008,"lang":"en","type":"article","venue":"European Journal of Pharmaceutics and Biopharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacology; Systemic administration; Chemistry; Dosage form; Cytochrome P450; Medicine; Biochemistry; Biology; In vivo; Metabolism","score_opus":0.09937835513620248,"score_gpt":0.3832758603621553,"score_spread":0.2838975052259528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070840005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732064,0.010845486,0.00920559,0.00029872524,0.00022523261,0.00017432768,0.00075642456,0.00027709975,0.005010867],"genre_scores_gemma":[0.9816049,0.00409001,0.003092137,0.00009991072,0.00008745139,0.00008969402,0.0012055397,0.00006897368,0.009661509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994584,0.00018974379,0.000038274637,0.00008987599,0.00011014525,0.00011367654],"domain_scores_gemma":[0.9996338,0.00014589426,0.000061993116,0.00007918688,0.00005021869,0.0000289366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034316306,0.00047673873,0.00073547923,0.00026430588,0.0001850028,0.0004420878,0.00025084,0.00047430216,0.0022020766],"category_scores_gemma":[0.00045885146,0.00024422584,0.00056429993,0.00028660859,0.0003171164,0.00027436155,0.0001903429,0.0008449274,0.0011875372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008520462,0.0001323252,0.0004006682,0.00012721939,0.000038544105,0.000111774476,0.00002862473,0.00007374953,0.9902417,0.00012613069,0.00032233796,0.00754485],"study_design_scores_gemma":[0.000054635748,0.00078986643,0.0026706161,0.000007274013,0.000028019533,0.00017612147,0.00001249544,0.00031755574,0.99436176,0.000023165294,0.0015544941,0.000004086099],"about_ca_topic_score_codex":0.00071107113,"about_ca_topic_score_gemma":0.0013849594,"teacher_disagreement_score":0.0022020766,"about_ca_system_score_codex":0.00027157195,"about_ca_system_score_gemma":0.00032132777,"threshold_uncertainty_score":0.0073666573},"labels":[],"label_agreement":null},{"id":"W2070880390","doi":"10.3390/ijms14048381","title":"Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis","year":2013,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; National Cancer Institute; Centre for Addiction and Mental Health; National Institutes of Health; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Centre for Addiction and Mental Health Foundation; Campbell Family Mental Health Research Institute","keywords":"CYP2A6; Nitrosamine; Carcinogen; Lung cancer; Carcinogenesis; Odds ratio; Genotype; Oncology; Nicotine; Internal medicine; Medicine; Cancer; Gastroenterology; Physiology; Chemistry; Genetics; Biology; Gene; Cytochrome P450; Metabolism; CYP3A4","score_opus":0.11285145300166753,"score_gpt":0.42800498701203527,"score_spread":0.3151535340103677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070880390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637526,0.000084090556,0.002714034,0.000054344953,0.000011772338,0.00009680675,0.00024584908,0.000020643725,0.00039714633],"genre_scores_gemma":[0.99692947,0.000047844,0.0021833898,0.000068260975,0.00001627391,0.00006960073,0.0001772557,0.000015901338,0.00049196713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811125,0.0012708881,0.000044629687,0.00028087274,0.00019926339,0.000093052986],"domain_scores_gemma":[0.997004,0.0014985688,0.00025128937,0.00060345366,0.00021515593,0.00042766187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002955211,0.00071790867,0.0005299003,0.0003808137,0.0005321923,0.0003640224,0.0004745599,0.0006099243,0.0015562514],"category_scores_gemma":[0.0043960456,0.000339886,0.0010556222,0.0003808556,0.00034381798,0.00027099336,0.00043845165,0.0009926164,0.00029339577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012683009,0.004513821,0.8968908,0.00009506158,0.0013308402,0.0029383171,0.0016257359,0.0010494873,0.060339395,0.0009393902,0.00060986204,0.016984355],"study_design_scores_gemma":[0.0009848472,0.026456416,0.95205444,0.000015530095,0.00079200085,0.0027892191,0.00034132798,0.005283186,0.0076070335,0.0006252594,0.003008382,0.000042433578],"about_ca_topic_score_codex":0.0032140925,"about_ca_topic_score_gemma":0.002167889,"teacher_disagreement_score":0.0032140925,"about_ca_system_score_codex":0.00018898603,"about_ca_system_score_gemma":0.0003541636,"threshold_uncertainty_score":0.015628874},"labels":[],"label_agreement":null},{"id":"W2070885472","doi":"10.1016/s0167-4781(00)00278-5","title":"Genomic organization of a human 5β-reductase and its pseudogene and substrate selectivity of the expressed enzyme","year":2001,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Medical Research Council","keywords":"Pseudogene; Biology; Intron; Gene; Reductase; Molecular biology; Complementary DNA; Genetics; Enzyme; Biochemistry","score_opus":0.03625721302176637,"score_gpt":0.3384614510543071,"score_spread":0.3022042380325407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070885472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792292,0.0011017488,0.014789726,0.0003146127,0.00008169087,0.00006553157,0.0025921452,0.0001674416,0.0016578364],"genre_scores_gemma":[0.97291905,0.0006694242,0.009140415,0.0002111646,0.000052624266,0.000049223094,0.0125061385,0.000098166856,0.00435379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.000021758196,0.000012297181,0.00005526493,0.000022448427,0.000021354272],"domain_scores_gemma":[0.99966574,0.00012497237,0.000043347503,0.00005652572,0.000040722996,0.000068595036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010801876,0.00033061195,0.00038508215,0.0004357786,0.00035024903,0.00045961203,0.00032848373,0.00043280702,0.0014910635],"category_scores_gemma":[0.00027166284,0.00038156263,0.00082889746,0.00032168825,0.00041478086,0.00016694845,0.00019028319,0.00074809,0.0011750477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061863253,0.00006137577,0.0011718967,0.00006649042,0.00002019693,0.0008297686,0.00011862043,0.00040395092,0.9912868,0.0010773165,0.00012369806,0.0042211344],"study_design_scores_gemma":[0.0001333223,0.0008557471,0.055864625,0.0000484767,0.00019747009,0.0047418117,0.00038794626,0.0039018942,0.9125342,0.0013789651,0.019870596,0.00008495715],"about_ca_topic_score_codex":0.001974461,"about_ca_topic_score_gemma":0.0014643639,"teacher_disagreement_score":0.001974461,"about_ca_system_score_codex":0.0003580055,"about_ca_system_score_gemma":0.00044006878,"threshold_uncertainty_score":0.004988134},"labels":[],"label_agreement":null},{"id":"W2071101196","doi":"10.1097/fpc.0b013e3282f01aa3","title":"CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine","year":2007,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"","keywords":"Perphenazine; Pharmacogenetics; Pharmacodynamics; CYP2D6; Pharmacology; Gene; Medicine; Biology; Pharmacokinetics; Genetics; Genotype","score_opus":0.035398069190745,"score_gpt":0.4098867385297899,"score_spread":0.3744886693390449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071101196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991073,0.00021830123,0.00015075383,0.000058200978,0.0000032163632,0.0000070280107,0.00021496373,0.0000040946434,0.00023611421],"genre_scores_gemma":[0.99934274,0.00006615514,0.00015601258,0.000023155342,0.000004211239,0.000003055749,0.00012843196,0.0000029819266,0.00027328177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974734,0.00005186699,0.000014584091,0.00007255524,0.00006500827,0.000048802747],"domain_scores_gemma":[0.9996306,0.0000939476,0.00014202247,0.00002492559,0.000048295562,0.000060235856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022772868,0.00028307553,0.0002679425,0.00028207066,0.00018952668,0.00030923064,0.00017293214,0.0002492943,0.0015610899],"category_scores_gemma":[0.0006859782,0.00012885848,0.0003550632,0.00052862725,0.00027362045,0.0000880951,0.000104578176,0.00032701172,0.000119024044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026933646,0.00011272192,0.9360488,0.00003715551,0.00027439758,0.000651783,0.0002246762,0.0002884319,0.049488325,0.00007981838,0.000223439,0.009877221],"study_design_scores_gemma":[0.00002575114,0.0000991833,0.99701405,0.0000015833974,0.00005007189,0.0005337201,0.000040560553,0.00026458286,0.0017485077,0.000021227708,0.00019706508,0.000003752907],"about_ca_topic_score_codex":0.030619498,"about_ca_topic_score_gemma":0.024420595,"teacher_disagreement_score":0.030619498,"about_ca_system_score_codex":0.00057408976,"about_ca_system_score_gemma":0.00044285212,"threshold_uncertainty_score":0.06088257},"labels":[],"label_agreement":null},{"id":"W2071268710","doi":"10.1039/c4cc09218j","title":"Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation","year":2014,"lang":"en","type":"article","venue":"Chemical Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Hydroxylation; Stereoselectivity; Monooxygenase; Catalysis; Chemistry; Oxidative phosphorylation; Organic chemistry; Combinatorial chemistry; Cytochrome P450; Enzyme; Biochemistry","score_opus":0.0647364823448931,"score_gpt":0.39646363939381846,"score_spread":0.33172715704892536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071268710","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23831771,0.36611277,0.23330429,0.037647806,0.004231683,0.00038006084,0.00060411886,0.0016235189,0.11777803],"genre_scores_gemma":[0.5290942,0.30022112,0.12648907,0.008051881,0.0020278692,0.0002914596,0.00055113784,0.00023675419,0.033036485],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995295,0.00014999475,0.000018881132,0.0000743281,0.0001546189,0.00007275928],"domain_scores_gemma":[0.9996024,0.00015453613,0.000037449958,0.000033358177,0.00006067752,0.00011168311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015920216,0.00068950444,0.00047696647,0.00072978006,0.00042015564,0.0017725434,0.0005943454,0.0012047746,0.0034494414],"category_scores_gemma":[0.0010026031,0.00026937743,0.0005163687,0.00062007766,0.001134398,0.0021373273,0.0018185881,0.0018129997,0.0017126789],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050374545,0.0004520925,0.001920412,0.0016445018,0.000106651445,0.00078168674,0.00089285057,0.0075735906,0.23841108,0.10764441,0.013045196,0.6270237],"study_design_scores_gemma":[0.00022241155,0.0020630404,0.0018060433,0.00063166127,0.00013364632,0.001194561,0.0007042952,0.0086268475,0.13571677,0.09364007,0.7551271,0.0001336202],"about_ca_topic_score_codex":0.00030818407,"about_ca_topic_score_gemma":0.00043149164,"teacher_disagreement_score":0.0034494414,"about_ca_system_score_codex":0.00063870335,"about_ca_system_score_gemma":0.0009532029,"threshold_uncertainty_score":0.011539519},"labels":[],"label_agreement":null},{"id":"W2071337957","doi":"10.1002/1098-2280(2000)35:4<328::aid-em7>3.0.co;2-c","title":"Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2","year":2000,"lang":"en","type":"article","venue":"Environmental and Molecular Mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mutagen; Mutagenesis; Escherichia coli; Carcinogen; Enzyme; Recombinant DNA; Quinoline; Biochemistry; Mutant; Mutation; Biology; Cytochrome P450; Enterobacteriaceae; Molecular biology; Chemistry; Genetics; Gene; Organic chemistry","score_opus":0.045951388634159616,"score_gpt":0.35495890128133684,"score_spread":0.30900751264717724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071337957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956499,0.00041491637,0.003106152,0.000044322725,0.000008362557,0.00004155824,0.00020586414,0.000042593703,0.0004864351],"genre_scores_gemma":[0.9935163,0.00034696172,0.0038342457,0.000022441165,0.0000057269217,0.00003601291,0.00078788784,0.000026414984,0.0014241087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996568,0.000097743876,0.000031969383,0.00008407378,0.00008111586,0.000048266713],"domain_scores_gemma":[0.99985206,0.000047796733,0.000035912817,0.00002941783,0.00001609999,0.00001879354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002620731,0.00042584093,0.00028834268,0.00016961199,0.000102571306,0.00019869677,0.00023137275,0.00026371033,0.0010588306],"category_scores_gemma":[0.00030164758,0.00019401548,0.00025546853,0.00015738193,0.0001674302,0.0001136192,0.00021323514,0.00034380142,0.00033893468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004304885,0.000011856297,0.000080962986,0.000007474286,0.0000020764094,0.000010715624,0.000005047073,0.00003720632,0.99948704,0.000009244645,0.0000057572684,0.00029968497],"study_design_scores_gemma":[0.000007094775,0.00019158516,0.0015237211,0.0000010152252,0.000004252278,0.000085724925,0.000007101707,0.00028581903,0.9975309,0.0000072304033,0.00035349804,0.0000020444686],"about_ca_topic_score_codex":0.000835892,"about_ca_topic_score_gemma":0.0011507488,"teacher_disagreement_score":0.0010588306,"about_ca_system_score_codex":0.00024585048,"about_ca_system_score_gemma":0.00010516068,"threshold_uncertainty_score":0.0035421252},"labels":[],"label_agreement":null},{"id":"W2071417087","doi":"10.1016/j.bcp.2004.06.005","title":"GABAA/central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A","year":2004,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"GABAA receptor; Flunitrazepam; Bicuculline; Pregnane X receptor; Chemistry; Receptor; Benzodiazepine; Agonist; Phenobarbital; Pharmacology; Molecular biology; Biology; Biochemistry; Nuclear receptor; Transcription factor; Gene","score_opus":0.04669701488331166,"score_gpt":0.38053462030408547,"score_spread":0.3338376054207738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071417087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815802,0.007207256,0.0043451036,0.0004078407,0.00008006397,0.0001409765,0.00054063206,0.0002267459,0.005471218],"genre_scores_gemma":[0.99132675,0.0020862243,0.0022377216,0.00007848009,0.000024255396,0.00004825832,0.0004913574,0.000037985432,0.0036689618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995136,0.00027997608,0.000022591232,0.00004229043,0.000065663065,0.00007585052],"domain_scores_gemma":[0.99979156,0.000045199187,0.000050984396,0.000028258453,0.000029059758,0.000054884138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005098153,0.00023874511,0.00037750276,0.00041412248,0.00021503489,0.00040163033,0.0001502294,0.00027421353,0.0022939513],"category_scores_gemma":[0.0004421601,0.0002376278,0.000240572,0.00046437283,0.00021207516,0.0002875112,0.00022787639,0.00045583336,0.0004150684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117839575,0.0007332228,0.017716106,0.00023881954,0.00012665371,0.00055793894,0.0001859996,0.0009062753,0.89974433,0.0023906988,0.0021838506,0.0634321],"study_design_scores_gemma":[0.00072613807,0.004172001,0.048112363,0.000021122141,0.0002189572,0.001870097,0.00013113167,0.004072095,0.91430384,0.00054588873,0.025795406,0.000031051415],"about_ca_topic_score_codex":0.0011331857,"about_ca_topic_score_gemma":0.0034821916,"teacher_disagreement_score":0.0022939513,"about_ca_system_score_codex":0.00045146383,"about_ca_system_score_gemma":0.0003297828,"threshold_uncertainty_score":0.007673979},"labels":[],"label_agreement":null},{"id":"W2071498240","doi":"10.1210/endo.142.2.7958","title":"Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members**This work was supported by the Medical Research Council of Canada, the Fonds de la Recherche en Sante du Quebec, and Endorecherche.","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":330,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medical Council of Canada; Université Laval","funders":"","keywords":"Glucuronidation; Steroid; UGT2B7; Chemistry; Hydroxysteroid; Farnesoid X receptor; Enzyme; Biochemistry; Biology; Hormone; Nuclear receptor; Transcription factor; Microsome; Gene","score_opus":0.36567457736892456,"score_gpt":0.48189703564911074,"score_spread":0.11622245828018618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071498240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951667,0.02361964,0.008784419,0.00043871294,0.00016600861,0.000093495335,0.010509823,0.00022158507,0.004499366],"genre_scores_gemma":[0.9351588,0.0063836016,0.0076607605,0.00022785628,0.00012367802,0.000152032,0.038030855,0.00014769522,0.0121148545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969375,0.000034030152,0.00002550377,0.0001167243,0.00006827845,0.000061748826],"domain_scores_gemma":[0.9997857,0.000031889365,0.000036848447,0.000025989542,0.00007433942,0.000045259745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027310674,0.00054497604,0.00036247738,0.000842933,0.0002885781,0.00071113714,0.00016665182,0.00034953823,0.0023742286],"category_scores_gemma":[0.0005447418,0.000166383,0.00045530245,0.0010151201,0.00020856765,0.00020532617,0.00020986747,0.00037328762,0.0014505017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019479581,0.00012803654,0.02551194,0.00026133753,0.0002829953,0.00038572587,0.00018249903,0.00030216188,0.93355525,0.0003745096,0.0024919445,0.03457568],"study_design_scores_gemma":[0.00013036875,0.00079888164,0.42188847,0.000044630608,0.00038262262,0.006093879,0.00022655266,0.0056826775,0.5028629,0.0003296589,0.0614999,0.000059458438],"about_ca_topic_score_codex":0.0049646613,"about_ca_topic_score_gemma":0.0027136868,"teacher_disagreement_score":0.0049646613,"about_ca_system_score_codex":0.00045899337,"about_ca_system_score_gemma":0.00025327274,"threshold_uncertainty_score":0.009871483},"labels":[],"label_agreement":null},{"id":"W2071524497","doi":"10.2174/1389200043335559","title":"Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection","year":2004,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Inflammation; Cytochrome P450; Drug; Drug metabolism; Cytochrome; Biology; Biotransformation; Pharmacology; Immunology; Enzyme; Biochemistry","score_opus":0.0914768666611086,"score_gpt":0.42805996022643555,"score_spread":0.33658309356532695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071524497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047791534,0.9961278,0.0003409971,0.0002365619,0.0001444256,0.000006033329,0.00001926876,0.000013254848,0.0026337234],"genre_scores_gemma":[0.0035244976,0.9920402,0.00028780435,0.00013652239,0.00018543577,0.000008008873,0.000036417237,0.0000022173977,0.003778846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985135,0.000028795737,0.000015368085,0.000029310386,0.000058976482,0.000016125687],"domain_scores_gemma":[0.99988043,0.000038789407,0.000023764054,0.0000058016467,0.000039874954,0.000011316094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028619246,0.0005842714,0.0007752414,0.0011589432,0.00023524144,0.00066711067,0.0004988235,0.00081086543,0.0029350382],"category_scores_gemma":[0.00029712956,0.00019928285,0.0002694866,0.0017365484,0.00038611493,0.0009269035,0.0003119406,0.0008390433,0.0026255446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010795387,0.00008868415,0.00045202978,0.006939688,0.000049178605,0.0006310086,0.00006957341,0.0005184386,0.008893477,0.0027607214,0.024153728,0.9553355],"study_design_scores_gemma":[0.000020526473,0.00015971123,0.0033061723,0.00091986475,0.00005912642,0.004354002,0.00006783954,0.00018105283,0.0044642906,0.0028451127,0.9836045,0.00001779633],"about_ca_topic_score_codex":0.001233751,"about_ca_topic_score_gemma":0.0020039731,"teacher_disagreement_score":0.0029350382,"about_ca_system_score_codex":0.0005494839,"about_ca_system_score_gemma":0.0005554223,"threshold_uncertainty_score":0.009818733},"labels":[],"label_agreement":null},{"id":"W2071537307","doi":"10.1016/j.abb.2003.11.019","title":"Functional characterization of four allelic variants of human cytochrome P450 1A2","year":2003,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Allele; Genetics; Biology; Gene","score_opus":0.06298303521208766,"score_gpt":0.34596978596900635,"score_spread":0.2829867507569187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071537307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975666,0.000164587,0.0013904503,0.00007332942,0.000021170454,0.000013121287,0.00039469887,0.000012228355,0.00036387955],"genre_scores_gemma":[0.99855584,0.000057444035,0.000504801,0.000032204625,0.00000875392,0.0000062451577,0.0004232845,0.000013074537,0.00039834378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997961,0.000047631387,0.00003456336,0.00005125075,0.000040132454,0.000030321977],"domain_scores_gemma":[0.9996934,0.000105764506,0.00006676562,0.000032449712,0.00004788445,0.000053799744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019060842,0.00037718026,0.00021917964,0.00044564705,0.00019497926,0.0002788922,0.00024064699,0.00030449106,0.001317407],"category_scores_gemma":[0.0007117067,0.00010967422,0.00028370938,0.00030457816,0.0002969186,0.000108718246,0.00020771587,0.0004526689,0.00023719319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085996935,0.00012851045,0.020264758,0.000041022577,0.00010372117,0.0021785232,0.00022924675,0.0003030265,0.96930444,0.0006356289,0.00017379671,0.005777408],"study_design_scores_gemma":[0.00036377463,0.0016913648,0.25080314,0.00002161183,0.0004934772,0.033982486,0.00055111037,0.004489326,0.69802856,0.00090745225,0.008606375,0.00006123676],"about_ca_topic_score_codex":0.0014187146,"about_ca_topic_score_gemma":0.0008602848,"teacher_disagreement_score":0.0014187146,"about_ca_system_score_codex":0.00015667535,"about_ca_system_score_gemma":0.00010603319,"threshold_uncertainty_score":0.0044071674},"labels":[],"label_agreement":null},{"id":"W2071759664","doi":"10.1124/dmd.31.9.1134","title":"BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"U.S. Public Health Service","keywords":"Biotransformation; Microsome; Human lung; Microsoma; Chemistry; Carcinogen; In vitro; Peripheral; Lung; Pharmacology; Toxicology; Biochemistry; Biology; Medicine; Enzyme; Internal medicine","score_opus":0.03190195871812364,"score_gpt":0.37676368776488006,"score_spread":0.34486172904675644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071759664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904587,0.0014513583,0.005071972,0.00007564177,0.000029705057,0.000049761034,0.0007155793,0.00009941673,0.0020478894],"genre_scores_gemma":[0.9929367,0.00073950837,0.0015141644,0.0000186752,0.000011189578,0.000037741138,0.00094751315,0.000023545745,0.0037709747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997203,0.00010542516,0.000016810387,0.000063103165,0.000037271224,0.00005712047],"domain_scores_gemma":[0.9997516,0.00010234072,0.000033092412,0.000040138973,0.000036304307,0.000036450707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038799582,0.00037043198,0.00038355312,0.0003581796,0.0006026565,0.0003449969,0.00022764708,0.00035634264,0.002057302],"category_scores_gemma":[0.00064127886,0.00030041122,0.0003843331,0.0003683276,0.00023722937,0.00040994346,0.00025285844,0.0004102368,0.0009368812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004405986,0.00017883717,0.006516555,0.00019775657,0.00010736377,0.000625385,0.00033245268,0.0012651184,0.9726345,0.0009317608,0.00023004596,0.012574244],"study_design_scores_gemma":[0.000046699115,0.00078311417,0.016359417,0.000011122497,0.00007644829,0.0005327419,0.000097949654,0.0026320035,0.9781935,0.00015327931,0.0010977915,0.000015983436],"about_ca_topic_score_codex":0.008119784,"about_ca_topic_score_gemma":0.009734665,"teacher_disagreement_score":0.008119784,"about_ca_system_score_codex":0.0005837657,"about_ca_system_score_gemma":0.0009592811,"threshold_uncertainty_score":0.01614505},"labels":[],"label_agreement":null},{"id":"W2072017244","doi":"10.1002/cbic.200900318","title":"Mechanistic Insights into the Cytochrome P450‐Mediated Oxidation and Rearrangement of Littorine in Tropane Alkaloid Biosynthesis","year":2009,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Plant Biotechnology Institute","funders":"","keywords":"Chemistry; Tropane; Hydroxylation; Carbocation; Stereochemistry; Iminium; Hyoscyamine; Reaction intermediate; Medicinal chemistry; Organic chemistry; Enzyme; Catalysis; Biochemistry","score_opus":0.048090260856575924,"score_gpt":0.37113188624620275,"score_spread":0.32304162538962683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072017244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632263,0.012207858,0.013084037,0.0011667231,0.00007829957,0.000101690195,0.00026381714,0.00012276384,0.009748477],"genre_scores_gemma":[0.9921349,0.00408266,0.0022506386,0.0001160131,0.000020753796,0.00002141398,0.00012514685,0.000008886549,0.0012396488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999273,0.000015810343,0.0000037443501,0.000016539892,0.000017615928,0.000019046705],"domain_scores_gemma":[0.9999212,0.000021548636,0.000020297353,0.000007750824,0.000011393843,0.000017769396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024858298,0.00045296416,0.0001993182,0.00014755737,0.0001948042,0.00034481013,0.00028385414,0.00054504594,0.0014747629],"category_scores_gemma":[0.00013488674,0.00014577928,0.00025278758,0.0000920864,0.00038190198,0.0006587511,0.00020800425,0.0007035211,0.0003647606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028424748,0.00006137161,0.0012533613,0.00022272045,0.000018196497,0.0008386394,0.00013271917,0.0011604306,0.98561674,0.002917915,0.00010780498,0.007385941],"study_design_scores_gemma":[0.000068747635,0.0009818673,0.012785042,0.000045042863,0.000054901688,0.0023074027,0.00040052176,0.010807181,0.9586447,0.0040779924,0.009776734,0.00004988188],"about_ca_topic_score_codex":0.00049844774,"about_ca_topic_score_gemma":0.000777466,"teacher_disagreement_score":0.0014747629,"about_ca_system_score_codex":0.00045382985,"about_ca_system_score_gemma":0.0002501777,"threshold_uncertainty_score":0.0049335957},"labels":[],"label_agreement":null},{"id":"W2072346051","doi":"10.1016/s1359-6446(05)03394-5","title":"Peroxidases: a role in the metabolism and side effects of drugs","year":2005,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peroxidase; Metabolite; Cytochrome P450; Drug metabolism; Chemistry; Biochemistry; Drug; Metabolism; Enzyme; Oxidative stress; Cytotoxicity; Pharmacology; Biology; In vitro","score_opus":0.04769646468540292,"score_gpt":0.4093106950513331,"score_spread":0.3616142303659302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072346051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004412487,0.9975776,0.00074855133,0.00028495464,0.00013479135,0.000003776346,0.000014170099,0.00001346786,0.00078148115],"genre_scores_gemma":[0.0025351476,0.994918,0.00064664637,0.00013869363,0.00024015082,0.000006144795,0.000042190914,0.000001962216,0.0014710587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998196,0.000029842615,0.000020188365,0.000040772247,0.000069763366,0.000019985519],"domain_scores_gemma":[0.9997578,0.000094803945,0.000051992833,0.000010693615,0.000060435435,0.000024292443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064656156,0.0010485622,0.0014271886,0.0012990754,0.00022912606,0.0011262622,0.0008862444,0.0010889496,0.0019128796],"category_scores_gemma":[0.0003580084,0.0003350347,0.00047944664,0.0019038491,0.00065105193,0.0011776665,0.00061261066,0.0015264294,0.0016549913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013960364,0.000075176395,0.00050868327,0.0055022,0.00010233295,0.00045273307,0.000060270704,0.00039947577,0.01183493,0.004430252,0.011570839,0.96492344],"study_design_scores_gemma":[0.00003959298,0.00014794117,0.0015023932,0.00065372826,0.00015575966,0.002749405,0.000062071704,0.00022152565,0.0055781696,0.004552231,0.98431176,0.00002542636],"about_ca_topic_score_codex":0.0006534029,"about_ca_topic_score_gemma":0.0011186625,"teacher_disagreement_score":0.0019128796,"about_ca_system_score_codex":0.0005655004,"about_ca_system_score_gemma":0.0006978047,"threshold_uncertainty_score":0.006399274},"labels":[],"label_agreement":null},{"id":"W2072370222","doi":"10.1016/s0006-2952(00)00247-1","title":"Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2","year":2000,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Endocrinology; Hypophysectomy; Messenger RNA; Testosterone (patch); Hormone; Biology; Medicine; Gene","score_opus":0.040511619622718605,"score_gpt":0.3602781545237984,"score_spread":0.3197665349010798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072370222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227554,0.002665246,0.0012650739,0.000204698,0.000047675952,0.000013400942,0.0012355971,0.000091855305,0.0022009583],"genre_scores_gemma":[0.9892625,0.0011253095,0.001028646,0.00010821975,0.000020904878,0.000030411196,0.001341624,0.00006559647,0.0070167477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986744,0.000015335347,0.000008427145,0.000033882585,0.000024440395,0.00005046012],"domain_scores_gemma":[0.99961424,0.00008825998,0.00008239085,0.00004273916,0.000065097505,0.000107342385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118273594,0.00030055243,0.00024870533,0.00065603165,0.00025282736,0.00048341067,0.00014880642,0.00019305886,0.002270432],"category_scores_gemma":[0.00028978568,0.00027370785,0.00039564003,0.00029872614,0.0004675212,0.00028082854,0.00028092437,0.00059372565,0.0004020971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001701044,0.000047304762,0.0054212427,0.000029553903,0.000017329612,0.00023868348,0.00012988599,0.00008640776,0.9865124,0.00042645013,0.00019591392,0.0051938496],"study_design_scores_gemma":[0.00007709213,0.00053124875,0.22565034,0.000016477914,0.00007159872,0.0006816645,0.0003848653,0.0007320558,0.76512206,0.00029990092,0.006405441,0.000027174381],"about_ca_topic_score_codex":0.0082038175,"about_ca_topic_score_gemma":0.013365445,"teacher_disagreement_score":0.0082038175,"about_ca_system_score_codex":0.0010094768,"about_ca_system_score_gemma":0.0004667337,"threshold_uncertainty_score":0.016312122},"labels":[],"label_agreement":null},{"id":"W2073056252","doi":"10.1067/mcp.2001.116892","title":"Red wine–cisapride interaction: Comparison with grapefruit juice","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cisapride; Grapefruit juice; Pharmacokinetics; Crossover study; Citrus paradisi; Pharmacology; Area under the curve; Chemistry; Wine; Drug interaction; Oral administration; Medicine; Food science; Placebo; Rutaceae; Botany; Biology","score_opus":0.36433467423857135,"score_gpt":0.5632199207657329,"score_spread":0.19888524652716155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073056252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786735,0.0017103313,0.000093733164,0.000025015912,0.000018937626,0.000040886785,0.000054815195,0.0000051350585,0.0001837772],"genre_scores_gemma":[0.9981608,0.0008688217,0.0002849921,0.000088604844,0.0000543428,0.000025570667,0.00015080474,0.00000467376,0.00036149207],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99945194,0.0002847613,0.00003112766,0.000107144355,0.000082840554,0.00004230892],"domain_scores_gemma":[0.99943155,0.00022559786,0.0001564645,0.00002933023,0.00005191671,0.00010506554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074516324,0.00054101675,0.0010380514,0.00018521426,0.00019345188,0.00048205594,0.00020150558,0.0005065959,0.0013472082],"category_scores_gemma":[0.0011310914,0.00021242951,0.0010250492,0.00015047297,0.00031841427,0.00037201867,0.00016668742,0.00040485358,0.00013733761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6665439,0.0056820414,0.11791112,0.0014261741,0.0064402306,0.00061481504,0.00037688145,0.00078692386,0.13854128,0.00011477809,0.00032722394,0.061234545],"study_design_scores_gemma":[0.013682613,0.27931875,0.66413915,0.000079610545,0.006235134,0.0011756473,0.00021871708,0.0036494639,0.02793451,0.00016083167,0.0033267303,0.000078812365],"about_ca_topic_score_codex":0.001496942,"about_ca_topic_score_gemma":0.0018490956,"teacher_disagreement_score":0.001496942,"about_ca_system_score_codex":0.00035777845,"about_ca_system_score_gemma":0.0002612436,"threshold_uncertainty_score":0.004506886},"labels":[],"label_agreement":null},{"id":"W2073220539","doi":"10.14797/mdcj-10-1-13","title":"Cardiovascular Drugs and the Genetic Response","year":2014,"lang":"en","type":"review","venue":"Methodist DeBakey Cardiovascular Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Webcast; MEDLINE; Medical education; Subject (documents); Subject matter; Library science; World Wide Web","score_opus":0.1187944786931287,"score_gpt":0.4428088466873386,"score_spread":0.3240143679942099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073220539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002221025,0.9925882,0.00010839143,0.0031819206,0.00082718505,0.0000037970653,0.000018891553,0.000012154247,0.003037389],"genre_scores_gemma":[0.0053625954,0.9873898,0.00018961704,0.003176607,0.0011441148,0.00000907913,0.000043463315,0.0000036079373,0.0026812223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999629,0.00011940873,0.00004091856,0.00004570275,0.00013043289,0.000034523193],"domain_scores_gemma":[0.9992854,0.0004277017,0.00009455468,0.00002294718,0.0001277792,0.00004156886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053922797,0.00042950318,0.00064814463,0.0011991754,0.00025331354,0.0009126607,0.00036842452,0.0013452793,0.0067717233],"category_scores_gemma":[0.0017291789,0.00013891654,0.00042268008,0.00094290695,0.0005521286,0.0007144851,0.00048031693,0.0020012883,0.0021880297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000666551,0.00006801164,0.00045429543,0.004572526,0.00009440167,0.00068614155,0.00007724867,0.00015611165,0.00074823335,0.0063670413,0.10307615,0.8836332],"study_design_scores_gemma":[0.00003098309,0.00007681813,0.0021454177,0.0043236846,0.00007991569,0.0058490527,0.00010139866,0.00007733744,0.00052162225,0.0045029833,0.98227066,0.000020043695],"about_ca_topic_score_codex":0.0008183655,"about_ca_topic_score_gemma":0.0011739715,"teacher_disagreement_score":0.0067717233,"about_ca_system_score_codex":0.00047416743,"about_ca_system_score_gemma":0.00073379447,"threshold_uncertainty_score":0.02265364},"labels":[],"label_agreement":null},{"id":"W2073499207","doi":"10.1271/bbb.50656","title":"Production of α,ω-Alkanediols Using<i>Escherichia coli</i>Expressing a Cytochrome P450 from<i>Acinetobacter</i>sp. OC4","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Ministry of Economy, Trade and Industry; University of Melbourne","keywords":"Biotransformation; Incubation; Bioproduction; Inducer; Escherichia coli; Cytochrome P450; Octane; Chemistry; Cytochrome; Incubation period; Biochemistry; Chromatography; Enzyme; Organic chemistry; Gene","score_opus":0.044698512060910155,"score_gpt":0.3464899682505736,"score_spread":0.30179145618966347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073499207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725008,0.00085878634,0.021695532,0.00023068766,0.00010531427,0.00017084072,0.0011164848,0.00025349183,0.0030680925],"genre_scores_gemma":[0.952928,0.0011189479,0.038586937,0.000085409876,0.000019809788,0.00007972526,0.002608148,0.000146796,0.0044262297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960154,0.00008393951,0.000051282917,0.000076228935,0.00013000297,0.000057006866],"domain_scores_gemma":[0.9997565,0.000042343487,0.00008279723,0.000035736455,0.00005313845,0.00002945443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002865086,0.0007066352,0.00039266396,0.0002111893,0.00016971843,0.00041708432,0.00024227233,0.00033197703,0.00064247695],"category_scores_gemma":[0.00035774772,0.00016751948,0.00035846705,0.00036241088,0.00017763078,0.00027577323,0.00031312977,0.0005643008,0.0006286366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002232312,0.00002107402,0.00015754033,0.0000358994,0.0000038055,0.000034457506,0.000007814175,0.0000669851,0.9982791,0.000028206745,0.000021955268,0.0013208],"study_design_scores_gemma":[0.0000027332019,0.00007753353,0.00033538134,0.0000023537552,0.00000596544,0.000052252803,0.0000088556,0.00017166023,0.99853337,0.000008859148,0.00079861324,0.0000024403864],"about_ca_topic_score_codex":0.0009650637,"about_ca_topic_score_gemma":0.0009552808,"teacher_disagreement_score":0.0009650637,"about_ca_system_score_codex":0.00034886223,"about_ca_system_score_gemma":0.0002772223,"threshold_uncertainty_score":0.0025312304},"labels":[],"label_agreement":null},{"id":"W2073582856","doi":"10.1038/sj.clpt.6100246","title":"Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; NIH Clinical Center; National Institutes of Health; National Center for Research Resources; National Institute on Drug Abuse; Canada Research Chairs","keywords":"CYP2A6; Nicotine; Cotinine; In vivo; Genotype; Pharmacology; Metabolism; Chemistry; Biology; Medicine; Endocrinology; Internal medicine; Genetics; Cytochrome P450; Biochemistry; CYP1A2; Gene","score_opus":0.17446933955008317,"score_gpt":0.4823130279593351,"score_spread":0.3078436884092519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073582856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998147,0.00042562562,0.0008251724,0.000087985565,0.000016120075,0.000016403093,0.00014972774,0.00001585122,0.0003161612],"genre_scores_gemma":[0.998211,0.00009130357,0.00078717264,0.00008485629,0.000034269873,0.000013849132,0.00018470653,0.000023463102,0.0005693693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961805,0.00010339067,0.000029661807,0.00014594234,0.00007235191,0.000030630443],"domain_scores_gemma":[0.99948573,0.00009819407,0.00018624314,0.000047298698,0.000048853854,0.00013371698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110345,0.00043713537,0.0006254677,0.00047990071,0.00026065373,0.0004148564,0.00018519237,0.0005804664,0.0024750612],"category_scores_gemma":[0.0009425886,0.00018992646,0.00031021363,0.00040345022,0.00029475865,0.0001133744,0.00017703812,0.000642553,0.00041684168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055665327,0.0006514459,0.7540733,0.00009226638,0.00036856078,0.0033127984,0.00057761243,0.0001245396,0.21873726,0.00044210049,0.00066257926,0.015391016],"study_design_scores_gemma":[0.0001691251,0.0008065099,0.9831724,0.000010052715,0.00010105674,0.008532748,0.00006975665,0.00047069334,0.005412473,0.0001371886,0.0011051215,0.00001298215],"about_ca_topic_score_codex":0.0007520982,"about_ca_topic_score_gemma":0.0005090054,"teacher_disagreement_score":0.0024750612,"about_ca_system_score_codex":0.00011115931,"about_ca_system_score_gemma":0.000074510885,"threshold_uncertainty_score":0.00827986},"labels":[],"label_agreement":null},{"id":"W2074172198","doi":"10.1007/s40142-012-0001-3","title":"Pharmacogenetic Advances in Cardiovascular Medicine: Relevance to Personalized Medicine","year":2013,"lang":"en","type":"article","venue":"Current Genetic Medicine Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Medicine; Precision medicine; Relevance (law); Internal medicine; Bioinformatics; Biology; Pathology","score_opus":0.09413028705879177,"score_gpt":0.44987497641419427,"score_spread":0.3557446893554025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074172198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06812949,0.43147644,0.16172388,0.28932753,0.003986841,0.00015280674,0.0014122392,0.0005624591,0.04322821],"genre_scores_gemma":[0.5001353,0.3282942,0.10426459,0.03591973,0.025564417,0.00012760784,0.000894017,0.00014063902,0.0046595237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982906,0.00093825883,0.0001323249,0.0002332556,0.00033459163,0.00007092738],"domain_scores_gemma":[0.99253523,0.005308317,0.0007810329,0.0005968737,0.0005330051,0.00024549506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041020266,0.0006854283,0.0013004501,0.0018486881,0.0003971637,0.0023857595,0.0012070748,0.002275024,0.003660344],"category_scores_gemma":[0.007649851,0.00032893877,0.0007919786,0.0017601363,0.0016407016,0.0030400022,0.00095362164,0.0037191743,0.00072719925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071637204,0.0008266746,0.07068422,0.0017945779,0.00091147434,0.002407189,0.00043901507,0.0056271316,0.018662648,0.15087825,0.021276817,0.72577566],"study_design_scores_gemma":[0.00026464253,0.0008731038,0.092944294,0.0017288901,0.0014542589,0.009354004,0.00079768704,0.015434865,0.010383831,0.6203108,0.24620494,0.00024874927],"about_ca_topic_score_codex":0.0007092303,"about_ca_topic_score_gemma":0.0010947656,"teacher_disagreement_score":0.0041020266,"about_ca_system_score_codex":0.0008898133,"about_ca_system_score_gemma":0.0014956882,"threshold_uncertainty_score":0.021693826},"labels":[],"label_agreement":null},{"id":"W2074185276","doi":"10.1016/j.jaut.2007.02.008","title":"Pharmacogenomics and its implications for autoimmune disease","year":2007,"lang":"en","type":"article","venue":"Journal of Autoimmunity","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Dosing; Disease; Drug; Drug reaction; Pharmacogenetics; Intensive care medicine; Bioinformatics; Pharmacology; Internal medicine; Genetics; Biology; Genotype","score_opus":0.1606746833126483,"score_gpt":0.47461913176092524,"score_spread":0.31394444844827696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074185276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63085175,0.13871907,0.04541445,0.13214841,0.0013534589,0.000044607506,0.0008299655,0.00020081624,0.05043747],"genre_scores_gemma":[0.97586435,0.013880757,0.0049538813,0.0025128536,0.0012421282,0.000012418771,0.00006380153,0.000011344273,0.0014585548],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995104,0.0003346792,0.000022375118,0.000044955057,0.000059968123,0.00002757446],"domain_scores_gemma":[0.9976178,0.0017707242,0.00024996887,0.00012178873,0.0001305332,0.00010913168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013484855,0.00027918298,0.000517182,0.00086851546,0.0003011749,0.0010474704,0.00025757408,0.0010314707,0.0024757101],"category_scores_gemma":[0.0033610128,0.00012740491,0.00026403184,0.00078244234,0.0009305962,0.00075119897,0.00032048032,0.0010856496,0.00022197103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030546254,0.00079290185,0.36198008,0.000639893,0.0009265776,0.010549247,0.00055991614,0.007818953,0.033387966,0.20796159,0.01004564,0.36228254],"study_design_scores_gemma":[0.00020696032,0.0008694662,0.24490297,0.00017399577,0.0005910253,0.017886585,0.00067505386,0.015252162,0.0073273955,0.658883,0.053158607,0.000072840136],"about_ca_topic_score_codex":0.00028411648,"about_ca_topic_score_gemma":0.00038506254,"teacher_disagreement_score":0.0024757101,"about_ca_system_score_codex":0.00030103564,"about_ca_system_score_gemma":0.00035135166,"threshold_uncertainty_score":0.008282065},"labels":[],"label_agreement":null},{"id":"W2074828925","doi":"10.1080/00498250050077986","title":"Metabolic activity of fresh and cryopreserved cynomolgus monkey (<i>Macaca fascicularis</i>) hepatocytes","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Hepatocyte; Chemistry; Cryopreservation; Incubation; Glutathione; Microsome; Biochemistry; Enzyme; In vitro; Biology","score_opus":0.06825649116434354,"score_gpt":0.3810317269194958,"score_spread":0.3127752357551522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074828925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887494,0.0052935164,0.0019476943,0.00009098297,0.000064951004,0.000047778783,0.0015086355,0.00006482292,0.0022321888],"genre_scores_gemma":[0.9816898,0.0024265351,0.004990719,0.000119543474,0.000055472392,0.00012790272,0.005334021,0.00005474472,0.0052012964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998429,0.000031010535,0.000021807322,0.000040863782,0.00003133765,0.00003211708],"domain_scores_gemma":[0.9998054,0.000040348536,0.000032666332,0.00003254528,0.000062836305,0.000026220712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025019297,0.000382728,0.00033717148,0.00024498635,0.00020668795,0.00032102127,0.00020568729,0.00018749076,0.0011830122],"category_scores_gemma":[0.00026758687,0.000098041986,0.00035572285,0.00030762752,0.00022338421,0.00028722407,0.0001580201,0.00031146896,0.00036417792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009979836,0.000039024053,0.0026680732,0.000072807175,0.000041426003,0.00015624336,0.00009787032,0.00019618683,0.99011445,0.000043834352,0.000104591265,0.005467529],"study_design_scores_gemma":[0.000025454216,0.002034594,0.039603595,0.00001917605,0.0001670213,0.0004664257,0.000139934,0.0013533953,0.95166975,0.00005765467,0.004441723,0.00002139141],"about_ca_topic_score_codex":0.002855472,"about_ca_topic_score_gemma":0.0037516032,"teacher_disagreement_score":0.002855472,"about_ca_system_score_codex":0.00030305458,"about_ca_system_score_gemma":0.0002115307,"threshold_uncertainty_score":0.0056777},"labels":[],"label_agreement":null},{"id":"W2075029351","doi":"10.1371/journal.pone.0086435","title":"CYB5D2 Requires Heme-Binding to Regulate HeLa Cell Growth and Confer Survival from Chemotherapeutic Agents","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"University of Illinois at Urbana-Champaign; McMaster University","keywords":"Heme; Biology; HeLa; Biochemistry; Cytochrome P450 reductase; Cytochrome b5; Gene knockdown; Cytochrome; Cell biology; Cytochrome P450; Cytochrome c; Cell; Coenzyme Q – cytochrome c reductase; Apoptosis; Metabolism; Enzyme","score_opus":0.18251045212163602,"score_gpt":0.37310082931436056,"score_spread":0.19059037719272454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075029351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988533,0.001928624,0.0031598753,0.0002484657,0.000042633445,0.00003908565,0.0015237143,0.00011049229,0.0044140727],"genre_scores_gemma":[0.99021274,0.0005482763,0.0021680943,0.000114096845,0.0000058662636,0.00005457126,0.0021139598,0.000026956828,0.0047553075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985695,0.000014413647,0.000012216089,0.000038141858,0.00004190594,0.00003638772],"domain_scores_gemma":[0.9999516,0.000006197478,0.000009654633,0.000007914941,0.000008026904,0.000016612381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080184065,0.00022268605,0.00020680543,0.00014132468,0.00026702162,0.00022930001,0.00018232384,0.0002719453,0.0011274273],"category_scores_gemma":[0.00008117266,0.00012571288,0.00018914233,0.00014520827,0.0001527625,0.00011608736,0.00020038894,0.00032031993,0.0004713004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042087504,0.000010906673,0.00013359777,0.000016967228,0.000002197139,0.000031427713,0.000008100731,0.00003495762,0.9991177,0.000087575805,0.00006583151,0.00044880607],"study_design_scores_gemma":[0.000013604257,0.00006254456,0.006341249,0.0000053821864,0.0000087802355,0.00019866822,0.000029389372,0.0017975046,0.9861522,0.000025285884,0.005361769,0.0000035111111],"about_ca_topic_score_codex":0.0024083056,"about_ca_topic_score_gemma":0.0039316462,"teacher_disagreement_score":0.0024083056,"about_ca_system_score_codex":0.000659466,"about_ca_system_score_gemma":0.00024476385,"threshold_uncertainty_score":0.004788637},"labels":[],"label_agreement":null},{"id":"W2075089790","doi":"10.1097/fpc.0b013e3283330767","title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institute of Environmental Health Sciences; National Institute on Deafness and Other Communication Disorders; National Institutes of Health","keywords":"Glucuronidation; Complementary DNA; Molecular biology; Recombinant DNA; Biology; genomic DNA; Exon; Glucuronosyltransferase; UGT2B7; Chemistry; Biochemistry; Gene; Enzyme; Microsome","score_opus":0.05646111701490544,"score_gpt":0.36415622683245163,"score_spread":0.3076951098175462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075089790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245778,0.012483227,0.043572973,0.001174836,0.00039874786,0.0005653131,0.011201311,0.00060254993,0.005423255],"genre_scores_gemma":[0.8241007,0.011896271,0.08897986,0.0004446764,0.00037899494,0.000701619,0.05055974,0.00038360214,0.02255461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974746,0.000034465138,0.000021412567,0.00008023738,0.000082267245,0.000034200355],"domain_scores_gemma":[0.9998753,0.000019459661,0.000023720233,0.000017078624,0.000035382196,0.000029071367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033322824,0.0004841397,0.00045020398,0.0003630309,0.00028945875,0.00049136556,0.0002940794,0.00054466084,0.0018312443],"category_scores_gemma":[0.00033565224,0.00021619789,0.0005677214,0.000745322,0.0002961482,0.00029545615,0.00017570067,0.0005933676,0.0013462706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002173649,0.00004360527,0.00065175735,0.00012875165,0.000018172526,0.00014522702,0.000029208622,0.00020168565,0.9936215,0.0001888362,0.0003882842,0.0043657073],"study_design_scores_gemma":[0.00011366009,0.000396975,0.015639551,0.00002512891,0.00014377071,0.0033598216,0.00004802035,0.004682197,0.9276226,0.00022097767,0.047715012,0.000032222248],"about_ca_topic_score_codex":0.0012163422,"about_ca_topic_score_gemma":0.0012256089,"teacher_disagreement_score":0.0018312443,"about_ca_system_score_codex":0.00042268148,"about_ca_system_score_gemma":0.00044047544,"threshold_uncertainty_score":0.006126106},"labels":[],"label_agreement":null},{"id":"W207511860","doi":"10.1097/00008571-200007000-00006","title":"Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.","year":2000,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); Université Laval","funders":"American College of Clinical Pharmacy; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Dextrorphan; Dextromethorphan; Metoprolol; CYP2D6; Luteal phase; Medicine; Menstrual cycle; Endocrinology; Internal medicine; Pharmacology; Hormone; Metabolism","score_opus":0.06461701107515362,"score_gpt":0.39633324937229364,"score_spread":0.33171623829714003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W207511860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981426,0.0008799315,0.00022081133,0.000019443472,0.0000072792063,0.000007333171,0.00023342349,0.00000683094,0.00048242437],"genre_scores_gemma":[0.9991115,0.00023277047,0.00021281042,0.000020908305,0.000009250254,0.0000066698854,0.0001976168,0.0000036357242,0.00020490034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999713,0.00014496144,0.000016690698,0.000054355205,0.000048291065,0.000022696098],"domain_scores_gemma":[0.9989517,0.0005258492,0.00025928134,0.0000832404,0.00004967455,0.00013027801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044287363,0.00022736896,0.00019252318,0.0002295715,0.000075757605,0.00019287485,0.00008946529,0.00013832503,0.0010084348],"category_scores_gemma":[0.0019085639,0.00012628935,0.00016363,0.00023064193,0.00019018071,0.00013901606,0.0001493789,0.000114935676,0.00017232129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065183113,0.000109461704,0.9348777,0.000044133834,0.00023348666,0.000326143,0.000190974,0.00015210085,0.03307628,0.000040831685,0.00015353432,0.024276981],"study_design_scores_gemma":[0.000014092872,0.0010022098,0.9963469,0.0000017308123,0.00004354518,0.00037348343,0.000032630323,0.00016208217,0.0017823726,0.000017173159,0.00022090589,0.0000027644169],"about_ca_topic_score_codex":0.0004251761,"about_ca_topic_score_gemma":0.00080015376,"teacher_disagreement_score":0.0010084348,"about_ca_system_score_codex":0.000081698476,"about_ca_system_score_gemma":0.000090312256,"threshold_uncertainty_score":0.0033735037},"labels":[],"label_agreement":null},{"id":"W2075397172","doi":"10.1139/y01-063","title":"Differential effects of phenobarbital on the constitutive and inducible expression of P450 2B and 3A subfamilies in sheep tissues","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Benzphetamine; Duodenum; Ileum; Endocrinology; Biology; Jejunum; Internal medicine; Cytochrome P450; Metabolism; Medicine","score_opus":0.04261097855497109,"score_gpt":0.351215316449093,"score_spread":0.3086043378941219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075397172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981687,0.00066916156,0.00048728962,0.000050191833,0.00000783767,0.000007751886,0.00021889902,0.0000250123,0.00036511122],"genre_scores_gemma":[0.99648935,0.00059177546,0.00061909953,0.00005554772,0.000009667975,0.000025218558,0.0005357556,0.000020952586,0.0016526286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980265,0.0000556233,0.000015422687,0.000051073093,0.00003363193,0.000041702297],"domain_scores_gemma":[0.99977285,0.000054544984,0.000053711487,0.000029677889,0.000034241366,0.000054965763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010251322,0.00028268876,0.00031642997,0.00024089929,0.00012362884,0.00019807652,0.000068180765,0.00022405676,0.000788326],"category_scores_gemma":[0.00023767672,0.00019359637,0.00018009427,0.00011828194,0.00027768128,0.00014433774,0.00017679721,0.00034916337,0.0002499119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006486919,0.000014837401,0.0009857409,0.000027500526,0.000009749211,0.000069858535,0.000033134213,0.000023034945,0.9969246,0.000015617186,0.000022273727,0.0012250048],"study_design_scores_gemma":[0.00003722531,0.001907646,0.059673082,0.000012844984,0.00006511002,0.00046144525,0.00014515623,0.0004086578,0.9355748,0.00006155077,0.0016410635,0.000011365373],"about_ca_topic_score_codex":0.0011096278,"about_ca_topic_score_gemma":0.0028702454,"teacher_disagreement_score":0.0011096278,"about_ca_system_score_codex":0.00017886194,"about_ca_system_score_gemma":0.0001272989,"threshold_uncertainty_score":0.0026372075},"labels":[],"label_agreement":null},{"id":"W2075713006","doi":"10.1038/tpj.2009.11","title":"A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo","year":2009,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Allele; Nonsynonymous substitution; In vivo; Biology; Genetics; Biochemistry; Enzyme; Cytochrome P450; Gene; CYP3A4","score_opus":0.11426631655196424,"score_gpt":0.40404589571936705,"score_spread":0.2897795791674028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075713006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708086,0.00027922058,0.0015519395,0.0002515641,0.00006262601,0.000017435466,0.00023375655,0.000064397,0.00045816725],"genre_scores_gemma":[0.9986149,0.000064972664,0.00047408213,0.00010937419,0.000037262053,0.000008504243,0.00023495003,0.000024757222,0.0004312366],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994885,0.00017552543,0.000051886305,0.00015450804,0.00007913483,0.000050581606],"domain_scores_gemma":[0.99897087,0.000343205,0.000314756,0.00008255506,0.00003354334,0.00025502627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005530841,0.0011645744,0.000740367,0.0006678893,0.0004897591,0.00041681703,0.00044700087,0.0011628679,0.003193618],"category_scores_gemma":[0.0008028747,0.00024208138,0.0006902727,0.0005004196,0.00071279675,0.00019918295,0.0002650531,0.0014251602,0.00050160417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012698862,0.0021679273,0.056998532,0.00013497069,0.00072347507,0.032128416,0.00031886334,0.00055285596,0.88314265,0.0008932766,0.0012924019,0.008947867],"study_design_scores_gemma":[0.002413635,0.019894028,0.51223224,0.00006230331,0.0016115686,0.23531964,0.0003242573,0.009243105,0.20947737,0.0017425311,0.0074597183,0.0002196019],"about_ca_topic_score_codex":0.00094002177,"about_ca_topic_score_gemma":0.00041483543,"teacher_disagreement_score":0.003193618,"about_ca_system_score_codex":0.00021316338,"about_ca_system_score_gemma":0.00018949558,"threshold_uncertainty_score":0.010683715},"labels":[],"label_agreement":null},{"id":"W2075816225","doi":"10.1016/j.neuropharm.2008.07.017","title":"Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment","year":2008,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Nicotine; Dentate gyrus; Internal medicine; Endocrinology; MPTP; Caudate nucleus; Substantia nigra; Immunocytochemistry; Pharmacology; Neurotoxin; Chemistry; Hippocampus; Medicine; Dopamine","score_opus":0.088787257796526,"score_gpt":0.39387687350573664,"score_spread":0.3050896157092106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075816225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388736,0.0014173938,0.0014156754,0.00027958275,0.00006593168,0.000022965665,0.00041180276,0.000048889568,0.0024505076],"genre_scores_gemma":[0.9938951,0.0006763521,0.0006548643,0.000059803155,0.000018489476,0.000029325312,0.00048925297,0.00002177147,0.004154859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999039,0.000014226813,0.0000045339552,0.000028211973,0.000017165625,0.00003190001],"domain_scores_gemma":[0.99990654,0.000016930933,0.000014312393,0.000025408317,0.000015822807,0.000021008063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080863545,0.00018492893,0.0003032728,0.00028989455,0.00034724368,0.00033684217,0.00015452493,0.00026793664,0.0017390439],"category_scores_gemma":[0.00017055178,0.0001871812,0.0003006152,0.00020857959,0.00042154276,0.00022213002,0.00012859004,0.0006919681,0.00042822174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096665416,0.0001344374,0.0021131244,0.000031404055,0.00003259618,0.00017318879,0.000054989723,0.00005846551,0.9906888,0.0002652363,0.00022088256,0.005260173],"study_design_scores_gemma":[0.000048361435,0.0015561758,0.030873068,0.000011190683,0.000098827775,0.0009149956,0.0001730361,0.0015356985,0.96052647,0.00049801776,0.0037525105,0.000011700947],"about_ca_topic_score_codex":0.009473504,"about_ca_topic_score_gemma":0.015185881,"teacher_disagreement_score":0.009473504,"about_ca_system_score_codex":0.0007363882,"about_ca_system_score_gemma":0.00049574004,"threshold_uncertainty_score":0.018836737},"labels":[],"label_agreement":null},{"id":"W2076946354","doi":"10.1139/y03-003","title":"The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons","year":2003,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytochrome P450; Aryl hydrocarbon receptor; Xenobiotic; Carcinogen; Aromatic hydrocarbon; Biology; Gene expression; Gene; Chemistry; Biochemistry; Enzyme; Transcription factor","score_opus":0.05570823443388346,"score_gpt":0.35529586240192834,"score_spread":0.2995876279680449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076946354","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009840195,0.087006114,0.0043885023,0.20212604,0.09298571,0.00052483665,0.009459771,0.0008990923,0.5927698],"genre_scores_gemma":[0.0062367804,0.01331566,0.0012332107,0.0021068524,0.0014294442,0.000028876831,0.0015807694,0.00008379489,0.9739847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998757,0.000067910434,0.000038236834,0.00017508546,0.00073569897,0.00022609367],"domain_scores_gemma":[0.99373513,0.00014856792,0.00007659942,0.00013472316,0.003534985,0.002369961],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014064601,0.0008872954,0.0009941965,0.0014479596,0.001793219,0.0024162428,0.0011989715,0.002924726,0.30805588],"category_scores_gemma":[0.0013928746,0.00027987882,0.00049203157,0.0010119298,0.0008027075,0.0008895738,0.0015886917,0.0022554346,0.10246157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016818996,0.00007679836,0.001072191,0.00020440189,0.00002484742,0.00043344218,0.000090063215,0.00016175705,0.0036531861,0.00459066,0.80150205,0.18802235],"study_design_scores_gemma":[0.000013683554,0.00003468587,0.0016887977,0.000057752055,0.000005538635,0.00021537613,0.00007375886,0.00007711558,0.00028608963,0.00036748796,0.9971718,0.000008001224],"about_ca_topic_score_codex":0.13522165,"about_ca_topic_score_gemma":0.29713336,"teacher_disagreement_score":0.30805588,"about_ca_system_score_codex":0.007563881,"about_ca_system_score_gemma":0.017413726,"threshold_uncertainty_score":0.9869743},"labels":[],"label_agreement":null},{"id":"W2076985436","doi":"10.1073/pnas.130155097","title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","year":2000,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":938,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperforin; Hypericum perforatum; Pregnane X receptor; CYP3A4; Hypericum; Pharmacology; Hypericin; Pregnane; Drug metabolism; Chemistry; Cytochrome P450; Indinavir; Nuclear receptor; Angelica sinensis; Drug; Metabolism; Biochemistry; Medicine; Traditional medicine; Transcription factor; Stereochemistry; Human immunodeficiency virus (HIV)","score_opus":0.10874296573715132,"score_gpt":0.40701082468897404,"score_spread":0.29826785895182273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076985436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954644,0.0020795958,0.0006934472,0.00014939214,0.000030688596,0.000018435321,0.00011220733,0.000036554156,0.001415261],"genre_scores_gemma":[0.9964611,0.0011877213,0.0003971711,0.00006594752,0.000017881788,0.000012330956,0.00017242604,0.000006311565,0.0016790897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998934,0.000026285994,0.0000061367527,0.000015021323,0.000026063783,0.000033119966],"domain_scores_gemma":[0.9999169,0.00001953159,0.000020368314,0.000012269118,0.000007777899,0.000023169332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008304636,0.00028637916,0.00019537138,0.00019868805,0.00012683593,0.00019942257,0.000073935444,0.00016720526,0.001973008],"category_scores_gemma":[0.0001154624,0.00012338258,0.00025736273,0.00012176705,0.00025716133,0.00011476352,0.00019120364,0.0003102873,0.00025563617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004012061,0.000048119415,0.00064940617,0.00005818825,0.000018560837,0.00027021483,0.000019391893,0.00003455765,0.9950524,0.0000750074,0.0000857145,0.0032872881],"study_design_scores_gemma":[0.000053365802,0.001496893,0.021478906,0.0000076175133,0.000027835871,0.0009485561,0.000054320608,0.0003033461,0.9736481,0.00007776854,0.0018976977,0.000005589992],"about_ca_topic_score_codex":0.00069324824,"about_ca_topic_score_gemma":0.001145677,"teacher_disagreement_score":0.001973008,"about_ca_system_score_codex":0.00022116593,"about_ca_system_score_gemma":0.00016526389,"threshold_uncertainty_score":0.00660038},"labels":[],"label_agreement":null},{"id":"W2077136462","doi":"10.1067/mcp.2001.113185","title":"Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Association of Pharmaceutical Scientists; U.S. Public Health Service; Medical Research Council Canada; National Center for Research Resources; National Institute of General Medical Sciences; Medical Research Council; University of Washington","keywords":"Grapefruit juice; Chemistry; Felodipine; Orange juice; Furocoumarins; Orange (colour); Food science; Citrus paradisi; Pharmacokinetics; Metabolite; Pharmacology; Chromatography; Biochemistry; Rutaceae; Botany; Medicine; Endocrinology","score_opus":0.3144994907808211,"score_gpt":0.5280572764054656,"score_spread":0.2135577856246445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077136462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991436,0.00056614773,0.000078415884,0.000012478322,0.000005543435,0.000040621533,0.000027731823,0.000005687843,0.00011968403],"genre_scores_gemma":[0.9989588,0.00030025758,0.00035208525,0.000035308523,0.000017884498,0.000028672304,0.000075244585,0.0000031502095,0.0002285841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996724,0.00013105276,0.000021594,0.0000712565,0.000071314695,0.00003244223],"domain_scores_gemma":[0.9997242,0.000081362996,0.00009756048,0.000018426033,0.000017676832,0.000060702747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042934273,0.0004134852,0.0007705285,0.00014775842,0.00014479512,0.0003044603,0.00018227239,0.0004949541,0.0014006997],"category_scores_gemma":[0.0006941328,0.00014642849,0.00046374174,0.00015568755,0.00028949766,0.00026869975,0.00015005702,0.00032513813,0.00007398073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2124079,0.0050209956,0.021825181,0.00079053146,0.0010684981,0.00038290815,0.00018172464,0.00041826852,0.71340466,0.00008564839,0.00017850522,0.044235233],"study_design_scores_gemma":[0.017258959,0.384841,0.43639258,0.000057975372,0.002180676,0.0013538032,0.00017688837,0.0026957032,0.1515023,0.000098735654,0.003365353,0.00007601818],"about_ca_topic_score_codex":0.00096862036,"about_ca_topic_score_gemma":0.0016112078,"teacher_disagreement_score":0.0014006997,"about_ca_system_score_codex":0.00027526284,"about_ca_system_score_gemma":0.00022118365,"threshold_uncertainty_score":0.004685819},"labels":[],"label_agreement":null},{"id":"W2077169416","doi":"10.1007/s10695-013-9779-5","title":"Molecular cloning and expression analysis of cytochrome P450 3A gene in the turbot Scophthalmus maximus","year":2013,"lang":"en","type":"article","venue":"Fish Physiology and Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Turbot; Biology; Complementary DNA; Molecular biology; Rapid amplification of cDNA ends; CYP3A; Scophthalmus; Open reading frame; Gene expression; Untranslated region; Messenger RNA; Gene; Peptide sequence; Molecular cloning; Cytochrome P450; Biochemistry","score_opus":0.03682035617025701,"score_gpt":0.36337165772820534,"score_spread":0.3265513015579483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077169416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949214,0.0005201528,0.002405161,0.00016427477,0.00002637692,0.000033171204,0.0009422856,0.000037562815,0.0009496049],"genre_scores_gemma":[0.98020416,0.0007598765,0.0053947587,0.00009522051,0.000026295023,0.000045687473,0.0055422154,0.00004607295,0.007885646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.000007845032,0.000008655712,0.000023917522,0.00002405757,0.00002276511],"domain_scores_gemma":[0.9998658,0.000034546785,0.00003145703,0.000012751569,0.000026309493,0.000029115621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011587116,0.00022613103,0.00019609326,0.00040880256,0.00030371637,0.00023782953,0.00014528458,0.0002630632,0.0007832357],"category_scores_gemma":[0.00014957644,0.00020427286,0.0004511726,0.00028597945,0.0002908641,0.00015942381,0.00016798142,0.00047006228,0.00047840714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084792424,0.000013669528,0.0007365555,0.000026935888,0.000004841037,0.00008242767,0.000048757567,0.00007162546,0.99769753,0.00013014498,0.000042084797,0.0010605898],"study_design_scores_gemma":[0.000061979845,0.00072960876,0.09239765,0.000023443665,0.00011112655,0.0010234514,0.00033483963,0.0026955034,0.8925457,0.00023496833,0.00981598,0.000025709944],"about_ca_topic_score_codex":0.0046263,"about_ca_topic_score_gemma":0.0048409645,"teacher_disagreement_score":0.0046263,"about_ca_system_score_codex":0.00039528075,"about_ca_system_score_gemma":0.00046405112,"threshold_uncertainty_score":0.009198725},"labels":[],"label_agreement":null},{"id":"W2077257393","doi":"10.1210/en.2006-0229","title":"Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation","year":2006,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"LNCaP; Glucuronidation; Internal medicine; Endocrinology; Androgen; Glucuronosyltransferase; Chemistry; Dihydrotestosterone; Prostate cancer; Uridine; Biology; Microsome; Enzyme; Biochemistry; Cancer; Hormone; Medicine; Gene; RNA","score_opus":0.061148256697095955,"score_gpt":0.37251597862982144,"score_spread":0.3113677219327255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077257393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902542,0.007202366,0.0010538696,0.000070997194,0.000027362905,0.00001608573,0.000545933,0.000048408445,0.00078076846],"genre_scores_gemma":[0.9938751,0.0022208919,0.00065320637,0.000052980373,0.000013869955,0.000018588571,0.00091918703,0.00001524632,0.002230988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999912,0.000018632692,0.0000048476013,0.000028933833,0.000015496249,0.000020007466],"domain_scores_gemma":[0.9999497,0.0000056686717,0.000011730413,0.0000065268164,0.0000095346395,0.000016857324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008323084,0.00021120763,0.000185242,0.00022952202,0.00012353738,0.00028250582,0.000061834246,0.00013140829,0.0013224354],"category_scores_gemma":[0.00006886616,0.0001401002,0.00024169024,0.00026197542,0.00013434557,0.00007628318,0.0001016121,0.00016793128,0.0003443067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067688007,0.000043676533,0.0033341662,0.000044090895,0.000021633807,0.00009117228,0.000043596385,0.000035471912,0.991459,0.00005786957,0.000079915844,0.0041124895],"study_design_scores_gemma":[0.000052498526,0.00074135896,0.21904413,0.0000075049534,0.000095787764,0.0011056887,0.00018380019,0.00060541753,0.77250177,0.00008862351,0.0055580083,0.00001545507],"about_ca_topic_score_codex":0.001543977,"about_ca_topic_score_gemma":0.0016584552,"teacher_disagreement_score":0.001543977,"about_ca_system_score_codex":0.00020511991,"about_ca_system_score_gemma":0.00019001032,"threshold_uncertainty_score":0.0044240355},"labels":[],"label_agreement":null},{"id":"W2078828442","doi":"10.1016/j.jep.2014.06.045","title":"The effect of Cree traditional medicinal teas on the activity of human cytochrome P450-mediated metabolism","year":2014,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Decoction; Juniperus communis; Traditional medicine; CYP3A4; Cytochrome P450; Juniper; Botany; Chemistry; Biology; Metabolism; Biochemistry; Medicine","score_opus":0.1100198123032564,"score_gpt":0.43263665087699404,"score_spread":0.32261683857373763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078828442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740905,0.0014932426,0.000098877994,0.00009192146,0.000019758274,0.0000096848935,0.000090551766,0.0000113193,0.00077554514],"genre_scores_gemma":[0.997165,0.0008920866,0.00015030356,0.000061968116,0.000019300747,0.000008455805,0.00009452534,0.0000047724975,0.0016035734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987435,0.000055410786,0.000007142082,0.000015072536,0.000012316144,0.00003575287],"domain_scores_gemma":[0.999742,0.000100219506,0.00003799864,0.000039919578,0.00002829062,0.000051560837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022793027,0.000317098,0.0003430388,0.00019093456,0.00019213131,0.00027557428,0.00020807705,0.00034070012,0.0030564405],"category_scores_gemma":[0.0006364793,0.00016120942,0.00045473818,0.00017588655,0.00027947806,0.00035001672,0.00021571132,0.0005960597,0.00019476614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07624811,0.0038015335,0.0064491727,0.00043808305,0.00059901044,0.0004409837,0.0005327326,0.000399362,0.8599013,0.00044822626,0.0004885061,0.05025297],"study_design_scores_gemma":[0.0019775103,0.046938203,0.15450874,0.00006218019,0.0013867702,0.00078886194,0.0005479295,0.0019112729,0.7846884,0.00035303616,0.006773254,0.000063944295],"about_ca_topic_score_codex":0.00077539944,"about_ca_topic_score_gemma":0.00125978,"teacher_disagreement_score":0.9992246,"about_ca_system_score_codex":0.00011210232,"about_ca_system_score_gemma":0.00020584327,"threshold_uncertainty_score":0.010224819},"labels":[],"label_agreement":null},{"id":"W2079178949","doi":"10.1016/j.clinbiochem.2006.03.004","title":"Toxicology: Then and now","year":2006,"lang":"en","type":"review","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical toxicology; Forensic toxicology; Toxicology; Environmental toxicology; Pharmacology; Medicine; Biology; Chemistry; Toxicity","score_opus":0.3213879074882492,"score_gpt":0.5782470575847082,"score_spread":0.256859150096459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079178949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000729013,0.9827398,0.00078320206,0.007838881,0.005064628,0.0000066208804,0.000020306685,0.00004089618,0.0034327426],"genre_scores_gemma":[0.0017938073,0.9569816,0.0014740673,0.014876001,0.009103383,0.000021974307,0.00006252059,0.000021300342,0.015665269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987955,0.00033692064,0.00013989086,0.00021284499,0.00039221204,0.0001226535],"domain_scores_gemma":[0.9974383,0.0008944393,0.00016686223,0.00020737626,0.0009028904,0.00039022058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034677102,0.001701708,0.0025931355,0.0021548048,0.0008781265,0.0037565825,0.0015038664,0.0040327804,0.010015872],"category_scores_gemma":[0.0031265616,0.0005143723,0.0006870637,0.0028028935,0.003862044,0.008421152,0.0030268088,0.006362983,0.008761628],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011529073,0.00008021985,0.0002964898,0.0034885397,0.00004989616,0.00027506275,0.00013846558,0.00016907624,0.0008865165,0.01683072,0.19384475,0.783825],"study_design_scores_gemma":[0.000010864261,0.00003829501,0.00018066137,0.00094927696,0.000016384329,0.0004934746,0.0000812522,0.000029406161,0.00007725549,0.0040274155,0.99408466,0.0000109408065],"about_ca_topic_score_codex":0.0025011636,"about_ca_topic_score_gemma":0.005270356,"teacher_disagreement_score":0.010015872,"about_ca_system_score_codex":0.0015314231,"about_ca_system_score_gemma":0.0034975037,"threshold_uncertainty_score":0.033506453},"labels":[],"label_agreement":null},{"id":"W2079329807","doi":"10.1016/j.neuropharm.2013.04.022","title":"Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys","year":2013,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Canada Research Chairs; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health","keywords":"Nicotine; CYP2E1; Pharmacology; Putamen; Ethanol; Internal medicine; Endocrinology; Chemistry; Medicine; Anesthesia; Biochemistry; Metabolism; Cytochrome P450","score_opus":0.09390333858416737,"score_gpt":0.4039466296934429,"score_spread":0.31004329110927553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079329807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829155,0.00021708537,0.00035649975,0.00010054122,0.000012018842,0.000011511689,0.0002464657,0.000022820486,0.00074151036],"genre_scores_gemma":[0.9921136,0.00046583154,0.0007641221,0.000100168894,0.000013158197,0.00007190646,0.00054968963,0.000043023392,0.005878532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998727,0.000017277722,0.0000070179303,0.000034503035,0.000024599323,0.000043929675],"domain_scores_gemma":[0.99979967,0.000027800204,0.000053108975,0.00003639896,0.000022176644,0.000060814236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009834808,0.00030112523,0.00027125754,0.0007522678,0.00037746248,0.00034223258,0.00015296409,0.00036654674,0.001844559],"category_scores_gemma":[0.00021138956,0.00028752218,0.00030768558,0.00025423177,0.0006259967,0.00031818758,0.0002423264,0.00094206876,0.0005002715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014295249,0.00029389554,0.004424084,0.000020766856,0.000025756486,0.0002131659,0.00011675127,0.00006494791,0.98988533,0.0002580747,0.00015145118,0.0031163467],"study_design_scores_gemma":[0.000093348965,0.0022005192,0.16210611,0.000015282883,0.00011563382,0.0011359116,0.00044535066,0.0013046375,0.82840043,0.00060468586,0.0035515,0.000026575037],"about_ca_topic_score_codex":0.002743473,"about_ca_topic_score_gemma":0.0055694575,"teacher_disagreement_score":0.002743473,"about_ca_system_score_codex":0.0005832262,"about_ca_system_score_gemma":0.00023269615,"threshold_uncertainty_score":0.0061706305},"labels":[],"label_agreement":null},{"id":"W2079423637","doi":"10.1038/tpj.2014.22","title":"Pharmacogenomic diversity in Singaporean populations and Europeans","year":2014,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Child and Family Research Institute; University of British Columbia","funders":"Biomedical Research Council; Canadian Institutes of Health Research; National University of Singapore; Agency for Science, Technology and Research","keywords":"Pharmacogenomics; CYP2C19; Genetic diversity; Allele frequency; Population; Allele; Medicine; Clopidogrel; Biology; Genetics; Internal medicine; Gene; Genotype; Environmental health","score_opus":0.2535966274977663,"score_gpt":0.43677491240895044,"score_spread":0.18317828491118415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079423637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917006,0.00008315774,0.00008140627,0.000028566124,0.0000022668733,0.0000047188055,0.00016142425,0.0000017748303,0.00046653292],"genre_scores_gemma":[0.9992366,0.00009349852,0.00007865373,0.00003624016,0.000004768322,0.000007043502,0.00036100476,0.000002281991,0.00017997975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955124,0.00012831332,0.00007791597,0.00012414939,0.000075911266,0.000042450665],"domain_scores_gemma":[0.9995246,0.00009607108,0.00015446,0.00005997149,0.00009010921,0.00007486206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005419646,0.0002500315,0.00029364147,0.0008389437,0.00039671204,0.0005680164,0.00016902223,0.0002358847,0.0020791662],"category_scores_gemma":[0.0010832389,0.000120360295,0.00033453555,0.001094521,0.0003758918,0.00019849834,0.00049524766,0.00017582082,0.00022443585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003895074,0.00003588317,0.9789985,0.000041899177,0.00029761516,0.00091118494,0.0019335591,0.00014003323,0.007937729,0.00027771035,0.00019661707,0.008839681],"study_design_scores_gemma":[0.00000816944,0.000075854994,0.99736625,0.000007785987,0.000037463094,0.00079759385,0.00062061806,0.00017972547,0.00029412142,0.000101101934,0.0005044372,0.0000067665896],"about_ca_topic_score_codex":0.0051973946,"about_ca_topic_score_gemma":0.005992645,"teacher_disagreement_score":0.0051973946,"about_ca_system_score_codex":0.00022395895,"about_ca_system_score_gemma":0.00018972284,"threshold_uncertainty_score":0.010334313},"labels":[],"label_agreement":null},{"id":"W2079700993","doi":"10.1210/jc.2007-0359","title":"The Uridine Diphosphate Glucuronosyltransferase 2B15 D85Y and 2B17 Deletion Polymorphisms Predict the Glucuronidation Pattern of Androgens and Fat Mass in Men","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Glucuronidation; Androsterone; Endocrinology; Glucuronosyltransferase; Internal medicine; Chemistry; Dihydrotestosterone; Androgen; Glucuronide; Uridine diphosphate; Urine; Hormone; Biology; Medicine; Steroid; Biochemistry; Microsome; In vitro; Enzyme","score_opus":0.07418747677206014,"score_gpt":0.42673317387834986,"score_spread":0.3525456971062897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079700993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942744,0.00021551979,0.00016332348,0.000013209264,0.0000025681504,0.00000250987,0.00010641567,0.0000028363736,0.00006617166],"genre_scores_gemma":[0.99939513,0.000056249537,0.00020058274,0.000012179593,0.000004054936,0.0000042780985,0.00017479277,0.000002439559,0.00015026091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998412,0.000050319148,0.000018019438,0.000048141093,0.000024904632,0.000017376951],"domain_scores_gemma":[0.9995679,0.00011468158,0.00020801452,0.000028671488,0.000022051287,0.0000586695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036086843,0.0004457639,0.00026521183,0.00036905814,0.00011433861,0.00030087386,0.00016165167,0.00038526504,0.0013077803],"category_scores_gemma":[0.00091482897,0.00024019336,0.00028275995,0.00034408557,0.00020296723,0.000118036085,0.00018236104,0.00027099103,0.00025410674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010267097,0.000030054623,0.9888632,0.000013071397,0.00014679877,0.00012548368,0.000053310323,0.00016231099,0.0076075885,0.000023368068,0.000049731552,0.0018983101],"study_design_scores_gemma":[0.000044562443,0.000223075,0.9968117,0.000006894272,0.000091259426,0.000778125,0.000036550955,0.00044447463,0.0013228137,0.000031928263,0.00020518868,0.0000033264016],"about_ca_topic_score_codex":0.0012305018,"about_ca_topic_score_gemma":0.0010049413,"teacher_disagreement_score":0.0013077803,"about_ca_system_score_codex":0.00009283911,"about_ca_system_score_gemma":0.00009020484,"threshold_uncertainty_score":0.004374981},"labels":[],"label_agreement":null},{"id":"W2079756400","doi":"10.1038/tpj.2015.20","title":"Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing","year":2015,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Transcriptome; Gene; Glucuronidation; Exon; Biology; Glucuronosyltransferase; Alternative splicing; Exon skipping; Human genome; RNA splicing; Computational biology; RNA; Genome; Genetics; RNA-Seq; Gene expression","score_opus":0.15548531622534506,"score_gpt":0.39196674416575117,"score_spread":0.2364814279404061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079756400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272286,0.005240035,0.054447126,0.0008635572,0.00009441801,0.00008096721,0.0073878686,0.0003235407,0.004333867],"genre_scores_gemma":[0.953262,0.0029641122,0.03372558,0.0007847905,0.00008250532,0.00008662182,0.0057664756,0.00016803885,0.0031599712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998387,0.000025602956,0.0000073241436,0.000066161716,0.000036152676,0.000026088639],"domain_scores_gemma":[0.9997695,0.000096618045,0.000051340863,0.000019903131,0.000042698943,0.000019943242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002725288,0.00028903905,0.00029300136,0.0004626523,0.00026329933,0.0007234328,0.00017461326,0.0002758708,0.0008131875],"category_scores_gemma":[0.0004885035,0.00018007969,0.00038748866,0.00040955303,0.0002196652,0.00030069117,0.00024064287,0.00060994644,0.00031016694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007786822,0.000010283533,0.004709723,0.00007780839,0.00003223203,0.0000613873,0.000062497966,0.0006141954,0.9835576,0.00055777136,0.00016383409,0.010074865],"study_design_scores_gemma":[0.000045376146,0.00070555194,0.37281552,0.00013711966,0.0004560702,0.0012163111,0.00093094667,0.052644838,0.5274847,0.007996083,0.035478838,0.00008852917],"about_ca_topic_score_codex":0.0009355404,"about_ca_topic_score_gemma":0.0032451877,"teacher_disagreement_score":0.0009355404,"about_ca_system_score_codex":0.0002370858,"about_ca_system_score_gemma":0.00045400637,"threshold_uncertainty_score":0.002720356},"labels":[],"label_agreement":null},{"id":"W2081057141","doi":"10.1177/0091270009340417","title":"Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Metoprolol; Diphenhydramine; Medicine; Placebo; Pharmacokinetics; CYP2D6; Internal medicine; Chronotropic; Pharmacology; Anesthesia; Blood pressure; Heart rate","score_opus":0.15756673208901237,"score_gpt":0.5327479104422379,"score_spread":0.3751811783532255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081057141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246,0.021398861,0.0007545988,0.0013985584,0.00016406277,0.000050845072,0.00015383151,0.0000103833745,0.0036088924],"genre_scores_gemma":[0.9964851,0.0018623857,0.0004080553,0.00065692444,0.00013583261,0.000021583695,0.00004194916,0.0000071067216,0.0003810217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987923,0.0007835434,0.000092497816,0.00012193574,0.00013577109,0.00007398308],"domain_scores_gemma":[0.9974637,0.0017094772,0.00046673795,0.00012477893,0.000080341524,0.00015492304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002148848,0.00017426646,0.000627942,0.00016049501,0.00018971307,0.00051832595,0.000153175,0.0004167469,0.0024905554],"category_scores_gemma":[0.0056322464,0.00011035265,0.0004108838,0.00020643763,0.00026095833,0.00033929403,0.00023967908,0.00040403387,0.00024140236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03919859,0.00049670984,0.77505267,0.0006687474,0.001324375,0.0011036975,0.00095800223,0.00019290531,0.013070048,0.000850607,0.0011092321,0.16597438],"study_design_scores_gemma":[0.0009583212,0.007942693,0.9777819,0.00016882071,0.0011487068,0.0015396411,0.00060342427,0.00034513662,0.0017197637,0.00064862764,0.007124159,0.000018696954],"about_ca_topic_score_codex":0.00019373062,"about_ca_topic_score_gemma":0.00047036598,"teacher_disagreement_score":0.0024905554,"about_ca_system_score_codex":0.00011429445,"about_ca_system_score_gemma":0.0002179869,"threshold_uncertainty_score":0.011364341},"labels":[],"label_agreement":null},{"id":"W2081060183","doi":"10.1016/j.steroids.2009.07.004","title":"Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation","year":2009,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Glucuronidation; Epitestosterone; Testosterone (patch); Glucuronosyltransferase; Microsome; Chemistry; UGT2B7; Pharmacology; Endocrinology; Glucuronide; Internal medicine; Androgen; Diclofenac; Metabolism; Medicine; Biochemistry; Hormone; Enzyme","score_opus":0.03658619101543597,"score_gpt":0.37481440463715343,"score_spread":0.33822821362171746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081060183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660364,0.009482766,0.013759263,0.000549596,0.00012216804,0.00007767184,0.0010469242,0.00025778046,0.008667408],"genre_scores_gemma":[0.99357235,0.0012742806,0.0020068183,0.0000942554,0.00003705008,0.000011666476,0.00034140074,0.00004270636,0.0026195333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990846,0.0005533068,0.00004101861,0.00007819097,0.00017439552,0.00006858066],"domain_scores_gemma":[0.9992623,0.00026390346,0.0002409176,0.000072635834,0.00009347303,0.000066819615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007024408,0.0003975438,0.00043529208,0.0005609516,0.00022440203,0.0007402467,0.00017414437,0.00026021223,0.0032809053],"category_scores_gemma":[0.0014898011,0.0002620184,0.00080873223,0.00057998364,0.00023062808,0.00022995858,0.00021313615,0.00028713373,0.0006466706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008122633,0.00026784246,0.41783348,0.00048376343,0.0017319932,0.0025276036,0.00045967955,0.0034508172,0.4443031,0.004810888,0.0018935408,0.114114575],"study_design_scores_gemma":[0.00021937946,0.0013131248,0.47001174,0.000038171365,0.00079849706,0.008336201,0.00016137878,0.009489183,0.4971687,0.002189176,0.01020668,0.000067709785],"about_ca_topic_score_codex":0.0025778029,"about_ca_topic_score_gemma":0.0020311621,"teacher_disagreement_score":0.0032809053,"about_ca_system_score_codex":0.0003850315,"about_ca_system_score_gemma":0.00055369776,"threshold_uncertainty_score":0.0109757185},"labels":[],"label_agreement":null},{"id":"W2081433798","doi":"10.2165/11531190-000000000-00000","title":"Rate and Extent of Drug Accumulation after Multiple Dosing Revisited","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Pharmacokinetics; Drug; Pharmacology; Bolus (digestion); Medicine; Plasma concentration; Analyte; Intensive care medicine; Chemistry; Internal medicine","score_opus":0.3070457126826455,"score_gpt":0.5598952058502331,"score_spread":0.2528494931675876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081433798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003986717,0.984571,0.0067560524,0.0009800722,0.0002088252,0.000013323852,0.00009617834,0.000054331595,0.003333428],"genre_scores_gemma":[0.03538413,0.95613015,0.003195029,0.0006580356,0.00070906046,0.0000288928,0.00008283,0.00003625179,0.0037756863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932003,0.00016583715,0.0000974989,0.00020004292,0.0001823572,0.000034235716],"domain_scores_gemma":[0.9982394,0.0009954381,0.00039543,0.00010237807,0.00023819262,0.000029093306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749081,0.000980465,0.0021025974,0.0011838108,0.0001187249,0.0014964987,0.0011531744,0.0011712098,0.0024807707],"category_scores_gemma":[0.0026117293,0.00046401372,0.00088117784,0.0012910579,0.0009675495,0.0031480975,0.0006223055,0.0022437966,0.0017988965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005762812,0.00009329453,0.0016254442,0.0046548285,0.0001596982,0.00054390857,0.0000976181,0.0018322547,0.010266761,0.014879663,0.00541395,0.9598563],"study_design_scores_gemma":[0.00016608005,0.0022677667,0.020153789,0.0036824462,0.0012068411,0.042422842,0.0003669932,0.007800702,0.045079395,0.043188788,0.83347523,0.00018915563],"about_ca_topic_score_codex":0.00072741584,"about_ca_topic_score_gemma":0.0007108699,"teacher_disagreement_score":0.0024807707,"about_ca_system_score_codex":0.0008376022,"about_ca_system_score_gemma":0.0010045862,"threshold_uncertainty_score":0.009250164},"labels":[],"label_agreement":null},{"id":"W2081881629","doi":"10.1139/cjpp-78-7-578","title":"Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ferrochelatase; Bioassay; Microsome; Isozyme; Biochemistry; Cytochrome P450; Xenobiotic; Recombinant DNA; Heme; Complementary DNA; Hemeprotein; Biology; In vitro; Porphyria; Chemistry; Enzyme; Molecular biology; Gene","score_opus":0.06409154204016622,"score_gpt":0.36463957640535655,"score_spread":0.30054803436519034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081881629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948614,0.0038030506,0.044823773,0.00020083514,0.000054335203,0.00017466025,0.0005171216,0.00040994637,0.0014023476],"genre_scores_gemma":[0.9557684,0.0017624331,0.03855865,0.000094911025,0.00003966106,0.00012251118,0.0013242947,0.000041788364,0.002287347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993259,0.00025536082,0.000060371654,0.00014828889,0.00014156668,0.00006855837],"domain_scores_gemma":[0.9995616,0.00019066532,0.00009263998,0.00007826404,0.00004594105,0.000030853127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006398473,0.0007349555,0.0004291647,0.00034729615,0.00015153833,0.00028049218,0.00027513586,0.00050134293,0.00051309157],"category_scores_gemma":[0.0004058391,0.00019516956,0.0003004797,0.00030941586,0.0003617592,0.0002667832,0.0002490603,0.0004894767,0.0005073688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002975014,0.0000141972005,0.000113549824,0.00001282165,0.00000395286,0.000015405214,0.000005924514,0.000026006826,0.9994522,0.000014113974,0.0000051255283,0.00030697102],"study_design_scores_gemma":[0.0000038396693,0.00015806782,0.0008041503,0.0000015167203,0.000012218956,0.000121449586,0.000006266979,0.000259173,0.9983058,0.000010965428,0.0003147721,0.000001730059],"about_ca_topic_score_codex":0.0009127655,"about_ca_topic_score_gemma":0.0011001644,"teacher_disagreement_score":0.0009127655,"about_ca_system_score_codex":0.00034179923,"about_ca_system_score_gemma":0.00032552955,"threshold_uncertainty_score":0.0033838153},"labels":[],"label_agreement":null},{"id":"W2081931643","doi":"10.1007/s13238-011-1082-6","title":"Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1)","year":2011,"lang":"en","type":"article","venue":"Protein & Cell","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cooperativity; Bacillus megaterium; Chemistry; Ionic strength; Heme; Phosphate; Phospholipid; Cooperative binding; Electron transfer; Kinetics; Biochemistry; Stereochemistry; Binding site; Enzyme; Organic chemistry; Membrane; Biology; Bacteria","score_opus":0.09737550775960752,"score_gpt":0.35876081178476393,"score_spread":0.2613853040251564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081931643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865353,0.00016504801,0.0008432457,0.000025552763,0.0000021801216,0.000005608296,0.00008127484,0.00002966825,0.00019397766],"genre_scores_gemma":[0.99866164,0.000084652944,0.00077969336,0.000008934173,0.0000012144108,0.000007044103,0.00017953204,0.000011808831,0.00026560965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997663,0.00006035157,0.000018929635,0.000044487388,0.00007424552,0.000035662615],"domain_scores_gemma":[0.99964094,0.00014436827,0.000090394635,0.000032749787,0.000059243812,0.000032237407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023981006,0.00019678345,0.00021832052,0.00011867283,0.0000939813,0.00020623519,0.00017085487,0.00017015642,0.000550625],"category_scores_gemma":[0.0004855796,0.00020368316,0.00021620838,0.00014984168,0.00015053927,0.00016009973,0.00015936531,0.00025905843,0.00023616393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010228261,0.000012544954,0.001336059,0.000012108211,0.0000042892448,0.000019494819,0.000017411397,0.00012705856,0.99748933,0.000016469647,0.000011884101,0.00085106614],"study_design_scores_gemma":[0.000010636784,0.00015995206,0.018348178,0.0000017978047,0.000009851208,0.00018282158,0.000015339729,0.0034552154,0.9775448,0.00004156855,0.0002195414,0.000010308571],"about_ca_topic_score_codex":0.0015647298,"about_ca_topic_score_gemma":0.0012024197,"teacher_disagreement_score":0.0015647298,"about_ca_system_score_codex":0.00029727662,"about_ca_system_score_gemma":0.00010692967,"threshold_uncertainty_score":0.0031112432},"labels":[],"label_agreement":null},{"id":"W2082018761","doi":"10.1016/j.neurobiolaging.2011.08.014","title":"The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients","year":2011,"lang":"en","type":"article","venue":"Neurobiology of Aging","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Ontario Ministry of Research and Innovation; Research and Innovation Foundation; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Substantia nigra; CYP2D6; Internal medicine; Parkinson's disease; Endocrinology; MPTP; Neuroprotection; Human brain; Biology; Pharmacology; Psychology; Medicine; Neuroscience; Disease; Cytochrome P450; Metabolism","score_opus":0.05481556436743853,"score_gpt":0.33412922846110693,"score_spread":0.2793136640936684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082018761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338067,0.0040835612,0.00028165555,0.00014097647,0.000021978898,0.0000045910974,0.0006976402,0.00002787135,0.0013609845],"genre_scores_gemma":[0.9976974,0.00074307213,0.00018958206,0.00007352777,0.00003049559,0.0000047302065,0.00044003382,0.0000073189062,0.000813921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998517,0.000029867579,0.000020867123,0.000039232124,0.00003880331,0.000019415604],"domain_scores_gemma":[0.9994399,0.00006853821,0.00031916713,0.000028128026,0.00009180239,0.00005233761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014501979,0.00030671028,0.00066919165,0.0007559421,0.00030820875,0.0005293662,0.00013401418,0.00046992072,0.0019064269],"category_scores_gemma":[0.0007518761,0.000215144,0.00029835044,0.0007601304,0.00016670093,0.0003410615,0.00016294385,0.00045533932,0.00030162113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028838166,0.00010358192,0.9472374,0.000112465204,0.00039401802,0.0012574203,0.0001957235,0.00010459552,0.015502057,0.00008886639,0.00074580405,0.03137432],"study_design_scores_gemma":[0.000014351653,0.00020925341,0.9951845,0.0000064718206,0.00012571974,0.0020238871,0.000054854256,0.000089176356,0.0015659569,0.00010777782,0.0006143664,0.0000037825619],"about_ca_topic_score_codex":0.0013729975,"about_ca_topic_score_gemma":0.0015632147,"teacher_disagreement_score":0.0019064269,"about_ca_system_score_codex":0.00021477693,"about_ca_system_score_gemma":0.00008920537,"threshold_uncertainty_score":0.0063776374},"labels":[],"label_agreement":null},{"id":"W2082819068","doi":"10.1016/j.taap.2005.07.001","title":"Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice","year":2005,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Inhalation; Pharmacokinetics; Cmax; Inhalation exposure; Chemistry; Toxicokinetics; Ethylbenzene; Kinetics; Pharmacology; Toxicology; Animal science; Internal medicine; Medicine; Biology; Anesthesia; Biochemistry","score_opus":0.061876599892132136,"score_gpt":0.4070910698820604,"score_spread":0.3452144699899283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082819068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880369,0.0017356576,0.0039681275,0.00043715248,0.000120530334,0.000084598505,0.0035491725,0.0004045134,0.0016634605],"genre_scores_gemma":[0.9694872,0.0020666507,0.0028801083,0.00030678997,0.00008509684,0.00018503204,0.0034781415,0.00035381672,0.021157155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994517,0.000069951384,0.000023392062,0.00014887452,0.00013197669,0.00017415771],"domain_scores_gemma":[0.9994498,0.00009533741,0.00017128867,0.000078709236,0.000053897547,0.00015093152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043918178,0.00086112425,0.0007771209,0.0010913439,0.00034841537,0.0007219597,0.0005224653,0.0011628141,0.001859947],"category_scores_gemma":[0.00029871817,0.00061121356,0.0007485086,0.00040972893,0.00066639617,0.0008361533,0.00021948306,0.002263886,0.0009104186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005714944,0.00063107,0.0011460576,0.000037982823,0.000038126356,0.00012238856,0.000080614955,0.00038864784,0.98664397,0.00016613079,0.00044744313,0.004582635],"study_design_scores_gemma":[0.00022578586,0.0064588715,0.014495387,0.000015191751,0.00013744074,0.00036615928,0.00013380076,0.0025703602,0.97281903,0.00024094677,0.0024811341,0.00005588997],"about_ca_topic_score_codex":0.0052122525,"about_ca_topic_score_gemma":0.0066691083,"teacher_disagreement_score":0.0052122525,"about_ca_system_score_codex":0.0009964786,"about_ca_system_score_gemma":0.00068185275,"threshold_uncertainty_score":0.010363817},"labels":[],"label_agreement":null},{"id":"W2083979572","doi":"10.1038/tpj.2014.29","title":"Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients","year":2014,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Medicine; Heart failure; Confidence interval; Odds ratio; Confidentiality; Internal medicine; Heart transplantation; Population; Pharmacology; Environmental health","score_opus":0.09242426398764272,"score_gpt":0.4205480789134788,"score_spread":0.3281238149258361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083979572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7280587,0.0098120645,0.00090188894,0.24843921,0.0013936748,0.00003830793,0.00052228995,0.000013189214,0.010820702],"genre_scores_gemma":[0.95979506,0.0037869774,0.00046417606,0.033960838,0.001160376,0.000021514956,0.00013081462,0.000007875667,0.00067225844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570495,0.002243144,0.00037376,0.00025622064,0.0010592139,0.0003627216],"domain_scores_gemma":[0.9827136,0.010029284,0.00226453,0.0003726658,0.0018384883,0.0027815148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012468792,0.000112623806,0.00037978587,0.00074727915,0.00105648,0.002512944,0.00048611846,0.0017084766,0.002318906],"category_scores_gemma":[0.032289613,0.0001376705,0.00060848816,0.00066312484,0.0017590257,0.0017342921,0.0013334685,0.0017541561,0.00024374078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019425529,0.0003458514,0.7914962,0.00063264125,0.0005255841,0.0019796556,0.019309351,0.00022112778,0.0015207075,0.0061189556,0.021192374,0.15471494],"study_design_scores_gemma":[0.00027317056,0.0012683044,0.7933098,0.0010726977,0.0005459739,0.0043507526,0.13739967,0.00060338835,0.0007192485,0.011916191,0.048393313,0.00014747404],"about_ca_topic_score_codex":0.003799654,"about_ca_topic_score_gemma":0.0053353147,"teacher_disagreement_score":0.012468792,"about_ca_system_score_codex":0.0007045379,"about_ca_system_score_gemma":0.00086780195,"threshold_uncertainty_score":0.06594205},"labels":[],"label_agreement":null},{"id":"W2084104182","doi":"10.1016/j.rpor.2013.04.014","title":"Minimizing the side effects of ADT","year":2013,"lang":"en","type":"article","venue":"Reports of Practical Oncology & Radiotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.07957921634723514,"score_gpt":0.47906558607430466,"score_spread":0.3994863697270695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084104182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5744119,0.20731865,0.061159007,0.007203025,0.0013569442,0.0005744683,0.0011852082,0.0008259631,0.14596477],"genre_scores_gemma":[0.9260449,0.030366765,0.014415355,0.001269916,0.0007422703,0.00011771468,0.00042951855,0.00017377452,0.026439818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997969,0.000065727414,0.000023742996,0.000030430025,0.00005750928,0.000025697507],"domain_scores_gemma":[0.9996599,0.00013794725,0.00006317016,0.00006091735,0.00005302863,0.000025081483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003283973,0.00041454803,0.00046946763,0.0004064555,0.00023874147,0.00043605248,0.00032301986,0.00033818232,0.0054179044],"category_scores_gemma":[0.0009340722,0.00007395751,0.0005017165,0.0003743155,0.00021375829,0.0003338897,0.00023246997,0.0008904574,0.0010828432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014695394,0.00062109815,0.007068422,0.001265454,0.00025853264,0.0012564884,0.00017008363,0.001334009,0.11277787,0.0039973813,0.004803076,0.86497813],"study_design_scores_gemma":[0.00047451662,0.010182112,0.09461562,0.0005428031,0.001133861,0.04752939,0.00049049215,0.0027770125,0.3862152,0.01006157,0.44591668,0.000060816314],"about_ca_topic_score_codex":0.00044961966,"about_ca_topic_score_gemma":0.0009877449,"teacher_disagreement_score":0.0054179044,"about_ca_system_score_codex":0.00028669194,"about_ca_system_score_gemma":0.0004350268,"threshold_uncertainty_score":0.0181247},"labels":[],"label_agreement":null},{"id":"W2084509790","doi":"10.1331/154434504773062573","title":"Drug-Drug Interactions: Where Do We Go From Here?","year":2004,"lang":"en","type":"letter","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Compendium; Drug; Harm; Pharmacology; Law; Political science; Philosophy","score_opus":0.04644596507344729,"score_gpt":0.402242063359116,"score_spread":0.3557960982856687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084509790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019558839,0.0017175763,0.0001438076,0.99217844,0.0042708046,0.0000060439625,0.000022107242,0.000019929304,0.0014456534],"genre_scores_gemma":[0.0035093213,0.0029934514,0.00060796,0.95695543,0.031080239,0.000027102096,0.000034828267,0.000015784048,0.0047759824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945405,0.001983063,0.0007778951,0.00053385255,0.0015924912,0.00057222997],"domain_scores_gemma":[0.98258716,0.007954735,0.0016037355,0.00034494628,0.0034318247,0.0040775836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004860491,0.00094729546,0.0033970934,0.0012753803,0.0046417047,0.0053427187,0.002192198,0.0715026,0.01160639],"category_scores_gemma":[0.031179829,0.0007467822,0.0018230191,0.0012865615,0.0035741464,0.008260188,0.0021738478,0.052545078,0.008476899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009011827,0.000073264724,0.0024036088,0.000123542,0.00005149948,0.0024623037,0.0001399865,0.00010319692,0.00011439309,0.0027266305,0.9658632,0.025848232],"study_design_scores_gemma":[0.0003707087,0.00023602608,0.0046391473,0.0013603052,0.00015058248,0.006073172,0.0012501722,0.0009960533,0.00015802414,0.019988073,0.9646521,0.00012566659],"about_ca_topic_score_codex":0.008908537,"about_ca_topic_score_gemma":0.026956795,"teacher_disagreement_score":0.0715026,"about_ca_system_score_codex":0.0058592246,"about_ca_system_score_gemma":0.0070551718,"threshold_uncertainty_score":0.04251188},"labels":[],"label_agreement":null},{"id":"W2084685770","doi":"10.1016/j.bcp.2007.10.032","title":"Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress","year":2007,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxidative stress; Menadione; Chemistry; Oxidative phosphorylation; Catalase; Cytochrome P450; Biochemistry; Pharmacology; Molecular biology; Biology; Enzyme","score_opus":0.07061726555809142,"score_gpt":0.4030959073619679,"score_spread":0.33247864180387643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084685770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856484,0.00094230636,0.009462097,0.0005069155,0.00015033067,0.00010492751,0.0014817393,0.00027406623,0.0014293902],"genre_scores_gemma":[0.9828174,0.0007948989,0.00669049,0.00015565494,0.00003546212,0.00012837205,0.0011752741,0.0001001336,0.008102236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993987,0.00008382841,0.00007846239,0.00016416908,0.00015173026,0.00012303519],"domain_scores_gemma":[0.99934214,0.00006937876,0.00024284184,0.00006804432,0.00004550829,0.0002321347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004969164,0.00091615174,0.00044841217,0.0018672157,0.00048851816,0.00086648733,0.0006076414,0.0014844736,0.0025295804],"category_scores_gemma":[0.00032215903,0.00066432793,0.0007869937,0.0005713356,0.0009866928,0.0005693701,0.00034833202,0.001905868,0.000642872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005482374,0.00017725129,0.00045672513,0.00003962539,0.000022728596,0.0003079753,0.000042394066,0.00020300926,0.9960181,0.0010573122,0.0001515969,0.0009751631],"study_design_scores_gemma":[0.0002044027,0.0009968921,0.004639291,0.000035972163,0.00013458985,0.0014090544,0.00013994008,0.002797237,0.9861692,0.0004971635,0.0029540414,0.000022101864],"about_ca_topic_score_codex":0.0014359908,"about_ca_topic_score_gemma":0.002278474,"teacher_disagreement_score":0.0025295804,"about_ca_system_score_codex":0.0007758848,"about_ca_system_score_gemma":0.00048527724,"threshold_uncertainty_score":0.00846231},"labels":[],"label_agreement":null},{"id":"W2085034992","doi":"10.1016/s0731-7085(01)00546-5","title":"Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Chemistry; Chromatography; CYP1A2; Caffeine; High-performance liquid chromatography; Urine; Analyte; Extraction (chemistry); Solid phase extraction; Urinary system; Enzyme; Biochemistry; Cytochrome P450; Internal medicine","score_opus":0.2266810644528653,"score_gpt":0.44258972464027624,"score_spread":0.21590866018741095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085034992","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54622054,0.025717024,0.40029794,0.0014044594,0.0007455371,0.0013678503,0.006994719,0.005914182,0.011337704],"genre_scores_gemma":[0.702299,0.0059017064,0.2766118,0.0016095494,0.00023350072,0.0014023298,0.0030343914,0.00083486515,0.008072949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783224,0.0007985918,0.0001303418,0.00047134247,0.00063450896,0.00013295858],"domain_scores_gemma":[0.9986498,0.00043419714,0.00019470791,0.0001626757,0.00040209497,0.00015642369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018534377,0.0011277657,0.0010739149,0.0022993695,0.00099532,0.0009089144,0.00077372434,0.0017018417,0.00187794],"category_scores_gemma":[0.0038437666,0.0008224271,0.0005748599,0.0013243078,0.000595215,0.0010270424,0.0004819441,0.0013543487,0.0012809174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017700827,0.00033389204,0.020791546,0.00041461934,0.00034621736,0.0001768253,0.00020795212,0.00028751604,0.89735067,0.0006104253,0.0013803074,0.0763299],"study_design_scores_gemma":[0.000081516526,0.0010946591,0.04263171,0.00003178787,0.00028040886,0.002050767,0.000066275876,0.0050979103,0.94287264,0.00035776876,0.005349026,0.00008542711],"about_ca_topic_score_codex":0.0023098951,"about_ca_topic_score_gemma":0.005548759,"teacher_disagreement_score":0.0023098951,"about_ca_system_score_codex":0.00040784167,"about_ca_system_score_gemma":0.0010556495,"threshold_uncertainty_score":0.009802043},"labels":[],"label_agreement":null},{"id":"W2085439942","doi":"10.1177/0269881113512041","title":"Genetic differences in cytochrome P450 enzymes and antidepressant treatment response","year":2013,"lang":"en","type":"article","venue":"Journal of Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"Lundbeckfonden; National Institute for Health and Care Research","keywords":"Antidepressant; Cytochrome P450; Pharmacology; CYP2D6; Psychology; Medicine; Psychiatry; Internal medicine; Metabolism; Anxiety","score_opus":0.08094645007149964,"score_gpt":0.42272629523067207,"score_spread":0.3417798451591724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085439942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983058,0.00058140035,0.00017122041,0.00008985543,0.000006534357,0.0000077009845,0.0003272856,0.0000065126255,0.00050364237],"genre_scores_gemma":[0.99948835,0.00008970844,0.00008819123,0.000024757475,0.000007565892,0.0000038192775,0.00020718429,0.0000023728232,0.00008806533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943596,0.00023295489,0.00007402701,0.00013160383,0.00008699287,0.000038513528],"domain_scores_gemma":[0.9981963,0.0007914977,0.000701178,0.000103544255,0.00009555879,0.000111928784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057972805,0.00020091506,0.00032920888,0.00034042515,0.00013989421,0.00027111662,0.0001742756,0.00045479665,0.0025584435],"category_scores_gemma":[0.0030380834,0.00009665125,0.0003679931,0.0005306494,0.00020088768,0.00013141731,0.000114702576,0.00029865297,0.00033064347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070077257,0.000051496027,0.99173975,0.000022456392,0.00040150154,0.00012895493,0.00004092151,0.000101576734,0.0021671194,0.000026491305,0.0001041233,0.0045148577],"study_design_scores_gemma":[0.000015315967,0.0001021401,0.9991173,0.000004243796,0.000049590617,0.00028110004,0.000012880657,0.00013003904,0.00017332465,0.000034326444,0.00007793022,0.000001853627],"about_ca_topic_score_codex":0.00089154165,"about_ca_topic_score_gemma":0.00077378406,"teacher_disagreement_score":0.0025584435,"about_ca_system_score_codex":0.00014228688,"about_ca_system_score_gemma":0.000062861676,"threshold_uncertainty_score":0.00855881},"labels":[],"label_agreement":null},{"id":"W2085913165","doi":"10.1016/j.cbi.2008.09.013","title":"Safety testing of metabolites: Expectations and outcomes","year":2008,"lang":"en","type":"review","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Toxicity; Pharmacology; Chemistry; Active metabolite; Kidney; Transporter; Biochemistry; Drug; Metabolism; Biology; Endocrinology","score_opus":0.3709393384965347,"score_gpt":0.5204592740062784,"score_spread":0.14951993550974374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085913165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037993193,0.96929055,0.009773153,0.009225477,0.0003770035,0.00011183542,0.00026212004,0.000060907518,0.007099553],"genre_scores_gemma":[0.07312993,0.9005295,0.011546915,0.009321927,0.0016657523,0.00024780896,0.00072513026,0.00003802046,0.0027950492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9859811,0.0050919293,0.0020648607,0.0009398476,0.0056548677,0.0002672922],"domain_scores_gemma":[0.9187265,0.05557318,0.008362984,0.001499099,0.014552334,0.001285883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03500198,0.0015001656,0.0035285938,0.0021769623,0.00032249553,0.003074092,0.0029101174,0.004287886,0.0021813607],"category_scores_gemma":[0.037187457,0.00032219806,0.0019522263,0.0015659975,0.0016394946,0.0029378373,0.000993742,0.0031018474,0.0010662992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073512783,0.00026145816,0.0062738056,0.007951368,0.00034795242,0.00076149905,0.00012336895,0.0023305803,0.0023685372,0.0068835705,0.009575826,0.9623869],"study_design_scores_gemma":[0.0012170702,0.010788229,0.04575055,0.0534091,0.004949805,0.032505464,0.0017663772,0.010701223,0.04325763,0.07280477,0.72241503,0.00043473393],"about_ca_topic_score_codex":0.0009581037,"about_ca_topic_score_gemma":0.0011206239,"teacher_disagreement_score":0.03500198,"about_ca_system_score_codex":0.0017635906,"about_ca_system_score_gemma":0.003487046,"threshold_uncertainty_score":0.18511039},"labels":[],"label_agreement":null},{"id":"W2086310887","doi":"10.1097/00004714-200206000-00014","title":"Treatment of Codeine Dependence With Inhibitors of Cytochrome P450 2D6","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Codeine; Dextromethorphan; Quinidine; CYP2D6; Placebo; Morphine; Pharmacology; Analgesic; Anesthesia; Fluoxetine; Medicine; Randomized controlled trial; Cocaine dependence; Internal medicine; Cytochrome P450; Serotonin; Psychiatry; Addiction","score_opus":0.22944764219403752,"score_gpt":0.5288180988072396,"score_spread":0.2993704566132021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086310887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904433,0.006303816,0.00050391466,0.00024182172,0.000087932516,0.00066660315,0.00015016111,0.00002959714,0.0015727681],"genre_scores_gemma":[0.9950853,0.0027531416,0.0007499283,0.00016944362,0.00010806348,0.00030160937,0.00017504356,0.0000036925699,0.00065376726],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996668,0.00018259749,0.00003656738,0.000035037225,0.00003851163,0.000040535735],"domain_scores_gemma":[0.9994885,0.00019662228,0.00011622064,0.000028120918,0.000027091637,0.00014356713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061973085,0.00043408666,0.0010892224,0.00023741426,0.00023331576,0.00017482099,0.00024653424,0.0003790836,0.0016678927],"category_scores_gemma":[0.0010220668,0.00015249429,0.0003870451,0.00018173996,0.00035697286,0.00020477735,0.00016463052,0.0007517998,0.00018805348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44250467,0.033871148,0.04093812,0.0027761897,0.0016948859,0.0009681938,0.00021954578,0.00095852785,0.086891934,0.00056417345,0.0025082722,0.38610438],"study_design_scores_gemma":[0.24137323,0.59097266,0.13788144,0.00018414929,0.0007665874,0.002393812,0.00013174118,0.002539757,0.015852453,0.0003561221,0.007502243,0.000045808058],"about_ca_topic_score_codex":0.00040268208,"about_ca_topic_score_gemma":0.0011940058,"teacher_disagreement_score":0.0016678927,"about_ca_system_score_codex":0.000247955,"about_ca_system_score_gemma":0.00027221325,"threshold_uncertainty_score":0.0055796504},"labels":[],"label_agreement":null},{"id":"W2086430566","doi":"10.1007/s11010-011-0994-z","title":"Estradiol-mediated suppression of CYP1B1 expression in mouse MA-10 Leydig cells is independent of protein kinase A and estrogen receptor","year":2011,"lang":"en","type":"article","venue":"Molecular and Cellular Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Estradiol benzoate; Internal medicine; Endocrinology; CYP1B1; Estrogen; Estrogen receptor; Biology; Luteinizing hormone; Receptor; Messenger RNA; Antagonist; Hormone; Chemistry; Cytochrome P450; Metabolism; Medicine; Biochemistry; Cancer; Gene","score_opus":0.0308398030580363,"score_gpt":0.30137420925240116,"score_spread":0.27053440619436486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086430566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839974,0.0028080205,0.002982887,0.00030519208,0.00014080704,0.00003695483,0.0018208714,0.00027805768,0.0032274008],"genre_scores_gemma":[0.977248,0.0014222445,0.0017291779,0.000105882966,0.000043996115,0.00006409131,0.0022292759,0.00013869505,0.01701858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997123,0.000042319494,0.00002366404,0.000063317755,0.00006754488,0.000090798705],"domain_scores_gemma":[0.999696,0.000063894244,0.00007427061,0.00005215538,0.000030100186,0.000083551684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020355717,0.00045746722,0.00034522623,0.0006874059,0.00028201847,0.00054180267,0.00030133256,0.00025159545,0.003028873],"category_scores_gemma":[0.00015487144,0.00042909125,0.0004965935,0.00031719232,0.0004851059,0.00032304114,0.00030179115,0.0008891768,0.0013157574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013889866,0.000018432862,0.00016111649,0.000016024755,0.000004315333,0.00003950646,0.000016121632,0.000011517084,0.99901664,0.00009156987,0.00004287441,0.0004430296],"study_design_scores_gemma":[0.000016572345,0.00008693729,0.0039811293,0.000002960854,0.000009014903,0.00013351688,0.000026840711,0.000112599344,0.99400723,0.000024172645,0.0015950699,0.0000039980664],"about_ca_topic_score_codex":0.0014493198,"about_ca_topic_score_gemma":0.0027952539,"teacher_disagreement_score":0.003028873,"about_ca_system_score_codex":0.0004684859,"about_ca_system_score_gemma":0.000341448,"threshold_uncertainty_score":0.010132551},"labels":[],"label_agreement":null},{"id":"W2086562471","doi":"10.1177/009286150303700102","title":"Response to Senn Paper (Drug Information Journal, 2001;35: 1479–1494)","year":2003,"lang":"en","type":"article","venue":"Drug Information Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacy; Drug; Pharmacology; Medicine; Family medicine","score_opus":0.047021281762970046,"score_gpt":0.38541452258122544,"score_spread":0.3383932408182554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086562471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006450579,0.0019425784,0.00023058461,0.828233,0.16317472,0.00012548461,0.000853284,0.00024508554,0.004550223],"genre_scores_gemma":[0.0021786431,0.0013583143,0.0002653192,0.905458,0.05642569,0.00016280747,0.00032860803,0.00006439839,0.033758245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757653,0.00035812656,0.00040642562,0.00031951378,0.0009602884,0.0003790873],"domain_scores_gemma":[0.9889466,0.004354476,0.0009819745,0.00033784006,0.0037477335,0.0016313423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037380776,0.0019097868,0.0027445506,0.0019550156,0.0037420823,0.0039714435,0.0023210526,0.049571157,0.030752916],"category_scores_gemma":[0.017324228,0.0010339519,0.002615037,0.0012483478,0.0018935872,0.0021335648,0.0024766535,0.025016237,0.03205931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067522895,0.000018646684,0.00024992184,0.00007241842,0.000012025502,0.0002841034,0.000022440065,0.00003078176,0.00007634887,0.00010973717,0.9952931,0.003763003],"study_design_scores_gemma":[0.00010407799,0.00011235787,0.0033323416,0.00035465218,0.000064069856,0.0005662447,0.0002550929,0.00035036323,0.0003440122,0.00072223914,0.99372756,0.00006707666],"about_ca_topic_score_codex":0.0075148223,"about_ca_topic_score_gemma":0.010595528,"teacher_disagreement_score":0.049571157,"about_ca_system_score_codex":0.0050484524,"about_ca_system_score_gemma":0.0044234786,"threshold_uncertainty_score":0.10287881},"labels":[],"label_agreement":null},{"id":"W2086609307","doi":"10.1139/y10-023","title":"Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Nephrotoxicity; Pharmacology; Toxicity; Metabolite; Cell culture; Pharmacokinetics; Drug; In vitro; Kidney; Ifosfamide; Active metabolite; Chemistry; Medicine; Biology; Internal medicine; Biochemistry; Chemotherapy; Cisplatin","score_opus":0.07271497306116342,"score_gpt":0.3900717585397407,"score_spread":0.31735678547857726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086609307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92631525,0.013235461,0.050415862,0.0006028288,0.00048011634,0.000630408,0.0030801776,0.00021443113,0.005025416],"genre_scores_gemma":[0.9069981,0.011381219,0.068038784,0.00027179375,0.00014779155,0.00064349256,0.007022292,0.00010157256,0.0053949202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987093,0.00047959987,0.00021618826,0.00014938024,0.0003321261,0.00011334354],"domain_scores_gemma":[0.99905735,0.0002884363,0.00012028528,0.00017959959,0.0002692417,0.00008509914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001886849,0.0005477016,0.00081004336,0.0008749345,0.00044724956,0.00066941266,0.0007891689,0.0007530966,0.0013759073],"category_scores_gemma":[0.0009506874,0.00031224647,0.0006935407,0.0008934776,0.00032880862,0.0009077404,0.0005148285,0.000946506,0.00073382177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007400828,0.0003832663,0.0026029707,0.00020674327,0.000043945114,0.00017680266,0.000106396124,0.00020001778,0.9918697,0.00023275959,0.00022931078,0.0032080445],"study_design_scores_gemma":[0.00009128398,0.0038780987,0.01779023,0.00003142295,0.00015456138,0.0025501503,0.00020007759,0.003618298,0.96390843,0.00012230042,0.007612252,0.000043000942],"about_ca_topic_score_codex":0.0036618083,"about_ca_topic_score_gemma":0.0071223225,"teacher_disagreement_score":0.0036618083,"about_ca_system_score_codex":0.00047248317,"about_ca_system_score_gemma":0.0005809964,"threshold_uncertainty_score":0.009978712},"labels":[],"label_agreement":null},{"id":"W2087019997","doi":"10.1124/dmd.31.5.670","title":"Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glucuronidation; Xenobiotic; Glucuronosyltransferase; Enzyme; Chemistry; Biochemistry; Metabolism; Galangin; Microsome; Kaempferol; Flavonoid; Antioxidant","score_opus":0.050512699763427836,"score_gpt":0.3622494155833755,"score_spread":0.31173671581994766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087019997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841558,0.0058908043,0.005057054,0.00022556481,0.000072701325,0.000035200817,0.0011303729,0.00010938654,0.0033231317],"genre_scores_gemma":[0.989391,0.0017947078,0.0024307535,0.00006228422,0.000031479933,0.000022036664,0.002004867,0.00005358038,0.004209234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996214,0.00015051183,0.000022209471,0.00006678297,0.000086205284,0.000052912874],"domain_scores_gemma":[0.9997725,0.00004434906,0.0000479029,0.000029376577,0.000057025532,0.000048898408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044149463,0.0005067509,0.00037866586,0.00069704093,0.0001854295,0.00056533684,0.00014797371,0.00030515657,0.0024291188],"category_scores_gemma":[0.0008336163,0.0002395941,0.0004892959,0.0005312797,0.00019870074,0.00016044297,0.00019563551,0.0003639735,0.00075824757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036560504,0.00015627044,0.11129711,0.00035495133,0.00062498875,0.00074085244,0.00019665468,0.0012816796,0.8006963,0.0011987162,0.0016567244,0.07813964],"study_design_scores_gemma":[0.000083216764,0.0010295818,0.11173228,0.000035278226,0.00017225953,0.002743749,0.00006343883,0.0023398704,0.8737394,0.0002444524,0.007795229,0.000021188132],"about_ca_topic_score_codex":0.0035215756,"about_ca_topic_score_gemma":0.002384929,"teacher_disagreement_score":0.0035215756,"about_ca_system_score_codex":0.00051806815,"about_ca_system_score_gemma":0.0006881826,"threshold_uncertainty_score":0.008126259},"labels":[],"label_agreement":null},{"id":"W2087192577","doi":"10.1371/journal.pgen.1004648","title":"Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements","year":2014,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Human Genome Research Institute; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Canadian Institutes of Health Research; National Institutes of Health; Oak Ridge Institute for Science and Education","keywords":"Pregnane X receptor; Biology; Enhancer; Genetics; Drug metabolism; Gene; Computational biology; Genome-wide association study; CYP3A4; Transcription factor; Single-nucleotide polymorphism; Cytochrome P450; Drug; Nuclear receptor; Pharmacology; Genotype; Biochemistry; Enzyme","score_opus":0.07357397746529869,"score_gpt":0.36719074534052165,"score_spread":0.29361676787522295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087192577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763907,0.0021851042,0.0029834255,0.00012743559,0.000016317199,0.000028268278,0.005957213,0.00007766259,0.0009854828],"genre_scores_gemma":[0.98830557,0.00056040246,0.0025681623,0.00022021696,0.000020741645,0.00003212391,0.007548479,0.000034105768,0.0007101674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971074,0.000033804467,0.000014315625,0.00016305553,0.00004284009,0.000035317382],"domain_scores_gemma":[0.9997483,0.00012467806,0.000051250256,0.000024637511,0.000020706522,0.000030453222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030279352,0.00016417794,0.00048458434,0.0004986908,0.00015776958,0.0002720293,0.00016789463,0.00025318292,0.0017124596],"category_scores_gemma":[0.00040448498,0.00019987163,0.00054609246,0.0007129798,0.00013663487,0.00006219386,0.00022703838,0.0003633058,0.00026495708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022449733,0.00020498135,0.4120195,0.0007512168,0.0019828945,0.0024499588,0.0004635009,0.0020758768,0.5211632,0.0011499877,0.0032538373,0.052239973],"study_design_scores_gemma":[0.000102226775,0.00014014434,0.9775997,0.000028835433,0.00045617708,0.0012748216,0.0000835361,0.0022020347,0.012114201,0.00032602812,0.00564859,0.000023698689],"about_ca_topic_score_codex":0.0016074338,"about_ca_topic_score_gemma":0.003539882,"teacher_disagreement_score":0.0017124596,"about_ca_system_score_codex":0.000115796705,"about_ca_system_score_gemma":0.00021413324,"threshold_uncertainty_score":0.005728781},"labels":[],"label_agreement":null},{"id":"W2087313521","doi":"10.1517/14740330903405593","title":"Clinically based evidence of drug–herb interactions: a systematic review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine","funders":"","keywords":"Medicine; Drug; Herb; Drug interaction; Pharmacology; Traditional medicine; Medicinal herbs","score_opus":0.26412354879274036,"score_gpt":0.5583105977799898,"score_spread":0.29418704898724946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087313521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039814386,0.99826837,0.000108918386,0.00032564875,0.00012322077,0.00017178874,0.00022131986,0.0000051019406,0.00037751446],"genre_scores_gemma":[0.0060250075,0.99245775,0.0004754587,0.0004616184,0.000075648924,0.000235805,0.00014385108,0.0000030127346,0.00012194299],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99272645,0.0026279404,0.0023428733,0.00038859207,0.0017551326,0.0001590638],"domain_scores_gemma":[0.96324515,0.02599637,0.006538298,0.00038987192,0.0034602655,0.00037016303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007811985,0.0013794156,0.00839479,0.0086631505,0.00043024158,0.0018772333,0.0023700397,0.002280723,0.0119302105],"category_scores_gemma":[0.044558886,0.0008790264,0.0041306834,0.011796877,0.0007895815,0.002752377,0.0011633309,0.0011068949,0.0010131834],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025082653,0.000018926365,0.0005017069,0.91678625,0.004432037,0.00021220869,0.00009487844,0.00008285142,0.00016180021,0.00019274522,0.003936197,0.07332944],"study_design_scores_gemma":[0.00053286785,0.00028231807,0.0047841715,0.9100526,0.04064134,0.0007886298,0.00027043023,0.00009302363,0.00026955912,0.00040969567,0.04184048,0.000034884262],"about_ca_topic_score_codex":0.0048266654,"about_ca_topic_score_gemma":0.015838953,"teacher_disagreement_score":0.0119302105,"about_ca_system_score_codex":0.003069087,"about_ca_system_score_gemma":0.010160067,"threshold_uncertainty_score":0.041314185},"labels":[],"label_agreement":null},{"id":"W2087413883","doi":"10.1016/j.abb.2010.06.018","title":"Functional differences in the cytochrome P450 1 family enzymes from Zebrafish (Danio rerio) using heterologously expressed proteins","year":2010,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Environmental Health Sciences; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Cytochrome P450; Danio; Zebrafish; Metabolite; CYP1B1; Biochemistry; Cytochrome; Biology; Enzyme; Benzo(a)pyrene; Coumarin; Hydroxylation; Substrate (aquarium); Chemistry; Gene; Carcinogen; Botany","score_opus":0.06844823868913401,"score_gpt":0.3333913210165195,"score_spread":0.2649430823273855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087413883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443686,0.0008236225,0.0028820639,0.00024921866,0.000039416325,0.0000138344785,0.0005004657,0.000051154806,0.0010035484],"genre_scores_gemma":[0.98975384,0.00071003224,0.0032348502,0.000107023094,0.00001645592,0.000023630697,0.0016104119,0.000054553668,0.0044891923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998946,0.00000937216,0.0000124186645,0.0000292912,0.00003194115,0.000022379874],"domain_scores_gemma":[0.9999008,0.000021794176,0.000032087373,0.000012780382,0.000015630161,0.000016958404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016069115,0.00031307456,0.00017248503,0.00027259818,0.00020689599,0.00031550127,0.0002749578,0.0003862541,0.0009088646],"category_scores_gemma":[0.0001724385,0.00019584043,0.0004583151,0.00013311692,0.00031226018,0.00035160483,0.00017616736,0.00073167245,0.00044153252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033164066,0.0000050267945,0.00008624702,0.000011587805,0.0000027236877,0.000027742693,0.000012054951,0.000026958336,0.999355,0.00011246275,0.000018329893,0.00030871286],"study_design_scores_gemma":[0.000015813011,0.000082353385,0.0069898083,0.000006055168,0.00003758293,0.00040861397,0.000041018488,0.0008586872,0.9881711,0.00011029048,0.003268452,0.000010213931],"about_ca_topic_score_codex":0.0025174613,"about_ca_topic_score_gemma":0.0029467063,"teacher_disagreement_score":0.0025174613,"about_ca_system_score_codex":0.0005995521,"about_ca_system_score_gemma":0.00023253691,"threshold_uncertainty_score":0.005005598},"labels":[],"label_agreement":null},{"id":"W2087442671","doi":"10.1186/1744-8603-7-30","title":"Pharmacogenomic technologies: a necessary \"luxury\" for better global public health?","year":2011,"lang":"en","type":"article","venue":"Globalization and Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Public health; Emerging technologies; Population; Psychological intervention; Medicine; Drug development; Health care; Business; Health administration; Risk analysis (engineering); Biotechnology; Economic growth; Environmental health; Drug; Pharmacology; Economics; Computer science; Biology; Nursing","score_opus":0.3135427175318022,"score_gpt":0.47915067446729187,"score_spread":0.1656079569354897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087442671","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01237933,0.026556326,0.035239764,0.8692169,0.0018802346,0.00028186082,0.00024144887,0.0002454596,0.05395865],"genre_scores_gemma":[0.6070221,0.048777495,0.117496975,0.21134427,0.0043789884,0.00072776986,0.00034126436,0.00028991868,0.0096211815],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.945904,0.035686728,0.002344552,0.0018623964,0.011709978,0.0024923517],"domain_scores_gemma":[0.8588936,0.090311415,0.013748948,0.014022984,0.016805327,0.006217737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.081304535,0.000955163,0.0010598545,0.0021722524,0.0024631512,0.019266859,0.0019078518,0.01037144,0.010388049],"category_scores_gemma":[0.08421406,0.00049574074,0.0013308573,0.002473843,0.02156516,0.023289245,0.0073011983,0.0080009885,0.0017868086],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021673663,0.00021469998,0.01051331,0.0028703604,0.00021042727,0.0004751386,0.0023541467,0.0036753265,0.0021257065,0.70200425,0.047794998,0.22754483],"study_design_scores_gemma":[0.00010571214,0.00075463223,0.006721347,0.0061686225,0.0002422816,0.001174474,0.0063807927,0.0027048294,0.003938541,0.47794175,0.49367392,0.0001929715],"about_ca_topic_score_codex":0.002665253,"about_ca_topic_score_gemma":0.0019767813,"teacher_disagreement_score":0.081304535,"about_ca_system_score_codex":0.009259698,"about_ca_system_score_gemma":0.027026525,"threshold_uncertainty_score":0.42998463},"labels":[],"label_agreement":null},{"id":"W2087518177","doi":"10.1080/004982500406390","title":"Regional and cellular distribution of CYP2D subfamily members in rat brain","year":2000,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; Medical Research Council; Centre for Addiction and Mental Health","keywords":"Subfamily; Blot; Human brain; Biology; Molecular biology; Western blot; Gene isoform; Gene; Genetics; Neuroscience","score_opus":0.057534225407250825,"score_gpt":0.3703727062381976,"score_spread":0.3128384808309468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087518177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680951,0.016428541,0.0074715787,0.0002317885,0.0000618439,0.000041360094,0.0026763948,0.00031192394,0.0046814643],"genre_scores_gemma":[0.9539526,0.0149202775,0.013789793,0.00013734178,0.000059930975,0.00016249299,0.0062976386,0.000109826164,0.010570158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998735,0.000007934485,0.0000072504663,0.00004735628,0.000032623942,0.00003124044],"domain_scores_gemma":[0.999856,0.000020221918,0.00003771849,0.000018225926,0.000035576777,0.000032323896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012215677,0.00034885775,0.00025178862,0.0015031863,0.0003044835,0.0004142855,0.00014519677,0.00020975005,0.0024201802],"category_scores_gemma":[0.00014484678,0.00027934328,0.00029572696,0.00046557884,0.00026169085,0.0002533515,0.00021708941,0.00033373185,0.0010934873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006109568,0.000046778077,0.004437364,0.00014776684,0.000058158716,0.00014106344,0.00007169346,0.000107108775,0.97946644,0.00030428468,0.00024628686,0.01436202],"study_design_scores_gemma":[0.00010188527,0.0014710393,0.24100801,0.000052998264,0.0002992572,0.004000191,0.00030652105,0.001174767,0.7348355,0.0007069516,0.015994115,0.000048847432],"about_ca_topic_score_codex":0.0015370842,"about_ca_topic_score_gemma":0.0027595034,"teacher_disagreement_score":0.0024201802,"about_ca_system_score_codex":0.00036131524,"about_ca_system_score_gemma":0.00024818064,"threshold_uncertainty_score":0.008096337},"labels":[],"label_agreement":null},{"id":"W2087592754","doi":"10.1097/01.ypg.0000185030.35558.6d","title":"Assay for the simultaneous detection of the *1C and *1F alleles of the CYP1A2 gene by real-time polymerase chain reaction and melting curve analysis","year":2006,"lang":"en","type":"article","venue":"Psychiatric Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Government of Canada; Health Canada","funders":"","keywords":"Genotyping; CYP1A2; Allele; Polymerase chain reaction; Genotype; Melting curve analysis; Biology; Pharmacogenetics; Genetics; Gene; Pharmacology; Cytochrome P450; Enzyme; Biochemistry","score_opus":0.01859545749216046,"score_gpt":0.3286212168641466,"score_spread":0.3100257593719861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087592754","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025861302,0.0008677739,0.966113,0.00032033178,0.00027571092,0.0009192783,0.000981624,0.0023783173,0.0022827622],"genre_scores_gemma":[0.051785536,0.0007122803,0.93676305,0.00042410323,0.00011249894,0.0040936572,0.0017765957,0.00027575297,0.0040565897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.988139,0.0043084132,0.000849659,0.0035175027,0.0026319653,0.00055351044],"domain_scores_gemma":[0.9929276,0.0037926033,0.0009801459,0.00091926765,0.001077328,0.00030293048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006224259,0.0028641953,0.0021536774,0.0046402467,0.00074253866,0.0011360666,0.002015069,0.0030443205,0.0048435754],"category_scores_gemma":[0.009215349,0.0019556845,0.0017560091,0.0019254248,0.0018076908,0.0017551992,0.0012874128,0.004185983,0.0053079715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035261677,0.00031276868,0.0031552208,0.0002972419,0.00010919162,0.0001410785,0.00026562664,0.0005592205,0.9584895,0.0016000955,0.001164183,0.03355325],"study_design_scores_gemma":[0.0001943169,0.0018882848,0.010024723,0.00019248504,0.00024646625,0.0013824259,0.00017333543,0.031550415,0.9324158,0.0032225281,0.01846003,0.00024937844],"about_ca_topic_score_codex":0.0004797486,"about_ca_topic_score_gemma":0.0010028181,"teacher_disagreement_score":0.006224259,"about_ca_system_score_codex":0.0008669474,"about_ca_system_score_gemma":0.0010041116,"threshold_uncertainty_score":0.03291744},"labels":[],"label_agreement":null},{"id":"W2087660740","doi":"10.3399/bjgp09x453800","title":"What affects anticoagulation control in patients taking warfarin?","year":2009,"lang":"en","type":"article","venue":"British Journal of General Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Warfarin; Medicine; Control (management); Intensive care medicine; Internal medicine; Computer science; Atrial fibrillation; Artificial intelligence","score_opus":0.05655407815392492,"score_gpt":0.4202396308953216,"score_spread":0.3636855527413967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087660740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408857,0.040358264,0.00020980334,0.008556699,0.0002610644,0.00003166391,0.0005065303,0.000014439243,0.009175683],"genre_scores_gemma":[0.99329114,0.005005114,0.00015368436,0.00092953065,0.00025006384,0.00001014519,0.00013049717,0.0000022740883,0.00022745223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984133,0.0005473026,0.0003175911,0.00023244924,0.00038167054,0.00010771458],"domain_scores_gemma":[0.9951761,0.0020147134,0.0020352514,0.00010237781,0.0002519653,0.0004195569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095014134,0.00016653158,0.0007965003,0.00061054545,0.0004237797,0.00091221725,0.00030201738,0.0009744225,0.002669557],"category_scores_gemma":[0.009029278,0.000103864215,0.00066861283,0.0016047866,0.0004745025,0.000647509,0.00017003284,0.0006374573,0.0002938787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067421625,0.00017448049,0.9705082,0.00030310234,0.00025524604,0.00045220254,0.00022885278,0.000047099376,0.000100349105,0.00010080019,0.0007587252,0.026396729],"study_design_scores_gemma":[0.0000756421,0.0006034597,0.9925621,0.00027787432,0.00035163088,0.003116258,0.0005292386,0.0001607048,0.00008447432,0.0003904518,0.0018335694,0.000014619361],"about_ca_topic_score_codex":0.002311213,"about_ca_topic_score_gemma":0.003118683,"teacher_disagreement_score":0.002669557,"about_ca_system_score_codex":0.0005584023,"about_ca_system_score_gemma":0.00045438047,"threshold_uncertainty_score":0.008930504},"labels":[],"label_agreement":null},{"id":"W2088489265","doi":"10.1016/s1056-8719(02)00190-9","title":"Porphyrinogenic xenobiotic-induced N-alkylprotoporphyrin IX formation: a bioassay utilizing chick embryo hepatic ferrochelatase","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; Embryo; Bioassay; Microsome; Ferrochelatase; Cytochrome P450; Biochemistry; Biology; Enzyme; Drug metabolism; Heme; Chemistry; Molecular biology; Cell biology; Genetics","score_opus":0.2873985512816267,"score_gpt":0.49096069544264553,"score_spread":0.2035621441610188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088489265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818479,0.0013557466,0.013669776,0.00008942639,0.000042980926,0.000151946,0.0005327952,0.00018605843,0.0021233896],"genre_scores_gemma":[0.9816351,0.0012643423,0.0109217055,0.00003503109,0.000008582994,0.000079088386,0.00065884495,0.000033555647,0.005363855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997075,0.000068809924,0.000030482197,0.000068650515,0.00007944847,0.000044994038],"domain_scores_gemma":[0.9995523,0.00017224492,0.00007304522,0.00008311716,0.000056353158,0.000062884355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039025026,0.0007487037,0.00033805726,0.0004198908,0.000298171,0.00027233476,0.00028343766,0.00056338444,0.000764868],"category_scores_gemma":[0.0002955198,0.00039281897,0.00028261088,0.0002519231,0.0004582041,0.000270975,0.0003024542,0.0006461855,0.0002637375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012806828,0.000008533736,0.00010258797,0.000018214316,0.0000031454636,0.00003137553,0.000011636602,0.000056935078,0.9993449,0.000055566343,0.000007998482,0.00023104934],"study_design_scores_gemma":[0.000004114282,0.00012414336,0.00052210246,0.0000012771708,0.000006152894,0.00003951193,0.0000059053755,0.00012926028,0.99903405,0.000008052501,0.00012375106,0.0000016051854],"about_ca_topic_score_codex":0.0056200097,"about_ca_topic_score_gemma":0.00913149,"teacher_disagreement_score":0.0056200097,"about_ca_system_score_codex":0.0009369432,"about_ca_system_score_gemma":0.000682741,"threshold_uncertainty_score":0.01117456},"labels":[],"label_agreement":null},{"id":"W2088641690","doi":"10.1016/j.toxlet.2008.10.019","title":"Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy","year":2008,"lang":"en","type":"review","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacogenomics; Toxicogenomics; Computational biology; Pharmacogenetics; Genotyping; Drug; Medicine; Drug development; Bioinformatics; Biology; Pharmacology; Genetics; Genotype; Gene","score_opus":0.4700305489504826,"score_gpt":0.5615932813255406,"score_spread":0.09156273237505808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088641690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010952449,0.9843693,0.009673858,0.001976581,0.00045111412,0.000055862598,0.00012314663,0.000057672925,0.0021972363],"genre_scores_gemma":[0.010888867,0.9689735,0.014694007,0.002435914,0.0009856625,0.0001408555,0.00022082258,0.000013136984,0.0016473292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991554,0.0003530741,0.000089529705,0.000120850986,0.00024698264,0.0000340548],"domain_scores_gemma":[0.99756646,0.001870757,0.00020629309,0.00008032245,0.0002399017,0.000036298617],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035124393,0.0013175142,0.003171258,0.0018221098,0.00015881723,0.001157171,0.0010754209,0.001277242,0.0024369922],"category_scores_gemma":[0.0035288217,0.00031903625,0.0010490223,0.0022389148,0.000712244,0.0009132261,0.0006175675,0.001815464,0.0011460618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018199993,0.000115649455,0.0012227797,0.004618749,0.00032458146,0.00037809482,0.000022967037,0.00057901925,0.003466909,0.0029863704,0.007872886,0.97823],"study_design_scores_gemma":[0.00063158735,0.0017668917,0.025582682,0.011818734,0.0038377205,0.008370721,0.00029939276,0.0036430224,0.017016085,0.046084676,0.8807557,0.00019267085],"about_ca_topic_score_codex":0.0005776916,"about_ca_topic_score_gemma":0.0012760819,"teacher_disagreement_score":0.99648756,"about_ca_system_score_codex":0.00052358024,"about_ca_system_score_gemma":0.0011524053,"threshold_uncertainty_score":0.018575788},"labels":[],"label_agreement":null},{"id":"W2089092612","doi":"10.1134/s0006297910050056","title":"Mechanism of steroidogenic electron transport: Role of conserved Glu429 in destabilization of CYP11A1-Adrenodoxin complex","year":2010,"lang":"en","type":"article","venue":"Biochemistry (Moscow)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adrenodoxin; Cholesterol side-chain cleavage enzyme; Chemistry; Hemeprotein; Cytochrome; Ionic strength; Cytochrome c; Electron transport chain; Biophysics; Mutant; Dissociation (chemistry); Stereochemistry; Cytochrome P450; Biochemistry; Enzyme; Mitochondrion; Heme; Biology","score_opus":0.04941577240373465,"score_gpt":0.3619158691488349,"score_spread":0.31250009674510026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089092612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930692,0.0016546259,0.003917532,0.00025653178,0.000033128654,0.000015395224,0.00007452355,0.000044225344,0.000934844],"genre_scores_gemma":[0.9983387,0.00037204588,0.0006187184,0.000022074575,0.000003366206,0.0000039066404,0.00009137544,0.0000057976804,0.00054396957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999132,0.000021443833,0.0000057483044,0.000021598418,0.000019847723,0.000018131026],"domain_scores_gemma":[0.99993193,0.000011900574,0.000017934388,0.000008270935,0.000012482154,0.000017514729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019418297,0.000315621,0.00018213289,0.00008288338,0.0002642056,0.00026674735,0.00026032142,0.0003175548,0.0012640896],"category_scores_gemma":[0.00013825843,0.00008114069,0.00018109941,0.0000817786,0.00023800919,0.00027054132,0.00023815765,0.00028224013,0.0004120611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048924144,0.000046956742,0.0030244421,0.00012286422,0.000036720994,0.0009921908,0.0000688847,0.00043817883,0.9899289,0.0007948045,0.00009529407,0.00396149],"study_design_scores_gemma":[0.00005830495,0.0002534215,0.011516478,0.000012355636,0.000027442677,0.0018928794,0.00014122514,0.0040851994,0.9789979,0.0007924654,0.0022087095,0.000013587674],"about_ca_topic_score_codex":0.0003547357,"about_ca_topic_score_gemma":0.00020678238,"teacher_disagreement_score":0.0012640896,"about_ca_system_score_codex":0.0002246855,"about_ca_system_score_gemma":0.00012884263,"threshold_uncertainty_score":0.0042288303},"labels":[],"label_agreement":null},{"id":"W2089203579","doi":"10.3109/10408363.2011.620601","title":"Methadone: a review of drug-drug and pathophysiological interactions","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Methadone; Medicine; Drug; Pharmacology; Methadone maintenance; Addiction; Drug interaction; Pharmacokinetics; Psychiatry","score_opus":0.5108621722003761,"score_gpt":0.6330056651490932,"score_spread":0.12214349294871707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089203579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008944982,0.9995833,0.000018915634,0.000084801395,0.000053268202,0.000014826902,0.000032225158,0.0000013413058,0.000121949575],"genre_scores_gemma":[0.0008878553,0.99862933,0.000118470096,0.00015975696,0.00006245299,0.000028856015,0.000042408275,8.978131e-7,0.00007002973],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703574,0.0006242747,0.0013136098,0.00023998064,0.00068104547,0.000105362786],"domain_scores_gemma":[0.98959714,0.007295947,0.0018385518,0.000102267855,0.0010161789,0.00014997776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033960312,0.0014646169,0.005243369,0.013791642,0.0005572697,0.0021319664,0.0014003796,0.0018957512,0.0063861473],"category_scores_gemma":[0.010197815,0.0007026641,0.0038660602,0.015747853,0.0006079774,0.002364706,0.0012245388,0.0010796398,0.0006640608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020764153,0.00003473992,0.00048294774,0.7781259,0.0017594775,0.0002836857,0.00018462402,0.0001515253,0.0003495365,0.0006285983,0.0071938518,0.21059747],"study_design_scores_gemma":[0.00015708382,0.0003220536,0.0054854183,0.77699137,0.014850464,0.002331872,0.00027691346,0.00010033651,0.00025298074,0.000849013,0.19833381,0.000048584767],"about_ca_topic_score_codex":0.0050338204,"about_ca_topic_score_gemma":0.010582425,"teacher_disagreement_score":0.013791642,"about_ca_system_score_codex":0.0030648645,"about_ca_system_score_gemma":0.0063962103,"threshold_uncertainty_score":0.0222373},"labels":[],"label_agreement":null},{"id":"W2089947577","doi":"10.1080/00498250310001638460","title":"Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review","year":2004,"lang":"en","type":"review","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kidney; Intracellular; Biology; Enzyme; Chemistry; Pharmacology; Endocrinology; Internal medicine; Medicine; Cell biology; Biochemistry","score_opus":0.06439543471889159,"score_gpt":0.40965000339739316,"score_spread":0.34525456867850157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089947577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001594022,0.99863786,0.00012511025,0.00011301811,0.00012829696,0.000004510195,0.000027472883,0.000007660783,0.0007966079],"genre_scores_gemma":[0.0006106662,0.9984995,0.00014409055,0.00008488899,0.00010266222,0.00000600623,0.000037373728,0.0000013195673,0.00051357085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985456,0.000023196408,0.000025301068,0.000030323314,0.000052510542,0.000014119643],"domain_scores_gemma":[0.9997402,0.00010531712,0.00004849101,0.0000072615394,0.000075208845,0.00002350384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033782108,0.0010411424,0.0015503729,0.0020716772,0.0002515216,0.0007827008,0.0008026459,0.00088851363,0.004395163],"category_scores_gemma":[0.00041758615,0.0002698813,0.00038148917,0.0025176564,0.00030336823,0.0012181189,0.00043723543,0.00086821546,0.003053334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013624932,0.00008112126,0.00027471854,0.020106023,0.00008968137,0.00045523484,0.000059287693,0.0003463632,0.0026232055,0.0012201238,0.023000514,0.95160747],"study_design_scores_gemma":[0.000024697076,0.00017024607,0.0021335513,0.0036777728,0.00018583017,0.0034420926,0.00006797998,0.000087379805,0.0011892751,0.0009196375,0.9880773,0.000024383775],"about_ca_topic_score_codex":0.0012516159,"about_ca_topic_score_gemma":0.0019368081,"teacher_disagreement_score":0.004395163,"about_ca_system_score_codex":0.00044763935,"about_ca_system_score_gemma":0.00090551906,"threshold_uncertainty_score":0.014703274},"labels":[],"label_agreement":null},{"id":"W2090113900","doi":"10.1016/j.amjopharm.2011.07.003","title":"Cytochrome P450 2D6 Phenotyping in an Elderly Population With Dementia and Response to Galantamine in Dementia: A Pilot Study","year":2011,"lang":"en","type":"article","venue":"˜The œAmerican journal of geriatric pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University; Health Sciences North","funders":"","keywords":"Galantamine; Medicine; CYP2D6; Dextromethorphan; Dementia; Population; Dextrorphan; Internal medicine; Pharmacology; Disease; Donepezil; Cytochrome P450","score_opus":0.07233219960403652,"score_gpt":0.39006184127772103,"score_spread":0.3177296416736845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090113900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996407,0.000046168432,0.00006262067,0.00000943074,0.0000025870925,0.0000329484,0.000048617036,0.0000019268225,0.00015505268],"genre_scores_gemma":[0.9995159,0.00004685771,0.00011412759,0.000035355686,0.000012969396,0.000032344695,0.000094506606,0.0000015923741,0.00014634902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995043,0.00021932428,0.000038461145,0.00010015995,0.00007520329,0.000062458676],"domain_scores_gemma":[0.99917114,0.00022223245,0.00014371713,0.000078511956,0.00012708019,0.00025729628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007756412,0.0008092233,0.00092462293,0.00072647503,0.00094059337,0.00055571826,0.00029148007,0.00063863856,0.0010282246],"category_scores_gemma":[0.001739342,0.00036766106,0.0007357243,0.0007060953,0.0005080417,0.0005654966,0.00040506935,0.0007098896,0.00032071903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011999379,0.0045072124,0.96595085,0.000045767385,0.0003511784,0.0026388047,0.0014298498,0.00012195224,0.005979135,0.000033266137,0.00013893224,0.0068035787],"study_design_scores_gemma":[0.0008653731,0.011628926,0.983805,0.000005226585,0.00027183365,0.0018035123,0.0006252448,0.00028920814,0.00037233753,0.000041459105,0.00027807307,0.000013953119],"about_ca_topic_score_codex":0.0039558,"about_ca_topic_score_gemma":0.0037168264,"teacher_disagreement_score":0.0039558,"about_ca_system_score_codex":0.00040223266,"about_ca_system_score_gemma":0.0003553927,"threshold_uncertainty_score":0.007865548},"labels":[],"label_agreement":null},{"id":"W2090767709","doi":"10.1081/dmr-100000140","title":"MECHANISMS OF 1,1-DICHLOROETHYLENE-INDUCED CYTOTOXICITY IN LUNG AND LIVER<sup>*,†</sup>","year":2001,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Glutathione; Chemistry; Biochemistry; Microsome; Epoxide; Cytotoxicity; Lung; In vivo; Hepatocyte; In vitro; Biology; Internal medicine; Enzyme; Medicine","score_opus":0.15371251696697216,"score_gpt":0.4410058204818649,"score_spread":0.2872933035148927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090767709","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53792167,0.4127542,0.018183652,0.0032360961,0.00035702536,0.00036239636,0.0012404947,0.0007538578,0.025190638],"genre_scores_gemma":[0.8734764,0.107576855,0.0026785443,0.000693431,0.00018291683,0.0001993248,0.00070105674,0.000028761424,0.014462663],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998568,0.000047231595,0.000011248676,0.00002038417,0.000040006867,0.00002423475],"domain_scores_gemma":[0.9998969,0.000021000587,0.00003602049,0.00001051843,0.000020699785,0.000014897074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031843127,0.00043288784,0.00036019544,0.000386004,0.000127723,0.0004138255,0.00052160025,0.0006021329,0.0016156012],"category_scores_gemma":[0.00011147447,0.00016542786,0.00024109162,0.00013354309,0.00032025616,0.0002558505,0.00023150977,0.00033163727,0.00079020066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000603832,0.00017392152,0.0013521359,0.001276591,0.00006102787,0.0011362463,0.0000739483,0.0012370526,0.93088007,0.004367305,0.0018923467,0.05694557],"study_design_scores_gemma":[0.00007607824,0.001894926,0.020437237,0.00013674232,0.000097433505,0.0053276094,0.00009815218,0.0018681686,0.9195835,0.0020253952,0.04841875,0.00003603043],"about_ca_topic_score_codex":0.0005077873,"about_ca_topic_score_gemma":0.0005358467,"teacher_disagreement_score":0.0016156012,"about_ca_system_score_codex":0.00058550254,"about_ca_system_score_gemma":0.00018875407,"threshold_uncertainty_score":0.0054047704},"labels":[],"label_agreement":null},{"id":"W2090887850","doi":"10.1002/em.1045","title":"Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in <i>Escherichia coli lacZ</i> strains","year":2001,"lang":"en","type":"article","venue":"Environmental and Molecular Mutagenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; University of Guelph; Vanderbilt University","keywords":"Mutagen; Escherichia coli; Cytochrome P450; Quinoxaline; Carcinogen; Recombinant DNA; Enzyme; Chemistry; Biochemistry; Indole test; Heterocyclic amine; Quinoline; Reductase; Heterocyclic compound; Gene; Organic chemistry","score_opus":0.0358639784513549,"score_gpt":0.33260369998112005,"score_spread":0.29673972152976513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090887850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628805,0.001602372,0.02854289,0.0003228977,0.00008956101,0.0004011592,0.0029578442,0.00049178436,0.0027111347],"genre_scores_gemma":[0.93761575,0.0012016001,0.03104118,0.00010575517,0.0000389148,0.00033004163,0.01496509,0.00017451802,0.014527178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993808,0.0001545841,0.00004614411,0.000107436725,0.00022393317,0.00008706053],"domain_scores_gemma":[0.9998273,0.000033079523,0.000040954164,0.000036093184,0.000029793566,0.000032751333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045896607,0.0007028021,0.00033670187,0.00038983327,0.00019380766,0.0003790946,0.00037169765,0.00039700052,0.0016310426],"category_scores_gemma":[0.00031587027,0.00037086057,0.0003064262,0.00047633584,0.00024389398,0.00018071164,0.0002208366,0.00066038105,0.0013059443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015976046,0.000059510876,0.00026290654,0.000032042597,0.000008120101,0.000029211504,0.000015006694,0.000085435924,0.9979152,0.00018957915,0.00014079663,0.0011024239],"study_design_scores_gemma":[0.000043381886,0.00019198169,0.0015519155,0.000004300807,0.000016700884,0.00023252527,0.000013697975,0.0006176676,0.99286425,0.00006757785,0.004390657,0.0000053036815],"about_ca_topic_score_codex":0.0010815319,"about_ca_topic_score_gemma":0.0013182999,"teacher_disagreement_score":0.0016310426,"about_ca_system_score_codex":0.0005771222,"about_ca_system_score_gemma":0.00023588244,"threshold_uncertainty_score":0.005456388},"labels":[],"label_agreement":null},{"id":"W2090903342","doi":"10.1002/jbt.20057","title":"Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's wort","year":2005,"lang":"en","type":"review","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnane X receptor; Hypericum perforatum; CYP3A4; Mechanism of action; Mechanism (biology); Xenobiotic; Pharmacology; Drug; Kava; Medicine; Cytochrome P450; Traditional medicine; Chemistry; Nuclear receptor; Biochemistry; Enzyme; Transcription factor; Philosophy","score_opus":0.21022730785746369,"score_gpt":0.47937578387000257,"score_spread":0.2691484760125389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090903342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09487996,0.7136285,0.00777184,0.114809334,0.0069962703,0.00016710981,0.00017552418,0.000081033206,0.06149047],"genre_scores_gemma":[0.4515409,0.47274396,0.014110659,0.030922329,0.013267044,0.00011268187,0.0001524952,0.000058178164,0.017091753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918383,0.00030765164,0.0000827326,0.0001308963,0.00020111108,0.000093821116],"domain_scores_gemma":[0.99758613,0.0013748638,0.00029091007,0.00018812898,0.00040204442,0.0001578697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018548992,0.000555749,0.0008127402,0.0017802193,0.0008632414,0.0013586056,0.0006895353,0.0038307256,0.0031603184],"category_scores_gemma":[0.0032404573,0.0002600746,0.0007696343,0.0008116559,0.0033911418,0.0044667046,0.0011032006,0.0035740123,0.0009860989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019045332,0.0008908041,0.02322191,0.008424499,0.00032366317,0.3375336,0.008765178,0.0002969313,0.059035987,0.100224614,0.042378485,0.41699985],"study_design_scores_gemma":[0.0001269386,0.0010081308,0.015709294,0.002884154,0.00037207597,0.370531,0.008198598,0.0005132399,0.01301803,0.056986943,0.530507,0.00014455205],"about_ca_topic_score_codex":0.0012307332,"about_ca_topic_score_gemma":0.0013495667,"teacher_disagreement_score":0.0038307256,"about_ca_system_score_codex":0.0010152633,"about_ca_system_score_gemma":0.00090943504,"threshold_uncertainty_score":0.010572374},"labels":[],"label_agreement":null},{"id":"W2091173057","doi":"10.1016/j.bcp.2007.09.009","title":"Microarray analysis of hepatic gene expression in pyrazole-mediated hepatotoxicity: Identification of potential stimuli of Cyp2a5 induction","year":2007,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; University Health Network","keywords":"Pyrazole; Microarray analysis techniques; Biology; Gene expression; Downregulation and upregulation; Gene; Cytochrome P450; Biochemistry; Cell biology; Molecular biology; Metabolism; Chemistry","score_opus":0.05231740914517804,"score_gpt":0.40294011078668424,"score_spread":0.3506227016415062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091173057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379034,0.001203988,0.008756861,0.00029014642,0.000075579286,0.00008983587,0.0033068806,0.00010872287,0.0023778134],"genre_scores_gemma":[0.97534704,0.001106404,0.010207427,0.00026717078,0.00005330284,0.00031752224,0.005773335,0.000027451953,0.006900288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997441,0.000036830963,0.000017335738,0.000050785206,0.00007103905,0.000079919046],"domain_scores_gemma":[0.9999075,0.000030528914,0.000013770567,0.000009801844,0.000022107617,0.00001630303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015649096,0.0002491731,0.00046857365,0.0003462021,0.00037797992,0.00030007574,0.00013284532,0.00025887054,0.0023182451],"category_scores_gemma":[0.00016185618,0.00016664405,0.00044512446,0.0006916311,0.00024949596,0.00016412565,0.00014986412,0.0005649337,0.0003894063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026177877,0.000023506092,0.00043460468,0.000031706804,0.00000489291,0.000018605793,0.000014416917,0.000050232913,0.9982534,0.000033235796,0.00005530186,0.0008183232],"study_design_scores_gemma":[0.000022325947,0.00041498526,0.06694687,0.0000064025025,0.00004352875,0.00016281003,0.00010256907,0.0017296519,0.92906266,0.000068780566,0.0014272808,0.000012028965],"about_ca_topic_score_codex":0.0016751058,"about_ca_topic_score_gemma":0.0049380506,"teacher_disagreement_score":0.0023182451,"about_ca_system_score_codex":0.00042720747,"about_ca_system_score_gemma":0.0002845543,"threshold_uncertainty_score":0.0077552795},"labels":[],"label_agreement":null},{"id":"W2091598258","doi":"10.1016/j.taap.2006.03.012","title":"The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat","year":2006,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Inflammation; Cytochrome P450; Downregulation and upregulation; Cycloheximide; Biology; Messenger RNA; Signal transduction; Pharmacology; Chemistry; Endocrinology; Internal medicine; Molecular biology; Immunology; Biochemistry; Medicine; Metabolism; Protein biosynthesis; Gene","score_opus":0.042709592791396876,"score_gpt":0.36510183227267395,"score_spread":0.3223922394812771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091598258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658114,0.00097104174,0.0011064281,0.00025127933,0.00004680789,0.00001746163,0.00046210157,0.00005129548,0.0005123774],"genre_scores_gemma":[0.9938245,0.0007878133,0.00065891846,0.000096846095,0.000034627305,0.000046531746,0.00067425164,0.000021889671,0.0038546037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977463,0.00003966461,0.000009515349,0.00004922562,0.000043951684,0.00008291409],"domain_scores_gemma":[0.99955434,0.000042164967,0.00015056547,0.00005315877,0.00007168694,0.0001279326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021399281,0.00057887856,0.0005716079,0.0008013902,0.00034336024,0.00050000334,0.00020524199,0.0005279329,0.0012943785],"category_scores_gemma":[0.00041822594,0.00032788582,0.0004806597,0.00036189886,0.0008001309,0.00050393614,0.0002446409,0.0012274384,0.00036749005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009482749,0.00033218015,0.00373938,0.000060652466,0.000031713753,0.00040075358,0.00014220194,0.00017360684,0.97972614,0.0002496991,0.00018255958,0.0054783914],"study_design_scores_gemma":[0.00012761295,0.003036374,0.08358417,0.00001732884,0.00012066974,0.00043653263,0.00033490185,0.0010677628,0.90922815,0.00044082874,0.0015608426,0.00004492244],"about_ca_topic_score_codex":0.0022040966,"about_ca_topic_score_gemma":0.0032088538,"teacher_disagreement_score":0.0022040966,"about_ca_system_score_codex":0.00066654827,"about_ca_system_score_gemma":0.0005234505,"threshold_uncertainty_score":0.004836142},"labels":[],"label_agreement":null},{"id":"W2091745408","doi":"10.1080/0049825031000121608","title":"Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N -demethylation in human liver microsomes","year":2003,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"AstraZeneca","keywords":"CYP3A4; Microsome; Cytochrome P450; Demethylation; CYP2C8; Chemistry; Pharmacology; Morphine; Hydroxylation; CYP2B6; Enzyme; Biochemistry; Biology; Gene expression; Gene","score_opus":0.07376148550610745,"score_gpt":0.4232556176795827,"score_spread":0.34949413217347525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091745408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96343035,0.012750311,0.020798232,0.0003396574,0.00004267187,0.00014336898,0.00090087723,0.00014807766,0.0014464075],"genre_scores_gemma":[0.97405744,0.004112172,0.016767545,0.00010172911,0.00007433637,0.00008871599,0.0024419362,0.000023366183,0.0023327377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984896,0.000051575505,0.000012519732,0.000035274294,0.000033830234,0.000017765879],"domain_scores_gemma":[0.99983716,0.00003136857,0.00004319823,0.000017700017,0.000054824857,0.00001574107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002509455,0.00032058574,0.00025888265,0.00035725647,0.0001839576,0.00019916377,0.00011927956,0.00026453327,0.0012814178],"category_scores_gemma":[0.0004061139,0.00012758959,0.0003577561,0.00034397453,0.00017043295,0.00015348158,0.00014560466,0.0002965695,0.00061383395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057147775,0.00007162928,0.019743092,0.00020636698,0.00008365682,0.00034761275,0.000060549934,0.00040152975,0.95124173,0.00016964508,0.0003026339,0.026799995],"study_design_scores_gemma":[0.00008289868,0.001430187,0.2788805,0.000027271126,0.0002533078,0.0036971327,0.00009449512,0.0056917346,0.700711,0.0003626931,0.008745323,0.000023533135],"about_ca_topic_score_codex":0.0015747127,"about_ca_topic_score_gemma":0.0017166489,"teacher_disagreement_score":0.0015747127,"about_ca_system_score_codex":0.00021538639,"about_ca_system_score_gemma":0.000300254,"threshold_uncertainty_score":0.004286766},"labels":[],"label_agreement":null},{"id":"W2092190477","doi":"10.1021/bi0268753","title":"2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin<sup>,</sup>","year":2003,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Hyperforin; Pregnane X receptor; Chemistry; Ligand (biochemistry); Hypericum perforatum; Pharmacology; Ligand efficiency; Transporter; Nuclear receptor; Receptor; Stereochemistry; Biochemistry; Biology; Gene; Transcription factor","score_opus":0.060742301055424955,"score_gpt":0.36832489062320156,"score_spread":0.3075825895677766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092190477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391681,0.011233007,0.008454547,0.0056969933,0.0005720248,0.0001748493,0.010751385,0.0014335399,0.022515548],"genre_scores_gemma":[0.9294635,0.008137827,0.022985574,0.0016780667,0.00020547077,0.0002191242,0.025499016,0.0003665254,0.011444922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995683,0.000058379177,0.000014626912,0.00006931562,0.00021403821,0.000075300326],"domain_scores_gemma":[0.9996973,0.00011987125,0.00006185797,0.000009519224,0.0000488945,0.000062552404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029118985,0.0008421635,0.0009672997,0.00034087364,0.0010894648,0.0012285156,0.0016369208,0.0014605486,0.007868439],"category_scores_gemma":[0.00047944413,0.00045954259,0.00043727667,0.0006983904,0.00044356947,0.00060699694,0.00044774584,0.002426502,0.00075549236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004402169,0.0024391764,0.016382644,0.0019966834,0.00063140516,0.0104934145,0.0017310526,0.030440852,0.79862595,0.012346107,0.07745694,0.043053556],"study_design_scores_gemma":[0.0034948213,0.0033031993,0.12403555,0.00037400445,0.00084489427,0.013452205,0.003203849,0.25052282,0.35412687,0.006379897,0.23964247,0.0006194293],"about_ca_topic_score_codex":0.009970547,"about_ca_topic_score_gemma":0.009185605,"teacher_disagreement_score":0.009970547,"about_ca_system_score_codex":0.0014157358,"about_ca_system_score_gemma":0.0013921334,"threshold_uncertainty_score":0.026322544},"labels":[],"label_agreement":null},{"id":"W2092718944","doi":"10.1016/j.ejphar.2006.09.006","title":"Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism","year":2006,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chlorzoxazone; CYP2E1; Phenobarbital; In vivo; Pharmacology; Drug metabolism; Chemistry; Metabolism; In vitro; Endocrinology; Cerebellum; Internal medicine; Cytochrome P450; Biology; Biochemistry; Medicine; Genetics","score_opus":0.05834972505856281,"score_gpt":0.36518217215811544,"score_spread":0.3068324470995526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092718944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849894,0.0018317146,0.006711415,0.0006386666,0.00016823327,0.000108764165,0.0019317631,0.00041200948,0.0032079758],"genre_scores_gemma":[0.979731,0.001839426,0.0033954517,0.00015694863,0.000074887954,0.00011964392,0.004254929,0.00023265777,0.0101949265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997042,0.000065728775,0.000017770659,0.00006506811,0.000055469183,0.000091822985],"domain_scores_gemma":[0.99970967,0.00008584771,0.000050629966,0.00006494448,0.00003448215,0.000054416487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019876253,0.0007341642,0.0004568347,0.0005582263,0.0003961135,0.0003939579,0.00022830653,0.00031571128,0.003498536],"category_scores_gemma":[0.000282932,0.00049844297,0.00043190914,0.00045508335,0.0006144503,0.00031223666,0.00023092446,0.0010274452,0.0010776222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070591364,0.00006590986,0.00023766469,0.000039560833,0.000018147352,0.000054046857,0.000038307673,0.000050459617,0.99764305,0.00012390906,0.00018426478,0.00083867664],"study_design_scores_gemma":[0.000035288278,0.00034541695,0.0018459021,0.000002962063,0.000024850484,0.00015845636,0.000022375005,0.0002525857,0.9960437,0.00004318583,0.001221784,0.0000036555114],"about_ca_topic_score_codex":0.0067575052,"about_ca_topic_score_gemma":0.015416408,"teacher_disagreement_score":0.0067575052,"about_ca_system_score_codex":0.00077191123,"about_ca_system_score_gemma":0.0007024425,"threshold_uncertainty_score":0.013436317},"labels":[],"label_agreement":null},{"id":"W2092854154","doi":"10.1016/j.cbpc.2014.06.008","title":"Expression patterns of cytochrome P450 3B and 3C genes in model fish species","year":2014,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Trent University; McMaster University","keywords":"Biology; Zebrafish; Oryzias; Danio; Cytochrome P450; Gene; Xenobiotic; Gene expression; Drug metabolism; Catfish; Genetics; Cell biology; Metabolism; Endocrinology; Fish <Actinopterygii>; Enzyme; Biochemistry; Fishery","score_opus":0.11352140422180933,"score_gpt":0.407139315328244,"score_spread":0.29361791110643465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092854154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959194,0.00030437135,0.0007692459,0.000037217764,0.000007247349,0.000013950154,0.0010089035,0.000017841208,0.0019219194],"genre_scores_gemma":[0.9909315,0.00039267776,0.0014108232,0.000058394737,0.0000055936357,0.00007146837,0.0013576245,0.000030492238,0.005741386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999293,0.0000048793127,0.000004441187,0.000030846295,0.0000119770775,0.000018591087],"domain_scores_gemma":[0.99986804,0.000022693926,0.000035564724,0.000009699054,0.000033746586,0.000030307448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074106836,0.00013844101,0.00017414619,0.0009401454,0.0003415538,0.00022519422,0.00011435245,0.0002458976,0.002005871],"category_scores_gemma":[0.00015825851,0.0002083967,0.00026458374,0.000339805,0.00033619668,0.00020838855,0.00021286441,0.0003387449,0.00031840062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358295,0.000024773171,0.019056592,0.000051012434,0.000026831387,0.00008776355,0.0002847441,0.00014623275,0.9755744,0.00034866887,0.00013956687,0.003723603],"study_design_scores_gemma":[0.00005044407,0.0009118135,0.78624284,0.000024629062,0.00013655327,0.0007476863,0.0010662631,0.0011617094,0.20443065,0.00035671087,0.0048269057,0.000043855038],"about_ca_topic_score_codex":0.007566141,"about_ca_topic_score_gemma":0.016229954,"teacher_disagreement_score":0.007566141,"about_ca_system_score_codex":0.00057361036,"about_ca_system_score_gemma":0.00031063982,"threshold_uncertainty_score":0.015044212},"labels":[],"label_agreement":null},{"id":"W2093353667","doi":"10.1002/path.2805","title":"Immunohistochemical expression of conjugating UGT1A‐derived isoforms in normal and tumoral drug‐metabolizing tissues in humans","year":2010,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Gene isoform; Biology; Glucuronidation; Drug metabolism; Glucuronosyltransferase; Isozyme; Carcinogenesis; Xenobiotic; Biochemistry; In vitro; Enzyme; Microsome; Gene","score_opus":0.043729141937628314,"score_gpt":0.39713026886093994,"score_spread":0.3534011269233116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093353667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837441,0.006150857,0.0042454717,0.00006785189,0.000022278531,0.00004166403,0.00045364737,0.000079500925,0.0051946263],"genre_scores_gemma":[0.9934001,0.0020689953,0.0020439294,0.000043324573,0.000018936655,0.000029576364,0.0004459176,0.000013871076,0.00193535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987197,0.000021195394,0.000009971192,0.000046590416,0.000027460652,0.000022779208],"domain_scores_gemma":[0.9998791,0.000023513428,0.00003402572,0.000013456142,0.000022990022,0.000026931144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025321794,0.00017579301,0.00012450962,0.0007504298,0.00011724959,0.00020718183,0.00013363251,0.00020299024,0.0017753857],"category_scores_gemma":[0.00019215731,0.00019102507,0.00014723494,0.00034979807,0.00024741233,0.00016429978,0.00013593753,0.00015008492,0.00033623385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010121907,0.00007586161,0.059436377,0.00021284276,0.00009041582,0.0021908924,0.00022333486,0.00013729665,0.92047143,0.00051459414,0.0005016392,0.015133147],"study_design_scores_gemma":[0.000072189476,0.0010649918,0.7899362,0.000050121827,0.00022869592,0.019222734,0.00047937775,0.001693985,0.17152038,0.00052495074,0.015172675,0.000033684624],"about_ca_topic_score_codex":0.000540633,"about_ca_topic_score_gemma":0.00048070672,"teacher_disagreement_score":0.0017753857,"about_ca_system_score_codex":0.00011712645,"about_ca_system_score_gemma":0.0000716228,"threshold_uncertainty_score":0.005939245},"labels":[],"label_agreement":null},{"id":"W2093889398","doi":"10.1046/j.1472-8206.2002.00109.x","title":"Pharmacogenetics and personalised medicine","year":2002,"lang":"en","type":"review","venue":"Fundamental and Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Personalized medicine; Mendelian inheritance; Precision medicine; Drug; Medicine; Pharmacology; Bioinformatics; Computational biology; Genetics; Biology; Gene; Genotype","score_opus":0.4544090659561705,"score_gpt":0.593700282924942,"score_spread":0.13929121696877156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093889398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026693806,0.96676093,0.0038858252,0.010053887,0.0011310423,0.000022434333,0.00002096229,0.00005994927,0.01779792],"genre_scores_gemma":[0.006425217,0.9740272,0.0031946865,0.0062895715,0.0020358893,0.000044401797,0.00004340576,0.000013399023,0.007926211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887925,0.0005428108,0.00006748641,0.00013017008,0.00032163042,0.00005861678],"domain_scores_gemma":[0.9988691,0.0007559893,0.000080320795,0.000100856734,0.00012713474,0.00006649626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016714123,0.0010915113,0.0014865523,0.0016404713,0.00040650432,0.0022073656,0.0012643388,0.0032467735,0.006147463],"category_scores_gemma":[0.0023473653,0.0003016082,0.0005368423,0.0019249575,0.0033153095,0.0026628028,0.0014092764,0.003820667,0.0038007696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004899823,0.00011776921,0.00033258638,0.0049716835,0.00012858263,0.00043422758,0.00038150875,0.0012255986,0.00074294,0.08198257,0.0666542,0.8429794],"study_design_scores_gemma":[0.00002047104,0.000043888493,0.0006254178,0.002328682,0.00003113193,0.0020176235,0.00011745999,0.00017761336,0.00024628968,0.067917995,0.926451,0.000022375256],"about_ca_topic_score_codex":0.0010748693,"about_ca_topic_score_gemma":0.0012919583,"teacher_disagreement_score":0.006147463,"about_ca_system_score_codex":0.0018940857,"about_ca_system_score_gemma":0.0018292773,"threshold_uncertainty_score":0.020565331},"labels":[],"label_agreement":null},{"id":"W2093903277","doi":"10.1503/cmaj.1031558","title":"Natural products and adverse drug interactions","year":2004,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Natural (archaeology); Drug; Medicine; Public health; Alternative medicine; Computer science; Internet privacy; Data science; Pharmacology; Pathology; History","score_opus":0.02880084396721209,"score_gpt":0.36818451239638944,"score_spread":0.33938366842917733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093903277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14017195,0.63111895,0.0020369424,0.0889678,0.002335123,0.00016629319,0.0027469103,0.00008639923,0.13236961],"genre_scores_gemma":[0.77363735,0.19561821,0.0016884846,0.014866281,0.0037346664,0.000081525555,0.00080106815,0.000015476375,0.009556976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964516,0.0017816422,0.00037555507,0.00023496796,0.0010066951,0.00014940956],"domain_scores_gemma":[0.98135424,0.010385433,0.0055892123,0.00040087002,0.0015413114,0.0007289567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018481261,0.00020846725,0.0005190913,0.0013763111,0.0004223005,0.0011121893,0.00026916538,0.0015707017,0.009580995],"category_scores_gemma":[0.011918615,0.00016348403,0.0007979996,0.0015790827,0.0006787692,0.000685427,0.00051973964,0.0016649393,0.00069428195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020830773,0.00068069063,0.39448348,0.0046528364,0.0022493629,0.0069194166,0.00060992106,0.0012355674,0.0012157379,0.030606506,0.0797908,0.47547254],"study_design_scores_gemma":[0.00047201323,0.0010543702,0.59324145,0.003003661,0.0016677006,0.028508333,0.00078364526,0.0013805442,0.0012088465,0.05193055,0.31662744,0.00012140037],"about_ca_topic_score_codex":0.0028671394,"about_ca_topic_score_gemma":0.004566604,"teacher_disagreement_score":0.009580995,"about_ca_system_score_codex":0.00083736284,"about_ca_system_score_gemma":0.0009081331,"threshold_uncertainty_score":0.032051623},"labels":[],"label_agreement":null},{"id":"W2093920606","doi":"10.1016/s1532-0456(03)00113-3","title":"The role of CYP 1A1 in the in vitro metabolism of pregnenolone by the liver of rainbow trout embryos","year":2003,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Agriculture, Food and Rural Affairs","keywords":"Rainbow trout; Metabolite; Pregnenolone; Metabolism; Biology; Cytochrome P450; Catabolism; Isozyme; Incubation; Embryo; Enzyme; In vitro; Trout; Internal medicine; Endocrinology; Biochemistry; Steroid; Hormone; Fish <Actinopterygii>","score_opus":0.05703638152172458,"score_gpt":0.37755930012064637,"score_spread":0.3205229185989218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093920606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992021,0.0024486247,0.0018870588,0.00025943335,0.00002602701,0.000019728472,0.0007745416,0.000036229543,0.0025272828],"genre_scores_gemma":[0.9892107,0.0010531523,0.0010215332,0.00006135614,0.000008589473,0.000019865962,0.0010722838,0.000032035583,0.0075204624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986017,0.000036338108,0.00001229881,0.000029265284,0.000026688664,0.00003519129],"domain_scores_gemma":[0.9997936,0.00007181716,0.000035411707,0.0000337621,0.00003634584,0.00002911069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002051518,0.0002650483,0.00024292807,0.00040743328,0.0004136693,0.000556949,0.00022387845,0.0002610367,0.0016397459],"category_scores_gemma":[0.00034312427,0.00039110205,0.0003219303,0.00018659067,0.00044331208,0.00041050187,0.0002820408,0.0008096533,0.0005452904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004618678,0.000012862695,0.0024091352,0.000048972863,0.000012098963,0.0001191755,0.000111309666,0.00032717132,0.9937604,0.00050177705,0.00006237681,0.0021728543],"study_design_scores_gemma":[0.000021804957,0.00026239554,0.02921301,0.00001419344,0.000037805738,0.00023192771,0.00017236159,0.00081062625,0.9666159,0.00016881744,0.0024326385,0.00001857919],"about_ca_topic_score_codex":0.013369028,"about_ca_topic_score_gemma":0.021009838,"teacher_disagreement_score":0.013369028,"about_ca_system_score_codex":0.0014555758,"about_ca_system_score_gemma":0.00082977064,"threshold_uncertainty_score":0.02658242},"labels":[],"label_agreement":null},{"id":"W2094218863","doi":"10.1016/j.taap.2013.04.013","title":"Cytochrome P450 2A5 and bilirubin: Mechanisms of gene regulation and cytoprotection","year":2013,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Reporter gene; Transfection; Molecular biology; Chemistry; Microsome; Cytoprotection; Endogeny; Gene expression; Biology; In vitro; Gene; Apoptosis; Biochemistry","score_opus":0.0461619068202838,"score_gpt":0.35186476098432645,"score_spread":0.30570285416404264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094218863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92722774,0.051265106,0.013830777,0.0016953016,0.00012903663,0.0000538665,0.00043016518,0.00015266228,0.005215486],"genre_scores_gemma":[0.99305785,0.0035722982,0.0009943881,0.000117448035,0.000043979297,0.000012450359,0.00015128407,0.0000072209864,0.0020429846],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972385,0.00010812394,0.000013955277,0.00004918886,0.00005344576,0.00005148704],"domain_scores_gemma":[0.99980086,0.000041992236,0.00007027919,0.000024126673,0.000027125185,0.00003551394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042551287,0.0002523563,0.00031383836,0.00041497484,0.00019984455,0.00082007895,0.0002557993,0.00038635943,0.0011696985],"category_scores_gemma":[0.00040682315,0.00014991901,0.0003207817,0.00028927226,0.0005740449,0.0003576693,0.000284378,0.00037097177,0.0001640562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038588291,0.00019474122,0.019498587,0.00032658974,0.00016602527,0.0006994293,0.00030671185,0.0007699081,0.9039105,0.012537489,0.0006370472,0.05709409],"study_design_scores_gemma":[0.0001339644,0.0015493135,0.23282298,0.00004708161,0.00020282723,0.0024318676,0.0004501812,0.003431757,0.7391271,0.00539868,0.014364779,0.000039492497],"about_ca_topic_score_codex":0.0017254058,"about_ca_topic_score_gemma":0.001187837,"teacher_disagreement_score":0.0017254058,"about_ca_system_score_codex":0.0006166835,"about_ca_system_score_gemma":0.0003097937,"threshold_uncertainty_score":0.0044744015},"labels":[],"label_agreement":null},{"id":"W2094881146","doi":"10.1097/fpc.0b013e3282fb02ba","title":"Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers","year":2008,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; COPD; CYP3A5; Vital capacity; Odds ratio; Lung transplantation; Internal medicine; Genotype; Spirometry; Pulmonary function testing; Lung; Diffusing capacity; Lung function; Asthma; Biology; Genetics","score_opus":0.0492857758618142,"score_gpt":0.3451118820476309,"score_spread":0.2958261061858167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094881146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993476,0.000101725556,0.00004448568,0.0000347585,0.0000033784988,0.000003345529,0.00025299733,0.0000028697677,0.00020880894],"genre_scores_gemma":[0.99913293,0.00008120932,0.000057347796,0.000034430588,0.0000025316092,0.000005058809,0.00031807533,0.0000017646969,0.0003667524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974424,0.000052503947,0.000021534963,0.00007362207,0.00004887936,0.00005920791],"domain_scores_gemma":[0.9993772,0.00011405921,0.00015996429,0.00006158675,0.00013301379,0.00015427663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000335933,0.00029471537,0.00023147157,0.0004921575,0.000555745,0.0004063495,0.00029657313,0.0003940965,0.0019432007],"category_scores_gemma":[0.0006099644,0.00023709801,0.0003338041,0.00076223357,0.00026485758,0.00013745527,0.00024593322,0.0004829846,0.00029593112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009702356,0.0000236623,0.99793375,0.000004098533,0.000067308436,0.000091128604,0.000076009186,0.000021967502,0.000842959,0.0000071155873,0.00009861022,0.0007364475],"study_design_scores_gemma":[0.0000036016454,0.000021611459,0.99969006,0.0000024694164,0.000014357192,0.000041834544,0.00007174702,0.000051074356,0.00003492841,0.0000049186237,0.000061744126,0.0000016605429],"about_ca_topic_score_codex":0.32453135,"about_ca_topic_score_gemma":0.43585846,"teacher_disagreement_score":0.6754687,"about_ca_system_score_codex":0.0010571001,"about_ca_system_score_gemma":0.0009299177,"threshold_uncertainty_score":0.6452848},"labels":[],"label_agreement":null},{"id":"W2095886291","doi":"10.1124/mol.111.071787","title":"In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation","year":2011,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Constitutive androstane receptor; Pharmacology; In vivo; Chemistry; Nuclear receptor; Receptor; Biology; Biochemistry; Transcription factor","score_opus":0.06212254743634515,"score_gpt":0.3450595616488686,"score_spread":0.28293701421252343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095886291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433626,0.004853667,0.006796827,0.00030687882,0.000069824644,0.00013387186,0.0010646455,0.00012393884,0.002314056],"genre_scores_gemma":[0.98739773,0.0032513984,0.0036700494,0.00012952015,0.000034618955,0.000044959994,0.0016487046,0.000027014881,0.0037960622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998888,0.000031746993,0.000006437515,0.000018041084,0.000021860984,0.000033218632],"domain_scores_gemma":[0.999884,0.000028192153,0.000026380802,0.000015419177,0.000018024712,0.000027978336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019051721,0.0003817904,0.00038035182,0.00026715864,0.00019027483,0.0002642313,0.00032195024,0.00030510043,0.0013616399],"category_scores_gemma":[0.00020086527,0.00013108178,0.00025246196,0.00016805592,0.00019222237,0.00024946834,0.000107367894,0.0006285378,0.0003860264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005135798,0.00018726413,0.0002121145,0.000041841176,0.000021795659,0.000119376215,0.000018278673,0.0005967647,0.9934557,0.00008543972,0.00014444687,0.004603331],"study_design_scores_gemma":[0.00011645861,0.004512332,0.0017887409,0.0000052977493,0.00006657187,0.0007925085,0.000027351336,0.0013993697,0.9871149,0.000062294195,0.004103487,0.000010621839],"about_ca_topic_score_codex":0.00087609276,"about_ca_topic_score_gemma":0.0014711644,"teacher_disagreement_score":0.0013616399,"about_ca_system_score_codex":0.00030958405,"about_ca_system_score_gemma":0.00025809498,"threshold_uncertainty_score":0.004555106},"labels":[],"label_agreement":null},{"id":"W2096718798","doi":"10.3109/03602530903210682","title":"UGT genomic diversity: beyond gene duplication","year":2009,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Gene; Glucuronosyltransferase; Biology; Phenotype; Epigenetics; Genetics; Gene duplication; Enzyme; Biochemistry; Microsome","score_opus":0.1939527410100668,"score_gpt":0.45582667840413016,"score_spread":0.2618739373940634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096718798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073700403,0.98262674,0.001827091,0.0011332728,0.00016046269,0.000008845182,0.0001306354,0.000042972133,0.00669981],"genre_scores_gemma":[0.042125985,0.9515223,0.0018350307,0.00053971336,0.0003303077,0.000013281018,0.00033967808,0.000012623887,0.003281199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998536,0.000029765864,0.000011916109,0.000047472404,0.000043500437,0.000013658602],"domain_scores_gemma":[0.9998982,0.00003651935,0.000022065284,0.0000074941013,0.000023898614,0.000011897949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021631314,0.00029852855,0.0008954552,0.000608195,0.00011457795,0.0006203165,0.0003527778,0.00046724366,0.002157379],"category_scores_gemma":[0.00030281054,0.000099844205,0.00024359513,0.0009962042,0.0002952863,0.00066561194,0.00030819466,0.00051150186,0.0010170373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102044534,0.000016185442,0.0017153079,0.0026920703,0.000110805275,0.0018451967,0.000115458824,0.0004814383,0.01567245,0.00735937,0.005893864,0.9639959],"study_design_scores_gemma":[0.000025675308,0.00022266826,0.014109366,0.0009398837,0.0002340111,0.020189483,0.00016362399,0.0002784429,0.008017943,0.010586582,0.9451966,0.000035775436],"about_ca_topic_score_codex":0.0007155795,"about_ca_topic_score_gemma":0.0006936894,"teacher_disagreement_score":0.002157379,"about_ca_system_score_codex":0.00043651328,"about_ca_system_score_gemma":0.0004929117,"threshold_uncertainty_score":0.007217169},"labels":[],"label_agreement":null},{"id":"W2097103427","doi":"10.2174/187231210790980462","title":"Assessment of the Inactivation Potential of Desethylamiodarone on Human CYP1A1","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Dilution; Non-competitive inhibition; Enzyme; Food science; Chromatography; Biochemistry; Pharmacology; Biology","score_opus":0.05181478934585863,"score_gpt":0.4172774924222502,"score_spread":0.36546270307639156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097103427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367727,0.0051656137,0.008872356,0.000103261846,0.000026859325,0.00010424657,0.0003012754,0.000044320506,0.0017047739],"genre_scores_gemma":[0.9911678,0.0023777522,0.0036226925,0.000048087506,0.0000243183,0.00011157449,0.0005935396,0.000015213071,0.0020390816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951756,0.00022842726,0.000034144523,0.00006470791,0.000105859115,0.00004935923],"domain_scores_gemma":[0.99950206,0.00023286347,0.00005188434,0.00007057958,0.00011619573,0.00002653093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000718436,0.0005143939,0.0003060271,0.00017345646,0.00017073013,0.0002374611,0.00024329247,0.00039133814,0.0011000035],"category_scores_gemma":[0.0011465739,0.00017851625,0.00023871259,0.00023896011,0.00020538137,0.00021988754,0.00013464951,0.00049644936,0.00037169928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032588653,0.0000462679,0.0009317956,0.000058237085,0.000027092345,0.00004342183,0.000058393027,0.0001907122,0.99446493,0.000053060878,0.00003322527,0.003766948],"study_design_scores_gemma":[0.000009511921,0.0007921358,0.0049684294,0.000003823999,0.000027141195,0.00008149751,0.000014755174,0.00064878137,0.99291927,0.000022915634,0.00050876057,0.000003087477],"about_ca_topic_score_codex":0.00056326983,"about_ca_topic_score_gemma":0.00057996565,"teacher_disagreement_score":0.0011000035,"about_ca_system_score_codex":0.00018877171,"about_ca_system_score_gemma":0.0001892159,"threshold_uncertainty_score":0.0037994385},"labels":[],"label_agreement":null},{"id":"W2097195964","doi":"10.1136/bmjopen-2013-002857","title":"Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions","year":2013,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; London Health Sciences Centre; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences; Western University","funders":"Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre; Lawson Health Research Institute","keywords":"Medicine; Azithromycin; Clarithromycin; Internal medicine; Retrospective cohort study; Population; Antibiotics","score_opus":0.3012585843008348,"score_gpt":0.5627864723495077,"score_spread":0.26152788804867294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097195964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895174,0.0052683456,0.0006753025,0.00013234038,0.000060918417,0.00019746754,0.0036107067,0.000015074756,0.0010881809],"genre_scores_gemma":[0.996236,0.0007124575,0.0009094629,0.00009371577,0.00006178729,0.00017256902,0.0015388186,0.0000051672378,0.00027006632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99175817,0.0023150519,0.0011978959,0.0015338172,0.0028084645,0.00038658746],"domain_scores_gemma":[0.9835722,0.004821671,0.0086307805,0.0006817895,0.0016640318,0.00062960223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040611695,0.00082251604,0.0011891786,0.0023306112,0.0005613744,0.0011416494,0.0009513638,0.0010077294,0.0019007454],"category_scores_gemma":[0.014757171,0.00031050213,0.002731176,0.003023468,0.0003932236,0.0008586117,0.0007733252,0.0007700414,0.00013709372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015107307,0.00004559982,0.99173427,0.00019125165,0.003686087,0.000041594805,0.000052625608,0.00009301104,0.00014367426,0.000027957782,0.00011395276,0.0023592757],"study_design_scores_gemma":[0.00017231451,0.00097454555,0.9957975,0.000049000162,0.0014728543,0.00020021763,0.000116485135,0.0005077038,0.00012861246,0.00005102266,0.0005179075,0.000011951271],"about_ca_topic_score_codex":0.025237044,"about_ca_topic_score_gemma":0.05246176,"teacher_disagreement_score":0.025237044,"about_ca_system_score_codex":0.0015584211,"about_ca_system_score_gemma":0.001507178,"threshold_uncertainty_score":0.050180316},"labels":[],"label_agreement":null},{"id":"W2098130430","doi":"10.1002/jps.22136","title":"Extrapolating In vitro Metabolic Interactions to Isolated Perfused Liver: Predictions of Metabolic Interactions between R-Bufuralol, Bunitrolol, and Debrisoquine","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Debrisoquine; In vitro; Chemistry; Pharmacology; Biochemistry; Metabolism; Biology; Cytochrome P450; CYP2D6","score_opus":0.12829367325099594,"score_gpt":0.4695342371850012,"score_spread":0.34124056393400526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098130430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436118,0.0008754268,0.052131157,0.00024800657,0.0000311017,0.000052414318,0.0005070608,0.00012363035,0.0024195109],"genre_scores_gemma":[0.99480116,0.00043841513,0.0038357093,0.00004765734,0.000006996492,0.000039611303,0.00020420848,0.000020251084,0.00060604216],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998714,0.00005677427,0.0000056125327,0.000031276326,0.00001938346,0.00001556311],"domain_scores_gemma":[0.9993861,0.00043871737,0.000069803384,0.00002121461,0.000054892964,0.000029215054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005033111,0.0009493311,0.000749944,0.00019676564,0.00022364441,0.0006860093,0.00068768143,0.00086962467,0.00088183215],"category_scores_gemma":[0.0015299203,0.00040902512,0.0008133391,0.00018158875,0.00024943246,0.0004942052,0.0002510532,0.00083965913,0.0003291461],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000912418,0.00012938889,0.005739315,0.00018691995,0.00014603199,0.00044695972,0.000056099365,0.8885158,0.097275086,0.00046458267,0.0002539443,0.0058734776],"study_design_scores_gemma":[0.000056238416,0.0005260707,0.0029222989,0.000007741759,0.000099367244,0.000138143,0.0000388907,0.9608978,0.03442634,0.0005677639,0.00029530912,0.000024070163],"about_ca_topic_score_codex":0.009969953,"about_ca_topic_score_gemma":0.005440939,"teacher_disagreement_score":0.009969953,"about_ca_system_score_codex":0.00094170216,"about_ca_system_score_gemma":0.0006480001,"threshold_uncertainty_score":0.01982385},"labels":[],"label_agreement":null},{"id":"W2098153346","doi":"10.1124/dmd.112.045245","title":"Down-Regulation of Hepatic CYP3A and CYP2C Mediated Metabolism in Rats with Moderate Chronic Kidney Disease","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Metabolism; CYP3A; Kidney disease; Kidney; Biology; Internal medicine; Endocrinology; Pharmacology; Chemistry; Medicine; Cytochrome P450","score_opus":0.024813872870603847,"score_gpt":0.32894159648297205,"score_spread":0.30412772361236823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098153346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998492,0.0003011566,0.0006368527,0.000097726675,0.00003990554,0.00001691111,0.00016249373,0.000043979646,0.0002088509],"genre_scores_gemma":[0.99658597,0.0003670364,0.0006248581,0.0000612471,0.000021132204,0.000060314233,0.00036132638,0.000020502495,0.0018976039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996679,0.00003753848,0.00003160171,0.000070361166,0.00006007907,0.00013257762],"domain_scores_gemma":[0.99950695,0.000044797926,0.00012070756,0.00007381134,0.000056115925,0.00019762134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031142504,0.00058018515,0.0010027942,0.0007671454,0.0005335906,0.00046916876,0.0003208077,0.0004586015,0.0022044186],"category_scores_gemma":[0.0003222088,0.00035121353,0.00082332024,0.0004921216,0.0008157744,0.0004720879,0.00038319844,0.0013781092,0.0002894662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019013768,0.0012406947,0.0031005226,0.00010628007,0.000074746145,0.0003074058,0.000101910526,0.0001879238,0.97035563,0.00026595462,0.00015635126,0.005088789],"study_design_scores_gemma":[0.000810598,0.009849472,0.056014527,0.00001791425,0.0003490043,0.00066706917,0.00041257747,0.0021352472,0.92657083,0.0003386684,0.0027693305,0.00006465273],"about_ca_topic_score_codex":0.0033711288,"about_ca_topic_score_gemma":0.0047426037,"teacher_disagreement_score":0.0033711288,"about_ca_system_score_codex":0.00055590237,"about_ca_system_score_gemma":0.0007644836,"threshold_uncertainty_score":0.007374525},"labels":[],"label_agreement":null},{"id":"W2098768607","doi":"10.1002/gps.1522","title":"CYP2D6 genotype and venlafaxine‐XR concentrations in depressed elderly","year":2006,"lang":"en","type":"article","venue":"International Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"CYP2D6; Venlafaxine; Pharmacogenetics; Adverse effect; Ven; Internal medicine; Medicine; Tolerability; Genotype; Polypharmacy; Pharmacology; Depression (economics); Endocrinology; Antidepressant; Biology; Genetics","score_opus":0.029391841915274247,"score_gpt":0.387762583106084,"score_spread":0.3583707411908098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098768607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944884,0.0002680191,0.000040160045,0.000011681947,0.0000018327515,0.0000025886543,0.00009808357,0.0000013267833,0.00012757505],"genre_scores_gemma":[0.99967,0.00008692955,0.000055168483,0.000009330793,0.000003302535,0.0000019092708,0.0000799941,4.4467959e-7,0.00009287171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989605,0.000027028396,0.000016920505,0.000024342906,0.000023236647,0.00001235389],"domain_scores_gemma":[0.99953496,0.00007121899,0.00028422792,0.000024373621,0.00003901589,0.000046353245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024405008,0.00014704693,0.0002312036,0.00019828646,0.00015207204,0.0002403285,0.000098193086,0.00021752596,0.001339755],"category_scores_gemma":[0.0008809118,0.000103651204,0.00017659017,0.00024270559,0.000076907825,0.00008845336,0.00010334141,0.00016659319,0.00016243952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000495661,0.000026751415,0.99615353,0.000011758735,0.00005504262,0.000098924334,0.000032714,0.000029073106,0.0010239098,0.0000059439335,0.00004291722,0.0020237851],"study_design_scores_gemma":[0.000011768862,0.00017833615,0.99898726,0.000003498108,0.000027311151,0.00043217133,0.000025854028,0.00008758726,0.00016807606,0.000008427792,0.000068450296,0.0000011201479],"about_ca_topic_score_codex":0.0010033567,"about_ca_topic_score_gemma":0.0011599107,"teacher_disagreement_score":0.001339755,"about_ca_system_score_codex":0.00009112491,"about_ca_system_score_gemma":0.000052598127,"threshold_uncertainty_score":0.0044819713},"labels":[],"label_agreement":null},{"id":"W2099037673","doi":"10.1139/v00-122","title":"The tamoxifen cation reacts to give indene products","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Carbocation; Chemistry; Indene; Yield (engineering); Isomerization; Medicinal chemistry; Ring (chemistry); Intramolecular force; Epimer; Stereochemistry; Photochemistry; Organic chemistry; Catalysis","score_opus":0.05399028719642234,"score_gpt":0.3655880659245553,"score_spread":0.31159777872813293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099037673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94878995,0.006455115,0.01766115,0.00039839093,0.00024247727,0.0002457099,0.0009670699,0.00028473182,0.024955342],"genre_scores_gemma":[0.9483966,0.0025499018,0.005366828,0.00021743447,0.000051358573,0.000100602585,0.001060014,0.00006986024,0.04218731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988365,0.000008595265,0.0000044553303,0.000036839054,0.00003221358,0.000034311062],"domain_scores_gemma":[0.99993455,0.0000118431135,0.000016148513,0.00001016318,0.000014800165,0.000012552798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090622736,0.0003700222,0.00016536428,0.00021308535,0.0001555055,0.0001499855,0.00017791944,0.0002907299,0.008688027],"category_scores_gemma":[0.00016859744,0.00012910101,0.00034548188,0.0001142611,0.00013083951,0.0002532602,0.00021667108,0.0005288815,0.0026564596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072154224,0.00001262494,0.00020051177,0.00004405579,0.0000070826245,0.00011610731,0.000022612885,0.00003229541,0.9954731,0.00013004828,0.0001307115,0.0037586477],"study_design_scores_gemma":[0.0000073228853,0.00021170212,0.0010203765,0.0000031329794,0.000009441165,0.0002738336,0.000012611947,0.00007262362,0.9919802,0.00005292124,0.00635137,0.0000044770554],"about_ca_topic_score_codex":0.0003753207,"about_ca_topic_score_gemma":0.00080821913,"teacher_disagreement_score":0.008688027,"about_ca_system_score_codex":0.00018813436,"about_ca_system_score_gemma":0.00015153443,"threshold_uncertainty_score":0.029064357},"labels":[],"label_agreement":null},{"id":"W2099103888","doi":"10.1124/dmd.112.049072","title":"Regiospecificity and Stereospecificity of Human UDP-Glucuronosyltransferases in the Glucuronidation of Estriol, 16-Epiestriol, 17-Epiestriol, and 13-Epiestradiol","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Glucuronidation; Stereospecificity; Estriol; Chemistry; Stereochemistry; Chromatography; Biochemistry; Enzyme; Microsome; Hormone","score_opus":0.05412782173617828,"score_gpt":0.3502302022940657,"score_spread":0.2961023805578874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099103888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946069,0.0010773365,0.002591691,0.000047229692,0.000008767731,0.000009746667,0.00023903741,0.000029254297,0.0013899369],"genre_scores_gemma":[0.99660337,0.0006739417,0.00084734784,0.000030229328,0.000006160261,0.000009751266,0.000522526,0.00002534886,0.0012812623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973875,0.00012822764,0.000018712868,0.00003892568,0.0000337134,0.000041665207],"domain_scores_gemma":[0.9996816,0.00012795585,0.00005778742,0.000051313935,0.000043853397,0.00003753492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005945913,0.00022716723,0.00016971407,0.00031196675,0.00009959621,0.00029448423,0.00012247471,0.00015373323,0.0011928106],"category_scores_gemma":[0.0007332101,0.00026079145,0.0003116169,0.00018771275,0.00023500425,0.00014348366,0.000149707,0.00026264694,0.00032821577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025637494,0.000047585923,0.00818438,0.0000473331,0.00010510985,0.00016187725,0.00019297516,0.0012291512,0.97259057,0.0009886724,0.00012029397,0.0137683675],"study_design_scores_gemma":[0.000034188644,0.00037159468,0.025473116,0.000007055818,0.00009655697,0.00067984633,0.00005743574,0.0011945313,0.97031456,0.0002163874,0.0015406212,0.000014055676],"about_ca_topic_score_codex":0.0012777561,"about_ca_topic_score_gemma":0.0014481534,"teacher_disagreement_score":0.0012777561,"about_ca_system_score_codex":0.000310551,"about_ca_system_score_gemma":0.00027943568,"threshold_uncertainty_score":0.003990352},"labels":[],"label_agreement":null},{"id":"W2099474750","doi":"10.1124/dmd.113.052613","title":"The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Enzyme; Glucuronosyltransferase; Biochemistry; Chemistry; Isozyme; Bile acid; Microsome","score_opus":0.027515619710265917,"score_gpt":0.3443380838293738,"score_spread":0.3168224641191079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099474750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152754,0.037541416,0.027758151,0.0010042778,0.00021410744,0.00011266368,0.004554826,0.000756692,0.012782532],"genre_scores_gemma":[0.97838116,0.004692039,0.005985716,0.00021516593,0.0000785285,0.000037108388,0.0031469194,0.00009330863,0.0073701045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995414,0.00018532579,0.000020259384,0.0000899512,0.00011467099,0.000048453818],"domain_scores_gemma":[0.9996911,0.00006854191,0.000105560306,0.000030873434,0.000067854395,0.000036045858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734642,0.00052866706,0.0006675985,0.0006199063,0.00022331243,0.00087447814,0.00011062605,0.00040362813,0.0014356846],"category_scores_gemma":[0.000944458,0.0002493074,0.00048544127,0.0011625323,0.0002534167,0.00023648166,0.00025257052,0.00038157008,0.00066105707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038054571,0.00031845403,0.21517102,0.0006696047,0.00200049,0.0021717146,0.0003667296,0.0030333344,0.45901382,0.004829798,0.008276897,0.30034262],"study_design_scores_gemma":[0.00020878253,0.0012904543,0.45534056,0.000055569006,0.0006843428,0.011204212,0.00018534489,0.0050793244,0.4092034,0.002386783,0.11428041,0.00008085011],"about_ca_topic_score_codex":0.0022496446,"about_ca_topic_score_gemma":0.001750966,"teacher_disagreement_score":0.0022496446,"about_ca_system_score_codex":0.00041433843,"about_ca_system_score_gemma":0.00032110972,"threshold_uncertainty_score":0.0048028827},"labels":[],"label_agreement":null},{"id":"W2099744961","doi":"10.1177/00912700122010663","title":"Population Pharmacokinetics of Fentanyl in Healthy Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Pharmacokinetics; Fentanyl; Volume of distribution; Population pharmacokinetics; Population; Medicine; Distribution (mathematics); Anesthesia; Nonparametric statistics; Pharmacology; Mathematics; Statistics","score_opus":0.23344573158738122,"score_gpt":0.5612801435504464,"score_spread":0.3278344119630652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099744961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992964,0.00025088096,0.0062477477,0.000026869471,0.000006484336,0.000051024173,0.00007627547,0.000052799318,0.00032373192],"genre_scores_gemma":[0.99717724,0.00010410954,0.0023247031,0.000040283296,0.000011474586,0.00005999412,0.0001297791,0.000006270739,0.00014614186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969053,0.0001391227,0.000014109937,0.00007412889,0.00006315915,0.000018981638],"domain_scores_gemma":[0.9995529,0.00021883851,0.000080932965,0.000045354493,0.00006826518,0.000033738877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007818506,0.00028116527,0.00040028946,0.00015983495,0.00011242025,0.0002397497,0.00009927146,0.00029708396,0.00037786298],"category_scores_gemma":[0.0029436832,0.0001445107,0.0001619383,0.000106992295,0.00020148385,0.00021370714,0.00016261652,0.00023994363,0.00013406045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031338718,0.0020258396,0.63504547,0.00029815728,0.001027201,0.0018027293,0.0014802603,0.028357467,0.09865296,0.0012697388,0.0016564118,0.19704512],"study_design_scores_gemma":[0.0015855347,0.06924828,0.75803405,0.00003350363,0.0007855219,0.0066554295,0.00050848396,0.13125727,0.024980715,0.002775818,0.004024136,0.00011123223],"about_ca_topic_score_codex":0.00048149913,"about_ca_topic_score_gemma":0.00031306918,"teacher_disagreement_score":0.0007818506,"about_ca_system_score_codex":0.0001536853,"about_ca_system_score_gemma":0.00016984406,"threshold_uncertainty_score":0.004134834},"labels":[],"label_agreement":null},{"id":"W2100987417","doi":"10.1097/mcp.0b013e32833b1c6c","title":"Predicting warfarin dose","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Pulmonary Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research; LEO Pharma; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Warfarin; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.38462502801839854,"score_gpt":0.5577681301893264,"score_spread":0.17314310217092782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100987417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004601343,0.99346477,0.0031213923,0.00082788436,0.00044279473,0.000021730479,0.00023134853,0.00006748993,0.0013624938],"genre_scores_gemma":[0.006094851,0.9895327,0.0026194723,0.00027296474,0.0005843729,0.000027983593,0.0003521807,0.000011631682,0.0005038419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992366,0.0002214023,0.00013735125,0.00014071682,0.00024263376,0.000021313757],"domain_scores_gemma":[0.9982778,0.0010356534,0.00028681612,0.000039045233,0.00033506186,0.000025648746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011774292,0.001861123,0.0031967955,0.0020157585,0.0001467693,0.0013209023,0.0016838121,0.0014549582,0.0038091668],"category_scores_gemma":[0.004917804,0.0004175623,0.0012114097,0.0020162323,0.00025859228,0.0011526748,0.00042333698,0.0010601943,0.0038972746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107321415,0.000031356016,0.0012222114,0.01948307,0.00053107005,0.00008701627,0.000020325926,0.0045115305,0.00045198138,0.0012464833,0.02395742,0.9483502],"study_design_scores_gemma":[0.00020086371,0.0004879194,0.01194818,0.03929609,0.0040398533,0.006195319,0.00014489458,0.025272682,0.0045578806,0.010840111,0.89676386,0.00025237334],"about_ca_topic_score_codex":0.002333235,"about_ca_topic_score_gemma":0.0015284889,"teacher_disagreement_score":0.0038091668,"about_ca_system_score_codex":0.00062038895,"about_ca_system_score_gemma":0.0011508699,"threshold_uncertainty_score":0.012742877},"labels":[],"label_agreement":null},{"id":"W2101434962","doi":"10.1002/jbt.10022","title":"Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat","year":2002,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytochrome P450; Heme oxygenase; Microsome; Chemistry; Sodium arsenite; Monooxygenase; Aryl hydrocarbon receptor; Bilirubin; Internal medicine; Messenger RNA; Endocrinology; Pharmacology; Heme; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.055215908450279794,"score_gpt":0.36624236454639597,"score_spread":0.3110264560961162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101434962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964484,0.0012508611,0.0012815695,0.00007254578,0.000018908244,0.000021138902,0.00023238304,0.00018113464,0.00049310154],"genre_scores_gemma":[0.99403423,0.0010529549,0.0011292394,0.000050250008,0.00002110529,0.000043839245,0.0006476497,0.000030460358,0.0029902456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982566,0.000028532875,0.000008769944,0.00004221545,0.000048270074,0.000046516514],"domain_scores_gemma":[0.9997675,0.000025305428,0.00007832362,0.000029033105,0.000031273732,0.0000687035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013182723,0.0006300753,0.0004958069,0.0006552965,0.00020756481,0.000308976,0.00021956992,0.00032921546,0.0013213878],"category_scores_gemma":[0.00013277137,0.00037822104,0.00033401483,0.00030805366,0.0005968072,0.0002912212,0.00021300877,0.000756298,0.000496713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009923585,0.00009751372,0.0009304134,0.00003053879,0.00001681224,0.0000731241,0.000025440402,0.000043120435,0.99564856,0.000032204985,0.000052578984,0.0020573689],"study_design_scores_gemma":[0.000053688145,0.004048094,0.015219834,0.0000043909113,0.000071969545,0.0003064596,0.00008117352,0.0004524789,0.9786002,0.0000682842,0.0010839064,0.00000950623],"about_ca_topic_score_codex":0.0018935583,"about_ca_topic_score_gemma":0.0036085376,"teacher_disagreement_score":0.0018935583,"about_ca_system_score_codex":0.00038501187,"about_ca_system_score_gemma":0.00027419967,"threshold_uncertainty_score":0.0044204593},"labels":[],"label_agreement":null},{"id":"W2101980933","doi":"10.1373/clinchem.2006.078139","title":"Estimation of Warfarin Maintenance Dose Based on VKORC1 (−1639 G&amp;gt;A) and CYP2C9 Genotypes","year":2007,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"VKORC1; Warfarin; CYP2C9; Maintenance dose; Genotype; Vitamin K epoxide reductase; Internal medicine; Allele; Biology; Medicine; Endocrinology; Gastroenterology; Pharmacology; Genetics; Atrial fibrillation","score_opus":0.16540674597107144,"score_gpt":0.50496501357986,"score_spread":0.3395582676087886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101980933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889684,0.00011807834,0.0005393934,0.000015530219,0.0000027194028,0.000008783322,0.0001518529,0.000008614399,0.00025816518],"genre_scores_gemma":[0.99926466,0.000021904856,0.0003748198,0.0000050647377,0.0000034756326,0.000007190266,0.00024012108,0.0000030330798,0.00007980138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935454,0.00021855296,0.00009091262,0.00015712128,0.00013227203,0.000046597223],"domain_scores_gemma":[0.99687356,0.0015333835,0.00098583,0.0002087621,0.00019221596,0.00020624339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009049575,0.00037974023,0.0003810902,0.00080581405,0.00019790228,0.00049762265,0.0003370993,0.00041683213,0.0016725018],"category_scores_gemma":[0.0040885415,0.00017497492,0.00057051657,0.0005167149,0.00021807192,0.00026123365,0.00028245547,0.00047713786,0.00056383625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043277515,0.000018046972,0.99735284,0.0000039740694,0.000050534698,0.000023584405,0.000025864312,0.00014811881,0.00049092196,0.000010075095,0.000033362936,0.0014097801],"study_design_scores_gemma":[0.000023796201,0.0003074552,0.9952468,0.000005518298,0.00007548661,0.00042803393,0.000043724856,0.0031766098,0.0005140437,0.000041518648,0.0001303537,0.0000064991937],"about_ca_topic_score_codex":0.0014957642,"about_ca_topic_score_gemma":0.0011757022,"teacher_disagreement_score":0.0016725018,"about_ca_system_score_codex":0.0002448313,"about_ca_system_score_gemma":0.0001575624,"threshold_uncertainty_score":0.005595088},"labels":[],"label_agreement":null},{"id":"W2102425178","doi":"10.1503/cmaj.100702","title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Clarithromycin; Erythromycin; Azithromycin; Calcium channel blocker; Macrolide Antibiotics; Odds ratio; Anesthesia; Internal medicine; Confidence interval; Pharmacology; Antibiotics; Calcium; Biology; Microbiology","score_opus":0.059706927749916226,"score_gpt":0.35534915277625095,"score_spread":0.29564222502633475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102425178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987581,0.0006303742,0.00019902775,0.00004551159,0.000010657055,0.000011255277,0.00008138962,0.0000046000855,0.0002591191],"genre_scores_gemma":[0.9995535,0.000112615824,0.00017572661,0.000022433216,0.000026822452,0.000004234113,0.00006328548,9.76271e-7,0.00004033587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973291,0.0012739224,0.00019839552,0.00047247624,0.00051354425,0.00021252096],"domain_scores_gemma":[0.9905178,0.0034711119,0.0045992015,0.00045727508,0.0003294419,0.00062525796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022245732,0.00026624653,0.00050390995,0.00067620235,0.00029433012,0.0007041486,0.00043348063,0.0006969808,0.001122492],"category_scores_gemma":[0.009534474,0.00042649033,0.0012564684,0.0006545453,0.00035956845,0.00037599806,0.00064269255,0.0007520399,0.00010974965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043065954,0.000028198636,0.9979988,0.000011399996,0.00019528407,0.000099460085,0.000019504685,0.000040316827,0.00013719863,0.000013095112,0.000024364446,0.0010016466],"study_design_scores_gemma":[0.000024860503,0.0004055056,0.9979678,0.000011337734,0.00017825766,0.00062357663,0.000048273196,0.0005650198,0.000073565025,0.00003658473,0.000060259033,0.0000048567595],"about_ca_topic_score_codex":0.0022885578,"about_ca_topic_score_gemma":0.0020902567,"teacher_disagreement_score":0.0022885578,"about_ca_system_score_codex":0.00028854923,"about_ca_system_score_gemma":0.0003513912,"threshold_uncertainty_score":0.011764824},"labels":[],"label_agreement":null},{"id":"W2103715266","doi":"10.1007/s002280100330","title":"Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP1A2; Fluvoxamine; Caffeine; Chemistry; Analysis of variance; Cytochrome P450; Internal medicine; Endocrinology; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.1731870082302075,"score_gpt":0.48344738447724644,"score_spread":0.31026037624703895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103715266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96137345,0.0021147954,0.031398576,0.00014478144,0.00006212451,0.00010740625,0.002261124,0.00021432519,0.002323435],"genre_scores_gemma":[0.9801595,0.0010320385,0.011257363,0.000055814995,0.000022134149,0.00010071757,0.004547991,0.00007527508,0.0027491478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.000044295237,0.000019513369,0.00005409484,0.00004201483,0.00003824837],"domain_scores_gemma":[0.9998406,0.00008259235,0.000015752357,0.000031472056,0.00001967984,0.000009859848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002786312,0.00026099218,0.00035454144,0.00024479418,0.00020459312,0.00032800963,0.0001498337,0.00021133614,0.0013616774],"category_scores_gemma":[0.000424946,0.00018049603,0.00034417232,0.00022602775,0.00027763812,0.00016549363,0.0001524972,0.0005076201,0.0004332361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014591648,0.00003450985,0.00042884887,0.000020222911,0.000008859026,0.00002385431,0.000014627894,0.00014296488,0.9973367,0.00012700944,0.000028968176,0.0016875176],"study_design_scores_gemma":[0.000016611308,0.00019886356,0.004618058,0.0000018347935,0.00002272392,0.00016742908,0.000016564229,0.000839777,0.99262637,0.000047073743,0.0014405451,0.0000041438266],"about_ca_topic_score_codex":0.0013076338,"about_ca_topic_score_gemma":0.00213475,"teacher_disagreement_score":0.0013616774,"about_ca_system_score_codex":0.0002990091,"about_ca_system_score_gemma":0.00024173726,"threshold_uncertainty_score":0.0045552254},"labels":[],"label_agreement":null},{"id":"W2103933819","doi":"10.1124/dmd.32.4.460","title":"THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cimetidine; Dextromethorphan; Quinidine; Microsome; CYP2D6; Chemistry; Recombinant DNA; Pharmacology; Microsoma; Cytochrome P450; Drug interaction; Pharmacokinetics; Enzyme; Biochemistry; Biology","score_opus":0.02910905688775452,"score_gpt":0.3750711169909364,"score_spread":0.3459620601031819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103933819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920489,0.0035637545,0.0010052798,0.0002738236,0.00018697417,0.000045432902,0.00056267955,0.000089851426,0.0022233482],"genre_scores_gemma":[0.9933187,0.001244856,0.0011972365,0.00006745788,0.000083531486,0.000028971961,0.0014976335,0.00002998957,0.0025317352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989901,0.0004925968,0.00009901594,0.00013386026,0.00012839292,0.00015606018],"domain_scores_gemma":[0.9982089,0.0011195298,0.00013405147,0.00020879788,0.00015773687,0.00017086958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009961914,0.00072739995,0.00086610724,0.00037960344,0.00033676028,0.0005613196,0.00053776515,0.00089561817,0.002253796],"category_scores_gemma":[0.0027374432,0.0005836536,0.0008692141,0.0005335685,0.00068603473,0.0006514725,0.0003144215,0.0011019633,0.00069324597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02218195,0.0006190353,0.0023691186,0.0003167774,0.00021026372,0.00033522144,0.00025959697,0.00096933695,0.9619492,0.0005060259,0.00050614035,0.009777268],"study_design_scores_gemma":[0.00022906261,0.0029005853,0.006974113,0.00001123,0.00009344515,0.0003088813,0.00005160546,0.002245348,0.98598236,0.00004034494,0.0011460496,0.000016985652],"about_ca_topic_score_codex":0.0046866713,"about_ca_topic_score_gemma":0.004358567,"teacher_disagreement_score":0.0046866713,"about_ca_system_score_codex":0.0008106886,"about_ca_system_score_gemma":0.0007000336,"threshold_uncertainty_score":0.009318829},"labels":[],"label_agreement":null},{"id":"W2103995433","doi":"10.1186/bcr798","title":"Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Research (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"Health Canada","keywords":"CYP1A2; Breast cancer; Internal medicine; Endocrinology; Medicine; Caffeine; Triglyceride; Body mass index; Paraxanthine; Hormone; Physiology; Oncology; Cancer; Cholesterol; Cytochrome P450; Metabolism","score_opus":0.222883660157993,"score_gpt":0.5500821810253077,"score_spread":0.3271985208673147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103995433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807835,0.0005454032,0.00033568376,0.000043483542,0.00000960481,0.000032542517,0.000580419,0.0000075202893,0.0003669295],"genre_scores_gemma":[0.9984341,0.00019139252,0.00040083725,0.00007447264,0.000018991728,0.00003899794,0.000578598,0.0000032045455,0.00025931606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993229,0.0002750622,0.000048596386,0.00017173927,0.00012444922,0.000057190133],"domain_scores_gemma":[0.99820685,0.00044805004,0.0005068906,0.00026064683,0.00029043586,0.00028708583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016516227,0.0003394398,0.00036167816,0.00044034256,0.0004933759,0.00046433587,0.00024683907,0.00047816755,0.0015229377],"category_scores_gemma":[0.00222432,0.0005093735,0.00039637656,0.0007258879,0.0002441085,0.00030029553,0.0002685233,0.0006632326,0.0004305971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087961904,0.00007428754,0.9989317,0.000007298549,0.00013971233,0.00001791035,0.000035537927,0.000012422108,0.000179861,0.0000059450467,0.0000638409,0.0004436274],"study_design_scores_gemma":[0.000012620391,0.00018872698,0.9991903,0.0000031857141,0.00008326719,0.00017379217,0.00003693839,0.00007031065,0.000071350616,0.000007375309,0.00016032287,0.0000018897659],"about_ca_topic_score_codex":0.0029351793,"about_ca_topic_score_gemma":0.003679717,"teacher_disagreement_score":0.0029351793,"about_ca_system_score_codex":0.00017848442,"about_ca_system_score_gemma":0.0002633804,"threshold_uncertainty_score":0.008734763},"labels":[],"label_agreement":null},{"id":"W2104124411","doi":"10.1124/dmd.106.013508","title":"Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Vlaamse regering","keywords":"Hypoxia (environmental); In vivo; P-glycoprotein; Glycoprotein; Biology; Cytochrome P450; Messenger RNA; In vitro; Gene expression; Downregulation and upregulation; Gene isoform; Pharmacology; Internal medicine; Endocrinology; Chemistry; Molecular biology; Biochemistry; Gene; Metabolism; Oxygen; Multiple drug resistance; Medicine","score_opus":0.03312668926294158,"score_gpt":0.32171052393750066,"score_spread":0.28858383467455906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104124411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820941,0.0023468917,0.009831534,0.0007753755,0.0002584432,0.00021428146,0.0018172213,0.00023827143,0.0024238355],"genre_scores_gemma":[0.9867491,0.0027321859,0.0028811202,0.00030581772,0.00010435592,0.00043445636,0.0026723945,0.000035670597,0.004084833],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997397,0.000049699225,0.000018206887,0.00004500016,0.00008336829,0.00006395623],"domain_scores_gemma":[0.99949384,0.000042365646,0.00027709617,0.00004782629,0.00003218235,0.00010660294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001991444,0.0006618072,0.00061485474,0.00058564876,0.00040403448,0.0003627951,0.00029215837,0.00040119464,0.002285857],"category_scores_gemma":[0.00016611892,0.00018803125,0.00040842802,0.0003585016,0.0006721325,0.00024385563,0.00033800586,0.0008793658,0.00024760392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072211805,0.0013066969,0.008892694,0.00048029263,0.00028432932,0.0013535428,0.00015334673,0.0006617995,0.96475077,0.0014227821,0.0019747522,0.011497853],"study_design_scores_gemma":[0.0005354664,0.01953728,0.17646262,0.00014215319,0.00048677417,0.006765003,0.0006163257,0.0041132174,0.77349454,0.0018933362,0.015857125,0.000096149255],"about_ca_topic_score_codex":0.0017835542,"about_ca_topic_score_gemma":0.004293566,"teacher_disagreement_score":0.002285857,"about_ca_system_score_codex":0.0007271213,"about_ca_system_score_gemma":0.0003946881,"threshold_uncertainty_score":0.007646978},"labels":[],"label_agreement":null},{"id":"W2104528385","doi":"10.1124/dmd.32.2.212","title":"STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Fetus; Pharmacokinetics; Chemistry; Metabolite; Volume of distribution; Stereoselectivity; Urine; Internal medicine; Free fraction; Endocrinology; Pregnancy; Medicine; Biology; Biochemistry","score_opus":0.028847113738746464,"score_gpt":0.355603129736175,"score_spread":0.32675601599742854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104528385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824476,0.00041651956,0.00035591453,0.00004584711,0.0000047853814,0.0000075804055,0.00019656084,0.000013183684,0.0007148557],"genre_scores_gemma":[0.99725705,0.0005061133,0.00045303928,0.00005169868,0.0000063633684,0.00002164512,0.00023656416,0.00001508044,0.0014524317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999018,0.000021817988,0.0000066627526,0.00003695302,0.000017587412,0.000015171667],"domain_scores_gemma":[0.9996195,0.00013101434,0.00008859177,0.000047759146,0.00004577315,0.000067373025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017362177,0.0001794241,0.0003993393,0.0003592053,0.0002610671,0.0002488792,0.00017210569,0.00033992715,0.00081267825],"category_scores_gemma":[0.0008129385,0.00030485907,0.00014611146,0.00014862433,0.0004551189,0.00029260412,0.0001707485,0.0005479426,0.00031491317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025345989,0.0005615034,0.23254135,0.0003002168,0.00019557496,0.0069719837,0.0035198678,0.0010810192,0.63028157,0.0015586263,0.0013867117,0.09625558],"study_design_scores_gemma":[0.00022350257,0.009902594,0.80031383,0.00007066428,0.00030679716,0.007876784,0.003131519,0.004673654,0.1663668,0.0009898741,0.0060605025,0.000083464576],"about_ca_topic_score_codex":0.006490772,"about_ca_topic_score_gemma":0.009695731,"teacher_disagreement_score":0.006490772,"about_ca_system_score_codex":0.00048538108,"about_ca_system_score_gemma":0.00025444906,"threshold_uncertainty_score":0.012905955},"labels":[],"label_agreement":null},{"id":"W2104585553","doi":"10.1503/jpn.120133","title":"Cytochrome P450–mediated drug metabolism in the brain","year":2013,"lang":"en","type":"review","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Drug metabolism; Cytochrome P450; Drug; Pharmacology; Metabolism; CYP2D6; Medicine; Neuroscience; Biology; Internal medicine","score_opus":0.13171246887353988,"score_gpt":0.4560111337267143,"score_spread":0.32429866485317443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104585553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003801453,0.994995,0.00049654685,0.00028304162,0.00013598839,0.000010949091,0.000053869066,0.000026096473,0.0036184613],"genre_scores_gemma":[0.002085537,0.99537367,0.00037695197,0.00013275286,0.00011710673,0.000010955025,0.000074135976,0.0000024405556,0.0018265586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998248,0.000029055183,0.000022278826,0.000035236055,0.00007197697,0.00001662398],"domain_scores_gemma":[0.99984527,0.00005277473,0.00002781993,0.0000065993295,0.000052476214,0.000015091113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002833677,0.00066615135,0.0010636532,0.001545604,0.00026843548,0.00068468763,0.00060777145,0.00074914336,0.00523791],"category_scores_gemma":[0.0003688211,0.00021372222,0.00048197672,0.0020366663,0.00032714987,0.0008495508,0.00046632902,0.001078789,0.004177435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004615558,0.000053171836,0.0003208991,0.0093828635,0.0000883333,0.00034921744,0.000037409667,0.00028259272,0.004157369,0.0021781905,0.022451479,0.9606523],"study_design_scores_gemma":[0.000017440325,0.00008591653,0.0020648036,0.0017425097,0.00010715729,0.0035281316,0.00004291684,0.00012585497,0.0018898221,0.0022053756,0.98816746,0.000022576756],"about_ca_topic_score_codex":0.0011418805,"about_ca_topic_score_gemma":0.0019787203,"teacher_disagreement_score":0.00523791,"about_ca_system_score_codex":0.0004492604,"about_ca_system_score_gemma":0.000775087,"threshold_uncertainty_score":0.017522573},"labels":[],"label_agreement":null},{"id":"W2104938725","doi":"10.2174/157488611794479991","title":"Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine","year":2011,"lang":"en","type":"article","venue":"Current Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Codeine; CYP2D6; Medicine; Breastfeeding; Pharmacogenetics; Morphine; Opioid; Pharmacology; Acetaminophen; Genotype; Anesthesia; Cytochrome P450; Internal medicine; Genetics; Pediatrics; Gene; Metabolism; Biology; Receptor","score_opus":0.15908942575721055,"score_gpt":0.4206818796954218,"score_spread":0.2615924539382113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104938725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893288,0.0012357954,0.0040013283,0.0029926724,0.000027037995,0.000019559164,0.00015291665,0.000023750974,0.0022181624],"genre_scores_gemma":[0.99605125,0.001159616,0.0021315285,0.00021481141,0.000038162936,0.000007769539,0.00004034955,0.000007751105,0.00034889454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950194,0.00031217202,0.00003077682,0.00006468215,0.000053273874,0.00003719233],"domain_scores_gemma":[0.9988514,0.00066530635,0.00029820416,0.00005996077,0.000054756336,0.000070327296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005671659,0.00031096785,0.00021382392,0.0004640894,0.00044356546,0.00032310118,0.0002057844,0.00048206077,0.0021386407],"category_scores_gemma":[0.0037752753,0.00010588376,0.0002452474,0.00044105822,0.0003801896,0.0002990892,0.00027774458,0.00034873755,0.00012350547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005272959,0.00015213258,0.91427624,0.000058892445,0.000058164045,0.015638715,0.00059617095,0.00048993353,0.006986852,0.0026640035,0.0007277058,0.05782387],"study_design_scores_gemma":[0.0000694912,0.0008028388,0.90437984,0.00019061984,0.0003695144,0.069847405,0.0016207778,0.0057896143,0.004350982,0.005393689,0.0071423803,0.0000427705],"about_ca_topic_score_codex":0.0035726475,"about_ca_topic_score_gemma":0.0023923444,"teacher_disagreement_score":0.0035726475,"about_ca_system_score_codex":0.00021190374,"about_ca_system_score_gemma":0.00025730385,"threshold_uncertainty_score":0.0071544647},"labels":[],"label_agreement":null},{"id":"W2105658004","doi":"","title":"Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prodrug; Vitamin D and neurology; Calcitriol; Chemistry; Cytochrome P450; Hydroxylation; Context (archaeology); Vitamin D-binding protein; CYP24A1; Catabolism; Pharmacology; Metabolism; Calcipotriol; Calcitriol receptor; Biochemistry; Vitamin; Biology; Endocrinology; Enzyme; Psoriasis; Immunology","score_opus":0.06507707301676101,"score_gpt":0.3661899331374693,"score_spread":0.30111286012070826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105658004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9127374,0.030464636,0.038226184,0.00033525395,0.0001139056,0.00032505675,0.0019328572,0.0005487632,0.015315811],"genre_scores_gemma":[0.976927,0.0066080084,0.008745819,0.00013045412,0.000022932812,0.00009617195,0.0008540689,0.00004310265,0.0065725143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971753,0.00008143799,0.000017874168,0.000068603294,0.00008264963,0.000031781692],"domain_scores_gemma":[0.9998198,0.000051888364,0.00005401766,0.000034638753,0.000025237532,0.000014447625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022534154,0.00032326384,0.00024976538,0.00043253088,0.00017175404,0.0003473675,0.00014399517,0.00030952826,0.0019680564],"category_scores_gemma":[0.00031381386,0.00013158497,0.00039178866,0.0002890939,0.00019365177,0.00017437084,0.00016566303,0.0002893095,0.000685445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015258542,0.000023510096,0.0013022615,0.00019576927,0.000026992118,0.00018668182,0.000030053588,0.00015477884,0.9804175,0.00027095916,0.0001405038,0.017098278],"study_design_scores_gemma":[0.000008178078,0.00021093633,0.0034416667,0.0000062017616,0.00001801331,0.0008198636,0.000021160859,0.00040015896,0.9902676,0.0001004742,0.0047016237,0.000004199945],"about_ca_topic_score_codex":0.00053161074,"about_ca_topic_score_gemma":0.00058022083,"teacher_disagreement_score":0.0019680564,"about_ca_system_score_codex":0.0003056192,"about_ca_system_score_gemma":0.00022159104,"threshold_uncertainty_score":0.00658381},"labels":[],"label_agreement":null},{"id":"W2105730642","doi":"10.1210/jcem.85.12.7019","title":"Cellular Localization of Uridine Diphosphoglucuronosyltransferase 2B Enzymes in the Human Prostate by<i>in Situ</i>Hybridization and Immunohistochemistry<sup>1</sup>","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Medical Council of Canada","funders":"","keywords":"Biology; Prostate; Androsterone; Glucuronosyltransferase; In situ hybridization; Epithelium; Molecular biology; Glucuronidation; Androgen; Enzyme; Microsome; Gene expression; Biochemistry; Hormone; Gene; Steroid","score_opus":0.05159917807226991,"score_gpt":0.41615855541824653,"score_spread":0.36455937734597665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105730642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341431,0.028673796,0.025801267,0.00033926,0.000094833704,0.000067065084,0.0012996648,0.00046689558,0.009114121],"genre_scores_gemma":[0.9757268,0.007068848,0.009975607,0.00015007176,0.000047956575,0.000073590825,0.001781961,0.000049663016,0.0051255296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998894,0.00001836283,0.000005397906,0.000027325961,0.000027423966,0.00003215627],"domain_scores_gemma":[0.9999536,0.000007941526,0.0000088554925,0.000006901619,0.0000102701215,0.000012400591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014141203,0.0002559825,0.00018551598,0.00050724065,0.00022479628,0.0004517781,0.00015070371,0.0002557627,0.0012356021],"category_scores_gemma":[0.00007024931,0.00028970448,0.00035008564,0.0004872876,0.00022399268,0.00014328132,0.00017514853,0.00028561513,0.00053266756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015710549,0.000022250064,0.0013920561,0.00011862089,0.000023063178,0.00023428928,0.00006869501,0.0000618302,0.99390525,0.00019898632,0.00012954316,0.0036882844],"study_design_scores_gemma":[0.000069322865,0.00076678,0.14325395,0.000029271352,0.0002198727,0.0051863664,0.00040152474,0.002783568,0.82127225,0.00031540607,0.025672548,0.00002909196],"about_ca_topic_score_codex":0.0033864635,"about_ca_topic_score_gemma":0.0029655544,"teacher_disagreement_score":0.0033864635,"about_ca_system_score_codex":0.00021028613,"about_ca_system_score_gemma":0.00026529326,"threshold_uncertainty_score":0.0067335367},"labels":[],"label_agreement":null},{"id":"W2105786255","doi":"10.1093/jnci/djq390","title":"Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation","year":2010,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Pharmacogenomics; Medicine; Clinical trial; Translational research; Observational study; Pharmacoepidemiology; Family medicine; Oncology; Internal medicine; Pharmacology; Pathology","score_opus":0.5333017482597454,"score_gpt":0.605515499141323,"score_spread":0.07221375088157755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105786255","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007458761,0.006291137,0.0010508148,0.97661257,0.015173125,0.000045304565,0.000041148513,0.000030360927,0.0006809341],"genre_scores_gemma":[0.0055813445,0.038862735,0.015823938,0.8815257,0.056025855,0.00043093742,0.00017616904,0.000056640652,0.0015167341],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8465348,0.10275546,0.01780275,0.0057065394,0.023289142,0.0039113234],"domain_scores_gemma":[0.48798734,0.3715516,0.0150970435,0.0127709815,0.0968967,0.015696365],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22220019,0.0019347031,0.0036641993,0.005048232,0.005050772,0.015631575,0.008892511,0.046161983,0.007624406],"category_scores_gemma":[0.38719764,0.0018435662,0.0039937953,0.0044722487,0.013215755,0.023523184,0.009682568,0.05514819,0.0037806255],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002578698,0.0002340978,0.0009938889,0.005049556,0.00025162255,0.0006491445,0.0022047183,0.0010244404,0.00036668588,0.06717854,0.7981696,0.123619765],"study_design_scores_gemma":[0.00045434776,0.00028139513,0.001901818,0.014892916,0.0004230502,0.0003329584,0.0038458398,0.0021372726,0.0006379004,0.13569127,0.8390952,0.00030598565],"about_ca_topic_score_codex":0.02026773,"about_ca_topic_score_gemma":0.021603668,"teacher_disagreement_score":0.22220019,"about_ca_system_score_codex":0.015737036,"about_ca_system_score_gemma":0.08153745,"threshold_uncertainty_score":0.95916563},"labels":[],"label_agreement":null},{"id":"W2105874372","doi":"10.1517/17425250902800153","title":"Ethnic differences in drug metabolism and toxicity from chemotherapy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacokinetics; Irinotecan; Drug; Pharmacology; Drug metabolism; Toxicity; Pharmacogenetics; Paclitaxel; Medicine; Pharmacodynamics; Biology; Chemotherapy; Cancer; Internal medicine; Genetics; Genotype; Gene","score_opus":0.1774474249782567,"score_gpt":0.4679789391038559,"score_spread":0.2905315141255992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105874372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026309775,0.9963987,0.00022158222,0.00073833874,0.00020019087,0.00000951615,0.000049633716,0.000008407269,0.0021105558],"genre_scores_gemma":[0.0015581589,0.99654824,0.00017586153,0.00037578426,0.00019827478,0.000011920835,0.00007922233,0.0000018283633,0.0010507451],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995968,0.0000965995,0.00004625688,0.000071551396,0.00015916044,0.00002962256],"domain_scores_gemma":[0.99965036,0.00014617607,0.00008127446,0.00001053508,0.00009234943,0.000019302042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081183534,0.0007018573,0.0022520476,0.0009246534,0.00016287612,0.00082708825,0.0010555228,0.0010924393,0.005924247],"category_scores_gemma":[0.0009694684,0.00020804213,0.0007720653,0.0013760908,0.0003022795,0.0006963866,0.0005012648,0.0009953751,0.00322738],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098245044,0.00003790712,0.00049887144,0.01125598,0.00020658164,0.00038302204,0.00003793041,0.0003620816,0.0011701905,0.0014896677,0.02862348,0.9558359],"study_design_scores_gemma":[0.00008318699,0.00019486377,0.0050635845,0.0059418906,0.00037552862,0.0049879346,0.00008273902,0.00022278455,0.0009289155,0.0031997408,0.9788841,0.000034726676],"about_ca_topic_score_codex":0.0014840566,"about_ca_topic_score_gemma":0.002891784,"teacher_disagreement_score":0.005924247,"about_ca_system_score_codex":0.00071609725,"about_ca_system_score_gemma":0.00090077234,"threshold_uncertainty_score":0.019818604},"labels":[],"label_agreement":null},{"id":"W2105939555","doi":"10.1080/17441692.2014.887137","title":"Global pharmacogenomics: Where is the research taking us?","year":2014,"lang":"en","type":"review","venue":"Global Public Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Drug development; Medicine; Medical prescription; Health care; Political science; Pharmacology; Drug","score_opus":0.5157097529606041,"score_gpt":0.6047911280183111,"score_spread":0.08908137505770708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105939555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007103499,0.99105835,0.00021071536,0.0074680476,0.00039543133,0.0000043586974,0.000015130052,0.000008260185,0.00076861144],"genre_scores_gemma":[0.0009640691,0.99648273,0.00032033102,0.0016010435,0.00041233705,0.0000071840745,0.000012653844,0.000002858753,0.00019679072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983284,0.00068422087,0.00019650928,0.00021560618,0.00044528872,0.0001300023],"domain_scores_gemma":[0.9927649,0.004783654,0.0004763871,0.0002880753,0.0013516266,0.00033544545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006141267,0.0010811161,0.002837022,0.0056576543,0.0009961744,0.0053936667,0.0014984509,0.0044671074,0.0039567524],"category_scores_gemma":[0.007820549,0.0006138211,0.0013729681,0.010574001,0.003524487,0.00962244,0.0016955384,0.00511321,0.0019175345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008206943,0.00006808364,0.00074671395,0.032790527,0.0002834871,0.00026105027,0.00057923136,0.0003673904,0.0007957249,0.043798763,0.040437736,0.87978923],"study_design_scores_gemma":[0.000035715275,0.000104341045,0.0029610645,0.035238873,0.00035983845,0.0011373658,0.0012267636,0.0001399665,0.00040284434,0.034849424,0.92347485,0.00006890145],"about_ca_topic_score_codex":0.0057991603,"about_ca_topic_score_gemma":0.005740504,"teacher_disagreement_score":0.006141267,"about_ca_system_score_codex":0.00297833,"about_ca_system_score_gemma":0.009836843,"threshold_uncertainty_score":0.03247845},"labels":[],"label_agreement":null},{"id":"W2105940326","doi":"10.1038/clpt.2010.340","title":"Pharmacogenomics at the Tipping Point: Challenges and Opportunities","year":2011,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Citation; Clinical pharmacology; Library science; Addiction; Medicine; Psychology; Psychiatry; Pharmacology; Computer science","score_opus":0.46675862260967427,"score_gpt":0.5089552714008087,"score_spread":0.042196648791134383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105940326","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024571144,0.025594816,0.00030127756,0.06170094,0.91155434,0.000009110461,0.000025810621,0.000049128677,0.0007399802],"genre_scores_gemma":[0.00023574482,0.012890959,0.0002489484,0.024380904,0.95923555,0.000010639291,0.000013138298,0.000021406251,0.002962693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99165547,0.001994086,0.0011877987,0.00078295416,0.0039604222,0.00041919327],"domain_scores_gemma":[0.928813,0.040514257,0.0025274262,0.0013812721,0.021041699,0.0057222964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017643413,0.00333584,0.0048654317,0.003736377,0.0029014675,0.010298993,0.0038289113,0.019103443,0.0062303497],"category_scores_gemma":[0.042723946,0.0013159843,0.0028759146,0.0019463329,0.0043871305,0.007983892,0.0021610311,0.031030538,0.005808436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025033569,0.000012554856,0.000026441323,0.0003132599,0.000029110264,0.00010943269,0.00001807306,0.000037002155,0.000051840398,0.0006622297,0.9889137,0.009801393],"study_design_scores_gemma":[0.00005967376,0.000042201827,0.0002615374,0.0009777381,0.000091615235,0.0006033757,0.00008993385,0.00025574025,0.000103667735,0.004390877,0.9930782,0.000045345307],"about_ca_topic_score_codex":0.0016877305,"about_ca_topic_score_gemma":0.0065221437,"teacher_disagreement_score":0.019103443,"about_ca_system_score_codex":0.002886037,"about_ca_system_score_gemma":0.0051745432,"threshold_uncertainty_score":0.09330839},"labels":[],"label_agreement":null},{"id":"W2106972824","doi":"10.1177/1740774513517063","title":"Simulating sequential multiple assignment randomized trials to generate optimal personalized warfarin dosing strategies","year":2014,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Dosing; Warfarin; Pharmacodynamics; Medicine; Pharmacokinetics; Computer science; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.6609817779989111,"score_gpt":0.6237253747213521,"score_spread":0.03725640327755897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106972824","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22987916,0.00074816955,0.7595832,0.0015735151,0.00020069645,0.0020438062,0.00083271385,0.0006153653,0.00452336],"genre_scores_gemma":[0.8330335,0.00028387396,0.16198406,0.00045211895,0.00006192409,0.0023782921,0.0004515127,0.000040681585,0.0013140859],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9939318,0.004944287,0.00018638208,0.00040014743,0.00025222835,0.00028513125],"domain_scores_gemma":[0.92042047,0.071941346,0.0035172466,0.0016324505,0.0014927997,0.0009957342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01625008,0.0011234616,0.002004736,0.0010991393,0.00036586667,0.0010732169,0.0019784085,0.0017261673,0.004069724],"category_scores_gemma":[0.047918648,0.00081481534,0.001512252,0.00091067585,0.0011439355,0.0010487965,0.0010361499,0.0023117582,0.00028685218],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031518698,0.000051860367,0.0010537928,0.000047560028,0.000051991152,0.000025200161,0.0000361431,0.9902244,0.00006171805,0.0046072877,0.00021509183,0.003309761],"study_design_scores_gemma":[0.00020569946,0.0001022926,0.00011832598,0.000012817995,0.000022722204,0.000005785987,0.0000083991545,0.9920575,0.000084632746,0.007180048,0.00019554609,0.000006238472],"about_ca_topic_score_codex":0.00836669,"about_ca_topic_score_gemma":0.00685997,"teacher_disagreement_score":0.01625008,"about_ca_system_score_codex":0.0019210496,"about_ca_system_score_gemma":0.0037375093,"threshold_uncertainty_score":0.085939646},"labels":[],"label_agreement":null},{"id":"W2106988558","doi":"10.1345/aph.1g003","title":"Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials","year":2005,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St. Joseph’s Healthcare Hamilton; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Warfarin; Crossover study; Randomized controlled trial; Crossover; Brand names; Internal medicine; Advertising; Alternative medicine; Artificial intelligence; Atrial fibrillation","score_opus":0.41253580092468994,"score_gpt":0.5213821955737448,"score_spread":0.10884639464905482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106988558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8816309,0.08253265,0.005825051,0.004234605,0.004283794,0.013712572,0.0019021805,0.00039351222,0.00548472],"genre_scores_gemma":[0.9560979,0.01555806,0.006901576,0.003807714,0.0028401588,0.010983481,0.00096428505,0.00005779944,0.002789106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99184304,0.0058097374,0.00078696123,0.00081150624,0.00045763125,0.00029115594],"domain_scores_gemma":[0.9910965,0.004450234,0.0027701813,0.00068359857,0.00035695938,0.00064253487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011094467,0.0014158646,0.0057831598,0.0006561977,0.0006360372,0.001458336,0.0013792949,0.0042776624,0.0070421197],"category_scores_gemma":[0.012471521,0.0010357867,0.0028074218,0.00075084006,0.0016072264,0.0025085148,0.00041935817,0.0025941913,0.00079337903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9789742,0.0016869056,0.0005200519,0.0013176935,0.0026001504,0.000029783392,0.00004565147,0.00010002056,0.0008294606,0.00015403934,0.00048763637,0.0132544525],"study_design_scores_gemma":[0.96119344,0.03518511,0.0009944475,0.00009940398,0.0011442556,0.00004591874,0.000015349478,0.00023848412,0.00019697649,0.00029056182,0.00058421236,0.000011884029],"about_ca_topic_score_codex":0.00034538063,"about_ca_topic_score_gemma":0.00059847167,"teacher_disagreement_score":0.011094467,"about_ca_system_score_codex":0.0006650409,"about_ca_system_score_gemma":0.0008864226,"threshold_uncertainty_score":0.05867386},"labels":[],"label_agreement":null},{"id":"W2107702110","doi":"10.3389/fphar.2010.00121","title":"Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants","year":2010,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Genetics; Gene; Exon; Locus (genetics); Genotype; Intron; Allele; CYP2D6","score_opus":0.04969411865652998,"score_gpt":0.36825887915832684,"score_spread":0.31856476050179683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107702110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960776,0.00016438538,0.0028510406,0.0000592517,0.000017715076,0.000025577383,0.0002846404,0.000032988035,0.00048667123],"genre_scores_gemma":[0.9932308,0.00010013816,0.0028079767,0.00008498032,0.000023458613,0.000031558466,0.0016583495,0.000053234275,0.0020093885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977964,0.0000359244,0.000021670794,0.000058509027,0.00007606269,0.00002817827],"domain_scores_gemma":[0.9997949,0.000077527395,0.000042654123,0.000019477646,0.000019047,0.0000464071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018726672,0.00027802354,0.000181069,0.00029145757,0.00016434115,0.00024513496,0.00016925753,0.0003173257,0.001812255],"category_scores_gemma":[0.00022782989,0.00012727754,0.0002429809,0.00012775444,0.00023279712,0.00008119798,0.00019978246,0.0005976238,0.0004285917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021724157,0.000084127445,0.004571963,0.000021885928,0.000031286854,0.000996999,0.00006849814,0.00007221968,0.9906098,0.000270541,0.00009538091,0.0029599804],"study_design_scores_gemma":[0.00012397111,0.0014070447,0.09402954,0.000008766861,0.00013015784,0.025942493,0.00019261746,0.0019750267,0.86399424,0.00043169066,0.0117209125,0.000043544314],"about_ca_topic_score_codex":0.00018392902,"about_ca_topic_score_gemma":0.00040519005,"teacher_disagreement_score":0.001812255,"about_ca_system_score_codex":0.0001914826,"about_ca_system_score_gemma":0.00006802211,"threshold_uncertainty_score":0.0060625672},"labels":[],"label_agreement":null},{"id":"W2108129761","doi":"10.1345/aph.1r621","title":"Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy","year":2013,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Jewish General Hospital","funders":"","keywords":"Polypharmacy; Medicine; Drug; Drug interaction; Pharmacology","score_opus":0.040482965453290234,"score_gpt":0.4005104843500155,"score_spread":0.3600275188967253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108129761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961877,0.00007283408,0.000045831694,0.000021547872,0.0000013894273,0.000004843024,0.000098593955,0.0000022015267,0.00013399291],"genre_scores_gemma":[0.99970144,0.000048705286,0.00008002263,0.000014034281,0.000005493377,0.000003418324,0.00011798146,6.0908786e-7,0.00002837824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941134,0.00012807899,0.000121199846,0.00009183951,0.0001774599,0.00007010831],"domain_scores_gemma":[0.99585754,0.0007512671,0.0024771765,0.00014534355,0.00034157658,0.0004270976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006382622,0.00018052805,0.00029498638,0.0009751488,0.00028237872,0.00044402553,0.00019580235,0.00038211717,0.0015056136],"category_scores_gemma":[0.0046139234,0.00023733324,0.00034283704,0.0006731036,0.00015772686,0.00046369823,0.00032518554,0.00041056512,0.00016180571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017560817,0.000011149811,0.99945,0.0000018918894,0.000008002879,0.000019876043,0.000015001937,0.000007464884,0.000037611062,0.0000017503793,0.000013116432,0.00041652084],"study_design_scores_gemma":[0.0000027029532,0.00006979829,0.9994466,0.0000032879743,0.00000838367,0.00023443812,0.000040693885,0.00013865753,0.000025648282,0.0000044134326,0.00002401285,0.0000013159969],"about_ca_topic_score_codex":0.0036370927,"about_ca_topic_score_gemma":0.0040492387,"teacher_disagreement_score":0.0036370927,"about_ca_system_score_codex":0.00023229602,"about_ca_system_score_gemma":0.00020386832,"threshold_uncertainty_score":0.007231891},"labels":[],"label_agreement":null},{"id":"W2108182085","doi":"10.2174/1389200215666140130124910","title":"Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process","year":2014,"lang":"en","type":"article","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":436,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Vetenskapsrådet; National Institutes of Health; National Heart, Lung, and Blood Institute","keywords":"Guideline; Clinical Practice; Medicine; Grading (engineering); Pharmacogenomics; Precision medicine; Dosing; Medical physics; Pharmacology; Family medicine; Pathology; Engineering","score_opus":0.1829097713412273,"score_gpt":0.5727360438001791,"score_spread":0.38982627245895174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108182085","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013002274,0.011211533,0.33536565,0.5023659,0.00880745,0.049559448,0.0013677555,0.0025299669,0.07579008],"genre_scores_gemma":[0.03072015,0.007016837,0.9050377,0.036028374,0.0019543981,0.01180999,0.0013000898,0.000512278,0.005620181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6322712,0.21045768,0.06673744,0.0083310045,0.07673747,0.0054652374],"domain_scores_gemma":[0.42556536,0.21069479,0.03547332,0.025741253,0.2823317,0.0201936],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.41579157,0.0014476038,0.0024833514,0.010261011,0.0050329533,0.015786087,0.008548897,0.011137442,0.0035257179],"category_scores_gemma":[0.4779783,0.0027083755,0.0032069478,0.010433761,0.005220802,0.009235298,0.014117131,0.019566992,0.0035317657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112914684,0.0010924374,0.005240215,0.0030289495,0.00022613692,0.0015758787,0.016151948,0.0025079485,0.0017580432,0.02737882,0.3008689,0.6400578],"study_design_scores_gemma":[0.0005334411,0.00078817183,0.013505286,0.024023302,0.00030978138,0.0019422002,0.00940255,0.008170027,0.0034059545,0.045387268,0.89187443,0.00065759924],"about_ca_topic_score_codex":0.0214969,"about_ca_topic_score_gemma":0.028527634,"teacher_disagreement_score":0.41579157,"about_ca_system_score_codex":0.019022226,"about_ca_system_score_gemma":0.12862283,"threshold_uncertainty_score":0.720433},"labels":[],"label_agreement":null},{"id":"W2109558038","doi":"10.1124/dmd.30.3.314","title":"Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Miconazole; Chemistry; Clotrimazole; Econazole; Hydroxylation; CYP2A6; Microsome; CYP2B6; Pharmacology; Stereochemistry; CYP1A2; Biochemistry; Biology; In vitro; Enzyme","score_opus":0.04292062512114255,"score_gpt":0.347355702439152,"score_spread":0.30443507731800945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109558038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851972,0.0058184164,0.0041708825,0.00020951274,0.000060954586,0.000034902878,0.00024540068,0.00014509921,0.0041177697],"genre_scores_gemma":[0.9977295,0.0009345879,0.00053157826,0.000024884284,0.000015291336,0.0000068849226,0.00010545792,0.0000043324626,0.0006474535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984705,0.00005829764,0.00001539065,0.000019673736,0.000026508467,0.000033118427],"domain_scores_gemma":[0.99990594,0.000025510253,0.000031699314,0.000013033464,0.000012224847,0.0000115674875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016662339,0.00022108518,0.00024909544,0.00016833177,0.0001387205,0.00016081946,0.0001705378,0.00015916106,0.0009934414],"category_scores_gemma":[0.0004099843,0.000075905264,0.0001917914,0.00018703385,0.000089775,0.00008918368,0.00008055722,0.0003088323,0.00018760591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028990633,0.00023643859,0.010075802,0.00014929198,0.00010032649,0.00074331154,0.00007196707,0.0007246843,0.88960004,0.0006832909,0.00095405424,0.09376174],"study_design_scores_gemma":[0.00011570498,0.0024832524,0.026733939,0.000016141234,0.000077474084,0.0021304847,0.00003448991,0.002172836,0.96072406,0.00012181017,0.005380753,0.000009220965],"about_ca_topic_score_codex":0.0008554914,"about_ca_topic_score_gemma":0.0014169357,"teacher_disagreement_score":0.0009934414,"about_ca_system_score_codex":0.00024285444,"about_ca_system_score_gemma":0.00011193174,"threshold_uncertainty_score":0.0033233762},"labels":[],"label_agreement":null},{"id":"W2109720671","doi":"10.1016/s0022-3565(24)29650-6","title":"Pulmonary Bioactivation of 1,1-Dichloroethylene Is Associated with CYP2E1 Levels in A/J, CD-1, and C57BL/6 Mice","year":2001,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glutathione; CYP2E1; Chemistry; Cytosol; Lung; Metabolite; Molecular biology; Ratón; Conjugate; Glutathione S-transferase; Toxicity; Biochemistry; Immunology; Internal medicine; Biology; Metabolism; Cytochrome P450; Medicine; Enzyme","score_opus":0.10434009170810296,"score_gpt":0.42539914795908,"score_spread":0.3210590562509771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109720671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948059,0.0008457634,0.001973981,0.0003169788,0.000043775977,0.00004073818,0.0011627518,0.0001243558,0.00068585575],"genre_scores_gemma":[0.98840314,0.0008095008,0.00209413,0.00019578499,0.000050622202,0.00011855418,0.0015588825,0.00017035354,0.006598997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990459,0.0001465645,0.0000715458,0.00026250604,0.00024703215,0.00022642755],"domain_scores_gemma":[0.9985922,0.00019545683,0.0004935181,0.0001513345,0.00010032521,0.0004670637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005354357,0.0008891133,0.0007696963,0.0025250907,0.0005633684,0.00090687635,0.0006079655,0.0012830935,0.002398031],"category_scores_gemma":[0.0004118901,0.00085618085,0.00078894675,0.00073012157,0.0012828766,0.0007380553,0.00034232167,0.0024132587,0.00067661103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001293948,0.00021992793,0.00058548,0.000017872368,0.000011602121,0.000093105235,0.000026190182,0.00004988633,0.9970386,0.000103249535,0.00006439015,0.0004956956],"study_design_scores_gemma":[0.00015134594,0.001294759,0.021072503,0.000010813777,0.00008138544,0.0006589628,0.00009927146,0.0010838526,0.97447544,0.0001357943,0.00090576557,0.000030005918],"about_ca_topic_score_codex":0.0023528098,"about_ca_topic_score_gemma":0.0037205787,"teacher_disagreement_score":0.0025250907,"about_ca_system_score_codex":0.00086799834,"about_ca_system_score_gemma":0.00035946563,"threshold_uncertainty_score":0.008022249},"labels":[],"label_agreement":null},{"id":"W2110513442","doi":"10.1124/jpet.109.162610","title":"Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse Model","year":2009,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; University of Toronto; University of Minnesota; Bristol-Myers Squibb","keywords":"Nicotine; CYP2A6; In vivo; Pharmacology; CYP2B6; Drug metabolism; Cytochrome P450; Chemistry; Biology; CYP1A2; Metabolism; Drug; Biochemistry; Neuroscience; Genetics","score_opus":0.09661502666764893,"score_gpt":0.44793950829222745,"score_spread":0.3513244816245785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110513442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592203,0.003784894,0.031469688,0.0012558638,0.00021260942,0.000116424824,0.0018486286,0.00034118988,0.0017502782],"genre_scores_gemma":[0.982485,0.0016940552,0.009242958,0.00023787348,0.000050456918,0.00010788859,0.0011336076,0.00013036779,0.0049178544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934787,0.000104532366,0.00006671963,0.0001799574,0.00022446585,0.00007652209],"domain_scores_gemma":[0.99936706,0.000108019194,0.0001912714,0.00009600081,0.000053760235,0.00018393391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007544211,0.0013314919,0.0009963214,0.0015827231,0.00046182174,0.001105118,0.0009565704,0.0015333862,0.0021530637],"category_scores_gemma":[0.00047821016,0.0006038132,0.0011511391,0.00032796554,0.0010699288,0.0009204999,0.00039832678,0.0023431936,0.00046830685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094495836,0.0001558285,0.0012903492,0.00007120896,0.00006589233,0.0004094043,0.00003865986,0.00026908578,0.99227726,0.0013002766,0.0001702418,0.0030067337],"study_design_scores_gemma":[0.0001047259,0.000818616,0.007505323,0.000021840564,0.0002367049,0.0016424091,0.00009299248,0.003258567,0.98224336,0.00066300185,0.0033850197,0.000027499194],"about_ca_topic_score_codex":0.0017271173,"about_ca_topic_score_gemma":0.0023415224,"teacher_disagreement_score":0.0021530637,"about_ca_system_score_codex":0.00080828957,"about_ca_system_score_gemma":0.0005138837,"threshold_uncertainty_score":0.0072027445},"labels":[],"label_agreement":null},{"id":"W2110565069","doi":"10.1080/00498250902954296","title":"Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling","year":2009,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Recombinant DNA; Chemistry; Biology; Biochemistry","score_opus":0.26169503692010365,"score_gpt":0.4253406080847287,"score_spread":0.16364557116462503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110565069","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40855604,0.0032911452,0.5811955,0.0005785906,0.00005417223,0.0004554293,0.0017381638,0.0012746291,0.0028562965],"genre_scores_gemma":[0.9289743,0.0014452463,0.066813126,0.000117200376,0.000018814864,0.00025856492,0.0015162295,0.000084710475,0.0007717133],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991726,0.00046282983,0.00004820778,0.000083976665,0.00019791239,0.00003435114],"domain_scores_gemma":[0.9982718,0.0011218803,0.0003131679,0.00007919295,0.00017385428,0.000039988194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017290851,0.0007419215,0.00090998976,0.0003882354,0.0001327468,0.00092795724,0.0006221161,0.0005667188,0.000987887],"category_scores_gemma":[0.0046452023,0.0003089454,0.0008627335,0.00034120117,0.00022869282,0.0005158962,0.00021290866,0.0009691331,0.000693127],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009375016,0.00021642946,0.00968941,0.00029060373,0.00020032533,0.00019912327,0.000058870435,0.8952332,0.04462848,0.0012282239,0.0010930985,0.046224736],"study_design_scores_gemma":[0.000089791676,0.0016042325,0.0038169709,0.000017521783,0.00010551288,0.000308364,0.00001666693,0.95924205,0.031431664,0.0013837251,0.0019484371,0.00003512502],"about_ca_topic_score_codex":0.002236929,"about_ca_topic_score_gemma":0.0014032653,"teacher_disagreement_score":0.002236929,"about_ca_system_score_codex":0.00076304463,"about_ca_system_score_gemma":0.0006929996,"threshold_uncertainty_score":0.009144366},"labels":[],"label_agreement":null},{"id":"W2111074312","doi":"10.1517/14656566.6.8.1299","title":"A pharmacogeneticist’s look at drug effects and the drug development process: an overview","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug; Drug development; Personalized medicine; Pharmacogenetics; Identification (biology); Drug response; Pharmacology; Drug action; Intensive care medicine; Bioinformatics; Genetics","score_opus":0.21577903902343207,"score_gpt":0.5352320778405615,"score_spread":0.3194530388171294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111074312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010986319,0.99106723,0.0017042577,0.004016416,0.00069548935,0.000010291515,0.000010080666,0.000018561102,0.0023677957],"genre_scores_gemma":[0.0008391237,0.9936108,0.0015565231,0.0019517115,0.0009997542,0.00001667391,0.00001507594,0.0000040186305,0.0010063465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989072,0.00041606225,0.00012225553,0.00012447887,0.00037370934,0.000056271798],"domain_scores_gemma":[0.9982309,0.0012529152,0.00010364585,0.00005465087,0.00027733497,0.000080545295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024992514,0.001405365,0.002472315,0.0061495784,0.00052414625,0.001909747,0.0015208705,0.003800663,0.003374405],"category_scores_gemma":[0.0018412663,0.0006244637,0.0010567824,0.0046483343,0.002001459,0.0059065456,0.0011533211,0.0040580905,0.0032901824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009200986,0.00017404128,0.00052398123,0.011623586,0.00018510564,0.001252451,0.00037045355,0.0009813856,0.0016645278,0.026002543,0.049006384,0.90812355],"study_design_scores_gemma":[0.000029386694,0.00015052997,0.0010066432,0.0035050125,0.00007627644,0.0045849895,0.00019631667,0.00026483412,0.00035093553,0.018216975,0.9715788,0.000039421142],"about_ca_topic_score_codex":0.001968419,"about_ca_topic_score_gemma":0.0029764941,"teacher_disagreement_score":0.0061495784,"about_ca_system_score_codex":0.0019652066,"about_ca_system_score_gemma":0.0020292096,"threshold_uncertainty_score":0.014258683},"labels":[],"label_agreement":null},{"id":"W2111331724","doi":"10.1186/1741-7015-11-179","title":"Personalizing health care: feasibility and future implications","year":2013,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Sunnybrook Health Science Centre; Centre for Global Health Research","funders":"Conservatoire National des Arts et Métiers; Vetenskapsrådet; Stockholms Läns Landsting; Karolinska Institutet; NHS Health Scotland","keywords":"Medicine; Pharmacogenomics; Personalized medicine; Precision medicine; Stakeholder; Health care; Risk analysis (engineering); Variety (cybernetics); Intensive care medicine; Pharmacology; Bioinformatics; Public relations; Pathology","score_opus":0.4292138280629503,"score_gpt":0.5653152161168731,"score_spread":0.1361013880539228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111331724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042957693,0.95660055,0.0014020067,0.03609969,0.00046647375,0.0000124921535,0.000031439522,0.000009638856,0.004948179],"genre_scores_gemma":[0.013177827,0.976074,0.0022658724,0.0064722495,0.0011745297,0.000053740278,0.000028980698,0.0000056366584,0.0007472375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726534,0.0014583087,0.00016432245,0.0002702977,0.00066147733,0.0001803353],"domain_scores_gemma":[0.98103416,0.01585744,0.00054494897,0.00037795544,0.0016850454,0.00050049555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011216454,0.00059281813,0.0013782963,0.0012555586,0.0005395889,0.003070641,0.001766639,0.0044889026,0.008040478],"category_scores_gemma":[0.011213404,0.00028556012,0.00093185215,0.002109405,0.003173342,0.00515233,0.001866012,0.005327925,0.0014227905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009354669,0.00010024301,0.0007416357,0.010141358,0.00010156605,0.00026305066,0.00031441814,0.0009436342,0.00028594618,0.12577033,0.026191652,0.8350527],"study_design_scores_gemma":[0.00007938366,0.00022637627,0.0034893008,0.031430148,0.00015374226,0.0020888885,0.0018824891,0.001343036,0.000500216,0.1426595,0.81606454,0.00008239078],"about_ca_topic_score_codex":0.0027456186,"about_ca_topic_score_gemma":0.003674591,"teacher_disagreement_score":0.011216454,"about_ca_system_score_codex":0.0031253446,"about_ca_system_score_gemma":0.00536057,"threshold_uncertainty_score":0.05931896},"labels":[],"label_agreement":null},{"id":"W2111676569","doi":"10.1124/dmd.32.12.","title":"USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTES","year":2004,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Microsome; CYP3A; Hepatocyte; Metabolite; Enzyme inducer; Chemistry; Cytochrome P450; Glucuronidation; Enzyme; Phenobarbital; Biochemistry; Enzyme inhibitor; Molecular biology; Biology; Pharmacology; In vitro","score_opus":0.047391999343260084,"score_gpt":0.3580090161846279,"score_spread":0.3106170168413678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111676569","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417354,0.0035453292,0.046521503,0.00044223203,0.00018080737,0.00008364376,0.00067902874,0.0003571284,0.0064548436],"genre_scores_gemma":[0.9786849,0.0014385006,0.0153332995,0.00010275796,0.00003087155,0.00007449631,0.000665484,0.000055962915,0.0036137425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999793,0.00005507423,0.000013002992,0.000051167182,0.000034229713,0.000053577558],"domain_scores_gemma":[0.99979347,0.00009808464,0.000020523143,0.000040073795,0.000027672271,0.000020271935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045859543,0.00027229034,0.00043419466,0.00019013193,0.00036524946,0.00032920134,0.00030494193,0.00032557547,0.0012120693],"category_scores_gemma":[0.00019380488,0.00023071031,0.00045250193,0.00022149515,0.00026229533,0.00024231554,0.00015821203,0.0006866679,0.00031794043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023450582,0.000025113699,0.00012097105,0.000026148056,0.000006814496,0.00005501907,0.00002109327,0.00009561397,0.9980995,0.0001858054,0.00006420682,0.0010651943],"study_design_scores_gemma":[0.000009247257,0.00010840373,0.00039343824,8.5430185e-7,0.000010237558,0.00006926078,0.000008929221,0.00037752997,0.99854505,0.000014009265,0.00046112025,0.0000018657265],"about_ca_topic_score_codex":0.0031465176,"about_ca_topic_score_gemma":0.0055375746,"teacher_disagreement_score":0.0031465176,"about_ca_system_score_codex":0.00044643343,"about_ca_system_score_gemma":0.0004128351,"threshold_uncertainty_score":0.0062564015},"labels":[],"label_agreement":null},{"id":"W2111753974","doi":"10.2217/14622416.7.2.219","title":"Pharmacogenomic Data Sample Collection and Storage: Ethical Issues and Policy Approaches","year":2006,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biobank; Pharmacogenomics; Mainstream; Sample (material); Data collection; Perspective (graphical); Population; Ethical issues; Data science; Medicine; Engineering ethics; Political science; Computer science; Sociology; Bioinformatics; Pharmacology; Environmental health; Engineering; Biology; Social science","score_opus":0.4607023734111636,"score_gpt":0.5289519496593159,"score_spread":0.06824957624815231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111753974","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014213971,0.15860544,0.29286706,0.470611,0.007989924,0.0061760372,0.006065764,0.0007229955,0.042747848],"genre_scores_gemma":[0.12417536,0.20300429,0.5091686,0.09379665,0.01072688,0.02347826,0.009681551,0.0006673369,0.025301043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8336528,0.1166086,0.01404279,0.0054494194,0.028704803,0.0015416656],"domain_scores_gemma":[0.69779295,0.19740462,0.02193677,0.04570331,0.034453157,0.0027091815],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18572775,0.0008010963,0.0018470989,0.004189708,0.0021987432,0.010783245,0.006327474,0.0055603613,0.0036972484],"category_scores_gemma":[0.19799054,0.0008724449,0.00090285175,0.010517235,0.010611917,0.009645861,0.0049230387,0.006132559,0.0039112014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053903356,0.0002813346,0.008962239,0.005307209,0.00017413753,0.00066500664,0.004667844,0.0011189206,0.0021414945,0.18866767,0.09786855,0.68960655],"study_design_scores_gemma":[0.0001377824,0.0002587422,0.011129054,0.010467164,0.00016409805,0.0030658839,0.0054032705,0.0022246677,0.0063502393,0.12071265,0.83992577,0.00016076656],"about_ca_topic_score_codex":0.0042520426,"about_ca_topic_score_gemma":0.0031592667,"teacher_disagreement_score":0.8142723,"about_ca_system_score_codex":0.0044017844,"about_ca_system_score_gemma":0.019455127,"threshold_uncertainty_score":0.98223394},"labels":[],"label_agreement":null},{"id":"W2111842648","doi":"10.1124/dmd.106.013243","title":"Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Peroxisome proliferator-activated receptor; Genetically modified mouse; Peroxisome proliferator; Peroxisome; Transgene; Metabolism; Drug; Locus (genetics); Biology; Chemistry; Pharmacology; Receptor; Endocrinology; Internal medicine; Biochemistry; Gene; Medicine","score_opus":0.030784343679233744,"score_gpt":0.3366847351071157,"score_spread":0.30590039142788195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111842648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96701235,0.0016136863,0.021153405,0.0012176824,0.00026453452,0.00021560676,0.0033609138,0.0013161759,0.0038456353],"genre_scores_gemma":[0.95868623,0.0017663272,0.015833475,0.0002554478,0.00007439161,0.0003512327,0.003228333,0.00058612414,0.019218354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995646,0.00007483136,0.00004271186,0.00014136234,0.000085459455,0.00009109873],"domain_scores_gemma":[0.9995577,0.00007942997,0.00019463213,0.000042808373,0.000019386918,0.0001060771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037325616,0.0009914128,0.00046249112,0.0012800564,0.0004149776,0.00066289044,0.0005556703,0.0013159479,0.0040947595],"category_scores_gemma":[0.00025055892,0.0007777572,0.0007679855,0.00050798774,0.0010698716,0.0004242102,0.0003002895,0.0019386257,0.001112211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034863947,0.00006203551,0.00014505215,0.000021974452,0.0000112815405,0.00015401132,0.000026739886,0.00008018672,0.99750817,0.0005419277,0.0001191904,0.0009807257],"study_design_scores_gemma":[0.00017277696,0.00028578183,0.0014209879,0.000011976101,0.0000625928,0.00085864775,0.00003258088,0.0012541095,0.9921681,0.00016613817,0.0035543204,0.0000119812075],"about_ca_topic_score_codex":0.0019432812,"about_ca_topic_score_gemma":0.0037098601,"teacher_disagreement_score":0.0040947595,"about_ca_system_score_codex":0.0006570782,"about_ca_system_score_gemma":0.00059492065,"threshold_uncertainty_score":0.01369828},"labels":[],"label_agreement":null},{"id":"W2112200883","doi":"10.1080/03602530701836712","title":"Expression, Activity and Regulation of CYP3A in Human and Rodent Brain","year":2008,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Division of Materials Research; Canadian Institutes of Health Research","keywords":"CYP3A; Cytochrome P450; Biology; Human brain; Drug metabolism; Isozyme; Enzyme; Function (biology); Rodent; Cell biology; Neuroscience; Biochemistry","score_opus":0.16506738117245323,"score_gpt":0.4740940236489169,"score_spread":0.30902664247646366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112200883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004785267,0.9883321,0.0015386223,0.00021187394,0.000068235786,0.000013198246,0.00020749711,0.000047187314,0.0047959858],"genre_scores_gemma":[0.019451002,0.97406363,0.0019341862,0.00016247503,0.00007607066,0.000029493338,0.00030747597,0.000011680911,0.003963974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989676,0.000016421165,0.000010640509,0.00003221695,0.00003487235,0.000009018563],"domain_scores_gemma":[0.9999368,0.000016175847,0.000017168286,0.0000033266913,0.000022011069,0.0000044637204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017496725,0.00036520144,0.0006337684,0.00096374564,0.0001181532,0.00038972404,0.0003090709,0.00035965708,0.0018509271],"category_scores_gemma":[0.00019743449,0.0001410261,0.00032502532,0.0011530756,0.0001836672,0.00031330384,0.00017608189,0.00040628368,0.0015128562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017237324,0.000048033733,0.001382416,0.0068682,0.00012021823,0.00071771996,0.00010562096,0.00048627218,0.08011674,0.0020076635,0.007614187,0.90036047],"study_design_scores_gemma":[0.000047145735,0.00065374054,0.03734185,0.0019184604,0.00056901464,0.014793134,0.00018544246,0.00046905808,0.0700735,0.0036894223,0.870175,0.00008415608],"about_ca_topic_score_codex":0.0014265364,"about_ca_topic_score_gemma":0.0016230419,"teacher_disagreement_score":0.0018509271,"about_ca_system_score_codex":0.00032101883,"about_ca_system_score_gemma":0.00033159176,"threshold_uncertainty_score":0.006191969},"labels":[],"label_agreement":null},{"id":"W2112521086","doi":"10.1097/moh.0b013e32833c06b3","title":"Will there be a role for genotyping in warfarin therapy?","year":2010,"lang":"en","type":"review","venue":"Current Opinion in Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Warfarin; Dosing; Medicine; Intensive care medicine; Therapeutic index; Thrombosis; VKORC1; CYP2C9; Internal medicine; Pharmacology; Drug; Atrial fibrillation","score_opus":0.38506051172235367,"score_gpt":0.5514394381103891,"score_spread":0.16637892638803542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112521086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042406507,0.9969854,0.00013372982,0.0022049109,0.00039896296,0.000003929263,0.000010273206,0.0000038933204,0.00021650732],"genre_scores_gemma":[0.00062148896,0.99689686,0.00033678344,0.0014609597,0.0005288082,0.0000098033315,0.000015474105,0.0000022767565,0.0001275257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982835,0.00073307875,0.00032518012,0.00020128314,0.00039829672,0.000058696798],"domain_scores_gemma":[0.9942268,0.0037401947,0.0008853044,0.00014971184,0.00084310427,0.00015471807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050339894,0.00094455207,0.0057270904,0.0014138301,0.00019695616,0.0015668344,0.0019918594,0.002847485,0.003626975],"category_scores_gemma":[0.0115898,0.00040901345,0.0015505162,0.002464478,0.0012171627,0.0030357707,0.00055337563,0.002485742,0.0022357693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018844978,0.000031818916,0.00053020334,0.04823569,0.00043738543,0.00023958347,0.000048428836,0.0002433076,0.00043133742,0.0036436638,0.032185182,0.91378486],"study_design_scores_gemma":[0.00023739296,0.0002474497,0.0037951611,0.09425137,0.0025984386,0.0050563384,0.00021331094,0.00036941736,0.00050335214,0.008585207,0.8840554,0.00008722504],"about_ca_topic_score_codex":0.0021343303,"about_ca_topic_score_gemma":0.0020863258,"teacher_disagreement_score":0.0057270904,"about_ca_system_score_codex":0.00091920013,"about_ca_system_score_gemma":0.0027069654,"threshold_uncertainty_score":0.026622593},"labels":[],"label_agreement":null},{"id":"W2112547742","doi":"10.1067/mcp.2000.110774","title":"Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Grapefruit juice; Naringin; Felodipine; Naringenin; Chemistry; Pharmacology; Furanocoumarin; Citrus paradisi; CYP3A4; Drug interaction; Pharmacokinetics; Food science; Flavonoid; Rutaceae; Chromatography; Biochemistry; Botany; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.15016354409023558,"score_gpt":0.5123970513687449,"score_spread":0.36223350727850934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897087,0.00060863234,0.00010621541,0.000015761816,0.00001058911,0.000045109915,0.00006472058,0.000008642283,0.00016950657],"genre_scores_gemma":[0.99834144,0.00031795583,0.00053938583,0.000037680147,0.00002513172,0.000025326992,0.00015304534,0.0000075133817,0.00055262394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975985,0.00009053584,0.00001596986,0.00006560756,0.00004274062,0.00002526641],"domain_scores_gemma":[0.99959964,0.00017240855,0.000094664545,0.00003054805,0.000025124595,0.000077614335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034495728,0.00038838235,0.0007007335,0.00013374865,0.00012380473,0.00038392516,0.00019451986,0.00038992602,0.0022544437],"category_scores_gemma":[0.0007663381,0.00014143846,0.00050264684,0.0001244206,0.00023439848,0.00028425196,0.00011354566,0.00033156553,0.00011438266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3238608,0.0078719435,0.0145820705,0.00058991765,0.0018157706,0.0003984512,0.00011161266,0.0005273967,0.60831153,0.00008461425,0.00019734682,0.041648608],"study_design_scores_gemma":[0.012465752,0.35788944,0.34688294,0.000051123796,0.003247727,0.0014145522,0.00012991516,0.004879372,0.2685816,0.00020003552,0.0041932305,0.000064270906],"about_ca_topic_score_codex":0.0010548482,"about_ca_topic_score_gemma":0.001491734,"teacher_disagreement_score":0.0022544437,"about_ca_system_score_codex":0.00031791133,"about_ca_system_score_gemma":0.0002060351,"threshold_uncertainty_score":0.007541895},"labels":[],"label_agreement":null},{"id":"W2113122443","doi":"10.1002/jms.3375","title":"Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time‐of‐flight mass spectrometry","year":2014,"lang":"en","type":"article","venue":"Journal of Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Chemistry; Chromatography; Mass spectrometry; Urine; Hydroxylation; Metabolomics; Metabolite; Tamoxifen; Fragmentation (computing); Breast cancer; Cancer; Biochemistry; Internal medicine; Enzyme","score_opus":0.02702595252843914,"score_gpt":0.34420125528986795,"score_spread":0.3171753027614288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113122443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810559,0.008632468,0.008306114,0.00023296083,0.000033978893,0.000056322195,0.0008121677,0.00008670197,0.0007831776],"genre_scores_gemma":[0.98315835,0.002635515,0.011585053,0.00026537475,0.00004820166,0.000045706885,0.0009852141,0.000021992608,0.0012545874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999083,0.000017208054,0.0000065965683,0.000024061594,0.000030529027,0.000013323439],"domain_scores_gemma":[0.9998399,0.000032979013,0.00005184113,0.000011196066,0.00004458028,0.00001942104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012930442,0.00028750187,0.00022925738,0.0006400074,0.00019756744,0.00022974293,0.00017053976,0.00038905494,0.0008625429],"category_scores_gemma":[0.000392594,0.00012140948,0.000204842,0.00030601077,0.00013872658,0.00018318955,0.00011223303,0.00023285794,0.0002314517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047319426,0.000049176975,0.010970199,0.00008307123,0.000053665823,0.0006940573,0.000071809314,0.000084642474,0.971142,0.00007228113,0.0000944228,0.016211458],"study_design_scores_gemma":[0.000074143136,0.0019077943,0.100304,0.000023333801,0.000279749,0.007273145,0.00017423996,0.0016728704,0.879001,0.00026517946,0.008984266,0.000040216964],"about_ca_topic_score_codex":0.00049959647,"about_ca_topic_score_gemma":0.0010878278,"teacher_disagreement_score":0.0008625429,"about_ca_system_score_codex":0.000127639,"about_ca_system_score_gemma":0.00023452459,"threshold_uncertainty_score":0.0028854609},"labels":[],"label_agreement":null},{"id":"W2113187341","doi":"","title":"Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles: studies of human UDP-glucuronosyltransferases involved and substrate specificities.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Chemistry; Enzyme kinetics; Metabolite; Stereochemistry; Tertiary amine; Substrate (aquarium); Lipophilicity; UGT2B7; Enzyme; Organic chemistry; Microsome; Active site; Biochemistry","score_opus":0.2576837597796968,"score_gpt":0.4143162402860982,"score_spread":0.15663248050640138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113187341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069864,0.005388117,0.0029861848,0.000044218636,0.000008845313,0.000016847938,0.00017837403,0.00003569376,0.00064321357],"genre_scores_gemma":[0.99202746,0.0024204145,0.004001278,0.000028368331,0.000007934874,0.000010701538,0.00049198937,0.000014337267,0.0009974921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987185,0.00006171609,0.000007549525,0.000023621456,0.000019089146,0.00001625854],"domain_scores_gemma":[0.9998933,0.000024193008,0.000037220165,0.0000074878567,0.00002154368,0.000016273874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023005025,0.00040484354,0.00025892165,0.00010639548,0.00006851951,0.00019095623,0.00011718219,0.00021012597,0.0004445969],"category_scores_gemma":[0.00028151262,0.0000944473,0.00018839267,0.00021750358,0.00010811625,0.00015777952,0.00007525215,0.00018677794,0.0002357262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021743702,0.000018205119,0.0011252007,0.00007609231,0.000019948184,0.00005454012,0.00003261609,0.00023087737,0.99390477,0.00003173497,0.00002620057,0.0042624404],"study_design_scores_gemma":[0.0000053163735,0.00046226496,0.005681002,0.000005243983,0.000034547535,0.00041494245,0.000019431747,0.00081566366,0.99135816,0.000018068129,0.0011803403,0.000005072817],"about_ca_topic_score_codex":0.0009349238,"about_ca_topic_score_gemma":0.0010650529,"teacher_disagreement_score":0.0009349238,"about_ca_system_score_codex":0.00028734625,"about_ca_system_score_gemma":0.00013963607,"threshold_uncertainty_score":0.0020847917},"labels":[],"label_agreement":null},{"id":"W2113976730","doi":"10.1093/carcin/bgu235","title":"CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers—findings from two independent populations","year":2014,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; National Cancer Institute; Vanderbilt-Ingram Cancer Center; Vanderbilt University","keywords":"Lung cancer; CYP2A6; Odds ratio; Medicine; Internal medicine; Population; Oncology; Demography; Biology; Environmental health","score_opus":0.08900709973242153,"score_gpt":0.42089925420857555,"score_spread":0.331892154476154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113976730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999196,0.00016163269,0.00026443842,0.000031192845,0.000004849085,0.000013661405,0.00007895264,0.0000026650048,0.0002465846],"genre_scores_gemma":[0.99932134,0.000092851624,0.00024918342,0.000043339016,0.000014936653,0.000016010605,0.00011879631,0.0000048790257,0.00013867783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998936,0.00048783724,0.0000654827,0.00026511314,0.0001523204,0.000093297356],"domain_scores_gemma":[0.9986803,0.00045968362,0.00023617879,0.00025268667,0.00019530824,0.00017577129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017096391,0.00052322407,0.00058732997,0.00094388035,0.0011373868,0.00070177735,0.00045535451,0.0006023877,0.0017845291],"category_scores_gemma":[0.003645249,0.00031342992,0.00070132373,0.0007708472,0.00069911557,0.00024225687,0.00064542744,0.0005687738,0.00018577493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033273797,0.00026550845,0.9655108,0.000043739157,0.0008985591,0.0010914267,0.0029690298,0.00010602623,0.018516768,0.0002938796,0.0002163624,0.0067603975],"study_design_scores_gemma":[0.00020111061,0.00041350254,0.99472624,0.00001793601,0.0005226489,0.0012885614,0.0005917969,0.00035907514,0.00094765425,0.00016637109,0.0007451714,0.000019942847],"about_ca_topic_score_codex":0.009154199,"about_ca_topic_score_gemma":0.006778933,"teacher_disagreement_score":0.009154199,"about_ca_system_score_codex":0.00018892477,"about_ca_system_score_gemma":0.00030880346,"threshold_uncertainty_score":0.018201828},"labels":[],"label_agreement":null},{"id":"W2114229890","doi":"10.1124/dmd.105.006528","title":"MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pyrrolidine dithiocarbamate; CYP1A2; Nitric oxide; Nitric oxide synthase; Chemistry; Biochemistry; Janus kinase; Pharmacology; Kinase; Molecular biology; Endocrinology; Biology; Cytochrome P450; Enzyme; Signal transduction; NF-κB","score_opus":0.020568682949819898,"score_gpt":0.315790857103446,"score_spread":0.2952221741536261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114229890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500316,0.0010486869,0.0024014527,0.00029007718,0.00015491391,0.000063994936,0.00014573621,0.0000805741,0.00081128225],"genre_scores_gemma":[0.99640614,0.0006090777,0.0010281671,0.00018241443,0.00013676798,0.00009511635,0.00036812952,0.000022736824,0.0011514388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993155,0.0001558281,0.00009219479,0.000112106005,0.00013046387,0.00019394138],"domain_scores_gemma":[0.9992125,0.00017021912,0.00022277172,0.00016845771,0.00008126188,0.00014476679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074679113,0.0010009467,0.00072670873,0.000711823,0.00039712092,0.00045388934,0.00028348874,0.0007394475,0.0013899084],"category_scores_gemma":[0.0010563296,0.00043303645,0.00073117967,0.00035648482,0.0009217124,0.0005011716,0.00029834846,0.0018304853,0.0006754549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016086733,0.00080088305,0.003355386,0.00010808282,0.000059968803,0.00061528315,0.00021712772,0.0001341469,0.9730132,0.00028725574,0.00021438679,0.0051074675],"study_design_scores_gemma":[0.0007320339,0.007338678,0.019163568,0.000021157111,0.00016823555,0.0013607594,0.00013090333,0.002205244,0.9670156,0.00022940358,0.0016086036,0.000025856458],"about_ca_topic_score_codex":0.00052335375,"about_ca_topic_score_gemma":0.00054070406,"teacher_disagreement_score":0.0013899084,"about_ca_system_score_codex":0.00034791318,"about_ca_system_score_gemma":0.00031618148,"threshold_uncertainty_score":0.0046497583},"labels":[],"label_agreement":null},{"id":"W211447915","doi":"10.1097/fpc.0000000000000143","title":"Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Vitamin K epoxide reductase; Pharmacogenomics; Vitamin K antagonist; Genotyping; Population; Biology; Therapeutic index; Pharmacology; Medicine; Demography; Internal medicine; Drug; Genetics; Gene; Atrial fibrillation; Environmental health; Genotype","score_opus":0.058967227767481305,"score_gpt":0.38799223859410265,"score_spread":0.32902501082662133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W211447915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913824,0.00009969365,0.00009324747,0.000020296397,0.0000032045034,0.00000612747,0.00019962389,0.0000034036373,0.00043613324],"genre_scores_gemma":[0.99949455,0.000054224565,0.00014008908,0.000017737439,0.0000032392327,0.000006852232,0.00010307183,0.0000017574357,0.00017843489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971,0.00006619037,0.000028482382,0.00010594273,0.000055762393,0.000033565953],"domain_scores_gemma":[0.9997553,0.000064184904,0.00007721951,0.000024025765,0.000036593086,0.000042700456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866168,0.0002708792,0.00017721833,0.0006785864,0.00058092416,0.00032045282,0.0002509522,0.0003013926,0.001381045],"category_scores_gemma":[0.000831594,0.000116162555,0.00021286523,0.0008696288,0.000287526,0.000118426506,0.0002049078,0.0002188937,0.0001255393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022937472,0.00004404507,0.99210745,0.00001590628,0.00009838986,0.00048946484,0.00062349235,0.0001433795,0.0025251284,0.00009519571,0.00014728418,0.003480871],"study_design_scores_gemma":[0.0000073484543,0.000038798546,0.9982931,0.0000060976977,0.00003565754,0.00067236583,0.00028329442,0.00016673295,0.00019105784,0.000056654284,0.00024458492,0.0000042231027],"about_ca_topic_score_codex":0.02639486,"about_ca_topic_score_gemma":0.016086707,"teacher_disagreement_score":0.02639486,"about_ca_system_score_codex":0.00023941735,"about_ca_system_score_gemma":0.0001837089,"threshold_uncertainty_score":0.052482486},"labels":[],"label_agreement":null},{"id":"W2114771048","doi":"10.1124/dmd.109.030528","title":"Chlorzoxazone Metabolism by Porcine Cytochrome P450 Enzymes and the Effect of Cytochrome b5","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chlorzoxazone; Cytochrome P450; Microsome; CYP2E1; Complementary DNA; CYP3A; Metabolism; CYP3A4; Chemistry; Enzyme; Drug metabolism; Biology; Molecular biology; Biochemistry; Gene","score_opus":0.010651027567086016,"score_gpt":0.3300994829181508,"score_spread":0.31944845535106475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114771048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645776,0.0017335756,0.00080968055,0.00009235892,0.000009549772,0.000013754596,0.00016043703,0.000012332186,0.0007105703],"genre_scores_gemma":[0.9983961,0.0004962723,0.0003619328,0.00002615044,0.00000659138,0.0000048956263,0.00020852855,0.000004803748,0.00049474195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967015,0.00018464781,0.000019076087,0.00004364337,0.000038312184,0.000044227785],"domain_scores_gemma":[0.9996722,0.00015290875,0.000077816825,0.00003835284,0.00002285392,0.000035849764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041626388,0.00018601157,0.0002000806,0.00029609623,0.000137792,0.00042776152,0.00011330016,0.00027779434,0.0012748337],"category_scores_gemma":[0.00087340595,0.00017029064,0.0004204658,0.00026826435,0.00038408936,0.000291981,0.0001227071,0.00037522067,0.00020128263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050630458,0.00036176282,0.06349014,0.0001973917,0.00047330046,0.00059835403,0.00027285967,0.0016056396,0.851152,0.00085083983,0.00031417026,0.030053064],"study_design_scores_gemma":[0.0007860169,0.012321462,0.41208252,0.000033724053,0.00036329945,0.0014833766,0.00021889867,0.0057119937,0.5623752,0.00037239026,0.004203927,0.00004715074],"about_ca_topic_score_codex":0.0058848164,"about_ca_topic_score_gemma":0.004346113,"teacher_disagreement_score":0.0058848164,"about_ca_system_score_codex":0.0004864944,"about_ca_system_score_gemma":0.00023591483,"threshold_uncertainty_score":0.011701167},"labels":[],"label_agreement":null},{"id":"W2114902018","doi":"10.3109/00498251003713958","title":"Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism","year":2010,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP2B6; CYP2A6; Nicotine; Phenobarbital; Genotype; Cytochrome P450; Metabolism; Pharmacology; Drug metabolism; Biology; Endocrinology; Chemistry; Internal medicine; Biochemistry; Medicine; CYP3A4; Gene","score_opus":0.027312478202408817,"score_gpt":0.32761411909839233,"score_spread":0.3003016408959835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114902018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906515,0.0044994145,0.0024086353,0.000167989,0.000014005753,0.000011129989,0.0005681041,0.000048406764,0.0016308004],"genre_scores_gemma":[0.99676514,0.0009821377,0.0005327199,0.000032841333,0.000014868851,0.000007794768,0.00043697527,0.00002233344,0.0012052295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99962497,0.0001102479,0.000022611639,0.00012038106,0.00009133459,0.000030434165],"domain_scores_gemma":[0.99957854,0.00007111527,0.00017573303,0.00006202718,0.00005676452,0.000055865978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027911324,0.00023917276,0.00035658068,0.00037362412,0.00018182628,0.00033445552,0.000096792646,0.00020102428,0.0018804863],"category_scores_gemma":[0.0007731318,0.00015786994,0.00024339362,0.00047554937,0.00025197834,0.00013455916,0.0001252442,0.00023255819,0.00061697955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002097814,0.00010813584,0.40541023,0.0001498351,0.00020570502,0.0005547821,0.000103352446,0.00022674202,0.5544519,0.00023958943,0.00033244665,0.036119454],"study_design_scores_gemma":[0.000018914925,0.00022945163,0.95526075,0.000011439489,0.00006965228,0.0024123972,0.00004166448,0.00036108965,0.03912761,0.00018046159,0.0022801273,0.0000064682868],"about_ca_topic_score_codex":0.0012600938,"about_ca_topic_score_gemma":0.0009426465,"teacher_disagreement_score":0.0018804863,"about_ca_system_score_codex":0.0001856802,"about_ca_system_score_gemma":0.00015814613,"threshold_uncertainty_score":0.0062909126},"labels":[],"label_agreement":null},{"id":"W2115350199","doi":"10.1098/rstb.2005.1688","title":"Pharmacogenetics in drug development","year":2005,"lang":"en","type":"review","venue":"Philosophical Transactions of the Royal Society B Biological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Drug development; Scope (computer science); Disease; Drug; Identification (biology); Drug discovery; Risk analysis (engineering); Biology; Computational biology; Medicine; Bioinformatics; Pharmacology; Computer science; Genetics; Gene; Genotype","score_opus":0.3328739654459081,"score_gpt":0.4796032639946208,"score_spread":0.1467292985487127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115350199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023389974,0.98043823,0.0029480145,0.003094615,0.0005914089,0.000022222943,0.00003084985,0.00004904858,0.012591709],"genre_scores_gemma":[0.0045648697,0.98567355,0.0022751275,0.0019988269,0.00086972385,0.000039353323,0.00004721246,0.000013160308,0.004518174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985227,0.00055043376,0.000120466175,0.00020060557,0.0005284885,0.00007730435],"domain_scores_gemma":[0.99810165,0.0012204336,0.00019158823,0.00014234614,0.00024057101,0.00010340635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026418502,0.0012255266,0.0020497786,0.002684771,0.00046749559,0.0023123182,0.0017041456,0.002762501,0.008002934],"category_scores_gemma":[0.0031179166,0.00048243176,0.0005582176,0.0034560338,0.0027778668,0.0025181763,0.0015431885,0.0033396357,0.006982881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005808186,0.00009546956,0.00038608979,0.004663123,0.00008374491,0.00039627487,0.00012346303,0.0012229838,0.0009516014,0.056035604,0.035251226,0.9007323],"study_design_scores_gemma":[0.000026087588,0.000066028006,0.0004251367,0.0016469036,0.000028189253,0.0012963478,0.000047870708,0.0002144414,0.0004837925,0.029499244,0.96624625,0.000019699643],"about_ca_topic_score_codex":0.0012082389,"about_ca_topic_score_gemma":0.001387125,"teacher_disagreement_score":0.008002934,"about_ca_system_score_codex":0.0017843269,"about_ca_system_score_gemma":0.0020984635,"threshold_uncertainty_score":0.0267725},"labels":[],"label_agreement":null},{"id":"W2116184147","doi":"10.1002/rcm.2996","title":"MS <sup>E</sup> with mass defect filtering for <i>in vitro</i> and <i>in vivo</i> metabolite identification","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Chemistry; Metabolite; Mass spectrometry; In vivo; Chromatography; Mass; Identification (biology); In vitro; Mass spectrum; Biochemistry","score_opus":0.059966717949458376,"score_gpt":0.3859389317189198,"score_spread":0.3259722137694614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116184147","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24571812,0.005817532,0.67095107,0.003068435,0.0015236768,0.0017111752,0.019618465,0.016637754,0.034953773],"genre_scores_gemma":[0.38717026,0.004813325,0.5449715,0.0038776202,0.00064812665,0.0018419055,0.025329433,0.0029435728,0.028404174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999368,0.00011468117,0.00008684281,0.00011714051,0.00025364102,0.00005975721],"domain_scores_gemma":[0.99820924,0.00060039456,0.00031592743,0.00029517038,0.00051952386,0.000059760376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011321342,0.0011918298,0.00060727494,0.0011860953,0.000548679,0.00060220255,0.0014856184,0.0009873473,0.016870692],"category_scores_gemma":[0.002537465,0.00036705588,0.00044544318,0.0010674202,0.00050618267,0.0012172555,0.00046243297,0.00078949454,0.008834173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000992589,0.00012061763,0.0016497264,0.0004223694,0.00005329154,0.0006946111,0.000053960106,0.00040837508,0.9168864,0.0012048398,0.01163258,0.065880574],"study_design_scores_gemma":[0.00005378275,0.00046773974,0.0034582533,0.000030322237,0.00004355572,0.0029347169,0.000045867637,0.0050239996,0.95726204,0.0005208177,0.0301189,0.000039967148],"about_ca_topic_score_codex":0.0007143666,"about_ca_topic_score_gemma":0.0012177426,"teacher_disagreement_score":0.016870692,"about_ca_system_score_codex":0.00026800536,"about_ca_system_score_gemma":0.000690347,"threshold_uncertainty_score":0.056438148},"labels":[],"label_agreement":null},{"id":"W2116375554","doi":"10.3945/ajcn.112.038794","title":"Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Nutrition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Caffeine; Single-nucleotide polymorphism; CYP1A2; Genotype; Medicine; Internal medicine; Haplotype; Case-control study; Genetics; Endocrinology; Biology; Gene; Cytochrome P450","score_opus":0.23914029559819971,"score_gpt":0.512913269000075,"score_spread":0.27377297340187523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116375554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988279,0.0003393189,0.000098613615,0.000050242797,0.000007714239,0.0000043826703,0.0001904429,0.0000069876355,0.00047433248],"genre_scores_gemma":[0.99908936,0.000095619755,0.00010963224,0.000022728733,0.000015607873,0.000005908722,0.00011388442,0.0000041210874,0.0005431011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997521,0.00009214864,0.000021372722,0.000066514425,0.000031311716,0.00003660721],"domain_scores_gemma":[0.9985092,0.0005642558,0.0005461439,0.00009599619,0.000092644616,0.00019171693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003575941,0.00026623128,0.00032238304,0.00043839883,0.0002562377,0.00032817258,0.0002350083,0.00043296916,0.0029261487],"category_scores_gemma":[0.0012411423,0.00033960308,0.0004706593,0.00058179215,0.00023583545,0.00020342077,0.00019356555,0.0005031883,0.00017913384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00123064,0.00012118518,0.9918629,0.000023964172,0.0004472906,0.0001501926,0.00007109735,0.000098552264,0.0039472184,0.000054799842,0.00009489129,0.0018972812],"study_design_scores_gemma":[0.00001083373,0.000082731196,0.99928313,0.000001627503,0.000076962686,0.00013920825,0.000019816971,0.00017139621,0.000110976434,0.000024412233,0.000076458266,0.0000024929866],"about_ca_topic_score_codex":0.0050015487,"about_ca_topic_score_gemma":0.0056738616,"teacher_disagreement_score":0.0050015487,"about_ca_system_score_codex":0.0001698298,"about_ca_system_score_gemma":0.00013415406,"threshold_uncertainty_score":0.009944856},"labels":[],"label_agreement":null},{"id":"W2116758239","doi":"10.1124/dmd.113.052993","title":"Downregulation of Mouse Hepatic CYP3A Protein by 3-Methylcholanthrene Does Not Require Cytochrome P450-Dependent Metabolism","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP3A; Cytochrome P450; Methylcholanthrene; Metabolism; Drug metabolism; Cytochrome; Downregulation and upregulation; Biology; Chemistry; Biochemistry; Enzyme; Carcinogen; Gene","score_opus":0.0236520422539231,"score_gpt":0.3334170269440819,"score_spread":0.3097649846901588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116758239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982864,0.0017885766,0.009775197,0.00040266584,0.000116911804,0.00009408509,0.0021530334,0.0005997098,0.002205728],"genre_scores_gemma":[0.983017,0.0007273912,0.00410797,0.00010430235,0.00002292836,0.000111833186,0.0028834871,0.0002306463,0.008794315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994733,0.000074607764,0.00005606386,0.00011211655,0.00015425938,0.00012956302],"domain_scores_gemma":[0.9991615,0.00016387923,0.00025409117,0.0002071578,0.00007159606,0.00014187733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035640108,0.0006060324,0.00046813212,0.0009451633,0.0004118271,0.00067703094,0.0004789611,0.0006541447,0.0023152626],"category_scores_gemma":[0.00034783027,0.0005412901,0.0011293489,0.0004902376,0.0006780583,0.00046721264,0.0002973988,0.0013706321,0.0012517972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022632258,0.000032354146,0.0002332075,0.000016443606,0.0000081778035,0.000056713696,0.000011240269,0.00003532988,0.9987379,0.00014314103,0.00003808812,0.00046105098],"study_design_scores_gemma":[0.000016534976,0.00012681453,0.0028957739,0.0000036266313,0.000016512882,0.00018530124,0.000016713524,0.00030925407,0.9951558,0.00005172325,0.0012176877,0.0000043035043],"about_ca_topic_score_codex":0.002333035,"about_ca_topic_score_gemma":0.0051531144,"teacher_disagreement_score":0.002333035,"about_ca_system_score_codex":0.0007809079,"about_ca_system_score_gemma":0.00051528163,"threshold_uncertainty_score":0.007745266},"labels":[],"label_agreement":null},{"id":"W2117192628","doi":"10.1124/dmd.112.050641","title":"Decreased CYP3A Expression and Activity in Guinea Pig Models of Diet-Induced Metabolic Syndrome: Is Fatty Liver Infiltration Involved?","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Endocrinology; Internal medicine; CYP3A; Biology; Fatty acid; Triglyceride; Long chain fatty acid; Fatty liver; Metabolic syndrome; Diabetes mellitus; Biochemistry; Cholesterol; Metabolism; Cytochrome P450; Medicine","score_opus":0.056554426562006724,"score_gpt":0.3395355759340074,"score_spread":0.2829811493720007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117192628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932238,0.0025710901,0.002233623,0.0007115773,0.0001110094,0.000032072767,0.00020460559,0.000060472295,0.0008516765],"genre_scores_gemma":[0.9944003,0.0022916682,0.0011944387,0.00025793316,0.000034011886,0.000056550383,0.00026258884,0.000020084091,0.0014824186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998361,0.000046322173,0.000015693613,0.00002956823,0.00003519753,0.000037059395],"domain_scores_gemma":[0.99978393,0.000033918615,0.00007927349,0.00003676077,0.000019059236,0.000047067853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035563047,0.0004863182,0.0005086297,0.00055137207,0.00017467204,0.00032680103,0.0002587911,0.000648921,0.0016704759],"category_scores_gemma":[0.0002571324,0.00028304933,0.0004314141,0.00028406095,0.0007517615,0.00047914172,0.00020665959,0.0011024248,0.00027426975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004733157,0.00022271555,0.004481686,0.00014122638,0.000051672632,0.0008221993,0.000048205544,0.00006516005,0.98376286,0.00038627558,0.0001031903,0.005181529],"study_design_scores_gemma":[0.0005455539,0.008353684,0.115371004,0.00008857616,0.0005001231,0.0046126763,0.00053909287,0.0012736396,0.863723,0.0007596352,0.004192782,0.000040249397],"about_ca_topic_score_codex":0.00050062925,"about_ca_topic_score_gemma":0.0010453974,"teacher_disagreement_score":0.0016704759,"about_ca_system_score_codex":0.00031530642,"about_ca_system_score_gemma":0.00025266013,"threshold_uncertainty_score":0.005588293},"labels":[],"label_agreement":null},{"id":"W2117195973","doi":"10.1124/dmd.104.002360","title":"EFFECT OF EARLY PHASE ADJUVANT ARTHRITIS ON HEPATIC P450 ENZYMES AND PHARMACOKINETICS OF VERAPAMIL: AN ALTERNATIVE APPROACH TO THE USE OF AN ANIMAL MODEL OF INFLAMMATION FOR PHARMACOKINETIC STUDIES","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Pharmacology; Verapamil; Arthritis; Medicine; Internal medicine","score_opus":0.10021319095670733,"score_gpt":0.42011554140362795,"score_spread":0.3199023504469206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117195973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961067,0.00092017493,0.0014796063,0.00021697104,0.00016864187,0.00006635841,0.00030226816,0.00008042588,0.00065889594],"genre_scores_gemma":[0.99360645,0.0007158353,0.0017525586,0.000096389806,0.000104588245,0.000099768156,0.00037852916,0.000035105983,0.003210701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994344,0.00016506667,0.000047350248,0.0000702935,0.00008945117,0.0001934605],"domain_scores_gemma":[0.99854326,0.00057721615,0.00025093125,0.00025879743,0.000094938776,0.00027477683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006118413,0.00081926276,0.0010458889,0.0005474764,0.00026313745,0.0007889313,0.00044951722,0.00076580554,0.0017963423],"category_scores_gemma":[0.0010713445,0.0003746213,0.00056631217,0.00047687755,0.0010515247,0.0010696877,0.00022364891,0.0028606972,0.0003919799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056974284,0.003745614,0.0006955645,0.00008307349,0.000049983257,0.00021724681,0.000103732986,0.00060861063,0.92765653,0.000298568,0.00017567062,0.009391133],"study_design_scores_gemma":[0.0012565276,0.04129788,0.0031958632,0.000009436556,0.00012955553,0.00015071934,0.000061183164,0.0022242228,0.950499,0.00019972134,0.0009421908,0.000033853674],"about_ca_topic_score_codex":0.0014052598,"about_ca_topic_score_gemma":0.002947366,"teacher_disagreement_score":0.0017963423,"about_ca_system_score_codex":0.0006145592,"about_ca_system_score_gemma":0.00086054386,"threshold_uncertainty_score":0.0060093403},"labels":[],"label_agreement":null},{"id":"W2117518921","doi":"10.1016/s0009-9236(03)90707-7","title":"Teaching pharmacokinetic logic through example: Application of modeling to observations from three perplexing overdoses","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacokinetics; Computer science; Intensive care medicine; Medicine; Pharmacology","score_opus":0.47775503349477993,"score_gpt":0.5345246530623515,"score_spread":0.056769619567571594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117518921","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12689698,0.00034193005,0.85720706,0.0017746078,0.000091267815,0.00018706985,0.00046275023,0.003639986,0.009398379],"genre_scores_gemma":[0.55265033,0.00045415462,0.44199955,0.00025599083,0.00004136862,0.00022757778,0.0003208945,0.00027287542,0.0037772425],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9995383,0.00023214771,0.000029981196,0.00008965614,0.00007903724,0.000030949483],"domain_scores_gemma":[0.98949045,0.009645328,0.00018211351,0.00021728124,0.00036452673,0.00010039478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001189255,0.0011891106,0.00054689514,0.0003084945,0.00045451347,0.001043054,0.0013289213,0.0015395215,0.0059915567],"category_scores_gemma":[0.010417454,0.00040063495,0.00062147813,0.00031235337,0.00041443782,0.0008827779,0.0010399678,0.001661745,0.0007074569],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082934275,0.0004600163,0.006323086,0.00045653436,0.0000854509,0.0009126652,0.0017719493,0.6902928,0.0055589536,0.018086432,0.0076501723,0.26757267],"study_design_scores_gemma":[0.000060193695,0.00008664908,0.00043246645,0.000031632,0.000020439638,0.00012555292,0.000098292985,0.97542405,0.0029077209,0.017611999,0.0031803662,0.000020744337],"about_ca_topic_score_codex":0.0076859305,"about_ca_topic_score_gemma":0.009067232,"teacher_disagreement_score":0.0076859305,"about_ca_system_score_codex":0.0008479624,"about_ca_system_score_gemma":0.00082043116,"threshold_uncertainty_score":0.02004373},"labels":[],"label_agreement":null},{"id":"W2117646661","doi":"10.1007/978-3-319-10527-7_4","title":"Pharmacokinetic Drug Interactions Affecting Antimalarials","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Medicine","score_opus":0.11544430794998965,"score_gpt":0.43667013711570335,"score_spread":0.3212258291657137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117646661","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027452465,0.4781998,0.04777988,0.006200217,0.005199524,0.00010231866,0.00053786294,0.00075634086,0.4584787],"genre_scores_gemma":[0.014608922,0.30132577,0.02315939,0.004075097,0.004354863,0.00011715037,0.00047101823,0.00026358457,0.65162426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997247,0.00005850715,0.000011419624,0.00002779634,0.00016399757,0.000013590476],"domain_scores_gemma":[0.9997787,0.00014329226,0.00001553726,0.000012815312,0.000041178533,0.000008482012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034038536,0.00083638035,0.00057213445,0.00092133565,0.00021221452,0.00093342667,0.00050996325,0.0008428981,0.020216115],"category_scores_gemma":[0.0007837602,0.00024860504,0.00032977617,0.00091288367,0.00033973766,0.001056405,0.00072834117,0.0013742377,0.013084731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032492004,0.000049970226,0.000125956,0.0006609448,0.00001836364,0.00026016257,0.00007104633,0.0010130475,0.00395183,0.022053441,0.12367076,0.84809196],"study_design_scores_gemma":[0.0000057220736,0.000049824805,0.0003510081,0.0002995347,0.000017601811,0.0017302005,0.000020055733,0.0006650692,0.002257479,0.018549982,0.97604275,0.000010837958],"about_ca_topic_score_codex":0.00048032057,"about_ca_topic_score_gemma":0.0013202627,"teacher_disagreement_score":0.020216115,"about_ca_system_score_codex":0.00048770255,"about_ca_system_score_gemma":0.00036206038,"threshold_uncertainty_score":0.067629635},"labels":[],"label_agreement":null},{"id":"W2117908683","doi":"10.1016/j.aquatox.2004.04.010","title":"Characterization and profiling of hepatic cytochromes P450 and phase II xenobiotic-metabolizing enzymes in beluga whales (Delphinapterus leucas) from the St. Lawrence River Estuary and the Canadian Arctic","year":2004,"lang":"en","type":"article","venue":"Aquatic Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fisheries and Oceans Canada; Université de Montréal; University of Windsor","funders":"","keywords":"Beluga Whale; Beluga; CYP3A; Biology; Xenobiotic; Population; Leucas; Estuary; Drug metabolism; Isozyme; Cytochrome P450; Zoology; Enzyme; Biochemistry; Ecology; Fishery; Arctic; Medicine","score_opus":0.054725380970346495,"score_gpt":0.3540452174297862,"score_spread":0.29931983645943966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117908683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987888,0.00021899282,0.0001697474,0.000020582922,0.000001529484,0.000005674361,0.00038704826,0.000002866522,0.00040481618],"genre_scores_gemma":[0.99705243,0.00023000415,0.0003292763,0.00003191217,0.0000027072022,0.000007804967,0.0010817399,0.0000038637427,0.0012602065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998739,0.000010131114,0.0000059962276,0.000036407982,0.00003442275,0.00003920531],"domain_scores_gemma":[0.9998055,0.000015394166,0.000029397697,0.000008775397,0.000101039135,0.00003981854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103024184,0.00018783145,0.00018043116,0.00092713756,0.0006466213,0.0003870951,0.00016783828,0.00019469224,0.00033221924],"category_scores_gemma":[0.00022202205,0.00013275782,0.0001240316,0.0005575486,0.00034281728,0.00010341386,0.00017396462,0.00019560437,0.00011522099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041290733,0.000065575776,0.6339793,0.00005703503,0.00008611786,0.0004975507,0.001713905,0.0002927735,0.35080153,0.00016481268,0.00021394125,0.011714465],"study_design_scores_gemma":[0.0000024651802,0.000056060704,0.9944636,0.000002491904,0.000015884016,0.00021187215,0.0005156259,0.00009672095,0.0038723578,0.000016173622,0.0007430723,0.0000036940376],"about_ca_topic_score_codex":0.35056835,"about_ca_topic_score_gemma":0.57054496,"teacher_disagreement_score":0.64943165,"about_ca_system_score_codex":0.0007279325,"about_ca_system_score_gemma":0.0007934206,"threshold_uncertainty_score":0.69705564},"labels":[],"label_agreement":null},{"id":"W2118407518","doi":"10.1016/j.bmcl.2008.09.018","title":"Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: An analog of formestane","year":2008,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Aromatase; In vitro; Cell culture; Cancer; Breast cancer; Cancer cell lines; Chemical synthesis; Stereochemistry; Cancer research; Pharmacology; Biochemistry; Cancer cell; Internal medicine; Biology; Medicine; Genetics","score_opus":0.1496066646559138,"score_gpt":0.40126308749235623,"score_spread":0.2516564228364424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118407518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647534,0.008876047,0.010503779,0.00043845747,0.0003002208,0.0004584925,0.0014318472,0.00015060102,0.013087307],"genre_scores_gemma":[0.9748526,0.004235109,0.0075320383,0.00014118564,0.000036758684,0.000073933494,0.000966152,0.000016699594,0.012145553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991703,0.000014314346,0.000009746541,0.000018085453,0.000018715204,0.000022061051],"domain_scores_gemma":[0.9999243,0.0000057998486,0.000013078416,0.000008351679,0.000014038133,0.000034364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015456884,0.0003405915,0.00023144156,0.00029826284,0.00021201652,0.00022650218,0.00033636,0.00024520647,0.0026855601],"category_scores_gemma":[0.000108683635,0.00012684318,0.00021853816,0.00018891359,0.00018914863,0.00023577968,0.00020172223,0.0003478979,0.0005861111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006177884,0.00030622538,0.00031024398,0.00018602546,0.000026780039,0.0006164022,0.00006576373,0.0010030707,0.97800326,0.0006548708,0.0002773913,0.017932171],"study_design_scores_gemma":[0.00020085025,0.0038302755,0.0015192198,0.000013695354,0.00006528841,0.0009685396,0.00004954193,0.00067479035,0.9685883,0.0001278951,0.023942536,0.000019170391],"about_ca_topic_score_codex":0.0007538573,"about_ca_topic_score_gemma":0.00186727,"teacher_disagreement_score":0.0026855601,"about_ca_system_score_codex":0.00028834955,"about_ca_system_score_gemma":0.00048865064,"threshold_uncertainty_score":0.008984029},"labels":[],"label_agreement":null},{"id":"W2118451906","doi":"10.3109/09540261.2013.838944","title":"Towards the implementation of<i>CYP2D6</i>and<i>CYP2C19</i>genotypes in clinical practice: Update and report from a pharmacogenetic service clinic","year":2013,"lang":"en","type":"review","venue":"International Review of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacogenetics; Medicine; Pharmacogenomics; Pharmacology; Genotype; Drug; Antidepressant; Internal medicine; Psychiatry; Gene; Genetics; Biology; Cytochrome P450","score_opus":0.15492359490016452,"score_gpt":0.5745530816189005,"score_spread":0.419629486718736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118451906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01393039,0.8106667,0.007888093,0.14226684,0.0031967547,0.00028439952,0.0012895218,0.0005441068,0.019933103],"genre_scores_gemma":[0.08114965,0.85471797,0.024137164,0.030388229,0.004113166,0.00040022912,0.002195989,0.0001832856,0.0027143753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98697126,0.005695549,0.0026392976,0.0011781345,0.003034438,0.00048138207],"domain_scores_gemma":[0.8907118,0.042261567,0.018525708,0.0033589613,0.040642932,0.00449894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021049686,0.0005383993,0.0013380419,0.003867017,0.0005292123,0.0036459262,0.0020061056,0.002679836,0.004462466],"category_scores_gemma":[0.054688152,0.00045033812,0.00091304426,0.0062134047,0.0009398422,0.005058357,0.0019377614,0.003973151,0.002992015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014448812,0.00015454844,0.03261675,0.008715697,0.0001099043,0.00042050265,0.00075254263,0.00025284174,0.00067571714,0.0020971072,0.06362093,0.89043903],"study_design_scores_gemma":[0.00017779291,0.0006610532,0.13623166,0.042516265,0.00070988864,0.005456074,0.0027219898,0.00084416365,0.0015197721,0.004157866,0.80484444,0.00015907688],"about_ca_topic_score_codex":0.008948178,"about_ca_topic_score_gemma":0.010194143,"teacher_disagreement_score":0.021049686,"about_ca_system_score_codex":0.0023754134,"about_ca_system_score_gemma":0.008820726,"threshold_uncertainty_score":0.11132276},"labels":[],"label_agreement":null},{"id":"W2119325428","doi":"10.1158/1078-0432.ccr-05-0252","title":"Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pregnane X receptor; Pharmacology; Paclitaxel; Nuclear receptor; Transcription factor; Biology; In vivo; Chemistry; Cell biology; Biochemistry; Cancer; Gene","score_opus":0.4170434883543968,"score_gpt":0.5987963018884374,"score_spread":0.18175281353404055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119325428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286216,0.0033429312,0.0016171797,0.00008655289,0.000020382455,0.000051266463,0.00015328551,0.00003970677,0.001826555],"genre_scores_gemma":[0.99335724,0.002109501,0.0016963748,0.000039999064,0.000014545815,0.00004387085,0.000316487,0.0000063534326,0.0024156426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998264,0.000055799628,0.000018270199,0.000025028881,0.000046466845,0.000028073073],"domain_scores_gemma":[0.9999063,0.000027517932,0.000032531556,0.000012068067,0.000010254476,0.000011281292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014092219,0.00026774104,0.0001908188,0.00015557179,0.000112570226,0.00018390342,0.00012373214,0.00013220437,0.0019605742],"category_scores_gemma":[0.00013279845,0.00007428789,0.00030959232,0.0001168226,0.00017035886,0.00013669598,0.000097762655,0.00021955234,0.00038656924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014875962,0.000028712819,0.0002976519,0.00004961376,0.000006239513,0.000057425008,0.000009482472,0.00003799755,0.99754566,0.000060208215,0.00002267953,0.0017356212],"study_design_scores_gemma":[0.000021100166,0.00054086605,0.0032488084,0.000004146433,0.000012648194,0.00025374867,0.000015890177,0.00022381157,0.99393976,0.000016326667,0.0017203316,0.000002553601],"about_ca_topic_score_codex":0.00038991688,"about_ca_topic_score_gemma":0.00072411913,"teacher_disagreement_score":0.0019605742,"about_ca_system_score_codex":0.00027471333,"about_ca_system_score_gemma":0.00019603437,"threshold_uncertainty_score":0.006558776},"labels":[],"label_agreement":null},{"id":"W2119702644","doi":"10.1093/toxsci/71.1.11","title":"Real-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver","year":2003,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia","keywords":"CYP1A2; CYP1B1; Cytochrome P450; Messenger RNA; Molecular biology; Gene expression; Real-time polymerase chain reaction; Polymerase chain reaction; Enzyme; Chemistry; Biology; Gene; Biochemistry","score_opus":0.1331305506460059,"score_gpt":0.4395979303279824,"score_spread":0.30646737968197646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119702644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64445424,0.012432718,0.3228605,0.00077715405,0.0008239506,0.0029725388,0.008058247,0.0014933072,0.0061273845],"genre_scores_gemma":[0.4365156,0.0061308085,0.5084217,0.0010627937,0.00042756373,0.0148406895,0.01624678,0.0005724731,0.015781563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958073,0.0011744748,0.0003243661,0.0014282593,0.00095479266,0.0003108796],"domain_scores_gemma":[0.9986656,0.00059846713,0.00016976775,0.00015265954,0.00034891834,0.00006465084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018423243,0.0012348297,0.0012888919,0.0012521597,0.0004920489,0.0010190756,0.00081106403,0.0008658065,0.002786752],"category_scores_gemma":[0.001908591,0.00081421883,0.0007844211,0.0014636548,0.00107336,0.0004180841,0.00045103303,0.0017270156,0.0020139655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080984156,0.00023153167,0.0013169858,0.00027098577,0.000051285384,0.000097734504,0.00032337778,0.00042617816,0.9892554,0.00026257604,0.0002350948,0.006719072],"study_design_scores_gemma":[0.00056175375,0.004123704,0.018862821,0.00016002287,0.00029353073,0.00077802903,0.00024640874,0.015963122,0.93389684,0.00070572825,0.024283318,0.00012468347],"about_ca_topic_score_codex":0.00047566585,"about_ca_topic_score_gemma":0.0009236329,"teacher_disagreement_score":0.002786752,"about_ca_system_score_codex":0.0005733824,"about_ca_system_score_gemma":0.0007128739,"threshold_uncertainty_score":0.009743214},"labels":[],"label_agreement":null},{"id":"W2119942000","doi":"10.1093/toxsci/kfp255","title":"Effects of Cytochrome P450 Inhibitors on the Biotransformation of Fluorogenic Substrates by Adult Male Rat Liver Microsomes and cDNA-Expressed Rat Cytochrome P450 Isoforms","year":2009,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Microsome; Biotransformation; Cytochrome P450; Biochemistry; Chemistry; Coumarin; CYP2E1; Trifluoromethyl; Microsoma; Chlorzoxazone; Complementary DNA; Isozyme; Gene isoform; Cytochrome; Pharmacology; Enzyme; Biology; Gene","score_opus":0.04330124482707328,"score_gpt":0.3466815848649864,"score_spread":0.30338034003791314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119942000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247193,0.002522509,0.003722165,0.000074734795,0.000025897134,0.00004036041,0.0004003239,0.00008452482,0.0006575659],"genre_scores_gemma":[0.98716986,0.0034235464,0.0055533564,0.00005776678,0.00002876202,0.00008288958,0.0017607864,0.000046093264,0.0018770386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995759,0.0001314692,0.000047480138,0.00008172612,0.00008879429,0.00007467217],"domain_scores_gemma":[0.9995554,0.00015595606,0.00012650006,0.000044823857,0.00006757417,0.00004967912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004897878,0.0007407629,0.00042924305,0.0003345244,0.00015394314,0.00027510646,0.00016240033,0.00023727327,0.0007894457],"category_scores_gemma":[0.0004182814,0.0001880273,0.0003795517,0.00030729626,0.00019418649,0.00020019207,0.000119709715,0.0005094944,0.00029675447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003659789,0.00006486722,0.00063308433,0.000033656077,0.000017229526,0.000042427117,0.000017958297,0.0001119203,0.9967167,0.000022367607,0.000026409249,0.0019473785],"study_design_scores_gemma":[0.000008309565,0.0007377891,0.0020094684,0.0000022773004,0.000037915215,0.00007363029,0.000008751216,0.00025935043,0.99645543,0.0000050862095,0.0003992545,0.0000028119057],"about_ca_topic_score_codex":0.0010891686,"about_ca_topic_score_gemma":0.0017889983,"teacher_disagreement_score":0.0010891686,"about_ca_system_score_codex":0.00026755958,"about_ca_system_score_gemma":0.0002787699,"threshold_uncertainty_score":0.002640903},"labels":[],"label_agreement":null},{"id":"W2120604922","doi":"10.1002/rcm.3758","title":"Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies","year":2008,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Chemistry; Drug; Human plasma; Biotransformation; Pharmacology; Tandem mass spectrometry; Metabolite; Liquid chromatography–mass spectrometry; Chromatography; Drug development; Mass spectrometry; Computational biology; Biochemical engineering; Biochemistry; Medicine","score_opus":0.4448887988026948,"score_gpt":0.5502199302394477,"score_spread":0.10533113143675293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120604922","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31282443,0.024070902,0.6468518,0.0013414823,0.00053457584,0.0011503489,0.0013128974,0.003282502,0.008631058],"genre_scores_gemma":[0.63004166,0.005871905,0.35709277,0.0013582208,0.00037260243,0.00059919135,0.00078702,0.00026827335,0.003608345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99530447,0.0021239202,0.00024827794,0.0006068168,0.0015449085,0.00017160043],"domain_scores_gemma":[0.99244267,0.00399704,0.0011890681,0.0008376685,0.0013041871,0.0002293026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011308683,0.00079765596,0.0009948835,0.0030288082,0.00056230085,0.0014432336,0.0007229087,0.001669979,0.001458784],"category_scores_gemma":[0.012508321,0.00042393955,0.0003449701,0.0018700502,0.0009878366,0.0011823322,0.00044652921,0.0010667762,0.00074824004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005623676,0.00059577666,0.053790662,0.00072242867,0.00021752728,0.0004975589,0.00044343114,0.0023653035,0.49679682,0.0036079811,0.0029157754,0.43242303],"study_design_scores_gemma":[0.00027485087,0.007959437,0.15871337,0.00017156643,0.0005591589,0.005651513,0.0003102646,0.039632823,0.7442851,0.008594794,0.033555914,0.0002911757],"about_ca_topic_score_codex":0.0010852907,"about_ca_topic_score_gemma":0.0014634841,"teacher_disagreement_score":0.011308683,"about_ca_system_score_codex":0.0005173849,"about_ca_system_score_gemma":0.00090147334,"threshold_uncertainty_score":0.059806764},"labels":[],"label_agreement":null},{"id":"W2121373591","doi":"10.1074/jbc.m506683200","title":"Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institute of General Medical Sciences; U.S. Public Health Service","keywords":"Hormone; Locus (genetics); Glucuronosyltransferase; Biology; Cell biology; Endocrinology; Gene; Enzyme; Genetics; Biochemistry; Microsome","score_opus":0.0946326092039207,"score_gpt":0.3832520420772717,"score_spread":0.288619432873351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121373591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802991,0.0070702424,0.0078125205,0.00017543363,0.000062994775,0.00006927793,0.0013740801,0.00033282756,0.002803372],"genre_scores_gemma":[0.98899883,0.0022073532,0.0032495428,0.000066448396,0.000021838712,0.000049964143,0.0016486141,0.000039390932,0.0037179915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998349,0.000031093532,0.000009105244,0.000065910375,0.000030637086,0.000028380025],"domain_scores_gemma":[0.99991107,0.000009915311,0.000036898713,0.000011884811,0.000010545024,0.00001965193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007285343,0.00031170098,0.00014111864,0.00026069,0.00011109415,0.0002478399,0.00013958481,0.00015228563,0.00094182417],"category_scores_gemma":[0.0001202621,0.0001281798,0.00020139283,0.00015572437,0.0002119575,0.00008609148,0.00017762756,0.00027174546,0.00034096738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006529888,0.000009684351,0.0006118604,0.000021262269,0.0000043458103,0.0000650252,0.0000134892,0.000053026084,0.9963731,0.00011785912,0.000059004098,0.002605846],"study_design_scores_gemma":[0.000032416054,0.00025460802,0.0258732,0.000009133223,0.000028219907,0.0008426998,0.00003318921,0.000592793,0.963979,0.00009687841,0.008248183,0.000009614938],"about_ca_topic_score_codex":0.0010295195,"about_ca_topic_score_gemma":0.0013485285,"teacher_disagreement_score":0.0010295195,"about_ca_system_score_codex":0.0003177141,"about_ca_system_score_gemma":0.00019609774,"threshold_uncertainty_score":0.0031507015},"labels":[],"label_agreement":null},{"id":"W2121420708","doi":"10.2217/pgs.11.120","title":"Validation of Warfarin Pharmacogenetic Algorithms in Clinical Practice","year":2011,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; VKORC1; Pharmacogenetics; Dosing; Algorithm; Medicine; CYP2C9; Internal medicine; Mathematics; Atrial fibrillation; Biology; Genotype","score_opus":0.3181945789941228,"score_gpt":0.5113060201547232,"score_spread":0.19311144116060036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121420708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.834966,0.0020570562,0.15006958,0.0025554488,0.00023978736,0.001237348,0.0010690856,0.0012468921,0.0065587903],"genre_scores_gemma":[0.9284417,0.0003039578,0.069203384,0.0005070494,0.00006719879,0.00022777675,0.0010206456,0.000048347916,0.00018004575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9438504,0.03965785,0.0041203694,0.0048818914,0.006994768,0.0004948479],"domain_scores_gemma":[0.83995694,0.12132781,0.01330892,0.009074528,0.015291981,0.0010397449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06516635,0.000978895,0.00086182525,0.0020408467,0.00050329405,0.0032966973,0.0017215909,0.0019239235,0.0012535726],"category_scores_gemma":[0.25609618,0.00041725632,0.0005910018,0.0012798432,0.0012917744,0.0018059965,0.0012592294,0.0013385129,0.0008646745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016161362,0.0006786221,0.757238,0.0002973566,0.00095512316,0.00013633688,0.00048010377,0.05861749,0.0013391528,0.0015456624,0.0023427906,0.17475323],"study_design_scores_gemma":[0.0013270433,0.003069824,0.319598,0.0006045706,0.00064077013,0.0015392281,0.00045835716,0.64755255,0.008655368,0.0077609494,0.008654762,0.00013857902],"about_ca_topic_score_codex":0.001996532,"about_ca_topic_score_gemma":0.0012101906,"teacher_disagreement_score":0.06516635,"about_ca_system_score_codex":0.0014342606,"about_ca_system_score_gemma":0.0027347135,"threshold_uncertainty_score":0.34463668},"labels":[],"label_agreement":null},{"id":"W2121452631","doi":"10.1016/s0090-9556(24)15195-1","title":"Role of Reactive Oxygen Intermediates in the Decrease of Hepatic Cytochrome P450 Activity by Serum of Humans and Rabbits with an Acute Inflammatory Reaction","year":2000,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemistry; Lipid peroxidation; Cytochrome P450; Internal medicine; CYP1A2; Endocrinology; Sodium nitroprusside; Reactive oxygen species; Metabolism; Biochemistry; Enzyme; Nitric oxide; Medicine","score_opus":0.01302800869540698,"score_gpt":0.31663505271234377,"score_spread":0.3036070440169368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121452631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489236,0.0019786144,0.0017030414,0.00014266347,0.000043166776,0.00003245216,0.00006403517,0.00003381949,0.0011098132],"genre_scores_gemma":[0.99869126,0.00043334707,0.00039188773,0.000047304886,0.000023887347,0.000013716656,0.0000714307,0.0000053877366,0.00032172262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966264,0.00015005695,0.000035167337,0.000051494684,0.000046402423,0.00005427022],"domain_scores_gemma":[0.99925286,0.00015671324,0.00024376702,0.00014733645,0.000066751214,0.00013258996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084562885,0.0006395153,0.00049289106,0.0006620412,0.00035313074,0.000512497,0.00019010274,0.0006881223,0.0008017924],"category_scores_gemma":[0.0011909158,0.0003396696,0.0004007327,0.00024231344,0.001007787,0.00039533147,0.00021510545,0.0007343503,0.00029539305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057737995,0.0010707125,0.04792462,0.00029923912,0.00023567167,0.0028300106,0.0010059717,0.0002961627,0.86523587,0.0017262435,0.000309619,0.021327829],"study_design_scores_gemma":[0.0006768526,0.018073253,0.1449691,0.000032702636,0.00051593315,0.0056404383,0.00056013546,0.003254221,0.82245487,0.0010732056,0.0027061545,0.00004314443],"about_ca_topic_score_codex":0.0006046878,"about_ca_topic_score_gemma":0.00033745798,"teacher_disagreement_score":0.00084562885,"about_ca_system_score_codex":0.00025666485,"about_ca_system_score_gemma":0.00024704603,"threshold_uncertainty_score":0.0044721365},"labels":[],"label_agreement":null},{"id":"W2121512476","doi":"10.1080/0049825021000012637","title":"Comparison of rat and human cytochrome P450 (CYP) sources of<i>N</i>-alkylprotoporphyrin IX. Formation after interaction with porphyrinogenic xenobiotics: studies with cDNA-expressed single CYP enzymes","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; CYP1A2; Cytochrome P450; Enzyme; Biochemistry; Complementary DNA; Microsome; Chemistry; CYP2B6; Cytochrome; Biology; Gene","score_opus":0.14730390052528133,"score_gpt":0.4175698082173464,"score_spread":0.27026590769206504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121512476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98953515,0.0025571252,0.0059516574,0.000079668025,0.00001924098,0.000026467833,0.00061828067,0.0000723383,0.0011400899],"genre_scores_gemma":[0.984452,0.0020753883,0.0073987693,0.00005977765,0.000024633062,0.00004872832,0.003033667,0.000034107605,0.0028728414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977356,0.000058197704,0.000017177354,0.00006249921,0.000060199964,0.00002845053],"domain_scores_gemma":[0.9996687,0.00010507213,0.000073235926,0.000039413968,0.000073576164,0.000039936567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029310808,0.0002962414,0.00028239327,0.00033110625,0.00013846545,0.00025645862,0.00010084105,0.00021137444,0.0009307607],"category_scores_gemma":[0.00039424267,0.0001397453,0.0003175224,0.0002799154,0.00017657671,0.00017406468,0.00012101361,0.00026859678,0.0003739435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003771725,0.000023665421,0.0015298257,0.00005435761,0.000028605053,0.000079232304,0.000036419635,0.00008285147,0.9944606,0.000074643554,0.000036550395,0.0032160792],"study_design_scores_gemma":[0.000012265126,0.00044899154,0.019232662,0.0000039296847,0.0000623903,0.0006220624,0.000034056186,0.00048059065,0.9773193,0.000039665334,0.0017383776,0.0000057192833],"about_ca_topic_score_codex":0.0007972973,"about_ca_topic_score_gemma":0.0007763781,"teacher_disagreement_score":0.0009307607,"about_ca_system_score_codex":0.00017714956,"about_ca_system_score_gemma":0.00014653144,"threshold_uncertainty_score":0.003113687},"labels":[],"label_agreement":null},{"id":"W2122150294","doi":"10.18433/j3sk5v","title":"Effects of Some Antihypertensive Drugs on the Metabolism and Pharmacokinetics of Indapamide in Rats","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Indapamide; Pharmacology; Felodipine; Pharmacokinetics; Diuretic; Chemistry; Bioavailability; Valsartan; Medicine; Endocrinology; Blood pressure","score_opus":0.10997384818204722,"score_gpt":0.44305333763054855,"score_spread":0.3330794894485013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122150294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931098,0.0023967358,0.0018189552,0.00026212356,0.000144556,0.000057158206,0.0005423392,0.00017524586,0.0014931456],"genre_scores_gemma":[0.98413485,0.003285717,0.0031573127,0.00021910491,0.00008331137,0.00013416537,0.0009711342,0.000045982284,0.00796844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975497,0.000034303146,0.000019199115,0.000060813843,0.0000563187,0.000074387775],"domain_scores_gemma":[0.99966836,0.00004192861,0.00009607702,0.000042561853,0.00004681603,0.000104251834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025094263,0.00087533926,0.00061810075,0.0005993067,0.00030974436,0.00025818803,0.0002775942,0.00040635996,0.002365505],"category_scores_gemma":[0.0002559032,0.00042637208,0.00075237965,0.00028016503,0.00039595924,0.00055063603,0.00017629356,0.0016233611,0.000563381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008687842,0.0029402,0.0017202082,0.0001387519,0.00007794804,0.00026736176,0.00008434457,0.0002661158,0.9748434,0.00013065586,0.00037474628,0.010468415],"study_design_scores_gemma":[0.00045162404,0.016760806,0.016185429,0.00001810475,0.00024228949,0.00041500584,0.00012782085,0.0025690992,0.95946103,0.00012552564,0.0036041273,0.00003918036],"about_ca_topic_score_codex":0.0014982339,"about_ca_topic_score_gemma":0.0018889983,"teacher_disagreement_score":0.002365505,"about_ca_system_score_codex":0.0004312599,"about_ca_system_score_gemma":0.0004987229,"threshold_uncertainty_score":0.007913411},"labels":[],"label_agreement":null},{"id":"W2122202379","doi":"10.1124/dmd.107.017590","title":"Evaluation of the Assumptions of an Ontogeny Model of Rat Hepatic Cytochrome P450 Activity","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Ontogeny; Cytochrome P450; Biology; Internal medicine; Endocrinology; Metabolism; Medicine","score_opus":0.10695472508486922,"score_gpt":0.42814206227395,"score_spread":0.32118733718908077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122202379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74963886,0.0012849292,0.2097711,0.0014101807,0.00015934942,0.00016241948,0.0010136514,0.0001781952,0.03638137],"genre_scores_gemma":[0.95851696,0.00073679927,0.031870797,0.0001575151,0.00003055743,0.0001547969,0.00044822326,0.000060146274,0.008024243],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996598,0.0001272872,0.000015832366,0.00009589239,0.00006409271,0.00003709526],"domain_scores_gemma":[0.9978441,0.0012575043,0.0002858496,0.00025555986,0.00026267933,0.000094388946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011927992,0.0004331479,0.00022415206,0.00065616396,0.0003703605,0.00058928016,0.00054440676,0.00033684826,0.0033159005],"category_scores_gemma":[0.0025813486,0.00016625313,0.00036319724,0.0002918157,0.00076729164,0.00088217086,0.00057775463,0.0007221097,0.00043788445],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003942144,0.00063458126,0.0689464,0.00044054486,0.00022272328,0.0014673518,0.0010942664,0.03785989,0.24384513,0.4738649,0.0014483795,0.16623366],"study_design_scores_gemma":[0.0002978104,0.0063022263,0.18203679,0.00021191756,0.00058310473,0.003767833,0.0012116267,0.23174363,0.25565132,0.2591467,0.05887405,0.0001730478],"about_ca_topic_score_codex":0.0020161432,"about_ca_topic_score_gemma":0.0019429816,"teacher_disagreement_score":0.0033159005,"about_ca_system_score_codex":0.0009021934,"about_ca_system_score_gemma":0.0009920667,"threshold_uncertainty_score":0.011092782},"labels":[],"label_agreement":null},{"id":"W2122267147","doi":"","title":"A sensitive and specific high performance liquid chromatographic assay for milrinone in rat and human plasma using a commercially available internal standard and low sample volume.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Milrinone; Chromatography; High-performance liquid chromatography; Chemistry; Diethyl ether; Pharmacokinetics; Amrinone; Inotrope; Pharmacology","score_opus":0.0744692657228286,"score_gpt":0.33623586417489354,"score_spread":0.26176659845206496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267147","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32810658,0.02760583,0.6251569,0.00099248,0.0007311713,0.0019441287,0.001961104,0.005512343,0.00798944],"genre_scores_gemma":[0.5684343,0.007498038,0.4011841,0.0011644135,0.00045882803,0.0033351511,0.0040084687,0.00014361244,0.013773055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977718,0.00069450395,0.00014347796,0.00044965948,0.0008545001,0.00008607746],"domain_scores_gemma":[0.9990094,0.0002034716,0.0002946071,0.00014506596,0.00023662821,0.00011074804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016969709,0.0014052163,0.0005475915,0.001053039,0.0003437444,0.00060547004,0.0009966989,0.001356493,0.0021270511],"category_scores_gemma":[0.0020686532,0.0004531898,0.00043443273,0.00048529552,0.00069490686,0.0006691352,0.00055041985,0.0013048198,0.0019427339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031571178,0.00018028147,0.0010225887,0.00020199253,0.000034247892,0.00009527422,0.000037476704,0.00014470698,0.9736483,0.0002043418,0.0003099927,0.023805091],"study_design_scores_gemma":[0.00019965497,0.0030543262,0.013897892,0.00011100429,0.00015769416,0.003850385,0.000044720844,0.0031688898,0.9630904,0.0003040974,0.01206335,0.00005762222],"about_ca_topic_score_codex":0.00028731718,"about_ca_topic_score_gemma":0.0008230531,"teacher_disagreement_score":0.0021270511,"about_ca_system_score_codex":0.00043031544,"about_ca_system_score_gemma":0.0010918223,"threshold_uncertainty_score":0.008974552},"labels":[],"label_agreement":null},{"id":"W2122267374","doi":"10.1158/1078-0432.ccr-06-1592","title":"Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Ketoconazole; Pharmacology; Paclitaxel; CYP3A4; Pregnenolone; Transcription factor; Chemistry; In vivo; Biology; Drug metabolism; Nuclear receptor; Cytochrome P450; Drug; Gene; Biochemistry; Cancer; Metabolism; Steroid; Genetics; Antifungal; Hormone","score_opus":0.5732678557880453,"score_gpt":0.6682249783394519,"score_spread":0.09495712255140665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617259,0.02758297,0.0043938817,0.0008719608,0.0000892503,0.000050281156,0.00032114773,0.00014240737,0.004822218],"genre_scores_gemma":[0.9915455,0.0048493836,0.00088396703,0.0001353143,0.000028107046,0.000019319496,0.00030620839,0.000010190878,0.002221934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983776,0.00002876661,0.000013337766,0.000024846659,0.00006625725,0.000029041154],"domain_scores_gemma":[0.9998671,0.000025462985,0.000054581455,0.000016714901,0.000017383467,0.000018723107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015883798,0.0002373312,0.00023168178,0.000111561996,0.0001428053,0.00035060034,0.00019867574,0.0001959895,0.0019116156],"category_scores_gemma":[0.00019075896,0.000078158126,0.00022698406,0.00018465475,0.00025787854,0.00012756928,0.000119245684,0.0003948518,0.00045171328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045053771,0.000041177434,0.0022481924,0.00013448551,0.000015508893,0.00036045283,0.00002064935,0.00021167692,0.982819,0.00038285606,0.00028307733,0.013032528],"study_design_scores_gemma":[0.00010527278,0.0013279001,0.020876778,0.000027947206,0.000092462644,0.004338922,0.00007427924,0.0013949324,0.95055187,0.00031136104,0.020885564,0.000012640356],"about_ca_topic_score_codex":0.0006465033,"about_ca_topic_score_gemma":0.0009419515,"teacher_disagreement_score":0.0019116156,"about_ca_system_score_codex":0.00038933245,"about_ca_system_score_gemma":0.00031520185,"threshold_uncertainty_score":0.0063949823},"labels":[],"label_agreement":null},{"id":"W2123959629","doi":"","title":"Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; CYP3A4; Pharmacodynamics; Pharmacokinetics; Drug; Medicine; Drug interaction; Adverse effect; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.0629832689451676,"score_gpt":0.35311565368548065,"score_spread":0.29013238474031305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123959629","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2517048,0.70323926,0.008632452,0.0076097986,0.00095189584,0.00019958931,0.000567669,0.00020404378,0.026890382],"genre_scores_gemma":[0.7965719,0.18134217,0.0055802786,0.0035236103,0.0014004068,0.00010023353,0.00036056654,0.000033731285,0.011087088],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990689,0.0004268138,0.000071349445,0.00006697957,0.00033525925,0.000030673436],"domain_scores_gemma":[0.99853265,0.0007099524,0.00040625996,0.000065205306,0.00020170929,0.00008414149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094743166,0.00037893528,0.000854357,0.0005842861,0.00034717002,0.0005552581,0.00028202735,0.0012026145,0.0030852142],"category_scores_gemma":[0.0021224369,0.00014512852,0.00061289535,0.00042130428,0.00022081535,0.00031977805,0.00039772424,0.00048819327,0.00061622343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019389957,0.00032449624,0.078036495,0.0065485192,0.0012958854,0.015267845,0.00032465288,0.0007203257,0.07168903,0.0022962026,0.011323807,0.8102337],"study_design_scores_gemma":[0.000416979,0.011837485,0.33494923,0.0019130711,0.0025112361,0.16799061,0.00051088457,0.0024321936,0.080659606,0.005495793,0.39115673,0.00012627992],"about_ca_topic_score_codex":0.0005680069,"about_ca_topic_score_gemma":0.0011672204,"teacher_disagreement_score":0.0030852142,"about_ca_system_score_codex":0.00029566325,"about_ca_system_score_gemma":0.0004075296,"threshold_uncertainty_score":0.010321081},"labels":[],"label_agreement":null},{"id":"W2124163794","doi":"10.1080/03602530701468391","title":"Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Purdue Pharma (Canada)","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Recombinant DNA; Guinea pig; Reductase; Biochemistry; Enzyme; Fusion protein; Chemistry; Biology; Gene; Endocrinology","score_opus":0.15221926203931693,"score_gpt":0.45903517028110863,"score_spread":0.3068159082417917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124163794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943024,0.0020012818,0.0021506103,0.00009575891,0.000023008453,0.00001817156,0.00043544295,0.00002614108,0.00094721565],"genre_scores_gemma":[0.9838807,0.0022947325,0.004418124,0.00011804742,0.000030470388,0.000036333902,0.006958269,0.000035825455,0.0022274551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979454,0.0000458694,0.000016052014,0.00004122445,0.000048953894,0.00005332175],"domain_scores_gemma":[0.99968815,0.00008540011,0.00007390664,0.000027319993,0.00004782409,0.00007753553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003325342,0.00045158388,0.0002736241,0.00045271293,0.00011249071,0.0002895112,0.00014849132,0.0003050539,0.00065017113],"category_scores_gemma":[0.00036045496,0.00017846978,0.00052980817,0.00031936524,0.00020903292,0.00019485864,0.00013809808,0.0003731375,0.00044074468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020030417,0.000019880366,0.0011330827,0.000038622326,0.000020894657,0.00007111447,0.00002347122,0.00005518497,0.9969522,0.000040287185,0.00002558129,0.001419378],"study_design_scores_gemma":[0.000052392556,0.0008080619,0.03856638,0.00001687549,0.00010486714,0.0011809048,0.000073288415,0.0013207147,0.9530869,0.000051932857,0.004727995,0.0000096725535],"about_ca_topic_score_codex":0.0009979274,"about_ca_topic_score_gemma":0.00080552767,"teacher_disagreement_score":0.0009979274,"about_ca_system_score_codex":0.00027527937,"about_ca_system_score_gemma":0.00017487418,"threshold_uncertainty_score":0.002175033},"labels":[],"label_agreement":null},{"id":"W2124210169","doi":"10.1354/vp.43-6-1044","title":"Book Review: Human Drug Metabolism. An Introduction","year":2006,"lang":"en","type":"article","venue":"Veterinary Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Drug metabolism; Drug; Computational biology; Biology; Pharmacology","score_opus":0.07479515352443616,"score_gpt":0.42793590552809724,"score_spread":0.3531407520036611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124210169","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005692875,0.71720886,0.0029773396,0.021026451,0.12734658,0.0001609355,0.00066099747,0.00055334327,0.12949623],"genre_scores_gemma":[0.003693208,0.47001103,0.00435324,0.031072509,0.0886349,0.00020155369,0.0008609044,0.00027587413,0.40089676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970204,0.000044110406,0.000023939472,0.00005428695,0.00015291024,0.000022711809],"domain_scores_gemma":[0.9984143,0.000768595,0.00010054879,0.000056589768,0.00040925565,0.00025067115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047343192,0.0017559862,0.0018835927,0.00386325,0.00062542595,0.0017554383,0.0012557601,0.0019762688,0.08341062],"category_scores_gemma":[0.0019833492,0.0005990572,0.0010735808,0.0022117947,0.00071501435,0.0024751436,0.0011953954,0.0038655372,0.06442101],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054202592,0.000061800616,0.00006556938,0.00063671207,0.000015598827,0.00018064257,0.000017022405,0.00015487323,0.0005506648,0.0012406051,0.88741875,0.109603524],"study_design_scores_gemma":[0.000016640946,0.000039184422,0.00022698617,0.00036729668,0.000011268819,0.0009718068,0.000011212337,0.000057012938,0.00006939939,0.0019783336,0.9962418,0.0000092438595],"about_ca_topic_score_codex":0.0010605787,"about_ca_topic_score_gemma":0.0029288672,"teacher_disagreement_score":0.08341062,"about_ca_system_score_codex":0.00073316717,"about_ca_system_score_gemma":0.0008353012,"threshold_uncertainty_score":0.27903634},"labels":[],"label_agreement":null},{"id":"W2124448589","doi":"10.1016/s0140-6736(06)69255-6","title":"Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother","year":2006,"lang":"en","type":"article","venue":"The Lancet","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Office of the Chief Medical Examiner; Hospital for Sick Children","funders":"","keywords":"Codeine; Medicine; Morphine; Lethargy; Breastfeeding; Anesthesia; Pediatrics; Internal medicine","score_opus":0.09465134951513061,"score_gpt":0.40540054162882444,"score_spread":0.31074919211369384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124448589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980122,0.00019827369,0.00020417113,0.00057883,0.00002884825,0.000012308198,0.00008958646,0.000009258556,0.00086661003],"genre_scores_gemma":[0.99874604,0.00023751665,0.00027598304,0.00025248216,0.000029091892,0.000004064409,0.00004521919,0.0000095598425,0.00040005287],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995974,0.00008783839,0.00005690147,0.00007921971,0.00009909361,0.000079524776],"domain_scores_gemma":[0.99886787,0.00050625484,0.00024175561,0.000060445414,0.00010944594,0.0002142637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030439877,0.00041081387,0.00070191856,0.0010020345,0.0009991042,0.00059772946,0.00055085676,0.0015036844,0.0012720077],"category_scores_gemma":[0.0033984932,0.0004380297,0.00048489298,0.00056312117,0.000604277,0.00027361547,0.00051047467,0.0012245174,0.0002094547],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010570653,0.0002125872,0.52664644,0.000052677893,0.00009127045,0.45359597,0.002270777,0.0002949877,0.008680733,0.0003150891,0.00051017985,0.006272205],"study_design_scores_gemma":[0.000036403155,0.002138867,0.5745435,0.00007791539,0.00023991577,0.4107335,0.0043086745,0.0023610997,0.0041818516,0.00032812776,0.0009951718,0.0000549449],"about_ca_topic_score_codex":0.011913989,"about_ca_topic_score_gemma":0.007976358,"teacher_disagreement_score":0.011913989,"about_ca_system_score_codex":0.0008396087,"about_ca_system_score_gemma":0.00058307144,"threshold_uncertainty_score":0.02368927},"labels":[],"label_agreement":null},{"id":"W2124808968","doi":"10.1016/j.critrevonc.2006.09.006","title":"Pharmacogenetics of paclitaxel metabolism","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paclitaxel; Pharmacogenetics; Medicine; Pharmacology; Chemotherapy; Drug metabolism; Drug; Oncology; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3217679777041367,"score_gpt":0.5847237841736879,"score_spread":0.2629558064695512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124808968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083698216,0.9942715,0.0013684022,0.0006939531,0.0002845745,0.000009539475,0.00005119066,0.0000335212,0.0024503586],"genre_scores_gemma":[0.0067591416,0.98857236,0.0012739158,0.00055341213,0.0006570738,0.000019352414,0.00011874932,0.0000059549143,0.0020399455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998036,0.000062064166,0.000023944485,0.00003328087,0.00006423087,0.000012834369],"domain_scores_gemma":[0.99975795,0.00013307766,0.00004482627,0.000011918719,0.000040602114,0.000011549925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004249016,0.0007196643,0.001136366,0.0010656391,0.000119754586,0.00071613997,0.00044924478,0.0005649514,0.0021560828],"category_scores_gemma":[0.00060175505,0.0002066925,0.0004050601,0.0010313075,0.00022907778,0.00039918153,0.00029953066,0.0008164541,0.0010964302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014675522,0.00007276407,0.0009597753,0.0023454966,0.00012648679,0.000607633,0.000014424395,0.00053797837,0.0046927603,0.0021756978,0.019186998,0.96913314],"study_design_scores_gemma":[0.00011803339,0.00036253198,0.007326187,0.002084183,0.0006078446,0.009270279,0.00004090999,0.0008072551,0.010496355,0.0065249563,0.96231747,0.000044029704],"about_ca_topic_score_codex":0.0006379329,"about_ca_topic_score_gemma":0.0011368878,"teacher_disagreement_score":0.0021560828,"about_ca_system_score_codex":0.00041183532,"about_ca_system_score_gemma":0.0006980517,"threshold_uncertainty_score":0.0072128177},"labels":[],"label_agreement":null},{"id":"W2124959655","doi":"10.1124/jpet.104.068171","title":"Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung","year":2004,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"CYP2E1; Pharmacology; Lung; Chemistry; Toxicology; Internal medicine; Medicine; Biology; Biochemistry; Cytochrome P450; Metabolism","score_opus":0.0539391404406168,"score_gpt":0.4344174515844249,"score_spread":0.3804783111438081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124959655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896115,0.0027209693,0.0045955656,0.00014382195,0.000033999986,0.00005627896,0.0009528101,0.000077507655,0.0018075615],"genre_scores_gemma":[0.9919904,0.0012135644,0.0017222848,0.00004198857,0.00001195066,0.00005924958,0.0010903596,0.000024706062,0.0038454744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996001,0.00013558977,0.00002113123,0.00006961502,0.00008772411,0.00008584789],"domain_scores_gemma":[0.99979526,0.00007348049,0.00003497502,0.00004261197,0.000024999288,0.000028684355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044303114,0.0003688872,0.00027720834,0.000571013,0.00027146167,0.00027916304,0.0002797121,0.00044234665,0.0010921791],"category_scores_gemma":[0.00026661306,0.00029493013,0.0004751821,0.00036652983,0.0003338668,0.00030092662,0.00017610421,0.0004676614,0.00026225808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036388074,0.00003265687,0.00045177824,0.00002779093,0.000011943193,0.000055700166,0.000027163082,0.00038077153,0.99732864,0.00014529613,0.00006415185,0.0011102546],"study_design_scores_gemma":[0.000010081865,0.00029950181,0.0018789726,0.0000028083155,0.000009867939,0.00013124393,0.00002357904,0.0005003581,0.9964824,0.000034388042,0.0006221994,0.0000045440356],"about_ca_topic_score_codex":0.003360259,"about_ca_topic_score_gemma":0.004509052,"teacher_disagreement_score":0.003360259,"about_ca_system_score_codex":0.0006076417,"about_ca_system_score_gemma":0.0003707987,"threshold_uncertainty_score":0.0066814423},"labels":[],"label_agreement":null},{"id":"W2125354536","doi":"10.1016/s0378-4274(01)00383-6","title":"Ovariectomy modulates the response of some cytochrome P450 isozymes to lindane in the rat","year":2001,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Consejo Nacional de Ciencia y Tecnología","keywords":"Ovariectomized rat; Internal medicine; Cytochrome P450; Endocrinology; Microsome; Isozyme; Chemistry; Corn oil; Western blot; Lindane; Metabolism; Biology; Enzyme; Estrogen; Biochemistry; Medicine","score_opus":0.07791151777792191,"score_gpt":0.40749237052369364,"score_spread":0.32958085274577176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125354536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985752,0.00046677215,0.00019149148,0.00011184298,0.000017400556,0.000005693663,0.0002956401,0.000028239177,0.00030776],"genre_scores_gemma":[0.9930233,0.0010194978,0.00035998318,0.00011543694,0.00002693519,0.000025042893,0.0007468577,0.00003511678,0.004647701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984276,0.000018843366,0.000008320852,0.000033555938,0.000031566025,0.00006482466],"domain_scores_gemma":[0.9995122,0.00010197311,0.00013566748,0.00006966866,0.000044644832,0.00013572093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013638235,0.0004495969,0.000447231,0.0007766408,0.00028278984,0.00047502204,0.00018804666,0.0004172959,0.0022730324],"category_scores_gemma":[0.00046243804,0.0004936264,0.00035153193,0.00030314302,0.00074200775,0.00045783276,0.00021498038,0.0009290565,0.0004360288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01365865,0.00035303168,0.0052117337,0.000040084804,0.000041872085,0.00015102794,0.00010974687,0.00009811075,0.9753582,0.00009491761,0.00012671713,0.0047559896],"study_design_scores_gemma":[0.0002733182,0.005068421,0.124490224,0.000014935459,0.00021882103,0.00028365766,0.00041951158,0.00059152517,0.8665645,0.0003040977,0.0017153843,0.000055588684],"about_ca_topic_score_codex":0.0033069267,"about_ca_topic_score_gemma":0.006689745,"teacher_disagreement_score":0.0033069267,"about_ca_system_score_codex":0.0005283522,"about_ca_system_score_gemma":0.00038203652,"threshold_uncertainty_score":0.007604003},"labels":[],"label_agreement":null},{"id":"W2125711506","doi":"10.1124/dmd.112.048991","title":"NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology","year":2012,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Complementary and Integrative Health; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute of General Medical Sciences","keywords":"Cytochrome P450; Cytochrome P450 reductase; Biology; Gene isoform; Microsome; Heme; CYP1A2; Computational biology; Biochemistry; Cell biology; Pharmacology; In vitro; Gene; Metabolism; Cytochrome c; Enzyme; Mitochondrion; Coenzyme Q – cytochrome c reductase","score_opus":0.033210786715325645,"score_gpt":0.373365587240539,"score_spread":0.34015480052521335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125711506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3848276,0.506172,0.062168986,0.022231622,0.0007372565,0.00010589606,0.00091369374,0.00047319985,0.022369813],"genre_scores_gemma":[0.9172553,0.067381606,0.008562642,0.00052336615,0.0005173512,0.000020101397,0.00030425226,0.000016555976,0.005418832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998416,0.000058974892,0.000006863802,0.000033350603,0.00004142329,0.000017661347],"domain_scores_gemma":[0.99980086,0.000047779155,0.00003978689,0.000014412426,0.00005441849,0.00004271739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045043818,0.0002570672,0.0002881654,0.00031051782,0.00019813943,0.0006588506,0.00022661235,0.00039977883,0.0009984048],"category_scores_gemma":[0.0005478669,0.00008329452,0.000118254306,0.0003653409,0.0002588138,0.0003208227,0.00020384268,0.0006052263,0.00029184436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015502882,0.00040831935,0.04301838,0.0008035709,0.0002689348,0.0014990713,0.00019417107,0.0013286951,0.2111861,0.026492855,0.0084453905,0.70480424],"study_design_scores_gemma":[0.00037985574,0.0026900193,0.29707193,0.00034465455,0.00066683046,0.021931242,0.00064029027,0.010284064,0.28673968,0.051686585,0.32742608,0.00013883413],"about_ca_topic_score_codex":0.0017026002,"about_ca_topic_score_gemma":0.0016237414,"teacher_disagreement_score":0.0017026002,"about_ca_system_score_codex":0.00042092396,"about_ca_system_score_gemma":0.00053463376,"threshold_uncertainty_score":0.003385365},"labels":[],"label_agreement":null},{"id":"W2126104556","doi":"10.1258/cvd.2012.012001","title":"Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues","year":2012,"lang":"en","type":"review","venue":"JRSM Cardiovascular Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Medicine; Drug response; Drug; Precision medicine; Quality (philosophy); Intensive care medicine; Pharmacology; Psychology; Bioinformatics; Biology; Genotype; Genetics","score_opus":0.7690919594905862,"score_gpt":0.5755296491581999,"score_spread":0.19356231033238624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126104556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001695178,0.97966915,0.008422962,0.010006876,0.00094051356,0.00014040848,0.00007611936,0.000021282087,0.0005532686],"genre_scores_gemma":[0.0045700897,0.9480991,0.03463997,0.007856607,0.0032365369,0.0010743352,0.000116153315,0.000055923167,0.00035118908],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8980557,0.07648362,0.010123365,0.003137487,0.011624362,0.00057551236],"domain_scores_gemma":[0.60678923,0.3616624,0.007752522,0.006842784,0.015995637,0.00095746707],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20824577,0.0019723442,0.008940295,0.0053481236,0.000849626,0.0057333717,0.004901287,0.0048512737,0.0017679266],"category_scores_gemma":[0.2086098,0.001163076,0.003872469,0.0073480695,0.004682009,0.005957555,0.0026244447,0.0062728506,0.0010008167],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039309164,0.000074011616,0.002227345,0.04852472,0.0024761024,0.00024114011,0.00032284643,0.0011495942,0.00050611,0.023220344,0.016349174,0.9045154],"study_design_scores_gemma":[0.00059534545,0.0011223761,0.009295782,0.16885485,0.008993689,0.0026859618,0.0008601436,0.004545359,0.0015645898,0.1666375,0.63449496,0.00034948508],"about_ca_topic_score_codex":0.0035560592,"about_ca_topic_score_gemma":0.005096108,"teacher_disagreement_score":0.79175425,"about_ca_system_score_codex":0.0045856507,"about_ca_system_score_gemma":0.012362638,"threshold_uncertainty_score":0.9763739},"labels":[],"label_agreement":null},{"id":"W2126333303","doi":"10.1038/clpt.2012.184","title":"Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"VKORC1; Confidence interval; Coumarin; Meta-analysis; Internal medicine; Clinical pharmacology; Medicine; CYP2C9; Polymorphism (computer science); Allele; Pharmacology; Oncology; Biology; Genetics","score_opus":0.617369271961051,"score_gpt":0.6106917275112662,"score_spread":0.006677544449784745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126333303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021574185,0.99675024,0.00026463097,0.00014216371,0.000062589774,0.00012069731,0.00033791343,0.000010211412,0.00015413914],"genre_scores_gemma":[0.061190877,0.9357912,0.0012483546,0.000379317,0.00012160923,0.0004583015,0.00055115216,0.000011187328,0.00024800733],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954501,0.0019360868,0.0012829085,0.00049130083,0.00066028396,0.0001794202],"domain_scores_gemma":[0.98584855,0.0106601985,0.0019365918,0.00025860075,0.001152336,0.00014364447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009032188,0.0022937187,0.01449276,0.006740037,0.0004661788,0.0023278897,0.0017569319,0.0017443058,0.003162249],"category_scores_gemma":[0.020508077,0.0010387276,0.019413788,0.008719624,0.00046645908,0.0011407019,0.001119558,0.001116705,0.00026175246],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015222848,0.000030536215,0.003929273,0.6553782,0.29835632,0.00028218998,0.00008556362,0.00063217175,0.00037702644,0.00018617373,0.0014064641,0.037813727],"study_design_scores_gemma":[0.0004726057,0.00022752391,0.0055331774,0.048116654,0.93994355,0.00028742824,0.000059305123,0.0002118189,0.0002606672,0.00023819004,0.0046228967,0.00002624816],"about_ca_topic_score_codex":0.005918482,"about_ca_topic_score_gemma":0.014008598,"teacher_disagreement_score":0.01449276,"about_ca_system_score_codex":0.0023693654,"about_ca_system_score_gemma":0.0038814775,"threshold_uncertainty_score":0.04776734},"labels":[],"label_agreement":null},{"id":"W2126347322","doi":"10.1093/toxsci/kfr240","title":"Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in Mice","year":2011,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cytochrome P450; Biology; Kidney; Gene expression; Gene isoform; Drug metabolism; Internal medicine; Gene; Endocrinology; Molecular biology; Genetics; Metabolism","score_opus":0.3241416573998902,"score_gpt":0.4554920667789627,"score_spread":0.1313504093790725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126347322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850523,0.0016138745,0.0069150142,0.00014617949,0.0000434109,0.000087772416,0.0034419687,0.00027376105,0.0024256648],"genre_scores_gemma":[0.9661927,0.0024476957,0.012180998,0.00037942606,0.000051016643,0.0005563313,0.006014573,0.00038239028,0.011794856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99913484,0.000090540525,0.0000755328,0.00035828736,0.00018769971,0.00015313542],"domain_scores_gemma":[0.99950075,0.00006204774,0.0001777322,0.000054191405,0.00006145588,0.00014370328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043512403,0.0005213057,0.00047124785,0.0028281894,0.00035047365,0.0005675444,0.00030787895,0.00049021235,0.0023988727],"category_scores_gemma":[0.00028091422,0.00054651476,0.00058480876,0.00057154277,0.00048128053,0.00037476522,0.00034355128,0.00086640025,0.0009372543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004574692,0.0000824352,0.0023123515,0.000027671913,0.000013691237,0.00008560852,0.000055510674,0.00005123275,0.9935074,0.00010477927,0.00008108954,0.0032206709],"study_design_scores_gemma":[0.0001537286,0.0025124433,0.15592523,0.00005541571,0.00015023524,0.0021632377,0.00028908838,0.0014851624,0.8295585,0.00043274948,0.007215095,0.000059201393],"about_ca_topic_score_codex":0.00055032276,"about_ca_topic_score_gemma":0.0008197465,"teacher_disagreement_score":0.0028281894,"about_ca_system_score_codex":0.00038341293,"about_ca_system_score_gemma":0.00021354583,"threshold_uncertainty_score":0.00802505},"labels":[],"label_agreement":null},{"id":"W2126973461","doi":"10.1016/j.thromres.2015.05.006","title":"Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment","year":2015,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Pharmacogenetics; Warfarin; Randomized controlled trial; Medicine; Meta-analysis; VKORC1; Clinical trial; Intensive care medicine; CYP2C9; Pharmacology; Internal medicine; Genotype; Biology; Atrial fibrillation","score_opus":0.7663918700285941,"score_gpt":0.6275726054424634,"score_spread":0.1388192645861307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126973461","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010806045,0.008686132,0.00072244636,0.9622805,0.024858184,0.000055747296,0.0007860194,0.00010001571,0.0014303103],"genre_scores_gemma":[0.011558945,0.0017655685,0.0011358955,0.9444584,0.03982459,0.0001067897,0.00011835523,0.000038567567,0.0009928675],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9584285,0.024044702,0.0060263244,0.004504242,0.0059612473,0.0010349802],"domain_scores_gemma":[0.743127,0.22867043,0.0095425565,0.006082747,0.009943648,0.0026336703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053798504,0.0014348241,0.00418142,0.0014786018,0.001531458,0.0030803077,0.0044534677,0.030014899,0.005876816],"category_scores_gemma":[0.23822193,0.0011502473,0.006612953,0.0023568908,0.0034388164,0.0033195931,0.0018643147,0.025758095,0.0041317954],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002494321,0.000055689296,0.0044503007,0.002172924,0.0041717375,0.0012288144,0.00028349488,0.00047576646,0.000351628,0.003453217,0.957161,0.023701089],"study_design_scores_gemma":[0.021483986,0.0016236486,0.016265173,0.010389581,0.025311433,0.0050061475,0.00074941013,0.0058602276,0.0032955767,0.08299363,0.826191,0.000830094],"about_ca_topic_score_codex":0.0064084255,"about_ca_topic_score_gemma":0.007958316,"teacher_disagreement_score":0.053798504,"about_ca_system_score_codex":0.0041645686,"about_ca_system_score_gemma":0.0049268263,"threshold_uncertainty_score":0.2845171},"labels":[],"label_agreement":null},{"id":"W2127055978","doi":"10.1021/bp000047o","title":"Characterization of a Perfusion Reactor Utilizing Mammalian Cells on Microcarrier Beads","year":2000,"lang":"en","type":"article","venue":"Biotechnology Progress","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; National Aeronautics and Space Administration","keywords":"Microcarrier; Bioreactor; Physiologically based pharmacokinetic modelling; Chemistry; Cell culture; Bioprocess; Biophysics; Cell; Biochemistry; Biology; Pharmacokinetics; Pharmacology","score_opus":0.05107714386584852,"score_gpt":0.36572992009018107,"score_spread":0.3146527762243325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127055978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243036,0.0014898564,0.07160435,0.00016620794,0.000054327356,0.0002640851,0.0006224972,0.0003653056,0.0011297591],"genre_scores_gemma":[0.9207124,0.001385532,0.07410566,0.000121771736,0.000031238007,0.0003921812,0.00096960587,0.00007228931,0.0022093302],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995036,0.00009687038,0.00005202831,0.000101746686,0.00018664154,0.000059115864],"domain_scores_gemma":[0.99941075,0.00026770213,0.000118352444,0.000051185674,0.0001053681,0.0000466934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007855686,0.0004080754,0.00044967045,0.00022207711,0.0002022914,0.00053579354,0.00049904815,0.0004792447,0.00047186922],"category_scores_gemma":[0.00093463477,0.00013979196,0.0004360637,0.0002324715,0.0002517334,0.00023258457,0.00018858696,0.00040930457,0.00035464286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005591319,0.0000148717345,0.00037546988,0.00004182875,0.000003771728,0.000036403715,0.000024140267,0.00054801337,0.9973131,0.00006392329,0.000016657332,0.0015059256],"study_design_scores_gemma":[0.000005610097,0.00029267045,0.0024815924,0.000006289833,0.00001729433,0.00007558773,0.0000199655,0.0027145883,0.9931854,0.000017827899,0.0011751197,0.00000804106],"about_ca_topic_score_codex":0.0019333113,"about_ca_topic_score_gemma":0.001245202,"teacher_disagreement_score":0.0019333113,"about_ca_system_score_codex":0.00045395966,"about_ca_system_score_gemma":0.00057927566,"threshold_uncertainty_score":0.004154563},"labels":[],"label_agreement":null},{"id":"W2127594213","doi":"10.1038/sj.bjp.0706138","title":"Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450","year":2005,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic renal failure; Cytochrome P450; Internal medicine; Pharmacology; Endocrinology; Metabolism","score_opus":0.015185397953337228,"score_gpt":0.3263623993519701,"score_spread":0.31117700139863286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127594213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951952,0.0038170102,0.00027004853,0.00010749711,0.00006153525,0.0000127176645,0.00010542767,0.000025658803,0.00040473207],"genre_scores_gemma":[0.99750215,0.0011157481,0.00044028202,0.000085803025,0.000040576542,0.0000120804425,0.00035529363,0.0000047780377,0.00044344668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980825,0.00008290763,0.00001928838,0.000021593061,0.00003340899,0.000034536068],"domain_scores_gemma":[0.9997274,0.000090794536,0.000057103938,0.000024597226,0.000041765306,0.000058336045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026320395,0.00037828845,0.00048350048,0.0001974377,0.00015988006,0.00024720602,0.00007502244,0.00017670756,0.0009931386],"category_scores_gemma":[0.00043754748,0.000094572024,0.0003616173,0.00013971944,0.00023221674,0.00009168833,0.0002154326,0.00044737046,0.00019644284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016219743,0.00054841745,0.012633164,0.0003245364,0.00013771962,0.00058744435,0.00021978946,0.00017624574,0.94415146,0.00006944494,0.00036776686,0.024564296],"study_design_scores_gemma":[0.0006655112,0.027293557,0.18272291,0.000054126474,0.000340813,0.0022505568,0.0003227056,0.0009934498,0.7796146,0.00009831875,0.0056170076,0.000026400401],"about_ca_topic_score_codex":0.0005912579,"about_ca_topic_score_gemma":0.0010187858,"teacher_disagreement_score":0.0009931386,"about_ca_system_score_codex":0.00013664788,"about_ca_system_score_gemma":0.0002087489,"threshold_uncertainty_score":0.003322363},"labels":[],"label_agreement":null},{"id":"W2128181693","doi":"10.1080/15476910701680020","title":"Changes In Gene Expression Induced by Tienilic Acid and Sulfamethoxazole: Testing the Danger Hypothesis","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotoxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sulfamethoxazole; Medicine; Gene; Pharmacology; Biology; Internal medicine; Genetics; Antibiotics","score_opus":0.14361434635551243,"score_gpt":0.4046373724086695,"score_spread":0.2610230260531571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128181693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980521,0.00040038332,0.0006748512,0.00006033457,0.000022046423,0.000020839958,0.0003930498,0.000016321348,0.00036002704],"genre_scores_gemma":[0.99523735,0.00052162935,0.0014004222,0.00008562658,0.000019634457,0.00012155121,0.0006574736,0.000006362302,0.0019500231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979967,0.000036602145,0.000015646416,0.000043868364,0.000038187787,0.000066156616],"domain_scores_gemma":[0.9998343,0.000042991465,0.000048049715,0.000015339912,0.000019320347,0.00003997538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015634808,0.000265092,0.00030498815,0.0002885679,0.00013468831,0.0002076242,0.00011006575,0.00038301494,0.0012426138],"category_scores_gemma":[0.00017094123,0.00013295304,0.00036538357,0.00037484439,0.00034626765,0.00016657588,0.00012592271,0.00048561807,0.00019417371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009232516,0.0000702036,0.00097494345,0.00003180295,0.000009985657,0.000074988704,0.000036123725,0.00005726742,0.99691087,0.00002878247,0.00001806859,0.00086370634],"study_design_scores_gemma":[0.000057140882,0.0042935214,0.045877326,0.0000069108924,0.000059994996,0.0002307141,0.00017420828,0.001384612,0.94698894,0.000055499375,0.0008614454,0.00000979725],"about_ca_topic_score_codex":0.00062150566,"about_ca_topic_score_gemma":0.0009214283,"teacher_disagreement_score":0.0012426138,"about_ca_system_score_codex":0.0002722309,"about_ca_system_score_gemma":0.00016768808,"threshold_uncertainty_score":0.004156947},"labels":[],"label_agreement":null},{"id":"W2129122576","doi":"10.1016/j.thromres.2009.11.020","title":"A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism","year":2010,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"VKORC1; Warfarin; Medicine; Dosing; CYP2C9; Vitamin K epoxide reductase; Maintenance dose; Internal medicine; Pharmacogenomics; Cohort; Genotyping; Pharmacogenetics; Vitamin K antagonist; Venous thromboembolism; Thrombosis; Pharmacology; Atrial fibrillation; Biology; Genotype","score_opus":0.30597136883628495,"score_gpt":0.5106648445691896,"score_spread":0.20469347573290464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129122576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894615,0.00022678036,0.018511297,0.00050169043,0.00009284451,0.00007048139,0.0010039029,0.00018956777,0.00045726437],"genre_scores_gemma":[0.9884322,0.00016086825,0.007369446,0.00007105619,0.00005762334,0.000105287494,0.0018202513,0.00004599916,0.0019372714],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99898416,0.00064075575,0.00005349206,0.00017540826,0.00007211514,0.00007407708],"domain_scores_gemma":[0.99184483,0.006859724,0.00022107684,0.00033605265,0.00051538553,0.00022284307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004553325,0.0011126858,0.0009830175,0.0008984062,0.00053919584,0.0008116504,0.0015183403,0.0007751039,0.0027401627],"category_scores_gemma":[0.009133031,0.00062943605,0.0015679626,0.0006972791,0.0002345125,0.0003502459,0.00053990737,0.0018738545,0.0010096547],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007927235,0.0030895239,0.79036325,0.00010658465,0.004250833,0.00092679885,0.00042022028,0.104995936,0.0032841144,0.0010297656,0.007921515,0.07568416],"study_design_scores_gemma":[0.00075307785,0.0008969631,0.12164831,0.000034989273,0.0012233712,0.0006141685,0.00019854595,0.8721078,0.0007872644,0.0007245212,0.0009647549,0.000046254783],"about_ca_topic_score_codex":0.014185909,"about_ca_topic_score_gemma":0.0070153023,"teacher_disagreement_score":0.014185909,"about_ca_system_score_codex":0.0005372428,"about_ca_system_score_gemma":0.0014084453,"threshold_uncertainty_score":0.028206646},"labels":[],"label_agreement":null},{"id":"W2129209019","doi":"10.1681/asn.2009010082","title":"ESRD Impairs Nonrenal Clearance of Fexofenadine but not Midazolam","year":2009,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fexofenadine; Midazolam; Pharmacology; Medicine; Pharmacokinetics; Chemistry","score_opus":0.059332120989362185,"score_gpt":0.3967026514567031,"score_spread":0.3373705304673409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129209019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993093,0.00021369624,0.00022557825,0.000038000857,0.000006966199,0.000003450055,0.0000508938,0.000008847813,0.00014328262],"genre_scores_gemma":[0.99921083,0.00014314588,0.0001996281,0.000030571457,0.0000050507088,0.0000054839834,0.000057045265,0.000003563969,0.00034467783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99978584,0.00007778501,0.000022515384,0.000037383783,0.000044749268,0.00003178326],"domain_scores_gemma":[0.99969697,0.00007799082,0.000082063045,0.000036948695,0.000020791354,0.000085324085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023875535,0.00013540001,0.00040975318,0.00015587531,0.00012200206,0.0003254762,0.00011218937,0.0002200658,0.0011176185],"category_scores_gemma":[0.0005282603,0.00013300807,0.00021649945,0.00010585227,0.00025910267,0.00020644156,0.0001361099,0.00048261182,0.00012704449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059929234,0.0005500231,0.011304883,0.000051267692,0.000052761796,0.0002980361,0.000098164965,0.0001047362,0.9743274,0.00012539754,0.00013228097,0.006962213],"study_design_scores_gemma":[0.00044669575,0.009806551,0.37367317,0.00001858701,0.00019332567,0.002254926,0.00020851781,0.0033772467,0.6068511,0.0001590548,0.0029901105,0.00002076115],"about_ca_topic_score_codex":0.00074543984,"about_ca_topic_score_gemma":0.0010757021,"teacher_disagreement_score":0.0011176185,"about_ca_system_score_codex":0.00017151315,"about_ca_system_score_gemma":0.00019527192,"threshold_uncertainty_score":0.0037388206},"labels":[],"label_agreement":null},{"id":"W2129319352","doi":"10.18433/j3688m","title":"Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Metabolite; Pharmacokinetics; Pharmacology; Subfamily; Active metabolite; Medicine; Chemistry; Internal medicine; Biochemistry; Gene","score_opus":0.15110300434386886,"score_gpt":0.4599331404346859,"score_spread":0.30883013609081705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129319352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971379,0.0012553005,0.0009926816,0.00005757308,0.000014773079,0.000015170879,0.00019682867,0.00003889186,0.00029084232],"genre_scores_gemma":[0.9939219,0.0015036975,0.0014249414,0.00007322005,0.00003461531,0.00003878702,0.00062631594,0.000021359623,0.0023552706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998901,0.000022886035,0.0000062269787,0.000028320055,0.00002642868,0.000026080801],"domain_scores_gemma":[0.9998254,0.000019298885,0.00005352863,0.000026122474,0.00002030412,0.00005541341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016006906,0.00046135864,0.00039894888,0.00034568206,0.00021525563,0.0002594141,0.00014596219,0.00031365504,0.0014183864],"category_scores_gemma":[0.00019804858,0.00039410064,0.00037282478,0.00019469818,0.00028527415,0.0005391941,0.00008801021,0.0005722604,0.00027483096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027297422,0.0013234022,0.010572249,0.00015023294,0.00012688906,0.0002463647,0.00011240226,0.0005095413,0.9395235,0.0002748596,0.000244119,0.019619051],"study_design_scores_gemma":[0.00079325866,0.023316799,0.09140243,0.000020790958,0.00049223885,0.0010783812,0.00019016051,0.004464655,0.8737534,0.0001954929,0.00424211,0.000050235853],"about_ca_topic_score_codex":0.00082320103,"about_ca_topic_score_gemma":0.0010580915,"teacher_disagreement_score":0.0014183864,"about_ca_system_score_codex":0.00036992464,"about_ca_system_score_gemma":0.0003203435,"threshold_uncertainty_score":0.004744947},"labels":[],"label_agreement":null},{"id":"W2129470929","doi":"10.1186/1940-0640-9-20","title":"Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds","year":2014,"lang":"en","type":"review","venue":"Addiction Science & Clinical Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Addiction; Personalized medicine; Precision medicine; Medicine; Psychology; Risk analysis (engineering); Psychiatry; Bioinformatics; Biology; Genetics","score_opus":0.7441610175572767,"score_gpt":0.671339387385834,"score_spread":0.07282163017144272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129470929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017660926,0.9959478,0.0004694081,0.0022622203,0.00011806175,0.000011034122,0.000010445043,0.000006089066,0.0009984402],"genre_scores_gemma":[0.0021466233,0.99542075,0.0011119783,0.00082650105,0.00019894395,0.000019952317,0.00001570793,0.0000024314847,0.0002570821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987212,0.00058649125,0.00015619502,0.00011894948,0.0003612612,0.00005590607],"domain_scores_gemma":[0.99390113,0.0049238936,0.00031639377,0.000103749284,0.00064004003,0.00011481438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055595683,0.0005918051,0.001691994,0.002015579,0.0002491211,0.0015519644,0.0013130091,0.0018983975,0.0022466646],"category_scores_gemma":[0.006002998,0.0003053239,0.00095209375,0.0016623947,0.0011529147,0.0017071204,0.00093219266,0.0033763077,0.0007717954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057310062,0.0000658793,0.00026782503,0.011444585,0.00012262087,0.00010771513,0.00007950722,0.00044404302,0.00035013648,0.009358748,0.0066861473,0.9710154],"study_design_scores_gemma":[0.00010087571,0.00029653715,0.0030644245,0.026994763,0.0004997419,0.001885792,0.00029306728,0.0007941386,0.0007471683,0.026029391,0.93923455,0.000059554197],"about_ca_topic_score_codex":0.0013765523,"about_ca_topic_score_gemma":0.003288669,"teacher_disagreement_score":0.0055595683,"about_ca_system_score_codex":0.0011804102,"about_ca_system_score_gemma":0.0025072526,"threshold_uncertainty_score":0.029402137},"labels":[],"label_agreement":null},{"id":"W2129509075","doi":"10.1007/s00228-009-0741-5","title":"Ontogeny of midazolam glucuronidation in preterm infants","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University","funders":"","keywords":"Midazolam; Urine; Glucuronidation; Bolus (digestion); Medicine; Chemistry; Anesthesia; Endocrinology; Internal medicine; Microsome","score_opus":0.20983649816865482,"score_gpt":0.531550800048629,"score_spread":0.3217143018799742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129509075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993298,0.0030340524,0.0012120693,0.00007082618,0.000013361586,0.000022048762,0.00038632937,0.00003359567,0.0019296888],"genre_scores_gemma":[0.9927899,0.003642919,0.0011167756,0.0000370815,0.000012146728,0.000070033515,0.00042432387,0.000020820027,0.0018858713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997248,0.000063355685,0.000019287063,0.00007757758,0.00008443716,0.000030415182],"domain_scores_gemma":[0.9990515,0.0001651177,0.00041398156,0.000050069677,0.00018268988,0.0001366229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943071,0.00026592892,0.0003601182,0.000879106,0.00031237895,0.00064308004,0.00028707954,0.00046505613,0.0017815604],"category_scores_gemma":[0.0014928884,0.00024072891,0.0003199842,0.00029156066,0.0004488824,0.0005256425,0.00055084284,0.0006101743,0.00041719622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034892522,0.00024975103,0.40328762,0.00035596345,0.000089073896,0.003269872,0.001775584,0.0004269818,0.47311628,0.0011076238,0.00045870492,0.112373374],"study_design_scores_gemma":[0.0000063034636,0.0007892168,0.97374874,0.000055055945,0.000031847016,0.0025173288,0.000420917,0.00034628392,0.019972885,0.00030648411,0.001789451,0.000015456977],"about_ca_topic_score_codex":0.0015323989,"about_ca_topic_score_gemma":0.00083147077,"teacher_disagreement_score":0.0017815604,"about_ca_system_score_codex":0.0004195779,"about_ca_system_score_gemma":0.00045049633,"threshold_uncertainty_score":0.0059598684},"labels":[],"label_agreement":null},{"id":"W2129684544","doi":"10.1093/annonc/mdr476","title":"Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials","year":2011,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network","funders":"Centre Léon Bérard; Académie française","keywords":"Medicine; Oncology; Clinical trial; Internal medicine","score_opus":0.7244290692160772,"score_gpt":0.6638508701986854,"score_spread":0.06057819901739181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129684544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004703832,0.98383915,0.0044065258,0.002164187,0.00044842606,0.00067727815,0.00051503506,0.000074459786,0.0031710379],"genre_scores_gemma":[0.121583,0.83101434,0.029255215,0.009618326,0.0012312835,0.0030272652,0.0022755547,0.0001256631,0.0018693942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9675588,0.015284574,0.01006599,0.0021125332,0.0046048155,0.00037333654],"domain_scores_gemma":[0.8409627,0.13406849,0.01805612,0.002673286,0.0036534506,0.00058593677],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043747816,0.000783288,0.0042534256,0.004563039,0.0004908934,0.0025223945,0.002405178,0.0021576015,0.005258243],"category_scores_gemma":[0.112168856,0.00074121484,0.0040220385,0.0042699245,0.0014557941,0.0030977363,0.0016605265,0.0019643893,0.000593842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029542914,0.00008171097,0.0022434727,0.09960543,0.0037603218,0.00016148176,0.00031293367,0.0006864231,0.0013866121,0.0035631442,0.008701959,0.8765423],"study_design_scores_gemma":[0.011912071,0.0036488064,0.02625495,0.28487852,0.06589261,0.00401992,0.0007486672,0.002006812,0.008235327,0.025697863,0.5664073,0.000297169],"about_ca_topic_score_codex":0.00076447154,"about_ca_topic_score_gemma":0.00186384,"teacher_disagreement_score":0.95625216,"about_ca_system_score_codex":0.0025935327,"about_ca_system_score_gemma":0.005786322,"threshold_uncertainty_score":0.2313633},"labels":[],"label_agreement":null},{"id":"W2129920562","doi":"10.1081/dmr-120034149","title":"The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics","year":2004,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Cytochrome P450; Biology; Xenobiotic; Isozyme; Drug metabolism; CYP2E1; CYP2B6; Enzyme; Biochemistry; Pharmacology; Cell biology; CYP3A4","score_opus":0.10339823955707572,"score_gpt":0.4435344160855489,"score_spread":0.34013617652847317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129920562","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263511,0.016944299,0.03939781,0.001351412,0.00016346676,0.00007846962,0.0012814493,0.0002533552,0.014178765],"genre_scores_gemma":[0.98305327,0.0050830515,0.008012197,0.00029302452,0.00007492408,0.000069270456,0.00042867332,0.00007669303,0.0029088205],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938905,0.00023165572,0.00003707905,0.00018219021,0.0001240212,0.00003600082],"domain_scores_gemma":[0.9996253,0.00011094004,0.000111077876,0.000056809586,0.00006503741,0.000030803705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002641527,0.00021924402,0.00034174926,0.00039352267,0.00015913449,0.0004015396,0.00014814115,0.00022466578,0.0008790788],"category_scores_gemma":[0.0006144661,0.00016650617,0.00032064688,0.00034749618,0.00045126374,0.00021206806,0.00028455837,0.00033210777,0.0002446696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044538718,0.000092112314,0.049235288,0.00023473839,0.00026094765,0.0013073346,0.00024543892,0.0005717726,0.8628843,0.004924447,0.0013071577,0.07849112],"study_design_scores_gemma":[0.00006150241,0.00070421025,0.75465024,0.00006082033,0.0002794402,0.013271978,0.00023021598,0.0025204376,0.1803858,0.006983561,0.040772583,0.000079253514],"about_ca_topic_score_codex":0.0009792369,"about_ca_topic_score_gemma":0.0010616579,"teacher_disagreement_score":0.0009792369,"about_ca_system_score_codex":0.0003328152,"about_ca_system_score_gemma":0.00016652331,"threshold_uncertainty_score":0.0029408336},"labels":[],"label_agreement":null},{"id":"W2130120706","doi":"10.1503/cmaj.070946","title":"Drug interactions with warfarin: what clinicians need to know","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Warfarin; Drug; Medical prescription; Medicine; Need to know; Drug interaction; Computer science; Intensive care medicine; Data science; Pharmacology; Computer security; Internal medicine; Atrial fibrillation","score_opus":0.049769717128284714,"score_gpt":0.40304007536520536,"score_spread":0.35327035823692066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130120706","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034289545,0.0061613177,0.00032264096,0.9827063,0.008279439,0.00001765609,0.000023637636,0.00004556608,0.0021005091],"genre_scores_gemma":[0.004374452,0.016412413,0.0022550942,0.9139067,0.059643656,0.000070328926,0.00007351664,0.000028704542,0.0032351383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995415,0.0012578855,0.0008814926,0.00045953915,0.0015479318,0.00043802825],"domain_scores_gemma":[0.9742954,0.010374173,0.0014108536,0.00078901206,0.007886928,0.005243752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045022657,0.0015677289,0.0030876526,0.0016596043,0.004483457,0.004547944,0.0029021488,0.05204453,0.009166114],"category_scores_gemma":[0.028306613,0.0011441077,0.0020720903,0.0009933312,0.004463987,0.01500996,0.0025803125,0.049024697,0.0081096515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008034953,0.00017601628,0.0031949806,0.00041725894,0.000048002054,0.012020485,0.0004189386,0.00025675094,0.00037447643,0.0023702108,0.9136144,0.067028075],"study_design_scores_gemma":[0.00031715303,0.00023190494,0.0063325833,0.0053455154,0.00010844098,0.054960966,0.0064317733,0.0012777406,0.00022617474,0.041283894,0.8831322,0.00035173705],"about_ca_topic_score_codex":0.0074387197,"about_ca_topic_score_gemma":0.017561797,"teacher_disagreement_score":0.05204453,"about_ca_system_score_codex":0.0034982718,"about_ca_system_score_gemma":0.0063154087,"threshold_uncertainty_score":0.030663729},"labels":[],"label_agreement":null},{"id":"W2130496753","doi":"10.18433/j3fc7f","title":"The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2C9; Aspirin; Internal medicine; Genotype; Medicine; Gastroenterology; Cyclooxygenase; Proportional hazards model; Gastritis; Endocrinology; Pharmacology; Biology; Helicobacter pylori; Cytochrome P450; Gene; Genetics; Enzyme; Biochemistry; Metabolism","score_opus":0.11749081024479323,"score_gpt":0.41312356958896257,"score_spread":0.2956327593441693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130496753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941826,0.00027341978,0.00004767559,0.00002325764,0.000003758826,0.000002354938,0.00007089997,0.0000010042592,0.00015945346],"genre_scores_gemma":[0.9997161,0.000076701544,0.000041351937,0.000010537229,0.0000054236248,0.0000014884249,0.000049959654,5.3063525e-7,0.000097885684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974006,0.00008513716,0.000032651802,0.000062,0.00004616043,0.000034034554],"domain_scores_gemma":[0.9996038,0.00009790522,0.0001666285,0.000028527087,0.00003481974,0.00006834123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022204682,0.00017642135,0.00018673981,0.00033111792,0.0002386245,0.0002669432,0.00012186962,0.00024504334,0.0015573188],"category_scores_gemma":[0.0010388389,0.00013027508,0.00021660188,0.00038999904,0.0001541842,0.00012280146,0.00010905205,0.00034210112,0.00012965803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017323949,0.000026619047,0.9966968,0.000011094375,0.000039544804,0.0001607948,0.00006231437,0.000018405219,0.0009568297,0.000015412832,0.00004787062,0.0017910537],"study_design_scores_gemma":[0.0000072608177,0.00010919833,0.9982004,0.0000053588687,0.000044123102,0.0009674898,0.00007573331,0.00012408865,0.00028012577,0.000026562766,0.00015762726,0.0000019380977],"about_ca_topic_score_codex":0.0015996645,"about_ca_topic_score_gemma":0.0016161627,"teacher_disagreement_score":0.0015996645,"about_ca_system_score_codex":0.00010527306,"about_ca_system_score_gemma":0.000113724134,"threshold_uncertainty_score":0.005209744},"labels":[],"label_agreement":null},{"id":"W2130748375","doi":"10.1002/etc.5620220324","title":"Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (<i>Halichoerus grypus</i>)","year":2003,"lang":"en","type":"article","venue":"Environmental Toxicology and Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Microsome; Metabolism; Cytochrome P450; Chemistry; Biotransformation; Enzyme; Unspecific monooxygenase; Polychlorinated biphenyl; Biochemistry; Stereochemistry; Monooxygenase; Environmental chemistry","score_opus":0.023236711015658853,"score_gpt":0.3070009450125005,"score_spread":0.2837642339968417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130748375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846786,0.000520742,0.0003886656,0.000027266742,0.000009528758,0.000007917115,0.00016821807,0.00001343751,0.00039633116],"genre_scores_gemma":[0.9959645,0.0005462931,0.0005934871,0.000025134079,0.000012016905,0.00002214376,0.000749727,0.000008092975,0.0020786256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987507,0.000026387383,0.000010460781,0.000037762005,0.000026092126,0.000024161],"domain_scores_gemma":[0.9998441,0.000020623698,0.000049027243,0.000016134953,0.000029796622,0.0000403938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012222062,0.0002443502,0.00014929732,0.00017204515,0.00015053482,0.0001980008,0.00007989129,0.00013463052,0.0007401631],"category_scores_gemma":[0.000186498,0.00016132937,0.00017645012,0.00016660606,0.0002733722,0.00009489553,0.00010499765,0.0002100685,0.00023230445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041742716,0.000030483823,0.0046897028,0.000039414594,0.00001769001,0.00004913892,0.00007608347,0.00009471693,0.9931971,0.000031881733,0.000029554307,0.0013268604],"study_design_scores_gemma":[0.000029555158,0.001730248,0.10901619,0.0000057402103,0.0000761884,0.0002364858,0.000106701336,0.00061114505,0.887091,0.000041622017,0.0010464627,0.000008882416],"about_ca_topic_score_codex":0.0033659965,"about_ca_topic_score_gemma":0.004311348,"teacher_disagreement_score":0.0033659965,"about_ca_system_score_codex":0.0002823276,"about_ca_system_score_gemma":0.00019194288,"threshold_uncertainty_score":0.0066928267},"labels":[],"label_agreement":null},{"id":"W2130813724","doi":"10.1016/s0378-4274(03)00230-3","title":"Hepatic CYP1A, 2B, 2C, 2E and 3A regulation by methoxychlor in male and female rats","year":2003,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Methoxychlor; Cytochrome P450; Internal medicine; Endocrinology; CYP2E1; Biology; Enzyme inducer; Corn oil; Inducer; Endocrine system; Enzyme; Metabolism; Hormone; Pesticide; Biochemistry; Medicine; Gene","score_opus":0.06106326262390513,"score_gpt":0.38633070021335,"score_spread":0.3252674375894449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130813724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960846,0.0004023618,0.0014502682,0.00024330252,0.000058294398,0.000013467107,0.0009133278,0.00012717789,0.0007071789],"genre_scores_gemma":[0.98014414,0.0006899032,0.0018193065,0.00017348358,0.000054380045,0.00010557975,0.0013581114,0.000181743,0.0154733835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946207,0.00007556877,0.000025287713,0.00014748567,0.000106927604,0.00018272453],"domain_scores_gemma":[0.9993113,0.00007580588,0.00021879147,0.00011925291,0.00007549069,0.00019919973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021553165,0.00088525726,0.0007053884,0.0016716406,0.0005774373,0.00050693256,0.00037290298,0.00061312615,0.0048085134],"category_scores_gemma":[0.00031980855,0.00085146213,0.00066927297,0.00048328628,0.0009999474,0.0007698917,0.00036419806,0.0012469615,0.00104603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009135118,0.00040614096,0.0037319737,0.0000319056,0.00003409867,0.00021750812,0.00016501226,0.00012930189,0.9817615,0.00023669712,0.00024649975,0.0039042719],"study_design_scores_gemma":[0.00017798987,0.0031347736,0.038244255,0.000009245285,0.00012382235,0.00042521922,0.0003587454,0.0008750898,0.9548798,0.00024183639,0.0014746713,0.00005444373],"about_ca_topic_score_codex":0.0032150047,"about_ca_topic_score_gemma":0.0050055417,"teacher_disagreement_score":0.0048085134,"about_ca_system_score_codex":0.0007209315,"about_ca_system_score_gemma":0.00042992158,"threshold_uncertainty_score":0.016086102},"labels":[],"label_agreement":null},{"id":"W2130987050","doi":"10.1007/s00213-013-3083-z","title":"Adolescence: a time of transition for the phenotype of dcc heterozygous mice","year":2013,"lang":"en","type":"article","venue":"Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Douglas Mental Health University Institute; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies; Concordia University","keywords":"Sensitization; Amphetamine; Ventral tegmental area; Heterozygote advantage; Downregulation and upregulation; Endocrinology; Internal medicine; Psychology; Biology; Medicine; Neuroscience; Dopamine; Genetics; Allele","score_opus":0.054986061142510055,"score_gpt":0.4073215573902773,"score_spread":0.3523354962477673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130987050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720365,0.0014681657,0.007676925,0.0014314459,0.00044268285,0.00014546725,0.005316495,0.0011018616,0.010380497],"genre_scores_gemma":[0.97547513,0.001203938,0.0033437305,0.0007185999,0.0000539705,0.0002509396,0.001971288,0.0006795559,0.016302772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997186,0.00002694429,0.000016768265,0.000079423975,0.00007728401,0.00008095812],"domain_scores_gemma":[0.99866533,0.00015399333,0.00032867328,0.00006569248,0.000116564865,0.00066972274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023217402,0.00048769783,0.00061026594,0.0014216981,0.0010496146,0.0012128962,0.0005121866,0.0011463899,0.0050938413],"category_scores_gemma":[0.0007215707,0.00035920597,0.00045663418,0.00032683593,0.0009640956,0.0005251427,0.0011296705,0.0028449288,0.0011413477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017469955,0.00048019865,0.012635253,0.00011995067,0.00004878181,0.0060601057,0.0011218624,0.00014899982,0.9537073,0.004619959,0.0037492665,0.015561456],"study_design_scores_gemma":[0.00012787084,0.00084213854,0.2961042,0.0005054019,0.00022597951,0.0135848215,0.0027225534,0.0009081233,0.63644487,0.0046860026,0.04368247,0.000165581],"about_ca_topic_score_codex":0.003123295,"about_ca_topic_score_gemma":0.0060525024,"teacher_disagreement_score":0.0050938413,"about_ca_system_score_codex":0.0007426879,"about_ca_system_score_gemma":0.0009474863,"threshold_uncertainty_score":0.01704061},"labels":[],"label_agreement":null},{"id":"W2131356514","doi":"","title":"Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2A6; Tranylcypromine; Chemistry; Pharmacology; Hydroxylation; Methoxsalen; Microsome; Dextromethorphan; CYP1A2; Biochemistry; Monoamine oxidase; Biology; Enzyme","score_opus":0.15151453331691345,"score_gpt":0.4104899720855356,"score_spread":0.25897543876862217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131356514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94712645,0.029646657,0.016914537,0.00031209076,0.000180858,0.00026214367,0.0015508395,0.0002760381,0.0037304081],"genre_scores_gemma":[0.95939606,0.015306559,0.014501057,0.00015994652,0.00008832664,0.00024562477,0.004536823,0.000058704438,0.005706997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994779,0.00017283447,0.000045745026,0.0000818938,0.00017091165,0.000050762384],"domain_scores_gemma":[0.9997173,0.000059224214,0.00006813832,0.000030480227,0.0000826694,0.00004209486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046214127,0.00068110845,0.0006368843,0.0002413246,0.00022494764,0.00027661692,0.00027200233,0.00040239582,0.00090341707],"category_scores_gemma":[0.00036517793,0.00027652728,0.00039342983,0.000322128,0.00013240788,0.00021534039,0.0001823826,0.00055146567,0.00049010536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027813666,0.00012179593,0.0002796274,0.00010547539,0.00004239066,0.00004071079,0.000018098879,0.00020054958,0.99410003,0.000039788745,0.00011232627,0.004661026],"study_design_scores_gemma":[0.000030899213,0.0012279003,0.0017359193,0.0000046913215,0.00008228074,0.00027606593,0.000011255032,0.0008323394,0.9929224,0.000011007424,0.0028599433,0.0000052504397],"about_ca_topic_score_codex":0.0010443641,"about_ca_topic_score_gemma":0.0023990874,"teacher_disagreement_score":0.0010443641,"about_ca_system_score_codex":0.00026214158,"about_ca_system_score_gemma":0.00028295277,"threshold_uncertainty_score":0.0030222535},"labels":[],"label_agreement":null},{"id":"W2131441643","doi":"10.1124/mol.107.039354","title":"Dexamethasone-Mediated Up-Regulation of Human CYP2A6 Involves the Glucocorticoid Receptor and Increased Binding of Hepatic Nuclear Factor 4α to the Proximal Promoter","year":2007,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chromatin immunoprecipitation; Hepatocyte nuclear factor 4; Transactivation; Glucocorticoid receptor; Molecular biology; Biology; Electrophoretic mobility shift assay; Promoter; Transcription factor; Chemistry; Endocrinology; Nuclear receptor; Gene expression; Glucocorticoid; Gene; Biochemistry","score_opus":0.05278774633892928,"score_gpt":0.3865000972303615,"score_spread":0.3337123508914322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131441643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96387136,0.011684206,0.012683448,0.001055924,0.0005738282,0.0001479166,0.0040462185,0.00061606505,0.0053210305],"genre_scores_gemma":[0.98386073,0.001813136,0.0034065999,0.00018083405,0.00007810176,0.000064553555,0.0028938747,0.0000815327,0.0076206694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950945,0.00008510599,0.00002451492,0.00014975363,0.000115008355,0.00011618307],"domain_scores_gemma":[0.99958354,0.00011596807,0.00007211837,0.00008196028,0.000058722755,0.00008772809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021420246,0.00058965373,0.0005852651,0.0006341693,0.00040751192,0.00058250985,0.00029992327,0.00030887354,0.0051489137],"category_scores_gemma":[0.0003796219,0.00038610795,0.0009373459,0.0004439189,0.00055276044,0.0002226504,0.00040098053,0.00089809555,0.0010109695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092630275,0.00008517671,0.0010191605,0.00006861263,0.000018705754,0.00017647071,0.00008259499,0.00007593465,0.9933734,0.00030841856,0.00023593726,0.0036293883],"study_design_scores_gemma":[0.00008984551,0.00040581077,0.03758759,0.000015567713,0.000041491465,0.000758666,0.00017179275,0.00051609956,0.95292467,0.00023431312,0.007234035,0.000020094196],"about_ca_topic_score_codex":0.0037659649,"about_ca_topic_score_gemma":0.008001931,"teacher_disagreement_score":0.0051489137,"about_ca_system_score_codex":0.0008450937,"about_ca_system_score_gemma":0.0004423015,"threshold_uncertainty_score":0.017224848},"labels":[],"label_agreement":null},{"id":"W2131567043","doi":"10.1080/03602530600959615","title":"Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction","year":2006,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Metabolite; Reactive intermediate; Circumstantial evidence; Drug reaction; Mechanism (biology); Chemistry; Drug; Pharmacology; Biochemistry; Biology; Epistemology","score_opus":0.3331959719031033,"score_gpt":0.5179051538150201,"score_spread":0.18470918191191682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131567043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055852574,0.98168266,0.0024385958,0.0010755747,0.00021793187,0.000052321604,0.00007613685,0.00003094196,0.008840638],"genre_scores_gemma":[0.026635068,0.96483827,0.002408243,0.000600414,0.00029379592,0.00003607049,0.00012922341,0.000007287089,0.005051472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999744,0.0000721034,0.000029070017,0.000033235177,0.00009828466,0.000023304992],"domain_scores_gemma":[0.99971694,0.000110194975,0.00005606293,0.000012645385,0.00008511831,0.000019061705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468299,0.0005250343,0.0015586606,0.000952926,0.00016644632,0.0006769668,0.00047958357,0.0009103258,0.003995503],"category_scores_gemma":[0.00063065416,0.00013828665,0.0006668726,0.0006638128,0.00029817983,0.0005814473,0.00019688855,0.00058023183,0.0023520486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003719963,0.00014068904,0.003085988,0.009890775,0.00016341644,0.0021145553,0.000058262252,0.00043408238,0.029078616,0.002580463,0.0076998286,0.94438136],"study_design_scores_gemma":[0.00016943834,0.0017114371,0.02051874,0.0066676615,0.0015003062,0.03956997,0.00045798026,0.0010451714,0.07696603,0.008264892,0.8430343,0.00009395698],"about_ca_topic_score_codex":0.0005847048,"about_ca_topic_score_gemma":0.0009150116,"teacher_disagreement_score":0.003995503,"about_ca_system_score_codex":0.00033751124,"about_ca_system_score_gemma":0.00058484386,"threshold_uncertainty_score":0.013366282},"labels":[],"label_agreement":null},{"id":"W2131973888","doi":"10.1073/pnas.0705110104","title":"Exploring the biochemical properties and remediation applications of the unusual explosive-degrading P450 system XplA/B","year":2007,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"Biotechnology and Biological Sciences Research Council","keywords":"Environmental remediation; Chemistry; Trinitrotoluene; Environmental chemistry; Contamination; Phytoremediation; Biodegradation; Groundwater remediation; Bioremediation; Degradation (telecommunications); Geobacter; Explosive material; Organic chemistry; Biology","score_opus":0.3192680229988518,"score_gpt":0.4093075712968274,"score_spread":0.09003954829797556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131973888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956905,0.0005567371,0.0031898941,0.0000808193,0.000002182781,0.000009854062,0.000113113936,0.000031287134,0.0003255872],"genre_scores_gemma":[0.9960393,0.00045608275,0.0025809666,0.000017941335,0.0000031270001,0.00000596764,0.00030049417,0.0000068775535,0.0005892535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995196,0.000009877983,0.0000030341876,0.000012681209,0.000012289796,0.000010234526],"domain_scores_gemma":[0.9999466,0.000010335153,0.00001540559,0.000006605357,0.000011032624,0.000009952071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011911362,0.00020120319,0.00012391953,0.00007693892,0.00009211643,0.00021201449,0.00011308256,0.00023290899,0.00025254983],"category_scores_gemma":[0.0001261145,0.000058619487,0.00010857434,0.000083090476,0.00011312505,0.00021877876,0.000102652135,0.00031592837,0.00018002353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018171284,0.000011342003,0.0003422239,0.000009690824,0.0000017862313,0.000014864997,0.0000048682264,0.0000324289,0.9987301,0.000020411848,0.000007198835,0.00080681586],"study_design_scores_gemma":[0.0000062191166,0.00038873003,0.011219543,0.0000030770598,0.000011665194,0.00030739658,0.000036440295,0.0017094983,0.98498106,0.000058449474,0.0012742728,0.0000036470385],"about_ca_topic_score_codex":0.00063519157,"about_ca_topic_score_gemma":0.0004379986,"teacher_disagreement_score":0.00063519157,"about_ca_system_score_codex":0.00015323854,"about_ca_system_score_gemma":0.00007717524,"threshold_uncertainty_score":0.0012630224},"labels":[],"label_agreement":null},{"id":"W2132083761","doi":"10.1124/dmd.108.020966","title":"Cytochrome P450 2C11 5′-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylcholanthrene; Cytochrome P450; In vivo; Flanking maneuver; Biology; Molecular biology; Genetics; Chemistry; Enzyme; Carcinogen; Biochemistry","score_opus":0.043162318871766525,"score_gpt":0.3520303319730257,"score_spread":0.30886801310125916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132083761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671246,0.0005642311,0.0091661895,0.00024944628,0.00012373088,0.00007742962,0.0010593644,0.00025473564,0.001792501],"genre_scores_gemma":[0.98949057,0.00030072476,0.0021864728,0.00005877091,0.000023970162,0.000066026005,0.0014284954,0.00013358929,0.0063113887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923074,0.00017738299,0.00006529333,0.00020470582,0.00012651844,0.00019540172],"domain_scores_gemma":[0.99916255,0.00037455763,0.00012930836,0.00013109214,0.000040848947,0.00016158738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051636726,0.0006967172,0.0004921047,0.00059064396,0.00033884682,0.0006692219,0.00050785363,0.00051359483,0.0037743396],"category_scores_gemma":[0.0004491146,0.0006849431,0.00065754773,0.0002750029,0.00080758013,0.00031295966,0.00042479107,0.0015350685,0.0010523294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032267472,0.000073560914,0.00017533552,0.00001136607,0.000005747961,0.000032913005,0.000025608924,0.00012501076,0.9985594,0.00020211945,0.000050053226,0.00041620128],"study_design_scores_gemma":[0.00001930576,0.00011575659,0.001160171,0.0000027542903,0.000009383785,0.00007384136,0.000033027365,0.00079661334,0.9971624,0.000026703836,0.0005960273,0.000003973299],"about_ca_topic_score_codex":0.0036782117,"about_ca_topic_score_gemma":0.0046973913,"teacher_disagreement_score":0.0037743396,"about_ca_system_score_codex":0.0006614638,"about_ca_system_score_gemma":0.00069632224,"threshold_uncertainty_score":0.012626469},"labels":[],"label_agreement":null},{"id":"W2132124948","doi":"10.1016/j.psychres.2015.07.032","title":"Physicians' opinions following pharmacogenetic testing for psychotropic medication","year":2015,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Medical prescription; CYP2C19; Genetic testing; Drug response; Psychiatry; Drug; Family medicine; Pharmacology; Internal medicine; Genetics; Genotype; Biology","score_opus":0.462524712156223,"score_gpt":0.5800618040460228,"score_spread":0.11753709188979983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132124948","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24319279,0.0077254893,0.000988286,0.69765073,0.010757701,0.0000822678,0.0007411683,0.0000472819,0.038814276],"genre_scores_gemma":[0.80490124,0.0057115513,0.0016899501,0.16744064,0.012456795,0.00006530308,0.00034621087,0.000038298906,0.0073500415],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99178207,0.0042263395,0.0011325722,0.0005739148,0.0013644468,0.00092058897],"domain_scores_gemma":[0.93154526,0.038549583,0.010154008,0.0009532845,0.011147428,0.0076504727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007850016,0.00016638699,0.00033361575,0.000742809,0.0026464425,0.001613552,0.00055798003,0.0057165083,0.00902572],"category_scores_gemma":[0.09226374,0.00023141465,0.00083819346,0.00043520203,0.0009396489,0.0015178517,0.0010675371,0.00433425,0.001522818],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017452706,0.00043705665,0.36810517,0.000873982,0.00035097494,0.01957457,0.023354206,0.0008026893,0.0024018479,0.0038018322,0.39433172,0.18422066],"study_design_scores_gemma":[0.0005987842,0.0016890522,0.43769553,0.0039361706,0.000743702,0.025742982,0.0988666,0.0017208414,0.0035259805,0.00789359,0.4170993,0.00048749844],"about_ca_topic_score_codex":0.005487648,"about_ca_topic_score_gemma":0.010373035,"teacher_disagreement_score":0.00902572,"about_ca_system_score_codex":0.0020803628,"about_ca_system_score_gemma":0.0020584683,"threshold_uncertainty_score":0.04151535},"labels":[],"label_agreement":null},{"id":"W2132624405","doi":"10.1124/dmd.109.031138","title":"Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases","year":2009,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Helsingin Yliopiston Tiedesäätiö; National Institutes of Health; Academy of Finland; National Institute of General Medical Sciences; Helsingin Yliopisto","keywords":"Glucuronidation; Chemistry; Microsome; Kinetics; Substrate (aquarium); Biochemistry; Enzyme; Biology","score_opus":0.031661021772739266,"score_gpt":0.36931649797112165,"score_spread":0.3376554761983824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132624405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98730844,0.0030606524,0.006965627,0.00010661653,0.000016896138,0.000013179133,0.0002241255,0.00006331971,0.0022411193],"genre_scores_gemma":[0.9949444,0.0008131173,0.001959963,0.0000401364,0.0000075811536,0.000007906719,0.00046429122,0.000014997749,0.0017477067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983335,0.00009287077,0.0000070989004,0.000023855235,0.000018396016,0.000024397317],"domain_scores_gemma":[0.9998412,0.00004169898,0.000047028956,0.000020333257,0.000023407161,0.000026294123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273646,0.00025103166,0.0001701428,0.00021982988,0.00008760612,0.00035053364,0.0000889207,0.00020130778,0.0006998739],"category_scores_gemma":[0.00044027288,0.00014333954,0.00024133193,0.00016445715,0.00019065259,0.00015581764,0.0001432525,0.00028484582,0.000222097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005047935,0.00010164302,0.024762828,0.00013249052,0.00020392748,0.00056567707,0.0004346652,0.002481253,0.8622426,0.0035204976,0.0005755386,0.09993103],"study_design_scores_gemma":[0.0000897645,0.0019941533,0.10292622,0.000035788726,0.00012645648,0.0025807158,0.00015085418,0.007984711,0.8749709,0.0010739332,0.008028754,0.00003765234],"about_ca_topic_score_codex":0.0020474603,"about_ca_topic_score_gemma":0.0014798174,"teacher_disagreement_score":0.0020474603,"about_ca_system_score_codex":0.00043900646,"about_ca_system_score_gemma":0.00034047724,"threshold_uncertainty_score":0.0040711164},"labels":[],"label_agreement":null},{"id":"W2132649715","doi":"10.2174/138920008784746373","title":"Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions","year":2008,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Ziprasidone; Quetiapine; Aripiprazole; Amisulpride; Pharmacology; Olanzapine; Clozapine; Atypical antipsychotic; Risperidone; Asenapine; Paliperidone; Sertindole; CYP3A4; Chemistry; CYP2D6; Drug metabolism; Antipsychotic; Cytochrome P450; Medicine; Drug; Metabolism; Biochemistry; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.19780855701770922,"score_gpt":0.4896649825532538,"score_spread":0.2918564255355446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132649715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041414043,0.9930328,0.0007292125,0.000573286,0.00011042649,0.000009270283,0.00004948993,0.000016793405,0.001337315],"genre_scores_gemma":[0.026051313,0.970803,0.0009777457,0.00031849951,0.00043749064,0.000011819842,0.00008877047,0.000005896485,0.0013054351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958986,0.0001106658,0.00006824298,0.0000519393,0.00014118268,0.00003811538],"domain_scores_gemma":[0.99940324,0.00022414715,0.00021448774,0.000013127054,0.000115989176,0.0000289997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050930213,0.00068680214,0.0008870123,0.00066064985,0.00018095665,0.00066082936,0.00036481398,0.00055909244,0.0015332177],"category_scores_gemma":[0.000723203,0.00015032267,0.0005366837,0.001232364,0.00025958507,0.0005866605,0.00039709196,0.0007124864,0.0005308214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005115005,0.00010814951,0.008402855,0.018122874,0.0005361353,0.005466312,0.00020878513,0.0010999409,0.01976742,0.0027037351,0.01597313,0.9270991],"study_design_scores_gemma":[0.00011862528,0.0020052113,0.114144005,0.0062352074,0.0018453002,0.058426566,0.00054766994,0.0015354737,0.015056379,0.0127527565,0.78719795,0.00013497692],"about_ca_topic_score_codex":0.0007997471,"about_ca_topic_score_gemma":0.001742724,"teacher_disagreement_score":0.0015332177,"about_ca_system_score_codex":0.000463487,"about_ca_system_score_gemma":0.00041286126,"threshold_uncertainty_score":0.005129099},"labels":[],"label_agreement":null},{"id":"W2133002022","doi":"10.1592/phco.2005.25.11.1656","title":"Increase in International Normalized Ratio After Smoking Cessation in a Patient Receiving Warfarin","year":2005,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Warfarin; Medicine; Smoking cessation; Emergency medicine; Anesthesia; Pediatrics; Internal medicine; Atrial fibrillation","score_opus":0.04571418493673224,"score_gpt":0.4000730892369731,"score_spread":0.35435890430024086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133002022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901928,0.0016565953,0.00052382133,0.0017219476,0.00015108168,0.00005253179,0.000049915427,0.000055563312,0.0055956477],"genre_scores_gemma":[0.99745435,0.00065005466,0.00018072277,0.0007987227,0.00020615564,0.000007328981,0.000033756874,0.000008659269,0.0006601609],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995396,0.000079303725,0.00005116602,0.000081094135,0.00012720225,0.00012163645],"domain_scores_gemma":[0.99833715,0.00060327543,0.00038994954,0.00009264631,0.00013312828,0.0004437622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039055006,0.0005459592,0.001158292,0.0010810745,0.0015398822,0.0008927934,0.00045359865,0.002516341,0.0015606818],"category_scores_gemma":[0.004697964,0.0004991976,0.00059720274,0.0008556695,0.00073907094,0.00076205604,0.00040404464,0.0023518363,0.00041066666],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005883481,0.00029515603,0.19000533,0.00004050336,0.00004758809,0.798017,0.0010438306,0.000092141054,0.0031343948,0.00018559722,0.00044853237,0.0061015463],"study_design_scores_gemma":[0.000076653996,0.0012569445,0.14331257,0.00003089134,0.00013847918,0.8508227,0.00048541947,0.0007955088,0.0012066799,0.00020366539,0.0016296114,0.00004089254],"about_ca_topic_score_codex":0.002382686,"about_ca_topic_score_gemma":0.0028324423,"teacher_disagreement_score":0.002516341,"about_ca_system_score_codex":0.0006655333,"about_ca_system_score_gemma":0.0006178157,"threshold_uncertainty_score":0.0052210093},"labels":[],"label_agreement":null},{"id":"W2133013045","doi":"10.1124/dmd.31.6.748","title":"IN VITRO METABOLISM OF CHLOROQUINE: IDENTIFICATION OF CYP2C8, CYP3A4, AND CYP2D6 AS THE MAIN ISOFORMS CATALYZING N-DESETHYLCHLOROQUINE FORMATION","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"CYP3A4; CYP2C8; Metabolite; Microsome; Cytochrome P450; Ketoconazole; CYP3A; Pharmacology; CYP2D6; Hydroxylation; Chemistry; Metabolism; In vivo; Biology; In vitro; Biochemistry; Enzyme","score_opus":0.023771396761042746,"score_gpt":0.345650322664084,"score_spread":0.3218789259030413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133013045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97529334,0.009907746,0.010639937,0.0002146307,0.00011272403,0.00008680047,0.0016571945,0.000104179744,0.0019834798],"genre_scores_gemma":[0.98842144,0.0022034415,0.0046650395,0.00006592812,0.000042663934,0.000044389373,0.0028953666,0.000029084844,0.0016327867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989525,0.00052617723,0.00009226947,0.00014793663,0.00016055643,0.000120541474],"domain_scores_gemma":[0.9992501,0.00034399983,0.00008869359,0.00012158197,0.000135993,0.000059556394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007806263,0.0005660116,0.0007802269,0.00028655477,0.00039467268,0.000410762,0.0004256995,0.0005304506,0.0014664074],"category_scores_gemma":[0.0010818492,0.00031955648,0.0005814731,0.00048216694,0.00031892737,0.00023734814,0.0002824792,0.00071918167,0.00044582933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001743182,0.00022829422,0.0025423714,0.0001591706,0.00011202437,0.00012415266,0.000106407104,0.001700868,0.98790586,0.00010040679,0.00028329747,0.004994028],"study_design_scores_gemma":[0.00006887924,0.0012739094,0.005314133,0.000006647679,0.00011980775,0.00023305457,0.000024070201,0.0025611129,0.98913133,0.00003781513,0.001213521,0.000015736894],"about_ca_topic_score_codex":0.009072451,"about_ca_topic_score_gemma":0.0114149,"teacher_disagreement_score":0.009072451,"about_ca_system_score_codex":0.0008148646,"about_ca_system_score_gemma":0.00050186383,"threshold_uncertainty_score":0.018039286},"labels":[],"label_agreement":null},{"id":"W2134046939","doi":"10.4021/jocmr2009.08.1255","title":"Pharmacogenomics: The Right Drug to the Right Person","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacogenetics; Drug; Personalized medicine; Pharmacology; Single-nucleotide polymorphism; Efficacy; Drug reaction; Drug response; Bioinformatics; Computational biology; Gene; Genotype; Genetics; Biology","score_opus":0.4250392385150973,"score_gpt":0.6307897006184299,"score_spread":0.2057504621033326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134046939","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090173783,0.04265186,0.023255045,0.8537675,0.015422011,0.00010553483,0.0004192728,0.000848287,0.0626287],"genre_scores_gemma":[0.07128944,0.10392132,0.047958013,0.64387876,0.057618577,0.0005364906,0.00060076447,0.00079999695,0.07339672],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9927201,0.0037703358,0.00056671276,0.0005687887,0.0020382437,0.0003358886],"domain_scores_gemma":[0.98417956,0.0074377735,0.0014399776,0.0021481237,0.002853465,0.0019411086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009530274,0.0008426516,0.0020384903,0.0011308144,0.0017050804,0.005286903,0.001315451,0.010689314,0.028090367],"category_scores_gemma":[0.037375305,0.00048818372,0.00062741525,0.0008750265,0.008720997,0.0065296874,0.0028612646,0.0092201885,0.022600811],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022144109,0.00016000484,0.00239149,0.0011184854,0.000118901306,0.00068724947,0.00035835215,0.00039532862,0.0009462681,0.08042615,0.5558552,0.35732108],"study_design_scores_gemma":[0.000112878966,0.000075034426,0.0011210177,0.0014634918,0.00005700321,0.0019549099,0.0002886158,0.00028524993,0.0006127838,0.14405143,0.8499241,0.00005346169],"about_ca_topic_score_codex":0.0010124443,"about_ca_topic_score_gemma":0.0009210574,"teacher_disagreement_score":0.028090367,"about_ca_system_score_codex":0.0013415401,"about_ca_system_score_gemma":0.0056991125,"threshold_uncertainty_score":0.09397161},"labels":[],"label_agreement":null},{"id":"W2134794720","doi":"10.1517/17425255.4.9.1143","title":"Whole body physiologically-based pharmacokinetic models: their use in clinical drug development","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Drug development; Pharmacokinetics; Drug; Pharmacology; Physiologically based pharmacokinetic modelling; Medicine; Intensive care medicine","score_opus":0.3293432199936731,"score_gpt":0.49376141390974265,"score_spread":0.16441819391606954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134794720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006366677,0.93619955,0.053118404,0.0023508829,0.00068495737,0.000071181144,0.00014475064,0.00019426919,0.0065993755],"genre_scores_gemma":[0.009509539,0.9610778,0.025599925,0.0008198842,0.00054534705,0.00012483886,0.0001600531,0.00004046077,0.0021222043],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99896014,0.00037808422,0.00007701628,0.00011898815,0.000437929,0.000027851926],"domain_scores_gemma":[0.9983923,0.0009902031,0.0001832208,0.00008485924,0.0003067572,0.000042770203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022905925,0.0011958663,0.0019967393,0.0014961909,0.00020934986,0.0016350105,0.001954078,0.0023771657,0.0028675813],"category_scores_gemma":[0.00357452,0.0005266472,0.0010185868,0.001731805,0.0008402054,0.001875965,0.0007328343,0.0022669348,0.0032153563],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006727778,0.00007141066,0.0003797802,0.008148477,0.00018156793,0.00031560642,0.00008091124,0.015128671,0.00271971,0.021014458,0.02730126,0.9245909],"study_design_scores_gemma":[0.000049734943,0.00022917359,0.00092537253,0.0035969992,0.00024374168,0.002205012,0.00008570552,0.016526934,0.003009616,0.030836564,0.9421731,0.000118056],"about_ca_topic_score_codex":0.0018608095,"about_ca_topic_score_gemma":0.0014093153,"teacher_disagreement_score":0.0028675813,"about_ca_system_score_codex":0.0009895661,"about_ca_system_score_gemma":0.0013245259,"threshold_uncertainty_score":0.012113929},"labels":[],"label_agreement":null},{"id":"W2135163551","doi":"10.1542/peds.2009-1907","title":"Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions","year":2010,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute; Western University; Office of the Chief Medical Examiner","funders":"","keywords":"Hydrocodone; Medicine; CYP2D6; Pharmacogenetics; Hydromorphone; Drug; Pharmacology; Drug interaction; Metabolite; Anesthesia; Opioid; Cytochrome P450; Internal medicine; Oxycodone; Genotype","score_opus":0.0383720846401747,"score_gpt":0.4019869959442818,"score_spread":0.36361491130410706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135163551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959044,0.00082566036,0.0007054402,0.0010476427,0.000028631699,0.000023081155,0.000099014345,0.000028736358,0.0013375577],"genre_scores_gemma":[0.99844366,0.00059983553,0.00044841925,0.00019772821,0.000026345035,0.0000047621306,0.000033441975,0.0000060681996,0.00023985562],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996805,0.00006460814,0.000044783144,0.00005284913,0.00007728924,0.000079879675],"domain_scores_gemma":[0.9993042,0.00024494453,0.00023350668,0.00002645711,0.000054640124,0.00013630642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002269159,0.00062280335,0.00057164225,0.00072210515,0.0010213562,0.0004985242,0.00027791833,0.0011410041,0.0007876768],"category_scores_gemma":[0.0018803162,0.0003107491,0.0004067547,0.0005410956,0.0008254089,0.00041765923,0.0004770499,0.0012293796,0.00013995773],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001065653,0.00009612033,0.15581389,0.00005400425,0.000022843516,0.83494884,0.0007476089,0.00020230911,0.0024978449,0.0002880224,0.00039838036,0.004823727],"study_design_scores_gemma":[0.000012455794,0.0003753434,0.080696374,0.00003465927,0.000048727215,0.91400856,0.0005817442,0.00054973667,0.00240268,0.0001785137,0.0010953738,0.000015909827],"about_ca_topic_score_codex":0.0057165595,"about_ca_topic_score_gemma":0.0065447628,"teacher_disagreement_score":0.0057165595,"about_ca_system_score_codex":0.0009425935,"about_ca_system_score_gemma":0.0006480909,"threshold_uncertainty_score":0.011366606},"labels":[],"label_agreement":null},{"id":"W2135247011","doi":"10.1124/dmd.108.022772","title":"Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Phenobarbital; Glucocorticoid receptor; Glucocorticoid; Inducer; Constitutive androstane receptor; Enzyme inducer; Biology; Nuclear receptor; Dexamethasone; Reporter gene; Gene expression; Endocrinology; Chemistry; Gene; Biochemistry; Enzyme; Transcription factor","score_opus":0.07280065866725785,"score_gpt":0.36826709757329845,"score_spread":0.29546643890604063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135247011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97549826,0.0036465346,0.012619797,0.000725384,0.00017875017,0.00009392714,0.003348991,0.00048409504,0.0034043407],"genre_scores_gemma":[0.9876029,0.000754748,0.0036683204,0.00014430576,0.000022158727,0.000057672205,0.002085429,0.00016538554,0.005499102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945647,0.000115822026,0.000030276053,0.00016067235,0.00012016579,0.00011656124],"domain_scores_gemma":[0.99942005,0.00014223924,0.00016948658,0.00011842784,0.000039488466,0.00011033405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020000698,0.0004622117,0.0002966888,0.0006754311,0.00028222156,0.0005623965,0.0002451146,0.0004211128,0.0026094972],"category_scores_gemma":[0.00031335314,0.00047388326,0.00066738925,0.00032322132,0.0005515863,0.0002595373,0.0003818945,0.00096492213,0.00094334007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035180416,0.000038759623,0.00046405877,0.000013475649,0.0000061457013,0.000047977275,0.000027000991,0.0000904366,0.9967135,0.000397472,0.000091304246,0.0017580256],"study_design_scores_gemma":[0.00003445198,0.00020213918,0.0055580465,0.000009931409,0.000010810876,0.00020913937,0.00004650199,0.0004863906,0.9900323,0.00014143171,0.0032597457,0.000009073801],"about_ca_topic_score_codex":0.0022788078,"about_ca_topic_score_gemma":0.005815941,"teacher_disagreement_score":0.0026094972,"about_ca_system_score_codex":0.000887336,"about_ca_system_score_gemma":0.0004257947,"threshold_uncertainty_score":0.008729637},"labels":[],"label_agreement":null},{"id":"W2135338861","doi":"10.1124/dmd.108.025635","title":"Developmental Expression and Endocrine Regulation of CYP1B1 in Rat Testis","year":2008,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Endocrinology; CYP1B1; Hypophysectomy; Biology; Testosterone propionate; Prolactin; Hormone; Endocrine system; Cytochrome P450; Testosterone (patch); Triiodothyronine; Thyroid; Luteinizing hormone; Androgen; Metabolism; Medicine","score_opus":0.04557831548049369,"score_gpt":0.347539064552609,"score_spread":0.30196074907211534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135338861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795473,0.009025306,0.0037350517,0.0003704466,0.00010655987,0.000027222008,0.0020979955,0.00010051691,0.004989486],"genre_scores_gemma":[0.9735884,0.0038988553,0.001617135,0.00016944755,0.00005837611,0.00003393964,0.0021466608,0.000102432365,0.018384673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998394,0.000014268042,0.000010137946,0.00005324041,0.00003520943,0.000047753754],"domain_scores_gemma":[0.99959844,0.000054501106,0.000095135765,0.000027977041,0.0000801582,0.00014382906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014882868,0.0001957344,0.00036885258,0.0009443316,0.00037098696,0.0006195726,0.00020830373,0.00021809852,0.003437024],"category_scores_gemma":[0.00024180919,0.00045771454,0.00037629282,0.00044037972,0.0004001956,0.0004703859,0.0003522211,0.0008424015,0.0006251125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042747898,0.000024624609,0.004415306,0.000051329043,0.000020060661,0.0002303185,0.00013150212,0.000053261236,0.98936135,0.0006156106,0.00018796668,0.004481187],"study_design_scores_gemma":[0.000057243273,0.0003541544,0.33284983,0.00004056439,0.00012678532,0.0012499475,0.00077283435,0.00056792796,0.6510374,0.00034065053,0.01256715,0.000035529058],"about_ca_topic_score_codex":0.004705408,"about_ca_topic_score_gemma":0.0074951495,"teacher_disagreement_score":0.004705408,"about_ca_system_score_codex":0.0007555881,"about_ca_system_score_gemma":0.000526592,"threshold_uncertainty_score":0.011497974},"labels":[],"label_agreement":null},{"id":"W2135962408","doi":"10.1002/bit.22143","title":"The activity of human CYP2D6 in low water organic solvents","year":2008,"lang":"en","type":"article","venue":"Biotechnology and Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Anhydrous; Chemistry; Hydroxylation; Enzyme; Trehalose; Aqueous solution; Solubility; Biocatalysis; Solvent; Organic chemistry; Limiting; Decane; Combinatorial chemistry; Chromatography; Catalysis; Reaction mechanism","score_opus":0.050849304743231585,"score_gpt":0.3436643498663098,"score_spread":0.2928150451230782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135962408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96927816,0.0075125806,0.016884545,0.00037475687,0.00009655194,0.00006766405,0.0015517886,0.00015537381,0.00407856],"genre_scores_gemma":[0.9745532,0.0039445674,0.009356852,0.00009078481,0.00006012005,0.00008122127,0.0034230198,0.00005822564,0.008432084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997118,0.00010190607,0.000022783512,0.00006806682,0.000062956504,0.000032513442],"domain_scores_gemma":[0.99988496,0.000047763217,0.000018580464,0.000016081938,0.000018530915,0.000014167782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002665701,0.00033584586,0.00019971293,0.00017044449,0.00017006592,0.00026439156,0.00017684174,0.00022631134,0.0012886935],"category_scores_gemma":[0.0004232006,0.00009478691,0.00015815969,0.0003167339,0.00015597105,0.0001837334,0.00015754979,0.0003305026,0.0006449632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017972852,0.000026827001,0.000278536,0.0000615228,0.0000059530707,0.000035967136,0.000020883985,0.00012717136,0.99540013,0.00007859361,0.00009481167,0.0036899447],"study_design_scores_gemma":[0.000009468372,0.00019685934,0.00090640574,0.000002687919,0.0000055011,0.00009145812,0.000009759078,0.00028470886,0.9962752,0.00002560369,0.0021892942,0.0000030226936],"about_ca_topic_score_codex":0.00079085596,"about_ca_topic_score_gemma":0.0010631051,"teacher_disagreement_score":0.0012886935,"about_ca_system_score_codex":0.00016052928,"about_ca_system_score_gemma":0.00015589924,"threshold_uncertainty_score":0.0043110847},"labels":[],"label_agreement":null},{"id":"W2136168442","doi":"10.1016/s0009-2797(02)00125-4","title":"Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes","year":2002,"lang":"en","type":"article","venue":"Chemico-Biological Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cytotoxicity; Glutathione; Dithiothreitol; Chemistry; Biochemistry; Hepatocyte; Toxicity; Dicoumarol; Pharmacology; Molecular biology; NAD+ kinase; Biology; In vitro; Enzyme","score_opus":0.15510809679379964,"score_gpt":0.4124020892387885,"score_spread":0.25729399244498885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136168442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032146,0.0019743643,0.0047351676,0.00014728469,0.00011826736,0.000058986032,0.0005473334,0.00010915476,0.0019879586],"genre_scores_gemma":[0.9958877,0.0005369139,0.0013333592,0.000035779914,0.000031611216,0.000030420048,0.0006653981,0.00002191663,0.0014569657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996538,0.0001221853,0.000023851475,0.000050900475,0.00006180097,0.00008743407],"domain_scores_gemma":[0.9997954,0.00008458587,0.000023379318,0.00004310412,0.00002915995,0.000024353898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003630264,0.00062012905,0.00050277455,0.00044471072,0.00032568694,0.00032678392,0.0003313061,0.00037189774,0.0020363417],"category_scores_gemma":[0.00024563164,0.00023613873,0.0007743801,0.00039374726,0.00039964376,0.00032838414,0.00031561046,0.0005493263,0.00056761183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033199186,0.00007286786,0.00067900756,0.000076448,0.000036360878,0.00024183102,0.000059912087,0.00045515818,0.9919722,0.00017551017,0.00007019185,0.0028406617],"study_design_scores_gemma":[0.000027894379,0.00051894126,0.0012501274,0.0000018889722,0.000018031034,0.00008043036,0.000028258446,0.00050038734,0.99720496,0.000041306055,0.00032315904,0.0000045755064],"about_ca_topic_score_codex":0.0020627338,"about_ca_topic_score_gemma":0.0032773756,"teacher_disagreement_score":0.0020627338,"about_ca_system_score_codex":0.00054198346,"about_ca_system_score_gemma":0.0005085483,"threshold_uncertainty_score":0.006812215},"labels":[],"label_agreement":null},{"id":"W2136605181","doi":"10.1124/dmd.114.061812","title":"Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; University of Toronto; National Institute of Environmental Health Sciences; New York State Department of Health - Wadsworth Center; New York State Department of Health","keywords":"CYP2B6; Nicotine; In vivo; Microsome; Cytochrome P450; Humanized mouse; Phenobarbital; Pharmacology; Transgene; Endocrinology; Chemistry; Internal medicine; Drug metabolism; Genetically modified mouse; Metabolism; Biology; In vitro; Biochemistry; Medicine; CYP3A4","score_opus":0.024986299092443466,"score_gpt":0.31723677047247495,"score_spread":0.29225047138003146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136605181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92590404,0.0041549513,0.05908314,0.0011659119,0.0003479072,0.00033932508,0.0054770326,0.0010816641,0.0024460373],"genre_scores_gemma":[0.94797647,0.0025178401,0.022609632,0.00031035996,0.00011972508,0.00045210024,0.0055090003,0.0007751763,0.01972971],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993955,0.00008523891,0.00005584094,0.00020138208,0.0001846036,0.00007729241],"domain_scores_gemma":[0.9993942,0.00006670834,0.00015308039,0.00013625421,0.000060464692,0.00018929153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006247471,0.0011063836,0.00068544043,0.0016876045,0.00046982736,0.00079466525,0.0005747623,0.00087833824,0.0038193858],"category_scores_gemma":[0.00028807286,0.0006628029,0.0009861623,0.0007288432,0.00078946486,0.00075437763,0.00027813888,0.0023909982,0.0016590988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006446413,0.00017280829,0.00037279277,0.00002823058,0.00001860075,0.000104621584,0.000027536804,0.000089739784,0.996885,0.0002723553,0.00011656965,0.0012669177],"study_design_scores_gemma":[0.00008218891,0.0006415819,0.0027619882,0.000005373582,0.00006380073,0.00063534273,0.000048842157,0.0012731344,0.99046737,0.00016302858,0.0038471317,0.000010173314],"about_ca_topic_score_codex":0.0012931371,"about_ca_topic_score_gemma":0.0017802184,"teacher_disagreement_score":0.0038193858,"about_ca_system_score_codex":0.000521693,"about_ca_system_score_gemma":0.0003814819,"threshold_uncertainty_score":0.01277709},"labels":[],"label_agreement":null},{"id":"W2136791626","doi":"10.1002/chir.20669","title":"Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate","year":2008,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Enantiomer; Pharmacokinetics; Ketoconazole; Oral administration; Volume of distribution; Pharmacology; Stereoisomerism; Blood plasma; Stereochemistry; Biochemistry","score_opus":0.10738721130680544,"score_gpt":0.4315809384688826,"score_spread":0.32419372716207717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136791626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929564,0.002386625,0.002585301,0.00011116606,0.000025998537,0.00002921773,0.000540299,0.00015967127,0.0012053453],"genre_scores_gemma":[0.9915765,0.0023862147,0.0020494645,0.00009938351,0.000026617176,0.000043201224,0.0008139234,0.00004231794,0.0029624167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998894,0.000020886844,0.0000053342956,0.000027402946,0.000023883502,0.000033136515],"domain_scores_gemma":[0.9998294,0.00002067373,0.000068059126,0.000022242692,0.000029032659,0.000030526877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014700012,0.00036843208,0.00046123637,0.00021130472,0.00012907504,0.00029337508,0.00014781127,0.00026361682,0.0012674509],"category_scores_gemma":[0.0002539476,0.00024233818,0.00024940178,0.00021244734,0.00025195722,0.00035304812,0.000084288506,0.0006098682,0.0004955314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044639455,0.00011821912,0.001579302,0.000069775095,0.00004158165,0.00015069668,0.00005502373,0.00040007813,0.9815004,0.00017035539,0.00022170525,0.011228932],"study_design_scores_gemma":[0.00017152788,0.0073671136,0.022121426,0.000010557386,0.00013597586,0.0008514035,0.00006750199,0.0029028098,0.9619311,0.00018906881,0.0042220955,0.000029354558],"about_ca_topic_score_codex":0.0015541065,"about_ca_topic_score_gemma":0.0022215755,"teacher_disagreement_score":0.0015541065,"about_ca_system_score_codex":0.00038535966,"about_ca_system_score_gemma":0.00047145222,"threshold_uncertainty_score":0.0042400956},"labels":[],"label_agreement":null},{"id":"W2136899763","doi":"10.1017/s1751731111002175","title":"The roles of different porcine cytochrome P450 enzymes and cytochrome b5A in skatole metabolism","year":2012,"lang":"en","type":"article","venue":"animal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Skatole; Boar taint; Metabolite; Cytochrome P450; Biochemistry; Chemistry; CYP2E1; Metabolism; Biology; Indole test; Genetics","score_opus":0.0593100244202329,"score_gpt":0.39616352082760387,"score_spread":0.33685349640737094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136899763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683812,0.015189758,0.011140302,0.00033712483,0.000044848577,0.00003514248,0.00071032526,0.000079688914,0.004081573],"genre_scores_gemma":[0.99189293,0.0030170754,0.0026145594,0.00007671935,0.000020864216,0.000011617006,0.000757538,0.000012710012,0.0015961651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985063,0.00004429563,0.000013344325,0.000036502744,0.000023393457,0.00003189542],"domain_scores_gemma":[0.99988914,0.00002763773,0.000029270095,0.000013753791,0.000018879387,0.000021306412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023882708,0.00017324969,0.00017592228,0.00041293073,0.0001250001,0.00041064885,0.00009660537,0.00029775742,0.000751117],"category_scores_gemma":[0.00017217973,0.000110871166,0.00042957294,0.00026788886,0.00013346123,0.00020320016,0.00009937338,0.00024951427,0.00028552636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010426725,0.000098251316,0.031131672,0.00019259233,0.00014395597,0.0008276285,0.00014370662,0.00048112628,0.9321058,0.0006513277,0.0002878237,0.032893408],"study_design_scores_gemma":[0.000069240166,0.0017204991,0.4925763,0.0000727954,0.00028534574,0.0042543104,0.00032614122,0.0059559736,0.47778225,0.0007443721,0.01616279,0.00005002525],"about_ca_topic_score_codex":0.0013614661,"about_ca_topic_score_gemma":0.0010592403,"teacher_disagreement_score":0.0013614661,"about_ca_system_score_codex":0.000156605,"about_ca_system_score_gemma":0.000101402635,"threshold_uncertainty_score":0.0027071238},"labels":[],"label_agreement":null},{"id":"W2137173003","doi":"10.1186/2001-1326-2-16","title":"Application of personalized medicine to chronic disease: a feasibility assessment","year":2013,"lang":"en","type":"article","venue":"Clinical and Translational Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bridgepoint Active Healthcare; Western University; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Medicine; Personalized medicine; Precision medicine; Intensive care medicine; Stroke (engine); Health care; Polypharmacy; Drug; Pharmacology; Bioinformatics; Pathology","score_opus":0.22352417141605233,"score_gpt":0.5569070132944096,"score_spread":0.3333828418783573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137173003","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15538861,0.082102716,0.37058815,0.25570688,0.0028880786,0.041294158,0.0028711045,0.00046010976,0.08870026],"genre_scores_gemma":[0.6509204,0.023566877,0.28593355,0.013496951,0.0013552784,0.022077637,0.0005746107,0.000099035926,0.0019755599],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.69715196,0.27822092,0.004521833,0.0030883236,0.01553711,0.0014797581],"domain_scores_gemma":[0.44046754,0.50970805,0.009174757,0.016100956,0.022008026,0.002540722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25715905,0.0011477404,0.0017711468,0.0024925272,0.0009531235,0.006383513,0.002372438,0.004287054,0.011646637],"category_scores_gemma":[0.36762282,0.00097479165,0.0039509535,0.00277219,0.00446673,0.0081501445,0.006922495,0.0042834054,0.0009571686],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006367708,0.0019502168,0.077013366,0.019812405,0.0041927034,0.0004658233,0.0023639824,0.018000651,0.0014263819,0.13682224,0.013046838,0.7185376],"study_design_scores_gemma":[0.006583472,0.055294737,0.14666817,0.054787148,0.00968362,0.0024639298,0.007280719,0.14086853,0.005370069,0.34390822,0.22611856,0.000972852],"about_ca_topic_score_codex":0.0033195333,"about_ca_topic_score_gemma":0.0033591746,"teacher_disagreement_score":0.25715905,"about_ca_system_score_codex":0.004950374,"about_ca_system_score_gemma":0.017976947,"threshold_uncertainty_score":0.91605514},"labels":[],"label_agreement":null},{"id":"W2137455008","doi":"10.1124/dmd.111.042879","title":"Species-Dependent and Receptor-Selective Action of Bilobalide on the Function of Constitutive Androstane Receptor and Pregnane X Receptor","year":2011,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Constitutive androstane receptor; CYP2B6; CYP3A4; Reporter gene; Biology; Pharmacology; Cytochrome P450; Molecular biology; Chemistry; Gene expression; Nuclear receptor; Biochemistry; Enzyme; Gene","score_opus":0.09146622068972644,"score_gpt":0.3410534522227419,"score_spread":0.24958723153301549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137455008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954324,0.0016401975,0.0008458503,0.00018663498,0.00006166742,0.000020522166,0.00021058714,0.00005340939,0.0015486631],"genre_scores_gemma":[0.9959926,0.00089280994,0.00048668656,0.00006286752,0.000016413615,0.000020725714,0.00031669118,0.000030218638,0.0021810583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991095,0.000022278537,0.000006494067,0.000014495427,0.000008379578,0.00003746134],"domain_scores_gemma":[0.9998642,0.000037703234,0.000020210784,0.000029255358,0.000013732728,0.000034818746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018241844,0.0003350539,0.00043784227,0.0002056708,0.00022320665,0.0003200431,0.00026197243,0.00025919804,0.0032975916],"category_scores_gemma":[0.0003495109,0.00021688873,0.00030738182,0.00015329671,0.0004581122,0.00041723382,0.00026181064,0.0007321178,0.00041818552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006098837,0.000098960816,0.0002508765,0.00007567383,0.000025369107,0.00010704409,0.000057322482,0.00008242088,0.9893215,0.00068437343,0.00014297538,0.0030546011],"study_design_scores_gemma":[0.00042512413,0.0013955712,0.005990562,0.000012744355,0.000117301366,0.00061669125,0.0001239935,0.0009364436,0.98558235,0.0004093673,0.0043691713,0.000020754858],"about_ca_topic_score_codex":0.0008933916,"about_ca_topic_score_gemma":0.0012964995,"teacher_disagreement_score":0.0032975916,"about_ca_system_score_codex":0.00031038286,"about_ca_system_score_gemma":0.00038390962,"threshold_uncertainty_score":0.011031568},"labels":[],"label_agreement":null},{"id":"W2138153828","doi":"10.1002/bdd.1931","title":"The guinea‐pig expresses functional CYP2C and P‐glycoprotein: further validation of its usefulness in drug biotransformation/transport studies","year":2014,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Guinea pig; Biology; P-glycoprotein; Transfection; Pharmacology; Molecular biology; Biochemistry; Gene; Multiple drug resistance; Endocrinology","score_opus":0.08987003790453561,"score_gpt":0.3904237972304724,"score_spread":0.30055375932593675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138153828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95475626,0.004335831,0.03182017,0.0007771797,0.00030741876,0.00050650287,0.002327669,0.00025086437,0.004918074],"genre_scores_gemma":[0.94463795,0.004609067,0.037901442,0.0003308083,0.00010294942,0.000442313,0.00589677,0.00022223423,0.0058565303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999706,0.00010092006,0.000027888542,0.00006559707,0.00005342167,0.00004620783],"domain_scores_gemma":[0.9993538,0.00020142189,0.0001027331,0.00016520642,0.00011480593,0.00006200834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009509887,0.00055069744,0.00033579097,0.00041964432,0.00018755512,0.0004129701,0.00035687943,0.0006509028,0.0024783679],"category_scores_gemma":[0.00059063046,0.00018697677,0.00050101284,0.00029027983,0.000443715,0.00037050384,0.0002059854,0.00091215345,0.0009670006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015160546,0.00011274519,0.00033117374,0.000066152556,0.000015965436,0.00015324676,0.000020895062,0.00002709683,0.9973918,0.00014026617,0.000093626506,0.001495385],"study_design_scores_gemma":[0.00012733277,0.0035457588,0.013365655,0.000041652558,0.00020459546,0.0022752,0.00007194898,0.0010093328,0.9640703,0.0001128815,0.015158595,0.000016868296],"about_ca_topic_score_codex":0.0006587646,"about_ca_topic_score_gemma":0.0006460133,"teacher_disagreement_score":0.0024783679,"about_ca_system_score_codex":0.00025332754,"about_ca_system_score_gemma":0.00020404237,"threshold_uncertainty_score":0.0082909465},"labels":[],"label_agreement":null},{"id":"W2138178267","doi":"10.4212/cjhp.v54i1.611","title":"2001 : L’Odyssée Pharmacogénomique","year":2001,"lang":"fr","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Computer science","score_opus":0.10798500100618877,"score_gpt":0.40219180330035303,"score_spread":0.2942068022941643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138178267","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01840332,0.22085239,0.02700892,0.18919265,0.035853904,0.00030835898,0.0054480997,0.002661531,0.50027084],"genre_scores_gemma":[0.10236378,0.07486781,0.018285843,0.013413186,0.01862129,0.00026319022,0.0030866512,0.00091849704,0.76817966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99457234,0.0012056064,0.00031686056,0.00076890906,0.0027461187,0.00039010792],"domain_scores_gemma":[0.9935846,0.0021488434,0.0004945959,0.0006493713,0.0021194478,0.0010030915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061673517,0.0021748326,0.0020293253,0.003069326,0.003239501,0.010551121,0.0013844761,0.005728079,0.09030712],"category_scores_gemma":[0.009787045,0.0008934601,0.001230884,0.002914468,0.0023972178,0.0037809736,0.0017587678,0.00883021,0.023156129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007212776,0.00027262597,0.0046828086,0.0006843281,0.00016943866,0.0021015934,0.00064335007,0.0029879136,0.0039674244,0.10335087,0.445068,0.43535027],"study_design_scores_gemma":[0.00008202461,0.000022737522,0.0037612026,0.00010270016,0.00000972539,0.0005172006,0.00006798451,0.00055640616,0.0004779307,0.001487088,0.9928966,0.000018407243],"about_ca_topic_score_codex":0.19981663,"about_ca_topic_score_gemma":0.12637188,"teacher_disagreement_score":0.19981663,"about_ca_system_score_codex":0.012389671,"about_ca_system_score_gemma":0.0141918855,"threshold_uncertainty_score":0.39730716},"labels":[],"label_agreement":null},{"id":"W2138359733","doi":"10.1124/dmd.105.005074","title":"PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute","keywords":"Microsome; CYP2E1; Recombinant DNA; Chloral hydrate; Cytochrome P450; Chemistry; Hydroxylation; Microsoma; Biochemistry; Cytochrome; Unspecific monooxygenase; Metabolism; Enzyme; Molecular biology; Biology; Pharmacology; CYP1A2; Gene","score_opus":0.02971548909317086,"score_gpt":0.3724688113440229,"score_spread":0.34275332225085203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138359733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228764,0.002813675,0.0032311317,0.000159622,0.000013619051,0.000035722518,0.00008569664,0.0000335808,0.001339314],"genre_scores_gemma":[0.99788994,0.0006666377,0.0005364464,0.00003099867,0.000009120385,0.0000114430395,0.00009314812,0.0000083776395,0.00075383566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996532,0.00015503496,0.000012998099,0.000043269934,0.00007805512,0.000057440837],"domain_scores_gemma":[0.99959713,0.00015234767,0.00007655993,0.000055757904,0.00006210914,0.000056164303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005240393,0.00028070164,0.00028066282,0.00029025823,0.00024245813,0.00042070012,0.00027195696,0.0003652039,0.0011628751],"category_scores_gemma":[0.0007561748,0.0001968163,0.00038492642,0.00025799952,0.0004275165,0.00023543845,0.00021499718,0.0004087215,0.00023533276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046787173,0.00007048427,0.017207159,0.00012146865,0.00014583122,0.00065004994,0.00018665317,0.0007571582,0.9566592,0.00034416397,0.0002845255,0.018894525],"study_design_scores_gemma":[0.000045469995,0.0011979605,0.08420462,0.000010837564,0.000117430645,0.002502828,0.00021440245,0.003662579,0.9059415,0.00009665452,0.0019854296,0.000020306969],"about_ca_topic_score_codex":0.008084039,"about_ca_topic_score_gemma":0.007605848,"teacher_disagreement_score":0.008084039,"about_ca_system_score_codex":0.0006023134,"about_ca_system_score_gemma":0.0005935353,"threshold_uncertainty_score":0.016073942},"labels":[],"label_agreement":null},{"id":"W2139251954","doi":"10.1124/dmd.30.7.788","title":"Identification of Human Hepatic Cytochrome P450 Sources of N-alkylprotoporphyrin IX after Interaction with Porphyrinogenic Xenobiotics, Implications for Detection of Xenobiotic-Induced Porphyria in Humans","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Xenobiotic; Microsome; CYP1A2; Cytochrome P450; CYP3A4; Enzyme; Biochemistry; CYP2B6; CYP2C9; Biology; Isozyme; Chemistry","score_opus":0.04493355716597812,"score_gpt":0.3605573143749616,"score_spread":0.31562375720898345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139251954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952337,0.00091334863,0.0025225724,0.00008334637,0.000008637173,0.00001820941,0.0002278162,0.000021777581,0.00097058836],"genre_scores_gemma":[0.9973241,0.00034209088,0.0007305173,0.000025703985,0.000012039152,0.000013146252,0.0003968893,0.0000069806965,0.0011484319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999014,0.00003303752,0.0000040580276,0.000020212228,0.000019966123,0.000021288435],"domain_scores_gemma":[0.9998497,0.000050315113,0.00003075481,0.000022658563,0.000024630188,0.00002186697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013471836,0.00016345285,0.00017505637,0.00038871128,0.00020483282,0.00020174071,0.000074095595,0.0002262846,0.0011546644],"category_scores_gemma":[0.00043511554,0.00013777544,0.00013893667,0.00025356148,0.00018867166,0.0001545298,0.00012169844,0.00027568176,0.00033733385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033695505,0.00008191093,0.023276955,0.000052701394,0.000045887173,0.00096925267,0.00011036656,0.00009878196,0.96003354,0.00023218554,0.0001890882,0.011539676],"study_design_scores_gemma":[0.00006639787,0.0007699295,0.21707602,0.000008393889,0.000110017594,0.0039349818,0.00013826514,0.0009664916,0.7744487,0.00035496018,0.0021180345,0.000007909513],"about_ca_topic_score_codex":0.0010813052,"about_ca_topic_score_gemma":0.00091906404,"teacher_disagreement_score":0.0011546644,"about_ca_system_score_codex":0.00017405207,"about_ca_system_score_gemma":0.00009420732,"threshold_uncertainty_score":0.0038627386},"labels":[],"label_agreement":null},{"id":"W2140459965","doi":"10.1124/dmd.113.053876","title":"Modulation of the UGT2B7 Enzyme Activity by C-Terminally Truncated Proteins Derived from Alternative Splicing","year":2013,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"UGT2B7; Immunoprecipitation; Glucuronidation; Alternative splicing; HEK 293 cells; Exon; Gene isoform; Biology; Biochemistry; Molecular biology; Enzyme; Microsome; Gene","score_opus":0.03003462281359642,"score_gpt":0.33190162129504924,"score_spread":0.3018669984814528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140459965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773766,0.0010787039,0.009145652,0.00030703077,0.00011841754,0.000042564745,0.0004131208,0.00008590668,0.0010709331],"genre_scores_gemma":[0.9930332,0.0005238961,0.0041002617,0.00010044338,0.00004982029,0.000026334166,0.000939538,0.000066392255,0.0011601587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971527,0.00010972845,0.00003220815,0.00005629885,0.000054370048,0.000032121032],"domain_scores_gemma":[0.9997317,0.000080358885,0.00007931406,0.000045954217,0.000027995613,0.000034562716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040073122,0.00045116438,0.00033123157,0.00017984184,0.00016298985,0.00045679527,0.00025467743,0.000383854,0.0013562067],"category_scores_gemma":[0.00038133535,0.00017645939,0.00055227434,0.00017148272,0.00048335624,0.0001615284,0.00016149637,0.00089559174,0.00061418064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003336237,0.00002419631,0.0002581112,0.000022231792,0.000022388922,0.0001340217,0.000017866541,0.00017650689,0.99669266,0.0004799263,0.000067380635,0.0017711484],"study_design_scores_gemma":[0.00009725214,0.0004713025,0.0020134782,0.0000088074285,0.00007472711,0.00083411083,0.000020992133,0.0027677447,0.98914975,0.0002132091,0.004336258,0.000012291986],"about_ca_topic_score_codex":0.00039779572,"about_ca_topic_score_gemma":0.00037280738,"teacher_disagreement_score":0.0013562067,"about_ca_system_score_codex":0.0003289259,"about_ca_system_score_gemma":0.0002500308,"threshold_uncertainty_score":0.0045369864},"labels":[],"label_agreement":null},{"id":"W2140561987","doi":"10.1111/j.1365-2052.2004.01140.x","title":"Molecular cloning, expression and functional characterization of the <i>cytochrome P450 2A6</i> gene in pig liver*","year":2004,"lang":"en","type":"article","venue":"Animal Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Skatole; Biology; CYP2A6; Boar taint; Gene; Cloning (programming); Cytochrome P450; Genetics; Endocrinology; Metabolism; Biochemistry","score_opus":0.0544572035282528,"score_gpt":0.3440955892109555,"score_spread":0.2896383856827027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140561987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785266,0.001176557,0.015307509,0.00044311807,0.00013986525,0.00016342255,0.0024210552,0.00008426773,0.00173765],"genre_scores_gemma":[0.9506878,0.0016740466,0.019966785,0.00023071823,0.00011463086,0.00012377198,0.017773647,0.00009537698,0.0093332585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998938,0.000019550871,0.000012745846,0.00002825536,0.000022371236,0.00002327794],"domain_scores_gemma":[0.9997998,0.000056189245,0.00004994373,0.000027706854,0.000028088503,0.000038328297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020868005,0.00029039773,0.00021630591,0.00027343008,0.000201175,0.0002807969,0.00022670353,0.0003353354,0.0011267462],"category_scores_gemma":[0.00020568808,0.00019328725,0.00056177936,0.00016650998,0.00027406245,0.00016166492,0.00015752095,0.0005024516,0.0010909536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000805066,0.000036171044,0.0003120687,0.000033715052,0.000004982308,0.000086489505,0.000019398962,0.000046433335,0.9982291,0.000104745464,0.000039777828,0.0010065988],"study_design_scores_gemma":[0.00008189981,0.0010367957,0.02759036,0.000022734994,0.000070248774,0.0019280097,0.00010192256,0.0019784092,0.9553935,0.00019958151,0.011577731,0.00001886054],"about_ca_topic_score_codex":0.0008667413,"about_ca_topic_score_gemma":0.0008458703,"teacher_disagreement_score":0.0011267462,"about_ca_system_score_codex":0.00021899394,"about_ca_system_score_gemma":0.00016529225,"threshold_uncertainty_score":0.0037693381},"labels":[],"label_agreement":null},{"id":"W2140675020","doi":"10.18433/j38c88","title":"The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion","year":2012,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Nakatomi Foundation","keywords":"Pregnane X receptor; Constitutive androstane receptor; Farnesoid X receptor; Pregnane; Nuclear receptor; Internal medicine; Multidrug resistance-associated protein 2; Receptor; Endocrinology; Blot; Chemistry; Biology; Biochemistry; Medicine; Transporter; Transcription factor; Gene; ATP-binding cassette transporter","score_opus":0.1073705201871103,"score_gpt":0.43610816376809325,"score_spread":0.32873764358098295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140675020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805119,0.014488585,0.0032206345,0.00020337786,0.000080349746,0.000028337094,0.00028927135,0.00016226545,0.0010154274],"genre_scores_gemma":[0.9887207,0.004805798,0.0015197773,0.00011358223,0.00004655328,0.00006800102,0.0006055469,0.000026928637,0.0040930375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980146,0.000029253912,0.00002255257,0.000046386922,0.000052058705,0.00004826624],"domain_scores_gemma":[0.99982786,0.000014686321,0.00007510778,0.000015302747,0.000026519541,0.00004040501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022708083,0.0004553254,0.0005066724,0.0003571623,0.00015347353,0.00027778296,0.00011723383,0.00029404095,0.0021252634],"category_scores_gemma":[0.00019223722,0.00016696309,0.0005002169,0.00021262364,0.00036622418,0.00038105063,0.000141171,0.0005929501,0.00043936374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011019272,0.000060273822,0.0017807651,0.00020584778,0.00002413045,0.00022753677,0.000049337123,0.000038835107,0.9933477,0.000058389203,0.000067548426,0.0030376075],"study_design_scores_gemma":[0.00010373529,0.0022027064,0.08392749,0.000036982598,0.00018315528,0.0019494315,0.00031034226,0.0006718128,0.9070556,0.00015487145,0.0033807023,0.00002319261],"about_ca_topic_score_codex":0.00031916462,"about_ca_topic_score_gemma":0.00035023436,"teacher_disagreement_score":0.0021252634,"about_ca_system_score_codex":0.00025265073,"about_ca_system_score_gemma":0.00018157298,"threshold_uncertainty_score":0.0071097016},"labels":[],"label_agreement":null},{"id":"W2141414647","doi":"10.1016/j.clpt.2004.08.019","title":"Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Pfizer","keywords":"Felodipine; Cmax; Grapefruit juice; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Crossover study; Bioavailability; Oral administration; Medicine; Biochemistry; Internal medicine; Placebo","score_opus":0.17119421496437587,"score_gpt":0.5234489298046765,"score_spread":0.35225471484030063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141414647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612206,0.0029694894,0.0002484904,0.00006700842,0.000010275809,0.00003925365,0.00007690513,0.000011880743,0.000454604],"genre_scores_gemma":[0.9983803,0.0007335355,0.00035093713,0.00009721316,0.000016862099,0.000018200275,0.00005743399,0.0000027770757,0.00034274603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998474,0.00006468299,0.000007147149,0.00004105212,0.000023880108,0.000015798592],"domain_scores_gemma":[0.99988043,0.000034964996,0.000039367384,0.000012853754,0.000007009998,0.000025365092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035941065,0.00033912927,0.00053650927,0.000109331835,0.0002282876,0.00040167055,0.00011936855,0.00054550666,0.0014938172],"category_scores_gemma":[0.00052745175,0.00017630433,0.00026643748,0.00012047121,0.00025533023,0.00021440841,0.00008456578,0.00029831915,0.0001549568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19239114,0.004266933,0.36405748,0.0012961421,0.0025135106,0.002206076,0.00059144193,0.0009833361,0.28161263,0.0005427252,0.0011662893,0.14837223],"study_design_scores_gemma":[0.0028449085,0.03892144,0.9316251,0.000043385855,0.0010866319,0.0025834544,0.00011668436,0.001765569,0.016054448,0.00031387605,0.004603127,0.000041282536],"about_ca_topic_score_codex":0.0014326253,"about_ca_topic_score_gemma":0.0018589956,"teacher_disagreement_score":0.0014938172,"about_ca_system_score_codex":0.0003119403,"about_ca_system_score_gemma":0.0001968925,"threshold_uncertainty_score":0.004997313},"labels":[],"label_agreement":null},{"id":"W2141433964","doi":"10.1104/pp.008011","title":"Cloning, Functional Expression, and Subcellular Localization of Multiple NADPH-Cytochrome P450 Reductases from Hybrid Poplar","year":2002,"lang":"en","type":"article","venue":"PLANT PHYSIOLOGY","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Arabidopsis; Cytochrome P450; Biochemistry; Yeast; Saccharomyces cerevisiae; Subcellular localization; Gene isoform; Green fluorescent protein; Fusion protein; Monooxygenase; Endoplasmic reticulum; Heterologous expression; Cytochrome; Gene; Arabidopsis thaliana; Reductase; Enzyme; Recombinant DNA","score_opus":0.0853372045055348,"score_gpt":0.3239583739178341,"score_spread":0.23862116941229933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141433964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057615,0.0008046577,0.0065751118,0.00014281471,0.000013994048,0.000021766562,0.0011098544,0.00007493435,0.0006807133],"genre_scores_gemma":[0.9815607,0.0007742009,0.006965629,0.000060461924,0.000019071658,0.000022471046,0.008005497,0.000053975404,0.0025379937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998634,0.000020952835,0.000011367657,0.000036761307,0.00003884094,0.000028661098],"domain_scores_gemma":[0.9998253,0.000040965253,0.000044060343,0.000022408947,0.000028311955,0.000038909082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021423268,0.00035693642,0.00017603337,0.0002891377,0.00021362322,0.0003455201,0.00017629442,0.0002442461,0.000547473],"category_scores_gemma":[0.00016846006,0.00016774533,0.00037357764,0.0002824183,0.00018143677,0.0002062222,0.00021517847,0.0005183788,0.0003851147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048624785,0.000010233401,0.00032291393,0.000021772414,0.0000051148636,0.000045679502,0.000023602108,0.000047317455,0.998588,0.00008357418,0.000020576665,0.0007825025],"study_design_scores_gemma":[0.000029605517,0.0002474439,0.025485367,0.000009298002,0.00008321114,0.0015207572,0.000106895975,0.0014446035,0.9655186,0.00022025293,0.0053181155,0.00001592456],"about_ca_topic_score_codex":0.0008579097,"about_ca_topic_score_gemma":0.0009826944,"teacher_disagreement_score":0.0008579097,"about_ca_system_score_codex":0.00034437652,"about_ca_system_score_gemma":0.00015880133,"threshold_uncertainty_score":0.0024986863},"labels":[],"label_agreement":null},{"id":"W2141768943","doi":"10.1681/asn.v122326","title":"Downregulation of Hepatic Cytochrome P450 in Chronic Renal Failure","year":2001,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Endocrinology; Internal medicine; Phenobarbital; Cytochrome P450; CYP1A2; CYP2E1; Dexamethasone; Downregulation and upregulation; Drug metabolism; Medicine; Chemistry; Biology; Metabolism; Gene","score_opus":0.04922851269049775,"score_gpt":0.388355913755556,"score_spread":0.33912740106505823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141768943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978409,0.0012653472,0.0004931223,0.00004074798,0.000007961062,0.000009974215,0.000045032124,0.000008138746,0.00028880776],"genre_scores_gemma":[0.99891686,0.0005003012,0.00024912436,0.000032111824,0.000018181703,0.000010929969,0.00010093065,0.000001677985,0.00016980286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999163,0.00002348911,0.0000065215963,0.00001559504,0.00002375743,0.000014341609],"domain_scores_gemma":[0.9998264,0.000025051877,0.0000596567,0.000015947058,0.00002161113,0.00005136955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017613663,0.00017500778,0.00028559606,0.000139643,0.00020186097,0.00010965875,0.000073804425,0.00019022495,0.000664782],"category_scores_gemma":[0.00021335372,0.000069853646,0.00018372045,0.00012236323,0.0002661633,0.00009027841,0.00013393932,0.000354687,0.00007967301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006444176,0.00053284195,0.16604757,0.00030150954,0.00019032578,0.0022561636,0.00013662371,0.0003428652,0.78664243,0.00010744888,0.0003741764,0.03662389],"study_design_scores_gemma":[0.000082177874,0.0028612928,0.97661746,0.000011331373,0.00007681481,0.00217247,0.00005939616,0.00030768648,0.016744649,0.00006705014,0.0009914411,0.000008205848],"about_ca_topic_score_codex":0.00069078634,"about_ca_topic_score_gemma":0.000720883,"teacher_disagreement_score":0.00069078634,"about_ca_system_score_codex":0.00014801223,"about_ca_system_score_gemma":0.00015574248,"threshold_uncertainty_score":0.002223909},"labels":[],"label_agreement":null},{"id":"W2141825656","doi":"10.1073/pnas.1019441108","title":"Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system","year":2011,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Structural Genomics Consortium; University of Toronto","funders":"Knut och Alice Wallenbergs Stiftelse; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; Ontario Innovation Trust; Wellcome Trust; GlaxoSmithKline","keywords":"Adrenodoxin; Cholesterol side-chain cleavage enzyme; Pregnenolone; Monooxygenase; Chemistry; Cytochrome P450; Stereochemistry; Heme; Steroid biosynthesis; Cytochrome; Steroid; Biochemistry; Enzyme; Hormone","score_opus":0.18492638363825886,"score_gpt":0.4017444171117118,"score_spread":0.21681803347345296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141825656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92450297,0.015994318,0.031782135,0.0041540265,0.00040193397,0.00011268824,0.00047455291,0.00044494937,0.02213239],"genre_scores_gemma":[0.99013305,0.0035487826,0.0039205095,0.00014672495,0.00006549217,0.000018968516,0.0004179311,0.000011748205,0.0017368541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999356,0.000011318327,0.0000041851663,0.0000125660345,0.000023901695,0.000012367818],"domain_scores_gemma":[0.9999385,0.000010065201,0.000016416809,0.0000071520967,0.0000099230565,0.000017895858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103715756,0.00026777803,0.00025708412,0.00011893577,0.00045993135,0.00041822676,0.0004152455,0.00037524232,0.0023920315],"category_scores_gemma":[0.00022731954,0.00011809812,0.00019372065,0.00012253359,0.00041981437,0.00030447537,0.00030188612,0.0005121983,0.0008984139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006659308,0.00014480493,0.0059955013,0.000788737,0.00006818094,0.0028681452,0.0003431501,0.014680822,0.86299914,0.08494392,0.0018397982,0.024661813],"study_design_scores_gemma":[0.000528003,0.0022097025,0.023163674,0.000265308,0.00014846747,0.006397472,0.0011370317,0.07634794,0.62225145,0.10383827,0.1635442,0.0001685072],"about_ca_topic_score_codex":0.00091658917,"about_ca_topic_score_gemma":0.0006888805,"teacher_disagreement_score":0.0023920315,"about_ca_system_score_codex":0.0006152394,"about_ca_system_score_gemma":0.0004444632,"threshold_uncertainty_score":0.008002102},"labels":[],"label_agreement":null},{"id":"W2141840620","doi":"10.1001/jama.2013.282426","title":"Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury","year":2013,"lang":"en","type":"article","venue":"JAMA","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University; St. Michael's Hospital; London Health Sciences Centre; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clarithromycin; Azithromycin; Amlodipine; Calcium channel blocker; Nifedipine; Internal medicine; Population; Acute kidney injury; Pharmacology; Calcium; Blood pressure; Antibiotics","score_opus":0.059671964273727604,"score_gpt":0.4090034394094295,"score_spread":0.3493314751357019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141840620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967546,0.0053529744,0.00016789393,0.0004911542,0.000030603383,0.00004936849,0.0016435108,0.000009466671,0.0025795419],"genre_scores_gemma":[0.99709284,0.0013344834,0.00022155374,0.000116494586,0.000060907296,0.000015478121,0.0006800736,0.0000020009127,0.00047624327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991738,0.00008611419,0.00011029635,0.000118505304,0.00038056524,0.00013067947],"domain_scores_gemma":[0.99738663,0.00021770778,0.0016654669,0.00006716371,0.00034957257,0.00031339668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261331,0.00023134117,0.00039786,0.00061808276,0.000578108,0.0006378748,0.0003623862,0.00038054748,0.0024221751],"category_scores_gemma":[0.002445888,0.00014432095,0.00046528582,0.0015817959,0.0003250374,0.00036031,0.00030612195,0.0005901955,0.00017893189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097294746,0.000026773567,0.99678826,0.00006287298,0.00008871096,0.000083894105,0.00003586579,0.000021577953,0.00014438071,0.000013945198,0.000196416,0.0024400917],"study_design_scores_gemma":[0.0000071694085,0.000021603437,0.99933136,0.000016806604,0.000040336752,0.00020112368,0.000021414397,0.000059696013,0.000033405602,0.000008757736,0.0002567284,0.0000016674534],"about_ca_topic_score_codex":0.17840694,"about_ca_topic_score_gemma":0.26222414,"teacher_disagreement_score":0.17840694,"about_ca_system_score_codex":0.0018546,"about_ca_system_score_gemma":0.002727451,"threshold_uncertainty_score":0.35473704},"labels":[],"label_agreement":null},{"id":"W2141887125","doi":"10.1124/dmd.105.006742","title":"DETERMINATION OF THE ENZYME(S) INVOLVED IN THE METABOLISM OF AMIODARONE IN LIVER AND INTESTINE OF RAT: THE CONTRIBUTION OF CYTOCHROME P450 3A ISOFORMS","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ketoconazole; Cytochrome P450; Microsome; CYP3A4; CYP3A; Metabolite; Metabolism; CYP1A2; In vivo; Isozyme; Pharmacokinetics; Enzyme; Drug metabolism; Pharmacology; Internal medicine; Endocrinology; Chemistry; Biology; Biochemistry; Medicine","score_opus":0.028599046237132556,"score_gpt":0.3363189644912888,"score_spread":0.30771991825415623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141887125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138206,0.0022045304,0.004445907,0.00011421491,0.000026490743,0.000027924752,0.00061982527,0.000045504967,0.0011336274],"genre_scores_gemma":[0.9904856,0.0015629352,0.004230192,0.00005092867,0.000027628716,0.000037904334,0.0009606282,0.000026775273,0.0026173803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991333,0.000015120003,0.000005906127,0.000024612526,0.00001618079,0.000024782792],"domain_scores_gemma":[0.99970764,0.000055608147,0.00006185124,0.000033379896,0.000055611967,0.0000858157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018453208,0.00031270346,0.0003492246,0.00055631786,0.00023714708,0.00025852327,0.00016832341,0.00033581693,0.0011549102],"category_scores_gemma":[0.0002799111,0.00024670424,0.00043147927,0.00034259722,0.00028871544,0.00040482098,0.00012886622,0.0006513946,0.00034726536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014910505,0.000047936257,0.0069935434,0.00006300129,0.000042147432,0.00013953952,0.000049100232,0.00009270548,0.9853158,0.00024090867,0.000051224277,0.0054729837],"study_design_scores_gemma":[0.00005368819,0.0009333413,0.12374025,0.0000142733525,0.00018638425,0.0006802942,0.00014849026,0.0012733791,0.8706845,0.0002616492,0.0020083499,0.000015398904],"about_ca_topic_score_codex":0.001926401,"about_ca_topic_score_gemma":0.0025233065,"teacher_disagreement_score":0.001926401,"about_ca_system_score_codex":0.00022535854,"about_ca_system_score_gemma":0.0002943436,"threshold_uncertainty_score":0.0038635135},"labels":[],"label_agreement":null},{"id":"W2142335982","doi":"10.1371/journal.pone.0027808","title":"Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Robarts Clinical Trials; Western University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Warfarin; Pharmacodynamics; VKORC1; CYP2C9; Dosing; Medicine; Pharmacokinetics; Pharmacogenetics; Pharmacology; Internal medicine; Vitamin K epoxide reductase; Atrial fibrillation; Renal function; Biology; Genotype","score_opus":0.3086663071683788,"score_gpt":0.43226499691060294,"score_spread":0.12359868974222415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142335982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989473,0.00013273765,0.00055060454,0.00003479186,0.0000017166636,0.000007041684,0.000116076655,0.000008153538,0.00020170187],"genre_scores_gemma":[0.99946195,0.00003838088,0.0002716518,0.000009863957,0.0000025511465,0.0000052325768,0.00015178371,0.0000031148984,0.000055544773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915457,0.00033093363,0.00008490354,0.00016659538,0.00017211365,0.00009084711],"domain_scores_gemma":[0.9962178,0.0021761497,0.00097057107,0.0003033042,0.00012602861,0.00020612933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011524567,0.00023662602,0.00056162034,0.000334876,0.00018279818,0.0005214198,0.00021051342,0.00039528453,0.00067886885],"category_scores_gemma":[0.0059019583,0.00022262406,0.0006036093,0.0004992482,0.00023336068,0.00022486872,0.00017533716,0.00068476197,0.00021759006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004083396,0.0000366452,0.9921665,0.000008144267,0.00008137951,0.00014656527,0.00006417996,0.001406706,0.00080920395,0.000073653806,0.00006805592,0.0047306395],"study_design_scores_gemma":[0.000022914723,0.0003908119,0.98782027,0.000004831155,0.000068880436,0.000685415,0.000059324197,0.009893201,0.00063648185,0.00021054731,0.0001975624,0.000009664692],"about_ca_topic_score_codex":0.0022221738,"about_ca_topic_score_gemma":0.001771834,"teacher_disagreement_score":0.0022221738,"about_ca_system_score_codex":0.00048381882,"about_ca_system_score_gemma":0.00044506224,"threshold_uncertainty_score":0.0060948133},"labels":[],"label_agreement":null},{"id":"W2142783300","doi":"10.1208/s12248-009-9135-y","title":"Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines","year":2009,"lang":"en","type":"review","venue":"The AAPS Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Constitutive androstane receptor; Pregnane X receptor; Pregnane; Pharmacology; Receptor; Chemistry; Nuclear receptor; Biology; Biochemistry; Transcription factor; Gene; Stereochemistry","score_opus":0.11987898279930992,"score_gpt":0.45032839951489584,"score_spread":0.3304494167155859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142783300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021376004,0.99163425,0.0008323848,0.0002486085,0.00017430047,0.000012510772,0.00007677361,0.000028682185,0.004854867],"genre_scores_gemma":[0.0061482415,0.9882563,0.000910343,0.00014370788,0.00016050022,0.000013887031,0.000109700144,0.0000027582164,0.004254636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999131,0.000010458027,0.000012374265,0.000016223867,0.000038115526,0.0000096419235],"domain_scores_gemma":[0.99993443,0.000027257021,0.000015709908,0.0000038223893,0.000014026887,0.0000047095436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016504356,0.00046564118,0.0007773889,0.00081983407,0.00013501247,0.0003887802,0.00038399527,0.0004318912,0.0030169352],"category_scores_gemma":[0.0001975066,0.00017188971,0.00030595213,0.0008960492,0.00018787748,0.00038988382,0.00025966155,0.0004887419,0.0018185315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014823044,0.00006938746,0.00032288165,0.0057674553,0.00007041782,0.0005269207,0.000027718706,0.00038808296,0.017540865,0.0018324477,0.0074866964,0.9658188],"study_design_scores_gemma":[0.000059417107,0.0002586052,0.003613647,0.0008341778,0.00019111298,0.00491058,0.00006541981,0.00022605604,0.01343935,0.0016682711,0.97470605,0.00002736065],"about_ca_topic_score_codex":0.00074734003,"about_ca_topic_score_gemma":0.0013941727,"teacher_disagreement_score":0.0030169352,"about_ca_system_score_codex":0.0002266614,"about_ca_system_score_gemma":0.00034990598,"threshold_uncertainty_score":0.010092676},"labels":[],"label_agreement":null},{"id":"W2142971789","doi":"10.1124/jpet.111.184671","title":"Generation and Characterization of a Cyp2f2-Null Mouse and Studies on the Role of CYP2F2 in Naphthalene-Induced Toxicity in the Lung and Nasal Olfactory Mucosa","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; University of California, Davis; University of Toronto; University of Michigan","keywords":"Toxicity; Xenobiotic; Olfactory mucosa; Pharmacology; Biology; Chemistry; Respiratory tract; Respiratory system; Biochemistry; Enzyme; Olfactory system; Anatomy","score_opus":0.23798269610214934,"score_gpt":0.4333925461781499,"score_spread":0.19540985007600054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142971789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9042277,0.004155472,0.064131804,0.0023334615,0.0005515324,0.0013488622,0.016027594,0.0009069796,0.0063164732],"genre_scores_gemma":[0.87391347,0.0051109726,0.052265704,0.0009099627,0.0002281443,0.0021395853,0.0142387245,0.0011337597,0.050059743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990042,0.000101298785,0.00016114168,0.00026500612,0.0003211679,0.00014724233],"domain_scores_gemma":[0.99885476,0.00021370845,0.00030304564,0.0001728836,0.00011888067,0.00033677858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013513371,0.0014878396,0.0008832226,0.0039170836,0.0011029217,0.001202635,0.0013924668,0.002428444,0.006845288],"category_scores_gemma":[0.00076458085,0.0013786941,0.001498976,0.0007628367,0.0013916177,0.0010930538,0.00076621206,0.0031356865,0.0021876476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003658321,0.00029585947,0.00064773066,0.00008442841,0.000039746214,0.00078371115,0.00012555753,0.0002179096,0.99207765,0.0023834282,0.00040198246,0.0025761002],"study_design_scores_gemma":[0.00038321552,0.0009890089,0.009355608,0.000096660304,0.0002341417,0.005533143,0.00028626097,0.002910923,0.9505218,0.0012152035,0.028403139,0.00007095436],"about_ca_topic_score_codex":0.0014797597,"about_ca_topic_score_gemma":0.0028684568,"teacher_disagreement_score":0.006845288,"about_ca_system_score_codex":0.0007560523,"about_ca_system_score_gemma":0.000521189,"threshold_uncertainty_score":0.022899806},"labels":[],"label_agreement":null},{"id":"W2143918910","doi":"10.1111/bcpt.12492","title":"Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome <scp>P</scp>450 3<scp>A</scp> Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects","year":2015,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"MicroDose; CYP3A; Midazolam; Endogeny; Pharmacology; Pharmacokinetics; Endocrinology; Oral administration; Basal (medicine); Chemistry; Internal medicine; In vivo; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.2766665519382691,"score_gpt":0.4385634322602433,"score_spread":0.1618968803219742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993788,0.00026109876,0.00014462126,0.000009514004,0.0000014857362,0.00000489288,0.00010394638,0.00000547708,0.00009021007],"genre_scores_gemma":[0.99961144,0.00005158411,0.00012977967,0.000011020221,0.000002630931,0.000004625546,0.000105395186,0.0000022680995,0.00008130116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999653,0.000099450845,0.000031596475,0.00012500785,0.000058136655,0.000032781714],"domain_scores_gemma":[0.9993192,0.00016132582,0.00031785108,0.0000791046,0.000054298882,0.000068206544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037064287,0.00025365865,0.00035580833,0.00035245813,0.00015602208,0.00043190664,0.00011749123,0.00040722862,0.00072655396],"category_scores_gemma":[0.0010209759,0.00021565004,0.00021002724,0.00031687194,0.00024519293,0.00016206327,0.00019989107,0.00029914168,0.00017034782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003448179,0.000082181956,0.96500856,0.00003149078,0.00022509623,0.000273821,0.00014636692,0.000109358014,0.024872264,0.00003512444,0.00007531464,0.0056923144],"study_design_scores_gemma":[0.000010249766,0.00030930826,0.99829143,0.000001247676,0.000029987004,0.0002984682,0.00003160422,0.00017289935,0.00078185764,0.000019129755,0.00005142577,0.000002366084],"about_ca_topic_score_codex":0.001199541,"about_ca_topic_score_gemma":0.0013132972,"teacher_disagreement_score":0.001199541,"about_ca_system_score_codex":0.00015266538,"about_ca_system_score_gemma":0.00009948961,"threshold_uncertainty_score":0.0024305582},"labels":[],"label_agreement":null},{"id":"W2144969114","doi":"10.1124/dmd.105.008128","title":"THE ROLE OF CYP2A AND CYP2E1 IN THE METABOLISM OF 3-METHYLINDOLE IN PRIMARY CULTURED PORCINE HEPATOCYTES","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"CYP2E1; Cytochrome P450; Metabolism; Incubation; Microsome; Biology; Isozyme; CYP1A2; Biochemistry; Hepatocyte; Enzyme; Internal medicine; In vitro; Medicine","score_opus":0.014725850361218987,"score_gpt":0.3177207614971744,"score_spread":0.3029949111359554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144969114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280126,0.0060044494,0.005119486,0.00034912062,0.000098238495,0.000044804165,0.001190303,0.000053246364,0.0043390146],"genre_scores_gemma":[0.9933622,0.0011174491,0.0013951394,0.000090097026,0.000024608169,0.000035175024,0.00095446367,0.000014196566,0.0030066317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971896,0.00011728294,0.000025071342,0.0000399524,0.000052859526,0.00004579386],"domain_scores_gemma":[0.999624,0.00019732017,0.000024238538,0.00006642211,0.00005846746,0.000029467776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033667716,0.00016306136,0.0003547974,0.00035062188,0.00032362156,0.0005932514,0.0001718458,0.00029228738,0.0012983598],"category_scores_gemma":[0.00036092298,0.00024224208,0.0005519089,0.00023516877,0.00024887634,0.00031149958,0.00016431561,0.0004570351,0.0004820799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016750674,0.00009572718,0.004809132,0.000113912385,0.000054956872,0.0005442648,0.00012869846,0.00047105047,0.985263,0.00036168256,0.00024546342,0.006236984],"study_design_scores_gemma":[0.00006521942,0.0012384293,0.05636112,0.000016580598,0.00010438167,0.0010562392,0.00032785645,0.003167908,0.9341486,0.00017242107,0.0033179736,0.000023254568],"about_ca_topic_score_codex":0.005367996,"about_ca_topic_score_gemma":0.007170375,"teacher_disagreement_score":0.005367996,"about_ca_system_score_codex":0.00041469367,"about_ca_system_score_gemma":0.00040867884,"threshold_uncertainty_score":0.010673523},"labels":[],"label_agreement":null},{"id":"W2145560209","doi":"10.1186/bcr2747","title":"Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Surgical oncology; Oncology; Oestrogen receptor; Internal medicine; Cancer; Antidepressant; Pharmacology","score_opus":0.07700388714980293,"score_gpt":0.46746011276293703,"score_spread":0.3904562256131341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145560209","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1831645,0.65412056,0.00088498567,0.11389635,0.0060051694,0.00038885637,0.0065060603,0.00016619335,0.034867365],"genre_scores_gemma":[0.5426906,0.3865672,0.0022753915,0.035061553,0.010981071,0.00040671986,0.002246355,0.000034708875,0.019736439],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99962795,0.0001335679,0.000049560495,0.000037373564,0.000120528806,0.00003104577],"domain_scores_gemma":[0.9985953,0.00051906775,0.0005272919,0.000041434276,0.00022282785,0.00009406375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007118993,0.00019360708,0.0009327706,0.00025993254,0.00014753302,0.00038854007,0.0003940336,0.0012246182,0.0128494715],"category_scores_gemma":[0.0037129002,0.00014775193,0.0006810283,0.00028321266,0.00021624818,0.0005063494,0.00010309298,0.00076747814,0.002770777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014258286,0.0014340256,0.022709057,0.007827417,0.0022468513,0.00021809852,0.0001431635,0.00015641178,0.0020107436,0.0018425814,0.06292839,0.884225],"study_design_scores_gemma":[0.018289605,0.028381463,0.4841716,0.012420367,0.011248517,0.0025810958,0.0009346166,0.0011424753,0.003391363,0.0070654307,0.4302505,0.00012298462],"about_ca_topic_score_codex":0.0015365661,"about_ca_topic_score_gemma":0.00818549,"teacher_disagreement_score":0.0128494715,"about_ca_system_score_codex":0.00053348095,"about_ca_system_score_gemma":0.00042663308,"threshold_uncertainty_score":0.042985797},"labels":[],"label_agreement":null},{"id":"W2146261034","doi":"10.1177/1534735408328573","title":"Nutrition and the Prevention and Treatment of Cancer: Association of Cytochrome P450 CYP1B1 With the Role of Fruit and Fruit Extracts","year":2008,"lang":"en","type":"review","venue":"Integrative Cancer Therapies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer; Cancer prevention; CYP1B1; Health benefits; Enzyme; Cancer treatment; Cancer cell; Medicine; Cytochrome P450; Biotechnology; Biology; Pharmacology; Biochemistry; Traditional medicine; Internal medicine","score_opus":0.0846628672544112,"score_gpt":0.4446114760901638,"score_spread":0.35994860883575264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146261034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025795674,0.99769056,0.0002053553,0.00039031272,0.00010241619,0.0000048611373,0.000007799415,0.000008037194,0.0013327121],"genre_scores_gemma":[0.0011802001,0.99749976,0.0002427057,0.00016985282,0.00013216071,0.0000063625325,0.000013168268,0.0000014186239,0.0007543041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998325,0.000046998866,0.00001664067,0.000032159318,0.000059430833,0.000012132697],"domain_scores_gemma":[0.9997799,0.00010738936,0.000034072702,0.000009812779,0.000053018506,0.000015759935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004329601,0.00058275193,0.0010196213,0.0017631651,0.00022742752,0.00063138094,0.00053021836,0.00092289347,0.0028686123],"category_scores_gemma":[0.00040311072,0.00019984703,0.00036326074,0.0023331004,0.0005101871,0.00079494435,0.00039819506,0.0012315038,0.0018091507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057444387,0.00008604308,0.00034252726,0.0056923204,0.00007275383,0.00020995378,0.000045986548,0.00020806081,0.001977767,0.0016562162,0.013073885,0.9765771],"study_design_scores_gemma":[0.00003886695,0.00020880594,0.003894851,0.00226083,0.000117884156,0.0033550428,0.000076402845,0.00013412519,0.0012977879,0.0022933537,0.9862996,0.00002248713],"about_ca_topic_score_codex":0.0014607093,"about_ca_topic_score_gemma":0.0024496792,"teacher_disagreement_score":0.0028686123,"about_ca_system_score_codex":0.00048322385,"about_ca_system_score_gemma":0.00063619274,"threshold_uncertainty_score":0.009596527},"labels":[],"label_agreement":null},{"id":"W2146859352","doi":"10.18433/j3ss35","title":"Melatonin Interaction Resulting in Severe Sedation","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Health Canada; University of Ottawa","funders":"Canadian Institutes of Health Research; Health Canada; Alberta Innovates; Canadian Patient Safety Institute","keywords":"Melatonin; CYP2C19; Pharmacology; CYP2D6; CYP3A4; Adverse effect; Nortriptyline; Drug interaction; Medicine; Drug; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.354844045881168,"score_gpt":0.5457197620734927,"score_spread":0.19087571619232468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146859352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896567,0.0033315762,0.0015370024,0.00076876394,0.000093274946,0.00012531444,0.00010926307,0.00008863106,0.0042894995],"genre_scores_gemma":[0.99776554,0.000583231,0.0003533966,0.00059406215,0.0000479755,0.000009402086,0.00005877974,0.000004484113,0.0005831634],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997136,0.00006997171,0.000039472197,0.000039794075,0.0000918538,0.00004525868],"domain_scores_gemma":[0.999453,0.0001142949,0.00027235365,0.000031533447,0.00005378353,0.00007505799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002494101,0.0002778823,0.00031617755,0.00018310835,0.00033737838,0.00033119463,0.00015899086,0.00061901956,0.0014775632],"category_scores_gemma":[0.0010957448,0.00009851469,0.0005169011,0.00015889479,0.00022093032,0.00018282451,0.00028561076,0.0005864062,0.00028158646],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005534668,0.00091381656,0.36810485,0.0007133298,0.00050714787,0.31837496,0.0008188915,0.0004799323,0.19660534,0.000632406,0.002855241,0.10445946],"study_design_scores_gemma":[0.00045269862,0.014959272,0.377783,0.00015736882,0.00064374687,0.5211559,0.0006531614,0.0031908911,0.06211804,0.0005157563,0.018309996,0.00006017919],"about_ca_topic_score_codex":0.00089808827,"about_ca_topic_score_gemma":0.0019687337,"teacher_disagreement_score":0.0014775632,"about_ca_system_score_codex":0.00044412224,"about_ca_system_score_gemma":0.0003100889,"threshold_uncertainty_score":0.0049429536},"labels":[],"label_agreement":null},{"id":"W2147147806","doi":"10.1124/dmd.105.004374","title":"CANCER CHEMOTHERAPY AND DRUG METABOLISM","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Prodrug; Pharmacology; Drug metabolism; Drug; Pharmacokinetics; Chemistry; Biology","score_opus":0.031256672280271056,"score_gpt":0.37595169551803365,"score_spread":0.3446950232377626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147147806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3025932,0.5421699,0.003744043,0.022601735,0.0006827092,0.00009861097,0.0018605585,0.00015826062,0.12609093],"genre_scores_gemma":[0.86754155,0.10613485,0.0009820781,0.0019474806,0.0005264806,0.00003078802,0.0005375036,0.000025860916,0.022273466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959046,0.00022164108,0.00002896461,0.000049518614,0.000077995675,0.000031363074],"domain_scores_gemma":[0.99927753,0.00027202602,0.00025328135,0.00004507804,0.00008834626,0.00006370757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036009258,0.00017743543,0.00027953243,0.0005875419,0.00021387184,0.0012076257,0.00014361246,0.00043942113,0.009029679],"category_scores_gemma":[0.0014971622,0.00012770838,0.00026013757,0.0010669149,0.00032323643,0.0004439276,0.00032146013,0.0005274065,0.0012518581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028025107,0.0005320841,0.31746572,0.0012526911,0.00093801785,0.002796733,0.0003367771,0.0036764184,0.01700443,0.038537867,0.02886907,0.58578765],"study_design_scores_gemma":[0.00015763158,0.0012830993,0.532984,0.0004987013,0.0006488913,0.010848872,0.00033901932,0.0033383244,0.009093921,0.026290905,0.41445455,0.00006201642],"about_ca_topic_score_codex":0.003145239,"about_ca_topic_score_gemma":0.0036223154,"teacher_disagreement_score":0.009029679,"about_ca_system_score_codex":0.0010609,"about_ca_system_score_gemma":0.00068986433,"threshold_uncertainty_score":0.030207336},"labels":[],"label_agreement":null},{"id":"W2147257532","doi":"10.1155/2009/315687","title":"Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report","year":2009,"lang":"en","type":"article","venue":"Case Reports in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network","funders":"","keywords":"Ketoconazole; Warfarin; Medicine; Pharmacology; Adverse effect; Internal medicine; Antifungal; Dermatology; Atrial fibrillation","score_opus":0.10757631726493783,"score_gpt":0.46958141924666263,"score_spread":0.3620051019817248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147257532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9356323,0.018766632,0.010049505,0.007341543,0.0013010222,0.0002801712,0.0002456351,0.0004964349,0.025886754],"genre_scores_gemma":[0.9873367,0.0029383986,0.0027455967,0.00162245,0.0023753264,0.000043985277,0.00008809006,0.00004778465,0.0028015783],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979411,0.00035122962,0.00020795462,0.0004328242,0.00030816524,0.00075883616],"domain_scores_gemma":[0.99562436,0.0015405896,0.001155965,0.00052012684,0.00023985241,0.00091907347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008030334,0.0037473657,0.0020491662,0.003632625,0.004224966,0.003306515,0.0019852822,0.009533736,0.004151212],"category_scores_gemma":[0.0060890396,0.0021420228,0.0025201712,0.002647141,0.0026695062,0.0045165536,0.002969365,0.0056037093,0.001835652],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018796565,0.00003921596,0.0022426283,0.000014502312,0.000009376782,0.99652666,0.00011395557,0.00002703161,0.00018618276,0.000105645966,0.00015576504,0.00056028244],"study_design_scores_gemma":[0.0000063083153,0.000020784164,0.00050859037,0.0000041053413,0.000007732221,0.9989901,0.00004262763,0.0000612771,0.00009094457,0.000044864177,0.00021793992,0.0000047389376],"about_ca_topic_score_codex":0.002993303,"about_ca_topic_score_gemma":0.0030478812,"teacher_disagreement_score":0.009533736,"about_ca_system_score_codex":0.0017251218,"about_ca_system_score_gemma":0.0011508288,"threshold_uncertainty_score":0.013887227},"labels":[],"label_agreement":null},{"id":"W2147316397","doi":"10.1136/tc.2003.007070","title":"Genetically decreased<i>CYP2A6</i>and the risk of tobacco dependence: a prospective study of novice smokers","year":2004,"lang":"en","type":"article","venue":"Tobacco Control","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; McGill University","funders":"Canadian Institutes of Health Research; National Cancer Institute; Centre for Addiction and Mental Health","keywords":"CYP2A6; Medicine; Psychology; Environmental health; Advertising; Business; Internal medicine","score_opus":0.027399064669853392,"score_gpt":0.3565260057322769,"score_spread":0.3291269410624235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147316397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963963,0.00007110577,0.000055816407,0.000008586573,0.0000023740654,0.0000070346055,0.000100788806,0.0000014264245,0.00011314896],"genre_scores_gemma":[0.99940145,0.000064033076,0.000078318095,0.000023561644,0.000006451373,0.000008963543,0.00020921207,0.000002057453,0.00020593005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997186,0.00008102733,0.00002428403,0.000073746254,0.00005893115,0.00004341446],"domain_scores_gemma":[0.99896216,0.00017208609,0.00039180752,0.00011021064,0.00009218021,0.00027160943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044018435,0.00034241634,0.00030825578,0.00049306656,0.0005174954,0.00048162538,0.00028961943,0.00050632964,0.0015234817],"category_scores_gemma":[0.001226837,0.0005367407,0.00035183234,0.0004585056,0.0003011341,0.00027187247,0.0003091543,0.00067393965,0.00040826685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010572278,0.00008715499,0.9989436,0.0000037083441,0.000034806137,0.000117526964,0.00006020537,0.000014210439,0.00022952867,0.0000056892113,0.000033942182,0.00036385053],"study_design_scores_gemma":[0.000010290505,0.0002301928,0.9990939,0.0000032220426,0.000018049812,0.00039075103,0.000062510175,0.00006759845,0.000039752573,0.0000071733466,0.00007409158,0.000002425533],"about_ca_topic_score_codex":0.004303636,"about_ca_topic_score_gemma":0.0039187786,"teacher_disagreement_score":0.004303636,"about_ca_system_score_codex":0.00015729207,"about_ca_system_score_gemma":0.00017870989,"threshold_uncertainty_score":0.008557141},"labels":[],"label_agreement":null},{"id":"W2147950066","doi":"10.1016/j.taap.2010.05.009","title":"Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates","year":2010,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Formic acid; Pharmacokinetics; Methanol; Pharmacology; Chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.056430861379635294,"score_gpt":0.3698630597294164,"score_spread":0.3134321983497811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147950066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961527,0.0010801775,0.00088779035,0.000110236266,0.00001979706,0.00003682599,0.00036638137,0.000055199806,0.0012909742],"genre_scores_gemma":[0.99449134,0.00118996,0.0009852451,0.00015377998,0.000021433503,0.000111767375,0.0006416556,0.00007842921,0.0023263684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996718,0.00010185837,0.000023636445,0.00008765998,0.000063067746,0.000052019055],"domain_scores_gemma":[0.99929166,0.00013927478,0.00020604413,0.00015135689,0.00006826889,0.00014329747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041974493,0.00037369996,0.0004768176,0.00094795175,0.00035753925,0.00055951305,0.00026171055,0.00048095858,0.0012457524],"category_scores_gemma":[0.0008948169,0.00038569188,0.00034372212,0.00029002753,0.0010706303,0.0006024118,0.0002905459,0.0007828645,0.0004931053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017656075,0.0006510785,0.012684421,0.0001172522,0.00019499802,0.0006151242,0.00081304833,0.00037047485,0.9483737,0.0019015213,0.000580734,0.016041705],"study_design_scores_gemma":[0.00067116646,0.0201661,0.2396201,0.000057893296,0.0007422232,0.004759508,0.0015162288,0.00455218,0.712623,0.0037745088,0.011365715,0.00015136578],"about_ca_topic_score_codex":0.0017129064,"about_ca_topic_score_gemma":0.0019065249,"teacher_disagreement_score":0.0017129064,"about_ca_system_score_codex":0.0004915674,"about_ca_system_score_gemma":0.00024670849,"threshold_uncertainty_score":0.004167497},"labels":[],"label_agreement":null},{"id":"W2148873733","doi":"10.1002/bit.21449","title":"Activity of human P450 2D6 in biphasic solvent systems","year":2007,"lang":"en","type":"article","venue":"Biotechnology and Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cofactor; Substrate (aquarium); Chemistry; Solvent; Hydrogen peroxide; Redox; Combinatorial chemistry; Enzyme; Organic synthesis; Organic chemistry; Catalysis; Biology","score_opus":0.06988047184778479,"score_gpt":0.39278734053143294,"score_spread":0.32290686868364815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148873733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96595055,0.0059118895,0.024210872,0.00021114196,0.000068795445,0.00011585182,0.00087832886,0.00016413577,0.0024884928],"genre_scores_gemma":[0.9776199,0.0028376193,0.012586931,0.000062424726,0.000039837916,0.00008494419,0.0019615989,0.0000422831,0.0047643883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959916,0.0001418369,0.000032261956,0.00008966091,0.00009928118,0.000037838883],"domain_scores_gemma":[0.99983895,0.000056774545,0.00002678131,0.00001907658,0.000039200313,0.00001909121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040650298,0.00034067643,0.00026960098,0.00022585542,0.00013352997,0.00024793964,0.00016399065,0.00024852777,0.0009028999],"category_scores_gemma":[0.0005264422,0.000105151856,0.0001731501,0.00034963203,0.00015775002,0.00020699504,0.00023021987,0.00040090756,0.0004912372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026748626,0.000046493005,0.00019818173,0.00008319762,0.000008212445,0.00004445877,0.000033537355,0.00016615128,0.99548423,0.00008573347,0.00007212792,0.0035102933],"study_design_scores_gemma":[0.000020011274,0.00029993404,0.000432022,0.0000035913122,0.000008097369,0.000113459086,0.000009946673,0.0006155964,0.99682945,0.000030965264,0.0016328747,0.0000041181274],"about_ca_topic_score_codex":0.0008499103,"about_ca_topic_score_gemma":0.00086224044,"teacher_disagreement_score":0.0009028999,"about_ca_system_score_codex":0.00023401911,"about_ca_system_score_gemma":0.00019450855,"threshold_uncertainty_score":0.0030204654},"labels":[],"label_agreement":null},{"id":"W2149041141","doi":"10.1038/sj.clpt.6100125","title":"Identification and Characterization of CYP2D6*56B, an Allele Associated with the Poor Metabolizer Phenotype","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"CYP2D6; Genotype; Allele; Phenotype; Dextromethorphan; Pharmacogenetics; Genetics; Genotype-phenotype distinction; Biology; Allele frequency; Pharmacology; Gene","score_opus":0.15461644015628376,"score_gpt":0.4811678891458,"score_spread":0.32655144898951627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149041141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997703,0.00030946042,0.00046961897,0.00040053914,0.000030277288,0.000028258162,0.00016921994,0.000012453118,0.0008771604],"genre_scores_gemma":[0.99798125,0.00030808419,0.00060077745,0.00015808306,0.0000433994,0.000009943439,0.00022024043,0.000015595795,0.0006626441],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998265,0.000024329167,0.000019097566,0.00004676341,0.00003779469,0.000045602053],"domain_scores_gemma":[0.99972695,0.000085816864,0.000057657697,0.000018770557,0.00002468202,0.00008614469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017096355,0.00043067904,0.00043564406,0.00077972526,0.00047918348,0.00037136296,0.000276244,0.0009073582,0.0015332234],"category_scores_gemma":[0.0011386517,0.00028305608,0.00031298024,0.00038945867,0.0004453025,0.0001882072,0.00024268686,0.00086421863,0.00057996373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008887149,0.00055004365,0.18947788,0.000077116885,0.000049740378,0.63380814,0.0010799101,0.00017337818,0.15676379,0.00050674495,0.0013743751,0.015250099],"study_design_scores_gemma":[0.00009049991,0.00090300204,0.22142558,0.000025140675,0.00006258669,0.7538763,0.00046679136,0.0007491242,0.017722843,0.00021035482,0.0044433163,0.000024416353],"about_ca_topic_score_codex":0.001495024,"about_ca_topic_score_gemma":0.0008547396,"teacher_disagreement_score":0.0015332234,"about_ca_system_score_codex":0.00019478286,"about_ca_system_score_gemma":0.0001542751,"threshold_uncertainty_score":0.005129099},"labels":[],"label_agreement":null},{"id":"W2149415764","doi":"10.18433/j3vk5g","title":"Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology","keywords":"CYP3A4; Pharmacology; Ketoconazole; Microsome; Chemistry; Cytochrome P450; Biology; In vitro; Biochemistry; Enzyme; Microbiology","score_opus":0.2253720399815805,"score_gpt":0.5030008218189227,"score_spread":0.2776287818373422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149415764","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42157358,0.013604966,0.5432477,0.00078473,0.0010251249,0.0026558037,0.005798442,0.00277364,0.008536099],"genre_scores_gemma":[0.5179263,0.008086503,0.43803328,0.0004085212,0.00030894284,0.004588432,0.01702714,0.00042746885,0.013193519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983078,0.0003850014,0.00022067544,0.00037177154,0.0005925728,0.00012217484],"domain_scores_gemma":[0.99910057,0.00017004494,0.0002135919,0.00018994957,0.00024763722,0.00007828892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018738153,0.0011143931,0.00083312986,0.0011359288,0.0004783677,0.0007006794,0.0010280826,0.00078835606,0.0020235828],"category_scores_gemma":[0.0010811363,0.00048409266,0.00085863343,0.0008303172,0.0006474439,0.0006483316,0.0006619201,0.001440342,0.0015041219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000586221,0.000058324877,0.00022601965,0.000110290144,0.000016037811,0.000026801834,0.000018877274,0.00011601621,0.9969171,0.000111857866,0.0000940941,0.0022460301],"study_design_scores_gemma":[0.000028863013,0.00054538576,0.0017359081,0.0000214442,0.000058363632,0.00015968236,0.000018182003,0.0010660827,0.9911294,0.00007529199,0.0051430976,0.000018247734],"about_ca_topic_score_codex":0.00087354286,"about_ca_topic_score_gemma":0.0013729106,"teacher_disagreement_score":0.0020235828,"about_ca_system_score_codex":0.00063947873,"about_ca_system_score_gemma":0.0006496168,"threshold_uncertainty_score":0.009909809},"labels":[],"label_agreement":null},{"id":"W2149441567","doi":"10.1007/s12519-013-0429-x","title":"Hepatic CYP3A expression and activity in low birth weight developing female rats","year":2013,"lang":"en","type":"article","venue":"World Journal of Pediatrics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Canada","keywords":"Offspring; CYP3A; Internal medicine; Medicine; Endocrinology; Birth weight; Messenger RNA; Group A; Andrology; Biology; Cytochrome P450; Pregnancy; Metabolism; Gene; Biochemistry","score_opus":0.0523800272155953,"score_gpt":0.37081177119264186,"score_spread":0.31843174397704654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149441567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961314,0.0004459293,0.0012396977,0.00011256299,0.000030250822,0.000009658606,0.0009796364,0.00006870654,0.0009821964],"genre_scores_gemma":[0.9754156,0.0008989723,0.0020632409,0.00011237417,0.0000249089,0.0000738427,0.0017546522,0.00011141782,0.01954506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998455,0.000011957085,0.000009178085,0.00005613017,0.000034222172,0.000042970998],"domain_scores_gemma":[0.9995491,0.00006112556,0.00013054241,0.000051483094,0.000056764147,0.00015095156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009091477,0.0003498349,0.00037746786,0.0012403729,0.00036487693,0.00039327686,0.00024246528,0.000320983,0.0032821186],"category_scores_gemma":[0.00020182632,0.00034195912,0.00027520748,0.00039371103,0.0005342993,0.00040316107,0.00021631416,0.001337173,0.0006794332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021530415,0.0002238144,0.0040162783,0.000026233403,0.000011193985,0.00029822555,0.00009413816,0.000062549945,0.9885893,0.00022528492,0.00011236516,0.004187673],"study_design_scores_gemma":[0.000059855935,0.0012072468,0.07324464,0.000011274884,0.00006794433,0.00069877954,0.00051256537,0.0006297925,0.92143124,0.00023025664,0.0018765016,0.000029778315],"about_ca_topic_score_codex":0.0029488995,"about_ca_topic_score_gemma":0.0038446088,"teacher_disagreement_score":0.0032821186,"about_ca_system_score_codex":0.0005873008,"about_ca_system_score_gemma":0.0003510624,"threshold_uncertainty_score":0.010979831},"labels":[],"label_agreement":null},{"id":"W2149451456","doi":"10.1124/dmd.107.017343","title":"Analysis of CYP2A Contributions to Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone in Human Peripheral Lung Microsomes","year":2007,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Metabolite; Microsome; Hydroxylation; Metabolism; Chemistry; CYP2A6; Internal medicine; Enzyme; Endocrinology; Cytochrome P450; Biochemistry; CYP3A4; Biology; Medicine","score_opus":0.02346603515718466,"score_gpt":0.41036627489627375,"score_spread":0.3869002397390891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149451456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280965,0.0013248371,0.0041490593,0.00008488921,0.000015568885,0.00003593078,0.00057648844,0.000046510166,0.0009570113],"genre_scores_gemma":[0.9947319,0.00044520662,0.0013373896,0.000022511176,0.000013926215,0.000033308665,0.0009910185,0.000025153922,0.0023996148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997795,0.00008968419,0.000011777487,0.000043616474,0.000039635797,0.0000356416],"domain_scores_gemma":[0.9996619,0.00015374196,0.000035210163,0.000039989995,0.00006209261,0.00004707167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040526481,0.00034739863,0.00031503598,0.0005350436,0.00045314492,0.0003712557,0.00015703251,0.0003375682,0.0024055236],"category_scores_gemma":[0.0009029314,0.0002992187,0.00044234452,0.00048654331,0.00021974376,0.00024211509,0.00019196905,0.00038404358,0.0005766101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058583086,0.00013852413,0.020329377,0.0001239127,0.00024234495,0.0005354325,0.0001976133,0.0010183789,0.95666164,0.00083923317,0.00019984224,0.013855441],"study_design_scores_gemma":[0.00012319325,0.0007343816,0.116845824,0.000010619746,0.0002772475,0.0015207152,0.00010892929,0.0058958796,0.8724306,0.0003140209,0.0017170527,0.000021394146],"about_ca_topic_score_codex":0.004631753,"about_ca_topic_score_gemma":0.005083854,"teacher_disagreement_score":0.004631753,"about_ca_system_score_codex":0.00035499045,"about_ca_system_score_gemma":0.00042650008,"threshold_uncertainty_score":0.009209573},"labels":[],"label_agreement":null},{"id":"W2149734586","doi":"10.1096/fj.03-0837lte","title":"The discovery of Captopril: reply","year":2004,"lang":"en","type":"letter","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hypertension Canada","funders":"","keywords":"Bradykinin; Saralasin; Captopril; Renin–angiotensin system; Angiotensin-converting enzyme; Angiotensin II; Medicine; Heart failure; Pharmacology; Internal medicine; Chemistry; Blood pressure; Receptor","score_opus":0.08118373522993777,"score_gpt":0.3869264635912159,"score_spread":0.30574272836127814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149734586","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014318408,0.009079062,0.00021293975,0.9275428,0.062371075,0.000010831828,0.00010034025,0.00005184127,0.00048787132],"genre_scores_gemma":[0.0011676268,0.005713428,0.0002529154,0.91736287,0.07351588,0.00002792227,0.000044567863,0.000025134419,0.0018897345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964412,0.0006935129,0.00064259185,0.00086079113,0.0010634995,0.0002983941],"domain_scores_gemma":[0.9826812,0.008788742,0.00094565627,0.00068593066,0.0044712345,0.0024271922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076824436,0.0017267575,0.0022986957,0.0013037085,0.0023546775,0.0039588767,0.0039141206,0.037397947,0.0051356186],"category_scores_gemma":[0.02745444,0.0008842887,0.0019825941,0.0009959248,0.0044492474,0.013110736,0.0030383796,0.06759058,0.0054203174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075118216,0.000026344263,0.00021398616,0.00013300762,0.000022040045,0.00040679224,0.00007640419,0.000039258193,0.00013714902,0.0014602528,0.9897656,0.007643976],"study_design_scores_gemma":[0.00014472491,0.000100924386,0.0009979915,0.00039928628,0.000057975623,0.0015717084,0.0005700768,0.00018889371,0.00058269984,0.007420643,0.98783475,0.0001302644],"about_ca_topic_score_codex":0.003280372,"about_ca_topic_score_gemma":0.0029865636,"teacher_disagreement_score":0.037397947,"about_ca_system_score_codex":0.0026373423,"about_ca_system_score_gemma":0.0034440886,"threshold_uncertainty_score":0.04062915},"labels":[],"label_agreement":null},{"id":"W2149799880","doi":"10.1038/clpt.2010.242","title":"Demonstrating Utility of Pharmacogenetics in Pediatric Populations: Methodological Considerations","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Quality (philosophy); Medicine; Computer science; Psychology; Intensive care medicine; Pharmacology; Biology; Genetics","score_opus":0.8109777463779481,"score_gpt":0.6636165452362309,"score_spread":0.14736120114171714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149799880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029467966,0.93413305,0.03145291,0.024458177,0.0014737713,0.00091073103,0.00055822864,0.00005452366,0.0040119127],"genre_scores_gemma":[0.057129428,0.85942346,0.06557128,0.010629609,0.0023669421,0.003441229,0.00054880296,0.00007072916,0.00081854453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9134575,0.06523973,0.008653874,0.0027374872,0.009508632,0.00040277577],"domain_scores_gemma":[0.6792477,0.27300557,0.011710508,0.01281723,0.022323867,0.0008951612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16400589,0.0010843518,0.0049156295,0.0030139422,0.00045511065,0.0041413796,0.0051272763,0.0018556286,0.0017887778],"category_scores_gemma":[0.2631954,0.00062312576,0.002024287,0.0042848415,0.0035152447,0.00436026,0.0023222233,0.0035213246,0.000701675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004548391,0.000089098234,0.009362757,0.043143246,0.0026152427,0.00029951567,0.00078048767,0.0010140919,0.00092284416,0.013648063,0.012632456,0.9150373],"study_design_scores_gemma":[0.0006915164,0.0012695278,0.06640947,0.15522654,0.008184171,0.004792839,0.0024266236,0.004190995,0.004345451,0.14037026,0.61180925,0.00028329104],"about_ca_topic_score_codex":0.004187112,"about_ca_topic_score_gemma":0.005983418,"teacher_disagreement_score":0.8359941,"about_ca_system_score_codex":0.001713753,"about_ca_system_score_gemma":0.008205917,"threshold_uncertainty_score":0.8673564},"labels":[],"label_agreement":null},{"id":"W2150274550","doi":"10.1034/j.1600-0447.2001.00299.x","title":"CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages","year":2001,"lang":"en","type":"article","venue":"Acta Psychiatrica Scandinavica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":423,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2D6; CYP2C19; Pharmacogenetics; Pharmacology; Dose; Medicine; Tricyclic; Drug; Pharmacokinetics; Therapeutic drug monitoring; Genotype; Cytochrome P450; Internal medicine; Biology; Genetics; Gene; Metabolism","score_opus":0.13592437100606178,"score_gpt":0.4378611409673693,"score_spread":0.30193676996130747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150274550","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2747521,0.12352309,0.4954932,0.060342748,0.0018160936,0.002204382,0.004457083,0.002388443,0.03502278],"genre_scores_gemma":[0.43556136,0.016342297,0.53592503,0.005731093,0.00093040394,0.0012258609,0.0019580084,0.00024293072,0.0020830364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99332607,0.0038970774,0.0014441612,0.00024715427,0.0010160817,0.00006936252],"domain_scores_gemma":[0.98443747,0.008825588,0.0019094164,0.0010557714,0.003587494,0.00018424151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010598968,0.0006568672,0.0017768593,0.0017289114,0.00042915856,0.0012580089,0.0016805282,0.0015346966,0.002039049],"category_scores_gemma":[0.03481377,0.00040940446,0.0012041935,0.0011298243,0.0003061523,0.0011752935,0.0004949956,0.0021474182,0.0009833768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019479843,0.0004579971,0.07897245,0.004103911,0.0013665082,0.0005384246,0.0009632647,0.011787909,0.008915185,0.005777577,0.029450107,0.85571873],"study_design_scores_gemma":[0.0036274858,0.011317487,0.45075577,0.009454554,0.006307158,0.010813191,0.002548644,0.059028197,0.03255609,0.05225159,0.36054394,0.00079588],"about_ca_topic_score_codex":0.00096116884,"about_ca_topic_score_gemma":0.002346778,"teacher_disagreement_score":0.010598968,"about_ca_system_score_codex":0.00067455263,"about_ca_system_score_gemma":0.0015060481,"threshold_uncertainty_score":0.0560534},"labels":[],"label_agreement":null},{"id":"W2150276412","doi":"10.1177/0091270004265642","title":"The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Medicine; Traditional medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.14819380871095922,"score_gpt":0.5163174603508064,"score_spread":0.36812365163984717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150276412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814653,0.001230434,0.00013116706,0.000033653898,0.000014595748,0.000015669364,0.00005300787,0.0000051388474,0.0003696676],"genre_scores_gemma":[0.9989642,0.00038466087,0.00017209187,0.00004127397,0.000029192668,0.000012073161,0.00006147153,0.0000030693293,0.00033201862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99958366,0.00021197033,0.00003175287,0.000070199014,0.000066649,0.00003585141],"domain_scores_gemma":[0.9993057,0.00034037957,0.00017228078,0.000058232523,0.00003177266,0.000091626076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040704542,0.00024998884,0.00055721606,0.00014366917,0.00011536676,0.00019005997,0.00008037606,0.00026780536,0.0015950971],"category_scores_gemma":[0.0010246651,0.00014378305,0.00034951756,0.00017622617,0.00022570818,0.00012450582,0.00009458835,0.00021197143,0.00016934179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.108657,0.0021677767,0.36276883,0.0005302098,0.0013471107,0.0014526412,0.00032305566,0.00063078315,0.37946546,0.00015820425,0.0006448005,0.14185409],"study_design_scores_gemma":[0.00089766295,0.026918303,0.9497904,0.000012712524,0.00036684383,0.0014074577,0.000056117147,0.0005132569,0.018986434,0.000043829048,0.0009938459,0.00001298699],"about_ca_topic_score_codex":0.00026986352,"about_ca_topic_score_gemma":0.0005522907,"teacher_disagreement_score":0.0015950971,"about_ca_system_score_codex":0.00010448279,"about_ca_system_score_gemma":0.00007551151,"threshold_uncertainty_score":0.0053361654},"labels":[],"label_agreement":null},{"id":"W2150595547","doi":"10.1586/17512433.2014.910111","title":"Understanding and preventing drug–drug and drug–gene interactions","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"","keywords":"Drug; Medicine; Pharmacology; Pharmacogenetics; Drug interaction; Drug action; Cytochrome P450; Drug metabolism; Pharmacogenomics; Computational biology; Gene; Biology; Genetics; Internal medicine; Genotype","score_opus":0.4669670775692211,"score_gpt":0.6204686295753388,"score_spread":0.15350155200611765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150595547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007113469,0.99230725,0.0015975614,0.0012778084,0.00020739938,0.00003455381,0.000080637525,0.000039774186,0.003743796],"genre_scores_gemma":[0.0038231614,0.99275655,0.0013436036,0.00054119993,0.00017647234,0.000025062585,0.00009968396,0.000005507095,0.0012287541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950206,0.00012854656,0.00006088613,0.000064977205,0.00020692748,0.000036505433],"domain_scores_gemma":[0.9994466,0.00027739425,0.00009368018,0.00002165969,0.00013077873,0.000029914898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008381975,0.0008365525,0.0014664982,0.0023130632,0.00023212665,0.0009272697,0.00089315034,0.0012269439,0.0047437903],"category_scores_gemma":[0.0012158899,0.00021378662,0.00096005056,0.0012094945,0.00045313494,0.0010725234,0.0007193698,0.0015156103,0.0021018353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043564112,0.00012865075,0.00043288438,0.012044187,0.00016231925,0.00027047913,0.000047576134,0.0004560678,0.002541409,0.003349036,0.014231814,0.966292],"study_design_scores_gemma":[0.000035618265,0.00024162098,0.0025015282,0.0049378187,0.00033183143,0.0025762264,0.00008527868,0.00040020558,0.0027959656,0.0047062584,0.98134965,0.00003805637],"about_ca_topic_score_codex":0.0011199558,"about_ca_topic_score_gemma":0.0017780352,"teacher_disagreement_score":0.0047437903,"about_ca_system_score_codex":0.00045450567,"about_ca_system_score_gemma":0.0012017454,"threshold_uncertainty_score":0.015869558},"labels":[],"label_agreement":null},{"id":"W2151552217","doi":"10.1016/j.ejps.2009.01.006","title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","year":2009,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; CYP3A; Isozyme; Calcitriol receptor; Pharmacology; Chemistry; Biology; Internal medicine; Biochemistry; Nuclear receptor; Cytochrome P450; Metabolism; Receptor; Medicine; Enzyme; Gene; Transcription factor","score_opus":0.17974507132693684,"score_gpt":0.47439486891350224,"score_spread":0.2946497975865654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151552217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624324,0.0023475813,0.00039594472,0.00009186008,0.000029869938,0.0000128741285,0.00018447642,0.000021747117,0.00067245506],"genre_scores_gemma":[0.9959902,0.0012955487,0.00039491415,0.000051086732,0.000032852036,0.000020641477,0.0003396384,0.000012246722,0.0018627384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996933,0.00012524953,0.000023849709,0.000054769152,0.000028837105,0.00007408612],"domain_scores_gemma":[0.9995814,0.00021874125,0.00004035608,0.00006765169,0.000032095668,0.000059736805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035355656,0.00033217014,0.00064756704,0.00021137041,0.00017559885,0.0003463079,0.00015086388,0.00033530634,0.0019789878],"category_scores_gemma":[0.00062381563,0.00026691295,0.00066755776,0.0002132888,0.0004692752,0.00032986203,0.00015569497,0.0005789511,0.00027554826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03489057,0.00035640996,0.00208528,0.0001863044,0.00012293903,0.00026457437,0.00012410384,0.00056698924,0.9473396,0.0002163563,0.00017259877,0.013674283],"study_design_scores_gemma":[0.0005496041,0.01753181,0.031103801,0.000016989667,0.00030493145,0.000688029,0.00026433798,0.0012274559,0.9451582,0.00012730359,0.0029986484,0.000028983113],"about_ca_topic_score_codex":0.0009293247,"about_ca_topic_score_gemma":0.0015120202,"teacher_disagreement_score":0.0019789878,"about_ca_system_score_codex":0.00019041423,"about_ca_system_score_gemma":0.00023674878,"threshold_uncertainty_score":0.006620407},"labels":[],"label_agreement":null},{"id":"W2152161503","doi":"10.1345/aph.1k615","title":"Induction Effects of Ritonavir: Implications for Drug Interactions","year":2008,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Ritonavir; Darunavir; CYP3A; Pharmacology; Medicine; Drug interaction; Drug; Cobicistat; Drug metabolism; Cytochrome P450; Internal medicine; Metabolism; Immunology; Human immunodeficiency virus (HIV)","score_opus":0.29311779385289366,"score_gpt":0.5361824232976135,"score_spread":0.2430646294447198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152161503","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008996792,0.9974953,0.00013875063,0.0007783439,0.00012971273,0.00003368076,0.0000736318,0.0000041855087,0.00044669982],"genre_scores_gemma":[0.011031999,0.9852422,0.00084038265,0.0015678853,0.00088892214,0.000069591144,0.000119472425,0.0000042268116,0.00023532078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944172,0.0019360156,0.0019481173,0.000383943,0.0011866825,0.0001279497],"domain_scores_gemma":[0.95845664,0.029055666,0.009294385,0.00024054998,0.002794238,0.0001585269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066686408,0.0013177226,0.0042533935,0.005628656,0.0003865276,0.002173098,0.0014425294,0.0023379694,0.005335284],"category_scores_gemma":[0.019899948,0.00043553693,0.002698027,0.0065890383,0.0007341064,0.0041474686,0.0008616471,0.0012437897,0.0007375263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061850384,0.00015178988,0.0052889744,0.4542627,0.0038841409,0.0028377632,0.00040665249,0.0005292009,0.0014315273,0.0021114233,0.011018145,0.5174592],"study_design_scores_gemma":[0.00081802515,0.002148767,0.040842764,0.50922865,0.03652662,0.023581957,0.0018801789,0.0011169467,0.0036578404,0.007489034,0.37248012,0.00022906381],"about_ca_topic_score_codex":0.0011346294,"about_ca_topic_score_gemma":0.0026961095,"teacher_disagreement_score":0.0066686408,"about_ca_system_score_codex":0.002091577,"about_ca_system_score_gemma":0.0034753215,"threshold_uncertainty_score":0.03526759},"labels":[],"label_agreement":null},{"id":"W2152193974","doi":"10.1124/dmd.105.003822","title":"CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS","year":2005,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CYP3A5; Biology; Genetics; Allele; Polymorphism (computer science); CYP3A; Population; Allele frequency; White (mutation); Single-nucleotide polymorphism; Genotype; Genetic variation; Gene; Medicine","score_opus":0.08882325038046779,"score_gpt":0.40857120840884986,"score_spread":0.3197479580283821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152193974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788517,0.00025405525,0.00029282575,0.00006459145,0.000013759411,0.000010560437,0.00012631169,0.0000051272377,0.0013475862],"genre_scores_gemma":[0.99890506,0.00009761655,0.00013702967,0.0000677386,0.00001281385,0.000009445556,0.00017967106,0.000009127086,0.00058137166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993106,0.00024472125,0.000086131324,0.00017940167,0.0000685021,0.00011068048],"domain_scores_gemma":[0.9995004,0.00019258173,0.00010750585,0.00007356468,0.00006031009,0.000065682485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006161988,0.0005579617,0.00071455556,0.0006404073,0.0007926758,0.00051068683,0.00031818665,0.0004974669,0.0048916736],"category_scores_gemma":[0.0018840645,0.0003037039,0.0008995282,0.00083800417,0.0004435145,0.000309913,0.00033745734,0.0005241375,0.0004777407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006412613,0.00036603396,0.9434463,0.00006749589,0.001746705,0.003803109,0.0021536537,0.00030599884,0.02257088,0.0011940838,0.00075543846,0.017177746],"study_design_scores_gemma":[0.00012696919,0.0002939584,0.9933269,0.000011665742,0.00049817754,0.0025922153,0.0005956264,0.00031078354,0.00094986183,0.0004274668,0.0008480406,0.000018305329],"about_ca_topic_score_codex":0.003750878,"about_ca_topic_score_gemma":0.0031912937,"teacher_disagreement_score":0.0048916736,"about_ca_system_score_codex":0.0002779093,"about_ca_system_score_gemma":0.00012903013,"threshold_uncertainty_score":0.016364217},"labels":[],"label_agreement":null},{"id":"W2152535380","doi":"10.2217/14622416.9.9.1267","title":"Pharmacogenetic Insights into Codeine Analgesia: Implications to Pediatric Codeine Use","year":2008,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Western University","funders":"","keywords":"Codeine; Pharmacogenetics; Pharmacogenomics; Medicine; Analgesic; Drug; Pharmacology; Genetic variability; Breastfeeding; Bioinformatics; Anesthesia; Biology; Genotype; Morphine; Gene; Pediatrics; Genetics","score_opus":0.2542039254300078,"score_gpt":0.48577000206218507,"score_spread":0.23156607663217726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152535380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022171944,0.99773777,0.00042281146,0.00078415667,0.00007642547,0.0000025435027,0.000013282718,0.000004553676,0.0007367886],"genre_scores_gemma":[0.0009764435,0.998052,0.0003108153,0.000190715,0.00014850392,0.0000036133547,0.0000134237935,8.1895513e-7,0.00030365522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998115,0.000056333538,0.00002567855,0.000038264432,0.00005554544,0.00001280271],"domain_scores_gemma":[0.99943143,0.00034370247,0.00007253363,0.000013729454,0.0001102089,0.000028346882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055765547,0.0006555192,0.0011217277,0.0014380285,0.00017272515,0.00064135407,0.00063457555,0.0010066441,0.0018199899],"category_scores_gemma":[0.0010161985,0.00020135789,0.00045556595,0.0019357759,0.0005946468,0.0011093302,0.00045817555,0.0012943101,0.00090662314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005623923,0.000074830015,0.0013224442,0.005805028,0.000113369024,0.0009912077,0.00011749152,0.00071240397,0.0015694142,0.0065737693,0.012608969,0.9700548],"study_design_scores_gemma":[0.000034052195,0.00016370199,0.00835247,0.0054726675,0.00023288124,0.010668763,0.00026983052,0.00064862386,0.0012393574,0.01371786,0.95914686,0.000052882595],"about_ca_topic_score_codex":0.0018596648,"about_ca_topic_score_gemma":0.0025276598,"teacher_disagreement_score":0.0018596648,"about_ca_system_score_codex":0.00060779636,"about_ca_system_score_gemma":0.0011915909,"threshold_uncertainty_score":0.0060884953},"labels":[],"label_agreement":null},{"id":"W2152578425","doi":"10.1016/j.gene.2013.03.128","title":"Allele frequency distribution of CYP2C9*2 and CYP2C9*3 polymorphisms in six Mexican populations","year":2013,"lang":"en","type":"article","venue":"Gene","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Instituto Mexicano del Seguro Social; Consejo Nacional de Ciencia y Tecnología","keywords":"Biology; CYP2C9; Allele; Allele frequency; Genetics; Polymorphism (computer science); Population; Genetic variation; Genotype; Demography; Gene","score_opus":0.09817265785402347,"score_gpt":0.4000857656625544,"score_spread":0.3019131078085309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152578425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944717,0.000040708153,0.00011901063,0.000015078947,0.0000018756186,0.0000045202905,0.000084844134,0.0000018700372,0.00028490555],"genre_scores_gemma":[0.9992803,0.000057282236,0.00018869594,0.000013433754,0.0000037794991,0.000011019511,0.00015277856,0.0000024414198,0.00029023478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997534,0.00008074396,0.00002111964,0.00007931463,0.00002685357,0.000038566566],"domain_scores_gemma":[0.99975616,0.00005281267,0.00007726119,0.00002796785,0.000042135372,0.000043701228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000398114,0.00025854027,0.00025397108,0.00085950486,0.0005201163,0.0003699651,0.00023234167,0.0002538256,0.0018095855],"category_scores_gemma":[0.000752792,0.00017216659,0.00029784854,0.00086729194,0.00033497723,0.00012570509,0.00022859473,0.00028239435,0.0001486789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017050718,0.00021650842,0.9734587,0.000028661063,0.00021324631,0.0006382563,0.0030717559,0.00012791088,0.008069647,0.0004693538,0.00027998557,0.011720821],"study_design_scores_gemma":[0.00006258705,0.00027415145,0.9958973,0.0000071711147,0.00011885082,0.0006106992,0.001468419,0.00021978535,0.00042655654,0.00010424547,0.00080110965,0.000009156989],"about_ca_topic_score_codex":0.005197017,"about_ca_topic_score_gemma":0.0035215842,"teacher_disagreement_score":0.005197017,"about_ca_system_score_codex":0.00023945114,"about_ca_system_score_gemma":0.00013134128,"threshold_uncertainty_score":0.010333538},"labels":[],"label_agreement":null},{"id":"W2152964734","doi":"10.1124/dmd.31.7.815","title":"THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":784,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmaceutical industry; Drug; Pharmacology; Business; Drug development; In vivo; Medicine; Biology; Biotechnology","score_opus":0.13308467488237608,"score_gpt":0.4867489728515031,"score_spread":0.353664297969127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152964734","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03745858,0.3159289,0.26224098,0.28902307,0.009348489,0.0017170203,0.001598273,0.00088770175,0.081797004],"genre_scores_gemma":[0.2734265,0.1511512,0.43826863,0.10045818,0.017518476,0.0014421138,0.0010459987,0.0003954907,0.016293386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9342147,0.048839215,0.0038634604,0.0024048833,0.009886582,0.0007911943],"domain_scores_gemma":[0.79174376,0.14467762,0.013757975,0.008136493,0.036812425,0.0048716962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09618574,0.0011207354,0.003172859,0.0026617972,0.0014580799,0.0074801487,0.0030723712,0.007155532,0.004854652],"category_scores_gemma":[0.07019285,0.00109298,0.0013091087,0.0022439044,0.005571362,0.0061020283,0.0019167683,0.007449649,0.0014813078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019225859,0.0025899734,0.027587516,0.003042498,0.0007010406,0.0007758296,0.0009953254,0.001957772,0.06443174,0.045473468,0.044716273,0.805806],"study_design_scores_gemma":[0.0007350656,0.019407462,0.06261149,0.0024744691,0.0016747527,0.006232475,0.005129542,0.006449374,0.09650543,0.07130916,0.72711086,0.00035989078],"about_ca_topic_score_codex":0.003063063,"about_ca_topic_score_gemma":0.009211333,"teacher_disagreement_score":0.09618574,"about_ca_system_score_codex":0.0023927004,"about_ca_system_score_gemma":0.009488428,"threshold_uncertainty_score":0.5086849},"labels":[],"label_agreement":null},{"id":"W2153126387","doi":"10.1067/mcp.2000.108023","title":"Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings*1","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Mexiletine; Propafenone; Pharmacokinetics; Pharmacology; CYP2D6; Medicine; Pharmacodynamics; Drug interaction; Oral administration; Active metabolite; Antiarrhythmic agent; Anesthesia; Cytochrome P450; Internal medicine; Metabolism; Atrial fibrillation","score_opus":0.1979069222556447,"score_gpt":0.5324100385057167,"score_spread":0.33450311625007195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153126387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963831,0.0013847041,0.0006594629,0.00006146058,0.000014503085,0.000020682313,0.00010093198,0.000019008992,0.0013560748],"genre_scores_gemma":[0.9979401,0.00055695977,0.0006482751,0.000093516595,0.000049419185,0.000028495258,0.00016639971,0.000006015071,0.00051078614],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998202,0.00007609392,0.000010299862,0.000034835615,0.00004336458,0.000015270221],"domain_scores_gemma":[0.9996619,0.00014733548,0.000070690316,0.000024909072,0.00002971648,0.000065528155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002451733,0.00022921235,0.00030057653,0.00015268635,0.0002505637,0.00027198627,0.00006687334,0.00026769075,0.0014862325],"category_scores_gemma":[0.0009094077,0.000117363576,0.0001453343,0.00013816565,0.00017634653,0.0001640021,0.00010031153,0.000262997,0.00032517905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018131623,0.001863824,0.70675224,0.00029046115,0.0005732073,0.0037681533,0.00085189997,0.0010135808,0.14883383,0.00017765525,0.001843812,0.11589962],"study_design_scores_gemma":[0.00024349218,0.016004788,0.95525587,0.000022053126,0.00030395447,0.009128802,0.0002236514,0.0017223372,0.012126659,0.00020006459,0.0047418196,0.000026613252],"about_ca_topic_score_codex":0.00048265944,"about_ca_topic_score_gemma":0.00048093242,"teacher_disagreement_score":0.0014862325,"about_ca_system_score_codex":0.00010392683,"about_ca_system_score_gemma":0.00011943901,"threshold_uncertainty_score":0.004971981},"labels":[],"label_agreement":null},{"id":"W2153709558","doi":"10.1097/01.asn.0000017575.50319.77","title":"Downregulation of Intestinal Cytochrome P450 in Chronic Renal Failure","year":2002,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; American Society of Nephrology","keywords":"Cytochrome P450; CYP3A; Endocrinology; Internal medicine; Downregulation and upregulation; Cytochrome; Drug metabolism; Gene expression; Chemistry; Biology; Medicine; Metabolism; Enzyme; Gene; Biochemistry","score_opus":0.06625344667382091,"score_gpt":0.3787255714115317,"score_spread":0.3124721247377108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153709558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984205,0.00092965877,0.00036447664,0.000029252089,0.000005580847,0.00000757283,0.00004495553,0.0000073976094,0.00019067827],"genre_scores_gemma":[0.9988275,0.00047890015,0.00029628785,0.000025823134,0.000013033843,0.000013286591,0.00013714583,0.0000020516075,0.00020595806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992,0.000021509846,0.0000056698873,0.00001763291,0.000021042575,0.000013979008],"domain_scores_gemma":[0.9998436,0.00002003,0.00005642455,0.000014585412,0.000016663278,0.00004874377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015947719,0.00020545268,0.0003164342,0.00016731196,0.00018590501,0.00011801797,0.000078972334,0.00020561612,0.000655568],"category_scores_gemma":[0.00017097138,0.00007830912,0.0002087505,0.00013233213,0.00024244378,0.00009882527,0.00013499727,0.00040515856,0.00007660392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00481197,0.00035115329,0.06360913,0.00018039485,0.000099078694,0.0008947063,0.000073713905,0.0001507911,0.9117919,0.000054347733,0.00018005367,0.017802725],"study_design_scores_gemma":[0.00010610533,0.0038177762,0.96025276,0.000009954018,0.000083796185,0.0017793796,0.0000594548,0.00034799075,0.032453403,0.000048162932,0.00103148,0.000009751617],"about_ca_topic_score_codex":0.0006675285,"about_ca_topic_score_gemma":0.00072847796,"teacher_disagreement_score":0.0006675285,"about_ca_system_score_codex":0.00015215586,"about_ca_system_score_gemma":0.0001254864,"threshold_uncertainty_score":0.0021930933},"labels":[],"label_agreement":null},{"id":"W2153985019","doi":"10.1146/annurev.pharmtox.010909.105826","title":"Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment","year":2010,"lang":"en","type":"review","venue":"The Annual Review of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; U.S. Food and Drug Administration","keywords":"Pharmacogenetics; Drug; Genetic variation; Addiction; Heritability; Pharmacogenomics; Affect (linguistics); Biology; Gene; Genetics; Genotype; Pharmacology; Medicine; Psychology; Neuroscience","score_opus":0.06599665463926711,"score_gpt":0.45356391951325814,"score_spread":0.387567264873991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153985019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029151244,0.99673694,0.00040994506,0.00054383685,0.00010776225,0.000005411048,0.000032098967,0.000011685678,0.0018607914],"genre_scores_gemma":[0.0017849256,0.9967145,0.00034832183,0.00018118111,0.00016766472,0.000007727715,0.00004775688,0.000002605072,0.00074529595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996728,0.00010139017,0.00003387657,0.000053275915,0.00011816961,0.000020548903],"domain_scores_gemma":[0.99969244,0.00017196407,0.000044704735,0.000010201148,0.00006166342,0.000019151614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058685907,0.0006235048,0.0014915534,0.0011014637,0.00015421111,0.00072255335,0.0006927622,0.000829558,0.00298817],"category_scores_gemma":[0.0008217636,0.0001734912,0.00041206562,0.0015637223,0.00039840807,0.000536533,0.0004738518,0.0010447208,0.0017977067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000653898,0.00006170834,0.0009283175,0.0048655183,0.000115298906,0.0003331879,0.000042915468,0.00035441312,0.0014219874,0.0031029868,0.015874371,0.9728338],"study_design_scores_gemma":[0.000050205977,0.00019349346,0.009958234,0.005105476,0.00027460288,0.0064408667,0.00010117214,0.00037871665,0.0012979676,0.008102104,0.9680522,0.000044844757],"about_ca_topic_score_codex":0.0015653878,"about_ca_topic_score_gemma":0.001893989,"teacher_disagreement_score":0.00298817,"about_ca_system_score_codex":0.0006053174,"about_ca_system_score_gemma":0.0009577678,"threshold_uncertainty_score":0.009996414},"labels":[],"label_agreement":null},{"id":"W2154141109","doi":"10.1128/aac.45.4.1184-1191.2001","title":"Amphotericin B Lipid Complex or Amphotericin B Multiple-Dose Administration to Rabbits with Elevated Plasma Cholesterol Levels: Pharmacokinetics in Plasma and Blood, Plasma Lipoprotein Levels, Distribution in Tissues, and Renal Toxicities","year":2001,"lang":"en","type":"article","venue":"Antimicrobial Agents and Chemotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Pharmacokinetics; Amphotericin B; Triglyceride; Cholesterol; Pharmacology; Creatinine; Lipoprotein; Blood plasma; Distribution (mathematics); Endocrinology; Toxicity; Internal medicine; Chemistry; Medicine","score_opus":0.08963282707222787,"score_gpt":0.3636514857717986,"score_spread":0.27401865869957076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154141109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976387,0.0005560773,0.0012435436,0.000053143587,0.000017081667,0.000039947747,0.000046256482,0.00003418287,0.00037110609],"genre_scores_gemma":[0.9933469,0.0008432563,0.0032143653,0.000103040635,0.000025479014,0.000110378016,0.00023243185,0.00002455741,0.0020995955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995728,0.00007259899,0.00005893234,0.00009712964,0.000117637894,0.00008089083],"domain_scores_gemma":[0.9995023,0.00005261915,0.0002067833,0.00008397185,0.00006938247,0.00008508071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038068157,0.00038301307,0.000663164,0.00039911224,0.0002207368,0.00039177126,0.00023265356,0.00039937813,0.0005291286],"category_scores_gemma":[0.00041086168,0.00023293943,0.00033626126,0.00022412556,0.0004190257,0.00042088865,0.00023091785,0.0010214857,0.00028625384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010252228,0.00025033558,0.00071491324,0.000029396779,0.00001131035,0.000080748345,0.000037310652,0.00003439707,0.99530494,0.00004831734,0.00002464203,0.0024384153],"study_design_scores_gemma":[0.00015958642,0.009594783,0.00848713,0.000011610497,0.00008385852,0.0007717813,0.000063116786,0.0010182849,0.97785175,0.000057888235,0.0018857213,0.000014581475],"about_ca_topic_score_codex":0.00054590404,"about_ca_topic_score_gemma":0.00088422844,"teacher_disagreement_score":0.000663164,"about_ca_system_score_codex":0.00040189092,"about_ca_system_score_gemma":0.0003132059,"threshold_uncertainty_score":0.0029158592},"labels":[],"label_agreement":null},{"id":"W2155663558","doi":"10.1124/dmd.32.4.367","title":"TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS","year":2004,"lang":"en","type":"review","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Endogeny; Xenobiotic; Cytochrome P450; Biology; Gene; Drug metabolism; Aryl hydrocarbon receptor; Transcriptional regulation; Gene expression; Regulation of gene expression; Transcription factor; Chemical biology; Biochemistry; Computational biology; Metabolism; Enzyme","score_opus":0.09645135171304067,"score_gpt":0.4007837565954398,"score_spread":0.3043324048823991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155663558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031523434,0.9877396,0.003137349,0.00023108763,0.00023345357,0.000012872818,0.000111435606,0.00005696407,0.0053248913],"genre_scores_gemma":[0.010071442,0.9835386,0.0014633654,0.00021338016,0.00014545144,0.00001677483,0.00022667111,0.0000077805735,0.004316486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999262,0.000009642932,0.000006973937,0.000023737508,0.000025200436,0.000008163474],"domain_scores_gemma":[0.9999291,0.000030642106,0.000014320499,0.000005363953,0.000015444302,0.000005129402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018506317,0.0006215119,0.0008224882,0.000615784,0.00011122092,0.00043255583,0.00046683563,0.00038039568,0.0018502384],"category_scores_gemma":[0.00013961503,0.00017586259,0.00029621174,0.0008745089,0.00024969538,0.00033521716,0.00022294886,0.00055862876,0.0014414843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013121989,0.00006612884,0.00040947655,0.0037315106,0.000056126035,0.0003169534,0.000026642747,0.000642508,0.061025087,0.0017128056,0.005239029,0.9266426],"study_design_scores_gemma":[0.000048501668,0.00027797776,0.0046398146,0.0007079769,0.00020273076,0.002666427,0.00007410172,0.00033412542,0.060609575,0.0018899804,0.9285172,0.00003157963],"about_ca_topic_score_codex":0.0005778202,"about_ca_topic_score_gemma":0.0010654163,"teacher_disagreement_score":0.0018502384,"about_ca_system_score_codex":0.00026737063,"about_ca_system_score_gemma":0.00034064281,"threshold_uncertainty_score":0.006189704},"labels":[],"label_agreement":null},{"id":"W2156003012","doi":"10.1007/s10549-010-0902-3","title":"Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Medicine; Oncology; Internal medicine; Genotype; Hazard ratio; Meta-analysis; Adjuvant therapy; Cancer; Pharmacology; Confidence interval; Biology; Cytochrome P450; Genetics","score_opus":0.5229333359174899,"score_gpt":0.5894168278163905,"score_spread":0.06648349189890057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156003012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034597393,0.96280587,0.0009939948,0.00021833534,0.00015828118,0.000055944744,0.00085311243,0.000030617673,0.00028646537],"genre_scores_gemma":[0.4457185,0.54860586,0.002367353,0.0005736695,0.0003265642,0.00015304136,0.0015850321,0.000034848632,0.0006350936],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99780744,0.0010886826,0.0003538401,0.00039693492,0.00025993475,0.00009322626],"domain_scores_gemma":[0.99606824,0.0028885528,0.0005409708,0.00019130297,0.00023978253,0.000071208044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004411981,0.0018528997,0.00831158,0.001079751,0.0002422885,0.0010580049,0.0011267955,0.0009677546,0.0019326214],"category_scores_gemma":[0.006843165,0.0008595237,0.017135806,0.0024881174,0.00025073095,0.0005911562,0.00063860137,0.0012749096,0.00019126727],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018474568,0.00008741223,0.02164269,0.050865225,0.86488664,0.00022394737,0.0000527834,0.0014145469,0.00077266595,0.00012975116,0.0017506654,0.03969913],"study_design_scores_gemma":[0.001778197,0.00035723246,0.017097868,0.0013302042,0.9764955,0.00014413068,0.000025544143,0.00040665,0.00020172069,0.00018481103,0.0019545427,0.000023464556],"about_ca_topic_score_codex":0.005248251,"about_ca_topic_score_gemma":0.010136185,"teacher_disagreement_score":0.00831158,"about_ca_system_score_codex":0.0008403611,"about_ca_system_score_gemma":0.0008640486,"threshold_uncertainty_score":0.023333073},"labels":[],"label_agreement":null},{"id":"W2156466727","doi":"10.2217/pgs.12.197","title":"An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics","year":2013,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical Practice; Test (biology); Family medicine; Clinical pharmacy; Pharmacotherapy; Pharmacy; Medical education; Pharmacology; Nursing","score_opus":0.21882436163117444,"score_gpt":0.4939361860743263,"score_spread":0.27511182444315185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156466727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955479,0.00008122317,0.00020807273,0.00092806446,0.000011710739,0.00007349016,0.0000924318,0.000007793903,0.0030492854],"genre_scores_gemma":[0.99883825,0.00010683213,0.00026143028,0.00035113058,0.000009446581,0.000040647403,0.000076020646,0.00000221899,0.00031415853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923516,0.0025452322,0.0006784875,0.00026575246,0.0033180004,0.0008410247],"domain_scores_gemma":[0.957658,0.014541163,0.010977508,0.00070710096,0.010263362,0.00585285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009295224,0.00019287449,0.00022364783,0.0005586676,0.0011662407,0.0016725662,0.0005753762,0.0009137605,0.0025715297],"category_scores_gemma":[0.037116364,0.00022441082,0.00063233846,0.00046205884,0.00085314654,0.00083324104,0.0011960834,0.0014320906,0.00036788193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005811875,0.00060329796,0.9509268,0.00024577367,0.000093019444,0.0006210402,0.016751936,0.00035380168,0.0011536215,0.00015540462,0.0022585972,0.02625562],"study_design_scores_gemma":[0.00007125492,0.0011866837,0.9585492,0.00015208806,0.000048674563,0.0006986803,0.03246488,0.0012574663,0.0006320942,0.00013825938,0.0047395537,0.00006112394],"about_ca_topic_score_codex":0.026164953,"about_ca_topic_score_gemma":0.02604569,"teacher_disagreement_score":0.026164953,"about_ca_system_score_codex":0.0034887432,"about_ca_system_score_gemma":0.0049785078,"threshold_uncertainty_score":0.05202532},"labels":[],"label_agreement":null},{"id":"W2156560694","doi":"10.1080/0049825021000017948","title":"Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine","year":2003,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"CYP1A2; CYP2B6; CYP2E1; Microsome; Chemistry; Cytochrome P450; Enantiomer; Mexiletine; Enzyme; Pharmacology; Biochemistry; CYP3A4; Stereochemistry; Internal medicine; Biology; Medicine","score_opus":0.059021881531100676,"score_gpt":0.3674600806618039,"score_spread":0.30843819913070325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156560694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97807753,0.01088912,0.00931861,0.00025054114,0.00002075547,0.000031261647,0.00018013491,0.00007921565,0.0011529421],"genre_scores_gemma":[0.99386615,0.0022557012,0.0024669366,0.000035472753,0.000024605115,0.000013143381,0.00028411817,0.000007045377,0.0010468095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998411,0.000065085645,0.000010642962,0.00003769729,0.000026289055,0.00001918739],"domain_scores_gemma":[0.9997217,0.000076643126,0.00008578581,0.000027935857,0.000044583216,0.000043308195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037632493,0.00033097022,0.00023330239,0.00018196415,0.0001219774,0.00022960323,0.000104742656,0.00024602984,0.0006634447],"category_scores_gemma":[0.00041843552,0.00013096185,0.00021717139,0.0001120069,0.00013159552,0.00019465771,0.00012951976,0.00020890281,0.00033566885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082393334,0.00007087981,0.01841024,0.00010873053,0.00010180289,0.0005025654,0.00007181545,0.00029622842,0.9570278,0.00025768628,0.0001532757,0.022175036],"study_design_scores_gemma":[0.0000643734,0.0014673693,0.3350389,0.00002666274,0.000167948,0.0036627129,0.00008862857,0.003739608,0.6507213,0.00043198792,0.0045693703,0.000021072883],"about_ca_topic_score_codex":0.0004849607,"about_ca_topic_score_gemma":0.00054673385,"teacher_disagreement_score":0.0006634447,"about_ca_system_score_codex":0.00014561035,"about_ca_system_score_gemma":0.00009275699,"threshold_uncertainty_score":0.0022194982},"labels":[],"label_agreement":null},{"id":"W2156687558","doi":"10.1001/archinte.165.10.1095","title":"Systematic Overview of Warfarin and Its Drug and Food Interactions","year":2005,"lang":"en","type":"review","venue":"Archives of Internal Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Warfarin; Medicine; MEDLINE; Drug; Rofecoxib; Adverse effect; Drug interaction; Anticoagulant; Intensive care medicine; Pharmacology; Internal medicine; Cyclooxygenase; Atrial fibrillation","score_opus":0.22077615148656668,"score_gpt":0.5050865627263667,"score_spread":0.28431041123979994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156687558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013429228,0.9961314,0.00018079352,0.00028349384,0.0001181297,0.00033120596,0.001216853,0.000012013728,0.00038314596],"genre_scores_gemma":[0.011462614,0.9846305,0.0012601556,0.00049181207,0.00013912634,0.00080555823,0.0010411687,0.0000059656945,0.00016309039],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855387,0.0044104774,0.0064697023,0.00079583365,0.0025556746,0.00022967272],"domain_scores_gemma":[0.9612158,0.02435094,0.009623869,0.0005796228,0.0038586133,0.00037130597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009413403,0.0016542178,0.007084112,0.030043092,0.0006459163,0.0021983855,0.0013985278,0.0017185025,0.004811074],"category_scores_gemma":[0.035525996,0.0010895863,0.00512679,0.021990733,0.000728091,0.0021945199,0.0014956809,0.00081276766,0.00042545708],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018126871,0.000014323373,0.0015293594,0.94005036,0.0057903826,0.00019591524,0.00021162287,0.000079374695,0.00017660148,0.00014140802,0.0028384093,0.048791043],"study_design_scores_gemma":[0.00036183166,0.00040185958,0.013625106,0.87182647,0.06334935,0.0012028363,0.00033972628,0.00011856735,0.00028484143,0.00035110334,0.048087355,0.000051017363],"about_ca_topic_score_codex":0.009950331,"about_ca_topic_score_gemma":0.0320199,"teacher_disagreement_score":0.030043092,"about_ca_system_score_codex":0.0033033956,"about_ca_system_score_gemma":0.012339134,"threshold_uncertainty_score":0.04978347},"labels":[],"label_agreement":null},{"id":"W2156704652","doi":"10.1002/jps.10031","title":"Effect of omeprazole on oral and intravenous RS‐methadone pharmacokinetics and pharmacodynamics in the rat","year":2002,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omeprazole; Pharmacokinetics; Pharmacodynamics; Pharmacology; Methadone; Medicine","score_opus":0.10772097302449643,"score_gpt":0.45785001049302093,"score_spread":0.35012903746852453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156704652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967084,0.0009753346,0.00052731717,0.00025721246,0.00005950243,0.000030023628,0.00046674276,0.00009294055,0.00088260096],"genre_scores_gemma":[0.99357927,0.0013230897,0.0009912447,0.000116486306,0.00007699385,0.000040671777,0.0005443308,0.00005009579,0.0032777889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956197,0.00009496397,0.00002458298,0.00008841644,0.00006667432,0.00016339579],"domain_scores_gemma":[0.9984281,0.00047341725,0.00030781177,0.00029011897,0.000087074375,0.0004135303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038340123,0.0007785603,0.0010023974,0.0006267369,0.0003630946,0.0006482784,0.00068372133,0.001270473,0.0017897913],"category_scores_gemma":[0.001284532,0.0008781989,0.00080285326,0.00040913257,0.0014290846,0.0015449028,0.00026278544,0.0024438063,0.0005874987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12645955,0.003972308,0.0016166192,0.00019063738,0.00019113308,0.0005337128,0.00024641765,0.0013623962,0.8360219,0.00061943836,0.00072696956,0.028058838],"study_design_scores_gemma":[0.0028022917,0.037642505,0.019431967,0.000032197568,0.00037125076,0.00044545758,0.00026191608,0.007216055,0.92945087,0.00041593477,0.0018103699,0.000119178905],"about_ca_topic_score_codex":0.004414967,"about_ca_topic_score_gemma":0.005173664,"teacher_disagreement_score":0.004414967,"about_ca_system_score_codex":0.000713846,"about_ca_system_score_gemma":0.0009629044,"threshold_uncertainty_score":0.008778572},"labels":[],"label_agreement":null},{"id":"W2157062572","doi":"10.1111/j.1365-2125.2006.02629.x","title":"Paroxetine: population pharmacokinetic analysis in late‐life depression using sparse concentration sampling","year":2006,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Mental Health","keywords":"Paroxetine; NONMEM; CYP2D6; Pharmacokinetics; Population; Depression (economics); Medicine; Internal medicine; Volume of distribution; Serotonin","score_opus":0.19456734297451442,"score_gpt":0.5156837161460757,"score_spread":0.3211163731715613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157062572","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16775423,0.00066700974,0.82945514,0.00042059235,0.000022514467,0.00020304706,0.00042328515,0.00036335867,0.0006907852],"genre_scores_gemma":[0.878616,0.0010832889,0.1158415,0.00019843239,0.0000644475,0.00077732926,0.0009367997,0.000044361797,0.0024379569],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99939716,0.00035930134,0.000023907605,0.00010859116,0.00007475393,0.000036263267],"domain_scores_gemma":[0.9978124,0.0016459216,0.00023833971,0.000062899126,0.00020152323,0.000038841416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024042674,0.0005713004,0.0012822432,0.00031633102,0.00019714629,0.00070302206,0.0010718426,0.00087182,0.00061818614],"category_scores_gemma":[0.005757156,0.0005612661,0.0008598529,0.00036014756,0.0004661097,0.00056999124,0.00042466715,0.000973656,0.0002478458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041546408,0.00009783334,0.006849169,0.00010041754,0.00020860485,0.00015401094,0.00008214308,0.9670906,0.0015407433,0.002345262,0.0005059364,0.020609833],"study_design_scores_gemma":[0.000043217027,0.000070970644,0.0009901102,0.0000046459977,0.000027862883,0.000031530868,0.0000047273734,0.9975573,0.00015917097,0.00085769687,0.0002468542,0.0000059941444],"about_ca_topic_score_codex":0.0128791,"about_ca_topic_score_gemma":0.007675076,"teacher_disagreement_score":0.0128791,"about_ca_system_score_codex":0.0006520514,"about_ca_system_score_gemma":0.0012212442,"threshold_uncertainty_score":0.025608301},"labels":[],"label_agreement":null},{"id":"W2157932545","doi":"10.1177/00912700022009558","title":"Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sainte Foy","funders":"","keywords":"Bioequivalence; Warfarin; Medicine; Pharmacokinetics; Crossover study; Pharmacology; Therapeutic index; Replicate; CYP2C9; Internal medicine; Drug; Statistics; Mathematics; Placebo","score_opus":0.421124098491936,"score_gpt":0.5880239667940168,"score_spread":0.1668998683020808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932545","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037481066,0.09648057,0.06676552,0.78139514,0.0041073593,0.00064705056,0.00017548572,0.0003642361,0.012583619],"genre_scores_gemma":[0.44027263,0.04866009,0.22385173,0.2646632,0.016606279,0.0019293388,0.0002476187,0.00044523322,0.0033238556],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8584155,0.09531488,0.011521415,0.0067906175,0.025919564,0.0020379645],"domain_scores_gemma":[0.68871415,0.2358036,0.0150881875,0.028481731,0.025731008,0.0061812634],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26738182,0.0008919906,0.0070125023,0.0023213173,0.0020764265,0.00637444,0.004801951,0.022100838,0.0025708827],"category_scores_gemma":[0.3001836,0.000988311,0.0034700788,0.0023067587,0.013752464,0.020724429,0.003239846,0.016202545,0.0008176496],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044942037,0.00096715335,0.02304313,0.0023343398,0.00090799003,0.0042808335,0.0028975487,0.0017195509,0.0031763632,0.07401786,0.04896589,0.83319515],"study_design_scores_gemma":[0.004149545,0.010624705,0.037854712,0.008150579,0.0016781371,0.029430322,0.007291748,0.01819642,0.0061957072,0.5793167,0.29628935,0.00082210574],"about_ca_topic_score_codex":0.001645582,"about_ca_topic_score_gemma":0.002816782,"teacher_disagreement_score":0.26738182,"about_ca_system_score_codex":0.0031283202,"about_ca_system_score_gemma":0.0058891787,"threshold_uncertainty_score":0.90344864},"labels":[],"label_agreement":null},{"id":"W2158213155","doi":"10.1007/s11095-004-9010-6","title":"Selective Downregulation of Hepatic Cytochrome P450 Expression and Activity in a Rat Model of Inflammatory Pain","year":2005,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Université de Montréal","funders":"","keywords":"CYP2E1; Downregulation and upregulation; Cytochrome P450; Pharmacology; Chemistry; Inflammation; Endocrinology; Messenger RNA; Pharmacokinetics; Internal medicine; Medicine; Metabolism; Biochemistry","score_opus":0.24672603893382727,"score_gpt":0.5226125022133294,"score_spread":0.27588646327950217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158213155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956358,0.00095310446,0.0023163157,0.0002138178,0.000048809765,0.000039439245,0.00015846673,0.00007877951,0.0005554602],"genre_scores_gemma":[0.9950806,0.0009824913,0.0013405022,0.000059696144,0.000027226977,0.000061207684,0.00022071098,0.0000200424,0.0022074657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997552,0.000048480455,0.000012421315,0.00003992913,0.000049314218,0.00009461194],"domain_scores_gemma":[0.9997042,0.000042612155,0.00008922938,0.000056809622,0.000027744896,0.00007931709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028396782,0.00068298506,0.0006423983,0.0007739109,0.00031903049,0.0003171802,0.00031301484,0.0004014826,0.0019472102],"category_scores_gemma":[0.00025777653,0.0003364346,0.00044578596,0.00038728726,0.00083607517,0.00042684644,0.00019296187,0.0013817331,0.00032339426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005495453,0.000804582,0.00045446638,0.00005969013,0.00001993634,0.00025424626,0.00003449296,0.00012290562,0.9878477,0.00021678173,0.0001224687,0.004567318],"study_design_scores_gemma":[0.00025467694,0.0070383344,0.0061413655,0.000009845756,0.000088628876,0.00057034136,0.00009392965,0.0008818877,0.9842017,0.00014366281,0.00056321145,0.000012434231],"about_ca_topic_score_codex":0.0010010106,"about_ca_topic_score_gemma":0.0019836635,"teacher_disagreement_score":0.0019472102,"about_ca_system_score_codex":0.00041224758,"about_ca_system_score_gemma":0.00043250425,"threshold_uncertainty_score":0.006514132},"labels":[],"label_agreement":null},{"id":"W2158774304","doi":"10.1124/dmd.114.062877","title":"Quantitative Profiling of Human Renal UDP-glucuronosyltransferases and Glucuronidation Activity: A Comparison of Normal and Tumoral Kidney Tissues","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Center for Research Resources; Canadian Institutes of Health Research","keywords":"Glucuronidation; UGT2B7; Kidney; Chemistry; Glucuronosyltransferase; Endocrinology; Internal medicine; Metabolism; Enzyme; Biology; Biochemistry; Microsome; Medicine","score_opus":0.11136422580705083,"score_gpt":0.43878405707872914,"score_spread":0.3274198312716783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158774304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98254794,0.0034377933,0.011672145,0.000044330627,0.0000162923,0.00003272769,0.0010552116,0.00007778866,0.0011157641],"genre_scores_gemma":[0.9893167,0.0014534594,0.005581209,0.000043166157,0.000011166011,0.00004242485,0.0013731507,0.000031243126,0.002147457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983287,0.000030599913,0.000010073856,0.000053259962,0.000045059285,0.000028099237],"domain_scores_gemma":[0.9998579,0.000034413013,0.00002407631,0.000025179017,0.00003828979,0.000020181458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002516564,0.00017887047,0.00026148782,0.00040374222,0.00020364685,0.00041647325,0.00013193651,0.0002639903,0.0005810183],"category_scores_gemma":[0.00031379948,0.00015001839,0.00023848395,0.0004832669,0.00020527293,0.00019275535,0.0001500387,0.00027929508,0.00018791655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007829198,0.00003135362,0.0050836024,0.00004376237,0.000035278998,0.00004698211,0.000048216767,0.00013391937,0.9876518,0.00010535176,0.000042377415,0.005994308],"study_design_scores_gemma":[0.000020713385,0.00038471475,0.09456201,0.0000055675255,0.0001156956,0.0007731521,0.000088147615,0.0017640623,0.8996088,0.00010826015,0.0025568914,0.000012073453],"about_ca_topic_score_codex":0.0017654048,"about_ca_topic_score_gemma":0.0018200505,"teacher_disagreement_score":0.0017654048,"about_ca_system_score_codex":0.00020699918,"about_ca_system_score_gemma":0.00034741402,"threshold_uncertainty_score":0.0035102963},"labels":[],"label_agreement":null},{"id":"W2159639329","doi":"10.1124/jpet.103.052183","title":"Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP2E1; Nicotine; Cotinine; Pharmacology; Metabolite; Chemistry; Toxicity; Tobacco smoke; Enzyme inducer; Toxicology; Internal medicine; Endocrinology; Medicine; Biochemistry; Biology; Metabolism; Enzyme; Cytochrome P450","score_opus":0.06326835787656508,"score_gpt":0.40740661538548645,"score_spread":0.34413825750892135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159639329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98624504,0.00391132,0.0074422136,0.00021539185,0.00009378059,0.00008396134,0.00054215593,0.00019871422,0.001267446],"genre_scores_gemma":[0.98939276,0.001544954,0.0033232537,0.00008137884,0.0000408552,0.000091705915,0.0010845056,0.00006138604,0.0043792548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974793,0.00006244793,0.000018859735,0.00004835183,0.00007267655,0.000049698927],"domain_scores_gemma":[0.9994289,0.00014610119,0.000103352664,0.00016109785,0.00007397709,0.00008659354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029375797,0.00035585888,0.0006640083,0.0005187438,0.00020473888,0.00028888366,0.00027292452,0.00035106958,0.0014422601],"category_scores_gemma":[0.0004355322,0.00036218396,0.0007127642,0.0005250293,0.0004662537,0.00033894746,0.00021817049,0.001327937,0.00048145902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001545443,0.00021011778,0.0016617478,0.000046848487,0.00003184289,0.00006305445,0.000040580926,0.00009486299,0.99132687,0.00010557258,0.00008838164,0.004784713],"study_design_scores_gemma":[0.000030515597,0.0019349884,0.016932115,0.000007413332,0.000072811476,0.0002418182,0.00003438928,0.00079690304,0.97887415,0.000073377225,0.0009912399,0.0000100974785],"about_ca_topic_score_codex":0.0013829699,"about_ca_topic_score_gemma":0.0041166213,"teacher_disagreement_score":0.0014422601,"about_ca_system_score_codex":0.00051035377,"about_ca_system_score_gemma":0.00031388985,"threshold_uncertainty_score":0.004824817},"labels":[],"label_agreement":null},{"id":"W2160380703","doi":"10.1124/dmd.114.060285","title":"Gene Variants in CYP2C19 Are Associated with Altered In Vivo Bupropion Pharmacokinetics but Not Bupropion-Assisted Smoking Cessation Outcomes","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Center for Research Resources; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Bupropion; CYP2C19; Pharmacology; CYP2B6; Pharmacokinetics; Active metabolite; Medicine; Smoking cessation; Internal medicine; CYP3A4; Cytochrome P450; Metabolism","score_opus":0.04157439323671207,"score_gpt":0.33988079053459275,"score_spread":0.29830639729788067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160380703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803275,0.0002807031,0.00035558417,0.00015492809,0.000025687536,0.000009602366,0.0004794135,0.000016385238,0.0006449171],"genre_scores_gemma":[0.99890864,0.00008017084,0.00016916641,0.00004073673,0.000028266366,0.0000060617454,0.00025522476,0.000016421856,0.0004953491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993382,0.00019265685,0.00007354026,0.00019961243,0.00011692574,0.00007909411],"domain_scores_gemma":[0.9982222,0.00047430917,0.00094441057,0.00010753981,0.00008333253,0.00016825434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031080068,0.00083660556,0.0005755468,0.00054876134,0.0004113392,0.00061734155,0.00038752487,0.0008022525,0.0046766303],"category_scores_gemma":[0.0015800627,0.0002955894,0.00088969636,0.0009208521,0.00036920048,0.0002814332,0.00024340267,0.00091026246,0.0003285736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043636677,0.00045808515,0.94419605,0.000060796803,0.0018215106,0.002216345,0.00018639713,0.00028684534,0.039545584,0.00035266363,0.0004634646,0.0060485415],"study_design_scores_gemma":[0.000052520558,0.00021669577,0.99587375,0.000006246604,0.00028040135,0.0013453913,0.000038789916,0.0005095691,0.0013023333,0.00012689705,0.0002376959,0.000009784345],"about_ca_topic_score_codex":0.0026027248,"about_ca_topic_score_gemma":0.0020108875,"teacher_disagreement_score":0.0046766303,"about_ca_system_score_codex":0.00023699946,"about_ca_system_score_gemma":0.00018349811,"threshold_uncertainty_score":0.015644908},"labels":[],"label_agreement":null},{"id":"W2160706662","doi":"10.1124/dmd.30.9.991","title":"N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases","year":2002,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Glucuronidation; Glucuronide; Cotinine; Chemistry; Metabolite; UGT2B7; Microsome; Nicotine; Chromatography; Microsoma; Electrospray ionization; Enzyme; Mass spectrometry; Biochemistry; Internal medicine","score_opus":0.06293668385582499,"score_gpt":0.3557887957136797,"score_spread":0.29285211185785476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160706662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416095,0.0023991058,0.0023003907,0.00006215499,0.000015116213,0.000019195206,0.00022322928,0.000044142675,0.00077562075],"genre_scores_gemma":[0.9974975,0.0005874818,0.00077945425,0.000022004793,0.0000070573687,0.00000903311,0.0003822075,0.000010274965,0.00070502015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973375,0.00012199132,0.00002165848,0.000060818988,0.00003405687,0.000027601565],"domain_scores_gemma":[0.9997278,0.00008286602,0.00005971246,0.000050615723,0.000033712582,0.000045245255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000425319,0.00029919445,0.000340362,0.0002804911,0.00022787551,0.00034508095,0.00014742474,0.00037166616,0.0007097884],"category_scores_gemma":[0.00087865384,0.00029588572,0.00025192334,0.00026012567,0.000269897,0.00021424024,0.00012981106,0.00031428243,0.00026685288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0131757455,0.00021421944,0.053539917,0.0002393335,0.00028993122,0.0015054953,0.0005570909,0.00071671774,0.89611953,0.00071946863,0.00031139093,0.032611124],"study_design_scores_gemma":[0.00011512635,0.0019791278,0.23275019,0.000020676776,0.00042691003,0.006409803,0.00027833914,0.0052021607,0.749441,0.0003746434,0.0029697183,0.000032285596],"about_ca_topic_score_codex":0.007151536,"about_ca_topic_score_gemma":0.005781151,"teacher_disagreement_score":0.007151536,"about_ca_system_score_codex":0.00032753526,"about_ca_system_score_gemma":0.0004082723,"threshold_uncertainty_score":0.0142198205},"labels":[],"label_agreement":null},{"id":"W2160787317","doi":"","title":"Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Bioequivalence; Bioavailability; Warfarin; Pharmacokinetics; Pharmacology; Medicine; Internal medicine","score_opus":0.19565525350017038,"score_gpt":0.4305156957269867,"score_spread":0.23486044222681635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160787317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81463295,0.0007753657,0.17567578,0.0014179321,0.000031471594,0.00032823207,0.00038129382,0.00022840405,0.006528574],"genre_scores_gemma":[0.9843961,0.00013297237,0.014777477,0.0001158119,0.000006667483,0.00013265583,0.00016696184,0.0000085592665,0.0002628267],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967631,0.0022893245,0.00011928233,0.00025747373,0.00045746178,0.00011331562],"domain_scores_gemma":[0.97966206,0.01689962,0.0016592867,0.00081449165,0.000799361,0.00016516737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0083917305,0.00043316116,0.0007230596,0.00033678548,0.00016368306,0.00096201315,0.0008482695,0.0011849847,0.0016050984],"category_scores_gemma":[0.04256298,0.00034541864,0.0006654844,0.00023581386,0.0007257478,0.0011856423,0.00028750324,0.00069791434,0.00024603336],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026642953,0.0004169191,0.04239344,0.00021766113,0.00038356884,0.00015860378,0.0002024057,0.91339195,0.0028921477,0.0068515525,0.00067712966,0.02975035],"study_design_scores_gemma":[0.00041226926,0.0011390345,0.008089658,0.000045411984,0.00015776008,0.00025312448,0.000051249688,0.98163927,0.0014224083,0.0057121874,0.0010551088,0.000022606546],"about_ca_topic_score_codex":0.0031068055,"about_ca_topic_score_gemma":0.0018481498,"teacher_disagreement_score":0.0083917305,"about_ca_system_score_codex":0.00093149225,"about_ca_system_score_gemma":0.0013829758,"threshold_uncertainty_score":0.044380188},"labels":[],"label_agreement":null},{"id":"W2160975047","doi":"10.1002/9780470921920.edm036","title":"Physiologically Based Pharmacokinetic (<scp>PBPK</scp>) Modeling: Usefulness and Applications","year":2012,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Transporter; Drug; Chemistry; Computational biology; Drug metabolism; Biology; Biochemistry","score_opus":0.05412130262230114,"score_gpt":0.3674084926980199,"score_spread":0.31328719007571876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160975047","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008242288,0.121742286,0.6420626,0.004946222,0.001168275,0.0003005651,0.0041218065,0.006025476,0.21139044],"genre_scores_gemma":[0.12815161,0.32032153,0.38332412,0.0022157342,0.0014208809,0.0007410312,0.0064665307,0.0016773423,0.1556812],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99957126,0.00009797983,0.000028014005,0.000056480018,0.00022709822,0.000019126095],"domain_scores_gemma":[0.99968493,0.00012450831,0.000033634,0.00003071267,0.00011416954,0.000012142133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000675163,0.000886219,0.0007295958,0.0011625716,0.00026400216,0.0019946157,0.00080266583,0.0010308101,0.012200877],"category_scores_gemma":[0.001146954,0.00028572654,0.00069405837,0.0019239098,0.0003748251,0.0012571759,0.000730574,0.0010096624,0.011342342],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010158403,0.00011200222,0.0009399427,0.002547165,0.00007427753,0.0005464258,0.00007970419,0.0611611,0.01739999,0.05621237,0.08386974,0.77695566],"study_design_scores_gemma":[0.000023376915,0.00010613454,0.0012312016,0.00077769416,0.00007692882,0.0012791988,0.000077194425,0.11344341,0.015351737,0.03624628,0.83129156,0.000095321295],"about_ca_topic_score_codex":0.0019785273,"about_ca_topic_score_gemma":0.0013991871,"teacher_disagreement_score":0.012200877,"about_ca_system_score_codex":0.00065407855,"about_ca_system_score_gemma":0.0008081644,"threshold_uncertainty_score":0.04081595},"labels":[],"label_agreement":null},{"id":"W2161324288","doi":"10.1128/jb.187.2.415-421.2005","title":"Evolutionarily Divergent Extradiol Dioxygenases Possess Higher Specificities for Polychlorinated Biphenyl Metabolites","year":2005,"lang":"en","type":"article","venue":"Journal of Bacteriology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Biphenyl; Polychlorinated biphenyl; Genetics; Biochemistry; Ecology","score_opus":0.12245253915983284,"score_gpt":0.40296770736415893,"score_spread":0.2805151682043261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161324288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750036,0.00031411916,0.0012330418,0.000037589565,0.000005313031,0.00000795795,0.0002356104,0.000021589392,0.00064435706],"genre_scores_gemma":[0.99354494,0.00027930792,0.002675407,0.00006527698,0.000008630021,0.000015802832,0.0016525729,0.000032866556,0.0017251484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997887,0.000025980897,0.000023254457,0.000055190823,0.000062137864,0.00004475217],"domain_scores_gemma":[0.9996718,0.00005467274,0.00007144113,0.000047926358,0.0000722909,0.00008191125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023045727,0.0003926271,0.00027132506,0.00038226004,0.000106345986,0.00053193665,0.00022848578,0.00031796104,0.00051173836],"category_scores_gemma":[0.00037561203,0.00018946666,0.00028145546,0.0003984377,0.00019549136,0.00024304948,0.00051698386,0.00066021207,0.00042709024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000915733,0.000025994634,0.0035497905,0.000021742353,0.000012371702,0.000055196044,0.000047797406,0.000072203184,0.99316907,0.0000505321,0.000011024807,0.0028928341],"study_design_scores_gemma":[0.000041970947,0.00043360508,0.26686427,0.00001357167,0.00009785825,0.0036138631,0.00032600213,0.0020500803,0.71976304,0.00020233913,0.0065499675,0.000043377273],"about_ca_topic_score_codex":0.0007784086,"about_ca_topic_score_gemma":0.0009130477,"teacher_disagreement_score":0.0007784086,"about_ca_system_score_codex":0.00024251429,"about_ca_system_score_gemma":0.00012875874,"threshold_uncertainty_score":0.0017595887},"labels":[],"label_agreement":null},{"id":"W2161620765","doi":"10.1002/cpt.147","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":975,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute","keywords":"Fluvoxamine; Escitalopram; Citalopram; CYP2C19; Paroxetine; Pharmacogenetics; Sertraline; Dosing; Medicine; Pharmacology; CYP2D6; Fluoxetine; Psychiatry; Anxiety; Serotonin; Internal medicine; Genotype; Antidepressant; Biology","score_opus":0.294731120690238,"score_gpt":0.567269353284168,"score_spread":0.27253823259393006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161620765","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011194002,0.036517806,0.14095032,0.4023223,0.015822269,0.013785518,0.028588708,0.006784952,0.34403417],"genre_scores_gemma":[0.0707724,0.040000096,0.37880924,0.34171903,0.008223399,0.022073831,0.045622353,0.0021044493,0.090675235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9704014,0.012374651,0.0062290896,0.0010374684,0.008671718,0.0012857359],"domain_scores_gemma":[0.93157506,0.021636408,0.006707125,0.0027167758,0.033556968,0.0038076607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025839278,0.00081958214,0.0015012944,0.0024769856,0.0012249051,0.002844032,0.004162837,0.009051238,0.010914114],"category_scores_gemma":[0.059795942,0.00086469634,0.0031630746,0.0028433856,0.0010377147,0.0016473777,0.0020830461,0.009615181,0.007039742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028118587,0.00053031644,0.003967255,0.0012486689,0.0001209934,0.00064895535,0.0003597022,0.00085892336,0.0014130063,0.00978035,0.78707075,0.19371988],"study_design_scores_gemma":[0.0006351756,0.0003827201,0.0144266095,0.0050725183,0.00032314283,0.0012386871,0.00024226437,0.0013534902,0.002020613,0.0068254415,0.96738315,0.00009610628],"about_ca_topic_score_codex":0.020655483,"about_ca_topic_score_gemma":0.024182426,"teacher_disagreement_score":0.025839278,"about_ca_system_score_codex":0.0025000195,"about_ca_system_score_gemma":0.019542934,"threshold_uncertainty_score":0.13665283},"labels":[],"label_agreement":null},{"id":"W2161713195","doi":"10.1016/j.jchromb.2013.11.014","title":"Determination of warfarin alcohols by ultra-high performance liquid chromatography–tandem mass spectrometry: Application to in vitro enzyme kinetic studies","year":2013,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chemistry; Chromatography; Tandem mass spectrometry; Mass spectrometry; Liquid chromatography–mass spectrometry; Tandem; Enzyme; Warfarin; Biochemistry","score_opus":0.034846416972938075,"score_gpt":0.3609922328969089,"score_spread":0.32614581592397085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161713195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6259513,0.018803267,0.34183812,0.001113603,0.00044983593,0.000500893,0.0021749523,0.002256872,0.0069111465],"genre_scores_gemma":[0.8176035,0.009888223,0.16180122,0.00054370065,0.0000827653,0.0003465318,0.0021149083,0.00023243643,0.0073866853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989612,0.00034215918,0.00010665593,0.00018146592,0.0003208969,0.000087468274],"domain_scores_gemma":[0.99874556,0.00040025057,0.00016177152,0.00013326964,0.00041914947,0.00013998782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011744031,0.0011944108,0.0008574835,0.0011020792,0.0006669273,0.0009327724,0.0007637547,0.0010741323,0.0010550965],"category_scores_gemma":[0.0017826188,0.00057440967,0.00071779476,0.00081853976,0.00066601613,0.00093892444,0.00047357052,0.0012293521,0.0013526356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003536903,0.00010746212,0.0012846289,0.00007708883,0.000057125246,0.000072756,0.00008675434,0.00028426127,0.9872836,0.0002545032,0.00015338212,0.009984897],"study_design_scores_gemma":[0.0000115362245,0.00012702483,0.0014758604,0.0000072839216,0.00003854999,0.00019541431,0.000029411229,0.002043119,0.9945879,0.0001096566,0.0013554374,0.000018830655],"about_ca_topic_score_codex":0.0033512434,"about_ca_topic_score_gemma":0.0041584293,"teacher_disagreement_score":0.0033512434,"about_ca_system_score_codex":0.0006827423,"about_ca_system_score_gemma":0.0011722132,"threshold_uncertainty_score":0.0066634417},"labels":[],"label_agreement":null},{"id":"W2161848421","doi":"10.1081/dmr-120005667","title":"<i>N</i>-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS","year":2002,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Drug; Reactive intermediate; Redox; Reactive oxygen species; Nitro; Reactive nitrogen species; Combinatorial chemistry; Pharmacology; Biochemistry; Organic chemistry; Medicine; Alkyl; Catalysis","score_opus":0.16351389565732402,"score_gpt":0.4358942445447321,"score_spread":0.27238034888740803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161848421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007311875,0.98875695,0.00067634473,0.00031721607,0.00049406826,0.00001180226,0.000030737356,0.000027570108,0.008954217],"genre_scores_gemma":[0.004833493,0.98778754,0.00070238364,0.00042388757,0.0004241613,0.000016376152,0.00006496176,0.000004383507,0.005742806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998498,0.000033818396,0.000021730804,0.000024020566,0.000057847486,0.000012833174],"domain_scores_gemma":[0.99986935,0.00004455116,0.000028829287,0.00000719938,0.000041057407,0.000008984715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023618671,0.0006865279,0.0007006874,0.001383597,0.00021057363,0.00046057563,0.000446964,0.0006466805,0.0035196918],"category_scores_gemma":[0.00031803804,0.00014757086,0.00034911477,0.0015138786,0.00024981587,0.0006317683,0.0003152526,0.0005307065,0.0034317249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009116122,0.00007058044,0.0006875572,0.011733706,0.00007477836,0.0010193223,0.00006474973,0.00032771297,0.009882401,0.0034494416,0.040264603,0.932334],"study_design_scores_gemma":[0.000016189275,0.00014172864,0.0030518097,0.0015583581,0.000067293404,0.008530892,0.000058017067,0.00016538151,0.006113106,0.0022604207,0.9780215,0.0000152255125],"about_ca_topic_score_codex":0.00074716134,"about_ca_topic_score_gemma":0.0012263359,"teacher_disagreement_score":0.0035196918,"about_ca_system_score_codex":0.00033250693,"about_ca_system_score_gemma":0.00037158784,"threshold_uncertainty_score":0.01177454},"labels":[],"label_agreement":null},{"id":"W2162172301","doi":"10.1177/1060028014561474","title":"Calcium Channel Blocker–Clarithromycin Drug Interaction Did Not Increase the Risk of Nonvertebral Fracture","year":2014,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Clarithromycin; Medicine; Azithromycin; Amlodipine; Internal medicine; Nifedipine; Population; Retrospective cohort study; Pharmacology; Blood pressure; Calcium; Antibiotics","score_opus":0.11720621055397129,"score_gpt":0.44803841139423795,"score_spread":0.33083220084026665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162172301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423176,0.0014088063,0.00011970018,0.00013850708,0.00004041644,0.000041628315,0.0011042298,0.000010288343,0.0029045758],"genre_scores_gemma":[0.99873656,0.00015509353,0.00007430916,0.00005919281,0.000023123275,0.00000749935,0.00025323383,0.000002769388,0.0006882348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924797,0.00006174932,0.00007985227,0.0002049254,0.00024402075,0.00016143714],"domain_scores_gemma":[0.99786097,0.00032625557,0.0009289663,0.00019084895,0.00038413092,0.0003089447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037835372,0.0002694835,0.0005725589,0.00031344488,0.0007541426,0.00071986497,0.00045043667,0.0006876922,0.004755683],"category_scores_gemma":[0.003597012,0.00022467673,0.0013966497,0.00085674686,0.00028151693,0.00027188592,0.00024665063,0.0007473126,0.00025190244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091499725,0.00004671334,0.99441445,0.000060741197,0.00034080425,0.00021201973,0.000053434516,0.000026481712,0.00037423457,0.000018024772,0.00026857638,0.003269433],"study_design_scores_gemma":[0.000049816856,0.00017544867,0.9982495,0.000019228431,0.0003447532,0.0004201448,0.00003959477,0.00012539564,0.000064140935,0.000014992979,0.000493189,0.00000375945],"about_ca_topic_score_codex":0.1681742,"about_ca_topic_score_gemma":0.2493096,"teacher_disagreement_score":0.1681742,"about_ca_system_score_codex":0.0019704988,"about_ca_system_score_gemma":0.0027689754,"threshold_uncertainty_score":0.33439064},"labels":[],"label_agreement":null},{"id":"W2162575317","doi":"10.1016/s0149-2918(01)80100-4","title":"Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction","year":2001,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pantoprazole; Medicine; Pharmacokinetics; Gastroenterology; Adverse effect; Internal medicine; Proton-pump inhibitor; Pharmacology; Omeprazole","score_opus":0.14867049779999697,"score_gpt":0.4505362289100531,"score_spread":0.30186573111005616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162575317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984925,0.0005596685,0.00012632423,0.0001076574,0.000009976884,0.000009451078,0.00009144644,0.000012064077,0.0005908747],"genre_scores_gemma":[0.9994856,0.00012951423,0.00006630255,0.000062132895,0.000015892772,0.000004816913,0.00010081952,0.0000023488747,0.0001324953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997619,0.00007585757,0.000027862694,0.00003812296,0.000048578848,0.000047637026],"domain_scores_gemma":[0.9991054,0.00037856356,0.00017933609,0.000044035925,0.00006158644,0.00023102459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002814713,0.00034534093,0.0009104294,0.00025431323,0.0003195035,0.0003927746,0.00013517927,0.00047657517,0.000752404],"category_scores_gemma":[0.0025461235,0.00023232836,0.00037808224,0.0003146089,0.00027061717,0.00044673015,0.00022233621,0.00072812295,0.00014117772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05642869,0.00063019764,0.8801984,0.00015424656,0.0005178247,0.0036808238,0.0005596524,0.0014996892,0.013024848,0.00021184162,0.00095430465,0.04213938],"study_design_scores_gemma":[0.0005295564,0.006493167,0.986728,0.000011020596,0.0001717305,0.0028944514,0.00019233525,0.0014810229,0.00084104424,0.00010306242,0.0005369053,0.000017766597],"about_ca_topic_score_codex":0.0016705571,"about_ca_topic_score_gemma":0.002972926,"teacher_disagreement_score":0.0016705571,"about_ca_system_score_codex":0.0004942359,"about_ca_system_score_gemma":0.00034248078,"threshold_uncertainty_score":0.0035859942},"labels":[],"label_agreement":null},{"id":"W2162743898","doi":"10.3402/tdp.v2.24663","title":"Genetics of antipsychotic drug outcome and implications for the clinician: into the limelight","year":2014,"lang":"en","type":"article","venue":"Translational Developmental Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Limelight; Antipsychotic drug; Antipsychotic; Drug; Genetics; Medicine; Psychiatry; Biology; Bioinformatics; Pharmacology; Schizophrenia (object-oriented programming); Chemistry","score_opus":0.10615484739405154,"score_gpt":0.44727457062006065,"score_spread":0.34111972322600914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162743898","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018126568,0.14841309,0.004447054,0.81495214,0.003932321,0.000027208167,0.00021997347,0.00015894597,0.009722633],"genre_scores_gemma":[0.46784872,0.26239663,0.018455343,0.2144003,0.023919716,0.00020821876,0.0005672572,0.00032497203,0.011878882],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979335,0.0011075635,0.00019407549,0.0002638387,0.00034929658,0.00015177447],"domain_scores_gemma":[0.9923024,0.0044391793,0.0005919775,0.00033552572,0.0012238319,0.0011071183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005531617,0.0005049141,0.0009389937,0.0011795986,0.00090863777,0.0030100744,0.0009045036,0.0029350424,0.0058749886],"category_scores_gemma":[0.019450076,0.00027980973,0.0004503454,0.00076087285,0.0038838251,0.0050398945,0.0020747574,0.0039506946,0.0011083663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040822124,0.00024926782,0.09541194,0.00097442575,0.00022221883,0.004227593,0.004422442,0.0005758622,0.0013277972,0.062930055,0.18626885,0.6429813],"study_design_scores_gemma":[0.00024610106,0.0005643166,0.12973416,0.0103205275,0.00038897627,0.017839042,0.014412301,0.004064965,0.00062730577,0.3993224,0.42212576,0.00035419158],"about_ca_topic_score_codex":0.004989785,"about_ca_topic_score_gemma":0.0062429775,"teacher_disagreement_score":0.0058749886,"about_ca_system_score_codex":0.002549799,"about_ca_system_score_gemma":0.003896882,"threshold_uncertainty_score":0.029254377},"labels":[],"label_agreement":null},{"id":"W2163125822","doi":"10.1309/1e34uapr06pj6hml","title":"Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Genotyping; Warfarin; Medicine; Genotype; Biology; Genetics; Internal medicine; Gene; Atrial fibrillation","score_opus":0.2488417998922073,"score_gpt":0.4957011130206611,"score_spread":0.2468593131284538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163125822","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41088724,0.003031658,0.56347775,0.0007047267,0.0005065049,0.0017130396,0.0042960676,0.0058520036,0.009530924],"genre_scores_gemma":[0.41457126,0.0005683921,0.5706952,0.00061013456,0.00010491845,0.0019833688,0.0057135187,0.0006103432,0.0051427996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9852459,0.0044588693,0.0013236966,0.0031978118,0.005187186,0.0005865401],"domain_scores_gemma":[0.9875115,0.00701298,0.0011595611,0.0017108126,0.0024437632,0.00016134807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011719705,0.0011597151,0.0007109054,0.0012372921,0.0004783011,0.0010314638,0.0013434016,0.0014879345,0.0041539175],"category_scores_gemma":[0.018806156,0.00076909835,0.0006881472,0.0009930548,0.0005848408,0.00077382533,0.0007540434,0.0007777917,0.0024795306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028262278,0.0007177315,0.040144823,0.0007418284,0.00043418247,0.00024536633,0.0005653582,0.005672036,0.7777782,0.001762422,0.005925254,0.16318652],"study_design_scores_gemma":[0.00028413854,0.0027212242,0.055986214,0.0001262797,0.00047507035,0.0017659593,0.00014801644,0.05399495,0.8596571,0.001540178,0.023146868,0.00015391127],"about_ca_topic_score_codex":0.0010983298,"about_ca_topic_score_gemma":0.0020833623,"teacher_disagreement_score":0.011719705,"about_ca_system_score_codex":0.0006069162,"about_ca_system_score_gemma":0.0005851235,"threshold_uncertainty_score":0.061980486},"labels":[],"label_agreement":null},{"id":"W2163844104","doi":"10.1016/j.aquatox.2005.11.010","title":"Up-regulation of the alligator CYP3A77 gene by toxaphene and dexamethasone and its short term effect on plasma testosterone concentrations","year":2006,"lang":"en","type":"article","venue":"Aquatic Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institute for Materials Science; Florida Fish and Wildlife Conservation Commission; National Science Foundation","keywords":"Toxaphene; Internal medicine; Endocrinology; CYP3A; Glucocorticoid receptor; Biology; Estrogen receptor; Cytochrome P450; Testosterone (patch); Alligator; Estrogen; Steroid hormone; Glucocorticoid; Chemistry; Hormone; Metabolism; Medicine; Pesticide","score_opus":0.04345394564975763,"score_gpt":0.3556075802752934,"score_spread":0.31215363462553575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163844104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960006,0.0010800697,0.0007987826,0.00025664622,0.00011030745,0.000023787255,0.0006611887,0.000074021125,0.0009946729],"genre_scores_gemma":[0.99035865,0.0006363881,0.0006798129,0.00008284277,0.000029675864,0.00005866169,0.0009190687,0.000037399746,0.0071974983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996896,0.000047514797,0.000029374532,0.000059117952,0.000055787314,0.00011869182],"domain_scores_gemma":[0.9993772,0.00022801063,0.000083033825,0.00011369897,0.000050229024,0.00014783222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001684578,0.00040963854,0.00049559237,0.00042805538,0.00029455443,0.000515317,0.0003777515,0.0003763859,0.0031455606],"category_scores_gemma":[0.00046795412,0.00028629645,0.0007001931,0.00035736887,0.0008190075,0.0004127137,0.00041059148,0.0010034145,0.00039735282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022854705,0.00012304228,0.0009641469,0.000034024564,0.000020714964,0.00023098406,0.000082612496,0.00010487212,0.99366164,0.00021046348,0.00012950151,0.0021525363],"study_design_scores_gemma":[0.00008415102,0.001192073,0.01674342,0.0000071442596,0.00004645927,0.00023073755,0.00027019624,0.0005941047,0.9786551,0.00011912677,0.0020350774,0.000022502214],"about_ca_topic_score_codex":0.004659354,"about_ca_topic_score_gemma":0.0077842143,"teacher_disagreement_score":0.004659354,"about_ca_system_score_codex":0.00061895436,"about_ca_system_score_gemma":0.00065071485,"threshold_uncertainty_score":0.010522902},"labels":[],"label_agreement":null},{"id":"W2164576175","doi":"10.1158/0008-5472.can-03-3295","title":"The Functional <b> <i>UGT1A1</i> </b> Promoter Polymorphism Decreases Endometrial Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Endometrial cancer; Odds ratio; Genotype; Allele; Internal medicine; Confidence interval; Case-control study; Carcinogenesis; Medicine; Endocrinology; Metabolite; Biology; Gastroenterology; Oncology; Cancer; Gene; Genetics","score_opus":0.26724815707206856,"score_gpt":0.5216540665629215,"score_spread":0.2544059094908529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164576175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984479,0.0005214872,0.00036569024,0.00009491288,0.0000074806776,0.0000053259246,0.000117446565,0.000024225355,0.00041547057],"genre_scores_gemma":[0.9988815,0.00023525336,0.00047055542,0.0000529787,0.0000085027505,0.000005128634,0.00009568241,0.00000874244,0.00024168676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966395,0.00016499848,0.00001772568,0.000078059675,0.00004202571,0.00003315885],"domain_scores_gemma":[0.99919957,0.00023346665,0.000357926,0.00005653553,0.000055418244,0.00009708116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040691567,0.00020844162,0.0002779594,0.00024436603,0.00011711718,0.00020274769,0.00015759667,0.00027865806,0.0012963173],"category_scores_gemma":[0.0017229764,0.00015233704,0.00020852471,0.00025124595,0.00021050037,0.000083053244,0.00010202503,0.00029435707,0.00017605201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038224591,0.00038498096,0.86405027,0.00010825117,0.0006475075,0.00047573523,0.00016959796,0.0004087159,0.106838375,0.00025695472,0.00060796476,0.022229128],"study_design_scores_gemma":[0.00009751004,0.0014065396,0.9864894,0.00001820292,0.00030254963,0.0013739656,0.0000565405,0.001292206,0.007721934,0.0001684334,0.0010646282,0.000008032006],"about_ca_topic_score_codex":0.002688516,"about_ca_topic_score_gemma":0.0017473474,"teacher_disagreement_score":0.002688516,"about_ca_system_score_codex":0.00010466997,"about_ca_system_score_gemma":0.0001558432,"threshold_uncertainty_score":0.005345762},"labels":[],"label_agreement":null},{"id":"W2164770365","doi":"10.1124/dmd.114.060053","title":"Adaptive Hepatic and Intestinal Alterations in Mice after Deletion of NADPH-Cytochrome P450 Oxidoreductase (Cpr) in Hepatocytes","year":2014,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; York University","keywords":"Cytochrome P450; Constitutive androstane receptor; Biology; Drug metabolism; Small intestine; Internal medicine; Endocrinology; Multidrug resistance-associated protein 2; Metabolism; Pharmacology; Transporter; Biochemistry; ATP-binding cassette transporter; Nuclear receptor; Gene; Medicine; Transcription factor","score_opus":0.026578085971890833,"score_gpt":0.33611946523169967,"score_spread":0.30954137925980885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164770365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309,0.00060444465,0.003089559,0.00033965887,0.00008949677,0.000044663815,0.001175449,0.0003500073,0.0012167636],"genre_scores_gemma":[0.9913291,0.0005848386,0.0016251575,0.00015415315,0.000031808482,0.00008309097,0.0009233511,0.00014317565,0.005125386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995764,0.00003936536,0.000035994453,0.00015229978,0.00008093896,0.00011503976],"domain_scores_gemma":[0.9993104,0.000065921995,0.000251199,0.000063387015,0.000040793515,0.00026828377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021350794,0.00096402067,0.00044622732,0.0010810241,0.00029406056,0.0004928666,0.00039898616,0.00089559006,0.0036805754],"category_scores_gemma":[0.00028313708,0.0006024377,0.0005657786,0.00034785632,0.0010552538,0.00058079266,0.00038805517,0.0019552314,0.00059950846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001373365,0.00013290155,0.00057936634,0.000040580337,0.000015472637,0.00043125448,0.000025826823,0.0001644802,0.99576855,0.00032752278,0.00007362782,0.0010669595],"study_design_scores_gemma":[0.00031346476,0.0014532802,0.020262992,0.000019217852,0.00011785426,0.0019098701,0.0002287588,0.00158626,0.9717477,0.0005450679,0.001784735,0.000030860563],"about_ca_topic_score_codex":0.00085600425,"about_ca_topic_score_gemma":0.0010427783,"teacher_disagreement_score":0.0036805754,"about_ca_system_score_codex":0.0005169802,"about_ca_system_score_gemma":0.00040181875,"threshold_uncertainty_score":0.01231277},"labels":[],"label_agreement":null},{"id":"W2164900475","doi":"10.1177/0091270007305504","title":"Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Pharmacokinetics; Warfarin; Pharmacodynamics; Ciprofloxacin; Crossover study; Medicine; Pharmacology; Prothrombin time; Drug interaction; Partial thromboplastin time; Anticoagulant; Antibiotics; Internal medicine; Chemistry; Atrial fibrillation; Coagulation; Placebo","score_opus":0.16523373510749947,"score_gpt":0.5281118326839626,"score_spread":0.36287809757646305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164900475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983688,0.0009796132,0.00029363923,0.00004691091,0.00001448337,0.000020252974,0.000033347653,0.000012363781,0.00023061287],"genre_scores_gemma":[0.9987525,0.00036145878,0.00036975535,0.00005162912,0.000033319582,0.000008215767,0.000072506344,0.0000053045433,0.0003452394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995377,0.00017435818,0.000034555153,0.00007373277,0.00013154595,0.000048130976],"domain_scores_gemma":[0.9990355,0.00028367896,0.00043182573,0.00007396116,0.000056220873,0.00011886941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002692475,0.00020301735,0.000638812,0.00009518127,0.00015768551,0.0002951515,0.00014041182,0.00040992742,0.0016203307],"category_scores_gemma":[0.001686534,0.00020336162,0.0003059603,0.00010095554,0.00023738798,0.00030464988,0.0001028576,0.0005695929,0.0002743011],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08793614,0.00221002,0.042245965,0.00043600565,0.00056560274,0.0017574496,0.00032027336,0.00037927245,0.71494704,0.00009942216,0.0005455898,0.14855728],"study_design_scores_gemma":[0.007858407,0.29978445,0.54818875,0.00004238304,0.0008800142,0.013404865,0.00026449718,0.0020951754,0.120001175,0.0001440947,0.007269055,0.00006709172],"about_ca_topic_score_codex":0.0003602248,"about_ca_topic_score_gemma":0.0005922447,"teacher_disagreement_score":0.0016203307,"about_ca_system_score_codex":0.00013709295,"about_ca_system_score_gemma":0.00016144663,"threshold_uncertainty_score":0.005420506},"labels":[],"label_agreement":null},{"id":"W2164909389","doi":"10.1021/tx0498861","title":"Detection of Covalent Adducts to Cytochrome P450 3A4 Using Liquid Chromatography Mass Spectrometry","year":2004,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Adduct; Chemistry; Mass spectrometry; Chromatography; Cytochrome P450; Liquid chromatography–mass spectrometry; Organic chemistry; Enzyme","score_opus":0.23217138900543147,"score_gpt":0.509172604711702,"score_spread":0.27700121570627056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164909389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62580216,0.008848547,0.34205976,0.0014684815,0.0002934323,0.0005333673,0.0015567004,0.004351388,0.015086271],"genre_scores_gemma":[0.7972934,0.007977147,0.17738459,0.0013429327,0.00016650808,0.00052528473,0.0015557922,0.00015954665,0.013594823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991837,0.00018354379,0.000038763374,0.00014317407,0.00035002246,0.00010078311],"domain_scores_gemma":[0.999418,0.00019637511,0.00016009719,0.000056813242,0.00011207689,0.00005652648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007918231,0.0007680946,0.00034912775,0.0015551583,0.00054936163,0.00053321663,0.000580309,0.0010919408,0.0014934181],"category_scores_gemma":[0.0009245441,0.00037023003,0.00032353762,0.0007372325,0.00063739927,0.00057534827,0.000491492,0.0009976008,0.001567991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037958387,0.00005263631,0.0007780508,0.000032854758,0.00001486085,0.000091637456,0.000014926498,0.00010044375,0.9940866,0.00020586184,0.00014880073,0.004435473],"study_design_scores_gemma":[0.000009022349,0.0002952037,0.0024768685,0.0000051589323,0.000017562472,0.00039324345,0.000023057688,0.0016661499,0.9920202,0.0002949499,0.0027857267,0.000012899145],"about_ca_topic_score_codex":0.001180994,"about_ca_topic_score_gemma":0.0015937968,"teacher_disagreement_score":0.0015551583,"about_ca_system_score_codex":0.0004738082,"about_ca_system_score_gemma":0.0005290504,"threshold_uncertainty_score":0.0049960017},"labels":[],"label_agreement":null},{"id":"W2165341378","doi":"10.18433/j3wc7g","title":"Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: Faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education and Human Resources Development","keywords":"Omeprazole; Pharmacokinetics; Pharmacology; Oral administration; Diabetes mellitus; Alloxan; Streptozotocin; Endocrinology; Chemistry; Internal medicine; Medicine","score_opus":0.1127287426547365,"score_gpt":0.4475086422129697,"score_spread":0.33477989955823323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165341378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817574,0.00047819395,0.00075280387,0.00008109269,0.00003420519,0.000020574878,0.00017072445,0.00004464292,0.00024218256],"genre_scores_gemma":[0.9953816,0.0008653102,0.0016526715,0.00012744337,0.00003193367,0.00007618982,0.00044790667,0.000021076796,0.001395872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979025,0.000019324376,0.000019466137,0.000054713695,0.00005596538,0.000060282837],"domain_scores_gemma":[0.99956435,0.000027011496,0.00019096829,0.000038398695,0.000034985987,0.00014422413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020585033,0.00077554217,0.0007174857,0.0005649294,0.00023097731,0.0003006238,0.00019430429,0.00043996307,0.0011990075],"category_scores_gemma":[0.00020854756,0.00028595544,0.0005552203,0.00035288307,0.00049006473,0.0005246166,0.00016513173,0.0015586228,0.0002419328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005711058,0.00048715025,0.0027463045,0.000069567024,0.00003225608,0.00016112404,0.000032146567,0.00008790013,0.9878592,0.00007059896,0.00006178104,0.002680942],"study_design_scores_gemma":[0.00055673695,0.012684756,0.050855715,0.000015755382,0.00017652083,0.00068666856,0.00015618817,0.0019879716,0.9311342,0.000097163764,0.0016143846,0.00003390897],"about_ca_topic_score_codex":0.0013476021,"about_ca_topic_score_gemma":0.0015578275,"teacher_disagreement_score":0.0013476021,"about_ca_system_score_codex":0.0005500687,"about_ca_system_score_gemma":0.00039380093,"threshold_uncertainty_score":0.0040110946},"labels":[],"label_agreement":null},{"id":"W2165692369","doi":"","title":"In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"CYP1A2; CYP3A4; Cytochrome P450; Microsome; Recombinant DNA; Isozyme; Biochemistry; Enzyme; Chemistry; Metabolism; Biology; Gene","score_opus":0.09776231957590173,"score_gpt":0.358001457043794,"score_spread":0.2602391374678923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165692369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8307891,0.026577553,0.12856857,0.00079006236,0.00024636457,0.00058383273,0.0066382885,0.00093767565,0.0048685195],"genre_scores_gemma":[0.9179283,0.012157395,0.043200325,0.00019316706,0.00013675458,0.00037281145,0.019067923,0.00016164481,0.0067817043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954516,0.00020747486,0.00003947398,0.00006548689,0.00009419867,0.000048123904],"domain_scores_gemma":[0.9997062,0.00009275417,0.000053677948,0.00005004633,0.00007977157,0.00001765872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062100915,0.00073469925,0.0004376764,0.0003039745,0.00019377125,0.00028522193,0.00022011451,0.0002724711,0.00084896374],"category_scores_gemma":[0.0005542194,0.00022664366,0.0005557187,0.00043992154,0.00016152562,0.00020284436,0.00014786315,0.0005452475,0.00085731846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023199561,0.000094213545,0.0006782244,0.00015066944,0.000056919536,0.00013543856,0.000028675418,0.0002616297,0.99320495,0.00008448695,0.00016947315,0.004903352],"study_design_scores_gemma":[0.000025745816,0.0006992108,0.004221599,0.000006986286,0.00010963944,0.0006103949,0.000018987253,0.0011139044,0.9867764,0.00005886362,0.006349458,0.000008850556],"about_ca_topic_score_codex":0.001591307,"about_ca_topic_score_gemma":0.0018947275,"teacher_disagreement_score":0.001591307,"about_ca_system_score_codex":0.000285251,"about_ca_system_score_gemma":0.00030496897,"threshold_uncertainty_score":0.003284216},"labels":[],"label_agreement":null},{"id":"W2165909199","doi":"10.1002/rcm.3329","title":"Determining protein adducts of fipexide: mass spectrometry based assay for confirming the involvement of its reactive metabolite in covalent binding","year":2007,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; F. Hoffmann-La Roche","keywords":"Chemistry; Metabolite; Adduct; Cysteine; Glutathione; Microsome; Mass spectrometry; Biochemistry; Amino acid; Drug metabolism; Chromatography; Metabolism; Enzyme; Organic chemistry","score_opus":0.1514846472384997,"score_gpt":0.4371948207227738,"score_spread":0.28571017348427413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165909199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89384323,0.007485096,0.09338674,0.00016417947,0.00011300421,0.00035104272,0.0009587145,0.00042382217,0.0032740806],"genre_scores_gemma":[0.89818704,0.0058274404,0.08770118,0.00028267165,0.00006528463,0.00043780165,0.0015910111,0.00006707455,0.0058404934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937767,0.00015618728,0.000042217107,0.00014321184,0.00020829866,0.000072579205],"domain_scores_gemma":[0.99947304,0.00013017272,0.0001302328,0.00006705115,0.00013112075,0.00006834115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069612946,0.0010653092,0.0004461376,0.0010517887,0.00042155202,0.00032454598,0.00045891968,0.0011411803,0.0012449245],"category_scores_gemma":[0.0006582958,0.00039618165,0.00041331592,0.0007118088,0.0004371383,0.00042522702,0.0004095948,0.0008204913,0.00067381124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006103719,0.00003026174,0.0005992251,0.000045362016,0.000018486322,0.000049019833,0.000026290778,0.000034551555,0.9981431,0.000039029575,0.000014533956,0.00093913305],"study_design_scores_gemma":[0.000005149901,0.00040341893,0.005002227,0.000005653352,0.000029894341,0.00022544192,0.000026859312,0.0006297283,0.992831,0.000047006008,0.0007863115,0.0000072181188],"about_ca_topic_score_codex":0.0006517156,"about_ca_topic_score_gemma":0.0013664861,"teacher_disagreement_score":0.0012449245,"about_ca_system_score_codex":0.00030655242,"about_ca_system_score_gemma":0.00037620586,"threshold_uncertainty_score":0.0041646957},"labels":[],"label_agreement":null},{"id":"W2165921276","doi":"10.1002/bdd.1855","title":"Assessment of CYP3A‐mediated drug–drug interaction potential for victim drugs using an <i>in vivo</i> rat model","year":2013,"lang":"en","type":"article","venue":"Biopharmaceutics & Drug Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Ketoconazole; CYP3A; Pharmacology; Buspirone; Pharmacokinetics; Verapamil; In vivo; Drug interaction; Ritonavir; Chemistry; Microsome; Medicine; In vitro; Biology; Biochemistry; Serotonin; Immunology; Receptor","score_opus":0.06432302620584197,"score_gpt":0.42919626346637796,"score_spread":0.364873237260536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165921276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770666,0.0021151085,0.017258545,0.00026923898,0.00013107026,0.00016231081,0.0006848846,0.00045450788,0.0018577668],"genre_scores_gemma":[0.98035514,0.0026202113,0.011241696,0.0001970761,0.00005846948,0.00020719091,0.00096161186,0.00009968708,0.0042588776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994573,0.00012870418,0.00003490716,0.00014002481,0.00013373411,0.00010534658],"domain_scores_gemma":[0.9993537,0.00007892716,0.00024108538,0.00012233024,0.00008106142,0.00012287934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058950426,0.0018460837,0.00090764783,0.0007799244,0.00037953685,0.0007448938,0.0005149426,0.0006545684,0.002038176],"category_scores_gemma":[0.00041204446,0.00037047733,0.00082630524,0.000380005,0.0005495292,0.0009732451,0.00030848625,0.0019846626,0.0007271774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017464226,0.0007059446,0.0015198808,0.00012285156,0.00007663077,0.00013974338,0.000046395653,0.00034488138,0.98739165,0.00019126612,0.00019085106,0.007523515],"study_design_scores_gemma":[0.000042247404,0.009453414,0.0033488693,0.0000068503023,0.0001543964,0.00040750837,0.000060741302,0.0023996104,0.9824223,0.00007365556,0.0016077231,0.000022788461],"about_ca_topic_score_codex":0.0010638969,"about_ca_topic_score_gemma":0.0013223038,"teacher_disagreement_score":0.002038176,"about_ca_system_score_codex":0.00047865184,"about_ca_system_score_gemma":0.00046838456,"threshold_uncertainty_score":0.0068184137},"labels":[],"label_agreement":null},{"id":"W2165936366","doi":"10.1016/j.cbpa.2011.02.014","title":"Ontogenesis of UDP-glucuronosyltransferase enzymes in sheep","year":2011,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Fetus; Biology; Enzyme; Messenger RNA; Internal medicine; Endocrinology; Blot; Glucuronosyltransferase; Complementary DNA; Microsome; Ontogeny; Molecular biology; Gene; Biochemistry; Pregnancy; Medicine; Genetics","score_opus":0.12450593394723496,"score_gpt":0.399685223999175,"score_spread":0.27517929005194003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165936366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876644,0.004144494,0.0025411332,0.000105952764,0.000041988438,0.000027151844,0.0007537897,0.00006914871,0.01354995],"genre_scores_gemma":[0.977032,0.0031986244,0.0013000382,0.00011616645,0.00003549065,0.000059142596,0.0011494454,0.000068417845,0.01704063],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999038,0.000014324672,0.000007591208,0.000039320916,0.000019019068,0.00001584162],"domain_scores_gemma":[0.9995844,0.00013380776,0.00009555379,0.00003716561,0.00006041504,0.0000886304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016693953,0.00029588322,0.0004175619,0.0010878226,0.0002870634,0.0005703255,0.00029614763,0.00043381486,0.0018965625],"category_scores_gemma":[0.0003874331,0.00048014478,0.00024784295,0.00033117537,0.00046904734,0.00057339715,0.00040877602,0.0007735954,0.0010251431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016196588,0.00008360586,0.01764465,0.0001996313,0.00004637781,0.001360286,0.0005994021,0.00045871016,0.93420076,0.003458615,0.00041132572,0.039917044],"study_design_scores_gemma":[0.00008812383,0.0012063327,0.7243646,0.00020920119,0.00010125498,0.0034615416,0.001009853,0.0014233442,0.23765503,0.0029330775,0.027488872,0.00005876822],"about_ca_topic_score_codex":0.0016683524,"about_ca_topic_score_gemma":0.002382874,"teacher_disagreement_score":0.0018965625,"about_ca_system_score_codex":0.00040534127,"about_ca_system_score_gemma":0.0002537373,"threshold_uncertainty_score":0.0063446164},"labels":[],"label_agreement":null},{"id":"W2166210552","doi":"10.1002/cpt.280","title":"Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Human Genome Research Institute; National Institute on Drug Abuse; Wellcome Trust","keywords":"Workgroup; Standardization; Confusion; Pharmacogenetics; Nomenclature; Chemical nomenclature; Transparency (behavior); Computer science; Computational biology; Medicine; Biology; Genetics; Psychology; Gene; Taxonomy (biology); Genotype","score_opus":0.7130136977464977,"score_gpt":0.6624251810135845,"score_spread":0.0505885167329132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166210552","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038052546,0.5428125,0.12398876,0.17858523,0.026216948,0.004973473,0.011295055,0.003617397,0.10470535],"genre_scores_gemma":[0.023520885,0.48014536,0.33641842,0.075545885,0.008006455,0.007695498,0.030154876,0.001310163,0.03720246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9736039,0.010573743,0.006584542,0.0010848755,0.0074405144,0.0007123699],"domain_scores_gemma":[0.95473564,0.015437073,0.005707568,0.0027277123,0.020266691,0.0011253278],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038746458,0.0014959844,0.002438515,0.0098529495,0.0011186054,0.003697521,0.006163349,0.0046689147,0.0071518878],"category_scores_gemma":[0.055343684,0.00085334125,0.003109267,0.007673485,0.0026994324,0.0027426614,0.0027551083,0.008084188,0.008778172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018539409,0.00019714572,0.002142851,0.005193467,0.00013353422,0.00055153493,0.0007854595,0.00053864915,0.0022039253,0.026175704,0.35096866,0.6109237],"study_design_scores_gemma":[0.000078781915,0.00009543528,0.0019894545,0.00749649,0.00020526665,0.0014150693,0.00031335713,0.0002579964,0.001496304,0.009081248,0.9775114,0.000059165184],"about_ca_topic_score_codex":0.0066077826,"about_ca_topic_score_gemma":0.00415896,"teacher_disagreement_score":0.9612535,"about_ca_system_score_codex":0.0020572706,"about_ca_system_score_gemma":0.012771007,"threshold_uncertainty_score":0.20491332},"labels":[],"label_agreement":null},{"id":"W2166761612","doi":"10.1093/toxsci/kfh010","title":"Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of In Vitro Benzo[a]pyrene Covalent Binding and Cytotoxicity","year":2003,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glucuronidation; Chemistry; Carcinogen; UGT2B7; Cytotoxicity; Glucuronosyltransferase; Microsome; Benzo(a)pyrene; Xenobiotic; In vitro; Biochemistry; Isozyme; Population; Pyrene; Pharmacology; Enzyme; Biology; Medicine; Organic chemistry","score_opus":0.1425561427474743,"score_gpt":0.4361603760266812,"score_spread":0.29360423327920687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166761612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737394,0.0005804227,0.0012031387,0.000013992102,0.000006642164,0.000012873433,0.00018908065,0.000022177423,0.00059771445],"genre_scores_gemma":[0.99943656,0.000056048168,0.00016480702,0.000011307415,0.000003984526,0.000006779297,0.00015809572,0.0000053986214,0.0001570302],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990752,0.00029599806,0.0000611182,0.00036650014,0.0001429382,0.00005831033],"domain_scores_gemma":[0.99900264,0.00041526594,0.00016950486,0.00023588871,0.00010107128,0.00007565631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000727592,0.00021630242,0.0003278333,0.0004128174,0.00017108211,0.0004445619,0.00015302813,0.00032244725,0.0006820773],"category_scores_gemma":[0.0020161632,0.00017968244,0.00013794056,0.00047466872,0.00027651092,0.00014033713,0.0001878422,0.0002609643,0.00020246931],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017827629,0.00016173067,0.86147195,0.000055752607,0.00052200176,0.0003969113,0.0008648822,0.0008965803,0.11019609,0.00031116806,0.00038496565,0.022955237],"study_design_scores_gemma":[0.000009414703,0.0005032512,0.9901917,0.0000036475203,0.00007388793,0.00096067385,0.00008197436,0.00078523974,0.0066609997,0.00016115046,0.0005591651,0.000008940146],"about_ca_topic_score_codex":0.00073645695,"about_ca_topic_score_gemma":0.00048511304,"teacher_disagreement_score":0.00073645695,"about_ca_system_score_codex":0.00012223367,"about_ca_system_score_gemma":0.000057258312,"threshold_uncertainty_score":0.0038479567},"labels":[],"label_agreement":null},{"id":"W2167719907","doi":"10.1517/17425255.2013.799137","title":"Drug absorption, distribution, metabolism and excretion considerations in critically ill adults","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"ADME; Pharmacokinetics; Drug; Critically ill; Excretion; Medicine; Distribution (mathematics); Drug metabolism; Pharmacology; Metabolic clearance rate; Intensive care medicine; Internal medicine","score_opus":0.09864579190547527,"score_gpt":0.4382375260399172,"score_spread":0.33959173413444194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167719907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015619662,0.99837995,0.00016692853,0.0004185164,0.00012657513,0.0000054893553,0.00001743835,0.000005342956,0.00072361436],"genre_scores_gemma":[0.001711148,0.99688244,0.00029399304,0.00031499518,0.00022789523,0.000009136732,0.000030097854,0.0000014782786,0.000528879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963355,0.0000927399,0.00006939436,0.000049819748,0.00013278337,0.000021719829],"domain_scores_gemma":[0.9995358,0.00022620462,0.0001084486,0.000008043141,0.0001023599,0.000019185301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060756964,0.00056697294,0.0013180602,0.0011893524,0.00014874754,0.00077708677,0.00056502194,0.001046171,0.0027584801],"category_scores_gemma":[0.0010714817,0.0001813809,0.0006348463,0.0010495206,0.0003153452,0.0008992703,0.00036987072,0.0013136382,0.001314389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012794997,0.00004763064,0.00033478622,0.030075021,0.00014364676,0.00046575424,0.00007046761,0.00034567268,0.002092485,0.002344173,0.025486885,0.9384655],"study_design_scores_gemma":[0.000043668042,0.00026051083,0.0024433518,0.009726312,0.00037177477,0.0057513355,0.00011488003,0.00034912236,0.0014571466,0.002658142,0.9767892,0.000034520817],"about_ca_topic_score_codex":0.0011737869,"about_ca_topic_score_gemma":0.0016015649,"teacher_disagreement_score":0.0027584801,"about_ca_system_score_codex":0.0004178707,"about_ca_system_score_gemma":0.00096047774,"threshold_uncertainty_score":0.009227991},"labels":[],"label_agreement":null},{"id":"W2167742437","doi":"10.1038/clpt.2013.235","title":"Progress in Pharmacogenomics: Bridging the Gap From Research to Practice","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Viewpoints; Drug response; Epigenetics; Clinical Practice; Computational biology; Medicine; Pharmacology; Bioinformatics; Drug; Biology; Gene; Genetics; Genotype","score_opus":0.356520977217391,"score_gpt":0.6184123225768028,"score_spread":0.2618913453594118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167742437","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041170824,0.07700202,0.0006126793,0.113608696,0.8071304,0.000018068173,0.000033305303,0.000074304146,0.001479384],"genre_scores_gemma":[0.00033291485,0.06037621,0.0005173511,0.037939254,0.8978264,0.000014269626,0.000023205977,0.00003732502,0.0029331034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991771,0.00203802,0.0011055782,0.000673101,0.0041662455,0.000246068],"domain_scores_gemma":[0.9457183,0.035195544,0.00166664,0.0010769939,0.0130341435,0.0033084839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016713604,0.0029293632,0.0035640546,0.003627344,0.0020328977,0.0076298444,0.0033100226,0.0121695455,0.006549114],"category_scores_gemma":[0.042685837,0.0011337672,0.002251242,0.0022477969,0.004174575,0.009639041,0.0023824049,0.034038175,0.0051916013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002920637,0.00001756653,0.00003994296,0.0007087844,0.000041484225,0.00010437033,0.0000459663,0.00007896535,0.00009390566,0.0017981292,0.96873915,0.028302474],"study_design_scores_gemma":[0.000034812652,0.000026316764,0.00018616169,0.0011651979,0.00004886697,0.0003063731,0.00006968592,0.00017995533,0.000073883675,0.0053265262,0.99256057,0.000021589214],"about_ca_topic_score_codex":0.0012222787,"about_ca_topic_score_gemma":0.0036251163,"teacher_disagreement_score":0.016713604,"about_ca_system_score_codex":0.0031596408,"about_ca_system_score_gemma":0.0050584883,"threshold_uncertainty_score":0.088391066},"labels":[],"label_agreement":null},{"id":"W2167836153","doi":"10.1124/dmd.110.035584","title":"The Aryl Hydrocarbon Receptor Pathway and the Response to 3-Methylcholanthrene Are Altered in the Liver of Adrenalectomized Rats","year":2010,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Aryl hydrocarbon receptor; Internal medicine; Endocrinology; CYP1B1; Cytochrome P450; Chemistry; CYP1A2; Methylcholanthrene; Enzyme inducer; Adrenalectomy; Metabolism; Carcinogen; Biology; Enzyme; Medicine; Biochemistry","score_opus":0.023980320158408053,"score_gpt":0.33725013076072996,"score_spread":0.3132698106023219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167836153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979202,0.00044201023,0.00042008594,0.00012631695,0.000048961145,0.0000092276805,0.00063289056,0.000054367483,0.0003459608],"genre_scores_gemma":[0.99230886,0.00067455624,0.0006126191,0.00012822177,0.000025530155,0.000042288902,0.0013964078,0.00007383641,0.004737671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966264,0.000029142622,0.000017932089,0.00008232407,0.00008520829,0.00012284312],"domain_scores_gemma":[0.9989028,0.00014907755,0.00022811463,0.00015383148,0.00010924652,0.00045689172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018637853,0.0010542399,0.0008475629,0.0018638188,0.00054608827,0.0007021684,0.00033167904,0.000594922,0.0036104324],"category_scores_gemma":[0.00048616756,0.00080722285,0.0007186688,0.0007083896,0.0014632925,0.00086235465,0.0004585443,0.0016051679,0.00062698364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015776386,0.00043054545,0.0051341257,0.00005169798,0.00008653218,0.00028974906,0.00012307396,0.00022064317,0.97418797,0.00019559368,0.00012102729,0.0033827485],"study_design_scores_gemma":[0.0003854425,0.0029820786,0.15019032,0.000015898664,0.00030482872,0.00062142196,0.00071047404,0.0017292458,0.8402481,0.0006580251,0.0020408253,0.00011337415],"about_ca_topic_score_codex":0.007849276,"about_ca_topic_score_gemma":0.010019613,"teacher_disagreement_score":0.007849276,"about_ca_system_score_codex":0.00085988943,"about_ca_system_score_gemma":0.0008019078,"threshold_uncertainty_score":0.015607178},"labels":[],"label_agreement":null},{"id":"W2168103670","doi":"10.1124/dmd.31.1.7","title":"Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels","year":2003,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pregnane X receptor; Constitutive androstane receptor; CYP2B6; Biology; Cytochrome P450; Messenger RNA; Gene expression; Receptor; CYP3A4; Gene; Nuclear receptor; Endocrinology; Internal medicine; Molecular biology; Transcription factor; Genetics; Metabolism; Medicine","score_opus":0.03922641977277825,"score_gpt":0.3361975998094348,"score_spread":0.29697118003665657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168103670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683434,0.00078136154,0.0010742174,0.000023630506,0.000010722998,0.000011079748,0.0005667812,0.000026175054,0.0006717548],"genre_scores_gemma":[0.9975418,0.00024142269,0.0004991729,0.000023034638,0.000015903943,0.000028678473,0.00078570883,0.000019750862,0.0008444943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995753,0.00013087867,0.000032391003,0.00013085957,0.00008542712,0.000045040117],"domain_scores_gemma":[0.998906,0.0004673224,0.00020690153,0.00022476603,0.00012547272,0.000069369584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038993065,0.00012494445,0.00037656017,0.00058772333,0.00021979386,0.0004352985,0.0001036774,0.00025113387,0.001316376],"category_scores_gemma":[0.001186085,0.00029925237,0.0002236843,0.00062727055,0.00032600848,0.00017436816,0.00019316105,0.00029111738,0.0004160237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005481038,0.0002347093,0.491547,0.0001240499,0.0005431112,0.00042369566,0.001057798,0.00094536087,0.47365654,0.00033241892,0.00047893572,0.025175447],"study_design_scores_gemma":[0.00002391755,0.00031717517,0.979146,0.0000037724578,0.00008377379,0.0010498662,0.00012321338,0.00059296854,0.017930914,0.00010669597,0.00061060727,0.000011076245],"about_ca_topic_score_codex":0.0010543751,"about_ca_topic_score_gemma":0.0015634975,"teacher_disagreement_score":0.001316376,"about_ca_system_score_codex":0.00014714469,"about_ca_system_score_gemma":0.00010801845,"threshold_uncertainty_score":0.0044037104},"labels":[],"label_agreement":null},{"id":"W2168484164","doi":"10.1677/joe-10-0075","title":"Cytochrome P450-mediated 17β-estradiol metabolism in zebrafish (Danio rerio)","year":2010,"lang":"en","type":"article","venue":"Journal of Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Environmental Health Sciences; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; McMaster University","keywords":"CYP3A; Cytochrome P450; Metabolite; Metabolism; Zebrafish; Danio; CYP1B1; Biology; Drug metabolism; Biochemistry; Cytochrome; Chemistry; Gene; Enzyme","score_opus":0.062031198869780306,"score_gpt":0.4023504431201033,"score_spread":0.340319244250323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168484164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908414,0.0030579418,0.002639479,0.00014296798,0.000029493462,0.000067916684,0.0013482465,0.00011395488,0.0017585354],"genre_scores_gemma":[0.97974443,0.0034784211,0.006900548,0.000109137756,0.000013214783,0.00011209579,0.0020153744,0.000035602556,0.007591356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999013,0.000008004638,0.0000062108456,0.000032728934,0.00003596991,0.000015802878],"domain_scores_gemma":[0.99994016,0.0000053651684,0.000021800792,0.0000054032994,0.000017573433,0.000009685934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014944686,0.0003602104,0.00021617582,0.00024548438,0.00019014427,0.00015780464,0.00014932422,0.0002255509,0.0006527667],"category_scores_gemma":[0.00010324272,0.0002142088,0.00032498813,0.00013343706,0.00017847763,0.00017825175,0.00016098317,0.00031709677,0.0002995829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049340957,0.0000057091797,0.0006571188,0.000036570313,0.000006449924,0.00004994081,0.00001966794,0.000086632914,0.99780196,0.000051578805,0.000048731945,0.0011863362],"study_design_scores_gemma":[0.000026800379,0.00029363512,0.036482446,0.00001341142,0.000047184392,0.00040119566,0.000040891035,0.0008173264,0.95759916,0.00006095188,0.0041986224,0.000018331815],"about_ca_topic_score_codex":0.0071438504,"about_ca_topic_score_gemma":0.007235439,"teacher_disagreement_score":0.0071438504,"about_ca_system_score_codex":0.0006131001,"about_ca_system_score_gemma":0.00032434278,"threshold_uncertainty_score":0.014204562},"labels":[],"label_agreement":null},{"id":"W2168535709","doi":"10.1016/s0731-7085(03)00528-4","title":"Determination of urinary 13C-caffeine metabolites by liquid chromatography–mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity","year":2004,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Chemistry; Caffeine; Chromatography; CYP1A2; Urine; Mass spectrometry; Liquid chromatography–mass spectrometry; High-performance liquid chromatography; Tandem mass spectrometry; Metabolism; Biochemistry; Endocrinology; Cytochrome P450","score_opus":0.11118737188550944,"score_gpt":0.42220772133978146,"score_spread":0.31102034945427204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168535709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7647085,0.032588292,0.18717289,0.0011424065,0.00046316112,0.00081115396,0.003656379,0.002351263,0.0071058925],"genre_scores_gemma":[0.8492758,0.005876615,0.13567555,0.00118873,0.0001781076,0.00067471113,0.0017230503,0.00050097686,0.0049065175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975419,0.00085951126,0.00014114572,0.00048397377,0.00085137354,0.00012219072],"domain_scores_gemma":[0.99870205,0.00036453546,0.00024737234,0.00014744606,0.00038710583,0.0001515194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002154524,0.0009980163,0.0011759917,0.0024808412,0.0008830896,0.0010202422,0.00084483554,0.0019421837,0.0010946065],"category_scores_gemma":[0.0037736688,0.0007797245,0.0006098113,0.0015811214,0.00075206277,0.00090206537,0.0004457418,0.0011700931,0.0007006186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025454476,0.0002459814,0.034925148,0.00029931523,0.00049548125,0.0001987051,0.00018862658,0.00040658566,0.89535576,0.00049109606,0.0008256127,0.06402229],"study_design_scores_gemma":[0.00012031638,0.0012241855,0.071594216,0.000038864968,0.00040323182,0.0021269505,0.00007657795,0.008505133,0.9110056,0.00033302195,0.004469026,0.00010292256],"about_ca_topic_score_codex":0.0030957018,"about_ca_topic_score_gemma":0.0060631232,"teacher_disagreement_score":0.0030957018,"about_ca_system_score_codex":0.0005063446,"about_ca_system_score_gemma":0.0012311947,"threshold_uncertainty_score":0.0113943815},"labels":[],"label_agreement":null},{"id":"W2168786728","doi":"10.18433/j30593","title":"Inhibition of Human Liver Cytochrome P450 by Star Fruit Juice","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Fruit juice; Cytochrome P450; Star (game theory); Chemistry; Food science; Human liver; Biochemistry; Metabolism; Enzyme; Mathematics","score_opus":0.17450300688268175,"score_gpt":0.49629016659249814,"score_spread":0.3217871597098164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168786728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778065,0.017998973,0.0021927832,0.00012817424,0.00004951266,0.00007377118,0.00031473287,0.00008368711,0.0013517782],"genre_scores_gemma":[0.9896662,0.0055014202,0.0023346287,0.000088104855,0.000035219346,0.000041896063,0.00070328143,0.000014629265,0.001614518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980885,0.00006605924,0.000015599491,0.00003955962,0.000050181086,0.000019751113],"domain_scores_gemma":[0.99989915,0.000029902796,0.00002404871,0.0000091454785,0.00002637031,0.000011401886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024507652,0.0005102455,0.0003936553,0.00017537629,0.0001111802,0.0001692225,0.00015556334,0.0002553227,0.0019147233],"category_scores_gemma":[0.0002894767,0.00012062445,0.0003872745,0.00017183251,0.00014803454,0.00018629024,0.00015007233,0.00034134206,0.00034721158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006864234,0.000104812156,0.001207032,0.00031243748,0.00004712761,0.00010960456,0.000036492696,0.000106086285,0.9885239,0.00002958492,0.00013239672,0.008704129],"study_design_scores_gemma":[0.00006318308,0.00392436,0.015091308,0.000024554538,0.00009459637,0.0004697121,0.000027360267,0.00063324755,0.976262,0.000024475234,0.003376848,0.000008431845],"about_ca_topic_score_codex":0.0006187155,"about_ca_topic_score_gemma":0.000830994,"teacher_disagreement_score":0.0019147233,"about_ca_system_score_codex":0.00014243416,"about_ca_system_score_gemma":0.00015405062,"threshold_uncertainty_score":0.0064053535},"labels":[],"label_agreement":null},{"id":"W2169020135","doi":"10.1124/dmd.106.010363","title":"In Vivo and in Vitro Characterization of Chlorzoxazone Metabolism and Hepatic CYP2E1 Levels in African Green Monkeys: Induction by Chronic Nicotine Treatment","year":2006,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Chlorzoxazone; In vivo; Nicotine; CYP2E1; Pharmacology; Biology; Drug metabolism; In vitro; Metabolism; Microsome; Chemistry; Endocrinology; Internal medicine; Biochemistry; Medicine","score_opus":0.024225973695588397,"score_gpt":0.3164565283292743,"score_spread":0.2922305546336859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169020135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954268,0.00109109,0.0018330851,0.00010872089,0.00003287841,0.000036849266,0.0006932222,0.00006438147,0.0007129292],"genre_scores_gemma":[0.99287087,0.000711997,0.0013745584,0.000049479404,0.000020793765,0.000078600984,0.0010934558,0.000053429834,0.0037467778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997733,0.000048469497,0.000014400309,0.00004777378,0.000045253186,0.00007073272],"domain_scores_gemma":[0.999701,0.000056383586,0.000063842555,0.00006512092,0.000046560508,0.00006703678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022581022,0.00042310316,0.0005528026,0.0005725439,0.0003988297,0.00041312212,0.00023117515,0.00042959716,0.0012841228],"category_scores_gemma":[0.0003123185,0.00029049936,0.00046668632,0.00038347306,0.00051057443,0.0002867283,0.00016142924,0.0010938288,0.0004604944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028382987,0.00024824947,0.002285958,0.000026805217,0.000027903867,0.000072004594,0.000088752415,0.00010942939,0.991861,0.00007394455,0.000079838836,0.0022878486],"study_design_scores_gemma":[0.00008737179,0.0017741577,0.020288352,0.0000036682811,0.000088446475,0.00019540914,0.000102308346,0.0007663389,0.97534925,0.00006356955,0.0012679346,0.000013244527],"about_ca_topic_score_codex":0.0058643264,"about_ca_topic_score_gemma":0.0094690025,"teacher_disagreement_score":0.0058643264,"about_ca_system_score_codex":0.0005387982,"about_ca_system_score_gemma":0.00039262863,"threshold_uncertainty_score":0.011660397},"labels":[],"label_agreement":null},{"id":"W2169470980","doi":"10.1016/s0165-6147(00)01493-0","title":"Ethical considerations in clinical pharmacogenomics research","year":2000,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Pharmacogenomics; Confidentiality; Ethical issues; Medicine; Pharmacogenetics; Engineering ethics; Psychiatry; Psychology; Pharmacology; Genotype; Political science; Biology; Genetics","score_opus":0.818077506940643,"score_gpt":0.7092402758541994,"score_spread":0.10883723108644361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169470980","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011666743,0.4147514,0.026707638,0.5211154,0.010581746,0.00014426722,0.000056056146,0.00005613992,0.02542053],"genre_scores_gemma":[0.08097616,0.31884462,0.055050045,0.49208993,0.039881628,0.0014341864,0.00013942299,0.00012436588,0.011459614],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9122097,0.065051354,0.005724989,0.00228493,0.013460905,0.0012681363],"domain_scores_gemma":[0.74299824,0.22969262,0.0063684233,0.0073783365,0.0104003595,0.0031620332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11665582,0.0007623142,0.0030204956,0.0015700324,0.0028534513,0.006577793,0.00297946,0.019908184,0.003185135],"category_scores_gemma":[0.15605265,0.0007838338,0.0009747527,0.0016723044,0.02255456,0.0068112663,0.0047870004,0.02562302,0.0012121658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013276366,0.00016904321,0.0014076601,0.00418302,0.00011662073,0.0026396334,0.0033086166,0.0009220539,0.00043192084,0.4852472,0.121962555,0.3794789],"study_design_scores_gemma":[0.00013832547,0.0000957862,0.0014335254,0.013798631,0.000104565406,0.0057914667,0.0015761066,0.0006544413,0.0004233046,0.45481497,0.5211016,0.00006727271],"about_ca_topic_score_codex":0.001141285,"about_ca_topic_score_gemma":0.0020152829,"teacher_disagreement_score":0.11665582,"about_ca_system_score_codex":0.0037624831,"about_ca_system_score_gemma":0.018099472,"threshold_uncertainty_score":0.6169423},"labels":[],"label_agreement":null},{"id":"W2169746137","doi":"10.4997/jrcpe.2012.312","title":"Pharmacogenetics: transforming clinical medicine","year":2012,"lang":"en","type":"review","venue":"The Journal of the Royal College of Physicians of Edinburgh","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Drug response; Medicine; Precision medicine; Genetic testing; Drug development; Genetic variation; Drug; Bioinformatics; Computational biology; Pharmacology; Biology; Genetics; Internal medicine; Genotype; Pathology; Gene; Population","score_opus":0.21062982001683236,"score_gpt":0.4891259861523526,"score_spread":0.2784961661355202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169746137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016520501,0.96700656,0.0024182159,0.022710418,0.002610993,0.000012218576,0.00002992294,0.000052126295,0.004994284],"genre_scores_gemma":[0.0022906177,0.9803885,0.002678601,0.0081649255,0.004545473,0.000018740378,0.000035206573,0.0000121388675,0.0018658331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848336,0.00065073336,0.00011720045,0.00016461042,0.0005086367,0.000075428565],"domain_scores_gemma":[0.99506724,0.0035196915,0.00023265238,0.00017625063,0.0006952603,0.0003090022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037222654,0.0009851618,0.0014762868,0.002245427,0.00046448503,0.0031066178,0.0010886458,0.0042938148,0.0052840924],"category_scores_gemma":[0.0054892404,0.0003932836,0.0005617488,0.002128187,0.0029763414,0.004364808,0.0022956063,0.007575445,0.0036218385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000385247,0.0000768425,0.0002734306,0.0042450293,0.000060396913,0.00031264377,0.00020267481,0.0005154528,0.0006686276,0.04216629,0.08479118,0.866649],"study_design_scores_gemma":[0.000015779364,0.000045370933,0.0004326052,0.0034150016,0.000021297543,0.001043858,0.00015189528,0.00015740447,0.00013775226,0.036309436,0.95824754,0.000022140828],"about_ca_topic_score_codex":0.0011567317,"about_ca_topic_score_gemma":0.0015854487,"teacher_disagreement_score":0.0052840924,"about_ca_system_score_codex":0.0020320553,"about_ca_system_score_gemma":0.0025863207,"threshold_uncertainty_score":0.019685447},"labels":[],"label_agreement":null},{"id":"W2170078964","doi":"10.1097/00008571-200108000-00003","title":"Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates","year":2001,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse","keywords":"CYP2D6; Dextromethorphan; Debrisoquine; MDMA; Pharmacology; Cytochrome P450; Sparteine; Chemistry; Stereochemistry; Hydroxylation; Quinidine; Metabolism; Biology; Enzyme; Biochemistry","score_opus":0.1495562412011606,"score_gpt":0.44125100301229303,"score_spread":0.2916947618111324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170078964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92423,0.01746465,0.03638599,0.0017993966,0.00036675093,0.00020657048,0.0062657767,0.00047169512,0.012809115],"genre_scores_gemma":[0.9453448,0.006010971,0.02450362,0.0005432674,0.00016746976,0.00016562101,0.008190577,0.000105012994,0.01496872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926037,0.0001583586,0.000073559786,0.00018358116,0.00023738165,0.00008669519],"domain_scores_gemma":[0.9996314,0.000057570436,0.00013043109,0.000042899315,0.00008123085,0.000056375895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004724012,0.0004815852,0.0004961322,0.00040799528,0.00020136058,0.000703626,0.0002674086,0.00052831793,0.0028361413],"category_scores_gemma":[0.000663037,0.00035916042,0.00061010395,0.0008658771,0.00026818327,0.00031034704,0.00023047352,0.00083406956,0.0017095804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010889502,0.0002614044,0.016310455,0.00032171232,0.00012748096,0.0008755921,0.00014646085,0.00044700826,0.92983603,0.0026236419,0.0019330677,0.046028156],"study_design_scores_gemma":[0.00046674334,0.0011888796,0.14214315,0.00004861861,0.00022391045,0.024430806,0.00014971287,0.004028999,0.7201687,0.0020533733,0.10502633,0.000070822956],"about_ca_topic_score_codex":0.0006334701,"about_ca_topic_score_gemma":0.00048550882,"teacher_disagreement_score":0.0028361413,"about_ca_system_score_codex":0.00034505283,"about_ca_system_score_gemma":0.00020213697,"threshold_uncertainty_score":0.009487808},"labels":[],"label_agreement":null},{"id":"W2170360953","doi":"10.1074/jbc.m005776200","title":"Mutational Analysis of the CYP2B2 Phenobarbital Response Unit and Inhibitory Effect of the Constitutive Androstane Receptor on Phenobarbital Responsiveness","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Medical Research Council","keywords":"Constitutive androstane receptor; Retinoic acid; Enhancer; Molecular biology; Transfection; Reporter gene; Transcription (linguistics); Androstane; Transcription factor; Phenobarbital; Biology; Context (archaeology); Nuclear receptor; Chemistry; Gene; Cell biology; Biochemistry; Gene expression; Genetics; Endocrinology","score_opus":0.04596279724641665,"score_gpt":0.3726882575481396,"score_spread":0.32672546030172295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170360953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994622,0.00036314104,0.003659332,0.000045674322,0.000010182469,0.000032893433,0.00025943504,0.00007189253,0.0009353316],"genre_scores_gemma":[0.99628335,0.00022211995,0.0017494429,0.000030870062,0.0000058364753,0.000029285615,0.00053510413,0.00004338994,0.0011005912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999845,0.00005411348,0.000015014838,0.000022691478,0.00003964044,0.000023458604],"domain_scores_gemma":[0.9998179,0.00006759385,0.000047496793,0.000021482723,0.000015206882,0.000030213554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001485855,0.00035833978,0.00021874328,0.00017272713,0.00010225236,0.00012344813,0.00015901649,0.00017965795,0.0017277794],"category_scores_gemma":[0.00017637428,0.00015601834,0.00027777662,0.00011315386,0.00017941742,0.000070658534,0.0001516573,0.00032202576,0.0006887216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065011795,0.000018648694,0.00012909857,0.000013778173,0.000003229067,0.00007263,0.0000069748376,0.000081736616,0.99908864,0.00006215111,0.000008765593,0.0004493633],"study_design_scores_gemma":[0.00001641958,0.00017877636,0.0053317617,0.000006981497,0.000016799873,0.000500844,0.000015108233,0.0012565574,0.99120843,0.00002381283,0.0014382487,0.0000061618425],"about_ca_topic_score_codex":0.00063173514,"about_ca_topic_score_gemma":0.00094377523,"teacher_disagreement_score":0.0017277794,"about_ca_system_score_codex":0.00018901414,"about_ca_system_score_gemma":0.00015369365,"threshold_uncertainty_score":0.005780041},"labels":[],"label_agreement":null},{"id":"W2171032970","doi":"10.1345/aph.10088","title":"Drug Interaction between St. John's Wort and Cyclosporine","year":2000,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CYP3A4; Drug interaction; Drug; Pharmacology; Dialysis; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.16847930061588257,"score_gpt":0.4924598215240041,"score_spread":0.3239805209081215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171032970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95763123,0.021580534,0.0021590604,0.004381792,0.00048268968,0.000079546524,0.00014076385,0.000100604,0.013443776],"genre_scores_gemma":[0.9917887,0.0034302257,0.00091098854,0.001315877,0.0006193791,0.0000096878275,0.00006571151,0.000010516689,0.0018488284],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996525,0.000071016824,0.000056540768,0.00006809746,0.000093810806,0.000058107584],"domain_scores_gemma":[0.9988803,0.0005289001,0.0003660132,0.000040729206,0.0000763913,0.000107531516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020784306,0.00046246513,0.00045485867,0.0005347658,0.00062043266,0.00052051677,0.0002660065,0.0014619248,0.0028354363],"category_scores_gemma":[0.0016554759,0.0001791323,0.0004332718,0.00038628394,0.00054002804,0.0004499466,0.00028551195,0.000968523,0.0005521633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061879883,0.0003144602,0.09295207,0.00032382584,0.00015883327,0.869729,0.00032061496,0.00027731623,0.010999903,0.0005494177,0.0023546838,0.021401186],"study_design_scores_gemma":[0.00007709775,0.0005987228,0.03202421,0.00007486122,0.00017505256,0.9469974,0.00019115298,0.0010329732,0.007264464,0.00025304608,0.0112921735,0.000018763467],"about_ca_topic_score_codex":0.0010669307,"about_ca_topic_score_gemma":0.0014191314,"teacher_disagreement_score":0.0028354363,"about_ca_system_score_codex":0.0004322852,"about_ca_system_score_gemma":0.0002776008,"threshold_uncertainty_score":0.009485424},"labels":[],"label_agreement":null},{"id":"W2171154262","doi":"10.1093/bioinformatics/btv232","title":"Cypiripi: exact genotyping of <i>CYP2D6</i> using high-throughput sequencing data","year":2015,"lang":"en","type":"article","venue":"Bioinformatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute","keywords":"Genotyping; Context (archaeology); Pseudogene; Biology; Computational biology; Copy-number variation; Genotype; Computer science; Genetics; Data mining; Algorithm; Gene; Genome","score_opus":0.4461480385382918,"score_gpt":0.47036580555392304,"score_spread":0.02421776701563122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171154262","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04969396,0.0012242716,0.86318326,0.0015916936,0.0002517038,0.00045232283,0.019453138,0.058910083,0.0052396487],"genre_scores_gemma":[0.25478026,0.0007879964,0.6928635,0.001008182,0.00017966368,0.00066132564,0.043977797,0.0027388437,0.0030024443],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884087,0.0003829362,0.000060437844,0.00036833022,0.00027668942,0.00007067807],"domain_scores_gemma":[0.99779665,0.0011922948,0.00023379856,0.0003358336,0.0003172712,0.00012413194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00252684,0.0010092272,0.0008960082,0.00087825296,0.00069736456,0.0013662219,0.0016396709,0.0011018992,0.0060775853],"category_scores_gemma":[0.007951858,0.0005320875,0.0007430309,0.0011096172,0.00043007202,0.00082569214,0.000995855,0.0014339467,0.0051318025],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025796841,0.0004732058,0.042780574,0.0014731224,0.00072249357,0.0010973018,0.00028657005,0.2101962,0.038821924,0.008474849,0.13057117,0.5625228],"study_design_scores_gemma":[0.0002924614,0.00020815301,0.007012959,0.00007101637,0.00009068106,0.0007813138,0.00004714622,0.925543,0.024522085,0.013725713,0.027631283,0.00007421302],"about_ca_topic_score_codex":0.0027478782,"about_ca_topic_score_gemma":0.0034691505,"teacher_disagreement_score":0.0060775853,"about_ca_system_score_codex":0.00065805553,"about_ca_system_score_gemma":0.0016230326,"threshold_uncertainty_score":0.020331562},"labels":[],"label_agreement":null},{"id":"W2171597228","doi":"10.1530/eje-11-0596","title":"Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways","year":2011,"lang":"en","type":"article","venue":"European Journal of Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Abdominal obesity; Medicine; Nicotine; Odds ratio; Internal medicine; Cotinine; Insulin resistance; Diabetes mellitus; Obesity; Endocrinology; Type 2 Diabetes Mellitus; Logistic regression; Type 2 diabetes; Genotype; Body mass index; Waist; Biology; Genetics","score_opus":0.1969002856443646,"score_gpt":0.38147365692498625,"score_spread":0.18457337128062165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171597228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949248,0.0036427432,0.0003847243,0.00028177016,0.000019246776,0.000009672433,0.00022220303,0.000009768275,0.0005051743],"genre_scores_gemma":[0.9986681,0.00066795805,0.0002512989,0.000047086847,0.000054341024,0.000005685711,0.00010027486,0.000003230094,0.00020215707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878377,0.00067781133,0.00006281906,0.00018728372,0.00014875844,0.00013953893],"domain_scores_gemma":[0.9968009,0.0015546111,0.0008770642,0.00021764677,0.00018784292,0.00036193617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012116722,0.00044285462,0.0005466781,0.00057592243,0.0002741999,0.0006088327,0.0003372094,0.0005645386,0.0023127692],"category_scores_gemma":[0.0022533091,0.00032423332,0.0012382204,0.0008418983,0.0003279574,0.00036534577,0.0003977779,0.0005408824,0.00015803428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054164405,0.00005353557,0.994849,0.000023373106,0.0004174471,0.00014920313,0.00003614771,0.000076143246,0.0007925245,0.000032025586,0.000043362197,0.0029853964],"study_design_scores_gemma":[0.000009691703,0.000111536625,0.9989722,0.0000074555824,0.00018916775,0.00014459179,0.00002436896,0.00030813023,0.00010759845,0.00003986389,0.0000822436,0.000003110573],"about_ca_topic_score_codex":0.002502187,"about_ca_topic_score_gemma":0.002899727,"teacher_disagreement_score":0.002502187,"about_ca_system_score_codex":0.00018654228,"about_ca_system_score_gemma":0.00031584734,"threshold_uncertainty_score":0.0077370405},"labels":[],"label_agreement":null},{"id":"W2171600156","doi":"10.1038/srep09257","title":"SNP genotyping using TaqMan® technology: the CYP2D6*17 assay conundrum","year":2015,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; National Institutes of Health","keywords":"TaqMan; Genotyping; Genotype; SNP genotyping; Biology; Locus (genetics); Genetics; CYP2D6; SNP; Primer (cosmetics); Single-nucleotide polymorphism; Computational biology; Gene; Allele; Polymerase chain reaction; Chemistry","score_opus":0.23317090470254642,"score_gpt":0.4530663668042264,"score_spread":0.21989546210167998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171600156","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09224713,0.012264688,0.8398689,0.008676512,0.0030819396,0.0025780364,0.007434534,0.0077549154,0.02609338],"genre_scores_gemma":[0.2160779,0.0071363095,0.7028507,0.009659516,0.0012501181,0.0054447493,0.009803119,0.0009262408,0.046851344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.97215027,0.0106177265,0.0015594757,0.004836422,0.0100062955,0.00082969025],"domain_scores_gemma":[0.9942356,0.0023571015,0.0008440642,0.0011164282,0.0011356361,0.00031115566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013020049,0.0009774086,0.00167761,0.0018751187,0.0005843694,0.0021472373,0.0016933461,0.003284074,0.005925385],"category_scores_gemma":[0.00998021,0.0012223829,0.0010557345,0.0019037131,0.0016885495,0.00083396985,0.0012622854,0.0030753755,0.006868122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010688396,0.00057616725,0.052511103,0.001482566,0.0004914702,0.0012020449,0.0011524861,0.0012971609,0.5074844,0.015284897,0.0428516,0.37459728],"study_design_scores_gemma":[0.000482532,0.004444825,0.048360858,0.00066455774,0.0004928007,0.013597377,0.000296275,0.017073622,0.38475057,0.017489841,0.5120644,0.0002822868],"about_ca_topic_score_codex":0.00062339276,"about_ca_topic_score_gemma":0.0010427769,"teacher_disagreement_score":0.013020049,"about_ca_system_score_codex":0.0007316999,"about_ca_system_score_gemma":0.0016710948,"threshold_uncertainty_score":0.06885743},"labels":[],"label_agreement":null},{"id":"W2171770274","doi":"10.2174/138920011795016845","title":"CYP2A5 Induction and Hepatocellular Stress: An Adaptive Response to Perturbations of Heme Homeostasis","year":2011,"lang":"en","type":"review","venue":"Current Drug Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Cytochrome P450; Xenobiotic; Carcinogen; Homeostasis; Detoxification (alternative medicine); Biology; Endoplasmic reticulum; Oxidative stress; Heme; Liver injury; Enzyme; Cell biology; Pharmacology; Biochemistry; Medicine; Pathology","score_opus":0.26377789033262855,"score_gpt":0.4583563841434681,"score_spread":0.19457849381083953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171770274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004214475,0.9968532,0.00032416408,0.0002477926,0.00012546444,0.000006051696,0.000025063951,0.000014171022,0.0019827832],"genre_scores_gemma":[0.0017545336,0.9959896,0.00033390033,0.00014150007,0.000120295634,0.000007426818,0.000044483542,0.0000021036467,0.0016061973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999105,0.0000136077615,0.0000109131215,0.000020957059,0.000034187928,0.000009729454],"domain_scores_gemma":[0.999874,0.000042005202,0.000023011817,0.000005116281,0.000039655955,0.000016211354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029323777,0.00060893135,0.0009098544,0.0014095703,0.00017858366,0.00058935425,0.0005264462,0.00069595006,0.0028633333],"category_scores_gemma":[0.0002311659,0.00018623588,0.00025496923,0.0015587363,0.0002967669,0.0007602669,0.00035436574,0.0007974644,0.0028309464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007940988,0.00006200499,0.00030054097,0.0076768883,0.000058960213,0.00028423025,0.000038892464,0.0002663359,0.005960117,0.001960739,0.013626648,0.9696852],"study_design_scores_gemma":[0.000020641042,0.00011256667,0.0020309992,0.0010762018,0.00007562055,0.0026815915,0.000054974793,0.000107037304,0.0027211474,0.0013267075,0.9897739,0.000018613977],"about_ca_topic_score_codex":0.0006361321,"about_ca_topic_score_gemma":0.0012595557,"teacher_disagreement_score":0.0028633333,"about_ca_system_score_codex":0.0004024495,"about_ca_system_score_gemma":0.0005410835,"threshold_uncertainty_score":0.009578824},"labels":[],"label_agreement":null},{"id":"W2171899958","doi":"10.1152/ajprenal.2001.280.2.f266","title":"Molecular and biochemical characterization of prostacyclin receptors in rat kidney","year":2001,"lang":"en","type":"article","venue":"American Journal of Physiology-Renal Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Prostacyclin; Vasopressin; Receptor; Endocrinology; Internal medicine; Chemistry; Calcium; Molecular biology; Biology; Biochemistry; Medicine","score_opus":0.024154243843675528,"score_gpt":0.35399867730776596,"score_spread":0.3298444334640904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171899958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847169,0.006384267,0.0056174956,0.00011073231,0.000029887246,0.000037859794,0.00090651796,0.000114026036,0.0020823344],"genre_scores_gemma":[0.9760582,0.0048705493,0.009768291,0.00012036626,0.000101615224,0.00012486924,0.0026867092,0.00004866999,0.0062208152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999902,0.0000060383513,0.000007839876,0.000029354169,0.00001945712,0.000035347122],"domain_scores_gemma":[0.99980146,0.000032160224,0.000034854234,0.000034756977,0.00003916884,0.000057671128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014645795,0.00028322078,0.00040336268,0.0004989797,0.00022982949,0.00037393658,0.00024668284,0.000240472,0.0010495482],"category_scores_gemma":[0.00018192756,0.00034962784,0.00047853077,0.00024172089,0.00021318838,0.00029094671,0.00014035667,0.00044037134,0.00047762023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013578105,0.000010803673,0.00031226885,0.000045588255,0.000004581177,0.00007676774,0.0000116914625,0.000025457915,0.99837226,0.000077529825,0.000011798555,0.0009156118],"study_design_scores_gemma":[0.00009246816,0.000594347,0.06362298,0.000026331567,0.00014156554,0.0014301378,0.00013662962,0.001397977,0.9264842,0.00036917804,0.0056758523,0.0000282981],"about_ca_topic_score_codex":0.001665752,"about_ca_topic_score_gemma":0.0014394877,"teacher_disagreement_score":0.001665752,"about_ca_system_score_codex":0.00023455163,"about_ca_system_score_gemma":0.00033806788,"threshold_uncertainty_score":0.0035110712},"labels":[],"label_agreement":null},{"id":"W2178462841","doi":"10.1124/dmd.115.066357","title":"In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Vertex Pharmaceuticals","keywords":"Pharmacokinetics; In vivo; Pharmacology; Drug metabolism; Metabolism; Chemistry; Oral administration; Drug; Absorption (acoustics); First pass effect; Drug interaction; Cytochrome P450; Medicine; Biology; Biochemistry","score_opus":0.10881133443803996,"score_gpt":0.4007740290749717,"score_spread":0.29196269463693175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178462841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9435222,0.008177286,0.041480366,0.0009375174,0.00010966298,0.00031096092,0.0010916761,0.00028054346,0.0040897694],"genre_scores_gemma":[0.9804059,0.005852883,0.008717069,0.00017563037,0.000060796687,0.00010667037,0.0007651149,0.000044356366,0.0038715093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959654,0.00019587016,0.000025552901,0.000046865774,0.00006526481,0.000069955044],"domain_scores_gemma":[0.9994179,0.00019970376,0.00015888464,0.000075059375,0.000083571314,0.00006491722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081515854,0.0009794468,0.0007380458,0.0006787821,0.0005816685,0.0006919918,0.00061884226,0.00061574735,0.0034119827],"category_scores_gemma":[0.0008137709,0.00043666558,0.00070512266,0.0003368208,0.0007873781,0.0008680861,0.00024266513,0.0014276964,0.0006190617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023763292,0.00077019574,0.0017877734,0.0001797404,0.000059837894,0.00023292458,0.00011178977,0.0010351561,0.98470104,0.0009998304,0.0002092591,0.0075360727],"study_design_scores_gemma":[0.00015217732,0.005857125,0.010516595,0.000027246446,0.00032849913,0.0010713891,0.00021916856,0.0065280064,0.97084135,0.0006080165,0.0038215278,0.000029006567],"about_ca_topic_score_codex":0.007288325,"about_ca_topic_score_gemma":0.011929497,"teacher_disagreement_score":0.007288325,"about_ca_system_score_codex":0.00096715085,"about_ca_system_score_gemma":0.0009188255,"threshold_uncertainty_score":0.014491856},"labels":[],"label_agreement":null},{"id":"W2183183125","doi":"","title":"Effect of several Chinese natural health products of human cytochrome P450 metabolism.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada); Health Canada","funders":"","keywords":"Cytochrome P450; Isozyme; Drug metabolism; Pharmacology; Metabolism; Traditional Chinese medicine; Natural product; Drug; CYP2C9; Chemistry; Traditional medicine; Biology; Biochemistry; Enzyme; Medicine","score_opus":0.07026630394686059,"score_gpt":0.4010890408121269,"score_spread":0.3308227368652663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183183125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834953,0.012199828,0.0007429282,0.00018103274,0.000066682434,0.00008459939,0.00026899224,0.000030965704,0.0029295827],"genre_scores_gemma":[0.99403524,0.00276931,0.0010402411,0.0001123048,0.000034521014,0.00003889684,0.0004130813,0.000004704217,0.001551661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998493,0.000057910718,0.000016103217,0.00001929771,0.000035757603,0.000021574766],"domain_scores_gemma":[0.9998203,0.000055083667,0.000052039733,0.000016730643,0.000026348796,0.000029489756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030393913,0.00056384783,0.00018272187,0.0003083219,0.00021433279,0.00014984111,0.00012356084,0.00022029884,0.0029709],"category_scores_gemma":[0.00040357214,0.000108099346,0.00041999426,0.00019761246,0.0002164747,0.00013947532,0.00019891173,0.00025820278,0.00022729461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031946339,0.00070622656,0.007503479,0.0009053767,0.00020375938,0.00050400477,0.00010882983,0.00025116096,0.9337581,0.00021398407,0.00042848042,0.05222192],"study_design_scores_gemma":[0.00018125252,0.010608376,0.036586676,0.000067264875,0.00032184875,0.0009346507,0.000057824036,0.00045056624,0.9456587,0.00007327273,0.005048206,0.000011404094],"about_ca_topic_score_codex":0.0008318935,"about_ca_topic_score_gemma":0.0012488032,"teacher_disagreement_score":0.0029709,"about_ca_system_score_codex":0.00019564634,"about_ca_system_score_gemma":0.00025790656,"threshold_uncertainty_score":0.009938657},"labels":[],"label_agreement":null},{"id":"W2186092389","doi":"10.1124/mol.105.015891","title":"Inactivation of the Pure Antiestrogen Fulvestrant and Other Synthetic Estrogen Molecules by UDP-Glucuronosyltransferase 1A Enzymes Expressed in Breast Tissue","year":2005,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Glucuronidation; Fulvestrant; Enzyme; Chemistry; Glucuronosyltransferase; Antiestrogen; Biochemistry; Estrogen; Estrogen receptor; Microsome; Biology; Cancer; Endocrinology; Breast cancer","score_opus":0.02167709174274309,"score_gpt":0.34478193430852655,"score_spread":0.3231048425657835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186092389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085706,0.0018385083,0.0057222964,0.000100771875,0.00002942187,0.000015677497,0.00028391517,0.00008042222,0.001071779],"genre_scores_gemma":[0.9949942,0.0005765581,0.0015121918,0.000038467188,0.0000065591557,0.000008201064,0.0004965602,0.0000199416,0.0023475187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000019633017,0.0000054522247,0.00002404795,0.000024381197,0.000028265804],"domain_scores_gemma":[0.99992144,0.00001527876,0.00002075778,0.000021000904,0.000011888222,0.00000958697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013454685,0.0002844539,0.0001391171,0.00018925831,0.00009606329,0.00024038673,0.00012983756,0.00017754441,0.0006786945],"category_scores_gemma":[0.00018757266,0.00013051528,0.00024687225,0.00013594842,0.00015570551,0.0001365101,0.00012460999,0.00027914465,0.00023315342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006521718,0.0000068848294,0.00016095644,0.0000059938116,0.0000043790524,0.000014859876,0.0000050330586,0.000055711596,0.99818134,0.00009255979,0.000017956203,0.001389148],"study_design_scores_gemma":[0.000003907085,0.000088218694,0.0012042879,0.0000011871766,0.0000071445306,0.000098619596,0.0000069155303,0.00030012708,0.99749666,0.00003587735,0.00075587013,0.0000012567625],"about_ca_topic_score_codex":0.0008579125,"about_ca_topic_score_gemma":0.0012746935,"teacher_disagreement_score":0.0008579125,"about_ca_system_score_codex":0.00032343125,"about_ca_system_score_gemma":0.00022589139,"threshold_uncertainty_score":0.0023466349},"labels":[],"label_agreement":null},{"id":"W2188010897","doi":"10.1002/chir.22054","title":"Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes","year":2012,"lang":"en","type":"article","venue":"Chirality","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Montréal","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Chemistry; Internal medicine; Endocrinology; Metabolism; Metabolite; Hepatocyte; Enantiomer; Cytochrome P450; Biochemistry; In vitro; Biology","score_opus":0.057126775801462,"score_gpt":0.4278086637722961,"score_spread":0.3706818879708341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188010897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971276,0.001072151,0.00060725125,0.000047084075,0.00002214705,0.000012499701,0.00015622491,0.00003207403,0.00092298264],"genre_scores_gemma":[0.99600047,0.00077214645,0.0010797926,0.00007648829,0.000013204798,0.00002489756,0.0003739631,0.000011382204,0.0016477075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998524,0.000053098916,0.000017417497,0.000021745536,0.000023568344,0.000031670214],"domain_scores_gemma":[0.9998816,0.000027634254,0.000027320537,0.000018794275,0.000021043692,0.000023540279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016464182,0.00027695048,0.00023904695,0.00013568914,0.00008565624,0.00018654602,0.00008856062,0.00013535973,0.00093983463],"category_scores_gemma":[0.00012149506,0.00009831948,0.00022619226,0.00011366061,0.00011109022,0.00013092563,0.00016300663,0.0002406337,0.00026668707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011420764,0.00006260841,0.0005844442,0.00003643067,0.000007907545,0.0000752576,0.000024643736,0.00003645771,0.99605477,0.00003372282,0.00003395446,0.0019077205],"study_design_scores_gemma":[0.000018448405,0.0008487217,0.004297465,0.0000031036288,0.00001401028,0.000084123676,0.000029556022,0.00020200497,0.9938498,0.000009537176,0.00063992187,0.000003217678],"about_ca_topic_score_codex":0.0007930944,"about_ca_topic_score_gemma":0.0013474307,"teacher_disagreement_score":0.00093983463,"about_ca_system_score_codex":0.0001822239,"about_ca_system_score_gemma":0.00018798841,"threshold_uncertainty_score":0.0031440854},"labels":[],"label_agreement":null},{"id":"W2188378454","doi":"","title":"The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Metabolite; Microsome; Demethylation; Chemistry; Cytochrome P450; Metabolism; CYP2D6; Microsoma; Chromatography; Enzyme; Biochemistry; Gene expression","score_opus":0.23152675730749486,"score_gpt":0.3954723274777223,"score_spread":0.16394557017022746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188378454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8392299,0.029621908,0.120815344,0.0012659966,0.00017562756,0.00027772144,0.0008735885,0.0005256498,0.007214233],"genre_scores_gemma":[0.9630672,0.0055183293,0.025689075,0.00020990787,0.000064377724,0.00011231638,0.001118329,0.000024995676,0.0041953805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999617,0.00015106305,0.000014734788,0.000112565205,0.00007478106,0.000029736322],"domain_scores_gemma":[0.99975973,0.00007872531,0.000060843835,0.000046410558,0.00003178134,0.000022457067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036252732,0.0003494466,0.00025252718,0.00021807273,0.00024759024,0.00024296652,0.00024139685,0.00071788405,0.0008572376],"category_scores_gemma":[0.00040724105,0.00018302037,0.00028938535,0.0002266815,0.0003365401,0.00033399602,0.00021384431,0.0006931327,0.0005498428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045756682,0.00000979529,0.00023619257,0.000040276936,0.000008342356,0.000034989742,0.000009043778,0.000060073042,0.99680126,0.00007699244,0.00003842706,0.0026388909],"study_design_scores_gemma":[0.000006947175,0.00015350909,0.002001207,0.0000024998453,0.000011504455,0.00034501505,0.000006784548,0.00042168083,0.99440515,0.000038145714,0.0026034063,0.0000040537125],"about_ca_topic_score_codex":0.0010868282,"about_ca_topic_score_gemma":0.001353918,"teacher_disagreement_score":0.0010868282,"about_ca_system_score_codex":0.0005129928,"about_ca_system_score_gemma":0.00024034388,"threshold_uncertainty_score":0.003722012},"labels":[],"label_agreement":null},{"id":"W2188695576","doi":"10.1139/gen-2015-0100","title":"The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada","year":2015,"lang":"en","type":"review","venue":"Genome","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Pharmacogenomics; Confidentiality; Public policy; Policy development; Political science; Public administration; Bioinformatics; Biology","score_opus":0.42488825775136363,"score_gpt":0.4941829590761387,"score_spread":0.06929470132477505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188695576","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039642244,0.062400036,0.21018067,0.23291698,0.0021849028,0.0052604983,0.005694938,0.0007659921,0.4766318],"genre_scores_gemma":[0.20247582,0.09449718,0.6220378,0.035438273,0.000676652,0.009355586,0.004247726,0.00050366344,0.030767197],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.94815105,0.02703725,0.0034916233,0.0023848766,0.014403847,0.004531235],"domain_scores_gemma":[0.94912565,0.02465098,0.0022496681,0.0016207469,0.018666144,0.0036868195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061442364,0.0022621956,0.0023188395,0.014698667,0.012426242,0.01876105,0.009582637,0.008589841,0.0061845463],"category_scores_gemma":[0.05807094,0.0014773407,0.00390446,0.018512461,0.024924712,0.0069852024,0.00956475,0.009993906,0.0013513796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000112089,0.00001752674,0.0005302927,0.0012134942,0.000040017465,0.00018987875,0.0033781163,0.0035583668,0.0000541445,0.9498173,0.02257235,0.0186172],"study_design_scores_gemma":[0.000047477362,0.000022393102,0.0012953889,0.012069006,0.00011804022,0.00016869293,0.0064028865,0.0041413913,0.0001957602,0.36064947,0.6147692,0.00012025568],"about_ca_topic_score_codex":0.9087648,"about_ca_topic_score_gemma":0.89194167,"teacher_disagreement_score":0.2079771,"about_ca_system_score_codex":0.2079771,"about_ca_system_score_gemma":0.56535745,"threshold_uncertainty_score":0.9186343},"labels":[],"label_agreement":null},{"id":"W2196030797","doi":"10.1124/dmd.115.066829","title":"Metabolism of Oral Turinabol by Human Steroid Hormone–Synthesizing Cytochrome P450 Enzymes","year":2015,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Steroid; Cholesterol side-chain cleavage enzyme; Chemistry; Cytochrome P450; Stereochemistry; Steroid 11-beta-hydroxylase; Enzyme; Hydroxylation; Biochemistry; Hormone","score_opus":0.0719171909990786,"score_gpt":0.3874007805826685,"score_spread":0.3154835895835899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196030797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955953,0.0054581547,0.0016809695,0.00012749976,0.000012939667,0.000060725102,0.0003801952,0.00006991509,0.0026499995],"genre_scores_gemma":[0.99668604,0.001539165,0.0005875046,0.000033175194,0.000012213239,0.000012707065,0.0002003057,0.0000069205944,0.00092186546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986684,0.000079611855,0.000005606195,0.000016841946,0.000015194173,0.000015921443],"domain_scores_gemma":[0.99989116,0.000028499771,0.0000465715,0.000012472566,0.000009670645,0.00001155305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018079676,0.0002550407,0.00028765269,0.00019874299,0.00012248463,0.00028595954,0.000097152915,0.00015218939,0.0015985745],"category_scores_gemma":[0.00042916305,0.00013198055,0.00020353193,0.00023288635,0.00016950269,0.00014867252,0.00008830351,0.00029398658,0.00024358656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029266663,0.0005229379,0.12028464,0.0007734685,0.00081008265,0.002439406,0.0005099992,0.0036694796,0.4566576,0.0011792823,0.00227835,0.3816082],"study_design_scores_gemma":[0.0017315304,0.020146232,0.471416,0.00013232161,0.00082778407,0.006865861,0.0004344492,0.00773247,0.47123483,0.000551533,0.018860565,0.000066372726],"about_ca_topic_score_codex":0.0029842786,"about_ca_topic_score_gemma":0.0023587504,"teacher_disagreement_score":0.0029842786,"about_ca_system_score_codex":0.0003638269,"about_ca_system_score_gemma":0.00029403705,"threshold_uncertainty_score":0.005933821},"labels":[],"label_agreement":null},{"id":"W2202197024","doi":"10.1158/1055-9965.epi-15-0694","title":"Digoxin Use After Diagnosis of Colorectal Cancer and Survival: A Population-Based Cohort Study","year":2015,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Yarmouk University; Queen's University Belfast; Public Health Agency; National Institute for Health and Care Research","keywords":"Medicine; Colorectal cancer; Digoxin; Internal medicine; Population; Cancer; Oncology; Cohort; Cohort study; Proportional hazards model; Confounding; Heart failure","score_opus":0.19942897072172613,"score_gpt":0.4868337639960159,"score_spread":0.2874047932742898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202197024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997769,0.0003233702,0.00014397086,0.00007237025,0.000012179576,0.00003118646,0.0013548757,0.0000052220544,0.00028793086],"genre_scores_gemma":[0.9985531,0.00019358154,0.00014128139,0.000054316686,0.000014813062,0.000028426259,0.00085955946,0.0000030280537,0.00015185945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989982,0.00022966166,0.00010272848,0.00032465227,0.00018008103,0.00016463814],"domain_scores_gemma":[0.9981205,0.0002810583,0.0006150564,0.00038083427,0.00023531211,0.0003671881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015773335,0.00043788485,0.00054707605,0.00092213054,0.000668386,0.0010298594,0.00063838746,0.00086304964,0.0014539286],"category_scores_gemma":[0.002799802,0.0005677555,0.0011810659,0.0019613479,0.0003425417,0.00066215196,0.0007401265,0.0011801178,0.0002756489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028365554,0.00007259161,0.99829966,0.000013917731,0.00030108768,0.00009857237,0.00008447527,0.00004277721,0.00018114559,0.000014928855,0.00014666036,0.00046055013],"study_design_scores_gemma":[0.00004254527,0.0001518409,0.9989397,0.000009515902,0.00016701304,0.00019492926,0.00009994111,0.00016945554,0.00002553465,0.000015925836,0.00017628034,0.0000073702954],"about_ca_topic_score_codex":0.018660353,"about_ca_topic_score_gemma":0.020426,"teacher_disagreement_score":0.018660353,"about_ca_system_score_codex":0.00058486726,"about_ca_system_score_gemma":0.0007642621,"threshold_uncertainty_score":0.037103474},"labels":[],"label_agreement":null},{"id":"W2209144082","doi":"10.1016/j.jinorgbio.2015.12.019","title":"The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4","year":2015,"lang":"en","type":"article","venue":"Journal of Inorganic Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"National Institute of General Medical Sciences; Fonds de recherche du Québec – Nature et technologies; National Institutes of Health","keywords":"Chemistry; Allosteric regulation; Binding site; Resonance Raman spectroscopy; Dimer; Stereochemistry; Substrate (aquarium); Allosteric enzyme; Molecule; CYP3A4; Plasma protein binding; Cytochrome P450; Monomer; Biophysics; Enzyme; Raman spectroscopy; Biochemistry; Polymer; Organic chemistry","score_opus":0.19808050682975845,"score_gpt":0.4033312502316051,"score_spread":0.20525074340184665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209144082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142176,0.0012074717,0.0029457551,0.0002511996,0.00010325033,0.0000609224,0.00028235163,0.000051265564,0.003675991],"genre_scores_gemma":[0.993834,0.00079142867,0.0019602883,0.00010258011,0.000023563674,0.000026848295,0.00026045064,0.000026960524,0.0029739006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995283,0.00020418451,0.000022942253,0.00007998001,0.000091636866,0.00007294302],"domain_scores_gemma":[0.9997578,0.00008491082,0.000034699427,0.000049427723,0.000036565547,0.000036580546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042927047,0.00032895757,0.0003791467,0.00017597631,0.0004205718,0.0005050501,0.00045401396,0.00036643443,0.0036870367],"category_scores_gemma":[0.0007184549,0.00026030926,0.00032715732,0.00034419989,0.00036678865,0.0002760534,0.0001769345,0.001014639,0.0003147265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029786096,0.00070376723,0.001223146,0.00011124235,0.000083094004,0.00016205962,0.00026972854,0.0011980786,0.9827408,0.0011058922,0.00051023194,0.008913373],"study_design_scores_gemma":[0.00022932986,0.0041613327,0.0036855133,0.000011017105,0.00009723373,0.00042864523,0.00022566873,0.004414799,0.9800805,0.00020807785,0.006419389,0.000038502243],"about_ca_topic_score_codex":0.0028296367,"about_ca_topic_score_gemma":0.0045711403,"teacher_disagreement_score":0.0036870367,"about_ca_system_score_codex":0.00036805207,"about_ca_system_score_gemma":0.00039140004,"threshold_uncertainty_score":0.012334347},"labels":[],"label_agreement":null},{"id":"W2209243252","doi":"10.2165/00128071-200304090-00005","title":"Drug Interactions of Clinical Significance for the Dermatologist","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Drug interaction; Pharmacogenetics; Intensive care medicine; Pharmacotherapy; Clinical Practice; Pharmacology; Psychiatry; Family medicine; Biology","score_opus":0.4406664389583803,"score_gpt":0.636099180920618,"score_spread":0.1954327419622377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209243252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024267336,0.9954881,0.00032460777,0.0007018511,0.00031976355,0.0000061803025,0.000023714554,0.000019796686,0.002873298],"genre_scores_gemma":[0.0021596183,0.99284875,0.000623211,0.00091405504,0.0005872117,0.000007898769,0.00005360063,0.000003420015,0.0028022104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997106,0.00006515416,0.00003553668,0.000046984354,0.00012182665,0.000019853906],"domain_scores_gemma":[0.99913317,0.00046117103,0.00015995848,0.00002361202,0.00016063295,0.00006140634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306028,0.0009489449,0.0016853429,0.0018600294,0.00027466356,0.00087533135,0.000729341,0.0016070902,0.0058080642],"category_scores_gemma":[0.0009978637,0.00023223954,0.0006188992,0.0016574804,0.00032257856,0.0007125614,0.0004757532,0.0013837868,0.0030841378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008769692,0.00008373375,0.00049755047,0.0032974454,0.00007666911,0.0008646696,0.000019878004,0.0001936225,0.0011006978,0.00054957916,0.03283887,0.9603897],"study_design_scores_gemma":[0.00007005647,0.00020332038,0.0030593695,0.0029114275,0.0002776657,0.010652887,0.00007775043,0.0002073129,0.0010329292,0.0014208059,0.98006094,0.000025711015],"about_ca_topic_score_codex":0.0010472154,"about_ca_topic_score_gemma":0.0036273357,"teacher_disagreement_score":0.0058080642,"about_ca_system_score_codex":0.00044795102,"about_ca_system_score_gemma":0.0008445864,"threshold_uncertainty_score":0.019429862},"labels":[],"label_agreement":null},{"id":"W2216596139","doi":"10.1158/1538-7445.sabcs14-p3-06-43","title":"Abstract P3-06-43: A genetic deletion in the uridine diphosphate glucuronosyltransferase 2B17 affects the pharmacokinetics of exemestane","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exemestane; Glucuronidation; Glucuronosyltransferase; Internal medicine; Uridine diphosphate; Pharmacokinetics; Chemistry; Uridine; Endocrinology; Medicine; Aromatase; Pharmacology; Cancer; Enzyme; Breast cancer; Biochemistry; Microsome; Gene","score_opus":0.2807887475047311,"score_gpt":0.5201519390325852,"score_spread":0.23936319152785407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216596139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716395,0.00021040575,0.00059904106,0.00011015682,0.000039140763,0.00013747388,0.0013011566,0.00004342643,0.00039522274],"genre_scores_gemma":[0.9908236,0.00022305266,0.0015877413,0.00019618192,0.00004134039,0.0003435448,0.0019366811,0.00008715296,0.004760597],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996612,0.00009258729,0.000033017706,0.00009283202,0.000050115428,0.00007014082],"domain_scores_gemma":[0.9997036,0.00006492978,0.00006691533,0.000026433932,0.000014564385,0.00012367997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002690476,0.0006416616,0.00069288525,0.00035479048,0.00034410867,0.00022783379,0.00036623672,0.00059246254,0.006854699],"category_scores_gemma":[0.00022569226,0.00035942812,0.0005089093,0.00026817637,0.000560842,0.00020127266,0.0002641021,0.0011671381,0.0010487036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02603029,0.0038064262,0.004055279,0.00009465302,0.00012555091,0.00073088147,0.00008223439,0.00031352474,0.95753074,0.00012816547,0.00068349345,0.0064187758],"study_design_scores_gemma":[0.013123939,0.11181404,0.13170928,0.00006004733,0.00068773574,0.008309766,0.0003193142,0.0039930283,0.71690375,0.0005032818,0.012471089,0.000104855106],"about_ca_topic_score_codex":0.0011551947,"about_ca_topic_score_gemma":0.00094362954,"teacher_disagreement_score":0.006854699,"about_ca_system_score_codex":0.0002684524,"about_ca_system_score_gemma":0.00035921094,"threshold_uncertainty_score":0.022931278},"labels":[],"label_agreement":null},{"id":"W2224333234","doi":"10.1016/j.yrtph.2016.01.004","title":"Assessing Natural Product–Drug Interactions: An End-to-End Safety Framework","year":2016,"lang":"en","type":"article","venue":"Regulatory Toxicology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Polypharmacy; Drug; Medicine; Pharmacology; Natural product; Population; Risk analysis (engineering); Environmental health; Biology","score_opus":0.07085481792971768,"score_gpt":0.44367235334879906,"score_spread":0.37281753541908136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224333234","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016694726,0.0035909063,0.95538044,0.0052981307,0.00017296798,0.0019398506,0.0015581703,0.0005373973,0.014827505],"genre_scores_gemma":[0.3914804,0.0037705384,0.5925648,0.004462232,0.0005394573,0.0017703221,0.0025186015,0.00013156908,0.0027621626],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.91956764,0.05021451,0.0064781527,0.0047397255,0.017797535,0.0012024594],"domain_scores_gemma":[0.8841516,0.081244074,0.010565652,0.008479383,0.013766245,0.0017930738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.084703274,0.005604429,0.0046872003,0.0070985993,0.0011012648,0.010947753,0.00670595,0.005154104,0.0026945665],"category_scores_gemma":[0.08802708,0.0012348391,0.005818801,0.0016679054,0.005499373,0.0066848267,0.0062955553,0.0058181942,0.0011096711],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021702421,0.0030170206,0.038042195,0.005326163,0.006745057,0.0015645039,0.0006989675,0.26068094,0.01282066,0.2654977,0.00799727,0.3954392],"study_design_scores_gemma":[0.00050974335,0.010360347,0.016428974,0.0031490766,0.0056397817,0.002358718,0.00085587596,0.3139142,0.029420625,0.5686629,0.04823649,0.00046324485],"about_ca_topic_score_codex":0.0021946682,"about_ca_topic_score_gemma":0.0017657459,"teacher_disagreement_score":0.084703274,"about_ca_system_score_codex":0.0032094517,"about_ca_system_score_gemma":0.011215329,"threshold_uncertainty_score":0.44795907},"labels":[],"label_agreement":null},{"id":"W2231133613","doi":"10.1097/00008571-200301000-00006","title":"Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.","year":2003,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Quinidine; Venlafaxine; CYP2D6; Venlafaxine Hydrochloride; Pharmacology; Pharmacokinetics; Chemistry; Oral administration; Dosing; Internal medicine; Medicine; Metabolism; Cytochrome P450","score_opus":0.0721968665002955,"score_gpt":0.42409105370093014,"score_spread":0.35189418720063464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231133613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98238385,0.012121227,0.0027810216,0.00021775646,0.000026245094,0.000024157072,0.00054092146,0.0000317351,0.001873191],"genre_scores_gemma":[0.99710864,0.0011498685,0.0007887048,0.000056496367,0.000026546977,0.0000061570213,0.0002664624,0.0000070012807,0.0005901185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999699,0.00013078631,0.000017086624,0.000073637704,0.00006219317,0.000017325123],"domain_scores_gemma":[0.9997427,0.00005960104,0.0001177989,0.000026166388,0.000029474535,0.00002437434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004078998,0.00023144642,0.00031620078,0.00034019834,0.00016333617,0.00031785617,0.00009591875,0.00023418026,0.0011571121],"category_scores_gemma":[0.0005367062,0.00013878387,0.00022074944,0.00028127735,0.0001906573,0.00012193273,0.00010720605,0.00019712544,0.00022189338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066500683,0.00016090226,0.7041895,0.00032321303,0.00069889484,0.0017763991,0.0002401219,0.00066337513,0.20029,0.0004599232,0.0006918034,0.083855875],"study_design_scores_gemma":[0.00007602544,0.0011434107,0.95682126,0.000016948885,0.00018453994,0.006017274,0.00007850625,0.00095617893,0.029445384,0.00024759563,0.005001899,0.00001106526],"about_ca_topic_score_codex":0.0008168171,"about_ca_topic_score_gemma":0.0007787636,"teacher_disagreement_score":0.0011571121,"about_ca_system_score_codex":0.0001845238,"about_ca_system_score_gemma":0.000106004285,"threshold_uncertainty_score":0.0038709044},"labels":[],"label_agreement":null},{"id":"W2239796040","doi":"10.1007/978-3-319-10527-7","title":"Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials","year":2014,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacodynamics; Drug; Pharmacokinetics; Medicine; Pharmacology; Computer science; Intensive care medicine; Management science; Medical physics; Engineering","score_opus":0.1078097069697019,"score_gpt":0.46900643608694265,"score_spread":0.36119672911724077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239796040","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002767452,0.5746689,0.043744035,0.017667126,0.009078051,0.00015306126,0.0006284663,0.0007687773,0.3505242],"genre_scores_gemma":[0.021866648,0.37756878,0.03081506,0.009908759,0.015707355,0.00020114801,0.00072198105,0.00031945884,0.5428908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995926,0.00011349021,0.00002292142,0.000032590775,0.00022526119,0.000013285045],"domain_scores_gemma":[0.9993781,0.00042867268,0.000031296306,0.000024179872,0.000110391724,0.000027287671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006612915,0.0008101314,0.00059190835,0.0010464779,0.00015287647,0.00081482506,0.00046397126,0.00079360505,0.016233189],"category_scores_gemma":[0.0016091304,0.00023581204,0.00040259745,0.00083175325,0.0004407384,0.00091053837,0.00053746614,0.0016329585,0.008183872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007329439,0.000064933614,0.00032835515,0.000596349,0.000022940829,0.00035235196,0.00004383107,0.00074158463,0.002161266,0.011528978,0.2518421,0.73224396],"study_design_scores_gemma":[0.000017308408,0.00013598755,0.0013544672,0.00037577417,0.000024937659,0.0048198784,0.000022818747,0.000919311,0.001152412,0.018097544,0.9730631,0.000016398122],"about_ca_topic_score_codex":0.0003848372,"about_ca_topic_score_gemma":0.0014411125,"teacher_disagreement_score":0.016233189,"about_ca_system_score_codex":0.0004442262,"about_ca_system_score_gemma":0.00046010825,"threshold_uncertainty_score":0.054305375},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2269037162","doi":"10.1007/s40262-015-0352-5","title":"Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Itraconazole; Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Drug; Chemistry; Medicine; Antifungal","score_opus":0.327424888735298,"score_gpt":0.5071408996172214,"score_spread":0.1797160108819234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269037162","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025512163,0.00028713967,0.9680265,0.00034199245,0.00006494362,0.00011444535,0.00032263514,0.0011186851,0.004211412],"genre_scores_gemma":[0.77787673,0.00073631475,0.20813018,0.0002888677,0.00008753645,0.00071980356,0.00092797587,0.00023848761,0.010994075],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997849,0.00004630862,0.000016534414,0.000054841912,0.0000770773,0.000020309108],"domain_scores_gemma":[0.99963,0.00017363565,0.00003761751,0.00001979887,0.00012301191,0.00001597196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004464728,0.00066663243,0.00095219543,0.0003645013,0.00038784993,0.0009059358,0.0012325259,0.0012951184,0.0017973019],"category_scores_gemma":[0.0012601417,0.00057471875,0.0010049514,0.0003024193,0.00021061058,0.0007158158,0.00050767575,0.001279115,0.00089467026],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023995763,0.000042740452,0.0006884819,0.000042539614,0.00003824155,0.000096546464,0.000023623674,0.97416794,0.004357907,0.0020981668,0.00061434804,0.01780552],"study_design_scores_gemma":[0.000003256098,0.000011168532,0.00011541938,0.0000021763433,0.00000723881,0.000019429564,0.0000019173679,0.9984546,0.00048060672,0.00038735202,0.00051272684,0.000004179948],"about_ca_topic_score_codex":0.012145648,"about_ca_topic_score_gemma":0.007309276,"teacher_disagreement_score":0.012145648,"about_ca_system_score_codex":0.0007074977,"about_ca_system_score_gemma":0.0018909897,"threshold_uncertainty_score":0.024149895},"labels":[],"label_agreement":null},{"id":"W2269609889","doi":"10.1002/chem.201600246","title":"Direct Observation of an Oxepin from a Bacterial Cytochrome P450‐Catalyzed Oxidation","year":2016,"lang":"en","type":"article","venue":"Chemistry - A European Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Australian Research Council; University of Queensland","keywords":"Hydroxylation; Chemistry; Tautomer; Cytochrome P450; Catalysis; Flavin group; Reactive intermediate; Phenols; Stereochemistry; Combinatorial chemistry; Photochemistry; Organic chemistry; Enzyme","score_opus":0.09599393693691344,"score_gpt":0.3677334245001588,"score_spread":0.27173948756324534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269609889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97906107,0.0011773822,0.009165474,0.00025862234,0.00008724689,0.00007781858,0.0012620118,0.000080741906,0.008829609],"genre_scores_gemma":[0.98992425,0.0004913915,0.0032779954,0.000077261706,0.000021971462,0.000020653097,0.0013628647,0.000011517466,0.0048121763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998178,0.000023743673,0.0000068208,0.00003473667,0.000078398036,0.000038495375],"domain_scores_gemma":[0.9997819,0.000042677653,0.00005091622,0.000025680556,0.000049864408,0.00004899741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013584773,0.00034298905,0.00014215519,0.0002748671,0.0001728807,0.00022625999,0.00017842095,0.0003828636,0.0020292879],"category_scores_gemma":[0.00024290053,0.00011810172,0.00018379615,0.00018849327,0.00020042296,0.0002190622,0.00039757034,0.0006478115,0.0008086952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012149787,0.000023881084,0.0011243443,0.00004069075,0.000005995667,0.00053649745,0.000029490468,0.000033919536,0.9959777,0.00014487945,0.000071549395,0.0018896403],"study_design_scores_gemma":[0.000009015881,0.0002454528,0.009271672,0.000005297828,0.000010867411,0.0010685035,0.00003601798,0.00035242818,0.9868134,0.000117644166,0.0020654749,0.0000041673684],"about_ca_topic_score_codex":0.0005707309,"about_ca_topic_score_gemma":0.00049059215,"teacher_disagreement_score":0.0020292879,"about_ca_system_score_codex":0.0001989453,"about_ca_system_score_gemma":0.00019289252,"threshold_uncertainty_score":0.006788671},"labels":[],"label_agreement":null},{"id":"W2269993080","doi":"10.1093/toxsci/kfv107","title":"NADPH Oxidase-Mediated Superoxide Production by Intermediary Bacterial Metabolites of Dibenzofuran: A Potential Cause for Trans-Mitochondrial Membrane Potential (ΔΨm) Collapse in Human Hepatoma Cells","year":2015,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Dibenzofuran; Chemistry; Superoxide; Reactive oxygen species; Oxidative stress; Toxicity; Mitochondrion; Biochemistry; Photobacterium phosphoreum; NADPH oxidase; Catalase; Oxidase test; Enzyme","score_opus":0.11021668086561852,"score_gpt":0.3970106824841867,"score_spread":0.28679400161856816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269993080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870952,0.0058055026,0.005303333,0.00022066748,0.00006157151,0.000041582094,0.0005232495,0.00006431658,0.00088470767],"genre_scores_gemma":[0.99579996,0.0011435626,0.0014718125,0.000046791632,0.000010600005,0.000025213274,0.00054403726,0.0000050107183,0.00095307344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984205,0.000028106195,0.000014430074,0.00003248414,0.0000471071,0.000035857018],"domain_scores_gemma":[0.9999089,0.00000887356,0.00003425354,0.000009128211,0.000022861946,0.000015923724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013238995,0.00039327724,0.00023184421,0.00018645762,0.00014792278,0.00016440556,0.00015739347,0.00028248053,0.0007650903],"category_scores_gemma":[0.00010875112,0.00014949105,0.0002812736,0.0002449422,0.00012793558,0.00021408383,0.00017280669,0.0004848114,0.00021613357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000159683,0.000024661938,0.0007671654,0.000051000236,0.0000073090596,0.00014906721,0.000028037735,0.000023877448,0.9979128,0.00003279482,0.00003526957,0.0008083701],"study_design_scores_gemma":[0.000009794406,0.0003765764,0.009790572,0.000006084954,0.000020821648,0.0004124759,0.000048739625,0.0003264993,0.98807436,0.000045470893,0.0008843324,0.0000042324664],"about_ca_topic_score_codex":0.0008313341,"about_ca_topic_score_gemma":0.0009320199,"teacher_disagreement_score":0.0008313341,"about_ca_system_score_codex":0.00022949818,"about_ca_system_score_gemma":0.00012242683,"threshold_uncertainty_score":0.002559483},"labels":[],"label_agreement":null},{"id":"W2277931495","doi":"10.1385/0-89603-519-0:129","title":"Determination of CYP2CSGatalyzed Diclofenac 4'-Hydroxylation by High-Performance Liquid Chromatography","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Hydroxylation; Chromatography; Perchloric acid; Diclofenac; Chemistry; High-performance liquid chromatography; Acetonitrile; Methanol; Microsome; Organic chemistry; Enzyme; Biochemistry","score_opus":0.07930400567876678,"score_gpt":0.3711577096430251,"score_spread":0.2918537039642583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277931495","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38945547,0.08138403,0.39926007,0.0023132886,0.0013470766,0.0035336902,0.038045265,0.01516738,0.06949378],"genre_scores_gemma":[0.44270578,0.042958617,0.35204574,0.003511073,0.000915279,0.004369444,0.04005377,0.0018562835,0.11158402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981394,0.00019549477,0.00007839387,0.00032684556,0.0010354797,0.00022437837],"domain_scores_gemma":[0.99935704,0.0001548277,0.00006310973,0.000056629484,0.00028919664,0.000079052166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008618195,0.001620461,0.0010357862,0.002153622,0.000889101,0.0010666903,0.00072548987,0.00093873346,0.010145739],"category_scores_gemma":[0.0015437397,0.0005614375,0.0005585545,0.0012382948,0.00051160477,0.0005361226,0.00053311425,0.0013665004,0.009295625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027339422,0.00024160942,0.0015552359,0.00031373693,0.000085796426,0.000118275275,0.00006421561,0.00023077981,0.940182,0.00044938189,0.0021301955,0.05435537],"study_design_scores_gemma":[0.00006805618,0.0004509856,0.012807383,0.00005891884,0.000074579904,0.0004192402,0.000038648282,0.0026814286,0.94247645,0.00027671503,0.040597156,0.00005027288],"about_ca_topic_score_codex":0.0042070816,"about_ca_topic_score_gemma":0.0072877076,"teacher_disagreement_score":0.010145739,"about_ca_system_score_codex":0.000996209,"about_ca_system_score_gemma":0.0011826415,"threshold_uncertainty_score":0.03394091},"labels":[],"label_agreement":null},{"id":"W2279906559","doi":"10.1139/jpn.0261","title":"Drug-metabolizing cytochrome P450s in the brain","year":2002,"lang":"en","type":"review","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Brain function; Cytochrome P450; Neuroscience; Biology; Drug metabolism; Brain chemistry; Function (biology); Drug; Bioinformatics; Pharmacology; Metabolism; Genetics; Endocrinology","score_opus":0.17418983423724288,"score_gpt":0.47088411652016376,"score_spread":0.2966942822829209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279906559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004433055,0.99559057,0.00039580025,0.00029228083,0.000119495344,0.000009670482,0.000022649721,0.000020086014,0.0031062332],"genre_scores_gemma":[0.002171225,0.9947313,0.0004100475,0.000116737996,0.00017960159,0.0000082545375,0.000030047231,0.0000016192446,0.002351149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998658,0.00002469708,0.00001451829,0.000030652616,0.000051071154,0.000013261657],"domain_scores_gemma":[0.9998603,0.000044202712,0.000024073153,0.000007908831,0.000046432986,0.000016979759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037290086,0.00084759283,0.0012271432,0.001731074,0.00031423388,0.0007113039,0.0006200564,0.0008472448,0.004154338],"category_scores_gemma":[0.00031157798,0.0002295636,0.00030236223,0.0022686094,0.0003923001,0.0010244879,0.00034163342,0.0008540339,0.004731164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000498226,0.000058140242,0.00040331224,0.004207918,0.000041934876,0.0004729907,0.000035355162,0.00027007793,0.002976166,0.0015264942,0.015442611,0.97451514],"study_design_scores_gemma":[0.000025848209,0.00014886039,0.003801173,0.001245038,0.00008677661,0.0049490053,0.00006654021,0.0001366597,0.001756068,0.0034000718,0.98436445,0.000019456324],"about_ca_topic_score_codex":0.0014147749,"about_ca_topic_score_gemma":0.0025048484,"teacher_disagreement_score":0.004154338,"about_ca_system_score_codex":0.00046694776,"about_ca_system_score_gemma":0.0007586053,"threshold_uncertainty_score":0.013897598},"labels":[],"label_agreement":null},{"id":"W2283946288","doi":"","title":"St. John's wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and/or P-glycoproteins.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnane X receptor; Colitis; Inflammatory bowel disease; Pathogenesis; Tumor necrosis factor alpha; Ulcerative colitis; Chemistry; Orosomucoid; Myeloperoxidase; Pharmacology; Receptor; Internal medicine; Endocrinology; Immunology; Medicine; Inflammation; Biochemistry; Nuclear receptor; Glycoprotein","score_opus":0.1697292111323969,"score_gpt":0.37936324949474853,"score_spread":0.20963403836235164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283946288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940402,0.0037784956,0.00049616233,0.00020435434,0.000076848766,0.000036884052,0.00017902568,0.000092330636,0.0010956455],"genre_scores_gemma":[0.99033815,0.004492995,0.0010421072,0.000093484734,0.000041565654,0.000040780986,0.00037040666,0.0000094631405,0.0035710032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992096,0.000014511727,0.00000943684,0.000012095552,0.00001634092,0.000026727526],"domain_scores_gemma":[0.99987113,0.000009584404,0.000044918477,0.000008720558,0.000009299149,0.00005629302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010525368,0.00063541526,0.00041677928,0.00042869305,0.00016675706,0.0001410405,0.00015405635,0.00030972218,0.0017625575],"category_scores_gemma":[0.00008937712,0.00017400975,0.00031912478,0.0001920432,0.00029749208,0.00020548559,0.0001392939,0.00056380674,0.00027482517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002897314,0.0010162157,0.0007604563,0.00025016753,0.00003272724,0.0002689925,0.00003995888,0.00008687355,0.9872938,0.00008740107,0.00015785742,0.0071082395],"study_design_scores_gemma":[0.00053743314,0.037127156,0.032682806,0.000047425434,0.00016242694,0.0009582801,0.00015410571,0.0010061489,0.9227868,0.00014993941,0.004364128,0.000023184377],"about_ca_topic_score_codex":0.00083277636,"about_ca_topic_score_gemma":0.0019396398,"teacher_disagreement_score":0.0017625575,"about_ca_system_score_codex":0.00013173488,"about_ca_system_score_gemma":0.00030382728,"threshold_uncertainty_score":0.0058963895},"labels":[],"label_agreement":null},{"id":"W2284709444","doi":"10.1016/j.xphs.2015.12.009","title":"Ketoconazole Stereoisomers Differentially Induce Cytochrome P450 1A1 Between Human Hepatoma HepG2 and Mouse Hepatoma Hepa1c1c7 Cells","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Ketoconazole; Enzyme; Chemistry; Receptor; Cytochrome P450; In vivo; Recombinant DNA; Biochemistry; Biology; Gene","score_opus":0.16761478360388882,"score_gpt":0.4607510310830186,"score_spread":0.2931362474791298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284709444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454075,0.0004520865,0.0014830953,0.0001274503,0.000056531135,0.000031373318,0.0011895386,0.00008506237,0.002034072],"genre_scores_gemma":[0.9915787,0.0003888052,0.0008626617,0.00006655479,0.000014208698,0.000034934917,0.0024289365,0.000032652046,0.0045925984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955684,0.00009511131,0.00004960647,0.00007549929,0.000116746945,0.000106244166],"domain_scores_gemma":[0.99981636,0.00005119815,0.000024101635,0.000039534727,0.00004030741,0.000028576942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017424933,0.00022397196,0.00029716777,0.00046389963,0.00027410008,0.000407349,0.00012863934,0.00022243694,0.0032884032],"category_scores_gemma":[0.0002230003,0.00024883886,0.00041608693,0.0005112362,0.00021843273,0.00025594883,0.00017405572,0.0005721227,0.00075502275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006730761,0.00006794752,0.0010228594,0.000026771944,0.000012309569,0.00009667251,0.00006503706,0.000040668736,0.99659,0.00016921567,0.00014860081,0.0010868153],"study_design_scores_gemma":[0.00004254507,0.0005462497,0.011627616,0.0000026447876,0.000034069082,0.0002874693,0.00014765638,0.0004270988,0.9846943,0.000046406298,0.002135443,0.000008540966],"about_ca_topic_score_codex":0.00377037,"about_ca_topic_score_gemma":0.0043013417,"teacher_disagreement_score":0.00377037,"about_ca_system_score_codex":0.0003988031,"about_ca_system_score_gemma":0.00029685802,"threshold_uncertainty_score":0.011000872},"labels":[],"label_agreement":null},{"id":"W2289811051","doi":"10.4212/cjhp.v69i1.1522","title":"Interaction between Warfarin and Apple Juice","year":2016,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Alberta Health Services; University of Calgary","funders":"","keywords":"Warfarin; Food science; Chemistry; Medicine; Internal medicine","score_opus":0.09591263570445974,"score_gpt":0.4058268559580316,"score_spread":0.30991422025357185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289811051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96711105,0.017417876,0.0006972508,0.0011105272,0.0004861165,0.00021183923,0.00127049,0.00014878505,0.011546071],"genre_scores_gemma":[0.9914703,0.0021174382,0.00049439137,0.00032857992,0.000111691275,0.000023842073,0.00042264714,0.000008559393,0.0050226],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993205,0.00036868674,0.00004580679,0.00009610718,0.00010463203,0.00006424651],"domain_scores_gemma":[0.99960095,0.00019874866,0.00007108302,0.00003165944,0.00004126327,0.00005632796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039168017,0.0003779237,0.000641113,0.00025214825,0.0002762727,0.0004929035,0.00023940616,0.00073009485,0.010110368],"category_scores_gemma":[0.001739973,0.00016507614,0.0013008956,0.00020146543,0.00019828987,0.0003093492,0.00023146629,0.0005651356,0.0008455769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35176057,0.0051520816,0.1412277,0.0024413096,0.009230278,0.0049476963,0.0004465659,0.0006799882,0.15831342,0.0010300272,0.009834191,0.31493625],"study_design_scores_gemma":[0.015594069,0.10700374,0.64628,0.00031927472,0.010786026,0.013272253,0.00057446,0.0044742683,0.13941501,0.0011793429,0.060899843,0.00020171098],"about_ca_topic_score_codex":0.0035950164,"about_ca_topic_score_gemma":0.0058379015,"teacher_disagreement_score":0.010110368,"about_ca_system_score_codex":0.0004902453,"about_ca_system_score_gemma":0.00045907215,"threshold_uncertainty_score":0.033822596},"labels":[],"label_agreement":null},{"id":"W2289967391","doi":"10.1111/bcpt.12536","title":"Effect of Omeprazole and Dextromethorphan on the Urinary Metabolic Ratio of Flurbiprofen","year":2015,"lang":"en","type":"article","venue":"Basic & Clinical Pharmacology & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dextromethorphan; Omeprazole; Flurbiprofen; CYP2C19; Pharmacology; CYP2C9; CYP2D6; Drug; Drug metabolism; Medicine; CYP3A4; Cytochrome P450; Drug interaction; Dextrorphan; Pharmacogenetics; Internal medicine; Chemistry; Metabolism; Genotype; Biochemistry","score_opus":0.20651575682134435,"score_gpt":0.5175748918779414,"score_spread":0.311059135056597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289967391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940276,0.004550816,0.00034301582,0.00010471293,0.00006981588,0.00006443079,0.00029465574,0.00005051249,0.00049454847],"genre_scores_gemma":[0.9975898,0.0007437594,0.00060698116,0.000098906385,0.000045197045,0.000030804076,0.00026841505,0.00001777937,0.00059837603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949574,0.00018719357,0.000029596582,0.000111990514,0.00010214945,0.000073425705],"domain_scores_gemma":[0.9994344,0.00014941827,0.00012816612,0.00005162812,0.000056852437,0.00017950467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045410375,0.00066339155,0.0010898213,0.00042845443,0.0002255477,0.00040233025,0.00027634305,0.0007461879,0.0014666343],"category_scores_gemma":[0.0015272747,0.0002462845,0.00066234823,0.0003963133,0.0002852959,0.00044717622,0.0002437538,0.0006838419,0.00023966354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3186951,0.009131875,0.027142435,0.00082071306,0.0012426481,0.0010849925,0.00037186482,0.0010023833,0.5466772,0.00014744242,0.0009972003,0.09268623],"study_design_scores_gemma":[0.005636299,0.15840933,0.37169948,0.0000860234,0.0016323852,0.0020460233,0.000420976,0.007518341,0.44499674,0.00017697748,0.0072592567,0.00011803046],"about_ca_topic_score_codex":0.00094281766,"about_ca_topic_score_gemma":0.0008810451,"teacher_disagreement_score":0.0014666343,"about_ca_system_score_codex":0.00024595083,"about_ca_system_score_gemma":0.0003074768,"threshold_uncertainty_score":0.0049063563},"labels":[],"label_agreement":null},{"id":"W2290974032","doi":"10.1096/fasebj.24.1_supplement.757.11","title":"Rat hepatic cytochrome P450 oxidoreductase is up‐regulated by low dose dexamethasone and down‐regulated by adrenalectomy","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Internal medicine; Endocrinology; Adrenalectomy; Dexamethasone; Cytochrome P450; Glucocorticoid; Glucocorticoid receptor; Microsome; Chemistry; Biology; Nuclear receptor; Medicine; Enzyme; Metabolism; Gene; Biochemistry","score_opus":0.029962726809646425,"score_gpt":0.34992204734252597,"score_spread":0.31995932053287957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290974032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943203,0.0023427617,0.0011929389,0.00011137174,0.000048912076,0.000019604306,0.0008822097,0.00011246789,0.00096935313],"genre_scores_gemma":[0.9909898,0.0016531448,0.0013731846,0.000065861146,0.000023191536,0.00005192501,0.001760833,0.00003775028,0.004044402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998323,0.000015351794,0.00001606092,0.000045307974,0.00004327706,0.000047686197],"domain_scores_gemma":[0.9996717,0.000043250475,0.000096605545,0.000050806422,0.00004052886,0.00009711776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009162776,0.00040231377,0.0003714752,0.0005624978,0.00018148003,0.00032422467,0.000119542936,0.00019607849,0.0019326819],"category_scores_gemma":[0.00015838743,0.00019361981,0.00036526378,0.00044743717,0.00035922756,0.00018918687,0.00015479332,0.00061642466,0.0005102421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048822703,0.00004521705,0.0008074225,0.0000243827,0.000006059554,0.00006224476,0.000013133298,0.00001889852,0.99729687,0.000021927284,0.00003407708,0.0011814419],"study_design_scores_gemma":[0.00003746239,0.00060786266,0.034118146,0.000006088617,0.000033738812,0.00029448923,0.0000678432,0.00018824585,0.9631215,0.000039045844,0.0014773522,0.0000083176465],"about_ca_topic_score_codex":0.0013003078,"about_ca_topic_score_gemma":0.0023088118,"teacher_disagreement_score":0.0019326819,"about_ca_system_score_codex":0.00037707886,"about_ca_system_score_gemma":0.00022477719,"threshold_uncertainty_score":0.006465435},"labels":[],"label_agreement":null},{"id":"W2292289790","doi":"10.1096/fasebj.27.1_supplement.673.2","title":"Pharmacogenetics of warfarin safety and effectiveness in children","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"","keywords":"VKORC1; CYP2C9; Warfarin; Pharmacogenetics; Dosing; Medicine; Vitamin K epoxide reductase; Genotyping; Genotype; Internal medicine; Cohort; Odds ratio; Pharmacology; Biology; Atrial fibrillation; Genetics","score_opus":0.04394257027666998,"score_gpt":0.3745001369722935,"score_spread":0.33055756669562353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292289790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960049,0.00092722377,0.00094736373,0.00015622427,0.000007771015,0.000011321501,0.0010927748,0.000015196986,0.0008373346],"genre_scores_gemma":[0.9980457,0.00042443318,0.00071685895,0.000038319224,0.000011722958,0.000010410598,0.00059678976,0.000008621443,0.00014718567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991239,0.00032285493,0.00008589017,0.00018002123,0.00020006088,0.00008724573],"domain_scores_gemma":[0.9979469,0.0005863329,0.001085854,0.00010302614,0.00016915592,0.00010867107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008475508,0.00036830374,0.00037266416,0.000596691,0.00019090816,0.00048420666,0.00024319762,0.00026920642,0.000996687],"category_scores_gemma":[0.0038756893,0.0001603026,0.00048340097,0.00082124537,0.0002921386,0.00026624906,0.00032047942,0.00040010194,0.00015309337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011847624,0.000008941082,0.9948835,0.000012567743,0.00006129327,0.000112165064,0.000047944293,0.00049483764,0.00032281777,0.000076659715,0.00018644067,0.003674366],"study_design_scores_gemma":[0.000012367042,0.00016718674,0.9961039,0.000017666212,0.000066725464,0.0012135518,0.00006988048,0.0010003337,0.00058107503,0.00012839524,0.00063332415,0.0000057185357],"about_ca_topic_score_codex":0.006191009,"about_ca_topic_score_gemma":0.0031600178,"teacher_disagreement_score":0.006191009,"about_ca_system_score_codex":0.0005448532,"about_ca_system_score_gemma":0.0005050913,"threshold_uncertainty_score":0.0123099685},"labels":[],"label_agreement":null},{"id":"W2292946704","doi":"10.1002/cpt.364","title":"Disease–drug database for pharmacogenomic‐based prescribing","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Ontario; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Pharmacogenomics; Drug; Disease; Medicine; Database; Pharmacology; Computer science; Internal medicine","score_opus":0.3552165596201565,"score_gpt":0.5361870192128482,"score_spread":0.18097045959269165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292946704","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012918756,0.0027991352,0.05370481,0.003249685,0.0003698454,0.0015226894,0.86710817,0.017662985,0.040664002],"genre_scores_gemma":[0.06833167,0.0028195821,0.11453272,0.0026267625,0.0004079733,0.0021412652,0.80226314,0.0013893936,0.0054874523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755716,0.0006121924,0.0008046426,0.0004648883,0.0004876845,0.00007350937],"domain_scores_gemma":[0.9859266,0.0067351237,0.0026708138,0.0023326764,0.0014461068,0.00088862225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033691255,0.0006620791,0.001483757,0.0059225457,0.0005272392,0.0021723362,0.0019485042,0.0012562147,0.037140854],"category_scores_gemma":[0.020099804,0.0006404488,0.0010783555,0.007726057,0.0002338333,0.0014591007,0.0013737523,0.0015012095,0.017193582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002818307,0.000673791,0.05205983,0.0054803197,0.0014325466,0.0014550977,0.00035571243,0.0106951585,0.004846948,0.033597875,0.62886345,0.25772107],"study_design_scores_gemma":[0.0011745341,0.0002621651,0.041916203,0.00061993336,0.0005319864,0.0012531457,0.000095164025,0.020071708,0.0046847877,0.020590413,0.9086395,0.00016041947],"about_ca_topic_score_codex":0.0033595515,"about_ca_topic_score_gemma":0.004407148,"teacher_disagreement_score":0.037140854,"about_ca_system_score_codex":0.0010701887,"about_ca_system_score_gemma":0.003601559,"threshold_uncertainty_score":0.124248505},"labels":[],"label_agreement":null},{"id":"W2294096027","doi":"10.1053/j.ackd.2015.10.002","title":"The Effects of CKD on Cytochrome P450–Mediated Drug Metabolism","year":2016,"lang":"en","type":"review","venue":"Advances in Chronic Kidney Disease","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Cytochrome P450; Drug metabolism; Kidney disease; Drug; Pharmacology; Population; Pharmacokinetics; Adverse effect; Debrisoquine; CYP2D6; Metabolism; Bioinformatics; Internal medicine; Biology","score_opus":0.037677913953655426,"score_gpt":0.4400270862204303,"score_spread":0.40234917226677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294096027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027009446,0.9985942,0.00018861692,0.00024024873,0.00008392781,0.0000027366655,0.00002296637,0.0000055496835,0.00059154636],"genre_scores_gemma":[0.0019968788,0.9970765,0.00024190525,0.0001531187,0.00019041363,0.000002807587,0.000029390267,0.0000010284668,0.00030794262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979824,0.000040345516,0.0000361697,0.00003691306,0.000072319905,0.000016038042],"domain_scores_gemma":[0.99955505,0.00025456387,0.00007179646,0.000012882258,0.00008355959,0.000022133316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005242087,0.000522667,0.0011544081,0.0012439082,0.00012724029,0.0007293424,0.0005095163,0.0005700834,0.0024734607],"category_scores_gemma":[0.0008042331,0.00018067975,0.0006086288,0.0013655233,0.0003131271,0.0008389366,0.0005822345,0.001116815,0.00062379125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011255683,0.00006489165,0.0006928529,0.011088629,0.00022090417,0.00018466442,0.00002896665,0.00030706116,0.0015145087,0.0017067977,0.008332238,0.975746],"study_design_scores_gemma":[0.000061388346,0.0003066111,0.006022754,0.004084335,0.000774602,0.0024985748,0.00007403047,0.00040641826,0.0018020363,0.0037424422,0.98018163,0.00004513642],"about_ca_topic_score_codex":0.0010692985,"about_ca_topic_score_gemma":0.0025347364,"teacher_disagreement_score":0.0024734607,"about_ca_system_score_codex":0.00029194955,"about_ca_system_score_gemma":0.0008614796,"threshold_uncertainty_score":0.008274615},"labels":[],"label_agreement":null},{"id":"W2300183130","doi":"10.1139/cjpp-2015-0509","title":"Assessment of 25 <i>CYP2D6</i> alleles found in the Chinese population on propafenone metabolism in vitro","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Propafenone; CYP2D6; Cytochrome P450; Allele; Hydroxylation; Enzyme; Biology; Population; Chemistry; Biochemistry; Pharmacology; Internal medicine; Medicine; Gene","score_opus":0.04230752384152641,"score_gpt":0.3965363881761747,"score_spread":0.3542288643346483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300183130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914455,0.00017004805,0.00021144102,0.000019084795,0.0000043616487,0.000006654933,0.00013799545,0.000003941406,0.0003017903],"genre_scores_gemma":[0.99901927,0.00014072367,0.00021194402,0.000021924452,0.000006273199,0.0000066685448,0.00020660908,0.000004896356,0.00038161856],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997737,0.000048135316,0.000023495126,0.000063981955,0.00005983531,0.000030845556],"domain_scores_gemma":[0.9998128,0.000034693454,0.000060869697,0.00001802948,0.000035534147,0.000038104143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029541444,0.00030874458,0.00028913026,0.00038204103,0.0002642575,0.00024476455,0.00012517639,0.00018855352,0.0010543239],"category_scores_gemma":[0.00041101172,0.00010966428,0.00026326193,0.0005109746,0.00022036985,0.00009191979,0.00012262652,0.00024175407,0.00016310505],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016355669,0.00016246963,0.76232284,0.00009092919,0.00027819155,0.002534499,0.0009569719,0.000190241,0.21556115,0.00019554823,0.00027456877,0.015797062],"study_design_scores_gemma":[0.000020532863,0.0005593272,0.9785963,0.000006194669,0.0002182241,0.0025792548,0.00031773592,0.00042710605,0.015805291,0.000062128594,0.0013923327,0.000015491083],"about_ca_topic_score_codex":0.003043195,"about_ca_topic_score_gemma":0.0027282152,"teacher_disagreement_score":0.003043195,"about_ca_system_score_codex":0.00012864682,"about_ca_system_score_gemma":0.000119227036,"threshold_uncertainty_score":0.006051004},"labels":[],"label_agreement":null},{"id":"W2305015145","doi":"","title":"Cytochrome P450 down-regulation by serum from humans with a viral infection and from rabbits with an inflammatory reaction.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytochrome P450; Hepatocyte; Incubation; Internal medicine; Endocrinology; Enzyme; Chemistry; Enzyme inducer; Metabolism; Biology; In vitro; Biochemistry; Medicine","score_opus":0.04384608622284731,"score_gpt":0.31772365792045854,"score_spread":0.27387757169761123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305015145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925527,0.004466732,0.0012427849,0.000117943186,0.000079457146,0.000054407934,0.00018659819,0.000029829609,0.0012693264],"genre_scores_gemma":[0.9943817,0.0018249524,0.0012189653,0.00014377125,0.00007290066,0.00006423811,0.0007906673,0.000009786061,0.0014929812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99960977,0.00011420625,0.00005088241,0.00006837828,0.000091090515,0.000065759436],"domain_scores_gemma":[0.9998253,0.000024228279,0.000052178,0.000031193114,0.00003534923,0.00003172343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003100451,0.0004621183,0.000334018,0.00039331752,0.00019581654,0.0002596321,0.00009177037,0.0003498416,0.0013956565],"category_scores_gemma":[0.0004089456,0.00015023483,0.000417624,0.00017903463,0.0003186186,0.0001414881,0.00020381098,0.00045511566,0.00052219967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010929467,0.0001024033,0.003238001,0.00009631079,0.000028420289,0.0002606477,0.00006461537,0.000015273628,0.9906158,0.000040195933,0.00007104473,0.004374389],"study_design_scores_gemma":[0.00025036297,0.008162858,0.13316588,0.00003955217,0.0002061424,0.005774315,0.00021816813,0.00048425293,0.8440317,0.00012282717,0.0075232415,0.000020722578],"about_ca_topic_score_codex":0.00035586345,"about_ca_topic_score_gemma":0.00044636728,"teacher_disagreement_score":0.0013956565,"about_ca_system_score_codex":0.00012124751,"about_ca_system_score_gemma":0.0001272039,"threshold_uncertainty_score":0.0046688914},"labels":[],"label_agreement":null},{"id":"W2312978113","doi":"10.1021/es200673q","title":"Factors Affecting Phase I Stereoselective Biotransformation of Chiral Polychlorinated Biphenyls by Rat Cytochrome P-450 2B1 Isozyme","year":2011,"lang":"en","type":"article","venue":"Environmental Science & Technology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"","keywords":"Biotransformation; Stereoselectivity; Atropisomer; Chemistry; Enantiomer; Polychlorinated biphenyl; Congener; Cytochrome; Cytochrome P450; Isozyme; Stereochemistry; Microsome; Environmental chemistry; Chromatography; Biochemistry; Enzyme","score_opus":0.07782877457360367,"score_gpt":0.3754555304196769,"score_spread":0.29762675584607323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312978113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955,0.0006886395,0.0026784153,0.00004452036,0.00000923378,0.00002524364,0.0002949667,0.000027688779,0.00073120417],"genre_scores_gemma":[0.99548537,0.0005495702,0.0018243497,0.00005239748,0.0000060595457,0.00003429181,0.00079019996,0.000019520314,0.0012381637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996884,0.000088011235,0.000024424788,0.00006365905,0.00007850955,0.000057002086],"domain_scores_gemma":[0.9997979,0.00005436189,0.00006741848,0.000014654291,0.000041763866,0.000023935263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024668142,0.0003665366,0.00025770426,0.00013980687,0.00009986506,0.00027947378,0.00010385223,0.00013448374,0.00095246575],"category_scores_gemma":[0.0004136224,0.00018257278,0.00020505187,0.00020054242,0.00016581097,0.00013200661,0.00010221141,0.000209522,0.00027795357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028828654,0.00003100212,0.0025332805,0.000039060615,0.000012322984,0.000037105667,0.000012701687,0.0001762968,0.9953336,0.000032230582,0.00003722937,0.0014668244],"study_design_scores_gemma":[0.000016156346,0.00043845395,0.018014364,0.0000030414715,0.000025835894,0.000121097284,0.000025830721,0.00086059887,0.9798821,0.00003213508,0.00057247956,0.000007931251],"about_ca_topic_score_codex":0.0022511939,"about_ca_topic_score_gemma":0.0032579282,"teacher_disagreement_score":0.0022511939,"about_ca_system_score_codex":0.0002237135,"about_ca_system_score_gemma":0.00036592456,"threshold_uncertainty_score":0.0044761896},"labels":[],"label_agreement":null},{"id":"W2315359168","doi":"10.3821/1913-701x-144.1.21","title":"Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips","year":2011,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; Alberta Health Services","funders":"","keywords":"Warfarin; Drug; Medicine; Intensive care medicine; Pharmacology; Computer science; Internal medicine; Atrial fibrillation","score_opus":0.16964788052966367,"score_gpt":0.39867526183975116,"score_spread":0.22902738131008749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315359168","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128228925,0.043511454,0.14772515,0.70911455,0.0066565387,0.0016343917,0.0015913028,0.0065812427,0.070362516],"genre_scores_gemma":[0.09999941,0.10571357,0.66251767,0.079529256,0.016552486,0.0030528472,0.0022755545,0.0010952504,0.029264042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98449546,0.0069368808,0.003174229,0.0007168731,0.0042668893,0.0004097083],"domain_scores_gemma":[0.9427578,0.028028725,0.0037634694,0.0023780765,0.01788029,0.005191614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020011846,0.0038792286,0.0026227443,0.006015821,0.0016975744,0.005552252,0.0044001383,0.007951517,0.013243346],"category_scores_gemma":[0.0571935,0.0011474644,0.0019568773,0.0025072442,0.0013389004,0.011617484,0.0038981913,0.0078269085,0.008934521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017447911,0.0010608315,0.01329221,0.0015573298,0.00010206455,0.0028097266,0.0012803901,0.0016462082,0.00043389248,0.0051620565,0.36121398,0.61126685],"study_design_scores_gemma":[0.0011712695,0.0019293444,0.038486704,0.031637628,0.00069097785,0.03747341,0.015072994,0.019390794,0.002677802,0.117053166,0.7335118,0.00090409827],"about_ca_topic_score_codex":0.0040734364,"about_ca_topic_score_gemma":0.01739479,"teacher_disagreement_score":0.020011846,"about_ca_system_score_codex":0.0033325553,"about_ca_system_score_gemma":0.0075008054,"threshold_uncertainty_score":0.10583401},"labels":[],"label_agreement":null},{"id":"W2316649866","doi":"10.1097/00004714-200008000-00008","title":"Inhibition of Cytochrome P450 2D6 Modifies Codeine Abuse Liability","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Codeine; Quinidine; Pharmacology; Morphine; Placebo; Medicine; Anesthesia; Chemistry","score_opus":0.17483217560793057,"score_gpt":0.5378821078846676,"score_spread":0.36304993227673704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316649866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990101,0.00033029556,0.00025351005,0.00002936151,0.000011062108,0.00002030386,0.00007550752,0.000011407554,0.00025841198],"genre_scores_gemma":[0.99853075,0.00034021973,0.00031509265,0.000028578002,0.000013922255,0.000018489496,0.00017750722,0.0000049410082,0.00057058845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998411,0.00005609797,0.000011662204,0.000028350876,0.0000271882,0.000035564917],"domain_scores_gemma":[0.99980074,0.00004089009,0.00005974718,0.000022167915,0.000019150913,0.00005730147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015258548,0.00024255086,0.00037437316,0.00014273368,0.000095341245,0.00015977232,0.000120805176,0.0002241369,0.0014589187],"category_scores_gemma":[0.00042642592,0.00014370272,0.00015138583,0.00013745068,0.00025047915,0.00013710836,0.00011185609,0.00046172555,0.00018101343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006903314,0.00072781317,0.003003782,0.000049639693,0.00003667357,0.00007085856,0.000051592164,0.00006929717,0.9827368,0.00004193557,0.00007610232,0.006232308],"study_design_scores_gemma":[0.0011997322,0.0547021,0.18229817,0.000019217034,0.00015643713,0.00091967144,0.00014536447,0.003077954,0.7548577,0.00009421269,0.0025024998,0.000027001222],"about_ca_topic_score_codex":0.0005890726,"about_ca_topic_score_gemma":0.0010613004,"teacher_disagreement_score":0.0014589187,"about_ca_system_score_codex":0.00011135686,"about_ca_system_score_gemma":0.000117774915,"threshold_uncertainty_score":0.0048805475},"labels":[],"label_agreement":null},{"id":"W2317608031","doi":"10.1097/00004714-200304000-00009","title":"The Role of Cytochrome P450 2C19 Activity in Flunitrazepam Metabolism In Vivo","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute on Drug Abuse; AstraZeneca Canada","keywords":"Flunitrazepam; CYP2C19; Pharmacology; Pharmacokinetics; Benzodiazepine; Triazolam; In vivo; Chemistry; Omeprazole; Hypnotic; Metabolism; Medicine; Internal medicine; Cytochrome P450; Biology","score_opus":0.11118766353520972,"score_gpt":0.5174642610055018,"score_spread":0.4062765974702921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317608031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110776,0.0037526975,0.0028425336,0.0001152358,0.000019230287,0.00006527161,0.00045746146,0.00003844512,0.0016013234],"genre_scores_gemma":[0.99687994,0.00069532025,0.0013199378,0.00005620528,0.00002926372,0.000037893984,0.00040166973,0.00001227467,0.0005675718],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908113,0.0004948671,0.00005011932,0.00013774108,0.00016876809,0.00006735781],"domain_scores_gemma":[0.9989459,0.00037866613,0.0003183456,0.00016366084,0.000116847514,0.00007666139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009630926,0.00031176786,0.0003277286,0.00045682446,0.0002586167,0.0005631931,0.00013760358,0.00039321178,0.0015514452],"category_scores_gemma":[0.0021066784,0.00034534704,0.00021754981,0.00034322,0.00027640077,0.0003117283,0.00014559535,0.0003040162,0.00039574906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008862889,0.00047828254,0.4384947,0.00018863396,0.00045065192,0.00068670284,0.00024994588,0.00068387855,0.51088625,0.00027464697,0.0004996065,0.038243696],"study_design_scores_gemma":[0.00013652835,0.0025798464,0.884822,0.000014854827,0.00017844599,0.0019223575,0.00007171323,0.002698271,0.105857134,0.00012974795,0.0015751881,0.000013918336],"about_ca_topic_score_codex":0.0016373432,"about_ca_topic_score_gemma":0.0012234593,"teacher_disagreement_score":0.0016373432,"about_ca_system_score_codex":0.0001945208,"about_ca_system_score_gemma":0.00017846297,"threshold_uncertainty_score":0.005190134},"labels":[],"label_agreement":null},{"id":"W2325105969","doi":"10.1021/tx5000409","title":"Reactive Metabolite Trapping Screens and Potential Pitfalls: Bioactivation of a Homomorpholine and Formation of an Unstable Thiazolidine Adduct","year":2014,"lang":"en","type":"article","venue":"Chemical Research in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Adduct; Chemistry; Glutathione; Thiazolidine; Reactive intermediate; Metabolite; Stereochemistry; Cysteine; Covalent bond; Nuclear magnetic resonance spectroscopy; Carcinogen; Combinatorial chemistry; Biochemistry; Enzyme; Organic chemistry","score_opus":0.2010250116287437,"score_gpt":0.48419157217810277,"score_spread":0.28316656054935907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325105969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844371,0.0019373957,0.010819125,0.00025154543,0.000029962675,0.00014768103,0.00032931438,0.00021722782,0.0018307792],"genre_scores_gemma":[0.98755497,0.0018227884,0.0078035677,0.0001238566,0.000012659254,0.00005345989,0.00034140193,0.00004584845,0.0022414203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997316,0.00008016513,0.000018736126,0.000051044924,0.00007721259,0.000041248124],"domain_scores_gemma":[0.99973255,0.000057818972,0.00007847498,0.0000489679,0.000052437532,0.000029741008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048324664,0.000430593,0.00029111403,0.00023357038,0.00023502957,0.00030927607,0.0003371043,0.00047827812,0.0010370936],"category_scores_gemma":[0.00037179142,0.0001541407,0.0002620781,0.00021956846,0.0002682326,0.00032677266,0.00022500512,0.00053557375,0.00032732612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001063569,0.000031257903,0.0002925665,0.000055634555,0.000013685773,0.00020921788,0.00004876512,0.0001300851,0.9960114,0.00006908537,0.000052536278,0.0029795226],"study_design_scores_gemma":[0.0000074156524,0.0012058116,0.000938998,0.0000062601684,0.000027094253,0.00036404392,0.00003675633,0.00035072016,0.9955342,0.000051669595,0.0014708248,0.0000063615657],"about_ca_topic_score_codex":0.0003985095,"about_ca_topic_score_gemma":0.0012543985,"teacher_disagreement_score":0.0010370936,"about_ca_system_score_codex":0.00023435424,"about_ca_system_score_gemma":0.00021652857,"threshold_uncertainty_score":0.0034694076},"labels":[],"label_agreement":null},{"id":"W2328147613","doi":"10.1182/blood-2010-09-307900","title":"The “age” of understanding VKA dose","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin k; Intensive care medicine; Internal medicine","score_opus":0.1791364927972956,"score_gpt":0.413488375052902,"score_spread":0.23435188225560638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328147613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076864555,0.0041022645,0.0014512173,0.9870166,0.0046788296,0.000006446014,0.000031927724,0.000037250156,0.0019067299],"genre_scores_gemma":[0.021132007,0.013487748,0.0037319385,0.89498484,0.06290045,0.000055106128,0.000059619168,0.00005323322,0.0035950025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946603,0.0021901983,0.0009332065,0.0007251052,0.0012139764,0.00027731236],"domain_scores_gemma":[0.9747618,0.01725584,0.0014081919,0.0009303533,0.004526678,0.0011170087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059370156,0.0007833663,0.0017952208,0.00085554965,0.0016871707,0.0023745922,0.0015167479,0.015864512,0.004404136],"category_scores_gemma":[0.034887325,0.0006105824,0.0008086058,0.0006003581,0.005034773,0.010009374,0.0016619342,0.03603509,0.0038707014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002489843,0.00011394995,0.006902835,0.0005211536,0.000074848525,0.007473548,0.0016096069,0.000640615,0.001761069,0.025127443,0.7657166,0.18980928],"study_design_scores_gemma":[0.00013733006,0.0003320394,0.006347036,0.0013574314,0.00007664519,0.035486035,0.001576608,0.002704962,0.0011898802,0.10566026,0.8449502,0.0001817188],"about_ca_topic_score_codex":0.0054388936,"about_ca_topic_score_gemma":0.005724151,"teacher_disagreement_score":0.015864512,"about_ca_system_score_codex":0.005453031,"about_ca_system_score_gemma":0.002734984,"threshold_uncertainty_score":0.03956473},"labels":[],"label_agreement":null},{"id":"W2332608279","doi":"10.1021/ja200551y","title":"Predictable Stereoselective and Chemoselective Hydroxylations and Epoxidations with P450 3A4","year":2011,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Chemistry; Hydroxylation; Stereoselectivity; Selectivity; Substrate (aquarium); Enantioselective synthesis; Enzyme; Stereochemistry; Chemical synthesis; Combinatorial chemistry; Organic chemistry; Biochemistry; Catalysis","score_opus":0.05675445811163024,"score_gpt":0.35489680026309794,"score_spread":0.29814234215146773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332608279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396402,0.0011424442,0.044629358,0.0004473861,0.000076409095,0.00014932422,0.0003619101,0.00041529257,0.013137625],"genre_scores_gemma":[0.98754454,0.000801427,0.008329018,0.000053616943,0.000022515407,0.00003957985,0.00014594138,0.000046364352,0.0030170868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977833,0.00004657619,0.000018314937,0.000047990652,0.000053838605,0.000054841814],"domain_scores_gemma":[0.99989355,0.000017505672,0.00004148577,0.000022395863,0.00001260295,0.000012407275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045255778,0.00044599152,0.00022585285,0.00018857975,0.00017566197,0.00026131736,0.00030983592,0.00022112567,0.000926659],"category_scores_gemma":[0.00034620147,0.00021877499,0.00024812433,0.00023035138,0.0002973044,0.00042562748,0.00044310378,0.0007477956,0.00050989597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015206415,0.00008326581,0.00028720064,0.000053400614,0.000010118548,0.00016624719,0.000038023616,0.0006416406,0.98766965,0.0017821515,0.00019857755,0.00891764],"study_design_scores_gemma":[0.00001912808,0.00026496896,0.00028886466,0.0000021459005,0.0000063851876,0.00008317327,0.0000073187975,0.0010721576,0.9956656,0.00015337406,0.0024305042,0.000006303574],"about_ca_topic_score_codex":0.00037195857,"about_ca_topic_score_gemma":0.00074513414,"teacher_disagreement_score":0.000926659,"about_ca_system_score_codex":0.00026156014,"about_ca_system_score_gemma":0.00023983292,"threshold_uncertainty_score":0.0031000376},"labels":[],"label_agreement":null},{"id":"W2333953760","doi":"10.5414/cpp38061","title":"Interethnic differences of drug-metabolizing enzymes","year":2000,"lang":"en","type":"review","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Pharmacogenetics; Biology; Ethnic group; Population; Genetics; Allele; Genotype; Phenotype; Drug; Population genetics; Evolutionary biology; Gene; Pharmacology; Medicine; Environmental health","score_opus":0.37425123815277705,"score_gpt":0.5991028266829549,"score_spread":0.22485158853017784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333953760","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868406,0.003936077,0.0014551234,0.00016756299,0.000042313906,0.000011399674,0.0005842803,0.000015673908,0.006946853],"genre_scores_gemma":[0.99766904,0.00087284984,0.00033363857,0.000040261286,0.000014540317,0.0000057536845,0.00028665244,0.000008659052,0.0007684778],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995303,0.00012779712,0.000062389816,0.00013607966,0.0000861381,0.000057188263],"domain_scores_gemma":[0.9993173,0.00017985923,0.00020862445,0.00009644034,0.00012234783,0.00007551691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885533,0.00011440655,0.00025938218,0.0003740512,0.00026594056,0.00052418275,0.00013164709,0.00016474185,0.0021209356],"category_scores_gemma":[0.0013273932,0.00008185209,0.0002217208,0.0007194949,0.0001629033,0.00018961595,0.00027605655,0.00023978333,0.00034830908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006390257,0.00010643817,0.9039592,0.0001147709,0.00074300397,0.00063898356,0.0017542053,0.00014926154,0.041066222,0.001957652,0.0006613067,0.048209827],"study_design_scores_gemma":[0.0000033542779,0.00007291547,0.9939314,0.000009802025,0.00009297294,0.0005471468,0.000254191,0.0001229206,0.0016277782,0.00030353185,0.0030275763,0.000006451121],"about_ca_topic_score_codex":0.0020132766,"about_ca_topic_score_gemma":0.002307426,"teacher_disagreement_score":0.0021209356,"about_ca_system_score_codex":0.00012303481,"about_ca_system_score_gemma":0.00012009879,"threshold_uncertainty_score":0.0070952773},"labels":[],"label_agreement":null},{"id":"W2334285469","doi":"10.1097/fpc.0000000000000051","title":"Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort","year":2014,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; CYP2D6; Phenytoin; Pharmacology; Medicine; Metabolite; Pharmacogenetics; Active metabolite; Therapeutic drug monitoring; Drug interaction; CYP2C9; Genotype; Drug; Internal medicine; Cytochrome P450; Epilepsy; Pharmacokinetics; Biology; Metabolism; Genetics; Cancer; Psychiatry; Breast cancer","score_opus":0.05976936688541686,"score_gpt":0.36975667885828867,"score_spread":0.3099873119728718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334285469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998569,0.00014952329,0.000085096406,0.0001224539,0.000010438053,0.000007926923,0.00008618691,0.000007852188,0.0009614519],"genre_scores_gemma":[0.9995425,0.00006419572,0.00004518612,0.000083047395,0.000013686711,0.0000016103826,0.000052154035,0.0000028855377,0.00019480987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998454,0.000019361101,0.000016076883,0.00004365535,0.000038309838,0.000037275782],"domain_scores_gemma":[0.9997241,0.000077153345,0.000053805605,0.00001949617,0.000024915087,0.000100542624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104179555,0.00028023127,0.00037055663,0.00062429474,0.00043144825,0.00032571674,0.00015801513,0.0005305796,0.0015063701],"category_scores_gemma":[0.0008360983,0.00014902011,0.0003057859,0.00031208844,0.00024776923,0.00022473156,0.00024210193,0.00059609895,0.00020840524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017262336,0.00037701655,0.679958,0.000040067465,0.000100658144,0.27666387,0.0010691843,0.00019507417,0.023691684,0.00019082225,0.0006279838,0.0153595535],"study_design_scores_gemma":[0.000043955755,0.001612576,0.750723,0.0000093292965,0.00009000301,0.24254239,0.0005412168,0.00057210354,0.0025433481,0.00013116197,0.001168437,0.000022493201],"about_ca_topic_score_codex":0.0023245488,"about_ca_topic_score_gemma":0.0017332564,"teacher_disagreement_score":0.0023245488,"about_ca_system_score_codex":0.0002692126,"about_ca_system_score_gemma":0.0001558875,"threshold_uncertainty_score":0.0050392747},"labels":[],"label_agreement":null},{"id":"W2334920908","doi":"10.1039/c5ra25948g","title":"Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: key intermediate of ticagrelor","year":2016,"lang":"en","type":"article","venue":"RSC Advances","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Ticagrelor; Ketone; Chemistry; Enantioselective synthesis; Combinatorial chemistry; Organic chemistry; Aspirin; Catalysis; Biochemistry; Clopidogrel","score_opus":0.05125154224645446,"score_gpt":0.3829456032737171,"score_spread":0.3316940610272626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334920908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384659,0.003009382,0.046370957,0.0004153826,0.00012580378,0.00010903662,0.0003596464,0.00030792446,0.010835867],"genre_scores_gemma":[0.98681694,0.0011841649,0.009194579,0.00004025329,0.000011365879,0.000029288101,0.0001598179,0.00001765156,0.0025459249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979204,0.00003281508,0.000014539944,0.000040745625,0.000055885586,0.000063947504],"domain_scores_gemma":[0.9999578,0.000006571426,0.000012902034,0.0000056551535,0.00000909442,0.000008065483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027339565,0.00040517747,0.00024430268,0.0002244917,0.00013615767,0.00019608485,0.00035365883,0.0002976047,0.00054374867],"category_scores_gemma":[0.00014937192,0.00012969351,0.0002765953,0.00015129043,0.00015785145,0.00023468207,0.0002482088,0.0004880197,0.00034049441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052492087,0.000035213736,0.00008617421,0.00006528791,0.000009157432,0.00016863566,0.000028455152,0.0002702106,0.99486804,0.0005885519,0.00012590709,0.0037018717],"study_design_scores_gemma":[0.0000057898287,0.00007886308,0.00020112615,0.0000018846147,0.000008247524,0.00015185679,0.000008419991,0.00069440785,0.9976229,0.00003760541,0.0011841478,0.000004784462],"about_ca_topic_score_codex":0.00087513577,"about_ca_topic_score_gemma":0.0015321836,"teacher_disagreement_score":0.00087513577,"about_ca_system_score_codex":0.00031080365,"about_ca_system_score_gemma":0.00032286346,"threshold_uncertainty_score":0.0022550821},"labels":[],"label_agreement":null},{"id":"W2339975648","doi":"10.1016/s0090-9556(24)15124-0","title":"Population-Specific Polymorphisms of the Human FMO3 Gene: Significance for Detoxication","year":2000,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Trimethylamine; Flavin-containing monooxygenase; Monooxygenase; Population; Biology; Biochemistry; Chemistry; Trimethylamine N-oxide; Genetics; Cytochrome P450; Metabolism; Medicine","score_opus":0.045134006950044464,"score_gpt":0.36369729166876735,"score_spread":0.31856328471872286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339975648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734974,0.00036617747,0.0012285756,0.00018559113,0.000010059193,0.0000055068235,0.00013974181,0.000013913933,0.0007005904],"genre_scores_gemma":[0.9992194,0.0000807347,0.00028402547,0.000027141486,0.000011892469,0.0000029502983,0.00008408686,0.0000057929697,0.00028395967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998229,0.0000656403,0.000013544969,0.00005481022,0.00002208476,0.00002097876],"domain_scores_gemma":[0.99960786,0.00021805971,0.0000708128,0.000044192482,0.000025404726,0.000033725577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030203984,0.00027274113,0.0002815945,0.00038049452,0.00023757524,0.00023073408,0.00016991177,0.00038359515,0.002399124],"category_scores_gemma":[0.0008080459,0.00009790595,0.0003005837,0.000331182,0.0002502409,0.00013997094,0.000118557226,0.00039714703,0.00014712408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043341657,0.00023130764,0.80436474,0.000055950408,0.00061038404,0.0025714189,0.0005795397,0.0006915034,0.15005513,0.00173291,0.00050990743,0.034262996],"study_design_scores_gemma":[0.000055731947,0.00026549608,0.9858261,0.0000091258935,0.0002290547,0.0024715555,0.0001304624,0.001303281,0.007679301,0.00092875684,0.0010904572,0.000010712714],"about_ca_topic_score_codex":0.0014605854,"about_ca_topic_score_gemma":0.00094507186,"teacher_disagreement_score":0.002399124,"about_ca_system_score_codex":0.00012981502,"about_ca_system_score_gemma":0.00013522983,"threshold_uncertainty_score":0.008025825},"labels":[],"label_agreement":null},{"id":"W2339993263","doi":"10.71781/30903","title":"Rôles des polymorphismes génétiques dans la détermination de la dose individuelle de la warfarine chez les patients traités avec de l’amiodarone","year":2011,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.07916486725684223,"score_gpt":0.4349378641577295,"score_spread":0.35577299690088726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339993263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203473,0.003877327,0.0013393271,0.0006594873,0.0000490882,0.000015044448,0.0003637956,0.000022062193,0.0016390495],"genre_scores_gemma":[0.9980432,0.0005265997,0.0007037378,0.00011997287,0.000032358603,0.000010170596,0.000116280025,0.0000072850926,0.00044041098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989644,0.00043173716,0.00011122516,0.00024014809,0.00017380493,0.00007866545],"domain_scores_gemma":[0.9978848,0.0010416865,0.00069703284,0.000100572644,0.00016753438,0.0001082799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008762455,0.00037254515,0.0004195561,0.0007883707,0.00034705037,0.00089085253,0.000277363,0.0008168809,0.0020457297],"category_scores_gemma":[0.003730077,0.00016852898,0.0005630385,0.0008807585,0.00046999863,0.00032750497,0.00019904338,0.0005932782,0.00034454445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009480805,0.000053067186,0.97357666,0.000044616954,0.00029517766,0.0007773258,0.00026047797,0.00021191135,0.00498657,0.00024440396,0.0002527684,0.018348986],"study_design_scores_gemma":[0.00003086207,0.00033658257,0.9912475,0.000051690993,0.00020037862,0.0039373143,0.00018323968,0.00074835797,0.001436441,0.00047712392,0.0013333082,0.000017265655],"about_ca_topic_score_codex":0.0023721096,"about_ca_topic_score_gemma":0.0013973995,"teacher_disagreement_score":0.0023721096,"about_ca_system_score_codex":0.00032289454,"about_ca_system_score_gemma":0.0003871285,"threshold_uncertainty_score":0.0068436265},"labels":[],"label_agreement":null},{"id":"W2342699699","doi":"10.1097/ftd.0000000000000192","title":"Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy","year":2015,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Child and Family Research Institute; University of Toronto; SickKids Foundation; BC Children's Hospital; Centre Hospitalier de l’Université de Montréal; Hospital for Sick Children; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; London Health Sciences Centre","keywords":"Warfarin; VKORC1; Medicine; Dosing; CYP2C9; Pharmacogenetics; Vitamin K epoxide reductase; Genetic testing; Intensive care medicine; Adverse effect; Internal medicine; Genotype; Atrial fibrillation","score_opus":0.5431120409138199,"score_gpt":0.5915064735913468,"score_spread":0.048394432677526855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342699699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012431082,0.8136934,0.005314974,0.15714522,0.0097099915,0.001035712,0.0017729196,0.00022089828,0.009863838],"genre_scores_gemma":[0.017709209,0.8718467,0.041475996,0.05837053,0.0037896486,0.002282285,0.002081505,0.000096768,0.0023474316],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.96051115,0.01762435,0.011766316,0.0023055684,0.006738224,0.0010543814],"domain_scores_gemma":[0.8510983,0.090009734,0.0140802665,0.0024922856,0.039396495,0.002922973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036990225,0.0020143709,0.0047488515,0.008517768,0.0017255191,0.005107842,0.00533388,0.009048045,0.0101036895],"category_scores_gemma":[0.14996879,0.0014748296,0.006114204,0.006176545,0.002433362,0.005291303,0.004115902,0.007504043,0.0038914776],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037525053,0.00021342881,0.0028100987,0.18238808,0.002440568,0.00056070247,0.0016767947,0.0015895708,0.0005793008,0.007757182,0.26079997,0.5388091],"study_design_scores_gemma":[0.00053117075,0.00019326794,0.0028264823,0.5219597,0.0043130517,0.00054939114,0.0009555886,0.0005315607,0.00032288214,0.013407941,0.45424652,0.0001623751],"about_ca_topic_score_codex":0.012996405,"about_ca_topic_score_gemma":0.019361941,"teacher_disagreement_score":0.036990225,"about_ca_system_score_codex":0.0056433906,"about_ca_system_score_gemma":0.023447962,"threshold_uncertainty_score":0.19562536},"labels":[],"label_agreement":null},{"id":"W2343284837","doi":"10.1160/th15-12-0955","title":"An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance","year":2016,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; U.S. Air Force","keywords":"Dosing; Warfarin; VKORC1; Pharmacogenomics; Medicine; CYP2C9; Pharmacogenetics; Cohort; Internal medicine; Pharmacology; Genotype; Biology; Atrial fibrillation; Gene","score_opus":0.19519330878989577,"score_gpt":0.44106752954293865,"score_spread":0.24587422075304288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343284837","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07740742,0.0032437549,0.65635234,0.0074540395,0.000535661,0.0014286569,0.17163035,0.05444244,0.027505353],"genre_scores_gemma":[0.26171258,0.0012676724,0.65075,0.0021462594,0.00031635538,0.0007107621,0.07743931,0.0023058043,0.0033512719],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99412656,0.0023537187,0.0008313944,0.0010154779,0.0015422482,0.00013056457],"domain_scores_gemma":[0.96608824,0.021921493,0.0024167062,0.0050675306,0.004134249,0.0003718571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008705445,0.00062552013,0.0011472147,0.0027796954,0.00040496048,0.0032857351,0.0011659185,0.0011529751,0.009856746],"category_scores_gemma":[0.0481167,0.00058952393,0.0010676825,0.0031114686,0.0003101205,0.0014400752,0.0012567012,0.0014325285,0.0031790093],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017538554,0.00028182828,0.07131769,0.00077879423,0.00048731425,0.0004547422,0.0004002582,0.08624587,0.0036528497,0.015377158,0.15099172,0.66825795],"study_design_scores_gemma":[0.0016437365,0.00050559215,0.04912922,0.00088434067,0.0004477254,0.0013527463,0.00014683467,0.458123,0.011944348,0.041663874,0.4337601,0.0003985321],"about_ca_topic_score_codex":0.013974298,"about_ca_topic_score_gemma":0.013645382,"teacher_disagreement_score":0.013974298,"about_ca_system_score_codex":0.0013315255,"about_ca_system_score_gemma":0.0033345306,"threshold_uncertainty_score":0.046039402},"labels":[],"label_agreement":null},{"id":"W2343497810","doi":"10.1097/fpc.0000000000000182","title":"Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations","year":2015,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"Biomedical Research Council; National Medical Research Council; Medical Research Council; National University of Singapore; Agency for Science, Technology and Research","keywords":"Pharmacogenomics; Genetic diversity; Population; Biology; Genetics; Evolutionary biology; Medicine; Environmental health","score_opus":0.16080492077681025,"score_gpt":0.3984915745155805,"score_spread":0.23768665373877024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343497810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988632,0.0002253578,0.00019639624,0.000034080866,0.0000022078348,0.0000068121767,0.00016847931,0.000003929999,0.00049955084],"genre_scores_gemma":[0.99918824,0.00017335596,0.00027851103,0.000018897126,0.0000044951435,0.000009347871,0.00025261537,0.0000024688525,0.000072082556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992261,0.00021122527,0.00009940079,0.0002658972,0.0001109663,0.000086371525],"domain_scores_gemma":[0.99923635,0.0002261196,0.00027772022,0.00008724357,0.000097241886,0.000075483724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086543534,0.0002794285,0.00033335088,0.0011986649,0.0005238633,0.000638904,0.00033190963,0.000316871,0.0018204483],"category_scores_gemma":[0.0013975551,0.00014864729,0.0005435536,0.0015800039,0.000651755,0.00020443849,0.00047723227,0.000325672,0.00014754864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020216049,0.00002312874,0.9793331,0.00005064801,0.0006624078,0.00044612115,0.0016394736,0.00037912285,0.006415876,0.00030861824,0.00015770453,0.010381605],"study_design_scores_gemma":[0.000010149763,0.00007186783,0.99775475,0.00001697881,0.00010304265,0.00043941496,0.0006830621,0.0002318911,0.00022510234,0.00012229304,0.00032971165,0.000011740819],"about_ca_topic_score_codex":0.009110206,"about_ca_topic_score_gemma":0.009492987,"teacher_disagreement_score":0.009110206,"about_ca_system_score_codex":0.00036288935,"about_ca_system_score_gemma":0.0003089902,"threshold_uncertainty_score":0.018114388},"labels":[],"label_agreement":null},{"id":"W2343915366","doi":"10.1007/s00204-016-1720-0","title":"2,3,7,8 Tetrachlorodibenzo-p-dioxin-induced RNA abundance changes identify Ackr3, Col18a1, Cyb5a and Glud1 as candidate mediators of toxicity","year":2016,"lang":"en","type":"article","venue":"Archives of Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Terry Fox Research Institute; Ontario Institute for Cancer Research; Academy of Finland; Canadian Institutes of Health Research; Dow Chemical Company","keywords":"Toxicity; Abundance (ecology); RNA; Chemistry; Biology; Medicine; Internal medicine; Biochemistry; Ecology; Gene","score_opus":0.05451493813368015,"score_gpt":0.3978568858871757,"score_spread":0.3433419477534956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343915366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954733,0.0014113393,0.0014013555,0.000066717,0.000012889771,0.000016387794,0.001016934,0.000039547747,0.00056138344],"genre_scores_gemma":[0.9919137,0.0011755927,0.0024231726,0.00013089125,0.000010161542,0.00004528803,0.0019336127,0.000017191429,0.0023504624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.000010274303,0.000008873828,0.000050007697,0.00002572313,0.00003280292],"domain_scores_gemma":[0.9998796,0.00001392756,0.00005055567,0.000007486776,0.000019139423,0.000029219947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099994846,0.0003145669,0.00017632585,0.0003668028,0.000121693694,0.00018625116,0.00012350417,0.00021208567,0.00077637663],"category_scores_gemma":[0.00009936731,0.00011775806,0.00026276064,0.00022279097,0.00023292635,0.00014526713,0.00016567962,0.00023006582,0.0002489162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102135025,0.00000994949,0.0036134466,0.000030003797,0.000004554813,0.000039987688,0.000012791686,0.000021448615,0.9953863,0.000021136597,0.000019175146,0.00073908514],"study_design_scores_gemma":[0.00001935068,0.00040755028,0.35733786,0.000015717069,0.000057192676,0.00042871645,0.00018945674,0.00081294274,0.6390012,0.00009438115,0.0016239182,0.000011685205],"about_ca_topic_score_codex":0.00060249335,"about_ca_topic_score_gemma":0.0012452874,"teacher_disagreement_score":0.00077637663,"about_ca_system_score_codex":0.00019146872,"about_ca_system_score_gemma":0.00013281277,"threshold_uncertainty_score":0.0025972724},"labels":[],"label_agreement":null},{"id":"W2346762247","doi":"10.1007/s40272-016-0176-2","title":"Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine","year":2016,"lang":"en","type":"review","venue":"Pediatric Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacogenetics; Personalized medicine; Population; Dosing; Clinical trial; Intensive care medicine; Bioinformatics; Oncology; Pharmacology; Internal medicine; Genetics; Genotype; Biology","score_opus":0.124043814483962,"score_gpt":0.4609432757484127,"score_spread":0.3368994612644507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346762247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022726072,0.4003518,0.16642559,0.37459126,0.003280158,0.00026685875,0.0047854404,0.0012472537,0.02632556],"genre_scores_gemma":[0.27168107,0.40082163,0.21467823,0.08689729,0.015268817,0.0005588531,0.0042451755,0.00050396385,0.005345075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598134,0.0027179474,0.00022080986,0.00046662023,0.0005003508,0.00011298178],"domain_scores_gemma":[0.9878056,0.008340194,0.0009634425,0.00083604455,0.0015248323,0.00052987627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068886233,0.0005892307,0.0018770267,0.001605634,0.0003427944,0.0025820069,0.0009826565,0.0017002182,0.0033914074],"category_scores_gemma":[0.018766671,0.000354907,0.0012573441,0.0014626029,0.00081291446,0.0022603655,0.0023789124,0.007352122,0.0011089029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039569428,0.0001877227,0.062162008,0.0025967907,0.0015096874,0.0010520628,0.0009058228,0.0037398506,0.0023911702,0.034773853,0.101150736,0.78913456],"study_design_scores_gemma":[0.000272805,0.0005338589,0.05852592,0.009164292,0.0018608875,0.003401256,0.0012625298,0.00830958,0.0026063914,0.23608872,0.6777902,0.00018343299],"about_ca_topic_score_codex":0.0025822695,"about_ca_topic_score_gemma":0.002714189,"teacher_disagreement_score":0.0068886233,"about_ca_system_score_codex":0.0014768927,"about_ca_system_score_gemma":0.0024146847,"threshold_uncertainty_score":0.036430955},"labels":[],"label_agreement":null},{"id":"W2368041099","doi":"10.1186/s12885-016-2342-x","title":"Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Tamoxifen; Surgical oncology; Ulcerative colitis; Active metabolite; Breast cancer; Metabolite; Internal medicine; Oncology; Pharmacology; Cancer; Disease","score_opus":0.0957907317281902,"score_gpt":0.43403624439900496,"score_spread":0.33824551267081476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368041099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680606,0.0124084735,0.0025964135,0.006393972,0.00044686013,0.00017720081,0.00026775847,0.00015587456,0.009492908],"genre_scores_gemma":[0.99364436,0.002588126,0.000804531,0.0011903467,0.0006179529,0.000015150736,0.00007278168,0.00002318349,0.0010435167],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993376,0.00008972914,0.000072370734,0.00019634752,0.00010809783,0.00019586612],"domain_scores_gemma":[0.99870265,0.00031815062,0.00035810046,0.00007637072,0.000101056925,0.00044366863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026335355,0.0013240605,0.0012593936,0.0020927647,0.002145298,0.0015861281,0.00077255664,0.004148057,0.0020010981],"category_scores_gemma":[0.0023343484,0.0010277414,0.0011713203,0.0011938575,0.0011495666,0.0018035861,0.0010611351,0.0032488373,0.00062133156],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026196818,0.000028902177,0.0052973162,0.000019376823,0.0000069838165,0.99317497,0.00015866589,0.000027883789,0.00042020754,0.00004547918,0.00019411843,0.00059984444],"study_design_scores_gemma":[0.0000050546582,0.00005244099,0.0030836044,0.000013513686,0.000012312322,0.99602985,0.00012349075,0.00010874319,0.00018326988,0.000046316323,0.0003336684,0.00000773647],"about_ca_topic_score_codex":0.0032449332,"about_ca_topic_score_gemma":0.0037628154,"teacher_disagreement_score":0.004148057,"about_ca_system_score_codex":0.0011898096,"about_ca_system_score_gemma":0.0007313333,"threshold_uncertainty_score":0.0086327195},"labels":[],"label_agreement":null},{"id":"W2395881780","doi":"10.1159/000457103","title":"Hydroxylation and Glucuronidation of Various Xenobiotics by Hepatic Microsomes from the Fetal Lamb, Pregnant Ewe and Human Fetus","year":2017,"lang":"en","type":"article","venue":"Developmental Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute on Drug Abuse","keywords":"Microsome; Glucuronidation; Hexobarbital; Fetus; Hydroxylation; Chemistry; Cytochrome; Biotransformation; Microsoma; Drug metabolism; Internal medicine; Xenobiotic; Endocrinology; Cytochrome P450; Pharmacology; Metabolism; Biochemistry; Biology; Pregnancy; Enzyme; Medicine","score_opus":0.05451451887463708,"score_gpt":0.3804349613715216,"score_spread":0.3259204424968845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395881780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940673,0.0026377211,0.0016397847,0.00009953221,0.000013716378,0.000021569222,0.00052122236,0.000016724707,0.0009823767],"genre_scores_gemma":[0.9929819,0.0017623453,0.0015950992,0.000031140782,0.0000111720565,0.000026211666,0.0017272244,0.00001046126,0.0018544035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991703,0.000025176858,0.000009499811,0.000019288527,0.00001619907,0.000012774253],"domain_scores_gemma":[0.99990773,0.00003051844,0.00001556317,0.000017157588,0.000015829513,0.0000130912895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017551298,0.00020151211,0.00016216622,0.0002619874,0.00013225507,0.00016805384,0.00007045313,0.00014512174,0.0008907172],"category_scores_gemma":[0.00046940878,0.00014466485,0.00015472279,0.00013598628,0.00021086997,0.00014818269,0.0001585157,0.00020236915,0.0003037682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014096794,0.000036668887,0.0130926,0.00009815012,0.000042828182,0.0007470276,0.0003337128,0.00009388784,0.97106624,0.0002884259,0.00015525999,0.012635562],"study_design_scores_gemma":[0.000064770305,0.0011227014,0.21330062,0.00003827733,0.0002197029,0.005554578,0.0005292242,0.00082171586,0.7694909,0.00034427887,0.008492358,0.000020962047],"about_ca_topic_score_codex":0.0015662644,"about_ca_topic_score_gemma":0.0012816205,"teacher_disagreement_score":0.0015662644,"about_ca_system_score_codex":0.00012363873,"about_ca_system_score_gemma":0.00014558787,"threshold_uncertainty_score":0.0031143427},"labels":[],"label_agreement":null},{"id":"W2397350160","doi":"10.1385/0-89603-519-0:95","title":"Catalytic Assays for Human Cytochrome P450","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Cytochrome P450; Enzyme; Biochemistry; Biology; Chemistry; Endogeny","score_opus":0.3289435275482273,"score_gpt":0.48429325091120573,"score_spread":0.15534972336297842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397350160","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12160544,0.056530576,0.6847263,0.0023919016,0.0056893155,0.008831059,0.019352548,0.008726663,0.09214622],"genre_scores_gemma":[0.27460322,0.03958231,0.46664223,0.002464062,0.0017238152,0.009660469,0.07238554,0.0010641901,0.13187414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9924446,0.0026547187,0.00060359057,0.0011929179,0.0025288837,0.00057527854],"domain_scores_gemma":[0.9977469,0.0005219166,0.0002008481,0.0004647023,0.0008587013,0.00020680753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003701097,0.002124676,0.0010124785,0.0021442203,0.0007084021,0.0011653972,0.0014967582,0.0017914574,0.016107718],"category_scores_gemma":[0.0037600405,0.0008399892,0.0011267258,0.0022000545,0.0005547836,0.0007363622,0.0009513104,0.0027229658,0.013381733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082489377,0.00083406956,0.0022150958,0.0016424761,0.00017981032,0.00018454988,0.00018923542,0.000321278,0.90737474,0.0031947538,0.014960885,0.06807822],"study_design_scores_gemma":[0.00040408902,0.0021216795,0.006378748,0.00027085026,0.00026203404,0.001372902,0.00008083414,0.0023213327,0.76933116,0.0012168703,0.21616793,0.0000715284],"about_ca_topic_score_codex":0.00084723555,"about_ca_topic_score_gemma":0.0015207604,"teacher_disagreement_score":0.016107718,"about_ca_system_score_codex":0.000648903,"about_ca_system_score_gemma":0.0007283874,"threshold_uncertainty_score":0.05388564},"labels":[],"label_agreement":null},{"id":"W2398743016","doi":"10.1385/0-89603-519-0:103","title":"Enzymatic Analysis of cDNA-Expressed Human CYPIAI, CYPlA2, and CYPIBI with 7-Ethoxyresorufin as Substrate","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Complementary DNA; Substrate (aquarium); Enzyme; Biochemistry; Chemistry; Molecular biology; Biology; Gene","score_opus":0.17159127623285714,"score_gpt":0.431553775192021,"score_spread":0.25996249895916385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398743016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87547535,0.016138474,0.06477671,0.0010275515,0.00074331695,0.0007600506,0.02713762,0.0007649773,0.0131760035],"genre_scores_gemma":[0.75408435,0.012092061,0.064875245,0.000453454,0.0005650645,0.0007870105,0.117405675,0.0005168493,0.04922024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999595,0.000059316957,0.00003322186,0.00010332706,0.00012012401,0.00008903596],"domain_scores_gemma":[0.9997204,0.00007321374,0.000039212304,0.00004123162,0.00008046932,0.00004554098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046378115,0.00070910493,0.0006294702,0.00064509816,0.0005306481,0.0006897026,0.0003556057,0.00044157484,0.0033232807],"category_scores_gemma":[0.00040313916,0.00033834565,0.0008524501,0.001046436,0.00032038163,0.00030379742,0.00022044823,0.0010069525,0.0030009826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014135342,0.000055573626,0.00027667347,0.000103540624,0.000016981423,0.000074480144,0.000046351342,0.00010412248,0.9964978,0.00027151522,0.00017715123,0.0022344373],"study_design_scores_gemma":[0.00008709801,0.00048881717,0.009029266,0.000026071406,0.00010344526,0.00079659483,0.00010755762,0.002527561,0.9583086,0.0002010179,0.028298875,0.000025084679],"about_ca_topic_score_codex":0.0017852071,"about_ca_topic_score_gemma":0.0023004462,"teacher_disagreement_score":0.0033232807,"about_ca_system_score_codex":0.0006013196,"about_ca_system_score_gemma":0.000602101,"threshold_uncertainty_score":0.011117518},"labels":[],"label_agreement":null},{"id":"W2399384755","doi":"10.1385/1-59259-998-2:133","title":"Thin-Layer Chromatography Analysis of Human CYP3A-Catalyzed Testosterone 6β-Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Hydroxylation; Chromatography; Thin-layer chromatography; Chemistry; Metabolite; CYP3A; Cytochrome P450; Microsome; Chloroform; Testosterone (patch); Enzyme; Silica gel; Steroid; Acetone; Biochemistry; Biology; Hormone; Endocrinology","score_opus":0.1476660952029309,"score_gpt":0.41649429899779833,"score_spread":0.26882820379486744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399384755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8383056,0.03917746,0.07996189,0.0007044162,0.0005144326,0.0008810491,0.008663852,0.0024238823,0.029367434],"genre_scores_gemma":[0.87191737,0.026672233,0.056422777,0.0009214424,0.00037373003,0.0005890874,0.017384695,0.0005242826,0.02519435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999785,0.00003765522,0.000011764799,0.000034952587,0.000096416115,0.0000341549],"domain_scores_gemma":[0.99954116,0.000101519625,0.00004160171,0.00003197593,0.00020204438,0.00008170894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004202576,0.00075233774,0.0004155213,0.0014526498,0.00062789355,0.00035224328,0.00030349955,0.00032152326,0.003398587],"category_scores_gemma":[0.0007935994,0.00023622725,0.00034960106,0.00090858573,0.00024753832,0.00012940717,0.00015156665,0.00053262716,0.0016011008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031793525,0.00010274715,0.0014691675,0.0001242245,0.00007391881,0.00021159733,0.000089895686,0.000095766125,0.9882117,0.0002181352,0.00041752344,0.008667415],"study_design_scores_gemma":[0.000052093015,0.00046214857,0.024301669,0.000037038353,0.00022162146,0.0008877362,0.00008341805,0.0011970783,0.9549719,0.00015225254,0.017605765,0.000027082675],"about_ca_topic_score_codex":0.004556745,"about_ca_topic_score_gemma":0.005021324,"teacher_disagreement_score":0.004556745,"about_ca_system_score_codex":0.0003281031,"about_ca_system_score_gemma":0.00065743807,"threshold_uncertainty_score":0.011369467},"labels":[],"label_agreement":null},{"id":"W2401995582","doi":"10.1385/0-89603-519-0:135","title":"CYP2Cl g-Mediated (S)-Mephenytoin 4'-Hydroxylation Assayed by High-Performance Liquid Chromatography with Radiometric Detection","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Mephenytoin; Chromatography; Chemistry; Hydroxylation; High-performance liquid chromatography; Methanol; CYP2C19; Enzyme; Biochemistry; Cytochrome P450; Organic chemistry","score_opus":0.0635677270666119,"score_gpt":0.33677805400717536,"score_spread":0.27321032694056346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401995582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6559464,0.019909786,0.28444442,0.00094487116,0.00051544496,0.0017127674,0.008728627,0.0057012946,0.022096412],"genre_scores_gemma":[0.68657464,0.010875621,0.21989153,0.00087150163,0.0004905185,0.0023369014,0.026083095,0.0006842553,0.05219194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986921,0.0003525259,0.00007283071,0.00029978977,0.0003745743,0.00020822547],"domain_scores_gemma":[0.99942696,0.00015038584,0.000097383134,0.00006183263,0.00018997375,0.00007345076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100352,0.0017897306,0.0009886553,0.0011033944,0.0006005945,0.0005004005,0.00084247044,0.00080261345,0.007257454],"category_scores_gemma":[0.00090835383,0.00049829716,0.0005991688,0.0010027254,0.00053672487,0.000495926,0.00051389256,0.0012902692,0.005492988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029548962,0.0001676962,0.0008433602,0.00021550532,0.000062196246,0.00007866242,0.00003773494,0.00016917079,0.9892163,0.0002435265,0.0005921722,0.008078269],"study_design_scores_gemma":[0.00008022439,0.00075395836,0.008310751,0.000023541905,0.000076050026,0.00046966114,0.000018821584,0.0046678237,0.9778765,0.000103972554,0.0075941393,0.00002454877],"about_ca_topic_score_codex":0.0023427645,"about_ca_topic_score_gemma":0.0031837984,"teacher_disagreement_score":0.007257454,"about_ca_system_score_codex":0.00075294374,"about_ca_system_score_gemma":0.001010957,"threshold_uncertainty_score":0.02427864},"labels":[],"label_agreement":null},{"id":"W2403825736","doi":"","title":"Drug interactions: gasoline and matches.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drug; Gasoline; Pharmacology; Waste management","score_opus":0.11604160581165397,"score_gpt":0.39556564523079424,"score_spread":0.2795240394191403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403825736","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17682293,0.42018607,0.045706317,0.018559327,0.004720691,0.00077456766,0.036912307,0.0018968522,0.29442096],"genre_scores_gemma":[0.79962987,0.094380386,0.025694132,0.0044671427,0.0024638164,0.00033175322,0.008993592,0.00019375906,0.063845664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982703,0.0008081933,0.0002293571,0.00019949196,0.00039408353,0.00009855395],"domain_scores_gemma":[0.99707603,0.0016819527,0.0006661899,0.00019383644,0.00026917865,0.00011272572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011509857,0.0005286144,0.00075838994,0.0023127066,0.00037584107,0.0010075163,0.0007006317,0.00087950437,0.038736064],"category_scores_gemma":[0.010868079,0.0001522804,0.00076797523,0.0041427505,0.00043988088,0.0019376057,0.0007528533,0.00044531177,0.004275504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004632006,0.00028208946,0.036918253,0.0066037844,0.0012496168,0.0024290595,0.00032014225,0.003365559,0.0023265837,0.065494195,0.10551384,0.77086484],"study_design_scores_gemma":[0.00043967977,0.0013845942,0.070277005,0.0032555799,0.0024246078,0.016322011,0.0009470836,0.013638029,0.004332297,0.17161036,0.7151994,0.00016941015],"about_ca_topic_score_codex":0.003898354,"about_ca_topic_score_gemma":0.006260488,"teacher_disagreement_score":0.038736064,"about_ca_system_score_codex":0.00053092535,"about_ca_system_score_gemma":0.0008754027,"threshold_uncertainty_score":0.12958509},"labels":[],"label_agreement":null},{"id":"W2407107523","doi":"10.1385/1-59259-998-2:73","title":"Catalytic Assays for Human Cytochrome P450: &lt;i&gt;An Introduction&lt;/i&gt;","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health","keywords":"CYP2A6; CYP2B6; Cytochrome P450; CYP2E1; CYP1A2; Enzyme; CYP2C9; Biochemistry; CYP3A4; CYP3A; CYP2C19; Monooxygenase; Chemistry; Biology","score_opus":0.12554574018984838,"score_gpt":0.40653773309797087,"score_spread":0.2809919929081225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407107523","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07467181,0.047968872,0.6943336,0.0033205973,0.0043351813,0.002975849,0.00864415,0.010056008,0.15369399],"genre_scores_gemma":[0.22569321,0.041622948,0.4585767,0.0024725948,0.0012892138,0.005125046,0.040272444,0.0013318502,0.22361599],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976108,0.0007134155,0.00019271561,0.00044775647,0.0008318208,0.00020342911],"domain_scores_gemma":[0.99896455,0.00030645687,0.0001165122,0.00015238345,0.0003745329,0.00008566576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013405745,0.0017120936,0.00053797255,0.00148158,0.00049433485,0.0006987732,0.0010503558,0.0015510833,0.020956047],"category_scores_gemma":[0.0014597594,0.0006613898,0.00072037725,0.0013625128,0.0004515258,0.0005929713,0.00057139737,0.002149662,0.017838426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034248433,0.00045389374,0.0019192129,0.001007773,0.000082946055,0.00024566075,0.00009993208,0.00022015322,0.867505,0.0037317325,0.028328415,0.096062735],"study_design_scores_gemma":[0.000110548535,0.0010402356,0.006359413,0.00021276603,0.00014951297,0.0019757813,0.000049344693,0.0016661818,0.73682874,0.0012649655,0.25029087,0.000051649455],"about_ca_topic_score_codex":0.000789521,"about_ca_topic_score_gemma":0.0017830865,"teacher_disagreement_score":0.020956047,"about_ca_system_score_codex":0.0005316082,"about_ca_system_score_gemma":0.00057250157,"threshold_uncertainty_score":0.07010496},"labels":[],"label_agreement":null},{"id":"W2409043673","doi":"","title":"Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier de l’Université de Montréal; Hospital for Sick Children","funders":"","keywords":"Codeine; Guideline; Medicine; CYP2D6; Genotyping; Pharmacology; Intensive care medicine; Internal medicine; Genotype; Genetics; Pathology; Biology","score_opus":0.17693871812523976,"score_gpt":0.4758073709523521,"score_spread":0.29886865282711234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409043673","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044057695,0.08004495,0.038737748,0.46757323,0.016797574,0.006667077,0.016269224,0.0025376796,0.36696666],"genre_scores_gemma":[0.038648583,0.09438401,0.18071032,0.5083251,0.010575208,0.0115055945,0.02883813,0.00072948856,0.12628351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99399984,0.00179768,0.0012406069,0.00025512118,0.0024005063,0.0003062821],"domain_scores_gemma":[0.98863065,0.003714827,0.0013225775,0.000292938,0.005342335,0.0006967499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041619833,0.0010837147,0.0018606182,0.0024208596,0.0011480893,0.0016771522,0.0037080492,0.013539287,0.010290564],"category_scores_gemma":[0.014887946,0.0007074198,0.0025236185,0.0018304426,0.0008732291,0.0013703705,0.0014374104,0.007261124,0.012744377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042286963,0.00013175323,0.00067105994,0.00088254514,0.00004109411,0.00068131427,0.00009960452,0.00037067506,0.0004355364,0.0020115965,0.92231214,0.07232031],"study_design_scores_gemma":[0.00029709478,0.00012758026,0.005480904,0.008099355,0.00016058287,0.003345413,0.00013974785,0.0008289698,0.00061842235,0.0049785147,0.9758589,0.000064513915],"about_ca_topic_score_codex":0.018716136,"about_ca_topic_score_gemma":0.039157934,"teacher_disagreement_score":0.018716136,"about_ca_system_score_codex":0.0022682145,"about_ca_system_score_gemma":0.0074419915,"threshold_uncertainty_score":0.0372144},"labels":[],"label_agreement":null},{"id":"W2411172204","doi":"10.1021/acs.biochem.5b00903","title":"Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies","year":2015,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Chemistry; Electron paramagnetic resonance; Pregnenolone; Photochemistry; Ferric; Ternary complex; Hydroxylation; Hyperfine structure; Ternary operation; Electron nuclear double resonance; Stereochemistry; Steroid; Inorganic chemistry; Organic chemistry; Nuclear magnetic resonance; Enzyme; Biochemistry","score_opus":0.2901483038949986,"score_gpt":0.44708533477791695,"score_spread":0.15693703088291833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411172204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964878,0.0057343845,0.019917676,0.0005846676,0.00009882482,0.00003569422,0.00043968644,0.0001353456,0.00817573],"genre_scores_gemma":[0.9878884,0.0020569526,0.005291318,0.0002309541,0.0000380835,0.00001958476,0.00077782647,0.000043445303,0.003653472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998646,0.000016833046,0.000007160221,0.0000479207,0.00003434445,0.000029209843],"domain_scores_gemma":[0.99972934,0.00004264823,0.00007598288,0.000055104556,0.00006442665,0.000032419946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002484382,0.00032375025,0.00018294169,0.00015520124,0.00022912365,0.00036405103,0.0004142263,0.00043043934,0.0017911488],"category_scores_gemma":[0.0003849471,0.00016014648,0.00027970172,0.00016292163,0.00047938744,0.00043236662,0.00024795713,0.00085229054,0.0005841127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086004766,0.000013291727,0.00060196576,0.000042537176,0.000012399228,0.00008159107,0.00003914532,0.000042322186,0.9975369,0.00025544074,0.000087182285,0.0012013173],"study_design_scores_gemma":[0.000005500255,0.00013018135,0.0033364107,0.000005037853,0.000023516583,0.0003611238,0.000034261488,0.00019360261,0.9936325,0.00008613789,0.002185589,0.000006174356],"about_ca_topic_score_codex":0.00096254126,"about_ca_topic_score_gemma":0.00072302413,"teacher_disagreement_score":0.0017911488,"about_ca_system_score_codex":0.00027086446,"about_ca_system_score_gemma":0.00016537975,"threshold_uncertainty_score":0.0059919953},"labels":[],"label_agreement":null},{"id":"W2411332481","doi":"10.1385/0-89603-519-0:111","title":"Spectrofluorometric Analysis of CYP2A6-Catalyzed Coumarin 7-Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2A6; Microsome; Hydroxylation; Biochemistry; Chemistry; Cytochrome P450; Enzyme; Biology; Molecular biology; CYP1A2","score_opus":0.21041274969693383,"score_gpt":0.4409976971898734,"score_spread":0.2305849474929396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411332481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8196832,0.012126944,0.13996352,0.0005180877,0.00045158455,0.00040806254,0.0056129014,0.0021431767,0.019092565],"genre_scores_gemma":[0.84986466,0.009675584,0.10900107,0.00031624062,0.0002558734,0.0008710516,0.00814398,0.00038918966,0.021482266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985013,0.00040792552,0.00006844133,0.00024163649,0.00062256877,0.00015813587],"domain_scores_gemma":[0.9991702,0.0002078695,0.00010913234,0.00007481311,0.0003539623,0.00008408656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010543384,0.0013447361,0.0009211641,0.0018073027,0.00075625663,0.0005280944,0.0007726737,0.0010097822,0.002921027],"category_scores_gemma":[0.00068884203,0.00034409738,0.0006398497,0.0018036377,0.0004663837,0.00038929423,0.00039386554,0.0017893482,0.0014145721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011852324,0.00008426322,0.0005383532,0.00009641966,0.000028937073,0.00003147239,0.00006314672,0.0001543005,0.99620974,0.00015254402,0.00018761518,0.0023346215],"study_design_scores_gemma":[0.00001546368,0.00022507797,0.005105909,0.000010389738,0.00004111506,0.000126408,0.000052160412,0.002584604,0.98950255,0.00007331923,0.0022510416,0.000011976878],"about_ca_topic_score_codex":0.0025575114,"about_ca_topic_score_gemma":0.0027512948,"teacher_disagreement_score":0.002921027,"about_ca_system_score_codex":0.001060208,"about_ca_system_score_gemma":0.00039934425,"threshold_uncertainty_score":0.009771764},"labels":[],"label_agreement":null},{"id":"W2411333350","doi":"10.1385/1-59259-998-2:153","title":"Use of 7-Ethoxycoumarin to Monitor Multiple Enzymes in the Human CYP1, CYP2, and CYP3 Families","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"Cytochrome P450; Enzyme; Microsome; Substrate (aquarium); Biochemistry; Complementary DNA; Chemistry; Cytochrome; Incubation; Chromatography; Biology; Gene","score_opus":0.251794121074398,"score_gpt":0.43181238978303627,"score_spread":0.18001826870863824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411333350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8354306,0.011510385,0.14184698,0.00033703298,0.00008948895,0.00024724132,0.0015329823,0.0006296818,0.008375505],"genre_scores_gemma":[0.9086493,0.0047679245,0.07493851,0.00017713406,0.00007182696,0.0003893719,0.0018273469,0.00007769776,0.009100826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994467,0.00015628866,0.000028733428,0.00018248538,0.00014061642,0.0000452142],"domain_scores_gemma":[0.9997174,0.00009809205,0.000047123965,0.000034796838,0.00007167116,0.0000310188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043578655,0.00041914635,0.0004075296,0.0008887432,0.00035614343,0.00031937376,0.00023835164,0.0004814048,0.0010932044],"category_scores_gemma":[0.00042274396,0.00023765839,0.00019319143,0.00092365267,0.00020764656,0.00030380182,0.00018246888,0.00066681317,0.00044486122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008203315,0.00003361946,0.0007907954,0.000034280518,0.000016524951,0.000047130994,0.00003244284,0.00008762875,0.99435705,0.000094841664,0.000042012187,0.004381766],"study_design_scores_gemma":[0.000011128156,0.00015809265,0.007638849,0.0000041836943,0.000032901844,0.0002821393,0.000014278931,0.0010934103,0.9884624,0.000069151836,0.0022287006,0.000004883925],"about_ca_topic_score_codex":0.0005895045,"about_ca_topic_score_gemma":0.000976824,"teacher_disagreement_score":0.0010932044,"about_ca_system_score_codex":0.00027281864,"about_ca_system_score_gemma":0.00016894472,"threshold_uncertainty_score":0.0036571622},"labels":[],"label_agreement":null},{"id":"W2412549223","doi":"10.1385/1-59259-998-2:97","title":"Determination of CYP2B6 Component of 7-Ethoxy-4-Trifluoromethylcoumarin &lt;i&gt;O&lt;/i&gt;-Deethylation Activity in Human Liver Microsomes","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"CYP2B6; Microsome; CYP1A2; CYP2E1; Chemistry; Cytochrome P450; Drug metabolism; Enzyme; CYP2A6; Biochemistry; Pharmacology; Biology","score_opus":0.10535169178834691,"score_gpt":0.3878317476557571,"score_spread":0.2824800558674102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412549223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86749357,0.00731844,0.112846576,0.0004326653,0.00012689277,0.00027727667,0.0037242528,0.0010606188,0.006719673],"genre_scores_gemma":[0.9025389,0.0041209157,0.06104658,0.0001858104,0.00010553407,0.00060492713,0.013399353,0.00022152334,0.017776463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942195,0.00016074527,0.000030562143,0.00014068576,0.0001868065,0.000059227958],"domain_scores_gemma":[0.99957865,0.000097093165,0.00007610711,0.000060056063,0.00013776998,0.000050338473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000515748,0.00068277254,0.00043712184,0.000975225,0.00041832466,0.00031552985,0.00022989414,0.0007082479,0.0021338044],"category_scores_gemma":[0.00084518094,0.00029050186,0.0003395989,0.00080562476,0.00023144177,0.00027056146,0.0001481728,0.0006462452,0.001382935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007465753,0.000026450918,0.00044696056,0.000026420892,0.000012507715,0.000026377387,0.000021638863,0.000057528578,0.997528,0.00007197817,0.0000629394,0.001644563],"study_design_scores_gemma":[0.000015281159,0.00019452658,0.0059223184,0.0000055807336,0.000023960527,0.00020533762,0.00001483286,0.0009040479,0.99013954,0.000057039557,0.0025117951,0.000005698711],"about_ca_topic_score_codex":0.0015251102,"about_ca_topic_score_gemma":0.0018473874,"teacher_disagreement_score":0.0021338044,"about_ca_system_score_codex":0.00035000054,"about_ca_system_score_gemma":0.00029287845,"threshold_uncertainty_score":0.007138312},"labels":[],"label_agreement":null},{"id":"W2412701302","doi":"","title":"Rational antipsychotic polypharmacy.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Clozapine; Haloperidol; Pharmacodynamics; Schizophrenia (object-oriented programming); Antipsychotic drug; Pharmacology; Psychiatry; Clinical Practice; Pharmacokinetics; Internal medicine; Family medicine","score_opus":0.13169010671454992,"score_gpt":0.4050554166852854,"score_spread":0.2733653099707355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412701302","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27949136,0.17402834,0.1418573,0.089821175,0.00391542,0.0021567694,0.0027488114,0.0019364887,0.3040444],"genre_scores_gemma":[0.870309,0.035462525,0.051346306,0.015836569,0.0010731983,0.00037038635,0.0007858964,0.000099828605,0.02471644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993969,0.00019319603,0.00004340182,0.00006532861,0.00025564723,0.000045510005],"domain_scores_gemma":[0.99951565,0.00012837484,0.000102450525,0.00006494507,0.000109566325,0.00007899613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071259437,0.00052353536,0.00044005932,0.0005798656,0.00023534508,0.00064412225,0.0003331844,0.0006006437,0.004695245],"category_scores_gemma":[0.0022544125,0.00013670498,0.00029387756,0.0003208111,0.0003651809,0.00047031482,0.0005194472,0.00095737964,0.0017020028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015020969,0.0006025516,0.010082524,0.0010856956,0.0002592191,0.0019004471,0.00013674342,0.0020356365,0.014705347,0.05176674,0.033233702,0.88268924],"study_design_scores_gemma":[0.0014102414,0.005249688,0.042272177,0.0013077436,0.0005284551,0.023126066,0.00020913505,0.021228552,0.018321639,0.18339439,0.7028395,0.0001124639],"about_ca_topic_score_codex":0.00061460753,"about_ca_topic_score_gemma":0.0023298087,"teacher_disagreement_score":0.004695245,"about_ca_system_score_codex":0.000785505,"about_ca_system_score_gemma":0.0010739522,"threshold_uncertainty_score":0.015707135},"labels":[],"label_agreement":null},{"id":"W2414073010","doi":"10.1136/annrheumdis-2015-eular.1627","title":"AB0492 Evaluation of Potential Drug-Drug Interactions with Baricitinib","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Pharmacology; Organic anion transporter 1; CYP2C19; CYP3A4; CYP3A; Ketoconazole; CYP2C9; Rheumatoid arthritis; Drug; Cmax; Pharmacokinetics; TNF inhibitor; Methotrexate; Transporter; Internal medicine; Cytochrome P450; Chemistry; Biochemistry; Etanercept; Metabolism","score_opus":0.27020762959871036,"score_gpt":0.4873810910400886,"score_spread":0.21717346144137822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414073010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979885,0.010823371,0.00080370397,0.0007050465,0.00023315415,0.00024142904,0.0013287656,0.00013414887,0.005845398],"genre_scores_gemma":[0.99333054,0.0019438628,0.0010701104,0.00025758098,0.000050210365,0.000053428168,0.0013585058,0.000016157228,0.0019196062],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99931157,0.00024910495,0.00006146335,0.00008694065,0.00021020797,0.0000806125],"domain_scores_gemma":[0.99967456,0.00008189664,0.0000697995,0.000018229362,0.00009867368,0.000056807294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081244676,0.00042583828,0.0008634787,0.00056235975,0.00026915022,0.0004353215,0.00039102096,0.00055426935,0.003416617],"category_scores_gemma":[0.0012176869,0.00014526171,0.00072072505,0.00053877715,0.00018669957,0.00023153955,0.00021363625,0.00072646746,0.00059929735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095200226,0.005085061,0.07614026,0.0020859656,0.0044931215,0.006338408,0.00021565892,0.005278945,0.42128024,0.0008697306,0.009659592,0.37335277],"study_design_scores_gemma":[0.015122833,0.13787463,0.22473504,0.0004069974,0.009927489,0.020389978,0.00042999175,0.023387413,0.44860864,0.00073918793,0.11811895,0.0002589432],"about_ca_topic_score_codex":0.0012237221,"about_ca_topic_score_gemma":0.0026904843,"teacher_disagreement_score":0.003416617,"about_ca_system_score_codex":0.0004771395,"about_ca_system_score_gemma":0.0005929032,"threshold_uncertainty_score":0.011429787},"labels":[],"label_agreement":null},{"id":"W2414467383","doi":"10.1007/978-1-60761-849-2_17","title":"Protocols of In Vitro Protein Covalent Binding Studies in Liver","year":2010,"lang":"en","type":"article","venue":"Methods in molecular biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Biochemistry; Covalent bond; Enzyme; Cytochrome P450; Chemistry; In vitro; Drug; Xenobiotic; Drug metabolism; Covalent binding; Microsome; Adduct; Reactive intermediate; Pharmacology; Electrophile; Small molecule; Biology","score_opus":0.249336558853156,"score_gpt":0.5976320094254666,"score_spread":0.3482954505723106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414467383","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07966594,0.0060217814,0.87041926,0.00048367545,0.00086447975,0.011353391,0.00603885,0.0033295879,0.021823086],"genre_scores_gemma":[0.12268254,0.012284444,0.76189125,0.00068708684,0.0002995893,0.04102243,0.021337943,0.001361045,0.038433664],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704725,0.000982837,0.00035319306,0.0005779944,0.00073747017,0.0003011709],"domain_scores_gemma":[0.99815756,0.00040704725,0.00018349575,0.00078956044,0.00036531873,0.000097001284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025332153,0.0022181885,0.0014071703,0.0011746762,0.0013058684,0.0007271244,0.0021021161,0.0010505319,0.007989363],"category_scores_gemma":[0.0014999998,0.0010560494,0.0010240059,0.0016717361,0.0008944895,0.0007619152,0.0012221233,0.00377776,0.009695168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022604493,0.0001648376,0.00005934703,0.00026174024,0.000025624691,0.00008690375,0.00012317541,0.0004137422,0.99303645,0.0009991486,0.00055950927,0.0040436224],"study_design_scores_gemma":[0.00007102357,0.0010339799,0.0006564533,0.00006449955,0.0000801616,0.00024352303,0.00004311883,0.0012815517,0.95172393,0.0008939036,0.04386229,0.00004545075],"about_ca_topic_score_codex":0.0012420517,"about_ca_topic_score_gemma":0.0036119611,"teacher_disagreement_score":0.007989363,"about_ca_system_score_codex":0.00073403056,"about_ca_system_score_gemma":0.0012107522,"threshold_uncertainty_score":0.02672714},"labels":[],"label_agreement":null},{"id":"W2420657719","doi":"","title":"Validation of a capillary electrophoresis assay for assessing the metabolic stability of verapamil in human liver microsomes.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Microsome; Verapamil; Chromatography; Human liver; Pharmacology; Chemistry; Reproducibility; Incubation; Drug; In vitro; Biochemistry; Medicine; Calcium","score_opus":0.11406103624738195,"score_gpt":0.3919856510727232,"score_spread":0.27792461482534125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420657719","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30167764,0.024516927,0.655552,0.001816189,0.0011985693,0.0028050698,0.0017722441,0.0033045309,0.0073567694],"genre_scores_gemma":[0.55079633,0.009154004,0.42326,0.0011145265,0.00027366335,0.0023303218,0.003640322,0.00033152796,0.009099265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933422,0.0026615744,0.0003529992,0.00080120575,0.0026010675,0.00024091905],"domain_scores_gemma":[0.99271363,0.0028101623,0.0006118007,0.00047816127,0.0029045085,0.00048162712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004283692,0.0015854585,0.0010412644,0.0016902263,0.0007277029,0.0010107331,0.0013246376,0.0022178255,0.0009784371],"category_scores_gemma":[0.011040424,0.00074633723,0.0006225636,0.00080044154,0.0012786868,0.0005619004,0.0007810028,0.0015483084,0.0011963351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002271257,0.000117549316,0.0009081312,0.00021490912,0.000059252496,0.00012812107,0.00009682317,0.00020035268,0.9827874,0.00027262623,0.00043676826,0.014550912],"study_design_scores_gemma":[0.000096153424,0.0010805615,0.007415243,0.00008039691,0.00013509803,0.002395412,0.00006161418,0.0047421674,0.9762388,0.00018958152,0.0074925334,0.00007244307],"about_ca_topic_score_codex":0.003905593,"about_ca_topic_score_gemma":0.006241652,"teacher_disagreement_score":0.004283692,"about_ca_system_score_codex":0.0009959874,"about_ca_system_score_gemma":0.0018577573,"threshold_uncertainty_score":0.022654593},"labels":[],"label_agreement":null},{"id":"W2426519130","doi":"10.1016/bs.apha.2015.03.003","title":"Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer","year":2015,"lang":"en","type":"review","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Reactive oxygen species; Chemistry; Biochemistry; Superoxide; Cytochrome P450; Hydroxyl radical; Oxidative stress; Cancer cell; Hydrogen peroxide; Enzyme; Radical; Biology; Cancer","score_opus":0.20505780416294883,"score_gpt":0.5221956942640424,"score_spread":0.3171378901010936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426519130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003934926,0.99805474,0.0003182106,0.00020265563,0.00010092608,0.0000046881905,0.000028274811,0.0000084747535,0.00088859483],"genre_scores_gemma":[0.002116339,0.9966613,0.00025555678,0.00009693091,0.00014696931,0.000004038726,0.000039192433,0.000001012224,0.00067867705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988973,0.000018179706,0.0000146065495,0.000021627346,0.000043850563,0.0000119109945],"domain_scores_gemma":[0.9998356,0.000073226365,0.000036352187,0.0000062636964,0.00003748239,0.000011047401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003477119,0.0004612995,0.0006800204,0.0010642421,0.00011860721,0.00046911938,0.00044276324,0.00051783706,0.0024965152],"category_scores_gemma":[0.0004112439,0.0001715632,0.00040632143,0.0011867174,0.00019397367,0.0005362613,0.00039739112,0.00074709224,0.0010150138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010224267,0.000081874125,0.00077289034,0.009709122,0.00017195752,0.00032524802,0.00002796175,0.00035214648,0.004084007,0.0017734652,0.011398262,0.9712008],"study_design_scores_gemma":[0.000050957697,0.00026441485,0.0047162655,0.0024970002,0.00050568156,0.0025649373,0.00006544071,0.00028566105,0.004193497,0.003371341,0.9814527,0.00003210525],"about_ca_topic_score_codex":0.0008607595,"about_ca_topic_score_gemma":0.0015348032,"teacher_disagreement_score":0.0024965152,"about_ca_system_score_codex":0.0002235344,"about_ca_system_score_gemma":0.0006227455,"threshold_uncertainty_score":0.008351684},"labels":[],"label_agreement":null},{"id":"W2430496159","doi":"","title":"Regulatory approval for new pharmacogenomic tests: a comparative overview.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; London Health Sciences Centre; BC Children's Hospital","funders":"","keywords":"Pharmacogenomics; Business; Drug development; Risk analysis (engineering); Medicine; Drug; Pharmacology","score_opus":0.4739635311193347,"score_gpt":0.44775541696860494,"score_spread":0.026208114150729767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430496159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01228768,0.80793583,0.014307978,0.037550382,0.0019871786,0.00031327934,0.0014987306,0.00035827476,0.12376061],"genre_scores_gemma":[0.18500184,0.7250555,0.023584848,0.043503087,0.003353887,0.00060662656,0.0035137103,0.0002624696,0.015118148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.983469,0.0060784593,0.0011909857,0.0013429937,0.007187935,0.0007305715],"domain_scores_gemma":[0.959225,0.027252888,0.0045328555,0.0010758018,0.0070103738,0.00090304913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025697032,0.00073800894,0.001012616,0.00642679,0.0008356746,0.004433862,0.001563214,0.005722946,0.009149236],"category_scores_gemma":[0.037113935,0.00035893486,0.0018023418,0.0058700754,0.001698343,0.0036958682,0.0013660294,0.0026994927,0.002063694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071368477,0.00019494002,0.0053500715,0.0046115136,0.00020768202,0.0006113911,0.00029399293,0.0008109111,0.0025852744,0.042161584,0.04839172,0.8940672],"study_design_scores_gemma":[0.00019124226,0.0009407414,0.025406724,0.0035802112,0.0005886454,0.003442322,0.00040076257,0.0007179637,0.0035263493,0.009269404,0.9518385,0.00009714951],"about_ca_topic_score_codex":0.0034905623,"about_ca_topic_score_gemma":0.004489789,"teacher_disagreement_score":0.025697032,"about_ca_system_score_codex":0.00465707,"about_ca_system_score_gemma":0.007086061,"threshold_uncertainty_score":0.13590056},"labels":[],"label_agreement":null},{"id":"W2438748188","doi":"10.18433/j3h03r","title":"Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atomoxetine; Bupropion; Drug; Pharmacology; Drug metabolism; Medicine; Drug-drug interaction; Drug interaction; Methylphenidate; Psychiatry; Attention deficit hyperactivity disorder; Smoking cessation","score_opus":0.16882104081996316,"score_gpt":0.4996675840237531,"score_spread":0.3308465432037899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438748188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773765,0.00079426565,0.00059075974,0.000028537119,0.00001900177,0.00034204024,0.00009834978,0.000021655016,0.00036763685],"genre_scores_gemma":[0.99800223,0.00020455323,0.0007325382,0.00013237793,0.000040071143,0.00019706486,0.00024082801,0.000008185953,0.00044203876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886024,0.00054569443,0.000054303404,0.0001953574,0.00026220235,0.00008221384],"domain_scores_gemma":[0.9991448,0.00030409903,0.00022924256,0.000077618686,0.00009315645,0.00015105508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014037056,0.0006796272,0.0009557683,0.00018511804,0.00042709024,0.00039679796,0.000252703,0.00073406653,0.0017502409],"category_scores_gemma":[0.0022012827,0.00038019504,0.00042521727,0.00014403088,0.0004466214,0.00031698373,0.0002842132,0.00042133944,0.00037522067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28806433,0.009933405,0.2655709,0.0010944592,0.0013684575,0.0023642662,0.00073936395,0.0008747811,0.33337274,0.00021509783,0.0009915376,0.095410645],"study_design_scores_gemma":[0.005612074,0.25338838,0.7045472,0.000025053501,0.0008788058,0.0029781433,0.00017910336,0.003464651,0.027048232,0.00014435261,0.0016942867,0.000039709732],"about_ca_topic_score_codex":0.00072618545,"about_ca_topic_score_gemma":0.0009709478,"teacher_disagreement_score":0.0017502409,"about_ca_system_score_codex":0.00029006266,"about_ca_system_score_gemma":0.00039558197,"threshold_uncertainty_score":0.0074235797},"labels":[],"label_agreement":null},{"id":"W2461268409","doi":"10.1055/s-0031-1296226","title":"Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review","year":2011,"lang":"en","type":"review","venue":"Arzneimittelforschung","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Felodipine; Pharmacokinetics; Medicine; Pharmacology; Chemistry; Internal medicine; Blood pressure","score_opus":0.15680341751202995,"score_gpt":0.4688459681864443,"score_spread":0.31204255067441433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461268409","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92692846,0.070437096,0.00046847007,0.00008812598,0.000012635284,0.00010321007,0.0010181495,0.000020931555,0.00092294125],"genre_scores_gemma":[0.95696545,0.039977826,0.0005922691,0.00015926431,0.000041541785,0.00009898088,0.0016675722,0.000008277024,0.00048888166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991177,0.00014155365,0.00034165694,0.00019826704,0.0001652446,0.00003565107],"domain_scores_gemma":[0.996756,0.00089560996,0.0017301408,0.00018782567,0.00036446707,0.000065943896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009332106,0.00019567787,0.0006097735,0.0016845794,0.00016600158,0.0005096719,0.00032394938,0.00032458652,0.00074790395],"category_scores_gemma":[0.0022414385,0.00023391045,0.0005423103,0.0020290646,0.00023691905,0.00031158066,0.00017277292,0.00016060844,0.00020758243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005050944,0.00008186838,0.92314273,0.003892067,0.0008574379,0.008191673,0.00075441226,0.00010761252,0.0056752176,0.00006634401,0.00056036806,0.056165226],"study_design_scores_gemma":[0.000064410124,0.00086181797,0.96172935,0.00053652655,0.0013846622,0.025891133,0.00055072777,0.00018745835,0.0020706702,0.000019618965,0.0066745305,0.000029022669],"about_ca_topic_score_codex":0.0022626359,"about_ca_topic_score_gemma":0.0024716612,"teacher_disagreement_score":0.0022626359,"about_ca_system_score_codex":0.00030684308,"about_ca_system_score_gemma":0.0005450025,"threshold_uncertainty_score":0.004935384},"labels":[],"label_agreement":null},{"id":"W2465671661","doi":"10.1186/s13643-016-0280-y","title":"Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis","year":2016,"lang":"en","type":"article","venue":"Systematic Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"VKORC1; Medicine; Warfarin; Meta-analysis; Vitamin K epoxide reductase; MEDLINE; CYP2C9; Internal medicine; Cytochrome P450; Atrial fibrillation","score_opus":0.1790577737719707,"score_gpt":0.4744469414993939,"score_spread":0.2953891677274232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465671661","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013542426,0.026773658,0.005617453,0.00094778574,0.00057021563,0.9558505,0.007597656,0.0002921431,0.0009963233],"genre_scores_gemma":[0.0016052213,0.0062503153,0.0062632035,0.00039325317,0.000037595226,0.9843007,0.00076654623,0.000016925404,0.00036618504],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9685061,0.012624756,0.011620043,0.0026957046,0.0034907253,0.0010626325],"domain_scores_gemma":[0.97052336,0.013142504,0.007040367,0.0024293202,0.0059944987,0.00086983904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06122979,0.005036233,0.023674889,0.01081848,0.0026873553,0.0060089165,0.0049173557,0.0065971743,0.036454275],"category_scores_gemma":[0.08823223,0.003579224,0.034260724,0.009842957,0.0027511274,0.0054943166,0.0042847297,0.00467141,0.0034934643],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031810952,0.0001051897,0.0006278843,0.95155597,0.018433958,0.00024181903,0.0005412794,0.0007429746,0.0005419307,0.0014850828,0.007592635,0.014950213],"study_design_scores_gemma":[0.030984312,0.0018111054,0.005903721,0.6491079,0.21405181,0.00055787916,0.0007664207,0.0020737888,0.001606262,0.008394905,0.08428839,0.0004535727],"about_ca_topic_score_codex":0.005922849,"about_ca_topic_score_gemma":0.013397722,"teacher_disagreement_score":0.06122979,"about_ca_system_score_codex":0.011462036,"about_ca_system_score_gemma":0.037873317,"threshold_uncertainty_score":0.32381797},"labels":[],"label_agreement":null},{"id":"W2467694195","doi":"10.1007/978-3-319-27883-4_20","title":"Clinical Significant Interactions with Opioid Analgesics","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacology; Pharmacodynamics; Pharmacokinetics; Medicine; Opioid; Alfentanil; Drug; Pharmacogenetics; Tramadol; Analgesic; Chemistry; Fentanyl; Internal medicine","score_opus":0.19255288915707053,"score_gpt":0.475978156003168,"score_spread":0.2834252668460975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467694195","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030716027,0.4476764,0.008724905,0.01345999,0.00454985,0.000097047756,0.00042583572,0.0002452071,0.52174914],"genre_scores_gemma":[0.027505899,0.32294744,0.009439593,0.010487586,0.0064295554,0.00012009345,0.00051067,0.0001857314,0.6223734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972194,0.00008089988,0.000017502436,0.000020987305,0.0001413184,0.000017271195],"domain_scores_gemma":[0.9996799,0.00020760973,0.00002584325,0.000012133738,0.000055251694,0.000019236748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042000948,0.0005786598,0.000391445,0.0006148709,0.00023926399,0.0008208495,0.00036994283,0.00066908513,0.03049348],"category_scores_gemma":[0.001059375,0.00015686445,0.00033456297,0.0005647315,0.00041415935,0.00061101874,0.00061670085,0.0013750755,0.009011303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093893774,0.000066266395,0.00034639152,0.0007967171,0.00002001909,0.0006827225,0.0001115864,0.00021041468,0.0025324654,0.01744693,0.18152289,0.7961697],"study_design_scores_gemma":[0.0000142118415,0.00008368606,0.0014323074,0.00058982335,0.000021393873,0.004163215,0.000063810694,0.00017127827,0.0011879472,0.01669758,0.9755644,0.000010337224],"about_ca_topic_score_codex":0.0005908168,"about_ca_topic_score_gemma":0.0028488962,"teacher_disagreement_score":0.03049348,"about_ca_system_score_codex":0.0004787422,"about_ca_system_score_gemma":0.00061274617,"threshold_uncertainty_score":0.10201079},"labels":[],"label_agreement":null},{"id":"W2474397727","doi":"10.1124/dmd.116.070060","title":"Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters","year":2016,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Sulfation; Perfusion; Glucuronidation; Albumin; Biology; Enzyme; Internal medicine; Chemistry; Endocrinology; Biochemistry; Microsome; Medicine","score_opus":0.04095210611705749,"score_gpt":0.3114703662772778,"score_spread":0.2705182601602203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474397727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709076,0.0016984737,0.022273913,0.00066038076,0.000119805336,0.000040835563,0.0016881523,0.00046799923,0.002142808],"genre_scores_gemma":[0.9877509,0.00047650325,0.006097965,0.00011839067,0.000015216363,0.000040067836,0.0011383066,0.00014368945,0.0042189327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964786,0.000056680874,0.000048405585,0.0000980841,0.00007996517,0.00006908612],"domain_scores_gemma":[0.99958867,0.000064295375,0.00014257862,0.00008260391,0.00005003944,0.00007177506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056880136,0.00045616805,0.00043207407,0.00047399342,0.00023584104,0.0009784409,0.00046016026,0.00064501143,0.002719521],"category_scores_gemma":[0.00034646693,0.00026650736,0.00042655092,0.00029071604,0.00086700026,0.000874939,0.00025808834,0.00093845575,0.0005248742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007546967,0.000032705477,0.00033791835,0.00005001702,0.000021561984,0.00010053572,0.000047905196,0.00015380974,0.9953784,0.0016697092,0.00007246546,0.0013803836],"study_design_scores_gemma":[0.00002257845,0.00010010345,0.0011926278,0.000003732651,0.000027795284,0.00033684765,0.000040313284,0.00065725466,0.99525476,0.00020051425,0.0021571822,0.000006429607],"about_ca_topic_score_codex":0.0014551032,"about_ca_topic_score_gemma":0.0012341065,"teacher_disagreement_score":0.002719521,"about_ca_system_score_codex":0.0004860418,"about_ca_system_score_gemma":0.00059457996,"threshold_uncertainty_score":0.009097695},"labels":[],"label_agreement":null},{"id":"W2481094411","doi":"10.1186/s12920-016-0207-4","title":"DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions","year":2016,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China","keywords":"Pharmacogenomics; Single-nucleotide polymorphism; Biology; Computational biology; Genetics; Linkage disequilibrium; Human genetics; Genome-wide association study; Bioinformatics; Genotype; Gene","score_opus":0.1358765444349655,"score_gpt":0.4152546294074259,"score_spread":0.2793780849724604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481094411","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13834187,0.003843617,0.84260404,0.0028234706,0.00036317372,0.00019238437,0.0026948529,0.0038623565,0.0052741426],"genre_scores_gemma":[0.9085465,0.0009890321,0.07907474,0.0011961475,0.00012561276,0.00027126304,0.0024121816,0.00006938015,0.0073150843],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996062,0.000101988546,0.000030421494,0.00012459437,0.00006194513,0.00007485746],"domain_scores_gemma":[0.9994186,0.00028385702,0.00006360831,0.000033479133,0.0001569907,0.000043466756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010180508,0.0009418269,0.0009529963,0.00088526617,0.00029844092,0.00074636744,0.002194047,0.0014283498,0.00211776],"category_scores_gemma":[0.0018225028,0.00040082517,0.0010052765,0.0005415334,0.00044683513,0.0009006539,0.00089687906,0.0018487964,0.0005879399],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040977012,0.00036553145,0.011183859,0.00013182576,0.00025412336,0.00024581223,0.00006372088,0.7391936,0.002409923,0.0050617107,0.0074858656,0.23319422],"study_design_scores_gemma":[0.000008440302,0.000022263905,0.00019955437,0.0000053457634,0.000010429231,0.000016275935,0.0000023756002,0.9979134,0.00020563362,0.0014028585,0.00020954646,0.000003801426],"about_ca_topic_score_codex":0.013257417,"about_ca_topic_score_gemma":0.011254887,"teacher_disagreement_score":0.013257417,"about_ca_system_score_codex":0.0012613895,"about_ca_system_score_gemma":0.0010872314,"threshold_uncertainty_score":0.026360512},"labels":[],"label_agreement":null},{"id":"W2481657687","doi":"10.5812/hepatmon.35953","title":"Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis","year":2016,"lang":"en","type":"article","venue":"Hepatitis Monthly","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Universität des Saarlandes; Canadian Liver Foundation","keywords":"Pregnane X receptor; Cholestasis; Constitutive androstane receptor; Medicine; Nuclear receptor; Anabolic steroid; Bile acid; Internal medicine; Cholestyramine; Bile Salt Export Pump; Endocrinology; CYP3A4; Multidrug resistance-associated protein 2; Biology; Gene; Cytochrome P450; Anabolism; Genetics; Transcription factor","score_opus":0.04198835655938451,"score_gpt":0.3247240142313402,"score_spread":0.2827356576719557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481657687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464464,0.00052968087,0.0008843932,0.0007641314,0.000071435104,0.000054849912,0.00014329601,0.00006099211,0.002846651],"genre_scores_gemma":[0.9989562,0.00015379189,0.0002542161,0.000109729546,0.000069263595,0.000005449396,0.000039543906,0.000009271504,0.00040242574],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999607,0.00004165543,0.000046962505,0.00013934808,0.00006146453,0.000103536535],"domain_scores_gemma":[0.99936694,0.00021696987,0.0001122954,0.000042887397,0.000036012178,0.00022485001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029442698,0.0014396398,0.0006841479,0.0018245095,0.001557654,0.00076471234,0.0006233832,0.002190832,0.0025754205],"category_scores_gemma":[0.0014216203,0.000661386,0.00053032197,0.0008762964,0.0012863728,0.0006237877,0.0007474372,0.0011623711,0.00046816742],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010931652,0.000058250953,0.017429175,0.000021786853,0.000011373695,0.9761194,0.00033899007,0.000058525467,0.0042579854,0.0001643035,0.00017915986,0.0012516617],"study_design_scores_gemma":[0.0000202113,0.00018262341,0.016604582,0.000010108594,0.00002563551,0.98086995,0.00015238383,0.00024512777,0.0014412758,0.00012749995,0.00030760927,0.0000130261815],"about_ca_topic_score_codex":0.0015731091,"about_ca_topic_score_gemma":0.0014904736,"teacher_disagreement_score":0.0025754205,"about_ca_system_score_codex":0.00051387714,"about_ca_system_score_gemma":0.0004656514,"threshold_uncertainty_score":0.008615673},"labels":[],"label_agreement":null},{"id":"W2482609357","doi":"10.1016/j.abb.2016.07.018","title":"Role of active site loop in coenzyme binding and flavin reduction in cytochrome P450 reductase","year":2016,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Flavin group; Stereochemistry; Active site; Reductase; Cofactor; Cytochrome P450 reductase; Coenzyme Q – cytochrome c reductase; Biochemistry; Enzyme; Cytochrome c","score_opus":0.024063561760104237,"score_gpt":0.33928532273853024,"score_spread":0.315221760978426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482609357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98365384,0.0005496713,0.012576485,0.0003559698,0.000096468415,0.00004319501,0.00014231801,0.00029999155,0.0022819564],"genre_scores_gemma":[0.99659616,0.00010812388,0.0017585421,0.000095011725,0.000019236517,0.000007718489,0.00011256836,0.00002711431,0.0012754926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996487,0.000098197714,0.000019902607,0.000082313105,0.00007469861,0.00007620999],"domain_scores_gemma":[0.9995154,0.00019472824,0.00006525466,0.000049818704,0.00007518548,0.0000996156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005195061,0.00045316777,0.00063839724,0.0001820794,0.00070809264,0.00062037,0.0010853946,0.00097405823,0.0044491612],"category_scores_gemma":[0.00072825723,0.00026525027,0.00046429556,0.00011715136,0.00045157224,0.00066920405,0.00034121418,0.0009696296,0.0014107663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004298266,0.0005286488,0.0027601295,0.00016341596,0.000064613865,0.001596363,0.0002835361,0.0029503158,0.9608783,0.004999334,0.0008632675,0.020613898],"study_design_scores_gemma":[0.00030372836,0.0012189801,0.0066961353,0.000039819104,0.00012928474,0.001454561,0.00014845288,0.03029583,0.9543331,0.0019238429,0.0033630326,0.00009331918],"about_ca_topic_score_codex":0.0012575903,"about_ca_topic_score_gemma":0.0008815667,"teacher_disagreement_score":0.0044491612,"about_ca_system_score_codex":0.0004976101,"about_ca_system_score_gemma":0.0003757492,"threshold_uncertainty_score":0.014883935},"labels":[],"label_agreement":null},{"id":"W2484588887","doi":"10.1002/bmc.3786","title":"<i>In vitro</i> metabolism of specific CYP2D and CYP3A opioid substrates using rat liver S9 fractions and mass spectrometry reveal a severe metabolic impairment with increasing age","year":2016,"lang":"en","type":"article","venue":"Biomedical Chromatography","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Chromatography; Oxycodone; Codeine; Oxymorphone; Mass spectrometry; CYP3A; Ammonium acetate; Pharmacology; Metabolism; Opioid; High-performance liquid chromatography; Morphine; Biochemistry; Cytochrome P450; Receptor; Medicine","score_opus":0.03523743424579491,"score_gpt":0.3294679787834704,"score_spread":0.2942305445376755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484588887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96668655,0.0030347786,0.024447586,0.00021901685,0.00008701766,0.00009776869,0.0018714719,0.0003558583,0.0031999587],"genre_scores_gemma":[0.9722455,0.0019329407,0.0141355945,0.00015890316,0.000033434324,0.00014461676,0.0039369725,0.00009679101,0.0073154387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980384,0.000039436476,0.000020547463,0.000059552185,0.000039624443,0.000037138656],"domain_scores_gemma":[0.99982303,0.000026920492,0.000060229475,0.00003332274,0.000036473233,0.000020038378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027173717,0.0006174892,0.00019146928,0.00031095717,0.00022292015,0.00019421834,0.0002004071,0.0002512105,0.0015870209],"category_scores_gemma":[0.00017074347,0.00017725956,0.0004344907,0.00025904016,0.00024743873,0.00021852128,0.00015556869,0.00044166067,0.0008598529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000290038,0.000033693144,0.00077603396,0.00003264275,0.000014535019,0.00005327439,0.00001842429,0.00007732646,0.9969926,0.00006216207,0.000078461526,0.0015708507],"study_design_scores_gemma":[0.000006537504,0.00028768764,0.005868825,0.00000387471,0.000018374303,0.00015550386,0.000015102186,0.00039993998,0.9919803,0.000030576168,0.0012283466,0.0000051063225],"about_ca_topic_score_codex":0.0014467577,"about_ca_topic_score_gemma":0.0016865885,"teacher_disagreement_score":0.0015870209,"about_ca_system_score_codex":0.00022671586,"about_ca_system_score_gemma":0.00021608865,"threshold_uncertainty_score":0.0053091645},"labels":[],"label_agreement":null},{"id":"W2497999703","doi":"10.1007/978-1-59745-350-9_14","title":"Cytokines and Pharmacokinetic Drug Interactions","year":2007,"lang":"en","type":"book-chapter","venue":"Methods in pharmacology and toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cytokine; Cytochrome P450; Inflammation; Tumor necrosis factor alpha; Transcription factor; Biology; Drug; Proinflammatory cytokine; Interleukin; Immunology; Pharmacology; Enzyme; Gene; Biochemistry","score_opus":0.17954470780517534,"score_gpt":0.5337244310969486,"score_spread":0.3541797232917732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497999703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017057696,0.75523484,0.0050827395,0.012132358,0.009587641,0.00008191524,0.00028548084,0.00027804697,0.21561119],"genre_scores_gemma":[0.014021686,0.35165307,0.00699012,0.012320498,0.008904739,0.00015029521,0.00031508767,0.0001710247,0.6054735],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996327,0.00009845702,0.000020347577,0.000056006214,0.00017061044,0.000021732343],"domain_scores_gemma":[0.9996037,0.00022730797,0.000028929328,0.000019008556,0.000087533044,0.000033448214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043856577,0.0007927604,0.00059258513,0.00081445393,0.0003837713,0.0020625826,0.0005549457,0.0012116439,0.026011346],"category_scores_gemma":[0.0011593655,0.00026149928,0.00035410587,0.00094393804,0.00057712715,0.0017879877,0.0008628396,0.0022101442,0.014054123],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001424235,0.000080686055,0.00032354146,0.0013167687,0.000030290677,0.00049310195,0.00033655233,0.00060300325,0.0033528628,0.05371851,0.382936,0.5566662],"study_design_scores_gemma":[0.000007868599,0.000032823657,0.00020816394,0.00018174225,0.0000066410366,0.0009536068,0.000029289447,0.00014791246,0.0004147987,0.008229563,0.98978126,0.0000064291485],"about_ca_topic_score_codex":0.00042632915,"about_ca_topic_score_gemma":0.0010556193,"teacher_disagreement_score":0.026011346,"about_ca_system_score_codex":0.00082304643,"about_ca_system_score_gemma":0.0005451727,"threshold_uncertainty_score":0.08701664},"labels":[],"label_agreement":null},{"id":"W2499462156","doi":"10.1016/b978-012406061-6/50048-5","title":"Cytochrome P-450","year":2006,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cytochrome; Chemistry; Biochemistry","score_opus":0.0745697060764952,"score_gpt":0.3817367114837826,"score_spread":0.30716700540728736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499462156","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004903648,0.0609693,0.017725822,0.0020603617,0.0014062121,0.0001900582,0.0023200999,0.0027353193,0.90768915],"genre_scores_gemma":[0.010519134,0.01558434,0.0045488817,0.00057960715,0.0002855435,0.00008436698,0.0015988388,0.000106016065,0.9666932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998159,0.000020563471,0.000007994205,0.000056399316,0.000079576756,0.000019567591],"domain_scores_gemma":[0.99989927,0.00002235323,0.000013502396,0.000018656014,0.00003130856,0.000014922475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018686574,0.00085456175,0.0004773535,0.00075801526,0.00038017076,0.0008834873,0.00044056342,0.0008913922,0.12895042],"category_scores_gemma":[0.00042379444,0.00027388404,0.0002872742,0.0006858518,0.00025645227,0.00051693287,0.0006368455,0.0010678306,0.10544434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006918546,0.00007523803,0.00036727166,0.00035613266,0.000019680243,0.0004198804,0.000048949543,0.000100919744,0.013658367,0.0060667447,0.14997485,0.8288428],"study_design_scores_gemma":[0.000015907106,0.000104936466,0.0016022378,0.00011654254,0.000013963228,0.001634644,0.000015504795,0.000100862526,0.00398269,0.0018594944,0.9905461,0.0000071488043],"about_ca_topic_score_codex":0.0016051831,"about_ca_topic_score_gemma":0.0025282418,"teacher_disagreement_score":0.12895042,"about_ca_system_score_codex":0.00035197742,"about_ca_system_score_gemma":0.0004187358,"threshold_uncertainty_score":0.43138212},"labels":[],"label_agreement":null},{"id":"W2512717750","doi":"10.1056/wh201005130000001","title":"Revisiting Breast Cancer Outcomes in Concomitant Users of Tamoxifen and Selective Serotonin Reuptake Inhibitors","year":2010,"lang":"en","type":"article","venue":"Journal watch","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxetine; Tamoxifen; Breast cancer; Concomitant; Medicine; Serotonin reuptake inhibitor; Oncology; Reuptake inhibitor; Internal medicine; CYP2D6; Serotonin; Pharmacology; Cancer; Cytochrome P450; Receptor","score_opus":0.04575149152006397,"score_gpt":0.4130539609462616,"score_spread":0.36730246942619765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512717750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407566,0.002046249,0.00009435695,0.00085781945,0.000048061822,0.000010087716,0.0009479878,0.0000084467965,0.0019112232],"genre_scores_gemma":[0.9985611,0.0005208368,0.00006504951,0.00012759467,0.000052376836,0.000004601127,0.00044706196,0.0000022599543,0.00021912045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999244,0.00017259424,0.00008141291,0.000111213965,0.00021975367,0.00017105865],"domain_scores_gemma":[0.99707127,0.0005425139,0.0012698817,0.00013071849,0.0005676379,0.0004178917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010858135,0.00020056881,0.00042922422,0.0013004724,0.00058028416,0.0008665757,0.0004886576,0.0005065838,0.0012168445],"category_scores_gemma":[0.0056002666,0.00017363518,0.00073867064,0.0020749508,0.00033090363,0.0007065285,0.0003976905,0.0009069856,0.00017446713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014842895,0.000019030402,0.99585813,0.000015492027,0.000073190015,0.00013233234,0.000049124938,0.000017105027,0.000093573784,0.000017484344,0.00021444945,0.003361641],"study_design_scores_gemma":[0.0000058218,0.0000556908,0.9989704,0.000010488178,0.000097705364,0.0001754465,0.00013318096,0.00006558101,0.00007936734,0.00002305663,0.00037999183,0.000003350469],"about_ca_topic_score_codex":0.061051685,"about_ca_topic_score_gemma":0.1240274,"teacher_disagreement_score":0.061051685,"about_ca_system_score_codex":0.0007623207,"about_ca_system_score_gemma":0.001163807,"threshold_uncertainty_score":0.12139267},"labels":[],"label_agreement":null},{"id":"W2515277963","doi":"10.1016/j.foodchem.2016.09.026","title":"CYP2D6 and CYP2A6 biotransform dietary tyrosol into hydroxytyrosol","year":2016,"lang":"en","type":"article","venue":"Food Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Instituto de Salud Carlos III; Canadian Institutes of Health Research; Rat für Forschung und Technologieentwicklung; Department of Psychiatry, University of Toronto; Centre for Addiction and Mental Health Foundation; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; National Institutes of Health; Generalitat de Catalunya; Centre for Addiction and Mental Health","keywords":"Tyrosol; Hydroxytyrosol; CYP2A6; Chemistry; Biochemistry; Pharmacology; Biotransformation; Cytochrome P450; CYP3A4; Enzyme; Antioxidant; Polyphenol; Biology","score_opus":0.06607398754303452,"score_gpt":0.3770852513657949,"score_spread":0.3110112638227604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515277963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616066,0.005533692,0.022475004,0.0007299909,0.00029072413,0.00016518253,0.0016981345,0.00029883432,0.007201921],"genre_scores_gemma":[0.97813773,0.0017997266,0.0064759613,0.00022171994,0.00008926468,0.00007206091,0.0010471381,0.00009116332,0.012065205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996587,0.000100085184,0.000023764587,0.00009405334,0.00007252896,0.000050864666],"domain_scores_gemma":[0.9997068,0.00004153233,0.0001227708,0.00003838791,0.000055755405,0.000034680714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003553104,0.0004354896,0.00029849695,0.00031163206,0.00018121945,0.00043408998,0.00022702127,0.0004218961,0.0030157936],"category_scores_gemma":[0.000565667,0.00030577162,0.00058110914,0.00028800502,0.00017864734,0.00028831218,0.00026557746,0.0005109405,0.0010867594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036371313,0.00044887583,0.029803129,0.00037497847,0.00049511035,0.0009080705,0.00020439828,0.0009498846,0.8627476,0.0017892949,0.0024277004,0.09621384],"study_design_scores_gemma":[0.00013120697,0.00083275756,0.019740136,0.000015508149,0.00009146349,0.0017582239,0.00006144399,0.0019330092,0.9608944,0.0003971167,0.014125133,0.000019696752],"about_ca_topic_score_codex":0.0013609993,"about_ca_topic_score_gemma":0.001596229,"teacher_disagreement_score":0.0030157936,"about_ca_system_score_codex":0.00041825965,"about_ca_system_score_gemma":0.00029593904,"threshold_uncertainty_score":0.010088801},"labels":[],"label_agreement":null},{"id":"W2519223696","doi":"10.1038/srep33099","title":"Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s","year":2016,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Department of Higher Education and Training; Ministry of Science, ICT and Future Planning; Central University of Technology; Allard Foundation; National Research Foundation; University of Wisconsin-Madison","keywords":"Monooxygenase; Biology; Cytochrome P450; Phylogenetic tree; Function (biology); Genome; Evolutionary biology; Molecular evolution; Computational biology; Genetics; Functional diversity; Gene; Ecology; Biochemistry; Enzyme","score_opus":0.048340512846255616,"score_gpt":0.38356674936859925,"score_spread":0.3352262365223436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519223696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788806,0.013199325,0.004834777,0.00026424276,0.000015828324,0.000013074785,0.00033802804,0.000031528132,0.0024225523],"genre_scores_gemma":[0.9908742,0.0037875709,0.004067628,0.000050786282,0.000016395552,0.000010313915,0.00054257293,0.00001689656,0.00063372677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965453,0.000078446035,0.000026419582,0.00011839972,0.00006938383,0.000052792144],"domain_scores_gemma":[0.99938405,0.00014999609,0.00021308743,0.000051068462,0.00012639373,0.000075364675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005084375,0.00021262688,0.0003002331,0.0010897653,0.00040779018,0.00069449143,0.00017172817,0.00033523695,0.00090376014],"category_scores_gemma":[0.00083286234,0.00010590638,0.00026474244,0.0013790408,0.00026833877,0.0007179121,0.000428841,0.00047406755,0.00036198032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071683445,0.000087023436,0.34647393,0.0006359414,0.0002163442,0.0010284226,0.001654678,0.0015263924,0.47386536,0.00322377,0.00049956015,0.17007175],"study_design_scores_gemma":[0.000013099712,0.00031538797,0.9334614,0.000085842235,0.00014650352,0.0026428148,0.0010239554,0.0038235628,0.030854795,0.0018655548,0.025731444,0.00003565349],"about_ca_topic_score_codex":0.00069212174,"about_ca_topic_score_gemma":0.0008059746,"teacher_disagreement_score":0.0010897653,"about_ca_system_score_codex":0.00029343914,"about_ca_system_score_gemma":0.00019027558,"threshold_uncertainty_score":0.003023386},"labels":[],"label_agreement":null},{"id":"W2519688704","doi":"10.1016/j.bmcl.2016.09.046","title":"Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives","year":2016,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"Chemistry; Steroid; Cytochrome P450; CYP1B1; Stereochemistry; Heme; Pharmacology; IC50; Enzyme; Estrone; Active site; Docking (animal); CYP3A4; Structure–activity relationship; Biochemistry; In vitro","score_opus":0.04944998651031944,"score_gpt":0.35174573372370865,"score_spread":0.3022957472133892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519688704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93254244,0.020863172,0.0237927,0.001646393,0.00031051735,0.00015053432,0.00041236478,0.0003839826,0.019897955],"genre_scores_gemma":[0.9868885,0.0049794405,0.0023680972,0.00015810698,0.000043770648,0.000020373012,0.00014134527,0.000021366173,0.0053790626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990356,0.000031197313,0.0000044424874,0.000017700382,0.000019160336,0.000023920062],"domain_scores_gemma":[0.9999542,0.000010178318,0.000012476184,0.0000075168828,0.0000065587997,0.0000090019375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016708269,0.00017577641,0.00019283826,0.00014107721,0.0001098264,0.0002200656,0.00012209901,0.00015681854,0.0022220078],"category_scores_gemma":[0.0002237133,0.000072739516,0.00018565186,0.00022547848,0.0001480975,0.00010274585,0.00013788861,0.00043726398,0.00055174297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011504159,0.00024331851,0.0025076966,0.00028787798,0.00008636223,0.00059620786,0.0001321644,0.0016418482,0.84443533,0.0037494963,0.0029602349,0.14220908],"study_design_scores_gemma":[0.00020353583,0.0029666978,0.0033797529,0.000020136948,0.00009501272,0.001873462,0.000054254357,0.0023036813,0.93667537,0.00058931956,0.051820405,0.000018401885],"about_ca_topic_score_codex":0.00053939555,"about_ca_topic_score_gemma":0.0012169019,"teacher_disagreement_score":0.0022220078,"about_ca_system_score_codex":0.00021058929,"about_ca_system_score_gemma":0.0001704622,"threshold_uncertainty_score":0.007433355},"labels":[],"label_agreement":null},{"id":"W2520490671","doi":"10.5005/jp-journals-10036-1067","title":"In Silico-based Study of Cytochrome P450 and Multidrug Resistance Protein 1 from Docking Perspective to Understand Kidney Failure","year":2015,"lang":"en","type":"article","venue":"MGM Journal of Medical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docking (animal); Multiple drug resistance; In silico; Computational biology; Cytochrome P450; Perspective (graphical); Computer science; Chemistry; Biology; Drug resistance; Medicine; Biochemistry; Genetics; Artificial intelligence; Veterinary medicine; Enzyme; Gene","score_opus":0.19732961380148267,"score_gpt":0.4854054561425204,"score_spread":0.2880758423410377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520490671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8616368,0.0054081194,0.09073248,0.0021196797,0.00025626362,0.00022661344,0.009574467,0.0045154262,0.02553017],"genre_scores_gemma":[0.94543976,0.0023375174,0.039728228,0.00024298838,0.000041239746,0.00020586,0.0081320815,0.000299225,0.003573122],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998504,0.00004623174,0.000007731399,0.000027474727,0.00003691907,0.000031162945],"domain_scores_gemma":[0.9998431,0.00008242488,0.000017548684,0.000008969455,0.000027401547,0.000020512303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029057555,0.0009899338,0.0011718264,0.00062655803,0.0006072911,0.0008023978,0.00087967917,0.0007902631,0.006311448],"category_scores_gemma":[0.00054718764,0.00031047314,0.0015054517,0.0005950755,0.00019278696,0.0004811686,0.000570229,0.0006178981,0.0010763694],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005911073,0.0004169857,0.025845544,0.0013421585,0.00075812364,0.0017175148,0.00017646808,0.9003883,0.031183684,0.006078113,0.00866093,0.022841133],"study_design_scores_gemma":[0.00007519763,0.0001950452,0.004416147,0.000057231293,0.00013862863,0.00034823958,0.000115066796,0.9823844,0.004073737,0.0031882962,0.0049778493,0.000030103598],"about_ca_topic_score_codex":0.0056475424,"about_ca_topic_score_gemma":0.005646423,"teacher_disagreement_score":0.006311448,"about_ca_system_score_codex":0.00043083917,"about_ca_system_score_gemma":0.0006916925,"threshold_uncertainty_score":0.021113873},"labels":[],"label_agreement":null},{"id":"W2522860656","doi":"10.1038/gim.2016.141","title":"Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study","year":2016,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Brigham and Women's Hospital; National Cancer Institute; National Institutes of Health; University of Minnesota; Stichting Jo Kolk Studiefonds; School of Public Health, University of Michigan; McMaster University; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Pharmacogenomics; Medicine; Medical prescription; Confidence interval; Odds ratio; Adverse effect; Genetic testing; Prescription drug; Pharmacy; Family medicine; Health care; Personal genomics; Internal medicine; Pharmacology; Genomics","score_opus":0.1515590852857511,"score_gpt":0.4378002259921142,"score_spread":0.2862411407063631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522860656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501157,0.00027271645,0.0001081397,0.00066050375,0.00002736336,0.00005868905,0.0013105847,0.000005907637,0.0025444783],"genre_scores_gemma":[0.99762636,0.00028299532,0.00019603074,0.0004779941,0.000051765048,0.00003997839,0.00058302586,0.000005382408,0.00073656335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969708,0.001003368,0.00029313637,0.0005203004,0.0009746739,0.00023773931],"domain_scores_gemma":[0.9837803,0.0061834,0.0067774877,0.00086310215,0.0011911456,0.001204543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00166951,0.0002596237,0.00041503517,0.00054321927,0.0006869609,0.0010323239,0.00072609197,0.0013467906,0.002345396],"category_scores_gemma":[0.016293755,0.0003669485,0.0008930949,0.0013478776,0.00040462206,0.0010745616,0.0010941869,0.0017300452,0.00031216315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012286691,0.00079548685,0.986061,0.000065307664,0.00023087692,0.00025424815,0.000575388,0.00004949145,0.00012741494,0.00007564487,0.0005186449,0.010017853],"study_design_scores_gemma":[0.00003630909,0.00027143973,0.9983113,0.000019880566,0.00012165624,0.00018345263,0.00035239584,0.00013000579,0.000061521816,0.00005842934,0.00044468656,0.000008949567],"about_ca_topic_score_codex":0.024885157,"about_ca_topic_score_gemma":0.027046205,"teacher_disagreement_score":0.024885157,"about_ca_system_score_codex":0.0011554394,"about_ca_system_score_gemma":0.0011365148,"threshold_uncertainty_score":0.049480617},"labels":[],"label_agreement":null},{"id":"W2522936975","doi":"10.9778/cmajo.20150070","title":"Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study","year":2016,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical decision support system; Medicine; Genotyping; Decision support system; Pharmacy; Pharmacogenetics; Pharmacist; Personalized medicine; Clinical pharmacy; Family medicine; Genotype; Bioinformatics; Data mining; Genetics","score_opus":0.21223345675622216,"score_gpt":0.5097739643622945,"score_spread":0.2975405076060723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522936975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916037,0.00009563836,0.000561035,0.00040099933,0.000019235691,0.006055684,0.00015840972,0.000020806558,0.0010845792],"genre_scores_gemma":[0.9852272,0.00023186898,0.006720021,0.00059486873,0.000099503115,0.0067505403,0.00016327765,0.00000766669,0.00020509666],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.97833055,0.016152717,0.000991509,0.0013114755,0.0015466596,0.0016670815],"domain_scores_gemma":[0.95613843,0.025773866,0.0048462497,0.0033848912,0.0030375726,0.006819027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0239032,0.00089592376,0.00079400593,0.0011791156,0.0017754929,0.0020713008,0.0012360174,0.0018077837,0.0046515274],"category_scores_gemma":[0.038347587,0.0013206399,0.0013513942,0.0011760824,0.0017663614,0.0025098417,0.0024104272,0.0018052341,0.00083897414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02661907,0.2644478,0.5860711,0.0011962606,0.00046679997,0.002068769,0.0133992545,0.00086169166,0.0016700441,0.0003714603,0.0018745061,0.10095329],"study_design_scores_gemma":[0.03202059,0.3882403,0.56070554,0.00041892356,0.00057807757,0.0012261232,0.00714898,0.0046122125,0.0008557238,0.00068258116,0.003331518,0.00017939426],"about_ca_topic_score_codex":0.006952106,"about_ca_topic_score_gemma":0.009485216,"teacher_disagreement_score":0.0239032,"about_ca_system_score_codex":0.002961753,"about_ca_system_score_gemma":0.008822798,"threshold_uncertainty_score":0.12641376},"labels":[],"label_agreement":null},{"id":"W2523790029","doi":"10.1136/bmj.i5309","title":"Revisiting the drug interaction between tamoxifen and SSRI antidepressants","year":2016,"lang":"en","type":"letter","venue":"BMJ","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Drug; Medicine; Harm; Pharmacology; Antidepressant; Attribution; Psychology; Psychiatry; Cancer; Internal medicine; Cytochrome P450; Anxiety; Social psychology","score_opus":0.13934483813948334,"score_gpt":0.4614536018219248,"score_spread":0.32210876368244146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523790029","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037323516,0.36441886,0.001765555,0.60008705,0.023219196,0.000046375193,0.00020802877,0.000054097443,0.0064684968],"genre_scores_gemma":[0.04638305,0.45967203,0.0037389603,0.3606634,0.12422668,0.00006148182,0.00028226813,0.00013448996,0.0048376285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9794581,0.009422877,0.00438623,0.0014159726,0.0048255683,0.0004912689],"domain_scores_gemma":[0.88172686,0.09325951,0.008191125,0.0018311788,0.013808536,0.0011828792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018288935,0.0007398641,0.0023395736,0.0030077184,0.0014400786,0.0043715043,0.0023787958,0.007780161,0.004175787],"category_scores_gemma":[0.07547646,0.0008106063,0.0020757478,0.002237244,0.0037943854,0.009705543,0.0023139403,0.014679634,0.0020210508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005058316,0.00016532668,0.012329508,0.016614707,0.0016057277,0.008602903,0.004321855,0.0005348902,0.0013082055,0.025195353,0.43707383,0.49174184],"study_design_scores_gemma":[0.00014011502,0.00027804912,0.006982862,0.0198182,0.0010694666,0.008588907,0.0035374248,0.0005391202,0.00047226175,0.018899787,0.9395457,0.00012805902],"about_ca_topic_score_codex":0.012608495,"about_ca_topic_score_gemma":0.037429754,"teacher_disagreement_score":0.018288935,"about_ca_system_score_codex":0.0043395567,"about_ca_system_score_gemma":0.006202121,"threshold_uncertainty_score":0.096722305},"labels":[],"label_agreement":null},{"id":"W2524956930","doi":"10.1021/acscatal.6b02154","title":"Evolution of P450 Monooxygenases toward Formation of Transient Channels and Exclusion of Nonproductive Gases","year":2016,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Compute Canada","keywords":"Bacillus megaterium; Monooxygenase; Chemistry; Molecular dynamics; Ligand (biochemistry); Protein dynamics; Allosteric regulation; Biophysics; Enzyme; Cytochrome P450; Biology; Biochemistry; Computational chemistry; Genetics; Bacteria","score_opus":0.07094586892274068,"score_gpt":0.3664268244716949,"score_spread":0.2954809555489542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524956930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958936,0.00008218413,0.0034556426,0.00005941258,0.0000025201089,0.0000042340985,0.00002794684,0.000044663055,0.00042972527],"genre_scores_gemma":[0.997198,0.00009532312,0.0024640136,0.0000119997485,0.0000012079056,0.0000042140236,0.000043803262,0.000009168792,0.00017236904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993277,0.000012424575,0.0000029311025,0.000017871094,0.000015125027,0.000018831981],"domain_scores_gemma":[0.99988484,0.000034016117,0.000023193614,0.000014672262,0.000014498021,0.000028633436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018406007,0.00017013581,0.00017296264,0.00008784025,0.00019567394,0.00040685246,0.000162372,0.0003139901,0.00035224532],"category_scores_gemma":[0.00045150405,0.00014046593,0.00018390149,0.00011425196,0.0002525043,0.0003231249,0.00023303852,0.00041124003,0.0001049436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003202717,0.00011484207,0.021007068,0.00006763977,0.000022499731,0.00034010748,0.00014697366,0.02052572,0.93957454,0.005839049,0.00021268064,0.011828669],"study_design_scores_gemma":[0.00008591181,0.0005580489,0.05028405,0.00001895188,0.000044819262,0.00081260246,0.00033576033,0.30561796,0.6319753,0.005669426,0.0045455825,0.000051622825],"about_ca_topic_score_codex":0.0009632541,"about_ca_topic_score_gemma":0.00097295915,"teacher_disagreement_score":0.0009632541,"about_ca_system_score_codex":0.00033322634,"about_ca_system_score_gemma":0.00023662692,"threshold_uncertainty_score":0.0024176836},"labels":[],"label_agreement":null},{"id":"W2527567516","doi":"10.1097/mol.0000000000000351","title":"Pharmacogenomic approaches to lipid-regulating trials","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical trial; Drug development; Drug; Bioinformatics; Pharmacogenetics; Population; Intensive care medicine; Repurposing; Drug response; Pharmacology; Internal medicine; Biology; Gene; Genetics; Genotype","score_opus":0.82353938007887,"score_gpt":0.5939195800335803,"score_spread":0.2296198000452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527567516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075127384,0.9946557,0.0016286467,0.0017207362,0.00065285346,0.00014963308,0.00007942695,0.000032278007,0.0010056352],"genre_scores_gemma":[0.0014330975,0.99217343,0.0029468236,0.0018673949,0.0007724456,0.0003282136,0.00008070289,0.00001559056,0.00038231682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99389607,0.003682927,0.0008732694,0.00044067265,0.0009830922,0.0001239312],"domain_scores_gemma":[0.97739685,0.018508274,0.0019073975,0.00047314752,0.0014620019,0.00025239083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010003881,0.0016077872,0.0040761344,0.0034558186,0.00030776096,0.0027654264,0.002350665,0.0026057728,0.00995544],"category_scores_gemma":[0.03192619,0.0005962549,0.0023789213,0.0034571735,0.00145783,0.0019055406,0.0015858366,0.0033666014,0.0025396068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024924095,0.000068633824,0.00021035585,0.117911965,0.0013021262,0.00016630109,0.000072352384,0.00069771614,0.00037119904,0.013091441,0.030778151,0.83508056],"study_design_scores_gemma":[0.00052255916,0.00031789005,0.0017011389,0.15193772,0.0041424083,0.0011263621,0.00012944562,0.0007589427,0.00084330945,0.03481501,0.8036176,0.00008773434],"about_ca_topic_score_codex":0.00058060145,"about_ca_topic_score_gemma":0.0008841299,"teacher_disagreement_score":0.010003881,"about_ca_system_score_codex":0.0017036314,"about_ca_system_score_gemma":0.004161999,"threshold_uncertainty_score":0.052906215},"labels":[],"label_agreement":null},{"id":"W2533187150","doi":"10.1007/s12630-016-0748-1","title":"Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacogenomics; Pharmacology; Bioinformatics; Biology; Genotype","score_opus":0.10765718170267914,"score_gpt":0.40976121450300707,"score_spread":0.30210403280032794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533187150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007932621,0.9994665,0.000042830517,0.00020920295,0.000057915764,0.000002738565,0.000018306693,0.0000012986397,0.000121826866],"genre_scores_gemma":[0.0005752301,0.9988889,0.00011813023,0.00021190949,0.00012483251,0.0000036925255,0.000018446877,4.3010735e-7,0.00005847006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958605,0.00009531677,0.00009654948,0.00008689307,0.00010843439,0.000026757714],"domain_scores_gemma":[0.9976847,0.0016430889,0.00038871443,0.000026940294,0.00020810514,0.00004838688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012224574,0.0008499706,0.0019167991,0.0029074787,0.0002340856,0.001454572,0.0009178887,0.0012951542,0.0030039987],"category_scores_gemma":[0.0037101142,0.00030659538,0.0013616126,0.0035899743,0.00038998845,0.0012748484,0.0008254215,0.001283149,0.0004323019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019702956,0.00010132226,0.001933795,0.13508916,0.0015821061,0.0006817701,0.00013096939,0.0005783586,0.0008433449,0.003284504,0.032312397,0.8232652],"study_design_scores_gemma":[0.00014577969,0.00032331533,0.01004111,0.11737971,0.0075940723,0.005711652,0.00038548117,0.00046633885,0.0005840637,0.00461094,0.85263497,0.00012256345],"about_ca_topic_score_codex":0.0023416658,"about_ca_topic_score_gemma":0.0058660866,"teacher_disagreement_score":0.0030039987,"about_ca_system_score_codex":0.00065113604,"about_ca_system_score_gemma":0.0027576052,"threshold_uncertainty_score":0.010049343},"labels":[],"label_agreement":null},{"id":"W2535322980","doi":"10.2217/pgs-2016-0092","title":"Addressing Ethical Challenges at the Intersection of Pharmacogenomics and Primary Care Using Deliberative Consultations","year":2016,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McGill University","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada; Genome Canada; McGill University; Genomic Health","keywords":"Pharmacogenomics; Intersection (aeronautics); Primary care; Medicine; Psychology; Pharmacology; Family medicine; Geography","score_opus":0.3131163019317046,"score_gpt":0.4709055873271369,"score_spread":0.1577892853954323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535322980","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08024747,0.0036706382,0.1603069,0.7087092,0.0021880444,0.0021930905,0.00005326068,0.00016742642,0.042463947],"genre_scores_gemma":[0.85230446,0.0014717393,0.066253096,0.07359819,0.0008232531,0.0021644589,0.000028909442,0.000083691506,0.0032722477],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.4625195,0.5004919,0.007703627,0.0073428084,0.011006206,0.010935949],"domain_scores_gemma":[0.5024288,0.43129012,0.017814932,0.014246047,0.015438158,0.018781984],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29670534,0.0011604958,0.0013244628,0.0018155739,0.026596682,0.019027254,0.0043665012,0.019664994,0.0037444278],"category_scores_gemma":[0.25540617,0.0012605409,0.00186219,0.001365028,0.071251765,0.016069086,0.034215786,0.02930409,0.0006994032],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002179536,0.00033833517,0.0035953256,0.0010642296,0.00013694208,0.006568511,0.60955286,0.0016592274,0.0019435851,0.32181573,0.016878568,0.03622873],"study_design_scores_gemma":[0.000155689,0.00019612713,0.0011543854,0.002383485,0.00005205776,0.0030082783,0.26722628,0.0026250032,0.0018728474,0.5734979,0.14762998,0.0001979865],"about_ca_topic_score_codex":0.0031905943,"about_ca_topic_score_gemma":0.0035683957,"teacher_disagreement_score":0.29670534,"about_ca_system_score_codex":0.016949361,"about_ca_system_score_gemma":0.04761059,"threshold_uncertainty_score":0.8672875},"labels":[],"label_agreement":null},{"id":"W2535554156","doi":"10.1038/tpj.2016.77","title":"The global spectrum of protein-coding pharmacogenomic diversity","year":2016,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Biology; Genetics; Genetic variation; Minor allele frequency; 1000 Genomes Project; Genetic diversity; Allele frequency; Evolutionary biology; Genome; Population; Allele; Computational biology; Gene; Single-nucleotide polymorphism; Genotype; Medicine","score_opus":0.1007823355141766,"score_gpt":0.3989009761193356,"score_spread":0.298118640605159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535554156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685753,0.0020097485,0.0043147136,0.00026264295,0.00001169723,0.000025349571,0.0036622463,0.00006569939,0.0027904084],"genre_scores_gemma":[0.9956702,0.00050808064,0.0010938306,0.000091219015,0.000018373166,0.000019444373,0.0023990364,0.000023614459,0.00017611019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890494,0.0003780107,0.000077603014,0.00036288038,0.00016899906,0.000107537744],"domain_scores_gemma":[0.99801743,0.00102821,0.00038121062,0.00027415247,0.00018617998,0.00011279128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459918,0.00027716524,0.0006969104,0.0018852224,0.00017991441,0.000714932,0.00025993006,0.00030721512,0.0023739224],"category_scores_gemma":[0.0029474124,0.00016529445,0.0005345973,0.002125933,0.0005159061,0.0005367661,0.00090730673,0.00033407693,0.00026699388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005120472,0.000033522818,0.920873,0.00018011889,0.0014483184,0.00035684003,0.00041613387,0.001049834,0.025922196,0.0006595302,0.00077944377,0.047768973],"study_design_scores_gemma":[0.000006109584,0.000054003936,0.9963851,0.000012636072,0.0001030612,0.0003851635,0.00012463544,0.0003170548,0.00053899304,0.00092935347,0.0011354818,0.000008380897],"about_ca_topic_score_codex":0.0007689181,"about_ca_topic_score_gemma":0.0009161242,"teacher_disagreement_score":0.0023739224,"about_ca_system_score_codex":0.00017033434,"about_ca_system_score_gemma":0.00011565503,"threshold_uncertainty_score":0.007941604},"labels":[],"label_agreement":null},{"id":"W2537847509","doi":"10.1182/blood.v118.21.4335.4335","title":"Study of Octaplex Dosing Accuracy: An In Vitro Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre; McMaster University","funders":"","keywords":"Dosing; Warfarin; Medicine; Internal medicine; Gastroenterology; Factor IX; Prothrombin complex concentrate; Prothrombin time; Factor VII; Surgery; Coagulation; Atrial fibrillation","score_opus":0.20142735202482526,"score_gpt":0.4445880529881058,"score_spread":0.24316070096328052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537847509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719892,0.0048617045,0.01934161,0.0002033053,0.00020462996,0.00034355998,0.0009656227,0.00012669113,0.0019636338],"genre_scores_gemma":[0.9816151,0.0013702483,0.013042353,0.0001631456,0.0000720094,0.00010721207,0.0018985354,0.000049414793,0.0016819546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941532,0.0022515832,0.00073437684,0.000763823,0.0018637447,0.0002332692],"domain_scores_gemma":[0.990341,0.005092478,0.0013891729,0.000954192,0.0020505395,0.0001726411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004153533,0.00066073646,0.0005707097,0.0006495827,0.00023278558,0.0013790841,0.0006443251,0.00057808345,0.0016122506],"category_scores_gemma":[0.008094622,0.00035697967,0.00049109326,0.00092972367,0.00047878653,0.0005413639,0.00046789483,0.0007934278,0.00079510536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031854757,0.0010611849,0.023833994,0.00046975823,0.00038397557,0.00013786046,0.00057499995,0.0050706873,0.93280905,0.00036258082,0.0006554708,0.031455014],"study_design_scores_gemma":[0.000055558165,0.0042372225,0.015209799,0.000037508522,0.00024821368,0.00031912237,0.00012972449,0.019936683,0.95746136,0.000097767595,0.00223239,0.000034612716],"about_ca_topic_score_codex":0.0015956454,"about_ca_topic_score_gemma":0.0007139539,"teacher_disagreement_score":0.004153533,"about_ca_system_score_codex":0.0006573792,"about_ca_system_score_gemma":0.00031704537,"threshold_uncertainty_score":0.021966279},"labels":[],"label_agreement":null},{"id":"W2548208806","doi":"10.1124/jpet.116.237594","title":"Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; U.S. National Library of Medicine; National Institute of General Medical Sciences; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Biology; Genotype; Cytochrome P450; Reductase; Messenger RNA; Phenotype; Endocrinology; Internal medicine; Genetics; Enzyme; Metabolism; Gene; Biochemistry; Medicine; CYP1A2","score_opus":0.05215489596841646,"score_gpt":0.38604787466293217,"score_spread":0.33389297869451573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548208806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909484,0.00008258018,0.0001795904,0.000038888516,0.0000037172977,0.0000028588188,0.000282149,0.000004137031,0.00031123945],"genre_scores_gemma":[0.99950767,0.000026073709,0.000079463956,0.000014490521,0.0000060899565,0.000002553778,0.0002194292,0.0000049402233,0.00013925094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989176,0.0004420758,0.0001018256,0.00026353807,0.00016583691,0.00010914899],"domain_scores_gemma":[0.99692494,0.0012763588,0.000791013,0.0003179683,0.00033485566,0.00035487086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009420706,0.00015845434,0.00034120964,0.0008626711,0.00045914875,0.0007826239,0.0002552796,0.00033155005,0.002110676],"category_scores_gemma":[0.003450761,0.00015725577,0.00026726027,0.0014497401,0.0005464712,0.0003207328,0.00035478218,0.00044414387,0.0004865802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024336991,0.000019401705,0.997273,0.000003526042,0.000044374032,0.00007827057,0.000056312234,0.00008725128,0.0010351395,0.00003017674,0.00008331398,0.001045772],"study_design_scores_gemma":[0.0000054732645,0.00008929799,0.9980161,0.0000022185047,0.000034447934,0.00037821123,0.00017871193,0.000456925,0.000590588,0.00004943718,0.00019465991,0.000003861801],"about_ca_topic_score_codex":0.0040210458,"about_ca_topic_score_gemma":0.004188202,"teacher_disagreement_score":0.0040210458,"about_ca_system_score_codex":0.00028402603,"about_ca_system_score_gemma":0.00031452192,"threshold_uncertainty_score":0.007995307},"labels":[],"label_agreement":null},{"id":"W2549035745","doi":"10.18433/j31s53","title":"Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ryobi Teien Memory Foundation","keywords":"Ketoconazole; CYP2C8; Azole; CYP2C9; Tolbutamide; Miconazole; Chemistry; Cytochrome P450; Pharmacology; Itraconazole; CYP3A4; CYP2C19; Biochemistry; Metabolism; Biology; Endocrinology; Antifungal; Microbiology","score_opus":0.18777868892371355,"score_gpt":0.4969228298296273,"score_spread":0.3091441409059138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549035745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800295,0.013719584,0.0020171136,0.00023594133,0.00006348755,0.000060567014,0.0004965533,0.00006713358,0.0033101283],"genre_scores_gemma":[0.99472743,0.0022570381,0.0010302105,0.00007907969,0.00004316752,0.000039594466,0.0005273921,0.000013094966,0.0012830364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994723,0.00022076163,0.00003805591,0.000111722264,0.00010049439,0.000056736735],"domain_scores_gemma":[0.99969757,0.00012348242,0.00005710681,0.00002760791,0.00006924245,0.00002505307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039766813,0.00034916968,0.00036886946,0.00018831006,0.0002093788,0.00028619327,0.00012130222,0.00031444334,0.0021395772],"category_scores_gemma":[0.0006861299,0.00013951602,0.00034607472,0.0003157748,0.00021713183,0.00018371029,0.00009693609,0.00033541967,0.00039838013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008247318,0.000110936875,0.0074166385,0.00022313408,0.00008210375,0.00019034737,0.000046746205,0.00031954955,0.9771221,0.000074807016,0.00034473668,0.013244171],"study_design_scores_gemma":[0.00007281837,0.0017553682,0.078982845,0.000020082563,0.00012277823,0.0011006468,0.00006241068,0.0018355445,0.91057813,0.000057310153,0.0053931978,0.000018877809],"about_ca_topic_score_codex":0.001219465,"about_ca_topic_score_gemma":0.0011169816,"teacher_disagreement_score":0.0021395772,"about_ca_system_score_codex":0.0002491484,"about_ca_system_score_gemma":0.00018495024,"threshold_uncertainty_score":0.007157564},"labels":[],"label_agreement":null},{"id":"W2557663861","doi":"10.1002/cbic.201600546","title":"Active Site Crowding of Cytochrome P450 3A4 as a Strategy To Alter Its Selectivity","year":2016,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Steric effects; Chemistry; Active site; Selectivity; Hydroxylation; Cytochrome P450; Stereochemistry; Stereoselectivity; Substrate (aquarium); Protein engineering; Combinatorial chemistry; Rational design; Steroid; Enzyme; Biochemistry; Catalysis; Biology; Hormone","score_opus":0.10403937678240176,"score_gpt":0.4469718959792338,"score_spread":0.34293251919683204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557663861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747005,0.0009880824,0.022096626,0.00023695215,0.000046645033,0.00006476972,0.00010912296,0.00015078353,0.0016066107],"genre_scores_gemma":[0.9918848,0.00044486305,0.0065555354,0.000068221765,0.000016458513,0.000023628761,0.00008605866,0.000030257754,0.0008901505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972135,0.00007305542,0.000020084186,0.00006527632,0.00007144004,0.00004881037],"domain_scores_gemma":[0.9997904,0.00005467302,0.000066955996,0.000030347868,0.000028574428,0.000028988807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037888435,0.0003481695,0.00032439225,0.0001476173,0.00019192841,0.0003093902,0.00025645082,0.000335213,0.0006228488],"category_scores_gemma":[0.00039829887,0.00014047798,0.00028581836,0.0001434797,0.00029529756,0.00023315432,0.00029385937,0.00053350645,0.00026202737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007301334,0.00001678402,0.000120039316,0.000027800834,0.000006558241,0.00006286914,0.000023257548,0.00044009925,0.9969374,0.00024127412,0.000035655878,0.0020153096],"study_design_scores_gemma":[0.000009403278,0.0001337255,0.0002029719,0.000002287681,0.0000072909743,0.000098649834,0.000008167513,0.0010225889,0.9969285,0.00006862166,0.0015125148,0.000005240755],"about_ca_topic_score_codex":0.0004600175,"about_ca_topic_score_gemma":0.0005008228,"teacher_disagreement_score":0.0006228488,"about_ca_system_score_codex":0.00032713736,"about_ca_system_score_gemma":0.00023427115,"threshold_uncertainty_score":0.0023735762},"labels":[],"label_agreement":null},{"id":"W2560643933","doi":"10.1016/j.jchromb.2016.12.006","title":"Highly sensitive LC–MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human","year":2016,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Chemistry; Chlorzoxazone; Chromatography; Tolbutamide; Ammonium formate; Formic acid; Paraxanthine; Dextromethorphan; CYP1A2; Tandem mass spectrometry; Dextrorphan; Mass spectrometry; Pharmacology; Cytochrome P450; Metabolism; Insulin; Biochemistry; CYP2E1","score_opus":0.11888473025561992,"score_gpt":0.4681582879903784,"score_spread":0.3492735577347585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560643933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64010924,0.01812418,0.3317206,0.0010301794,0.00028596222,0.0007363635,0.0024488925,0.0010649466,0.0044796136],"genre_scores_gemma":[0.81815094,0.004788911,0.16781786,0.0015028648,0.00015593512,0.00080379716,0.0015901765,0.00008735997,0.0051020565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999302,0.00015778813,0.000042296637,0.0001778854,0.00027597768,0.000043993376],"domain_scores_gemma":[0.9994128,0.0002708306,0.00008861443,0.000049043076,0.00010845769,0.00007036314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009123399,0.0006372149,0.00043378922,0.0006892771,0.00037341967,0.00032170909,0.00039318707,0.00081517565,0.0010277609],"category_scores_gemma":[0.0012111599,0.0005391478,0.00035425968,0.00037656806,0.00057515607,0.00031399578,0.00034111404,0.0014799258,0.00058449415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036684395,0.00008029019,0.0017103445,0.000106807376,0.000064357424,0.00007666482,0.000053213826,0.00022988407,0.9717396,0.00018612194,0.0003134391,0.02507236],"study_design_scores_gemma":[0.0001096576,0.0012572409,0.015101999,0.000026600032,0.0002230439,0.0023565132,0.000059065023,0.003234858,0.97152203,0.00046690652,0.0055943625,0.000047655834],"about_ca_topic_score_codex":0.00081595435,"about_ca_topic_score_gemma":0.0033443738,"teacher_disagreement_score":0.0010277609,"about_ca_system_score_codex":0.00040813666,"about_ca_system_score_gemma":0.0007102096,"threshold_uncertainty_score":0.0048249364},"labels":[],"label_agreement":null},{"id":"W2561831579","doi":"10.1002/cpt.597","title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute of Mental Health; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Dosing; Pharmacogenetics; Guideline; CYP2C19; CYP2D6; Tricyclic; Medicine; Pharmacology; Internal medicine; Genotype; Biology; Genetics","score_opus":0.19379102528921807,"score_gpt":0.5511572408294994,"score_spread":0.35736621554028125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561831579","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009176486,0.13838892,0.07751295,0.4574609,0.02544258,0.006473005,0.029612081,0.0052565667,0.25067654],"genre_scores_gemma":[0.049969804,0.19573869,0.26809534,0.2808834,0.015474319,0.011807032,0.09142127,0.0019658653,0.08464431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97544235,0.0068528214,0.007086213,0.00086317665,0.008841082,0.0009142948],"domain_scores_gemma":[0.932613,0.017203089,0.0064267246,0.0020816193,0.039162904,0.0025126177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02014396,0.0010362077,0.0023816978,0.0035038267,0.0009914067,0.0031657352,0.005269953,0.008842861,0.007982027],"category_scores_gemma":[0.060057033,0.0010489528,0.0033297893,0.0041078534,0.001021314,0.0020089678,0.0026830074,0.008285037,0.0063590407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012333535,0.00027121181,0.0022499328,0.0016193014,0.000104421604,0.00045712272,0.00020146286,0.00060215115,0.00067601766,0.0034059328,0.747423,0.24286616],"study_design_scores_gemma":[0.00028915316,0.00012837359,0.007710365,0.0056919935,0.00030177223,0.0012775799,0.0001275303,0.00064738555,0.00083739695,0.0023405675,0.98057866,0.000069266236],"about_ca_topic_score_codex":0.027724981,"about_ca_topic_score_gemma":0.041854396,"teacher_disagreement_score":0.027724981,"about_ca_system_score_codex":0.0035962842,"about_ca_system_score_gemma":0.02102856,"threshold_uncertainty_score":0.10653269},"labels":[],"label_agreement":null},{"id":"W2562914031","doi":"10.4088/jcp.15r10583","title":"Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?","year":2017,"lang":"en","type":"review","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"","keywords":"Major depressive disorder; Pharmacogenomics; Psychology; Psychiatry; Medicine; Clinical psychology; Pharmacology; Mood","score_opus":0.45904534040828676,"score_gpt":0.622301210369262,"score_spread":0.16325586996097524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562914031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024868753,0.9539819,0.0016331259,0.01281532,0.00071212073,0.0002861458,0.0029327858,0.000039718412,0.002730059],"genre_scores_gemma":[0.47420055,0.5102385,0.0037531133,0.0070499247,0.0019399057,0.0004538862,0.0020124384,0.000036411126,0.00031524568],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9829928,0.009773336,0.0033594358,0.0013060246,0.0023384625,0.00022983961],"domain_scores_gemma":[0.90241444,0.07582878,0.016907364,0.0013947606,0.0030235758,0.00043124202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01985378,0.00052842376,0.0037211378,0.0018121094,0.00023051111,0.0019341102,0.0012046788,0.0013920326,0.0048736646],"category_scores_gemma":[0.10747161,0.00032950967,0.0074201683,0.003915279,0.0010117438,0.0016420378,0.0006435786,0.0016957071,0.0003261608],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014355889,0.00033859137,0.064817846,0.28820047,0.09676035,0.0003493789,0.00023256401,0.0026771708,0.00048527462,0.003805388,0.009839345,0.51813775],"study_design_scores_gemma":[0.016304718,0.0076062856,0.26690912,0.29296649,0.34299868,0.0016751616,0.00050363305,0.0041919574,0.0014420867,0.01521564,0.049912263,0.0002740052],"about_ca_topic_score_codex":0.0019127267,"about_ca_topic_score_gemma":0.0037244002,"teacher_disagreement_score":0.01985378,"about_ca_system_score_codex":0.0018783907,"about_ca_system_score_gemma":0.00251962,"threshold_uncertainty_score":0.10499811},"labels":[],"label_agreement":null},{"id":"W2564304028","doi":"10.18433/j3d313","title":"Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Ministerio de Economía y Competitividad","keywords":"Pharmacology; Dextrorphan; Paraxanthine; Pharmacokinetics; Dextromethorphan; Drug; Chemistry; Metabolite; CYP1A2; Cmax; Cytochrome P450; CYP3A4; Active metabolite; CYP2C19; CYP2C9; Medicine; Enzyme; Biochemistry","score_opus":0.40705014789223,"score_gpt":0.5650177962349782,"score_spread":0.15796764834274818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564304028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7986422,0.024755111,0.1601041,0.0042626387,0.0012761874,0.0017317707,0.0016250043,0.002554279,0.0050486587],"genre_scores_gemma":[0.85855246,0.01691449,0.1099691,0.0016890434,0.00041724407,0.0016773952,0.0027802214,0.00030811396,0.007691897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985806,0.0006583275,0.00007574821,0.00024011558,0.00034186657,0.000103384074],"domain_scores_gemma":[0.99888915,0.0002127432,0.0003074571,0.0002789765,0.00015228885,0.00015935855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023451687,0.0012486938,0.0011929974,0.00057468977,0.00023848214,0.0007310525,0.00055716006,0.0009336518,0.0019491647],"category_scores_gemma":[0.0017761623,0.0004598259,0.0006084913,0.00046243955,0.0007461861,0.0008049568,0.0003530106,0.0014078699,0.001165691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036572372,0.0006918515,0.0021900688,0.00031104914,0.00020475408,0.00014620837,0.00003055274,0.0004982572,0.94645876,0.0004645217,0.00079224765,0.044554323],"study_design_scores_gemma":[0.0005674076,0.029967507,0.0090442095,0.0000943179,0.0004515621,0.0015071217,0.000070047274,0.0028208022,0.91946083,0.00066865364,0.035286445,0.00006109008],"about_ca_topic_score_codex":0.00049447996,"about_ca_topic_score_gemma":0.00093272177,"teacher_disagreement_score":0.0023451687,"about_ca_system_score_codex":0.00038069155,"about_ca_system_score_gemma":0.0005617991,"threshold_uncertainty_score":0.012402594},"labels":[],"label_agreement":null},{"id":"W2567939023","doi":"10.1177/070674370404900115","title":"Book Review: Psychopharmacology: Pharmacogenetics of Psychotropic Drugs","year":2004,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychopharmacology; Pharmacogenetics; Psychotropic drug; Medicine; Psychiatry; Psychology; Pharmacology; Drug; Genetics; Biology; Genotype","score_opus":0.03770103427165227,"score_gpt":0.38996199579033164,"score_spread":0.35226096151867936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567939023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001826418,0.705108,0.0010206137,0.051274005,0.2070169,0.00007844321,0.00030741678,0.00016061247,0.034851395],"genre_scores_gemma":[0.0017194954,0.46047148,0.001702842,0.06176101,0.27135643,0.00010035296,0.00040958766,0.00014040779,0.20233841],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930584,0.00011431023,0.00005382173,0.000097514814,0.0003882485,0.000040230963],"domain_scores_gemma":[0.9974503,0.0010596715,0.00015484741,0.00006036654,0.00093525316,0.00033954935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009415658,0.001814114,0.002437477,0.0040965853,0.0007468712,0.0022738208,0.001468605,0.003926966,0.03170326],"category_scores_gemma":[0.0032473507,0.0006147265,0.0010246807,0.0028604784,0.00088369945,0.0022461389,0.0009806504,0.0051194476,0.02529276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014545578,0.00001357699,0.00004309096,0.00021814759,0.000012137036,0.00006932917,0.000005421065,0.000045059605,0.00007312277,0.00047847643,0.9701286,0.028898394],"study_design_scores_gemma":[0.00002571335,0.000026331938,0.00035063407,0.00033411186,0.000022817318,0.00071492116,0.000009898775,0.000053504766,0.000048014495,0.0011771959,0.99722713,0.000009716281],"about_ca_topic_score_codex":0.005504195,"about_ca_topic_score_gemma":0.021746406,"teacher_disagreement_score":0.03170326,"about_ca_system_score_codex":0.0020669086,"about_ca_system_score_gemma":0.0015727294,"threshold_uncertainty_score":0.106058},"labels":[],"label_agreement":null},{"id":"W2571716623","doi":"10.1177/070674370304800616","title":"Reply: Methylphenidate and the Cytochrome P450 System","year":2003,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Methylphenidate; Psychiatry; Psychology; Medicine; Attention deficit hyperactivity disorder","score_opus":0.05135224694632641,"score_gpt":0.3607866922528942,"score_spread":0.30943444530656783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571716623","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058566243,0.0049821655,0.00014519966,0.93021965,0.06324325,0.000009966145,0.00012416186,0.000021512691,0.0006684929],"genre_scores_gemma":[0.0053059193,0.0053940183,0.00028126617,0.85391045,0.12995256,0.000027296464,0.00008619431,0.000014197458,0.0050280727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876523,0.00035387828,0.0002365237,0.00018915995,0.0002936424,0.00016152913],"domain_scores_gemma":[0.99344736,0.0036996924,0.0004469287,0.00021020327,0.0015329726,0.000662857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022107689,0.00086451805,0.0012816094,0.0007758548,0.00143585,0.0016835275,0.0014077646,0.025112517,0.0050894306],"category_scores_gemma":[0.012221555,0.0006614613,0.0012351355,0.0007660058,0.0017880771,0.0025404876,0.0011189305,0.02423053,0.0030168837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013451155,0.000031113705,0.0012735171,0.00013114371,0.000059811195,0.001211554,0.00008767211,0.00006592924,0.00019239778,0.0008019434,0.98814887,0.007861648],"study_design_scores_gemma":[0.00026997968,0.00012389614,0.0058863293,0.0003176921,0.00015803034,0.0050238515,0.0006958772,0.00030128405,0.00043389932,0.0050492343,0.9816297,0.00011019814],"about_ca_topic_score_codex":0.0059485817,"about_ca_topic_score_gemma":0.007079465,"teacher_disagreement_score":0.025112517,"about_ca_system_score_codex":0.0015383697,"about_ca_system_score_gemma":0.0021159893,"threshold_uncertainty_score":0.017025828},"labels":[],"label_agreement":null},{"id":"W2572886822","doi":"10.2217/pme-2016-0083","title":"Highly Personalized Reports for Personalized Drug Selection by Expert Systems as Clinical Decision Support","year":2017,"lang":"en","type":"editorial","venue":"Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optina Diagnostics (Canada)","funders":"","keywords":"Pharmacogenomics; Medicine; MEDLINE; Personalized medicine; Pharmacogenetics; Family medicine; Pharmacology; Bioinformatics; Political science; Genotype","score_opus":0.09652853675061328,"score_gpt":0.502140253848471,"score_spread":0.40561171709785776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572886822","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045009958,0.010724654,0.0010539169,0.0729249,0.91385454,0.000031808057,0.00006420412,0.000119842975,0.0011810617],"genre_scores_gemma":[0.00051371695,0.0056814607,0.0007155823,0.031346675,0.9579575,0.000032063323,0.000031007065,0.000041880958,0.003680044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98824316,0.0039991224,0.0018263963,0.00092370145,0.0046119536,0.00039573095],"domain_scores_gemma":[0.92108727,0.05421093,0.0032204608,0.0020466093,0.016442483,0.002992286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015742015,0.0032980447,0.0035270047,0.0038921265,0.0018609539,0.009086206,0.0037812393,0.018506644,0.009210357],"category_scores_gemma":[0.059264243,0.0014983738,0.0032369338,0.001467001,0.0033796886,0.005615362,0.0025237387,0.026496401,0.0070204493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004337018,0.00001282722,0.000027803912,0.00028357178,0.000053852535,0.000096902215,0.000011738522,0.000057145546,0.000056362478,0.0009947435,0.98546195,0.012899679],"study_design_scores_gemma":[0.0001451779,0.000038688584,0.00020433283,0.00080402807,0.00015801095,0.00033169717,0.00002748601,0.0007488236,0.00023558318,0.005973491,0.9912888,0.00004383991],"about_ca_topic_score_codex":0.0009366554,"about_ca_topic_score_gemma":0.0022723738,"teacher_disagreement_score":0.018506644,"about_ca_system_score_codex":0.00274178,"about_ca_system_score_gemma":0.0031318064,"threshold_uncertainty_score":0.08325273},"labels":[],"label_agreement":null},{"id":"W2573364903","doi":"10.1161/atvb.32.suppl_1.a20","title":"Abstract 20: Evidence of UGT2B7 as a Pharmacogenetic Determinant of Variability in Serum Fenofibric Acid Levels in Human Subjects","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"UGT2B7; Fenofibrate; Pharmacogenetics; Pharmacokinetics; Internal medicine; Medicine; Genotype; Pharmacology; SNP; Area under the curve; Lipid profile; Analysis of variance; Endocrinology; Single-nucleotide polymorphism; Cholesterol; Gastroenterology; Biology; In vitro; Biochemistry; Gene","score_opus":0.20849667805414573,"score_gpt":0.4575235565975492,"score_spread":0.24902687854340344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573364903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981198,0.00032959646,0.0005142825,0.0000697575,0.000014037461,0.0000134734955,0.0002608999,0.000009400815,0.0006687147],"genre_scores_gemma":[0.99945706,0.00003023187,0.00018774752,0.00003203697,0.000019579904,0.000007294446,0.00012184536,0.0000058317237,0.00013842802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986273,0.0006374136,0.00011238151,0.00036330338,0.0001899409,0.000069661706],"domain_scores_gemma":[0.99636865,0.0014273442,0.001096515,0.00051220244,0.00025900232,0.00033625608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017201599,0.00039385576,0.00038823244,0.0005452416,0.00034614356,0.0005864738,0.00040009167,0.00072807056,0.0029943162],"category_scores_gemma":[0.00344429,0.0001738628,0.00041690998,0.0006694899,0.00053052214,0.00017862437,0.00027525207,0.00041095528,0.00047408565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013693353,0.00006488255,0.99035114,0.000027634345,0.0002821118,0.00057284517,0.00012750711,0.00009779928,0.004036476,0.00009399571,0.00019203215,0.0027841155],"study_design_scores_gemma":[0.00003457528,0.00050744566,0.9960233,0.000007309803,0.0001445186,0.0014187171,0.00007369091,0.0004962313,0.0007754303,0.00010904936,0.0004029668,0.000006735455],"about_ca_topic_score_codex":0.0012264468,"about_ca_topic_score_gemma":0.0006347171,"teacher_disagreement_score":0.0029943162,"about_ca_system_score_codex":0.00011619734,"about_ca_system_score_gemma":0.00017624431,"threshold_uncertainty_score":0.010017037},"labels":[],"label_agreement":null},{"id":"W2580337984","doi":"10.3390/ijms18010217","title":"In Vitro Biotransformation of Two Human CYP3A Probe Substrates and Their Inhibition during Early Zebrafish Development","year":2017,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Universiteit Antwerpen","keywords":"Zebrafish; Biotransformation; CYP3A4; Cytochrome P450; Metabolite; Microsome; Drug metabolism; Biochemistry; Biology; In vitro; Chemistry; Pharmacology; Enzyme","score_opus":0.06568454856530508,"score_gpt":0.41413441973436027,"score_spread":0.3484498711690552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580337984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96384877,0.006310662,0.022218717,0.00020336565,0.000061880215,0.00026842268,0.0032135823,0.0002478643,0.0036267159],"genre_scores_gemma":[0.96841365,0.0045115924,0.015176191,0.00009096188,0.00001745409,0.0003544193,0.0032981276,0.00006145961,0.008076118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997892,0.000043152224,0.00001837213,0.00005381712,0.00006524677,0.000030341349],"domain_scores_gemma":[0.999913,0.00002388944,0.000022345992,0.000010298128,0.000021162772,0.000009360692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031744887,0.00044160683,0.00024930027,0.00022739693,0.00017350461,0.00016790326,0.00015549513,0.00023076225,0.0011630822],"category_scores_gemma":[0.00024333074,0.00019377403,0.00033554088,0.00019020519,0.00017653563,0.00011928866,0.00014971373,0.0004728639,0.00054794835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052729833,0.000010390419,0.00017295795,0.000031476484,0.000004079173,0.000029750703,0.000016353692,0.00007255782,0.9986946,0.00002856743,0.00004561137,0.00084094494],"study_design_scores_gemma":[0.000007976953,0.0004005382,0.0035691634,0.0000048267725,0.000028808061,0.000086743115,0.000015813599,0.00039011668,0.99304974,0.000018015884,0.0024222294,0.0000060472453],"about_ca_topic_score_codex":0.0036123027,"about_ca_topic_score_gemma":0.005446278,"teacher_disagreement_score":0.0036123027,"about_ca_system_score_codex":0.00042839444,"about_ca_system_score_gemma":0.00035031,"threshold_uncertainty_score":0.0071825385},"labels":[],"label_agreement":null},{"id":"W2580818401","doi":"10.1139/cjpp-2016-0403","title":"A reappraisal of the 6-<i>O</i>-desmethylnaproxen-sulfating activity of the human cytosolic sulfotransferases","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sulfation; Cytosol; Sulfotransferase; Metabolite; In vivo; In vitro; Chemistry; Biochemistry; Kidney; Enzyme; Molecular biology; Biology; Endocrinology","score_opus":0.09516120243580925,"score_gpt":0.41715914374361557,"score_spread":0.32199794130780635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580818401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.772234,0.1923048,0.027076323,0.0020664742,0.00034488778,0.000050681923,0.00039639857,0.00013111133,0.005395402],"genre_scores_gemma":[0.86425066,0.11552271,0.015260131,0.0005946927,0.00046341665,0.000025251777,0.0007019278,0.000027549573,0.0031536922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999087,0.000019694568,0.000014909444,0.000021880232,0.000021184469,0.000013624372],"domain_scores_gemma":[0.9998313,0.00004266934,0.000034946337,0.000020245769,0.000049233713,0.000021626762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039892606,0.00059113343,0.0003334383,0.00036394174,0.00011693016,0.00047932603,0.00021935922,0.0003269921,0.00043793413],"category_scores_gemma":[0.00026296664,0.00015889433,0.0004266904,0.00024035144,0.00032047267,0.0007527403,0.00022837795,0.00056613435,0.00016184646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048567352,0.00004937609,0.009518244,0.0015242543,0.00012936641,0.0008917012,0.00033070883,0.00077000674,0.8723453,0.0010259292,0.00035032097,0.11257906],"study_design_scores_gemma":[0.000023508648,0.0025860723,0.037095707,0.00021476383,0.00045277146,0.0067027477,0.0010213137,0.003681958,0.864119,0.0017640208,0.082261704,0.00007644054],"about_ca_topic_score_codex":0.00039793606,"about_ca_topic_score_gemma":0.00050870026,"teacher_disagreement_score":0.00059113343,"about_ca_system_score_codex":0.00023633245,"about_ca_system_score_gemma":0.00031581937,"threshold_uncertainty_score":0.0021097064},"labels":[],"label_agreement":null},{"id":"W2585183403","doi":"10.1139/cjpp-2017-0014","title":"Downregulation of cytochrome P450 2C8 by 3-methylcholanthrene in human hepatocellular carcinoma cell lines","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Cytochrome P450; Cell culture; Methylcholanthrene; Hepatocyte; Hepatocellular carcinoma; CYP2C8; Biology; Messenger RNA; Chemistry; Cancer research; Cell biology; Carcinogen; Endocrinology; Metabolism; In vitro; Biochemistry; Gene; CYP2C9; Genetics","score_opus":0.060807045269917155,"score_gpt":0.379998645426156,"score_spread":0.3191916001562389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585183403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721835,0.0039367047,0.012819316,0.00031833161,0.00014286449,0.00031713228,0.0055156024,0.00031979734,0.004446699],"genre_scores_gemma":[0.96255577,0.0033674487,0.014789056,0.00014191827,0.00004180391,0.00050658645,0.010266917,0.00007227023,0.008258288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930716,0.00016239994,0.000113890885,0.00009308118,0.00024711344,0.00007640463],"domain_scores_gemma":[0.99969065,0.0000796364,0.000030125097,0.00008198016,0.00009278475,0.000024804509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047869224,0.00029443426,0.00049520825,0.0005694542,0.00039951445,0.0003865149,0.0001987487,0.0002353379,0.001989153],"category_scores_gemma":[0.0003031121,0.00021662602,0.0003693934,0.00086684205,0.00021692946,0.00022322283,0.00019936459,0.00053329114,0.0012151552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014217496,0.00007659786,0.0007291499,0.00006606235,0.00001525279,0.00009929445,0.00008608041,0.00012709465,0.9967873,0.00010364946,0.00019485959,0.0015725123],"study_design_scores_gemma":[0.00002540077,0.00044378696,0.009016617,0.00000545127,0.00003251151,0.00030642847,0.00007782151,0.001103266,0.98457664,0.00003399099,0.004367082,0.000011039638],"about_ca_topic_score_codex":0.0053883283,"about_ca_topic_score_gemma":0.007681826,"teacher_disagreement_score":0.0053883283,"about_ca_system_score_codex":0.0004477309,"about_ca_system_score_gemma":0.0004003339,"threshold_uncertainty_score":0.010713935},"labels":[],"label_agreement":null},{"id":"W2586508238","doi":"10.1097/fpc.0000000000000271","title":"Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"CYP2A6; Cotinine; Nicotine; Genotype; Lung cancer; Biology; Medicine; Genetics; Demography; Internal medicine; Oncology; Metabolism; Gene","score_opus":0.04418432566383716,"score_gpt":0.39351837328252376,"score_spread":0.3493340476186866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586508238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996629,0.00002074426,0.00007299878,0.0000101182795,0.0000012021823,0.000005310275,0.000034849436,0.0000013211879,0.00019052596],"genre_scores_gemma":[0.9996345,0.000015580985,0.00012570478,0.000012448856,0.000002540561,0.000006609684,0.000060434028,0.0000016272356,0.00014067261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996556,0.00013314084,0.00002418239,0.000079846526,0.00006667948,0.00004043849],"domain_scores_gemma":[0.9996338,0.00007106821,0.00008414773,0.000054563097,0.000066816225,0.0000895888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035761527,0.00022631587,0.0001699667,0.00049889716,0.00054050365,0.000376982,0.00026445233,0.00019434004,0.0011183247],"category_scores_gemma":[0.00094457006,0.00010567677,0.00022125663,0.000555427,0.00031828467,0.00014826721,0.00025276013,0.00023148196,0.00016999798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035058678,0.00017947952,0.98454976,0.000010955779,0.00012567974,0.00031887938,0.001353244,0.00006079028,0.008089745,0.00008089143,0.000099796365,0.004780152],"study_design_scores_gemma":[0.000010014798,0.00009740741,0.99829847,0.0000026288387,0.000027189053,0.00042448964,0.0005891637,0.00016780151,0.00021639238,0.000024735975,0.00013845836,0.0000032989067],"about_ca_topic_score_codex":0.012274738,"about_ca_topic_score_gemma":0.011522902,"teacher_disagreement_score":0.012274738,"about_ca_system_score_codex":0.0001776345,"about_ca_system_score_gemma":0.00016439757,"threshold_uncertainty_score":0.024406612},"labels":[],"label_agreement":null},{"id":"W2594345661","doi":"10.1182/blood.v112.11.988.988","title":"Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Warfarin; VKORC1; Medicine; CYP2C9; Vitamin K epoxide reductase; Pharmacogenetics; Retrospective cohort study; Genotyping; Population; Internal medicine; Dosing; Surgery; Pediatrics; Atrial fibrillation; Genotype; Biology","score_opus":0.10408123361477373,"score_gpt":0.3851185748491991,"score_spread":0.28103734123442536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594345661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781513,0.00035555955,0.00016759682,0.000041893374,0.000008313439,0.000030562864,0.0012262838,0.0000051860898,0.00034949408],"genre_scores_gemma":[0.99865854,0.00024048956,0.00018577177,0.000034467088,0.000009475602,0.000034928526,0.00076975184,0.000004820451,0.00006182022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986462,0.00024906592,0.00021256735,0.00041005248,0.00032307013,0.00015902243],"domain_scores_gemma":[0.9967709,0.00050329644,0.0017993201,0.0003221828,0.00030300638,0.00030123905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012045738,0.00042892355,0.00066884735,0.0014390656,0.00056658156,0.00075612834,0.0005489772,0.00051101064,0.0016530511],"category_scores_gemma":[0.0031271842,0.0005017868,0.0009634496,0.0025005962,0.00046745612,0.0006207133,0.00053838285,0.00084079604,0.0002702294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003430387,0.000008627665,0.99955493,0.0000052676924,0.0000336631,0.000055999717,0.000025102443,0.000013901876,0.000047198246,0.000005826841,0.00004075434,0.00017436252],"study_design_scores_gemma":[0.00000892234,0.00007825111,0.9986343,0.000009962897,0.000054971908,0.0006942556,0.00013458225,0.000120291,0.000060293467,0.0000069678904,0.00019274397,0.0000044215312],"about_ca_topic_score_codex":0.010205924,"about_ca_topic_score_gemma":0.006586707,"teacher_disagreement_score":0.010205924,"about_ca_system_score_codex":0.0006652577,"about_ca_system_score_gemma":0.000822417,"threshold_uncertainty_score":0.020293057},"labels":[],"label_agreement":null},{"id":"W2595774540","doi":"10.71781/31824","title":"Rôle du système endocrinien de la vitamine D³ sur l'induction de cytochromes P450 hépatiques impliquées dans la détoxication-cytoprotection","year":2006,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytoprotection; Medicine; Internal medicine; Oxidative stress","score_opus":0.04551776290879555,"score_gpt":0.41717136367317575,"score_spread":0.3716536007643802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595774540","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14470854,0.70048255,0.011246752,0.026627082,0.002374435,0.00012738672,0.0023539797,0.00034448318,0.11173471],"genre_scores_gemma":[0.47854894,0.3828957,0.0070342296,0.0014200748,0.0011062202,0.000082714614,0.0010280417,0.00007272274,0.12781137],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998708,0.000022734628,0.0000065108843,0.000033769342,0.00003921065,0.000026952992],"domain_scores_gemma":[0.99966323,0.00009369317,0.00003636291,0.000024900197,0.0001372458,0.000044592725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049869105,0.0003841126,0.00033882193,0.00085028895,0.00067183113,0.0012320305,0.00033738997,0.00039602476,0.008913173],"category_scores_gemma":[0.00060128234,0.00019858654,0.0003840998,0.0007273753,0.0007565392,0.0004363712,0.00032287484,0.00056483404,0.00067114097],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016736675,0.00016065735,0.010447836,0.004766846,0.0002697827,0.0015514769,0.0010581142,0.0011784792,0.35320228,0.052095424,0.030606525,0.54298896],"study_design_scores_gemma":[0.00017350973,0.00065950013,0.117210306,0.0010652058,0.000428755,0.0014314286,0.00060756423,0.0006180408,0.21294098,0.013142345,0.6516235,0.00009891445],"about_ca_topic_score_codex":0.057267852,"about_ca_topic_score_gemma":0.07912064,"teacher_disagreement_score":0.057267852,"about_ca_system_score_codex":0.0027054225,"about_ca_system_score_gemma":0.0034876578,"threshold_uncertainty_score":0.11386901},"labels":[],"label_agreement":null},{"id":"W2597143300","doi":"10.1097/mib.0000000000001062","title":"CYP3A4 Activity is Markedly Lower in Patients with Crohnʼs Disease","year":2017,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Crohn's disease; Medicine; Crohn disease; Gastroenterology; CYP3A4; Internal medicine; Disease","score_opus":0.035759694919710414,"score_gpt":0.35957335240041804,"score_spread":0.3238136574807076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597143300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683505,0.0014694014,0.0001889302,0.00009909572,0.000015051677,0.0000054400557,0.00024176342,0.000015907432,0.0011293496],"genre_scores_gemma":[0.9992588,0.00020627565,0.00013595918,0.000036762845,0.000018576106,0.0000034515197,0.00018037415,0.0000036181825,0.00015599605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967647,0.000068020425,0.000046817433,0.00009770199,0.00006488394,0.000046210433],"domain_scores_gemma":[0.99895513,0.00027445218,0.0005010447,0.000051158342,0.00009491872,0.00012333377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028425225,0.000272646,0.00050483353,0.00064634555,0.00040211133,0.00053476036,0.00012788508,0.000406651,0.0028865752],"category_scores_gemma":[0.0016918096,0.00013152577,0.00027431131,0.0007970644,0.00022885203,0.00021583331,0.00019415964,0.00052542455,0.0003793408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004107468,0.000025361727,0.9925061,0.000027861051,0.00004973552,0.00047240607,0.00005519614,0.00003315534,0.0021036994,0.000018757723,0.00014408864,0.004152805],"study_design_scores_gemma":[0.0000100368125,0.00011916107,0.9972361,0.000005911061,0.000047571444,0.0016249818,0.000065619606,0.00009481495,0.00030129572,0.000029708699,0.00046238303,0.0000023961486],"about_ca_topic_score_codex":0.0012032063,"about_ca_topic_score_gemma":0.0011367887,"teacher_disagreement_score":0.0028865752,"about_ca_system_score_codex":0.00025614657,"about_ca_system_score_gemma":0.00013681465,"threshold_uncertainty_score":0.009656489},"labels":[],"label_agreement":null},{"id":"W2597899656","doi":"","title":"Approval of new pharmacogenomic tests: is the Canadian regulatory process adequate?","year":2010,"lang":"en","type":"article","venue":"eYLS (Yale Law School)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Process (computing); Pharmacogenomics; Business; Risk analysis (engineering); Computer science; Medicine; Pharmacology","score_opus":0.0579327529319097,"score_gpt":0.3738509795033023,"score_spread":0.3159182265713926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597899656","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044919346,0.018041706,0.02576945,0.23048167,0.0018090281,0.0012288381,0.00468293,0.0003157814,0.67275125],"genre_scores_gemma":[0.74154556,0.019722583,0.031084688,0.12688836,0.0011525472,0.000653021,0.002544698,0.0002298306,0.076178774],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.88571,0.012900848,0.0035404295,0.0052373433,0.076127194,0.016484143],"domain_scores_gemma":[0.872395,0.03750014,0.0118635,0.005282821,0.0675542,0.0054043457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04645146,0.00076651154,0.0013215208,0.0064200163,0.0092238225,0.01844114,0.0046949643,0.008541726,0.008914754],"category_scores_gemma":[0.116736546,0.0007679409,0.0026668643,0.009800118,0.00981034,0.008603065,0.0026735922,0.007138343,0.0009827843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014216933,0.00007991871,0.022831844,0.00061251473,0.00014711024,0.00056917674,0.0011864569,0.0031646967,0.00057828863,0.8580212,0.05633585,0.056330748],"study_design_scores_gemma":[0.00025773104,0.00025904516,0.09509123,0.002792883,0.00081897306,0.00074348925,0.0045390893,0.011893684,0.0018129866,0.10487137,0.77644897,0.00047052966],"about_ca_topic_score_codex":0.95015705,"about_ca_topic_score_gemma":0.96591836,"teacher_disagreement_score":0.88682455,"about_ca_system_score_codex":0.113175474,"about_ca_system_score_gemma":0.2531499,"threshold_uncertainty_score":0.82114935},"labels":[],"label_agreement":null},{"id":"W2599508584","doi":"10.1111/bph.13787","title":"Constitutive androstane receptor regulates the intestinal mucosal response to injury","year":2017,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Crohn's and Colitis Canada; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Foundation","keywords":"Constitutive androstane receptor; Ulcerative colitis; Inflammatory bowel disease; Colitis; Inflammation; Pregnane X receptor; Receptor; Intestinal mucosa; Xenobiotic; Pharmacology; Immunology; Downregulation and upregulation; Medicine; Biology; Internal medicine; Chemistry; Nuclear receptor; Disease; Transcription factor; Biochemistry","score_opus":0.06599492103804959,"score_gpt":0.4350965312499956,"score_spread":0.369101610211946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599508584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844095,0.011672009,0.0016552741,0.00016036443,0.000027790064,0.000026069129,0.0002677883,0.00010378414,0.0016774544],"genre_scores_gemma":[0.99336135,0.0033263217,0.00089178083,0.00004557856,0.000019842399,0.000025125159,0.0002366853,0.000016733979,0.0020764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.000046064437,0.000012310805,0.000030732535,0.00003700972,0.000048883354],"domain_scores_gemma":[0.9998166,0.000022130054,0.000070536385,0.000018534683,0.00002856477,0.000043575063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017734325,0.00023649247,0.00024263017,0.0002263079,0.00014568548,0.00043887587,0.00014763519,0.00028084457,0.0016252495],"category_scores_gemma":[0.00017436768,0.00012969092,0.00028674444,0.00015063661,0.0002829924,0.00021359672,0.00017082455,0.00051747216,0.0005683104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047839995,0.000031070387,0.0014416802,0.00009661607,0.000008833762,0.00012487033,0.000024312814,0.00004736331,0.99555814,0.00011405902,0.0000609629,0.0020137837],"study_design_scores_gemma":[0.000095946794,0.0016440641,0.13776845,0.00005830695,0.00017601163,0.0031535607,0.00035209526,0.0011860431,0.8440913,0.00026424392,0.011189555,0.000020408526],"about_ca_topic_score_codex":0.00019350741,"about_ca_topic_score_gemma":0.00027409327,"teacher_disagreement_score":0.0016252495,"about_ca_system_score_codex":0.00019574915,"about_ca_system_score_gemma":0.00014851327,"threshold_uncertainty_score":0.005436957},"labels":[],"label_agreement":null},{"id":"W2602060348","doi":"10.1021/acs.bioconjchem.6b00604","title":"Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation","year":2017,"lang":"ca","type":"article","venue":"Bioconjugate Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; University of California, San Francisco","keywords":"Allosteric regulation; Chemistry; Cooperativity; CYP3A4; Cytochrome P450; Allosteric enzyme; Cooperative binding; Bioconjugation; Enzyme; Binding site; Biochemistry; Active site","score_opus":0.09445168265934384,"score_gpt":0.41161321144131896,"score_spread":0.3171615287819751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602060348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992415,0.00041704692,0.005535512,0.00009730676,0.00001768168,0.000023870074,0.000039113835,0.000055633758,0.0013988466],"genre_scores_gemma":[0.99597555,0.00024312375,0.002418303,0.000032343003,0.000004418322,0.000013182474,0.000046204652,0.000010763039,0.0012561888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998179,0.00006094866,0.000008845362,0.00004210046,0.000037616872,0.00003255276],"domain_scores_gemma":[0.99989915,0.000020848876,0.00003444628,0.000022037546,0.0000140315815,0.000009445106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018185089,0.00030249832,0.00016899644,0.00009906067,0.00012350311,0.0001594737,0.00019758382,0.00021030678,0.0005496238],"category_scores_gemma":[0.0002645073,0.00011600791,0.0002256047,0.00015435852,0.00021876539,0.00012603166,0.0002018985,0.000338983,0.00018341189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057604288,0.000022639175,0.00016309069,0.000018827748,0.0000045808406,0.00004705957,0.000019596442,0.00016213123,0.99732167,0.00023282549,0.00002919204,0.0019206705],"study_design_scores_gemma":[0.0000044845488,0.0001254623,0.00036636417,8.8683504e-7,0.00000586766,0.00006383724,0.000003875284,0.00047775923,0.99817276,0.000016367141,0.00076034287,0.0000019866957],"about_ca_topic_score_codex":0.00060336076,"about_ca_topic_score_gemma":0.0005909075,"teacher_disagreement_score":0.00060336076,"about_ca_system_score_codex":0.00029591928,"about_ca_system_score_gemma":0.00012135232,"threshold_uncertainty_score":0.0021470785},"labels":[],"label_agreement":null},{"id":"W2605453051","doi":"10.1016/j.ejmech.2017.04.042","title":"Inhibitors of cytochrome P450 (CYP) 1B1","year":2017,"lang":"en","type":"review","venue":"European Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"CYP1B1; Cytochrome P450; Chemistry; Hydroxylation; Enzyme; Carcinogenesis; Carcinogen; Biochemistry; Cytochrome; Unspecific monooxygenase; CYP1A2; Gene","score_opus":0.34223543808148477,"score_gpt":0.5229245309550812,"score_spread":0.1806890928735964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605453051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009638869,0.9951416,0.00073897146,0.00033537755,0.00026402203,0.000017769835,0.00008545634,0.00003475126,0.0024180785],"genre_scores_gemma":[0.004952793,0.99145186,0.00066903816,0.00033691275,0.00020270837,0.000016182517,0.00014151081,0.000004073893,0.002224877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998522,0.000020433103,0.000018292654,0.00002927281,0.00006366376,0.000016210923],"domain_scores_gemma":[0.9998229,0.000081973805,0.000043665023,0.000006399777,0.000028084383,0.000017032804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029807267,0.000763452,0.0011544466,0.0011893836,0.00015572362,0.00054535957,0.00073682476,0.00044681813,0.0040103504],"category_scores_gemma":[0.000452662,0.00015977444,0.00049856724,0.0011935186,0.00024069635,0.00049150136,0.00040378975,0.0014200297,0.0016771203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012072872,0.00014973979,0.00026215045,0.0076659936,0.00015838708,0.00022678036,0.000021511376,0.00033582226,0.0025557405,0.0014536494,0.017131487,0.9699181],"study_design_scores_gemma":[0.00015511108,0.00040413032,0.0022085006,0.0021404603,0.00042149491,0.0025786855,0.000035347686,0.00024192948,0.0026474008,0.0015584029,0.9875799,0.000028739136],"about_ca_topic_score_codex":0.0005422948,"about_ca_topic_score_gemma":0.0016479,"teacher_disagreement_score":0.0040103504,"about_ca_system_score_codex":0.00022687415,"about_ca_system_score_gemma":0.00039050853,"threshold_uncertainty_score":0.013415933},"labels":[],"label_agreement":null},{"id":"W2606052450","doi":"10.4172/2153-0645.1000164","title":"The Pharmacogenomic Era in Asia: Potential Roles and Challenges for Asian Pharmacists","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmacogenomics & Pharmacoproteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.1111152566667161,"score_gpt":0.4257625396099905,"score_spread":0.3146472829432744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606052450","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06422999,0.038031332,0.004996386,0.85991204,0.0020295072,0.00007182804,0.00047400524,0.00019175748,0.030063078],"genre_scores_gemma":[0.61481094,0.14798433,0.020540692,0.19831848,0.0035511146,0.00018842585,0.00069788186,0.00016704274,0.013741146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706024,0.0013328434,0.00022469866,0.00022503492,0.0004676042,0.0006895877],"domain_scores_gemma":[0.983615,0.0033442616,0.0020166351,0.0008112447,0.0042259563,0.0059869653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010836962,0.00064259826,0.00076670514,0.00084988517,0.0032370845,0.0065637054,0.0015413,0.002545978,0.011752207],"category_scores_gemma":[0.00808051,0.00031419552,0.0008320842,0.001972269,0.0032307704,0.0070450106,0.007014087,0.0066152676,0.0019674357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071261567,0.0007046433,0.100906,0.0041116443,0.00028120264,0.008621323,0.02376937,0.0010424954,0.0061326334,0.053279743,0.12390613,0.67653227],"study_design_scores_gemma":[0.00016379381,0.0009271148,0.09008367,0.0056505427,0.00036807562,0.010450952,0.09948564,0.0029425232,0.00402695,0.06552871,0.7200029,0.00036910907],"about_ca_topic_score_codex":0.017373158,"about_ca_topic_score_gemma":0.025932565,"teacher_disagreement_score":0.017373158,"about_ca_system_score_codex":0.0027318047,"about_ca_system_score_gemma":0.028548164,"threshold_uncertainty_score":0.05731201},"labels":[],"label_agreement":null},{"id":"W2609096722","doi":"10.1038/tpj.2017.8","title":"CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction","year":2017,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Sildenafil; Medicine; Pharmacogenetics; Heart failure with preserved ejection fraction; Pharmacokinetics; Internal medicine; Heart failure; Ejection fraction; CYP3A4; Population; Cardiology; Pharmacology; Randomized controlled trial; Bioavailability; Genotype; Biology","score_opus":0.060396977084376836,"score_gpt":0.3659489137543977,"score_spread":0.30555193667002084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609096722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984281,0.00070001464,0.000094148774,0.00011598977,0.000023767587,0.000002529109,0.000114216135,0.0000069504317,0.00051421113],"genre_scores_gemma":[0.99944025,0.00011560595,0.000064139356,0.00006129747,0.000045254892,0.000002547488,0.0001241195,0.000003307004,0.00014345703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969137,0.00007945908,0.00003991512,0.00007650985,0.000050422757,0.0000623735],"domain_scores_gemma":[0.9985291,0.00046979135,0.0006180269,0.000084513864,0.0000797364,0.00021881648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030270807,0.0004170191,0.00073820516,0.00059117563,0.00042014907,0.0007492086,0.00032758212,0.0008298228,0.0029050536],"category_scores_gemma":[0.0017091867,0.000313065,0.0009215052,0.00089518266,0.0003079917,0.00039293565,0.00028595954,0.0009581014,0.0002960395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068937795,0.00005141349,0.99540484,0.000012891909,0.00024803032,0.00029205304,0.000040228188,0.000049628583,0.001360318,0.000027355178,0.0000930662,0.001730834],"study_design_scores_gemma":[0.000019942212,0.00010817755,0.9987973,0.000004412135,0.00013651767,0.00041458808,0.000051716295,0.00022800354,0.000103147366,0.000045676046,0.00008573486,0.000004831666],"about_ca_topic_score_codex":0.0016558527,"about_ca_topic_score_gemma":0.0017605536,"teacher_disagreement_score":0.0029050536,"about_ca_system_score_codex":0.0002392811,"about_ca_system_score_gemma":0.00021929249,"threshold_uncertainty_score":0.0097183585},"labels":[],"label_agreement":null},{"id":"W2610397959","doi":"10.1124/dmd.117.075945","title":"Crypt Organoid Culture as an In Vitro Model in Drug Metabolism and Cytotoxicity Studies","year":2017,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences","keywords":"Crypt; Drug metabolism; Biology; Xenobiotic; Pregnane X receptor; Gene expression; Metabolism; Organoid; Biochemistry; Molecular biology; Pharmacology; Cell biology; Gene; Nuclear receptor; Enzyme; Endocrinology; Transcription factor","score_opus":0.060010883494069335,"score_gpt":0.40999518758940456,"score_spread":0.3499843040953352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610397959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8103379,0.019868696,0.14307204,0.0005363793,0.0005376356,0.00078081107,0.0073994766,0.0008630868,0.016603993],"genre_scores_gemma":[0.92670923,0.009791803,0.045339257,0.00022646085,0.00007013737,0.0005097053,0.005389926,0.00017641616,0.011786982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989473,0.00034306324,0.0000994252,0.00019041318,0.0002989983,0.000120781806],"domain_scores_gemma":[0.99889886,0.00034665514,0.00012869277,0.00032196016,0.00019714073,0.000106540894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571498,0.0009496698,0.0010911266,0.0011236726,0.0007112138,0.00092095917,0.00070740056,0.0006241035,0.0026176288],"category_scores_gemma":[0.00049375393,0.00038800912,0.0009724235,0.0011330956,0.0006281392,0.0007343489,0.00068491604,0.0018822862,0.0014586139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006244475,0.00015952434,0.0012043039,0.00015153221,0.000032019994,0.00036027978,0.00011145933,0.0007594378,0.9927402,0.00044951384,0.00017002199,0.003237114],"study_design_scores_gemma":[0.00003248633,0.0016975789,0.0038171678,0.000019790317,0.000119712946,0.00064565137,0.00015046888,0.0012660557,0.9855005,0.00018053805,0.0065454994,0.000024510113],"about_ca_topic_score_codex":0.0049416744,"about_ca_topic_score_gemma":0.009060961,"teacher_disagreement_score":0.0049416744,"about_ca_system_score_codex":0.00086291356,"about_ca_system_score_gemma":0.00089903304,"threshold_uncertainty_score":0.009825826},"labels":[],"label_agreement":null},{"id":"W2611653650","doi":"10.1016/j.xphs.2017.04.072","title":"Professor Yuichi Sugiyama: A Brilliant, Creative, Amicable, Charming, and Humorous Pharmaceutical Scientist","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tribute; Art; Psychology; Art history","score_opus":0.19880517040586082,"score_gpt":0.5207006905514581,"score_spread":0.32189552014559725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611653650","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00720655,0.0602958,0.007329991,0.71725565,0.1855543,0.0001450082,0.0004690903,0.0003749553,0.021368716],"genre_scores_gemma":[0.072426304,0.08232709,0.012513574,0.28871995,0.18139334,0.00026399872,0.00087000907,0.00043809027,0.3610477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985644,0.00018868793,0.000105631865,0.0003312208,0.0005940673,0.00021597186],"domain_scores_gemma":[0.98778874,0.0005502078,0.0005995176,0.0002170874,0.0038654513,0.0069789956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032367583,0.0006479044,0.0006925892,0.0008686756,0.0009969561,0.0024661159,0.0008470127,0.0024554012,0.016311832],"category_scores_gemma":[0.009412572,0.00034174763,0.000531241,0.00039427576,0.0009421715,0.0016519576,0.0013700866,0.005834136,0.012718192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021657202,0.000060011374,0.0028739632,0.00022382359,0.000035921094,0.00059772556,0.00016100483,0.000112312475,0.0017771466,0.0033600654,0.90993,0.0806515],"study_design_scores_gemma":[0.00012589381,0.00027739583,0.003927942,0.00020535018,0.00005865694,0.0044703837,0.00038466326,0.00036699243,0.0019936885,0.0037528093,0.98439354,0.000042770433],"about_ca_topic_score_codex":0.0011444902,"about_ca_topic_score_gemma":0.002362734,"teacher_disagreement_score":0.016311832,"about_ca_system_score_codex":0.0013249492,"about_ca_system_score_gemma":0.00532526,"threshold_uncertainty_score":0.05456847},"labels":[],"label_agreement":null},{"id":"W2614817220","doi":"10.1385/0-89603-519-0:123","title":"High-Performance Liquid Chromatographic Analysis of CYP2CSCatalyzed Paclitaxel 6α-Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2C8; Paclitaxel; Hydroxylation; Chemistry; Carbamazepine; Phenobarbital; Pharmacology; High-performance liquid chromatography; Biochemistry; Chromatography; Biology; Cytochrome P450; Metabolism; Enzyme; Chemotherapy; CYP2C9","score_opus":0.12185587697294373,"score_gpt":0.39320834019038564,"score_spread":0.2713524632174419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614817220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8556404,0.0120042525,0.098539725,0.0007652473,0.000629926,0.0012370186,0.008977831,0.0027372001,0.019468257],"genre_scores_gemma":[0.8975664,0.00723526,0.046752036,0.0008379088,0.0004290269,0.00089529174,0.015843341,0.0005632369,0.02987746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994312,0.000078553436,0.000028534867,0.00012000528,0.00022938484,0.00011227328],"domain_scores_gemma":[0.99958414,0.000079187776,0.000060766695,0.000032366494,0.00017171881,0.00007184671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036278125,0.0011612999,0.0005754377,0.0014316542,0.00087439275,0.0004750639,0.0003634927,0.0006184263,0.004510619],"category_scores_gemma":[0.0007897749,0.00029278186,0.0005167023,0.0010661468,0.00037852547,0.00027831446,0.00021299151,0.0010317581,0.0031922236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055491354,0.00031503738,0.0018438392,0.00010753808,0.00008059225,0.00023496182,0.000064458116,0.00036760644,0.9844357,0.00023413086,0.00054760353,0.011213535],"study_design_scores_gemma":[0.00007740065,0.00050830806,0.011571366,0.000014199988,0.000064517524,0.00057210954,0.0000502394,0.0035259353,0.9730613,0.000092405986,0.010434849,0.00002742944],"about_ca_topic_score_codex":0.0038097568,"about_ca_topic_score_gemma":0.003832287,"teacher_disagreement_score":0.004510619,"about_ca_system_score_codex":0.0007198663,"about_ca_system_score_gemma":0.0008045002,"threshold_uncertainty_score":0.015089512},"labels":[],"label_agreement":null},{"id":"W2615474257","doi":"10.1111/j.1365-2885.2000.00269.x","title":"Plasma pharmacokinetics of warfarin enantiomers in cats","year":2000,"lang":"en","type":"article","venue":"Journal of Veterinary Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"Winn Feline Foundation","keywords":"Warfarin; Pharmacokinetics; CATS; Chemistry; Oral administration; Enantiomer; Bolus (digestion); Pharmacology; Area under the curve; Plasma concentration; Chromatography; Medicine; Internal medicine; Stereochemistry; Atrial fibrillation","score_opus":0.12424457437001228,"score_gpt":0.44441829686354795,"score_spread":0.32017372249353565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615474257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987759,0.0003938562,0.00043595428,0.000026721167,0.0000036773736,0.000018109886,0.00012357463,0.0000103811135,0.00021182995],"genre_scores_gemma":[0.9970155,0.00048739254,0.0013113532,0.000082622995,0.0000050750377,0.00003428574,0.0003609413,0.000005707248,0.00069720077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998204,0.00002988009,0.000015523645,0.000069740876,0.00004779157,0.000016743668],"domain_scores_gemma":[0.9996282,0.000062639956,0.00014607889,0.00003985478,0.00007690625,0.00004633688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022530867,0.0001486755,0.00036173555,0.00028630928,0.00020132582,0.00043601447,0.000117323405,0.00030303726,0.0006100859],"category_scores_gemma":[0.00068109325,0.00015042334,0.0001777892,0.00015543243,0.0004042589,0.00026725009,0.000107003005,0.0003288387,0.00019655563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007320839,0.00033387064,0.1490964,0.0002695752,0.00012106048,0.0010023238,0.0009004498,0.0008424214,0.7947508,0.00034931116,0.00069364056,0.04431921],"study_design_scores_gemma":[0.00036719086,0.023369418,0.6344944,0.000057592468,0.00035532264,0.0076901834,0.0010799099,0.010280236,0.3119493,0.0005371937,0.009733093,0.00008606266],"about_ca_topic_score_codex":0.0036199135,"about_ca_topic_score_gemma":0.004543894,"teacher_disagreement_score":0.0036199135,"about_ca_system_score_codex":0.00060696335,"about_ca_system_score_gemma":0.00031671577,"threshold_uncertainty_score":0.007197678},"labels":[],"label_agreement":null},{"id":"W2615622121","doi":"10.1016/j.japh.2017.05.006","title":"The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Human Genome Research Institute; U.S. Food and Drug Administration","keywords":"Medicine; Pharmacogenomics; Pharmacy; Medication therapy management; Family medicine; Pharmacist; Personalized medicine; Pharmacotherapy; Pharmaceutical care; Drug; Pharmacology; Internal medicine; Bioinformatics","score_opus":0.181913459089852,"score_gpt":0.48306418906417253,"score_spread":0.3011507299743206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615622121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88779765,0.007898065,0.0013763733,0.01004598,0.0005777314,0.001182843,0.062580794,0.00010401878,0.028436527],"genre_scores_gemma":[0.9680941,0.0028083785,0.0023782472,0.0051200935,0.00032080535,0.00046353872,0.016597157,0.00002971196,0.0041879173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620396,0.0006653337,0.00014499876,0.00053863454,0.0017337217,0.0007133408],"domain_scores_gemma":[0.99607736,0.00030113396,0.0007590243,0.00028166,0.001481278,0.0010995574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025987457,0.0010417501,0.0009670583,0.0011961573,0.002429611,0.0017827326,0.0020528545,0.0014109046,0.0026946138],"category_scores_gemma":[0.0069766412,0.00043375778,0.0011742964,0.0045410544,0.0006592872,0.0005264906,0.0017926984,0.0015929769,0.00028841884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021391234,0.00061495753,0.91510487,0.00026428644,0.0016409584,0.0002541669,0.00030425075,0.00047881043,0.00046423613,0.0022418464,0.04828278,0.028209673],"study_design_scores_gemma":[0.00067834405,0.00022511472,0.9856338,0.00016242835,0.0008628615,0.00014280452,0.0003955695,0.0005965672,0.0001639798,0.0004028123,0.010691317,0.000044346787],"about_ca_topic_score_codex":0.927928,"about_ca_topic_score_gemma":0.9662226,"teacher_disagreement_score":0.98317903,"about_ca_system_score_codex":0.016820988,"about_ca_system_score_gemma":0.03251295,"threshold_uncertainty_score":0.14499289},"labels":[],"label_agreement":null},{"id":"W2615961084","doi":"","title":"Effect of St Johns wort extract LI 160 on metabolic activity ofCYP2C6 in isolated perfused rat liver.","year":2004,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Traditional medicine; Pharmacology; Medicine","score_opus":0.06045548227223416,"score_gpt":0.4138055772476079,"score_spread":0.35335009497537373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615961084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911821,0.0037410865,0.00068077893,0.00027961662,0.00013038311,0.00003816663,0.001102383,0.00011102786,0.0027345493],"genre_scores_gemma":[0.9881237,0.0023805092,0.0012783945,0.00015149715,0.00006950434,0.00006587672,0.0016004259,0.000021290622,0.006308774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998958,0.000025517053,0.000011049637,0.000020826192,0.00001466915,0.00003209297],"domain_scores_gemma":[0.9998229,0.000048405425,0.000032013962,0.000021681739,0.000016491796,0.000058460024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021648193,0.00045625545,0.0003405613,0.00025824687,0.00017222225,0.00017472517,0.00019273881,0.00039684784,0.0033330335],"category_scores_gemma":[0.000264615,0.00020594771,0.0004067371,0.00021902377,0.00030631843,0.00028300213,0.00015673363,0.00081738114,0.00064521737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011194864,0.00047414037,0.00062058127,0.00021799549,0.00004848598,0.00023691819,0.00008273441,0.00019451743,0.98013455,0.0001299022,0.00042818472,0.006237084],"study_design_scores_gemma":[0.00035526737,0.011590691,0.007799721,0.00001743093,0.00008286689,0.00026191078,0.00006834625,0.0007725131,0.9773154,0.000072740404,0.0016458839,0.000017335886],"about_ca_topic_score_codex":0.0009386878,"about_ca_topic_score_gemma":0.0018699185,"teacher_disagreement_score":0.0033330335,"about_ca_system_score_codex":0.00023713463,"about_ca_system_score_gemma":0.0003900292,"threshold_uncertainty_score":0.011150122},"labels":[],"label_agreement":null},{"id":"W2617574211","doi":"10.18433/j3mg71","title":"Quantitative Structure – Pharmacokinetic Relationships for Plasma Clearance of Basic Drugs with Consideration of the Major Elimination Pathway","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Clearance; Chemistry; Lipophilicity; Drug; Stepwise regression; Pharmacology; Drug metabolism; Linear regression; Quantitative structure–activity relationship; Drug development; Stereochemistry; Internal medicine; Medicine; Mathematics","score_opus":0.2080293285512433,"score_gpt":0.47323848451914535,"score_spread":0.26520915596790207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617574211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74759465,0.007479999,0.231492,0.0008180593,0.000035760404,0.0003215453,0.008654493,0.00082151016,0.002781965],"genre_scores_gemma":[0.98200125,0.00060163747,0.01412737,0.00007899363,0.000014740505,0.00013471438,0.0026744583,0.000021792639,0.00034511494],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992655,0.0003503196,0.00004388801,0.00013378369,0.00017276149,0.00003384695],"domain_scores_gemma":[0.9960979,0.0028734573,0.0006137257,0.00015786587,0.00022343417,0.000033626395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022173715,0.00072729145,0.0005102747,0.0011021711,0.00012534922,0.0006002057,0.00042772663,0.0004715594,0.0013740557],"category_scores_gemma":[0.0049685165,0.00016071445,0.001559474,0.0007699662,0.0002826058,0.00057275675,0.000244853,0.0006981905,0.0005197013],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029429744,0.00026817792,0.029917972,0.0004868567,0.00037054357,0.00013867476,0.00003569082,0.91809094,0.00868178,0.0017260964,0.0010645266,0.03892443],"study_design_scores_gemma":[0.000032114713,0.0003752886,0.011133198,0.000025723419,0.00009912113,0.00017466652,0.000011374068,0.98226523,0.0022299576,0.0025424084,0.0010929712,0.000018010252],"about_ca_topic_score_codex":0.0020746992,"about_ca_topic_score_gemma":0.0014564118,"teacher_disagreement_score":0.0022173715,"about_ca_system_score_codex":0.00082990824,"about_ca_system_score_gemma":0.0007346299,"threshold_uncertainty_score":0.011726677},"labels":[],"label_agreement":null},{"id":"W2617724428","doi":"10.1021/acs.jmedchem.7b00343","title":"Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells","year":2017,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Hôpital Saint-François d'Assise","funders":"Canadian Institutes of Health Research","keywords":"Prodrug; Chemistry; In vivo; In vitro; Pharmacology; Cancer; Breast cancer; Mechanism of action; Cancer research; Cytochrome P450; Cancer cell; Human breast; Stereochemistry; Enzyme; Biochemistry; Internal medicine; Medicine; Biology","score_opus":0.050798939599226434,"score_gpt":0.4145257381529548,"score_spread":0.36372679855372836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617724428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976165,0.0022572563,0.0055277348,0.000077112556,0.000018858284,0.0000692741,0.0001494176,0.000072105155,0.0020665703],"genre_scores_gemma":[0.99348044,0.0014475056,0.0029851543,0.000026165346,0.000009032858,0.000039481976,0.00014459532,0.000008333927,0.001859209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999337,0.000022305618,0.000004496533,0.000009379948,0.000016196684,0.000013820423],"domain_scores_gemma":[0.9999528,0.000008510651,0.00002092689,0.000004680999,0.0000062694266,0.000006721394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011181184,0.00023928477,0.00013619664,0.000112900365,0.000065148146,0.000103312246,0.00009576713,0.0001435596,0.00084421557],"category_scores_gemma":[0.00009638683,0.00009334404,0.000107666856,0.0001081079,0.00010812831,0.00010618285,0.000098594195,0.00018294326,0.00025451626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009732273,0.00002252249,0.00011334577,0.00004374939,0.0000025083,0.0000391388,0.0000131971,0.00023059048,0.9961492,0.00016291963,0.00003848287,0.0030869325],"study_design_scores_gemma":[0.000023754083,0.00065169757,0.00070997764,0.0000019977138,0.000003974763,0.0001141249,0.0000064718774,0.00039594749,0.99660265,0.00001706147,0.0014702054,0.0000021449478],"about_ca_topic_score_codex":0.00020734426,"about_ca_topic_score_gemma":0.00050586,"teacher_disagreement_score":0.00084421557,"about_ca_system_score_codex":0.00013566947,"about_ca_system_score_gemma":0.00015411923,"threshold_uncertainty_score":0.0028241873},"labels":[],"label_agreement":null},{"id":"W2621142725","doi":"10.71781/4943","title":"Études métaboliques des isoenzymes du cytochrome P450 exprimées dans les ventricules de cœurs humains","year":2015,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Fondation du CHUM","keywords":"Physics; Molecular biology; Humanities; Philosophy; Biology","score_opus":0.034460394730334465,"score_gpt":0.2992792217276497,"score_spread":0.26481882699731524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621142725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868385,0.0055927746,0.004587684,0.00008744996,0.000044230586,0.000032434404,0.0002807696,0.000056600766,0.0024795395],"genre_scores_gemma":[0.98639655,0.003945032,0.004430913,0.00013277846,0.0000549966,0.00009967433,0.00051853753,0.000053159292,0.0043683066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996363,0.00006331372,0.000020947336,0.00010777394,0.00011673586,0.00005479487],"domain_scores_gemma":[0.999572,0.00013290416,0.000085875676,0.000035637087,0.00012015745,0.00005348307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040848914,0.00039136197,0.00056753715,0.0010263416,0.00050088484,0.001143431,0.00024511578,0.00050124736,0.0014224057],"category_scores_gemma":[0.0010555324,0.00023219615,0.00037471042,0.00062831526,0.0006840123,0.00045572472,0.00023442732,0.00061279925,0.0004089996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013031572,0.000086547516,0.04378271,0.00034480818,0.0002222846,0.0025752154,0.001690129,0.00028400336,0.9005529,0.00050942047,0.00025245597,0.048396245],"study_design_scores_gemma":[0.000062620726,0.0013698791,0.46587798,0.00013770208,0.00033549467,0.006879129,0.0019734425,0.0028780752,0.504217,0.00063381996,0.015567989,0.00006686372],"about_ca_topic_score_codex":0.003990792,"about_ca_topic_score_gemma":0.0026074788,"teacher_disagreement_score":0.003990792,"about_ca_system_score_codex":0.00036753892,"about_ca_system_score_gemma":0.0003244606,"threshold_uncertainty_score":0.007935166},"labels":[],"label_agreement":null},{"id":"W2625470338","doi":"10.1038/tpj.2017.22","title":"On the readiness of physicians for pharmacogenomics testing: an empirical assessment","year":2017,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; The Quebec Population Health Research Network; Université Laval","funders":"","keywords":"Pharmacogenomics; Test (biology); Psychology; Family medicine; Medical education; Medicine","score_opus":0.3966516316277158,"score_gpt":0.5494180679820447,"score_spread":0.15276643635432896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625470338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94990844,0.0012403,0.0034745254,0.021664301,0.00009023826,0.00024244456,0.000465797,0.00004497811,0.022868972],"genre_scores_gemma":[0.99646264,0.0004516415,0.0014507509,0.0010331357,0.00005258881,0.00006613985,0.00014154674,0.000011839103,0.0003295885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9767338,0.014744441,0.002129698,0.0010118803,0.0034183273,0.001961809],"domain_scores_gemma":[0.49356812,0.40520862,0.045687694,0.012290052,0.02849785,0.014747634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030749312,0.0003324261,0.0004445977,0.00221591,0.0017530534,0.0027116255,0.0016132785,0.0027858128,0.0124331135],"category_scores_gemma":[0.31261957,0.00052768283,0.0009791683,0.0014070282,0.0030073326,0.0043044714,0.0030882997,0.0035590203,0.0014633706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060016575,0.00049406814,0.95370704,0.0002502123,0.00018210436,0.0007369345,0.005220881,0.0006597402,0.00038373496,0.0028555244,0.0018233792,0.033086162],"study_design_scores_gemma":[0.000067851644,0.001133356,0.95092505,0.00076793623,0.00023902053,0.0020452223,0.028627891,0.0025261783,0.0007132896,0.005410751,0.007468989,0.000074519034],"about_ca_topic_score_codex":0.0027711357,"about_ca_topic_score_gemma":0.0038979927,"teacher_disagreement_score":0.030749312,"about_ca_system_score_codex":0.0013839265,"about_ca_system_score_gemma":0.006346606,"threshold_uncertainty_score":0.16261983},"labels":[],"label_agreement":null},{"id":"W2625842840","doi":"10.1016/j.ijms.2017.06.002","title":"Mapping ligand binding using microfluidics-enabled millisecond timescale hydrogen-deuterium exchange","year":2017,"lang":"en","type":"article","venue":"International Journal of Mass Spectrometry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Chemistry; Hydrogen–deuterium exchange; Millisecond; Ligand (biochemistry); Allosteric regulation; Protein dynamics; Binding site; Molecular dynamics; Nanotechnology; Biophysics; Hydrogen; Computational chemistry; Biochemistry; Enzyme","score_opus":0.0961214276129013,"score_gpt":0.4143639466330993,"score_spread":0.31824251902019796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625842840","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9306045,0.002208488,0.05622937,0.00084443047,0.0004825895,0.00007929876,0.00090753846,0.0006924901,0.0079513],"genre_scores_gemma":[0.97235715,0.0010281288,0.022632873,0.00035778605,0.000056242756,0.00008140555,0.0002597726,0.000041323314,0.0031853043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998209,0.000012772318,0.0000074352424,0.000057241883,0.000055501376,0.000046139074],"domain_scores_gemma":[0.9997826,0.00010760647,0.000039900227,0.000022562299,0.000022288385,0.000025031295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027103545,0.00028837653,0.0002843745,0.00015517829,0.00026585057,0.0005943771,0.0004792783,0.00051039486,0.0012835902],"category_scores_gemma":[0.00043046376,0.00020291092,0.00013564878,0.00015420612,0.0004410023,0.00048153813,0.00054609013,0.00058988534,0.00034298922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006826039,0.000026934567,0.00030837272,0.000055974266,0.0000074454483,0.000036592217,0.00002988302,0.00035986726,0.99342656,0.00051172625,0.0003516785,0.0048167338],"study_design_scores_gemma":[0.000021285614,0.00009492667,0.001293171,0.000005072951,0.000007384543,0.00007458231,0.000047439786,0.009186309,0.98531705,0.00029865376,0.0036330756,0.000021042886],"about_ca_topic_score_codex":0.00085666194,"about_ca_topic_score_gemma":0.0022585446,"teacher_disagreement_score":0.0012835902,"about_ca_system_score_codex":0.00058160693,"about_ca_system_score_gemma":0.0004656106,"threshold_uncertainty_score":0.004294038},"labels":[],"label_agreement":null},{"id":"W2626356663","doi":"10.1016/j.bbapap.2017.06.007","title":"Use of bioconjugation with cytochrome P450 enzymes","year":2017,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Bioconjugation; Biocatalysis; Chemistry; Cytochrome P450; Biosensor; Biomolecule; Chemical biology; Enzyme; Biochemistry; Nanotechnology; Combinatorial chemistry; Materials science; Reaction mechanism","score_opus":0.3781391428507866,"score_gpt":0.48329231746081364,"score_spread":0.10515317461002704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626356663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012791214,0.9639069,0.011970996,0.00046819894,0.00057863974,0.000057117093,0.000108484965,0.00009873901,0.010019751],"genre_scores_gemma":[0.050451275,0.9332829,0.005887533,0.0004656593,0.00025476006,0.00005558385,0.00023198621,0.000019141164,0.009351024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998387,0.000024228602,0.000012512823,0.00003718464,0.000066989196,0.000020386638],"domain_scores_gemma":[0.99991834,0.00002735293,0.000023473394,0.000008038012,0.00001804191,0.000004813675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033214228,0.0008541649,0.0006413052,0.0009194301,0.000110366425,0.0004393315,0.00038445037,0.0005432239,0.001161479],"category_scores_gemma":[0.00026814925,0.00019192642,0.0004659451,0.0007852988,0.00025820895,0.0005131561,0.0004148307,0.00084185903,0.0009845805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015005172,0.00015831144,0.0005719355,0.0076513244,0.00022411994,0.00081086997,0.00005564567,0.00068871275,0.15454863,0.0054298174,0.006114306,0.82359624],"study_design_scores_gemma":[0.000036227204,0.0005331136,0.0027832033,0.0007045814,0.0003553771,0.0042285104,0.00004018412,0.0005726169,0.23275962,0.0016010449,0.7563451,0.000040473264],"about_ca_topic_score_codex":0.00033002277,"about_ca_topic_score_gemma":0.0004938963,"teacher_disagreement_score":0.001161479,"about_ca_system_score_codex":0.00023016498,"about_ca_system_score_gemma":0.0002598659,"threshold_uncertainty_score":0.0038855672},"labels":[],"label_agreement":null},{"id":"W2726338622","doi":"10.1208/s12248-017-0102-8","title":"Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers","year":2017,"lang":"en","type":"article","venue":"The AAPS Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hamilton Health Sciences Foundation","keywords":"Pharmacokinetics; Pharmacogenomics; Bupropion; Pharmacology; Biopharmaceutics; Immediate release; Bioequivalence; Kinetics; Medicine; Chemistry; Pharmacognosy; Biological activity; Biochemistry; Physics","score_opus":0.10271803527537504,"score_gpt":0.41806851211202434,"score_spread":0.3153504768366493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726338622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768233,0.0006518144,0.0008545501,0.000030445,0.0000149291745,0.00013574105,0.0002203026,0.000023365175,0.00038655146],"genre_scores_gemma":[0.99742055,0.00029151965,0.00094911526,0.0001883857,0.000025777885,0.00016829646,0.00034312054,0.000011961439,0.00060122926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995284,0.00016251291,0.00003107398,0.00013431767,0.0001048444,0.00003882137],"domain_scores_gemma":[0.9997274,0.00007368139,0.00007215269,0.00003639824,0.000035406294,0.000054939057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005638865,0.00038971307,0.0005054325,0.00018462834,0.0002523195,0.00034256227,0.00010357798,0.0004824421,0.00084485253],"category_scores_gemma":[0.0011513468,0.00028068878,0.00031218186,0.000205214,0.00032197512,0.0002592885,0.00014786031,0.0003985564,0.00025671133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13621823,0.011310117,0.27097645,0.0007241254,0.001486066,0.0017900693,0.00208498,0.0017802503,0.4752585,0.00056548376,0.0016194932,0.096186206],"study_design_scores_gemma":[0.0034650962,0.1398161,0.81471384,0.000024800158,0.00094911415,0.0036314297,0.0005433733,0.003395555,0.029840054,0.00042840105,0.0031018786,0.00009033811],"about_ca_topic_score_codex":0.0005765692,"about_ca_topic_score_gemma":0.00043249023,"teacher_disagreement_score":0.00084485253,"about_ca_system_score_codex":0.00012822381,"about_ca_system_score_gemma":0.0001460602,"threshold_uncertainty_score":0.0029821992},"labels":[],"label_agreement":null},{"id":"W2735996965","doi":"10.1385/0-89603-519-0:175","title":"Use of 7-Ethoxycoumarin to Monitor Multiple Enzymes in the Human CYPI, CYP2, and CYP3 Families","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Enzyme; Microsome; Cytochrome P450; Substrate (aquarium); Recombinant DNA; Biochemistry; Isozyme; Chemistry; Complementary DNA; Enzyme kinetics; Enzyme assay; Biology; Active site; Gene","score_opus":0.31507601908011695,"score_gpt":0.4459606841591989,"score_spread":0.13088466507908192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735996965","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36648756,0.044974748,0.5315451,0.0008567648,0.00048671066,0.0011571834,0.004041607,0.0021352132,0.0483151],"genre_scores_gemma":[0.5873336,0.02818069,0.31151348,0.00070027006,0.00021033181,0.0028093522,0.005436373,0.00043660056,0.063379236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946445,0.00009629929,0.000029683224,0.00016799876,0.00020075723,0.000040824907],"domain_scores_gemma":[0.9997873,0.00006370446,0.000048275957,0.000025196456,0.000060080056,0.000015487713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060332316,0.00043643234,0.00037746446,0.000944458,0.0002854616,0.00033523983,0.00040337635,0.00052980817,0.0030374497],"category_scores_gemma":[0.00029510338,0.00035069644,0.00042176363,0.0009247886,0.00020991752,0.00032794304,0.00030527267,0.0009119935,0.0013401231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058410154,0.000041960662,0.0006950853,0.00015183521,0.000024774152,0.000036688692,0.0000423621,0.00013436751,0.98438513,0.00028353572,0.00040627865,0.013739577],"study_design_scores_gemma":[0.000021770926,0.00033975946,0.010964061,0.000035635276,0.00007090463,0.00040059915,0.00002688617,0.0012885949,0.9615032,0.00028215064,0.02505181,0.000014508663],"about_ca_topic_score_codex":0.0006728756,"about_ca_topic_score_gemma":0.0016675848,"teacher_disagreement_score":0.0030374497,"about_ca_system_score_codex":0.00036285495,"about_ca_system_score_gemma":0.0002183195,"threshold_uncertainty_score":0.010161281},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","score_opus":0.48975655035397786,"score_gpt":0.5137854583330572,"score_spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736936940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02408425,0.9743858,0.00009136638,0.00044365122,0.00004493166,0.00005128201,0.00044831034,0.000002347827,0.00044809066],"genre_scores_gemma":[0.37071216,0.62684757,0.00069945527,0.0007886125,0.00011179859,0.00019063213,0.00053862744,0.0000046464324,0.000106458116],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614894,0.0015491736,0.0012736181,0.00037666198,0.00048668295,0.0001650069],"domain_scores_gemma":[0.9849508,0.010482586,0.0036617627,0.00016690447,0.0006294876,0.00010851923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039088503,0.0005205736,0.0026371127,0.0030182838,0.0002966891,0.0011784817,0.0007040684,0.0007863715,0.0014455362],"category_scores_gemma":[0.019368194,0.00030057106,0.0029437027,0.004226535,0.00038802595,0.0008395051,0.0005592747,0.00043988903,0.00007072602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018044771,0.00005930504,0.10017442,0.6995077,0.0681951,0.0012390073,0.0010664361,0.0006007603,0.0011056877,0.0007125008,0.002416348,0.12311827],"study_design_scores_gemma":[0.00085319474,0.0006030716,0.3070052,0.43565235,0.223253,0.0035221484,0.0016159585,0.00036039014,0.00092213607,0.0010598022,0.025053848,0.00009885964],"about_ca_topic_score_codex":0.008172783,"about_ca_topic_score_gemma":0.014970111,"teacher_disagreement_score":0.008172783,"about_ca_system_score_codex":0.0009196242,"about_ca_system_score_gemma":0.0025409637,"threshold_uncertainty_score":0.020672262},"labels":[],"label_agreement":null},{"id":"W2745469089","doi":"10.1021/acscatal.7b02634","title":"Substrate-Specific Screening for Mutational Hotspots Using Biased Molecular Dynamics Simulations","year":2017,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Molecular dynamics; Docking (animal); Chemistry; Active site; Ligand (biochemistry); Binding site; Stereochemistry; Computational chemistry; Catalysis; Biochemistry","score_opus":0.2488243561479278,"score_gpt":0.4772036746509849,"score_spread":0.2283793185030571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745469089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8381361,0.0003236262,0.15556796,0.00021512806,0.000041012907,0.00019956105,0.0003209005,0.0010744748,0.0041212183],"genre_scores_gemma":[0.9318199,0.00023380012,0.06622107,0.000080311176,0.000011402655,0.00044499635,0.00041938527,0.0001514239,0.00061760953],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998306,0.000061548264,0.000008683566,0.000026189336,0.00004085225,0.00003207885],"domain_scores_gemma":[0.99942553,0.0003352782,0.000051276234,0.00004487457,0.00008321891,0.00006001206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006731514,0.0008074001,0.00091106375,0.00053741003,0.00042275825,0.00041647544,0.0008985945,0.00079484476,0.0012078454],"category_scores_gemma":[0.0015538054,0.00044653198,0.00057881564,0.00037309818,0.00035997026,0.00043882043,0.00049903983,0.00062750553,0.00020405989],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019929517,0.0001327715,0.0024661815,0.000081034814,0.00009751276,0.00013752303,0.00007204301,0.96799344,0.018399525,0.0034574873,0.00032219026,0.006641025],"study_design_scores_gemma":[0.000016679633,0.0000197401,0.00012682621,0.0000020876232,0.00000528632,0.0000039402225,0.0000046471464,0.9980609,0.001371807,0.00029328032,0.000091282,0.0000034652899],"about_ca_topic_score_codex":0.0039302665,"about_ca_topic_score_gemma":0.004334857,"teacher_disagreement_score":0.0039302665,"about_ca_system_score_codex":0.000672681,"about_ca_system_score_gemma":0.0010278657,"threshold_uncertainty_score":0.007814765},"labels":[],"label_agreement":null},{"id":"W2747156891","doi":"10.1016/j.bcp.2017.08.015","title":"Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response","year":2017,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Nicotine; Codeine; Morphine; Analgesic; Medicine; Pharmacology; Anesthesia; Drug tolerance; Saline; Opioid; Internal medicine; Receptor","score_opus":0.055320532646532354,"score_gpt":0.3962088917355255,"score_spread":0.3408883590889931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747156891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953282,0.00052619836,0.0026082904,0.00008076509,0.000039649145,0.000057671892,0.0003301949,0.00009066393,0.0009383897],"genre_scores_gemma":[0.9942622,0.00047384715,0.0015818872,0.00005424672,0.000019126073,0.00007788275,0.00063630124,0.00003375497,0.0028608625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997029,0.000057270838,0.000020728517,0.000058304853,0.000092680464,0.00006808388],"domain_scores_gemma":[0.9992353,0.0001311701,0.00025631426,0.000117019554,0.00007580821,0.00018442728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029460836,0.00044733123,0.0005108224,0.00037999172,0.00015874123,0.0002930765,0.00023467265,0.00045774796,0.0017125934],"category_scores_gemma":[0.0007180599,0.00023009678,0.00036019064,0.00025454198,0.0004578079,0.0004345327,0.00022470564,0.0014789102,0.00038477045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006373272,0.0009061434,0.012745609,0.000042902062,0.000081624254,0.000113615904,0.00007077862,0.00030766768,0.9677337,0.00021688039,0.00029427905,0.011113536],"study_design_scores_gemma":[0.00005158734,0.005798456,0.051776778,0.0000072367247,0.000086149004,0.00032950166,0.000070056405,0.004507409,0.93652385,0.000107288724,0.00072072947,0.000020944031],"about_ca_topic_score_codex":0.0020128167,"about_ca_topic_score_gemma":0.0039558373,"teacher_disagreement_score":0.0020128167,"about_ca_system_score_codex":0.00047183124,"about_ca_system_score_gemma":0.00037540603,"threshold_uncertainty_score":0.0057291985},"labels":[],"label_agreement":null},{"id":"W2748073152","doi":"10.1016/b978-0-12-394591-4.00010-6","title":"Development of Drugs from Plants","year":2012,"lang":"en","type":"book-chapter","venue":"Advances in botanical research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Children's Hospital of Western Ontario","funders":"","keywords":"Drug development; Process (computing); Acknowledgement; Drug; Biology; Biotechnology; Risk analysis (engineering); Engineering ethics; Pharmacology; Business; Engineering; Computer science","score_opus":0.30172983026209554,"score_gpt":0.5443563814510792,"score_spread":0.24262655118898369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748073152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045725137,0.42745903,0.096120685,0.007397054,0.0035743017,0.00050049607,0.00153052,0.000983678,0.4167091],"genre_scores_gemma":[0.20331101,0.47621953,0.06146484,0.004910885,0.0012763463,0.00039491145,0.0017550515,0.00022800118,0.25043947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999118,0.000011178392,0.000004077443,0.000020571899,0.00004205461,0.000010268928],"domain_scores_gemma":[0.99996424,0.000009927695,0.0000061772694,0.0000054986326,0.0000069694956,0.000007277471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018716765,0.000632474,0.00039802655,0.00081302336,0.00028892525,0.00064984715,0.0004263643,0.00054293557,0.0070627686],"category_scores_gemma":[0.00014890874,0.00025531222,0.00048471114,0.000388021,0.00048131033,0.00088895275,0.0006716653,0.0014987213,0.0058804913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014577789,0.00016303446,0.00015969669,0.002511838,0.00006908161,0.0006934362,0.0002553022,0.0011653465,0.34850124,0.0724289,0.023592163,0.5503141],"study_design_scores_gemma":[0.000050691986,0.00047301096,0.00038626321,0.00026897868,0.000048514354,0.000987053,0.000032416054,0.0004237981,0.10173758,0.009880401,0.8856892,0.000022125021],"about_ca_topic_score_codex":0.0002530087,"about_ca_topic_score_gemma":0.0005070932,"teacher_disagreement_score":0.0070627686,"about_ca_system_score_codex":0.00041015158,"about_ca_system_score_gemma":0.0002895656,"threshold_uncertainty_score":0.023627281},"labels":[],"label_agreement":null},{"id":"W2750108617","doi":"10.1016/b978-0-12-397220-0.00008-8","title":"Risperidone","year":2012,"lang":"en","type":"review","venue":"Profiles of drug substances, excipients, and related methodology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Risperidone; Pharmacology; Mania; Antipsychotic; ADME; Dopamine receptor D2; Atypical antipsychotic; Chemistry; Schizophrenia (object-oriented programming); Pharmacokinetics; Medicine; Dopamine; Bipolar disorder; Psychiatry; Internal medicine; Lithium (medication)","score_opus":0.33892386013262005,"score_gpt":0.4971902296789574,"score_spread":0.15826636954633733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750108617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025567855,0.9854726,0.0009315044,0.00031368644,0.00011936391,0.000028885379,0.0003514323,0.000079611615,0.010146039],"genre_scores_gemma":[0.023768181,0.9654915,0.002290452,0.00048762534,0.00017597272,0.0000484927,0.0007481732,0.000011809038,0.006977843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974877,0.00005118971,0.000040036055,0.00004933977,0.00009313146,0.000017602137],"domain_scores_gemma":[0.99985015,0.000049743132,0.00005114371,0.0000076134716,0.000033178534,0.000008229292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030725848,0.00078142603,0.00095633994,0.0013209463,0.00015251596,0.000515219,0.00050860643,0.0003208478,0.0031721941],"category_scores_gemma":[0.00044610543,0.00017149892,0.0005016257,0.00091308344,0.00016440822,0.0002576377,0.00035247052,0.0006234519,0.0019997833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014063301,0.000044582543,0.00060867565,0.0050455863,0.00012988753,0.00025236423,0.000034887875,0.00009276429,0.0026617101,0.0010295641,0.009785812,0.98017335],"study_design_scores_gemma":[0.00011546547,0.00042769252,0.009187586,0.0037658198,0.00073213154,0.010204885,0.00005711226,0.00023570999,0.006853693,0.001536028,0.9668365,0.000047264937],"about_ca_topic_score_codex":0.0011961249,"about_ca_topic_score_gemma":0.0032294823,"teacher_disagreement_score":0.0031721941,"about_ca_system_score_codex":0.00032866542,"about_ca_system_score_gemma":0.000581136,"threshold_uncertainty_score":0.010612011},"labels":[],"label_agreement":null},{"id":"W2751228627","doi":"10.1080/00498254.2017.1376260","title":"The effects of UDP-sugars, UDP and Mg<sup>2+</sup>on uridine diphosphate glucuronosyltransferase activity in human liver microsomes","year":2017,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glucuronidation; Uridine diphosphate; Chemistry; Glucuronosyltransferase; Enzyme; Microsome; Uridine; Glycosyltransferase; Biochemistry; Glucuronic acid; Enzyme kinetics; Enzyme assay; Active site; RNA","score_opus":0.04008693635173147,"score_gpt":0.3796839776649831,"score_spread":0.33959704131325164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751228627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97868216,0.016666282,0.001697707,0.00024166863,0.000112753405,0.000046502177,0.0005888256,0.00015615151,0.001807859],"genre_scores_gemma":[0.9925587,0.0028971727,0.0022239517,0.00010626179,0.000051514577,0.000023537948,0.00082648714,0.000033220178,0.0012792334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939895,0.00034561742,0.000078299,0.000058670208,0.00006465094,0.00005382151],"domain_scores_gemma":[0.9995734,0.0001851471,0.000102901686,0.000050180086,0.00004228094,0.000046056968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057052315,0.0007623418,0.0004581528,0.00020781334,0.00015639326,0.0004185203,0.00025613216,0.00038055622,0.0010144622],"category_scores_gemma":[0.00071947847,0.0003308989,0.0004176981,0.00025842618,0.00031893075,0.0002479167,0.00017898154,0.000381768,0.00059221586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009833185,0.00011289057,0.00171243,0.00025049545,0.00009858603,0.00033231688,0.00010892879,0.0005026859,0.97399116,0.00013495574,0.00026123432,0.012661185],"study_design_scores_gemma":[0.000071240815,0.0018299002,0.00454454,0.000010182314,0.00006815854,0.00025371372,0.00001752422,0.0010131081,0.9903156,0.000038317175,0.0018280608,0.000009840599],"about_ca_topic_score_codex":0.0016884739,"about_ca_topic_score_gemma":0.0011692547,"teacher_disagreement_score":0.0016884739,"about_ca_system_score_codex":0.00035197657,"about_ca_system_score_gemma":0.00023137846,"threshold_uncertainty_score":0.0033937693},"labels":[],"label_agreement":null},{"id":"W2752769263","doi":"10.18433/j3434r","title":"In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions","year":2017,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Higher Education, Malaysia","keywords":"In silico; Drug; Computational biology; Drug discovery; Drug development; Computer science; Pharmacology; Bioinformatics; Biology","score_opus":0.6829023743141998,"score_gpt":0.5971896781839786,"score_spread":0.08571269613022114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752769263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022143181,0.93256617,0.05735051,0.0007452982,0.00041680786,0.00017228912,0.00031726115,0.00025493753,0.0059623807],"genre_scores_gemma":[0.019532835,0.93824506,0.038045734,0.00058517966,0.00035636371,0.00023951157,0.0004187989,0.000043733045,0.002532866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998665,0.00050652097,0.00010541907,0.00017785643,0.0004926037,0.000052534775],"domain_scores_gemma":[0.9981164,0.0013184103,0.00020826665,0.00007067013,0.0002425479,0.000043854103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002470212,0.0019998404,0.0025321986,0.002799839,0.00031766048,0.0011820614,0.0017567289,0.001308433,0.0028517288],"category_scores_gemma":[0.002341247,0.0006368774,0.0019377633,0.001972607,0.00074377016,0.001119558,0.00074090087,0.0022495857,0.0016127609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017901344,0.00046223484,0.002328747,0.032937847,0.001192237,0.0008453384,0.00020602296,0.032277014,0.0431194,0.02218956,0.016491445,0.84777105],"study_design_scores_gemma":[0.00012773351,0.0013962359,0.004230788,0.0037200444,0.002010269,0.005331313,0.0002172928,0.027892234,0.06218641,0.02141353,0.87123567,0.00023855752],"about_ca_topic_score_codex":0.0012888003,"about_ca_topic_score_gemma":0.0016266939,"teacher_disagreement_score":0.0028517288,"about_ca_system_score_codex":0.0007817418,"about_ca_system_score_gemma":0.0009941643,"threshold_uncertainty_score":0.013063848},"labels":[],"label_agreement":null},{"id":"W2752779553","doi":"10.1176/appi.pn.2017.pp6a2","title":"Should You Order Genetic Tests Before Prescribing Psychotropics?","year":2017,"lang":"en","type":"article","venue":"Psychiatric News","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Genetic testing; Test (biology); Dosing; Medicine; Geneticist; Psychiatry; Psychology; Family medicine; Pharmacology; Genetics; Internal medicine; Biology","score_opus":0.14515483745269475,"score_gpt":0.4550282741424415,"score_spread":0.30987343668974676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752779553","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033165256,0.016353743,0.0072552757,0.5128975,0.067938864,0.0006002048,0.008784261,0.0053751394,0.37747845],"genre_scores_gemma":[0.025653472,0.03058951,0.010931773,0.26276898,0.028999802,0.0005952952,0.0048325052,0.002051807,0.6335768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990375,0.00022481491,0.00012054115,0.00008751668,0.00034588506,0.00018375914],"domain_scores_gemma":[0.9947411,0.0013944923,0.00038569648,0.00026631157,0.0020280746,0.0011842186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011748906,0.0007973915,0.0006939552,0.0014835056,0.0014437243,0.0021962307,0.0010056176,0.00472491,0.39843547],"category_scores_gemma":[0.015207084,0.00042233552,0.00085123506,0.0008635461,0.0006499268,0.0037771983,0.0011694595,0.0040294416,0.22832891],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005032033,0.00003865659,0.0004928612,0.00009184473,0.0000039368697,0.00026334432,0.000049982664,0.000018280187,0.00011967165,0.00054684066,0.9446904,0.05363397],"study_design_scores_gemma":[0.00004070486,0.000053427877,0.0012868666,0.00072459393,0.000009746813,0.00059844425,0.00018612997,0.00004956335,0.00032740622,0.0017946003,0.9948998,0.00002878803],"about_ca_topic_score_codex":0.0066786646,"about_ca_topic_score_gemma":0.013113611,"teacher_disagreement_score":0.39843547,"about_ca_system_score_codex":0.00191862,"about_ca_system_score_gemma":0.0022988357,"threshold_uncertainty_score":0.8580588},"labels":[],"label_agreement":null},{"id":"W2754369675","doi":"10.1002/adsc.201700637","title":"Regioselective Epoxidations by Cytochrome P450 3A4 Using a Theobromine Chemical Auxiliary to Predictably Produce N‐Protected β‐ or γ‐Amino Epoxides","year":2017,"lang":"en","type":"article","venue":"Advanced Synthesis & Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Centre in Green Chemistry and Catalysis","keywords":"Chemistry; Theobromine; Regioselectivity; Steric effects; Selectivity; Double bond; Synthon; Stereoselectivity; Epoxide; Olefin fiber; Stereochemistry; Desymmetrization; Amine gas treating; Organic chemistry; Combinatorial chemistry; Catalysis; Enantioselective synthesis; Caffeine","score_opus":0.10693813652453314,"score_gpt":0.44033620012452096,"score_spread":0.3333980635999878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754369675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242997,0.0024030495,0.03397017,0.001111738,0.00045600653,0.000084852225,0.0006649006,0.0009778934,0.036031604],"genre_scores_gemma":[0.9815662,0.0010469517,0.008726862,0.00012348282,0.00003944077,0.000026394668,0.00023007144,0.000060852966,0.008179806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999324,0.000008470834,0.0000028138813,0.000013661086,0.000019292504,0.00002324913],"domain_scores_gemma":[0.9999763,0.000005337635,0.000008013786,0.0000037993652,0.000002977799,0.0000036608417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108730164,0.00039467736,0.00013546135,0.00013761368,0.00007975237,0.00016628628,0.0002688348,0.00025987704,0.0026986124],"category_scores_gemma":[0.00007894765,0.000119138036,0.00016010585,0.00009709059,0.00017702614,0.00020135846,0.00018441335,0.00053790206,0.0007414974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102440965,0.000019758134,0.000049687907,0.00004158884,0.0000033833755,0.00014968532,0.000010298151,0.00018802412,0.9936452,0.0007746165,0.00044117187,0.004574131],"study_design_scores_gemma":[0.000016767752,0.00008329111,0.0002107855,0.0000024409442,0.000002984294,0.000117136566,0.0000051208053,0.00076591433,0.99500644,0.00013152935,0.0036538667,0.0000038010162],"about_ca_topic_score_codex":0.0005015554,"about_ca_topic_score_gemma":0.0006175169,"teacher_disagreement_score":0.0026986124,"about_ca_system_score_codex":0.00020643939,"about_ca_system_score_gemma":0.00013701792,"threshold_uncertainty_score":0.0090277195},"labels":[],"label_agreement":null},{"id":"W2754586269","doi":"10.1016/j.bbapap.2017.09.006","title":"Selecting of a cytochrome P450cam SeSaM library with 3-chloroindole and endosulfan – Identification of mutants that dehalogenate 3-chloroindole","year":2017,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Mutant; Pseudomonas putida; Mutagenesis; Enzyme kinetics; Endosulfan; Chemistry; Stereochemistry; Cytochrome; Biochemistry; Active site; Enzyme; Biology; Pesticide; Ecology; Gene","score_opus":0.06450779699176683,"score_gpt":0.36621596962834835,"score_spread":0.3017081726365815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754586269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698854,0.00016172975,0.010082304,0.0002108543,0.000047814745,0.00012801835,0.00086030556,0.00019454637,0.0013260288],"genre_scores_gemma":[0.97685325,0.0002544933,0.010035184,0.00013794281,0.000018327606,0.00011536616,0.003064887,0.00018965435,0.009331075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995196,0.000074162526,0.000052222967,0.00007359107,0.0002009476,0.000079621095],"domain_scores_gemma":[0.999676,0.00008556822,0.00007978818,0.000055527744,0.00004831913,0.00005478952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025938344,0.0007126725,0.00053628354,0.00040420008,0.00019432578,0.0003577892,0.00043204628,0.00043162433,0.0013603177],"category_scores_gemma":[0.00034964885,0.00030054097,0.00056170864,0.00043671473,0.00028870278,0.00018554836,0.0004836616,0.0007387854,0.0007935597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004438737,0.000033815013,0.000113200185,0.000006462762,0.0000050569242,0.000038643382,0.000011429194,0.000028519995,0.9991799,0.000028263905,0.000017400967,0.0004930173],"study_design_scores_gemma":[0.000011952876,0.00016287698,0.0025669688,0.0000020519792,0.000015740434,0.00027082075,0.000031156284,0.0006344572,0.9950388,0.00001631012,0.001242592,0.000006219127],"about_ca_topic_score_codex":0.0027823246,"about_ca_topic_score_gemma":0.0028852662,"teacher_disagreement_score":0.0027823246,"about_ca_system_score_codex":0.00033454958,"about_ca_system_score_gemma":0.00028169304,"threshold_uncertainty_score":0.0055323243},"labels":[],"label_agreement":null},{"id":"W2758448813","doi":"10.3390/pharmaceutics9040040","title":"Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues","year":2017,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Tolbutamide; Endocrinology; Internal medicine; Cytochrome P450; CYP3A; Microsome; Kidney; Biology; Diabetes mellitus; Type 2 diabetes; Drug metabolism; Enzyme; Metabolism; Medicine; Biochemistry","score_opus":0.1396658508275451,"score_gpt":0.43840565405088816,"score_spread":0.29873980322334304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758448813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257094,0.001288959,0.0039797695,0.00012760476,0.000033864275,0.000040385694,0.0010984658,0.00008739196,0.0007726187],"genre_scores_gemma":[0.9818512,0.0017074367,0.0073014954,0.00020313328,0.000031570624,0.00023288568,0.0025411865,0.0001132326,0.0060177483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997048,0.00004558511,0.000030815674,0.00009485172,0.00006826436,0.000055656],"domain_scores_gemma":[0.9997559,0.000023457207,0.00008567918,0.000039725535,0.000032112603,0.000063153224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023301072,0.0005464741,0.00034504474,0.00058808806,0.0001898267,0.00043494592,0.00016599857,0.00033150136,0.0019003791],"category_scores_gemma":[0.00013198672,0.0003048579,0.0005170698,0.00035422592,0.0003623943,0.0002442221,0.00017160428,0.0009782894,0.00037340494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041896818,0.00005528985,0.00092843757,0.00002556312,0.000010521393,0.000023799334,0.000011447875,0.00002115917,0.9975484,0.000022993265,0.000022368538,0.0009111157],"study_design_scores_gemma":[0.00006336843,0.0011098649,0.052943073,0.000011997444,0.0000858907,0.00030376558,0.000058706635,0.0006202839,0.9429094,0.000053826687,0.0018291887,0.000010581065],"about_ca_topic_score_codex":0.00065775367,"about_ca_topic_score_gemma":0.0015161848,"teacher_disagreement_score":0.0019003791,"about_ca_system_score_codex":0.00026036162,"about_ca_system_score_gemma":0.00017941331,"threshold_uncertainty_score":0.006357372},"labels":[],"label_agreement":null},{"id":"W2759360483","doi":"10.1093/nar/gkx911","title":"PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies","year":2017,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Genentech; Ontario Institute for Cancer Research; Stand Up To Cancer; Princess Margaret Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Compendium; Pharmacogenomics; Biology; Leverage (statistics); Data curation; Drug discovery; Computational biology; Drug response; Cancer cell lines; Prioritization; Drug; Identifier; Computer science; Bioinformatics; Data science; Cancer; Pharmacology; Cancer cell; Machine learning; Genetics","score_opus":0.43499143138287516,"score_gpt":0.6012958507078576,"score_spread":0.16630441932498247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759360483","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011815948,0.007380965,0.04604952,0.00077679666,0.00014997527,0.00061009015,0.901192,0.024304582,0.0077200956],"genre_scores_gemma":[0.022949964,0.0046147928,0.06987761,0.0004611225,0.000047048958,0.0011025823,0.8988985,0.0013011775,0.00074719195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719244,0.00054351904,0.00078454847,0.0007064401,0.0006442967,0.00012877457],"domain_scores_gemma":[0.98979455,0.0047603943,0.0017764578,0.0017267136,0.0011400565,0.0008017261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004607645,0.0024680921,0.0033692983,0.01611771,0.0010442884,0.0041812332,0.0040098554,0.0022841862,0.009664775],"category_scores_gemma":[0.016184404,0.0013251461,0.002017169,0.014631569,0.00064963446,0.0025966836,0.004515857,0.0019923437,0.0054820506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00396593,0.0009070723,0.048874617,0.03899432,0.0034690534,0.004495745,0.0014229304,0.030253641,0.050059106,0.033167105,0.51925015,0.26514035],"study_design_scores_gemma":[0.0007957153,0.00036407597,0.027612654,0.0021947245,0.0015400224,0.002361603,0.00048037866,0.028975887,0.022209683,0.0187103,0.8944256,0.00032939503],"about_ca_topic_score_codex":0.0060843755,"about_ca_topic_score_gemma":0.009095002,"teacher_disagreement_score":0.01611771,"about_ca_system_score_codex":0.002036675,"about_ca_system_score_gemma":0.0058126003,"threshold_uncertainty_score":0.032331884},"labels":[],"label_agreement":null},{"id":"W2761432469","doi":"10.1021/acsmedchemlett.7b00265","title":"Structure-Based Design and Synthesis of New Estrane–Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors","year":2017,"lang":"en","type":"article","venue":"ACS Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Consejo Nacional de Ciencia y Tecnología","keywords":"Chemistry; Cytochrome P450; CYP1B1; Steroid; Docking (animal); Stereochemistry; Moiety; IC50; Pharmacology; Potency; Enzyme; Biochemistry; In vitro; Biology; Medicine","score_opus":0.07270678584486652,"score_gpt":0.3891158669613458,"score_spread":0.3164090811164793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761432469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8830269,0.032845397,0.048525836,0.0006943874,0.00033309415,0.0016337445,0.0020994348,0.0005372064,0.030304043],"genre_scores_gemma":[0.93506277,0.019535005,0.031932957,0.00022120764,0.000049524493,0.0004932363,0.0017838597,0.000049257233,0.010872285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990535,0.000017567761,0.000009286917,0.00001713258,0.00002770209,0.000022995426],"domain_scores_gemma":[0.9999479,0.0000049023424,0.0000127902995,0.0000056943713,0.000012301531,0.000016460986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019894549,0.00044438886,0.0003706821,0.00039427762,0.00017361615,0.00029491493,0.0004898354,0.00034075047,0.0027573379],"category_scores_gemma":[0.00016278266,0.00025051401,0.00040228097,0.000384145,0.0001525497,0.0002883721,0.00024929407,0.0005523223,0.00085708604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029820637,0.00045117788,0.00027842744,0.0006561626,0.00006815127,0.00056549115,0.000104408406,0.010211597,0.9456609,0.003359474,0.00075550546,0.037590478],"study_design_scores_gemma":[0.00047895312,0.004780507,0.0028662425,0.00010897304,0.00016214453,0.000727698,0.00007326486,0.008552156,0.9199971,0.0008701273,0.061307706,0.00007527172],"about_ca_topic_score_codex":0.0005606167,"about_ca_topic_score_gemma":0.001372368,"teacher_disagreement_score":0.0027573379,"about_ca_system_score_codex":0.0003393228,"about_ca_system_score_gemma":0.00031353155,"threshold_uncertainty_score":0.009224236},"labels":[],"label_agreement":null},{"id":"W2761667289","doi":"10.1002/cpt.807","title":"Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; U.S. Food and Drug Administration; National Institutes of Health","keywords":"CYP2C8; CYP2C9; CYP2C19; CYP1A2; Pharmacology; CYP3A4; Cytochrome P450; Tolbutamide; Pharmacokinetics; CYP2D6; Chemistry; Kidney disease; Medicine; Biochemistry; Metabolism; Internal medicine","score_opus":0.1731719731352774,"score_gpt":0.537432668628869,"score_spread":0.3642606954935915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761667289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26045725,0.72835314,0.0067391973,0.0007378299,0.00007849535,0.00007752087,0.0011268806,0.000040470422,0.002389173],"genre_scores_gemma":[0.8143086,0.17720935,0.0053483546,0.0008381546,0.00020665098,0.00007005546,0.0011948699,0.000052755513,0.0007712935],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966899,0.0013271377,0.00061049376,0.0006913642,0.00059912296,0.00008205335],"domain_scores_gemma":[0.988649,0.0063552163,0.0023314352,0.00088201975,0.0015671201,0.00021513538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055369395,0.00037115236,0.001213422,0.0017839838,0.0002923774,0.0010432567,0.0002461066,0.00033890188,0.00094921625],"category_scores_gemma":[0.0058931913,0.00019591159,0.001882373,0.0031401122,0.0004568103,0.0006764763,0.00066631834,0.00052519125,0.00016328837],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001877122,0.00008839435,0.55432916,0.008382034,0.0099293785,0.00042174727,0.00037660918,0.0006403511,0.00798079,0.0005703991,0.0009931879,0.41441077],"study_design_scores_gemma":[0.00006661864,0.0011186103,0.9343912,0.0019772183,0.0155526865,0.0029642342,0.00022056383,0.0008461666,0.006172047,0.00057594414,0.03606651,0.000048318914],"about_ca_topic_score_codex":0.001764007,"about_ca_topic_score_gemma":0.0033365854,"teacher_disagreement_score":0.0055369395,"about_ca_system_score_codex":0.0004165088,"about_ca_system_score_gemma":0.0009686406,"threshold_uncertainty_score":0.02928251},"labels":[],"label_agreement":null},{"id":"W2762816559","doi":"10.1016/j.pharmthera.2017.10.008","title":"CYP-mediated drug metabolism in the brain impacts drug response","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Ontario Ministry of Research, Innovation and Science; Canada Research Chairs; Canada Foundation for Innovation; Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health","keywords":"Biology; Neuroscience; Drug development; Cytochrome P450; Pharmacology; Human brain; In vivo; Drug metabolism; Drug; Metabolism; Endocrinology","score_opus":0.2815211223130383,"score_gpt":0.5297347115403458,"score_spread":0.24821358922730752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762816559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034743026,0.9968162,0.000362846,0.0004124739,0.00011869361,0.0000061797423,0.00006618478,0.000015390528,0.0018545622],"genre_scores_gemma":[0.0021876073,0.9963977,0.00024804272,0.00018305505,0.00013425342,0.000006258139,0.000047003283,0.000002251521,0.0007938176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998845,0.000022107952,0.000014121992,0.000025351435,0.00004231302,0.000011661032],"domain_scores_gemma":[0.9997681,0.000120843695,0.00003814782,0.000008638439,0.00004919427,0.000015069785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032790803,0.0006522363,0.0012063994,0.0009940388,0.00015444185,0.0009872678,0.00059033104,0.0006986564,0.0047364277],"category_scores_gemma":[0.00049942575,0.00018879853,0.00046916254,0.0012044992,0.00032980542,0.0007760822,0.00047206,0.0011243059,0.0019174443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008549357,0.000067732704,0.00043641886,0.009650793,0.00015713926,0.00016799408,0.00002067552,0.00033103788,0.0031765911,0.0027291921,0.0118968915,0.97128],"study_design_scores_gemma":[0.0000375462,0.00019622697,0.003994806,0.0034442341,0.00045132355,0.0022457845,0.00007424745,0.00025940177,0.0034070304,0.0054786704,0.98036766,0.000043013773],"about_ca_topic_score_codex":0.00092554354,"about_ca_topic_score_gemma":0.0022715544,"teacher_disagreement_score":0.0047364277,"about_ca_system_score_codex":0.00037015276,"about_ca_system_score_gemma":0.00086002424,"threshold_uncertainty_score":0.015844941},"labels":[],"label_agreement":null},{"id":"W2764326385","doi":"10.24870/cjb.2017-a136","title":"To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Acenocoumarol; VKORC1; Medicine; Polymorphism (computer science); Internal medicine; Genetics; CYP2C9; Biology; Genotype; Warfarin; Atrial fibrillation","score_opus":0.11148756650387337,"score_gpt":0.4305755999784015,"score_spread":0.31908803347452813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764326385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981901,0.0008919945,0.00013375473,0.00007210023,0.000011016848,0.000018742057,0.0002166468,0.0000023032853,0.0004632157],"genre_scores_gemma":[0.9986808,0.0002749363,0.00017491505,0.00006197679,0.000032187316,0.00001734755,0.00034560545,0.0000019039468,0.00041032914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971527,0.00006441474,0.000056763136,0.00006326024,0.000043730914,0.00005659077],"domain_scores_gemma":[0.99927753,0.00014680385,0.00036285655,0.000033482134,0.00007299973,0.00010636278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003470461,0.00026431796,0.000355524,0.00052891654,0.00031896116,0.00048748383,0.00020139283,0.00039822428,0.0024863523],"category_scores_gemma":[0.0014014095,0.0001576595,0.00038020624,0.0006454539,0.00017123994,0.00030993903,0.00017471284,0.00048293304,0.0004757475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059740024,0.00017485362,0.9953525,0.00003686103,0.000067663714,0.0002652914,0.000048981205,0.000026569305,0.00033203984,0.000026651274,0.000119511664,0.0029516737],"study_design_scores_gemma":[0.0000416393,0.0009494348,0.9963349,0.000017454919,0.00009014578,0.0014623044,0.00013491725,0.00022146768,0.00021973226,0.00008292818,0.00043815636,0.0000068807167],"about_ca_topic_score_codex":0.0014628076,"about_ca_topic_score_gemma":0.0022296123,"teacher_disagreement_score":0.0024863523,"about_ca_system_score_codex":0.0002579395,"about_ca_system_score_gemma":0.00039280416,"threshold_uncertainty_score":0.008317649},"labels":[],"label_agreement":null},{"id":"W2765994390","doi":"10.1111/cts.12517","title":"Using Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation","year":2017,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Translation (biology); Computational biology; Computer science; Chemistry; Biology; Biochemistry","score_opus":0.6549223130597572,"score_gpt":0.5847734511055931,"score_spread":0.07014886195416414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765994390","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011380564,0.104429685,0.44431332,0.32639003,0.014290527,0.00036845278,0.0005423224,0.00089861784,0.09738644],"genre_scores_gemma":[0.45083472,0.10117316,0.29167533,0.1021634,0.0124625545,0.0017159103,0.00046606944,0.0016373182,0.03787153],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9882648,0.0057859216,0.0009437073,0.0010589472,0.003507579,0.00043908905],"domain_scores_gemma":[0.9519324,0.037880942,0.0013268287,0.00472498,0.0038108951,0.00032402953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021393895,0.0017873954,0.0018308399,0.0013146632,0.0013376679,0.0054286034,0.004362442,0.009910282,0.005054808],"category_scores_gemma":[0.06342362,0.0009917057,0.0034422264,0.0009689564,0.011905644,0.010958078,0.004424207,0.017740918,0.0023520074],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007188829,0.000041561092,0.00042006953,0.00076381303,0.000083982064,0.0010576552,0.0011187202,0.008809576,0.000528723,0.939582,0.016430069,0.03109194],"study_design_scores_gemma":[0.00003974619,0.00009183606,0.0001573806,0.0007375981,0.000047740756,0.0006648938,0.00034130772,0.02598535,0.00080684706,0.82988906,0.14116439,0.00007385564],"about_ca_topic_score_codex":0.005362965,"about_ca_topic_score_gemma":0.0025265685,"teacher_disagreement_score":0.021393895,"about_ca_system_score_codex":0.005034587,"about_ca_system_score_gemma":0.004345391,"threshold_uncertainty_score":0.11314309},"labels":[],"label_agreement":null},{"id":"W2766764745","doi":"10.1016/b978-0-12-802101-9.00020-x","title":"Introduction to Clinical Pharmacology","year":2016,"lang":"en","type":"book-chapter","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Drug; Clinical pharmacology; Drug action; Pharmacogenomics; Drug metabolism; Pharmacokinetics; Systems pharmacology; ADME; Computational biology; Medicine; Biology","score_opus":0.2261056930791441,"score_gpt":0.5263748928313229,"score_spread":0.3002691997521788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766764745","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005863075,0.34590393,0.022501163,0.039364733,0.027480414,0.00039373146,0.001475299,0.0015018235,0.56079274],"genre_scores_gemma":[0.0052193194,0.25955507,0.02458258,0.035135742,0.016875448,0.0004797306,0.0013643411,0.0005591483,0.6562286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988294,0.00020232823,0.000086057094,0.00020017558,0.000610683,0.00007122153],"domain_scores_gemma":[0.99814963,0.00075445586,0.000097777986,0.00014928114,0.000576842,0.00027193208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016835773,0.0011143989,0.0010795534,0.0017677743,0.0008377124,0.0036255503,0.0015992123,0.0027834505,0.099846],"category_scores_gemma":[0.0040358403,0.00044084722,0.00071458553,0.0018882342,0.0016619136,0.0028962933,0.0022234535,0.0061506303,0.08507295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003779837,0.000054483462,0.00010133173,0.0010251374,0.000008144916,0.00015690376,0.00019946125,0.00018567964,0.0005604533,0.045460146,0.6322122,0.31999806],"study_design_scores_gemma":[0.0000031471552,0.000012728463,0.00006914405,0.00030248583,0.0000014543965,0.00029819895,0.000016799073,0.000027535752,0.0000454006,0.006718687,0.99249953,0.0000048696697],"about_ca_topic_score_codex":0.0010184136,"about_ca_topic_score_gemma":0.001969223,"teacher_disagreement_score":0.099846,"about_ca_system_score_codex":0.0015772089,"about_ca_system_score_gemma":0.002738309,"threshold_uncertainty_score":0.33401817},"labels":[],"label_agreement":null},{"id":"W2767557583","doi":"10.1186/s40360-017-0173-2","title":"Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)","year":2017,"lang":"en","type":"article","venue":"BMC Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Interdisciplinary Research in Rehabilitation; Institut Universitaire en Santé Mentale de Québec","funders":"","keywords":"CYP2C19; Venlafaxine; CYP2D6; Medicine; Pharmacology; Dextromethorphan; Fexofenadine; Pharmacokinetics; CYP2C9; Internal medicine; Antidepressant; Cytochrome P450","score_opus":0.2965094400008791,"score_gpt":0.43603541099223486,"score_spread":0.13952597099135577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767557583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810034,0.0004968561,0.0004235381,0.00009264156,0.000007147819,0.000114516806,0.00041295128,0.000008240045,0.0003439128],"genre_scores_gemma":[0.9983569,0.00015434166,0.00046181137,0.00007450979,0.000017980954,0.00011424088,0.00049759913,0.0000038688418,0.00031880333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979983,0.0013660924,0.00007195808,0.00030213047,0.0001352579,0.00012625963],"domain_scores_gemma":[0.9986878,0.00027767234,0.0004488661,0.00022324923,0.00013649945,0.00022592802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00308566,0.001127218,0.00072028383,0.00068083266,0.0005809089,0.0007707789,0.00046119682,0.0009416766,0.0019301965],"category_scores_gemma":[0.0018351811,0.00037451345,0.0010494761,0.00077408977,0.00058618205,0.00036457652,0.00052848493,0.00046637037,0.00026650762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028589794,0.0019565225,0.9452062,0.00024231286,0.002639778,0.0012429559,0.0008455764,0.00084347354,0.0055670287,0.0004461209,0.0013008538,0.011119425],"study_design_scores_gemma":[0.0035348143,0.008550973,0.9836584,0.000032273078,0.0006459794,0.0008293263,0.00026762532,0.0009812127,0.0003471384,0.000098268865,0.0010259249,0.000028207824],"about_ca_topic_score_codex":0.012238486,"about_ca_topic_score_gemma":0.013351467,"teacher_disagreement_score":0.012238486,"about_ca_system_score_codex":0.0008703172,"about_ca_system_score_gemma":0.000699011,"threshold_uncertainty_score":0.02433449},"labels":[],"label_agreement":null},{"id":"W2769856431","doi":"10.1016/j.bbapap.2017.11.001","title":"Preface: Cytochrome P450","year":2017,"lang":"en","type":"editorial","venue":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Computational biology; Biology","score_opus":0.06422005469217126,"score_gpt":0.4198605908413041,"score_spread":0.3556405361491328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769856431","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019509815,0.01534465,0.0000837906,0.02592044,0.9572666,0.000013758086,0.000045174187,0.000028933571,0.00127707],"genre_scores_gemma":[0.00027660286,0.008100119,0.00006668837,0.018124688,0.96566784,0.000020791023,0.000057401703,0.000032402775,0.007653483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968041,0.0006215343,0.00052816933,0.0005352746,0.001263324,0.0002475003],"domain_scores_gemma":[0.9885201,0.0034307572,0.001103197,0.00044423112,0.0045567,0.0019450377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005198605,0.0033566884,0.0034281882,0.0050178017,0.002499791,0.0065275133,0.002649088,0.010831657,0.028813833],"category_scores_gemma":[0.018867215,0.000964589,0.0025910127,0.0023753943,0.0019557534,0.0045030713,0.0025864253,0.017985595,0.01884613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002503723,0.0000066496546,0.000013788013,0.0001446526,0.000011214944,0.000057960642,0.0000037893358,0.000012029055,0.000029590077,0.00012613287,0.994974,0.0045951414],"study_design_scores_gemma":[0.000084443374,0.00003088579,0.00024549395,0.0005301754,0.000048552323,0.00031417696,0.000018835828,0.0000696827,0.00009831682,0.000786793,0.9977552,0.000017459544],"about_ca_topic_score_codex":0.0020741571,"about_ca_topic_score_gemma":0.004290947,"teacher_disagreement_score":0.028813833,"about_ca_system_score_codex":0.004082393,"about_ca_system_score_gemma":0.0029789517,"threshold_uncertainty_score":0.09639192},"labels":[],"label_agreement":null},{"id":"W2770199471","doi":"10.1002/cpt.921","title":"Commentary on “The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Pharmacokinetics; Clearance; Drug; Metabolic clearance rate; Drug development; Subject (documents); Pharmacology; Medicine; Intensive care medicine; Nothing; Computer science; Epistemology; Philosophy; Urology","score_opus":0.2219440488571743,"score_gpt":0.4991478039572035,"score_spread":0.27720375510002915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770199471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013407826,0.0010335314,0.00008198142,0.9706104,0.02703843,0.00001024569,0.00007102321,0.000022462355,0.0009978375],"genre_scores_gemma":[0.0009834537,0.0005553464,0.00009895797,0.9645972,0.032136124,0.000024379344,0.000022016335,0.000016375541,0.0015661122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99474573,0.0015776535,0.0006928957,0.00085573766,0.0016217123,0.000506284],"domain_scores_gemma":[0.9874966,0.007573749,0.00086742325,0.0002879706,0.0026344631,0.0011397976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058024414,0.0012242211,0.0017547823,0.0008180595,0.0035861542,0.0029129607,0.0038041256,0.055915594,0.0049194377],"category_scores_gemma":[0.034038488,0.0010226391,0.0017875666,0.0008899838,0.003934914,0.0048260973,0.0014784603,0.05438742,0.009025558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036080553,0.000010667672,0.00010584327,0.000029613066,0.00000489834,0.00051749055,0.00005752162,0.00003058186,0.00006638211,0.0008621951,0.9962999,0.0019789378],"study_design_scores_gemma":[0.0001572243,0.000079843536,0.00088546495,0.00053932826,0.00004330994,0.0022193878,0.0003737877,0.00050773687,0.0005339087,0.011108831,0.9834411,0.00011009416],"about_ca_topic_score_codex":0.007798569,"about_ca_topic_score_gemma":0.009519005,"teacher_disagreement_score":0.055915594,"about_ca_system_score_codex":0.005482227,"about_ca_system_score_gemma":0.007169581,"threshold_uncertainty_score":0.039776504},"labels":[],"label_agreement":null},{"id":"W2771880689","doi":"10.3390/jpm7040020","title":"Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen","year":2017,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenomics; Tamoxifen; Warfarin; Medicine; Pharmacogenetics; Personalization; Personalized medicine; Intensive care medicine; Pharmacology; Bioinformatics; Internal medicine; Breast cancer; Cancer; Computer science; Biology; World Wide Web","score_opus":0.556044632740589,"score_gpt":0.5981635554475209,"score_spread":0.04211892270693185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771880689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029323713,0.9972773,0.00026974108,0.00066457404,0.00011269462,0.000008098829,0.000024206576,0.000007022916,0.0013431039],"genre_scores_gemma":[0.0028588278,0.99572587,0.00039993267,0.0003795141,0.00013933398,0.000009107517,0.000033122033,0.0000015711089,0.00045273468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996171,0.00010554857,0.00006580057,0.000049580613,0.0001404431,0.00002146158],"domain_scores_gemma":[0.999516,0.00030894403,0.00007339043,0.00001649416,0.00006819824,0.000016998096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471296,0.00037810206,0.00097140577,0.0015803197,0.00017599527,0.00078842964,0.00058031676,0.0009315987,0.0022124462],"category_scores_gemma":[0.0014827739,0.00016048872,0.0008000775,0.0009878023,0.00029348754,0.0006863425,0.00043125913,0.0014181647,0.0006956311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008095353,0.00006543699,0.00041869906,0.01788634,0.00022735007,0.00027563772,0.000056533052,0.0003037036,0.0010582975,0.0043173754,0.013162845,0.96214694],"study_design_scores_gemma":[0.00005716278,0.00015086608,0.0033795733,0.012389299,0.0006082495,0.005374504,0.0000882299,0.00034246352,0.0015005005,0.005199187,0.9708791,0.00003097917],"about_ca_topic_score_codex":0.0008427267,"about_ca_topic_score_gemma":0.0019276582,"teacher_disagreement_score":0.0022124462,"about_ca_system_score_codex":0.00038918311,"about_ca_system_score_gemma":0.00084695744,"threshold_uncertainty_score":0.007401347},"labels":[],"label_agreement":null},{"id":"W2774341657","doi":"10.3390/jpm7040018","title":"Variation in CYP2A6 Activity and Personalized Medicine","year":2017,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Nicotine; Pharmacology; Medicine; Cotinine; CYP2B6; Smoking cessation; Biology; Metabolism; CYP1A2; Cytochrome P450; Internal medicine","score_opus":0.37982175830355913,"score_gpt":0.563437463912288,"score_spread":0.18361570560872886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774341657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030612975,0.9958722,0.0004431747,0.0009865059,0.00025356087,0.000008034076,0.000056100827,0.000017723556,0.0020565686],"genre_scores_gemma":[0.0021464122,0.995808,0.00043387525,0.00037590534,0.00026372104,0.000010273137,0.00007829883,0.0000032736618,0.00088019593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969363,0.000070334,0.00004080733,0.000059261518,0.00011426257,0.000021755983],"domain_scores_gemma":[0.99952126,0.00028473107,0.000048047317,0.0000175586,0.000102727,0.000025785977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066609296,0.0005221546,0.001030679,0.0016464274,0.00020102698,0.00094490615,0.000587344,0.0010247227,0.0044389376],"category_scores_gemma":[0.001171476,0.00015919522,0.0006432928,0.0016277605,0.0003331441,0.00083863956,0.0005847901,0.0017113204,0.0016176745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004420612,0.000061375526,0.00044213436,0.009170152,0.00014277015,0.00020292253,0.00004964254,0.00032475995,0.000975289,0.0045584436,0.023184435,0.96084386],"study_design_scores_gemma":[0.000016652706,0.000071832495,0.0018210266,0.0029037187,0.00016269373,0.0018993474,0.000046322013,0.00018446133,0.0005743773,0.0037649206,0.98853207,0.000022651999],"about_ca_topic_score_codex":0.0007767732,"about_ca_topic_score_gemma":0.0012804259,"teacher_disagreement_score":0.0044389376,"about_ca_system_score_codex":0.0005868546,"about_ca_system_score_gemma":0.000873972,"threshold_uncertainty_score":0.014849722},"labels":[],"label_agreement":null},{"id":"W2776825260","doi":"10.30699/mmlj17.1.3.107","title":"New Platforms For Drug Screening And Toxicology: Necessity Or Need?","year":2018,"lang":"en","type":"article","venue":"Modern Medical Laboratory Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Drug metabolism; Biotransformation; Xenobiotic; Pharmacology; Biology; Risk analysis (engineering); Computational biology; Toxicology; Medicine; Biochemistry","score_opus":0.09705772068852357,"score_gpt":0.4386718224724832,"score_spread":0.3416141017839596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776825260","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026460445,0.45478985,0.34799665,0.10979214,0.006713279,0.0017702414,0.0047782073,0.0060176267,0.041681472],"genre_scores_gemma":[0.10685174,0.38110074,0.43519545,0.031237144,0.008258549,0.0028212753,0.0071692937,0.0009473377,0.026418423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956436,0.0013402607,0.00020860755,0.00045828192,0.0020588308,0.00029045716],"domain_scores_gemma":[0.9930408,0.0022903888,0.00046595235,0.0011018416,0.0021767085,0.0009242559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008754235,0.0012041396,0.0025747546,0.0020399254,0.00059794344,0.0038159818,0.0024464757,0.0029438834,0.01814489],"category_scores_gemma":[0.0065304334,0.0007493747,0.001110422,0.0011757022,0.0022128199,0.0062686577,0.003514745,0.005235247,0.010001103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094988884,0.0005822588,0.0031914052,0.0046082544,0.00020688341,0.00091113744,0.0004012866,0.0016681461,0.13502784,0.041099284,0.09380203,0.7175515],"study_design_scores_gemma":[0.00019399526,0.0020226801,0.0028885643,0.0015521123,0.00024222294,0.0031461837,0.00082851504,0.0037393954,0.034261413,0.046878986,0.9040765,0.00016942268],"about_ca_topic_score_codex":0.0007171582,"about_ca_topic_score_gemma":0.0013228001,"teacher_disagreement_score":0.01814489,"about_ca_system_score_codex":0.001021097,"about_ca_system_score_gemma":0.0018008738,"threshold_uncertainty_score":0.060700655},"labels":[],"label_agreement":null},{"id":"W2781698184","doi":"10.1016/j.jpsychires.2017.09.002","title":"Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study","year":2018,"lang":"en","type":"article","venue":"Journal of Psychiatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Ministry of Research, Innovation and Science; Ontario Ministry of Research and Innovation; Centre for Addiction and Mental Health Foundation; Institute for Clinical Evaluative Sciences; National Alliance for Research on Schizophrenia and Depression","keywords":"Medicine; Protocol (science); Pharmacogenetics; Psychiatry; Tolerability; Genetic testing; Personalized medicine; Health care; Population; Mental health; Precision medicine; Alternative medicine; Pharmacology; Bioinformatics; Adverse effect","score_opus":0.30017394012414556,"score_gpt":0.5821929723942281,"score_spread":0.2820190322700825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781698184","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017230766,0.00018176426,0.008188758,0.00023518654,0.00014757105,0.9703104,0.0011091944,0.000046324978,0.0025500704],"genre_scores_gemma":[0.018112518,0.00021318703,0.011182918,0.0003335215,0.00011335436,0.9688247,0.00038989563,0.000013537617,0.00081642973],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.97743225,0.013607222,0.003398963,0.0017145652,0.0023474426,0.0014996455],"domain_scores_gemma":[0.98315465,0.0055716014,0.0022442949,0.0027829013,0.004716561,0.0015299594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033341497,0.003139787,0.003957854,0.0028453602,0.0032293394,0.0022376187,0.0019029514,0.0036138545,0.02073266],"category_scores_gemma":[0.034782525,0.0025230714,0.0019529855,0.0023850242,0.0032508285,0.0018030951,0.0019172773,0.0034386478,0.0057965354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54981315,0.091817394,0.045864794,0.010422592,0.0017356526,0.002073593,0.0071488316,0.01045801,0.011092462,0.027267454,0.020149842,0.22215629],"study_design_scores_gemma":[0.51625043,0.18125284,0.09395849,0.0048621804,0.0032765835,0.00096081174,0.0036256732,0.014032972,0.012386519,0.0210182,0.1474604,0.0009148352],"about_ca_topic_score_codex":0.0043815817,"about_ca_topic_score_gemma":0.0050644754,"teacher_disagreement_score":0.033341497,"about_ca_system_score_codex":0.0036797412,"about_ca_system_score_gemma":0.015886795,"threshold_uncertainty_score":0.17632878},"labels":[],"label_agreement":null},{"id":"W2782322064","doi":"10.1038/s41397-017-0005-1","title":"Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Warfarin; CYP2C9; Calcitriol receptor; Single-nucleotide polymorphism; Nuclear receptor; Pharmacology; Biology; VKORC1; Pharmacogenetics; Internal medicine; Pregnane X receptor; Gene; Medicine; Genetics; Genotype; Transcription factor; Atrial fibrillation","score_opus":0.11906800606484878,"score_gpt":0.41069884615588936,"score_spread":0.29163084009104057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782322064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926219,0.0004911583,0.00031793714,0.00019661467,0.000010226351,0.00002335742,0.0048288135,0.000015730844,0.0014942278],"genre_scores_gemma":[0.9956982,0.00019637961,0.00019254656,0.000099380726,0.0000053751155,0.000015359037,0.002469643,0.000008657108,0.0013144129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960905,0.00006173359,0.000024605248,0.00013068403,0.000111178975,0.00006286358],"domain_scores_gemma":[0.9991171,0.00014837064,0.00020904765,0.00010882609,0.00028249423,0.0001341582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006040772,0.00029967548,0.00041714316,0.00057840423,0.0008053496,0.00071255054,0.00042649885,0.00038891513,0.0033716306],"category_scores_gemma":[0.0017540902,0.0001845458,0.00040044897,0.001152436,0.00030389972,0.00019230852,0.0002519291,0.00043345708,0.00031878726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002786803,0.000021517077,0.99253076,0.00001261855,0.00017204184,0.00013303546,0.00017784447,0.0002495388,0.001332606,0.00008397013,0.0013228933,0.003684461],"study_design_scores_gemma":[0.0000176503,0.00002777995,0.9980286,0.0000073554456,0.000051040697,0.00009295481,0.00008301292,0.00052626396,0.00008706029,0.000020025776,0.0010501891,0.000008012682],"about_ca_topic_score_codex":0.8756325,"about_ca_topic_score_gemma":0.86317915,"teacher_disagreement_score":0.124367476,"about_ca_system_score_codex":0.0029256705,"about_ca_system_score_gemma":0.0018992661,"threshold_uncertainty_score":0.25019974},"labels":[],"label_agreement":null},{"id":"W2783088493","doi":"10.2174/1386207321666180115094814","title":"Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models","year":2018,"lang":"en","type":"article","venue":"Combinatorial Chemistry & High Throughput Screening","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Computational biology; Computer science; Data mining; Bioinformatics; Genetics; Genotype; Biology; Gene","score_opus":0.043012628626827955,"score_gpt":0.3563074274735897,"score_spread":0.3132947988467617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783088493","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0843967,0.0016744757,0.90655136,0.0018208089,0.00011161707,0.00019960577,0.00081244047,0.0024172093,0.0020157392],"genre_scores_gemma":[0.7721748,0.00081548135,0.2220511,0.0004332815,0.00020192954,0.00051217916,0.0014686618,0.00010996595,0.002232586],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99862003,0.0007280009,0.00006831853,0.00023904478,0.00025119932,0.000093416864],"domain_scores_gemma":[0.9962179,0.0028552653,0.00034355122,0.00011961477,0.00036449477,0.00009921294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036278057,0.0014947128,0.0014653354,0.0024517716,0.000558907,0.0013861819,0.0010664419,0.0011961095,0.0019392829],"category_scores_gemma":[0.0067552268,0.0004817002,0.0016288598,0.0009553482,0.0004140133,0.00092285435,0.0009321839,0.0014046377,0.0006067453],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048456618,0.0004909692,0.023985663,0.00024389998,0.0004225909,0.0002623514,0.00013269138,0.7738589,0.0016065361,0.004649132,0.0050852858,0.18877745],"study_design_scores_gemma":[0.000011188398,0.00005589021,0.00092398707,0.000013213162,0.000026041256,0.000027165765,0.000008595459,0.99674916,0.00022169927,0.0017432926,0.00021067234,0.000009135745],"about_ca_topic_score_codex":0.005533249,"about_ca_topic_score_gemma":0.0036191102,"teacher_disagreement_score":0.005533249,"about_ca_system_score_codex":0.00084005523,"about_ca_system_score_gemma":0.0013608186,"threshold_uncertainty_score":0.0191859},"labels":[],"label_agreement":null},{"id":"W2788046162","doi":"10.3390/pharmaceutics10010013","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape—A Summary of This Indispensable Special Issue","year":2018,"lang":"en","type":"editorial","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Pharmacokinetics; Drug metabolism; Drug; Current (fluid); Pharmacology; Medicine; Engineering","score_opus":0.04818841988891613,"score_gpt":0.3908759117886192,"score_spread":0.34268749189970305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788046162","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048355876,0.07167775,0.00016539512,0.07375026,0.8526278,0.000018253657,0.00013380215,0.000059008053,0.00151925],"genre_scores_gemma":[0.00042263774,0.054397028,0.00017545978,0.020037515,0.92013615,0.000011153323,0.00008948986,0.000037158065,0.0046934388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995038,0.00051035435,0.000607508,0.00036155872,0.0031792447,0.00030340673],"domain_scores_gemma":[0.9560761,0.010523387,0.0016409504,0.00056128774,0.02720842,0.0039897114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006680107,0.002325729,0.0034036946,0.0045240936,0.0032413972,0.0061142794,0.002912699,0.007340769,0.007596963],"category_scores_gemma":[0.022403875,0.000748663,0.0019259216,0.003905884,0.0024334986,0.0032912958,0.001167088,0.014070213,0.003921309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012757053,0.0000059620506,0.000036449823,0.00015734517,0.00000985577,0.00003646363,0.000009384911,0.000021008667,0.000021954726,0.00012438497,0.9913668,0.008197692],"study_design_scores_gemma":[0.000021922155,0.000018873727,0.00058252166,0.00085492624,0.00004931939,0.00021092617,0.000056926092,0.00013955841,0.00005779465,0.0005443378,0.99743724,0.000025612686],"about_ca_topic_score_codex":0.09298231,"about_ca_topic_score_gemma":0.27901924,"teacher_disagreement_score":0.98763084,"about_ca_system_score_codex":0.012369143,"about_ca_system_score_gemma":0.02026814,"threshold_uncertainty_score":0.18488216},"labels":[],"label_agreement":null},{"id":"W2789350728","doi":"10.1016/j.euroneuro.2018.05.009","title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies","year":2018,"lang":"en","type":"review","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"National Human Genome Research Institute; National Institute of General Medical Sciences; Medical Research Council; National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; National Cancer Institute","keywords":"CYP2C19; Escitalopram; Citalopram; Internal medicine; Meta-analysis; CYP2D6; Pharmacogenetics; Medicine; Antidepressant; Pharmacology; Side effect (computer science); CYP3A4; Gastroenterology; Cytochrome P450; Genotype; Biology; Genetics; Gene; Metabolism","score_opus":0.29465795754216945,"score_gpt":0.5144122834458251,"score_spread":0.21975432590365568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789350728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020361153,0.97669584,0.001233338,0.0003276926,0.00016811967,0.000028012275,0.0009131033,0.000036220412,0.00023644186],"genre_scores_gemma":[0.47638375,0.5136642,0.0042456817,0.001302868,0.0006201827,0.00013800837,0.0029316978,0.00007499994,0.000638514],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99626666,0.0017827799,0.000672781,0.0008214031,0.0003164574,0.00013986028],"domain_scores_gemma":[0.9906517,0.007497614,0.0008618712,0.00048510826,0.00037645758,0.0001271716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065405136,0.0021118582,0.006865078,0.0017596746,0.0003328374,0.0015970257,0.0014968857,0.0014865502,0.0026784828],"category_scores_gemma":[0.011655345,0.00075997034,0.019120414,0.0034832982,0.00036453758,0.00086679915,0.0011325657,0.0016278327,0.0002552521],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035554531,0.000035961522,0.046704903,0.030806977,0.8762866,0.0002532482,0.00007524603,0.00093431154,0.00063837133,0.00021903244,0.0013897563,0.039100025],"study_design_scores_gemma":[0.00047341606,0.00022305326,0.050237235,0.001988673,0.9416351,0.00025124013,0.00005465092,0.00048748337,0.0002636371,0.0007229566,0.003623448,0.000039143055],"about_ca_topic_score_codex":0.004152145,"about_ca_topic_score_gemma":0.009298193,"teacher_disagreement_score":0.006865078,"about_ca_system_score_codex":0.0005909616,"about_ca_system_score_gemma":0.0009340442,"threshold_uncertainty_score":0.034589946},"labels":[],"label_agreement":null},{"id":"W2789711110","doi":"10.3390/jpm8010009","title":"P450 Pharmacogenetics in Indigenous North American Populations","year":2018,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute","keywords":"Indigenous; Pharmacogenetics; Personalized medicine; Drug response; Precision medicine; Medicine; Drug; Genotype; Bioinformatics; Pharmacology; Biology; Genetics; Ecology; Pathology","score_opus":0.3050140670190541,"score_gpt":0.5476900463026773,"score_spread":0.24267597928362317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789711110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004974654,0.9975636,0.00018165256,0.00045286486,0.00010607448,0.0000052453092,0.00004060428,0.000006985983,0.0011454744],"genre_scores_gemma":[0.002497881,0.99665725,0.00019718177,0.00013477492,0.00012035308,0.0000047996737,0.000039701863,0.000001017774,0.00034711094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999851,0.0000288504,0.000028846083,0.00003494053,0.000044521035,0.000011771771],"domain_scores_gemma":[0.9996443,0.00020514768,0.00005062617,0.000010380759,0.00007388832,0.000015603828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045657193,0.00038322163,0.0006827329,0.0013166104,0.00019412707,0.0005972454,0.00037141217,0.0004841508,0.0022527345],"category_scores_gemma":[0.0010682773,0.00012372565,0.00042257612,0.0010984893,0.00023837462,0.00052790367,0.0003776975,0.0008315393,0.00051546196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050654227,0.000040700885,0.001339927,0.012683592,0.00013840299,0.00022517555,0.00009578241,0.00018460078,0.0010572163,0.0015746201,0.010973541,0.9716357],"study_design_scores_gemma":[0.000020985006,0.00013745847,0.011723879,0.010767705,0.0006757251,0.005436093,0.00017293275,0.000236797,0.0012747358,0.0032967436,0.96622133,0.00003560639],"about_ca_topic_score_codex":0.0021741458,"about_ca_topic_score_gemma":0.0034610527,"teacher_disagreement_score":0.0022527345,"about_ca_system_score_codex":0.00028467938,"about_ca_system_score_gemma":0.00093728746,"threshold_uncertainty_score":0.0075361133},"labels":[],"label_agreement":null},{"id":"W2791191356","doi":"10.1007/s00115-017-0479-8","title":"Pharmakogenetik in der Psychiatrie: eine Standortbestimmung","year":2018,"lang":"de","type":"review","venue":"Der Nervenarzt","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Gynecology; Medicine; Philosophy","score_opus":0.19910285398830324,"score_gpt":0.5021384891058726,"score_spread":0.3030356351175693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791191356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012694567,0.9978098,0.00015298498,0.000878449,0.00031869308,0.0000034568475,0.000014527233,0.0000054104758,0.0006897465],"genre_scores_gemma":[0.001067619,0.9971384,0.00025525177,0.0005213944,0.00039584006,0.0000051621955,0.000020197864,0.0000012992501,0.0005949345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997392,0.00007299836,0.000042798347,0.000038125003,0.00008127906,0.000025572566],"domain_scores_gemma":[0.9992588,0.00040473044,0.00010579811,0.00002504905,0.0001469374,0.00005861188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010428315,0.00084765983,0.0013256888,0.0018068677,0.00025453567,0.0016310783,0.00057906006,0.001387205,0.004192872],"category_scores_gemma":[0.0011357946,0.00033874006,0.00062166323,0.0018103255,0.00063109543,0.0014106386,0.0010236792,0.002329699,0.0017235464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010567936,0.000097244665,0.00028070732,0.01075694,0.00014157005,0.00026377433,0.00006859363,0.0002751672,0.001555983,0.006430788,0.024574928,0.9554487],"study_design_scores_gemma":[0.00006936806,0.00021578836,0.0012971655,0.008036997,0.0003299536,0.0019150954,0.00010749234,0.00015529981,0.00068254163,0.005061786,0.9820979,0.000030527845],"about_ca_topic_score_codex":0.0010033771,"about_ca_topic_score_gemma":0.0024784151,"teacher_disagreement_score":0.004192872,"about_ca_system_score_codex":0.0006447515,"about_ca_system_score_gemma":0.0018459195,"threshold_uncertainty_score":0.014026523},"labels":[],"label_agreement":null},{"id":"W2792305076","doi":"10.1016/j.psychres.2018.02.055","title":"Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication","year":2018,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Charité – Universitätsmedizin Berlin; U.S. Food and Drug Administration; National Institutes of Health; Berlin Institute of Health; Centre for Addiction and Mental Health Foundation","keywords":"CYP2C19; Pharmacogenetics; CYP2D6; Medicine; Genotyping; Medical prescription; Antipsychotic; Antidepressant; Psychiatry; Pharmacogenomics; Clinical significance; Internal medicine; Clinical psychology; Pharmacology; Genotype; Schizophrenia (object-oriented programming); Genetics","score_opus":0.3046365639389016,"score_gpt":0.5505533726244565,"score_spread":0.24591680868555488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792305076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767749,0.0029064831,0.00092789385,0.004757692,0.00026763612,0.000041984043,0.0019267339,0.000092214956,0.012304549],"genre_scores_gemma":[0.99469227,0.0010419975,0.0006442744,0.0010105977,0.0001625796,0.000011765125,0.0011212357,0.000016627444,0.001298601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994809,0.000113077054,0.00006980461,0.000117719545,0.00015697668,0.00006164796],"domain_scores_gemma":[0.9982577,0.0005317235,0.00064161624,0.00014198414,0.00020918898,0.00021768501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048600126,0.0006475303,0.00056647573,0.0006317972,0.0004534558,0.000668964,0.00051441375,0.0012053354,0.0047606146],"category_scores_gemma":[0.0030080331,0.00013619312,0.00090068736,0.000785334,0.0004670339,0.00041866078,0.00021814075,0.0010394888,0.0007195474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001668786,0.00043180742,0.94737726,0.00008970861,0.0005705041,0.0068445345,0.00008487448,0.00018338501,0.010144051,0.00041433907,0.002821539,0.02936922],"study_design_scores_gemma":[0.00012154085,0.00094966206,0.975778,0.00004653908,0.00046975422,0.01420563,0.00014352171,0.0006801456,0.0035444745,0.0012179601,0.0028218457,0.000020855627],"about_ca_topic_score_codex":0.0025249287,"about_ca_topic_score_gemma":0.003700206,"teacher_disagreement_score":0.0047606146,"about_ca_system_score_codex":0.0005139286,"about_ca_system_score_gemma":0.0004320238,"threshold_uncertainty_score":0.015925884},"labels":[],"label_agreement":null},{"id":"W2792752410","doi":"10.1124/dmd.117.079921","title":"Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Common Fund; National Human Genome Research Institute; National Institute of Mental Health; NIH Office of the Director; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Université Laval","keywords":"Alternative splicing; Gene expression; RNA splicing; Transcriptional regulation; Chemistry; Expression (computer science); Biology; Cell biology; Regulation of gene expression; Biochemistry; Computational biology; Gene; Messenger RNA; RNA; Computer science","score_opus":0.02919582106917623,"score_gpt":0.35785123957489723,"score_spread":0.328655418505721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792752410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96487015,0.0036291135,0.021406021,0.00070806546,0.0002695639,0.00004828283,0.001956462,0.00026226832,0.00685012],"genre_scores_gemma":[0.9812789,0.0008144118,0.0067014177,0.00016837927,0.000068709734,0.000032068452,0.0024603875,0.00015201503,0.008323801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995814,0.00010010598,0.000027104543,0.00013115011,0.00008603741,0.00007428569],"domain_scores_gemma":[0.99968517,0.000092580856,0.00006406232,0.00004331305,0.000072810995,0.00004208572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003873282,0.0003310554,0.00029598223,0.0003300407,0.00021131056,0.00083421107,0.00018291449,0.00022762276,0.0031452766],"category_scores_gemma":[0.00036326388,0.00027154293,0.00056846644,0.00029229157,0.00037875792,0.000238048,0.00031957903,0.000603067,0.0012029656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003837687,0.000024054081,0.0021993953,0.000044947898,0.000021251006,0.00016635364,0.00006273653,0.00013547509,0.98989236,0.0010660384,0.00036091774,0.0056427675],"study_design_scores_gemma":[0.000070190865,0.00034361825,0.057487622,0.000031113756,0.00006795092,0.0013346863,0.0002062855,0.0039452817,0.9201181,0.00050804164,0.015858024,0.000029030154],"about_ca_topic_score_codex":0.0018884084,"about_ca_topic_score_gemma":0.0034310385,"teacher_disagreement_score":0.0031452766,"about_ca_system_score_codex":0.00048609733,"about_ca_system_score_gemma":0.00029889366,"threshold_uncertainty_score":0.010522008},"labels":[],"label_agreement":null},{"id":"W2793349513","doi":"10.1002/cpt.1048","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. National Library of Medicine; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Dosing; Medicine; Pharmacogenetics; Intensive care medicine; Computer science; Data science; Pharmacology; Psychology; Biology","score_opus":0.8349589273527223,"score_gpt":0.7219242324363636,"score_spread":0.11303469491635865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793349513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013238285,0.99296486,0.0005058532,0.0045546987,0.00027071958,0.000015509326,0.00004161966,0.000016126407,0.0014981534],"genre_scores_gemma":[0.0011055653,0.9960913,0.0011131786,0.0010940019,0.00026152414,0.000018942974,0.000041115964,0.00000535274,0.0002689605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976834,0.000850053,0.0003864002,0.0003192659,0.0006133142,0.0001475645],"domain_scores_gemma":[0.9868395,0.009212369,0.0008853891,0.00029059337,0.0022048443,0.0005673557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009566558,0.0008272144,0.0010084113,0.004510146,0.00050322426,0.0027271283,0.0014294079,0.0026412697,0.0056081186],"category_scores_gemma":[0.010847727,0.00043798442,0.0010659447,0.0056344154,0.0014239651,0.003787508,0.0017215769,0.0033038636,0.0016957113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057078,0.00008427693,0.0006663221,0.020901835,0.000085190295,0.00012981202,0.00018956995,0.0004128798,0.0003831091,0.019851761,0.023942249,0.9332959],"study_design_scores_gemma":[0.000019829906,0.00011986642,0.0016192349,0.025227617,0.00014985305,0.0007195279,0.00027799406,0.00020288656,0.00038766747,0.008137825,0.9631062,0.000031604082],"about_ca_topic_score_codex":0.0038314988,"about_ca_topic_score_gemma":0.0050726985,"teacher_disagreement_score":0.009566558,"about_ca_system_score_codex":0.002504173,"about_ca_system_score_gemma":0.01150925,"threshold_uncertainty_score":0.050593436},"labels":[],"label_agreement":null},{"id":"W2794045235","doi":"10.1016/bs.apha.2018.02.001","title":"Population Diversity in Pharmacogenetics: A Latin American Perspective","year":2018,"lang":"en","type":"review","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Genetic diversity; Latin Americans; Biology; Population; Diversity (politics); Evolutionary biology; Genotyping; Genetics; Demography; Political science; Gene; Genotype; Sociology; Anthropology","score_opus":0.1612162262032388,"score_gpt":0.5316853596355203,"score_spread":0.3704691334322815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794045235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009701803,0.99209714,0.00048220213,0.00415385,0.0002882205,0.0000029564387,0.000080547834,0.000008704567,0.0019162274],"genre_scores_gemma":[0.008971293,0.9872006,0.0005593602,0.0017566816,0.0010211027,0.0000066980874,0.000067133304,0.0000040015943,0.00041315221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970394,0.00010249836,0.000034252265,0.000068148256,0.000057009223,0.00003425556],"domain_scores_gemma":[0.9991302,0.0005487826,0.000111764144,0.000022072953,0.00014238892,0.000044865974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013942356,0.00044246874,0.00092935265,0.0014116707,0.00019983084,0.0012217253,0.0006034822,0.00080850645,0.0036148503],"category_scores_gemma":[0.0018221778,0.0001389621,0.00056270853,0.0023261085,0.0006054008,0.0010199959,0.00076025754,0.0011953481,0.0003564517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001283915,0.00009236808,0.0122372275,0.008581867,0.0004768499,0.00049306004,0.0004270749,0.0005230955,0.00076026266,0.018709263,0.020908212,0.9366623],"study_design_scores_gemma":[0.00004063422,0.0001566001,0.031069469,0.0111554945,0.00093590165,0.0026951502,0.0008131212,0.00037209035,0.00042094174,0.016576001,0.9357033,0.000061274615],"about_ca_topic_score_codex":0.005139984,"about_ca_topic_score_gemma":0.0074654995,"teacher_disagreement_score":0.005139984,"about_ca_system_score_codex":0.0006865357,"about_ca_system_score_gemma":0.0016680603,"threshold_uncertainty_score":0.012092829},"labels":[],"label_agreement":null},{"id":"W2794455666","doi":"10.18433/jpps29673","title":"Effect of Cytochrome P450 (CYP) 2D6 Genetic Polymorphism on the Inhibitory Action of Antidepressants on CYP2D6-Mediated Dopamine Formation from p-Tyramine","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2D6; Dopamine; Desipramine; Fluvoxamine; Imipramine; Pharmacology; Chemistry; Tyramine; Cytochrome P450; Endocrinology; Biology; Biochemistry; Metabolism; Medicine; Serotonin; Antidepressant; Receptor; Fluoxetine","score_opus":0.15230002310537025,"score_gpt":0.473319538542208,"score_spread":0.3210195154368377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794455666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781716,0.00069429935,0.00080599566,0.000040865394,0.000015615942,0.000012693418,0.00021042996,0.000010130137,0.0003929035],"genre_scores_gemma":[0.9988366,0.00019804762,0.00046004212,0.000022103703,0.000007983244,0.000010323483,0.00017954911,0.000007344683,0.0002779848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999584,0.00015892391,0.000036610585,0.00010684004,0.00007924465,0.000034457433],"domain_scores_gemma":[0.9996953,0.000115834024,0.00008545024,0.000027817827,0.000026250325,0.00004946311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003241326,0.0002943363,0.00033651188,0.00018313839,0.00009829867,0.00020104997,0.000100918674,0.00024638738,0.0015394834],"category_scores_gemma":[0.00050986314,0.00012574908,0.00032907553,0.00020938738,0.00018256999,0.00008890781,0.000071334885,0.00028769491,0.0002272825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009544211,0.0005058276,0.11544953,0.00014163175,0.0005703236,0.00093555404,0.000103341416,0.0006467592,0.8584784,0.00016600869,0.00031320896,0.013145143],"study_design_scores_gemma":[0.0004643686,0.005330256,0.6126599,0.00001728587,0.0005036702,0.0034714888,0.00006466196,0.0035431425,0.3711199,0.00013528719,0.0026579602,0.000032140942],"about_ca_topic_score_codex":0.0005399707,"about_ca_topic_score_gemma":0.0005294608,"teacher_disagreement_score":0.0015394834,"about_ca_system_score_codex":0.0001368748,"about_ca_system_score_gemma":0.00006943459,"threshold_uncertainty_score":0.00515002},"labels":[],"label_agreement":null},{"id":"W2796276845","doi":"10.1177/1715163518766376","title":"Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy","year":2018,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; University of Toronto","keywords":"Pharmacogenomics; Medicine; Medication therapy management; Pharmacotherapy; Pharmacist; Family medicine; Medical education; Pharmacy; Nursing; Pharmacology","score_opus":0.18696962716240795,"score_gpt":0.43765473278245304,"score_spread":0.2506851056200451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796276845","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031600178,0.004927281,0.0034781867,0.95075023,0.008308367,0.000094522984,0.000036596415,0.00022208167,0.029022839],"genre_scores_gemma":[0.08910001,0.021511748,0.03447432,0.7733149,0.022264307,0.00021148437,0.00013915205,0.0002900211,0.058694072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97059715,0.010641055,0.0013110334,0.0011554271,0.013189673,0.0031056008],"domain_scores_gemma":[0.8704699,0.019075766,0.005074748,0.0035594478,0.029359872,0.07246023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026378626,0.00058724766,0.00073734147,0.0018619373,0.0071323845,0.010572069,0.0017300738,0.01568206,0.023365282],"category_scores_gemma":[0.06506456,0.0010389873,0.0012438459,0.0010339539,0.005440227,0.006697316,0.012875506,0.018665802,0.0071857623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000827667,0.00075727404,0.0063861622,0.0004165079,0.00008384526,0.0021210443,0.0041523795,0.00046256106,0.0013374969,0.007783722,0.7642358,0.21218057],"study_design_scores_gemma":[0.00015750594,0.00019494497,0.012723955,0.0008363623,0.000037031412,0.003871732,0.006950019,0.0007499434,0.00033791218,0.021720987,0.9522858,0.00013384616],"about_ca_topic_score_codex":0.030518034,"about_ca_topic_score_gemma":0.11802905,"teacher_disagreement_score":0.030518034,"about_ca_system_score_codex":0.007891208,"about_ca_system_score_gemma":0.07263998,"threshold_uncertainty_score":0.13950521},"labels":[],"label_agreement":null},{"id":"W2803475077","doi":"10.7554/elife.33953","title":"Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins","year":2018,"lang":"en","type":"article","venue":"eLife","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of California, San Francisco; Searle Scholars Program; Damon Runyon Cancer Research Foundation; Natural Sciences and Engineering Research Council of Canada; Bill and Melinda Gates Foundation; David and Lucile Packard Foundation; National Institutes of Health; National Science Foundation","keywords":"Biology; Gene; Heterologous expression; Genetics; Enzyme; Population; Gene cluster; Microbiome; Biochemistry; Recombinant DNA","score_opus":0.10585075698181827,"score_gpt":0.40563600481116885,"score_spread":0.29978524782935057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803475077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942967,0.0010393931,0.0026528344,0.00015259531,0.000010927654,0.000030675288,0.0013375378,0.00004543196,0.0004337819],"genre_scores_gemma":[0.9877573,0.0007820933,0.007012826,0.00007648082,0.00001289482,0.000016969007,0.003421403,0.000022997632,0.00089689076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998392,0.00002312151,0.000015063127,0.000046841178,0.00004730956,0.00002849117],"domain_scores_gemma":[0.99987507,0.000020303889,0.000037165395,0.000021213133,0.000023810975,0.000022380334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013895947,0.00026654318,0.00033544222,0.00033055333,0.000095699754,0.00036014806,0.00013281542,0.00034686003,0.0003740045],"category_scores_gemma":[0.0002974711,0.00012791314,0.0002566986,0.00029222522,0.00014909416,0.00014255958,0.0002644725,0.00028233108,0.0002467967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010206529,0.000024618554,0.0042290147,0.00003698182,0.0000098904275,0.0001277265,0.000024602803,0.000044504868,0.9921733,0.00003180049,0.000034960834,0.003160444],"study_design_scores_gemma":[0.000024054587,0.00060273235,0.13761075,0.00002406941,0.00013115267,0.0031639233,0.00029727325,0.0017594778,0.8496377,0.00013572896,0.006597334,0.00001590043],"about_ca_topic_score_codex":0.00096385676,"about_ca_topic_score_gemma":0.0007550558,"teacher_disagreement_score":0.00096385676,"about_ca_system_score_codex":0.00012835201,"about_ca_system_score_gemma":0.00020394394,"threshold_uncertainty_score":0.0019165277},"labels":[],"label_agreement":null},{"id":"W2803784234","doi":"10.71781/4686","title":"Pharmacokinetic/pharmacodynamic relationship of pulmonary administration methods for milrinone : a translational approach","year":2016,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal","keywords":"Milrinone; Pharmacodynamics; Medicine; Pharmacokinetics; Administration (probate law); Pharmacology; Anesthesia; Hemodynamics; Political science","score_opus":0.23118770040669043,"score_gpt":0.5521011772569195,"score_spread":0.3209134768502291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803784234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65304697,0.14219338,0.1724909,0.00898083,0.0012407138,0.0016551678,0.0018025958,0.0007633344,0.017826121],"genre_scores_gemma":[0.9064375,0.04841351,0.0347887,0.0025733411,0.0009941154,0.0008008915,0.00083495205,0.00013833307,0.005018626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901533,0.0004269932,0.00003996375,0.00015045011,0.00029725753,0.00006995245],"domain_scores_gemma":[0.99864024,0.0005840649,0.00030453794,0.00015572636,0.00021891869,0.000096471354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003414234,0.0006063773,0.00088855816,0.00045786987,0.00025142016,0.0018428672,0.00075445883,0.0008190688,0.003383206],"category_scores_gemma":[0.0034263588,0.00028315998,0.0009148883,0.00052738114,0.0006124288,0.0009901433,0.00057168637,0.0015505148,0.0006024058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006240072,0.0030850086,0.020171061,0.0035534976,0.0008254037,0.0005677005,0.0006638677,0.0072466703,0.51643366,0.0076174103,0.0056727566,0.42792296],"study_design_scores_gemma":[0.0010274183,0.062443,0.19749275,0.0010283045,0.003484402,0.005298051,0.0013387863,0.11815973,0.4618122,0.010974896,0.13646367,0.00047678323],"about_ca_topic_score_codex":0.0011575635,"about_ca_topic_score_gemma":0.00069551775,"teacher_disagreement_score":0.003414234,"about_ca_system_score_codex":0.00095630577,"about_ca_system_score_gemma":0.001613778,"threshold_uncertainty_score":0.018056393},"labels":[],"label_agreement":null},{"id":"W2804186901","doi":"10.1136/bmjopen-2017-020922","title":"Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study","year":2018,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Tolbutamide; CYP2C19; Pharmacology; CYP2D6; CYP2B6; Population; Drug metabolism; Dextromethorphan; Drug; Type 2 Diabetes Mellitus; Diabetes mellitus; CYP1A2; Internal medicine; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.390045336484067,"score_gpt":0.6305879702458883,"score_spread":0.24054263376182133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804186901","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007079849,0.00028921297,0.004497219,0.00009062435,0.00012352374,0.98544216,0.0013438037,0.000058397698,0.0010750941],"genre_scores_gemma":[0.008130184,0.00015861278,0.0052628005,0.00013793337,0.000050474457,0.9851462,0.00070208655,0.000007368189,0.00040433145],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9858312,0.00685051,0.00311221,0.0016044173,0.0017175222,0.00088422385],"domain_scores_gemma":[0.9855854,0.002557395,0.0027902245,0.0026914994,0.0053284275,0.0010471013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023845138,0.0030982767,0.005792777,0.002355233,0.0023479853,0.0015542723,0.0024024781,0.0044524297,0.025237285],"category_scores_gemma":[0.019278899,0.0016133224,0.0025098382,0.0027549812,0.0019411515,0.0018181673,0.001610516,0.0021756825,0.006653131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44861174,0.065618634,0.08502876,0.049337853,0.004201818,0.0066084485,0.0049926145,0.013184984,0.032985874,0.01501628,0.059907515,0.21450546],"study_design_scores_gemma":[0.21888657,0.14772259,0.24027376,0.018034229,0.0025207978,0.0033935406,0.0023742584,0.013915951,0.013061037,0.010031118,0.32869583,0.0010903585],"about_ca_topic_score_codex":0.0019304198,"about_ca_topic_score_gemma":0.0017715708,"teacher_disagreement_score":0.025237285,"about_ca_system_score_codex":0.0024515593,"about_ca_system_score_gemma":0.00701696,"threshold_uncertainty_score":0.12610662},"labels":[],"label_agreement":null},{"id":"W2804291252","doi":"10.1111/bcp.13601","title":"Evaluation of sex‐by‐formulation interaction in bioequivalence studies of efavirenz tablets","year":2018,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Efavirenz; Sample size determination; Statistics; Test (biology); Medicine; Mathematics; Pharmacokinetics; Internal medicine; Human immunodeficiency virus (HIV); Biology; Family medicine","score_opus":0.44848270144107544,"score_gpt":0.620625452050883,"score_spread":0.1721427506098076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804291252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933343,0.024211427,0.03385824,0.0005056659,0.00043762903,0.002023306,0.00044096907,0.000074387746,0.0051053963],"genre_scores_gemma":[0.98735946,0.001305691,0.009366679,0.00022414222,0.00014821142,0.00063449686,0.00021077346,0.000035854646,0.00071464677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.88175535,0.090774305,0.0076578567,0.0028301554,0.016395155,0.00058718823],"domain_scores_gemma":[0.91940266,0.061333984,0.009349026,0.005360002,0.0042229258,0.00033138428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08066599,0.0006576913,0.0017124915,0.00081335724,0.0004453186,0.0012530115,0.0007284856,0.0013669794,0.002677688],"category_scores_gemma":[0.054311108,0.00036553442,0.0026995314,0.0010554654,0.0009982445,0.0008677701,0.00067544205,0.00090920494,0.00030267978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10797813,0.0026690161,0.41015467,0.005746437,0.014003071,0.0011939002,0.003562457,0.002375736,0.10441943,0.00263928,0.0013185084,0.3439394],"study_design_scores_gemma":[0.003302205,0.10619495,0.7702205,0.00051524,0.010264475,0.0030539718,0.00066846114,0.010689209,0.08086021,0.0021398163,0.011874674,0.0002163303],"about_ca_topic_score_codex":0.00022919445,"about_ca_topic_score_gemma":0.0002887991,"teacher_disagreement_score":0.08066599,"about_ca_system_score_codex":0.000483415,"about_ca_system_score_gemma":0.0006972662,"threshold_uncertainty_score":0.4266076},"labels":[],"label_agreement":null},{"id":"W2804371944","doi":"10.1038/s41397-018-0027-3","title":"Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Health and Medical Research Council; National Medical Research Council; U.S. Food and Drug Administration","keywords":"Pharmacogenetics; CYP2C19; Medicine; Dosing; Pharmacodynamics; CYP2D6; Pharmacogenomics; Psychiatry; Pharmacology; Psychology; Genotype; Internal medicine; Pharmacokinetics; Genetics; Biology; Gene","score_opus":0.12497483590642317,"score_gpt":0.4306686487054996,"score_spread":0.3056938127990764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804371944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9017124,0.0020648264,0.038790986,0.0069102733,0.00020828824,0.0006130672,0.028812896,0.0030585907,0.017828727],"genre_scores_gemma":[0.9678261,0.00024006223,0.021218682,0.00073723204,0.00007191928,0.0001201865,0.009003344,0.0001326387,0.0006497895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9838125,0.0066413037,0.0029076668,0.002260618,0.0035914874,0.0007864402],"domain_scores_gemma":[0.78792834,0.19014467,0.0068181376,0.0061392533,0.0073326216,0.0016369587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02953191,0.0007644661,0.0011454702,0.0043165158,0.0005458949,0.0039624567,0.0015028601,0.00190409,0.010577727],"category_scores_gemma":[0.14548299,0.0004114741,0.0015532374,0.003813166,0.00033839777,0.0021244588,0.0011918674,0.00096748956,0.0025702445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010111731,0.0010040663,0.70189565,0.00051110465,0.0014675466,0.00084218464,0.0007533066,0.014754518,0.0017153693,0.0027071454,0.02364348,0.24059393],"study_design_scores_gemma":[0.0027423324,0.0015035148,0.37889764,0.0009764417,0.0027842098,0.002908093,0.0018862645,0.52726907,0.026506472,0.024511792,0.02960231,0.00041190337],"about_ca_topic_score_codex":0.004373061,"about_ca_topic_score_gemma":0.0034798493,"teacher_disagreement_score":0.02953191,"about_ca_system_score_codex":0.0012888606,"about_ca_system_score_gemma":0.001673922,"threshold_uncertainty_score":0.15618151},"labels":[],"label_agreement":null},{"id":"W2805727844","doi":"10.1101/cshperspect.a033027","title":"The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Computational biology; DNA sequencing; Medicine; Biology; Genetics; Pharmacology; Genotype; Gene","score_opus":0.2544066047952023,"score_gpt":0.45646674879798144,"score_spread":0.20206014400277916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805727844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002476517,0.99371016,0.0016135975,0.0021193102,0.00045997545,0.000012840756,0.000047075366,0.000026765269,0.0017625944],"genre_scores_gemma":[0.0016393468,0.9937588,0.0019831767,0.0010651976,0.0005449478,0.000019374553,0.00007561112,0.0000064314695,0.0009070544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916327,0.0002755128,0.00007197209,0.00012174706,0.00030598658,0.000061572675],"domain_scores_gemma":[0.9977654,0.001508154,0.00014523021,0.00007698273,0.00038116323,0.00012295366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032952607,0.00091982447,0.0014211606,0.0025260479,0.00028168983,0.0014862551,0.0010716342,0.00206659,0.0031487918],"category_scores_gemma":[0.002608677,0.00029750288,0.00081903645,0.0023416292,0.0011703678,0.0019462717,0.001123015,0.0033175494,0.001727665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005533145,0.000054011824,0.00045057206,0.006673073,0.00014674854,0.000264611,0.00007375976,0.0007730299,0.0028076165,0.012103892,0.024256302,0.952341],"study_design_scores_gemma":[0.000020338148,0.00007684619,0.0011957737,0.0024892895,0.00012780288,0.0012841767,0.000080464255,0.0005326964,0.0015192513,0.01518192,0.9774507,0.000040696257],"about_ca_topic_score_codex":0.0016397499,"about_ca_topic_score_gemma":0.0018131973,"teacher_disagreement_score":0.0032952607,"about_ca_system_score_codex":0.0010347358,"about_ca_system_score_gemma":0.002167165,"threshold_uncertainty_score":0.017427206},"labels":[],"label_agreement":null},{"id":"W2805837446","doi":"10.5539/gjhs.v10n7p36","title":"Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia","year":2018,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Allele; Population; Polymorphism (computer science); Allele frequency; Pharmacogenetics; Genetics; Polymerase chain reaction; Gene polymorphism; Gene; Medicine; Biology; Environmental health","score_opus":0.10033511360053278,"score_gpt":0.48767928307520797,"score_spread":0.3873441694746752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805837446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983785,0.00030512526,0.00007598666,0.00006129644,0.0000053856793,0.000013383542,0.00022228011,0.0000024453445,0.0009355817],"genre_scores_gemma":[0.9992766,0.0001708215,0.00007090426,0.000027912822,0.0000056877866,0.000008075568,0.00018660504,0.0000013625988,0.00025198373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998449,0.000037419235,0.0000109080775,0.00003602927,0.000032590513,0.000038128233],"domain_scores_gemma":[0.99979764,0.000029227811,0.00006652513,0.000014256673,0.000042513926,0.00004984551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001444337,0.00025159618,0.00020440534,0.00061614125,0.00044076043,0.00041921425,0.0001547399,0.0001538812,0.0020991936],"category_scores_gemma":[0.0005564478,0.00009008372,0.0001383811,0.00039072527,0.00019361777,0.00009660454,0.0002134245,0.00016131492,0.00016681956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009159628,0.0000469531,0.9930432,0.000023504272,0.000020052015,0.0004477906,0.00041636263,0.00001775475,0.0013037447,0.000041923955,0.00019522937,0.004351958],"study_design_scores_gemma":[0.000005996579,0.000054618617,0.9975789,0.0000096878175,0.000015640393,0.0005622585,0.0008860177,0.000051722025,0.000115275165,0.000017357619,0.0006997069,0.0000029302043],"about_ca_topic_score_codex":0.043506082,"about_ca_topic_score_gemma":0.042413715,"teacher_disagreement_score":0.043506082,"about_ca_system_score_codex":0.0004544489,"about_ca_system_score_gemma":0.00026833493,"threshold_uncertainty_score":0.08650571},"labels":[],"label_agreement":null},{"id":"W2806025779","doi":"10.1007/s40262-018-0681-2","title":"The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Drug; Drug development; Drug metabolism; Medicine; Physiologically based pharmacokinetic modelling; Pharmacotherapy; Glucuronosyltransferase; Bioinformatics; Computational biology; Enzyme; Biology; Metabolism; Internal medicine; Biochemistry; Microsome","score_opus":0.47038958596848207,"score_gpt":0.5852079668511639,"score_spread":0.11481838088268187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806025779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011421811,0.99078923,0.004209402,0.0014250561,0.00025213632,0.000014081864,0.00010844424,0.000025616002,0.0020338874],"genre_scores_gemma":[0.0065457453,0.98713857,0.0038649004,0.0006226062,0.00023513826,0.000025852543,0.00015557483,0.000009861123,0.001401611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974805,0.000059611993,0.00003835992,0.000074581185,0.000057157642,0.000022167274],"domain_scores_gemma":[0.9993142,0.00034327578,0.00011129807,0.000042340744,0.00015339094,0.00003549225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013806414,0.00092939695,0.0011641113,0.0016473046,0.00017518627,0.0020390956,0.00094832125,0.0011218159,0.002179514],"category_scores_gemma":[0.0015200018,0.0005137087,0.0007712072,0.0018200307,0.00094921753,0.002353625,0.00072371,0.0024683245,0.00120394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019972322,0.00008838373,0.0011728063,0.009110188,0.000093043134,0.00034053082,0.0000985971,0.0031524138,0.0062946593,0.026547063,0.008590936,0.9443116],"study_design_scores_gemma":[0.000026728634,0.00023965277,0.003795273,0.0038988118,0.00021161004,0.0020501767,0.00019837373,0.001935042,0.0055539524,0.024904292,0.9571127,0.00007316982],"about_ca_topic_score_codex":0.0024818552,"about_ca_topic_score_gemma":0.0023599255,"teacher_disagreement_score":0.0024818552,"about_ca_system_score_codex":0.0011031727,"about_ca_system_score_gemma":0.0023985247,"threshold_uncertainty_score":0.008004129},"labels":[],"label_agreement":null},{"id":"W2806161302","doi":"10.1038/s41598-018-25044-0","title":"Comparative analyses and structural insights of the novel cytochrome P450 fusion protein family CYP5619 in Oomycetes","year":2018,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Medical Research Council; Central University of Technology; Allard Foundation; South African Medical Research Council","keywords":"Computational biology; Biology; Bioinformatics; Computer science; Evolutionary biology; Genetics","score_opus":0.18691329433641113,"score_gpt":0.4637595945264118,"score_spread":0.27684630019000067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806161302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552876,0.0006327026,0.0022050692,0.00006143589,0.000007966434,0.000011092655,0.000943665,0.0000436251,0.00056567736],"genre_scores_gemma":[0.98571616,0.00086803007,0.006861263,0.000036983038,0.0000150076485,0.00001802552,0.0054190164,0.000022188922,0.0010433601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992776,0.0000080613645,0.000006792552,0.00002508897,0.000020326039,0.00001194479],"domain_scores_gemma":[0.9999056,0.000012281809,0.000035597277,0.000009555683,0.000014653689,0.000022207692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007746656,0.00023645596,0.0002264277,0.00035333587,0.00023201956,0.00021746418,0.00013244386,0.00025435953,0.00097186916],"category_scores_gemma":[0.00017581195,0.00009709772,0.0004545847,0.00044167545,0.00009862767,0.00020128457,0.00015803774,0.00023997408,0.0003323662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027134496,0.00002990486,0.0048785373,0.00008523457,0.000017570137,0.00042620336,0.000051556424,0.00028609057,0.98910075,0.00014492143,0.000113115144,0.004594749],"study_design_scores_gemma":[0.00006019322,0.00075677596,0.29459396,0.000031342493,0.00021539746,0.007284576,0.00045311457,0.01765776,0.65055054,0.0005575844,0.027795572,0.000043169683],"about_ca_topic_score_codex":0.0006067161,"about_ca_topic_score_gemma":0.0005023001,"teacher_disagreement_score":0.00097186916,"about_ca_system_score_codex":0.00021791311,"about_ca_system_score_gemma":0.000105168205,"threshold_uncertainty_score":0.0032512546},"labels":[],"label_agreement":null},{"id":"W2806906739","doi":"10.1002/slct.201800633","title":"Importance of Azo‐Hydrazo Tautomerization in the Oxidative Degradation of Procarbazine by Cytochrome P450: Computational Insights","year":2018,"lang":"en","type":"article","venue":"ChemistrySelect","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Kermanshah University of Medical Sciences; Iran National Science Foundation","keywords":"Azoxy; Tautomer; Chemistry; Decomposition; Medicinal chemistry; Transition state; Homolysis; Photochemistry; Stereochemistry; Radical; Organic chemistry; Catalysis","score_opus":0.0469106583080535,"score_gpt":0.3907012452624814,"score_spread":0.3437905869544279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806906739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95302445,0.0019886983,0.011587834,0.0015160742,0.00013766623,0.00009316544,0.002975707,0.00034198802,0.028334308],"genre_scores_gemma":[0.9904399,0.00063827966,0.0048057237,0.0003131177,0.000039675266,0.00016190016,0.0017106027,0.00010202729,0.0017887265],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998149,0.000068768306,0.0000057769416,0.00002364833,0.000037361842,0.00004965592],"domain_scores_gemma":[0.999355,0.0004383932,0.000032825243,0.0000450576,0.000078031684,0.00005058045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005488733,0.00095502776,0.00175406,0.0006501191,0.0009481297,0.0011855277,0.0014636779,0.0016828143,0.0059888507],"category_scores_gemma":[0.0016393876,0.0004912035,0.0013192042,0.0006977774,0.000679644,0.0009484541,0.0007525832,0.0012327015,0.00047256536],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002474161,0.00015156991,0.004415334,0.00030412825,0.00017339979,0.0004213814,0.00005145141,0.9817883,0.0012973223,0.006042521,0.0019540396,0.0031531372],"study_design_scores_gemma":[0.00013737628,0.00014461033,0.0013003014,0.000038127713,0.000087431494,0.000062574036,0.00011180462,0.99351054,0.0004641236,0.0030602533,0.0010661483,0.000016728784],"about_ca_topic_score_codex":0.011576511,"about_ca_topic_score_gemma":0.011122087,"teacher_disagreement_score":0.011576511,"about_ca_system_score_codex":0.00075662497,"about_ca_system_score_gemma":0.001484772,"threshold_uncertainty_score":0.02301824},"labels":[],"label_agreement":null},{"id":"W2808278652","doi":"10.1186/s13104-018-3476-5","title":"Evaluation of buccal swabs for pharmacogenetics","year":2018,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada); College of Pharmacists of British Columbia; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Genotyping; Buccal swab; Medicine; Veterinary medicine; Genotype; Biology; Genetics; Gene","score_opus":0.7928889552184284,"score_gpt":0.6712531719170097,"score_spread":0.12163578330141867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808278652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7162844,0.013768012,0.2291918,0.0024816347,0.001820578,0.008183695,0.0097622285,0.0016880715,0.016819596],"genre_scores_gemma":[0.6221977,0.0076867933,0.33520254,0.0031366393,0.00055717316,0.006259835,0.008722004,0.0004925653,0.015744738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9906076,0.002601221,0.0008059636,0.0010684958,0.004636707,0.0002800225],"domain_scores_gemma":[0.9945688,0.0018277509,0.0007589582,0.00067907857,0.0020180228,0.00014745764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052490695,0.0011151923,0.0009188994,0.0014849309,0.0006746851,0.0011576049,0.0008929171,0.0012618888,0.005612564],"category_scores_gemma":[0.011560791,0.00054204906,0.00071053393,0.00078478595,0.00083870476,0.000525528,0.0009194258,0.0005913867,0.0031296352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015955985,0.0005192436,0.16371718,0.0022936435,0.0005636503,0.0019185568,0.0018066402,0.0006446131,0.6348794,0.000854495,0.006320192,0.18488689],"study_design_scores_gemma":[0.00020222657,0.0058698133,0.40323484,0.0015201255,0.0007600171,0.0109553905,0.0035524194,0.0053964416,0.49354485,0.0015814027,0.07316741,0.00021514122],"about_ca_topic_score_codex":0.0014355491,"about_ca_topic_score_gemma":0.0021830332,"teacher_disagreement_score":0.005612564,"about_ca_system_score_codex":0.00023064873,"about_ca_system_score_gemma":0.00063720974,"threshold_uncertainty_score":0.027760029},"labels":[],"label_agreement":null},{"id":"W2809392778","doi":"10.1007/s12104-018-9830-7","title":"Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A)","year":2018,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society of Canada","keywords":"Glucuronic acid; Chemistry; Biochemistry; Enzyme; Glucuronosyltransferase; Xenobiotic; Covalent bond; Drug metabolism; Stereochemistry; Polysaccharide; Organic chemistry","score_opus":0.061753110953328846,"score_gpt":0.4007837445645545,"score_spread":0.33903063361122565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809392778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835751,0.0009966948,0.010258028,0.0005204426,0.00007809368,0.000015229394,0.000941252,0.00013362222,0.003481505],"genre_scores_gemma":[0.9849605,0.0007601851,0.009095084,0.00015212447,0.000033264816,0.000016382097,0.002293031,0.00004269312,0.0026467533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999368,0.000015056828,0.0000031657257,0.00001649097,0.000013915053,0.00001443681],"domain_scores_gemma":[0.99970466,0.000046987745,0.00005721166,0.00003428951,0.00007875235,0.000078101206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026497678,0.00026988078,0.00017552167,0.00017764687,0.00037415625,0.0001975876,0.00036045015,0.00038602515,0.0028083085],"category_scores_gemma":[0.00059154537,0.00016100143,0.00020988169,0.00031160473,0.00016778355,0.00022535038,0.00013700969,0.00060770713,0.0003141659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010452726,0.00011159403,0.0025987548,0.00015127729,0.00006690348,0.0004387204,0.00014970248,0.0021464615,0.97629887,0.0016415053,0.00229496,0.013055976],"study_design_scores_gemma":[0.0003215395,0.0010359377,0.04021182,0.000051775594,0.00019421359,0.002129321,0.00023309319,0.060265936,0.8681779,0.001218487,0.026059868,0.00010013556],"about_ca_topic_score_codex":0.0018164235,"about_ca_topic_score_gemma":0.0017500076,"teacher_disagreement_score":0.0028083085,"about_ca_system_score_codex":0.00035290208,"about_ca_system_score_gemma":0.0003559313,"threshold_uncertainty_score":0.009394705},"labels":[],"label_agreement":null},{"id":"W2809836824","doi":"10.1101/cshperspect.a032607","title":"Principles of Translational Control","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Library science","score_opus":0.1967580673874403,"score_gpt":0.48497465983877797,"score_spread":0.2882165924513377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809836824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025372056,0.76044714,0.07313718,0.015128253,0.008799695,0.00022085899,0.00061106577,0.00081668934,0.13830192],"genre_scores_gemma":[0.07318345,0.7926542,0.04420019,0.01289284,0.009446669,0.0014014806,0.0007704623,0.0002536367,0.06519709],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860734,0.00024563776,0.00014199025,0.00040343567,0.00045868207,0.00014287508],"domain_scores_gemma":[0.9994733,0.00019181913,0.00009011464,0.00008866079,0.00011712894,0.00003910407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017444437,0.0013705773,0.0012718842,0.001762223,0.0012041877,0.0035412312,0.0020096716,0.002352183,0.007120357],"category_scores_gemma":[0.0009909231,0.00044381816,0.00096505083,0.0013492511,0.0070232362,0.0024176626,0.0020418959,0.0038846387,0.0062458836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007068872,0.000028867082,0.00014009375,0.0028091522,0.000056731442,0.00028032044,0.0003522564,0.00082652667,0.00615965,0.78414565,0.026138734,0.1789913],"study_design_scores_gemma":[0.000025839756,0.000062839994,0.00023312695,0.0005394314,0.000022067414,0.00042652208,0.000059492533,0.00031390466,0.0028114927,0.15843526,0.8370374,0.000032720505],"about_ca_topic_score_codex":0.00090253307,"about_ca_topic_score_gemma":0.0006164238,"teacher_disagreement_score":0.007120357,"about_ca_system_score_codex":0.002332237,"about_ca_system_score_gemma":0.0024032863,"threshold_uncertainty_score":0.023820043},"labels":[],"label_agreement":null},{"id":"W2809869273","doi":"10.1186/s12916-018-1093-8","title":"Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Biomedical Research Council; National Research Foundation Singapore; National Medical Research Council; Medical Research Council; Agency for Science, Technology and Research; National Research Foundation","keywords":"Medicine; Dosing; Warfarin; Randomized controlled trial; Internal medicine; Clinical endpoint; Randomization; Incidence (geometry); Therapeutic index; Clinical trial; Surgery; Pharmacology; Atrial fibrillation","score_opus":0.38548979249823195,"score_gpt":0.5168340295936595,"score_spread":0.13134423709542759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809869273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619542,0.020813312,0.0014973611,0.002059518,0.0016834346,0.006778417,0.0012177025,0.00021439965,0.0037817683],"genre_scores_gemma":[0.97958857,0.005304402,0.0023591358,0.0024269486,0.0009510137,0.0071159336,0.0007096152,0.000021765838,0.001522487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980584,0.0011647552,0.0002130895,0.00030470698,0.00011232573,0.0001467252],"domain_scores_gemma":[0.9976935,0.000955625,0.00062976463,0.0001816031,0.00016247746,0.00037703337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032139886,0.0014232446,0.0040034633,0.00041167694,0.00049900275,0.0011674195,0.0009440441,0.0025247207,0.006262076],"category_scores_gemma":[0.0049681864,0.000504756,0.0027154312,0.0006660225,0.0012236685,0.0011246321,0.00043383264,0.0022767445,0.00062821707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98837143,0.0015780622,0.00047345026,0.0009859174,0.0015327805,0.000025501296,0.000032653097,0.000109450935,0.00044119856,0.000094935865,0.00034886654,0.0060056983],"study_design_scores_gemma":[0.98021436,0.017010136,0.0009863205,0.00007848117,0.0009296368,0.00002194175,0.000013214113,0.0002651656,0.00006575671,0.00013738126,0.00026789733,0.000009638341],"about_ca_topic_score_codex":0.0007005328,"about_ca_topic_score_gemma":0.0016155967,"teacher_disagreement_score":0.006262076,"about_ca_system_score_codex":0.0007232829,"about_ca_system_score_gemma":0.0010691666,"threshold_uncertainty_score":0.020948708},"labels":[],"label_agreement":null},{"id":"W2811069189","doi":"10.1016/j.abb.2018.06.014","title":"Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency","year":2018,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; University of California, San Francisco; National Institutes of Health","keywords":"Allosteric regulation; Bioconjugation; Chemistry; CYP3A4; Steroid; Allosteric enzyme; Active site; Binding site; Cytochrome P450; Enzyme; Stereochemistry; Biochemistry","score_opus":0.034689999569702035,"score_gpt":0.3580046178513884,"score_spread":0.32331461828168634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811069189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979432,0.00027981415,0.0009387341,0.000030881005,0.000016027885,0.000009686532,0.00003303287,0.000024862191,0.0007236877],"genre_scores_gemma":[0.997336,0.00020818699,0.00071947806,0.000027082886,0.0000057981965,0.0000090537405,0.00007175338,0.000027726754,0.0015948747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952674,0.00016812255,0.000026813168,0.0000982916,0.000071447386,0.000108561646],"domain_scores_gemma":[0.9996333,0.00015270477,0.000057470595,0.000057525598,0.00005951052,0.000039535935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005063892,0.000307238,0.0003157173,0.00012002632,0.00022104009,0.00034393207,0.00026759147,0.0003000643,0.001857181],"category_scores_gemma":[0.00085495674,0.00021167293,0.0002700898,0.00035082735,0.00034805652,0.00019474572,0.00022974361,0.0004803382,0.00036152854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077316223,0.00007015702,0.00027232626,0.000026058106,0.000016893011,0.000052771764,0.00004433914,0.00017198267,0.99581724,0.0001399418,0.000050557173,0.0025646542],"study_design_scores_gemma":[0.000010757791,0.00020984288,0.00065953843,0.000001306596,0.000011098962,0.000029438352,0.0000076155206,0.00046826142,0.9981926,0.000007689133,0.0003982177,0.0000037053123],"about_ca_topic_score_codex":0.0017504984,"about_ca_topic_score_gemma":0.0015124623,"teacher_disagreement_score":0.001857181,"about_ca_system_score_codex":0.00035906865,"about_ca_system_score_gemma":0.0002946103,"threshold_uncertainty_score":0.0062129498},"labels":[],"label_agreement":null},{"id":"W2883678991","doi":"10.1186/s13034-018-0243-2","title":"A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents","year":2018,"lang":"en","type":"review","venue":"Child and Adolescent Psychiatry and Mental Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; BC Children's Hospital","keywords":"Risperidone; Irritability; Child and adolescent psychiatry; Psychology; Psychiatry; Antipsychotic; Extrapyramidal symptoms; Medicine; Clinical psychology; Schizophrenia (object-oriented programming); Cognition","score_opus":0.02716319449067241,"score_gpt":0.399122026123332,"score_spread":0.3719588316326596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883678991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006496764,0.9983072,0.000057802707,0.00013301223,0.00007145848,0.00008527482,0.00046115904,0.0000049048917,0.00022943343],"genre_scores_gemma":[0.0049598855,0.9941697,0.00019301963,0.0002307036,0.00003997467,0.00012673768,0.000204519,0.0000026310593,0.00007284579],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969013,0.00071088155,0.0014535172,0.00027777528,0.0005602092,0.00009638809],"domain_scores_gemma":[0.98832965,0.008132071,0.0023142323,0.00013236614,0.00097165717,0.00012005112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003192897,0.0010188207,0.0054062717,0.0075555784,0.00042217472,0.0015062288,0.0010842502,0.001061668,0.004567018],"category_scores_gemma":[0.015693327,0.00056997524,0.005116353,0.010480745,0.00049848075,0.0011307541,0.0009526696,0.00071235705,0.0003119977],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013423791,0.000009119911,0.00066106685,0.945724,0.004018303,0.00012998917,0.00014378216,0.00006803853,0.00015662664,0.0001641679,0.002160644,0.046629947],"study_design_scores_gemma":[0.00015261241,0.00015932172,0.006888366,0.89391094,0.058489393,0.0007667452,0.00020767048,0.00004822903,0.00018087587,0.00023246546,0.038933393,0.000029987237],"about_ca_topic_score_codex":0.008642454,"about_ca_topic_score_gemma":0.021012977,"teacher_disagreement_score":0.008642454,"about_ca_system_score_codex":0.0021953396,"about_ca_system_score_gemma":0.0071370527,"threshold_uncertainty_score":0.017184317},"labels":[],"label_agreement":null},{"id":"W2883772391","doi":"10.1101/368225","title":"Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; Queen's University; Canadian Institutes of Health Research; Government of Ontario","keywords":"Pharmacogenomics; Linkage disequilibrium; Genetics; Biology; 1000 Genomes Project; Genome; Gene; Genetic association; Genome-wide association study; Computational biology; Haplotype; Allele; Single-nucleotide polymorphism; Genotype","score_opus":0.05802416135768246,"score_gpt":0.346020541855976,"score_spread":0.28799638049829357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883772391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314893,0.0021336926,0.005378281,0.00052949594,0.000051455005,0.000030869367,0.0075116404,0.000125446,0.0010901873],"genre_scores_gemma":[0.9933797,0.00043609686,0.0027432416,0.00023856222,0.000037927053,0.000010477154,0.0028202743,0.000030368681,0.00030340903],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994141,0.00016256624,0.000051357278,0.00017640341,0.00013577711,0.00005975239],"domain_scores_gemma":[0.9986929,0.0008032842,0.0003027138,0.00008494617,0.000047948794,0.00006806992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085274095,0.00044420204,0.00044297118,0.00097239524,0.00023106145,0.0007292125,0.00025552773,0.00077015226,0.002636823],"category_scores_gemma":[0.0021294064,0.00015119152,0.00063930295,0.0014611677,0.0003440613,0.00018193311,0.0002799984,0.0006097636,0.00034165411],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001410624,0.00018225233,0.7174475,0.00059807673,0.0024670032,0.00415566,0.00026705104,0.005562617,0.20851071,0.0016928068,0.003403904,0.054301873],"study_design_scores_gemma":[0.000144792,0.00015964468,0.9625343,0.00008161982,0.00085762,0.0029113633,0.000104551866,0.006674764,0.018574705,0.001975782,0.0059440173,0.000036826812],"about_ca_topic_score_codex":0.0014234789,"about_ca_topic_score_gemma":0.002443304,"teacher_disagreement_score":0.002636823,"about_ca_system_score_codex":0.00020750704,"about_ca_system_score_gemma":0.00029933624,"threshold_uncertainty_score":0.00882107},"labels":[],"label_agreement":null},{"id":"W2883787065","doi":"","title":"Genomics and Biomarker Research in Drug Development: Overrated, or a Revolution to Come?","year":2017,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug development; Engineering ethics; Field (mathematics); Biomarker; Precision medicine; Genomics; Data science; Medicine; Computer science; Drug; Bioinformatics; Biology; Engineering; Pharmacology; Pathology; Genome","score_opus":0.36119855020183317,"score_gpt":0.5514500067521504,"score_spread":0.19025145655031722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883787065","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011565189,0.22239175,0.0044377474,0.7591122,0.009437388,0.000020375048,0.00006464299,0.0001001319,0.0032791728],"genre_scores_gemma":[0.087386176,0.3309373,0.021951042,0.5105414,0.043216024,0.00018763263,0.00014612368,0.00022674834,0.0054076808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95709443,0.023308918,0.0030822144,0.0044667455,0.009541643,0.0025060426],"domain_scores_gemma":[0.8706588,0.08538724,0.0045231143,0.010312454,0.021689592,0.007428823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11501979,0.0017754938,0.0049252976,0.0028045601,0.004561034,0.015209833,0.0048416816,0.021001361,0.010793076],"category_scores_gemma":[0.09030463,0.001028254,0.0017956985,0.0042137248,0.040231038,0.054523014,0.0111952415,0.029371774,0.004004833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082309864,0.00030461652,0.0028219523,0.0046833246,0.00038899676,0.00048265228,0.0017834699,0.001109899,0.0009435369,0.40387613,0.17640759,0.40637472],"study_design_scores_gemma":[0.0002971627,0.000560796,0.0026136704,0.0073981076,0.00023470777,0.0010161529,0.0041690227,0.0016181698,0.00051484973,0.5574034,0.42388535,0.00028854932],"about_ca_topic_score_codex":0.006357067,"about_ca_topic_score_gemma":0.005107995,"teacher_disagreement_score":0.11501979,"about_ca_system_score_codex":0.007698597,"about_ca_system_score_gemma":0.014371303,"threshold_uncertainty_score":0.6082901},"labels":[],"label_agreement":null},{"id":"W2886557322","doi":"10.1016/j.tiv.2018.08.004","title":"Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance","year":2018,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"European Commission; U.S. Environmental Protection Agency","keywords":"Biochemical engineering; In vitro; Computational biology; Computer science; Metabolite; Chemistry; Biochemistry; Biological system; Biology; Engineering","score_opus":0.10985869810134706,"score_gpt":0.5039570511157231,"score_spread":0.394098353014376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886557322","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006706861,0.0036994696,0.9844126,0.00028219318,0.00012625672,0.0013037797,0.00095694157,0.0007987193,0.0017131061],"genre_scores_gemma":[0.073656924,0.00847884,0.9025946,0.00063194043,0.00021677818,0.0047720545,0.0042737783,0.000730289,0.0046446896],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97343904,0.013417849,0.0029549403,0.0019302473,0.0076114675,0.000646411],"domain_scores_gemma":[0.97474325,0.00804796,0.002467362,0.0073475656,0.0069685434,0.0004253694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025015702,0.0029863536,0.003502899,0.0041393093,0.0015899022,0.005745701,0.0038522626,0.002436735,0.0015994224],"category_scores_gemma":[0.02301224,0.0016433821,0.0027917896,0.0019022315,0.0023574785,0.0028286749,0.004073398,0.004097757,0.003468282],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052628823,0.0006703149,0.005701487,0.0021148692,0.00041312937,0.00042660112,0.0005056633,0.007999511,0.8350296,0.016013924,0.0037518425,0.12684682],"study_design_scores_gemma":[0.000035018886,0.00071939215,0.0043247086,0.00028241336,0.00036938823,0.0009681665,0.00021299612,0.011244217,0.9442035,0.0039381883,0.033569753,0.00013218081],"about_ca_topic_score_codex":0.0044591073,"about_ca_topic_score_gemma":0.0071174004,"teacher_disagreement_score":0.025015702,"about_ca_system_score_codex":0.0024499157,"about_ca_system_score_gemma":0.0057169856,"threshold_uncertainty_score":0.13229722},"labels":[],"label_agreement":null},{"id":"W2889101019","doi":"10.1001/jamapsychiatry.2018.2344","title":"Pharmacogenetics in Psychiatry: A Companion, Rather Than Competitor, to Protocol-Based Care","year":2018,"lang":"en","type":"letter","venue":"JAMA Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health; University of Calgary","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry; MEDLINE; Law","score_opus":0.06370917184747929,"score_gpt":0.4318295880493795,"score_spread":0.36812041620190017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889101019","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029000785,0.0006856527,0.0025006465,0.9598103,0.012514083,0.00009210592,0.00006155387,0.00023672011,0.023808807],"genre_scores_gemma":[0.0077562504,0.0019141185,0.010220692,0.8787615,0.055608485,0.00040866935,0.000120419114,0.00036254246,0.044847336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.987336,0.005469648,0.0019334131,0.0009034577,0.0036295946,0.00072779675],"domain_scores_gemma":[0.943419,0.031717815,0.0027167273,0.004887375,0.008091528,0.009167522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016722484,0.0006275923,0.0006273226,0.0010281198,0.002212083,0.0043751793,0.0017984186,0.019358754,0.03849839],"category_scores_gemma":[0.06885177,0.0006884581,0.0010169894,0.0012135868,0.0045754407,0.0081166625,0.0035928804,0.026873808,0.022419013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017764969,0.0000535343,0.00036820074,0.000049756232,0.0000036518486,0.0007030877,0.00010174655,0.000059586997,0.00011551725,0.004471393,0.9720195,0.022036146],"study_design_scores_gemma":[0.000110415196,0.00008058665,0.0011666502,0.0005341882,0.000008228591,0.0041382215,0.00023486488,0.0006933945,0.00014267342,0.014354307,0.97849894,0.00003760516],"about_ca_topic_score_codex":0.0028116528,"about_ca_topic_score_gemma":0.0057532247,"teacher_disagreement_score":0.03849839,"about_ca_system_score_codex":0.0037688245,"about_ca_system_score_gemma":0.0070829447,"threshold_uncertainty_score":0.12878996},"labels":[],"label_agreement":null},{"id":"W2889126032","doi":"10.1096/fasebj.31.1_supplement.668.16","title":"Regulation of Hepatic CYP3A4 by 3‐Methylcholanthrene in Humanized PXR‐CAR‐CYP3A4/3A7 Mice","year":2017,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP3A4; Aryl hydrocarbon receptor; Pregnane X receptor; Cytochrome P450; Drug metabolism; Chemistry; Constitutive androstane receptor; Methylcholanthrene; Enzyme inducer; Pharmacology; Enzyme; Carcinogen; Biochemistry; Biology; Nuclear receptor; Gene; Transcription factor","score_opus":0.09914735422546347,"score_gpt":0.4270466895754119,"score_spread":0.3278993353499484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889126032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.956533,0.0034341814,0.020703437,0.001804568,0.0006022955,0.0007061979,0.00996906,0.0023260713,0.003921132],"genre_scores_gemma":[0.92350703,0.0036490955,0.020814113,0.0010202407,0.00023038064,0.0019185639,0.011254926,0.00092187326,0.036683682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981363,0.00021523808,0.00020848225,0.00062801864,0.00048234774,0.00032954718],"domain_scores_gemma":[0.99897754,0.00010017268,0.00033076078,0.00018625605,0.00009203379,0.00031325035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107354,0.0014483898,0.0011863229,0.003299589,0.0008193345,0.0011695899,0.0012211662,0.0022758425,0.0060601556],"category_scores_gemma":[0.00035129022,0.0013171593,0.0025157018,0.00094295776,0.0016953584,0.0011105303,0.00063449785,0.0043618665,0.0025738839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018062469,0.0011324245,0.0005367716,0.000083132814,0.000060639115,0.00033451314,0.00008940625,0.00027880483,0.9926117,0.0006272571,0.00038548096,0.002053605],"study_design_scores_gemma":[0.0007317394,0.005002241,0.005612876,0.000031708103,0.00018785652,0.0013782774,0.00018157286,0.0039310325,0.9717693,0.00047744965,0.010637723,0.000058176145],"about_ca_topic_score_codex":0.0019016875,"about_ca_topic_score_gemma":0.002391293,"teacher_disagreement_score":0.0060601556,"about_ca_system_score_codex":0.0011522181,"about_ca_system_score_gemma":0.00086410623,"threshold_uncertainty_score":0.020273209},"labels":[],"label_agreement":null},{"id":"W2889505073","doi":"10.1016/j.rcp.2018.07.002","title":"High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers","year":2018,"lang":"en","type":"article","venue":"Revista Colombiana de Psiquiatría","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"CYP3A4; Pharmacology; Inducer; Chemistry; Medicine; Internal medicine; Cytochrome P450; Biochemistry; Metabolism","score_opus":0.06025166596081876,"score_gpt":0.4254230873435385,"score_spread":0.36517142138271974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889505073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881421,0.0009901649,0.0015382024,0.0034855134,0.00017686265,0.000101755446,0.00019867026,0.0000935454,0.0052731847],"genre_scores_gemma":[0.9972582,0.00022067671,0.00051906606,0.0005507185,0.00006495783,0.000013076874,0.000095237185,0.00001682571,0.0012613822],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99972826,0.000040687657,0.00003854927,0.000053324577,0.000044201803,0.00009500668],"domain_scores_gemma":[0.99927145,0.00021364087,0.00009924939,0.000052404102,0.00007901991,0.00028425164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019165504,0.0005351933,0.000681715,0.0004252296,0.0011002702,0.0005595146,0.00028535575,0.0016026313,0.0022865988],"category_scores_gemma":[0.0017652283,0.00020918624,0.00080322556,0.00025444588,0.0003812421,0.00038937497,0.0002857832,0.0021754382,0.00041554845],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008355533,0.0035007123,0.35121584,0.0003423237,0.00025838715,0.4782592,0.0026218938,0.0005883922,0.047483258,0.0015924034,0.0036061634,0.102175854],"study_design_scores_gemma":[0.00063888216,0.013249234,0.35153893,0.00011372314,0.00065792835,0.5711988,0.0024496918,0.0030011716,0.042842925,0.0012249184,0.012911142,0.00017257594],"about_ca_topic_score_codex":0.0029263743,"about_ca_topic_score_gemma":0.002811237,"teacher_disagreement_score":0.0029263743,"about_ca_system_score_codex":0.0011367752,"about_ca_system_score_gemma":0.00065881043,"threshold_uncertainty_score":0.008247972},"labels":[],"label_agreement":null},{"id":"W2889618178","doi":"10.1038/s41525-018-0065-4","title":"User considerations in assessing pharmacogenomic tests and their clinical support tools","year":2018,"lang":"en","type":"review","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; WSP (Canada)","funders":"","keywords":"Pharmacogenomics; Computer science; Test (biology); Key (lock); Clinical decision support system; Decision support system; Risk analysis (engineering); Data science; Data mining; Medicine; Pharmacology","score_opus":0.48380413423267077,"score_gpt":0.5796990875447691,"score_spread":0.0958949533120983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889618178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025932435,0.96535105,0.005262531,0.015485755,0.0006427867,0.0001239021,0.00018919661,0.00007844348,0.010273075],"genre_scores_gemma":[0.052700512,0.9024691,0.023468247,0.015746312,0.0017744434,0.00037242877,0.00043605955,0.00007321608,0.0029596929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9741726,0.014802866,0.0031633445,0.0010283483,0.006413038,0.00041968818],"domain_scores_gemma":[0.9000648,0.08659229,0.0033389754,0.0010970389,0.008291492,0.00061536947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029844653,0.0006837301,0.0018861083,0.0024981569,0.0004362537,0.0048354617,0.0017580196,0.0038579977,0.0044560707],"category_scores_gemma":[0.080273114,0.0003858967,0.0010249424,0.00225316,0.0016056036,0.0041061523,0.0019247322,0.0029510735,0.00182868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013802524,0.000061527,0.004016982,0.01593483,0.00019371475,0.00059078226,0.00092283415,0.00019626698,0.00052341557,0.006441938,0.017849969,0.9531298],"study_design_scores_gemma":[0.00011429959,0.0003582583,0.010957551,0.056955907,0.00085289445,0.012060051,0.002405344,0.00065001356,0.0024355291,0.01557408,0.89746886,0.00016716677],"about_ca_topic_score_codex":0.0016014727,"about_ca_topic_score_gemma":0.002663864,"teacher_disagreement_score":0.029844653,"about_ca_system_score_codex":0.00076936884,"about_ca_system_score_gemma":0.0030788863,"threshold_uncertainty_score":0.15783554},"labels":[],"label_agreement":null},{"id":"W2889861811","doi":"10.1016/j.bmcl.2018.09.016","title":"Methyl-containing pharmaceuticals: Methylation in drug design","year":2018,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Chemistry; Drug; Pharmacokinetics; Methylation; Pharmacology; Pharmacodynamics; Drug metabolism; Biological activity; Computational biology; Combinatorial chemistry; In vitro; Biochemistry; Gene; Medicine","score_opus":0.27395406553412716,"score_gpt":0.4918970300860542,"score_spread":0.21794296455192702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889861811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010269085,0.99307126,0.001971423,0.00055556174,0.0003671069,0.000011968269,0.00003527207,0.000026691107,0.0029339034],"genre_scores_gemma":[0.007963446,0.9867764,0.0014715316,0.0004443865,0.0004372398,0.000017713584,0.00005423474,0.0000051947877,0.0028297387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998734,0.000027521697,0.000013410996,0.000024426281,0.00004322184,0.000017866523],"domain_scores_gemma":[0.99987745,0.000054754433,0.000028209854,0.000007463662,0.000019780593,0.000012292081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805145,0.0007495429,0.0008347836,0.0008289642,0.00016706104,0.0005809607,0.00067349215,0.00077903527,0.002860507],"category_scores_gemma":[0.00041061948,0.0003131008,0.00027982815,0.0010029289,0.00043513192,0.0011421661,0.000827238,0.001205104,0.0015741948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103267885,0.00007233813,0.0001551212,0.009016893,0.00008659004,0.00027390328,0.0000633386,0.00097653305,0.013915471,0.010591274,0.015836872,0.9489084],"study_design_scores_gemma":[0.00004002198,0.00027005989,0.00031612607,0.0011393445,0.00009792429,0.000987137,0.000035215846,0.00052046176,0.008985918,0.0051856837,0.9823972,0.000024943618],"about_ca_topic_score_codex":0.00028431026,"about_ca_topic_score_gemma":0.0008122091,"teacher_disagreement_score":0.002860507,"about_ca_system_score_codex":0.00034455647,"about_ca_system_score_gemma":0.00047376513,"threshold_uncertainty_score":0.0095694065},"labels":[],"label_agreement":null},{"id":"W2890068629","doi":"10.1021/acs.jmedchem.8b00907","title":"Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity","year":2018,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Universidad Nacional Autónoma de México; Fondation CHU de Québec; Consejo Nacional de Ciencia y Tecnología","keywords":"Chemistry; Cytochrome P450; Selectivity; Stereochemistry; CYP1B1; Ring (chemistry); IC50; Docking (animal); Enzyme; Combinatorial chemistry; In vitro; Biochemistry; Organic chemistry; Catalysis","score_opus":0.07483375476805847,"score_gpt":0.36246343762890637,"score_spread":0.2876296828608479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890068629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768138,0.009559615,0.008129528,0.00016798338,0.00005079337,0.00020335452,0.00047924294,0.00013016029,0.0044655814],"genre_scores_gemma":[0.98027724,0.005657567,0.010094397,0.000120986435,0.000017068956,0.00009971358,0.0005782008,0.000023322558,0.003131451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998934,0.00002188232,0.000012721809,0.000025578387,0.000022000588,0.000024236864],"domain_scores_gemma":[0.9999329,0.00000828833,0.000018926274,0.000008628968,0.000012788424,0.000018499823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019350725,0.0003795513,0.0003073965,0.00025280856,0.00011500332,0.00020449093,0.00031210808,0.00028417798,0.00087016466],"category_scores_gemma":[0.00012534528,0.00017321813,0.000269993,0.00032068172,0.00016996654,0.00020526431,0.00015093152,0.00045962015,0.00032094325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004384003,0.00020720637,0.0003388978,0.00018634411,0.000029787658,0.0001650804,0.000037413618,0.0010260193,0.9842392,0.00033170378,0.00018995999,0.01281006],"study_design_scores_gemma":[0.00015272388,0.0029443915,0.0017185264,0.000010727931,0.00007066168,0.0005166097,0.000016876955,0.0011839226,0.98367023,0.00006002266,0.009635156,0.000020085965],"about_ca_topic_score_codex":0.00053230184,"about_ca_topic_score_gemma":0.0009806602,"teacher_disagreement_score":0.00087016466,"about_ca_system_score_codex":0.00024731844,"about_ca_system_score_gemma":0.00019630483,"threshold_uncertainty_score":0.0029110312},"labels":[],"label_agreement":null},{"id":"W2891276185","doi":"10.1016/j.bmc.2018.09.001","title":"4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells","year":2018,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise","funders":"Canada Foundation for Innovation","keywords":"Chemistry; Prodrug; HaCaT; Stereochemistry; Cytochrome P450; Moiety; Chemical synthesis; Structure–activity relationship; Alkyl; Sulfonamide; In vitro; Biochemistry; Enzyme","score_opus":0.0410626882617693,"score_gpt":0.3872433365228238,"score_spread":0.3461806482610545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891276185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728214,0.008078681,0.005024927,0.00020648314,0.00013283225,0.000120528566,0.00043221514,0.00032563077,0.012857336],"genre_scores_gemma":[0.9881345,0.0036253766,0.0021223105,0.000051536274,0.0000158076,0.00004943285,0.00030224395,0.000018786173,0.0056800065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999162,0.000025153027,0.000006453219,0.000010324978,0.000015334852,0.000026470132],"domain_scores_gemma":[0.9999677,0.0000059384556,0.000007680566,0.0000033506583,0.0000065637564,0.000008785513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019133058,0.00028129236,0.00029117122,0.00021204988,0.00012973408,0.00016935618,0.00024019291,0.0001904431,0.0014999341],"category_scores_gemma":[0.000095725314,0.00012760273,0.00014405587,0.00019643984,0.00010836489,0.0001554932,0.00016789623,0.00032011906,0.00043808357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074183,0.00013148105,0.00029588488,0.00019321968,0.000012535241,0.00020565714,0.00011425016,0.0008397588,0.97593904,0.00114103,0.000576058,0.020043708],"study_design_scores_gemma":[0.00019262306,0.0025379574,0.0035290327,0.000021277583,0.000033993052,0.00036386627,0.00006440396,0.002158403,0.9771928,0.00009758106,0.013795655,0.00001236687],"about_ca_topic_score_codex":0.0013867947,"about_ca_topic_score_gemma":0.0043081744,"teacher_disagreement_score":0.0014999341,"about_ca_system_score_codex":0.0003334647,"about_ca_system_score_gemma":0.0002892025,"threshold_uncertainty_score":0.0050177574},"labels":[],"label_agreement":null},{"id":"W2891749579","doi":"10.1096/fasebj.27.1_supplement.666.3","title":"Pharmacogenomics of vincristine‐induced neurotoxicity in pediatric cancer patients","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Context (archaeology); Cohort; Oncology; Pediatric cancer; Internal medicine; Cancer; Bioinformatics; Biology","score_opus":0.0837949048185811,"score_gpt":0.39260042748887886,"score_spread":0.30880552267029776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891749579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989297,0.00031466887,0.00008667964,0.000035971752,0.0000012431628,0.000005088696,0.00037636212,0.0000031356587,0.0002471985],"genre_scores_gemma":[0.99914837,0.00020680336,0.00012081349,0.000027663595,0.000003742604,0.0000043858413,0.0003981182,0.0000025632985,0.00008758275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975127,0.0000797182,0.00002141214,0.00006464316,0.00004720049,0.0000356941],"domain_scores_gemma":[0.99954045,0.00009898558,0.00022657897,0.00003124469,0.000045831643,0.000056877292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002963538,0.00015878711,0.00027765773,0.00040998953,0.00021389572,0.00036923165,0.00014975885,0.000203582,0.0007502192],"category_scores_gemma":[0.0013042035,0.000108575376,0.00021353361,0.0009272317,0.00011592155,0.00014060274,0.00020794178,0.00027706038,0.00009873796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000206818,0.000019236595,0.9933123,0.000011540564,0.000053322634,0.00015155115,0.0000736381,0.00013061824,0.0011989078,0.000039500974,0.00012221443,0.00468033],"study_design_scores_gemma":[0.0000071492373,0.00013001676,0.998069,0.000004015479,0.000035248795,0.0006463512,0.00007400625,0.00020401653,0.0003861461,0.0000320183,0.00040977402,0.0000022299944],"about_ca_topic_score_codex":0.004660128,"about_ca_topic_score_gemma":0.0036647008,"teacher_disagreement_score":0.004660128,"about_ca_system_score_codex":0.000408443,"about_ca_system_score_gemma":0.00027618054,"threshold_uncertainty_score":0.009266019},"labels":[],"label_agreement":null},{"id":"W2896138992","doi":"10.1097/yco.0000000000000465","title":"Towards the integration of pharmacogenetics in psychiatry","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Pharmacogenomics; CYP2C19; Medicine; Genetic testing; Dosing; Psychiatry; Pharmacology; Psychology; Genetics; Gene; Biology; Genotype; Internal medicine","score_opus":0.35598024054537697,"score_gpt":0.553603772082564,"score_spread":0.19762353153718698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896138992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016596714,0.97783184,0.002889703,0.0146717,0.001902176,0.000058149708,0.00016382878,0.00008069408,0.0022359076],"genre_scores_gemma":[0.0028752359,0.97892934,0.0057941917,0.00933732,0.0021634274,0.00008362276,0.00027963743,0.00002725797,0.0005099134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954448,0.002102796,0.0007661944,0.00037028696,0.0011321859,0.00018370348],"domain_scores_gemma":[0.97365236,0.016448097,0.0026202195,0.0009311956,0.0056995936,0.00064859184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009200229,0.0008554123,0.0028848327,0.0040385397,0.0003612262,0.003852235,0.0018933375,0.003054057,0.0059721773],"category_scores_gemma":[0.02437967,0.00055563665,0.0025103085,0.0031411273,0.0011469491,0.004192711,0.002632406,0.0049646613,0.0029147312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083751285,0.00003871488,0.00048066,0.07222049,0.0007803869,0.00021889235,0.00018694719,0.0006884953,0.0004960223,0.018491855,0.05972252,0.8465913],"study_design_scores_gemma":[0.000031091433,0.00008018475,0.0017634573,0.09788305,0.0012540697,0.00068334845,0.00013188359,0.0004230772,0.00027294148,0.012713069,0.88472664,0.000037322035],"about_ca_topic_score_codex":0.0035024998,"about_ca_topic_score_gemma":0.003921523,"teacher_disagreement_score":0.009200229,"about_ca_system_score_codex":0.0024175914,"about_ca_system_score_gemma":0.010364816,"threshold_uncertainty_score":0.048656046},"labels":[],"label_agreement":null},{"id":"W2896289324","doi":"10.1002/dta.2523","title":"Zebrafish (<scp><i>Danio rerio</i></scp>) water tank model for the investigation of drug metabolism: Progress, outlook, and challenges","year":2018,"lang":"en","type":"article","venue":"Drug Testing and Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministério do Esporte; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; World Anti-Doping Agency","keywords":"Danio; Zebrafish; Drug; Drug metabolism; Chemistry; Computational biology; Pharmacology; Biology; Biochemistry; Gene","score_opus":0.1276785978959806,"score_gpt":0.36367371752348066,"score_spread":0.23599511962750006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896289324","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76537913,0.023268556,0.16445154,0.0038514093,0.0007943903,0.0010064503,0.013307049,0.003662958,0.024278542],"genre_scores_gemma":[0.8004799,0.017260723,0.14357936,0.0013660159,0.00008234367,0.00095239584,0.010787094,0.00072693924,0.024765275],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961555,0.00005233473,0.000030721494,0.00010923859,0.00014928482,0.000042741987],"domain_scores_gemma":[0.99977237,0.000025130661,0.00006492607,0.00003143098,0.00007093409,0.00003524691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007497826,0.00088039227,0.0006446654,0.00055296806,0.0003952075,0.0005407283,0.00046451448,0.0006313442,0.0022819627],"category_scores_gemma":[0.0002561141,0.0002978883,0.00075839856,0.0002830491,0.00043661814,0.00053307816,0.0005764513,0.0011153765,0.0007832137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007521959,0.000014473914,0.00040409458,0.00013491114,0.000018290828,0.00008479504,0.00001309967,0.00014037023,0.99477357,0.0002731616,0.00036599053,0.0037021204],"study_design_scores_gemma":[0.000036098503,0.0016587292,0.008233736,0.0000708329,0.00020389188,0.0008167806,0.0000872898,0.002294125,0.95607984,0.00045423483,0.029999133,0.00006523889],"about_ca_topic_score_codex":0.0052013625,"about_ca_topic_score_gemma":0.011883721,"teacher_disagreement_score":0.0052013625,"about_ca_system_score_codex":0.00094175996,"about_ca_system_score_gemma":0.0010518313,"threshold_uncertainty_score":0.010342181},"labels":[],"label_agreement":null},{"id":"W2898168462","doi":"10.1016/j.taap.2018.10.021","title":"CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish","year":2018,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; McMaster University","keywords":"Aryl hydrocarbon receptor; CYP3A; Biology; Cytochrome P450; Estrogen receptor; Subfamily; Vitellogenin; Aryl hydrocarbon receptor nuclear translocator; Gene expression; Gene; Xenobiotic; Receptor; Internal medicine; Endocrinology; Estrogen; Enzyme; Metabolism; Genetics; Biochemistry; Transcription factor","score_opus":0.03933859011057748,"score_gpt":0.3606560253366642,"score_spread":0.3213174352260867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898168462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867801,0.0009861152,0.0036551692,0.00039784302,0.00004057778,0.000032126674,0.0025528853,0.00014125658,0.005413808],"genre_scores_gemma":[0.9785653,0.00058141875,0.0024982733,0.00027144025,0.0000075936737,0.00007322699,0.0008478513,0.000124323,0.017030662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998497,0.000010824305,0.000007951052,0.000045336943,0.00004981498,0.00003629824],"domain_scores_gemma":[0.9998272,0.00003171871,0.00005355742,0.000017244376,0.00003860301,0.000031719042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114420734,0.00026515016,0.00023267862,0.0006348411,0.00031337645,0.00030145526,0.00020517682,0.00046721354,0.0018919485],"category_scores_gemma":[0.0001746607,0.000297915,0.00049757096,0.00020915913,0.000513071,0.00022589527,0.00031753271,0.00078271003,0.00041689072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013545994,0.0000066131165,0.0008384838,0.000016364687,0.0000055030473,0.00008116554,0.00004603253,0.0001311236,0.99698526,0.0004748717,0.00012079545,0.001158278],"study_design_scores_gemma":[0.00007656359,0.0002210781,0.07012855,0.000025579568,0.00007014984,0.00034206372,0.0002562189,0.002503619,0.91915244,0.0004225214,0.0067508398,0.000050376868],"about_ca_topic_score_codex":0.027753437,"about_ca_topic_score_gemma":0.043821905,"teacher_disagreement_score":0.027753437,"about_ca_system_score_codex":0.0018862617,"about_ca_system_score_gemma":0.00073762884,"threshold_uncertainty_score":0.055183828},"labels":[],"label_agreement":null},{"id":"W2899955386","doi":"10.1007/s10549-018-5027-0","title":"CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; CYP2D6; Medicine; Oncology; Genotyping; Context (archaeology); Metastatic breast cancer; Critical appraisal; Internal medicine; Gynecology; Cancer; Bioinformatics; Biology; Genotype; Alternative medicine; Pathology; Genetics","score_opus":0.39078011189290024,"score_gpt":0.6369050860232861,"score_spread":0.24612497413038587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899955386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027490413,0.9988029,0.00010360016,0.00031319106,0.00007637839,0.000051770327,0.00020362598,0.0000045258844,0.00016913367],"genre_scores_gemma":[0.006655123,0.9907986,0.0009962204,0.0009972584,0.000100008554,0.000093330666,0.0002212199,0.0000032287496,0.00013505669],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979754,0.00064633065,0.00078801875,0.0002357626,0.00029465943,0.000059778977],"domain_scores_gemma":[0.9936454,0.0045230803,0.0012544356,0.00007806116,0.00042700887,0.00007204855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031395138,0.0010153977,0.0042580366,0.0034655028,0.0002737916,0.0014647543,0.0012898509,0.0015764876,0.0060065757],"category_scores_gemma":[0.015047576,0.00058176246,0.0067259865,0.002970876,0.00037737683,0.0010697172,0.0007689163,0.0013655552,0.00037835972],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000915942,0.00006300628,0.0013623303,0.73517805,0.020682266,0.0001497132,0.00011106234,0.0003294716,0.00036847696,0.00069453864,0.010672636,0.22947253],"study_design_scores_gemma":[0.0024208566,0.00042985356,0.0066347197,0.65750045,0.21689108,0.00084772566,0.00022903144,0.0004097629,0.0004635402,0.0017100839,0.112341695,0.00012117756],"about_ca_topic_score_codex":0.004400493,"about_ca_topic_score_gemma":0.017413693,"teacher_disagreement_score":0.0060065757,"about_ca_system_score_codex":0.0011764164,"about_ca_system_score_gemma":0.0031893086,"threshold_uncertainty_score":0.020093977},"labels":[],"label_agreement":null},{"id":"W2900376768","doi":"10.1016/j.jmb.2018.11.007","title":"Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes","year":2018,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health","keywords":"Glucuronidation; Enzyme; Glucuronosyltransferase; Drug resistance; Biochemistry; Allosteric regulation; Drug; Substrate specificity; Biology; In vitro; Drug development; Chemistry; Pharmacology; Computational biology; Genetics; Microsome","score_opus":0.04720221271057111,"score_gpt":0.40730510450216156,"score_spread":0.36010289179159044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900376768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159271,0.03488556,0.03615913,0.0013317885,0.00032544078,0.00024820355,0.0005070146,0.0007798212,0.009835979],"genre_scores_gemma":[0.97360456,0.01502903,0.00761401,0.00029123976,0.000054940017,0.00006739665,0.00039263372,0.00003664317,0.0029096256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998995,0.000019944011,0.000008669824,0.000020552976,0.00002340087,0.000027863207],"domain_scores_gemma":[0.99992836,0.000011465429,0.000023475868,0.000008794623,0.000011865582,0.000015990565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002778097,0.0004809778,0.00048242256,0.00033760167,0.00012139109,0.00044853342,0.00038169432,0.0003145351,0.00094939343],"category_scores_gemma":[0.0002201246,0.00017826416,0.0002793414,0.00023674787,0.00020515024,0.00032841606,0.00027213644,0.0010465333,0.0002890823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006934693,0.0005248267,0.0012453411,0.00027473876,0.00010787581,0.00035531828,0.00006773388,0.0025362135,0.84299415,0.0034990534,0.0017449245,0.14595638],"study_design_scores_gemma":[0.0003926974,0.0043805973,0.0028345247,0.0000428774,0.00023422783,0.0017239866,0.000038108534,0.006082901,0.9442089,0.00071916095,0.039310034,0.00003194642],"about_ca_topic_score_codex":0.00031994365,"about_ca_topic_score_gemma":0.00089269644,"teacher_disagreement_score":0.00094939343,"about_ca_system_score_codex":0.00027200158,"about_ca_system_score_gemma":0.00025975515,"threshold_uncertainty_score":0.003175974},"labels":[],"label_agreement":null},{"id":"W2900478530","doi":"10.1002/jcph.1336","title":"Analyses of Adverse Drug Reactions–Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Western University; Provincial Health Services Authority; Child and Family Research Institute; Genome British Columbia; Pfizer Canada; Société Canadienne de Pédiatrie; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Medicine; Pharmacogenomics; Pharmacovigilance; Database; MedDRA; Drug reaction; Drug; Adverse drug reaction; Cardiotoxicity; Pharmacology; Internal medicine; Toxicity","score_opus":0.22913844339583006,"score_gpt":0.5357776064072207,"score_spread":0.30663916301139066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900478530","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026922302,0.0022579527,0.0013196691,0.0006466873,0.000050165836,0.0012501074,0.95754933,0.00032669492,0.009677071],"genre_scores_gemma":[0.10299114,0.0028246914,0.0066912207,0.00074297347,0.00007085106,0.00151273,0.8826443,0.00008104689,0.0024410957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99306595,0.000532212,0.0012683716,0.0007699295,0.003849642,0.00051387405],"domain_scores_gemma":[0.9604518,0.0023221925,0.005751465,0.0018785319,0.02784591,0.0017501736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004011103,0.0009394438,0.0012072881,0.010326817,0.0017420365,0.0015008092,0.0023678816,0.0006028891,0.005701078],"category_scores_gemma":[0.019493168,0.00045362418,0.0010104501,0.019933423,0.00032148985,0.0005956051,0.0011476672,0.0010458176,0.0012789846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009448536,0.00022236831,0.5073437,0.005144655,0.0015353924,0.00036656813,0.0005150145,0.0019771012,0.001161263,0.0023873686,0.4062529,0.072148785],"study_design_scores_gemma":[0.00020218515,0.000088995796,0.834719,0.00076982024,0.0005214252,0.00023581504,0.00026852242,0.0018004412,0.000944398,0.00037550906,0.15998302,0.00009087492],"about_ca_topic_score_codex":0.9155626,"about_ca_topic_score_gemma":0.92733413,"teacher_disagreement_score":0.08443737,"about_ca_system_score_codex":0.01721677,"about_ca_system_score_gemma":0.047919907,"threshold_uncertainty_score":0.16986924},"labels":[],"label_agreement":null},{"id":"W2900842113","doi":"10.1002/9780470921920.edm145","title":"Oxidative Drug Metabolism by Mammalian Cytochrome<scp>P450</scp>Enzymes Using Their Monooxygenase and Peroxygenase Functions","year":2017,"lang":"en","type":"other","venue":"Encyclopedia of Drug Metabolism and Interactions","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Monooxygenase; Cytochrome P450; Biotransformation; Drug metabolism; Enzyme; Chemistry; Biochemistry; Cytochrome; Prodrug; Oxidative phosphorylation; Drug; Metabolism; Pharmacology; Biology","score_opus":0.04009689119924323,"score_gpt":0.3576788264468414,"score_spread":0.31758193524759815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900842113","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02127729,0.6524939,0.02697779,0.0016139991,0.0021139963,0.00035285082,0.004263212,0.0014236709,0.2894833],"genre_scores_gemma":[0.08145675,0.64679873,0.020371715,0.0011905889,0.0013013673,0.0003147752,0.0065827677,0.00024503827,0.24173833],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978834,0.000027355009,0.000021799915,0.000040553503,0.00009722251,0.000024687044],"domain_scores_gemma":[0.99992216,0.000019090798,0.00002067817,0.000007443538,0.000023668692,0.000007011862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021564757,0.0006266784,0.0004399304,0.0012942287,0.00024094086,0.0012480066,0.00038490712,0.0004647685,0.023090804],"category_scores_gemma":[0.00022611853,0.0001641673,0.00044265625,0.0019127178,0.00026821805,0.0008613442,0.0006300639,0.0005409113,0.014017994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010411309,0.0000918341,0.0006127069,0.0047033457,0.000054098167,0.0006334596,0.000098732235,0.00049463427,0.07330445,0.014297781,0.03106563,0.87453914],"study_design_scores_gemma":[0.000009922906,0.00007769783,0.002048768,0.0004213956,0.000025371284,0.0012626615,0.00003753826,0.00018998382,0.027359609,0.0020805066,0.96647114,0.000015419504],"about_ca_topic_score_codex":0.0005247556,"about_ca_topic_score_gemma":0.00086458476,"teacher_disagreement_score":0.023090804,"about_ca_system_score_codex":0.0003744235,"about_ca_system_score_gemma":0.00048451917,"threshold_uncertainty_score":0.07724643},"labels":[],"label_agreement":null},{"id":"W2900859659","doi":"10.1016/j.jpsychires.2018.10.016","title":"Adequate evidence to support improved outcomes in depression by primary care physicians compared to psychiatrists when using combinatorial pharmacogenomics","year":2018,"lang":"en","type":"letter","venue":"Journal of Psychiatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Depression (economics); Primary care; Psychiatry; Medicine; Psychology; Clinical psychology; Family medicine; Pharmacology","score_opus":0.2328502124075531,"score_gpt":0.5217908815871977,"score_spread":0.28894066917964456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900859659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031476468,0.011145816,0.0002742383,0.9662202,0.011606816,0.000024482251,0.00022095155,0.000036632187,0.0073231934],"genre_scores_gemma":[0.046949018,0.009983891,0.0011562115,0.89278036,0.04626309,0.00006410151,0.00022721625,0.000026415839,0.0025497724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99100554,0.0037923618,0.0018548764,0.00085571024,0.0018905284,0.0006009682],"domain_scores_gemma":[0.89300686,0.086145885,0.0062605017,0.001780123,0.008056299,0.0047503477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008112901,0.0005825679,0.0018317307,0.00070521334,0.0011616312,0.0027379952,0.0016275676,0.01599239,0.011219893],"category_scores_gemma":[0.096485384,0.0003204024,0.0021408661,0.0010473966,0.0016457966,0.0017490775,0.0013935871,0.015200109,0.0026469133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036120557,0.0006733493,0.034595583,0.0031479322,0.0017882864,0.008413368,0.00034547807,0.00046721875,0.0010073738,0.0072273193,0.75538456,0.18333742],"study_design_scores_gemma":[0.011221179,0.0035738251,0.046490468,0.013469633,0.0047129164,0.01013906,0.0014795564,0.0019038307,0.0018533882,0.032967355,0.8719471,0.00024172405],"about_ca_topic_score_codex":0.0041902033,"about_ca_topic_score_gemma":0.007947542,"teacher_disagreement_score":0.01599239,"about_ca_system_score_codex":0.0033513121,"about_ca_system_score_gemma":0.0035887074,"threshold_uncertainty_score":0.04290569},"labels":[],"label_agreement":null},{"id":"W2901042022","doi":"10.1016/j.vhri.2018.09.003","title":"Drug Utilization Studies in Latin America: A Scoping Review and Survey of Ethical Requirements","year":2018,"lang":"en","type":"review","venue":"Value in Health Regional Issues","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Inro Consultants (Canada)","funders":"","keywords":"Latin Americans; Drug; Medicine; Political science; Pharmacology; Law","score_opus":0.8145457937045636,"score_gpt":0.6734986125990323,"score_spread":0.14104718110553127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901042022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019344309,0.98494524,0.0006555816,0.009767449,0.00029763393,0.00033831553,0.00051782443,0.000007903519,0.001535645],"genre_scores_gemma":[0.02660798,0.9595336,0.0050561475,0.006502018,0.0002962267,0.0012386262,0.0005225579,0.000023612083,0.00021913661],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8588905,0.06899447,0.04835948,0.0035089122,0.018483436,0.0017632288],"domain_scores_gemma":[0.50380456,0.40514073,0.051148504,0.007215641,0.031070005,0.0016205438],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20020398,0.00092864584,0.0044405754,0.020810202,0.002122954,0.00888238,0.002851464,0.0037555224,0.0023511269],"category_scores_gemma":[0.3388341,0.0011333654,0.0034658716,0.030852789,0.0046935314,0.0051597185,0.005788816,0.0031580941,0.00019480812],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039782806,0.00009323246,0.019500168,0.48015636,0.0030672261,0.00066305406,0.011637841,0.00033698085,0.00043259485,0.015666936,0.013999185,0.45404872],"study_design_scores_gemma":[0.00007469725,0.00005517603,0.011257077,0.8529972,0.0035161006,0.00050366175,0.0069329655,0.00010209466,0.00031044023,0.0037647963,0.12043417,0.000051633568],"about_ca_topic_score_codex":0.016835606,"about_ca_topic_score_gemma":0.03862062,"teacher_disagreement_score":0.9962445,"about_ca_system_score_codex":0.010709069,"about_ca_system_score_gemma":0.05130165,"threshold_uncertainty_score":0.9862909},"labels":[],"label_agreement":null},{"id":"W2902167120","doi":"10.1002/cpt.1323","title":"Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Queen's University Belfast; Queen's University; British Heart Foundation; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Dosing; Coumarin; Pharmacology; Acenocoumarol; Confidence interval; Meta-analysis; Medicine; Cytochrome P450; Internal medicine; Chemistry; Metabolism","score_opus":0.30353908317061196,"score_gpt":0.5164399306452812,"score_spread":0.2129008474746692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902167120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13610929,0.85282296,0.004767679,0.00091377203,0.00063480577,0.00032759327,0.0028765895,0.00014773589,0.001399594],"genre_scores_gemma":[0.90434974,0.088135384,0.0032987823,0.0010397204,0.00034551474,0.00032960984,0.0017450149,0.000087471104,0.0006688729],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931704,0.0038133333,0.0012265184,0.0011203242,0.00046173556,0.00020760493],"domain_scores_gemma":[0.9870292,0.010018437,0.0013161316,0.00089977775,0.0005805624,0.00015591657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010909215,0.0019244591,0.007130048,0.0021202061,0.00042840277,0.0022625509,0.0008988146,0.0015214584,0.0017924955],"category_scores_gemma":[0.016333293,0.0009900838,0.034978505,0.0034751692,0.00043854487,0.00088123366,0.00076493755,0.00174594,0.00030301933],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007304984,0.000033028464,0.02234406,0.019169286,0.9418631,0.00014653057,0.00003920963,0.0009832382,0.0006745582,0.000104400584,0.0004676188,0.0068699736],"study_design_scores_gemma":[0.00068184367,0.00022324441,0.008768843,0.0006730213,0.98813707,0.00006900479,0.0000111018235,0.00031587796,0.00025682925,0.00015783109,0.00069241744,0.000012841745],"about_ca_topic_score_codex":0.0048033935,"about_ca_topic_score_gemma":0.006893156,"teacher_disagreement_score":0.010909215,"about_ca_system_score_codex":0.0010312028,"about_ca_system_score_gemma":0.00088121893,"threshold_uncertainty_score":0.057694137},"labels":[],"label_agreement":null},{"id":"W2902998103","doi":"10.1124/dmd.118.084301","title":"Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche; American Society for Pharmacology and Experimental Therapeutics","keywords":"Glucuronidation; UGT2B7; Chemistry; Microsome; Chromatography; Enzyme; Uridine; Tris; Glucuronosyltransferase; Uridine diphosphate; Biochemistry","score_opus":0.030635830685994892,"score_gpt":0.35068469895227855,"score_spread":0.32004886826628365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902998103","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38720223,0.0050319512,0.5944024,0.0006147386,0.00044776898,0.0032530327,0.0020155148,0.0045203893,0.0025119705],"genre_scores_gemma":[0.41155294,0.0037644038,0.5699584,0.0007121174,0.0002714802,0.0054494673,0.005158758,0.0007222642,0.0024101995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933031,0.0016836028,0.0005771327,0.0013262954,0.0026482558,0.00046152208],"domain_scores_gemma":[0.9982008,0.0006120136,0.00026590112,0.0002022709,0.00055730034,0.00016175995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046255123,0.0028789146,0.0020841754,0.0014504187,0.0013294454,0.0013333077,0.0013530607,0.0018172356,0.0017798491],"category_scores_gemma":[0.004155871,0.0014565713,0.001283811,0.0012452874,0.0012416028,0.0011749694,0.0016047239,0.0020513,0.0015749894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001100178,0.00030808296,0.0012537871,0.0003039923,0.00016096236,0.0000735653,0.00007233297,0.0015422544,0.9828536,0.0002708737,0.00041430688,0.011646089],"study_design_scores_gemma":[0.00009932713,0.0006527409,0.0032206234,0.000027717026,0.00016866815,0.00020694625,0.00003371565,0.00746316,0.9846785,0.00019190501,0.00317302,0.000083680694],"about_ca_topic_score_codex":0.0023689463,"about_ca_topic_score_gemma":0.00376694,"teacher_disagreement_score":0.0046255123,"about_ca_system_score_codex":0.001212667,"about_ca_system_score_gemma":0.0031751855,"threshold_uncertainty_score":0.024462342},"labels":[],"label_agreement":null},{"id":"W2905335582","doi":"10.1186/s13058-018-1083-y","title":"CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Tamoxifen; Breast cancer; Medicine; Internal medicine; CYP2D6; Oncology; Surgical oncology; Population; Cancer; Logistic regression; Metabolism","score_opus":0.14033265430675462,"score_gpt":0.5192617170821467,"score_spread":0.3789290627753921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905335582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764156,0.00089227036,0.00007873147,0.00010957689,0.000009155408,0.000021068196,0.0005955772,0.0000028550387,0.0006491832],"genre_scores_gemma":[0.99895585,0.00019348793,0.000063758715,0.000068762514,0.0000136988865,0.00001789451,0.00051662046,0.0000028263833,0.0001671051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990312,0.00033856026,0.000107009,0.00021548345,0.00018722365,0.000120518205],"domain_scores_gemma":[0.99853647,0.00022764356,0.00061901065,0.00020149184,0.00015488704,0.00026058502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010142578,0.00025487444,0.00044891195,0.00055474264,0.00047261198,0.00067766424,0.00041338842,0.00053183123,0.0015960678],"category_scores_gemma":[0.002508999,0.0002057687,0.0006349703,0.0009866834,0.00026920927,0.00031402634,0.00053244166,0.00050294615,0.00014578554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000703067,0.000041076524,0.9971004,0.000017413277,0.00019009794,0.00015567052,0.000072532974,0.000016611048,0.00022224787,0.00004694564,0.00029975988,0.0011340863],"study_design_scores_gemma":[0.00009021112,0.00015433076,0.9982626,0.000011937015,0.00021517028,0.0004231642,0.00010678951,0.00010356051,0.000087285734,0.000047810718,0.0004915909,0.000005620967],"about_ca_topic_score_codex":0.012886861,"about_ca_topic_score_gemma":0.014297818,"teacher_disagreement_score":0.012886861,"about_ca_system_score_codex":0.00035488638,"about_ca_system_score_gemma":0.00038483355,"threshold_uncertainty_score":0.02562368},"labels":[],"label_agreement":null},{"id":"W2905593205","doi":"10.1124/dmd.118.084509","title":"Suppression of Hepatic CYP3A4 Expression and Activity by 3-Methylcholanthrene in Humanized PXR-CAR-CYP3A4/3A7 Mice","year":2018,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; CYP3A4; Constitutive androstane receptor; Messenger RNA; CYP3A; Biology; Internal medicine; Cytochrome P450; Endocrinology; Nuclear receptor; Chemistry; Metabolism; Biochemistry; Transcription factor; Medicine; Gene","score_opus":0.03158154888758917,"score_gpt":0.37544842381281734,"score_spread":0.34386687492522816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905593205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784042,0.000992782,0.01019588,0.000812136,0.00022197883,0.00015983597,0.005412435,0.0017275097,0.002073147],"genre_scores_gemma":[0.9696972,0.0008638106,0.0068686674,0.0001874445,0.00007814111,0.00035326483,0.0033843296,0.00063719065,0.01792996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899715,0.00013628208,0.00009732176,0.00027463547,0.00027475285,0.00021985972],"domain_scores_gemma":[0.999084,0.000119478915,0.00032110137,0.00017299618,0.000060044782,0.00024241148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059612305,0.001211071,0.0009093223,0.0028034744,0.00061326346,0.0010424788,0.0007994232,0.0013332118,0.0058357683],"category_scores_gemma":[0.0003343532,0.0009332889,0.0014273504,0.0010375337,0.0015897228,0.0008158117,0.0004133969,0.0030200132,0.0014600174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001373661,0.00026757465,0.00039528057,0.000031799085,0.000031380067,0.0001971954,0.00004491156,0.00022400108,0.99518555,0.00048879907,0.0001928268,0.0015668884],"study_design_scores_gemma":[0.00018199444,0.0006142442,0.0023800167,0.0000055868018,0.000061607956,0.00046502348,0.000064451815,0.0018136187,0.99201435,0.00021039147,0.0021673646,0.000021350736],"about_ca_topic_score_codex":0.002257352,"about_ca_topic_score_gemma":0.002949717,"teacher_disagreement_score":0.0058357683,"about_ca_system_score_codex":0.00088933995,"about_ca_system_score_gemma":0.00076561293,"threshold_uncertainty_score":0.019522607},"labels":[],"label_agreement":null},{"id":"W2905818180","doi":"","title":"Higher-order epistatic networks underlie the evolutionary fitness landscape of a xenobiotic- degrading enzyme","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epistasis; Fitness landscape; Biology; In silico; Enzyme; Function (biology); Computational biology; Adaptive evolution; Molecular evolution; Xenobiotic; Evolutionary biology; Genetics; Phylogenetics; Gene; Biochemistry; Population","score_opus":0.05139555612601422,"score_gpt":0.3218341852056817,"score_spread":0.2704386290796675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905818180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97848547,0.000096687254,0.019864026,0.000087253735,0.0000024505014,0.000011181725,0.00012713458,0.00007599245,0.0012498378],"genre_scores_gemma":[0.9944131,0.00006869211,0.0051561818,0.000025300122,0.0000024840804,0.0000122642805,0.00011045276,0.000019268458,0.00019227972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975604,0.0000746503,0.000015044819,0.00006889916,0.000044452998,0.000040918218],"domain_scores_gemma":[0.9996093,0.00017661734,0.000102132326,0.000043913456,0.00003233288,0.000035775618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037070434,0.00031417966,0.0003226296,0.00067579263,0.000383039,0.00067659526,0.00025277506,0.00041242034,0.0010714178],"category_scores_gemma":[0.001135497,0.00019360744,0.00035826635,0.00045225423,0.0004912529,0.0005020339,0.00042947635,0.00053652975,0.00010941047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003527471,0.00012345752,0.06316936,0.00013370803,0.00040438486,0.00086716004,0.00029902603,0.085198015,0.7974439,0.015516545,0.0005370924,0.03595458],"study_design_scores_gemma":[0.00005578855,0.0003207921,0.2860189,0.000012857139,0.0002571639,0.0015104107,0.00043071812,0.61568373,0.05151731,0.039581046,0.0045010196,0.00011030438],"about_ca_topic_score_codex":0.0016495993,"about_ca_topic_score_gemma":0.0029967725,"teacher_disagreement_score":0.0016495993,"about_ca_system_score_codex":0.00060995104,"about_ca_system_score_gemma":0.0002857034,"threshold_uncertainty_score":0.0044255257},"labels":[],"label_agreement":null},{"id":"W2912734692","doi":"10.1111/bcp.13884","title":"Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research","keywords":"Metronidazole; Medicine; Biology; Microbiology; Antibiotics","score_opus":0.23550837786317888,"score_gpt":0.5712022899553704,"score_spread":0.33569391209219146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912734692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980475,0.0005217483,0.00090309343,0.000037282494,0.000010850611,0.00015176533,0.00010437245,0.00001451406,0.00020892984],"genre_scores_gemma":[0.99700004,0.00024763987,0.0020375333,0.00007922794,0.000017544202,0.00014780894,0.000111359856,0.0000042036027,0.00035470593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878997,0.0006540744,0.00007448754,0.00020966452,0.00021859808,0.000053149637],"domain_scores_gemma":[0.99906117,0.00027715458,0.00031635,0.00007362007,0.00015618026,0.00011565329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016465198,0.00037391915,0.0004939921,0.00013418963,0.00021197852,0.00027492084,0.0002087107,0.00061993767,0.0009160448],"category_scores_gemma":[0.002152537,0.00022762643,0.00024543967,0.00016475677,0.0002815376,0.00029398545,0.00022242083,0.0003218272,0.00022384898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13577412,0.010028248,0.29341903,0.0007094295,0.00064144685,0.00039556838,0.0011315928,0.0010499111,0.43826273,0.0001239369,0.00056396506,0.117900066],"study_design_scores_gemma":[0.004239614,0.5378638,0.38733235,0.000026345357,0.00062230893,0.00082787086,0.0003464568,0.0021633946,0.06408036,0.000085469255,0.0023818407,0.00003015994],"about_ca_topic_score_codex":0.00045527835,"about_ca_topic_score_gemma":0.0010840038,"teacher_disagreement_score":0.0016465198,"about_ca_system_score_codex":0.00017932935,"about_ca_system_score_gemma":0.00031102746,"threshold_uncertainty_score":0.008707702},"labels":[],"label_agreement":null},{"id":"W2913514525","doi":"10.1007/s00228-019-02632-1","title":"Sex-by-formulation interaction in bioequivalence trials with transdermal patches","year":2019,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Transdermal; Medicine; Pharmacokinetics; Rivastigmine; Pharmacology; Transdermal patch; Internal medicine","score_opus":0.60535816344768,"score_gpt":0.6141343016009941,"score_spread":0.008776138153314128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913514525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009932906,0.9977181,0.00044411514,0.00020573557,0.0001038914,0.000023684097,0.000036598918,0.000010592829,0.00046407685],"genre_scores_gemma":[0.015854597,0.9800243,0.0022275706,0.0006256189,0.00029561273,0.000058944584,0.00011867217,0.000013517336,0.00078111835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847585,0.0007169795,0.00023812683,0.00016841093,0.0003534722,0.00004707666],"domain_scores_gemma":[0.9967631,0.0025754434,0.00042255115,0.00004950704,0.00015121757,0.000038071004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045780693,0.00067096314,0.0037285395,0.00087169994,0.000104615385,0.0010520498,0.0011912504,0.0014482974,0.0036738333],"category_scores_gemma":[0.0042429063,0.0002709285,0.0019178869,0.00096360204,0.00041614048,0.0008347092,0.00046406704,0.0015984952,0.0005435067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020644001,0.00017756116,0.00033492455,0.038756784,0.0015922538,0.00013891156,0.000057889833,0.0004232097,0.0015776848,0.0014696758,0.005441523,0.94796526],"study_design_scores_gemma":[0.008777564,0.010380448,0.018804071,0.042555075,0.024383113,0.005535906,0.00035568958,0.003583916,0.007947168,0.008036489,0.8693703,0.0002703047],"about_ca_topic_score_codex":0.00042327304,"about_ca_topic_score_gemma":0.0011878557,"teacher_disagreement_score":0.0045780693,"about_ca_system_score_codex":0.00038878687,"about_ca_system_score_gemma":0.0006770364,"threshold_uncertainty_score":0.024211407},"labels":[],"label_agreement":null},{"id":"W2913866147","doi":"10.1002/jcph.1391","title":"4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation","year":2019,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waterloo CFD Engineering Consulting","funders":"","keywords":"CYP3A; Biomarker; Pharmacology; Midazolam; Endogeny; Metabolite; Biology; Cholesterol; Cytochrome P450; Medicine; Endocrinology; Metabolism; Biochemistry","score_opus":0.6130139562391858,"score_gpt":0.6623758551971944,"score_spread":0.04936189895800869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913866147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013789297,0.99858737,0.00015836503,0.0006550871,0.00018389772,0.00001997801,0.00005093168,0.0000056041495,0.00020092931],"genre_scores_gemma":[0.0009324814,0.9977831,0.00030275318,0.0004933828,0.00029811967,0.000034391218,0.000067832574,0.0000023188175,0.00008567599],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981133,0.00040124592,0.0006329276,0.00025628082,0.00051419367,0.00008209251],"domain_scores_gemma":[0.9828419,0.010679575,0.0019762148,0.00028438953,0.003937269,0.00028062443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056360983,0.0014180323,0.0036020624,0.010372835,0.0006449512,0.0023684043,0.0019424048,0.0020500878,0.0053585004],"category_scores_gemma":[0.013496454,0.00077995117,0.002998802,0.009344283,0.0011440864,0.0034062348,0.0013127107,0.002071907,0.0010644662],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027666852,0.00008674227,0.0011583016,0.28360844,0.001025987,0.0004782325,0.00034431412,0.00042234553,0.00084920047,0.0032827025,0.026367273,0.68209976],"study_design_scores_gemma":[0.00010013945,0.00039100825,0.0063836495,0.3260787,0.009814206,0.0034798956,0.00061346387,0.00045449438,0.0010874021,0.00454359,0.646887,0.00016645058],"about_ca_topic_score_codex":0.003316184,"about_ca_topic_score_gemma":0.004909325,"teacher_disagreement_score":0.010372835,"about_ca_system_score_codex":0.0018148671,"about_ca_system_score_gemma":0.007603318,"threshold_uncertainty_score":0.029806852},"labels":[],"label_agreement":null},{"id":"W2913964388","doi":"10.1038/s41436-018-0431-8","title":"CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial","year":2019,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Florida Health; Agency for Healthcare Research and Quality; National Institutes of Health; National Human Genome Research Institute; American College of Clinical Pharmacy; National Center for Advancing Translational Sciences; Florida Department of Health; University of Florida; Mallinckrodt Pharmaceuticals; Pfizer","keywords":"CYP2D6; Tramadol; Codeine; Medicine; Opioid; Randomized controlled trial; Anesthesia; Pain ladder; Analgesic; Internal medicine; Morphine","score_opus":0.1397296108015888,"score_gpt":0.4937684642770148,"score_spread":0.354038853475426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913964388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97080594,0.014236584,0.0019356103,0.0033310975,0.0011024211,0.0036407092,0.0010256959,0.00013847735,0.0037835604],"genre_scores_gemma":[0.98903894,0.003173028,0.0019991626,0.0018976075,0.0004971585,0.0015796197,0.0005732024,0.000022709588,0.0012185781],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989221,0.0006364175,0.00008052985,0.00016655313,0.00007086268,0.0001235642],"domain_scores_gemma":[0.9988127,0.00043311258,0.0002397247,0.00008488534,0.000081113256,0.00034855862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002143291,0.001518383,0.0038877125,0.00034153654,0.00055481563,0.0010963801,0.0007663939,0.0021057653,0.007252045],"category_scores_gemma":[0.0033202148,0.00050674385,0.0032290174,0.00042480484,0.0011649427,0.0009884688,0.0006201421,0.003086267,0.00059646723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.954225,0.0052197827,0.001132112,0.0010266057,0.0027938364,0.000085141684,0.000078183846,0.00039160953,0.002175146,0.00024483778,0.0011055239,0.03152217],"study_design_scores_gemma":[0.9194988,0.07177681,0.004286753,0.00014789256,0.0017320553,0.00008895206,0.00005114131,0.00047472413,0.0002686304,0.0004740733,0.0011655216,0.00003449235],"about_ca_topic_score_codex":0.0007866589,"about_ca_topic_score_gemma":0.0016870366,"teacher_disagreement_score":0.007252045,"about_ca_system_score_codex":0.0008869387,"about_ca_system_score_gemma":0.00072989793,"threshold_uncertainty_score":0.024260461},"labels":[],"label_agreement":null},{"id":"W2914594769","doi":"10.18433/jpps30237","title":"Prediction of Hepatic Clearance of Stereoselective Metabolism of Carvedilol in Liver Microsomes and Hepatocytes of Sprague-Dawley and Cytochrome P450 2D-Deficient Dark Agouti Rats","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education, Culture, Sports, Science and Technology","keywords":"Microsome; In vivo; Cytochrome P450; In vitro; Metabolism; Microsoma; Internal medicine; Endocrinology; Pharmacology; Chemistry; Biology; Biochemistry; Medicine; Genetics","score_opus":0.10818823766416327,"score_gpt":0.4098067367442046,"score_spread":0.30161849908004135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914594769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949378,0.00009975066,0.0044483123,0.000016921642,0.0000041549174,0.000017262699,0.00022987886,0.000032241984,0.00021373067],"genre_scores_gemma":[0.99355364,0.00017316002,0.004874596,0.000019532945,0.0000029933494,0.00004464893,0.00057594664,0.00001516592,0.0007403201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998722,0.000022426717,0.00001179499,0.000039454597,0.000038525897,0.000015642761],"domain_scores_gemma":[0.99972874,0.000048788486,0.000097732445,0.000032709275,0.00003875479,0.000053338736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021329228,0.00033412914,0.00021239184,0.00027172032,0.00011962298,0.00021441988,0.00011754189,0.00019325389,0.00049473264],"category_scores_gemma":[0.00037036467,0.00019230614,0.00025195384,0.0001125082,0.00016329739,0.00016104933,0.00010076607,0.0003689528,0.00019156277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012092738,0.0001093634,0.00965693,0.00002025502,0.00002529346,0.0000650803,0.000023851459,0.0007638117,0.985201,0.00008294514,0.000032742908,0.0028094642],"study_design_scores_gemma":[0.00005559543,0.0014243524,0.028726824,0.0000014271682,0.000045009972,0.0001965518,0.000030556133,0.0069406205,0.9621379,0.0000615714,0.00036317692,0.000016468559],"about_ca_topic_score_codex":0.0020494831,"about_ca_topic_score_gemma":0.002183912,"teacher_disagreement_score":0.0020494831,"about_ca_system_score_codex":0.00036001747,"about_ca_system_score_gemma":0.00025877604,"threshold_uncertainty_score":0.0040751696},"labels":[],"label_agreement":null},{"id":"W2918993549","doi":"10.1007/s40262-019-00745-5","title":"Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Illinois at Chicago; Ministry of Education, Culture, Sports, Science and Technology; University of Chicago","keywords":"Warfarin; Pharmacodynamics; CYP2C9; Medicine; VKORC1; Internal medicine; Dosing; Population; Pharmacokinetics; Cohort; Creatinine; Demography; Atrial fibrillation","score_opus":0.18952589734530464,"score_gpt":0.48143453915943135,"score_spread":0.2919086418141267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918993549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993285,0.000045371216,0.000102890415,0.00003240473,0.0000030531537,0.0000046893065,0.00006348944,0.0000021056144,0.0004174078],"genre_scores_gemma":[0.9996117,0.000021526133,0.00006547077,0.000026200612,0.000005058096,0.000004945065,0.000085068845,0.0000030797687,0.00017706992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994234,0.00019967552,0.000049885188,0.00013956706,0.00006767539,0.000119856915],"domain_scores_gemma":[0.9993525,0.00019239006,0.00018106532,0.00006354039,0.00008212988,0.00012835192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047428883,0.000272442,0.0003716959,0.00059540477,0.00073500985,0.000693458,0.00028597098,0.0005387412,0.0019790377],"category_scores_gemma":[0.0019290395,0.00018232054,0.0005504807,0.0006499447,0.0004361668,0.00037416286,0.00050529203,0.00060347863,0.0002695971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019328771,0.000255154,0.9880937,0.000007390459,0.00018393573,0.00018649851,0.0008519076,0.000090081805,0.003657139,0.0002681136,0.000101615675,0.004371597],"study_design_scores_gemma":[0.000028739241,0.00023190386,0.99804,0.0000026137786,0.00005629409,0.00022975249,0.0006529077,0.00026489203,0.0002190038,0.000118643315,0.00014891852,0.000006325715],"about_ca_topic_score_codex":0.0062681525,"about_ca_topic_score_gemma":0.004065874,"teacher_disagreement_score":0.0062681525,"about_ca_system_score_codex":0.00027963027,"about_ca_system_score_gemma":0.00020262013,"threshold_uncertainty_score":0.012463331},"labels":[],"label_agreement":null},{"id":"W2919754601","doi":"10.1111/bcp.13908","title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Jejunum; Cytochrome P450; CYP3A4; CYP2B6; Ileum; CYP3A; Tolbutamide; Chlorzoxazone; CYP2C9; Biology; Small intestine; Molecular biology; Chemistry; Internal medicine; Biochemistry; CYP2E1; Endocrinology; Metabolism; Medicine; Insulin","score_opus":0.15703593008825215,"score_gpt":0.48096641535666007,"score_spread":0.32393048526840795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919754601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996064,0.0017535915,0.001131683,0.000021984551,0.0000038126952,0.000016141112,0.0004120278,0.000016241154,0.0005805212],"genre_scores_gemma":[0.99476826,0.0011959317,0.0016074973,0.000023106462,0.000010340612,0.000041912208,0.0009578272,0.0000073113642,0.0013878118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999225,0.000011822557,0.000005554819,0.000034526875,0.000014156253,0.0000113617825],"domain_scores_gemma":[0.99990976,0.000020998816,0.000026843147,0.0000068490276,0.00002302726,0.000012549279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102349804,0.00013867712,0.00014666437,0.00034373524,0.00013317888,0.00021309347,0.000052933603,0.00014330263,0.0013613455],"category_scores_gemma":[0.0001386557,0.00012531767,0.000179598,0.00024802593,0.00013767065,0.000105136816,0.00006993476,0.0001686423,0.0002671347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007640499,0.00002848209,0.028951466,0.00008082568,0.0000398668,0.00023264514,0.00008413997,0.00006482719,0.9623284,0.000031825988,0.000063290456,0.007330155],"study_design_scores_gemma":[0.00003490781,0.0011803695,0.82752705,0.000013818406,0.00011669164,0.0018314702,0.00021718672,0.0005481187,0.16656871,0.00005481012,0.0018991035,0.000007685792],"about_ca_topic_score_codex":0.001071567,"about_ca_topic_score_gemma":0.0010805334,"teacher_disagreement_score":0.0013613455,"about_ca_system_score_codex":0.00011515146,"about_ca_system_score_gemma":0.00008318046,"threshold_uncertainty_score":0.0045541525},"labels":[],"label_agreement":null},{"id":"W2924256667","doi":"10.1055/a-0863-4692","title":"Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?","year":2019,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Pharmacogenetics; Dosing; Medicine; Pharmacology; Drug; CYP2D6; Venlafaxine; Carbamazepine; Sertraline; CYP2C19; Psychiatry; Epilepsy; Internal medicine; Anxiety; Biology; Genetics; Gene; Antidepressant; Genotype","score_opus":0.3365395161513568,"score_gpt":0.5642967053018124,"score_spread":0.22775718915045562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924256667","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42140323,0.079087704,0.18294427,0.16595821,0.0025165053,0.0013418967,0.043788902,0.0043965504,0.098562755],"genre_scores_gemma":[0.7920767,0.012368392,0.16187675,0.016271276,0.0012285607,0.0006362175,0.01330356,0.00051267486,0.001725852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94091886,0.03667668,0.008166888,0.0036610893,0.0093946885,0.0011816608],"domain_scores_gemma":[0.6017392,0.30280447,0.04347517,0.022589022,0.026198676,0.003193558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057695955,0.0004022407,0.0007834171,0.0044659707,0.00061267166,0.0035841903,0.002104356,0.0014026813,0.009260376],"category_scores_gemma":[0.26584682,0.00045741792,0.00082611316,0.006867445,0.0013762777,0.003550663,0.0028187367,0.0016997836,0.0019283171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094032823,0.00017511235,0.23423596,0.0038738844,0.0006712204,0.000811015,0.0018409048,0.002093579,0.001548411,0.015432292,0.06291897,0.6754584],"study_design_scores_gemma":[0.00058723986,0.0005906035,0.43898982,0.013911524,0.0017737608,0.0036156466,0.0031446598,0.014021837,0.011209248,0.043297894,0.46856126,0.00029651122],"about_ca_topic_score_codex":0.007210993,"about_ca_topic_score_gemma":0.008200008,"teacher_disagreement_score":0.057695955,"about_ca_system_score_codex":0.0022764283,"about_ca_system_score_gemma":0.0054690647,"threshold_uncertainty_score":0.305129},"labels":[],"label_agreement":null},{"id":"W2932285628","doi":"10.1159/000497322","title":"Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity","year":2019,"lang":"en","type":"article","venue":"International Archives of Allergy and Immunology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"CYP2C19; Immunology; Allergy; Medicine; Genotype; Internal medicine; Biology; Gene; Genetics","score_opus":0.016236577491619792,"score_gpt":0.3292117562970293,"score_spread":0.31297517880540954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932285628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986749,0.00044128884,0.00009278148,0.00003237501,0.000007165096,0.000016908916,0.00015473737,0.0000031678576,0.0005766565],"genre_scores_gemma":[0.9994466,0.00012057889,0.00010155902,0.000034060795,0.000010682693,0.0000119784445,0.00012085024,0.0000011891843,0.00015245975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996959,0.000079986414,0.00004660932,0.00008205067,0.00005389262,0.000041589778],"domain_scores_gemma":[0.9995901,0.00009201692,0.00016077216,0.00002543448,0.00005242026,0.00007929723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033742987,0.00027371594,0.00051792763,0.00066833023,0.00038808532,0.0004003702,0.00016744522,0.0005300329,0.0018320804],"category_scores_gemma":[0.0009620082,0.00021881778,0.00038633475,0.00079048635,0.00017753374,0.0002969871,0.00020189887,0.00041224007,0.00030213114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024572093,0.0000590115,0.99665594,0.000019123892,0.000027810589,0.00054456666,0.00007826788,0.00003726682,0.0007561538,0.00001609925,0.000106961044,0.0014530708],"study_design_scores_gemma":[0.000024947085,0.00031933855,0.9958682,0.0000102468,0.00006154598,0.0026029062,0.00019075979,0.00022725383,0.00026573022,0.000030435816,0.00039247147,0.0000061299515],"about_ca_topic_score_codex":0.0009465574,"about_ca_topic_score_gemma":0.0007396572,"teacher_disagreement_score":0.0018320804,"about_ca_system_score_codex":0.00015916424,"about_ca_system_score_gemma":0.00014934358,"threshold_uncertainty_score":0.006128907},"labels":[],"label_agreement":null},{"id":"W2933589606","doi":"10.1007/s10928-019-09628-5","title":"Panos Macheras: a pioneering scientist in pharmaceutical science","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacokinetics and Pharmacodynamics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmaceutical sciences; Computer science; Medicine; Pharmacology","score_opus":0.046528727715095246,"score_gpt":0.4278935268306968,"score_spread":0.38136479911560156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933589606","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005434094,0.45243612,0.021449922,0.39477924,0.07327198,0.00006928013,0.00040569238,0.0006627431,0.0514909],"genre_scores_gemma":[0.12988514,0.42109182,0.031325236,0.15264846,0.09362137,0.0002244021,0.00031425053,0.00038698252,0.17050235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997072,0.00046981542,0.00014719921,0.00058261055,0.0015452695,0.00018309738],"domain_scores_gemma":[0.9947408,0.0013105781,0.00060649426,0.0001728591,0.0014214655,0.0017478706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038797394,0.000849905,0.0009445048,0.002356865,0.00091421115,0.0028152848,0.0009271177,0.0033949842,0.005555768],"category_scores_gemma":[0.008706461,0.00028991417,0.00041614423,0.0010198486,0.0025984268,0.003099981,0.0018616599,0.006417592,0.0035083832],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004266776,0.00019125399,0.002707835,0.0019816398,0.0001420852,0.0010961352,0.000999072,0.0005411955,0.0049235406,0.10735711,0.50158423,0.37804922],"study_design_scores_gemma":[0.000034948906,0.00012717642,0.0010417247,0.00038608347,0.00003492362,0.0020368653,0.0001664485,0.0002562335,0.0020908492,0.01618662,0.97760963,0.000028494043],"about_ca_topic_score_codex":0.0006732636,"about_ca_topic_score_gemma":0.00077860896,"teacher_disagreement_score":0.005555768,"about_ca_system_score_codex":0.0014627345,"about_ca_system_score_gemma":0.0029910963,"threshold_uncertainty_score":0.020518303},"labels":[],"label_agreement":null},{"id":"W2939463022","doi":"10.1002/cpt.1472","title":"Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP3A; Type 2 diabetes; Biomarker; Endocrinology; Internal medicine; Diabetes mellitus; Midazolam; Endogeny; Population; Cholesterol; Pharmacology; Medicine; Chemistry; Biology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.37673199915207994,"score_gpt":0.5106181238650749,"score_spread":0.13388612471299494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939463022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969195,0.0011874696,0.0007917906,0.000058424557,0.000016708898,0.00004688912,0.0001633773,0.000014777295,0.00080101617],"genre_scores_gemma":[0.99856985,0.00023589697,0.0007601127,0.000058839356,0.000014415479,0.000038310438,0.00013483962,0.0000032980922,0.0001843739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987626,0.00053238554,0.00014128166,0.00025480028,0.00025613443,0.000052802818],"domain_scores_gemma":[0.9988593,0.0003675202,0.00031487964,0.00012203546,0.0001973402,0.00013906576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019579756,0.00039477315,0.00063563,0.00032494817,0.00035798145,0.00066611014,0.00025343554,0.0005186232,0.0005172535],"category_scores_gemma":[0.0031922448,0.000196718,0.00022743508,0.0004394865,0.00039733754,0.00021861901,0.00026604024,0.0006075108,0.00019644489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035238883,0.00026603066,0.9620028,0.00007466549,0.00015003479,0.00020460616,0.00024232069,0.00016240026,0.016370093,0.000034756864,0.00014631289,0.016821979],"study_design_scores_gemma":[0.00014274141,0.0024940073,0.9886185,0.000016682903,0.0001207859,0.00083632855,0.00013762793,0.00075531524,0.0062730834,0.00005287566,0.00054016995,0.000011887785],"about_ca_topic_score_codex":0.0008262954,"about_ca_topic_score_gemma":0.0012256964,"teacher_disagreement_score":0.0019579756,"about_ca_system_score_codex":0.000230327,"about_ca_system_score_gemma":0.00026924725,"threshold_uncertainty_score":0.010354936},"labels":[],"label_agreement":null},{"id":"W2940295280","doi":"10.1016/s2215-0366(19)30138-5","title":"CYP2D6 testing to guide risperidone and aripiprazole therapy","year":2019,"lang":"en","type":"letter","venue":"The Lancet Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Aripiprazole; Risperidone; CYP2D6; Pharmacogenomics; Pharmacology; Medicine; Pharmacogenetics; Psychology; Psychiatry; Bioinformatics; Internal medicine; Schizophrenia (object-oriented programming); Genetics; Genotype; Biology; Gene","score_opus":0.19621276371426388,"score_gpt":0.44746666315648914,"score_spread":0.25125389944222526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940295280","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033790682,0.0010040788,0.00018382524,0.97953886,0.012356294,0.000016629676,0.00008420468,0.000041355455,0.0064369356],"genre_scores_gemma":[0.004602768,0.0008373587,0.00054532074,0.95290583,0.030978493,0.000037627506,0.00006318608,0.000028610542,0.0100007905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964419,0.0008940095,0.00063846295,0.00036323004,0.0010697816,0.0005926413],"domain_scores_gemma":[0.98874795,0.0055582654,0.0007410684,0.0004259567,0.0020081329,0.0025186175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028943757,0.00094074523,0.0015620094,0.0014548593,0.0034751347,0.004246101,0.0015224621,0.07914723,0.010910172],"category_scores_gemma":[0.030757194,0.00089770067,0.0020749094,0.00081812456,0.0027096702,0.0029859745,0.002030641,0.041165255,0.009338326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004549947,0.000043793443,0.0011424732,0.000043674827,0.000021039694,0.0037854593,0.00008714858,0.00009241914,0.00019554257,0.0025727598,0.97790754,0.014062629],"study_design_scores_gemma":[0.0004241049,0.00011627779,0.003121013,0.0010462786,0.00009586932,0.008557748,0.00032305947,0.0012487011,0.00039012847,0.027524397,0.95704824,0.00010413734],"about_ca_topic_score_codex":0.013624604,"about_ca_topic_score_gemma":0.029755328,"teacher_disagreement_score":0.07914723,"about_ca_system_score_codex":0.0049364837,"about_ca_system_score_gemma":0.008065352,"threshold_uncertainty_score":0.03649819},"labels":[],"label_agreement":null},{"id":"W2940403942","doi":"10.2174/1574884714666190408125206","title":"Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward","year":2019,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health","funders":"","keywords":"Bridging (networking); Medicine; Myocardial bridging; Ethnic group; Drug development; Drug; Pharmacology; Cardiology; Computer science; Sociology; Anthropology","score_opus":0.5696730716559849,"score_gpt":0.6346005067426914,"score_spread":0.06492743508670651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940403942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008057057,0.9954692,0.00029350072,0.0031558226,0.00042548953,0.00002089197,0.000010882589,0.000005597519,0.00053804077],"genre_scores_gemma":[0.0016227294,0.9941803,0.00092045596,0.0026346154,0.00044209976,0.000046729212,0.000018106779,0.0000038580915,0.00013108969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887545,0.0057691825,0.0021529936,0.00089009106,0.0021001643,0.0003330395],"domain_scores_gemma":[0.88857466,0.09113892,0.007114863,0.0016778471,0.010332801,0.0011609279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03395177,0.0011900835,0.0030930114,0.006386408,0.00092883117,0.0053983214,0.002581648,0.0037420609,0.0051625464],"category_scores_gemma":[0.05426841,0.00096184824,0.0023463638,0.008564317,0.0038031912,0.009166902,0.0026252924,0.0058849338,0.0009950626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026475155,0.00009410322,0.00042043522,0.2205803,0.00048583682,0.00019721071,0.0008950465,0.00048499284,0.0004135818,0.03860949,0.02336884,0.71418536],"study_design_scores_gemma":[0.000088221015,0.0003104938,0.0010441365,0.25249436,0.0011264088,0.00049270573,0.00079961267,0.00024249803,0.0003956424,0.016669141,0.7262735,0.00006332011],"about_ca_topic_score_codex":0.003045361,"about_ca_topic_score_gemma":0.0074262707,"teacher_disagreement_score":0.03395177,"about_ca_system_score_codex":0.004709644,"about_ca_system_score_gemma":0.01807148,"threshold_uncertainty_score":0.17955631},"labels":[],"label_agreement":null},{"id":"W2940964849","doi":"10.1002/prp2.475","title":"The effect of chronic kidney disease on <scp>CYP</scp>2B expression and activity in male Wistar rats","year":2019,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation","keywords":"Kidney disease; Renal function; Pharmacokinetics; Endocrinology; Metabolite; Internal medicine; Bupropion; Kidney; Medicine; Pharmacology; Population; Western blot; Chemistry; Pathology; Biochemistry","score_opus":0.06449477313228555,"score_gpt":0.46828558648771107,"score_spread":0.40379081335542555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940964849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955492,0.0005171183,0.0015304346,0.00017062618,0.00007833591,0.000063250234,0.0010323506,0.000102967955,0.0009556618],"genre_scores_gemma":[0.9799064,0.0012167597,0.0036431341,0.00020328832,0.000047634043,0.0003544708,0.0018812242,0.000083286424,0.012663835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957734,0.00003992648,0.000038367565,0.00011482569,0.00010117611,0.00012836966],"domain_scores_gemma":[0.9994435,0.000043623484,0.0001751398,0.00006878421,0.000082636114,0.00018627594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028804346,0.0007850821,0.0005859296,0.0012010232,0.00044459352,0.00039704877,0.00025090532,0.0005980725,0.0031700719],"category_scores_gemma":[0.0001517933,0.0005009952,0.000698454,0.00044473103,0.0006377894,0.00042986198,0.00024462596,0.0014354098,0.00076949014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003427813,0.0010647831,0.0014798678,0.000054171906,0.00002897526,0.00014752509,0.00006663665,0.00007851619,0.99111617,0.00011557047,0.00017026247,0.002249828],"study_design_scores_gemma":[0.00034875548,0.0100446325,0.050853368,0.000021718803,0.00017931177,0.0004585463,0.00024144434,0.0013383911,0.9332012,0.00014593397,0.0031133576,0.000053295553],"about_ca_topic_score_codex":0.0023967696,"about_ca_topic_score_gemma":0.0032161556,"teacher_disagreement_score":0.0031700719,"about_ca_system_score_codex":0.00045143667,"about_ca_system_score_gemma":0.00037548118,"threshold_uncertainty_score":0.010604978},"labels":[],"label_agreement":null},{"id":"W2941824774","doi":"10.1111/1440-1681.13097","title":"Pharmacogenomics guidelines: Current status and future development","year":2019,"lang":"en","type":"review","venue":"Clinical and Experimental Pharmacology and Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Medicine; Drug development; Natural Product Research; Pharmacology; Drug; Biology; Genotype; Genetics; Pharmacognosy","score_opus":0.37007485518044514,"score_gpt":0.5846043215873302,"score_spread":0.21452946640688508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941824774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007201187,0.9916509,0.0007359426,0.004186464,0.0008233069,0.000020829028,0.00013575732,0.000037572827,0.002337201],"genre_scores_gemma":[0.0005398115,0.9941076,0.0017892253,0.0020146896,0.00057670154,0.000027634498,0.00026104512,0.000010225624,0.00067313126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973851,0.00077837956,0.000563705,0.0002735394,0.00087477604,0.0001245898],"domain_scores_gemma":[0.9896544,0.0063532363,0.0009769176,0.0003030442,0.0023990301,0.0003132124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074921274,0.0011768226,0.0022974769,0.0054221638,0.0004299769,0.002640221,0.002720169,0.0030804249,0.0069225505],"category_scores_gemma":[0.01200997,0.0005114702,0.001435541,0.0066176527,0.0012444895,0.003235182,0.0016657931,0.004073336,0.0040713036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050827744,0.00006062834,0.0002422769,0.02247852,0.00014172833,0.000145271,0.00010013861,0.0003396163,0.00035183807,0.012240993,0.08843963,0.8754086],"study_design_scores_gemma":[0.000014395253,0.000026899337,0.00047243116,0.014595233,0.0001968421,0.00049553014,0.000073858384,0.00008536836,0.00012569116,0.0055793067,0.97831464,0.000019759695],"about_ca_topic_score_codex":0.0033859324,"about_ca_topic_score_gemma":0.004931546,"teacher_disagreement_score":0.0074921274,"about_ca_system_score_codex":0.0021010472,"about_ca_system_score_gemma":0.0070044394,"threshold_uncertainty_score":0.039622605},"labels":[],"label_agreement":null},{"id":"W2942319426","doi":"10.4212/cjhp.v72i2.2882","title":"Survey of Therapeutic Drug Monitoring Practices in Pediatric Health Care Programs across Canada","year":2019,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Drug; Clinical Practice; Health care; Intensive care medicine; Pharmacology; Family medicine","score_opus":0.11485334203121296,"score_gpt":0.44590243322188033,"score_spread":0.3310490911906674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942319426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864097,0.001150892,0.00033223734,0.0022054138,0.000013178467,0.00019875234,0.0044274386,0.00003947138,0.005222788],"genre_scores_gemma":[0.99562573,0.0012973219,0.00084767747,0.0006031577,0.000007439633,0.000076011296,0.0008971306,0.0000064745295,0.0006389922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701226,0.0003822379,0.00024486938,0.00031732634,0.0013190678,0.0007243052],"domain_scores_gemma":[0.987593,0.0012029237,0.0031139504,0.00019867561,0.00450853,0.0033829024],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016405297,0.00019762057,0.00024102173,0.0013652574,0.0021095483,0.001036852,0.0010723936,0.00035062054,0.0023860128],"category_scores_gemma":[0.0067841974,0.00028534132,0.00027178615,0.004541895,0.0008740382,0.00046165602,0.0010522602,0.00066870556,0.00016443033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000360639,0.000057475503,0.9778984,0.00014494885,0.000020077332,0.00010944444,0.0027764265,0.00014183384,0.00017445312,0.00014246066,0.0032302728,0.015268146],"study_design_scores_gemma":[0.000005520185,0.0000452245,0.9921673,0.00012930416,0.000007443517,0.00006579875,0.0042868895,0.00037804598,0.00009568568,0.00001711484,0.0027903477,0.000011250421],"about_ca_topic_score_codex":0.9862562,"about_ca_topic_score_gemma":0.989052,"teacher_disagreement_score":0.99835944,"about_ca_system_score_codex":0.03839747,"about_ca_system_score_gemma":0.06662023,"threshold_uncertainty_score":0.27859443},"labels":[],"label_agreement":null},{"id":"W2943669995","doi":"10.1111/pcn.12832","title":"The coming‐of‐age of pharmacogenetic testing in clinical psychiatry","year":2019,"lang":"en","type":"editorial","venue":"Psychiatry and Clinical Neurosciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Randomized controlled trial; Pharmacogenetics; Medicine; Depression (economics); Psychiatry; Internal medicine; Rating scale; Odds ratio; Hamd; Genetic testing; Clinical psychology; Psychology; Anxiety; Genetics","score_opus":0.15748357833527224,"score_gpt":0.5183589797233614,"score_spread":0.36087540138808916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943669995","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019988078,0.36409146,0.016127534,0.6005472,0.009366522,0.00016047046,0.0002665191,0.00019532838,0.0072462573],"genre_scores_gemma":[0.082271546,0.46312526,0.05794138,0.31350124,0.079366736,0.00060706993,0.00040762615,0.0003636642,0.002415516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8833115,0.08655945,0.0069016106,0.005527737,0.016707974,0.0009916846],"domain_scores_gemma":[0.33632812,0.56943035,0.020195026,0.020053295,0.044743735,0.009249387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18474278,0.0011137723,0.005519878,0.004900776,0.0022959658,0.010323772,0.0043284018,0.013448935,0.011970062],"category_scores_gemma":[0.3481238,0.001686876,0.0022687237,0.0047216304,0.011858807,0.019802613,0.007972993,0.021207016,0.00289363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010119737,0.00026388565,0.00744775,0.0075834687,0.00060053595,0.0002949451,0.0007781476,0.000637491,0.00047872006,0.03893797,0.113405906,0.82855916],"study_design_scores_gemma":[0.0014454755,0.0023158211,0.026136773,0.064773634,0.0012400491,0.0027790566,0.001462248,0.0044300067,0.0008840196,0.28456998,0.6093224,0.000640472],"about_ca_topic_score_codex":0.004757471,"about_ca_topic_score_gemma":0.00850689,"teacher_disagreement_score":0.18474278,"about_ca_system_score_codex":0.0071130423,"about_ca_system_score_gemma":0.011881952,"threshold_uncertainty_score":0.97702485},"labels":[],"label_agreement":null},{"id":"W2944789729","doi":"10.1016/j.jpba.2019.05.006","title":"Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Chromatography; Formic acid; Microsome; Electrospray ionization; Tandem mass spectrometry; Mass spectrometry; High-performance liquid chromatography; Selected reaction monitoring; Electrospray; Enzyme; Biochemistry","score_opus":0.05859933814958836,"score_gpt":0.4053547009288324,"score_spread":0.34675536277924407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944789729","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2580283,0.0051179244,0.7289632,0.0006517762,0.00036839407,0.0011675507,0.0019814128,0.0017797631,0.001941656],"genre_scores_gemma":[0.36555868,0.0020799225,0.6213596,0.00071207184,0.00015229458,0.0015517775,0.0039019848,0.00020144742,0.0044822097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99485886,0.0010994537,0.00026358728,0.0012001724,0.0023867742,0.00019112264],"domain_scores_gemma":[0.99824345,0.00039587135,0.00021531458,0.0002629657,0.00073206006,0.00015037501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004208186,0.0013049465,0.0011183252,0.0017590282,0.00086239004,0.0009458061,0.0012762181,0.0016478412,0.0007434159],"category_scores_gemma":[0.0027418034,0.00089313457,0.000936343,0.000977193,0.0012162143,0.00072445115,0.0011741834,0.0020023098,0.00086783007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074065865,0.0000685573,0.0006543762,0.00010842889,0.000046141733,0.000017609358,0.00003798155,0.00021890918,0.9902192,0.00022086693,0.0001490023,0.008184841],"study_design_scores_gemma":[0.000036345464,0.0007813566,0.0076733045,0.00002407862,0.0001162864,0.00053988514,0.00003369211,0.006075941,0.9807215,0.0002723532,0.003689366,0.00003582671],"about_ca_topic_score_codex":0.0012014667,"about_ca_topic_score_gemma":0.0035282131,"teacher_disagreement_score":0.004208186,"about_ca_system_score_codex":0.0009009221,"about_ca_system_score_gemma":0.0016754862,"threshold_uncertainty_score":0.022255301},"labels":[],"label_agreement":null},{"id":"W2944956458","doi":"10.1002/cpt.1496","title":"Modulation of <scp>CYP</scp>450 Activities in Patients With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Tolbutamide; CYP2B6; CYP2C19; CYP1A2; Chlorzoxazone; Type 2 diabetes; Pharmacology; CYP3A; CYP2D6; CYP2C9; Medicine; Diabetes mellitus; CYP2E1; Internal medicine; Dextromethorphan; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.09800917757700978,"score_gpt":0.4363264046354054,"score_spread":0.3383172270583956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944956458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986933,0.00082716905,0.00014424323,0.00002019291,0.0000059567474,0.000009234185,0.00008677689,0.0000050977633,0.00020812149],"genre_scores_gemma":[0.9991167,0.00025969095,0.00017285079,0.000045157307,0.000013129225,0.0000091041275,0.00017950768,0.0000024826313,0.00020136105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997209,0.00011319647,0.000023120294,0.00006394088,0.00004385863,0.00003501527],"domain_scores_gemma":[0.9997377,0.00006547628,0.00007640767,0.000026563972,0.00002289272,0.00007103154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034917635,0.000270843,0.0004869036,0.00025961254,0.00021975697,0.00037180822,0.000091182534,0.00028411267,0.0008001934],"category_scores_gemma":[0.00049600354,0.0001641737,0.00028352387,0.00032865195,0.00016838136,0.00013640823,0.00013692924,0.0004830732,0.00015409368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018567918,0.0010511158,0.85455006,0.00009485708,0.0005306601,0.00067643577,0.00025031634,0.00022869115,0.09520331,0.000029913359,0.00023161406,0.028585065],"study_design_scores_gemma":[0.00016385796,0.0038734945,0.988926,0.00000420925,0.00012430422,0.00061159185,0.00006416433,0.00026076203,0.0055041355,0.00002183904,0.00043929063,0.0000064609294],"about_ca_topic_score_codex":0.00081808795,"about_ca_topic_score_gemma":0.0009604613,"teacher_disagreement_score":0.00081808795,"about_ca_system_score_codex":0.00015780042,"about_ca_system_score_gemma":0.00010872416,"threshold_uncertainty_score":0.0026769042},"labels":[],"label_agreement":null},{"id":"W2945085657","doi":"10.1097/mbc.0000000000000746","title":"Clinical and genetic factors influencing acenocoumarol dosing","year":2018,"lang":"en","type":"article","venue":"Blood Coagulation & Fibrinolysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Universidad Nacional de Rosario","keywords":"Acenocoumarol; Dosing; VKORC1; Medicine; CYP2C9; Warfarin; Anticoagulant; Cohort; Internal medicine; Atrial fibrillation","score_opus":0.1255061971591769,"score_gpt":0.43645401427481545,"score_spread":0.31094781711563857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945085657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407476,0.00089109584,0.0031693683,0.00022762646,0.000016791799,0.000021412206,0.0004683616,0.00001834824,0.0011122903],"genre_scores_gemma":[0.9987035,0.00011562831,0.0006504877,0.000027646427,0.00001167241,0.000008263436,0.00015229598,0.000006292735,0.00032417444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989761,0.0004994306,0.000099934754,0.00022118232,0.00013163389,0.00007174783],"domain_scores_gemma":[0.99720925,0.0016310716,0.00067014224,0.0002357223,0.00012524011,0.00012854018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00108104,0.00030430185,0.00032888012,0.00043016658,0.00022013129,0.0006308002,0.00020987669,0.00042501098,0.0035575768],"category_scores_gemma":[0.005296838,0.00012542096,0.00059156737,0.0007474565,0.00024704414,0.0002511839,0.00019110431,0.00046556196,0.00042143968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044490906,0.00010500951,0.9890694,0.000031983298,0.00028892033,0.000270643,0.000085085696,0.0007099324,0.0018995155,0.00016385094,0.00015047497,0.0067803604],"study_design_scores_gemma":[0.000021743252,0.00038503212,0.99120307,0.000016720218,0.00023554328,0.0014813405,0.00008248492,0.0042040916,0.0011081134,0.00035988097,0.0008933354,0.00000874286],"about_ca_topic_score_codex":0.0019684818,"about_ca_topic_score_gemma":0.0011955388,"teacher_disagreement_score":0.0035575768,"about_ca_system_score_codex":0.00018859001,"about_ca_system_score_gemma":0.00035784292,"threshold_uncertainty_score":0.011901259},"labels":[],"label_agreement":null},{"id":"W2945410001","doi":"10.1139/cjpp-2019-0177","title":"Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Russian Science Foundation","keywords":"Mirtazapine; Hamd; CYP2D6; Internal medicine; Major depressive disorder; Adverse effect; Medicine; Pharmacology; Significant difference; Antidepressant","score_opus":0.0208684985091542,"score_gpt":0.3171872740228389,"score_spread":0.29631877551368474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945410001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998615,0.00090752484,0.00006309962,0.00003349499,0.0000063365405,0.000006970321,0.00005738835,0.0000026040127,0.00030758153],"genre_scores_gemma":[0.999509,0.00020887509,0.00009360968,0.000029869814,0.000012406891,0.0000041288345,0.00007082984,9.189527e-7,0.00007039656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994018,0.00026658893,0.00008298861,0.00008291749,0.00011761922,0.000048073613],"domain_scores_gemma":[0.99908924,0.00027037525,0.00041163524,0.000057934558,0.00007567874,0.00009527121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000531146,0.00023490592,0.000656235,0.00029452465,0.00023192113,0.00037341507,0.00013581963,0.0002894894,0.00078545406],"category_scores_gemma":[0.0017757777,0.0001638317,0.00056316383,0.00038322384,0.00017304017,0.0001726909,0.00016061809,0.00036407515,0.00014579708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004159965,0.00017897689,0.98167557,0.00005178347,0.00055554946,0.0002506815,0.00007901498,0.00011443089,0.0027147753,0.000025351757,0.000075263786,0.010118765],"study_design_scores_gemma":[0.00013958223,0.0011573589,0.99681526,0.0000055406053,0.00026432108,0.00055818463,0.00004795468,0.0002933451,0.00044850347,0.00002574608,0.00023929482,0.0000048445627],"about_ca_topic_score_codex":0.00070629956,"about_ca_topic_score_gemma":0.0013516607,"teacher_disagreement_score":0.00078545406,"about_ca_system_score_codex":0.0002423414,"about_ca_system_score_gemma":0.00014156771,"threshold_uncertainty_score":0.0028090477},"labels":[],"label_agreement":null},{"id":"W2946297337","doi":"10.1016/j.biopsych.2019.03.630","title":"F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram","year":2019,"lang":"en","type":"article","venue":"Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Nortriptyline; CYP2D6; Escitalopram; Pseudogene; CYP2C19; Genotyping; Pharmacology; Medicine; Genotype; Internal medicine; Genetics; Biology; Gene; Genome","score_opus":0.2062728499172168,"score_gpt":0.4991303363883159,"score_spread":0.2928574864710991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946297337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91254306,0.03979881,0.0014116451,0.026555274,0.0029065039,0.00087866635,0.004279712,0.00022903571,0.011397299],"genre_scores_gemma":[0.981417,0.005069957,0.0011518169,0.006463036,0.0016572676,0.00036104614,0.0015019858,0.00003536576,0.0023425855],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99821055,0.0011438357,0.00015284836,0.0002467957,0.00011412865,0.00013195744],"domain_scores_gemma":[0.99813443,0.00072638254,0.00048837526,0.000101441154,0.00013165639,0.00041784626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005280107,0.0010009321,0.0021258541,0.00026295288,0.0005337582,0.0014291989,0.00067768426,0.0025869347,0.0054481714],"category_scores_gemma":[0.0039049569,0.00032653476,0.0023531076,0.00057807466,0.0005981378,0.0010196577,0.0003017667,0.0030561541,0.0007876502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.752248,0.001819475,0.03649806,0.0017130978,0.011746187,0.0014618678,0.00028844556,0.0011913759,0.0137803685,0.0021718452,0.018962706,0.1581186],"study_design_scores_gemma":[0.6524555,0.10511599,0.15590295,0.00090320193,0.014871245,0.0029343253,0.0003218774,0.0026180719,0.00415697,0.003453147,0.057074316,0.00019242827],"about_ca_topic_score_codex":0.0010203526,"about_ca_topic_score_gemma":0.0052835587,"teacher_disagreement_score":0.0054481714,"about_ca_system_score_codex":0.0008036669,"about_ca_system_score_gemma":0.0009374409,"threshold_uncertainty_score":0.02792424},"labels":[],"label_agreement":null},{"id":"W2948503358","doi":"10.1186/s12920-019-0527-2","title":"Targeted next generation sequencing as a tool for precision medicine","year":2019,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Children's Health Foundation","keywords":"Copy-number variation; Biology; Genetics; Genotyping; Concordance; Exome sequencing; Allele frequency; Exome; Computational biology; Human genetics; DNA sequencing; Pseudogene; Personalized medicine; Massive parallel sequencing; Genotype; Gene; Mutation; Genome","score_opus":0.22920482654003135,"score_gpt":0.4394715403986303,"score_spread":0.21026671385859894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948503358","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012561482,0.07536849,0.8452908,0.022474876,0.0042474507,0.00032381844,0.006117443,0.011288743,0.022326956],"genre_scores_gemma":[0.08560958,0.037704702,0.84304017,0.015315514,0.0024787448,0.0006486518,0.0032766738,0.0007908394,0.011135135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955336,0.0019771443,0.0002005712,0.0006880038,0.00148484,0.00011576199],"domain_scores_gemma":[0.9939453,0.0036360384,0.0004425292,0.00085898687,0.00085009093,0.00026703253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008508466,0.0007474818,0.0013402145,0.002606369,0.00048414085,0.0025777011,0.0010544856,0.0022289304,0.00668704],"category_scores_gemma":[0.0068673543,0.0007415854,0.0009161911,0.0012394364,0.0012615859,0.0015729518,0.0017331798,0.0032185381,0.003056311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005431021,0.00012940695,0.00568929,0.002510109,0.0007492483,0.0005230262,0.00039747066,0.008229946,0.14166841,0.06498519,0.082633436,0.6919414],"study_design_scores_gemma":[0.00022931542,0.0008452129,0.010369714,0.0019309246,0.0005151836,0.002452719,0.0002571885,0.05465412,0.09049161,0.17495681,0.6629375,0.0003596918],"about_ca_topic_score_codex":0.0005794187,"about_ca_topic_score_gemma":0.000773435,"teacher_disagreement_score":0.008508466,"about_ca_system_score_codex":0.0011836507,"about_ca_system_score_gemma":0.0010473207,"threshold_uncertainty_score":0.044997573},"labels":[],"label_agreement":null},{"id":"W2949512585","doi":"10.1101/259838","title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"National Institutes of Health; King's College London; National Institute for Health and Care Research; National Institute of Mental Health; Medical Research Council; European Federation of Pharmaceutical Industries and Associations; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline; European Commission; University of Texas Southwestern Medical Center; Pfizer","keywords":"CYP2C19; Escitalopram; Citalopram; Meta-analysis; Internal medicine; Antidepressant; CYP2D6; Pharmacogenetics; Medicine; Side effect (computer science); Pharmacology; CYP3A4; Gastroenterology; Cytochrome P450; Genotype; Biology; Genetics; Gene; Metabolism","score_opus":0.14417274753803808,"score_gpt":0.41512032612302563,"score_spread":0.2709475785849875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949512585","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13291031,0.85059464,0.008227083,0.0009822972,0.0008838783,0.00032999157,0.004763996,0.0002942838,0.0010134779],"genre_scores_gemma":[0.93096197,0.06089324,0.0034030492,0.0007379981,0.0004025498,0.00046050161,0.0025612048,0.00013841187,0.00044107973],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9732539,0.017524976,0.0033469002,0.0037571294,0.0015341232,0.00058296486],"domain_scores_gemma":[0.95715576,0.03415705,0.0038000287,0.00291992,0.0015292078,0.00043799798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026714273,0.003944697,0.015614517,0.0048694084,0.000793843,0.0038476211,0.0026893818,0.002703447,0.0033794476],"category_scores_gemma":[0.037358195,0.0019023201,0.06718614,0.008368824,0.0008837033,0.0015677245,0.0018202341,0.0031351026,0.0003809551],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030334154,0.000014245316,0.016361281,0.00617266,0.9712385,0.00008027038,0.000016854621,0.000916807,0.00017358288,0.00004510178,0.00022215865,0.0017252072],"study_design_scores_gemma":[0.00056018186,0.0001352239,0.010595663,0.00047474646,0.98669726,0.000072673,0.00001562552,0.0007695896,0.00012058279,0.00018380702,0.00035910888,0.000015540676],"about_ca_topic_score_codex":0.0062066307,"about_ca_topic_score_gemma":0.0063679977,"teacher_disagreement_score":0.026714273,"about_ca_system_score_codex":0.0014277087,"about_ca_system_score_gemma":0.0011362745,"threshold_uncertainty_score":0.1412803},"labels":[],"label_agreement":null},{"id":"W2949677511","doi":"10.1016/j.pec.2019.06.008","title":"Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review","year":2019,"lang":"en","type":"review","venue":"Patient Education and Counseling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Nutrition, Metabolism and Diabetes; Institute of Infection and Immunity; Genome Canada; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Institute of Genetics; Government of Canada","keywords":"Pharmacogenomics; Health professionals; Health care; MEDLINE; Medicine; Psychology; Pharmacology","score_opus":0.33811212014863706,"score_gpt":0.5408053463895551,"score_spread":0.20269322624091807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949677511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001360649,0.9993303,0.00006911919,0.0002059028,0.000040691943,0.000013716443,0.000040436968,0.0000015628923,0.00016225832],"genre_scores_gemma":[0.0011132435,0.99824023,0.00024033793,0.00027701718,0.000029486764,0.000022400365,0.000036440615,7.992152e-7,0.000039976636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969664,0.0008747075,0.0009669441,0.00039601987,0.00066740427,0.00012845447],"domain_scores_gemma":[0.98014575,0.01668457,0.0016043189,0.00017650968,0.0012216055,0.00016719794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007049422,0.0011784519,0.0044690655,0.0071887765,0.0004578751,0.0032858944,0.0016954441,0.0026100993,0.003490546],"category_scores_gemma":[0.020760726,0.000801254,0.0033118385,0.0060975184,0.0009460809,0.0028508217,0.0017737766,0.0018058469,0.00038263135],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011001127,0.000103919454,0.0016277857,0.52359647,0.003194266,0.00017606949,0.00055297476,0.00029469814,0.0002700485,0.0013461567,0.0066060205,0.4621216],"study_design_scores_gemma":[0.00006232874,0.00009225798,0.0039766436,0.88306975,0.011572504,0.00061166193,0.000545522,0.00012979626,0.00020604559,0.0011662068,0.09851389,0.00005331961],"about_ca_topic_score_codex":0.011370705,"about_ca_topic_score_gemma":0.019491415,"teacher_disagreement_score":0.011370705,"about_ca_system_score_codex":0.0019609344,"about_ca_system_score_gemma":0.008473878,"threshold_uncertainty_score":0.037281394},"labels":[],"label_agreement":null},{"id":"W2952541172","doi":"10.1038/s41397-018-0048-y","title":"Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes","year":2018,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Linkage disequilibrium; Genetics; Biology; Genome-wide association study; Genome; Genetic association; 1000 Genomes Project; Gene; Computational biology; Haplotype; Single-nucleotide polymorphism; Allele; Genotype","score_opus":0.09886308670490605,"score_gpt":0.41698346283839427,"score_spread":0.3181203761334882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952541172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98091906,0.0024422011,0.0062153125,0.0009913677,0.00016215489,0.000037924987,0.0067477487,0.00026349572,0.0022206898],"genre_scores_gemma":[0.99338996,0.0005584331,0.0024780435,0.00041222008,0.00008302307,0.00001246864,0.0023387624,0.00008401846,0.0006431968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990231,0.00018642464,0.00008903952,0.00033939478,0.00024801795,0.00011394965],"domain_scores_gemma":[0.99815077,0.0011176299,0.0003458052,0.000128948,0.00009154637,0.00016535823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000711193,0.00097225304,0.00073813734,0.0015490502,0.00049891905,0.0012167043,0.0005255643,0.0014058334,0.004274544],"category_scores_gemma":[0.0028262176,0.00026327872,0.0012277494,0.0019724586,0.0005410559,0.0002911829,0.0004588438,0.0011132546,0.00050119864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037023015,0.0003568086,0.6306269,0.0005440266,0.006144116,0.013070587,0.0006040332,0.0041688965,0.25630626,0.0023589423,0.0052244863,0.07689258],"study_design_scores_gemma":[0.000202991,0.00031276396,0.9548794,0.00010654753,0.0028729136,0.008105045,0.000251369,0.00416018,0.018582102,0.0028465632,0.0076011256,0.00007902106],"about_ca_topic_score_codex":0.0034448595,"about_ca_topic_score_gemma":0.00707808,"teacher_disagreement_score":0.004274544,"about_ca_system_score_codex":0.00028535194,"about_ca_system_score_gemma":0.00040065538,"threshold_uncertainty_score":0.01429981},"labels":[],"label_agreement":null},{"id":"W2954818509","doi":"10.1002/cpt.1471","title":"Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Medical Research Council; National Institute for Health and Care Research; European Commission; Bundesinstitut für Arzneimittel und Medizinprodukte","keywords":"Pharmacogenomics; Agency (philosophy); Harmonization; Regulatory science; Specialty; Precision medicine; Medical education; Medicine; Family medicine; Pharmacology; Sociology","score_opus":0.3948679866942507,"score_gpt":0.55277601827374,"score_spread":0.1579080315794893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954818509","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003323536,0.02948948,0.0025190825,0.9507496,0.0043278737,0.000083678235,0.00011141451,0.000107459426,0.009287989],"genre_scores_gemma":[0.14435935,0.122493304,0.035385318,0.67391586,0.012432654,0.0008572381,0.0010209111,0.0003199958,0.009215369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97989094,0.011116607,0.0011020113,0.0015319725,0.0028460156,0.0035124402],"domain_scores_gemma":[0.9014932,0.03734022,0.0043496015,0.002654237,0.012374105,0.04178859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0480707,0.0010842258,0.0012073439,0.0033691812,0.005853864,0.013485259,0.0032617364,0.013039383,0.018826034],"category_scores_gemma":[0.04885667,0.0007509667,0.001424857,0.0023323682,0.008729657,0.029385244,0.022341939,0.018316636,0.0046026246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014714457,0.00084422587,0.009699894,0.00504307,0.0000845197,0.0012744112,0.034123104,0.00039443668,0.0010696357,0.06712334,0.36378977,0.5164065],"study_design_scores_gemma":[0.00013461636,0.00029417165,0.0076492736,0.016483497,0.00006497366,0.0019179867,0.06139823,0.00062549877,0.00043665353,0.10473339,0.80611116,0.00015061226],"about_ca_topic_score_codex":0.0037364052,"about_ca_topic_score_gemma":0.0037566323,"teacher_disagreement_score":0.0480707,"about_ca_system_score_codex":0.00548822,"about_ca_system_score_gemma":0.037043955,"threshold_uncertainty_score":0.2542252},"labels":[],"label_agreement":null},{"id":"W2955876419","doi":"10.71781/11819","title":"Accélération de l'exploration de l'espace chimique du cytochrome P450 BM3 par des méthodes de criblage à haut débit et bio-informatiques","year":2018,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies; Centre in Green Chemistry and Catalysis; Génome Québec; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Physics; Chemistry","score_opus":0.038162705829889905,"score_gpt":0.3140264456576361,"score_spread":0.2758637398277462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955876419","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33443987,0.035928264,0.5944254,0.0023461294,0.0007071484,0.0007705324,0.0012277567,0.0019889565,0.02816604],"genre_scores_gemma":[0.73358566,0.027408117,0.19291773,0.000884671,0.00019487964,0.000659469,0.0012868523,0.0005266889,0.04253594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993376,0.00013415236,0.00002765823,0.00017201225,0.00026255965,0.00006595875],"domain_scores_gemma":[0.99958676,0.00013918005,0.000060615846,0.00006694625,0.00011448103,0.000032007014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009229436,0.0007049029,0.00055486767,0.0006234632,0.00040928883,0.0007843549,0.0005211197,0.00078384834,0.006557611],"category_scores_gemma":[0.00097326963,0.00036576483,0.0008417383,0.00068960496,0.00048684023,0.00089006685,0.0006105367,0.002010476,0.0028338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002590931,0.00011309337,0.0004117784,0.0006142394,0.00004942304,0.00016907687,0.000109842804,0.000951707,0.94267684,0.0022355542,0.00094547676,0.051463872],"study_design_scores_gemma":[0.000038552393,0.00044636003,0.0012383233,0.000039081904,0.000042752352,0.000366725,0.000048364116,0.0037033742,0.95597184,0.0005649272,0.0375139,0.000025931724],"about_ca_topic_score_codex":0.0022127745,"about_ca_topic_score_gemma":0.0028282017,"teacher_disagreement_score":0.006557611,"about_ca_system_score_codex":0.00058213214,"about_ca_system_score_gemma":0.0007618258,"threshold_uncertainty_score":0.02193743},"labels":[],"label_agreement":null},{"id":"W2962678857","doi":"10.18433/jpps30558","title":"Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP3A4; Steroid; Chemistry; Hydroxylation; Docking (animal); CYP3A; Androstane; Cytochrome P450; Hormone; Stereochemistry; Pharmacology; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.18076087266066707,"score_gpt":0.536497333778581,"score_spread":0.3557364611179139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962678857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890842,0.00058045465,0.007379696,0.000096100186,0.000019229645,0.00002940193,0.00036276394,0.00022911016,0.002219203],"genre_scores_gemma":[0.9934581,0.0004079333,0.0041934196,0.000028817954,0.0000029167036,0.000028804243,0.0010126068,0.000042678,0.0008247649],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997634,0.00006836564,0.00001510069,0.000038242055,0.0000772289,0.000037624864],"domain_scores_gemma":[0.9998313,0.000059337995,0.000028099194,0.000018304663,0.000042289914,0.000020509833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039630875,0.00076746533,0.00050864596,0.00037135658,0.0003661729,0.00053496717,0.00045245234,0.00033118768,0.0021443204],"category_scores_gemma":[0.000943172,0.00019131617,0.0009229189,0.0005291752,0.00018005427,0.00023682193,0.00026393874,0.00033992215,0.0004851944],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020654744,0.0004418146,0.03677156,0.00046887438,0.00075929007,0.0006618611,0.00016403769,0.8248272,0.09250997,0.0024634735,0.002147421,0.03671911],"study_design_scores_gemma":[0.000251447,0.0011325035,0.027340781,0.000034232955,0.00025911772,0.00040557227,0.00018304867,0.8924502,0.072923996,0.0009865534,0.0039613526,0.00007124534],"about_ca_topic_score_codex":0.006201836,"about_ca_topic_score_gemma":0.0039805304,"teacher_disagreement_score":0.006201836,"about_ca_system_score_codex":0.00066976494,"about_ca_system_score_gemma":0.00036749916,"threshold_uncertainty_score":0.012331486},"labels":[],"label_agreement":null},{"id":"W2963524270","doi":"10.2196/13848","title":"Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study","year":2019,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Randomized controlled trial; Family medicine; Pharmacogenomics; Anxiety; Protocol (science); Population; Depression (economics); Alternative medicine; Psychiatry; Internal medicine; Pharmacology","score_opus":0.6150635496460872,"score_gpt":0.6538426243084504,"score_spread":0.03877907466236319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963524270","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005639755,0.0000631531,0.00073425804,0.000062232495,0.0001372911,0.9978109,0.00035159363,0.000041137442,0.0002354227],"genre_scores_gemma":[0.0008142866,0.000045581684,0.0016780773,0.00007734696,0.000025105877,0.9972017,0.000054338856,0.0000030353885,0.00010058367],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9467965,0.0364387,0.005955014,0.0026252712,0.004621522,0.003563064],"domain_scores_gemma":[0.95986336,0.012987668,0.007438333,0.005939253,0.009952778,0.003818602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0688173,0.006599118,0.0097281225,0.0038880575,0.0046889763,0.0043949187,0.0036412748,0.008469492,0.075121686],"category_scores_gemma":[0.05705818,0.0036091548,0.0050468147,0.005981606,0.0047428603,0.0033923134,0.0021625431,0.009070981,0.013035641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8005174,0.04740284,0.0025613839,0.038979035,0.0029455116,0.0009011197,0.0013833346,0.0040577254,0.004846459,0.008240524,0.037829053,0.050335634],"study_design_scores_gemma":[0.8661564,0.05317927,0.005570451,0.0062544104,0.0010239278,0.00015823318,0.00044188692,0.003607878,0.0016082611,0.003963558,0.057820912,0.00021473829],"about_ca_topic_score_codex":0.0026669304,"about_ca_topic_score_gemma":0.005867344,"teacher_disagreement_score":0.075121686,"about_ca_system_score_codex":0.005963516,"about_ca_system_score_gemma":0.019333709,"threshold_uncertainty_score":0.363945},"labels":[],"label_agreement":null},{"id":"W2965033615","doi":"10.3390/jpm9030040","title":"Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges","year":2019,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Mental Health & Substance Use Services; University of British Columbia","funders":"","keywords":"Medicine; Pharmacogenomics; Medical physics; Pharmacology","score_opus":0.7826698967804986,"score_gpt":0.6623877528341526,"score_spread":0.12028214394634595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965033615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017060876,0.9640474,0.0011074659,0.03133846,0.00090485765,0.000046335932,0.00014139446,0.000023966291,0.002219549],"genre_scores_gemma":[0.005559853,0.975486,0.0047267014,0.012146707,0.0013958053,0.00013677347,0.00021825322,0.000027276514,0.0003026963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9653646,0.017174438,0.0054101297,0.0019937537,0.009427738,0.00062931323],"domain_scores_gemma":[0.65419173,0.29532614,0.010484999,0.005691225,0.03192238,0.0023834044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08377217,0.001316107,0.0055296556,0.005381435,0.00070251146,0.007076539,0.0054038595,0.005936956,0.008329301],"category_scores_gemma":[0.18198274,0.0011387733,0.0025427928,0.006142664,0.00393148,0.008401096,0.0033800434,0.009143073,0.0026990115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001437982,0.0000620161,0.0007275027,0.04405481,0.00050137925,0.0001375457,0.00015269316,0.00037029182,0.0001334617,0.018894749,0.038140513,0.89668125],"study_design_scores_gemma":[0.00015321164,0.00020216049,0.002666467,0.26140815,0.0015630389,0.00093156437,0.0004812639,0.0007019261,0.0003706285,0.037805114,0.69363445,0.00008205342],"about_ca_topic_score_codex":0.0044125365,"about_ca_topic_score_gemma":0.006552735,"teacher_disagreement_score":0.08377217,"about_ca_system_score_codex":0.004893326,"about_ca_system_score_gemma":0.020423144,"threshold_uncertainty_score":0.4430349},"labels":[],"label_agreement":null},{"id":"W2966490111","doi":"10.1016/j.euroneuro.2018.08.332","title":"SA110PHARMACOGENETIC DECISION SUPPORT TOOLS AND SYMPTOM REMISSION: A META-ANALYSIS OF PROSPECTIVE RANDOMIZED CONTROLLED TRIALS IN MAJOR DEPRESSIVE DISORDER","year":2019,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pharmacogenetics; Dosing; CYP2C19; Clinical trial; Drug; Intensive care medicine; Pharmacology; Internal medicine; Genotype","score_opus":0.09509493544963457,"score_gpt":0.4286253783602861,"score_spread":0.3335304429106515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966490111","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3923392,0.5980839,0.0042013084,0.0009789369,0.0010105406,0.00032223074,0.001537155,0.00016674503,0.0013599718],"genre_scores_gemma":[0.9690773,0.026565466,0.0021833284,0.0006948685,0.00024342042,0.00016283419,0.0007104319,0.000030495718,0.0003318907],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.989958,0.0070389044,0.0010715226,0.0011671981,0.0005070672,0.00025724855],"domain_scores_gemma":[0.9891237,0.008117936,0.0015650893,0.0006871023,0.00028852705,0.00021765627],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00896527,0.002125846,0.0071065086,0.0010248765,0.0005052511,0.002218164,0.0013497858,0.0022111256,0.002904848],"category_scores_gemma":[0.016507216,0.0012419269,0.02020056,0.0019333545,0.0008294948,0.0012486641,0.001016813,0.0027893241,0.00021761516],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08342934,0.00018532264,0.0200472,0.016253715,0.863816,0.00006957975,0.00006592643,0.0015584945,0.0005382447,0.00020415959,0.0005663069,0.013265675],"study_design_scores_gemma":[0.029356396,0.002341552,0.022559762,0.0013020542,0.9403643,0.00008701999,0.00006630298,0.0017447447,0.00025768252,0.000798685,0.0010695203,0.00005203029],"about_ca_topic_score_codex":0.0025103886,"about_ca_topic_score_gemma":0.003639708,"teacher_disagreement_score":0.9928935,"about_ca_system_score_codex":0.000696308,"about_ca_system_score_gemma":0.00073294295,"threshold_uncertainty_score":0.04741347},"labels":[],"label_agreement":null},{"id":"W2969772949","doi":"","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Medicine; Pharmacogenetics; Data science; Intensive care medicine; Risk analysis (engineering); Computer science; Pharmacology; Psychology; Biology","score_opus":0.6732236853124157,"score_gpt":0.6680118248591355,"score_spread":0.005211860453280259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969772949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050810715,0.61190796,0.01356953,0.35090968,0.0024090812,0.00030298645,0.0005028017,0.00035902995,0.014957833],"genre_scores_gemma":[0.057513118,0.82521766,0.060327686,0.050257914,0.0033677556,0.00049742026,0.00073062646,0.00018616437,0.0019017118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97759306,0.01412623,0.0023604922,0.0014950054,0.0030440518,0.001381103],"domain_scores_gemma":[0.8743358,0.079247415,0.00757205,0.0044785836,0.02498043,0.009385648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07886285,0.0011451872,0.0010432001,0.0050373035,0.0015409222,0.007524053,0.002779817,0.004578754,0.0075185113],"category_scores_gemma":[0.059801705,0.0006659755,0.0015489683,0.0071334587,0.0050248653,0.008093658,0.005968117,0.006469859,0.0014262607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024531764,0.0003539131,0.010051589,0.007845435,0.0001644127,0.00018969066,0.0008534733,0.0016896107,0.00084973825,0.057664737,0.04268372,0.8774083],"study_design_scores_gemma":[0.00018909897,0.0011962015,0.022327282,0.040808905,0.00043997364,0.001019001,0.0037267748,0.00223797,0.0026664736,0.050047964,0.8751812,0.00015918005],"about_ca_topic_score_codex":0.015406733,"about_ca_topic_score_gemma":0.014513582,"teacher_disagreement_score":0.07886285,"about_ca_system_score_codex":0.008578082,"about_ca_system_score_gemma":0.058866855,"threshold_uncertainty_score":0.41707164},"labels":[],"label_agreement":null},{"id":"W2970909648","doi":"10.1111/bcp.14100","title":"Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre‐emptive pharmacogenomic testing","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Pharmacogenomics; Medicine; Dosing; Pharmacogenetics; Drug; Pharmacology; Internal medicine; Intensive care medicine; Biology","score_opus":0.12319083436497238,"score_gpt":0.4530064439289536,"score_spread":0.32981560956398126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970909648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669576,0.00038266848,0.0008434188,0.00020471608,0.000008011649,0.00009173674,0.0013111853,0.000006291055,0.00045620103],"genre_scores_gemma":[0.9976635,0.00013730541,0.0007974516,0.00017545006,0.000008315267,0.00012811179,0.0008652236,0.0000049243313,0.00021980045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907354,0.0058732717,0.0010906869,0.00089799287,0.00075364445,0.00064904295],"domain_scores_gemma":[0.96707255,0.013663214,0.013171846,0.0025372359,0.0026432376,0.0009118774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080765365,0.00028115828,0.00037542175,0.0009449651,0.00057760545,0.0009755819,0.0006401446,0.0005322123,0.0018758399],"category_scores_gemma":[0.028980067,0.0004597832,0.0009564529,0.0016399894,0.00039183945,0.000911583,0.0014726516,0.0005700103,0.00030791858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001543674,0.000028604949,0.99724627,0.000032688473,0.00006944434,0.000089886846,0.0006393818,0.00004699018,0.000073042225,0.000027310734,0.00015985583,0.0014321659],"study_design_scores_gemma":[0.00003091199,0.00033183233,0.9956102,0.00007874976,0.00013989948,0.00024296412,0.001446892,0.0008793042,0.00020431473,0.000073040435,0.00094812334,0.000013706261],"about_ca_topic_score_codex":0.028272366,"about_ca_topic_score_gemma":0.028399907,"teacher_disagreement_score":0.028272366,"about_ca_system_score_codex":0.0012869481,"about_ca_system_score_gemma":0.0017028718,"threshold_uncertainty_score":0.056215584},"labels":[],"label_agreement":null},{"id":"W2972367557","doi":"10.1002/jcph.1493","title":"Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"UGT2B7; Glucuronidation; Microsome; Gene isoform; Glucuronosyltransferase; Isozyme; In vivo; Enzyme; Internal medicine; Endocrinology; Pharmacokinetics; Ontogeny; In vitro; Chemistry; Pharmacology; Biology; Biochemistry; Medicine; Gene; Genetics","score_opus":0.12747881036509193,"score_gpt":0.4600267149257834,"score_spread":0.3325479045606915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972367557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827376,0.0046442994,0.008251124,0.00009821987,0.000022733575,0.00004445075,0.0017838174,0.00006791868,0.002349871],"genre_scores_gemma":[0.98616856,0.0037974757,0.0042903046,0.000069106,0.000020906542,0.00006183255,0.0022225047,0.00004603751,0.0033231948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988663,0.000018954046,0.000009383031,0.00004363592,0.000028242657,0.000013053987],"domain_scores_gemma":[0.99975675,0.00004022828,0.000078552424,0.000029015326,0.000060318544,0.000035172354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024064815,0.00024046237,0.000176073,0.00042436586,0.00009626319,0.00031945598,0.000110980756,0.00019655543,0.0010950268],"category_scores_gemma":[0.00046587674,0.00019340302,0.00022237713,0.00027800948,0.0001790826,0.00027620056,0.00016620827,0.0003332632,0.0005059634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071496336,0.00003553247,0.06300545,0.00010849992,0.000049769435,0.00028234947,0.00020706162,0.00015331178,0.90835446,0.00040247844,0.00022416042,0.026461909],"study_design_scores_gemma":[0.0000124442395,0.00066307845,0.6491069,0.000021184982,0.00008902768,0.0013775983,0.00013777861,0.0007177714,0.34005004,0.00018848202,0.007618577,0.000017107517],"about_ca_topic_score_codex":0.0012355138,"about_ca_topic_score_gemma":0.0010126618,"teacher_disagreement_score":0.0012355138,"about_ca_system_score_codex":0.0001842847,"about_ca_system_score_gemma":0.00023713801,"threshold_uncertainty_score":0.0036632419},"labels":[],"label_agreement":null},{"id":"W2972681847","doi":"10.1002/cpt.1611","title":"Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citation; Associate editor; Precision medicine; Library science; Medicine; Psychology; Computer science","score_opus":0.2889980624840852,"score_gpt":0.5879891898422483,"score_spread":0.29899112735816313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972681847","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07660357,0.010497201,0.10980212,0.7598947,0.003560566,0.0015674628,0.00038876076,0.0013294984,0.036355987],"genre_scores_gemma":[0.64668185,0.008855755,0.23668893,0.09954118,0.0024009193,0.0017247009,0.00044021016,0.00034525016,0.003321211],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9554568,0.0302001,0.0021626987,0.0032193519,0.005677984,0.003282995],"domain_scores_gemma":[0.8812662,0.061108865,0.005192691,0.010954225,0.015158308,0.02631975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06726998,0.0010060109,0.0011444914,0.001273904,0.00412121,0.011323711,0.0060641603,0.006978029,0.007612296],"category_scores_gemma":[0.10024092,0.0006925413,0.0013648863,0.0014778367,0.006005881,0.007454368,0.010469946,0.011919367,0.0010382339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009836775,0.008341721,0.055931225,0.002592111,0.00062274473,0.0022988298,0.0095318295,0.012451325,0.0016338209,0.06437286,0.07838789,0.76285195],"study_design_scores_gemma":[0.0053539583,0.012930854,0.18661368,0.02227927,0.00097300415,0.004434915,0.036475066,0.031612743,0.00835422,0.27838928,0.4113366,0.0012463073],"about_ca_topic_score_codex":0.019274054,"about_ca_topic_score_gemma":0.032483663,"teacher_disagreement_score":0.06726998,"about_ca_system_score_codex":0.010939144,"about_ca_system_score_gemma":0.06422392,"threshold_uncertainty_score":0.3557619},"labels":[],"label_agreement":null},{"id":"W2974606789","doi":"10.1016/j.mce.2019.110583","title":"Evaluating the effects on steroidogenesis of estragole and trans-anethole in a feto-placental co-culture model","year":2019,"lang":"en","type":"article","venue":"Molecular and Cellular Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Estragole; Anethole; Cholesterol side-chain cleavage enzyme; Pregnenolone; Chemistry; Internal medicine; Endocrinology; Hormone; Steroid; Biology; Biochemistry; Enzyme; Cytochrome P450; Medicine","score_opus":0.061996270388481066,"score_gpt":0.41537228130700304,"score_spread":0.353376010918522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974606789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749147,0.006223719,0.009530871,0.00034053862,0.00030286805,0.0001509643,0.001362224,0.00015591992,0.00701825],"genre_scores_gemma":[0.9684604,0.003719387,0.006960901,0.00016218316,0.000054682525,0.00013537683,0.0014276087,0.000056972487,0.019022468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996145,0.00007581318,0.00003363609,0.00008998369,0.00011164815,0.00007442905],"domain_scores_gemma":[0.99957746,0.00015091295,0.000040040955,0.000084353494,0.00006972107,0.00007750521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048102732,0.0005455389,0.00076440163,0.0005050922,0.0004262672,0.00054240803,0.0004927116,0.00047081633,0.0023719931],"category_scores_gemma":[0.00028115374,0.00019352994,0.00057614146,0.0005184119,0.0004006434,0.00045595286,0.00040073195,0.0014262239,0.0006670385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092196616,0.00020398911,0.00035848762,0.00008153439,0.000017919781,0.0003482895,0.000078727804,0.00021450885,0.9946161,0.00019056517,0.000103814324,0.0028641564],"study_design_scores_gemma":[0.0000321051,0.0013414859,0.0014501553,0.000008023191,0.00006434184,0.00020327615,0.0001533853,0.00080614217,0.9921698,0.00005756767,0.00370379,0.000009995903],"about_ca_topic_score_codex":0.0036954682,"about_ca_topic_score_gemma":0.0070858225,"teacher_disagreement_score":0.0036954682,"about_ca_system_score_codex":0.00048273214,"about_ca_system_score_gemma":0.00072443835,"threshold_uncertainty_score":0.007935107},"labels":[],"label_agreement":null},{"id":"W2975972081","doi":"10.1055/a-0979-2322","title":"From the Origins of Pharmacogenetics to First Applications in Psychiatry","year":2019,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Relevance (law); Clinical pharmacology; Pharmacogenomics; Psychology; Psychiatry; Medicine; Pharmacology; Biology; Genetics; Political science; Gene","score_opus":0.17751723211395196,"score_gpt":0.5055671253013257,"score_spread":0.32804989318737376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975972081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005783546,0.9970988,0.00016733569,0.0010066489,0.0003643352,0.000001938316,0.0000077650375,0.0000045876027,0.0012907784],"genre_scores_gemma":[0.000792902,0.9974291,0.00016821013,0.0005811699,0.00048819513,0.0000036668257,0.000010124768,0.000001624079,0.0005250141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962044,0.0001237164,0.000044098306,0.000058537826,0.00012442943,0.00002882516],"domain_scores_gemma":[0.99917585,0.0005504383,0.00005727707,0.000027203374,0.00014171709,0.00004749799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086335035,0.0008038955,0.00107288,0.0026241515,0.00042474063,0.0014654652,0.00077153544,0.0015541865,0.003379462],"category_scores_gemma":[0.0015309462,0.00028810278,0.00056459586,0.002715892,0.0015069577,0.0022086652,0.0010386256,0.003394087,0.0014560804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008990497,0.000053997926,0.0002577274,0.016546622,0.000084360494,0.0004467533,0.00026837084,0.0005166495,0.0010070411,0.049187474,0.04924113,0.88229996],"study_design_scores_gemma":[0.0000101759415,0.000040151015,0.0007546996,0.005007289,0.00003934492,0.0013146036,0.000117775984,0.00008962018,0.00020466036,0.015185828,0.9772181,0.000017827613],"about_ca_topic_score_codex":0.0018697057,"about_ca_topic_score_gemma":0.0028714288,"teacher_disagreement_score":0.003379462,"about_ca_system_score_codex":0.0019519401,"about_ca_system_score_gemma":0.0020498936,"threshold_uncertainty_score":0.014162302},"labels":[],"label_agreement":null},{"id":"W2976816195","doi":"10.1002/cpt.2166","title":"PharmVar GeneFocus: <i>CYP2B6</i>","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Medical Research Council; National Institutes of Health; Canada Research Chairs; Robert Bosch Stiftung; Horizon 2020 Framework Programme; European Federation of Pharmaceutical Industries and Associations; National Research Foundation; Canadian Institutes of Health Research; Australian Centre for HIV and Hepatitis Virology Research; European Commission; Vetenskapsrådet; Centre for Addiction and Mental Health; McGill University","keywords":"Medicine; Pharmacology","score_opus":0.5691523363200172,"score_gpt":0.6343200664153339,"score_spread":0.06516773009531673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976816195","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041440157,0.21896331,0.020651182,0.009555732,0.0019714818,0.0008629481,0.5724406,0.015637204,0.15577348],"genre_scores_gemma":[0.014103561,0.24647555,0.035800815,0.006131663,0.0009981839,0.00080714066,0.6544774,0.003279583,0.03792612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937916,0.0001138385,0.00012714835,0.00009077728,0.00023123846,0.000057795838],"domain_scores_gemma":[0.9979049,0.0008720625,0.00038697154,0.0001637348,0.00050035166,0.00017200236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012071386,0.0009353675,0.0014274156,0.006151922,0.00033404218,0.0022574004,0.0016513687,0.0013572728,0.060299613],"category_scores_gemma":[0.004253371,0.00036049655,0.0008132128,0.010703589,0.00041929624,0.0017757289,0.0015206764,0.0011544697,0.042961735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018224512,0.00004975457,0.000758612,0.015257738,0.00011630464,0.00027792453,0.0001698078,0.00041593608,0.0030915863,0.008721922,0.48648113,0.48447707],"study_design_scores_gemma":[0.000013175978,0.000008785602,0.00080074265,0.00090594275,0.000038800918,0.00018801185,0.000013531315,0.000047414323,0.0005502687,0.00073234586,0.9966912,0.000009790239],"about_ca_topic_score_codex":0.004728802,"about_ca_topic_score_gemma":0.004390454,"teacher_disagreement_score":0.060299613,"about_ca_system_score_codex":0.0007433943,"about_ca_system_score_gemma":0.0031748281,"threshold_uncertainty_score":0.20172226},"labels":[],"label_agreement":null},{"id":"W2977247797","doi":"10.1096/fasebj.24.1_supplement.757.5","title":"Differential activation of rat and human pregnane X receptor by terpene trilactones","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Pregnane X receptor; Ginkgolides; Chemistry; Terpene; Pharmacology; Stereochemistry; Biology; Biochemistry; Nuclear receptor; Transcription factor; Gene; Ginkgo biloba","score_opus":0.053562878391010024,"score_gpt":0.38579107872285034,"score_spread":0.3322282003318403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977247797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887162,0.0063778893,0.0019659281,0.00017152453,0.00002756805,0.00003274671,0.0008275043,0.00006196639,0.0018187065],"genre_scores_gemma":[0.98720795,0.0034556696,0.0023243544,0.0001761942,0.000020905816,0.000067862675,0.0028087392,0.000029290712,0.003909007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953055,0.00016358164,0.000053329844,0.00006635766,0.000083134684,0.00010298475],"domain_scores_gemma":[0.99979776,0.00008012924,0.000024347477,0.00003709634,0.000024430907,0.000036295492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037289053,0.0003037097,0.00040250766,0.00036871247,0.00010573817,0.00048237268,0.0001402138,0.00030285932,0.0027617405],"category_scores_gemma":[0.0004668881,0.00020706728,0.00044270523,0.0004245172,0.00031410955,0.00024477084,0.00018841548,0.00043980143,0.0010481686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007381829,0.000032829816,0.00032496316,0.000060213297,0.000020906886,0.00007842218,0.000046781108,0.00007884948,0.9972531,0.0000865964,0.00006558751,0.0012135404],"study_design_scores_gemma":[0.00012949908,0.001576175,0.018201998,0.000014589028,0.00008587706,0.0013573619,0.00019469835,0.0006688842,0.9718988,0.00012439048,0.00572571,0.000022056523],"about_ca_topic_score_codex":0.0008570318,"about_ca_topic_score_gemma":0.0010544925,"teacher_disagreement_score":0.0027617405,"about_ca_system_score_codex":0.00028294843,"about_ca_system_score_gemma":0.00018140842,"threshold_uncertainty_score":0.009238958},"labels":[],"label_agreement":null},{"id":"W2977898125","doi":"10.1101/792671","title":"Targeting the Pregnane X Receptor Using Microbial Metabolite Mimicry","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Albert Einstein College of Medicine, Yeshiva University; National Institutes of Health; Georgia Clinical and Translational Science Alliance; Crohn's and Colitis Foundation of America; U.S. Department of Defense","keywords":"Pregnane X receptor; Metabolite; Biology; Drug metabolism; G protein-coupled receptor; Secondary metabolite; Drug discovery; Chemical space; Regulator; Receptor; Pharmacology; Chemistry; Biochemistry; Cell biology; Nuclear receptor; Gene; Drug; Transcription factor","score_opus":0.06159226196383241,"score_gpt":0.3362175906060095,"score_spread":0.27462532864217704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977898125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664148,0.0042151664,0.022656286,0.00047593142,0.000111078545,0.00008019472,0.00059274473,0.0003401664,0.0051136795],"genre_scores_gemma":[0.9882665,0.0011309425,0.0074505513,0.000083442006,0.0000149659645,0.000027833785,0.00015273059,0.00001599531,0.0028569913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999125,0.000019557428,0.0000048420316,0.00001951216,0.000026246867,0.000017318944],"domain_scores_gemma":[0.9999703,0.0000043589303,0.000012173129,0.000004553427,0.0000027102046,0.0000059177573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013647614,0.00021034188,0.00017668027,0.0000999023,0.000077312696,0.00025123684,0.00017291367,0.00026085807,0.0013253329],"category_scores_gemma":[0.00008679123,0.0000758947,0.00019949845,0.00006805507,0.00020200168,0.00016489273,0.00022311899,0.00030622235,0.00041201245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064022766,0.000010677159,0.00008541837,0.000044072884,0.0000039241027,0.000054775777,0.0000058024134,0.0002872428,0.9974523,0.00044326409,0.00008196527,0.0014665308],"study_design_scores_gemma":[0.0000108419645,0.00015697896,0.00025773718,0.0000023514212,0.0000048061493,0.00015349295,0.0000047673284,0.0008198134,0.9956291,0.00009342031,0.0028632318,0.0000035792784],"about_ca_topic_score_codex":0.00022894218,"about_ca_topic_score_gemma":0.00023390846,"teacher_disagreement_score":0.0013253329,"about_ca_system_score_codex":0.00021069714,"about_ca_system_score_gemma":0.00012574357,"threshold_uncertainty_score":0.0044336915},"labels":[],"label_agreement":null},{"id":"W2979998128","doi":"10.1182/blood.v118.21.1243.1243","title":"The VKORC1 and CYP2C9 Genotypes Significantly Affect Vitamin K Antagonist Dosing Only in Patients Aged 20 Years or Older","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; VKORC1; CYP2C9; Genotyping; Vitamin K epoxide reductase; Genotype; Medicine; Vitamin K antagonist; Internal medicine; Pharmacology; Warfarin; Biology; Genetics; Cytochrome P450","score_opus":0.0583335750379268,"score_gpt":0.3491726163983779,"score_spread":0.2908390413604511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979998128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639493,0.00057231856,0.0001535416,0.0001111264,0.000032648517,0.0000186856,0.001293387,0.000006946022,0.0014163138],"genre_scores_gemma":[0.9982645,0.00019930367,0.0001403834,0.000086319356,0.000029901496,0.000014008349,0.00058000925,0.000004513878,0.00068110874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996723,0.000044608354,0.000037899983,0.00011689836,0.000057541172,0.000070804526],"domain_scores_gemma":[0.99907,0.0001265134,0.00046804364,0.000067758185,0.000089949084,0.00017774473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034671157,0.00026972388,0.00047050384,0.0003393285,0.00049822754,0.00059210806,0.00023462856,0.00043555064,0.00479198],"category_scores_gemma":[0.0014813486,0.00019638626,0.00057428185,0.00065718126,0.0001863421,0.00039615712,0.00022568987,0.0006402059,0.00089682866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038167054,0.0000556779,0.9965707,0.000016814643,0.000049437716,0.00027454752,0.00005459454,0.000016889404,0.00066404714,0.000020981233,0.00024732912,0.0016472521],"study_design_scores_gemma":[0.000017069575,0.00031047818,0.9976743,0.0000095459045,0.00006238862,0.0010405882,0.00005584118,0.000050163046,0.00012684226,0.000033896988,0.0006145393,0.000004274868],"about_ca_topic_score_codex":0.0022126124,"about_ca_topic_score_gemma":0.0024513295,"teacher_disagreement_score":0.00479198,"about_ca_system_score_codex":0.00016067032,"about_ca_system_score_gemma":0.0003247896,"threshold_uncertainty_score":0.016030729},"labels":[],"label_agreement":null},{"id":"W2981379533","doi":"10.1111/bph.14884","title":"Propranolol is a mechanism‐based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6‐transgenic mice: Effects on activity and drug responses","year":2019,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Dextrorphan; Pharmacology; Dextromethorphan; Catalepsy; In vivo; Propranolol; Haloperidol; Chemistry; CYP2D6; Biology; Endocrinology; Cytochrome P450; Biochemistry; Enzyme; Dopamine","score_opus":0.033260877376308194,"score_gpt":0.37794955088181936,"score_spread":0.3446886735055112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981379533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652699,0.001999865,0.02468746,0.00073674845,0.00015813213,0.0004814385,0.0035981117,0.00095020724,0.0021181132],"genre_scores_gemma":[0.9639346,0.0016803548,0.021105472,0.00020319143,0.00007799586,0.00067442487,0.0036118994,0.00029377334,0.008418357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953794,0.00009261278,0.0000623307,0.00012874184,0.00012432781,0.000054173477],"domain_scores_gemma":[0.9996978,0.000048374775,0.00012286774,0.000045113477,0.000019728945,0.000066112785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047386697,0.00080055225,0.00041559973,0.00057351164,0.00028991007,0.00046823165,0.00038233527,0.0006389241,0.0033395328],"category_scores_gemma":[0.00018460388,0.0004853873,0.00053764624,0.00027140602,0.000674355,0.00030894126,0.00017263195,0.0014344164,0.001023272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000603834,0.0001495856,0.00030794708,0.00004252169,0.00001489742,0.00008196216,0.000016390024,0.00008571614,0.99705964,0.000113750764,0.00015458849,0.0013693019],"study_design_scores_gemma":[0.00025561792,0.0011688609,0.0028236723,0.000006381481,0.000050120572,0.00076589204,0.000015439377,0.0011583742,0.9891099,0.000051606337,0.004584888,0.000009207491],"about_ca_topic_score_codex":0.0006609427,"about_ca_topic_score_gemma":0.00080246886,"teacher_disagreement_score":0.0033395328,"about_ca_system_score_codex":0.00050605263,"about_ca_system_score_gemma":0.00029821566,"threshold_uncertainty_score":0.011171818},"labels":[],"label_agreement":null},{"id":"W2982435673","doi":"10.4088/jcp.19m12910","title":"Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Mental Health; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; Agency for Healthcare Research and Quality; National Institutes of Health; Myriad Genetics; Sunovion; H. Lundbeck A/S; Eisai; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; Sage Therapeutics; LivaNova; GlaxoSmithKline; University of Kansas; Canadian Institutes of Health Research; Foundation for Barnes-Jewish Hospital; Stanley Medical Research Institute; Pfizer; Biogen; Allergan; Cancer Research Institute; AstraZeneca; Bristol-Myers Squibb; Ontario Brain Institute; Sanofi","keywords":"Pharmacogenomics; Randomized controlled trial; Drug; Medicine; Pharmacogenetics; Clinical trial; Psychiatry; Intensive care medicine; Pharmacology; Internal medicine; Gene; Genetics; Biology; Genotype","score_opus":0.15111043310386782,"score_gpt":0.5658280732367811,"score_spread":0.41471764013291323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982435673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96999234,0.008372237,0.0027822482,0.0023543267,0.0016636109,0.010068985,0.0011635495,0.0002309084,0.0033718883],"genre_scores_gemma":[0.9853527,0.0012625713,0.0024679068,0.001248257,0.00056240876,0.008106267,0.0003927523,0.000015055576,0.0005919658],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9910063,0.0069077034,0.0005592293,0.00082521455,0.00036606123,0.00033536882],"domain_scores_gemma":[0.9914955,0.0047256057,0.0020238496,0.000608679,0.00037942873,0.0007669939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075860457,0.0014279826,0.0031116903,0.00048529988,0.00058916415,0.0014156537,0.00088497356,0.0023873649,0.0040822364],"category_scores_gemma":[0.014525323,0.0004924604,0.0033386822,0.0005719556,0.0011522834,0.0013529571,0.0006296887,0.0029152785,0.00035773154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98262125,0.0025067544,0.0014911686,0.00055550796,0.0040462716,0.000036405487,0.000024825224,0.00029586317,0.00036476296,0.00013792679,0.00042611305,0.0074930955],"study_design_scores_gemma":[0.940543,0.049715478,0.0033141968,0.00010745823,0.0037145359,0.000029367251,0.00002069806,0.0012719956,0.00026579737,0.00051568344,0.00048256217,0.00001909814],"about_ca_topic_score_codex":0.00047539163,"about_ca_topic_score_gemma":0.00088148937,"teacher_disagreement_score":0.0075860457,"about_ca_system_score_codex":0.0007838013,"about_ca_system_score_gemma":0.0015191756,"threshold_uncertainty_score":0.04011935},"labels":[],"label_agreement":null},{"id":"W2982481126","doi":"10.1038/s41397-019-0117-x","title":"CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of British Columbia; BC Centre for Disease Control; Hospital for Sick Children","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Medicine; Meta-analysis; Internal medicine; Maintenance dose; Pharmacology; Cytochrome P450; Atrial fibrillation","score_opus":0.3003701331734773,"score_gpt":0.4744140693464879,"score_spread":0.17404393617301056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982481126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027507585,0.9963264,0.00019054474,0.00009908144,0.00005867817,0.000053709133,0.00041311342,0.00000972702,0.000098020064],"genre_scores_gemma":[0.06370931,0.9332881,0.0010902348,0.00061885937,0.00014407591,0.00022709943,0.0006139435,0.000014404699,0.00029399307],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99774325,0.0006030112,0.0008163749,0.00040262152,0.00029891144,0.00013586617],"domain_scores_gemma":[0.9953295,0.003196858,0.0009488432,0.00013439298,0.00031649997,0.00007392908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003567755,0.002176231,0.011448046,0.0041734893,0.00042158173,0.0019805008,0.0016196072,0.0017692652,0.004164688],"category_scores_gemma":[0.009889282,0.001036932,0.022894843,0.0068353624,0.0004345267,0.0012554671,0.001201014,0.0014063001,0.00035565216],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016142849,0.000051702627,0.008441301,0.48898163,0.4677983,0.0002605833,0.000110950394,0.00056732754,0.00045142023,0.0001845332,0.0018937023,0.029644327],"study_design_scores_gemma":[0.0004948137,0.00012211374,0.0070706503,0.023056218,0.96580404,0.00018504205,0.00007169685,0.00013542705,0.00010148447,0.00017277087,0.0027511222,0.00003459803],"about_ca_topic_score_codex":0.00841447,"about_ca_topic_score_gemma":0.024934385,"teacher_disagreement_score":0.011448046,"about_ca_system_score_codex":0.0013652523,"about_ca_system_score_gemma":0.0027498037,"threshold_uncertainty_score":0.018868327},"labels":[],"label_agreement":null},{"id":"W2985197001","doi":"10.1016/j.dib.2019.104787","title":"Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans","year":2019,"lang":"en","type":"article","venue":"Data in Brief","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"H2020 Marie Skłodowska-Curie Actions; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Generalitat de Catalunya; Instituto Nacional de Ciberseguridad; Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; Canada Research Chairs","keywords":"Hydroxytyrosol; Tyrosol; Endogeny; Crossover study; Randomized controlled trial; Medicine; Internal medicine; Pharmacology; Placebo; Biology; Food science; Biochemistry; Polyphenol; Pathology","score_opus":0.2463902788206263,"score_gpt":0.4306763440791141,"score_spread":0.18428606525848779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985197001","genre_codex":"review","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2373374,0.6847025,0.0044516507,0.0073587457,0.0018866218,0.00035774367,0.047218893,0.00015365893,0.016532796],"genre_scores_gemma":[0.6605662,0.27984032,0.0037627048,0.010051171,0.0030794414,0.00084776676,0.036074176,0.0001207217,0.0056575374],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977325,0.0009810341,0.00032146004,0.00046722766,0.00041859815,0.00007911296],"domain_scores_gemma":[0.99016446,0.0055259094,0.0023160733,0.0009258186,0.0007000165,0.00036774142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003946616,0.0008265824,0.0015888014,0.0006472647,0.0002812473,0.0008099661,0.00058127637,0.0015053621,0.006621431],"category_scores_gemma":[0.006564971,0.00034190321,0.0014733865,0.0014450978,0.00057744334,0.0005333328,0.00035995242,0.0012404355,0.0011393158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38502142,0.0031039605,0.07016564,0.023500405,0.021148928,0.0007188692,0.0003003641,0.0011158709,0.05003669,0.0023958352,0.046525445,0.39596662],"study_design_scores_gemma":[0.040791634,0.059434917,0.54242134,0.0054193265,0.040986806,0.0058402717,0.00026427876,0.0005312693,0.041125324,0.0048367637,0.25795785,0.00039019703],"about_ca_topic_score_codex":0.0011095745,"about_ca_topic_score_gemma":0.0011722344,"teacher_disagreement_score":0.006621431,"about_ca_system_score_codex":0.00038604296,"about_ca_system_score_gemma":0.0005503283,"threshold_uncertainty_score":0.022150874},"labels":[],"label_agreement":null},{"id":"W2986454255","doi":"10.1016/j.xphs.2019.11.007","title":"Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ministry of Education – Kingdom of Saudi Arabi","keywords":"CYP1A2; CYP3A; Internal medicine; Endocrinology; Cytochrome P450; Lidocaine; Messenger RNA; Drug metabolism; Metabolism; Diet-induced obese; Metabolite; Obesity; Chemistry; Biology; Medicine; Biochemistry; Gene; Anesthesia","score_opus":0.06373226754623942,"score_gpt":0.4070453158476014,"score_spread":0.343313048301362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986454255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628556,0.0010466782,0.0009792767,0.00015553812,0.000060339768,0.000037667767,0.00071807555,0.00009051328,0.00062619965],"genre_scores_gemma":[0.9911412,0.0014907245,0.0017273488,0.00016951033,0.000057418667,0.00014097571,0.0013600593,0.000101353304,0.0038112826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994672,0.00009379762,0.00004523825,0.00011046307,0.00008294435,0.00020031906],"domain_scores_gemma":[0.9988858,0.00012750697,0.0002690887,0.00018909386,0.00008622848,0.0004422873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004807058,0.0011866614,0.0007512823,0.0026954676,0.00056121283,0.000578894,0.00054938387,0.0009668017,0.0023646893],"category_scores_gemma":[0.00046588114,0.0008820053,0.0010314638,0.00096037437,0.0017564445,0.0013106725,0.0005021993,0.0021580912,0.0003930793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05594366,0.0023899488,0.004204638,0.00009581774,0.00013134495,0.00027250338,0.00014685966,0.0002672299,0.92981154,0.00054862903,0.00018522746,0.0060025062],"study_design_scores_gemma":[0.0006722338,0.011458209,0.034230817,0.000020602,0.00029544413,0.00047536677,0.0002615499,0.0011480659,0.94990724,0.0003655637,0.0011048109,0.000060124865],"about_ca_topic_score_codex":0.00218541,"about_ca_topic_score_gemma":0.003617058,"teacher_disagreement_score":0.0026954676,"about_ca_system_score_codex":0.00075418677,"about_ca_system_score_gemma":0.0006088977,"threshold_uncertainty_score":0.007910669},"labels":[],"label_agreement":null},{"id":"W2987429045","doi":"10.1002/cctc.201901974","title":"Indigo Formation and Rapid NADPH Consumption Provide Robust Prediction of Raspberry Ketone Synthesis by Engineered Cytochrome P450 BM3","year":2019,"lang":"en","type":"article","venue":"ChemCatChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"","keywords":"Ketone; Indigo; Chemistry; Total synthesis; Cytochrome P450; Hydroxylation; Stereochemistry; Combinatorial chemistry; Organic chemistry; Enzyme","score_opus":0.07110657581077548,"score_gpt":0.333139336138316,"score_spread":0.2620327603275405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987429045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728099,0.0005863868,0.022912191,0.00010569341,0.000018095501,0.000039815743,0.0020955864,0.0007091134,0.0007232104],"genre_scores_gemma":[0.9876944,0.00024910702,0.009528348,0.000023785682,0.000004833567,0.000027318316,0.002007596,0.000041118048,0.000423492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995902,0.000046743182,0.000018746237,0.00016328468,0.0001334694,0.00004764002],"domain_scores_gemma":[0.9997086,0.0000651075,0.00007156609,0.000032582153,0.000088567394,0.000033500186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040516147,0.0006157802,0.00037721405,0.00042715867,0.00017819279,0.00057691464,0.00022877613,0.00042181968,0.00037275246],"category_scores_gemma":[0.00075298,0.00019448853,0.00041056512,0.0003874726,0.00017016145,0.0002573291,0.0003023654,0.000634367,0.00033318633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034239478,0.00015458808,0.02449348,0.00009868327,0.0000646658,0.00009578283,0.00003641919,0.004998731,0.9565268,0.00012722122,0.0003728468,0.012688311],"study_design_scores_gemma":[0.000017876682,0.0004109124,0.034386296,0.000008846393,0.000051234874,0.00013471149,0.000060160804,0.08485031,0.87837696,0.00019314884,0.0014810105,0.000028536795],"about_ca_topic_score_codex":0.0027319386,"about_ca_topic_score_gemma":0.002389967,"teacher_disagreement_score":0.0027319386,"about_ca_system_score_codex":0.00041711036,"about_ca_system_score_gemma":0.00022611118,"threshold_uncertainty_score":0.0054320097},"labels":[],"label_agreement":null},{"id":"W2989483429","doi":"10.1007/978-3-030-24100-1_4","title":"Design and Implementing Pharmacogenomics Study in Cancer","year":2019,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacogenomics; Personalized medicine; Drug response; Identification (biology); Computational biology; Medicine; Precision medicine; Drug; Bioinformatics; Pharmacology; Biology; Pathology","score_opus":0.4170549558686819,"score_gpt":0.6158268834182113,"score_spread":0.19877192754952944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989483429","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011063319,0.39774314,0.5620396,0.010759852,0.0018561372,0.0020628823,0.0016146635,0.0010627363,0.011797738],"genre_scores_gemma":[0.10576279,0.32257774,0.55107296,0.009261325,0.0022423002,0.002276685,0.0017898772,0.00022577247,0.004790617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645364,0.0021641105,0.00025047132,0.000522579,0.0004759361,0.00013313905],"domain_scores_gemma":[0.9943376,0.0040230895,0.0004902775,0.0003791106,0.0006482268,0.00012160335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011076061,0.0008514601,0.0015721081,0.0013373533,0.0002631096,0.0021512501,0.001408297,0.00129949,0.0028136857],"category_scores_gemma":[0.010785972,0.00040330217,0.0011551881,0.0012562679,0.00094218587,0.0010778552,0.0012970442,0.0016209518,0.0012132452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005725319,0.00020909269,0.009139463,0.0051123835,0.0005689903,0.00034124736,0.00008524215,0.002473168,0.010062978,0.015036515,0.0058704196,0.95052797],"study_design_scores_gemma":[0.0011944267,0.003029562,0.034052894,0.007674718,0.005103939,0.004822879,0.0005073731,0.022521526,0.0661315,0.18467654,0.67003256,0.00025208577],"about_ca_topic_score_codex":0.0010590749,"about_ca_topic_score_gemma":0.0012385012,"teacher_disagreement_score":0.011076061,"about_ca_system_score_codex":0.00062023813,"about_ca_system_score_gemma":0.0039491244,"threshold_uncertainty_score":0.058576524},"labels":[],"label_agreement":null},{"id":"W2990226687","doi":"10.18433/jpps30622","title":"Inhibitory and Stimulatory Effects of Selective Serotonin Reuptake Inhibitors on Cytochrome P450 2D6-mediated Dopamine Formation from p-Tyramine","year":2019,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"CYP2D6; Dopamine; Tyramine; Fluoxetine; Reuptake; Paroxetine; Chemistry; Pharmacology; Serotonin; Reuptake inhibitor; Internal medicine; Endocrinology; Biology; Biochemistry; Cytochrome P450; Metabolism; Medicine; Receptor","score_opus":0.060479866600236576,"score_gpt":0.4121243973624847,"score_spread":0.3516445307622481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990226687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936546,0.006861805,0.00081371836,0.00010954492,0.000048071528,0.000028154156,0.0003496583,0.00003994234,0.002383546],"genre_scores_gemma":[0.993654,0.0031994442,0.0012329487,0.000051374675,0.00002670145,0.000024310251,0.00048374152,0.00000776167,0.0013197003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976224,0.00006949654,0.00002670662,0.000038759972,0.000056410918,0.000046498702],"domain_scores_gemma":[0.99981517,0.00007050683,0.000042734384,0.000016470105,0.000026515207,0.000028591137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024969847,0.00045527768,0.00041467018,0.00015890099,0.00011909522,0.00024407615,0.00017254737,0.0002739159,0.0021342672],"category_scores_gemma":[0.00038844917,0.00016998923,0.0004603875,0.00013439861,0.000173954,0.00014594397,0.0001307688,0.0003972699,0.00038812493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00215639,0.00022758952,0.0017275157,0.00026267162,0.000099740755,0.00012780735,0.000034724162,0.00031371613,0.9848451,0.00009087529,0.00020168275,0.009912269],"study_design_scores_gemma":[0.00021885378,0.0041326,0.030512339,0.000019944822,0.00014704447,0.000594272,0.000047352984,0.0015040474,0.960024,0.00003706937,0.0027471576,0.000015353306],"about_ca_topic_score_codex":0.0009141959,"about_ca_topic_score_gemma":0.0016027709,"teacher_disagreement_score":0.0021342672,"about_ca_system_score_codex":0.00025935302,"about_ca_system_score_gemma":0.00018021383,"threshold_uncertainty_score":0.007139802},"labels":[],"label_agreement":null},{"id":"W2990740129","doi":"10.1200/jco.2019.37.31_suppl.117","title":"Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Opioid; Internal medicine; Cancer; CYP2D6; Pharmacogenetics; McNemar's test; Pain assessment; Oncology; Physical therapy; Pain management; Genotype","score_opus":0.4763321080730114,"score_gpt":0.6492114431055761,"score_spread":0.1728793350325647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990740129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274933,0.0011943254,0.000506883,0.00036617857,0.000038338545,0.002434684,0.00024204588,0.000027876198,0.0024403853],"genre_scores_gemma":[0.99554646,0.00041593832,0.0017156467,0.00034442404,0.000043763765,0.0013858888,0.00013607103,0.000002691117,0.0004090312],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999193,0.0005155865,0.0000436894,0.000099958925,0.000088544846,0.000059187398],"domain_scores_gemma":[0.999005,0.00031611294,0.00027706765,0.00004502395,0.00004943169,0.0003073377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011749895,0.00023364254,0.00040336387,0.00019614767,0.00033838954,0.0004058505,0.00025639505,0.00048855634,0.0038545288],"category_scores_gemma":[0.0020214114,0.00018900604,0.00042275141,0.00024838257,0.00031611364,0.00023481187,0.00037972414,0.000552976,0.000448143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20520984,0.06490993,0.15371199,0.002837199,0.0009247295,0.0007302161,0.0008541135,0.0016846335,0.012937469,0.0005047899,0.004267628,0.5514275],"study_design_scores_gemma":[0.121514924,0.61503243,0.24874859,0.00029389607,0.00076508947,0.0011604404,0.00030539173,0.002430171,0.0026531997,0.00029228692,0.006773177,0.00003037163],"about_ca_topic_score_codex":0.00056916446,"about_ca_topic_score_gemma":0.0011573562,"teacher_disagreement_score":0.0038545288,"about_ca_system_score_codex":0.00043074388,"about_ca_system_score_gemma":0.0008664184,"threshold_uncertainty_score":0.01289475},"labels":[],"label_agreement":null},{"id":"W2991631967","doi":"10.1159/000504253","title":"Estimating the Potential Impact of CYP2C19 and CYP2D6 Genetic Testing on Protocol-Based Care for Depression in Canada and the United States","year":2019,"lang":"en","type":"article","venue":"Complex Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"CYP2C19; CYP2D6; Depression (economics); Genotyping; Pharmacogenetics; Protocol (science); Medicine; Demography; Algorithm; Biology; Genetics; Computer science; Genotype; Sociology","score_opus":0.06224234865140358,"score_gpt":0.4142778458330694,"score_spread":0.3520354971816658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991631967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548154,0.0016153279,0.02024471,0.0060184994,0.00013573948,0.0017210218,0.0075975135,0.00019196923,0.0076598227],"genre_scores_gemma":[0.98327017,0.0003961199,0.012127281,0.0010290651,0.000019028465,0.0004587912,0.0019304643,0.000021941478,0.0007472676],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9715577,0.019928878,0.0009545207,0.0025250239,0.0028118433,0.002221917],"domain_scores_gemma":[0.9332937,0.047598515,0.007391195,0.0032884125,0.0060544475,0.0023738246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02791728,0.00085731153,0.001114366,0.00077542575,0.0013996104,0.0016802562,0.0027830733,0.0012942442,0.0024132805],"category_scores_gemma":[0.11808515,0.0006307834,0.0028260294,0.0019089191,0.0012821076,0.00094699673,0.0018276027,0.0026434073,0.00024077184],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035030188,0.00047232336,0.6884319,0.00031873104,0.0033149167,0.00019364821,0.0006137248,0.2456625,0.00028109842,0.007010786,0.0046044006,0.045593005],"study_design_scores_gemma":[0.002091855,0.001780785,0.37034982,0.00047962173,0.0039816317,0.00022295177,0.0008668646,0.6030168,0.0009816266,0.0075560547,0.008509768,0.00016214974],"about_ca_topic_score_codex":0.8720634,"about_ca_topic_score_gemma":0.81468004,"teacher_disagreement_score":0.1279366,"about_ca_system_score_codex":0.031153098,"about_ca_system_score_gemma":0.042187016,"threshold_uncertainty_score":0.25738007},"labels":[],"label_agreement":null},{"id":"W2992911505","doi":"10.2147/ceor.s224277","title":"&lt;p&gt;Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Assurex Health","keywords":"Formulary; Medicine; Medical prescription; Pharmacogenomics; Pharmacy; Antipsychotic; Psychiatry; Test (biology); Family medicine; Schizophrenia (object-oriented programming); Pharmacology","score_opus":0.112147836875957,"score_gpt":0.483614907670712,"score_spread":0.37146707079475505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992911505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93556446,0.0047089206,0.0032700975,0.0050081112,0.00007438822,0.0005479551,0.028224733,0.00020662587,0.022394666],"genre_scores_gemma":[0.9873569,0.0011830463,0.0038896168,0.0005455352,0.000038273043,0.00008449079,0.0054223244,0.000020598867,0.0014592207],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99772745,0.0003321513,0.00010326659,0.00019906845,0.0013783836,0.00025972805],"domain_scores_gemma":[0.9965848,0.0005227993,0.0012695817,0.000118802156,0.0011406427,0.00036339802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011525452,0.00062685815,0.00028474617,0.0017643733,0.0007592023,0.0012575693,0.0010216049,0.00050599553,0.0032819659],"category_scores_gemma":[0.008258001,0.00032752746,0.0013143296,0.0023480153,0.00037999955,0.00043094062,0.00082302367,0.0006699545,0.00021781196],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010086527,0.00015441683,0.8670365,0.00050984364,0.0013788247,0.00019337554,0.00016836094,0.020581296,0.00035895867,0.0020086304,0.016480604,0.090120494],"study_design_scores_gemma":[0.00021761177,0.00035554668,0.9527123,0.0002504916,0.0008111417,0.0003278637,0.00025279255,0.033703037,0.0007146036,0.0005123032,0.0100757005,0.00006666802],"about_ca_topic_score_codex":0.9486081,"about_ca_topic_score_gemma":0.95123786,"teacher_disagreement_score":0.96499085,"about_ca_system_score_codex":0.035009146,"about_ca_system_score_gemma":0.032410502,"threshold_uncertainty_score":0.25401032},"labels":[],"label_agreement":null},{"id":"W2994882782","doi":"10.1139/cjpp-2019-0586","title":"Mechanisms of NADPH – cytochrome P450 oxidoreductase induction by dexamethasone in the H4IIE rat hepatoma cell line","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pregnane X receptor; Tyrosine aminotransferase; Agonist; Internal medicine; Endocrinology; Cytochrome P450; Glucocorticoid receptor; Glucocorticoid; Pregnenolone; Microsome; Chemistry; Dexamethasone; Biology; Receptor; Nuclear receptor; Enzyme inducer; Steroid; In vitro; Hormone; Biochemistry; Metabolism; Enzyme; Medicine; Transcription factor","score_opus":0.040533069297932024,"score_gpt":0.34742824668852024,"score_spread":0.3068951773905882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994882782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788423,0.006270704,0.0090954825,0.0002509459,0.000057255114,0.00009453016,0.0023023554,0.0002624406,0.0028238925],"genre_scores_gemma":[0.9903998,0.0016298902,0.0027055847,0.00005636339,0.0000127954545,0.000065218635,0.0018036913,0.000022778298,0.003303968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981254,0.00004472,0.000018177469,0.000037168775,0.00004548124,0.000041854673],"domain_scores_gemma":[0.99987566,0.000030344843,0.000023425344,0.00003100679,0.000023417815,0.000016140359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019149666,0.0002989159,0.00034849663,0.00030944005,0.00016470917,0.00032624663,0.0002023647,0.000231367,0.001427173],"category_scores_gemma":[0.000085147505,0.00015047583,0.0004526316,0.0002718709,0.00020774738,0.00018064548,0.00017208961,0.00049392006,0.00082731846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015411488,0.000030020625,0.00030697056,0.000031188865,0.0000051666766,0.000056462708,0.000018149898,0.000037251903,0.99840087,0.00006463907,0.000023562694,0.00087156205],"study_design_scores_gemma":[0.000015151783,0.0003206759,0.005999374,0.000003778345,0.0000107224805,0.00015640425,0.00006199275,0.00024805,0.99159056,0.00003823235,0.0015500317,0.0000050093427],"about_ca_topic_score_codex":0.001218639,"about_ca_topic_score_gemma":0.0012376362,"teacher_disagreement_score":0.001427173,"about_ca_system_score_codex":0.000304424,"about_ca_system_score_gemma":0.00013333379,"threshold_uncertainty_score":0.0047743917},"labels":[],"label_agreement":null},{"id":"W2995735764","doi":"10.1002/ccr3.2604","title":"Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics","year":2019,"lang":"en","type":"article","venue":"Clinical Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Precision medicine; Drug; Drug administration; Medical physics; Affect (linguistics); Intensive care medicine; Pharmacology; Psychology; Pathology","score_opus":0.2861139187664311,"score_gpt":0.5536936800650948,"score_spread":0.2675797612986637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995735764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7571192,0.025728758,0.098055236,0.037343953,0.00234459,0.001488477,0.000849761,0.00078580447,0.07628428],"genre_scores_gemma":[0.95564437,0.0062823296,0.026496384,0.0037539701,0.0014773497,0.00020464369,0.00021700395,0.000094957824,0.0058289785],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987185,0.00041030432,0.00019584187,0.00016127282,0.0002509521,0.0002631122],"domain_scores_gemma":[0.9967327,0.0016667369,0.00065551035,0.00022021489,0.00019542377,0.00052940834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008772313,0.002138375,0.000878378,0.0028000134,0.0027244126,0.002369831,0.0016593925,0.008406913,0.0035506291],"category_scores_gemma":[0.008128795,0.0008921033,0.0013815541,0.0019366689,0.0022249594,0.0021475633,0.0023461462,0.004632424,0.0012124747],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022514489,0.00004570335,0.0026999011,0.00004358907,0.000009329099,0.99110645,0.00030806856,0.00066661614,0.00024980982,0.0009771654,0.0010216837,0.0028492147],"study_design_scores_gemma":[0.000007331444,0.000031348845,0.00071521243,0.000046520523,0.00000782921,0.9945879,0.00026430277,0.0006702039,0.00024833306,0.0009318727,0.0024732999,0.00001583607],"about_ca_topic_score_codex":0.0030255413,"about_ca_topic_score_gemma":0.004141287,"teacher_disagreement_score":0.008406913,"about_ca_system_score_codex":0.0018078645,"about_ca_system_score_gemma":0.0015474808,"threshold_uncertainty_score":0.013117075},"labels":[],"label_agreement":null},{"id":"W2998100580","doi":"10.1002/jcph.1571","title":"Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Gene isoform; Ontogeny; Biology; Glucuronosyltransferase; Internal medicine; Endocrinology; Western blot; Blot; Uridine; Glucuronidation; Microsome; Genetics; Biochemistry; Medicine; Gene; Enzyme; RNA","score_opus":0.1620544192543954,"score_gpt":0.5110713937836602,"score_spread":0.3490169745292648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998100580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956749,0.001957746,0.00084008015,0.000046320707,0.000012682556,0.000005523073,0.000647001,0.000013717587,0.00080207083],"genre_scores_gemma":[0.9931358,0.0018177091,0.0014778463,0.000036775782,0.000015809044,0.000017001828,0.0014469798,0.000015708532,0.0020363135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988747,0.00001214633,0.000013309243,0.000040601833,0.000021212467,0.00002526019],"domain_scores_gemma":[0.99979585,0.000033556767,0.00006883235,0.000023610068,0.000038425314,0.000039773753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017047327,0.000112851056,0.00018054234,0.0004702299,0.00015529967,0.00033306342,0.00008703871,0.00017479467,0.0010026614],"category_scores_gemma":[0.000248878,0.00012687258,0.00021599699,0.00044977095,0.00014017409,0.0002467626,0.00020614632,0.0002038697,0.00034151654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085185736,0.00004382887,0.10876364,0.00006761554,0.000043138585,0.0005079455,0.0002170886,0.00009011602,0.87621444,0.0003130467,0.00014470474,0.012742698],"study_design_scores_gemma":[0.000010591436,0.0003274077,0.872444,0.000013833875,0.000048376372,0.0020211285,0.0002031131,0.00058454636,0.1200228,0.00017684157,0.00413557,0.000011846674],"about_ca_topic_score_codex":0.0014070321,"about_ca_topic_score_gemma":0.0012569287,"teacher_disagreement_score":0.0014070321,"about_ca_system_score_codex":0.00020301773,"about_ca_system_score_gemma":0.00016017334,"threshold_uncertainty_score":0.0033542514},"labels":[],"label_agreement":null},{"id":"W2998350645","doi":"10.1101/2019.12.24.870295","title":"Cross-validation of technologies for genotyping <i>CYP2D6</i> and <i>CYP2C19</i>","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Calgary; University of Alberta","funders":"Medical Research Council; Alberta Innovates; European Commission; National Institute for Health and Care Research; King's College London; University of Alberta; Department of Health and Social Care; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Genotyping; CYP2C19; Pseudogene; TaqMan; Concordance; Haplotype; Genetics; Amplicon; Biology; Pharmacogenomics; Gene; Copy-number variation; Computational biology; CYP2D6; Genotype; Polymerase chain reaction; Genome","score_opus":0.055161334091821605,"score_gpt":0.3590568890323318,"score_spread":0.3038955549405102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998350645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.761677,0.002125743,0.22168945,0.0002508664,0.0004885615,0.0033326491,0.0034826994,0.0009573328,0.005995765],"genre_scores_gemma":[0.80260867,0.00069306995,0.1813053,0.0008044411,0.00015343544,0.0035868236,0.0083414,0.0003172868,0.0021895482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9388366,0.029452352,0.0044718683,0.015419574,0.010140114,0.00167954],"domain_scores_gemma":[0.97059107,0.012768159,0.0034037204,0.006128183,0.006324079,0.00078473025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023652537,0.0014540725,0.0009869152,0.0026512747,0.00096824486,0.0013299576,0.0015562248,0.0023940906,0.0020157536],"category_scores_gemma":[0.02612429,0.001176641,0.0018131213,0.0016086195,0.0016162967,0.0005289612,0.0019885,0.001161551,0.0019495868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051898523,0.0025793463,0.28676644,0.0010093831,0.002640509,0.00032543257,0.0028388589,0.0057609696,0.5951461,0.0017057025,0.002077651,0.09395985],"study_design_scores_gemma":[0.0007455329,0.012307862,0.4030261,0.00033722358,0.002486575,0.0027979664,0.0005071023,0.018869262,0.54067457,0.0010981986,0.016860943,0.00028871428],"about_ca_topic_score_codex":0.0014981576,"about_ca_topic_score_gemma":0.002183669,"teacher_disagreement_score":0.023652537,"about_ca_system_score_codex":0.0006711937,"about_ca_system_score_gemma":0.00061866036,"threshold_uncertainty_score":0.1250881},"labels":[],"label_agreement":null},{"id":"W3000387542","doi":"10.2131/fts.7.9","title":"Usefulness and limitations of mRNA measurement in HepaRG cells for evaluation of cytochrome P450 induction","year":2020,"lang":"en","type":"article","venue":"Fundamental Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"Japan Agency for Medical Research and Development","keywords":"CYP2B6; CYP3A4; CYP1A2; Cytochrome P450; Pharmacology; Phenobarbital; Drug metabolism; Enzyme inducer; Messenger RNA; CYP2A6; Chemistry; Pregnane X receptor; Biology; Metabolism; Drug; Biochemistry; Enzyme; Transcription factor; Nuclear receptor","score_opus":0.6784075094608037,"score_gpt":0.4833525181894373,"score_spread":0.19505499127136644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000387542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54984105,0.032126606,0.39646906,0.0023178163,0.001732843,0.001017674,0.0039006223,0.0011932871,0.011401024],"genre_scores_gemma":[0.6886445,0.018161844,0.2742511,0.0019254613,0.00056610076,0.0026345986,0.006792769,0.00039734523,0.006626318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.991268,0.0030943414,0.0010687513,0.0015320549,0.0026992173,0.0003377075],"domain_scores_gemma":[0.9925035,0.0041964645,0.00081454875,0.00092727755,0.0014499716,0.00010823282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040426636,0.0011179599,0.0009344158,0.00095236866,0.00083369255,0.0012256755,0.0005526796,0.0011886315,0.0012932885],"category_scores_gemma":[0.00506343,0.00048341203,0.0006287328,0.0010828272,0.001527586,0.0007625929,0.00067195884,0.0014568917,0.0011230065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006484121,0.000046201018,0.0013483098,0.00030150128,0.00001215727,0.000068222806,0.00016283723,0.00018200991,0.99155575,0.000185117,0.00012740206,0.005945587],"study_design_scores_gemma":[0.000009460589,0.0004100006,0.006718682,0.00007170583,0.00009268332,0.00041522755,0.00021377885,0.0022926833,0.9811529,0.0004936767,0.008093418,0.000035832254],"about_ca_topic_score_codex":0.0013634936,"about_ca_topic_score_gemma":0.0024728114,"teacher_disagreement_score":0.0040426636,"about_ca_system_score_codex":0.0006057549,"about_ca_system_score_gemma":0.00071403245,"threshold_uncertainty_score":0.021379948},"labels":[],"label_agreement":null},{"id":"W3005677121","doi":"10.1021/acs.biochem.0c00027","title":"Biophysical Techniques for Distinguishing Ligand Binding Modes in Cytochrome P450 Monooxygenases","year":2020,"lang":"en","type":"article","venue":"Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Australian Research Council; Natural Sciences and Engineering Research Council of Canada; University of Queensland; Rhodes Scholarships; Australian Government; Australian Nuclear Science and Technology Organisation","keywords":"Monooxygenase; Cytochrome P450; Ligand (biochemistry); Chemistry; Cytochrome; Biochemistry; Computational biology; Biology; Receptor; Enzyme","score_opus":0.13157680225465865,"score_gpt":0.42940708549799006,"score_spread":0.2978302832433314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005677121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.809322,0.00883779,0.17183942,0.0011251044,0.00032138242,0.00028892918,0.0015540913,0.00068597257,0.0060253693],"genre_scores_gemma":[0.82544094,0.008530592,0.15734237,0.0006037715,0.00014692887,0.0008114382,0.002077546,0.00019046605,0.0048559792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994771,0.00015459812,0.0000469607,0.00011000476,0.00014592246,0.00006542539],"domain_scores_gemma":[0.99936026,0.00027040966,0.0001337081,0.000064421525,0.00011491468,0.000056286804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006351522,0.00051899336,0.00039829584,0.0007021798,0.00040779717,0.00064495765,0.00041187264,0.00076413,0.0011223675],"category_scores_gemma":[0.00095479033,0.00034456694,0.0003827503,0.0007015574,0.00035794577,0.0005115257,0.0004242322,0.0019093562,0.0005614132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020374555,0.00002386017,0.00019834205,0.00004203607,0.0000042522674,0.000015478001,0.00002276673,0.000053683692,0.99810505,0.00009417839,0.000031418596,0.0013886254],"study_design_scores_gemma":[0.000021654596,0.00023450168,0.0081006065,0.000025762893,0.000040269882,0.00032514826,0.00014575475,0.005400518,0.9805486,0.00048696526,0.004647508,0.000022673681],"about_ca_topic_score_codex":0.00037531674,"about_ca_topic_score_gemma":0.00061758637,"teacher_disagreement_score":0.0011223675,"about_ca_system_score_codex":0.00033557398,"about_ca_system_score_gemma":0.00018970639,"threshold_uncertainty_score":0.0037546754},"labels":[],"label_agreement":null},{"id":"W3006091015","doi":"10.1038/s41416-019-0722-0","title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","year":2020,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Context (archaeology); Cancer; Drug; Drug resistance; Pharmacology; Pharmacogenomics; Medicine; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.09272287703452319,"score_gpt":0.4991450429838892,"score_spread":0.406422165949366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006091015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015572806,0.99852824,0.000111183595,0.00023100279,0.000087891334,0.0000024358792,0.000016629345,0.000007853499,0.0008590025],"genre_scores_gemma":[0.0008892071,0.9982668,0.00011129568,0.00011487042,0.00007051509,0.0000041011917,0.000027157741,0.0000012044989,0.00051491533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998536,0.00003253009,0.000018478222,0.000026227955,0.000049511156,0.000019639672],"domain_scores_gemma":[0.99980193,0.00008600913,0.00002976793,0.0000065835866,0.00005292071,0.000022805849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043615996,0.00063406833,0.0010478348,0.0017127449,0.00020651224,0.0009915167,0.00060723413,0.0009818336,0.0045196293],"category_scores_gemma":[0.0005262573,0.00021036956,0.00049776473,0.001980154,0.00038812237,0.0009486864,0.0006593909,0.0014498291,0.0019752532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094779,0.000055384473,0.00022964043,0.013538577,0.00008648536,0.0002488856,0.0000615648,0.00052156526,0.0019486375,0.0049811103,0.019908145,0.95832527],"study_design_scores_gemma":[0.000019629446,0.00010293906,0.0010901261,0.0022859287,0.00011052305,0.0012671313,0.00004644236,0.00013338223,0.00055616786,0.0027322024,0.9916393,0.000016179483],"about_ca_topic_score_codex":0.00102931,"about_ca_topic_score_gemma":0.0019301627,"teacher_disagreement_score":0.0045196293,"about_ca_system_score_codex":0.0006472348,"about_ca_system_score_gemma":0.00094329164,"threshold_uncertainty_score":0.015119731},"labels":[],"label_agreement":null},{"id":"W3006140634","doi":"10.1177/0706743720904820","title":"Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada","year":2020,"lang":"en","type":"review","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Alberta; University of Calgary","funders":"","keywords":"Pharmacogenetics; Test (biology); Medicine; Psychiatry; Genetic testing; Family medicine; Psychology; Genetics; Genotype; Biology; Internal medicine","score_opus":0.10031361901779591,"score_gpt":0.412269174999788,"score_spread":0.3119555559819921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006140634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002589695,0.9933147,0.000117513366,0.003667841,0.00012788574,0.000009521219,0.00008989703,0.0000075491275,0.0024061883],"genre_scores_gemma":[0.0045078536,0.9932439,0.00044816267,0.0010904811,0.00011076968,0.000008255906,0.0000955358,0.0000023821108,0.0004926588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977825,0.00043174034,0.00017752686,0.00016670616,0.001158684,0.0002828615],"domain_scores_gemma":[0.9928712,0.0025663837,0.00071022386,0.000070234484,0.0033102517,0.0004715701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041831634,0.0006851452,0.0012995419,0.004669234,0.0011926135,0.0023846952,0.0012952369,0.0014811504,0.0044533913],"category_scores_gemma":[0.007754572,0.00029352,0.00078278355,0.0075295996,0.0014503463,0.001003445,0.0007888933,0.0019282876,0.0005091606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012530961,0.000040722596,0.0024076889,0.028030071,0.00021109416,0.00050315604,0.00028139757,0.0006406237,0.00037470114,0.0065738084,0.07332554,0.88748586],"study_design_scores_gemma":[0.00010776982,0.000084305204,0.02040991,0.059941113,0.0010407927,0.0021014428,0.0008274922,0.0006030463,0.00045022144,0.00329362,0.9110389,0.00010145368],"about_ca_topic_score_codex":0.8043615,"about_ca_topic_score_gemma":0.9082849,"teacher_disagreement_score":0.19563848,"about_ca_system_score_codex":0.021888953,"about_ca_system_score_gemma":0.076458104,"threshold_uncertainty_score":0.3935812},"labels":[],"label_agreement":null},{"id":"W3006589437","doi":"10.1177/0840470419901285","title":"Pharmacogenetics in primary care","year":2020,"lang":"en","type":"article","venue":"Healthcare Management Forum","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Anxiety; Drug; Anxiolytic; Antidepressant; Drug response; Pharmacology; Psychiatry","score_opus":0.11664058369279952,"score_gpt":0.4256577123194398,"score_spread":0.30901712862664027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006589437","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017708015,0.10502447,0.008429255,0.7575577,0.005207193,0.0001677653,0.0010268807,0.0007832268,0.10409561],"genre_scores_gemma":[0.48288864,0.2008145,0.040731188,0.2169253,0.025558755,0.00046430237,0.0018120275,0.00030095028,0.030504277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962058,0.0023040257,0.00023748373,0.0003042226,0.000710091,0.00023836683],"domain_scores_gemma":[0.98197895,0.01170882,0.0014417568,0.00066136854,0.0017490371,0.002460191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007148141,0.00023324725,0.00046645015,0.0015034527,0.0012695247,0.0022853785,0.00050546404,0.0028459015,0.014843406],"category_scores_gemma":[0.022512484,0.00024687249,0.00037653447,0.0016228883,0.0008614345,0.0017061033,0.0015610133,0.00263022,0.0021979786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010722041,0.00022832867,0.051193576,0.0009270892,0.00006661251,0.0019247594,0.0020481083,0.0003078367,0.00050360116,0.015339027,0.38713685,0.540217],"study_design_scores_gemma":[0.00011989888,0.00033612462,0.0950027,0.008637287,0.00014352235,0.0059047346,0.0030059586,0.001109232,0.0003923172,0.0746613,0.8105883,0.00009869613],"about_ca_topic_score_codex":0.00630642,"about_ca_topic_score_gemma":0.00844286,"teacher_disagreement_score":0.014843406,"about_ca_system_score_codex":0.0014325005,"about_ca_system_score_gemma":0.003350766,"threshold_uncertainty_score":0.049656153},"labels":[],"label_agreement":null},{"id":"W3006908109","doi":"10.1080/14636778.2020.1730165","title":"Clinical usefulness of genetic testing for drug toxicity in cancer care: decision-makers’ framing, knowledge and perceptions","year":2020,"lang":"en","type":"article","venue":"New Genetics and Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Framing (construction); Pharmacogenomics; Genetic testing; Perception; Ethnic group; Medicine; Pharmacogenetics; Drug; Context (archaeology); Risk perception; Psychology; Pharmacology; Political science; Internal medicine; Biology; Genetics","score_opus":0.17496592695984658,"score_gpt":0.47352497549923805,"score_spread":0.29855904853939147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006908109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97117156,0.0008616957,0.0019486175,0.01673389,0.000061332954,0.000060001836,0.000033706616,0.0000060130983,0.009123103],"genre_scores_gemma":[0.99874026,0.00018880342,0.00032421792,0.0006115152,0.000020094712,0.000012287377,0.0000092072005,0.000002009177,0.000091517744],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9196977,0.06688464,0.0025647816,0.001548454,0.006841277,0.0024631368],"domain_scores_gemma":[0.79723495,0.17538758,0.015417101,0.0022591916,0.0055631655,0.0041380394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061561164,0.0003609441,0.00055204675,0.0022115568,0.0033911238,0.008902952,0.0010125494,0.002351627,0.0016163836],"category_scores_gemma":[0.115833804,0.0004344139,0.0005614576,0.0011703494,0.011530361,0.0044047106,0.0047049257,0.003881004,0.0001351642],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032614596,0.00021304406,0.1505365,0.00035375304,0.00013132789,0.0013832416,0.79548275,0.00067921163,0.0009902411,0.010505821,0.0011676307,0.038230352],"study_design_scores_gemma":[0.00007476259,0.00043044903,0.058119595,0.0007514105,0.00010378956,0.0008813518,0.9104524,0.002032228,0.0010306053,0.013857826,0.012110115,0.0001554649],"about_ca_topic_score_codex":0.009632133,"about_ca_topic_score_gemma":0.008017029,"teacher_disagreement_score":0.061561164,"about_ca_system_score_codex":0.006363061,"about_ca_system_score_gemma":0.006837545,"threshold_uncertainty_score":0.32557046},"labels":[],"label_agreement":null},{"id":"W3007489417","doi":"10.1111/bcp.14247","title":"<i>CYP2D6</i> polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Université de Montréal","keywords":"Metoprolol; CYP2D6; Bradycardia; Medicine; Meta-analysis; Internal medicine; Blood pressure; Pharmacogenetics; Heart rate; Adverse effect; Cardiology; Pharmacology; Anesthesia; Genotype; Biology","score_opus":0.37394947863201966,"score_gpt":0.5991300640097504,"score_spread":0.22518058537773078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007489417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003974495,0.9941671,0.00035706873,0.000256884,0.00010554338,0.0002240099,0.00062186684,0.000019517212,0.00027354443],"genre_scores_gemma":[0.1369398,0.857544,0.001960769,0.0009899021,0.00027344844,0.00087885954,0.0010637401,0.000026364389,0.00032310493],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936382,0.002736141,0.0018629391,0.00066663563,0.0008574767,0.00023854057],"domain_scores_gemma":[0.9838284,0.012250253,0.0023193106,0.0003982489,0.001026858,0.00017695251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009073214,0.0020014541,0.013678209,0.005886178,0.0005347683,0.0026792116,0.001724075,0.001977551,0.0035447483],"category_scores_gemma":[0.021731703,0.0010884689,0.028076649,0.008042598,0.00060616696,0.0011165332,0.0011349656,0.0012963976,0.0003250538],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012680466,0.000024425599,0.005215428,0.50780433,0.4714255,0.00017055246,0.00008088875,0.00047164917,0.00031086672,0.00014873107,0.0009826095,0.012096929],"study_design_scores_gemma":[0.00035166,0.00013865468,0.005139602,0.035833288,0.9557713,0.0001369203,0.000035891873,0.00017318882,0.00012130096,0.00014430902,0.0021345732,0.000019290128],"about_ca_topic_score_codex":0.0075347545,"about_ca_topic_score_gemma":0.014981731,"teacher_disagreement_score":0.013678209,"about_ca_system_score_codex":0.0021251857,"about_ca_system_score_gemma":0.0032115972,"threshold_uncertainty_score":0.047984302},"labels":[],"label_agreement":null},{"id":"W3011648141","doi":"10.3138/jmvfh.2019-0027","title":"Pharmacogenomics: A primer for the military mental health provider","year":2020,"lang":"en","type":"article","venue":"Journal of Military Veteran and Family Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canadian Armed Forces","funders":"","keywords":"Pharmacogenomics; Relevance (law); Mental health; Medicine; Data science; Pharmacology; Psychiatry; Computer science; Political science","score_opus":0.16024178068494263,"score_gpt":0.44072059920449397,"score_spread":0.28047881851955137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011648141","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056245876,0.12682965,0.017561859,0.8332434,0.008913933,0.00006169962,0.00009275576,0.00021885413,0.012515451],"genre_scores_gemma":[0.013515766,0.32736453,0.059506163,0.53982675,0.043457076,0.00035492177,0.00017486863,0.00027493417,0.015525054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99493474,0.0028657913,0.0004597329,0.0003039489,0.0011900882,0.0002457569],"domain_scores_gemma":[0.9807819,0.014105066,0.00065453607,0.00050686527,0.0021756326,0.0017760738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014684856,0.0012789328,0.0013138828,0.0031670553,0.002846662,0.006132396,0.0022809946,0.0116263125,0.0072585843],"category_scores_gemma":[0.025291208,0.00091754034,0.001143827,0.002122931,0.0077317436,0.017870896,0.0055200667,0.032142803,0.0044236756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055207194,0.00025717463,0.0015394252,0.0011371505,0.00004062575,0.0022344538,0.003954597,0.00047945618,0.0009554367,0.08997338,0.6238483,0.27552468],"study_design_scores_gemma":[0.000015602125,0.0001015595,0.00079177483,0.0032750168,0.000017191498,0.007318517,0.0029889448,0.00035202393,0.00014153733,0.068364255,0.9165797,0.0000539718],"about_ca_topic_score_codex":0.0044811824,"about_ca_topic_score_gemma":0.008064681,"teacher_disagreement_score":0.014684856,"about_ca_system_score_codex":0.0033862346,"about_ca_system_score_gemma":0.0089457985,"threshold_uncertainty_score":0.07766187},"labels":[],"label_agreement":null},{"id":"W3012205610","doi":"10.1007/s12035-020-01896-4","title":"Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice","year":2020,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tyndale University; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; Campbell Family Mental Health Research Institute; Centre for Addiction and Mental Health","keywords":"In vivo; Pharmacology; Haloperidol; In vitro; Human brain; Propranolol; Genetically modified mouse; Chemistry; Transgene; Biology; Endocrinology; Biochemistry; Neuroscience; Dopamine","score_opus":0.16822596292093672,"score_gpt":0.4152948120940846,"score_spread":0.24706884917314786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012205610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549379,0.0040074973,0.031039303,0.0017072486,0.00034865073,0.000111927315,0.0038515932,0.0007467445,0.0032491423],"genre_scores_gemma":[0.97057647,0.0033721754,0.0124736475,0.0003972825,0.000110878704,0.00014782959,0.0038297612,0.00044334505,0.0086485315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995834,0.00006641574,0.000036188627,0.00014245174,0.000115000315,0.00005650317],"domain_scores_gemma":[0.99956316,0.00007391192,0.00014901672,0.00006280671,0.000048679234,0.00010230698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005215672,0.0007226632,0.000560426,0.0011254498,0.00043085354,0.00074292516,0.0005219011,0.00088979723,0.0031991773],"category_scores_gemma":[0.0003566832,0.00042811068,0.00055516156,0.00046373453,0.0011568977,0.00057733763,0.00026214556,0.0018430478,0.00077256723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595684,0.000087416265,0.00030961682,0.000049633458,0.000032664884,0.00026795306,0.000030675605,0.00006524524,0.9962205,0.0003884615,0.00028487708,0.0017033758],"study_design_scores_gemma":[0.00016855939,0.00053586636,0.004542074,0.000011829333,0.00015748096,0.002963826,0.000078314544,0.0011445385,0.9834704,0.00052676065,0.006383672,0.000016671887],"about_ca_topic_score_codex":0.0010066235,"about_ca_topic_score_gemma":0.0016291855,"teacher_disagreement_score":0.0031991773,"about_ca_system_score_codex":0.00043950367,"about_ca_system_score_gemma":0.0003012708,"threshold_uncertainty_score":0.010702372},"labels":[],"label_agreement":null},{"id":"W3012279685","doi":"10.15252/emmm.201911621","title":"Targeting the pregnane X receptor using microbial metabolite mimicry","year":2020,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Congressionally Directed Medical Research Programs; National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Army; Albert Einstein College of Medicine, Yeshiva University; National Cancer Institute; National Institutes of Health; Crohn's and Colitis Canada; Crohn's and Colitis Foundation of America","keywords":"Czech; Library science; Biology; Computer science; Philosophy","score_opus":0.10456797980695445,"score_gpt":0.4044294633954899,"score_spread":0.2998614835885355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012279685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95001674,0.0079002725,0.03317052,0.00055599224,0.00011596833,0.0001252597,0.00038743526,0.0003703449,0.007357416],"genre_scores_gemma":[0.98513097,0.0028856853,0.0093187,0.00010864844,0.000016887772,0.00003645884,0.00012743022,0.000011665111,0.002363554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999002,0.000022407849,0.0000053785297,0.000021735466,0.000027720658,0.000022429102],"domain_scores_gemma":[0.999964,0.000004731165,0.000015327689,0.0000053765857,0.000003173747,0.000007244874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011902199,0.0002368305,0.00018496066,0.0001258405,0.00008276894,0.00021755252,0.0002102789,0.00030036052,0.000844896],"category_scores_gemma":[0.000086715445,0.000088983295,0.00026179067,0.000076566095,0.0001971758,0.00022215121,0.0002584402,0.00036816084,0.00027811844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000701444,0.000013564733,0.000078667006,0.000051479317,0.000004309751,0.000095606854,0.000009989253,0.00027403884,0.99567515,0.00062256487,0.00005260757,0.0030519213],"study_design_scores_gemma":[0.0000133277,0.00045082642,0.0003242278,0.0000033604024,0.000007728716,0.00036118744,0.000008855846,0.0007752209,0.9942252,0.00012189203,0.0037018356,0.0000063813036],"about_ca_topic_score_codex":0.00017776868,"about_ca_topic_score_gemma":0.00028079317,"teacher_disagreement_score":0.000844896,"about_ca_system_score_codex":0.00018940419,"about_ca_system_score_gemma":0.00013685001,"threshold_uncertainty_score":0.0028264523},"labels":[],"label_agreement":null},{"id":"W3016652892","doi":"10.1016/j.psychres.2020.112984","title":"Impact of CYP2C19 genotype-predicted enzyme activity on hippocampal volume, anxiety, and depression","year":2020,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Health and Medical Research Council; Australian Research Council","keywords":"CYP2C19; Anxiety; Hippocampal formation; Depression (economics); Genotype; Psychology; Clinical psychology; Internal medicine; Psychiatry; Medicine; Endocrinology; Gene; Biology; Genetics","score_opus":0.17228816830969082,"score_gpt":0.49961777235544796,"score_spread":0.32732960404575717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016652892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974778,0.0004967551,0.00018281204,0.00021155908,0.00003925901,0.000004935261,0.00042882553,0.000014287519,0.0011437588],"genre_scores_gemma":[0.99922335,0.000079806,0.00009390396,0.000033011773,0.00002337352,0.0000025459735,0.00016575391,0.0000063987763,0.00037191503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955255,0.0001605553,0.000024298899,0.00012930765,0.000061840045,0.000071381735],"domain_scores_gemma":[0.9987582,0.0005617151,0.00024924497,0.000149139,0.000084763975,0.00019693034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064085244,0.0006751691,0.0005148692,0.0002573117,0.00036000475,0.00075475156,0.00041949493,0.0006000769,0.0032695325],"category_scores_gemma":[0.0024230336,0.00024498004,0.0013361966,0.00042286026,0.00038830054,0.000429024,0.00036037216,0.00097602064,0.00028319863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076063396,0.00024110479,0.9775243,0.000025566715,0.002298864,0.00043450587,0.00008422959,0.00043438203,0.002168914,0.00012891559,0.00052324566,0.008529691],"study_design_scores_gemma":[0.000059162703,0.0005574591,0.99636155,0.00000601541,0.0008112266,0.0003256482,0.00007639499,0.000937688,0.00035712376,0.00019941456,0.0002982192,0.000010038814],"about_ca_topic_score_codex":0.0080448575,"about_ca_topic_score_gemma":0.009461278,"teacher_disagreement_score":0.0080448575,"about_ca_system_score_codex":0.00034062055,"about_ca_system_score_gemma":0.00049213966,"threshold_uncertainty_score":0.015996099},"labels":[],"label_agreement":null},{"id":"W3020879553","doi":"10.3389/fphar.2020.00486","title":"Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions","year":2020,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institutes of Health","keywords":"Enhancer; Genetics; Single-nucleotide polymorphism; Biology; SNP; Locus (genetics); Haplotype; Allele; Tag SNP; Population; Computational biology; Gene; Genotype; Gene expression; Medicine","score_opus":0.11491076875049118,"score_gpt":0.3730680697910477,"score_spread":0.2581573010405565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020879553","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45378765,0.0013630897,0.5286786,0.0003685279,0.00060323795,0.0005377386,0.0049076118,0.0020857926,0.0076676947],"genre_scores_gemma":[0.5783541,0.00031922673,0.409723,0.00044323583,0.000100385376,0.00057968707,0.007735576,0.0006201911,0.0021246455],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99850684,0.0004749064,0.00011357069,0.00053838664,0.00026250706,0.0001038655],"domain_scores_gemma":[0.99685466,0.0017536074,0.00038316025,0.0004730802,0.00039204842,0.00014341238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032771435,0.0007782339,0.0010527791,0.0013587491,0.0009751971,0.0010179301,0.0010810096,0.00093524414,0.0065911897],"category_scores_gemma":[0.0073782336,0.0005033171,0.0015825959,0.0015173597,0.00057189347,0.000614691,0.0010208645,0.0018443721,0.0021099248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054457253,0.00085013744,0.15978271,0.0022933667,0.0012286776,0.0047796364,0.0019984206,0.075765975,0.33337155,0.03866084,0.01387399,0.36194906],"study_design_scores_gemma":[0.001209482,0.0022386508,0.1187911,0.0008843268,0.0018443947,0.0055422415,0.00078695297,0.51744705,0.21134,0.038657725,0.10083177,0.00042636972],"about_ca_topic_score_codex":0.0010975364,"about_ca_topic_score_gemma":0.003241531,"teacher_disagreement_score":0.0065911897,"about_ca_system_score_codex":0.0004205177,"about_ca_system_score_gemma":0.0013727577,"threshold_uncertainty_score":0.022049785},"labels":[],"label_agreement":null},{"id":"W3021250665","doi":"","title":"Comparative toxicoproteogenomics of mouse and rat liver identifies TCDD-resistance genes","year":2019,"lang":"en","type":"article","venue":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Aryl hydrocarbon receptor; Transcriptome; Gene; Biology; Gene isoform; Tetrachlorodibenzo-p-dioxin; Toxicity; Phenotype; Messenger RNA; Downregulation and upregulation; Genetically modified mouse; Gene expression; Internal medicine; Endocrinology; Transgene; Genetics; Molecular biology; Transcription factor; Medicine","score_opus":0.08456387764815469,"score_gpt":0.3882592447484522,"score_spread":0.3036953671002975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021250665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97966504,0.0026366543,0.008125398,0.000118822405,0.000029874842,0.000032357628,0.007640695,0.000169012,0.001582062],"genre_scores_gemma":[0.9610484,0.0037012477,0.010293448,0.00027279355,0.000022235425,0.00015472305,0.017484115,0.000117273354,0.0069057695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999811,0.000013269787,0.000012137782,0.00007168012,0.000049235106,0.00004275328],"domain_scores_gemma":[0.9998429,0.000020501582,0.000057541714,0.000016251637,0.000028575847,0.000034171404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015815593,0.00039154934,0.0002527136,0.0008966287,0.00016115732,0.00029610726,0.00013635178,0.00020536043,0.0013127889],"category_scores_gemma":[0.00012721262,0.00017280637,0.00045030055,0.0005120316,0.00020396846,0.00014137481,0.0002317454,0.00033009233,0.00045869377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015048985,0.000008415941,0.0013360454,0.00004062984,0.000012396813,0.000026691554,0.000010570853,0.000029530464,0.99706787,0.000030792864,0.000023383076,0.0012633239],"study_design_scores_gemma":[0.000023061759,0.00050846266,0.23037362,0.00002438208,0.00012862166,0.0010420391,0.00014594034,0.0007273416,0.76210696,0.00012855923,0.0047724503,0.000018532446],"about_ca_topic_score_codex":0.0007990272,"about_ca_topic_score_gemma":0.0013687564,"teacher_disagreement_score":0.0013127889,"about_ca_system_score_codex":0.00019078261,"about_ca_system_score_gemma":0.00019963697,"threshold_uncertainty_score":0.00439173},"labels":[],"label_agreement":null},{"id":"W3022842031","doi":"10.1016/j.jsbmb.2020.105686","title":"Using Omics to better understand steroid biosynthesis, metabolism, and functions","year":2020,"lang":"en","type":"editorial","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fondation CHU de Québec","keywords":"Biosynthesis; Steroid biosynthesis; Steroid; Computational biology; Biology; Metabolism; Steroid Metabolism; Biochemistry; Bioinformatics; Hormone; Gene","score_opus":0.062186974622596716,"score_gpt":0.39560630952035375,"score_spread":0.33341933489775705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022842031","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003579251,0.008364003,0.00024803614,0.036671456,0.9536591,0.000016281203,0.00007947734,0.000056046465,0.0008696941],"genre_scores_gemma":[0.00033004262,0.008860665,0.00024908126,0.02591467,0.9582511,0.00002173699,0.000057720605,0.000039224884,0.006275691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959805,0.0009053395,0.0005223901,0.00038866338,0.0019661323,0.00023691906],"domain_scores_gemma":[0.9731165,0.013659215,0.0011536547,0.00066561345,0.008425637,0.002979288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00938205,0.0029127614,0.0029236248,0.0032352372,0.001995365,0.007441012,0.0024163912,0.009642231,0.010312032],"category_scores_gemma":[0.02846143,0.0011575166,0.002374704,0.0013615419,0.0026333279,0.0042622965,0.001891762,0.019230936,0.00718582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004908471,0.0000103332095,0.00003528793,0.00025820293,0.000036490295,0.00007363317,0.000011501591,0.000028789578,0.00010933124,0.00044436817,0.991202,0.0077409036],"study_design_scores_gemma":[0.00011765115,0.000044759076,0.00046356267,0.0007244815,0.00011391565,0.00031602912,0.000043544256,0.00026999455,0.00019756146,0.0035556739,0.9941228,0.000030038187],"about_ca_topic_score_codex":0.0020685752,"about_ca_topic_score_gemma":0.006269463,"teacher_disagreement_score":0.010312032,"about_ca_system_score_codex":0.0024442968,"about_ca_system_score_gemma":0.0035165579,"threshold_uncertainty_score":0.049617648},"labels":[],"label_agreement":null},{"id":"W3023714932","doi":"10.1101/2020.05.10.087312","title":"Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Chan Zuckerberg Initiative; National Institutes of Health; National Science Foundation","keywords":"Vitamin K epoxide reductase; Biology; Missense mutation; Transmembrane domain; Genetics; Gene; Mutation","score_opus":0.08666435947309521,"score_gpt":0.36695506831533015,"score_spread":0.28029070884223495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023714932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731726,0.00066032796,0.008883846,0.00006656259,0.000020758205,0.000013524095,0.0021302858,0.00014447041,0.00076307193],"genre_scores_gemma":[0.992357,0.00019628157,0.0051996745,0.000045170604,0.000008164441,0.000012943285,0.0011734808,0.000022695556,0.0009845718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996346,0.000056390807,0.000027110691,0.0001423941,0.000102783335,0.00003654187],"domain_scores_gemma":[0.9997694,0.0000744474,0.00007142187,0.000031108168,0.000027536582,0.000026114483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003532954,0.00024394933,0.00021927996,0.0004196303,0.0001480358,0.00046377117,0.00012941593,0.00036179798,0.0014392274],"category_scores_gemma":[0.0005157465,0.00011035244,0.0001349575,0.00035680478,0.00021815633,0.00012509584,0.00019595101,0.00039423088,0.00042343687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034308125,0.000052725172,0.018115673,0.000033776465,0.000055461613,0.000085764914,0.00006237603,0.00042779275,0.97219807,0.00018635347,0.00021251386,0.008226356],"study_design_scores_gemma":[0.000015890642,0.0002731474,0.1163389,0.000008807716,0.000078104,0.00092974456,0.000076341305,0.0062526,0.87365305,0.00032830087,0.002024753,0.000020279445],"about_ca_topic_score_codex":0.00060471456,"about_ca_topic_score_gemma":0.00064539054,"teacher_disagreement_score":0.0014392274,"about_ca_system_score_codex":0.0001690356,"about_ca_system_score_gemma":0.000073805546,"threshold_uncertainty_score":0.004814625},"labels":[],"label_agreement":null},{"id":"W3023817465","doi":"10.1042/bsr20192513","title":"The role of cytochrome P450 gene rs1126742 polymorphism and risk of hypertension: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bioscience Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Odds ratio; Genetic model; Allele; Confidence interval; Genetics; Publication bias; Heterozygote advantage; Medicine; Subgroup analysis; Internal medicine; Locus (genetics); Polymorphism (computer science); Gene polymorphism; Gene; Bioinformatics; Biology","score_opus":0.18813047877802302,"score_gpt":0.4244418584599765,"score_spread":0.23631137968195348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023817465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043055494,0.9940789,0.00039722404,0.00024132407,0.000108777116,0.00018291858,0.00048005613,0.000018622193,0.00018659944],"genre_scores_gemma":[0.13150467,0.8636235,0.0016141156,0.0007345448,0.00031467288,0.0009471104,0.00094894756,0.000024233517,0.000288195],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99354374,0.002416294,0.0021212876,0.0007691925,0.0008606759,0.00028883023],"domain_scores_gemma":[0.9843083,0.0117770145,0.0022368198,0.00037245554,0.0011099783,0.00019541934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008740751,0.0023290287,0.015602599,0.0069013443,0.000700118,0.0027822726,0.0022327122,0.0020994563,0.0038276932],"category_scores_gemma":[0.02122234,0.0012039175,0.027190011,0.009634693,0.0005941941,0.0014112628,0.0012519057,0.0013724661,0.00026157062],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013703421,0.000029404004,0.010562509,0.5290557,0.44066727,0.00027046746,0.00012258215,0.00052362727,0.00028989208,0.00015487487,0.0010022803,0.015951026],"study_design_scores_gemma":[0.00032855902,0.000131017,0.007325279,0.03325223,0.9564519,0.00018162592,0.00005318112,0.00022003098,0.000102881844,0.00017915179,0.0017507636,0.000023401557],"about_ca_topic_score_codex":0.0061349887,"about_ca_topic_score_gemma":0.012040413,"teacher_disagreement_score":0.015602599,"about_ca_system_score_codex":0.0019730267,"about_ca_system_score_gemma":0.004059619,"threshold_uncertainty_score":0.046226084},"labels":[],"label_agreement":null},{"id":"W3023996685","doi":"10.1177/0706743720925735","title":"Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Psychiatry; Psychology; Medicine; Biology; Genetics; Genotype","score_opus":0.09554306668559955,"score_gpt":0.3633850709704804,"score_spread":0.26784200428488086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023996685","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008514954,0.0011788462,0.00007286039,0.9813804,0.007888391,0.000026999978,0.0001321085,0.000025852214,0.008443024],"genre_scores_gemma":[0.00853752,0.00134197,0.00026214606,0.9522958,0.012751688,0.00003942977,0.00006855531,0.000032930548,0.024669971],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958592,0.00040787988,0.00041998865,0.00045531633,0.0012927447,0.0015648867],"domain_scores_gemma":[0.9807643,0.004059148,0.0008953345,0.00029413844,0.004915243,0.0090716835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024319421,0.0009784399,0.0014484974,0.0014740104,0.014073204,0.005617748,0.0031334383,0.08053647,0.015116026],"category_scores_gemma":[0.017936049,0.0011649177,0.0014894586,0.0015702987,0.0039658286,0.002213739,0.0021285485,0.044995245,0.0038140826],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031751886,0.000028543698,0.001976939,0.00004002408,0.000017987011,0.004416158,0.00021536721,0.00015170283,0.00016152287,0.0019197759,0.9851246,0.005915582],"study_design_scores_gemma":[0.00020750774,0.0000549565,0.007872032,0.00073713955,0.00009740143,0.005018831,0.0020964735,0.0014217269,0.00025978894,0.007620628,0.9744522,0.00016122527],"about_ca_topic_score_codex":0.7841936,"about_ca_topic_score_gemma":0.91791797,"teacher_disagreement_score":0.7841936,"about_ca_system_score_codex":0.036319636,"about_ca_system_score_gemma":0.10491655,"threshold_uncertainty_score":0.4341547},"labels":[],"label_agreement":null},{"id":"W3026543144","doi":"10.1177/0706743720925736","title":"Reply to Dawes et al.","year":2020,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Alberta; University of Calgary","funders":"","keywords":"Materials science","score_opus":0.09014695755120856,"score_gpt":0.3997217685504358,"score_spread":0.30957481099922723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026543144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001497337,0.0008259891,0.000026029,0.98191327,0.015628368,0.000006696547,0.000044913988,0.000018483077,0.0013864954],"genre_scores_gemma":[0.0012952628,0.00043587195,0.000066544504,0.98157436,0.013564275,0.000018573211,0.000018731886,0.000010817945,0.0030155869],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997224,0.00070164155,0.0002982935,0.00040985722,0.00089813414,0.00046812007],"domain_scores_gemma":[0.9924085,0.0031896655,0.0004372731,0.00016745174,0.0018758902,0.0019212312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038517446,0.0009561718,0.0014911211,0.0010513323,0.00492822,0.0039455695,0.0022260097,0.05964122,0.0076900744],"category_scores_gemma":[0.026480978,0.0009290932,0.0010959333,0.0009002575,0.0034335847,0.0041023716,0.0017652956,0.03761637,0.008037642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022572336,0.0000078180765,0.00019698431,0.000019969584,0.000004882583,0.00066308235,0.00006964409,0.000016192418,0.000030596137,0.0005569099,0.9970379,0.0013735901],"study_design_scores_gemma":[0.00012949193,0.000046584213,0.0011856774,0.00032243747,0.000032819687,0.0034537953,0.0008770851,0.0003304313,0.00022615392,0.0067292913,0.9865643,0.000101902515],"about_ca_topic_score_codex":0.019389285,"about_ca_topic_score_gemma":0.028250374,"teacher_disagreement_score":0.05964122,"about_ca_system_score_codex":0.0051409425,"about_ca_system_score_gemma":0.007894087,"threshold_uncertainty_score":0.03855282},"labels":[],"label_agreement":null},{"id":"W3027175230","doi":"10.1016/j.jagp.2020.05.005","title":"Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression","year":2020,"lang":"en","type":"article","venue":"American Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; ACADIA Pharmaceuticals; National Institutes of Health; Janssen Pharmaceuticals; Sage Therapeutics; H. Lundbeck A/S; Sunovion; Stanley Medical Research Institute; Agency for Healthcare Research and Quality; Sanofi; Novartis; Pfizer; Biogen; GlaxoSmithKline; Pharmaceuticals Bayer; Ontario Brain Institute; Forest Laboratories; Bristol-Myers Squibb; Allergan; AstraZeneca; Takeda Pharmaceutical Company; National Institute of Mental Health; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Major depressive disorder; Depression (economics); Randomized controlled trial; Hamilton Rating Scale for Depression; Pharmacogenomics; Rating scale; Psychiatry; Internal medicine; Physical therapy; Mood; Psychology; Pharmacology","score_opus":0.03469591506181165,"score_gpt":0.364599585868742,"score_spread":0.3299036708069304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027175230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996141,0.0020651435,0.000312441,0.00023183861,0.000053035223,0.0002314123,0.0002012371,0.000028552435,0.0007352984],"genre_scores_gemma":[0.998395,0.00048721122,0.0004770137,0.00021399361,0.00003526044,0.00013920276,0.00013819287,0.0000011380071,0.000112998496],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99944776,0.00030197602,0.000056911947,0.00008959587,0.000062049534,0.00004167509],"domain_scores_gemma":[0.9990306,0.00032677664,0.0003664324,0.00006143284,0.000051616073,0.00016316821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009768788,0.00045501217,0.00065871875,0.00023538593,0.00017003738,0.00038584485,0.00024438166,0.00047646023,0.0015960633],"category_scores_gemma":[0.0024752803,0.00015010209,0.00076565816,0.00021608165,0.00018133198,0.00024721283,0.0002661176,0.00048342766,0.00012456413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31842434,0.02846984,0.15132672,0.0022542062,0.008046094,0.00017003335,0.00028700425,0.003400716,0.012537839,0.00031500426,0.0029109817,0.47185734],"study_design_scores_gemma":[0.13592933,0.293642,0.54393935,0.0005570702,0.0077840574,0.00030707984,0.00023427121,0.00939962,0.004218348,0.001166643,0.0027586275,0.00006365325],"about_ca_topic_score_codex":0.00064430735,"about_ca_topic_score_gemma":0.0020352576,"teacher_disagreement_score":0.0015960633,"about_ca_system_score_codex":0.00027616185,"about_ca_system_score_gemma":0.000330915,"threshold_uncertainty_score":0.005339384},"labels":[],"label_agreement":null},{"id":"W3027359205","doi":"10.1093/toxsci/kfaa072","title":"Characterizations of Human UDP-Glucuronosyltransferase Enzymes in the Conjugation of p-Cresol","year":2020,"lang":"en","type":"article","venue":"Toxicological Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Glucuronidation; Glucuronide; Chemistry; Microsome; Enzyme; Biochemistry; Kidney; Metabolism; Pharmacology; Toxicity; Internal medicine; Endocrinology; Biology; Medicine","score_opus":0.3516262852390853,"score_gpt":0.48971780631628664,"score_spread":0.13809152107720135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027359205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867243,0.0044281664,0.006552362,0.00008774675,0.000018707446,0.000059085418,0.0011745201,0.0000680091,0.00088717643],"genre_scores_gemma":[0.9855686,0.0021009813,0.0060298955,0.00007043089,0.000018671035,0.000030398998,0.0042843954,0.000025389845,0.0018712212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998287,0.000047069512,0.000014896356,0.000035622725,0.000039245326,0.000034470537],"domain_scores_gemma":[0.99988174,0.000022879909,0.000026826528,0.00001754143,0.000029058805,0.00002187255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002946291,0.0003438401,0.00023418716,0.00025371116,0.000063001025,0.00021897076,0.00013347651,0.00020523202,0.0004959655],"category_scores_gemma":[0.00044073418,0.00010994795,0.0003495809,0.0003139449,0.000102015685,0.000104709005,0.0000969926,0.00020258575,0.00042731036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037224978,0.00006867827,0.0047161756,0.000088036766,0.000045972694,0.00013724873,0.00005002506,0.00063243246,0.9828362,0.00012898662,0.00010907415,0.010814992],"study_design_scores_gemma":[0.00002300314,0.00061177224,0.04017041,0.00001429412,0.0000810405,0.0009266274,0.00005029429,0.0036854793,0.9486486,0.000085126754,0.005692379,0.000011030934],"about_ca_topic_score_codex":0.0012422535,"about_ca_topic_score_gemma":0.00089533196,"teacher_disagreement_score":0.0012422535,"about_ca_system_score_codex":0.0001672397,"about_ca_system_score_gemma":0.00017548536,"threshold_uncertainty_score":0.002470076},"labels":[],"label_agreement":null},{"id":"W3027368206","doi":"","title":"Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation","year":2010,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Clinical trial; Translational research; Pharmacoepidemiology; Observational study; Family medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.467392606563946,"score_gpt":0.5979599769176936,"score_spread":0.13056737035374766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027368206","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008731407,0.0061425036,0.0014722106,0.97897893,0.012558593,0.000057168163,0.00004994344,0.000038787857,0.0006146016],"genre_scores_gemma":[0.0067395708,0.04474599,0.030084888,0.87128496,0.0445405,0.0006262333,0.00021442755,0.00008006445,0.0016833451],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.81214637,0.12753111,0.021034446,0.007077038,0.027448663,0.0047623627],"domain_scores_gemma":[0.45923677,0.39098665,0.016528852,0.01387551,0.10379084,0.015581348],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25012574,0.0025857978,0.0043352363,0.0053849383,0.0056199674,0.017307863,0.008881528,0.05211649,0.008248789],"category_scores_gemma":[0.3844084,0.0023009474,0.005068465,0.0050898287,0.01449355,0.030112205,0.01086567,0.06266829,0.004303654],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036780938,0.00034167618,0.0009769247,0.007789926,0.00037656652,0.0008044264,0.0031603633,0.0017325737,0.0006345522,0.07722204,0.7552759,0.15131725],"study_design_scores_gemma":[0.00059598254,0.00038966612,0.0018539623,0.016746175,0.0005699969,0.00032211764,0.005054364,0.0025688454,0.0009448194,0.15037934,0.8201896,0.00038519324],"about_ca_topic_score_codex":0.021970032,"about_ca_topic_score_gemma":0.02207889,"teacher_disagreement_score":0.25012574,"about_ca_system_score_codex":0.017348543,"about_ca_system_score_gemma":0.08771245,"threshold_uncertainty_score":0.92472845},"labels":[],"label_agreement":null},{"id":"W3029249331","doi":"10.1007/s12687-020-00468-2","title":"The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities","year":2020,"lang":"en","type":"article","venue":"Journal of Community Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"St. George's, University of London; University of Cambridge","keywords":"Pharmacogenomics; Thematic analysis; Qualitative research; Medicine; Health informatics; Mainstream; Workforce; Health care; Public health; Nursing; Pharmacology; Sociology; Political science; Social science","score_opus":0.5173418183743203,"score_gpt":0.5481457331617672,"score_spread":0.03080391478744693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029249331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885759,0.0010001377,0.0013560043,0.0058542388,0.00008138426,0.0002667709,0.00013402433,0.000019824965,0.0027116812],"genre_scores_gemma":[0.99470454,0.0008891854,0.0008275337,0.0019080437,0.000021770507,0.00026240005,0.00004251339,0.000019010387,0.001324959],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97328466,0.021240579,0.000636533,0.000974366,0.0011699251,0.0026940617],"domain_scores_gemma":[0.95603037,0.032935068,0.0029547373,0.0009203453,0.002343369,0.0048160735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019677343,0.00063793344,0.0010646071,0.0014519541,0.008240313,0.004735508,0.0023772437,0.0033916864,0.0032444259],"category_scores_gemma":[0.030993829,0.0011795632,0.00049713906,0.0018894506,0.012061635,0.0050395266,0.0059964205,0.004103907,0.0004252116],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002980083,0.00003376532,0.0015375951,0.00015816653,0.0000030231508,0.0008336448,0.99475765,0.000024824316,0.00025285187,0.00029689985,0.00025733557,0.0018145655],"study_design_scores_gemma":[0.0000072087187,0.00007990987,0.0009626188,0.00018839604,0.0000027308604,0.00025225303,0.99547297,0.000038533733,0.00006540578,0.00013326235,0.0027859295,0.000010713563],"about_ca_topic_score_codex":0.027002152,"about_ca_topic_score_gemma":0.033368923,"teacher_disagreement_score":0.027002152,"about_ca_system_score_codex":0.009019594,"about_ca_system_score_gemma":0.00829092,"threshold_uncertainty_score":0.10406494},"labels":[],"label_agreement":null},{"id":"W3034011777","doi":"10.18332/tid/122465","title":"Cytochrome P450 2A6 whole-gene deletion (&lt;i&gt;CYP2A6*4&lt;/i&gt; ) polymorphism reduces risk of lung cancer: A meta-analysis","year":2020,"lang":"en","type":"review","venue":"Tobacco Induced Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Internal medicine; Genetics; Gene; Oncology; Meta-analysis; CYP2A6; Polymorphism (computer science); Biology; Medicine; Demography; Genotype; Cytochrome P450","score_opus":0.17680851767499803,"score_gpt":0.44814765591339367,"score_spread":0.2713391382383956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034011777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040342692,0.9548007,0.001770049,0.000490566,0.00032311515,0.0005112197,0.00095719646,0.00009814894,0.0007063308],"genre_scores_gemma":[0.64643645,0.344036,0.00416034,0.001273795,0.00045281462,0.0011338621,0.0013401691,0.000086367305,0.0010801855],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920243,0.004357376,0.0014918407,0.0010693129,0.0007340884,0.0003231117],"domain_scores_gemma":[0.9854822,0.01084416,0.0018254637,0.00059150974,0.000990446,0.00026609385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012555303,0.0027574582,0.014898571,0.0031798813,0.00067890086,0.0032151972,0.0022891522,0.002482585,0.003880086],"category_scores_gemma":[0.026707498,0.0015206345,0.049101412,0.0046742493,0.00069384975,0.0013093088,0.001288828,0.0021451816,0.0004095784],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006664885,0.00006325481,0.007438597,0.06748147,0.9101627,0.00017255764,0.000064604355,0.0009618293,0.00038208376,0.00008025425,0.0004854841,0.006042305],"study_design_scores_gemma":[0.0009669415,0.00023813461,0.0037654678,0.0024025845,0.99160576,0.000059988393,0.000017628887,0.00028432108,0.00011206356,0.00009708111,0.00043676377,0.000013342335],"about_ca_topic_score_codex":0.007952111,"about_ca_topic_score_gemma":0.010344659,"teacher_disagreement_score":0.014898571,"about_ca_system_score_codex":0.0018936762,"about_ca_system_score_gemma":0.0018155844,"threshold_uncertainty_score":0.066399574},"labels":[],"label_agreement":null},{"id":"W3034513236","doi":"10.1101/2020.06.09.142851","title":"Combining small-molecule bioconjugation and hydrogen-deuterium exchange mass spectrometry (HDX-MS) to expose allostery: the case of human cytochrome P450 3A4","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; Centre in Green Chemistry and Catalysis","keywords":"Allosteric regulation; Chemistry; Hydrogen–deuterium exchange; CYP3A4; Bioconjugation; Small molecule; Biophysics; Allosteric enzyme; Cytochrome P450; Mass spectrometry; Combinatorial chemistry; Enzyme; Biochemistry; Chromatography","score_opus":0.06919058215805077,"score_gpt":0.3384470058391087,"score_spread":0.26925642368105795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034513236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87636024,0.0029813352,0.11470794,0.000614806,0.00017885452,0.0001358685,0.00024437235,0.00036756287,0.0044089607],"genre_scores_gemma":[0.9249987,0.0017900408,0.069024995,0.00028465694,0.000048151032,0.000084762345,0.00018764271,0.00008938723,0.003491637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997472,0.00006997994,0.000011020298,0.0000740974,0.0000666587,0.000031128602],"domain_scores_gemma":[0.999861,0.000056188182,0.000027961822,0.000025913141,0.000017059903,0.00001182263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006816221,0.0004538024,0.00027612498,0.00027437802,0.00020425006,0.00037809036,0.00024271879,0.00052473665,0.0005929187],"category_scores_gemma":[0.0003312584,0.00022426622,0.00024260634,0.00020903032,0.00051193644,0.0003324163,0.0004738067,0.0006501284,0.00025652783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007178476,0.000016802675,0.0002820502,0.00003999064,0.000015754138,0.00008471317,0.000022524338,0.00017697345,0.9947214,0.00028198407,0.00007048337,0.0042155054],"study_design_scores_gemma":[0.0000068817967,0.00007247159,0.00051099906,0.0000014022801,0.000008898253,0.00013028213,0.000007869969,0.0008564167,0.9966395,0.00009517874,0.0016647661,0.0000054051447],"about_ca_topic_score_codex":0.0003972398,"about_ca_topic_score_gemma":0.00051063474,"teacher_disagreement_score":0.0006816221,"about_ca_system_score_codex":0.0002465373,"about_ca_system_score_gemma":0.000159781,"threshold_uncertainty_score":0.0036048293},"labels":[],"label_agreement":null},{"id":"W3035156032","doi":"10.1016/j.jamda.2020.04.009","title":"Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia","year":2020,"lang":"en","type":"article","venue":"Journal of the American Medical Directors Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baycrest Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Pharmacogenetics; Depression (economics); Cohort; Medical prescription; Drug; Pharmacotherapy; Dementia; Polypharmacy; CYP2D6; CYP2C19; Prior authorization; Emergency medicine; Internal medicine; Psychiatry; Pharmacology","score_opus":0.05600816021249493,"score_gpt":0.44209309481351167,"score_spread":0.3860849346010167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035156032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97579896,0.0017331336,0.00008749806,0.0059765745,0.00009174757,0.0002731788,0.0014889886,0.000033491815,0.014516374],"genre_scores_gemma":[0.99360895,0.0012087012,0.0007235193,0.0009954844,0.000055967674,0.00011384569,0.0007505798,0.0000062641943,0.0025367015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895453,0.0002096037,0.000115153416,0.00005567234,0.00040557436,0.00025946563],"domain_scores_gemma":[0.9966582,0.00030788037,0.0006115812,0.00005488605,0.0009833633,0.0013839569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736697,0.00012191251,0.00022880928,0.0004807193,0.0019988213,0.0010737445,0.00056934194,0.00039874093,0.0030492393],"category_scores_gemma":[0.00571037,0.00018969337,0.00033857898,0.0010281673,0.00030597427,0.00027810203,0.0009507816,0.00056928734,0.0001472807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000993222,0.0013916428,0.8493289,0.00014328505,0.00008523927,0.00032309504,0.0016743536,0.0003958579,0.00044380472,0.00030751276,0.018252963,0.12666018],"study_design_scores_gemma":[0.00009705369,0.0001593674,0.9951212,0.000056040237,0.000035865203,0.000043405802,0.00057231245,0.000264269,0.000049094906,0.000033461307,0.00355954,0.000008494639],"about_ca_topic_score_codex":0.86311966,"about_ca_topic_score_gemma":0.96948797,"teacher_disagreement_score":0.13688034,"about_ca_system_score_codex":0.021659672,"about_ca_system_score_gemma":0.042019,"threshold_uncertainty_score":0.27537286},"labels":[],"label_agreement":null},{"id":"W3038374010","doi":"10.1007/978-3-030-21573-6_234-1","title":"Nuclear Receptor Regulation of Hepatic Cytochrome P450 Enzymes","year":2020,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytochrome P450; Chemistry; Enzyme; Biochemistry; Pharmacology; Biology","score_opus":0.10095984559260092,"score_gpt":0.37567926554553777,"score_spread":0.27471941995293686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038374010","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018791666,0.4020927,0.020994654,0.003308995,0.0016874505,0.000042237167,0.0007298962,0.00049041247,0.551862],"genre_scores_gemma":[0.06951691,0.19390562,0.0064213644,0.0010349324,0.00092206144,0.000051741237,0.00073525985,0.000114023744,0.72729814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999254,0.000014251861,0.0000024631197,0.000014467297,0.000035148038,0.000008212575],"domain_scores_gemma":[0.9999627,0.000019105522,0.0000034726613,0.000004222862,0.000007230494,0.00000320067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108360866,0.00028090537,0.00019487203,0.00032300508,0.00013471629,0.00060577044,0.0004228455,0.00029753576,0.011476471],"category_scores_gemma":[0.000091401125,0.00014603946,0.00019168938,0.000378698,0.00027301014,0.00037351833,0.00024248309,0.00056754093,0.005231779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022581777,0.00013910187,0.00037654178,0.00094847026,0.0000308786,0.00078056735,0.00040263668,0.0017336381,0.21253857,0.09968706,0.081392966,0.6017437],"study_design_scores_gemma":[0.000014757338,0.00012769921,0.0019711,0.00017061141,0.00001806816,0.0013979173,0.00009991426,0.00055543904,0.030340131,0.01719936,0.9480846,0.00002053942],"about_ca_topic_score_codex":0.0009752835,"about_ca_topic_score_gemma":0.0020501162,"teacher_disagreement_score":0.011476471,"about_ca_system_score_codex":0.00046607215,"about_ca_system_score_gemma":0.00019406524,"threshold_uncertainty_score":0.038392603},"labels":[],"label_agreement":null},{"id":"W3044746939","doi":"10.1038/s41370-020-0252-0","title":"A feasibility study of metabolic phenotyping of dried blood spot specimens in rural Chinese women exposed to household air pollution","year":2020,"lang":"en","type":"article","venue":"Journal of Exposure Science & Environmental Epidemiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council","keywords":"Dried blood spot; Dried blood; Pollution; Stove; Environmental science; Exposure assessment; Reproducibility; Air pollution; Medicine; Chromatography; Environmental chemistry; Physiology; Chemistry; Environmental health; Biology; Waste management","score_opus":0.1342770712506827,"score_gpt":0.4054807593360517,"score_spread":0.271203688085369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044746939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99951303,0.00001422684,0.00015472255,0.00001447731,0.0000017285289,0.00004087364,0.000038045055,0.0000012354463,0.00022167528],"genre_scores_gemma":[0.9994061,0.000023544233,0.00024148898,0.000028120585,0.0000066719917,0.000033640725,0.000059274822,0.0000012130882,0.00020008725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995602,0.00017415654,0.000026420892,0.00010650057,0.00006361168,0.000069081965],"domain_scores_gemma":[0.9994363,0.00016673392,0.000089636735,0.000054118398,0.00011743913,0.00013570556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070340006,0.00047472172,0.0002175905,0.00074494915,0.00088795467,0.00039823834,0.0003639773,0.00040223516,0.0010693657],"category_scores_gemma":[0.0019071591,0.00039457786,0.0002416741,0.00057167164,0.0004898023,0.00038423695,0.00043736753,0.0002914951,0.00024310095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000595617,0.0004118762,0.9879395,0.000016329479,0.00001827678,0.0008014066,0.001093304,0.00003664597,0.0069684014,0.000040389765,0.000035156052,0.0020431094],"study_design_scores_gemma":[0.000046526962,0.0020817444,0.9933149,0.0000026501098,0.00003871867,0.00084799394,0.0022210346,0.00035800532,0.0008355507,0.00004834146,0.0001966405,0.000007861458],"about_ca_topic_score_codex":0.015022246,"about_ca_topic_score_gemma":0.0103231575,"teacher_disagreement_score":0.015022246,"about_ca_system_score_codex":0.0003301112,"about_ca_system_score_gemma":0.00080627756,"threshold_uncertainty_score":0.029869616},"labels":[],"label_agreement":null},{"id":"W3046490424","doi":"10.1038/s41525-020-0135-2","title":"A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping","year":2020,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"National Research Foundation; GlaxoSmithKline","keywords":"Genotyping; Focus (optics); Allele; CYP2D6; Star (game theory); Algorithm; Biology; Genetics; Computational biology; Bioinformatics; Computer science; Genotype; Mathematics; Gene; Physics","score_opus":0.18967526254272118,"score_gpt":0.44300636623285133,"score_spread":0.2533311036901301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046490424","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87884456,0.0072891675,0.10045797,0.00083931646,0.0002585877,0.00046395615,0.0031339151,0.005677772,0.0030347223],"genre_scores_gemma":[0.7998347,0.0017879227,0.18450342,0.00048289518,0.00005604685,0.00039587717,0.010709321,0.0016830253,0.00054674206],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9884792,0.0071224705,0.00090165867,0.0015992253,0.0016458804,0.00025151586],"domain_scores_gemma":[0.96877265,0.022567516,0.0009843477,0.003019217,0.0043463376,0.00030999977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020151984,0.00092752057,0.0013710506,0.0018700921,0.00064478593,0.0013440357,0.0014427127,0.001057088,0.00094953727],"category_scores_gemma":[0.037626572,0.00047476287,0.0016498679,0.001823814,0.0005387879,0.0012090079,0.0014135662,0.001042313,0.00044584292],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007983075,0.0010195519,0.18526934,0.0031800454,0.006003886,0.00032060262,0.0012132335,0.27491418,0.024280643,0.005430366,0.016613621,0.47377145],"study_design_scores_gemma":[0.0011663006,0.003032402,0.092263795,0.0007061561,0.0016782279,0.0007124524,0.000551538,0.85187924,0.022048453,0.0071507213,0.018552572,0.00025814687],"about_ca_topic_score_codex":0.0033404294,"about_ca_topic_score_gemma":0.0036479533,"teacher_disagreement_score":0.020151984,"about_ca_system_score_codex":0.00067571725,"about_ca_system_score_gemma":0.0015477916,"threshold_uncertainty_score":0.10657519},"labels":[],"label_agreement":null},{"id":"W3047024975","doi":"10.1007/s12035-020-02050-w","title":"Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice","year":2020,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Tyndale University; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Harmine; Neurotoxicity; Pharmacology; Hypothermia; In vivo; Human brain; Chemistry; Genetically modified mouse; Biology; Toxicity; Transgene; Medicine; Biochemistry; Internal medicine; Neuroscience","score_opus":0.18703280579641907,"score_gpt":0.42570089714479065,"score_spread":0.23866809134837158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047024975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985584,0.0024388211,0.008173166,0.00081337587,0.000130914,0.00004644659,0.0010796998,0.00028206108,0.0014516533],"genre_scores_gemma":[0.9908835,0.0021009545,0.0023868815,0.00018175926,0.000049264745,0.00004305681,0.00096418953,0.000084444604,0.0033059714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982566,0.000034226065,0.000014045438,0.00005343775,0.000042636966,0.000029983408],"domain_scores_gemma":[0.99977666,0.000023580473,0.000085672546,0.000034196655,0.000024992814,0.000054798853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026810606,0.0005618725,0.00040554788,0.00067907554,0.00027419627,0.00044925872,0.00033494338,0.00062385335,0.0022885425],"category_scores_gemma":[0.00022318918,0.00024348393,0.000400233,0.00030767327,0.00069507083,0.00036986015,0.00016411315,0.0011027477,0.00035982134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011356825,0.00013042643,0.00047953503,0.000057412013,0.00004606573,0.00023694013,0.000024633138,0.000082412895,0.9953341,0.0002909129,0.00021443596,0.0019675912],"study_design_scores_gemma":[0.00019198794,0.0014319753,0.0074127195,0.000013556389,0.00019892964,0.0020092486,0.00007402677,0.0009302858,0.98314905,0.0005167332,0.0040572803,0.000014351798],"about_ca_topic_score_codex":0.0007391875,"about_ca_topic_score_gemma":0.0010049931,"teacher_disagreement_score":0.0022885425,"about_ca_system_score_codex":0.00028779503,"about_ca_system_score_gemma":0.00022017391,"threshold_uncertainty_score":0.007655978},"labels":[],"label_agreement":null},{"id":"W3047868292","doi":"10.1016/j.pharma.2020.07.005","title":"Recommandations relatives à la réalisation de tests de pharmacogénétique dans les monographies de médicaments au Canada, en France et aux États-Unis","year":2020,"lang":"fr","type":"article","venue":"Annales Pharmaceutiques Françaises","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Humanities; Art; Political science; Physics","score_opus":0.10284766326334145,"score_gpt":0.4308828317683743,"score_spread":0.32803516850503284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047868292","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05396277,0.056505073,0.01650097,0.71428156,0.01721916,0.0014861138,0.01715812,0.001517688,0.12136863],"genre_scores_gemma":[0.44909433,0.053846758,0.09641486,0.2639557,0.010555638,0.0030386774,0.022475773,0.0006853318,0.09993294],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.95310146,0.012670074,0.007869325,0.0026355993,0.01997247,0.003751068],"domain_scores_gemma":[0.60265434,0.17240196,0.015514998,0.01326226,0.18499546,0.0111709675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055391856,0.00062065886,0.001060163,0.0070812753,0.0045853476,0.008812355,0.0038213746,0.0073920307,0.0057165627],"category_scores_gemma":[0.1962874,0.0006825152,0.0016210806,0.0056700422,0.0061823786,0.0028575556,0.002028692,0.0060339314,0.0014727679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086896797,0.00045386236,0.15772772,0.004228077,0.00041819975,0.0025483214,0.009534609,0.0015498786,0.005024663,0.04330651,0.51971436,0.2546248],"study_design_scores_gemma":[0.00015802571,0.00023072827,0.0852468,0.0061521316,0.0004413294,0.0011932885,0.0031765555,0.0011290773,0.004346261,0.005223577,0.892528,0.00017423544],"about_ca_topic_score_codex":0.6937871,"about_ca_topic_score_gemma":0.668386,"teacher_disagreement_score":0.3062129,"about_ca_system_score_codex":0.01821344,"about_ca_system_score_gemma":0.077108264,"threshold_uncertainty_score":0.6160325},"labels":[],"label_agreement":null},{"id":"W3048303536","doi":"10.3390/jpm10030084","title":"Optimising Seniors’ Metabolism of Medications and Avoiding Adverse Drug Events Using Data on How Metabolism by Their P450 Enzymes Varies with Ancestry and Drug–Drug and Drug–Drug–Gene Interactions","year":2020,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Pharmacogenetics; Medical prescription; DrugBank; Drug; Drug metabolism; CYP2D6; Pharmacology; Intensive care medicine; Cytochrome P450; Bioinformatics; Biology; Internal medicine; Metabolism; Genetics","score_opus":0.1412766602688,"score_gpt":0.41645006034328985,"score_spread":0.27517340007448987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048303536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27901882,0.14816836,0.071652815,0.23392065,0.004347551,0.0017189323,0.023721447,0.0073366626,0.23011479],"genre_scores_gemma":[0.5999977,0.12406122,0.1686144,0.040395394,0.0045452653,0.0010903346,0.012896379,0.0010329813,0.04736635],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965617,0.0013650894,0.0006400688,0.00027298223,0.0009092702,0.00025080278],"domain_scores_gemma":[0.99075645,0.0034944285,0.0018578931,0.00057433796,0.0018472811,0.0014695406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049846275,0.00049664744,0.0010047499,0.0018211233,0.00069865107,0.0021247217,0.0006413898,0.0011156874,0.015340214],"category_scores_gemma":[0.030115457,0.00030903495,0.0014515808,0.0014923633,0.0003160579,0.0024601687,0.0013571196,0.00149487,0.009554651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044547586,0.00038275617,0.050216135,0.001947031,0.00026511075,0.00043340557,0.0009005428,0.00064229843,0.0010910007,0.0009361189,0.13082886,0.8119113],"study_design_scores_gemma":[0.0007294838,0.0028940763,0.2539169,0.009976388,0.0014783654,0.0047426447,0.003628054,0.0029111374,0.005396261,0.01831273,0.69566464,0.0003492616],"about_ca_topic_score_codex":0.0034360408,"about_ca_topic_score_gemma":0.0071507473,"teacher_disagreement_score":0.015340214,"about_ca_system_score_codex":0.0007320947,"about_ca_system_score_gemma":0.0019406519,"threshold_uncertainty_score":0.05131811},"labels":[],"label_agreement":null},{"id":"W30536383","doi":"10.1111/jgs.15690","title":"Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol","year":2001,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Haloperidol; Tardive dyskinesia; Cytochrome P450; In vivo; Chemistry; Pharmacology; In vitro; Metabolism; Cytochrome; Drug metabolism; Dyskinesia; Parkinsonism; Biochemistry; Enzyme; Medicine; Schizophrenia (object-oriented programming); Internal medicine; Dopamine; Biology; Parkinson's disease; Psychiatry","score_opus":0.05478259441977181,"score_gpt":0.3854067295891205,"score_spread":0.3306241351693487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30536383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95906883,0.024603752,0.0024050232,0.0018791886,0.00012895565,0.00009432672,0.0007592677,0.00012934512,0.010931193],"genre_scores_gemma":[0.99395543,0.0033831075,0.00044740914,0.00019072958,0.000056569086,0.00001621076,0.00024404458,0.000006058241,0.0017004521],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977905,0.00011972053,0.000012476722,0.000017415387,0.00004977684,0.000021532222],"domain_scores_gemma":[0.9996271,0.0000796855,0.00015649693,0.000024700888,0.000052875694,0.00005915605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003173003,0.0002967256,0.00020393598,0.00031165642,0.00011969898,0.00028047958,0.00014929032,0.00026916666,0.0021585885],"category_scores_gemma":[0.00089304394,0.00010163963,0.00027817572,0.00014574816,0.0001469816,0.00012861959,0.00015523913,0.0003534777,0.0003453653],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014818608,0.0011694406,0.25086364,0.0010563504,0.0012500787,0.008336612,0.00032672973,0.0017696075,0.26540476,0.0021083965,0.009592366,0.44330344],"study_design_scores_gemma":[0.00068061036,0.005316671,0.8908386,0.0001055286,0.00042780905,0.015219325,0.00012540977,0.002478726,0.06838873,0.0014082898,0.014979585,0.000030648574],"about_ca_topic_score_codex":0.0021408522,"about_ca_topic_score_gemma":0.0029938647,"teacher_disagreement_score":0.0021585885,"about_ca_system_score_codex":0.00042935048,"about_ca_system_score_gemma":0.00028460965,"threshold_uncertainty_score":0.0072211623},"labels":[],"label_agreement":null},{"id":"W3080763434","doi":"10.1097/fpc.0000000000000418","title":"Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"","keywords":"Pharmacogenetics; Identification (biology); Drug; Genetics; Biology; Computational biology; Gene; Pharmacology; Genotype; Ecology","score_opus":0.08342893702688821,"score_gpt":0.3768694939897619,"score_spread":0.2934405569628737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080763434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95765775,0.0061489283,0.0034338222,0.0047515486,0.00012645204,0.00042210295,0.009428078,0.00014076346,0.01789056],"genre_scores_gemma":[0.9888165,0.0016502008,0.003906435,0.00136069,0.000024244606,0.00004559106,0.0020681184,0.000020505959,0.0021076198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781126,0.00026051071,0.00009185746,0.00027395552,0.00092252076,0.0006399498],"domain_scores_gemma":[0.9974577,0.00034546477,0.00043335225,0.00007364743,0.0010802159,0.000609606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016354807,0.0004214234,0.00039717145,0.0019839203,0.0021041008,0.0015691223,0.0013529608,0.00043416215,0.0023820365],"category_scores_gemma":[0.0031202768,0.00028381599,0.0005365282,0.004678817,0.0009884617,0.00025279025,0.0011119589,0.0006595854,0.00018795936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020788275,0.0000660903,0.95472956,0.0001459454,0.00012384985,0.00089050113,0.00071236934,0.00082377496,0.0011426097,0.0011749483,0.008050503,0.031932004],"study_design_scores_gemma":[0.000044489894,0.000046158868,0.98788226,0.00013834481,0.00013014201,0.00051604037,0.0015998349,0.0017887107,0.0004136822,0.00030961315,0.0071068048,0.000023911944],"about_ca_topic_score_codex":0.99106276,"about_ca_topic_score_gemma":0.99568045,"teacher_disagreement_score":0.029426077,"about_ca_system_score_codex":0.029426077,"about_ca_system_score_gemma":0.06462652,"threshold_uncertainty_score":0.21350211},"labels":[],"label_agreement":null},{"id":"W3082189057","doi":"10.1039/d0cp03083j","title":"Regio- and stereoselectivity in the CYP450<sub>BM3</sub>-catalyzed hydroxylation of complex terpenoids: a QM/MM study","year":2020,"lang":"en","type":"article","venue":"Physical Chemistry Chemical Physics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Natural Science Foundation of China; National Key Research and Development Program of China; European Regional Development Fund; Engineering and Physical Sciences Research Council; Invest Northern Ireland","keywords":"Hydroxylation; Stereoselectivity; QM/MM; Terpenoid; Catalysis; Chemistry; Stereochemistry; Computational chemistry; Organic chemistry; Enzyme","score_opus":0.11547063031908167,"score_gpt":0.3894519867686844,"score_spread":0.27398135644960275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082189057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786622,0.00050171546,0.014957024,0.00031051075,0.000022847848,0.000038296675,0.0003538442,0.00015718566,0.004996343],"genre_scores_gemma":[0.99523586,0.00040513187,0.0035778037,0.00008278427,0.000007683075,0.00004231906,0.00022070248,0.000048138205,0.00037951855],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999181,0.00002136665,0.0000029907912,0.000013119584,0.000019867703,0.000024558925],"domain_scores_gemma":[0.9998005,0.000097246506,0.000023338249,0.000020890284,0.000037809026,0.000020238389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103856,0.00052553724,0.0005659884,0.000120211655,0.00038108442,0.000263222,0.0006358529,0.00043805953,0.0024164647],"category_scores_gemma":[0.00049101905,0.0002725293,0.00046248696,0.00025199397,0.00034988244,0.00044085082,0.00029903103,0.0007834227,0.00029312988],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006104566,0.00034650916,0.006759808,0.00062418217,0.00016070802,0.00080387277,0.0003376766,0.8114262,0.14522743,0.017078241,0.001954096,0.014670793],"study_design_scores_gemma":[0.00014197099,0.00021988289,0.0020082572,0.000013910657,0.000033954184,0.000051189603,0.000062389874,0.97143227,0.023147663,0.001939613,0.00092497113,0.000023969398],"about_ca_topic_score_codex":0.0050893095,"about_ca_topic_score_gemma":0.0027243192,"teacher_disagreement_score":0.0050893095,"about_ca_system_score_codex":0.000725908,"about_ca_system_score_gemma":0.000643271,"threshold_uncertainty_score":0.010119379},"labels":[],"label_agreement":null},{"id":"W3082311577","doi":"10.7554/elife.58026","title":"Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact","year":2020,"lang":"en","type":"article","venue":"eLife","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Chan Zuckerberg Initiative; National Institutes of Health; National Science Foundation","keywords":"Vitamin K epoxide reductase; Biology; Transmembrane domain; Missense mutation; Genetics; Gene; Mutation","score_opus":0.1530283749634961,"score_gpt":0.437107931851903,"score_spread":0.2840795568884069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082311577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984435,0.00095962,0.011186371,0.0000809635,0.000018884857,0.000015660355,0.002142456,0.00014277782,0.0010183344],"genre_scores_gemma":[0.9880344,0.00043346535,0.008748954,0.000072650626,0.0000082439465,0.00001997612,0.0012916713,0.000025784839,0.0013647894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952066,0.000055564775,0.000030965766,0.00020518551,0.00013705672,0.000050608087],"domain_scores_gemma":[0.9997446,0.000075055985,0.00009361754,0.000029812785,0.000031937358,0.00002487208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034367462,0.00025225815,0.00023576147,0.00045887224,0.0001594968,0.0004609296,0.00015924318,0.00042497372,0.0010318639],"category_scores_gemma":[0.0006085122,0.0001226727,0.00014010609,0.00040272856,0.00023647244,0.00014681956,0.00022142525,0.0003900078,0.00032571054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003725047,0.000052443233,0.027418837,0.000044743083,0.000081384074,0.0001102929,0.00007467974,0.00044259045,0.9553107,0.00025257567,0.00022034957,0.015618913],"study_design_scores_gemma":[0.000019844578,0.00035745322,0.16782789,0.000013974447,0.000116835225,0.0012585324,0.00010576888,0.0052247266,0.8214141,0.0004779001,0.0031593808,0.000023614006],"about_ca_topic_score_codex":0.000682511,"about_ca_topic_score_gemma":0.0014088221,"teacher_disagreement_score":0.0010318639,"about_ca_system_score_codex":0.0002075852,"about_ca_system_score_gemma":0.00009117219,"threshold_uncertainty_score":0.0034519434},"labels":[],"label_agreement":null},{"id":"W3082792050","doi":"10.1016/j.steroids.2020.108716","title":"Synthesis of human long-term metabolites of dehydrochloromethyltestosterone and oxymesterone","year":2020,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hydroxymethyl; Metabolite; Stereochemistry; Stereocenter; Chemistry; Dehydroepiandrosterone; Testosterone (patch); Biochemistry; Biology; Enantioselective synthesis; Androgen; Endocrinology","score_opus":0.11301060817911615,"score_gpt":0.40944562030420906,"score_spread":0.29643501212509293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082792050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071465,0.02898127,0.042345855,0.00042602656,0.000370777,0.00069337455,0.006705695,0.00030576784,0.013024668],"genre_scores_gemma":[0.9489837,0.00923161,0.01860577,0.00018113093,0.00010655818,0.00020852934,0.0045287614,0.000048260994,0.01810574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998615,0.000041275365,0.000012626726,0.000022373159,0.000027282807,0.000034981607],"domain_scores_gemma":[0.9998623,0.000018120909,0.000021472739,0.000026862692,0.00003475724,0.00003640284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021692697,0.0003335531,0.00020345161,0.00022533016,0.00015965871,0.00017204057,0.0002588604,0.0002578618,0.0038503895],"category_scores_gemma":[0.00021208102,0.000117714284,0.00027008026,0.0002630361,0.000114779716,0.00014217025,0.00022307452,0.00027067753,0.0014905552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013320807,0.00014782601,0.0015491863,0.00034372922,0.00006223039,0.0010550633,0.00015641347,0.0004962145,0.948174,0.0006057445,0.0006181809,0.045459326],"study_design_scores_gemma":[0.00010214099,0.0023747303,0.0035024837,0.000022692597,0.00010271409,0.0015148711,0.000089225934,0.00017803888,0.9433167,0.00015584359,0.04862076,0.000019881883],"about_ca_topic_score_codex":0.0005326409,"about_ca_topic_score_gemma":0.0013889797,"teacher_disagreement_score":0.0038503895,"about_ca_system_score_codex":0.00017600752,"about_ca_system_score_gemma":0.00052177405,"threshold_uncertainty_score":0.012880862},"labels":[],"label_agreement":null},{"id":"W3083556913","doi":"10.3390/pharmaceutics12090846","title":"Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice","year":2020,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polypharmacy; Mechanism (biology); Drug; Pharmacology; Drug interaction; Mechanism of action; Medicine; Chemistry; Biochemistry","score_opus":0.38174770870448604,"score_gpt":0.548695033973512,"score_spread":0.166947325269026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083556913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006551485,0.9836949,0.0050757257,0.0040295594,0.0004341196,0.000078461315,0.00009026924,0.000064633095,0.005877179],"genre_scores_gemma":[0.008546203,0.9805423,0.005531434,0.0021476427,0.00096157263,0.0000798598,0.00015757476,0.000014158094,0.0020193309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998382,0.0005118185,0.0002687917,0.00019820438,0.0005444602,0.00009481406],"domain_scores_gemma":[0.9980685,0.0011679484,0.00028315774,0.00005823791,0.0003455252,0.00007668571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002331505,0.0011702798,0.0014049568,0.0027194328,0.00034326958,0.002205667,0.0014172683,0.0019807648,0.0048215375],"category_scores_gemma":[0.0040874775,0.00047485248,0.0013701537,0.0021365546,0.0009960595,0.0033166506,0.001119918,0.002728533,0.0020908972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012642542,0.00012827263,0.0019183649,0.028641872,0.000313915,0.0012245068,0.00040087092,0.0014123514,0.0032507093,0.024366362,0.043343544,0.89487284],"study_design_scores_gemma":[0.000042481428,0.00030749038,0.0036992356,0.0084780995,0.00040043198,0.0071111093,0.00024464892,0.0017191195,0.0019333448,0.024292108,0.95169747,0.00007453946],"about_ca_topic_score_codex":0.0014624059,"about_ca_topic_score_gemma":0.002244658,"teacher_disagreement_score":0.0048215375,"about_ca_system_score_codex":0.0014109558,"about_ca_system_score_gemma":0.0018717401,"threshold_uncertainty_score":0.016129673},"labels":[],"label_agreement":null},{"id":"W3085550079","doi":"10.3389/fphar.2020.575540","title":"Pharmacogenetics in Psychiatry: An Update on Clinical Usability","year":2020,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Medicine; Psychiatry; Medical prescription; Genetic testing; Personalized medicine; Genotyping; Pharmacology; Bioinformatics; Genotype; Genetics; Internal medicine; Biology","score_opus":0.2331278570605818,"score_gpt":0.552387905742148,"score_spread":0.3192600486815662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085550079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053543645,0.9971878,0.00019080499,0.0011363348,0.00041861006,0.000005469833,0.000038221606,0.000011266017,0.00095799286],"genre_scores_gemma":[0.00042493915,0.99749655,0.000316269,0.0007315012,0.000484456,0.000007938575,0.000052285784,0.0000035855198,0.00048246328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992865,0.00020705297,0.00013781854,0.00009276184,0.00023090963,0.000044999455],"domain_scores_gemma":[0.9967001,0.0022945872,0.00020360736,0.000077837,0.0005945959,0.00012922361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022667947,0.00080200145,0.0017886389,0.00277139,0.00026680683,0.0017513944,0.0010220308,0.0015222048,0.008497439],"category_scores_gemma":[0.0036025296,0.0003388418,0.0010726067,0.002490893,0.000668898,0.00223385,0.0011941377,0.0026388012,0.0033482092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052384807,0.000034932564,0.00015804199,0.016044442,0.00009830989,0.00015100592,0.000057609657,0.00014520893,0.0004905262,0.003480665,0.038227927,0.94105905],"study_design_scores_gemma":[0.000019044384,0.00006906493,0.00065524207,0.009811553,0.00016605385,0.0008774314,0.00005478476,0.00008400446,0.0001442262,0.0025389986,0.98555803,0.00002153846],"about_ca_topic_score_codex":0.0013845579,"about_ca_topic_score_gemma":0.002886438,"teacher_disagreement_score":0.008497439,"about_ca_system_score_codex":0.00092271983,"about_ca_system_score_gemma":0.0021655776,"threshold_uncertainty_score":0.028426766},"labels":[],"label_agreement":null},{"id":"W3087273430","doi":"10.1016/j.bja.2020.08.046","title":"Perioperative genetic screening: entering a new era","year":2020,"lang":"en","type":"letter","venue":"British Journal of Anaesthesia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Butyrylcholinesterase; Pharmacogenetics; Phenotype; Malignant hyperthermia; Genetics; Genotype; Medicine; Gene; Biology; Anesthesia; Biochemistry; Enzyme","score_opus":0.09446561631948286,"score_gpt":0.37074805763773844,"score_spread":0.2762824413182556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087273430","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089594355,0.0073625776,0.00041589755,0.9792628,0.0078621,0.0000064243627,0.000024825082,0.00002650266,0.0041429093],"genre_scores_gemma":[0.020812375,0.020494321,0.0016622277,0.8239034,0.1256655,0.000030155854,0.000062097,0.000045515706,0.0073243976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963946,0.0012776478,0.00039649179,0.00043126292,0.0010458912,0.00045423294],"domain_scores_gemma":[0.98332256,0.009640834,0.00085833634,0.0004073607,0.0019406728,0.0038301935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036907818,0.0006523979,0.0011582971,0.0010580225,0.0020095129,0.0034064697,0.0011541558,0.03127227,0.0069691893],"category_scores_gemma":[0.016631285,0.00038000464,0.00086578913,0.00065964856,0.00326585,0.005254423,0.0018443958,0.02315478,0.002351797],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021972138,0.00012838095,0.0048119472,0.00036356066,0.000039843148,0.0239227,0.0005419895,0.00024542076,0.001637591,0.013518781,0.8608486,0.09372158],"study_design_scores_gemma":[0.00014046204,0.0002447056,0.0055547804,0.0014159718,0.000055165212,0.041451767,0.0013439293,0.0008944056,0.000336648,0.038036812,0.91040945,0.00011608277],"about_ca_topic_score_codex":0.0027209907,"about_ca_topic_score_gemma":0.005304377,"teacher_disagreement_score":0.03127227,"about_ca_system_score_codex":0.002629142,"about_ca_system_score_gemma":0.0036670468,"threshold_uncertainty_score":0.023314238},"labels":[],"label_agreement":null},{"id":"W308793356","doi":"10.1096/fasebj.25.1_supplement.1014.7","title":"Meclizine is not an inverse agonist or antagonist of human constitutive androstane receptor","year":2011,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Constitutive androstane receptor; Inverse agonist; Agonist; Antagonist; Pharmacology; Receptor; Pregnane X receptor; Reporter gene; Partial agonist; Chemistry; CYP2B6; Endocrinology; Biology; CYP3A4; Gene expression; Nuclear receptor; Gene; Cytochrome P450; Biochemistry; Transcription factor","score_opus":0.23964407813101987,"score_gpt":0.4324865322181458,"score_spread":0.19284245408712594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W308793356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828774,0.009453716,0.0030837303,0.0003092983,0.00007233306,0.00007656371,0.0005724931,0.00009771797,0.0034567874],"genre_scores_gemma":[0.98951554,0.0031101122,0.0028157004,0.00015449917,0.0000237101,0.00006698199,0.0008164296,0.000009233643,0.0034878193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980193,0.000043778313,0.000024312749,0.000033585624,0.000066357636,0.000029979554],"domain_scores_gemma":[0.9999162,0.000025946792,0.00001980862,0.000011799268,0.000013388989,0.000012942558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111954694,0.00013207662,0.00033880497,0.00009321719,0.00009684417,0.00019552158,0.00017071774,0.0002302583,0.00095355994],"category_scores_gemma":[0.00018202854,0.00012066092,0.00015319238,0.000113171554,0.00014861667,0.00014741925,0.00008758189,0.00043371337,0.00025484237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004185241,0.000049160713,0.00058665243,0.00015490799,0.000027064332,0.00009707891,0.00002317705,0.000083074345,0.9918094,0.00012251135,0.00022349528,0.0064049643],"study_design_scores_gemma":[0.00012939636,0.001560955,0.0098028295,0.000015134163,0.000082002225,0.0011010029,0.00003616633,0.00089657336,0.96922284,0.00003570893,0.017105147,0.000012250679],"about_ca_topic_score_codex":0.00088809937,"about_ca_topic_score_gemma":0.00335374,"teacher_disagreement_score":0.00095355994,"about_ca_system_score_codex":0.00023165859,"about_ca_system_score_gemma":0.00024890056,"threshold_uncertainty_score":0.003189981},"labels":[],"label_agreement":null},{"id":"W3090949181","doi":"10.1146/annurev-pharmtox-030920-025745","title":"Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings","year":2020,"lang":"en","type":"review","venue":"The Annual Review of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institutes of Health","keywords":"Pharmacogenetics; Medicine; Genetic testing; Drug; Drug response; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics; Internal medicine; Gene","score_opus":0.4003053614121597,"score_gpt":0.5433675497631206,"score_spread":0.1430621883509609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090949181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005334079,0.9396938,0.0052031092,0.04764871,0.0014340115,0.00005613661,0.000048397953,0.000067996276,0.0053144014],"genre_scores_gemma":[0.006108166,0.9677081,0.011216091,0.012219741,0.0016276479,0.00010093729,0.00009449304,0.000024489056,0.00090040395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862076,0.008047947,0.001316992,0.0007889279,0.003080764,0.0005577423],"domain_scores_gemma":[0.94957185,0.038700424,0.0023373868,0.0012122769,0.0068479413,0.0013300785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03096296,0.0007081682,0.0015781283,0.0018371048,0.00067292876,0.004249473,0.002479586,0.0042987224,0.0037512095],"category_scores_gemma":[0.03813602,0.0004991881,0.0012658535,0.0020872224,0.0026848682,0.006229039,0.0032635708,0.007932821,0.0022219117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045746496,0.00008470758,0.00073907286,0.013962342,0.0001002647,0.00031394156,0.0005043157,0.0006905006,0.0005206612,0.022604795,0.025517855,0.93491584],"study_design_scores_gemma":[0.00003709102,0.00015143826,0.0013654254,0.026672818,0.00014392713,0.0015519253,0.0008600443,0.00044266137,0.0004882318,0.027378079,0.9408435,0.00006484236],"about_ca_topic_score_codex":0.0038033158,"about_ca_topic_score_gemma":0.005515273,"teacher_disagreement_score":0.03096296,"about_ca_system_score_codex":0.0022823482,"about_ca_system_score_gemma":0.014959265,"threshold_uncertainty_score":0.16374975},"labels":[],"label_agreement":null},{"id":"W3093182225","doi":"10.1101/2020.10.15.340976","title":"Sequential Measurements of Catalytic Activities of Multi-Drug-Resistance Transporters and Cytochrome P450 Enzymes by Cytometry of Reaction Rate Constant","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Cytochrome P450; Enzyme; Transporter; Microsome; Population; Chemistry; Enzyme assay; ATP-binding cassette transporter; Flow cytometry; Biology; Pharmacology; Biochemistry; Molecular biology; Gene; Medicine","score_opus":0.08672230766472082,"score_gpt":0.33976813025774166,"score_spread":0.25304582259302083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093182225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71752155,0.0042992346,0.27299723,0.00028857932,0.00021396873,0.0003552468,0.00083754415,0.00070475636,0.0027819828],"genre_scores_gemma":[0.90184724,0.0014827843,0.09326209,0.00017324324,0.000060033122,0.0004243784,0.00048239398,0.00005980222,0.0022080902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986105,0.0002731717,0.000113219976,0.00042567018,0.0004288329,0.0001486294],"domain_scores_gemma":[0.99723214,0.0011804575,0.0005135952,0.00034807695,0.0006225506,0.00010315559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014398325,0.0005854158,0.0005339674,0.0008736715,0.00019290521,0.000687979,0.00055191625,0.0009749101,0.0014237846],"category_scores_gemma":[0.0022624733,0.0002590372,0.00038395848,0.00066961464,0.00037332537,0.0009918578,0.00039889832,0.001400831,0.000499297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001497972,0.00006159414,0.0016919451,0.00007786036,0.000014167325,0.000019199364,0.000049950762,0.00037205315,0.9909315,0.0002784723,0.000059367234,0.0062941224],"study_design_scores_gemma":[0.0000118889075,0.0003118904,0.0036823922,0.0000075059957,0.00002552059,0.000060586233,0.000039935298,0.0054881354,0.9894098,0.0002137932,0.0007297707,0.000018750561],"about_ca_topic_score_codex":0.0004938363,"about_ca_topic_score_gemma":0.00047628317,"teacher_disagreement_score":0.0014398325,"about_ca_system_score_codex":0.00058801775,"about_ca_system_score_gemma":0.00037276666,"threshold_uncertainty_score":0.007614672},"labels":[],"label_agreement":null},{"id":"W3094652411","doi":"10.1055/a-1288-1061","title":"Review and Consensus on Pharmacogenomic Testing in Psychiatry","year":2020,"lang":"en","type":"review","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hotchkiss Brain Institute; Centre for Addiction and Mental Health; Alberta Children's Hospital; Women and Children’s Health Research Institute; University of Alberta; McGill University; University of Calgary","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; Alberta Innovates; National Human Genome Research Institute; National Alliance for Research on Schizophrenia and Depression; Bundesministerium für Bildung und Forschung; National Institutes of Health; University of Alberta","keywords":"Oxcarbazepine; Pharmacogenomics; Genetic testing; Medicine; Psychiatry; Psychology; Carbamazepine; Pharmacology; Epilepsy","score_opus":0.262532474387727,"score_gpt":0.5104466244649591,"score_spread":0.24791415007723216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094652411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007682204,0.99108607,0.00030252148,0.0064351424,0.0009953644,0.00002023878,0.00009759624,0.000008220117,0.0009780142],"genre_scores_gemma":[0.0014199171,0.9922699,0.000516349,0.0047161225,0.00075372873,0.00004489895,0.00011456397,0.0000066728944,0.0001578244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98797697,0.005059439,0.003384876,0.0010487577,0.0021953846,0.00033459274],"domain_scores_gemma":[0.9367851,0.048740543,0.0049399384,0.0011303874,0.007702832,0.0007012104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01631892,0.0010373628,0.0034809837,0.008294234,0.0006869864,0.0037179994,0.0037308058,0.004917088,0.0069854376],"category_scores_gemma":[0.052857265,0.0007932698,0.003762837,0.0075204223,0.0017276042,0.0037859287,0.0028001321,0.0038141173,0.0016428971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015718753,0.00003411793,0.0004690044,0.3187323,0.0016925503,0.00047733902,0.00046603428,0.00053884916,0.00035994075,0.010362172,0.09891134,0.56779915],"study_design_scores_gemma":[0.00006342838,0.000059309634,0.0013272109,0.47029895,0.002207036,0.00086411583,0.00027557916,0.00009688891,0.00017854704,0.005516559,0.5190722,0.00004014415],"about_ca_topic_score_codex":0.004069268,"about_ca_topic_score_gemma":0.0059975064,"teacher_disagreement_score":0.01631892,"about_ca_system_score_codex":0.0035278427,"about_ca_system_score_gemma":0.011903306,"threshold_uncertainty_score":0.08630371},"labels":[],"label_agreement":null},{"id":"W3095013792","doi":"10.1093/nar/gkaa990","title":"PK-DB: pharmacokinetics database for individualized and stratified computational modeling","year":2020,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Bundesministerium für Bildung und Forschung","keywords":"Pharmacokinetics; Physiologically based pharmacokinetic modelling; Database; Population; Computer science; Dosing; Bioinformatics; Pharmacology; Biology; Medicine","score_opus":0.40409109245586616,"score_gpt":0.5281909593777224,"score_spread":0.12409986692185626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095013792","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003955336,0.0047299773,0.3688203,0.0024570096,0.00066634803,0.0008698375,0.44692448,0.15638246,0.015194236],"genre_scores_gemma":[0.061827265,0.0068088844,0.26621613,0.003440031,0.0004625837,0.004436674,0.6161531,0.03347594,0.0071794004],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975266,0.0006812804,0.0005916253,0.00048919325,0.00056107034,0.00015034316],"domain_scores_gemma":[0.99248016,0.003802033,0.0006443143,0.0015890677,0.0010125149,0.00047190386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005696309,0.0017506317,0.00274921,0.0027354925,0.000584512,0.0061343634,0.004323448,0.0018806717,0.044992507],"category_scores_gemma":[0.019726643,0.0014229151,0.0027347566,0.0030031963,0.00048017845,0.002863717,0.0037148355,0.0027112619,0.024973113],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031649543,0.00034275305,0.007419471,0.008624568,0.0021191884,0.0008103959,0.00045416446,0.040935557,0.005106677,0.07031194,0.7047235,0.15598689],"study_design_scores_gemma":[0.0010975305,0.00013653263,0.0021821538,0.00068839506,0.0005175455,0.0005311336,0.00009056121,0.05361733,0.0050379196,0.0684986,0.86743075,0.00017149447],"about_ca_topic_score_codex":0.003637668,"about_ca_topic_score_gemma":0.0030891895,"teacher_disagreement_score":0.044992507,"about_ca_system_score_codex":0.0010889724,"about_ca_system_score_gemma":0.0051061925,"threshold_uncertainty_score":0.1505149},"labels":[],"label_agreement":null},{"id":"W3095729508","doi":"10.22541/au.159741407.76559359","title":"The Role of Sex, Age and Genetic Polymorphisms of CYP Enzymes on the Pharmacokinetics of Anticholinergic Drugs","year":2020,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"CYP2D6; Anticholinergic; Pharmacokinetics; CYP2C19; Medicine; Pharmacology; Drug; Adverse effect; Population; Drug metabolism; Pharmacogenetics; Glucuronidation; Clinical pharmacology; Internal medicine; Cytochrome P450; Biology; Genotype; Metabolism; Genetics","score_opus":0.06837416206811561,"score_gpt":0.3773067141047014,"score_spread":0.30893255203658576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095729508","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036984373,0.95553726,0.0011659345,0.0011774527,0.00036462361,0.000022668111,0.00045986116,0.00002072966,0.004267063],"genre_scores_gemma":[0.14715461,0.84594893,0.001166811,0.00093209493,0.0007922908,0.00004745053,0.0005319745,0.000016088237,0.0034096988],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994998,0.00016391612,0.00008806777,0.00008840359,0.00011159606,0.00004816635],"domain_scores_gemma":[0.99891067,0.00064810907,0.0002532154,0.000028661218,0.00012552405,0.000033854816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006305156,0.0002961959,0.0007502056,0.0004505773,0.00018257053,0.0006422514,0.0002733886,0.00044699784,0.0024526604],"category_scores_gemma":[0.0018197232,0.0001327249,0.0008690357,0.000708177,0.000242255,0.0004976312,0.00027353226,0.00041071366,0.0003595179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017445342,0.00016993383,0.10012778,0.01634129,0.002008839,0.0031675345,0.00060695794,0.0010052517,0.006383861,0.0028855065,0.010707351,0.85485125],"study_design_scores_gemma":[0.00013473527,0.0017225157,0.51095146,0.006066656,0.0043296916,0.022722382,0.00068117003,0.0009910432,0.0058193873,0.004926222,0.44151267,0.0001421573],"about_ca_topic_score_codex":0.0012379887,"about_ca_topic_score_gemma":0.0015146716,"teacher_disagreement_score":0.0024526604,"about_ca_system_score_codex":0.00023225395,"about_ca_system_score_gemma":0.00044957074,"threshold_uncertainty_score":0.008204997},"labels":[],"label_agreement":null},{"id":"W3096012551","doi":"10.1007/s00394-020-02421-y","title":"The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies","year":2020,"lang":"en","type":"review","venue":"European Journal of Nutrition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP1A2; Medicine; Cochrane Library; Pharmacology; Drug metabolism; Drug; CYP3A4; Obesity; CYP2D6; Cytochrome P450; Pharmacokinetics; Physiology; Internal medicine; Metabolism; Meta-analysis","score_opus":0.26901509399730383,"score_gpt":0.513582368053952,"score_spread":0.24456727405664813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096012551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039207755,0.99933124,0.00003593165,0.000048176687,0.000021819353,0.000010568812,0.00010750047,0.0000019985562,0.000050743318],"genre_scores_gemma":[0.0039678686,0.99550986,0.00018601265,0.00016026395,0.00003191063,0.000014926189,0.00008800654,0.0000013583108,0.00003980814],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99889565,0.00026486817,0.00039918415,0.00018847028,0.00020624355,0.000045644225],"domain_scores_gemma":[0.99511635,0.003745291,0.00079893705,0.00005606167,0.00022713358,0.00005612319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002257523,0.0011079066,0.0060513183,0.0033503503,0.00023798128,0.0014406575,0.0010465906,0.0011456334,0.0038186326],"category_scores_gemma":[0.0068757012,0.0005411875,0.005623222,0.0047862553,0.00039177056,0.00095753523,0.0008478772,0.00091059954,0.0002507121],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080226565,0.000050083203,0.002538724,0.78769416,0.032085616,0.0001460214,0.00010449849,0.0002879378,0.0005046001,0.00029049764,0.0030141035,0.17248149],"study_design_scores_gemma":[0.00092524884,0.0008252007,0.034740742,0.46491778,0.39775968,0.0011611852,0.00041017574,0.00033570747,0.0006068813,0.0012519113,0.09691744,0.00014811028],"about_ca_topic_score_codex":0.00439778,"about_ca_topic_score_gemma":0.014691011,"teacher_disagreement_score":0.0060513183,"about_ca_system_score_codex":0.0006824606,"about_ca_system_score_gemma":0.0020416558,"threshold_uncertainty_score":0.012774587},"labels":[],"label_agreement":null},{"id":"W3096669115","doi":"10.3390/biom10111517","title":"Functional Expression of All Human Sulfotransferases in Fission Yeast, Assay Development, and Structural Models for Isoforms SULT4A1 and SULT6B1","year":2020,"lang":"en","type":"article","venue":"Biomolecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Freie Universität Berlin; World Anti-Doping Agency","keywords":"Yeast; Sulfotransferase; Sulfation; Biochemistry; Enzyme; Chemistry; Cytosol; Gene isoform; Docking (animal); Cofactor; Saccharomyces cerevisiae; Gene","score_opus":0.1867030101747613,"score_gpt":0.4094199454727093,"score_spread":0.22271693529794803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096669115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785135,0.00096280425,0.016952224,0.00014618036,0.00001929212,0.000075722324,0.0022404192,0.00018808617,0.00090175436],"genre_scores_gemma":[0.9604765,0.0016773713,0.026796011,0.000020227557,0.000006739121,0.00008027698,0.008043332,0.000112885034,0.0027865858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983156,0.00003055467,0.000025153393,0.000032847536,0.00006372126,0.000016042506],"domain_scores_gemma":[0.9999025,0.000014267771,0.000028765126,0.000018923587,0.00001906417,0.000016479462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025632663,0.0006243938,0.0002535037,0.0002351829,0.00020790033,0.00034294018,0.0003305086,0.00027107887,0.0005821835],"category_scores_gemma":[0.00020843944,0.00021073231,0.00034907067,0.00039072416,0.00021121166,0.00018711857,0.0002652986,0.0004937238,0.00043587713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001448777,0.000030023952,0.0003685805,0.00005153841,0.000011452711,0.00007386395,0.000048747024,0.0012621301,0.99531806,0.00063131546,0.000083749364,0.0019756635],"study_design_scores_gemma":[0.000011977339,0.0001507366,0.00066670106,0.0000041531052,0.00001910319,0.00015698899,0.000031407355,0.0030143498,0.9899333,0.00009413894,0.0059112483,0.0000059042613],"about_ca_topic_score_codex":0.0016633571,"about_ca_topic_score_gemma":0.0013111638,"teacher_disagreement_score":0.0016633571,"about_ca_system_score_codex":0.0005304094,"about_ca_system_score_gemma":0.00026611963,"threshold_uncertainty_score":0.003848374},"labels":[],"label_agreement":null},{"id":"W3099354938","doi":"10.1111/bcp.14667","title":"Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine","year":2020,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; European Commission; National Institute for Health and Care Research; University of Manchester; FP7 Health; GlaxoSmithKline; AstraZeneca","keywords":"Carbamazepine; Pharmacokinetics; Pharmacology; Metabolite; Volume of distribution; Phenytoin; Population; Chemistry; Microsomal epoxide hydrolase; Pharmacogenetics; Epoxide hydrolase; Anticonvulsant; Medicine; Microsome; Epilepsy; Genotype; Biochemistry; Enzyme; Gene","score_opus":0.3830655425053972,"score_gpt":0.563296980206314,"score_spread":0.18023143770091682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099354938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971112,0.00044823744,0.001683539,0.00007995517,0.000005776008,0.000020207852,0.00023240548,0.000018091949,0.00040050072],"genre_scores_gemma":[0.9992348,0.000048221173,0.00045741684,0.000011938412,0.0000043372575,0.0000066917987,0.00012380887,0.000004203618,0.00010859547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887544,0.0006305384,0.000064470085,0.00024495993,0.00013450067,0.000050042236],"domain_scores_gemma":[0.9971546,0.0015046728,0.0006873629,0.0003166038,0.00018429088,0.00015261708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018082055,0.00041500607,0.000425422,0.00039628515,0.00019278495,0.000499792,0.0002723511,0.0004498964,0.0016168769],"category_scores_gemma":[0.004840228,0.000177686,0.0005368988,0.0005736828,0.0002739953,0.00032991832,0.00018926969,0.00043323424,0.00015134267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008548171,0.00006528813,0.99165547,0.000015875641,0.00042447654,0.00019389337,0.00005197069,0.0005897161,0.0019821948,0.00007096022,0.000060621558,0.004034637],"study_design_scores_gemma":[0.000021690397,0.00032584518,0.9936752,0.0000038514777,0.00016063788,0.00047693672,0.000038464514,0.004322352,0.00060096994,0.00014138776,0.00022717501,0.0000054383117],"about_ca_topic_score_codex":0.002229879,"about_ca_topic_score_gemma":0.0014581804,"teacher_disagreement_score":0.002229879,"about_ca_system_score_codex":0.00026646722,"about_ca_system_score_gemma":0.00031229827,"threshold_uncertainty_score":0.00956285},"labels":[],"label_agreement":null},{"id":"W3111048839","doi":"10.1016/j.psychres.2020.113649","title":"Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression","year":2020,"lang":"en","type":"article","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Greenwich Biosciences; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; Agency for Healthcare Research and Quality; National Institutes of Health; Spier Family Foundation; Rogers Family Foundation; Eli Lilly and Company; Canadian Network for Mood and Anxiety Treatments; Assurex Health; Cerecor; Myriad Genetics; Sunovion; H. Lundbeck A/S; National Institute of Mental Health; Avanir Pharmaceuticals; Eisai; ACADIA Pharmaceuticals; Sage Therapeutics; University of Kansas; Canadian Institutes of Health Research; Foundation for Barnes-Jewish Hospital; Stanley Medical Research Institute; Pfizer; Biogen; Allergan; Cancer Research Institute; AstraZeneca; Bristol-Myers Squibb; LivaNova; Ontario Brain Institute","keywords":"Medicine; Pharmacogenomics; Major depressive disorder; Pharmacogenetics; Depression (economics); Hamilton Rating Scale for Depression; Clinical trial; Internal medicine; Psychiatry; Pharmacology; Mood; Gene","score_opus":0.38175716343895116,"score_gpt":0.5489436165382022,"score_spread":0.16718645309925106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111048839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654996,0.0004864999,0.0013134106,0.0001664577,0.000021925893,0.00012644945,0.00047590476,0.000017144828,0.0008421129],"genre_scores_gemma":[0.99713445,0.000074587806,0.0020207188,0.00011793669,0.000027726095,0.000103713835,0.00043237308,0.00000486594,0.00008362876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98847497,0.0074196723,0.00077972695,0.0016222452,0.0013774915,0.00032592844],"domain_scores_gemma":[0.96951944,0.017748995,0.006903191,0.0026556798,0.0021788683,0.0009938201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00924758,0.00083472754,0.0012873361,0.00068544724,0.0003786,0.001148913,0.0006996455,0.0008825147,0.0007972262],"category_scores_gemma":[0.028587328,0.00035222783,0.0012160091,0.0010670521,0.0005787108,0.0006143961,0.0007441229,0.0009912536,0.00022518885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007517498,0.00047577615,0.97069037,0.00007870174,0.0016639875,0.00006295473,0.00012163158,0.0017204721,0.0006068865,0.000116313204,0.00025284383,0.016692588],"study_design_scores_gemma":[0.0022625893,0.011487922,0.9621,0.00009689653,0.0025210239,0.00041093462,0.00018068211,0.017502695,0.0015416943,0.0010541171,0.0007741694,0.00006722011],"about_ca_topic_score_codex":0.0011629515,"about_ca_topic_score_gemma":0.00226114,"teacher_disagreement_score":0.00924758,"about_ca_system_score_codex":0.00041184633,"about_ca_system_score_gemma":0.00090265996,"threshold_uncertainty_score":0.048906505},"labels":[],"label_agreement":null},{"id":"W3111078860","doi":"10.1055/a-1312-7175","title":"Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population","year":2020,"lang":"en","type":"article","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; Pharmacogenetics; CYP2D6; Single-nucleotide polymorphism; CYP3A5; SNP; Medicine; Genotype; CYP2C9; Population; Pharmacology; Internal medicine; Statistical significance; Genetics; Biology; Gene","score_opus":0.0703218792811785,"score_gpt":0.4074863423247235,"score_spread":0.337164463043545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111078860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996352,0.00004346469,0.00002336786,0.00000893458,0.0000011589888,0.0000026291978,0.00013036144,0.0000014619934,0.00015333037],"genre_scores_gemma":[0.9996742,0.000040207236,0.000023971728,0.000007961005,0.000001984454,0.0000030870717,0.00018589724,7.6848136e-7,0.00006180895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968386,0.00006293103,0.000034844485,0.00009939721,0.00005649155,0.00006252496],"domain_scores_gemma":[0.99966216,0.00005794832,0.00014459537,0.000032159423,0.00003415223,0.00006903962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022366745,0.00023241808,0.00025572052,0.0009340624,0.000297582,0.00037709757,0.00019229697,0.0002671645,0.0019577297],"category_scores_gemma":[0.00083832163,0.0001707495,0.00017858554,0.0007882276,0.00028627814,0.0001452077,0.00030509982,0.00018933196,0.00027150902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010415848,0.00003182801,0.99723035,0.000006777059,0.00003381502,0.00022402636,0.00011210021,0.000038908005,0.00064162066,0.000027458138,0.000108801294,0.0014401608],"study_design_scores_gemma":[0.000004664057,0.00005236257,0.9993007,0.0000019782715,0.000015951144,0.0002887923,0.00012772037,0.00005797164,0.000059885882,0.000013590025,0.00007447235,0.0000018816875],"about_ca_topic_score_codex":0.0069734505,"about_ca_topic_score_gemma":0.0052151456,"teacher_disagreement_score":0.0069734505,"about_ca_system_score_codex":0.0003156496,"about_ca_system_score_gemma":0.00019897147,"threshold_uncertainty_score":0.013865709},"labels":[],"label_agreement":null},{"id":"W3113372188","doi":"10.1177/1755738020972128","title":"Pharmacogenomics: Prescribing based on genetic variation","year":2020,"lang":"en","type":"article","venue":"InnovAiT Education and inspiration for general practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Drug; Pharmacogenetics; Drug response; Disease; Intensive care medicine; Clinical decision support system; Function (biology); Adverse effect; Clinical Practice; Decision support system; Pharmacology; Family medicine; Computer science; Data mining; Internal medicine; Biology","score_opus":0.14598671452020454,"score_gpt":0.4460471017501133,"score_spread":0.3000603872299088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113372188","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2567638,0.060780276,0.10329302,0.25978646,0.0029316728,0.0005788661,0.030243859,0.0053814203,0.2802406],"genre_scores_gemma":[0.8448597,0.033115163,0.062159795,0.0249156,0.0037733146,0.00021522252,0.009095531,0.00067625317,0.021189319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704784,0.0013513392,0.00034811703,0.00039269173,0.0007518668,0.00010808563],"domain_scores_gemma":[0.99431807,0.0033081262,0.0012346777,0.00035799487,0.0005015985,0.00027951246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022718506,0.0003765142,0.00059534656,0.0015033873,0.00035101906,0.0016847157,0.00046455167,0.0011861941,0.009784919],"category_scores_gemma":[0.010471556,0.0001778672,0.00055318896,0.0027944816,0.0005467763,0.0010671574,0.00067448744,0.0011714977,0.0030515348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054820685,0.00025529458,0.33353925,0.0007949578,0.0004878664,0.0018365659,0.0004652389,0.0032717902,0.0023436008,0.023790283,0.10073222,0.53193486],"study_design_scores_gemma":[0.00021778746,0.00048615836,0.55391806,0.0026051244,0.00071308226,0.016574256,0.0006561295,0.023781756,0.0045425943,0.14867586,0.24758486,0.0002442668],"about_ca_topic_score_codex":0.00619787,"about_ca_topic_score_gemma":0.005253845,"teacher_disagreement_score":0.009784919,"about_ca_system_score_codex":0.00095796364,"about_ca_system_score_gemma":0.00094946893,"threshold_uncertainty_score":0.032733798},"labels":[],"label_agreement":null},{"id":"W3114326816","doi":"10.1002/cpt.2149","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute on Drug Abuse; National Health and Medical Research Council; National Institute of General Medical Sciences; Medical Research Council; National Institutes of Health","keywords":"Pharmacogenetics; CYP2D6; Guideline; Opioid; Medicine; Pharmacology; Genotype; Internal medicine; Biology; Genetics; Gene; Cytochrome P450","score_opus":0.24691550981230617,"score_gpt":0.5716757893882056,"score_spread":0.3247602795758995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114326816","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009994241,0.06627764,0.083279826,0.43427196,0.011216462,0.011559338,0.022516843,0.0050773127,0.3558064],"genre_scores_gemma":[0.07262451,0.09274871,0.24918686,0.38217324,0.00874362,0.022082364,0.052045092,0.0016792327,0.11871634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97869635,0.007838729,0.0048313644,0.0007155113,0.0069844513,0.0009335966],"domain_scores_gemma":[0.96337456,0.012180308,0.003830398,0.001290632,0.017520433,0.0018036857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012946228,0.0008133802,0.0016230698,0.0021986407,0.00095749326,0.0025683786,0.0039842054,0.008146314,0.012735017],"category_scores_gemma":[0.042644843,0.00068143633,0.003695022,0.0019865287,0.0010693825,0.001720231,0.002426757,0.006926164,0.0073693227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002095376,0.00035439315,0.0028999634,0.0017328912,0.00011743665,0.00093351677,0.00037798003,0.00087061146,0.0010196639,0.009583808,0.7652492,0.21665104],"study_design_scores_gemma":[0.00055055035,0.00021033389,0.006559412,0.00855429,0.00029472684,0.0017160872,0.00022262834,0.00093990285,0.0010764602,0.0075494875,0.9722455,0.00008064441],"about_ca_topic_score_codex":0.017083677,"about_ca_topic_score_gemma":0.027022706,"teacher_disagreement_score":0.017083677,"about_ca_system_score_codex":0.002673751,"about_ca_system_score_gemma":0.014882693,"threshold_uncertainty_score":0.06846702},"labels":[],"label_agreement":null},{"id":"W3114373673","doi":"10.1007/s13318-020-00666-w","title":"Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech","keywords":"Microsome; Cytosol; Biochemistry; Biology; Enzyme kinetics; Enzyme; Computational biology","score_opus":0.3040208151044591,"score_gpt":0.41808110510860486,"score_spread":0.11406029000414575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114373673","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067443647,0.00033415342,0.9907767,0.00026544512,0.00007089274,0.00008633354,0.00012509787,0.00046039087,0.0011366488],"genre_scores_gemma":[0.30122364,0.00082719664,0.69393164,0.00043767152,0.00016853251,0.00059403805,0.00052948634,0.0010454712,0.0012422537],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99429893,0.003092714,0.0005209097,0.0007231101,0.0012003934,0.00016388243],"domain_scores_gemma":[0.961237,0.025450593,0.0017180743,0.0073803486,0.0039666267,0.00024735022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019707933,0.0016846884,0.001321101,0.0015340896,0.00092839723,0.0037217475,0.0024676837,0.0016620972,0.0022009518],"category_scores_gemma":[0.104997,0.00060880487,0.0013011707,0.001771232,0.0016909465,0.0034836594,0.0025239608,0.0037947728,0.0008547612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035605018,0.00032896316,0.008769009,0.00156097,0.0004384509,0.00040243226,0.0008066045,0.28388843,0.05714298,0.366823,0.0043532895,0.2751299],"study_design_scores_gemma":[0.00005181669,0.00015613208,0.0042939074,0.00027058576,0.00011052761,0.00027206607,0.0001517928,0.8109728,0.027563745,0.14430404,0.011706753,0.00014594014],"about_ca_topic_score_codex":0.0041995468,"about_ca_topic_score_gemma":0.0025860379,"teacher_disagreement_score":0.019707933,"about_ca_system_score_codex":0.0013691025,"about_ca_system_score_gemma":0.0021584642,"threshold_uncertainty_score":0.10422677},"labels":[],"label_agreement":null},{"id":"W3117825589","doi":"10.3390/jpm11010011","title":"Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia","year":2020,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Pfizer Canada; Genome British Columbia","keywords":"Pharmacogenomics; Medicine; Dosing; Pharmacy; Health care; Pharmacotherapy; Family medicine; Cohort; Pharmacogenetics; Pharmacology; Psychiatry; Internal medicine; Genotype","score_opus":0.16289451940346303,"score_gpt":0.44472927551540536,"score_spread":0.2818347561119423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117825589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954085,0.00039577277,0.00029918816,0.00067627785,0.000008035552,0.00037235476,0.0006522462,0.000013249346,0.0021743965],"genre_scores_gemma":[0.9938653,0.00047361144,0.0010274053,0.001234052,0.00000842032,0.00018043524,0.0004810723,0.000011124749,0.0027186288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979353,0.0005161466,0.00007777012,0.00029832416,0.000600073,0.0005723447],"domain_scores_gemma":[0.9961538,0.00037727514,0.0004215738,0.00014810605,0.0011100974,0.0017891631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012693541,0.00029584425,0.0003567444,0.0009379355,0.0032669648,0.0018119981,0.001309214,0.0008478675,0.0029709437],"category_scores_gemma":[0.0031777492,0.0005142204,0.00020934248,0.0024161763,0.00084100594,0.00053933647,0.0019477431,0.0009452438,0.0005325571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042532588,0.0010919231,0.93168163,0.00019760749,0.0000673048,0.0018995482,0.0080452105,0.00021035508,0.0023376523,0.00031938785,0.0025793456,0.051144633],"study_design_scores_gemma":[0.00010416599,0.000557224,0.982381,0.00008922161,0.000036375033,0.0005846076,0.0108552575,0.00091408036,0.00030278944,0.00010172689,0.0040457356,0.000027757671],"about_ca_topic_score_codex":0.8888986,"about_ca_topic_score_gemma":0.9310445,"teacher_disagreement_score":0.11110139,"about_ca_system_score_codex":0.01333401,"about_ca_system_score_gemma":0.028090473,"threshold_uncertainty_score":0.22351134},"labels":[],"label_agreement":null},{"id":"W3119947423","doi":"10.1002/cpdd.901","title":"A Colon‐Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Warfarin; Bioequivalence; Pharmacokinetics; Clonazepam; Crossover study; Pharmacology; Cmax; Concomitant; Pharmacodynamics; Drug; Internal medicine; Placebo","score_opus":0.16681087861956184,"score_gpt":0.497394297777827,"score_spread":0.33058341915826517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119947423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894017,0.00036353854,0.00018494885,0.000028744129,0.000028378165,0.00008591566,0.000115718816,0.000015109696,0.00023749395],"genre_scores_gemma":[0.9990308,0.00011051029,0.00022486916,0.00007889879,0.000033666533,0.00005837951,0.00011092726,0.00000457982,0.00034732278],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992163,0.00037192996,0.000048387916,0.00016941971,0.00011468301,0.000079211575],"domain_scores_gemma":[0.9994479,0.00015230777,0.0001540855,0.00007507165,0.00004551858,0.00012511302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010196111,0.00054628454,0.0010097321,0.00016791737,0.0003248122,0.0003446072,0.00019538254,0.0008938445,0.0018087107],"category_scores_gemma":[0.0014476996,0.00032240208,0.00051370426,0.00017032704,0.0005920607,0.0003734343,0.00017217545,0.0005457719,0.00031794075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74923384,0.01375313,0.02887851,0.0004074766,0.0011347143,0.0002844903,0.00033733173,0.00041398362,0.16571273,0.0001239547,0.0009706301,0.038749177],"study_design_scores_gemma":[0.048238363,0.7223735,0.19966057,0.00003129224,0.0012594564,0.0005948122,0.00018100328,0.001628385,0.022459902,0.00014604176,0.003367141,0.000059649792],"about_ca_topic_score_codex":0.0011699949,"about_ca_topic_score_gemma":0.0011900942,"teacher_disagreement_score":0.0018087107,"about_ca_system_score_codex":0.00025030534,"about_ca_system_score_gemma":0.0003421639,"threshold_uncertainty_score":0.006050706},"labels":[],"label_agreement":null},{"id":"W3121479225","doi":"10.1111/cts.12970","title":"Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting<i>CYP3A4*1G</i>allele function","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacogenetics; Allele; Biology; Genetics; Function (biology); CYP3A4; Evolutionary biology; Genotype; Gene; Cytochrome P450","score_opus":0.0956131092451558,"score_gpt":0.4346596610336445,"score_spread":0.3390465517884887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121479225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988349,0.00007819469,0.00026906008,0.00001566842,0.0000020772009,0.000012970527,0.00013835267,0.0000053243016,0.0006435016],"genre_scores_gemma":[0.9987723,0.00007297897,0.0005071709,0.000021553704,0.000003360328,0.000016438498,0.00020134503,0.000004433603,0.00040042217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998105,0.000048136677,0.00001616947,0.00006253598,0.000041493797,0.000021090977],"domain_scores_gemma":[0.9998056,0.000036881487,0.000058552414,0.000019734369,0.00004319287,0.000036114572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027575193,0.00020498695,0.0001370157,0.00055556546,0.00046476428,0.000281638,0.00013528825,0.00019500121,0.0010466509],"category_scores_gemma":[0.0006084687,0.00008806124,0.00016536855,0.0005654171,0.00017405406,0.00006821283,0.00014887878,0.00018075352,0.00015262056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043449068,0.00017236445,0.82651395,0.000048984828,0.00010879985,0.0011188956,0.0016765556,0.00019668124,0.15571156,0.00023012578,0.00018783391,0.013599912],"study_design_scores_gemma":[0.0000051135135,0.0001373428,0.9930393,0.000004929723,0.00004068318,0.001082564,0.0003726691,0.00024654155,0.004249033,0.000044940625,0.0007717216,0.0000051576267],"about_ca_topic_score_codex":0.015570829,"about_ca_topic_score_gemma":0.013295146,"teacher_disagreement_score":0.015570829,"about_ca_system_score_codex":0.00015175466,"about_ca_system_score_gemma":0.00019050103,"threshold_uncertainty_score":0.030960381},"labels":[],"label_agreement":null},{"id":"W3121813483","doi":"10.3389/fpsyt.2021.669446","title":"Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series","year":2021,"lang":"en","type":"article","venue":"Frontiers in Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Fluvoxamine; Clozapine; Pharmacology; CYP3A4; CYP1A2; Medicine; CYP2D6; Psychology; Psychiatry; Schizophrenia (object-oriented programming); Fluoxetine; Internal medicine; Cytochrome P450; Metabolism; Receptor","score_opus":0.033938604948964786,"score_gpt":0.37138168508412134,"score_spread":0.33744308013515656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121813483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921216,0.0046831635,0.0005812757,0.00042458109,0.000043529562,0.000035463814,0.00006907719,0.000025062447,0.0020162966],"genre_scores_gemma":[0.9964295,0.002406679,0.00040062825,0.00020053088,0.000066686254,0.000008706736,0.00007337175,0.000011919323,0.00040213144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995765,0.00008295255,0.00006873775,0.0000910523,0.00007590667,0.00010483015],"domain_scores_gemma":[0.99899,0.00028458625,0.00035055954,0.000063301755,0.00009369366,0.00021782436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022421809,0.00070183823,0.00043603376,0.0007156347,0.0009372825,0.00061507605,0.00040250173,0.0010384999,0.0012809535],"category_scores_gemma":[0.0018712549,0.00037238395,0.00056060415,0.0006089883,0.0008975442,0.00047072815,0.00061466673,0.0010634601,0.0002499383],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017386208,0.00017253932,0.27189562,0.00016313512,0.00008483888,0.7024396,0.0025046407,0.00014343286,0.0019882713,0.00023619017,0.00094699557,0.019250961],"study_design_scores_gemma":[0.000015319314,0.00018627947,0.05949642,0.000047812744,0.0000990127,0.9359123,0.0010241708,0.00011216656,0.0009892822,0.00009309405,0.0020030062,0.000021230662],"about_ca_topic_score_codex":0.0039864955,"about_ca_topic_score_gemma":0.0050444375,"teacher_disagreement_score":0.0039864955,"about_ca_system_score_codex":0.0007792339,"about_ca_system_score_gemma":0.0007128606,"threshold_uncertainty_score":0.007926583},"labels":[],"label_agreement":null},{"id":"W3123280459","doi":"10.3390/pharmaceutics13020148","title":"Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition","year":2021,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fluoxetine; CYP2D6; Pharmacology; Cytochrome P450; CYP2C9; Drug; Pharmacokinetics; Metabolite; Drug interaction; Chemistry; Active metabolite; CYP2C19; CYP3A; CYP3A4; Enzyme; Medicine; Biochemistry; Receptor; Serotonin","score_opus":0.35251652099592856,"score_gpt":0.5544263198431747,"score_spread":0.20190979884724614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123280459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10007717,0.8395913,0.03275807,0.003296197,0.00053142954,0.0003504929,0.0027226594,0.00038633568,0.02028634],"genre_scores_gemma":[0.5533117,0.4141385,0.01390691,0.0017157001,0.00056809414,0.0002562262,0.0030331295,0.00007601602,0.012993723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927527,0.00017245617,0.00008426592,0.00013188746,0.00026909605,0.0000671044],"domain_scores_gemma":[0.9995598,0.00014938088,0.00012183488,0.000019769295,0.00013039811,0.000018894312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008654931,0.00053660566,0.0005660097,0.0009012377,0.00018288656,0.0007691126,0.00044626286,0.00079550286,0.002748606],"category_scores_gemma":[0.0011838851,0.00020672403,0.00085002644,0.0007162757,0.00025861696,0.0005253815,0.00023625788,0.00062219583,0.00095340045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014031517,0.0002353772,0.05230511,0.011386702,0.0015613422,0.0033970443,0.00019865029,0.0020853663,0.19620939,0.0063496986,0.014447259,0.7104209],"study_design_scores_gemma":[0.00023269119,0.0031707701,0.13728882,0.001320039,0.0029420757,0.02419606,0.0002576401,0.0066202166,0.4434963,0.005218491,0.37512112,0.00013589204],"about_ca_topic_score_codex":0.0013298721,"about_ca_topic_score_gemma":0.0014835233,"teacher_disagreement_score":0.002748606,"about_ca_system_score_codex":0.00067797303,"about_ca_system_score_gemma":0.00049655774,"threshold_uncertainty_score":0.00919503},"labels":[],"label_agreement":null},{"id":"W3123453085","doi":"10.3389/fphar.2020.595219","title":"Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines","year":2021,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Genotyping; Medicine; Pharmacogenomics; Guideline; Precision medicine; Clinical Practice; Personalized medicine; Genotype; Pharmacology; Bioinformatics; Family medicine; Biology; Genetics; Gene; Pathology","score_opus":0.40834520196988233,"score_gpt":0.5718590805218602,"score_spread":0.16351387855197785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123453085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007471308,0.6263808,0.043935463,0.21249102,0.0055313236,0.0069816206,0.01936883,0.0012138451,0.07662583],"genre_scores_gemma":[0.042451423,0.55447435,0.250228,0.07607061,0.0029102024,0.012484753,0.047781873,0.00090892066,0.012689893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94566315,0.018937726,0.021314034,0.0019984539,0.010541281,0.0015454052],"domain_scores_gemma":[0.88860124,0.042448457,0.01368118,0.002935971,0.048167147,0.004166037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057769213,0.0011733426,0.0027221022,0.022031123,0.0012149573,0.0052348226,0.0046958956,0.005665259,0.0038047745],"category_scores_gemma":[0.10422521,0.0010439189,0.00296107,0.02308057,0.0017039621,0.0031731743,0.0039194003,0.0054400596,0.001944944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024080263,0.00024856243,0.0053722756,0.03253247,0.00049404876,0.000602817,0.0016577317,0.0021173432,0.0007894816,0.030115882,0.43385115,0.4919775],"study_design_scores_gemma":[0.00013593178,0.00010703141,0.008560508,0.0790986,0.00060544565,0.0009919943,0.0008423185,0.00075156236,0.00045670717,0.0068936925,0.90146005,0.00009614943],"about_ca_topic_score_codex":0.033839833,"about_ca_topic_score_gemma":0.032808114,"teacher_disagreement_score":0.057769213,"about_ca_system_score_codex":0.011495669,"about_ca_system_score_gemma":0.0409575,"threshold_uncertainty_score":0.30551642},"labels":[],"label_agreement":null},{"id":"W3125345026","doi":"10.1002/cpt.2173","title":"StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"GlaxoSmithKline foundation; National Research Foundation","keywords":"Genotyping; Genetics; Computational biology; 1000 Genomes Project; Biology; Haplotype; Pharmacogenomics; Genome; Gene; Allele; Genotype; Single-nucleotide polymorphism","score_opus":0.342208073002502,"score_gpt":0.5455487412779744,"score_spread":0.20334066827547237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125345026","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023755535,0.00057933043,0.59152913,0.00049841695,0.00018095144,0.00047518796,0.023217399,0.35712567,0.0026384569],"genre_scores_gemma":[0.1406633,0.00064933865,0.7372009,0.0012522736,0.00011233896,0.0024530757,0.08867635,0.022058267,0.0069341143],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992955,0.0001258832,0.00006112124,0.00026084352,0.00016807854,0.00008863175],"domain_scores_gemma":[0.999209,0.00039453403,0.00007422049,0.000115515955,0.00013813654,0.00006863775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022205906,0.0020295128,0.0010099342,0.0013100273,0.0009877759,0.0016230126,0.0017536733,0.0008596579,0.013315147],"category_scores_gemma":[0.0030724283,0.0011551039,0.0016888703,0.0007908843,0.0004781605,0.0015896979,0.0018179087,0.0020637223,0.0037434495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004361971,0.0006340565,0.027702257,0.0023330855,0.0014120016,0.0012382447,0.002132208,0.056794077,0.13362896,0.01535646,0.26862067,0.48578593],"study_design_scores_gemma":[0.0009506027,0.00038630102,0.015885875,0.00014979609,0.00026519815,0.00041967104,0.00016923189,0.73163295,0.09127318,0.03409235,0.124414854,0.0003600045],"about_ca_topic_score_codex":0.008101065,"about_ca_topic_score_gemma":0.006876069,"teacher_disagreement_score":0.013315147,"about_ca_system_score_codex":0.0010961707,"about_ca_system_score_gemma":0.0022886482,"threshold_uncertainty_score":0.044543564},"labels":[],"label_agreement":null},{"id":"W3125910964","doi":"10.1016/j.bcab.2021.101917","title":"Promising optimization of bacterial cytochrome P450BM3 enzyme production by engineered Escherichia coli BL21","year":2021,"lang":"en","type":"article","venue":"Biocatalysis and Agricultural Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Research Centre","keywords":"Escherichia coli; Chemistry; Enzyme; Production (economics); Cytochrome; Microbiology; Biochemistry; Biology; Gene; Economics","score_opus":0.026289667789309388,"score_gpt":0.30320795333413103,"score_spread":0.2769182855448216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125910964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96372217,0.0017796998,0.028557401,0.0005314669,0.000098559794,0.00009686369,0.0012498607,0.00045167515,0.0035122274],"genre_scores_gemma":[0.9718137,0.0011545254,0.021364866,0.000087921966,0.000010667396,0.000042110016,0.0019222128,0.000094372845,0.00350962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959403,0.00007154111,0.000036808124,0.00006552222,0.00016104181,0.000071126335],"domain_scores_gemma":[0.9998913,0.000020830248,0.000019342206,0.000015524403,0.000037686565,0.000015342779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034560656,0.00073442905,0.0004407909,0.00023719975,0.00022832354,0.0006417083,0.00029430122,0.00050956703,0.0011048823],"category_scores_gemma":[0.00031510807,0.00013935541,0.00050105393,0.00045667685,0.000114698196,0.00029196095,0.00023424144,0.00061797706,0.0006217364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001190674,0.00007269808,0.00023438597,0.000049721,0.000009733742,0.000063066924,0.000007320522,0.00036087498,0.9951597,0.000088698565,0.00008671876,0.0037480267],"study_design_scores_gemma":[0.000007831242,0.00012912552,0.000860749,0.0000024280241,0.000015082481,0.000067320034,0.000011621441,0.00092583813,0.996582,0.000033220294,0.001359607,0.0000052884793],"about_ca_topic_score_codex":0.0015830044,"about_ca_topic_score_gemma":0.0022905858,"teacher_disagreement_score":0.0015830044,"about_ca_system_score_codex":0.00045618913,"about_ca_system_score_gemma":0.0003134846,"threshold_uncertainty_score":0.0036962032},"labels":[],"label_agreement":null},{"id":"W3127733737","doi":"10.22541/au.159285510.07118043","title":"The influence of tobacco smoke/nicotine on CYP2A expression in human and African green monkey lungs","year":2020,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto","funders":"","keywords":"Nicotine; CYP2A6; Lung; Medicine; Pharmacology; Smoke; Internal medicine; CYP1A2; Endocrinology; Physiology; Chemistry; Metabolism","score_opus":0.11338667808223128,"score_gpt":0.4320021168020357,"score_spread":0.3186154387198044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127733737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650324,0.004683845,0.0016985285,0.00027514785,0.000034313984,0.00004254558,0.0038618315,0.00007330048,0.0028272413],"genre_scores_gemma":[0.989344,0.0020957156,0.0017112809,0.00016792191,0.00002246123,0.00010953607,0.0035479993,0.000043956326,0.0029572498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996816,0.00006913044,0.000015363923,0.00010555195,0.00008604439,0.000042311658],"domain_scores_gemma":[0.9998579,0.00003643839,0.000029213465,0.00002540534,0.00003180747,0.000019166371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002494762,0.00012790802,0.00022440759,0.00046434472,0.00033036902,0.00046726526,0.000091077556,0.00023155414,0.0027652187],"category_scores_gemma":[0.0003160085,0.00012019159,0.00034191526,0.00055713905,0.0003395537,0.00013304941,0.0001773507,0.00026748664,0.00056634593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015475653,0.00010858736,0.050587278,0.00022457892,0.00016125647,0.0002833815,0.00023013806,0.0002729933,0.9264952,0.00038316823,0.0009592882,0.018746525],"study_design_scores_gemma":[0.000059765513,0.0011991969,0.6711344,0.000050805116,0.00031274298,0.0027265484,0.00064803613,0.0015233739,0.28463963,0.0005772177,0.037094254,0.000033883905],"about_ca_topic_score_codex":0.0026838114,"about_ca_topic_score_gemma":0.0036425847,"teacher_disagreement_score":0.0027652187,"about_ca_system_score_codex":0.00028084163,"about_ca_system_score_gemma":0.00029667353,"threshold_uncertainty_score":0.009250522},"labels":[],"label_agreement":null},{"id":"W3127901377","doi":"10.1002/ddr.21778","title":"Anatomical distribution and expression of <scp>CYP</scp> in humans: Neuropharmacological implications","year":2021,"lang":"en","type":"review","venue":"Drug Development Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; Cytochrome P450; Epigenetics; Pharmacology; Gene isoform; Drug metabolism; Pharmacokinetics; Drug; Metabolism; Endocrinology; Genetics; Gene","score_opus":0.33657604998038493,"score_gpt":0.5473774208312959,"score_spread":0.210801370850911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127901377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040222224,0.99736327,0.00018770725,0.0002287535,0.00007649017,0.0000036046713,0.00007911581,0.0000088339775,0.0016501092],"genre_scores_gemma":[0.0027344855,0.9957644,0.00023548202,0.00014929271,0.00008173391,0.000006310347,0.00008989393,0.000002192559,0.0009362233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988747,0.000022016071,0.00001867461,0.000031530915,0.000030460162,0.000009799601],"domain_scores_gemma":[0.999858,0.00006589242,0.000027124719,0.000006129616,0.000033802553,0.0000089064015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023551185,0.00040564587,0.0006399671,0.000973926,0.00012418663,0.00059730175,0.00033702524,0.00044833138,0.0036658014],"category_scores_gemma":[0.00041558075,0.00011829209,0.0003787222,0.0012361959,0.00024372988,0.0005400283,0.00027148286,0.00072194,0.0015144288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010533508,0.000031877356,0.00063631084,0.015442885,0.0001347949,0.00025301607,0.000051596402,0.00020644545,0.004338648,0.0024083885,0.013033733,0.963357],"study_design_scores_gemma":[0.000022751103,0.00017643652,0.0071684937,0.0039613065,0.0003789197,0.004893462,0.00008143444,0.0001062841,0.0023273735,0.0024589535,0.9783959,0.00002871465],"about_ca_topic_score_codex":0.0011530255,"about_ca_topic_score_gemma":0.0017667355,"teacher_disagreement_score":0.0036658014,"about_ca_system_score_codex":0.0002970732,"about_ca_system_score_gemma":0.0005577458,"threshold_uncertainty_score":0.012263358},"labels":[],"label_agreement":null},{"id":"W3128424220","doi":"10.3390/pharmaceutics13020197","title":"Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy","year":2021,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Polypharmacy; Medicine; Precision medicine; Intensive care medicine; Personalized medicine; Pharmacology; Bioinformatics; Biology; Pathology","score_opus":0.05558214301569941,"score_gpt":0.4161266348303737,"score_spread":0.3605444918146743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128424220","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007991438,0.41085845,0.45166248,0.08781777,0.004760857,0.00030981153,0.0011026731,0.0011580196,0.034338538],"genre_scores_gemma":[0.24454904,0.3286983,0.35091242,0.048004027,0.019326197,0.0007943877,0.00078893494,0.00027100026,0.006655626],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865254,0.006628209,0.00091470545,0.001853794,0.0038446814,0.00023316748],"domain_scores_gemma":[0.97344244,0.020201793,0.0017990548,0.0023091885,0.0018342249,0.00041336726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022155073,0.0015587081,0.003716537,0.005557802,0.0010515327,0.006324374,0.0020964902,0.0036218471,0.00282019],"category_scores_gemma":[0.02262224,0.0006026921,0.0017352791,0.0032955504,0.01249034,0.0054789577,0.0044272174,0.006653317,0.001341261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032090486,0.000249477,0.008051683,0.00644587,0.0014972003,0.0006189867,0.0015272964,0.004676021,0.004493732,0.5174939,0.023800097,0.4308248],"study_design_scores_gemma":[0.00007204201,0.00049956824,0.0047617746,0.0023856966,0.00043668417,0.0018590654,0.00043973618,0.0047020656,0.0031788333,0.81342876,0.16802503,0.00021069977],"about_ca_topic_score_codex":0.002255525,"about_ca_topic_score_gemma":0.001744844,"teacher_disagreement_score":0.022155073,"about_ca_system_score_codex":0.003383764,"about_ca_system_score_gemma":0.004955542,"threshold_uncertainty_score":0.117168665},"labels":[],"label_agreement":null},{"id":"W3131026056","doi":"10.3390/books978-3-03842-798-8","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape","year":2018,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Drug metabolism; Current (fluid); Drug; Medicine; Pharmacology; Engineering","score_opus":0.05875969595178177,"score_gpt":0.37317114679606217,"score_spread":0.3144114508442804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131026056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00100001,0.8825761,0.001543462,0.0547297,0.0064010094,0.000026870212,0.001052989,0.0002937381,0.052376155],"genre_scores_gemma":[0.009731416,0.8858909,0.0030116092,0.013099186,0.005181125,0.000021675716,0.0009882938,0.00014963248,0.08192613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851066,0.00008344912,0.00006514264,0.00012710525,0.001106535,0.00010708348],"domain_scores_gemma":[0.9963626,0.00064238923,0.00014477452,0.00009973188,0.002360552,0.00038995402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018190632,0.00076877006,0.00085340464,0.0027665957,0.0016969638,0.004061341,0.0012794884,0.001816752,0.016924756],"category_scores_gemma":[0.004837185,0.00032817165,0.00045722353,0.007706954,0.0023613148,0.0018543563,0.000972191,0.0024029228,0.0047268793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044274213,0.000020719643,0.0007064108,0.00085001916,0.0000108512295,0.00013475156,0.00018502984,0.00030081352,0.0003499192,0.009910536,0.56193507,0.42555165],"study_design_scores_gemma":[0.0000039438983,0.00001083668,0.0016985093,0.0003545366,0.000010813338,0.00030079202,0.00007792712,0.00012554182,0.00012067518,0.002258892,0.9950204,0.000017127722],"about_ca_topic_score_codex":0.84617436,"about_ca_topic_score_gemma":0.91260463,"teacher_disagreement_score":0.96390295,"about_ca_system_score_codex":0.03609703,"about_ca_system_score_gemma":0.047583763,"threshold_uncertainty_score":0.30946308},"labels":[],"label_agreement":null},{"id":"W3131252500","doi":"10.71781/4996","title":"New and alternative approaches to the assessment of pharmacokinetic and pharmacodynamic equivalence","year":2020,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Equivalence (formal languages); Pharmacodynamics; Pharmacokinetics; Pharmacology; Medicine; Mathematics; Computer science; Discrete mathematics","score_opus":0.37149791538723537,"score_gpt":0.5072271883032126,"score_spread":0.1357292729159772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131252500","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013579004,0.0370326,0.91583806,0.0047579426,0.0013487769,0.0014641364,0.00093874545,0.0002645439,0.02477617],"genre_scores_gemma":[0.28835994,0.041477475,0.6460514,0.004796117,0.0019262483,0.0048692245,0.0011049367,0.00024024374,0.011174343],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9234468,0.04726106,0.00427416,0.006763123,0.017521247,0.0007336324],"domain_scores_gemma":[0.9205141,0.056187898,0.007967737,0.0075533474,0.0070876554,0.0006891672],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04787949,0.0024810266,0.004366085,0.00696783,0.0009443576,0.010105439,0.0041263504,0.0036755863,0.008305733],"category_scores_gemma":[0.09825608,0.00091808994,0.0044578183,0.0062235864,0.007169767,0.007990039,0.005200006,0.0076654614,0.0014302302],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088747113,0.00051821425,0.008266676,0.0046300283,0.0028709143,0.00037847165,0.0012954059,0.017963162,0.0051055704,0.54612464,0.005520233,0.40643924],"study_design_scores_gemma":[0.00040967853,0.0021134117,0.01052802,0.0023636243,0.0013394669,0.0017361593,0.0012474053,0.10206068,0.005102961,0.75652224,0.11612754,0.00044891157],"about_ca_topic_score_codex":0.0053216973,"about_ca_topic_score_gemma":0.0039143697,"teacher_disagreement_score":0.9521205,"about_ca_system_score_codex":0.0056848316,"about_ca_system_score_gemma":0.005792805,"threshold_uncertainty_score":0.25321394},"labels":[],"label_agreement":null},{"id":"W3133060081","doi":"10.18433/jpps31305","title":"The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism","year":2021,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Centre National de la Recherche Scientifique; Ministry of Higher Education, Malaysia","keywords":"Biology; Single-nucleotide polymorphism; Genetics; Gene; Genotype","score_opus":0.16437097867124498,"score_gpt":0.4248624400500307,"score_spread":0.26049146137878576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133060081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5846494,0.3756497,0.015760267,0.0046122936,0.00023036572,0.00011175484,0.0059301094,0.0005126317,0.012543565],"genre_scores_gemma":[0.9237917,0.05449461,0.0059235757,0.00041971065,0.00075497245,0.00007721659,0.0052632918,0.00008283554,0.009192024],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959654,0.00009749946,0.000033177712,0.00014725055,0.00010461623,0.000020959013],"domain_scores_gemma":[0.99971825,0.00006007213,0.00011692514,0.000019990966,0.00005799083,0.000026726186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000465489,0.00040422246,0.0005960424,0.0005415448,0.00017103074,0.0007276762,0.0002830407,0.000425184,0.0018260054],"category_scores_gemma":[0.00052262296,0.00013038618,0.0002739334,0.0013554281,0.00027914732,0.00028980448,0.00020101086,0.0005167402,0.0013973102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018937093,0.00033521914,0.17154875,0.001872003,0.0006351576,0.002048748,0.00040200294,0.0016038567,0.16597605,0.004168388,0.0120449485,0.63747126],"study_design_scores_gemma":[0.00013126811,0.0010125863,0.7350481,0.00019812389,0.00043384565,0.024429504,0.0001900923,0.0021312954,0.04765844,0.0028308749,0.1858356,0.00010031309],"about_ca_topic_score_codex":0.00096639193,"about_ca_topic_score_gemma":0.0004591816,"teacher_disagreement_score":0.0018260054,"about_ca_system_score_codex":0.00031573506,"about_ca_system_score_gemma":0.00015633614,"threshold_uncertainty_score":0.0061086416},"labels":[],"label_agreement":null},{"id":"W3135274413","doi":"10.1101/2021.03.09.434557","title":"Structural dynamics of cytochrome P450 3A4 in the presence of substrates and cytochrome P450 reductase","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Centre in Green Chemistry and Catalysis","keywords":"CYP3A4; Chemistry; Hydrogen–deuterium exchange; Cytochrome P450; Stereochemistry; Allosteric regulation; Cytochrome P450 reductase; Helix (gastropod); Enzyme; Ligand (biochemistry); Biophysics; Molecular dynamics; Biochemistry; Cytochrome c; Computational chemistry; Receptor; Hydrogen; Biology; Coenzyme Q – cytochrome c reductase","score_opus":0.04885943678002469,"score_gpt":0.3381783180266697,"score_spread":0.289318881246645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135274413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975721,0.0005862513,0.001082436,0.0000614032,0.000011460064,0.000003846101,0.00009387314,0.000011951329,0.00057662977],"genre_scores_gemma":[0.99898034,0.00017721376,0.00030934287,0.000014612163,0.000003937013,0.0000036934307,0.00012793294,0.0000046342525,0.00037820116],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998791,0.000027784492,0.0000038785342,0.00002882429,0.000031490596,0.000028895325],"domain_scores_gemma":[0.999881,0.00003543457,0.000035949703,0.000010918849,0.00001835522,0.000018225635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020960612,0.00017226841,0.00015288973,0.00007999741,0.00022184684,0.00021121789,0.00021922016,0.00020118362,0.0012463643],"category_scores_gemma":[0.00029561223,0.00010739543,0.00016342668,0.00013201075,0.00024451333,0.0002202329,0.00013331712,0.00037719912,0.00018883112],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047038082,0.00003641448,0.0027949668,0.000049864197,0.000040510397,0.00010845271,0.00006194069,0.0009139892,0.99324507,0.000215297,0.00010416267,0.0019589514],"study_design_scores_gemma":[0.000032819687,0.0004702024,0.035964094,0.00001051061,0.000053861742,0.00029632804,0.00016121342,0.017593017,0.9423257,0.00025780709,0.0028096929,0.00002486544],"about_ca_topic_score_codex":0.0012215606,"about_ca_topic_score_gemma":0.00085934554,"teacher_disagreement_score":0.0012463643,"about_ca_system_score_codex":0.00026862288,"about_ca_system_score_gemma":0.0001148788,"threshold_uncertainty_score":0.0041695237},"labels":[],"label_agreement":null},{"id":"W3135894867","doi":"10.1111/cts.12986","title":"Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto; University of Waterloo","funders":"","keywords":"Pharmacogenomics; Anxiety; Randomized controlled trial; Medicine; Pharmacy; Generalized anxiety disorder; Depression (economics); Psychiatry; Clinical trial; Antidepressant; Physical therapy; Clinical psychology; Internal medicine; Family medicine; Pharmacology","score_opus":0.25914694807119115,"score_gpt":0.5370956216223216,"score_spread":0.27794867355113045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135894867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483985,0.012243539,0.0023000673,0.0018444636,0.0027126395,0.029064646,0.00081353495,0.00023821481,0.002384497],"genre_scores_gemma":[0.9612259,0.0038974984,0.005210858,0.0020052406,0.0013039953,0.024404166,0.00036875915,0.00002146176,0.0015621627],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9902614,0.0067812,0.0008886317,0.0009741237,0.0005653126,0.0005293093],"domain_scores_gemma":[0.99202543,0.0039402917,0.0017076284,0.0005935469,0.00044361394,0.0012894091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006981618,0.001634398,0.004974017,0.0009955211,0.00092053495,0.0018178774,0.0015856964,0.0048545487,0.007429153],"category_scores_gemma":[0.011314693,0.00096760667,0.003711854,0.0010836135,0.002196561,0.0020420027,0.0009216597,0.0031064572,0.00074078265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98385936,0.006885854,0.0003134819,0.00089522044,0.0011271377,0.000020364669,0.000037849662,0.000089116664,0.00026180007,0.000074804535,0.00017802922,0.0062570586],"study_design_scores_gemma":[0.96340233,0.034967363,0.0004831379,0.00007556502,0.0005233972,0.000008357934,0.000017721106,0.0002235617,0.000062995656,0.00010112151,0.00012499517,0.000009449876],"about_ca_topic_score_codex":0.00151289,"about_ca_topic_score_gemma":0.002722959,"teacher_disagreement_score":0.007429153,"about_ca_system_score_codex":0.0015578371,"about_ca_system_score_gemma":0.0027452752,"threshold_uncertainty_score":0.036922753},"labels":[],"label_agreement":null},{"id":"W3136441191","doi":"10.1111/bcp.14833","title":"Drug–drug interactions with warfarin: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Hamilton Health Sciences; University of Toronto; University of Ottawa; Western University; Queen's University; McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Warfarin; Internal medicine; Odds ratio; Observational study; Drug; Confidence interval; Randomized controlled trial; Hazard ratio; Pharmacology; Atrial fibrillation","score_opus":0.3222111686277389,"score_gpt":0.5745221384572651,"score_spread":0.25231096982952617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136441191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018039037,0.9969869,0.00032331466,0.00015146374,0.00009747928,0.00025145023,0.00023932804,0.000011293261,0.00013492485],"genre_scores_gemma":[0.05373513,0.941268,0.0024036884,0.00061029824,0.00028213905,0.0010572629,0.0004403901,0.000015776526,0.00018723524],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9821284,0.008523346,0.0056879367,0.0012546316,0.0020203774,0.0003852613],"domain_scores_gemma":[0.9619814,0.028719101,0.006102389,0.0008349402,0.002083301,0.00027879656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017519895,0.003076272,0.02071764,0.012365311,0.0007211541,0.0035290448,0.0024155935,0.0026081088,0.003664666],"category_scores_gemma":[0.046538685,0.001743202,0.03063591,0.011792843,0.00073973014,0.001988094,0.00139106,0.0015500771,0.00037231066],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007831231,0.00003183101,0.0029576733,0.61182815,0.36930236,0.00017183933,0.0000809791,0.00035908923,0.0001781881,0.00012306914,0.00061781623,0.013565875],"study_design_scores_gemma":[0.00043834175,0.00029726516,0.003885814,0.068973765,0.92281705,0.00022862884,0.000062157866,0.00020803278,0.00013569692,0.00021637887,0.0027078863,0.000029023906],"about_ca_topic_score_codex":0.005102461,"about_ca_topic_score_gemma":0.0150818555,"teacher_disagreement_score":0.02071764,"about_ca_system_score_codex":0.0029002922,"about_ca_system_score_gemma":0.004865762,"threshold_uncertainty_score":0.09265512},"labels":[],"label_agreement":null},{"id":"W3137413844","doi":"10.1002/ansa.202000182","title":"Determining site occupancy of acetaminophen covalent binding to target proteins in vitro","year":2021,"lang":"en","type":"article","venue":"Analytical Science Advances","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; IONICS Mass Spectrometry (Canada); York University; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Microsome; Chromatography; Peptide; Trypsin; Biochemistry; Tandem mass spectrometry; Glutathione; Cysteine; In vitro; Mass spectrometry; Enzyme","score_opus":0.0894065477130122,"score_gpt":0.45793045371951063,"score_spread":0.3685239060064984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137413844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871744,0.00064822705,0.009722299,0.000028766835,0.00001194644,0.00003350609,0.00030896958,0.00007122604,0.00045769123],"genre_scores_gemma":[0.9843656,0.0007828184,0.011603472,0.000048967577,0.000010998656,0.00008144674,0.0009873561,0.000040184477,0.0020791523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995652,0.00009080786,0.000018911214,0.00011250443,0.00015937473,0.000053077685],"domain_scores_gemma":[0.9996748,0.000092587135,0.0000869327,0.000032480257,0.00007211615,0.000041122767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033839906,0.0004978243,0.00026144795,0.00020978725,0.0002251938,0.00022577705,0.00029343716,0.00028913,0.0008045002],"category_scores_gemma":[0.00045497125,0.00023140691,0.00022963673,0.0002912934,0.00022345409,0.00014596038,0.0002186972,0.00039321012,0.00036579205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041424893,0.000009296549,0.00019786907,0.000014807298,0.00000663165,0.000006193964,0.000010402856,0.000033650238,0.9993418,0.000008902745,0.000007948681,0.00032103786],"study_design_scores_gemma":[0.0000025578045,0.00009728528,0.003138283,0.000001408529,0.00001180613,0.000034273606,0.0000114830455,0.00083330274,0.9955171,0.00000735135,0.00034208564,0.0000030372944],"about_ca_topic_score_codex":0.0012412629,"about_ca_topic_score_gemma":0.0020256697,"teacher_disagreement_score":0.0012412629,"about_ca_system_score_codex":0.000353102,"about_ca_system_score_gemma":0.00020739606,"threshold_uncertainty_score":0.0026913881},"labels":[],"label_agreement":null},{"id":"W3137479900","doi":"10.1101/2021.03.12.435209","title":"Massively parallel characterization of CYP2C9 variant enzyme activity and abundance","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; National Institutes of Health; National Institute of General Medical Sciences; Canadian Institute for Advanced Research","keywords":"Missense mutation; CYP2C9; Cytochrome P450; Massive parallel sequencing; Biology; Enzyme; Genetics; Computational biology; Mutation; Gene; Biochemistry; DNA sequencing","score_opus":0.046612369599209114,"score_gpt":0.3204385899186883,"score_spread":0.2738262203194792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137479900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91605264,0.0008045866,0.058631856,0.00031965383,0.000121294746,0.00007789049,0.02073341,0.0017828775,0.0014757017],"genre_scores_gemma":[0.92846924,0.0003820505,0.039300043,0.00027570405,0.000049317016,0.00012665144,0.028978381,0.0005638912,0.0018546674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993931,0.000050573886,0.00003260618,0.00022033673,0.0002583597,0.000044936754],"domain_scores_gemma":[0.99931,0.00021245866,0.00007474327,0.0001350347,0.00019989046,0.00006786191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000861588,0.0004513739,0.0006708679,0.0006702764,0.0003317293,0.00065790943,0.00034558316,0.00042951462,0.0014014923],"category_scores_gemma":[0.00146948,0.00025012452,0.0005682698,0.00069687795,0.00030724498,0.00022014011,0.00038677827,0.0010700282,0.0007013712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006462485,0.00009523406,0.022897793,0.00019709936,0.00028767277,0.00020819726,0.00012478851,0.00632437,0.94508827,0.00068629987,0.0025621932,0.020881847],"study_design_scores_gemma":[0.00010457037,0.0003849841,0.14719476,0.000028412176,0.00023677097,0.0011935714,0.00013106948,0.10632773,0.7268394,0.0023495285,0.0151088545,0.000100237645],"about_ca_topic_score_codex":0.0014255504,"about_ca_topic_score_gemma":0.0019040611,"teacher_disagreement_score":0.0014255504,"about_ca_system_score_codex":0.00038777286,"about_ca_system_score_gemma":0.00024654387,"threshold_uncertainty_score":0.0046884418},"labels":[],"label_agreement":null},{"id":"W3137613371","doi":"10.1002/pds.5226","title":"Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine","year":2021,"lang":"en","type":"review","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; BC Children's Hospital; University of British Columbia; McGill University Health Centre","funders":"National Cancer Institute; International Society for Pharmacoepidemiology; GlaxoSmithKline","keywords":"Pharmacoepidemiology; Medicine; Precision medicine; Multidisciplinary approach; Observational study; Data science; Pharmacology; Computer science; Internal medicine","score_opus":0.2707884065667415,"score_gpt":0.5345554753125937,"score_spread":0.2637670687458522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137613371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011489787,0.955935,0.002275923,0.037646335,0.0022681938,0.000011824403,0.000022000531,0.000031656422,0.0016941611],"genre_scores_gemma":[0.0037062746,0.9666009,0.0046948087,0.017701538,0.005906892,0.00004432077,0.00004738406,0.000017379632,0.0012804982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99314284,0.0034044704,0.0005712444,0.0006127658,0.0020294017,0.00023932057],"domain_scores_gemma":[0.9766232,0.017641691,0.00088620937,0.0010057124,0.0030541015,0.00078906154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0148488395,0.0010779019,0.0034900717,0.0040702075,0.001030648,0.0059191664,0.0018072322,0.005152107,0.0033383188],"category_scores_gemma":[0.0131465625,0.0004955919,0.0017105556,0.0043685893,0.0065182177,0.010182088,0.0031912297,0.014468882,0.0014499872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012159573,0.00011256465,0.0006910286,0.018341085,0.00041360554,0.00034722866,0.00077342166,0.00061377825,0.00071974454,0.13562046,0.088737085,0.7535084],"study_design_scores_gemma":[0.000038480357,0.000083234256,0.0011219844,0.012555581,0.00012760315,0.00089939474,0.0005032272,0.0002197815,0.00019301598,0.09278126,0.8914163,0.00006019705],"about_ca_topic_score_codex":0.0020043212,"about_ca_topic_score_gemma":0.002862726,"teacher_disagreement_score":0.0148488395,"about_ca_system_score_codex":0.0042915503,"about_ca_system_score_gemma":0.00889933,"threshold_uncertainty_score":0.07852912},"labels":[],"label_agreement":null},{"id":"W3137643018","doi":"10.3389/fphar.2021.636650","title":"Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations","year":2021,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Women and Children’s Health Research Institute; University of Alberta; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Alberta Children's Hospital Research Institute; Alberta Innovates; University of Calgary","keywords":"Pharmacogenomics; Relevance (law); Computer science; Selection (genetic algorithm); Medicine; Pharmacology; Machine learning","score_opus":0.28351022781056223,"score_gpt":0.4678188859377251,"score_spread":0.18430865812716285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137643018","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006554544,0.0012522796,0.28635064,0.002533766,0.00086770725,0.0015485366,0.0737993,0.60919774,0.017895486],"genre_scores_gemma":[0.06992613,0.0029117996,0.6292002,0.00672643,0.00062494643,0.0047250194,0.10794919,0.14683186,0.031104418],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974564,0.0010310478,0.00039910825,0.00039068304,0.00057989464,0.00014281238],"domain_scores_gemma":[0.97843426,0.017268997,0.0013005589,0.0009922023,0.001050028,0.00095400296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056737186,0.00368896,0.0013150652,0.0031350132,0.0007252037,0.0031536962,0.0022661414,0.0026289131,0.06569855],"category_scores_gemma":[0.02226868,0.0016068592,0.0016559252,0.00182045,0.0010078201,0.0036366275,0.003401885,0.0028135306,0.038830213],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035464386,0.0004719878,0.005012475,0.0063832486,0.00033640594,0.0029787335,0.0019135898,0.006907466,0.01390159,0.008792914,0.68830043,0.26145473],"study_design_scores_gemma":[0.0017797808,0.00044477062,0.005975126,0.003590764,0.00017108323,0.0024286017,0.0005329588,0.06335467,0.034095906,0.035358872,0.8516033,0.000664141],"about_ca_topic_score_codex":0.0017605376,"about_ca_topic_score_gemma":0.0020382234,"teacher_disagreement_score":0.06569855,"about_ca_system_score_codex":0.0010384006,"about_ca_system_score_gemma":0.0026494195,"threshold_uncertainty_score":0.21978354},"labels":[],"label_agreement":null},{"id":"W3142974974","doi":"10.1080/03602532.2021.1909613","title":"Pharmacogenomics in the era of next generation sequencing – from byte to bedside","year":2021,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada); Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Personalized medicine; Identification (biology); Precision medicine; Drug response; Medicine; Computational biology; Drug development; Bioinformatics; Biology; Drug; Genetics; Pharmacology; Gene","score_opus":0.4136524474297684,"score_gpt":0.4852137435891885,"score_spread":0.07156129615942008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142974974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015573038,0.9950354,0.0007360081,0.0020399103,0.00037134142,0.000006136905,0.000040189865,0.000027745042,0.0015875178],"genre_scores_gemma":[0.0010493126,0.99560636,0.00097125693,0.0009824102,0.00046139894,0.000008632657,0.00006835767,0.0000065559466,0.00084557064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993419,0.00022896548,0.000064755855,0.000084400875,0.000232322,0.00004755783],"domain_scores_gemma":[0.9984072,0.0010006141,0.00012622299,0.000050455426,0.00033775799,0.00007772088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018058746,0.00073522807,0.0012896389,0.0019367252,0.00017897045,0.0014921273,0.00078516937,0.0015398521,0.004536252],"category_scores_gemma":[0.002147032,0.00024261976,0.0008190047,0.0019975386,0.000570633,0.0017338927,0.0008493209,0.0028285487,0.0025287624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006477601,0.00003892665,0.00022956748,0.010011149,0.00015755794,0.00023030031,0.000058227764,0.0005846807,0.0016242432,0.007841724,0.038345214,0.94081354],"study_design_scores_gemma":[0.000015253627,0.000073129195,0.00070717273,0.0038102805,0.00013416978,0.0014190444,0.00005261043,0.00023714114,0.00061734667,0.0071991454,0.98571044,0.00002426457],"about_ca_topic_score_codex":0.0012762054,"about_ca_topic_score_gemma":0.0018851148,"teacher_disagreement_score":0.004536252,"about_ca_system_score_codex":0.00089334603,"about_ca_system_score_gemma":0.0017647655,"threshold_uncertainty_score":0.015175223},"labels":[],"label_agreement":null},{"id":"W3150399700","doi":"10.1111/fcp.12674","title":"The numerical probability of carcinogenicity to humans of some pharmaceutical drugs: Alkylating agents, topoisomerase inhibitors or poisons, and DNA intercalators","year":2021,"lang":"en","type":"article","venue":"Fundamental and Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacology; Predictive testing; Safety pharmacology; Risk assessment; European union; Carcinogen; Oxcarbazepine; Toxicology; Drug; Carbamazepine; Biology; Genetic testing; Internal medicine; Business; Psychiatry; Computer science","score_opus":0.14353205725434814,"score_gpt":0.48414025489091667,"score_spread":0.3406081976365685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150399700","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22057953,0.049910896,0.49413764,0.024025258,0.002991322,0.0010464588,0.008736993,0.00086690724,0.19770509],"genre_scores_gemma":[0.9208134,0.007814382,0.06177229,0.0013128347,0.0007583416,0.0003996883,0.0015773989,0.00006926061,0.00548247],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97699773,0.012713695,0.002007396,0.0015335314,0.006462781,0.00028487522],"domain_scores_gemma":[0.8860901,0.090748526,0.010914164,0.005454764,0.0064297356,0.00036280346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0208637,0.00064873544,0.0006909414,0.0036964372,0.00041364998,0.0034027258,0.0012358858,0.0015306904,0.00687914],"category_scores_gemma":[0.09960893,0.0003000248,0.0014134774,0.0023752374,0.003542793,0.002306221,0.0011670731,0.0018913093,0.0012857671],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029998275,0.0002790825,0.1550658,0.006097124,0.0014178902,0.0012900775,0.0016333425,0.04022668,0.010104243,0.25301492,0.0208366,0.5070344],"study_design_scores_gemma":[0.0003145256,0.0058532585,0.22159664,0.0034128602,0.0021597997,0.011755636,0.0027712944,0.07286044,0.045838397,0.34942028,0.28335026,0.00066669635],"about_ca_topic_score_codex":0.0010213095,"about_ca_topic_score_gemma":0.0010586461,"teacher_disagreement_score":0.0208637,"about_ca_system_score_codex":0.0014302772,"about_ca_system_score_gemma":0.0016339606,"threshold_uncertainty_score":0.110339105},"labels":[],"label_agreement":null},{"id":"W3151820029","doi":"10.1016/j.jbc.2021.100645","title":"Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase","year":2021,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Oxidoreductase; Cytochrome P450; Chemistry; Cytochrome; Stereochemistry; Biology; Biochemistry; Enzyme","score_opus":0.14069016616531782,"score_gpt":0.3828959785332188,"score_spread":0.24220581236790095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151820029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227,0.00016336798,0.006755811,0.00006974967,0.000008194177,0.000025508885,0.0001442625,0.000059833506,0.0005033343],"genre_scores_gemma":[0.9895509,0.00019819279,0.00794381,0.000042597483,0.000004125397,0.000054659802,0.00043360825,0.000039155722,0.0017328433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990296,0.000021950793,0.000009771392,0.000023252634,0.00002572929,0.000016330065],"domain_scores_gemma":[0.9999188,0.0000148545,0.000024855406,0.000011140647,0.000015034388,0.000015275471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019374467,0.00028488846,0.00019733097,0.00011684801,0.0001380249,0.00027628615,0.0002448292,0.00032332703,0.00053874456],"category_scores_gemma":[0.00021746977,0.00015961503,0.00019223044,0.000102767015,0.0001834731,0.0002523799,0.00029911744,0.00049047946,0.00030510913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022712838,0.000009631263,0.000057364567,0.000012340292,0.0000030759777,0.00001907569,0.000011146526,0.00005181439,0.99932134,0.00006924894,0.000013721606,0.00040851388],"study_design_scores_gemma":[0.000006676928,0.000052819683,0.00059736666,0.0000013374017,0.000005575447,0.00006207509,0.000010129267,0.0017202569,0.99650663,0.000023780058,0.0010101919,0.000003100367],"about_ca_topic_score_codex":0.00034659938,"about_ca_topic_score_gemma":0.00036623064,"teacher_disagreement_score":0.00053874456,"about_ca_system_score_codex":0.0002607872,"about_ca_system_score_gemma":0.00012974176,"threshold_uncertainty_score":0.0018921494},"labels":[],"label_agreement":null},{"id":"W3152442784","doi":"10.1007/978-1-60327-362-6_4","title":"Drug-Metabolizing Enzymes","year":2009,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Xenobiotic; Drug; Enzyme; Drug metabolism; Biology; Computational biology; Pharmacology; Disposition; Biochemistry; Psychology","score_opus":0.21896576076369156,"score_gpt":0.42021657745495455,"score_spread":0.201250816691263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152442784","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012812754,0.33087137,0.032166287,0.006184801,0.0036437989,0.00049550436,0.008357189,0.00212533,0.60334295],"genre_scores_gemma":[0.043940675,0.17955777,0.028594235,0.0032888043,0.00078538293,0.00027250496,0.007312184,0.00024817206,0.7360004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984026,0.00001764629,0.0000119360575,0.000041528445,0.000066313674,0.000022405608],"domain_scores_gemma":[0.9999068,0.000017730816,0.000012544837,0.000012394973,0.0000365175,0.000014062031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018578663,0.00086264435,0.00045092145,0.0009537552,0.00030591918,0.001188459,0.00054009986,0.0006917353,0.029370459],"category_scores_gemma":[0.00020921955,0.00019889105,0.00052529585,0.001010374,0.00032544264,0.00082046975,0.0006634974,0.0011981187,0.04181334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015723807,0.00013629679,0.00095187075,0.0013252768,0.00003221521,0.00040274928,0.00012789693,0.00048451536,0.053825803,0.04673669,0.15339574,0.74242365],"study_design_scores_gemma":[0.00000830999,0.000042943568,0.00067518017,0.00009972945,0.0000072630696,0.0005966478,0.000017241853,0.000086794484,0.008749375,0.0029798527,0.98672926,0.0000073115716],"about_ca_topic_score_codex":0.001146859,"about_ca_topic_score_gemma":0.0014418798,"teacher_disagreement_score":0.029370459,"about_ca_system_score_codex":0.000586186,"about_ca_system_score_gemma":0.00055127457,"threshold_uncertainty_score":0.098253965},"labels":[],"label_agreement":null},{"id":"W3153779616","doi":"10.1007/s12010-021-03573-1","title":"Optimisation of Cytochrome P450 BM3 Assisted by Consensus-Guided Evolution","year":2021,"lang":"en","type":"article","venue":"Applied Biochemistry and Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cofactor; Bacillus megaterium; Mutant; Chemistry; Thermostability; Enzyme; Protein engineering; Directed evolution; Biochemistry; Reductase; Oxidase test; Oxidoreductase; Stereochemistry; Biology; Gene","score_opus":0.04895245608808637,"score_gpt":0.3611584704064935,"score_spread":0.31220601431840717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153779616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7266747,0.0023342404,0.2572158,0.00051949953,0.00021539548,0.00026738053,0.00046105965,0.0021645813,0.010147498],"genre_scores_gemma":[0.8926209,0.00057376834,0.10311175,0.00016693726,0.000020536385,0.0001754997,0.0007391509,0.00026033205,0.0023310834],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996542,0.00011557437,0.000016254971,0.00007714215,0.000077995224,0.00005901886],"domain_scores_gemma":[0.99978334,0.00010253074,0.000020660636,0.0000174244,0.000054049025,0.00002215527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064458285,0.0009261042,0.001078399,0.00034893476,0.0004299632,0.00071113784,0.000762586,0.000780819,0.0027081952],"category_scores_gemma":[0.0015508818,0.00026049573,0.00071855134,0.00049660675,0.00027023198,0.00029532152,0.0006247247,0.0011641828,0.00067034573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022156762,0.00075752963,0.004137005,0.0007929203,0.00038511716,0.0009943927,0.00027857185,0.5214834,0.21101871,0.009179311,0.0039577056,0.24479966],"study_design_scores_gemma":[0.0002773709,0.0007169728,0.0008345578,0.000029655097,0.00014486322,0.0002262685,0.00009747096,0.9406576,0.048514187,0.0019616897,0.0064979997,0.000041345313],"about_ca_topic_score_codex":0.0025807214,"about_ca_topic_score_gemma":0.0035706414,"teacher_disagreement_score":0.0027081952,"about_ca_system_score_codex":0.00064334035,"about_ca_system_score_gemma":0.0010367236,"threshold_uncertainty_score":0.009059846},"labels":[],"label_agreement":null},{"id":"W3154287913","doi":"10.1007/s12104-021-10024-9","title":"1H, 13C and 15N chemical shift assignments of the C-terminal domain of human UDP-Glucuronosyltransferase 2B7 (UGT2B7-C)","year":2021,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institutes of Health","keywords":"UGT2B7; Glucuronidation; Chemistry; Glucuronosyltransferase; Enzyme; Biochemistry; Pharmacology; Stereochemistry; Biology","score_opus":0.05190881118395088,"score_gpt":0.3939884056558117,"score_spread":0.34207959447186087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154287913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580506,0.004362144,0.022967719,0.0013464865,0.0002488544,0.000049988503,0.0023706562,0.00018158059,0.010421888],"genre_scores_gemma":[0.9496862,0.0030965796,0.03046729,0.0009970736,0.0001271669,0.00011511164,0.0064084465,0.00014879346,0.008953361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979776,0.000045355955,0.000009841765,0.000041526444,0.000052621657,0.00005280001],"domain_scores_gemma":[0.99939,0.00011198336,0.00007853163,0.000057871308,0.00021713882,0.00014438503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052236643,0.00047375748,0.0002901365,0.0005360758,0.0008768273,0.0001917967,0.000624337,0.0007480789,0.002749636],"category_scores_gemma":[0.00071368855,0.00019981562,0.0003188216,0.00086290785,0.00052403886,0.00044434858,0.00027367027,0.0009934693,0.0003696476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072040275,0.00007581752,0.000844444,0.00016605282,0.00004030192,0.00037663968,0.00017547207,0.0011367397,0.98479754,0.0008731355,0.0018140622,0.008979532],"study_design_scores_gemma":[0.000121723664,0.0006720422,0.015086411,0.000049302627,0.00012533192,0.0013185808,0.00028028383,0.012271944,0.94683224,0.0009502057,0.022210842,0.00008118464],"about_ca_topic_score_codex":0.0035662993,"about_ca_topic_score_gemma":0.0046478137,"teacher_disagreement_score":0.0035662993,"about_ca_system_score_codex":0.00056814036,"about_ca_system_score_gemma":0.0007148192,"threshold_uncertainty_score":0.009198427},"labels":[],"label_agreement":null},{"id":"W3156238525","doi":"10.1002/jgc4.1417","title":"Pharmacogenomic education among genetic counseling training programs in North America","year":2021,"lang":"en","type":"article","venue":"Journal of Genetic Counseling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Genetic counseling; Medicine; Medical education; Scope (computer science); Family medicine; Psychology; Pharmacology; Genetics; Computer science; Biology","score_opus":0.09227301561252313,"score_gpt":0.3854470921131844,"score_spread":0.2931740765006613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156238525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928462,0.00042178834,0.0001427517,0.003135453,0.000027318554,0.00008702924,0.00008529777,0.000014737479,0.0032393867],"genre_scores_gemma":[0.99612385,0.000515321,0.00051324704,0.0020293442,0.000020528314,0.00009369306,0.00008712274,0.0000049459227,0.00061191095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974279,0.00091361493,0.00010467117,0.0002691432,0.0005626892,0.0007220218],"domain_scores_gemma":[0.9876133,0.0024959461,0.0020073315,0.00032177073,0.0015961401,0.005965486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030725994,0.00017131277,0.00018570888,0.00092545804,0.002382635,0.0012113849,0.00075215526,0.0006343159,0.0027989591],"category_scores_gemma":[0.0066125295,0.00023591841,0.00018983522,0.001370161,0.0007147565,0.0006902184,0.0015611367,0.0008173679,0.00013304371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023201865,0.002094788,0.8296719,0.00023881071,0.00006002942,0.0006082206,0.024812974,0.00023777738,0.0022678657,0.0005460112,0.00638219,0.13284732],"study_design_scores_gemma":[0.00005162874,0.0005951316,0.95481145,0.0002798238,0.00003725917,0.00031731182,0.03501279,0.0003636957,0.0004254305,0.0001252106,0.00796338,0.000016868504],"about_ca_topic_score_codex":0.12772813,"about_ca_topic_score_gemma":0.35305542,"teacher_disagreement_score":0.12772813,"about_ca_system_score_codex":0.00464805,"about_ca_system_score_gemma":0.015644383,"threshold_uncertainty_score":0.25396937},"labels":[],"label_agreement":null},{"id":"W3158165938","doi":"10.1016/j.taap.2021.115553","title":"Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification","year":2021,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta; University of Alberta","keywords":"Mefenamic acid; Chemistry; Enzyme; Non-competitive inhibition; Metabolism; Sulfotransferase; Recombinant DNA; Biochemistry; Substrate (aquarium); Metabolite; Enzyme kinetics; Sulfation; Pharmacology; Chromatography; Biology; Active site","score_opus":0.0478711672261613,"score_gpt":0.3618449695363472,"score_spread":0.3139738023101859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158165938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194676,0.0010363316,0.005865602,0.000102594575,0.000010787494,0.000029565275,0.00048919657,0.000025027724,0.0004942065],"genre_scores_gemma":[0.9906529,0.0007197182,0.00396154,0.000038343645,0.000012433219,0.00001558476,0.0025545966,0.000012671033,0.0020323095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993074,0.000015626201,0.0000070393194,0.000011058383,0.000016180702,0.000019333804],"domain_scores_gemma":[0.99985576,0.000041267886,0.000025812966,0.000021353708,0.00003100807,0.000024772291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001928048,0.00020584484,0.00016872899,0.0001771847,0.00008852905,0.00016771782,0.00009830121,0.00014570048,0.00069026975],"category_scores_gemma":[0.00030169045,0.00010007164,0.00020809808,0.00012301769,0.00014109012,0.0001145454,0.00006733112,0.00018734655,0.0002527218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026052372,0.000039165436,0.0010283582,0.000014858435,0.000009743442,0.00008432605,0.000023892631,0.00016982295,0.9956993,0.00015608834,0.000032325737,0.0024816687],"study_design_scores_gemma":[0.000017748871,0.00035371154,0.008987818,0.0000025234785,0.00001965335,0.0007796998,0.000029627487,0.0010144701,0.98569655,0.00007414176,0.0030196644,0.0000043541336],"about_ca_topic_score_codex":0.001551279,"about_ca_topic_score_gemma":0.0014868709,"teacher_disagreement_score":0.001551279,"about_ca_system_score_codex":0.00016419486,"about_ca_system_score_gemma":0.00024811723,"threshold_uncertainty_score":0.0030844808},"labels":[],"label_agreement":null},{"id":"W3158869533","doi":"10.3390/ijms22094967","title":"Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity","year":2021,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Diabetes mellitus; Pharmacogenomics; Pharmacology; Population; Type 2 Diabetes Mellitus; Polypharmacy; Cytochrome P450; Disease; Drug; Metabolic syndrome; Internal medicine; Bioinformatics; Endocrinology; Biology; Metabolism","score_opus":0.10230852827192156,"score_gpt":0.42585599530431945,"score_spread":0.3235474670323979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158869533","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427792,0.03517234,0.0016555276,0.0013284523,0.00027642326,0.00021980306,0.0019698462,0.0001032101,0.016495029],"genre_scores_gemma":[0.98996395,0.0055465987,0.00095315353,0.0005088998,0.0002878777,0.00010311679,0.00092367304,0.000010336349,0.0017023176],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994773,0.0001454232,0.00008552202,0.0000957006,0.00011489592,0.000081208884],"domain_scores_gemma":[0.99912065,0.0001409284,0.0004357653,0.000038933904,0.00016505198,0.00009858224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039274787,0.00032708998,0.0005528964,0.00058415,0.00045953845,0.00053497247,0.00015005244,0.00040122832,0.0027376488],"category_scores_gemma":[0.0015088968,0.00014111704,0.00039978247,0.0009938754,0.0001686402,0.00028339418,0.00027697082,0.0007076558,0.0004032914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018600586,0.0002644995,0.95216674,0.00050859246,0.00020505673,0.0040607234,0.00034389552,0.00007711762,0.0070771324,0.00018908824,0.0020965552,0.031150533],"study_design_scores_gemma":[0.00005889326,0.00043900465,0.9814231,0.00018812175,0.00026577176,0.009054416,0.00034810294,0.00019461996,0.00092726183,0.00028764448,0.006793824,0.000019253159],"about_ca_topic_score_codex":0.001008999,"about_ca_topic_score_gemma":0.0010335885,"teacher_disagreement_score":0.0027376488,"about_ca_system_score_codex":0.00023457334,"about_ca_system_score_gemma":0.00020899964,"threshold_uncertainty_score":0.009158313},"labels":[],"label_agreement":null},{"id":"W3160783224","doi":"10.3389/fphar.2021.693922","title":"Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites","year":2021,"lang":"en","type":"editorial","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Drug metabolism; Medicine","score_opus":0.0653721387909663,"score_gpt":0.44584092350333554,"score_spread":0.3804687847123692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160783224","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045987123,0.0060981256,0.00033311403,0.021467747,0.96996206,0.000024323508,0.00009278525,0.00008038008,0.0018955559],"genre_scores_gemma":[0.00042291416,0.004409406,0.00020101768,0.014337249,0.9707187,0.00002403258,0.000055986617,0.00005561963,0.009775173],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971112,0.00052231125,0.0003886292,0.00044400545,0.0013906455,0.0001431219],"domain_scores_gemma":[0.9849102,0.0067057116,0.00095357525,0.00038610277,0.005541921,0.0015025656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004115435,0.003641633,0.0033215564,0.002464616,0.0019352003,0.0051293056,0.0025806096,0.01276534,0.011947895],"category_scores_gemma":[0.015006549,0.0011490914,0.0027804251,0.001014643,0.0017147968,0.0035736521,0.0011298045,0.0161695,0.018023051],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037799397,0.000014796499,0.000016643547,0.00012327131,0.0000113459955,0.00009400318,0.0000038703956,0.00004760888,0.00006479613,0.00016875031,0.9951031,0.00431389],"study_design_scores_gemma":[0.00009424603,0.000058832222,0.00033202142,0.0004277091,0.000055792458,0.0005950912,0.000017729344,0.00058967003,0.000244454,0.001469038,0.9960891,0.000026364645],"about_ca_topic_score_codex":0.0012680811,"about_ca_topic_score_gemma":0.0027741084,"teacher_disagreement_score":0.01276534,"about_ca_system_score_codex":0.0019861574,"about_ca_system_score_gemma":0.001780498,"threshold_uncertainty_score":0.039969683},"labels":[],"label_agreement":null},{"id":"W3161677145","doi":"10.48087/bjmstf.2014.1211","title":"Update on the drug-food interactions","year":2014,"lang":"en","type":"article","venue":"Batna Journal of Medical Sciences (BJMS)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Theophylline; Pharmacology; Chemistry; Grapefruit juice; Caffeine; Pharmacokinetics; Drug interaction; Drug metabolism; Pharmacodynamics; Free fraction; Medicine; Internal medicine","score_opus":0.18164412083202278,"score_gpt":0.4758485892151876,"score_spread":0.29420446838316483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161677145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048559628,0.9517708,0.0010467205,0.0222151,0.007057391,0.000078491765,0.0010671322,0.00018890276,0.016089858],"genre_scores_gemma":[0.0037379193,0.95469606,0.0018341282,0.01772313,0.008810375,0.00010153443,0.0022540118,0.000040649982,0.010802101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984016,0.00037817948,0.0003083398,0.00014801699,0.000676841,0.0000869578],"domain_scores_gemma":[0.99251705,0.0029261762,0.00086061994,0.0001791227,0.0030402008,0.00047683355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022788858,0.0009734709,0.0020581589,0.0029466823,0.00043737213,0.0020834247,0.0016586952,0.0027512044,0.018402107],"category_scores_gemma":[0.008226413,0.00033304724,0.0016514702,0.00268051,0.00045501717,0.0027627624,0.0009793427,0.003656461,0.007996323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017882706,0.000053642743,0.00067350577,0.0076203663,0.0001904552,0.00035475986,0.00005245031,0.00015932003,0.00032563615,0.0018124415,0.34738,0.6411986],"study_design_scores_gemma":[0.000030272586,0.00007029088,0.0007766096,0.0033929276,0.00020869626,0.0010861204,0.000029110555,0.00005692883,0.000099080295,0.00074215676,0.99349314,0.000014764377],"about_ca_topic_score_codex":0.0026664282,"about_ca_topic_score_gemma":0.0068845074,"teacher_disagreement_score":0.018402107,"about_ca_system_score_codex":0.0013912725,"about_ca_system_score_gemma":0.0024956272,"threshold_uncertainty_score":0.061561167},"labels":[],"label_agreement":null},{"id":"W3163833951","doi":"10.1002/prp2.775","title":"The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs","year":2021,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Health Research Foundation; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Anticholinergic; CYP2D6; Medicine; Pharmacokinetics; Pharmacology; Adverse effect; Drug; CYP2C19; Population; Drug metabolism; Internal medicine; Cytochrome P450; Metabolism","score_opus":0.18636445799063292,"score_gpt":0.5187489279675305,"score_spread":0.3323844699768975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163833951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2085417,0.7758299,0.0025803826,0.0023278221,0.0005237475,0.00005535745,0.0012571458,0.000031724147,0.008852227],"genre_scores_gemma":[0.5872363,0.40410686,0.0016068051,0.001297711,0.0009465457,0.00006134768,0.0009512673,0.0000301646,0.0037630778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994629,0.00018323962,0.00008237288,0.00010280469,0.00011841451,0.000050346902],"domain_scores_gemma":[0.9984182,0.0009119876,0.00038833154,0.00005894111,0.00017187154,0.00005056996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009817203,0.00026966754,0.0006599614,0.00037778952,0.0001878816,0.00063695473,0.00021259565,0.00037719661,0.0020852846],"category_scores_gemma":[0.002873625,0.0001595435,0.0008993012,0.00073827803,0.00025743758,0.000491889,0.00025103285,0.00039343868,0.00026631812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003372719,0.0001884503,0.47371268,0.008383213,0.004514852,0.0030871145,0.0007282052,0.0010407165,0.0069641895,0.0029386368,0.007936692,0.48713258],"study_design_scores_gemma":[0.000113119015,0.0010922278,0.9042474,0.0014419248,0.0029837384,0.008676258,0.00033972113,0.00079941784,0.0024756761,0.003004241,0.0747594,0.000066887085],"about_ca_topic_score_codex":0.0015249824,"about_ca_topic_score_gemma":0.0018544747,"teacher_disagreement_score":0.0020852846,"about_ca_system_score_codex":0.00022743012,"about_ca_system_score_gemma":0.00038351255,"threshold_uncertainty_score":0.0069760084},"labels":[],"label_agreement":null},{"id":"W3163983628","doi":"10.1111/cts.13083","title":"Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Health care; Pharmacogenomics; Personalized medicine; Medicine; Business; Public relations; Medical education; Family medicine; Knowledge management; Computer science; Political science; Bioinformatics; Pharmacology","score_opus":0.2621606496445811,"score_gpt":0.5196457410110468,"score_spread":0.2574850913664657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163983628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7624228,0.003294811,0.0052790074,0.18129528,0.00012706395,0.00026185357,0.00016647855,0.00004174569,0.047111046],"genre_scores_gemma":[0.9942047,0.0010748755,0.0013413866,0.0021886355,0.0000106815405,0.000037012647,0.000024606572,0.000009727092,0.0011083435],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9710414,0.011863806,0.00085962436,0.0012868826,0.0072902376,0.007658089],"domain_scores_gemma":[0.9707017,0.014755393,0.0023108574,0.000645815,0.006597664,0.0049884873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021839943,0.0005448867,0.0005380387,0.0025911964,0.031827543,0.014485059,0.002524848,0.0026353751,0.0022254358],"category_scores_gemma":[0.027176581,0.00056822324,0.00046054088,0.0041239862,0.018032793,0.005351179,0.007890644,0.004377492,0.0001031094],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000074528594,0.000083223014,0.054543372,0.00047788973,0.00004678019,0.0016434261,0.8070939,0.0008886558,0.0016586245,0.08418902,0.005360221,0.04394036],"study_design_scores_gemma":[0.000012089538,0.0000601986,0.033482697,0.0005521298,0.00004290694,0.0002016092,0.9159325,0.0017451249,0.00057959603,0.008892616,0.03839017,0.00010836843],"about_ca_topic_score_codex":0.94809145,"about_ca_topic_score_gemma":0.9556867,"teacher_disagreement_score":0.94809145,"about_ca_system_score_codex":0.15170316,"about_ca_system_score_gemma":0.24746926,"threshold_uncertainty_score":0.98390406},"labels":[],"label_agreement":null},{"id":"W3165001409","doi":"10.1001/jamanetworkopen.2021.10446","title":"Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting","year":2021,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; SickKids Foundation; University of Toronto; Institute for Clinical Evaluative Sciences; Ted Rogers Centre for Heart Research; Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Medicine; Cohort; Pharmacogenetics; Adverse effect; Dosing; Genetic testing; Intensive care medicine; Internal medicine; Pharmacology; Genotype; Genetics","score_opus":0.07478268916283516,"score_gpt":0.46571302854056784,"score_spread":0.3909303393777327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165001409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996412,0.00017712246,0.00042796243,0.0005305701,0.0000088745965,0.00011180619,0.0011646596,0.000018268507,0.0011487029],"genre_scores_gemma":[0.99840456,0.00012057041,0.0007268629,0.000150128,0.000014682936,0.00006811838,0.00041998952,0.000004573668,0.00009059212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932944,0.0025491351,0.0005318316,0.00078946457,0.0017420683,0.0010930932],"domain_scores_gemma":[0.9783028,0.0032274937,0.012164368,0.0010018706,0.0031061051,0.0021973355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005478378,0.00029195735,0.00024180433,0.00060491206,0.0007398951,0.0012233066,0.0013354574,0.0005002903,0.0015241229],"category_scores_gemma":[0.023490058,0.0003258801,0.0004147243,0.0011568284,0.0005752819,0.0008413153,0.0013282577,0.00091683556,0.00019638345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046546655,0.00004155245,0.99683917,0.000015370215,0.000017583343,0.000046155586,0.00019684834,0.000113996204,0.00005557427,0.00004097438,0.0002605607,0.0023255656],"study_design_scores_gemma":[0.000012280228,0.0003355677,0.9978212,0.000024966992,0.000019824509,0.00014831604,0.0006086257,0.00047695966,0.00015699724,0.000016208554,0.00037461688,0.0000044688322],"about_ca_topic_score_codex":0.07034631,"about_ca_topic_score_gemma":0.08583669,"teacher_disagreement_score":0.07034631,"about_ca_system_score_codex":0.0065156,"about_ca_system_score_gemma":0.00880288,"threshold_uncertainty_score":0.13987368},"labels":[],"label_agreement":null},{"id":"W3167235221","doi":"10.1096/fasebj.27.1_supplement.672.2","title":"FUNCTIONAL ACTIVITY IN HUMAN HEART EXPRESSING CYP1A1","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Metabolite; Western blot; Microsome; Cytosol; Chemistry; Metabolism; Monoclonal antibody; Human heart; Biochemistry; Active metabolite; Molecular biology; Pharmacology; Biology; Antibody; Enzyme; Internal medicine; Medicine; Gene; Immunology","score_opus":0.14030844601327447,"score_gpt":0.4162957883799558,"score_spread":0.2759873423666813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167235221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759235,0.009980562,0.0071902894,0.00031733137,0.00014046246,0.00010878845,0.0029111372,0.00025786928,0.0031701168],"genre_scores_gemma":[0.9744999,0.0036809095,0.0064324928,0.00014945785,0.0000933989,0.00012164727,0.009572867,0.000084451734,0.005364881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996948,0.00006227357,0.000026231619,0.000101485566,0.000072327384,0.00004283618],"domain_scores_gemma":[0.9998841,0.000037269303,0.00002005943,0.000020116117,0.00002590949,0.000012614134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035453943,0.00025568737,0.00029067666,0.000219459,0.00017591155,0.0003636055,0.0001365825,0.00023801463,0.0030216575],"category_scores_gemma":[0.00029904072,0.00013714928,0.00028552095,0.0003203569,0.00013709503,0.000143505,0.00015725862,0.00045862622,0.0013698909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021358952,0.000050740182,0.00088253524,0.00007887528,0.000015588967,0.00007298264,0.00003284861,0.00007602402,0.99479574,0.00006792772,0.00031536,0.0033979057],"study_design_scores_gemma":[0.000077050776,0.0014308166,0.01935287,0.000018412875,0.000110931,0.001786465,0.0000734046,0.0015483097,0.9583376,0.00008160622,0.017168336,0.000014224703],"about_ca_topic_score_codex":0.000905447,"about_ca_topic_score_gemma":0.00067104056,"teacher_disagreement_score":0.0030216575,"about_ca_system_score_codex":0.00025839044,"about_ca_system_score_gemma":0.0001226085,"threshold_uncertainty_score":0.010108471},"labels":[],"label_agreement":null},{"id":"W3167236456","doi":"10.3389/fendo.2021.633785","title":"Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase","year":2021,"lang":"en","type":"article","venue":"Frontiers in Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Freie Universität Berlin; World Anti-Doping Agency","keywords":"Pregnenolone; Hydroxylation; Steroid; Enzyme; Biosynthesis; Cytochrome P450; Biochemistry; Chemistry; Biotransformation; Steroid biosynthesis; Schizosaccharomyces pombe; Yeast; Saccharomyces cerevisiae; Hormone","score_opus":0.035982251324195226,"score_gpt":0.34676760779807475,"score_spread":0.3107853564738795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167236456","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.095515065,0.7737716,0.047113378,0.049224287,0.0054067792,0.0000447851,0.0006998387,0.0005618235,0.027662424],"genre_scores_gemma":[0.5296494,0.42836696,0.014199092,0.008938502,0.001683836,0.00003586063,0.0008745571,0.00022771276,0.016024098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993736,0.000117355296,0.000040902407,0.00020460648,0.00017094452,0.000092605864],"domain_scores_gemma":[0.9995802,0.00012022858,0.00005875628,0.000061425955,0.00011514711,0.000064291395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010847243,0.00066218985,0.0011606612,0.00030378558,0.00040047936,0.0016116159,0.0009433837,0.001373125,0.0026676913],"category_scores_gemma":[0.000880095,0.00023402066,0.00049711636,0.00061424036,0.0013722086,0.0024679725,0.0007928432,0.002712451,0.001340851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009794295,0.00007797734,0.004074565,0.005422967,0.00031274205,0.002913156,0.0005805529,0.0017316446,0.62538904,0.09030953,0.017408004,0.25080043],"study_design_scores_gemma":[0.000066108834,0.00064370094,0.0055028973,0.0006585911,0.00027215556,0.0046585714,0.00066122675,0.0021859528,0.25404987,0.04600182,0.6851711,0.00012800044],"about_ca_topic_score_codex":0.0021085497,"about_ca_topic_score_gemma":0.0024823416,"teacher_disagreement_score":0.0026676913,"about_ca_system_score_codex":0.0014467535,"about_ca_system_score_gemma":0.0010728387,"threshold_uncertainty_score":0.010496974},"labels":[],"label_agreement":null},{"id":"W3167472691","doi":"10.1096/fasebj.27.1_supplement.672.3","title":"Genetic and clinical determinants of CYP3A4 activity in patients using 4β‐hydroxycholesterol as an in vivo probe","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CYP3A; In vivo; CYP3A4; Chemistry; Metabolite; CYP3A5; Pharmacokinetics; Genotyping; Endocrinology; Cytochrome P450; Internal medicine; Pharmacology; Genotype; Metabolism; Biochemistry; Biology; Medicine; Gene; Genetics","score_opus":0.11065352537229572,"score_gpt":0.4468736080368727,"score_spread":0.336220082664577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167472691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994954,0.00010960047,0.000070826645,0.000021099133,0.000002757745,0.0000053752856,0.00007467235,0.0000029266146,0.00021737514],"genre_scores_gemma":[0.99967587,0.000029679992,0.000057428995,0.000014515464,0.000007778791,0.0000049220826,0.0001018683,0.0000025608733,0.000105303414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956065,0.00011458618,0.000050918836,0.00013639718,0.00007029206,0.0000672196],"domain_scores_gemma":[0.99856085,0.0004591837,0.00049888314,0.00010489905,0.00009167765,0.00028457335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044588884,0.00041342367,0.0005172485,0.00067758706,0.0005229299,0.0005430849,0.00026896247,0.00070035923,0.0019183188],"category_scores_gemma":[0.002213019,0.00028961914,0.00036832708,0.00082094804,0.0004042045,0.00031958878,0.00021717159,0.00068590825,0.00034433004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006703531,0.00005367668,0.99507314,0.0000055132223,0.00004989146,0.0006405815,0.00007176119,0.00006844047,0.0020201737,0.000036442416,0.000060805087,0.0012491235],"study_design_scores_gemma":[0.00002405477,0.00024696818,0.9965732,0.0000038060318,0.00003610739,0.0021972782,0.00008595437,0.0003317633,0.00031663684,0.00005577429,0.00012210582,0.000006245879],"about_ca_topic_score_codex":0.0014826285,"about_ca_topic_score_gemma":0.0011120765,"teacher_disagreement_score":0.0019183188,"about_ca_system_score_codex":0.00028762608,"about_ca_system_score_gemma":0.00018906443,"threshold_uncertainty_score":0.0064173937},"labels":[],"label_agreement":null},{"id":"W3169297055","doi":"10.3390/molecules26123614","title":"Molecular Dynamics Simulations of a Cytochrome P450 from Tepidiphilus thermophilus (P450-TT) Reveal How Its Substrate-Binding Channel Opens","year":2021,"lang":"en","type":"article","venue":"Molecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cytochrome P450; Molecular dynamics; Chemistry; Substrate (aquarium); Enzyme; Stereochemistry; Molecule; Xenobiotic; Side chain; Biophysics; Biochemistry; Computational chemistry; Organic chemistry; Biology; Polymer","score_opus":0.08729028499090143,"score_gpt":0.38269713511132236,"score_spread":0.29540685012042095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169297055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909185,0.00034703937,0.0017139888,0.0005289188,0.00007732986,0.000030187886,0.0005036607,0.00013686989,0.005743468],"genre_scores_gemma":[0.9945133,0.00026562644,0.00275497,0.00012587023,0.000020076319,0.000076711614,0.0010659988,0.000058159494,0.0011194447],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99987423,0.000027929837,0.00000540249,0.000019148083,0.000023435272,0.000049785],"domain_scores_gemma":[0.9994648,0.00028290102,0.000040533076,0.000024989735,0.000091195674,0.00009571235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034165347,0.0007627604,0.00081784197,0.0003740737,0.0011084884,0.0007345789,0.0007731837,0.0013124445,0.002969533],"category_scores_gemma":[0.0011728873,0.00042224032,0.00075751456,0.0004448154,0.00072918186,0.0006454234,0.0005143466,0.0014438673,0.00022517749],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015615368,0.0008853604,0.013892796,0.00028048997,0.00032327388,0.0008298082,0.0003996852,0.94875467,0.014244957,0.007271707,0.0039227116,0.0076330565],"study_design_scores_gemma":[0.00014161173,0.00020898422,0.0027523534,0.000018509652,0.000029698442,0.000018756205,0.00009883425,0.9940626,0.0010374982,0.00084705796,0.0007684644,0.000015677822],"about_ca_topic_score_codex":0.0219716,"about_ca_topic_score_gemma":0.015445182,"teacher_disagreement_score":0.0219716,"about_ca_system_score_codex":0.00089998695,"about_ca_system_score_gemma":0.0011055508,"threshold_uncertainty_score":0.043687463},"labels":[],"label_agreement":null},{"id":"W3172196938","doi":"10.1096/fasebj.27.1_supplement.666.2","title":"An investigation of morphine‐to‐codeine metabolic ratios in postmortem blood, drug interactions, and cytochrome P450 2D6 (CYP2D6) genotype","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; University of British Columbia; Advantage Forensics (Canada); Hospital for Sick Children","funders":"","keywords":"Codeine; Morphine; CYP2D6; Medicine; Forensic toxicology; Genotype; Pharmacology; Opioid; Drug; Heroin; Anesthesia; Internal medicine; Biology; Cytochrome P450; Gene; Chemistry; Genetics","score_opus":0.0530357158078275,"score_gpt":0.3740887740735566,"score_spread":0.3210530582657291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172196938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895096,0.0002581649,0.00012532888,0.000021784232,0.0000027762023,0.000008392381,0.00023685211,0.0000034252635,0.00039237522],"genre_scores_gemma":[0.99931324,0.00010605056,0.00015674511,0.000014505258,0.0000043857535,0.0000031531729,0.0001955754,0.0000019032711,0.00020437219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996599,0.000060798546,0.000036217152,0.00007256675,0.00012391942,0.000046593243],"domain_scores_gemma":[0.99869967,0.00021466117,0.0007035338,0.000077040415,0.00019940159,0.00010570503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037481225,0.00019950587,0.00022767721,0.0008343259,0.00035901766,0.0003566225,0.00019929711,0.0002578242,0.0010017462],"category_scores_gemma":[0.0021649976,0.00016019946,0.00019877616,0.0006105627,0.00024433667,0.00017166008,0.00019127311,0.0003005284,0.00016987337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017139882,0.000013573349,0.9973181,0.000006089343,0.00002355041,0.00024884762,0.000042477423,0.000013099966,0.0010117282,0.00000765595,0.000032826258,0.0011107024],"study_design_scores_gemma":[0.0000023028674,0.00007075916,0.99886036,0.0000015542563,0.000011514854,0.0006230107,0.00004802516,0.000066550616,0.00022623486,0.000004895834,0.000083579675,0.0000012041855],"about_ca_topic_score_codex":0.011625305,"about_ca_topic_score_gemma":0.018574907,"teacher_disagreement_score":0.011625305,"about_ca_system_score_codex":0.00033857636,"about_ca_system_score_gemma":0.00024690566,"threshold_uncertainty_score":0.023115218},"labels":[],"label_agreement":null},{"id":"W3173368603","doi":"10.1096/fasebj.27.1_supplement.673.1","title":"Application of a genomics‐guided warfarin dosing nomogram for hospitalized patients","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Warfarin; Dosing; VKORC1; CYP2C9; Pharmacogenomics; Medicine; Pharmacogenetics; Nomogram; Intensive care medicine; Pharmacology; Internal medicine; Emergency medicine; Genotype; Atrial fibrillation; Biology","score_opus":0.068735583091008,"score_gpt":0.39107039752594897,"score_spread":0.32233481443494094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173368603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89335465,0.0018140064,0.07533513,0.0069747316,0.0003789957,0.00071163697,0.0038528044,0.0012117452,0.016366377],"genre_scores_gemma":[0.9481383,0.0004557717,0.04752577,0.00094097725,0.00016483675,0.00019680176,0.001954091,0.000039517112,0.0005839552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988463,0.0005255621,0.0002413597,0.00012224891,0.00020672564,0.000057864374],"domain_scores_gemma":[0.99697936,0.0010547652,0.0006857488,0.00018683253,0.0008554833,0.00023780212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019026444,0.0005811889,0.0006835861,0.0016240753,0.00040676363,0.0011165991,0.00040399708,0.00053150736,0.0010722087],"category_scores_gemma":[0.008244433,0.00011281297,0.00052111596,0.0008223134,0.00013780908,0.00046941722,0.00045963045,0.0007301943,0.00046420842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013281824,0.00028273728,0.7939261,0.00009160001,0.00016355152,0.0008380433,0.00016711929,0.009431981,0.0027002506,0.0006991234,0.012859836,0.17751147],"study_design_scores_gemma":[0.00041227072,0.0019458762,0.6041929,0.00027034682,0.00069741905,0.0045367433,0.0008820648,0.3494737,0.0142435925,0.0032213076,0.01994231,0.00018134352],"about_ca_topic_score_codex":0.00221028,"about_ca_topic_score_gemma":0.0025909941,"teacher_disagreement_score":0.00221028,"about_ca_system_score_codex":0.0005555019,"about_ca_system_score_gemma":0.00067166757,"threshold_uncertainty_score":0.010062218},"labels":[],"label_agreement":null},{"id":"W3173531951","doi":"10.1002/cjce.24232","title":"Optimization of operation conditions for improved cytochrome <scp>P450BM3</scp> enzymatic reaction yield","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Chemical Engineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cofactor; Chemistry; Hydroxylation; Yield (engineering); Redox; Enzyme; Bacillus megaterium; Heme; Monooxygenase; Cytochrome; Biocatalysis; NAD+ kinase; Cytochrome P450; Stereochemistry; Combinatorial chemistry; Biochemistry; Catalysis; Organic chemistry; Reaction mechanism; Biology","score_opus":0.05140083857628043,"score_gpt":0.3333483159485162,"score_spread":0.2819474773722358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173531951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95745325,0.0017713602,0.035455264,0.0003679601,0.00012478637,0.00028633486,0.00090217794,0.0010570479,0.0025819016],"genre_scores_gemma":[0.96565944,0.0013769781,0.029071275,0.00009006223,0.000032081607,0.0002634868,0.0012919367,0.00041312238,0.0018015299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897003,0.00019040171,0.00010591793,0.0002491153,0.0003285905,0.00015609158],"domain_scores_gemma":[0.99969995,0.00007165973,0.0000629569,0.00002799037,0.00009713987,0.00004033782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009992127,0.0009877331,0.0006531006,0.0003590134,0.0003838584,0.00058441923,0.00061390793,0.00063399674,0.0019363794],"category_scores_gemma":[0.001063681,0.0002611435,0.00038416297,0.0005321212,0.00026439133,0.0005613048,0.00047537647,0.0008512901,0.0013114567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009324743,0.00003948962,0.0001758419,0.00006741381,0.000006342167,0.00004790107,0.000025406194,0.00015963704,0.997035,0.000044347325,0.00013141321,0.002173953],"study_design_scores_gemma":[0.0000087786875,0.00011236281,0.0009499012,0.0000066796456,0.00000946682,0.000054752538,0.000020026377,0.0006547533,0.9967487,0.000018383598,0.0014057352,0.000010307604],"about_ca_topic_score_codex":0.0015878266,"about_ca_topic_score_gemma":0.0020614855,"teacher_disagreement_score":0.0019363794,"about_ca_system_score_codex":0.000541059,"about_ca_system_score_gemma":0.0004923299,"threshold_uncertainty_score":0.006477833},"labels":[],"label_agreement":null},{"id":"W3175746056","doi":"10.1096/fasebj.20.4.a261","title":"Cytochrome P450 2A5 expression in a G6PD‐deficient mouse model of oxidative stress","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxidative stress; Glutathione peroxidase; Glutathione; Chemistry; Cytochrome P450; Downregulation and upregulation; Superoxide dismutase; Oxidative phosphorylation; Biochemistry; Inducer; Molecular biology; Pharmacology; Biology; Enzyme; Gene","score_opus":0.0834578783792524,"score_gpt":0.38514971319026453,"score_spread":0.30169183481101214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175746056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556167,0.001481265,0.008199441,0.0005572343,0.0001001481,0.00024521232,0.0016080827,0.00033758284,0.001909445],"genre_scores_gemma":[0.9758085,0.0016467426,0.009473227,0.00024655915,0.000038846338,0.00042336743,0.0023858256,0.00010944815,0.009867531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942744,0.00013172362,0.00006580584,0.00015974746,0.00012065561,0.000094687064],"domain_scores_gemma":[0.999553,0.000043643246,0.00013124009,0.00006638548,0.000040215247,0.00016544278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054456794,0.00095339236,0.0005482401,0.0017653106,0.00049165013,0.0006689111,0.00046283405,0.0012121779,0.0021320223],"category_scores_gemma":[0.00022590086,0.0005677273,0.00053006574,0.0006821205,0.0008062545,0.00052555074,0.00034576954,0.002110228,0.0006868018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012165207,0.000502502,0.00081547874,0.0000517517,0.000019907773,0.00031635768,0.00006068312,0.00018042183,0.99442106,0.00039287054,0.00020082375,0.0018216331],"study_design_scores_gemma":[0.0006505091,0.0064018974,0.012737675,0.000052663083,0.0001598916,0.0023575625,0.0001479451,0.003739636,0.96497136,0.00057802384,0.008168202,0.000034699788],"about_ca_topic_score_codex":0.0012354278,"about_ca_topic_score_gemma":0.0015105379,"teacher_disagreement_score":0.0021320223,"about_ca_system_score_codex":0.0007409574,"about_ca_system_score_gemma":0.00039524856,"threshold_uncertainty_score":0.0071323514},"labels":[],"label_agreement":null},{"id":"W3176565487","doi":"10.1096/fasebj.29.1_supplement.940.3","title":"<i>CYP2A6</i> Genetic Variation and Variable Nicotine Metabolism Among Two Distinct American Indian Tribal Groups With Different Levels of Smoking and Risk For Tobacco‐Related Cancer","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Cotinine; Genotype; Biology; Allele; Smoking cessation; Genetics; Medicine; Metabolism; Physiology; Internal medicine; Endocrinology; Gene; Pathology","score_opus":0.05170546718661642,"score_gpt":0.35319243738174533,"score_spread":0.30148697019512893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176565487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996723,0.000010529917,0.000059541057,0.000012495716,0.0000016779958,0.0000045282995,0.000025411162,0.000001334082,0.00021226547],"genre_scores_gemma":[0.9995801,0.000012608445,0.00011852839,0.0000192449,0.000004423192,0.0000077275545,0.00007343701,0.0000027855485,0.0001811696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970716,0.00009002431,0.000021979464,0.00007119051,0.000056775563,0.00005296851],"domain_scores_gemma":[0.99966145,0.00005591651,0.00007060969,0.000051371855,0.00005585921,0.00010474741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030989439,0.00025905969,0.00018904026,0.0005890648,0.00063691195,0.00047845274,0.00029339633,0.00020640908,0.0008040943],"category_scores_gemma":[0.0008147792,0.00014552567,0.00027426006,0.00045111577,0.0004072785,0.0001681545,0.00032904383,0.00033841855,0.00014314859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005206503,0.00023858019,0.97931254,0.000011280994,0.00011708701,0.0007261897,0.0019957984,0.00007398458,0.01112649,0.00018156768,0.0002142608,0.005481625],"study_design_scores_gemma":[0.000014390211,0.00011296703,0.9972959,0.0000031738573,0.00002465626,0.00082969945,0.0008185038,0.0003514368,0.00026052402,0.000049039736,0.00023338369,0.000006272957],"about_ca_topic_score_codex":0.016503515,"about_ca_topic_score_gemma":0.0145102525,"teacher_disagreement_score":0.016503515,"about_ca_system_score_codex":0.00023562978,"about_ca_system_score_gemma":0.00016696342,"threshold_uncertainty_score":0.03281492},"labels":[],"label_agreement":null},{"id":"W3176657909","doi":"10.1096/fasebj.2018.32.1_supplement.833.4","title":"INVESTIGATION INTO THE EFFECTS OF TESTOSTERONE ON DRUG METABOLIZING ENZYMES IN HEPATIC AND INTESTINAL HUMAN CELL LINES","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CYP3A4; Testosterone (patch); Drug metabolism; Bioavailability; Cytochrome P450; Internal medicine; Hormone; Endocrinology; Pharmacology; Chemistry; Cell culture; Metabolism; Biology; Medicine","score_opus":0.06045401336198806,"score_gpt":0.3719187595688022,"score_spread":0.31146474620681414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176657909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94294614,0.016454093,0.020140449,0.00056369836,0.0002575078,0.00030259567,0.008929608,0.00041855767,0.009987354],"genre_scores_gemma":[0.9533505,0.00888001,0.013250432,0.0002659217,0.00009204725,0.00029731446,0.011944625,0.000073374154,0.01184579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942195,0.00017163873,0.0000781382,0.00009404739,0.00015366884,0.00008048397],"domain_scores_gemma":[0.9996871,0.00008501086,0.000031189367,0.000070979055,0.00010118143,0.000024513338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004002597,0.00028903628,0.00047094648,0.00036205194,0.0002969579,0.00043708686,0.00018075402,0.00020252858,0.0031814824],"category_scores_gemma":[0.00026625133,0.00013028501,0.0004402043,0.000871962,0.00025966208,0.00014938817,0.00014251024,0.0004139052,0.0013549242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005860312,0.00020819284,0.003739048,0.0003349718,0.000031809665,0.00034943697,0.00012368282,0.00017693885,0.98625493,0.0001507555,0.0005191894,0.0075251237],"study_design_scores_gemma":[0.000049002778,0.0015587902,0.021741686,0.000021140733,0.00011680084,0.000992809,0.00025822586,0.00081887183,0.9592725,0.00004439979,0.0151072275,0.000018527498],"about_ca_topic_score_codex":0.0030595788,"about_ca_topic_score_gemma":0.0042526703,"teacher_disagreement_score":0.0031814824,"about_ca_system_score_codex":0.00022701976,"about_ca_system_score_gemma":0.0002952514,"threshold_uncertainty_score":0.010643125},"labels":[],"label_agreement":null},{"id":"W3176791188","doi":"10.1038/s41397-021-00249-1","title":"Economic evaluation in psychiatric pharmacogenomics: a systematic review","year":2021,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"European Commission","keywords":"Pharmacogenomics; Psychological intervention; Medical prescription; Psychiatry; Medicine; Systematic review; Cost effectiveness; Health care; MEDLINE; Risk analysis (engineering); Pharmacology; Political science","score_opus":0.23009512446407723,"score_gpt":0.5259656722907379,"score_spread":0.29587054782666067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176791188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032560594,0.9989875,0.00014524149,0.00022655407,0.000060689377,0.000053183172,0.00009787303,0.0000034128318,0.00009985719],"genre_scores_gemma":[0.012903732,0.9856263,0.0006396244,0.00046962412,0.000101644,0.000112723916,0.00008496133,0.000004598239,0.00005688373],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98815256,0.0067812204,0.002382774,0.00061151205,0.0017324563,0.00033948],"domain_scores_gemma":[0.95661867,0.03714892,0.0043623773,0.00034086648,0.0012492962,0.00027983682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016586239,0.0016020226,0.012209863,0.006005741,0.0003018654,0.0032973175,0.0017860016,0.0025443365,0.0055543454],"category_scores_gemma":[0.049533922,0.00092607416,0.008395334,0.0076140836,0.0008448416,0.00229775,0.0015745095,0.0024187807,0.00023661609],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012788743,0.00006543391,0.0009359752,0.8384273,0.04557728,0.00015364488,0.000066804576,0.0009491129,0.00012806123,0.00110597,0.0032856208,0.10802591],"study_design_scores_gemma":[0.00386962,0.0005991241,0.0075290115,0.6487998,0.29977763,0.0006586894,0.0002829409,0.001582013,0.00029957847,0.004233365,0.03224036,0.00012781394],"about_ca_topic_score_codex":0.006090437,"about_ca_topic_score_gemma":0.01618666,"teacher_disagreement_score":0.016586239,"about_ca_system_score_codex":0.0037873748,"about_ca_system_score_gemma":0.007644156,"threshold_uncertainty_score":0.08771747},"labels":[],"label_agreement":null},{"id":"W3177401802","doi":"10.1096/fasebj.20.4.a260-d","title":"Cytochrome P450 2C11 5′‐flanking region and promoter: regulation by aromatic hydrocarbons in vitro and in vivo","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Luciferase; Biology; Aryl hydrocarbon receptor; In vivo; Cytochrome P450; Messenger RNA; Transcription (linguistics); Molecular biology; Context (archaeology); Transfection; Transcription factor; Cell biology; Gene; Biochemistry; Genetics; Enzyme","score_opus":0.038399309507736436,"score_gpt":0.3329841753167964,"score_spread":0.29458486580905996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177401802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96226317,0.002391188,0.030081348,0.00032937256,0.000067462344,0.00009887304,0.003141978,0.00019774088,0.001428934],"genre_scores_gemma":[0.95038,0.0014641683,0.025827378,0.00018961926,0.000035447392,0.00023699334,0.013231324,0.0001535257,0.008481536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993692,0.0001328787,0.000046796264,0.00022890448,0.0001234037,0.000098834695],"domain_scores_gemma":[0.99964535,0.00011948496,0.00008197222,0.00004106301,0.00005317476,0.000058987447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047029575,0.00038543053,0.00035118323,0.00027020904,0.00020479492,0.00042075483,0.00027536467,0.0002636716,0.001376273],"category_scores_gemma":[0.0003177574,0.00034284833,0.00042870248,0.00030354035,0.00040394164,0.00017795728,0.00018856286,0.0006755975,0.00075093954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010751403,0.000041133662,0.00020074449,0.000025867917,0.0000034724026,0.000011412561,0.000023466375,0.000081982434,0.9987388,0.000053524738,0.000039125265,0.00067290093],"study_design_scores_gemma":[0.000021287942,0.00012907966,0.0061053634,0.000008698228,0.000019287614,0.00014855733,0.000039999908,0.001433297,0.9894232,0.000028091083,0.0026336599,0.0000095138585],"about_ca_topic_score_codex":0.0033073009,"about_ca_topic_score_gemma":0.003997281,"teacher_disagreement_score":0.0033073009,"about_ca_system_score_codex":0.00056232116,"about_ca_system_score_gemma":0.0006178083,"threshold_uncertainty_score":0.006576121},"labels":[],"label_agreement":null},{"id":"W3177417082","doi":"10.1124/dmd.121.000474","title":"Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes","year":2021,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytochrome P450; Enzyme; Population; Proteomics; Chemistry; Drug metabolism; Biochemistry; Isozyme; Biology; Gene","score_opus":0.04084995597145074,"score_gpt":0.3417061966385179,"score_spread":0.3008562406670672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177417082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004465,0.00034721082,0.008471292,0.00003531311,0.000010984945,0.000011713349,0.0005318484,0.000046943696,0.00050005515],"genre_scores_gemma":[0.99723744,0.000099609846,0.0016694228,0.00003371556,0.000012470239,0.000013823887,0.00045217894,0.00002079552,0.00046046547],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99967134,0.00006463416,0.000018074958,0.00014970334,0.00006738597,0.000028907842],"domain_scores_gemma":[0.99959487,0.00011341905,0.00010874675,0.00007007499,0.00008357853,0.000029367828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058310974,0.00022725931,0.00024402031,0.00043922427,0.00018348797,0.0003851308,0.00014124895,0.00021895069,0.00061697717],"category_scores_gemma":[0.0009349822,0.00012170181,0.00024900332,0.00052021,0.0001854341,0.00016414492,0.00016194927,0.00029896945,0.00020491934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012231101,0.00013063899,0.29530412,0.000056843106,0.0005673758,0.0002343075,0.00032698695,0.0006011518,0.66665816,0.0003402163,0.00031624938,0.034240972],"study_design_scores_gemma":[0.000008995901,0.00025982058,0.9485855,0.0000029233254,0.00012737553,0.00094329263,0.000079824815,0.0025949308,0.04623178,0.00021946018,0.0009320256,0.000014071925],"about_ca_topic_score_codex":0.0010680706,"about_ca_topic_score_gemma":0.0011032226,"teacher_disagreement_score":0.0010680706,"about_ca_system_score_codex":0.00012944468,"about_ca_system_score_gemma":0.00011674253,"threshold_uncertainty_score":0.003083825},"labels":[],"label_agreement":null},{"id":"W3177472539","doi":"10.1016/j.cbpc.2021.109114","title":"Development of a microplate method for the determination of hepatic UDP-glucuronosyltransferase activity in rainbow trout (Oncorhynchus mykiss) and Nile tilapia (Oreochromis niloticus)","year":2021,"lang":"en","type":"article","venue":"Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Rainbow trout; Nile tilapia; Glucuronidation; Oreochromis; Tilapia; Chemistry; Microsome; Kinetics; Chromatography; Biochemistry; Fish <Actinopterygii>; Biology; Enzyme; Fishery","score_opus":0.09372552727388625,"score_gpt":0.4297294037586751,"score_spread":0.3360038764847888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177472539","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07490414,0.0018018804,0.91012275,0.000446852,0.0006608262,0.0013839299,0.0014513145,0.0038414716,0.0053868555],"genre_scores_gemma":[0.095083766,0.0018192895,0.8780228,0.00040992457,0.000121359655,0.0055424697,0.0043079467,0.00027712295,0.014415351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967629,0.00080380565,0.0003228273,0.00079145405,0.0011031458,0.00021588815],"domain_scores_gemma":[0.9985238,0.0004134191,0.0002066514,0.00019489604,0.0004892995,0.00017197186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025299499,0.002953284,0.0013124014,0.0024719376,0.0009938953,0.0009681258,0.0025563561,0.0016828353,0.0031735725],"category_scores_gemma":[0.0013749301,0.0021365678,0.0012687087,0.0014787124,0.0008159707,0.0011894805,0.0012979426,0.0033941127,0.0035394568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011067408,0.00021605953,0.00058789627,0.00019843971,0.000054156575,0.000050261868,0.000101527025,0.00030607352,0.9886572,0.00059912633,0.0005435286,0.008575073],"study_design_scores_gemma":[0.00008331622,0.00089065346,0.0037857196,0.0000707785,0.0001135515,0.00028276647,0.000101880425,0.011639977,0.97405803,0.00055916695,0.008328143,0.00008601229],"about_ca_topic_score_codex":0.0020742528,"about_ca_topic_score_gemma":0.006860665,"teacher_disagreement_score":0.0031735725,"about_ca_system_score_codex":0.0008217577,"about_ca_system_score_gemma":0.0019794775,"threshold_uncertainty_score":0.013379812},"labels":[],"label_agreement":null},{"id":"W3180808017","doi":"10.1016/j.bmcl.2021.128255","title":"Biologically active metabolites in drug discovery","year":2021,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Chemistry; Drug discovery; Drug; Biological activity; Active metabolite; Drug development; Lead compound; Computational biology; Pharmacology; Metabolite; Biochemistry; In vitro; Biology","score_opus":0.12473688721997371,"score_gpt":0.44280691025526087,"score_spread":0.31807002303528714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180808017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002182888,0.9955161,0.00079148175,0.00039450394,0.00053749577,0.000011632462,0.000031232616,0.00002014467,0.0024791071],"genre_scores_gemma":[0.0021709988,0.99279493,0.00081958895,0.0004560571,0.0006478087,0.000019055005,0.00006135669,0.000004533023,0.003025652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973065,0.00006586097,0.000024511974,0.000038801794,0.00010828245,0.000031784384],"domain_scores_gemma":[0.9997694,0.00011013205,0.00003724744,0.0000133169015,0.0000462157,0.000023662818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008181565,0.0012140936,0.0015124953,0.0021517293,0.00025847348,0.0012384977,0.00080513436,0.001078529,0.0055324226],"category_scores_gemma":[0.000665703,0.00043103122,0.00044729753,0.002115017,0.0007269837,0.0013879105,0.0011886633,0.0022504334,0.0040945318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114556125,0.00013044024,0.000105870335,0.009154301,0.000068169036,0.0002473051,0.000037375143,0.00055687665,0.005810042,0.010600076,0.027555281,0.94561976],"study_design_scores_gemma":[0.000044132983,0.0001719176,0.0003587495,0.0014446187,0.00007520107,0.00073787355,0.000024866053,0.00019454565,0.001965068,0.005389951,0.98957765,0.000015452559],"about_ca_topic_score_codex":0.00045757517,"about_ca_topic_score_gemma":0.00095545285,"teacher_disagreement_score":0.0055324226,"about_ca_system_score_codex":0.00058178906,"about_ca_system_score_gemma":0.000855654,"threshold_uncertainty_score":0.018507779},"labels":[],"label_agreement":null},{"id":"W3183354255","doi":"10.1016/j.ajhg.2021.07.001","title":"Massively parallel characterization of CYP2C9 variant enzyme activity and abundance","year":2021,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of General Medical Sciences; Canadian Institute for Advanced Research; National Human Genome Research Institute; Howard Hughes Medical Institute","keywords":"Missense mutation; CYP2C9; Massive parallel sequencing; Cytochrome P450; Biology; Computational biology; Enzyme; Genetics; Mutation; Biochemistry; Gene; DNA sequencing","score_opus":0.06611490923011071,"score_gpt":0.39532413658268495,"score_spread":0.32920922735257424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183354255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535826,0.0011640476,0.12377511,0.00062818185,0.00019058946,0.00008743113,0.013079081,0.0031324527,0.0043603918],"genre_scores_gemma":[0.91342866,0.00057466706,0.06339211,0.00034526834,0.00013455305,0.00011434734,0.017907498,0.00067630695,0.003426592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996051,0.000032708384,0.000016176265,0.00015550696,0.00014730463,0.000043145963],"domain_scores_gemma":[0.99954695,0.000095365314,0.00006490134,0.00012273922,0.00011654233,0.000053441763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046188224,0.00046494819,0.0006329016,0.00072981627,0.0003270323,0.0008454738,0.0003526255,0.00041603617,0.0017655686],"category_scores_gemma":[0.0012078373,0.0003062819,0.00054932444,0.0007001964,0.00024512957,0.00028221993,0.00057643483,0.0010533666,0.001145975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008655522,0.000110987996,0.034974623,0.0001467563,0.00034311664,0.0002922915,0.000120581964,0.0032190126,0.9048365,0.0014884343,0.0038125287,0.049789622],"study_design_scores_gemma":[0.00014764776,0.00044393033,0.30178678,0.000034988137,0.00041554184,0.003386778,0.00013482964,0.09996479,0.5591058,0.0063571134,0.028094565,0.0001271436],"about_ca_topic_score_codex":0.0014067568,"about_ca_topic_score_gemma":0.0024130486,"teacher_disagreement_score":0.0017655686,"about_ca_system_score_codex":0.00024680587,"about_ca_system_score_gemma":0.0002913134,"threshold_uncertainty_score":0.0059064627},"labels":[],"label_agreement":null},{"id":"W3184054661","doi":"10.1097/ypg.0000000000000293","title":"Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder","year":2021,"lang":"en","type":"article","venue":"Psychiatric Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacogenetics; Antidepressant; Medicine; Population; Pharmacogenomics; Pharmacology; Depression (economics); Drug; Major depressive disorder; Psychiatry; Internal medicine; Cytochrome P450; Genetics; Biology; Gene; Genotype","score_opus":0.038841423876399044,"score_gpt":0.3912309444820134,"score_spread":0.35238952060561435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184054661","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027612508,0.00017283973,0.003103634,0.000295277,0.00036997645,0.9887657,0.0023269344,0.00009982469,0.0021046621],"genre_scores_gemma":[0.0021364621,0.00012902431,0.00450089,0.00027606287,0.00016869737,0.9906064,0.0010526978,0.000012103334,0.0011175771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98869437,0.0060666283,0.0021891599,0.0012693543,0.0008343476,0.0009461545],"domain_scores_gemma":[0.97875136,0.0042217136,0.0018869638,0.004915865,0.008117716,0.002106245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019426368,0.0029382021,0.005072107,0.0025963613,0.004402332,0.0015640946,0.002697673,0.0046330546,0.071413085],"category_scores_gemma":[0.020087177,0.0020738502,0.0030712048,0.0022162674,0.0015853213,0.0018185826,0.0022121514,0.0048072287,0.026859732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23284313,0.0380027,0.029849328,0.041265972,0.0021638572,0.0063105905,0.006472621,0.0083043715,0.028739586,0.024057778,0.3266885,0.25530154],"study_design_scores_gemma":[0.11708219,0.03883794,0.078702904,0.01037068,0.0008466373,0.0017008781,0.0021044253,0.0062533333,0.0069977134,0.011487735,0.7248822,0.00073338166],"about_ca_topic_score_codex":0.0024275456,"about_ca_topic_score_gemma":0.0037442108,"teacher_disagreement_score":0.071413085,"about_ca_system_score_codex":0.0032636311,"about_ca_system_score_gemma":0.013112834,"threshold_uncertainty_score":0.23890054},"labels":[],"label_agreement":null},{"id":"W3189138644","doi":"10.1007/s00520-021-06451-y","title":"Pharmacogenomics in cancer supportive care: key issues and future directions","year":2021,"lang":"en","type":"editorial","venue":"Supportive Care in Cancer","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Public Health Ontario","funders":"","keywords":"Pharmacogenomics; Pain medicine; Medicine; Nursing research; Cancer; Key (lock); Health informatics; Anesthesiology; Nursing; Intensive care medicine; Public health; Internal medicine; Psychiatry; Pharmacology","score_opus":0.04598488192798831,"score_gpt":0.4575850188968795,"score_spread":0.4116001369688912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189138644","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020047748,0.03323919,0.00016899109,0.061019085,0.90463746,0.000012932312,0.000032715237,0.00003700365,0.0008326009],"genre_scores_gemma":[0.00017911066,0.014133759,0.00013425456,0.019514482,0.9641982,0.000012229233,0.0000118699245,0.000013808264,0.0018023334],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98953867,0.0032538385,0.0014635824,0.00092529785,0.004298488,0.00052012905],"domain_scores_gemma":[0.9266145,0.042860046,0.0031678877,0.0012009621,0.019589208,0.006567353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02168213,0.004034688,0.006377455,0.0038535618,0.003112436,0.011905011,0.0046295356,0.025941607,0.009157253],"category_scores_gemma":[0.047481976,0.0015800814,0.003532996,0.0023960776,0.004123395,0.007958471,0.002573054,0.03125099,0.006010956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003937672,0.000012717962,0.00002759315,0.00046578527,0.000036680878,0.00010278621,0.000013540162,0.000036377452,0.00003054703,0.0005227529,0.9902046,0.008507277],"study_design_scores_gemma":[0.00015965801,0.0000690988,0.00037492433,0.0022796628,0.00017358933,0.000504424,0.00008991785,0.00037813926,0.00007592949,0.004012568,0.9918311,0.00005102417],"about_ca_topic_score_codex":0.0031484775,"about_ca_topic_score_gemma":0.009683995,"teacher_disagreement_score":0.025941607,"about_ca_system_score_codex":0.005297431,"about_ca_system_score_gemma":0.0076035047,"threshold_uncertainty_score":0.114667416},"labels":[],"label_agreement":null},{"id":"W3193927059","doi":"10.3389/fgene.2021.736626","title":"Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation","year":2021,"lang":"en","type":"editorial","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Robert Bosch Stiftung; European Commission; Japan Agency for Medical Research and Development; McGill University; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Eli Lilly and Company","keywords":"Pharmacogenomics; Identification (biology); Population; Computational biology; Biology; Bioinformatics; Data science; Medicine; Computer science; Environmental health; Ecology","score_opus":0.06669080851206693,"score_gpt":0.48550141907352,"score_spread":0.4188106105614531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193927059","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029916902,0.002599041,0.00014572027,0.028533049,0.9671536,0.000018160043,0.00010272874,0.00009652148,0.001321221],"genre_scores_gemma":[0.00038276444,0.002656204,0.00017141819,0.021148168,0.9643066,0.000027458313,0.00006806076,0.00006163538,0.011177699],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613744,0.00077659305,0.00044432844,0.000634303,0.0017237013,0.0002835326],"domain_scores_gemma":[0.9825661,0.007071483,0.0011723533,0.00047174792,0.005594567,0.003123757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070730182,0.003651749,0.0035284227,0.0029997474,0.0027824938,0.006571906,0.0030781121,0.011339604,0.03887276],"category_scores_gemma":[0.02505563,0.0010405513,0.002497622,0.0013191364,0.0019023627,0.00445594,0.0017684739,0.014192926,0.02308922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030163768,0.0000067233577,0.000015275178,0.00010658796,0.00000931581,0.00006631894,0.000005077172,0.00002319274,0.000028424254,0.00013988267,0.9964755,0.0030933465],"study_design_scores_gemma":[0.00012770203,0.00003304594,0.0002661374,0.00050779874,0.00004738531,0.00037546066,0.000030773816,0.00021832631,0.00012330098,0.0016811781,0.996566,0.000022972396],"about_ca_topic_score_codex":0.0012903074,"about_ca_topic_score_gemma":0.00334541,"teacher_disagreement_score":0.03887276,"about_ca_system_score_codex":0.0025981339,"about_ca_system_score_gemma":0.0030800616,"threshold_uncertainty_score":0.13004231},"labels":[],"label_agreement":null},{"id":"W3194737239","doi":"10.1016/j.sapharm.2021.08.009","title":"Applications for pharmacogenomics in pharmacy practice: A scoping review","year":2021,"lang":"en","type":"review","venue":"Research in Social and Administrative Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta","funders":"","keywords":"Pharmacogenomics; Pharmacy; Medicine; Pharmacist; Polypharmacy; Pharmacy practice; MEDLINE; Family medicine; Pharmacology","score_opus":0.7828016179235525,"score_gpt":0.7310810426929184,"score_spread":0.051720575230634114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194737239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042734497,0.9993755,0.00010305828,0.00022335952,0.000061862185,0.00001533109,0.000025399235,0.0000030227745,0.00014975411],"genre_scores_gemma":[0.00045603607,0.9988412,0.00036335923,0.00019564343,0.000055304987,0.000018357232,0.000025553494,0.0000014072876,0.000043114596],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99509346,0.0015596063,0.0013969301,0.00053386344,0.0012416254,0.00017455373],"domain_scores_gemma":[0.9659731,0.028615683,0.0022268647,0.00040657035,0.0024855766,0.0002921866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014915266,0.001770979,0.0056795324,0.013417306,0.0006333798,0.0054692253,0.0019332671,0.0037172276,0.004423031],"category_scores_gemma":[0.027165843,0.00092820043,0.0044615995,0.013977434,0.0015745395,0.004208456,0.002769975,0.002826376,0.0008125904],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094778785,0.00006906973,0.0005980831,0.38276628,0.0015601134,0.00016761206,0.00028804204,0.00048075616,0.0003753002,0.0037690261,0.009230826,0.6006001],"study_design_scores_gemma":[0.00008038284,0.00010849476,0.0022993092,0.7429132,0.0069672414,0.0005688409,0.00044748583,0.00031741438,0.00024980484,0.003740068,0.24223892,0.0000689106],"about_ca_topic_score_codex":0.0059936927,"about_ca_topic_score_gemma":0.013243576,"teacher_disagreement_score":0.014915266,"about_ca_system_score_codex":0.0032260304,"about_ca_system_score_gemma":0.010440253,"threshold_uncertainty_score":0.07888043},"labels":[],"label_agreement":null},{"id":"W3194919207","doi":"10.21203/rs.3.rs-123677/v1","title":"Validation of methodology for efficient genotyping of CYP2D6 and CYP2C19","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"Medical Research Council; H. Lundbeck A/S; Alberta Innovates; HLS Therapeutics; European Commission; National Institute for Health and Care Research; King's College London; University of Alberta; Department of Health and Social Care; South London and Maudsley NHS Foundation Trust; GlaxoSmithKline","keywords":"Genotyping; CYP2C19; CYP2D6; Computer science; Computational biology; Genotype; Biology; Genetics; Gene","score_opus":0.5193495215379011,"score_gpt":0.603594814352703,"score_spread":0.08424529281480186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194919207","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031657424,0.00053572527,0.960991,0.00024205593,0.00024618098,0.0003936766,0.0014893041,0.0034896233,0.0009550626],"genre_scores_gemma":[0.14679788,0.00049384125,0.84366727,0.000319902,0.00015772723,0.0008551035,0.0034840526,0.0011136391,0.0031106444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9884161,0.004742729,0.0006447725,0.0022550898,0.003530731,0.00041066532],"domain_scores_gemma":[0.98198813,0.008835431,0.00081601844,0.0044002677,0.0036454808,0.00031469195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010977335,0.0013729995,0.0012255424,0.001775285,0.00058933574,0.0016837134,0.001863205,0.0024653173,0.0048632314],"category_scores_gemma":[0.02630732,0.00085691625,0.0010709118,0.0009421046,0.00066509575,0.0006626349,0.0016893995,0.0013405962,0.0053161876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014481142,0.0005545363,0.015168195,0.00077901845,0.00064546533,0.0004670314,0.00036610969,0.010576262,0.6875221,0.004424055,0.008654394,0.2693947],"study_design_scores_gemma":[0.00035223685,0.0013499812,0.01790627,0.00013820762,0.00055452855,0.0019856843,0.00011472749,0.08841061,0.8483253,0.0051498935,0.035530705,0.00018190661],"about_ca_topic_score_codex":0.0010349602,"about_ca_topic_score_gemma":0.0009702006,"teacher_disagreement_score":0.010977335,"about_ca_system_score_codex":0.00030839158,"about_ca_system_score_gemma":0.0011994181,"threshold_uncertainty_score":0.058054447},"labels":[],"label_agreement":null},{"id":"W3195965191","doi":"10.3390/pharmaceutics13081261","title":"Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine","year":2021,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Northwestern Polytechnical University; Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China; Northwestern University","keywords":"CYP3A4; Drug; Pharmacology; Bioavailability; Drug metabolism; Pharmacokinetics; Cytochrome P450; Drug delivery; Chemistry; Medicine; Metabolism; Biochemistry","score_opus":0.2717321492503962,"score_gpt":0.5166222329162328,"score_spread":0.2448900836658366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195965191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019994841,0.98970103,0.0022298777,0.00040435378,0.00025946452,0.000033377106,0.000071758295,0.00005131651,0.0052493485],"genre_scores_gemma":[0.009698352,0.98367256,0.0020269048,0.0003436025,0.000118517026,0.000044569228,0.00010273956,0.000009000033,0.003983801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989223,0.000018302218,0.000008935249,0.000022519605,0.00004359353,0.000014351566],"domain_scores_gemma":[0.99993706,0.000024656008,0.000012653453,0.0000028903462,0.000017372287,0.000005320335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023743711,0.00063322496,0.00065705384,0.0014125819,0.00016563192,0.0005429664,0.00040447802,0.00065650017,0.0029701272],"category_scores_gemma":[0.00026122047,0.0002037057,0.0005312625,0.0008606362,0.00018689854,0.00068081607,0.00043636456,0.001021986,0.0013168061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007401227,0.00017473944,0.00020058408,0.019132465,0.00012427237,0.00038088718,0.00008361565,0.0010968432,0.03426034,0.008143412,0.018092874,0.91823596],"study_design_scores_gemma":[0.000021541988,0.0002244564,0.00074862584,0.0014449648,0.0001517905,0.0013843221,0.000042806314,0.0005733274,0.010145628,0.0018470193,0.98339266,0.00002279001],"about_ca_topic_score_codex":0.0004958062,"about_ca_topic_score_gemma":0.00088347966,"teacher_disagreement_score":0.0029701272,"about_ca_system_score_codex":0.00037219303,"about_ca_system_score_gemma":0.00043984904,"threshold_uncertainty_score":0.009936094},"labels":[],"label_agreement":null},{"id":"W3199710005","doi":"10.1111/bph.15538","title":"THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors","year":2021,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":488,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Université de Sherbrooke; Université de Montréal; University of Toronto","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"Clinical pharmacology; Computer science; Key (lock); Receptor; G protein-coupled receptor; Computational biology; Pharmacology; Medicine; Biology; Internal medicine","score_opus":0.0420940447113971,"score_gpt":0.41556435496907457,"score_spread":0.37347031025767746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199710005","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009830846,0.249536,0.07971781,0.042873368,0.0579591,0.0013370567,0.014369315,0.014867108,0.5383573],"genre_scores_gemma":[0.0038544757,0.22894277,0.04330418,0.026239892,0.012307704,0.0011950063,0.01645529,0.0037420115,0.66395867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974583,0.0005531384,0.00029537335,0.00021892416,0.0012651613,0.0002091784],"domain_scores_gemma":[0.9957046,0.0014073811,0.00036015577,0.00032,0.0015949877,0.00061301346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030440527,0.0016536919,0.0015735758,0.0028480957,0.00077546196,0.0056331703,0.0027103918,0.0029139025,0.14639704],"category_scores_gemma":[0.008141511,0.0009874029,0.00083373545,0.0026343712,0.0012269462,0.004141295,0.0024617456,0.006136161,0.24176781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024578378,0.00003123546,0.000028723525,0.00068897125,0.0000048492357,0.00006371486,0.000055266075,0.00013575314,0.0007872679,0.00728696,0.8374237,0.15346888],"study_design_scores_gemma":[0.0000043435175,0.00001720088,0.000029586861,0.00017837122,0.0000017881232,0.00011923823,0.000008205935,0.000027557297,0.0001165672,0.00123212,0.99825877,0.0000062072813],"about_ca_topic_score_codex":0.001849416,"about_ca_topic_score_gemma":0.0033496642,"teacher_disagreement_score":0.14639704,"about_ca_system_score_codex":0.0017416982,"about_ca_system_score_gemma":0.0053141234,"threshold_uncertainty_score":0.48974687},"labels":[],"label_agreement":null},{"id":"W3199772459","doi":"10.3390/medicina57090955","title":"Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report","year":2021,"lang":"en","type":"article","venue":"Medicina","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; CYP2D6; Drug; Polypharmacy; Pharmacotherapy; Pharmacogenetics; Pharmacist; Adverse effect; Intensive care medicine; Pharmacology; Internal medicine; Pharmacy; Family medicine","score_opus":0.20119150379588277,"score_gpt":0.4588697448306574,"score_spread":0.25767824103477466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199772459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9202839,0.010427181,0.017682709,0.0262822,0.0010236732,0.00042282412,0.0004184313,0.00048885104,0.022970263],"genre_scores_gemma":[0.981614,0.002792355,0.0064798067,0.0050378544,0.0012962506,0.00004851728,0.00012935375,0.0000791919,0.0025227724],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986966,0.0002624874,0.00018999123,0.00025252963,0.00025669773,0.0003416597],"domain_scores_gemma":[0.9974584,0.00069256866,0.0005877205,0.00013898162,0.00018266383,0.00093962345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054410513,0.0014649538,0.0009259251,0.002003543,0.002905283,0.0019944422,0.0012467204,0.004778321,0.0018419552],"category_scores_gemma":[0.00428797,0.0008959421,0.0017240593,0.0014273837,0.0012913413,0.0021247852,0.0020424644,0.0053076213,0.0006751409],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024196916,0.00012150432,0.010806242,0.000028689312,0.000017729368,0.98384744,0.0003782036,0.00013377424,0.00031005888,0.00026822308,0.00083362096,0.0032303056],"study_design_scores_gemma":[0.000009085993,0.000060638456,0.0025723032,0.000033053242,0.00001969266,0.99480045,0.00026093796,0.0006153649,0.00032742193,0.0002487875,0.0010349867,0.000017372016],"about_ca_topic_score_codex":0.005852118,"about_ca_topic_score_gemma":0.008320876,"teacher_disagreement_score":0.005852118,"about_ca_system_score_codex":0.0020631903,"about_ca_system_score_gemma":0.0018060998,"threshold_uncertainty_score":0.014969528},"labels":[],"label_agreement":null},{"id":"W3201047071","doi":"10.3390/curroncol28050306","title":"Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cervical cancer; Cancer; Internal medicine; Bioinformatics; Oncology; Cancer research; Biology","score_opus":0.16066684002099804,"score_gpt":0.47739297717695517,"score_spread":0.3167261371559571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201047071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996915,0.0017892467,0.00014382541,0.00014292856,0.000008409604,0.000008062885,0.00026417716,0.0000070492533,0.00072123867],"genre_scores_gemma":[0.99911517,0.00037117003,0.00009051811,0.000015204108,0.0000098392475,0.0000048321294,0.00020332127,0.0000013929825,0.0001885811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998455,0.000028634084,0.000013832917,0.00003372588,0.000040366205,0.000037916565],"domain_scores_gemma":[0.99924195,0.00015262284,0.00036742087,0.000028164111,0.0001134676,0.000096414304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027790957,0.00015796648,0.00024967847,0.0005408958,0.00032631287,0.00036979458,0.0001608173,0.0002973316,0.001794669],"category_scores_gemma":[0.0012233881,0.000095443764,0.00021108282,0.00069150596,0.00024019541,0.00015297694,0.00021696734,0.00046265914,0.00023501032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002166529,0.000010565895,0.9952192,0.000018036415,0.000024889325,0.00010813389,0.00002587688,0.000042188556,0.0012263125,0.000011582705,0.000117524854,0.0029790613],"study_design_scores_gemma":[0.000004767721,0.00006520199,0.99798113,0.0000064831165,0.000049328028,0.0006150555,0.00006166445,0.00017982151,0.0005050393,0.000040360625,0.0004881969,0.0000029436478],"about_ca_topic_score_codex":0.0013847887,"about_ca_topic_score_gemma":0.001708997,"teacher_disagreement_score":0.001794669,"about_ca_system_score_codex":0.00030772138,"about_ca_system_score_gemma":0.00023121682,"threshold_uncertainty_score":0.0060037374},"labels":[],"label_agreement":null},{"id":"W3201233127","doi":"10.17179/excli2021-3890","title":"Arsenic: Various species with different effects on cytochrome P450 regulation in humans","year":2021,"lang":"en","type":"review","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Arsenic; Arsenic toxicity; Xenobiotic; Cytochrome P450; Arsenate; Chemistry; Arsenite; Computational biology; Environmental chemistry; Biology; Biochemistry; Enzyme","score_opus":0.16512130728115157,"score_gpt":0.40933693447159725,"score_spread":0.24421562719044568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201233127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056653644,0.9947313,0.0003240045,0.0005635675,0.00028667535,0.000010397343,0.00009703066,0.00002741907,0.0033930035],"genre_scores_gemma":[0.0042692674,0.9924603,0.00034822966,0.0003091641,0.00017217029,0.00001110324,0.000105537874,0.000003632093,0.0023205227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998473,0.000033009084,0.00002604434,0.00003029812,0.000050554812,0.000012747575],"domain_scores_gemma":[0.99991655,0.000029485116,0.000017407254,0.0000043073983,0.000025403919,0.000006871161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026701298,0.000580804,0.0007024274,0.0014153274,0.00023098833,0.0006955085,0.0004061983,0.0006997395,0.005703143],"category_scores_gemma":[0.00025286523,0.00019713501,0.0005188435,0.0017225902,0.00026912073,0.00054517115,0.00047139922,0.0007829085,0.0024853165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098469885,0.000051813684,0.00045924648,0.023954194,0.00019312259,0.0003193893,0.000111282796,0.00023593259,0.005126249,0.003645734,0.031149294,0.9346552],"study_design_scores_gemma":[0.00001775072,0.00009847477,0.001361121,0.0028382486,0.00023671896,0.0020044127,0.000052937394,0.000047504393,0.0018672762,0.0013886638,0.99007297,0.000013894725],"about_ca_topic_score_codex":0.0013521584,"about_ca_topic_score_gemma":0.0028530767,"teacher_disagreement_score":0.005703143,"about_ca_system_score_codex":0.00034996853,"about_ca_system_score_gemma":0.0006822031,"threshold_uncertainty_score":0.01907897},"labels":[],"label_agreement":null},{"id":"W3201667309","doi":"10.1016/j.euroneuro.2021.08.150","title":"W65. EVALUATING TREATMENT OUTCOMES IN PHARMACOGENOMIC-GUIDED CARE FOR MAJOR DEPRESSION: A RAPID REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"review","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Medicine; Pharmacology; Drug; Bioinformatics; Intensive care medicine; Biology; Gene; Genetics; Genotype","score_opus":0.41006557159637663,"score_gpt":0.5511010450781461,"score_spread":0.14103547348176942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201667309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005414034,0.99770266,0.00042612912,0.0002812696,0.00021982836,0.00013404738,0.0004570545,0.000021573083,0.00021604924],"genre_scores_gemma":[0.023955628,0.96930045,0.0026808504,0.002015464,0.0004347426,0.00039772587,0.0007946976,0.000033116918,0.0003873204],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949307,0.002295804,0.0014259478,0.0005955123,0.00058943185,0.00016249192],"domain_scores_gemma":[0.9906448,0.006480337,0.0017518916,0.00029692892,0.00071012945,0.00011586869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009913449,0.002114207,0.012776533,0.0031938294,0.00027116443,0.0027215818,0.0015945217,0.001813672,0.007241486],"category_scores_gemma":[0.0218374,0.00095219223,0.018336881,0.003975824,0.00034514393,0.0015462177,0.001520788,0.00173454,0.0007658781],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029807482,0.00006536733,0.0023568496,0.5220144,0.2847381,0.00012681396,0.000065793174,0.0006111454,0.0006728469,0.00043236197,0.005609496,0.18032609],"study_design_scores_gemma":[0.004127648,0.0006613255,0.00918644,0.11391201,0.8353258,0.00025370342,0.000076037606,0.00061108486,0.00038342943,0.0013065033,0.034034085,0.00012188191],"about_ca_topic_score_codex":0.0032378444,"about_ca_topic_score_gemma":0.009591244,"teacher_disagreement_score":0.012776533,"about_ca_system_score_codex":0.0012779374,"about_ca_system_score_gemma":0.0029603238,"threshold_uncertainty_score":0.052427948},"labels":[],"label_agreement":null},{"id":"W3201797936","doi":"10.1038/s41398-021-01600-7","title":"Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis","year":2021,"lang":"en","type":"review","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Reimbursement; Pharmacogenomics; Context (archaeology); Stakeholder; Health care; Commercialization; Psychology; Medicine; Business; Political science; Public relations; Marketing","score_opus":0.28794055085047254,"score_gpt":0.5638701600992077,"score_spread":0.2759296092487351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201797936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038284576,0.9883767,0.0002859725,0.009953156,0.00024861883,0.00003044784,0.000029248135,0.000004652765,0.0006884681],"genre_scores_gemma":[0.006234221,0.9895069,0.00088843406,0.002895637,0.00027437456,0.000060885046,0.000033146345,0.0000040515097,0.00010242747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98314106,0.008559085,0.0030562365,0.0008294666,0.0039946293,0.00041957543],"domain_scores_gemma":[0.8493029,0.12937437,0.0065352223,0.0012449468,0.012852298,0.0006902376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038900357,0.0005946105,0.001961361,0.0039155525,0.0006051248,0.0038294538,0.0019451984,0.002252575,0.002007432],"category_scores_gemma":[0.08242431,0.00049942435,0.0015883204,0.004019455,0.0016192032,0.0046180515,0.0017733832,0.0038185187,0.0003827242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118623815,0.000042651172,0.0013939809,0.11033113,0.00070213655,0.00027853783,0.0011582413,0.00046622963,0.00023457497,0.014137563,0.018939273,0.8521971],"study_design_scores_gemma":[0.000083526145,0.00025071253,0.007006329,0.362448,0.0030030953,0.0016388511,0.0030696741,0.00061630184,0.0006799353,0.012683766,0.6084086,0.00011125042],"about_ca_topic_score_codex":0.005017373,"about_ca_topic_score_gemma":0.011401193,"teacher_disagreement_score":0.038900357,"about_ca_system_score_codex":0.0049858806,"about_ca_system_score_gemma":0.016279042,"threshold_uncertainty_score":0.20572722},"labels":[],"label_agreement":null},{"id":"W3202085191","doi":"10.1101/2021.09.21.461211","title":"PharmacoDB 2.0 : Improving scalability and transparency of <i>in vitro</i> pharmacogenomics analysis","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario; Genome Canada","keywords":"Pharmacogenomics; Drug response; Computer science; Profiling (computer programming); Computational biology; Bioinformatics; Data mining; Drug; Medicine; Biology; Pharmacology","score_opus":0.04259184064359825,"score_gpt":0.3287520670365142,"score_spread":0.28616022639291594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202085191","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015310802,0.001002246,0.2059169,0.002014004,0.0003704633,0.0006105097,0.12049365,0.6448896,0.009391852],"genre_scores_gemma":[0.14961477,0.0012417217,0.38934755,0.0034966562,0.00019494443,0.0021477484,0.3568637,0.08966817,0.007424827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927906,0.0012897091,0.0008105574,0.0019463407,0.002762571,0.000400197],"domain_scores_gemma":[0.9896678,0.0031502258,0.00065915356,0.0040375586,0.0018020419,0.0006833038],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011430774,0.0024442493,0.0022078499,0.0038500018,0.0010278955,0.006986393,0.0048743794,0.0013010603,0.014184816],"category_scores_gemma":[0.019561207,0.002370332,0.0030779582,0.0034089503,0.00092758425,0.004178861,0.0066992072,0.0035261568,0.011356712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073112594,0.0009128182,0.030919516,0.0027770267,0.002410977,0.0011061429,0.00061669777,0.027137257,0.07008936,0.015781397,0.61144173,0.22949584],"study_design_scores_gemma":[0.002290319,0.00040107305,0.019165693,0.0005581679,0.0005151741,0.0009891527,0.00030606828,0.391104,0.14200962,0.04135413,0.40051752,0.00078911637],"about_ca_topic_score_codex":0.0082016755,"about_ca_topic_score_gemma":0.0075293113,"teacher_disagreement_score":0.9885692,"about_ca_system_score_codex":0.0018003139,"about_ca_system_score_gemma":0.004191674,"threshold_uncertainty_score":0.0604524},"labels":[],"label_agreement":null},{"id":"W3202547533","doi":"10.1016/j.jagp.2021.09.013","title":"Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership","year":2021,"lang":"en","type":"article","venue":"American Journal of Geriatric Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Centre for Addiction and Mental Health; Alberta Children's Hospital","funders":"","keywords":"Obligation; Mental health; Mental healthcare; Liability; Medicine; Psychology; Association (psychology); Psychiatry; Political science","score_opus":0.16550960732457295,"score_gpt":0.44756832752624665,"score_spread":0.28205872020167366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202547533","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4657903,0.030418983,0.0025727742,0.47385278,0.0014253346,0.0000751354,0.0015214427,0.000073668234,0.024269711],"genre_scores_gemma":[0.92820346,0.015005887,0.0015618115,0.052557297,0.001451161,0.000044911525,0.00046496443,0.000014704049,0.00069571775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99218035,0.0041374858,0.0009890139,0.000527368,0.0015767545,0.00058896374],"domain_scores_gemma":[0.9454291,0.02664417,0.010252312,0.0013356541,0.009872479,0.006466206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01664205,0.0001631525,0.00031315244,0.0017329413,0.00086063816,0.0020956465,0.0007633265,0.0018307344,0.002040941],"category_scores_gemma":[0.037247825,0.00020907736,0.00040881484,0.0021021653,0.0010412758,0.0020989238,0.0010587015,0.0019760844,0.00023949452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008322305,0.00013504559,0.9307147,0.00014387142,0.00006737051,0.0001937618,0.0017954105,0.0001505231,0.0005641698,0.0013030249,0.0137839075,0.051065058],"study_design_scores_gemma":[0.00002217954,0.00018806459,0.9595376,0.00055380707,0.000056201563,0.0008181484,0.007074966,0.00056759187,0.00015876837,0.0009947573,0.02999448,0.000033403732],"about_ca_topic_score_codex":0.019601587,"about_ca_topic_score_gemma":0.0378319,"teacher_disagreement_score":0.019601587,"about_ca_system_score_codex":0.0010802128,"about_ca_system_score_gemma":0.0030603323,"threshold_uncertainty_score":0.088012636},"labels":[],"label_agreement":null},{"id":"W3203997738","doi":"10.1007/s13237-021-00373-0","title":"Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients","year":2021,"lang":"en","type":"article","venue":"The Nucleus","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Pharmacogenomics; CYP2C9; Cytochrome P450; Drug metabolism; Pharmacogenetics; Epigenetics; Pharmacology; Polymorphism (computer science); Biology; Drug; Medicine; Gene; Bioinformatics; Genotype; Genetics; Internal medicine; Metabolism","score_opus":0.07691669789942993,"score_gpt":0.388980085976602,"score_spread":0.31206338807717204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203997738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206054,0.004497927,0.00069803785,0.0003999235,0.000027922502,0.000008511294,0.00055420614,0.000011362269,0.0017415835],"genre_scores_gemma":[0.9985677,0.0006233707,0.00027340496,0.00006303162,0.000015455786,0.0000032725438,0.00011683994,0.0000042568686,0.0003326962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997379,0.00009057755,0.000027755043,0.000067096174,0.000044506323,0.000032148884],"domain_scores_gemma":[0.99960643,0.0001249744,0.00016433025,0.000029006178,0.000044859073,0.000030528805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018505027,0.00014034355,0.00027364993,0.0003502085,0.00020930776,0.00035709198,0.00016517093,0.00028586877,0.0020655938],"category_scores_gemma":[0.0009325422,0.00010074012,0.0002945415,0.0007955525,0.0002131839,0.00015996057,0.00012505148,0.0002557532,0.00016470997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023171927,0.00014245698,0.90429515,0.00017964134,0.00080119877,0.001185694,0.00043552136,0.0002984949,0.04809591,0.00079334073,0.0005261804,0.040929154],"study_design_scores_gemma":[0.000014495873,0.00013128512,0.99479216,0.000016465438,0.00019024026,0.00079816167,0.00015610622,0.00025712198,0.0023000203,0.000346467,0.0009912218,0.0000063845464],"about_ca_topic_score_codex":0.0027041747,"about_ca_topic_score_gemma":0.0035431178,"teacher_disagreement_score":0.0027041747,"about_ca_system_score_codex":0.00023872714,"about_ca_system_score_gemma":0.00019651065,"threshold_uncertainty_score":0.0069101453},"labels":[],"label_agreement":null},{"id":"W3206242311","doi":"10.1787/56e9bbf0-en","title":"Adverse Outcome Pathway on Cyp2E1 activation leading to liver cancer","year":2021,"lang":"en","type":"report","venue":"OECD series on adverse outcome pathways","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; University of Ottawa; Health Canada","funders":"","keywords":"CYP2E1; Oxidative stress; Reactive oxygen species; Chemistry; Cytochrome P450; Reactive intermediate; Liver injury; Cytotoxicity; Biochemistry; Cancer research; Cell biology; Pharmacology; Metabolism; Biology; Catalysis; In vitro","score_opus":0.3059958296056791,"score_gpt":0.47174545846639687,"score_spread":0.16574962886071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206242311","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12355143,0.038249724,0.014343308,0.021098152,0.0030034904,0.0043288697,0.32324198,0.0010800892,0.471103],"genre_scores_gemma":[0.46395925,0.06796195,0.019026788,0.0069647753,0.002359516,0.0029088226,0.29198074,0.00020767622,0.14463042],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9964211,0.001212443,0.00016340514,0.00019888175,0.0016004033,0.00040377377],"domain_scores_gemma":[0.9924786,0.0020046846,0.0014413007,0.0003309937,0.0029625285,0.00078187743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040836614,0.00093192223,0.00041133742,0.002370926,0.00039924297,0.0009335592,0.0008240168,0.0010991629,0.019884158],"category_scores_gemma":[0.004031647,0.0001720824,0.0009774021,0.0016748123,0.00028558492,0.00048592087,0.0010625994,0.0006963962,0.0045174393],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004613097,0.0011283957,0.17549607,0.00438851,0.00042844555,0.0033158897,0.00022350579,0.0051377467,0.006923752,0.011086897,0.5146405,0.27261725],"study_design_scores_gemma":[0.00040033113,0.0028361399,0.530576,0.0023558866,0.00067657034,0.0034035055,0.00036733015,0.002001772,0.027638743,0.0056473967,0.42400834,0.00008796917],"about_ca_topic_score_codex":0.013445448,"about_ca_topic_score_gemma":0.017760715,"teacher_disagreement_score":0.019884158,"about_ca_system_score_codex":0.001324369,"about_ca_system_score_gemma":0.004381361,"threshold_uncertainty_score":0.0665192},"labels":[],"label_agreement":null},{"id":"W3206887823","doi":"10.1007/s00439-021-02385-x","title":"Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health","year":2021,"lang":"en","type":"review","venue":"Human Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Innovative Medicines Initiative; Vetenskapsrådet; Karolinska Institutet; European Commission; McGill University; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Horizon 2020 Framework Programme; Eli Lilly and Company","keywords":"Pharmacogenomics; Biology; DPYD; Pharmacogenetics; Thiopurine methyltransferase; Population; Genotyping; Precision medicine; Personalized medicine; Genetics; Genotype; Disease; Internal medicine; Medicine; Gene; Environmental health; Inflammatory bowel disease","score_opus":0.67168818541495,"score_gpt":0.5501291538267473,"score_spread":0.12155903158820269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206887823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010523523,0.9192631,0.018683603,0.035859693,0.0022253052,0.00008403737,0.0047773034,0.00024033397,0.008342984],"genre_scores_gemma":[0.0565174,0.9039827,0.01892775,0.009971314,0.004480111,0.00024487218,0.0038973393,0.0000782404,0.0019002332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782807,0.0011282878,0.00024209936,0.0004013758,0.0003285735,0.00007168479],"domain_scores_gemma":[0.9851264,0.0104801105,0.00091647136,0.0010817122,0.0020953016,0.00030004748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009226306,0.0008391149,0.0018767114,0.005774957,0.00044364284,0.0020769937,0.001066194,0.0013802982,0.0040965057],"category_scores_gemma":[0.010636793,0.00044394552,0.0011703394,0.007061204,0.0012627376,0.0029376405,0.0022967183,0.0018273141,0.000455424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009571147,0.000051792053,0.035156474,0.004936373,0.00083809963,0.00036186606,0.0009065579,0.0005177932,0.0005838894,0.007985196,0.030561855,0.91800433],"study_design_scores_gemma":[0.00006311991,0.00017485568,0.13807756,0.01273608,0.0013418847,0.0026438553,0.0020045955,0.0011621143,0.0007549992,0.027904259,0.8129375,0.00019914449],"about_ca_topic_score_codex":0.00708749,"about_ca_topic_score_gemma":0.009703187,"teacher_disagreement_score":0.009226306,"about_ca_system_score_codex":0.0012581402,"about_ca_system_score_gemma":0.0020132056,"threshold_uncertainty_score":0.04879397},"labels":[],"label_agreement":null},{"id":"W3207996079","doi":"10.14740/wjon1405","title":"Genetic Polymorphisms in Pharmaceuticals and Chemotherapy","year":2021,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Personalized medicine; Medicine; Genome-wide association study; Pharmacogenomics; Precision medicine; Pharmacogenetics; Bioinformatics; Drug reaction; Drug; Single-nucleotide polymorphism; Genotype; Gene; Pharmacology; Genetics; Biology; Pathology","score_opus":0.21311105276420592,"score_gpt":0.5317747000781388,"score_spread":0.3186636473139328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207996079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052586988,0.77167565,0.0035895864,0.087139465,0.0021712473,0.000061368686,0.0008424578,0.000049980208,0.0818833],"genre_scores_gemma":[0.47849786,0.48015118,0.004242721,0.014055919,0.0035126177,0.00009858602,0.0008318295,0.00002919861,0.018579984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999,0.00040628502,0.00007896101,0.00014537468,0.00029509366,0.000074251686],"domain_scores_gemma":[0.99859315,0.0006442364,0.00041139923,0.000058821937,0.00014704552,0.00014538575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069100986,0.0001792466,0.00043292792,0.0005821519,0.00037424633,0.00114485,0.00024698008,0.0011165465,0.0055597476],"category_scores_gemma":[0.0029191053,0.0000988759,0.0003626286,0.0016171918,0.0009461341,0.00051189715,0.0004491465,0.0013910393,0.00091532985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007195905,0.0004887425,0.092547774,0.002386667,0.00079915044,0.0037733598,0.0006915359,0.002192047,0.004627685,0.18202618,0.07839459,0.63135266],"study_design_scores_gemma":[0.0001419117,0.00037922873,0.14919804,0.0018210488,0.00047711024,0.009887689,0.00049951207,0.00085906463,0.0014219417,0.12450171,0.7107354,0.00007736848],"about_ca_topic_score_codex":0.002571817,"about_ca_topic_score_gemma":0.0020815788,"teacher_disagreement_score":0.0055597476,"about_ca_system_score_codex":0.0009693344,"about_ca_system_score_gemma":0.0011073543,"threshold_uncertainty_score":0.018599212},"labels":[],"label_agreement":null},{"id":"W3208185303","doi":"10.14309/ctg.0000000000000263","title":"Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease","year":2020,"lang":"en","type":"article","venue":"Clinical and Translational Gastroenterology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Exome sequencing; Inflammatory bowel disease; Exome; Disease; Cohort; Bioinformatics; Internal medicine; Gene; Genetics; Mutation; Pharmacology","score_opus":0.29675806365712043,"score_gpt":0.4826146700926952,"score_spread":0.18585660643557478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208185303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914141,0.001057118,0.0044033355,0.00024739924,0.00000918101,0.000034415247,0.0021042998,0.000022919989,0.0007071464],"genre_scores_gemma":[0.99391186,0.0005040042,0.0039185947,0.00013058333,0.000018905961,0.000032570042,0.0013772717,0.000005930727,0.00010028827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994349,0.00021982961,0.000050058232,0.00015486532,0.00009546135,0.000044870714],"domain_scores_gemma":[0.9979785,0.0011928908,0.0004939845,0.000112394104,0.00011425695,0.00010807835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013822945,0.0003028521,0.00027684146,0.0011638413,0.00020502273,0.00051928434,0.00023143165,0.00029659577,0.0010115573],"category_scores_gemma":[0.003531885,0.0001358932,0.0002784448,0.0008016377,0.00019684294,0.00027613525,0.0004316089,0.00029510958,0.00011806558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036331857,0.00006688109,0.9581573,0.00012515401,0.00034744322,0.0006377692,0.00012793636,0.0017075624,0.015373433,0.00021603897,0.00040364356,0.022473473],"study_design_scores_gemma":[0.00004660706,0.00030118955,0.9801012,0.00008493578,0.00029546063,0.0027729,0.0001834933,0.0064450675,0.006449993,0.00078725285,0.002512496,0.000019340938],"about_ca_topic_score_codex":0.00090322306,"about_ca_topic_score_gemma":0.001859562,"teacher_disagreement_score":0.0013822945,"about_ca_system_score_codex":0.00020831385,"about_ca_system_score_gemma":0.00030583286,"threshold_uncertainty_score":0.007310331},"labels":[],"label_agreement":null},{"id":"W3208200825","doi":"10.1124/dmd.121.000637","title":"In Defense of Current Concepts and Applications of Clearance in Drug Development and Therapeutics","year":2021,"lang":"en","type":"letter","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"Physiologically based pharmacokinetic modelling; Metabolic clearance rate; Pharmacokinetics; Clearance; Drug; Pharmacology; Drug development; Clearance rate; Intensive care medicine; Medicine; Extrapolation; Chemistry; Mathematics; Internal medicine; Urology; Statistics","score_opus":0.056319293251576745,"score_gpt":0.3964351982274604,"score_spread":0.3401159049758836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208200825","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013936622,0.0019522632,0.00036672896,0.9755552,0.019451838,0.000013865002,0.000022420716,0.000021091759,0.0024773383],"genre_scores_gemma":[0.0014805,0.0009276474,0.00052111613,0.9496171,0.041498337,0.00004949963,0.00001054995,0.000015022313,0.0058801193],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9786945,0.006233847,0.0024078588,0.0028371157,0.007694886,0.002131756],"domain_scores_gemma":[0.96205544,0.023993982,0.0028898262,0.0011511006,0.005905115,0.0040045613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017656675,0.0022090885,0.0041761356,0.0013476516,0.008662057,0.019136144,0.00597702,0.17763403,0.0061499043],"category_scores_gemma":[0.06342467,0.0016806185,0.0030277802,0.0018097811,0.013875961,0.010307439,0.005838569,0.14053226,0.007395194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101752885,0.000059405214,0.0005600934,0.00012010682,0.00005013506,0.0015183926,0.00036713682,0.00018980939,0.00026705608,0.02476567,0.9584662,0.013534253],"study_design_scores_gemma":[0.00016849871,0.00011248802,0.00074176566,0.00047297883,0.00006825347,0.0011313785,0.00042079488,0.0013122918,0.00026431825,0.04797598,0.94722444,0.00010683701],"about_ca_topic_score_codex":0.012541542,"about_ca_topic_score_gemma":0.025322577,"teacher_disagreement_score":0.17763403,"about_ca_system_score_codex":0.01395136,"about_ca_system_score_gemma":0.016499491,"threshold_uncertainty_score":0.10122466},"labels":[],"label_agreement":null},{"id":"W3209449754","doi":"10.1016/b978-0-12-819869-8.00015-x","title":"Biochemical mechanisms of drug toxicity","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adverse effect; Drug; Pharmacology; Drug reaction; Toxicity; Medicine; SAFER; Toxicology; Biology; Internal medicine; Computer science","score_opus":0.05989299927713269,"score_gpt":0.3641601756035457,"score_spread":0.304267176326413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209449754","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064913086,0.26244733,0.022153763,0.0029388724,0.0014730808,0.00009052242,0.0009080504,0.0013189948,0.7021781],"genre_scores_gemma":[0.022992006,0.1111454,0.0063522384,0.0009613742,0.00053408864,0.00008480097,0.00069842144,0.00012699261,0.8571047],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9999064,0.000009930709,0.000004226029,0.000017916393,0.000052991145,0.000008524643],"domain_scores_gemma":[0.99995875,0.000012186112,0.0000039795846,0.000008469603,0.000010270116,0.0000064010496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017543432,0.0008167867,0.00051683997,0.0012650411,0.0003140512,0.0009926482,0.00068753323,0.00083923555,0.030619934],"category_scores_gemma":[0.00011880371,0.0003948456,0.00030536376,0.00073625694,0.00071117573,0.00097541726,0.00068358023,0.0012934757,0.025107661],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012105662,0.000107848275,0.00021288122,0.00072140753,0.00001591181,0.0004847282,0.00012538367,0.001097434,0.085808896,0.05842765,0.06776143,0.78511536],"study_design_scores_gemma":[0.0000142845465,0.00016300907,0.0012559802,0.00019289952,0.0000146067505,0.0018439114,0.000048677426,0.0006773209,0.030551396,0.03238572,0.932836,0.000016041353],"about_ca_topic_score_codex":0.0008128475,"about_ca_topic_score_gemma":0.0010454525,"teacher_disagreement_score":0.030619934,"about_ca_system_score_codex":0.0005464085,"about_ca_system_score_gemma":0.00037486528,"threshold_uncertainty_score":0.10243392},"labels":[],"label_agreement":null},{"id":"W3209772594","doi":"10.1093/pch/pxab061.102","title":"127 Impact of CYP2D6, CYP3A4, and CYP2C9 pharmacogenomic profile on pain relief and adverse events in Canadian children treated with oxycodone and ibuprofen","year":2021,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of British Columbia; University of Calgary; Université de Montréal; University of Alberta","funders":"","keywords":"Oxycodone; Medicine; Ibuprofen; CYP2D6; Adverse effect; Analgesic; Pharmacogenomics; CYP2C9; Anesthesia; Internal medicine; Pharmacology; Opioid","score_opus":0.026725463396073977,"score_gpt":0.3615150823519874,"score_spread":0.33478961895591347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209772594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941314,0.0010301413,0.000106538304,0.00027407226,0.00001043419,0.000040570296,0.002624678,0.0000057892585,0.0017764863],"genre_scores_gemma":[0.9972119,0.000667766,0.00028290582,0.00009488139,0.00000889251,0.000017195922,0.0012628107,0.0000036444599,0.0004499121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989139,0.00007710773,0.00006944387,0.00014919028,0.00052748027,0.00026293058],"domain_scores_gemma":[0.99831295,0.00013878426,0.0006397307,0.00004670331,0.00059965526,0.00026208718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005471118,0.0002964649,0.00043788445,0.0010102537,0.001289574,0.0006666598,0.0005293117,0.00028557374,0.0025716336],"category_scores_gemma":[0.0021619413,0.0002406727,0.0008198129,0.0025236497,0.00047452212,0.00019700236,0.0003580345,0.0006156837,0.00016529115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066274,0.000016481556,0.9969651,0.000022344482,0.000036387402,0.00008497293,0.00012431828,0.000028315437,0.00011831012,0.000030473,0.00031588017,0.002191109],"study_design_scores_gemma":[0.000007644692,0.00003051535,0.99895823,0.000011908175,0.000029004015,0.00016082721,0.00020801793,0.000074150004,0.000048414237,0.000007770924,0.00045992952,0.0000036242832],"about_ca_topic_score_codex":0.9174722,"about_ca_topic_score_gemma":0.9409077,"teacher_disagreement_score":0.08252782,"about_ca_system_score_codex":0.010080817,"about_ca_system_score_gemma":0.010804614,"threshold_uncertainty_score":0.1660276},"labels":[],"label_agreement":null},{"id":"W3211588721","doi":"10.1111/add.15742","title":"Does sex alter the relationship between <i>CYP2B6</i> variation, hydroxybupropion concentration and bupropion‐aided smoking cessation in African Americans? A moderated mediation analysis","year":2021,"lang":"en","type":"article","venue":"Addiction","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Cancer Institute; Campbell Family Mental Health Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Bupropion; CYP2B6; Smoking cessation; Medicine; Internal medicine; Mediation; Pharmacology","score_opus":0.06990458063834164,"score_gpt":0.3750508901201011,"score_spread":0.30514630948175947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211588721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992795,0.003928177,0.0013919268,0.0014115135,0.00018682636,0.00014613674,0.00075749087,0.000035311503,0.0022147198],"genre_scores_gemma":[0.99795216,0.00026548756,0.0006105978,0.00024533313,0.00004683895,0.00012766192,0.0001288529,0.000010069512,0.00061289576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994719,0.00350009,0.00018216825,0.0008413131,0.0002868849,0.0004705295],"domain_scores_gemma":[0.99386096,0.0039544255,0.0010820967,0.0006495903,0.00017473967,0.00027824062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051932125,0.0006662917,0.0008205434,0.0003447648,0.000605359,0.0010173197,0.0010183506,0.0012503964,0.006683228],"category_scores_gemma":[0.012526452,0.00046505567,0.0029420417,0.00048568775,0.000582047,0.0005423842,0.0008300894,0.0012221204,0.0003256944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022505488,0.0007746006,0.9403679,0.000520529,0.013012976,0.00029956273,0.0012990143,0.00028390906,0.0017606507,0.0010381698,0.0011679144,0.016969297],"study_design_scores_gemma":[0.002287008,0.004849348,0.9615011,0.0003151537,0.019577844,0.0005002672,0.001087792,0.0035996197,0.0010068585,0.0019546656,0.00327511,0.000045155502],"about_ca_topic_score_codex":0.0065056435,"about_ca_topic_score_gemma":0.0030781296,"teacher_disagreement_score":0.006683228,"about_ca_system_score_codex":0.00031768804,"about_ca_system_score_gemma":0.0007455943,"threshold_uncertainty_score":0.027464688},"labels":[],"label_agreement":null},{"id":"W3212365385","doi":"10.1038/s41380-021-01340-6","title":"Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application","year":2021,"lang":"en","type":"review","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ted Rogers Centre for Heart Research; University of Calgary; University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Antipsychotic; Medicine; Antidepressant; Psychiatry; Adverse effect; Clinical Practice; Drug; Schizophrenia (object-oriented programming); Pharmacology; Family medicine; Anxiety; Gene; Genetics; Genotype; Biology","score_opus":0.5194177180246066,"score_gpt":0.5761055332194733,"score_spread":0.056687815194866764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212365385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015496644,0.9987884,0.00017817282,0.0001668187,0.00007962244,0.000007948113,0.000048556733,0.0000046654736,0.0005709014],"genre_scores_gemma":[0.0015904965,0.99680066,0.0006161058,0.0003403723,0.0000947244,0.000014185068,0.00009965733,0.0000021692058,0.0004415937],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99970514,0.000082712555,0.000051519717,0.00006464535,0.000072696654,0.000023247303],"domain_scores_gemma":[0.9993284,0.0004816245,0.00007939759,0.000020380334,0.00006876402,0.000021554475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010748074,0.00080363353,0.0028512473,0.0012337321,0.00014906871,0.0010955454,0.0010433587,0.0011359217,0.0068823043],"category_scores_gemma":[0.0013812107,0.0002366481,0.0012114997,0.0014440522,0.00040414676,0.0006802914,0.00057388266,0.0013654962,0.0016716016],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032683974,0.000074065516,0.0004778184,0.03378208,0.00069236266,0.00027131703,0.000030044934,0.00037691562,0.001906164,0.0048161834,0.009744019,0.94750226],"study_design_scores_gemma":[0.00030159293,0.0005194184,0.0038605218,0.020986443,0.0029788094,0.0025619904,0.000108301996,0.00023348453,0.0014954436,0.006466724,0.9604255,0.00006181004],"about_ca_topic_score_codex":0.0010774944,"about_ca_topic_score_gemma":0.0030163857,"teacher_disagreement_score":0.0068823043,"about_ca_system_score_codex":0.00042536866,"about_ca_system_score_gemma":0.001337554,"threshold_uncertainty_score":0.023023605},"labels":[],"label_agreement":null},{"id":"W3212684436","doi":"10.1002/phar.2644","title":"Association of <i>CYP2B6</i> genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thompson Rivers University","funders":"","keywords":"Bupropion; CYP2B6; Medicine; Pharmacology; Meta-analysis; Genotype; Internal medicine; Smoking cessation; Genetics; Biology; Cytochrome P450; CYP3A4; Metabolism; Pathology","score_opus":0.08553217724164386,"score_gpt":0.42135551507733976,"score_spread":0.3358233378356959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212684436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004708959,0.99326926,0.0003748383,0.0002484332,0.00010187991,0.00034929244,0.00064956147,0.000019172337,0.0002786035],"genre_scores_gemma":[0.10944991,0.8851135,0.0017557731,0.0008924396,0.00022028442,0.0012605439,0.0009454138,0.000020652471,0.0003414571],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933522,0.0026737286,0.0021812154,0.00067922333,0.0008573828,0.0002562972],"domain_scores_gemma":[0.984584,0.011014981,0.0025197088,0.0003559798,0.001351288,0.00017403276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008872005,0.0020004725,0.015057261,0.005639625,0.00065714493,0.0030269197,0.0019740795,0.0021370405,0.0042211562],"category_scores_gemma":[0.021948222,0.001207049,0.026647437,0.008999477,0.0006762646,0.0013259276,0.0013160682,0.0013266045,0.00037941497],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011454556,0.000025943918,0.005818524,0.61881137,0.35921013,0.00017306562,0.00009872236,0.0003583465,0.00029336291,0.00013071756,0.00093510724,0.012999174],"study_design_scores_gemma":[0.00047986498,0.00020066342,0.006006017,0.05403166,0.9363989,0.00016325478,0.00005883442,0.00016715574,0.0001307848,0.00014153945,0.0021973317,0.000023972503],"about_ca_topic_score_codex":0.008181395,"about_ca_topic_score_gemma":0.01743916,"teacher_disagreement_score":0.015057261,"about_ca_system_score_codex":0.0024728302,"about_ca_system_score_gemma":0.004698372,"threshold_uncertainty_score":0.04692018},"labels":[],"label_agreement":null},{"id":"W3212700654","doi":"10.1016/j.lfs.2021.120133","title":"Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weight","year":2021,"lang":"en","type":"article","venue":"Life Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Children’s Health Research Institute; Western University","funders":"National Health and Medical Research Council; Australian Research Council; Canadian Institutes of Health Research","keywords":"CYP1A2; Internal medicine; Gestation; Endocrinology; Biology; Weaning; Physiology; Birth weight; Drug metabolism; Cytochrome P450; Metabolism; Medicine; Pregnancy","score_opus":0.10215592350348929,"score_gpt":0.4069261618240501,"score_spread":0.3047702383205608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212700654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986939,0.0003893656,0.00022448675,0.00009828888,0.000035055706,0.000006456958,0.0001979202,0.000030992986,0.00032354466],"genre_scores_gemma":[0.992324,0.0007294193,0.00038805147,0.0001650327,0.00002277307,0.00005342536,0.0008431093,0.000048448877,0.0054256786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998357,0.000018415756,0.000010188338,0.00005581383,0.000028097737,0.000051782903],"domain_scores_gemma":[0.9993788,0.00008016933,0.00016585086,0.00011858524,0.000044257922,0.00021242467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015388531,0.00059106894,0.0005996462,0.0007414349,0.0003051723,0.00038533797,0.00031584766,0.0005385926,0.0024153441],"category_scores_gemma":[0.00029907067,0.00043204275,0.00038995166,0.00023913126,0.000936136,0.00053460954,0.00037527096,0.001413334,0.00042305278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066996193,0.0005127697,0.0062980866,0.000064577056,0.000033788187,0.00043209546,0.000120598765,0.00003857466,0.98240626,0.000096724434,0.00013025245,0.003166563],"study_design_scores_gemma":[0.00020794953,0.008968051,0.355552,0.00004256051,0.0002501059,0.0011326682,0.0006001591,0.00078556687,0.62989575,0.0002527153,0.0022491193,0.00006337296],"about_ca_topic_score_codex":0.0014963127,"about_ca_topic_score_gemma":0.0019684948,"teacher_disagreement_score":0.0024153441,"about_ca_system_score_codex":0.0004736032,"about_ca_system_score_gemma":0.00028908122,"threshold_uncertainty_score":0.008080065},"labels":[],"label_agreement":null},{"id":"W3213251609","doi":"10.1177/07067437211058847","title":"Encountering Pharmacogenetic Test Results in the Psychiatric Clinic","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hotchkiss Brain Institute; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Psychiatry; Pharmacogenetics; Test (biology); Psychology; Medicine; Clinical psychology; Genotype; Genetics","score_opus":0.0880198768747529,"score_gpt":0.4125628024559389,"score_spread":0.324542925581186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213251609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6599725,0.019768314,0.0067799296,0.18605319,0.005643213,0.0006133769,0.0012850619,0.0006312313,0.11925331],"genre_scores_gemma":[0.9352404,0.0083733555,0.0065811025,0.037387006,0.0048904135,0.000065262764,0.0004161708,0.00013361023,0.0069127143],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820113,0.0004211291,0.00024719827,0.00017528531,0.00046892164,0.00048630478],"domain_scores_gemma":[0.99432963,0.0015258682,0.0007903243,0.000120993434,0.00082369265,0.0024094877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013365007,0.0004222393,0.00071980665,0.0018639474,0.002703663,0.0017802591,0.0008527195,0.0028475067,0.008985807],"category_scores_gemma":[0.00991227,0.00047924448,0.0006113144,0.0009748789,0.0008700291,0.0015791098,0.0012509277,0.004063606,0.0014745586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033647002,0.0007959378,0.506608,0.00030337003,0.00010480136,0.34052053,0.0028598409,0.00054800126,0.004134348,0.0016485987,0.0712681,0.07087206],"study_design_scores_gemma":[0.00014210353,0.0010708971,0.39082256,0.0020697257,0.00037215734,0.48408967,0.023779629,0.0038707284,0.0033878784,0.011364383,0.07873991,0.00029032334],"about_ca_topic_score_codex":0.019254036,"about_ca_topic_score_gemma":0.04360071,"teacher_disagreement_score":0.019254036,"about_ca_system_score_codex":0.0022334727,"about_ca_system_score_gemma":0.0035090016,"threshold_uncertainty_score":0.038283944},"labels":[],"label_agreement":null},{"id":"W3213644771","doi":"10.3390/jpm11111180","title":"Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?","year":2021,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Medicine; Pharmacotherapy; Intensive care medicine; Adverse effect; Precision medicine; MEDLINE; Personalized medicine; Internal medicine; Pharmacology; Bioinformatics; Genotype; Pathology","score_opus":0.37998475150089694,"score_gpt":0.6050634267504011,"score_spread":0.2250786752495042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213644771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009913337,0.9895789,0.0006255126,0.0073090163,0.00079802953,0.00003354171,0.00005448746,0.000023371738,0.0014780574],"genre_scores_gemma":[0.0011579503,0.9925485,0.0015410656,0.0035427397,0.00054259074,0.000050132094,0.00008819459,0.000007780054,0.000520941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770504,0.0010163955,0.0004219133,0.00017798602,0.0005742824,0.00010443021],"domain_scores_gemma":[0.9947747,0.0034433105,0.00047225476,0.00017158485,0.0010072337,0.00013084122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004936299,0.0008531619,0.002231767,0.0016473187,0.00025932954,0.0020197893,0.0013869829,0.0028840702,0.0061576185],"category_scores_gemma":[0.010030878,0.00036691473,0.0020238033,0.0015387308,0.000632796,0.002906449,0.0010406986,0.0038439003,0.0025940803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113487724,0.00006468396,0.00019344427,0.03212186,0.0003042821,0.00011301479,0.00008753401,0.00018931758,0.0004527693,0.0075597796,0.03507943,0.9237204],"study_design_scores_gemma":[0.00013214299,0.00014362272,0.0010057003,0.053246785,0.0006991891,0.0005997644,0.00012553617,0.00013587385,0.00030772813,0.0074774767,0.9360973,0.000028931094],"about_ca_topic_score_codex":0.0013873462,"about_ca_topic_score_gemma":0.0024093955,"teacher_disagreement_score":0.0061576185,"about_ca_system_score_codex":0.0008943425,"about_ca_system_score_gemma":0.0038813062,"threshold_uncertainty_score":0.02610594},"labels":[],"label_agreement":null},{"id":"W3214830960","doi":"10.1038/s41398-021-01717-9","title":"Methodology for clinical genotyping of CYP2D6 and CYP2C19","year":2021,"lang":"en","type":"article","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Alberta Health Services; Alberta Hospital Edmonton; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"Alberta Innovates; University of Alberta","keywords":"Genotyping; TaqMan; CYP2C19; Pharmacogenomics; Biology; Haplotype; Computational biology; Genetics; SNP genotyping; CYP2D6; Genotype; Polymerase chain reaction; Gene","score_opus":0.5035614336214067,"score_gpt":0.5902992162876949,"score_spread":0.08673778266628818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214830960","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012352323,0.00076341344,0.95692945,0.00032001632,0.00040675254,0.015788402,0.0043797796,0.0031750733,0.005884713],"genre_scores_gemma":[0.034952473,0.0008926264,0.9074001,0.0009952575,0.0001951691,0.041684426,0.006976847,0.00082088856,0.0060822363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.95938665,0.015449455,0.0050259605,0.00819624,0.010593657,0.0013480023],"domain_scores_gemma":[0.9873897,0.0034701328,0.0010330247,0.004306585,0.0033538602,0.00044664092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02000596,0.0019300826,0.0023697375,0.005682581,0.0015843124,0.0016239446,0.0023262524,0.002225492,0.012830692],"category_scores_gemma":[0.02343166,0.0019826868,0.002262622,0.0032775782,0.0016397997,0.0007535855,0.0019794435,0.0031158258,0.013649664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039219083,0.0023019842,0.04084777,0.0027165343,0.0007482013,0.0014996692,0.0018940642,0.0039771763,0.4956932,0.01203955,0.029623887,0.40473604],"study_design_scores_gemma":[0.001742207,0.008917335,0.09582537,0.0014908928,0.000984187,0.0077818963,0.0004893951,0.025945127,0.4720855,0.010901626,0.37311465,0.00072187884],"about_ca_topic_score_codex":0.0012164378,"about_ca_topic_score_gemma":0.0019306514,"teacher_disagreement_score":0.02000596,"about_ca_system_score_codex":0.0007709868,"about_ca_system_score_gemma":0.002206704,"threshold_uncertainty_score":0.10580289},"labels":[],"label_agreement":null},{"id":"W3215139907","doi":"10.1093/nar/gkab1084","title":"PharmacoDB 2.0: improving scalability and transparency of <i>in vitro</i> pharmacogenomics analysis","year":2021,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation; Genome Canada","keywords":"Pharmacogenomics; Drug response; Biology; Computational biology; Profiling (computer programming); Cancer cell lines; Genomics; Precision medicine; Bioinformatics; Standardization; Drug; Computer science; Cancer; Genome; Pharmacology; Genetics; Cancer cell; Gene","score_opus":0.1494120533310005,"score_gpt":0.4718074934385607,"score_spread":0.3223954401075602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215139907","genre_codex":"software","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00986743,0.00079644384,0.22896703,0.0013592665,0.00036758257,0.00057690707,0.076279104,0.673782,0.008004297],"genre_scores_gemma":[0.11851397,0.0013437772,0.44713792,0.0031085848,0.00021880023,0.0022773778,0.30650786,0.11290098,0.007990682],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9932575,0.0011999649,0.0008486719,0.0018054178,0.002475596,0.00041277683],"domain_scores_gemma":[0.988792,0.0038226808,0.0006517446,0.004165993,0.0017985132,0.0007690682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011662295,0.0027807094,0.002275758,0.004232596,0.0011935595,0.0078230845,0.005242026,0.001518205,0.013869309],"category_scores_gemma":[0.022809224,0.002815309,0.0034339728,0.003933942,0.00097382814,0.0051920423,0.007639686,0.0039539086,0.01119311],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068595014,0.00097165693,0.030889517,0.0027801665,0.0026051924,0.0010776392,0.0008303968,0.022866264,0.051282983,0.017260695,0.6017042,0.26087174],"study_design_scores_gemma":[0.002309878,0.00034486485,0.016377078,0.00053809927,0.0005428853,0.0010257737,0.00035070803,0.41162863,0.09745663,0.049531855,0.4191246,0.00076898804],"about_ca_topic_score_codex":0.0102670565,"about_ca_topic_score_gemma":0.010636046,"teacher_disagreement_score":0.013869309,"about_ca_system_score_codex":0.0018697751,"about_ca_system_score_gemma":0.004655128,"threshold_uncertainty_score":0.0616768},"labels":[],"label_agreement":null},{"id":"W3216168466","doi":"10.3390/ijms222312791","title":"Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics","year":2021,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Jejunum; Ileum; Duodenum; Small intestine; CYP3A4; Internal medicine; Proteomics; Biology; Chemistry; Endocrinology; Biochemistry; Metabolism; Cytochrome P450; Medicine","score_opus":0.09546359815302874,"score_gpt":0.42790314418875736,"score_spread":0.3324395460357286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216168466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931724,0.002463944,0.006469286,0.000058325357,0.000011404102,0.00003476037,0.0007818805,0.000044973476,0.00081808376],"genre_scores_gemma":[0.9829437,0.002455047,0.010907631,0.000100620346,0.000017929777,0.00008163799,0.0017285137,0.000020524423,0.001744359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998301,0.000027053125,0.000010021921,0.0000715707,0.000045239358,0.000015923562],"domain_scores_gemma":[0.9999018,0.000020021407,0.000026010563,0.000011553592,0.000030629202,0.000009999487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020917488,0.00018322955,0.00025483483,0.00036548616,0.00018290943,0.0002713483,0.000093726405,0.0002171604,0.00061890244],"category_scores_gemma":[0.00023573718,0.00014052432,0.00018043873,0.0003744733,0.00018907235,0.000119550234,0.00012686713,0.0002574496,0.00030304072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002955012,0.000010993913,0.006608233,0.000040912295,0.000021282927,0.000057065405,0.000030145064,0.00003214374,0.98957413,0.000014561055,0.00003168073,0.0032834536],"study_design_scores_gemma":[0.000025612813,0.00083068537,0.4946506,0.000016396234,0.00015216052,0.0015210712,0.00018011546,0.001117883,0.49872467,0.00009112334,0.0026780171,0.000011647468],"about_ca_topic_score_codex":0.00063939247,"about_ca_topic_score_gemma":0.0008349653,"teacher_disagreement_score":0.00063939247,"about_ca_system_score_codex":0.00010280662,"about_ca_system_score_gemma":0.000099817364,"threshold_uncertainty_score":0.002070427},"labels":[],"label_agreement":null},{"id":"W334693804","doi":"10.71781/4812","title":"Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiques","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.10456814665663251,"score_gpt":0.4905177515325066,"score_spread":0.3859496048758741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W334693804","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12923464,0.022671407,0.83040905,0.0012048882,0.0013986315,0.004085863,0.0022366561,0.0021803407,0.006578549],"genre_scores_gemma":[0.23568082,0.01119723,0.72777086,0.0015704571,0.00032175108,0.005721544,0.001782588,0.00054027967,0.015414366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9640909,0.009701036,0.0016677823,0.0064894785,0.017306596,0.0007441991],"domain_scores_gemma":[0.9801112,0.008735914,0.002004525,0.0027539283,0.006028082,0.00036640404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021117749,0.0021537184,0.0018954644,0.00401915,0.0014170794,0.0027955633,0.002029529,0.0042753494,0.002130357],"category_scores_gemma":[0.048964728,0.0022800136,0.0021444326,0.0016504877,0.0033047819,0.0015763494,0.0016946113,0.0031106449,0.0022561871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011068588,0.0004259831,0.013257625,0.0011931814,0.0008868676,0.00018495387,0.0014406282,0.002931652,0.70847994,0.0026691114,0.0018558783,0.2655672],"study_design_scores_gemma":[0.00049631915,0.003256319,0.065572165,0.00080485526,0.0008457961,0.0029477943,0.00035921042,0.028043125,0.8478641,0.001838346,0.047584064,0.00038797813],"about_ca_topic_score_codex":0.011737297,"about_ca_topic_score_gemma":0.012174941,"teacher_disagreement_score":0.021117749,"about_ca_system_score_codex":0.001869955,"about_ca_system_score_gemma":0.0055163903,"threshold_uncertainty_score":0.11168265},"labels":[],"label_agreement":null},{"id":"W4200051059","doi":"10.3390/pharmacy9040201","title":"Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices","year":2021,"lang":"en","type":"article","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Centre for Addiction and Mental Health; Trillium Health Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Service (business); Psychological intervention; Documentation; Pharmacy; Thematic analysis; Pharmacist; Workflow; Personalized medicine; Intervention (counseling); Medical education; Medicine; Nursing; Computer science; Qualitative research; Business","score_opus":0.24758046588221072,"score_gpt":0.5155950527501899,"score_spread":0.2680145868679792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200051059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915394,0.00039871098,0.00055973826,0.0039713746,0.000044697204,0.000100877434,0.000022380156,0.0000181031,0.0033446776],"genre_scores_gemma":[0.9951271,0.00047270913,0.001036003,0.0021804445,0.00002946053,0.00006762555,0.000018205323,0.000009669271,0.001058738],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9849219,0.010681278,0.0003921875,0.00085093704,0.0011104711,0.0020432833],"domain_scores_gemma":[0.97574574,0.0138374325,0.0025487351,0.0007448635,0.0013873676,0.0057359375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008991031,0.0003602875,0.000460717,0.00065098313,0.0066655683,0.0039407453,0.001562034,0.0027848778,0.0020752875],"category_scores_gemma":[0.032102056,0.0009260645,0.00041308132,0.00066072075,0.004166357,0.0036621878,0.00686539,0.0036570723,0.0002738569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011140233,0.00079171784,0.030785866,0.0003114794,0.000025962545,0.0031776852,0.9315209,0.00010369471,0.00066025706,0.00051204377,0.0018768074,0.030122183],"study_design_scores_gemma":[0.00009153429,0.0014513829,0.029446967,0.00031700192,0.00004572254,0.0035158286,0.943778,0.00032070407,0.0005297626,0.00051221397,0.019931413,0.000059553866],"about_ca_topic_score_codex":0.0068188054,"about_ca_topic_score_gemma":0.013318097,"teacher_disagreement_score":0.008991031,"about_ca_system_score_codex":0.0031575358,"about_ca_system_score_gemma":0.006684586,"threshold_uncertainty_score":0.047549665},"labels":[],"label_agreement":null},{"id":"W4200497292","doi":"10.1152/ajpgi.00160.2021","title":"Xenobiotic receptors and the regulation of intestinal homeostasis: harnessing the chemical output of the intestinal microbiota","year":2021,"lang":"en","type":"review","venue":"American Journal of Physiology-Gastrointestinal and Liver Physiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada; Crohn's and Colitis Canada; University of Calgary","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; Xenobiotic; Receptor; Biology; Immune system; Homeostasis; Cell biology; Catabolism; Intestinal mucosa; Gastrointestinal tract; Microbiology; Biochemistry; Nuclear receptor; Metabolism; Immunology; Enzyme; Internal medicine; Gene","score_opus":0.052256442617631224,"score_gpt":0.3512901231364465,"score_spread":0.29903368051881524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200497292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024838737,0.997591,0.00018095848,0.00019634505,0.00015119705,0.000005478995,0.000028598577,0.000010215845,0.0015878042],"genre_scores_gemma":[0.0007823013,0.99795,0.00017323758,0.00011070437,0.000088360524,0.0000060644593,0.000035223187,0.0000013259513,0.0008526927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991846,0.000013719099,0.000010238117,0.000014440758,0.00003256781,0.00001057578],"domain_scores_gemma":[0.99991596,0.000032337924,0.000012741874,0.0000031819377,0.000024079933,0.000011735668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022329796,0.0005857786,0.00084535294,0.0016546502,0.00018617995,0.0008039775,0.0004656632,0.0006729907,0.00396801],"category_scores_gemma":[0.00026685974,0.00016504971,0.00032612844,0.0014994614,0.00022164769,0.00080882706,0.00050848693,0.0011437398,0.0027448065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007725221,0.00010005571,0.00019005734,0.013372759,0.000081679056,0.00024404639,0.000069314825,0.0003586326,0.005083689,0.004557278,0.020903705,0.9549616],"study_design_scores_gemma":[0.0000112292655,0.0001300099,0.00079819816,0.0017710126,0.000070662434,0.0010423705,0.000054178512,0.000081196034,0.0008686499,0.0017690242,0.993389,0.000014371466],"about_ca_topic_score_codex":0.00052971044,"about_ca_topic_score_gemma":0.0010830676,"teacher_disagreement_score":0.00396801,"about_ca_system_score_codex":0.00032407106,"about_ca_system_score_gemma":0.0006127856,"threshold_uncertainty_score":0.013274312},"labels":[],"label_agreement":null},{"id":"W4205227961","doi":"10.1093/aje/kwab295","title":"The Random Effects Warfarin Days' Supply (REWarDS) Model: Development and Validation of a Novel Method for Estimating Exposure to Warfarin Using Administrative Data.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Social Innovation; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Intraclass correlation; Warfarin; Statistics; Pearson product-moment correlation coefficient; Correlation coefficient; Mathematics; Mean squared error; Medicine; Dosing; Random effects model; Linear regression; Population; Standard error; Econometrics; Internal medicine","score_opus":0.3018966394437953,"score_gpt":0.4668063103903786,"score_spread":0.16490967094658332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205227961","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046915345,0.00046052653,0.94834226,0.000591014,0.00008991258,0.0004101222,0.0013792409,0.0008220416,0.0009895031],"genre_scores_gemma":[0.36593682,0.00067774806,0.62372965,0.00042851607,0.00019312724,0.00136242,0.003609095,0.00034492605,0.0037177503],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9882399,0.0075945933,0.0005308777,0.0016037937,0.0018072146,0.0002237099],"domain_scores_gemma":[0.9576559,0.032382675,0.0041485443,0.0024123162,0.0030319921,0.0003685589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020557396,0.0010866268,0.0017135041,0.0015281672,0.0004280338,0.0013536086,0.0026773417,0.0012720858,0.0011590834],"category_scores_gemma":[0.058430176,0.0009944896,0.0020338371,0.0015546038,0.00075053,0.0014556146,0.0015367717,0.002443403,0.0006027515],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011215893,0.00043774664,0.10033578,0.0005231483,0.0018062433,0.00031971725,0.00064427144,0.6579631,0.0014767188,0.030153226,0.007796198,0.19742213],"study_design_scores_gemma":[0.000110907546,0.00018663968,0.009762828,0.000067473324,0.00012729273,0.00011200105,0.000044760553,0.97753567,0.00065260794,0.007791344,0.0035541558,0.000054350476],"about_ca_topic_score_codex":0.041679494,"about_ca_topic_score_gemma":0.03241259,"teacher_disagreement_score":0.041679494,"about_ca_system_score_codex":0.0017942983,"about_ca_system_score_gemma":0.004889014,"threshold_uncertainty_score":0.10871917},"labels":[],"label_agreement":null},{"id":"W4205970496","doi":"10.18433/jpps32488","title":"Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Obesity; Medicine; Lean body mass; Human obesity; Body weight; Drug; Internal medicine; Physiology; Endocrinology; Body mass index; Pharmacology","score_opus":0.40322623805008484,"score_gpt":0.5733060068859377,"score_spread":0.17007976883585285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205970496","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016624684,0.92133623,0.02327804,0.026386874,0.0063115526,0.0011662056,0.00064354326,0.00015439573,0.0040984154],"genre_scores_gemma":[0.21122697,0.58346444,0.10139458,0.08169328,0.014434362,0.0035314865,0.0014157031,0.00052906084,0.0023102195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8250882,0.13610637,0.018713381,0.005061423,0.013879989,0.0011506805],"domain_scores_gemma":[0.54550225,0.35581693,0.05168835,0.019905914,0.02482738,0.0022591983],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2877822,0.0009194643,0.0069893915,0.002139175,0.0006233957,0.0048729265,0.00305317,0.004398922,0.001807449],"category_scores_gemma":[0.2835297,0.0009079129,0.0038538051,0.00411651,0.0048889373,0.008176684,0.0019340209,0.0040391707,0.00061309396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02465173,0.0012169984,0.029340748,0.11331821,0.039855875,0.00090939755,0.0028977636,0.0015737725,0.010041607,0.022350797,0.036047384,0.7177957],"study_design_scores_gemma":[0.012835843,0.09276596,0.078570776,0.09833614,0.06521346,0.0050900686,0.0037324287,0.0030199764,0.017301435,0.066077225,0.55591875,0.0011379889],"about_ca_topic_score_codex":0.00091439585,"about_ca_topic_score_gemma":0.0019350079,"teacher_disagreement_score":0.2877822,"about_ca_system_score_codex":0.0016827391,"about_ca_system_score_gemma":0.0046341303,"threshold_uncertainty_score":0.87829137},"labels":[],"label_agreement":null},{"id":"W4205993769","doi":"10.1016/b978-0-12-820472-6.00179-1","title":"Drug-Drug Interactions With a Pharmacokinetic Basis","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacokinetics; Drug; Pharmacology; Bioavailability; Drug metabolism; Cytochrome P450; Transporter; Absorption (acoustics); Chemistry; Enzyme; Drug interaction; CYP3A4; Metabolism; Medicine; Biochemistry; Gene","score_opus":0.060892431486886035,"score_gpt":0.3751228454177184,"score_spread":0.31423041393083234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205993769","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003797804,0.21827212,0.04389033,0.0056301896,0.0029972985,0.00013273105,0.00066179526,0.0006855786,0.72393215],"genre_scores_gemma":[0.033307735,0.12272045,0.019394524,0.004029953,0.0024023612,0.00014238861,0.00044183808,0.00020027078,0.81736046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998016,0.000046534562,0.0000109361445,0.000027411674,0.000103649276,0.000009868325],"domain_scores_gemma":[0.99975497,0.00018368287,0.000014520655,0.000015565276,0.000023485143,0.000007791501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033088063,0.0008754072,0.00068928726,0.0007864768,0.00018148418,0.0011523064,0.0005106676,0.0012907591,0.038388807],"category_scores_gemma":[0.00054659887,0.0002798236,0.0004197153,0.0006647479,0.00043155375,0.0010385548,0.0006668609,0.0012502744,0.018414782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008864312,0.000103738035,0.00025188195,0.00089849567,0.000037124923,0.001079705,0.00008285702,0.0018241361,0.0073217214,0.074309856,0.10315124,0.8108506],"study_design_scores_gemma":[0.0000230962,0.00016835846,0.000793605,0.00040183592,0.00004382621,0.0048208768,0.000031407417,0.00218625,0.0030902536,0.045544542,0.9428802,0.000015768954],"about_ca_topic_score_codex":0.0003828751,"about_ca_topic_score_gemma":0.0008926998,"teacher_disagreement_score":0.038388807,"about_ca_system_score_codex":0.00031028021,"about_ca_system_score_gemma":0.00038586563,"threshold_uncertainty_score":0.1284234},"labels":[],"label_agreement":null},{"id":"W4206096232","doi":"10.1186/s12888-021-03659-4","title":"Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report","year":2022,"lang":"en","type":"article","venue":"BMC Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Université de Montréal","funders":"","keywords":"Major depressive disorder; Drug; Antidepressant; Escitalopram; Medicine; Venlafaxine; Pharmacogenomics; Pharmacogenetics; Pharmacotherapy; Psychiatry; Bupropion; Pharmacology; Anxiety; Mood; Gene","score_opus":0.06500475445872775,"score_gpt":0.43368800107663036,"score_spread":0.36868324661790264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206096232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95349765,0.00633191,0.006993969,0.012674041,0.00046591164,0.00032050998,0.0004848921,0.0002535918,0.018977528],"genre_scores_gemma":[0.99119055,0.0018610654,0.0020822142,0.0024747478,0.0005144354,0.000025012125,0.000126233,0.000046585614,0.0016791187],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988342,0.0001847413,0.00015304977,0.00029774234,0.00023238739,0.00029786478],"domain_scores_gemma":[0.99748504,0.0007721617,0.0006896265,0.00015229451,0.00021730132,0.00068358576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005659191,0.0014139027,0.00078015187,0.002518241,0.0024221116,0.001617864,0.0014224972,0.004111167,0.002089458],"category_scores_gemma":[0.004568175,0.0010132641,0.0012999207,0.001388741,0.001390999,0.0015983932,0.0020212508,0.004254411,0.00067275536],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000144485875,0.000035985573,0.010019147,0.00001423787,0.000009298405,0.9875854,0.0002499161,0.00006260482,0.00020652256,0.000110343535,0.00040462136,0.0012873987],"study_design_scores_gemma":[0.0000037780057,0.000023107079,0.0030035828,0.000015418327,0.000010052378,0.9959728,0.00014059711,0.00020977476,0.00014912359,0.00012064574,0.0003437097,0.000007440559],"about_ca_topic_score_codex":0.00712387,"about_ca_topic_score_gemma":0.007621563,"teacher_disagreement_score":0.00712387,"about_ca_system_score_codex":0.0017087758,"about_ca_system_score_gemma":0.0014530863,"threshold_uncertainty_score":0.014164805},"labels":[],"label_agreement":null},{"id":"W4206959344","doi":"10.1186/s12860-021-00402-5","title":"A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"BMC Molecular and Cell Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Université de Genève; Oak Foundation","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Glucuronosyltransferase; Stem cell; Hematopoietic stem cell; Haematopoiesis; Transplantation; Computational biology; Pharmacology; Chemistry; Medicine; Biology; Biochemistry; Internal medicine; Cell biology; Enzyme; Pathology","score_opus":0.03160570246372532,"score_gpt":0.32903786387410877,"score_spread":0.2974321614103834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206959344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96744734,0.004758678,0.013722654,0.00073085824,0.000075090706,0.00010602694,0.0040073097,0.00054893363,0.008603148],"genre_scores_gemma":[0.9777811,0.002564179,0.011647126,0.00023511554,0.000020902826,0.00009566621,0.005739204,0.00007397689,0.0018428771],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997377,0.00008849247,0.000012994438,0.000054065065,0.00005500867,0.00005171969],"domain_scores_gemma":[0.999529,0.00030030665,0.000053361608,0.000017847837,0.00005614714,0.000043379616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005113261,0.0010455223,0.0014197734,0.0005532072,0.00044056444,0.0010055897,0.00084796484,0.0009839353,0.0048964894],"category_scores_gemma":[0.0011044481,0.00037727895,0.0016284753,0.000565901,0.00024643575,0.00051043206,0.0004936339,0.0005575832,0.0010156024],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001270716,0.0006901322,0.07779393,0.002407133,0.00081510074,0.0032661653,0.00014220823,0.8341166,0.054461997,0.0040531117,0.0037946883,0.017188178],"study_design_scores_gemma":[0.00018267782,0.0010905747,0.0072892606,0.00011533581,0.0005317607,0.0011320813,0.00018421527,0.9668401,0.013852481,0.0021097474,0.006620394,0.00005140698],"about_ca_topic_score_codex":0.004605096,"about_ca_topic_score_gemma":0.004980915,"teacher_disagreement_score":0.0048964894,"about_ca_system_score_codex":0.00055200385,"about_ca_system_score_gemma":0.0011125215,"threshold_uncertainty_score":0.01638037},"labels":[],"label_agreement":null},{"id":"W4210285601","doi":"10.1111/cts.13230","title":"Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Metoprolol; Pharmacogenetics; Dosing; CYP2D6; Medicine; Pharmacogenomics; Observational study; Pharmacology; Pharmacokinetics; Therapeutic drug monitoring; Drug; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3843812829857067,"score_gpt":0.5457340278220729,"score_spread":0.16135274483636625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210285601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42238754,0.045280702,0.40940583,0.021660874,0.018911019,0.051307186,0.020037342,0.0019221453,0.009087459],"genre_scores_gemma":[0.6827749,0.006242082,0.2721866,0.008370008,0.0043836953,0.020619562,0.00412701,0.00044132402,0.0008548309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.87984973,0.099896654,0.006790488,0.005919347,0.0063333344,0.0012104608],"domain_scores_gemma":[0.4267289,0.4720972,0.025818678,0.049030833,0.021382563,0.0049417913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15899807,0.003639087,0.004051468,0.001830454,0.0016491361,0.0047788876,0.004860484,0.006161168,0.00831719],"category_scores_gemma":[0.3268957,0.0026891923,0.008957968,0.0022127978,0.0035435993,0.0055201477,0.0045682383,0.004760192,0.0012789993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.107674025,0.01589068,0.3093112,0.04149971,0.19485515,0.006226731,0.0025290304,0.010099831,0.01615346,0.02106121,0.034724295,0.23997462],"study_design_scores_gemma":[0.19138175,0.10479483,0.21978341,0.012281225,0.24335042,0.011240663,0.0020364295,0.034603678,0.012413681,0.051906466,0.11490592,0.0013015344],"about_ca_topic_score_codex":0.0012168515,"about_ca_topic_score_gemma":0.0012924876,"teacher_disagreement_score":0.15899807,"about_ca_system_score_codex":0.00090958964,"about_ca_system_score_gemma":0.0053328504,"threshold_uncertainty_score":0.8408722},"labels":[],"label_agreement":null},{"id":"W4210644225","doi":"10.1016/j.jmoldx.2021.12.011","title":"CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Human Genome Research Institute; School of Medicine, Indiana University; National Institutes of Health","keywords":"Genotyping; Haplotype; Genetics; Biology; Genotype; Allele; DNA sequencing; Haplotype estimation; Computational biology; Pharmacogenetics; Gene","score_opus":0.18788556885217178,"score_gpt":0.39889563791961513,"score_spread":0.21101006906744335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210644225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90096,0.0020770424,0.075819865,0.00060937204,0.0001021186,0.0005696387,0.015009463,0.00044586795,0.0044066003],"genre_scores_gemma":[0.9236014,0.0010294288,0.05630502,0.00069372763,0.00014827459,0.00039388874,0.014028767,0.00025634043,0.003543182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930716,0.00012397072,0.00007374663,0.00023686586,0.00017837557,0.000079960184],"domain_scores_gemma":[0.99896634,0.0003593198,0.0001782299,0.0001401187,0.00027946223,0.00007644117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000796804,0.0004738062,0.00057328405,0.0020876494,0.0003049774,0.0005120936,0.00033822312,0.0004970216,0.002030242],"category_scores_gemma":[0.0022698962,0.00018190155,0.00072121806,0.0013429545,0.00022420677,0.00019274579,0.00025322277,0.00080821844,0.0007671941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014230546,0.00034428056,0.32737422,0.00040267827,0.00096746994,0.0052468684,0.0007710199,0.0042492,0.44634557,0.0014776253,0.0051319352,0.20626603],"study_design_scores_gemma":[0.00030831076,0.0008761929,0.7010473,0.00015308218,0.0011604388,0.016932648,0.00036119853,0.027993374,0.21109912,0.0024251514,0.037519056,0.00012409227],"about_ca_topic_score_codex":0.0030318073,"about_ca_topic_score_gemma":0.0036144555,"teacher_disagreement_score":0.0030318073,"about_ca_system_score_codex":0.00021338116,"about_ca_system_score_gemma":0.00042521645,"threshold_uncertainty_score":0.0067918897},"labels":[],"label_agreement":null},{"id":"W4211158980","doi":"10.1016/j.bcp.2022.114949","title":"Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia","year":2022,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Centre for Addiction and Mental Health; National Institutes of Health; National Institute on Drug Abuse; Canada Research Chairs; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Oxymorphone; Oxycodone; Estrous cycle; Microdialysis; Ovariectomized rat; Internal medicine; Endocrinology; Pharmacology; Medicine; Estrogen; Opioid; Central nervous system","score_opus":0.0407211240547757,"score_gpt":0.36902679068056,"score_spread":0.3283056666257843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211158980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718213,0.00094317965,0.00050657766,0.0001897165,0.00003620592,0.000010710354,0.00033366884,0.00001764556,0.0007802139],"genre_scores_gemma":[0.99575377,0.0005681302,0.00037047858,0.00009705632,0.000017465363,0.000020110469,0.0002516312,0.000025381849,0.0028959517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999217,0.000018456758,0.0000041738836,0.000017287106,0.000013622951,0.000024851777],"domain_scores_gemma":[0.99988925,0.000015717258,0.000033172964,0.000018283148,0.000010519012,0.000033074943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085332584,0.00018066786,0.0002740784,0.00023042125,0.00021899871,0.00041395606,0.000116514006,0.00017615678,0.0036068745],"category_scores_gemma":[0.00023394324,0.00020186152,0.00026754555,0.00015219126,0.00036689392,0.00024139592,0.00016749329,0.00039520126,0.00020023558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016205156,0.00043875637,0.029724304,0.00008022095,0.00015793195,0.00043651782,0.00015672145,0.00023080937,0.92833686,0.00077922945,0.00066805346,0.022785297],"study_design_scores_gemma":[0.00040936918,0.0023557579,0.81364244,0.000021409394,0.00018750796,0.0011286419,0.0005144671,0.0015454013,0.17527331,0.0009132689,0.003970015,0.000038351503],"about_ca_topic_score_codex":0.002106101,"about_ca_topic_score_gemma":0.0052788593,"teacher_disagreement_score":0.0036068745,"about_ca_system_score_codex":0.00033329497,"about_ca_system_score_gemma":0.00030283423,"threshold_uncertainty_score":0.012066245},"labels":[],"label_agreement":null},{"id":"W4211225849","doi":"10.1016/b978-0-444-64066-6.00014-9","title":"Pharmacogenomics","year":2019,"lang":"en","type":"book-chapter","venue":"Handbook of analytical separations","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Medicine; Population; Drug; Pharmacology; Biology; Gene; Genetics; Genotype","score_opus":0.16265314139834067,"score_gpt":0.4480534519976671,"score_spread":0.28540031059932647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211225849","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011305471,0.2385929,0.1437366,0.005391361,0.005103357,0.00034729842,0.009243815,0.0071883784,0.58926576],"genre_scores_gemma":[0.0056664706,0.11912867,0.085287035,0.0038174263,0.0019879055,0.0003038657,0.00788931,0.001206181,0.77471316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992106,0.0001045174,0.000033972792,0.00016056238,0.00044741505,0.00004295223],"domain_scores_gemma":[0.99951684,0.00015503849,0.000026406171,0.000094002164,0.00016541374,0.00004225146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001051138,0.0015171358,0.0016126612,0.0025283042,0.0006256206,0.0032542448,0.0019978636,0.0016539982,0.10499712],"category_scores_gemma":[0.0013906275,0.0008720833,0.000785812,0.003035791,0.00071230857,0.0017720668,0.0017655351,0.0032431,0.12813476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003776567,0.000070567476,0.00019915018,0.0008452263,0.000037709924,0.00009869693,0.000065814645,0.0004788517,0.0059142364,0.02437078,0.3909234,0.5769578],"study_design_scores_gemma":[0.000003697563,0.000017526696,0.00018320035,0.000118804885,0.000008319343,0.0003080016,0.000012182372,0.00021690592,0.0012674552,0.00789236,0.9899616,0.00000996873],"about_ca_topic_score_codex":0.0015883272,"about_ca_topic_score_gemma":0.0033357765,"teacher_disagreement_score":0.10499712,"about_ca_system_score_codex":0.0008565064,"about_ca_system_score_gemma":0.0016482436,"threshold_uncertainty_score":0.3512504},"labels":[],"label_agreement":null},{"id":"W4212906205","doi":"10.1097/fpc.0000000000000466","title":"Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes","year":2022,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Genotyping; Gene; SNP genotyping; DNA sequencing; Chromosome; Homologous chromosome; SNP; Single-nucleotide polymorphism","score_opus":0.15998655469186432,"score_gpt":0.3937307608366337,"score_spread":0.2337442061447694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212906205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77149236,0.017376417,0.20089625,0.0013891138,0.00029747817,0.00021878413,0.0014712971,0.00044822032,0.006410092],"genre_scores_gemma":[0.9424163,0.0010772275,0.053753156,0.00042172728,0.00010817164,0.00011349142,0.0007956533,0.00011986306,0.0011943852],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9123187,0.057822034,0.0033418008,0.012487113,0.012951041,0.0010792878],"domain_scores_gemma":[0.88721913,0.07774791,0.010643222,0.014732229,0.009070984,0.0005864794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057329424,0.0010804804,0.0009370003,0.0017964602,0.00055280654,0.002110695,0.0016935284,0.0018249829,0.00095405465],"category_scores_gemma":[0.08662928,0.00065555674,0.0011962085,0.0013851639,0.0014171832,0.0010410254,0.0016449067,0.0013244982,0.0006389222],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001337202,0.00010095275,0.7798593,0.00054635416,0.0028990346,0.00017223813,0.0012917848,0.0142987985,0.033346307,0.0020111038,0.0008097015,0.1633272],"study_design_scores_gemma":[0.00012898142,0.0012811379,0.8459053,0.0003449422,0.002129618,0.0023145177,0.00044415222,0.07706937,0.054724023,0.005500621,0.010004348,0.0001528736],"about_ca_topic_score_codex":0.0033924489,"about_ca_topic_score_gemma":0.004621549,"teacher_disagreement_score":0.057329424,"about_ca_system_score_codex":0.0009024935,"about_ca_system_score_gemma":0.0007113144,"threshold_uncertainty_score":0.30319065},"labels":[],"label_agreement":null},{"id":"W4214770147","doi":"10.1002/cpt.2563","title":"PharmVar GeneFocus: <i>CYP3A5</i>","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba","funders":"National Human Genome Research Institute; Erzincan Üniversitesi; National Institutes of Health; Vetenskapsrådet; Ontario Institute for Cancer Research; National Institute of General Medical Sciences; European Federation of Pharmaceutical Industries and Associations; Kungliga Tekniska Högskolan; Robert Bosch Stiftung; McGill University","keywords":"Pharmacogenomics; CYP3A5; Pharmacogenetics; Allele; Locus (genetics); Tacrolimus; Biology; Genetics; Computational biology; Medicine; Gene; Bioinformatics; Transplantation; Genotype; Internal medicine","score_opus":0.6241503739757894,"score_gpt":0.6259530102670595,"score_spread":0.0018026362912700877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214770147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027351778,0.8195942,0.010309436,0.00922371,0.0030311537,0.00044676574,0.046889205,0.003184871,0.10458545],"genre_scores_gemma":[0.008993674,0.8586643,0.017321981,0.0061453898,0.0013921421,0.0003733899,0.07536711,0.0007587269,0.030983264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944884,0.000105523155,0.000104842155,0.00007591442,0.00021181525,0.000053069583],"domain_scores_gemma":[0.99882334,0.00044424494,0.00023990475,0.000067947214,0.0003285714,0.0000958765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010941911,0.00072177395,0.0013044159,0.0041687237,0.0002559969,0.0015758008,0.0012208662,0.0009658465,0.031054234],"category_scores_gemma":[0.0023875432,0.00021576048,0.00086326886,0.006543374,0.00036736115,0.0013435078,0.0010940202,0.001261583,0.024765074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012080786,0.000037841997,0.00044774023,0.0132789835,0.00009020314,0.00018291839,0.0000901892,0.00016428254,0.0025880889,0.005577997,0.1988713,0.7785496],"study_design_scores_gemma":[0.000009225324,0.000013489164,0.0005359068,0.0012096101,0.000044301283,0.00031418525,0.00001097693,0.000023283546,0.00040805424,0.00050962344,0.99691415,0.0000073133274],"about_ca_topic_score_codex":0.0022986478,"about_ca_topic_score_gemma":0.002756483,"teacher_disagreement_score":0.031054234,"about_ca_system_score_codex":0.00059647375,"about_ca_system_score_gemma":0.0024701627,"threshold_uncertainty_score":0.10388672},"labels":[],"label_agreement":null},{"id":"W4220729318","doi":"10.3389/fgene.2022.878191","title":"Editorial: Pharmacogenomics: From Bench to Bedside and Back Again","year":2022,"lang":"en","type":"editorial","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Economic and Social Research Council","keywords":"Pharmacogenomics; Pharmacogenetics; Bench to bedside; Medicine; Medical physics; Biology; Pharmacology; Genetics; Genotype; Gene","score_opus":0.03515236113004525,"score_gpt":0.37496462005336606,"score_spread":0.3398122589233208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220729318","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033772663,0.002519295,0.00012655603,0.030026214,0.96471226,0.000021608997,0.00010479643,0.000109825814,0.0023456067],"genre_scores_gemma":[0.000486775,0.0025422913,0.00014793233,0.025637731,0.95136493,0.000027552012,0.00008334536,0.000074414274,0.019635009],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631315,0.00062108244,0.0003626285,0.00050193095,0.0019145816,0.00028670687],"domain_scores_gemma":[0.9869638,0.0040049795,0.0009857591,0.00034038245,0.0050081084,0.0026970096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005693166,0.004229701,0.0032895443,0.0037339884,0.0032543947,0.006390522,0.003132421,0.01138273,0.043646365],"category_scores_gemma":[0.021057311,0.0010963655,0.0025963392,0.0013189983,0.0018225124,0.0041900836,0.0014250157,0.0121866735,0.033458725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003606998,0.00000780118,0.00001539733,0.00009297191,0.000009332026,0.00007441818,0.0000046862574,0.000019005096,0.000038541613,0.00013237748,0.99711704,0.0024523411],"study_design_scores_gemma":[0.00010246116,0.000030178964,0.0002347295,0.0003412442,0.000042812368,0.00033034454,0.000027797632,0.0001736928,0.00012700513,0.0012484402,0.9973199,0.00002145418],"about_ca_topic_score_codex":0.0013507316,"about_ca_topic_score_gemma":0.0040157386,"teacher_disagreement_score":0.043646365,"about_ca_system_score_codex":0.002620557,"about_ca_system_score_gemma":0.0027389692,"threshold_uncertainty_score":0.14601165},"labels":[],"label_agreement":null},{"id":"W4220891053","doi":"10.3390/biology11030403","title":"Androgen Glucuronidation in Mice: When, Where, and How","year":2022,"lang":"en","type":"article","venue":"Biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Biology; Dihydrotestosterone; Androgen; Internal medicine; Sulfotransferase; Androsterone; Endocrinology; Testosterone (patch); Hydroxysteroid; Enzyme; Glucuronosyltransferase; Kidney; Microsome; Hormone; Biochemistry; Dehydrogenase; Steroid","score_opus":0.08825635063079168,"score_gpt":0.4076224078820755,"score_spread":0.3193660572512838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220891053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9236893,0.02478822,0.029396484,0.002305858,0.00041756124,0.00015242134,0.010716525,0.0013887099,0.007145021],"genre_scores_gemma":[0.91674155,0.021689266,0.016902002,0.0012103266,0.00010096539,0.00025038605,0.012100796,0.0005541427,0.03045047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962986,0.000050132978,0.0000297176,0.00014905009,0.00008302797,0.00005820682],"domain_scores_gemma":[0.99985766,0.000009221749,0.000049898677,0.000020628268,0.00001788404,0.000044624758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031808417,0.00061601674,0.00046201792,0.0007600243,0.00028753065,0.00077123847,0.00032790925,0.00060418167,0.002557954],"category_scores_gemma":[0.00013276629,0.0003903061,0.00082263566,0.0004803739,0.0005266108,0.00075331365,0.00028838942,0.0014741732,0.0012917541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005251742,0.00009344923,0.0020173737,0.00014911329,0.000037726953,0.00011347349,0.00003851191,0.00007467986,0.98837435,0.00050419796,0.0004154989,0.0076565105],"study_design_scores_gemma":[0.000064439024,0.0009857534,0.014634908,0.00005398797,0.00019630004,0.0013469064,0.00013737856,0.0008421618,0.9564448,0.0005360356,0.024722157,0.000035110916],"about_ca_topic_score_codex":0.0012110065,"about_ca_topic_score_gemma":0.0020852953,"teacher_disagreement_score":0.002557954,"about_ca_system_score_codex":0.0005639916,"about_ca_system_score_gemma":0.00034216637,"threshold_uncertainty_score":0.00855726},"labels":[],"label_agreement":null},{"id":"W4221008442","doi":"10.1038/s41398-022-01845-w","title":"Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19","year":2022,"lang":"en","type":"erratum","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Genotyping; CYP2C19; CYP2D6; Medicine; MEDLINE; Psychology; Information retrieval; Computer science; Internal medicine; Genotype; Genetics; Political science; Biology","score_opus":0.3700051956545867,"score_gpt":0.5506330170029412,"score_spread":0.18062782134835448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221008442","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076492893,0.0016091825,0.00971768,0.05702522,0.91671854,0.00013910145,0.0054699467,0.002298704,0.00625671],"genre_scores_gemma":[0.042840194,0.011012817,0.096390635,0.13004076,0.23043698,0.0012316084,0.01877335,0.012911465,0.4563622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857708,0.0031114942,0.0029979958,0.0016642474,0.0058526755,0.00060277747],"domain_scores_gemma":[0.9141847,0.023900209,0.0045776735,0.008149021,0.047476303,0.0017121036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009710457,0.0025276009,0.0016440151,0.004219752,0.0031432544,0.003592078,0.0030017048,0.004940617,0.06708642],"category_scores_gemma":[0.13352245,0.0014541321,0.0018598125,0.0030001197,0.0023079945,0.002005325,0.0026211904,0.009819632,0.047076337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006093451,0.0000101586575,0.00019643526,0.000207366,0.000022281021,0.00038574118,0.00007022963,0.00007058961,0.00016656719,0.001341072,0.9822219,0.015246681],"study_design_scores_gemma":[0.000055612356,0.000028526825,0.00094585057,0.00048889825,0.00005391569,0.0019188753,0.00008349384,0.0003786189,0.00091638404,0.0019907232,0.99308395,0.000055167267],"about_ca_topic_score_codex":0.012312709,"about_ca_topic_score_gemma":0.013543989,"teacher_disagreement_score":0.06708642,"about_ca_system_score_codex":0.0034612354,"about_ca_system_score_gemma":0.0060288548,"threshold_uncertainty_score":0.22442645},"labels":[],"label_agreement":null},{"id":"W4221158461","doi":"","title":"Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; University of Calgary","funders":"","keywords":"Family medicine; Medicine; Dosing; Psychology; Medical education; Pharmacology","score_opus":0.0640097245234779,"score_gpt":0.3428768720807934,"score_spread":0.2788671475573155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221158461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936278,0.00087345217,0.000051453924,0.0020917999,0.000014028098,0.00002951703,0.00026512507,0.000008057879,0.0030388134],"genre_scores_gemma":[0.9972882,0.00088637427,0.00022119009,0.00081834913,0.000008368517,0.000013334114,0.00013433691,0.0000016781692,0.0006282698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889463,0.00013218797,0.000045482968,0.00007175909,0.0005583561,0.0002976204],"domain_scores_gemma":[0.9958931,0.0006434621,0.0012562372,0.000045652472,0.0007676324,0.001393793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009842977,0.00013441105,0.00013810914,0.0005912624,0.0014859453,0.00081650494,0.0005263524,0.00047126238,0.0022048152],"category_scores_gemma":[0.0033814139,0.00024125901,0.00015138135,0.00094325654,0.0009902461,0.00026815358,0.00044579557,0.0006750948,0.00017570688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028742752,0.00005789619,0.9837399,0.0000459018,0.00000973464,0.00036471465,0.004065108,0.00007582058,0.0002077467,0.0000582906,0.0015898793,0.009756231],"study_design_scores_gemma":[0.000008394711,0.0000557737,0.98838216,0.00008082062,0.0000076406495,0.00032535472,0.009611123,0.00014764564,0.00006318193,0.0000175488,0.0012943884,0.000005935016],"about_ca_topic_score_codex":0.924679,"about_ca_topic_score_gemma":0.95960855,"teacher_disagreement_score":0.07532102,"about_ca_system_score_codex":0.010364987,"about_ca_system_score_gemma":0.017952165,"threshold_uncertainty_score":0.15152913},"labels":[],"label_agreement":null},{"id":"W4224292486","doi":"10.1016/j.jmoldx.2022.03.008","title":"Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Diagnostics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institutes of Health; National Institute of General Medical Sciences; Indiana University","keywords":"Pharmacogenomics; Exome sequencing; Genotyping; Genetics; Exome; 1000 Genomes Project; Biology; Genotype; Single-nucleotide polymorphism; Gene; Mutation","score_opus":0.17096283068056078,"score_gpt":0.5015537103029486,"score_spread":0.3305908796223878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224292486","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1886177,0.00074244186,0.79704905,0.0014653774,0.00024143231,0.00032431865,0.0041902866,0.00466517,0.0027041936],"genre_scores_gemma":[0.6098262,0.0002545633,0.38059798,0.0007863162,0.0001566065,0.0005226778,0.005972468,0.00025073643,0.0016323755],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984054,0.0007576935,0.000101267324,0.00033948186,0.0003216069,0.0000745353],"domain_scores_gemma":[0.9914438,0.006772316,0.0002650646,0.0006644521,0.0007216852,0.00013265717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035223837,0.00081096624,0.0009931745,0.0012986752,0.00056316756,0.0015540621,0.0015800904,0.0011416434,0.0021238795],"category_scores_gemma":[0.01665951,0.00048124834,0.0010649196,0.0008216446,0.00043772376,0.0006359454,0.0011895308,0.0011747791,0.0008260305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012439765,0.0007846649,0.0405398,0.00047782998,0.0014919001,0.00067179214,0.0001446646,0.66543156,0.016810229,0.0082491655,0.009969096,0.2541853],"study_design_scores_gemma":[0.00006372639,0.00004936506,0.0024110898,0.000016043616,0.000049978407,0.00013739994,0.000012862524,0.99174666,0.0015710882,0.0031963952,0.00073101453,0.0000143938905],"about_ca_topic_score_codex":0.0069035664,"about_ca_topic_score_gemma":0.0075522535,"teacher_disagreement_score":0.0069035664,"about_ca_system_score_codex":0.00053657265,"about_ca_system_score_gemma":0.002542522,"threshold_uncertainty_score":0.018628359},"labels":[],"label_agreement":null},{"id":"W4225296657","doi":"10.2196/32902","title":"Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Dosing; Medicine; Medical prescription; Pharmacogenetics; Drug; Retrospective cohort study; Intensive care medicine; Pharmacology; Internal medicine; Genotype","score_opus":0.11658583307125034,"score_gpt":0.4695899407021608,"score_spread":0.3530041076309105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225296657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973425,0.0011468321,0.00032566898,0.000031287054,0.000008161038,0.00003375953,0.00031260704,0.0000054561497,0.0007935806],"genre_scores_gemma":[0.9992884,0.000244583,0.00013545714,0.000043290827,0.000015107295,0.00001157676,0.00021163041,0.0000038163034,0.000046102887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954423,0.0015214933,0.000729351,0.0012014867,0.0007843184,0.00032113717],"domain_scores_gemma":[0.9844691,0.0048767063,0.0066766157,0.0017655749,0.0013521437,0.0008597749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003100534,0.00038037682,0.00037493356,0.0014260318,0.00052521925,0.0008492546,0.0004222232,0.00054823543,0.0016619302],"category_scores_gemma":[0.011445974,0.00043179572,0.0005299768,0.0019469814,0.0007772871,0.0006388458,0.00082768116,0.0005646785,0.00045112203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008352735,0.000025361855,0.99835974,0.000013595018,0.000026932594,0.0003398988,0.00005080676,0.000019475692,0.00007803244,0.000009798252,0.00003825751,0.0009545456],"study_design_scores_gemma":[0.000013524509,0.0005947749,0.9920431,0.000024693898,0.00011372753,0.005924179,0.00031121683,0.00019411961,0.00015145222,0.000024386058,0.000595102,0.000009640407],"about_ca_topic_score_codex":0.0017005006,"about_ca_topic_score_gemma":0.0012860695,"teacher_disagreement_score":0.003100534,"about_ca_system_score_codex":0.0003439198,"about_ca_system_score_gemma":0.000549498,"threshold_uncertainty_score":0.016397357},"labels":[],"label_agreement":null},{"id":"W4225297281","doi":"10.2196/37242","title":"Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pain management; Medicine; Physical therapy; Pharmacology","score_opus":0.1688270014566855,"score_gpt":0.5058544427089622,"score_spread":0.3370274412522767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225297281","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014038899,0.0059499308,0.0017233944,0.45316243,0.5235905,0.00046823465,0.004858066,0.00052502623,0.0083185015],"genre_scores_gemma":[0.038514618,0.010202718,0.005516944,0.6079936,0.28101268,0.0021685562,0.004392958,0.001683748,0.048514225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9559296,0.012385413,0.012117564,0.003032867,0.014667582,0.001866925],"domain_scores_gemma":[0.6282735,0.08905935,0.02421283,0.0143886125,0.23669952,0.00736627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03374065,0.000788999,0.0021376163,0.0022542237,0.0026985148,0.004245226,0.0023410488,0.0064161266,0.05868282],"category_scores_gemma":[0.3760114,0.000746994,0.002174607,0.0020331445,0.0021884234,0.0020288792,0.003196434,0.0059329453,0.03210716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007254328,0.0000073532315,0.0007084376,0.00061163085,0.000046042936,0.00013781362,0.000099103476,0.000021464171,0.000051677885,0.00031746307,0.992554,0.00537239],"study_design_scores_gemma":[0.000106759944,0.000029622905,0.002492398,0.0024674798,0.000083329614,0.00042301582,0.00045753966,0.00020085968,0.00033533794,0.0007950749,0.9925485,0.00006005728],"about_ca_topic_score_codex":0.0038768142,"about_ca_topic_score_gemma":0.005378141,"teacher_disagreement_score":0.05868282,"about_ca_system_score_codex":0.0029269087,"about_ca_system_score_gemma":0.008841984,"threshold_uncertainty_score":0.19631362},"labels":[],"label_agreement":null},{"id":"W4225326793","doi":"10.2196/37145","title":"Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pain management; Pharmacogenomics; Medicine; Retrospective cohort study; Psychology; Physical therapy; Internal medicine; Pharmacology","score_opus":0.15680279152603166,"score_gpt":0.4967567393379063,"score_spread":0.33995394781187466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225326793","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041632235,0.045493297,0.02470219,0.2806079,0.44276565,0.0108344415,0.028904025,0.002540257,0.12252009],"genre_scores_gemma":[0.39152792,0.054567065,0.034574028,0.09728378,0.16905856,0.007849828,0.029032199,0.00440547,0.21170105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9405804,0.02151598,0.010952289,0.0032943732,0.022090899,0.0015660222],"domain_scores_gemma":[0.45155677,0.064366214,0.0264182,0.028542794,0.42083934,0.00827666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04215718,0.0006390903,0.0018733364,0.0048301183,0.00264054,0.004348344,0.0025896118,0.0029258612,0.05704342],"category_scores_gemma":[0.3640298,0.0006143572,0.0016485136,0.0035472752,0.0022512763,0.0025241072,0.0026331202,0.0019783312,0.02738064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052353815,0.000060927123,0.010712065,0.005858687,0.00032691078,0.0008067135,0.0006367331,0.000093686176,0.0007762643,0.001381391,0.8833478,0.09547519],"study_design_scores_gemma":[0.00017264286,0.00015026504,0.019339625,0.007164588,0.0002783769,0.0011952823,0.00096148945,0.0006198974,0.0018878859,0.0014689751,0.96666723,0.00009364845],"about_ca_topic_score_codex":0.0030377298,"about_ca_topic_score_gemma":0.0030343784,"teacher_disagreement_score":0.9578428,"about_ca_system_score_codex":0.0021261787,"about_ca_system_score_gemma":0.010395086,"threshold_uncertainty_score":0.22295117},"labels":[],"label_agreement":null},{"id":"W4225327440","doi":"10.2196/37513","title":"Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”","year":2022,"lang":"en","type":"article","venue":"JMIRx Med","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pain management; Medicine; Pharmacology; Physical therapy","score_opus":0.15680279152603166,"score_gpt":0.4967567393379063,"score_spread":0.33995394781187466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225327440","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14036629,0.09891465,0.029824222,0.25436178,0.21703677,0.009995831,0.05079025,0.0024737073,0.19623646],"genre_scores_gemma":[0.6412174,0.054198977,0.023153285,0.057951216,0.07472562,0.0047066077,0.031560782,0.003054956,0.10943115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.957105,0.015605566,0.009995657,0.0028649822,0.012783098,0.0016457152],"domain_scores_gemma":[0.605102,0.060231566,0.03220526,0.022822876,0.27102545,0.008612872],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032491,0.00051956205,0.0014668985,0.004085405,0.0025279257,0.0038374257,0.0022618542,0.002134886,0.06128461],"category_scores_gemma":[0.29222572,0.00052194565,0.0014636787,0.0037409929,0.0022033637,0.0030261602,0.002780675,0.001512283,0.024193855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064162514,0.00010214814,0.048482317,0.007646367,0.0004974134,0.0014195117,0.00081774447,0.00013581119,0.00095974526,0.0017793974,0.81275433,0.12476367],"study_design_scores_gemma":[0.00023491752,0.00022383108,0.07054676,0.008710146,0.000448618,0.002585605,0.0016584793,0.00088770053,0.0021787079,0.00220755,0.910206,0.00011173388],"about_ca_topic_score_codex":0.0032055853,"about_ca_topic_score_gemma":0.0032730568,"teacher_disagreement_score":0.96750903,"about_ca_system_score_codex":0.0018367426,"about_ca_system_score_gemma":0.008021971,"threshold_uncertainty_score":0.20501739},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4226112864","doi":"10.22215/etd/2022-14949","title":"Optimizing and Validating a Caenorhabditis Elegans Model as a Tool for Assessing Contaminant-Induced Oxidative Stress and Oxylipin Signalling","year":2022,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Oxylipin; Oxidative stress; Caenorhabditis elegans; Reactive oxygen species; Paraquat; Endoplasmic reticulum; CYP2E1; Oxidative phosphorylation; Cytochrome P450; Antioxidant; Biochemistry; Cell biology; Mitochondrion; Xenobiotic; Biology; Enzyme; Chemistry; Gene","score_opus":0.10265944524360186,"score_gpt":0.4465298166367333,"score_spread":0.3438703713931314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226112864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8938128,0.0027716632,0.07049946,0.00086235465,0.00043962267,0.0021730266,0.012411028,0.0009818713,0.01604825],"genre_scores_gemma":[0.7169843,0.006863243,0.20453133,0.00060637284,0.00004603456,0.003854138,0.0146329,0.0005154678,0.051966213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955076,0.000041309868,0.000041223597,0.00010535794,0.00019507472,0.000066314395],"domain_scores_gemma":[0.99955827,0.000058315716,0.00008263789,0.00005971674,0.00016504242,0.00007591339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007522983,0.0008342428,0.00035401338,0.0007938399,0.00078822195,0.0006021848,0.0006615061,0.0007540007,0.0021862357],"category_scores_gemma":[0.00038081966,0.00032461254,0.00052882836,0.0003072482,0.0003464025,0.0004960586,0.00064611156,0.0012234593,0.00082551985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006806263,0.000081852944,0.00041790667,0.00008935629,0.000008045235,0.000050021627,0.000033015393,0.00030398223,0.9956456,0.00033490133,0.00019273093,0.0027745184],"study_design_scores_gemma":[0.00006006514,0.0010890103,0.00781838,0.0001367498,0.00011276432,0.00020669843,0.00013790267,0.0032403085,0.9657101,0.00034986154,0.021090811,0.000047228066],"about_ca_topic_score_codex":0.006404698,"about_ca_topic_score_gemma":0.01580717,"teacher_disagreement_score":0.006404698,"about_ca_system_score_codex":0.000981183,"about_ca_system_score_gemma":0.0012017179,"threshold_uncertainty_score":0.01273483},"labels":[],"label_agreement":null},{"id":"W4229450592","doi":"","title":"Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes","year":2022,"lang":"en","type":"article","venue":"Lancaster EPrints (Lancaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of New Brunswick; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Genotyping; Genetics; Biology; Amplicon; Genotype; 1000 Genomes Project; Single-nucleotide polymorphism; SNP; Molecular Inversion Probe; DNA sequencing; Allele; Gene; Computational biology; Polymerase chain reaction","score_opus":0.1525181934845685,"score_gpt":0.34615258156730344,"score_spread":0.19363438808273495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229450592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7528199,0.011849375,0.22532795,0.0009609425,0.00027781457,0.00030689643,0.0015069641,0.0004609153,0.006489242],"genre_scores_gemma":[0.9110824,0.0010957918,0.08420629,0.00048418512,0.0001055654,0.0001997394,0.001177012,0.00019520849,0.0014537802],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.8885582,0.0734304,0.004472687,0.016670855,0.015364163,0.0015037056],"domain_scores_gemma":[0.8848724,0.0777756,0.010284775,0.01745103,0.008842311,0.00077392237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0692125,0.0011921307,0.0012423345,0.002080609,0.0006855064,0.002312943,0.0017238286,0.0017927882,0.0009651824],"category_scores_gemma":[0.09758831,0.00091948314,0.0015015627,0.0017629359,0.0016076281,0.0010821405,0.0019578747,0.0015569407,0.000704961],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019454858,0.0001335365,0.75382763,0.0006073987,0.00408557,0.00026527213,0.001993137,0.020730762,0.04672252,0.0029995542,0.00084702385,0.16584203],"study_design_scores_gemma":[0.00017703554,0.0016706864,0.79873544,0.00033791774,0.0025364347,0.002519322,0.00059167773,0.11108004,0.061880823,0.008335015,0.011905867,0.00022963103],"about_ca_topic_score_codex":0.0042380923,"about_ca_topic_score_gemma":0.0065655336,"teacher_disagreement_score":0.0692125,"about_ca_system_score_codex":0.000897047,"about_ca_system_score_gemma":0.0007890896,"threshold_uncertainty_score":0.36603504},"labels":[],"label_agreement":null},{"id":"W4229762152","doi":"10.1139/y01-065","title":"Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotyping; Allele; Allele frequency; Genetics; CYP2C9; Ethnic group; Biology; Population; Genotype; Polymorphism (computer science); Demography; Gene","score_opus":0.08544954109072975,"score_gpt":0.3947893581045216,"score_spread":0.3093398170137919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229762152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976017,0.0002599533,0.000109564455,0.000033536715,0.0000039673914,0.000012101957,0.0004876256,0.000008399761,0.0014832619],"genre_scores_gemma":[0.99834216,0.0002330075,0.00022477416,0.000028182041,0.0000032684552,0.000008886887,0.0004581275,0.0000070966457,0.0006945352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943763,0.00004006637,0.000033425727,0.00015887307,0.00020315002,0.00012679868],"domain_scores_gemma":[0.9994735,0.000055132605,0.00008437947,0.000035827536,0.00022528441,0.00012585917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038512185,0.00032318558,0.0003947112,0.0014159704,0.0019172736,0.00074688223,0.0004979206,0.00026887708,0.0014884879],"category_scores_gemma":[0.0012386835,0.00017570921,0.00025486862,0.0020007684,0.00048968697,0.00012576899,0.00028707707,0.00027061818,0.00013017101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003823179,0.0000612381,0.96640325,0.00007529119,0.00015768493,0.00056084676,0.005192756,0.00016006,0.0070729726,0.00035804193,0.0009795654,0.018596139],"study_design_scores_gemma":[0.000007023336,0.00003429686,0.9975176,0.000007631571,0.00004956252,0.0002986336,0.0007784578,0.00011913664,0.00035916467,0.000032159453,0.0007832509,0.000013146419],"about_ca_topic_score_codex":0.89909106,"about_ca_topic_score_gemma":0.9107817,"teacher_disagreement_score":0.100908935,"about_ca_system_score_codex":0.0038539057,"about_ca_system_score_gemma":0.0024985513,"threshold_uncertainty_score":0.20300639},"labels":[],"label_agreement":null},{"id":"W4230805293","doi":"10.1007/978-981-32-9779-1_12","title":"Drug Interactions","year":2019,"lang":"en","type":"book-chapter","venue":"Introduction to Basics of Pharmacology and Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lambda Therapeutic Research; Brampton Civic Hospital","funders":"","keywords":"Drug; Pharmacology; Drug interaction; Pharmacokinetics; In vivo; Pharmacodynamics; Polypharmacy; Chemistry; Medicine; Biology","score_opus":0.050870324620553097,"score_gpt":0.3932708450028266,"score_spread":0.34240052038227353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230805293","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002422907,0.07770535,0.005018441,0.007932209,0.0053760647,0.00050873513,0.005168989,0.0010907267,0.8947765],"genre_scores_gemma":[0.024699822,0.053051747,0.005483442,0.013720258,0.0027120633,0.00039662453,0.0048911455,0.00028794378,0.894757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992167,0.00017120414,0.00004601963,0.00009503724,0.00039793077,0.00007312613],"domain_scores_gemma":[0.9995173,0.00012209093,0.00005710141,0.000056882265,0.00017073707,0.00007585702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058318785,0.00086448464,0.00070487004,0.0012590945,0.00045645796,0.0013576063,0.0010049131,0.0010906106,0.22939223],"category_scores_gemma":[0.0017742933,0.0001751988,0.0008203134,0.00081375695,0.00027124898,0.0006444161,0.0010773255,0.0012761464,0.112970985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025097458,0.00013500749,0.00032237312,0.0011673962,0.00007453313,0.00052829174,0.000037052145,0.00011616118,0.001788783,0.008740208,0.4664545,0.5203847],"study_design_scores_gemma":[0.00003406578,0.000075792384,0.00031036526,0.00025977506,0.000028549282,0.0009380745,0.00001148099,0.000037108413,0.00041184097,0.0015372409,0.9963503,0.0000052746686],"about_ca_topic_score_codex":0.0009896618,"about_ca_topic_score_gemma":0.0026291031,"teacher_disagreement_score":0.22939223,"about_ca_system_score_codex":0.0006045987,"about_ca_system_score_gemma":0.00093082455,"threshold_uncertainty_score":0.76739347},"labels":[],"label_agreement":null},{"id":"W4231693518","doi":"10.1139/y00-030","title":"Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ferrochelatase; Bioassay; Microsome; Isozyme; Cytochrome P450; Biochemistry; Xenobiotic; Porphyria; Heme; Recombinant DNA; Complementary DNA; In vitro; Hemeprotein; Biology; Chemistry; Enzyme; Molecular biology; Gene; Endocrinology","score_opus":0.06409154204016622,"score_gpt":0.36463957640535655,"score_spread":0.30054803436519034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231693518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596251,0.0021235694,0.03608455,0.00015879163,0.00003995447,0.00012770806,0.0003988539,0.0002739835,0.0011675616],"genre_scores_gemma":[0.9634364,0.0012255085,0.03175184,0.000070331385,0.000027190521,0.00011525424,0.0011155681,0.000033756252,0.0022242302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993549,0.00023427582,0.00005846577,0.0001486829,0.00014418415,0.000059507285],"domain_scores_gemma":[0.99963856,0.00014658266,0.00007727819,0.000067406836,0.000040200128,0.000030103913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054298114,0.0007421884,0.0003730537,0.00037499666,0.00017991148,0.00025715423,0.00024026321,0.0004284563,0.00047523488],"category_scores_gemma":[0.0003753359,0.0001969522,0.0002739167,0.0003321318,0.0003274307,0.00023563384,0.00023659105,0.0005004079,0.0003871929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002437231,0.000013039226,0.00009375806,0.000011203785,0.0000029386438,0.000012410866,0.0000065172417,0.000022337577,0.9995689,0.000014193077,0.0000037988639,0.00022651195],"study_design_scores_gemma":[0.0000034076122,0.00013208546,0.0006373746,0.0000012890553,0.000010517357,0.00008530893,0.000005097394,0.00021629532,0.99867517,0.000009848665,0.00022205034,0.0000014823487],"about_ca_topic_score_codex":0.0009978841,"about_ca_topic_score_gemma":0.001058642,"teacher_disagreement_score":0.0009978841,"about_ca_system_score_codex":0.00028961804,"about_ca_system_score_gemma":0.000365848,"threshold_uncertainty_score":0.0028716326},"labels":[],"label_agreement":null},{"id":"W4233749695","doi":"10.1007/bf02916036","title":"Special Lectures","year":2007,"lang":"en","type":"article","venue":"Indian Journal of Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation; Hospital for Sick Children; SickKids Foundation; Sunnybrook Hospital; University of Toronto","funders":"University of Delhi; Maharashtra University of Health Sciences, Nashik; Indian Council of Medical Research; Postgraduate Institute of Medical Education and Research, Chandigarh","keywords":"Computer science; Medicine","score_opus":0.14235590347051974,"score_gpt":0.5277144605135777,"score_spread":0.385358557043058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233749695","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022356834,0.032730233,0.0029612244,0.04935556,0.40246242,0.00027649547,0.0011182122,0.0011931949,0.507667],"genre_scores_gemma":[0.0029879,0.005638189,0.00073186733,0.004751854,0.03829123,0.000053161828,0.0004514435,0.0001535167,0.9469407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958736,0.000048054666,0.000017793764,0.00008457133,0.00018343853,0.000078895035],"domain_scores_gemma":[0.99850166,0.000086102475,0.000053336662,0.00007746404,0.0004457002,0.0008358245],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00075403583,0.0012290833,0.00064025715,0.0012811128,0.00094812433,0.0019729638,0.0009957412,0.0018820668,0.3150257],"category_scores_gemma":[0.0021803488,0.00028815333,0.00062569487,0.00047826167,0.0003277805,0.0012214314,0.0021220925,0.0022596547,0.17367186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028999355,0.00002927827,0.00009587597,0.00005209416,0.0000025952088,0.00008634587,0.0000144807245,0.000039923547,0.00022994512,0.0008464475,0.9320826,0.066491455],"study_design_scores_gemma":[0.000007289836,0.000022183978,0.00038217072,0.000049029168,0.0000029326236,0.00023742432,0.000024935529,0.000034860448,0.00008166212,0.00090913975,0.9982445,0.0000037127174],"about_ca_topic_score_codex":0.0010284283,"about_ca_topic_score_gemma":0.0037696823,"teacher_disagreement_score":0.6849743,"about_ca_system_score_codex":0.00090175605,"about_ca_system_score_gemma":0.0013328348,"threshold_uncertainty_score":0.9770327},"labels":[],"label_agreement":null},{"id":"W4234451010","doi":"10.1139/y00-066","title":"Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Kidney Foundation of Canada","keywords":"CYP3A; CYP2E1; Cirrhosis; Breath test; Internal medicine; Cytochrome P450; Chemistry; Isozyme; Carbon tetrachloride; Endocrinology; Pharmacology; Biology; Metabolism; Biochemistry; Enzyme; Medicine","score_opus":0.061016831606421136,"score_gpt":0.3971796990691203,"score_spread":0.3361628674626992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234451010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486023,0.0010855378,0.002365761,0.00018484614,0.00010243163,0.00025072368,0.00025515188,0.00012594921,0.0007693854],"genre_scores_gemma":[0.98722655,0.0017333139,0.005319586,0.00023319082,0.00006271519,0.0009315543,0.0011391144,0.00005322691,0.003300633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991165,0.00022607716,0.00012183103,0.00013251144,0.00021538125,0.00018776947],"domain_scores_gemma":[0.99916065,0.00010957066,0.000224863,0.00010886426,0.00009628104,0.00029982318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005500674,0.0010999485,0.000941147,0.002216899,0.00061803235,0.00051345926,0.0002905617,0.00075836066,0.0019382429],"category_scores_gemma":[0.0005604436,0.00046462187,0.00065759756,0.0006422018,0.00096281094,0.00053425576,0.0005885498,0.0016324198,0.00030597372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054444224,0.0016575598,0.0020468659,0.000115924304,0.000053691747,0.00028286022,0.00009619301,0.00008682925,0.9873524,0.00013336877,0.00011080833,0.0026191338],"study_design_scores_gemma":[0.0009820425,0.042813797,0.047286402,0.00004413777,0.00034478592,0.0025260476,0.0002738185,0.0012435344,0.9008006,0.0002472338,0.0033480462,0.00008952508],"about_ca_topic_score_codex":0.0006360166,"about_ca_topic_score_gemma":0.0013309523,"teacher_disagreement_score":0.002216899,"about_ca_system_score_codex":0.0007666857,"about_ca_system_score_gemma":0.00051082025,"threshold_uncertainty_score":0.0064840913},"labels":[],"label_agreement":null},{"id":"W4234704195","doi":"10.1016/j.tiv.2012.10.005","title":"Modulation of trichloroethylene in vitro metabolism by different drugs in rats","year":2012,"lang":"en","type":"article","venue":"Toxicology in Vitro","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Chemistry; Glucuronidation; Naproxen; Mefenamic acid; Metabolite; Acetaminophen; Pharmacology; Salicylic acid; Microsome; Ibuprofen; Metabolism; Chromatography; Biochemistry; In vitro","score_opus":0.057114921182076596,"score_gpt":0.38729107331115775,"score_spread":0.33017615212908114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234704195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995507,0.00088414166,0.0019855497,0.00015730227,0.000054075754,0.00003432069,0.0004741251,0.00010550526,0.00079791865],"genre_scores_gemma":[0.9908379,0.0016362402,0.0019619607,0.00009398399,0.000041387062,0.00007754807,0.00075783505,0.000062800944,0.004530419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995943,0.00008335927,0.000029438643,0.00009844685,0.0000797066,0.00011481998],"domain_scores_gemma":[0.9993291,0.00012686159,0.00018588676,0.00012241698,0.000072869596,0.00016291106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002888214,0.0011360883,0.0006718574,0.00096577796,0.00042809377,0.00050716306,0.00046756022,0.0006797055,0.0015416719],"category_scores_gemma":[0.0004946044,0.000568693,0.0006775216,0.0005633987,0.00088208384,0.0006404174,0.00029339019,0.0013476234,0.00050621066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011110973,0.0005367661,0.0015090437,0.000050664723,0.00005857816,0.00020213678,0.000080785605,0.0003155253,0.98117197,0.00015727407,0.000113133974,0.004693091],"study_design_scores_gemma":[0.00006128448,0.0028117546,0.002782383,0.0000027436422,0.00006371417,0.00009759602,0.00005625266,0.00048632987,0.9931161,0.00005997717,0.00044901576,0.000012848854],"about_ca_topic_score_codex":0.0048959646,"about_ca_topic_score_gemma":0.0067772414,"teacher_disagreement_score":0.0048959646,"about_ca_system_score_codex":0.001072393,"about_ca_system_score_gemma":0.0008488335,"threshold_uncertainty_score":0.009734929},"labels":[],"label_agreement":null},{"id":"W4236455061","doi":"10.3410/f.10018.467508","title":"Faculty Opinions recommendation of CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.","year":2006,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"CYP2D6; Tamoxifen; Breast cancer; Antidepressant; Genotype; Oncology; Adjuvant; Medicine; Internal medicine; Pharmacology; Cancer; Bioinformatics; Biology; Metabolism; Genetics; Gene; Cytochrome P450","score_opus":0.08069509797434733,"score_gpt":0.4322443429382367,"score_spread":0.3515492449638894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236455061","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021147687,0.00007119829,0.000060952574,0.00008878855,0.000016433192,0.000015005861,0.99888235,0.00014143651,0.0005123635],"genre_scores_gemma":[0.0010281713,0.00010560707,0.00033678598,0.00009705219,0.0000113614005,0.000066966226,0.99727565,0.000038918643,0.0010394823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989517,0.00017194354,0.00016598152,0.00029317924,0.00030833733,0.00010889673],"domain_scores_gemma":[0.9962127,0.0010579852,0.00076911587,0.00070833875,0.00083077233,0.00042102576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012654768,0.0017045683,0.0016547581,0.0025030952,0.00041633967,0.0015218236,0.0025863242,0.0021577915,0.05558137],"category_scores_gemma":[0.0097151855,0.0006628332,0.0016214325,0.0039895335,0.00017752359,0.0009734687,0.00096312567,0.0016179234,0.03776706],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002174134,0.00005038127,0.004215668,0.0010157716,0.00014712456,0.000028277993,0.000008357127,0.00033915314,0.00015256311,0.00015696048,0.98794657,0.0057216627],"study_design_scores_gemma":[0.0015370428,0.000073239935,0.046291847,0.0007842638,0.00041070583,0.0002115272,0.000034832337,0.002056568,0.0009860804,0.0009753631,0.9465705,0.00006801511],"about_ca_topic_score_codex":0.023672583,"about_ca_topic_score_gemma":0.05391253,"teacher_disagreement_score":0.05558137,"about_ca_system_score_codex":0.0010879315,"about_ca_system_score_gemma":0.0029586286,"threshold_uncertainty_score":0.18593818},"labels":[],"label_agreement":null},{"id":"W4236581453","doi":"10.2165/11634200-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Computer science; Medicine; Pharmacology","score_opus":0.37905310127943986,"score_gpt":0.5525052629288641,"score_spread":0.17345216164942429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236581453","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037321128,0.0012078554,0.9930146,0.00040366195,0.00010884725,0.000022352211,0.00018545229,0.00019641238,0.0044874493],"genre_scores_gemma":[0.15721923,0.013225756,0.8038101,0.0007740733,0.0015921881,0.0006758773,0.0010191345,0.0004899313,0.02119375],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99851626,0.0006564088,0.00009645994,0.00024760832,0.0004150216,0.00006823329],"domain_scores_gemma":[0.9973959,0.0018434427,0.00013907593,0.00021890672,0.00035840285,0.000044311957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026238232,0.0013406082,0.0016939008,0.0011091654,0.0004475052,0.002442485,0.0022527794,0.0017926617,0.0056536216],"category_scores_gemma":[0.0077295452,0.0008884823,0.0020369843,0.0015058883,0.00095961255,0.0016492333,0.0013892786,0.0029741433,0.0035594313],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014976095,0.000030096002,0.000687979,0.0002274806,0.0001258997,0.00014997055,0.00014058917,0.41029668,0.00064215006,0.49299657,0.0076642265,0.08702329],"study_design_scores_gemma":[0.000009339218,0.0000152283965,0.00020869738,0.000060199956,0.000036281526,0.00013826467,0.0000129454875,0.653639,0.00028933867,0.32186952,0.02369274,0.000028394636],"about_ca_topic_score_codex":0.005769703,"about_ca_topic_score_gemma":0.0023281523,"teacher_disagreement_score":0.005769703,"about_ca_system_score_codex":0.0010424356,"about_ca_system_score_gemma":0.0015546792,"threshold_uncertainty_score":0.018913269},"labels":[],"label_agreement":null},{"id":"W4236647833","doi":"10.1016/j.clinbiochem.2008.08.043","title":"Paediatric reference intervals for 14 chemistries and immunoassays on the Roche Cobas 6000 system—A CALIPER (Canadian Laboratory Initiative on Pediatric Reference Range Database) pilot study","year":2008,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Estrone; Chemistry; Androstenedione; Aromatase; Hydroxylation; Steroid; Metabolite; Cytochrome P450; Docking (animal); CYP17A1; Stereochemistry; Enzyme; Androgen; Internal medicine; Biochemistry; Medicine","score_opus":0.34541354637015115,"score_gpt":0.45410016784922774,"score_spread":0.1086866214790766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236647833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92192566,0.0029561603,0.04868431,0.00034833062,0.00030563728,0.00095430843,0.015307586,0.000759305,0.008758675],"genre_scores_gemma":[0.9289262,0.0013802277,0.053384606,0.00040228217,0.00011514788,0.0009064932,0.013108787,0.0003277339,0.0014485114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9842,0.006748536,0.0011903328,0.0022598892,0.0050356393,0.00056558906],"domain_scores_gemma":[0.9856597,0.003484905,0.0023199236,0.0019550754,0.0058229165,0.00075745874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009822178,0.0012357121,0.0015614295,0.0021261324,0.00088700344,0.0011805518,0.0015123102,0.001033364,0.0011214932],"category_scores_gemma":[0.0126377465,0.00071413355,0.0012344168,0.004020675,0.0007699541,0.0008443841,0.0010294042,0.0017899461,0.00058501976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008821202,0.0012132394,0.8675698,0.0003894976,0.00064293045,0.00059618236,0.0013805255,0.0034901013,0.008911882,0.0019217902,0.0097297365,0.09533311],"study_design_scores_gemma":[0.001075637,0.006289019,0.96015793,0.00012537395,0.00067834783,0.0018076481,0.0003255905,0.0038584827,0.010809612,0.0003379033,0.014472146,0.000062224986],"about_ca_topic_score_codex":0.04455228,"about_ca_topic_score_gemma":0.029846998,"teacher_disagreement_score":0.9979473,"about_ca_system_score_codex":0.0020526992,"about_ca_system_score_gemma":0.002674435,"threshold_uncertainty_score":0.08858591},"labels":[],"label_agreement":null},{"id":"W4239332495","doi":"10.1002/cbic.200790039","title":"Replacement of Natural Cofactors by Selected Hydrogen Peroxide Donors or Organic Peroxides Results in Improved Activity for CYP3A4 and CYP2D6","year":2007,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Debrisoquine; Hydrogen peroxide; Chemistry; Cofactor; Cytochrome P450; Cumene hydroperoxide; Stereochemistry; CYP2D6; Enzyme; Biochemistry; Biocatalysis; Cytochrome; Catalysis; Reaction mechanism","score_opus":0.04757041394275949,"score_gpt":0.38970879637735384,"score_spread":0.3421383824345944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239332495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891367,0.0016041847,0.006738892,0.00023854074,0.00007650725,0.000015394644,0.0005244572,0.0001789681,0.0014862745],"genre_scores_gemma":[0.99289167,0.00057850283,0.004029411,0.0000379733,0.000010443723,0.000007789471,0.00070168823,0.00003686006,0.0017057488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998449,0.000030412222,0.000016411544,0.00004890937,0.00003486998,0.000024431549],"domain_scores_gemma":[0.9998411,0.000030912484,0.000045364148,0.000040288112,0.000016719347,0.000025542047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001874139,0.00023085884,0.00023247195,0.00011676414,0.00009853723,0.00023937147,0.00023491376,0.00016692872,0.0020144533],"category_scores_gemma":[0.00031592147,0.0000955566,0.00020688887,0.00017285466,0.00017933908,0.00015386418,0.000119422286,0.00035268549,0.00068110035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021576663,0.00003531361,0.00053871947,0.000030208877,0.000010319342,0.00008368099,0.000010260865,0.0000578885,0.99471986,0.00015029003,0.00014470766,0.0040029706],"study_design_scores_gemma":[0.000012969006,0.00012473544,0.0014973766,0.0000010774928,0.00000809281,0.0003204686,0.0000074145983,0.00020133768,0.994624,0.00004665008,0.003153008,0.0000029327637],"about_ca_topic_score_codex":0.0003608447,"about_ca_topic_score_gemma":0.0005146185,"teacher_disagreement_score":0.0020144533,"about_ca_system_score_codex":0.00020683109,"about_ca_system_score_gemma":0.00012176717,"threshold_uncertainty_score":0.0067390203},"labels":[],"label_agreement":null},{"id":"W4240682630","doi":"10.1016/b978-0-12-386454-3.00007-5","title":"Biotransformation/Metabolism","year":2014,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biotransformation; Detoxication; Xenobiotic; Chemistry; Drug metabolism; Metabolism; Enzyme; Biochemistry","score_opus":0.06588997468324723,"score_gpt":0.369760082221813,"score_spread":0.3038701075385658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240682630","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023833031,0.052329708,0.013456916,0.001265148,0.0014432922,0.00013788904,0.001491968,0.0014005234,0.9260914],"genre_scores_gemma":[0.004377577,0.018564587,0.003933665,0.0005009272,0.00030989465,0.00006416694,0.0008217627,0.00017707281,0.9712503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999724,0.000020755502,0.00001694467,0.00006751052,0.00014857747,0.000022160864],"domain_scores_gemma":[0.99989283,0.000024518757,0.000012362007,0.000027656815,0.00003022308,0.000012278328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030561863,0.0014889054,0.0008492218,0.0014841683,0.00045050663,0.0019540975,0.0006282449,0.0011968673,0.16931215],"category_scores_gemma":[0.00036675736,0.00043811093,0.000500422,0.0013877044,0.0007170987,0.0013917052,0.0015099583,0.0014922916,0.18982327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005881218,0.00006570678,0.00013793481,0.00068097963,0.000013073542,0.00029576413,0.00006901586,0.0003206071,0.022946544,0.013982972,0.08580375,0.8756249],"study_design_scores_gemma":[0.000007884103,0.00006551906,0.00031932612,0.0002170872,0.000010312565,0.00073170156,0.00002134306,0.00018344598,0.0077833724,0.004911351,0.9857401,0.0000085384],"about_ca_topic_score_codex":0.00089485897,"about_ca_topic_score_gemma":0.0011927078,"teacher_disagreement_score":0.16931215,"about_ca_system_score_codex":0.000575732,"about_ca_system_score_gemma":0.00075740914,"threshold_uncertainty_score":0.56640553},"labels":[],"label_agreement":null},{"id":"W4241441403","doi":"10.1385/1-59259-998-2:109","title":"Determination of CYP2C9-Catalyzed Diclofenac 4'-Hydroxylation by High-Performance Liquid Chromatography","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research","keywords":"Hydroxylation; Perchloric acid; Chromatography; Chemistry; Diclofenac; High-performance liquid chromatography; Methanol; Acetonitrile; Catalysis; Organic chemistry; Enzyme; Biochemistry","score_opus":0.07435217108953951,"score_gpt":0.34895170139994547,"score_spread":0.27459953031040596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241441403","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07205873,0.09354885,0.72354776,0.0014585214,0.0015359961,0.0008578859,0.0061893505,0.01169854,0.089104384],"genre_scores_gemma":[0.109658316,0.06633141,0.59270746,0.0017138497,0.00053100137,0.0012790031,0.009337326,0.0012806277,0.21716106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962676,0.000053161508,0.000023817234,0.00008707779,0.00018843365,0.000020797826],"domain_scores_gemma":[0.999801,0.00007366228,0.000023169783,0.000017166542,0.000067976165,0.000017103986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957613,0.0010669586,0.00083471835,0.0011238316,0.00028039192,0.0005667936,0.0009081617,0.00070422445,0.005801624],"category_scores_gemma":[0.00034663477,0.0005453523,0.0003898803,0.00074144267,0.00021581439,0.0005151331,0.00023617496,0.0010049514,0.009624235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006324616,0.00009160348,0.00017259624,0.0003457623,0.00001879143,0.00010561146,0.000015590456,0.00022816168,0.93143255,0.00051503995,0.0038660055,0.06314496],"study_design_scores_gemma":[0.000025328389,0.00031630928,0.0023974022,0.000061699524,0.000050838484,0.0012214317,0.00001313065,0.0024925212,0.8749875,0.00058197795,0.117803775,0.0000481375],"about_ca_topic_score_codex":0.0005435321,"about_ca_topic_score_gemma":0.0011853729,"teacher_disagreement_score":0.005801624,"about_ca_system_score_codex":0.00042794363,"about_ca_system_score_gemma":0.00042933962,"threshold_uncertainty_score":0.019408345},"labels":[],"label_agreement":null},{"id":"W4242214145","doi":"10.3821/1913-701x(2008)141[40:mefypa]2.0.co;2","title":"Made especially for you: Pharmacogenomics and pharmacy practice","year":2008,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacy; Pharmacy practice; Medicine; Business; Family medicine; Pharmacology","score_opus":0.15311925210105362,"score_gpt":0.39505269876622273,"score_spread":0.2419334466651691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242214145","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027116662,0.014573327,0.00035301206,0.7128555,0.26453942,0.00005208383,0.0002208046,0.0002016834,0.0069330297],"genre_scores_gemma":[0.004248689,0.012556347,0.0014175155,0.561707,0.30323413,0.0001275523,0.00025194683,0.00026455335,0.11619224],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900955,0.002577723,0.00089866493,0.0009813678,0.004212619,0.0012340493],"domain_scores_gemma":[0.9000405,0.011820015,0.0052039893,0.00308701,0.048332013,0.031516373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073934444,0.00236874,0.004282216,0.0038170568,0.005115947,0.012173599,0.0023577262,0.018812131,0.1026681],"category_scores_gemma":[0.08265211,0.0010196728,0.0022280908,0.003654441,0.0037323693,0.013594249,0.0103391,0.018386137,0.06390411],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009523205,0.000009464472,0.0002213972,0.00005775882,0.000005667298,0.00007998565,0.00006917877,0.000008802765,0.000022498505,0.00016900485,0.99097824,0.008368414],"study_design_scores_gemma":[0.00006183309,0.00003063261,0.0026206924,0.0007526723,0.000034405944,0.0008626522,0.0015685834,0.00006733614,0.0000553086,0.0027359868,0.9911452,0.000064607935],"about_ca_topic_score_codex":0.009993934,"about_ca_topic_score_gemma":0.032703575,"teacher_disagreement_score":0.1026681,"about_ca_system_score_codex":0.0036643387,"about_ca_system_score_gemma":0.012301366,"threshold_uncertainty_score":0.343459},"labels":[],"label_agreement":null},{"id":"W4242256274","doi":"10.1111/j.1538-7836.2005.01455.x","title":"Talking about…","year":2005,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Medicine","score_opus":0.18623103296962282,"score_gpt":0.47432279820385015,"score_spread":0.2880917652342273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242256274","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004472478,0.012540009,0.0016925256,0.58461094,0.093543455,0.000038876387,0.000111788635,0.00019511778,0.30279478],"genre_scores_gemma":[0.059289422,0.008473215,0.00086492894,0.44192204,0.036798753,0.00010397549,0.0001555874,0.00020884724,0.45218325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593973,0.0019406735,0.00018635865,0.00037004662,0.0009889739,0.00057420525],"domain_scores_gemma":[0.9940785,0.0017361562,0.00048520567,0.0003270517,0.0013421108,0.0020309999],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003726919,0.0007018619,0.0004873821,0.0008792622,0.0061785677,0.0059505305,0.0008864749,0.004904119,0.06474952],"category_scores_gemma":[0.018385768,0.00028766558,0.0006336536,0.0005138524,0.004841257,0.0055356873,0.004179542,0.011781795,0.03223601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046557256,0.000047543206,0.00085732696,0.00010201746,0.000018779609,0.00033684887,0.010310903,0.00001905011,0.00023675835,0.019176843,0.92846787,0.04037946],"study_design_scores_gemma":[0.00000715811,0.00002003959,0.0004001826,0.00015243143,0.000010220629,0.0004562599,0.0051219785,0.000014803121,0.00007021055,0.0038988483,0.9898323,0.000015562528],"about_ca_topic_score_codex":0.0021392573,"about_ca_topic_score_gemma":0.0035676165,"teacher_disagreement_score":0.93525046,"about_ca_system_score_codex":0.001701205,"about_ca_system_score_gemma":0.00250553,"threshold_uncertainty_score":0.2166087},"labels":[],"label_agreement":null},{"id":"W4243623252","doi":"10.1051/medsci/2010261s207","title":"Physiopathologie, modèles cellulaires et animaux (P553 – P604)","year":2010,"lang":"fr","type":"article","venue":"médecine/sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chemistry","score_opus":0.17052652195277138,"score_gpt":0.46969810772418086,"score_spread":0.29917158577140945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243623252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961908,0.0044131465,0.006922547,0.00087047275,0.00039016866,0.00016930165,0.0027529623,0.00017219293,0.022401247],"genre_scores_gemma":[0.9777724,0.0008597362,0.0030051102,0.00023075998,0.000042486237,0.00017183297,0.0013274988,0.0000352396,0.016554853],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99891376,0.00039118747,0.000054143984,0.00027936944,0.00021331567,0.00014826944],"domain_scores_gemma":[0.99949574,0.00014179153,0.00017383584,0.000086815984,0.000024470672,0.00007733947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010427271,0.0003449681,0.00033851055,0.0004966598,0.0005512922,0.0010752431,0.00033272067,0.0006032472,0.010849835],"category_scores_gemma":[0.000927826,0.00022173223,0.0006667919,0.00038313304,0.00075728534,0.00034539838,0.00048336413,0.0011209265,0.0015997605],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017328022,0.0041438034,0.38606912,0.0010650737,0.0014496525,0.00801779,0.0016447587,0.0034877288,0.40703616,0.010667309,0.0113788815,0.14771172],"study_design_scores_gemma":[0.0004914412,0.004431712,0.73055714,0.00021564755,0.00059144374,0.021829866,0.0014117657,0.00638385,0.109376274,0.0042641023,0.120365925,0.00008078851],"about_ca_topic_score_codex":0.004305152,"about_ca_topic_score_gemma":0.0037126373,"teacher_disagreement_score":0.010849835,"about_ca_system_score_codex":0.00065761135,"about_ca_system_score_gemma":0.0004230562,"threshold_uncertainty_score":0.036296308},"labels":[],"label_agreement":null},{"id":"W4244888445","doi":"10.1515/iupac.76.0329","title":"Pharmacogenetics","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Toxicology; Computer science; Medicine; Pharmacology; Biology; Linguistics; Philosophy","score_opus":0.08234467829453146,"score_gpt":0.5477336808670672,"score_spread":0.46538900257253574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244888445","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015112862,0.00050748873,0.00023217173,0.00011219075,0.000029504772,0.000022754795,0.9970578,0.00027322752,0.0016137868],"genre_scores_gemma":[0.0006185546,0.000561582,0.00072366203,0.00027911365,0.000019984132,0.00015664966,0.9964547,0.000116396724,0.0010693752],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835664,0.00032098696,0.00034075265,0.0005415098,0.0003185437,0.000121463294],"domain_scores_gemma":[0.9956014,0.0018632885,0.00074612786,0.0008681647,0.0006445669,0.0002763566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012735492,0.0016242772,0.0016547517,0.004163167,0.0006074063,0.0027083328,0.002027585,0.0016513609,0.10473194],"category_scores_gemma":[0.012011147,0.0006122409,0.0017261393,0.007797916,0.00031776194,0.0015104618,0.0019535562,0.0018613836,0.077480875],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022652786,0.000032826527,0.0032751355,0.004294732,0.00017920035,0.00009520108,0.000044755634,0.0004603084,0.00026059378,0.0019555814,0.969328,0.019847233],"study_design_scores_gemma":[0.00020314523,0.000020349667,0.0050115352,0.0011646542,0.00012370867,0.00021029773,0.000031545547,0.0001771011,0.0002228037,0.002299461,0.99050903,0.000026379015],"about_ca_topic_score_codex":0.009034621,"about_ca_topic_score_gemma":0.016823582,"teacher_disagreement_score":0.10473194,"about_ca_system_score_codex":0.0012452311,"about_ca_system_score_gemma":0.002814023,"threshold_uncertainty_score":0.35036325},"labels":[],"label_agreement":null},{"id":"W4245167824","doi":"10.1007/s40262-019-00839-0","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Lausanne; Université Paris Diderot; Università degli Studi di Udine; Radboud Universiteit; Università degli Studi di Pavia; Universiteit Utrecht; Rijksuniversiteit Groningen; University of Otago; Universiteit Leiden; Universität Heidelberg; University of Waterloo; Karolinska Institutet; University of South Carolina; King's College London; University of Alberta; University of Washington; Helsingin Yliopisto; East Tennessee State University; University of Southern California","keywords":"Pharmacotherapy; Acknowledgement; Medicine; Internal medicine; Computer science","score_opus":0.2598516706215862,"score_gpt":0.5568679580104303,"score_spread":0.2970162873888441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245167824","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016961994,0.0197713,0.016812004,0.30678093,0.57075214,0.0007284542,0.02362353,0.005134528,0.054700963],"genre_scores_gemma":[0.03900958,0.009487725,0.022254746,0.10682238,0.16393475,0.0016814154,0.016361315,0.0064177783,0.63403034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98240745,0.006142989,0.0020272222,0.0019394556,0.0067417496,0.0007411866],"domain_scores_gemma":[0.7580422,0.03629258,0.0070073307,0.011638869,0.17873119,0.008287839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009774452,0.0017968648,0.0028338241,0.009223582,0.0031995089,0.004773856,0.0034297083,0.0029393772,0.26781267],"category_scores_gemma":[0.1799845,0.0007377336,0.0019421764,0.005230501,0.0013485843,0.003575809,0.0063948105,0.005797624,0.12809323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003834793,0.0000117344725,0.00013867188,0.0001801006,0.000013995082,0.00018632387,0.00021584118,0.000098911514,0.00031175,0.0017989461,0.98750174,0.009503587],"study_design_scores_gemma":[0.00002330088,0.000010961387,0.000912859,0.0003069336,0.000037818605,0.00035148836,0.0004572418,0.0003355037,0.00027554942,0.003479501,0.9937629,0.00004591553],"about_ca_topic_score_codex":0.027221432,"about_ca_topic_score_gemma":0.024320394,"teacher_disagreement_score":0.73218733,"about_ca_system_score_codex":0.0074326913,"about_ca_system_score_gemma":0.0075274627,"threshold_uncertainty_score":0.89592266},"labels":[],"label_agreement":null},{"id":"W4245513075","doi":"10.1385/0-89603-519-0:153","title":"Thin-Layer Chromatographic Analysis of Human CYP3A-Catalyzed Testosterone 6P-Hydroxylation","year":2003,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"CYP3A; CYP3A4; Microsome; Cytochrome P450; Biology; Hydroxylation; Testosterone (patch); Chemistry; Enzyme; Biochemistry; Molecular biology; Endocrinology","score_opus":0.21165184569436435,"score_gpt":0.414705455220019,"score_spread":0.20305360952565465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245513075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7168585,0.093313195,0.13766128,0.0012804641,0.0017391465,0.0014343568,0.011327165,0.0036122163,0.032773737],"genre_scores_gemma":[0.8061129,0.0486505,0.08418656,0.0023471168,0.0008052092,0.00083360047,0.019189358,0.00076252175,0.0371123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995974,0.000052263702,0.000022377832,0.00007787975,0.00019085043,0.000059159254],"domain_scores_gemma":[0.99962664,0.00007306347,0.00004209646,0.000025597185,0.00016591825,0.00006678981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004399926,0.0013365714,0.00059766567,0.0015454289,0.0006967089,0.0004358721,0.00046929577,0.0006292063,0.0041157943],"category_scores_gemma":[0.00075000233,0.00032899177,0.0006939701,0.0009479856,0.00030601924,0.00023329795,0.00025395775,0.0010410476,0.0024206592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003162669,0.00014783745,0.0011065071,0.00024121706,0.00011714427,0.00040814962,0.00009580587,0.00011582688,0.987445,0.00019832629,0.0005717585,0.009236206],"study_design_scores_gemma":[0.000076222845,0.0009972255,0.02734711,0.0000978172,0.00042546986,0.0023746495,0.00016562229,0.0029594179,0.9352175,0.00021034425,0.030065345,0.000063399144],"about_ca_topic_score_codex":0.0036670275,"about_ca_topic_score_gemma":0.0043878676,"teacher_disagreement_score":0.0041157943,"about_ca_system_score_codex":0.00035874514,"about_ca_system_score_gemma":0.0006782419,"threshold_uncertainty_score":0.013768673},"labels":[],"label_agreement":null},{"id":"W4246032552","doi":"10.1542/peds.2007-1131","title":"Do We Need to Incorporate Pharmacogenetics in Randomized, Controlled Trials of Frequently Used Medicines?: In Reply","year":2007,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pharmacogenetics; Randomized controlled trial; Intensive care medicine; Medical physics; Internal medicine; Genetics; Genotype","score_opus":0.12517342990719016,"score_gpt":0.45828751173402904,"score_spread":0.3331140818268389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246032552","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042929754,0.004020203,0.0006594827,0.94284344,0.0511284,0.00006962388,0.00036654528,0.00006271921,0.0004202739],"genre_scores_gemma":[0.0022722548,0.0015149441,0.0017169496,0.9565835,0.036898483,0.00015996062,0.000067330875,0.000028874374,0.0007577152],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.981306,0.009015362,0.005072423,0.0016104146,0.0023959836,0.0005998551],"domain_scores_gemma":[0.7401915,0.21736072,0.009431727,0.0050218347,0.022751259,0.0052428674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050626114,0.001224038,0.004650201,0.0016481644,0.002255188,0.0037822204,0.00473607,0.03739983,0.006568915],"category_scores_gemma":[0.1789649,0.001562935,0.0024636432,0.0024219044,0.0049146037,0.006182967,0.0021319876,0.0444516,0.0032979446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006322563,0.000074870826,0.0018654534,0.000778232,0.00042670063,0.00032975446,0.00020208377,0.0001637664,0.00017970086,0.0020003566,0.9786245,0.0147223575],"study_design_scores_gemma":[0.004520405,0.00060387346,0.009457225,0.0023063547,0.0018176956,0.0013725221,0.001245226,0.0017174125,0.0009811639,0.016912717,0.9585968,0.00046867924],"about_ca_topic_score_codex":0.00420232,"about_ca_topic_score_gemma":0.008922749,"teacher_disagreement_score":0.050626114,"about_ca_system_score_codex":0.0032392086,"about_ca_system_score_gemma":0.0055769547,"threshold_uncertainty_score":0.26773965},"labels":[],"label_agreement":null},{"id":"W4247694356","doi":"10.1210/en.142.2.778","title":"Relative Enzymatic Activity, Protein Stability, and Tissue Distribution of Human Steroid-Metabolizing UGT2B Subfamily Members","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Glucuronidation; Steroid; Hydroxysteroid; Chemistry; Biochemistry; UGT2B7; Enzyme; Biology; Hormone; Microsome","score_opus":0.11544545251868055,"score_gpt":0.42514957715578927,"score_spread":0.3097041246371087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247694356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9425019,0.03248563,0.014358743,0.00035733113,0.00012242724,0.000060619346,0.005303446,0.00027622946,0.0045336355],"genre_scores_gemma":[0.9578325,0.009098851,0.00805798,0.00017280373,0.00011063425,0.00013007586,0.016961953,0.00012635671,0.0075089047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995024,0.000071971954,0.000043408178,0.00017142271,0.00014119134,0.00006958671],"domain_scores_gemma":[0.999826,0.000025830419,0.000040556697,0.000023370025,0.000058260284,0.00002599778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028835644,0.00047474608,0.000354606,0.0010631634,0.00029078312,0.0006528203,0.00015834151,0.000359337,0.0014978147],"category_scores_gemma":[0.0006533116,0.0001813152,0.00052084634,0.0012446316,0.00023211802,0.0002579774,0.00020567024,0.00041156786,0.0010002928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012754997,0.00014070151,0.032235254,0.0004046525,0.00032922934,0.0004839967,0.00024536697,0.0005745329,0.9090077,0.0006553683,0.0019682513,0.05267944],"study_design_scores_gemma":[0.00006207927,0.0005788789,0.28326303,0.00003980723,0.0003413266,0.0052591967,0.00017944878,0.0042895176,0.65046495,0.00038025517,0.05508529,0.000056133926],"about_ca_topic_score_codex":0.0022242428,"about_ca_topic_score_gemma":0.0012930613,"teacher_disagreement_score":0.0022242428,"about_ca_system_score_codex":0.00037680057,"about_ca_system_score_gemma":0.00021646108,"threshold_uncertainty_score":0.0050106645},"labels":[],"label_agreement":null},{"id":"W4247871824","doi":"10.1139/y01-059","title":"Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Structural isomer; Chemistry; Isozyme; Stereochemistry; Enzyme; Biochemistry","score_opus":0.042919526416198735,"score_gpt":0.3288963223380476,"score_spread":0.2859767959218489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247871824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992668,0.0011855343,0.004145704,0.00004052773,0.000010428334,0.000029614606,0.0005728759,0.00006431187,0.0012830104],"genre_scores_gemma":[0.98640233,0.0014802277,0.004320388,0.00005790845,0.000010177367,0.000047505444,0.0016953821,0.00005087344,0.0059352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994385,0.000007097573,0.000004297217,0.000017804405,0.000014601406,0.00001240339],"domain_scores_gemma":[0.99990153,0.000019481598,0.000025727832,0.000014895964,0.000018979688,0.000019435505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007308703,0.0003181818,0.00013848643,0.00021693546,0.00008226189,0.00012394517,0.00008833391,0.0001259161,0.0006008009],"category_scores_gemma":[0.00013521744,0.0001533707,0.00017893256,0.00010357314,0.00013230136,0.0001096919,0.00011876622,0.00029917876,0.0003232506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045839693,0.0000011458683,0.0001323262,0.000008953437,0.0000018013153,0.0000220229,0.00000683844,0.000013461238,0.9994548,0.000008734503,0.0000035812398,0.0003005316],"study_design_scores_gemma":[0.000003435845,0.00008541809,0.0092937,0.0000023980804,0.000011157435,0.00013492188,0.000016115782,0.000105872525,0.9897398,0.000012102413,0.00059274724,0.0000022637782],"about_ca_topic_score_codex":0.0014794779,"about_ca_topic_score_gemma":0.001782462,"teacher_disagreement_score":0.0014794779,"about_ca_system_score_codex":0.00017569665,"about_ca_system_score_gemma":0.0002005891,"threshold_uncertainty_score":0.0029417872},"labels":[],"label_agreement":null},{"id":"W4249455208","doi":"10.1007/3-540-29623-9_1420","title":"Idiosyncratic Drug Reactions","year":2006,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug; Pharmacology; Medicine","score_opus":0.10021744136304335,"score_gpt":0.4031214408379278,"score_spread":0.30290399947488444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249455208","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021845954,0.16874525,0.041305803,0.006183793,0.004432917,0.00078213116,0.0023172784,0.0018316047,0.7525554],"genre_scores_gemma":[0.12773503,0.082593024,0.010284879,0.014466444,0.0026774476,0.00035188158,0.0024356234,0.00039493825,0.75906074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994617,0.00012508447,0.000054363933,0.000067829176,0.00021312677,0.00007794704],"domain_scores_gemma":[0.99949205,0.0001273218,0.00011659284,0.00009744614,0.00011382878,0.000052749947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255141,0.00072181766,0.0006425988,0.0007643499,0.00031155156,0.0008133662,0.000568803,0.0009522149,0.041334525],"category_scores_gemma":[0.001490573,0.00016098024,0.0008192078,0.00082845835,0.00025567226,0.0004438992,0.00082540733,0.0014045581,0.022597741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023191304,0.00014059772,0.0023479362,0.0011811081,0.000107691914,0.01154723,0.00014983602,0.0003494738,0.0073413393,0.008595404,0.1587015,0.8093061],"study_design_scores_gemma":[0.000063493186,0.00030494665,0.003662752,0.0008220524,0.000117013726,0.07423356,0.000077755656,0.00021929071,0.004420778,0.003926089,0.91213,0.000022322622],"about_ca_topic_score_codex":0.00039618826,"about_ca_topic_score_gemma":0.00082988525,"teacher_disagreement_score":0.041334525,"about_ca_system_score_codex":0.0002845478,"about_ca_system_score_gemma":0.000376427,"threshold_uncertainty_score":0.13827783},"labels":[],"label_agreement":null},{"id":"W4250194478","doi":"10.1080/01621459.2016.1240080","title":"Comment","year":2016,"lang":"en","type":"article","venue":"Journal of the American Statistical Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Mathematics","score_opus":0.058158899861969975,"score_gpt":0.43457833319639233,"score_spread":0.37641943333442235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250194478","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037484986,0.00052796956,0.00030796134,0.9546807,0.038061447,0.00002839418,0.00045624163,0.000083486106,0.0054789395],"genre_scores_gemma":[0.0015933074,0.00016095124,0.00020127083,0.97874796,0.015690662,0.000058252164,0.000070141396,0.00003579552,0.0034415717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9710065,0.006579783,0.0032906272,0.0060127503,0.010607616,0.0025026945],"domain_scores_gemma":[0.77782565,0.14421473,0.011966448,0.01363043,0.0445993,0.0077634226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035985626,0.0008135441,0.0016198724,0.0017254369,0.0037627032,0.005283907,0.005546402,0.044064414,0.03460726],"category_scores_gemma":[0.28745422,0.001158312,0.002839766,0.0026887755,0.0064791623,0.0044306763,0.0029784164,0.04221438,0.026575463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005063057,0.000008566655,0.0009034272,0.00006953649,0.000026439502,0.00010506727,0.00014258125,0.000037682825,0.000056444682,0.0046094647,0.9909376,0.0030525262],"study_design_scores_gemma":[0.00015517157,0.000034836226,0.00508059,0.0007175307,0.00007291573,0.00040611922,0.00045698258,0.00023648478,0.00032708616,0.010073878,0.98233175,0.000106688654],"about_ca_topic_score_codex":0.019752149,"about_ca_topic_score_gemma":0.014812766,"teacher_disagreement_score":0.044064414,"about_ca_system_score_codex":0.0050410666,"about_ca_system_score_gemma":0.009407575,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4251737445","doi":"10.1111/j.1532-5415.2000.tb05017.x","title":"<i>Editors note:</i>","year":2000,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Donepezil; Medicine; Concomitant; Disease; Gerontology; Psychiatry; Intensive care medicine; Dementia; Internal medicine","score_opus":0.03822560987872146,"score_gpt":0.3953953062565051,"score_spread":0.3571696963777836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251737445","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044503296,0.0019575225,0.00021671805,0.7806146,0.21237871,0.000041571115,0.00013030536,0.0001475247,0.004067952],"genre_scores_gemma":[0.0036014419,0.001778885,0.00046083133,0.8088565,0.16943665,0.00006640158,0.00009016821,0.00006695417,0.015642263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997895,0.0003234169,0.0003371835,0.00037602178,0.0008368652,0.00023149743],"domain_scores_gemma":[0.98822683,0.0033124026,0.0010111082,0.0002874671,0.0060814405,0.0010807175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029002717,0.0011269421,0.0014862182,0.0010906663,0.0025909005,0.0029605085,0.0026661123,0.017126638,0.014570818],"category_scores_gemma":[0.022208259,0.00070394896,0.0012845045,0.0009274371,0.0019288806,0.0028404763,0.0010243977,0.020090686,0.016775286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020110649,0.000006140647,0.0002416114,0.000039056664,0.000004697254,0.0003633787,0.000035930585,0.000015268271,0.00004457447,0.00016409523,0.9968117,0.002253515],"study_design_scores_gemma":[0.00003164451,0.000038240494,0.0014195017,0.00021194623,0.000023544435,0.0016395632,0.0003378065,0.0002467103,0.00029460381,0.0011155948,0.9945722,0.000068585854],"about_ca_topic_score_codex":0.005213647,"about_ca_topic_score_gemma":0.0072127166,"teacher_disagreement_score":0.017126638,"about_ca_system_score_codex":0.0023411657,"about_ca_system_score_gemma":0.0020450933,"threshold_uncertainty_score":0.04874426},"labels":[],"label_agreement":null},{"id":"W4252027198","doi":"10.1101/504811","title":"Higher-order epistatic networks underlie the evolutionary fitness landscape of a xenobiotic-degrading enzyme","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Knut och Alice Wallenbergs Stiftelse; Michael Smith Health Research BC; Wenner-Gren Stiftelserna","keywords":"Epistasis; Fitness landscape; Biology; Function (biology); In silico; Computational biology; Enzyme; Molecular evolution; Evolutionary biology; Genetics; Phylogenetics; Gene; Biochemistry; Population","score_opus":0.053576150157889725,"score_gpt":0.32761449007134114,"score_spread":0.2740383399134514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252027198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875815,0.000060661478,0.0111594405,0.00007241814,0.0000018670266,0.0000077371415,0.00009230755,0.00004653189,0.0009776336],"genre_scores_gemma":[0.99721575,0.00003526837,0.0025138252,0.000016269878,0.0000016440457,0.0000061218593,0.00006458112,0.000009642866,0.00013680432],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99976605,0.00007409866,0.000014861128,0.00006014402,0.000044307682,0.00004041924],"domain_scores_gemma":[0.9996377,0.00015874887,0.00009147724,0.000040215742,0.000035045294,0.00003671535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039651926,0.0002625095,0.00029210185,0.00067245506,0.00036709875,0.00069845165,0.00026530618,0.0003640571,0.0010653873],"category_scores_gemma":[0.0010122119,0.00017538901,0.00032224166,0.0004279571,0.0004487932,0.00044484745,0.00038765144,0.00048194823,0.00010305436],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003347418,0.00013067201,0.07426537,0.0001039461,0.000371749,0.000842441,0.00026020512,0.08281762,0.7980938,0.014537575,0.00049354084,0.027748484],"study_design_scores_gemma":[0.00005059205,0.00028438997,0.27859697,0.000011942645,0.00021413472,0.0013173443,0.0004400158,0.62867314,0.057086024,0.029359741,0.0038759266,0.00008985371],"about_ca_topic_score_codex":0.0017059621,"about_ca_topic_score_gemma":0.0024615254,"teacher_disagreement_score":0.0017059621,"about_ca_system_score_codex":0.00060333346,"about_ca_system_score_gemma":0.00027489543,"threshold_uncertainty_score":0.0043774843},"labels":[],"label_agreement":null},{"id":"W4253006784","doi":"10.3410/f.734142754.793552618","title":"Faculty Opinions recommendation of Crystal structure of a membrane-bound O-acyltransferase.","year":2018,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Acyltransferase; Membrane; Crystal (programming language); Chemistry; Crystal structure; Crystallography; Computer science; Biochemistry; Enzyme","score_opus":0.07969987770242147,"score_gpt":0.44598079799164914,"score_spread":0.36628092028922765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253006784","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042309932,0.00027949136,0.00012581992,0.00028430912,0.00007690198,0.000018905836,0.99629116,0.000959579,0.0015407939],"genre_scores_gemma":[0.0005688226,0.00012325349,0.000341716,0.00010004511,0.000011391308,0.00003106837,0.9978271,0.00006598466,0.00093059905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906534,0.00010204735,0.000077840814,0.00029183863,0.00032064834,0.00014227028],"domain_scores_gemma":[0.9982697,0.00037731428,0.0001978071,0.00033618804,0.00045177995,0.00036727765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010550006,0.0030190325,0.0019179838,0.0023898748,0.0008888393,0.00263378,0.00321175,0.0035754915,0.08193706],"category_scores_gemma":[0.0052656434,0.0007986565,0.0017938243,0.0036049115,0.00036403732,0.0017896635,0.0015447395,0.002836909,0.10441265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011281382,0.000036786096,0.00064959045,0.0004268821,0.000032436074,0.00002987325,0.000007676286,0.00014298888,0.00022256652,0.00017038114,0.996139,0.002029106],"study_design_scores_gemma":[0.00080413924,0.000056662688,0.0052486276,0.00032674146,0.00010640661,0.0001666979,0.000043287673,0.0015684757,0.0011592953,0.0016009448,0.9888797,0.000039117785],"about_ca_topic_score_codex":0.022104975,"about_ca_topic_score_gemma":0.06587733,"teacher_disagreement_score":0.08193706,"about_ca_system_score_codex":0.001577046,"about_ca_system_score_gemma":0.0035056483,"threshold_uncertainty_score":0.2741068},"labels":[],"label_agreement":null},{"id":"W4255081909","doi":"10.1515/iupac.84.0676","title":"Idiosyncratic Drug Reaction (IDR)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Medicine; Immunology; Immune system; Philosophy; Linguistics","score_opus":0.05997542139695544,"score_gpt":0.5168997462364984,"score_spread":0.45692432483954293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255081909","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018678255,0.0033122918,0.0005065668,0.00031726333,0.000103730184,0.00024090703,0.98741806,0.00028170875,0.0059515308],"genre_scores_gemma":[0.01177172,0.0040075216,0.0013763467,0.0010825924,0.00015092653,0.00057521655,0.9765315,0.00010595992,0.004398173],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573094,0.0005437742,0.001803578,0.0008857771,0.00077254395,0.0002634294],"domain_scores_gemma":[0.9870658,0.0033586356,0.005167444,0.0022475217,0.0017424505,0.00041816957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019374524,0.0010974711,0.0019952822,0.0032365292,0.0005117657,0.0017949492,0.0012526984,0.0014110954,0.04536051],"category_scores_gemma":[0.013189732,0.00040475128,0.0030550647,0.0051084,0.0003911028,0.0014664934,0.0014422513,0.0020385785,0.018475879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024371925,0.00009664341,0.050946172,0.022568265,0.0013968942,0.0006330766,0.000069824,0.0011602964,0.00043712143,0.0026613337,0.8574391,0.060154032],"study_design_scores_gemma":[0.0014674041,0.00019763307,0.08713785,0.0088840965,0.0012343642,0.0028268828,0.00011013467,0.00086911296,0.0010233214,0.0055336226,0.89059246,0.00012312898],"about_ca_topic_score_codex":0.007364822,"about_ca_topic_score_gemma":0.014122812,"teacher_disagreement_score":0.04536051,"about_ca_system_score_codex":0.0014001235,"about_ca_system_score_gemma":0.0027019393,"threshold_uncertainty_score":0.15174603},"labels":[],"label_agreement":null},{"id":"W4255200503","doi":"10.1002/9780470249031.ch18","title":"Cytochrome P450 Enzymes","year":2007,"lang":"en","type":"other","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Health Canada","keywords":"Enzyme; Cytochrome P450; Identification (biology); Computational biology; Biochemistry; Biology; Chemistry; Ecology","score_opus":0.13105824435205096,"score_gpt":0.47846744074590253,"score_spread":0.3474091963938516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255200503","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046727476,0.24348757,0.03937902,0.004307024,0.0054783006,0.0009166123,0.03775036,0.0043684235,0.65964],"genre_scores_gemma":[0.011314686,0.1628864,0.023760298,0.0020077329,0.0021271822,0.00030841405,0.025658822,0.00036710364,0.7715693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996606,0.000031661933,0.00002429638,0.0000703263,0.0001869841,0.000026075684],"domain_scores_gemma":[0.99987054,0.000025364987,0.000016792628,0.000017599312,0.00005950898,0.000010244493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024656855,0.0009403783,0.0008478784,0.0013768013,0.00033005423,0.0010470604,0.00075294194,0.0007046762,0.122065686],"category_scores_gemma":[0.0004250979,0.00032845116,0.0006360957,0.0016348509,0.00018628243,0.0007154639,0.000492678,0.0011065302,0.121501505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065331165,0.0001165034,0.00047213765,0.0017758777,0.00004093337,0.0002627917,0.00003345469,0.00017376328,0.018344497,0.0053087864,0.3268575,0.6465484],"study_design_scores_gemma":[0.000010963574,0.000044988476,0.001152924,0.00015019962,0.000014800337,0.00050136837,0.000009319584,0.000048726644,0.005494291,0.0009447916,0.99161875,0.0000088540855],"about_ca_topic_score_codex":0.0011296226,"about_ca_topic_score_gemma":0.0017703807,"teacher_disagreement_score":0.122065686,"about_ca_system_score_codex":0.0003624356,"about_ca_system_score_gemma":0.0005798769,"threshold_uncertainty_score":0.4083504},"labels":[],"label_agreement":null},{"id":"W4255251190","doi":"10.1385/1-59259-998-2:85","title":"Enzymatic Analysis of cDNA-Expressed Human CYP1A1, CYP1A2, and CYP1B1 With 7-Ethoxyresorufin as Substrate","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institutes of Health","keywords":"CYP1A2; Cytochrome P450; CYP1B1; Enzyme; Fluorescence; CYP2E1; Chemistry; Substrate (aquarium); Biochemistry; Complementary DNA; Biology; Gene","score_opus":0.15906762667822685,"score_gpt":0.4052943736806498,"score_spread":0.24622674700242295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255251190","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.687,0.022392813,0.22682448,0.0015172298,0.0009421629,0.0010848645,0.028152062,0.0016894878,0.030396855],"genre_scores_gemma":[0.54954296,0.021581426,0.22324488,0.0004991658,0.00039796985,0.0010717657,0.115703285,0.0010111954,0.086947314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969554,0.000052498286,0.000023482671,0.00007975968,0.00010150393,0.00004717554],"domain_scores_gemma":[0.9997856,0.000087335495,0.000022922939,0.000028819806,0.00005449639,0.000020945192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034471235,0.0006552419,0.0005007982,0.0006447926,0.00029096837,0.00046594665,0.00044497187,0.00039448027,0.0030302051],"category_scores_gemma":[0.00033016375,0.0003691375,0.0006179567,0.0008909782,0.0002880215,0.00036069902,0.00019728769,0.0009021084,0.0035758805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005989646,0.00004372163,0.000103925006,0.0000796027,0.0000088831475,0.000050962,0.00002326507,0.000116796444,0.9959007,0.00026674563,0.00017028322,0.003175052],"study_design_scores_gemma":[0.0000309395,0.0001722237,0.0020623372,0.000016249407,0.0000386639,0.00028928928,0.00003084987,0.0012278549,0.97701615,0.00018718935,0.018914366,0.000013766253],"about_ca_topic_score_codex":0.0011175185,"about_ca_topic_score_gemma":0.0017357194,"teacher_disagreement_score":0.0030302051,"about_ca_system_score_codex":0.0004895131,"about_ca_system_score_gemma":0.00043468538,"threshold_uncertainty_score":0.010137081},"labels":[],"label_agreement":null},{"id":"W4255347352","doi":"10.1385/1-59259-998-2:115","title":"CYP2C19-Mediated ( S)-Mephenytoin 4'-Hydroxylation Assayed by High-Performance Liquid Chromatography With Radiometric Detection","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mephenytoin; Chromatography; Chemistry; Hydroxylation; High-performance liquid chromatography; CYP2C19; Methanol; Enzyme; Biochemistry; Cytochrome P450; Organic chemistry","score_opus":0.06016471578409149,"score_gpt":0.31768099410934564,"score_spread":0.25751627832525414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255347352","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20472716,0.04730482,0.6659309,0.0009227612,0.00062060746,0.0010881654,0.0064327954,0.012688352,0.060284413],"genre_scores_gemma":[0.28961322,0.031989433,0.54467666,0.0006434792,0.00042384843,0.0017453077,0.011991396,0.0013608489,0.117555864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994518,0.00012487988,0.000032229527,0.00010854243,0.00023636101,0.000046118344],"domain_scores_gemma":[0.99962974,0.0001437927,0.000051584266,0.000041918756,0.00010617707,0.00002675493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007039302,0.0009866008,0.00070558675,0.0011396789,0.0003363815,0.00059398776,0.0010502267,0.00058017933,0.0039848485],"category_scores_gemma":[0.00045808818,0.000608661,0.00042164285,0.00089199236,0.00035890765,0.00044726534,0.0002764822,0.0009521618,0.0068001756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046260462,0.000043924098,0.0001538047,0.00014293079,0.000014410435,0.000064813226,0.000014878608,0.00012165678,0.9819126,0.00028058566,0.000914689,0.016289478],"study_design_scores_gemma":[0.000011103183,0.00014575131,0.0013335764,0.000014853436,0.000023622677,0.00038107546,0.0000063106936,0.0011422167,0.98130924,0.00014320726,0.0154731935,0.0000157835],"about_ca_topic_score_codex":0.0007567652,"about_ca_topic_score_gemma":0.0013461956,"teacher_disagreement_score":0.0039848485,"about_ca_system_score_codex":0.0005127794,"about_ca_system_score_gemma":0.0005425497,"threshold_uncertainty_score":0.013330638},"labels":[],"label_agreement":null},{"id":"W4256649737","doi":"10.1385/0-89603-519-0:117","title":"Determination of the CYP2B6 Component of 7-Ethoxy-4-Trifluoromethylcoumarin O-Deethylation Activity in Human Liver Microsomes","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"CYP2B6; Microsome; Chemistry; Drug metabolism; Cytochrome P450; CYP2A6; Hepatocyte; Biochemistry; Molecular biology; Biology; Enzyme; Pharmacology; CYP1A2; In vitro","score_opus":0.17886193844391207,"score_gpt":0.42322992416729627,"score_spread":0.2443679857233842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256649737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423343,0.011634076,0.037177756,0.0002871043,0.00009676173,0.00021894737,0.0032855892,0.000339648,0.004625951],"genre_scores_gemma":[0.9395521,0.0069381627,0.0216621,0.00015474926,0.00017090038,0.0003062373,0.014938223,0.00011113013,0.016166387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972385,0.000061062594,0.000017569297,0.00007410818,0.000091135495,0.000032285803],"domain_scores_gemma":[0.9998461,0.000027678585,0.000024276707,0.00001674536,0.000057658082,0.000027401707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029714117,0.00046378514,0.0003654379,0.0007549551,0.00031217592,0.00028994598,0.0001545706,0.00047037692,0.0016796922],"category_scores_gemma":[0.00040089837,0.00023277271,0.00036061,0.0006108653,0.00014137186,0.00021300267,0.00014139665,0.00048712897,0.0015503583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006951366,0.000024698882,0.00062124885,0.000032716835,0.000011205025,0.00003536636,0.000022973925,0.000034188146,0.9973055,0.000030122057,0.000045007106,0.0017675181],"study_design_scores_gemma":[0.000026248883,0.00045295284,0.02302387,0.000009824968,0.00004795297,0.0004510813,0.00003168219,0.0010873227,0.9695058,0.00005667856,0.0052983337,0.0000082102815],"about_ca_topic_score_codex":0.0010872331,"about_ca_topic_score_gemma":0.0011332678,"teacher_disagreement_score":0.0016796922,"about_ca_system_score_codex":0.00018172368,"about_ca_system_score_gemma":0.00015921403,"threshold_uncertainty_score":0.0056191087},"labels":[],"label_agreement":null},{"id":"W4280512618","doi":"10.1002/cpt.2652","title":"Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Pharmacology; Pharmacokinetics; Drug interaction; Cytochrome P450; Chemistry; Medicine; Biochemistry; Enzyme","score_opus":0.7281972667024696,"score_gpt":0.6661751620883808,"score_spread":0.06202210461408886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280512618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049758335,0.9966718,0.00014632013,0.0018490046,0.00047141593,0.0000036749639,0.000016699505,0.000006109611,0.0007852127],"genre_scores_gemma":[0.0005022956,0.9963497,0.00031713725,0.0015146859,0.000615213,0.0000062342788,0.000026387039,0.0000034457207,0.000664965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999032,0.00033202977,0.0001383458,0.00009333382,0.0003673899,0.000036838548],"domain_scores_gemma":[0.9956527,0.0029143316,0.0002915338,0.000094229996,0.000960706,0.00008657608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028629098,0.0006270476,0.0015101474,0.0018456243,0.00020523043,0.0014631803,0.0009787425,0.0018640842,0.0045211506],"category_scores_gemma":[0.0034593246,0.00034504704,0.0011024914,0.001878876,0.0007972749,0.0025649227,0.0007063073,0.0037927998,0.0025016323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071620336,0.000060854094,0.00019699492,0.024488391,0.00021394406,0.00024029295,0.00011231477,0.00022014717,0.0018266842,0.008770343,0.07431984,0.8894785],"study_design_scores_gemma":[0.000015590178,0.000076947515,0.00044561358,0.005896491,0.00014900313,0.0008099052,0.0000596429,0.00005366134,0.00034053758,0.0029121847,0.98922414,0.000016103408],"about_ca_topic_score_codex":0.0011364591,"about_ca_topic_score_gemma":0.003239983,"teacher_disagreement_score":0.0045211506,"about_ca_system_score_codex":0.0007047021,"about_ca_system_score_gemma":0.002024024,"threshold_uncertainty_score":0.015140712},"labels":[],"label_agreement":null},{"id":"W4281658853","doi":"10.1038/s41398-022-01963-5","title":"Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial","year":2022,"lang":"en","type":"erratum","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Parkwood Institute; University of Ottawa; Thornhill Medical (Canada); University of Calgary; Impact; Ted Rogers Centre for Heart Research; Western University; University of Toronto; Montfort Hospital; University Health Network; Centre for Addiction and Mental Health; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Randomized controlled trial; Depression (economics); Medicine; Physical therapy; Clinical trial; Double blinded; Pharmacogenomics; Medical physics; Psychology; Psychiatry; Alternative medicine; Internal medicine; Placebo; Pharmacology; Pathology","score_opus":0.10094303150490212,"score_gpt":0.42382641784656444,"score_spread":0.3228833863416623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281658853","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020997769,0.0073629823,0.0059152762,0.17718357,0.76358706,0.0012200804,0.027944263,0.002172803,0.012514152],"genre_scores_gemma":[0.12258007,0.021139277,0.052702032,0.35620695,0.15271726,0.007226641,0.020327216,0.0057252026,0.2613754],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9873877,0.0046976493,0.002223743,0.0011834607,0.003962096,0.00054542866],"domain_scores_gemma":[0.901379,0.049721226,0.0061564557,0.0047546686,0.036079053,0.0019094633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01790515,0.001937918,0.0023240633,0.0016129353,0.0015859711,0.002931291,0.0023849064,0.0047602123,0.06840413],"category_scores_gemma":[0.2130357,0.00079414336,0.0025447467,0.0020499025,0.0018090766,0.0012152635,0.00087712595,0.0054833163,0.013728123],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086696324,0.000013897952,0.00019668207,0.0010546002,0.00020693311,0.00023171099,0.0000400341,0.00011860264,0.000060749455,0.001211704,0.98165786,0.014340223],"study_design_scores_gemma":[0.009155927,0.00043177643,0.0052112215,0.008002952,0.0023170349,0.0016103147,0.00014141756,0.0021626013,0.0013982761,0.0073885187,0.9618932,0.000286854],"about_ca_topic_score_codex":0.03251439,"about_ca_topic_score_gemma":0.036700793,"teacher_disagreement_score":0.9674856,"about_ca_system_score_codex":0.006347857,"about_ca_system_score_gemma":0.011534987,"threshold_uncertainty_score":0.22883463},"labels":[],"label_agreement":null},{"id":"W4283032637","doi":"10.3390/jpm12060974","title":"Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report","year":2022,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Quality of life (healthcare); Pain management; Pain control; Drug; Intensive care medicine; Pharmacogenetics; Analgesic; Pharmacology; Anesthesia; Nursing","score_opus":0.11730885117153748,"score_gpt":0.44965675710503505,"score_spread":0.33234790593349756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283032637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88201815,0.018308595,0.021036584,0.041125253,0.0011895144,0.0006142929,0.00044522088,0.0005712749,0.034691166],"genre_scores_gemma":[0.9757195,0.005267149,0.0068743266,0.0063953334,0.0015661763,0.00007080828,0.00013206319,0.00010907224,0.0038655626],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979361,0.0004652095,0.00024888717,0.00038566338,0.00043366678,0.0005305346],"domain_scores_gemma":[0.9956215,0.0015357494,0.0012119472,0.00026171058,0.00027058396,0.0010985585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095368025,0.0017299923,0.0009878323,0.0027582245,0.0034238556,0.0025127206,0.0014079462,0.005953445,0.002446968],"category_scores_gemma":[0.0066297227,0.001062149,0.0017871564,0.002088496,0.0019213193,0.0030613176,0.0029483654,0.006223448,0.0007562505],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000128175625,0.00008927904,0.0046393573,0.000029473915,0.000012210209,0.9913838,0.00041899373,0.00009324011,0.00019536428,0.00041035432,0.0006583378,0.0020566564],"study_design_scores_gemma":[0.000005201462,0.00002859348,0.0009610743,0.000024598865,0.000010876795,0.99725527,0.00019719606,0.00031186358,0.00017218209,0.0001939447,0.00083094643,0.000008301029],"about_ca_topic_score_codex":0.00519458,"about_ca_topic_score_gemma":0.005978893,"teacher_disagreement_score":0.005953445,"about_ca_system_score_codex":0.0024017594,"about_ca_system_score_gemma":0.0017278278,"threshold_uncertainty_score":0.017426014},"labels":[],"label_agreement":null},{"id":"W4283077391","doi":"10.21203/rs.3.rs-1759048/v1","title":"P450cam (CYP101A1) Mutants for Endosulfan Degradation: Complete Dehalogenation of Endosulfan Diol and Related Compounds","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University","keywords":"Chemistry; Diol; Stereochemistry; Endosulfan; Bicyclic molecule; Halogenation; Dihydroxylation; Organic chemistry; Ether; Medicinal chemistry; Catalysis; Pesticide; Enantioselective synthesis","score_opus":0.31663271161903334,"score_gpt":0.5330893440146617,"score_spread":0.21645663239562835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283077391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949708,0.00023066743,0.0027468142,0.000076641074,0.00002886822,0.000045926772,0.0009345783,0.00010224332,0.00086350495],"genre_scores_gemma":[0.9910959,0.00023034679,0.0025559184,0.000038280425,0.000008112677,0.000074211515,0.0021206075,0.00011450954,0.0037620766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996896,0.00004634441,0.00003565794,0.00005277889,0.00013379363,0.00004182028],"domain_scores_gemma":[0.9997657,0.000047891383,0.00006854205,0.000037401212,0.000037196503,0.00004329346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016392782,0.00070318725,0.0002985132,0.00018210926,0.00015448044,0.00026624094,0.00036837868,0.00034326958,0.0013671377],"category_scores_gemma":[0.00024685293,0.00017260233,0.00032318375,0.00023827779,0.0002269637,0.00014303424,0.0002498416,0.00055419985,0.00057955814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006466164,0.000048718248,0.0002602159,0.000015422936,0.000009736294,0.00007430148,0.000010807888,0.00009181704,0.99834,0.000058930258,0.000047946523,0.0009774065],"study_design_scores_gemma":[0.0000121729,0.00015759419,0.0033979933,0.000002147309,0.000010811737,0.00024266017,0.000022488126,0.0010608973,0.99410206,0.000018752211,0.000966597,0.000005853614],"about_ca_topic_score_codex":0.0025574504,"about_ca_topic_score_gemma":0.0022088806,"teacher_disagreement_score":0.0025574504,"about_ca_system_score_codex":0.00044897763,"about_ca_system_score_gemma":0.00028310035,"threshold_uncertainty_score":0.0050851703},"labels":[],"label_agreement":null},{"id":"W4283329104","doi":"10.1002/pcn5.26","title":"Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic","year":2022,"lang":"en","type":"review","venue":"Psychiatry and Clinical Neurosciences Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Reimbursement; Standardization; Test (biology); Health care; Workflow; Personalized medicine; Medicine; Psychology; Psychiatry; Computer science; Political science; Bioinformatics","score_opus":0.5203715903427888,"score_gpt":0.5533871100410023,"score_spread":0.03301551969821348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283329104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004351928,0.99060446,0.0016574137,0.004629154,0.00025684907,0.00003911399,0.000015927202,0.000037233956,0.0023246459],"genre_scores_gemma":[0.0046158344,0.9889531,0.0040466157,0.0017437962,0.00022781704,0.000048036833,0.000027095475,0.000005983765,0.00033179854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433774,0.0027085121,0.0008679725,0.00044146762,0.0013714386,0.00027285737],"domain_scores_gemma":[0.9879192,0.00880649,0.0010495249,0.00026201986,0.0016916557,0.00027103402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009343784,0.0008816901,0.00091867795,0.0020838957,0.00053841295,0.002404351,0.0018176412,0.0021481498,0.0015005814],"category_scores_gemma":[0.012137446,0.00049705926,0.0010380271,0.0016460983,0.0014023775,0.0027497748,0.0014939914,0.0039070253,0.0008304256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040082225,0.00007704125,0.00066374836,0.020477261,0.00012599923,0.00022425769,0.000330817,0.0005337141,0.0003715863,0.0063671675,0.009657924,0.96113044],"study_design_scores_gemma":[0.00005854648,0.00022954182,0.0044169226,0.058007192,0.0005248794,0.0042076414,0.0010755567,0.00065775844,0.0014649594,0.009439173,0.91982347,0.000094325405],"about_ca_topic_score_codex":0.004607564,"about_ca_topic_score_gemma":0.0070579513,"teacher_disagreement_score":0.009343784,"about_ca_system_score_codex":0.0017444396,"about_ca_system_score_gemma":0.006786977,"threshold_uncertainty_score":0.04941529},"labels":[],"label_agreement":null},{"id":"W4285126481","doi":"10.1016/bs.apha.2022.04.003","title":"Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain","year":2022,"lang":"en","type":"article","venue":"Advances in pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Xenobiotic; Drug metabolism; Cytochrome P450; Metabolite; Biology; Pharmacology; Endogeny; Unspecific monooxygenase; Metabolism; Biochemistry; Drug; Enzyme; Monooxygenase","score_opus":0.03397170083542602,"score_gpt":0.40017160548739145,"score_spread":0.36619990465196545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285126481","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5817634,0.3622988,0.033649284,0.004505261,0.00016999677,0.000068572,0.0007812933,0.00017824804,0.016585235],"genre_scores_gemma":[0.89326894,0.09566742,0.00569125,0.00030986592,0.00027705092,0.000020635684,0.00034400585,0.000016881495,0.004403902],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99980897,0.00006693183,0.000007372102,0.000040727587,0.000052762396,0.000023265222],"domain_scores_gemma":[0.99978465,0.00006842364,0.00006997109,0.000013777046,0.00003867628,0.000024444897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026350198,0.00020229796,0.00023175226,0.0005021383,0.00015300917,0.0005521404,0.000193928,0.00032562236,0.0008246825],"category_scores_gemma":[0.0005389456,0.00012375858,0.00019523692,0.00052142923,0.00044920924,0.00037896633,0.00021390039,0.00065086986,0.00020054817],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021988119,0.00041092123,0.088048905,0.0009284084,0.0007235674,0.003263925,0.00036930025,0.003022003,0.3152844,0.021997806,0.0031707506,0.5605811],"study_design_scores_gemma":[0.00010934565,0.0016732374,0.68649864,0.00021219457,0.00047384299,0.010852226,0.00046912674,0.006491578,0.18754596,0.034943484,0.070640355,0.00009007508],"about_ca_topic_score_codex":0.0044369805,"about_ca_topic_score_gemma":0.005053521,"teacher_disagreement_score":0.0044369805,"about_ca_system_score_codex":0.000457955,"about_ca_system_score_gemma":0.0004775629,"threshold_uncertainty_score":0.008822262},"labels":[],"label_agreement":null},{"id":"W4285392129","doi":"10.1186/s12896-022-00750-w","title":"Oleic acid based experimental evolution of Bacillus megaterium yielding an enhanced P450 BM3 variant","year":2022,"lang":"en","type":"article","venue":"BMC Biotechnology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bacillus megaterium; Monooxygenase; Biology; Cofactor; Directed evolution; Biochemistry; Cytochrome P450; Enzyme; Stereochemistry; Mutant; Chemistry; Bacteria; Gene; Genetics","score_opus":0.07481905090783386,"score_gpt":0.3818607414346483,"score_spread":0.30704169052681446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285392129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903894,0.00049400283,0.008026704,0.00018397988,0.000038419825,0.00007452468,0.00044275154,0.00014557267,0.0015551752],"genre_scores_gemma":[0.980807,0.0005860009,0.014926308,0.000074406584,0.00000873481,0.00007594542,0.0014766917,0.00010639036,0.0019384368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997204,0.000054488573,0.000042835025,0.00006148076,0.00008347615,0.00003746924],"domain_scores_gemma":[0.99981374,0.000039502964,0.000059083075,0.00003786246,0.000026071597,0.000023671657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003016148,0.00046641726,0.00033430537,0.0002108684,0.00016242062,0.00045489983,0.00033756418,0.00035829537,0.0006997305],"category_scores_gemma":[0.0004535738,0.00014294861,0.0003308371,0.00044787093,0.00022540452,0.00017075177,0.00054688577,0.00072038756,0.000281474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012445655,0.000076650824,0.00045275275,0.00006203994,0.000016332031,0.00010422532,0.000029816609,0.000396023,0.99445033,0.00012124273,0.00005277663,0.0041132797],"study_design_scores_gemma":[0.000032310112,0.00045385302,0.0028455025,0.000015230318,0.000047791345,0.00039705922,0.000040448434,0.002675141,0.98953015,0.000056899626,0.0038930017,0.000012597136],"about_ca_topic_score_codex":0.00070247526,"about_ca_topic_score_gemma":0.00076197763,"teacher_disagreement_score":0.00070247526,"about_ca_system_score_codex":0.00031974757,"about_ca_system_score_gemma":0.00021952849,"threshold_uncertainty_score":0.0023408532},"labels":[],"label_agreement":null},{"id":"W4285684482","doi":"10.2147/pgpm.s348851","title":"The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists","year":2022,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; University of Alberta","funders":"","keywords":"Pharmacogenomics; Likert scale; Medicine; Pharmacy; Medical education; Scale (ratio); Family medicine; Pharmacology; Psychology","score_opus":0.08072898205224215,"score_gpt":0.43765684782878245,"score_spread":0.3569278657765403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285684482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958989,0.00011429692,0.00019015318,0.00028515418,0.000029089024,0.0010274723,0.000040162493,0.000046706755,0.0023679994],"genre_scores_gemma":[0.9958889,0.00024600973,0.0019098183,0.00016393956,0.00003636549,0.0006533499,0.00008403612,0.0000027259168,0.0010149243],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987656,0.00042827168,0.000065766646,0.00015873247,0.00034281606,0.00023893738],"domain_scores_gemma":[0.9942021,0.0021446731,0.0006477517,0.00026149352,0.00054248614,0.0022015492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022125442,0.00052599807,0.0003423109,0.00062289624,0.00077971746,0.0005588399,0.0012016337,0.0010237952,0.0030050927],"category_scores_gemma":[0.011069378,0.00027777263,0.00037917378,0.0003738031,0.00040071135,0.00045543286,0.0011614962,0.0007913837,0.00023289814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030228209,0.29592806,0.036831237,0.00097608415,0.00017637094,0.0003545315,0.0027245085,0.003657662,0.0028687082,0.00034903619,0.0028052388,0.6231003],"study_design_scores_gemma":[0.049651418,0.2964412,0.6204428,0.00076127454,0.0006780757,0.00039985584,0.0018241015,0.013753169,0.0070070396,0.0006499579,0.008256649,0.00013438676],"about_ca_topic_score_codex":0.03900992,"about_ca_topic_score_gemma":0.04585942,"teacher_disagreement_score":0.9609901,"about_ca_system_score_codex":0.0038018238,"about_ca_system_score_gemma":0.0076722573,"threshold_uncertainty_score":0.07756573},"labels":[],"label_agreement":null},{"id":"W4287460293","doi":"","title":"Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.","year":2021,"lang":"en","type":"article","venue":"PubMed","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Selection (genetic algorithm); Depression (economics); Clinical decision support system; Medicine; Decision support system; Psychology; Computer science; Pharmacology; Data mining; Artificial intelligence","score_opus":0.2483906405352999,"score_gpt":0.4837030444758714,"score_spread":0.2353124039405715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287460293","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009126327,0.9074568,0.039762884,0.025334869,0.0009462572,0.006721033,0.0034718593,0.00044554647,0.006734381],"genre_scores_gemma":[0.27641127,0.48575932,0.19979738,0.016036952,0.0017062847,0.016169446,0.0030262177,0.00010269665,0.0009903489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9347948,0.04903406,0.0055196746,0.001855107,0.008276428,0.000519954],"domain_scores_gemma":[0.77513593,0.19397622,0.016478444,0.0026157778,0.010380439,0.0014131936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054813415,0.0018600816,0.005798608,0.010975612,0.00043587355,0.0044076373,0.002547497,0.0041146455,0.005119594],"category_scores_gemma":[0.17205057,0.0011111838,0.0149822235,0.006222805,0.00083600864,0.003416617,0.0026073994,0.0033148415,0.00049581873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035972975,0.0005206136,0.007066226,0.19271238,0.031437688,0.00021612507,0.0002695967,0.016058901,0.0003882457,0.007845296,0.011031018,0.7288566],"study_design_scores_gemma":[0.02080112,0.015253654,0.034177404,0.52936006,0.17122766,0.0015390819,0.00052125216,0.08106118,0.0022857252,0.0517217,0.09126283,0.00078838563],"about_ca_topic_score_codex":0.005893789,"about_ca_topic_score_gemma":0.00829765,"teacher_disagreement_score":0.054813415,"about_ca_system_score_codex":0.0082969405,"about_ca_system_score_gemma":0.012266294,"threshold_uncertainty_score":0.2898845},"labels":[],"label_agreement":null},{"id":"W4289918702","doi":"10.1007/s40261-022-01182-2","title":"Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective","year":2022,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Regione Autonoma della Sardegna; Università degli Studi di Cagliari","keywords":"Major depressive disorder; Cost-effectiveness analysis; CYP2C19; Medicine; Psychiatry; Quality-adjusted life year; Cost effectiveness; Cost–utility analysis; Clinical psychology; Risk analysis (engineering); Internal medicine","score_opus":0.3473253564150627,"score_gpt":0.532487651890823,"score_spread":0.18516229547576035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289918702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9458125,0.0025416387,0.03957378,0.0020983545,0.000041918247,0.00042694187,0.0016473314,0.0000575056,0.0077999434],"genre_scores_gemma":[0.99582434,0.00040007939,0.0028978589,0.00007589845,0.0000129871705,0.00008137592,0.00028642794,0.000006239769,0.00041476788],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9961416,0.0030608482,0.00007306702,0.00021995169,0.00021299325,0.0002915212],"domain_scores_gemma":[0.9757505,0.022048669,0.0010994296,0.00043460808,0.00041942592,0.00024733174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00810648,0.0011997769,0.0009912031,0.0013588993,0.0002629105,0.0014566885,0.0010410888,0.0011466241,0.0024115704],"category_scores_gemma":[0.020242989,0.00052475766,0.0026127768,0.0010322935,0.000692676,0.00092780736,0.0010554267,0.001066831,0.00009034696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061049045,0.000112239424,0.014181832,0.00012700818,0.00040074796,0.00019607731,0.000045500925,0.97231627,0.00024428967,0.0058399253,0.00031800606,0.005607568],"study_design_scores_gemma":[0.00013753763,0.00063439086,0.014221407,0.00008202001,0.00057768717,0.00019493663,0.00010661159,0.9770905,0.0002806667,0.006126394,0.00050537253,0.00004250052],"about_ca_topic_score_codex":0.012944223,"about_ca_topic_score_gemma":0.005888165,"teacher_disagreement_score":0.012944223,"about_ca_system_score_codex":0.0056644827,"about_ca_system_score_gemma":0.0022631665,"threshold_uncertainty_score":0.042871714},"labels":[],"label_agreement":null},{"id":"W4292220071","doi":"10.1101/2022.08.17.503990","title":"Single molecule long-read real-time amplicon-based sequencing of <i>CYP2D6</i> : a proof-of-concept with hybrid haplotypes","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Calgary; Women and Children’s Health Research Institute; University of Alberta","funders":"Faculty of Medicine and Dentistry, University of Alberta; Medical Research Council; Directorate for Biological Sciences; Alberta Innovates; European Commission; National Institute for Health and Care Research; U.S. Food and Drug Administration; University of Alberta; Department of Health and Social Care; GlaxoSmithKline","keywords":"Haplotype; Pseudogene; Genetics; Biology; Amplicon; Gene; Computational biology; Hypervariable region; Locus (genetics); Genome; Allele; Polymerase chain reaction","score_opus":0.04844588572887674,"score_gpt":0.31127933355861304,"score_spread":0.2628334478297363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292220071","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30174506,0.0025203587,0.6771268,0.0015212782,0.00077698583,0.0013412155,0.0043711,0.003685767,0.006911344],"genre_scores_gemma":[0.51702994,0.0013223637,0.4655807,0.0010400899,0.00012758627,0.0011030154,0.0065304805,0.0004935733,0.0067721773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878675,0.00028999272,0.000070738024,0.0003815201,0.00034725168,0.0001238138],"domain_scores_gemma":[0.99939775,0.00015305175,0.00012493685,0.00007885833,0.00016878164,0.00007650044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020253544,0.00057100184,0.00052824465,0.00030982087,0.00025874667,0.00060452207,0.00068140356,0.00096419384,0.0017059483],"category_scores_gemma":[0.0012942774,0.00034052803,0.00058556005,0.0002591785,0.00043092275,0.0004623501,0.000678101,0.0013750042,0.0013358137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002218652,0.00015408643,0.00085895514,0.00028483602,0.00005984608,0.00029111916,0.00014241223,0.001832409,0.9685866,0.0015416712,0.0021358689,0.02389022],"study_design_scores_gemma":[0.0001257852,0.0012657876,0.001924631,0.000038376806,0.0000821296,0.00078949414,0.00007998612,0.019621132,0.94853723,0.0011160484,0.026328573,0.00009098819],"about_ca_topic_score_codex":0.00035042557,"about_ca_topic_score_gemma":0.00054041424,"teacher_disagreement_score":0.0020253544,"about_ca_system_score_codex":0.00025920174,"about_ca_system_score_gemma":0.00046580145,"threshold_uncertainty_score":0.010711193},"labels":[],"label_agreement":null},{"id":"W4293758551","doi":"10.3390/jpm12091394","title":"A Systematic Review of Polygenic Models for Predicting Drug Outcomes","year":2022,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Health Canada; Genome British Columbia; Provincial Health Services Authority; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Pharmacogenomics; Context (archaeology); Pharmacogenetics; Precision medicine; Personalized medicine; Polygenic risk score; Predictive modelling; Medicine; Computational biology; Bioinformatics; Computer science; Machine learning; Biology; Genetics; Genotype","score_opus":0.25476346085135876,"score_gpt":0.5184883146027138,"score_spread":0.26372485375135507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293758551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002326454,0.9981681,0.0005240511,0.0002705075,0.00008477136,0.000065881,0.00041310219,0.000013304133,0.00022760275],"genre_scores_gemma":[0.0037590603,0.9943896,0.0010226285,0.00023190734,0.000070228416,0.00011559467,0.0003144794,0.000005774554,0.00009076964],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960115,0.001630873,0.0011166906,0.00040415453,0.0007635318,0.00007323069],"domain_scores_gemma":[0.9728477,0.023624342,0.002017261,0.00035947523,0.0010281448,0.00012313905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069925226,0.0021777507,0.005088255,0.0072718556,0.00035747193,0.0016126035,0.0019707445,0.0013669305,0.0067285704],"category_scores_gemma":[0.033084452,0.0007451703,0.008806633,0.007684967,0.00048045523,0.0015907973,0.0009433455,0.0013393175,0.00072966045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023239072,0.000040646304,0.0020916006,0.6430657,0.013410488,0.00016010366,0.00011140089,0.0015309068,0.00013119311,0.0018465685,0.009147034,0.32823193],"study_design_scores_gemma":[0.0003115587,0.00034686286,0.011941552,0.7701529,0.0924607,0.00113185,0.00014454749,0.0018546607,0.00030352263,0.004934841,0.116287306,0.00012973128],"about_ca_topic_score_codex":0.009860376,"about_ca_topic_score_gemma":0.019870274,"teacher_disagreement_score":0.009860376,"about_ca_system_score_codex":0.0019769932,"about_ca_system_score_gemma":0.00765354,"threshold_uncertainty_score":0.03698039},"labels":[],"label_agreement":null},{"id":"W4294200769","doi":"10.1192/j.eurpsy.2022.591","title":"Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study","year":2022,"lang":"en","type":"article","venue":"European Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2C19; CYP2D6; Discontinuation; Medicine; Hazard ratio; Citalopram; Fluoxetine; Cohort; Depression (economics); Internal medicine; Rate ratio; Sertraline; Poisson regression; Psychiatry; Confounding; Confidence interval; Population; Antidepressant; Anxiety","score_opus":0.06780791996725499,"score_gpt":0.42380031599942997,"score_spread":0.355992396032175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294200769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588746,0.0010072815,0.00027201918,0.00003544287,0.0000127582525,0.000024082827,0.0023850165,0.0000036312606,0.00037224824],"genre_scores_gemma":[0.9973252,0.0003733232,0.00022666811,0.000020645855,0.0000065398026,0.000017693506,0.0017834313,0.0000032091384,0.00024325756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821943,0.00040771742,0.00027577256,0.0006163613,0.00025765525,0.0002231292],"domain_scores_gemma":[0.9983164,0.00026355308,0.0005853854,0.0003936656,0.00022100884,0.00021994492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015769438,0.00045043818,0.000821753,0.00085731107,0.0007565244,0.0009758059,0.0006609553,0.00059203524,0.0014693898],"category_scores_gemma":[0.0024144955,0.00073758705,0.0016688632,0.0015021025,0.0004130987,0.00033454705,0.0008851569,0.0005215108,0.00023009631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037250563,0.000031273725,0.99701947,0.000051334537,0.0005837806,0.0002187133,0.00014362705,0.000108021246,0.0003193107,0.000045799046,0.00021518719,0.00089094636],"study_design_scores_gemma":[0.000050492476,0.000061773884,0.99840975,0.000019676094,0.00031442082,0.00032650316,0.00012312767,0.0001914373,0.00006999238,0.00001963826,0.00040406216,0.000009053639],"about_ca_topic_score_codex":0.041079614,"about_ca_topic_score_gemma":0.038942806,"teacher_disagreement_score":0.041079614,"about_ca_system_score_codex":0.00089121546,"about_ca_system_score_gemma":0.00077232654,"threshold_uncertainty_score":0.08168101},"labels":[],"label_agreement":null},{"id":"W4294771089","doi":"10.1016/j.bcp.2022.115243","title":"Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1","year":2022,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Japan Society for the Promotion of Science","keywords":"Sulfation; Sulfotransferase; In vivo; Cytosol; Nevirapine; Enzyme; Mechanism of action; Biology; Rash; Microsome; Pharmacology; Molecular biology; Chemistry; In vitro; Biochemistry; Immunology; Medicine; Human immunodeficiency virus (HIV); Internal medicine; Genetics; Viral load","score_opus":0.024902999844730538,"score_gpt":0.3504658220957387,"score_spread":0.32556282225100813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294771089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999323,0.00021420723,0.00008651388,0.00002108234,0.000003477583,0.0000024174606,0.0000720064,0.00000522062,0.00027214532],"genre_scores_gemma":[0.99927706,0.000082674764,0.00010630006,0.000009534525,0.0000029606013,0.0000016240325,0.00011292017,0.000005767648,0.0004011726],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996388,0.00015672234,0.000027225584,0.00005910475,0.00008386238,0.000034256438],"domain_scores_gemma":[0.9992968,0.00017730372,0.0002873223,0.00008040822,0.00006670165,0.00009139225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004011314,0.00028096457,0.00024740878,0.00039207804,0.00014797259,0.000319322,0.00013479686,0.0003012501,0.0016872197],"category_scores_gemma":[0.0013155349,0.0001756762,0.00032799836,0.00027178382,0.00021525541,0.00018723226,0.00015839921,0.00030923742,0.0001590591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015614767,0.00029301122,0.6761998,0.000090107045,0.0014282815,0.0018558855,0.00071893993,0.0009507933,0.27908632,0.0005727238,0.00027172538,0.022917628],"study_design_scores_gemma":[0.00009663006,0.001121219,0.9333395,0.0000095559535,0.000260399,0.0028471637,0.00022839605,0.0026864691,0.058017362,0.00024855958,0.0011244519,0.000020281279],"about_ca_topic_score_codex":0.0044992147,"about_ca_topic_score_gemma":0.0028820003,"teacher_disagreement_score":0.0044992147,"about_ca_system_score_codex":0.00032268837,"about_ca_system_score_gemma":0.00015362317,"threshold_uncertainty_score":0.008946061},"labels":[],"label_agreement":null},{"id":"W4294808364","doi":"10.1038/s41397-022-00288-2","title":"The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data","year":2022,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Karolinska Institutet; European Federation of Pharmaceutical Industries and Associations; Robert Bosch Stiftung; McGill University","keywords":"Biology; Genetics; Computational biology; Exome sequencing; Population; Genotyping; Exome; Gene; Genome; 1000 Genomes Project; Phenotype; Genotype; Single-nucleotide polymorphism; Medicine","score_opus":0.11006691880483373,"score_gpt":0.4088712943942562,"score_spread":0.29880437558942247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294808364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845221,0.0017522494,0.00925856,0.00035440235,0.000018751458,0.000016182074,0.0030752143,0.000047870242,0.0009546664],"genre_scores_gemma":[0.9874233,0.001364309,0.006346387,0.00017293691,0.000042945874,0.000018219334,0.0043667164,0.000037715716,0.00022741691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986111,0.0005449078,0.00011642056,0.00051570707,0.0001505089,0.00006137893],"domain_scores_gemma":[0.99727255,0.001057487,0.0005843368,0.0005133021,0.00042918604,0.00014310493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025397784,0.00025381375,0.00045135067,0.0014644092,0.00025460607,0.00092521607,0.0002998478,0.0002964287,0.0010687384],"category_scores_gemma":[0.004986524,0.000117125106,0.0004221872,0.0024881598,0.00028680157,0.0004715129,0.0006263392,0.000516122,0.00021936256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029211768,0.00003965345,0.9008992,0.00016984317,0.000848892,0.0006468157,0.00085860206,0.0020089012,0.016420264,0.0006897837,0.0013763132,0.07574963],"study_design_scores_gemma":[0.000008536516,0.000078328274,0.98726106,0.00003864827,0.00036756092,0.0013344861,0.00033899362,0.001774288,0.0012852342,0.0007883382,0.006699971,0.000024604647],"about_ca_topic_score_codex":0.002034848,"about_ca_topic_score_gemma":0.0033168162,"teacher_disagreement_score":0.0025397784,"about_ca_system_score_codex":0.00014726837,"about_ca_system_score_gemma":0.00026809634,"threshold_uncertainty_score":0.013431847},"labels":[],"label_agreement":null},{"id":"W4296028961","doi":"10.1002/cpt.2749","title":"Characterization of <scp><i>CYP2D6</i></scp> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; University of the Witwatersrand, Johannesburg; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline","keywords":"Genotyping; CYP2D6; Genetics; Allele; Biology; Context (archaeology); Pharmacogenetics; Haplotype; Population; Genotype; Gene; Computational biology; Medicine","score_opus":0.18229329636119448,"score_gpt":0.45458766997590283,"score_spread":0.2722943736147083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296028961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539125,0.0003655149,0.0020287153,0.00009147733,0.000006938179,0.000024637984,0.0015302363,0.000012847793,0.0005484188],"genre_scores_gemma":[0.99510694,0.00026693952,0.002866186,0.00009243915,0.000009398789,0.00003527487,0.0012927171,0.000017882572,0.00031224886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970394,0.000078743506,0.000025702077,0.00009874106,0.00005262284,0.00004010358],"domain_scores_gemma":[0.9996383,0.000108272456,0.00012479768,0.00004053922,0.000056125657,0.00003201691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051622407,0.00028586466,0.00029043763,0.0006991469,0.00041457592,0.00040826938,0.00020504033,0.00030791564,0.0017925714],"category_scores_gemma":[0.0013942119,0.0001121591,0.00038423878,0.0009125172,0.00023559901,0.00013376854,0.0002788893,0.00033673123,0.0003037514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095824327,0.00009547937,0.85175484,0.00019590085,0.0003755753,0.0017525282,0.001832213,0.0013641833,0.09311729,0.0008544611,0.001271207,0.046428],"study_design_scores_gemma":[0.00004636851,0.00021711946,0.9719635,0.00007843877,0.00018153782,0.0035483146,0.00091402687,0.0030038578,0.011031922,0.0006027457,0.008385155,0.000026885888],"about_ca_topic_score_codex":0.002311876,"about_ca_topic_score_gemma":0.0027872755,"teacher_disagreement_score":0.002311876,"about_ca_system_score_codex":0.00014200495,"about_ca_system_score_gemma":0.00017093128,"threshold_uncertainty_score":0.0059967637},"labels":[],"label_agreement":null},{"id":"W4296034623","doi":"10.1002/cpt.2748","title":"Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinical Trials","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Meta-analysis; Pharmacogenomics; Clinical trial; Medicine; MEDLINE; Internal medicine; Pharmacology","score_opus":0.6450440072230488,"score_gpt":0.6158629572286234,"score_spread":0.02918104999442539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296034623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004887618,0.99155676,0.0013999041,0.00047629632,0.0002458483,0.00051498605,0.0005981115,0.000042935815,0.00027742586],"genre_scores_gemma":[0.30683723,0.6759624,0.008708542,0.002535954,0.00068221934,0.0031416824,0.001666195,0.00007214174,0.00039372488],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96527517,0.020904703,0.00786256,0.002424314,0.0030030597,0.000530153],"domain_scores_gemma":[0.9393559,0.048063584,0.007868696,0.0019777345,0.0024304776,0.00030356104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03812591,0.0025895946,0.015996456,0.0059377244,0.0006143888,0.004082924,0.0018139828,0.0022485927,0.0024860268],"category_scores_gemma":[0.07689544,0.0014048108,0.036248963,0.008024605,0.0010664429,0.0019723133,0.0013504288,0.0018511693,0.00025094405],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018085438,0.00002080348,0.0065381574,0.28074178,0.6964943,0.00008328562,0.000057748883,0.00053367135,0.00019978055,0.0002023687,0.00073746545,0.012582152],"study_design_scores_gemma":[0.00084750913,0.00019346688,0.0049465797,0.028743194,0.9628629,0.00007316674,0.0000307858,0.00035211944,0.00013241447,0.00035709378,0.0014373604,0.000023462988],"about_ca_topic_score_codex":0.005174003,"about_ca_topic_score_gemma":0.010290244,"teacher_disagreement_score":0.03812591,"about_ca_system_score_codex":0.0024024886,"about_ca_system_score_gemma":0.004134547,"threshold_uncertainty_score":0.20163155},"labels":[],"label_agreement":null},{"id":"W4296252090","doi":"10.1124/dmd.122.000915","title":"Sexual Dimorphism in the Expression of Cytochrome P450 Enzymes in Rat Heart, Liver, Kidney, Lung, Brain, and Small Intestine","year":2022,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates","keywords":"Sexual dimorphism; Cytochrome P450; CYP1A2; Biology; CYP3A; CYP2E1; Internal medicine; Kidney; Endocrinology; CYP1B1; Monooxygenase; Isozyme; Drug metabolism; Enzyme; Metabolism; Biochemistry; Medicine","score_opus":0.03951423021162805,"score_gpt":0.3444009127862823,"score_spread":0.3048866825746543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296252090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946832,0.0008547459,0.00079122273,0.00010620627,0.000020493308,0.0000096820895,0.0007313926,0.000025984753,0.002777086],"genre_scores_gemma":[0.99180967,0.0006983607,0.0004929434,0.000118900396,0.00001386351,0.00002334663,0.0008254213,0.000030670606,0.0059868614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998772,0.00002735595,0.000010071469,0.000035261302,0.00002840164,0.000021814061],"domain_scores_gemma":[0.9996536,0.000072388924,0.00010069847,0.000050068902,0.000050790146,0.000072489165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016622063,0.00010121348,0.0001672024,0.00043387173,0.000119501114,0.00027891426,0.000106534164,0.00015491396,0.002153953],"category_scores_gemma":[0.000328438,0.00017298145,0.00017119978,0.00021246335,0.00018229742,0.00015576996,0.00018525013,0.00033711075,0.00029767962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075341924,0.00007118567,0.020562395,0.00004594226,0.00004806321,0.00026176922,0.00015780225,0.000049870134,0.9643243,0.0007437626,0.00025786748,0.0127236415],"study_design_scores_gemma":[0.000055663146,0.000741066,0.8276341,0.000017168944,0.000070480935,0.0021697218,0.00034925918,0.0003318704,0.16401373,0.000508579,0.004079746,0.000028593753],"about_ca_topic_score_codex":0.0005874693,"about_ca_topic_score_gemma":0.0010724452,"teacher_disagreement_score":0.002153953,"about_ca_system_score_codex":0.00014722288,"about_ca_system_score_gemma":0.00016293855,"threshold_uncertainty_score":0.0072057247},"labels":[],"label_agreement":null},{"id":"W4297181173","doi":"10.1016/j.jmgm.2022.108339","title":"In-depth analysis of the interactions of various aryl hydrocarbon receptor ligands from a computational perspective","year":2022,"lang":"en","type":"article","venue":"Journal of Molecular Graphics and Modelling","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Aryl hydrocarbon receptor; CYP1B1; Transcription factor; CYP1A2; Chemistry; In silico; Computational biology; Ligand (biochemistry); Cytochrome P450; Small molecule; Cell biology; Receptor; Biochemistry; Biology; Gene; Enzyme","score_opus":0.05420558436473942,"score_gpt":0.37657156900853966,"score_spread":0.32236598464380023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297181173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82747257,0.0028517705,0.115036845,0.0022270663,0.00017886686,0.00016451467,0.0065911547,0.0035061857,0.041971095],"genre_scores_gemma":[0.9628114,0.0009719014,0.029592944,0.00037500955,0.000042577813,0.00011987043,0.002483447,0.00041077984,0.0031921533],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997794,0.00006601951,0.000007967738,0.000023483499,0.000068297006,0.000054838474],"domain_scores_gemma":[0.99935323,0.0004380136,0.00004556869,0.000038645587,0.00007786139,0.000046596277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036613812,0.0012062237,0.0017711646,0.0007923012,0.0008258373,0.0013008298,0.0015431701,0.0016163675,0.009389871],"category_scores_gemma":[0.0012445113,0.00065900915,0.001494811,0.0008597907,0.000468802,0.00083301996,0.0007633919,0.0011663906,0.00082200445],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014357915,0.000102703714,0.0015339366,0.00019472628,0.000114394556,0.0002276811,0.00007109466,0.9841061,0.0028247212,0.0037250726,0.0014376879,0.0055182893],"study_design_scores_gemma":[0.000024209126,0.000021975056,0.00028475624,0.000007781252,0.000026124959,0.000032638018,0.000032510772,0.9969212,0.0005829297,0.0013224481,0.00073690945,0.000006629848],"about_ca_topic_score_codex":0.017598428,"about_ca_topic_score_gemma":0.0166368,"teacher_disagreement_score":0.017598428,"about_ca_system_score_codex":0.0007871861,"about_ca_system_score_gemma":0.0017263505,"threshold_uncertainty_score":0.03499198},"labels":[],"label_agreement":null},{"id":"W4297231491","doi":"10.1038/s41390-022-02313-3","title":"Pharmacogenetic profiling via genome sequencing in children with medical complexity","year":2022,"lang":"en","type":"article","venue":"Pediatric Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"Pharmacogenomics; Pharmacogenetics; Polypharmacy; Medicine; CYP2C19; Population; Personalized medicine; Computational biology; Bioinformatics; Pharmacology; Gene; Genetics; Biology; Genotype","score_opus":0.2916255501695349,"score_gpt":0.5027168091611328,"score_spread":0.21109125899159792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297231491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954804,0.004010749,0.0060899113,0.002255144,0.000049465933,0.00019466075,0.02805612,0.00012668339,0.004413284],"genre_scores_gemma":[0.9645889,0.0030256642,0.015237164,0.0012432451,0.000087607455,0.00020971369,0.014999881,0.000056443892,0.00055144733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864215,0.00039293536,0.00015157287,0.0003665548,0.0002998377,0.0001469354],"domain_scores_gemma":[0.9954145,0.0017556848,0.0015950636,0.00030235466,0.0005667734,0.00036560604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015852397,0.0003584206,0.00038589892,0.002523459,0.0003373684,0.0006954031,0.00045035916,0.0006379086,0.0021344074],"category_scores_gemma":[0.007797186,0.0001955294,0.00054398587,0.0032221272,0.00027158667,0.00040058032,0.0012232262,0.0007877804,0.00033839437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001149707,0.00002546064,0.97548896,0.00014859001,0.0001242485,0.0006500329,0.00033508055,0.00052779826,0.0011222867,0.00040667484,0.0034484996,0.017607478],"study_design_scores_gemma":[0.000021099986,0.00008966386,0.9840948,0.00018256433,0.00014655417,0.001915751,0.00036564388,0.0012728227,0.001058624,0.000926747,0.009910046,0.000015674901],"about_ca_topic_score_codex":0.013354161,"about_ca_topic_score_gemma":0.015487165,"teacher_disagreement_score":0.013354161,"about_ca_system_score_codex":0.0008430696,"about_ca_system_score_gemma":0.001171288,"threshold_uncertainty_score":0.026552856},"labels":[],"label_agreement":null},{"id":"W4297535571","doi":"10.1016/j.japh.2022.09.019","title":"Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Pharmacists Association","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Pharmacy; Medicine; Pharmacogenomics; Workflow; Community pharmacy; MEDLINE; Inclusion (mineral); Family medicine; Computer science; Psychology; Pharmacology","score_opus":0.26994694302694977,"score_gpt":0.5389538610506743,"score_spread":0.26900691802372456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297535571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021388584,0.99051476,0.002366397,0.0023553332,0.0001237461,0.00025206697,0.00020557141,0.000015566398,0.002027629],"genre_scores_gemma":[0.02152546,0.97162265,0.005621976,0.00056769716,0.000039230144,0.00024605606,0.00020452002,0.0000062179056,0.00016619512],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98469573,0.008238073,0.002561172,0.0010530208,0.00303352,0.00041840598],"domain_scores_gemma":[0.93684703,0.049179833,0.0059390184,0.0010363825,0.0066058105,0.0003919868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033418756,0.0010287038,0.0022921697,0.009289966,0.00051411625,0.0047482043,0.0022199664,0.0019564293,0.0020090635],"category_scores_gemma":[0.075389065,0.0007152161,0.003213576,0.013714598,0.0011622399,0.003815545,0.002221326,0.001940204,0.00025696502],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011143073,0.000075407224,0.0024073836,0.13083461,0.0016545728,0.00009828795,0.00064148323,0.001716402,0.00023138935,0.0070062964,0.0020877905,0.8531349],"study_design_scores_gemma":[0.00013188348,0.00052418525,0.018518256,0.763758,0.011218326,0.0005167709,0.0022417852,0.001993541,0.0016757114,0.0062146275,0.19311899,0.000087831395],"about_ca_topic_score_codex":0.023689399,"about_ca_topic_score_gemma":0.040057454,"teacher_disagreement_score":0.033418756,"about_ca_system_score_codex":0.007287918,"about_ca_system_score_gemma":0.031351455,"threshold_uncertainty_score":0.17673743},"labels":[],"label_agreement":null},{"id":"W4297770594","doi":"10.18103/mra.v10i8.2934","title":"Pharmacogenetics Implementation in Primary Care","year":2022,"lang":"en","type":"article","venue":"Medical Research Archives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Drug; Medical prescription; Intensive care medicine; SAFER; Workload; Drug response; Pharmacology; Computer science; Genotype; Biology","score_opus":0.16949753148391464,"score_gpt":0.5583257447641997,"score_spread":0.38882821328028505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297770594","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12442437,0.021231426,0.007370255,0.7341641,0.004051944,0.002314326,0.0012962003,0.0014997161,0.10364759],"genre_scores_gemma":[0.7196766,0.021945497,0.028379787,0.2091469,0.0047845175,0.0016058536,0.0013223924,0.00034855903,0.012789864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9721348,0.01451102,0.0018832422,0.0023806675,0.0054314393,0.0036587787],"domain_scores_gemma":[0.904611,0.032722976,0.0077116233,0.0054362435,0.015046275,0.03447182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03132996,0.00027892223,0.00067518326,0.0016306001,0.003695905,0.004868154,0.0022400187,0.0036665294,0.014203592],"category_scores_gemma":[0.097648785,0.000653824,0.0010320368,0.0022338491,0.0017189868,0.0025530038,0.0066778203,0.005266148,0.0024018656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026072355,0.0016501322,0.13769908,0.001951709,0.00016740931,0.0020108907,0.010231399,0.00060772395,0.0010704059,0.0066969125,0.13816777,0.6994858],"study_design_scores_gemma":[0.0005302954,0.0025194462,0.42510632,0.007975165,0.00025712152,0.0021800548,0.011248544,0.0015067618,0.0013743888,0.009581741,0.5375578,0.00016240454],"about_ca_topic_score_codex":0.045876093,"about_ca_topic_score_gemma":0.037900772,"teacher_disagreement_score":0.045876093,"about_ca_system_score_codex":0.01108406,"about_ca_system_score_gemma":0.048663203,"threshold_uncertainty_score":0.16569066},"labels":[],"label_agreement":null},{"id":"W4300658419","doi":"10.17615/tchk-ac83","title":"Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Hjärt-Lungfonden; British Heart Foundation; Fondation Leducq; University of North Carolina at Chapel Hill; Broad Institute; University of Texas Health Science Center at Houston; Donovan Family Foundation; Regione Emilia-Romagna; University of Wisconsin-Milwaukee; Canadian Institutes of Health Research; University of Washington; Massachusetts General Hospital; Russell and Diana Hawkins Family Foundation; U.S. Department of Agriculture","keywords":"Internal medicine; Cardiology; Mutation; Loss function; Coronary disease; Medicine; Function (biology); Coronary heart disease; Genetics; Biology; Gene; Phenotype","score_opus":0.17319856913769158,"score_gpt":0.41081280096376027,"score_spread":0.2376142318260687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300658419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6704735,0.020028936,0.025854293,0.021087168,0.0030015854,0.00022711702,0.11924375,0.012328789,0.12775476],"genre_scores_gemma":[0.89801943,0.00880148,0.0160194,0.003180309,0.00063656544,0.00008343283,0.021281388,0.0014109924,0.050567105],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9997603,0.00003995577,0.000014263729,0.000046926416,0.00011164134,0.000026867356],"domain_scores_gemma":[0.99934584,0.00023862041,0.00015917694,0.00009797782,0.000042658266,0.00011576637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042468414,0.00045852744,0.000367585,0.0006288277,0.0003267188,0.00064271066,0.00049355114,0.0009437451,0.06358038],"category_scores_gemma":[0.0017808912,0.00020389185,0.00041384718,0.0008900588,0.00037406673,0.00030594278,0.00042089427,0.0006211542,0.013890514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050574318,0.00031324825,0.07215081,0.0018745587,0.0006133527,0.0104615735,0.00027056542,0.0018115228,0.11294036,0.020302389,0.4361524,0.33805183],"study_design_scores_gemma":[0.0010728664,0.0006893725,0.25838032,0.0007799993,0.0011634887,0.053708892,0.00020149547,0.006203361,0.067182906,0.043093335,0.56737643,0.00014760123],"about_ca_topic_score_codex":0.00047688754,"about_ca_topic_score_gemma":0.0010690831,"teacher_disagreement_score":0.06358038,"about_ca_system_score_codex":0.00023914952,"about_ca_system_score_gemma":0.00025750362,"threshold_uncertainty_score":0.21269757},"labels":[],"label_agreement":null},{"id":"W4303856660","doi":"10.3390/metabo12100931","title":"Estradiol, Estrone and Ethinyl Estradiol Metabolism Studied by High Resolution LC-MS/MS Using Stable Isotope Labeling and Trapping of Reactive Metabolites","year":2022,"lang":"en","type":"article","venue":"Metabolites","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Courtois Foundation; Université du Québec à Montréal","keywords":"Chemistry; Estrone; Glutathione; Metabolite; Reactive intermediate; Xenobiotic; Adduct; Metabolism; Drug metabolism; Metabolomics; Microsome; Biotransformation; Hydroxylation; Carcinogen; Chromatography; Biochemistry; Hormone; In vitro; Enzyme; Organic chemistry","score_opus":0.08667192492435266,"score_gpt":0.3738234680480534,"score_spread":0.2871515431237007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303856660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719663,0.004771074,0.020241302,0.000083650106,0.000040795265,0.000062403924,0.0008588425,0.00013383068,0.0018416914],"genre_scores_gemma":[0.96802205,0.0040132976,0.022509722,0.0001582574,0.000024280604,0.00010425489,0.0011034033,0.000047788842,0.004017031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998517,0.00002131663,0.000010465585,0.000051976043,0.000047167076,0.000017242364],"domain_scores_gemma":[0.9999207,0.000013192577,0.000020952099,0.000008238951,0.000029453453,0.0000074661207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001912454,0.00029602143,0.00018183338,0.0002748278,0.0001721835,0.00025237747,0.00017352976,0.00030709273,0.0006221961],"category_scores_gemma":[0.00022849164,0.00014014215,0.00019497109,0.0003064639,0.00016426752,0.00021925592,0.00013531637,0.00021497485,0.00024748524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014682194,0.000016169779,0.0009308936,0.000037578586,0.000015095036,0.00007046032,0.000018418434,0.00017982225,0.9949168,0.00008442024,0.000042632786,0.0035408922],"study_design_scores_gemma":[0.000011387492,0.00026708492,0.008051553,0.000005604807,0.000037539594,0.0003477231,0.000029712124,0.002242043,0.9863353,0.00011303233,0.002543725,0.000015290787],"about_ca_topic_score_codex":0.00088685716,"about_ca_topic_score_gemma":0.001862064,"teacher_disagreement_score":0.00088685716,"about_ca_system_score_codex":0.00024562553,"about_ca_system_score_gemma":0.0003403357,"threshold_uncertainty_score":0.0020813942},"labels":[],"label_agreement":null},{"id":"W4304688685","doi":"10.1016/j.neuropharm.2022.109291","title":"CYP2D in the brain impacts oral hydrocodone analgesia in vivo","year":2022,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Institute of Neurosciences, Mental Health and Addiction; Canadian Institutes of Health Research; Centre for Addiction and Mental Health; National Institutes of Health; Rat für Forschung und Technologieentwicklung; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Hydrocodone; Hydromorphone; Pharmacology; Opioid; Microdialysis; Medicine; In vivo; Chemistry; Anesthesia; Internal medicine; Biology; Oxycodone; Receptor; Central nervous system","score_opus":0.08922511991186961,"score_gpt":0.42811228740606333,"score_spread":0.33888716749419373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304688685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923505,0.0013431692,0.0022677442,0.0005091332,0.00019896364,0.000038656588,0.001135127,0.000093631286,0.0020630786],"genre_scores_gemma":[0.9904655,0.0011566463,0.0011795119,0.00015214556,0.000053691285,0.000051005012,0.0010702668,0.000080206504,0.005791046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983,0.00003329362,0.000009474774,0.00003960689,0.000032026954,0.000055599787],"domain_scores_gemma":[0.99985313,0.00003103701,0.000027197399,0.00002727129,0.000022118393,0.000039237864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016950448,0.0003968543,0.00044461383,0.00026452748,0.00038893052,0.0007852734,0.00025827787,0.00044633046,0.005237182],"category_scores_gemma":[0.00033639642,0.00034310741,0.00036232037,0.00027707306,0.00074044353,0.00047809762,0.00015578719,0.0011046166,0.0008984122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015418574,0.00036497554,0.0015296353,0.000098347926,0.00007775178,0.00022998895,0.00006270865,0.00031700297,0.9727041,0.00050954835,0.0009907024,0.007696571],"study_design_scores_gemma":[0.00041934568,0.0026800972,0.021515513,0.000014389558,0.0001328014,0.00080485427,0.000241727,0.004322794,0.9655016,0.00053198024,0.0038048823,0.000030115372],"about_ca_topic_score_codex":0.004681998,"about_ca_topic_score_gemma":0.007917094,"teacher_disagreement_score":0.005237182,"about_ca_system_score_codex":0.00071285624,"about_ca_system_score_gemma":0.00073965365,"threshold_uncertainty_score":0.01752013},"labels":[],"label_agreement":null},{"id":"W4306392827","doi":"10.1002/jbt.23243","title":"Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro","year":2022,"lang":"en","type":"article","venue":"Journal of Biochemical and Molecular Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Aryl hydrocarbon receptor; Chemistry; Cytochrome P450; In vivo; In vitro; CYP1B1; Methylmercury; Biochemistry; Enzyme; Gene; Environmental chemistry; Transcription factor; Biology","score_opus":0.02700171959952816,"score_gpt":0.347044667466597,"score_spread":0.3200429478670688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306392827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599826,0.0017942572,0.00088923244,0.00009107685,0.0000436284,0.000019206485,0.00034115848,0.00005275137,0.00077043526],"genre_scores_gemma":[0.9922247,0.001246534,0.00097439816,0.00008012933,0.000028024047,0.000038868486,0.00072263187,0.000015787222,0.0046689804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982256,0.00004759632,0.00001130184,0.000030259427,0.000044188146,0.000044016124],"domain_scores_gemma":[0.9998865,0.000027795671,0.000023994959,0.000013976061,0.000019566454,0.000028180075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013279845,0.0003729762,0.0003012237,0.00031587266,0.00013913421,0.00020802884,0.00013849765,0.0002575505,0.0016238048],"category_scores_gemma":[0.00011608781,0.00021144681,0.00029858464,0.00025621642,0.0001936935,0.00013350502,0.00014127659,0.00040979063,0.0003420607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005114354,0.000065633496,0.00037545484,0.000028986808,0.0000109618395,0.000024814168,0.000011028876,0.000046533663,0.9982351,0.000021355763,0.00004036612,0.000628304],"study_design_scores_gemma":[0.0000320248,0.0015581868,0.009762897,0.00000373799,0.000037802947,0.00008178513,0.000033621163,0.00037580138,0.9868701,0.000023917673,0.0012152317,0.0000050099657],"about_ca_topic_score_codex":0.0012783867,"about_ca_topic_score_gemma":0.002634914,"teacher_disagreement_score":0.0016238048,"about_ca_system_score_codex":0.00025186906,"about_ca_system_score_gemma":0.0001849053,"threshold_uncertainty_score":0.0054321885},"labels":[],"label_agreement":null},{"id":"W4307548945","doi":"10.3390/pharmacy10060139","title":"Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals","year":2022,"lang":"en","type":"article","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Pharmacogenomics; Family medicine; Medicine; Demographics; Medical prescription; MEDLINE; Pharmacy; Health care; Nursing; Pharmacology","score_opus":0.048876501335424795,"score_gpt":0.43598881142095686,"score_spread":0.38711231008553204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307548945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997572,0.00022032634,0.000038834467,0.0006520699,0.0000063895236,0.000013473822,0.00003187914,0.0000025219715,0.0014624163],"genre_scores_gemma":[0.9983747,0.00043103955,0.00011487516,0.00043287748,0.0000069214066,0.000008084647,0.000035146448,0.000001216418,0.0005950411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780446,0.00052466063,0.00008781557,0.00013338274,0.0008025749,0.0006472123],"domain_scores_gemma":[0.99223775,0.0015471668,0.0014757538,0.0000923161,0.0012119267,0.0034350858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016205574,0.00012825096,0.00019025705,0.00039475452,0.0014589076,0.0015316176,0.0006057864,0.0004411091,0.0021264984],"category_scores_gemma":[0.006241158,0.00024632536,0.0001398026,0.00052220345,0.0008268275,0.00055585115,0.0011788495,0.0006947602,0.00013663368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119676966,0.00034075454,0.91807324,0.0001223141,0.000026708787,0.0008833608,0.052393034,0.00020155996,0.00080239575,0.000096223695,0.0019663237,0.024974415],"study_design_scores_gemma":[0.000030109168,0.0005888742,0.83504534,0.00018441463,0.00002281463,0.00090412615,0.1555871,0.00054819905,0.00019220395,0.00006378033,0.0067996476,0.000033535973],"about_ca_topic_score_codex":0.44556475,"about_ca_topic_score_gemma":0.5751162,"teacher_disagreement_score":0.55443525,"about_ca_system_score_codex":0.005791127,"about_ca_system_score_gemma":0.013138021,"threshold_uncertainty_score":0.8859425},"labels":[],"label_agreement":null},{"id":"W4307603329","doi":"10.1101/2022.10.25.513646","title":"Design and performance of a long-read sequencing panel for pharmacogenomics","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Pharmacogenomics; 1000 Genomes Project; Indel; Genetics; Computational biology; Benchmarking; DNA sequencing; Genotyping; Biology; Genome; Single-nucleotide polymorphism; Computer science; Gene; Genotype","score_opus":0.13411612955888316,"score_gpt":0.3511928531752271,"score_spread":0.21707672361634392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307603329","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5671626,0.00046801526,0.42022607,0.00028853293,0.00008989793,0.0013557979,0.004271754,0.0037513901,0.0023860345],"genre_scores_gemma":[0.47505066,0.00015995621,0.5131725,0.00047740393,0.00003874408,0.00096914585,0.0075771874,0.000365098,0.002189358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954366,0.001386892,0.00027457715,0.0013074455,0.0013129915,0.00028141576],"domain_scores_gemma":[0.99705493,0.0011824481,0.0003284316,0.00031999085,0.0009047051,0.00020943568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036866828,0.00083438633,0.00083703536,0.0007831589,0.00051115727,0.001145975,0.00089063315,0.0013609197,0.0021546152],"category_scores_gemma":[0.0040845904,0.0007797475,0.0006640412,0.0007267551,0.00035569572,0.0005685998,0.0007928575,0.0012847258,0.0016348882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007966672,0.000327582,0.017793763,0.000139719,0.0001585531,0.0001295132,0.00013163807,0.01664817,0.93101084,0.00033108363,0.0007225265,0.031809907],"study_design_scores_gemma":[0.00008010134,0.0017714454,0.03599629,0.000021412354,0.00019460385,0.0003869348,0.00007033278,0.13948154,0.8178925,0.00035651014,0.0036180452,0.00013022403],"about_ca_topic_score_codex":0.0017009345,"about_ca_topic_score_gemma":0.0029768776,"teacher_disagreement_score":0.0036866828,"about_ca_system_score_codex":0.000617135,"about_ca_system_score_gemma":0.00066120067,"threshold_uncertainty_score":0.019497275},"labels":[],"label_agreement":null},{"id":"W4308766063","doi":"10.1111/bcp.15591","title":"Implementation of pharmacogenomics: Where are we now?","year":2022,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Computer science; DPYD; Genotyping; Precision medicine; Data science; Medicine; Biology; Pharmacology","score_opus":0.3914069149162076,"score_gpt":0.6033629006466744,"score_spread":0.2119559857304668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308766063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028653606,0.917181,0.0024283424,0.07470144,0.0019641074,0.00002301336,0.000058216385,0.0000724601,0.0032849128],"genre_scores_gemma":[0.003471639,0.9791686,0.004259853,0.010368007,0.0014169096,0.00003141991,0.000061441446,0.00002416236,0.0011980599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957417,0.0020513574,0.000343724,0.00040730412,0.0011317205,0.0003241487],"domain_scores_gemma":[0.98161066,0.0118961185,0.0008591085,0.0006584714,0.003998952,0.0009767271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013914131,0.0009047523,0.0020041782,0.001243702,0.00057841995,0.0052110925,0.0020674455,0.004375175,0.0055261664],"category_scores_gemma":[0.017105741,0.0005104615,0.0011843866,0.0019215306,0.0029762888,0.009732749,0.0018764249,0.008963646,0.002840518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088700064,0.0000774069,0.0004475631,0.0077483747,0.0000815286,0.00012026622,0.00021547035,0.00044379925,0.00053981884,0.031973727,0.041224193,0.9170391],"study_design_scores_gemma":[0.000037922,0.0001492661,0.0015347482,0.011619995,0.0000997789,0.00047505525,0.0004393386,0.00030942223,0.00036328525,0.025016032,0.959905,0.000050223494],"about_ca_topic_score_codex":0.008225611,"about_ca_topic_score_gemma":0.008096854,"teacher_disagreement_score":0.013914131,"about_ca_system_score_codex":0.0035294842,"about_ca_system_score_gemma":0.012324962,"threshold_uncertainty_score":0.07358581},"labels":[],"label_agreement":null},{"id":"W4308998148","doi":"10.1016/j.scr.2022.102970","title":"Generation of cytochrome P450 enzyme-polymorphic human induced pluripotent stem cell lines with CYP2D6*10/CYP3A5*3C and CYP2D6*10/CYP2C19*2","year":2022,"lang":"en","type":"article","venue":"Stem Cell Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Korea Evaluation Institute of Industrial Technology; Ministry of Science and ICT, South Korea; Ministry of Science ICT and Future Planning; National Research Foundation of Korea","keywords":"Biology; CYP2D6; Induced pluripotent stem cell; Cytochrome P450; Single-nucleotide polymorphism; CYP2C19; CYP3A4; Drug metabolism; Gene; Cell culture; CYP3A5; Genotype; Drug; Genetics; Enzyme; Pharmacology; Biochemistry","score_opus":0.3674746136622723,"score_gpt":0.4653036000068799,"score_spread":0.09782898634460763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308998148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7316402,0.0034731633,0.21328954,0.0013395314,0.00093453337,0.0046092393,0.026824081,0.0015407255,0.016348919],"genre_scores_gemma":[0.8332516,0.0026753438,0.109368004,0.00139555,0.00015765414,0.00253743,0.03324528,0.00024013332,0.017128965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992829,0.000103536826,0.00015994158,0.000113174945,0.0002901927,0.00005022007],"domain_scores_gemma":[0.9991035,0.00021226672,0.00015576296,0.00021392012,0.00021090671,0.000103524166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009627384,0.0003547362,0.0004747178,0.00065659056,0.000270391,0.0005449672,0.00046833677,0.00058397435,0.0035957221],"category_scores_gemma":[0.00083064125,0.00026464427,0.0005779039,0.0005994122,0.0002828163,0.00022734923,0.000405736,0.001028842,0.0011812318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040030747,0.0004579328,0.0052419505,0.0002646582,0.00014240837,0.0009815033,0.00020989389,0.0017443972,0.95127,0.0036818525,0.003926762,0.03167829],"study_design_scores_gemma":[0.00030697178,0.0014567926,0.012341809,0.00007098726,0.00034016318,0.002759798,0.00016609611,0.00955974,0.9169167,0.0008787708,0.05513901,0.00006318219],"about_ca_topic_score_codex":0.0006430424,"about_ca_topic_score_gemma":0.0010447995,"teacher_disagreement_score":0.0035957221,"about_ca_system_score_codex":0.00019477359,"about_ca_system_score_gemma":0.00034777008,"threshold_uncertainty_score":0.012028873},"labels":[],"label_agreement":null},{"id":"W4309825818","doi":"10.1093/fampra/cmac124","title":"Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore","year":2022,"lang":"en","type":"article","venue":"Family Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Nanyang Technological University","keywords":"Medicine; Pharmacogenetics; Health care; Clinical decision support system; Primary health care; Primary care; Family medicine; Genotype; Environmental health","score_opus":0.3307162113090567,"score_gpt":0.5082645261015374,"score_spread":0.17754831479248068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309825818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981635,0.0000534984,0.0001236747,0.00024423923,0.0000068058007,0.0006541831,0.000098301534,0.0000062383006,0.00064970687],"genre_scores_gemma":[0.99737215,0.00008618061,0.0014756131,0.00027526688,0.00001679272,0.0005589734,0.0000777507,0.0000026686855,0.00013460689],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.98267627,0.012121835,0.0010917025,0.0009934477,0.0020273756,0.0010893525],"domain_scores_gemma":[0.9772659,0.008509649,0.005372202,0.0019735477,0.0022982024,0.004580468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014727327,0.00046071457,0.0006670382,0.00062902557,0.0014369594,0.0015632184,0.0007167404,0.0010489693,0.003004876],"category_scores_gemma":[0.025872821,0.0008781905,0.0007875403,0.0011115893,0.0009240937,0.0012536143,0.0018467702,0.0009441471,0.0006434869],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020005365,0.0067971693,0.9638934,0.00021635952,0.0001472211,0.00049288094,0.005639768,0.00018186575,0.0003777215,0.00007114261,0.00046404632,0.01971778],"study_design_scores_gemma":[0.0013619483,0.020838019,0.97050494,0.0001058377,0.00015337898,0.0004226372,0.003556265,0.0017223022,0.00025777213,0.00010105299,0.00093693845,0.00003895104],"about_ca_topic_score_codex":0.018072272,"about_ca_topic_score_gemma":0.024284579,"teacher_disagreement_score":0.018072272,"about_ca_system_score_codex":0.0031550273,"about_ca_system_score_gemma":0.008486628,"threshold_uncertainty_score":0.07788646},"labels":[],"label_agreement":null},{"id":"W4310235306","doi":"10.1177/07067437221140383","title":"Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders","year":2022,"lang":"en","type":"article","venue":"The Canadian Journal of Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; BC Mental Health & Substance Use Services; University of British Columbia","funders":"Genome British Columbia; Michael Smith Health Research BC; Genome Canada","keywords":"Perception; Pharmacogenomics; Genetic testing; Depression (economics); Medicine; Qualitative research; Test (biology); Psychology; Family medicine; Nursing; Medical education","score_opus":0.19469775877716958,"score_gpt":0.44655914504076316,"score_spread":0.25186138626359356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310235306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866588,0.00090551074,0.0026320496,0.0039336425,0.00011477882,0.0002869962,0.00022364655,0.000020848149,0.005223734],"genre_scores_gemma":[0.9942471,0.00088391034,0.0008695926,0.0014064929,0.000030923035,0.00035189462,0.000073637486,0.000024037608,0.0021123998],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9878501,0.009019946,0.00028773732,0.000533454,0.0006553979,0.0016534469],"domain_scores_gemma":[0.9801885,0.0145528,0.0011679092,0.00038361014,0.0014710475,0.0022362128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013523361,0.0007572006,0.0008344623,0.0014809212,0.009819094,0.004255268,0.0019006722,0.0021438573,0.0033671982],"category_scores_gemma":[0.01915247,0.00074084866,0.0005367627,0.0013964741,0.010636807,0.0051423036,0.0070660426,0.0039024968,0.00037445044],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013040872,0.000018297822,0.001065535,0.00006034554,0.000001779007,0.00041898256,0.9964426,0.000009578183,0.00021819938,0.0002897854,0.00022329311,0.0012385161],"study_design_scores_gemma":[0.0000018195676,0.00001677274,0.00043517732,0.00006723783,0.0000011515203,0.000107477725,0.9970553,0.000018185501,0.000064241685,0.00008497446,0.0021433635,0.000004404137],"about_ca_topic_score_codex":0.01578291,"about_ca_topic_score_gemma":0.02153122,"teacher_disagreement_score":0.01578291,"about_ca_system_score_codex":0.005799963,"about_ca_system_score_gemma":0.0062242853,"threshold_uncertainty_score":0.071519196},"labels":[],"label_agreement":null},{"id":"W4312428580","doi":"10.21037/atm-2022-60","title":"Pharmacogenetic screening in a knowledge-based economy: shouldn’t more be better?","year":2022,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; Institute for Clinical Evaluative Sciences; University Health Network","funders":"","keywords":"Pharmacogenetics; Medicine; Pharmacology; Biology; Genetics; Genotype; Gene","score_opus":0.33439564217564294,"score_gpt":0.49886575962029506,"score_spread":0.16447011744465212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312428580","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011051054,0.00036076969,0.0000806254,0.9960906,0.0023675268,0.0000031774885,0.000016057651,0.000006687903,0.0009640432],"genre_scores_gemma":[0.0012683708,0.00027051466,0.0001978984,0.9907051,0.006274787,0.0000114991135,0.000008661307,0.0000052440732,0.001257965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.983977,0.00588143,0.0017045974,0.0018647711,0.004104753,0.0024673643],"domain_scores_gemma":[0.94281673,0.0344708,0.002388843,0.0016483213,0.0062422426,0.012433049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022226894,0.0010742801,0.0022656012,0.0012583007,0.006657749,0.009482161,0.0039858785,0.1338104,0.013624021],"category_scores_gemma":[0.07027525,0.0009524145,0.0021596826,0.0010643881,0.011350113,0.015064752,0.0057106623,0.08341332,0.0057322434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010448379,0.00014017068,0.0009882605,0.000093537805,0.000061670784,0.0014324755,0.00023024928,0.00015538136,0.00024159254,0.023525087,0.9559779,0.01704916],"study_design_scores_gemma":[0.00045793518,0.00013341794,0.002122491,0.000894923,0.00008954951,0.0019654278,0.0009986307,0.0009229238,0.0002919679,0.10142033,0.89052,0.00018237912],"about_ca_topic_score_codex":0.01705601,"about_ca_topic_score_gemma":0.023417672,"teacher_disagreement_score":0.1338104,"about_ca_system_score_codex":0.008445746,"about_ca_system_score_gemma":0.021811642,"threshold_uncertainty_score":0.117548466},"labels":[],"label_agreement":null},{"id":"W4313521109","doi":"10.1503/jpn.220154","title":"Utilizing pharmacogenetics when treating first episode psychosis","year":2023,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lakeshore General Hospital; McGill University; Douglas Mental Health University Institute; Western University","funders":"","keywords":"Psychosis; Psychiatry; Pharmacogenetics; Persecution; Psychology; Schizophrenia (object-oriented programming); Accident and emergency; Medicine; Clinical psychology; Medical emergency; Genotype; Genetics; Biology","score_opus":0.12346546373801817,"score_gpt":0.42993208609384925,"score_spread":0.3064666223558311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313521109","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83048356,0.067519836,0.011937346,0.035220932,0.0016855288,0.00048083923,0.00022757535,0.0005007701,0.051943723],"genre_scores_gemma":[0.9711076,0.017482335,0.00524822,0.004332219,0.00053599355,0.00006104393,0.000083922525,0.00002284903,0.0011257912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996413,0.00014617557,0.000041406973,0.00003090451,0.00009196671,0.000048297043],"domain_scores_gemma":[0.9995117,0.00025211344,0.00007574338,0.0000156467,0.000052030075,0.0000926312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055494416,0.00026415597,0.0004248753,0.00063385506,0.0005214496,0.00065003237,0.0002624612,0.00083153177,0.00066175393],"category_scores_gemma":[0.0024347943,0.00014020044,0.0002993648,0.00035252364,0.00022929127,0.00039225954,0.00026555266,0.0013363487,0.00024894445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014051034,0.0012956331,0.19915715,0.0006353378,0.00029667604,0.105467916,0.0020378632,0.0016943222,0.023295738,0.0018028005,0.014698384,0.6482131],"study_design_scores_gemma":[0.0006875058,0.007275757,0.43085986,0.002638142,0.00094957993,0.36891574,0.0049280357,0.0070899515,0.022388991,0.011029889,0.1430297,0.00020683538],"about_ca_topic_score_codex":0.0015154326,"about_ca_topic_score_gemma":0.0043870597,"teacher_disagreement_score":0.0015154326,"about_ca_system_score_codex":0.00038049597,"about_ca_system_score_gemma":0.00059925136,"threshold_uncertainty_score":0.0030132532},"labels":[],"label_agreement":null},{"id":"W4313825860","doi":"10.3390/medicina59010118","title":"Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall","year":2023,"lang":"en","type":"article","venue":"Medicina","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Tabula Rasa HealthCare","keywords":"Hydrocodone; Medicine; Pharmacogenomics; Bupropion; Major depressive disorder; Antidepressant; Anxiety; Sedation; Hydromorphone; Elvitegravir; Adverse effect; Oxycodone; Pharmacogenetics; Pharmacology; Psychiatry; Mood; Opioid; Internal medicine","score_opus":0.12547143834284463,"score_gpt":0.432728575510951,"score_spread":0.3072571371681064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313825860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7733226,0.01942425,0.038555574,0.10045977,0.004669708,0.0012747798,0.0016611508,0.001448054,0.059183996],"genre_scores_gemma":[0.9558273,0.0037283057,0.013400421,0.016816078,0.0029497463,0.00015018338,0.0004155453,0.0001761163,0.00653627],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982046,0.00025627858,0.0002794945,0.00042597306,0.00036584146,0.00046780906],"domain_scores_gemma":[0.9969608,0.00087307364,0.00080483145,0.00016815249,0.0003175979,0.0008755212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048565134,0.0021126051,0.0012398172,0.0023226554,0.003436327,0.0021038263,0.0018669564,0.00842253,0.0037312876],"category_scores_gemma":[0.0065174866,0.0009462986,0.0021873927,0.0015797437,0.0013927103,0.0031972134,0.0021844015,0.0072703245,0.0013003071],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030036172,0.000068696594,0.0049686143,0.00003528776,0.000014186785,0.9892953,0.0003816623,0.00017560099,0.00029031752,0.00047907396,0.0017597359,0.0025015147],"study_design_scores_gemma":[0.000007776811,0.00003992371,0.0013287923,0.00007022939,0.000013521695,0.99558854,0.00025618824,0.0005584238,0.0002398063,0.0005155234,0.0013649749,0.00001622209],"about_ca_topic_score_codex":0.008547907,"about_ca_topic_score_gemma":0.009765742,"teacher_disagreement_score":0.008547907,"about_ca_system_score_codex":0.0024427674,"about_ca_system_score_gemma":0.002326164,"threshold_uncertainty_score":0.01772356},"labels":[],"label_agreement":null},{"id":"W4317773465","doi":"10.1016/s2215-0366(22)00432-1","title":"Psychiatry pharmacogenomics: Africans are not at the table","year":2023,"lang":"en","type":"letter","venue":"The Lancet Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacogenomics; MEDLINE; Table (database); Psychiatry; Medicine; Data science; Psychology; Computer science; Biology; Pharmacology; Data mining","score_opus":0.16241717871434935,"score_gpt":0.41520496587662215,"score_spread":0.2527877871622728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317773465","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001025494,0.0013206294,0.00004150081,0.99054974,0.006866341,0.000002993423,0.000013720107,0.000006948292,0.0010955682],"genre_scores_gemma":[0.0017989948,0.0013996257,0.00014368286,0.9664996,0.027070014,0.000013105844,0.000009732528,0.00001550689,0.0030495755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404234,0.0020332031,0.00062222156,0.0006625384,0.0015609474,0.0010786814],"domain_scores_gemma":[0.983096,0.007978994,0.0010700749,0.00056182645,0.0024503767,0.0048426096],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.00886359,0.001033303,0.0025801323,0.0010696443,0.007854506,0.00679421,0.002309328,0.063532695,0.010972232],"category_scores_gemma":[0.029623512,0.00093740347,0.0016309998,0.0010581964,0.0065657394,0.008882275,0.0035647575,0.058971737,0.0072699497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048720533,0.000033115917,0.00063251675,0.000075854216,0.000027227476,0.0014309236,0.00021890385,0.000039059032,0.00017161881,0.004413267,0.9813281,0.011580638],"study_design_scores_gemma":[0.00019776209,0.00007729039,0.0014710964,0.00082523085,0.00006407476,0.002028793,0.0014075143,0.00028670835,0.00015246496,0.03672916,0.9566727,0.00008716303],"about_ca_topic_score_codex":0.014134602,"about_ca_topic_score_gemma":0.02546888,"teacher_disagreement_score":0.9976907,"about_ca_system_score_codex":0.004362036,"about_ca_system_score_gemma":0.009935204,"threshold_uncertainty_score":0.046875656},"labels":[],"label_agreement":null},{"id":"W4318052381","doi":"10.12659/ajcr.938850","title":"Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report","year":2023,"lang":"en","type":"article","venue":"American Journal of Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Polypharmacy; Statin; Atorvastatin; Rosuvastatin; Intensive care medicine; Internal medicine","score_opus":0.08689469882592063,"score_gpt":0.40972132838870234,"score_spread":0.32282662956278174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318052381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923263,0.018184125,0.008426214,0.024010383,0.0011179149,0.00043344058,0.0007918983,0.00028798895,0.023484988],"genre_scores_gemma":[0.9849237,0.0048122527,0.0028068796,0.004066252,0.0013490655,0.000040732535,0.00022959658,0.00006094546,0.0017106055],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988728,0.00015886038,0.00015592123,0.0002866039,0.00019370319,0.00033214784],"domain_scores_gemma":[0.99782443,0.0005924011,0.0004505164,0.000094576666,0.00018212614,0.0008560292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044525767,0.0019265668,0.0011238123,0.002832283,0.0028528203,0.0018954455,0.0012768332,0.0051755644,0.002339073],"category_scores_gemma":[0.004395292,0.0010140602,0.001425693,0.0020829698,0.0013199218,0.0023796253,0.002119152,0.0045238575,0.0006773863],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017958202,0.000048571703,0.008298325,0.000024859793,0.000009408891,0.98898983,0.0002486557,0.000072121584,0.00021863595,0.00016413632,0.00061118323,0.0012963514],"study_design_scores_gemma":[0.000004865834,0.000025781781,0.0023627004,0.000040162206,0.000011920233,0.99626887,0.00027915396,0.0001915754,0.000085494416,0.0002572013,0.00046347675,0.000008798637],"about_ca_topic_score_codex":0.007426766,"about_ca_topic_score_gemma":0.0076773893,"teacher_disagreement_score":0.007426766,"about_ca_system_score_codex":0.0015870135,"about_ca_system_score_gemma":0.0013006155,"threshold_uncertainty_score":0.014767051},"labels":[],"label_agreement":null},{"id":"W4318773532","doi":"10.1016/j.jsps.2023.01.011","title":"Prediction of herb-drug interactions involving consumption of furanocoumarin-mixtures and cytochrome P450 1A2-mediated caffeine metabolism inhibition in humans","year":2023,"lang":"en","type":"article","venue":"Saudi Pharmaceutical Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"King Abdullah International Medical Research Center; Simon Fraser University","keywords":"Physiologically based pharmacokinetic modelling; Pharmacology; Drug; Caffeine; In vivo; Drug interaction; Furanocoumarin; Chemistry; Drug metabolism; Cytochrome P450; Pharmacokinetics; Medicine; Biology; Metabolism; Biochemistry; Biotechnology; Internal medicine","score_opus":0.1461295095450139,"score_gpt":0.4292556543516228,"score_spread":0.28312614480660886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318773532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91436225,0.0014163221,0.08049252,0.00036816177,0.000022924218,0.0000977195,0.000970966,0.0004360443,0.0018331332],"genre_scores_gemma":[0.9917766,0.00025666863,0.0065915133,0.000057668305,0.000008178161,0.000038245646,0.00047741478,0.000019001525,0.0007747533],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99972135,0.00010931279,0.000014507475,0.00009116708,0.00004008187,0.000023561053],"domain_scores_gemma":[0.9989735,0.00074455806,0.00015101419,0.000034114415,0.000058238034,0.000038641145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081802596,0.00082373654,0.0006638802,0.0004410105,0.00012789229,0.00058086874,0.00036922286,0.00071754,0.0007938683],"category_scores_gemma":[0.002183082,0.00035746358,0.0008851688,0.00024908475,0.00016348326,0.00027249343,0.00030353054,0.0005754204,0.00027231034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086358475,0.00036108372,0.05693015,0.00013198753,0.00034942676,0.00031908572,0.000047140926,0.8987971,0.0056589833,0.00032064115,0.00065718987,0.035563607],"study_design_scores_gemma":[0.000018991901,0.00030257233,0.011749923,0.000008095687,0.000090957394,0.000119160555,0.00001239774,0.98478216,0.0021312681,0.00038584077,0.00038642462,0.000012178661],"about_ca_topic_score_codex":0.007130497,"about_ca_topic_score_gemma":0.0043408917,"teacher_disagreement_score":0.007130497,"about_ca_system_score_codex":0.0005456458,"about_ca_system_score_gemma":0.00055918144,"threshold_uncertainty_score":0.014177978},"labels":[],"label_agreement":null},{"id":"W4319262795","doi":"10.3389/jpps.2023.11137","title":"Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition","year":2023,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inflammation; Medicine; Rheumatoid arthritis; Immunology; Tumor necrosis factor alpha; Pharmacology; Arthritis; Receptor; Internal medicine","score_opus":0.5114341975051152,"score_gpt":0.6247455163738764,"score_spread":0.11331131886876122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319262795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042416257,0.99591005,0.00044052835,0.0010191422,0.00033728871,0.00000857562,0.000043569325,0.000011473477,0.0018052148],"genre_scores_gemma":[0.0038759324,0.9927746,0.0004665346,0.00051155704,0.0004907455,0.000012703536,0.000045055047,0.0000029239345,0.0018200101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957305,0.00015421286,0.00006347374,0.000057511876,0.00012695648,0.000024812807],"domain_scores_gemma":[0.9995152,0.00024734554,0.00009917707,0.000011780236,0.00010189312,0.000024648401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000674327,0.0005738176,0.0011077215,0.00080108107,0.00020085645,0.0015178734,0.00040306768,0.0008106716,0.005767781],"category_scores_gemma":[0.00095316116,0.00013681086,0.0004926712,0.0009995755,0.0003296932,0.00094016327,0.0006589367,0.0010474948,0.0016261867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017400546,0.00006678442,0.00078009354,0.018596942,0.00024135582,0.0005441017,0.0001199162,0.00035546196,0.0033099335,0.0056916378,0.02334985,0.94676995],"study_design_scores_gemma":[0.00002773933,0.00031622365,0.0026101805,0.005496446,0.00035760735,0.0030930708,0.00016210023,0.00025801646,0.0018769228,0.0045126597,0.98125917,0.00002974154],"about_ca_topic_score_codex":0.00047604443,"about_ca_topic_score_gemma":0.0012889028,"teacher_disagreement_score":0.005767781,"about_ca_system_score_codex":0.000563428,"about_ca_system_score_gemma":0.0009481474,"threshold_uncertainty_score":0.019295216},"labels":[],"label_agreement":null},{"id":"W4319459775","doi":"10.1016/j.psychres.2023.115102","title":"Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Psychiatry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Mental Health & Substance Use Services; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Meta-analysis; Medicine; Major depressive disorder; MEDLINE; Randomized controlled trial; PsycINFO; Depression (economics); Pharmacogenomics; Relative risk; Strictly standardized mean difference; Psychiatry; Confidence interval; Internal medicine; Clinical psychology; Mood; Pharmacology","score_opus":0.8086740056597296,"score_gpt":0.6918852842257752,"score_spread":0.11678872143395436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319459775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008775375,0.9980605,0.0003532891,0.00013517063,0.00008524277,0.00018890323,0.0001596521,0.000014066619,0.00012558444],"genre_scores_gemma":[0.041448124,0.95418656,0.0021957383,0.00060155365,0.00015806073,0.00085684203,0.00037033722,0.00001777205,0.00016493215],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99085253,0.004890455,0.0023916417,0.0007109245,0.000928221,0.00022620632],"domain_scores_gemma":[0.97593087,0.019627448,0.0024291563,0.00052445335,0.0013106077,0.00017749009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016006848,0.0024991955,0.017617019,0.006558515,0.00050330826,0.002998567,0.0019775727,0.001979308,0.004221471],"category_scores_gemma":[0.036440905,0.0012385825,0.031560067,0.007163307,0.00053628354,0.001851802,0.001572231,0.0018801473,0.00030133198],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014826761,0.000034607285,0.001317448,0.6357162,0.31998375,0.00008612746,0.00006537663,0.0005293768,0.00018323933,0.00023854068,0.0008448505,0.039517816],"study_design_scores_gemma":[0.00083891593,0.00029587347,0.0024745204,0.07250405,0.9190067,0.00010701162,0.00004753034,0.0002596528,0.00014022306,0.00039543436,0.003903363,0.000026732017],"about_ca_topic_score_codex":0.005455056,"about_ca_topic_score_gemma":0.012103526,"teacher_disagreement_score":0.017617019,"about_ca_system_score_codex":0.003151628,"about_ca_system_score_gemma":0.00413744,"threshold_uncertainty_score":0.08465326},"labels":[],"label_agreement":null},{"id":"W4319656047","doi":"10.1007/s12104-023-10122-w","title":"1H, 13C, 15N Backbone and sidechain chemical shift assignments of the C-terminal domain of human UDP-glucuronosyltransferase 2B17 (UGT2B17-C)","year":2023,"lang":"en","type":"article","venue":"Biomolecular NMR Assignments","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Institutes of Health","keywords":"Glucuronidation; Chemistry; Enzyme; Glucuronosyltransferase; Biochemistry; Glycosyltransferase; Stereochemistry; Transferase; Pharmacology; Biology; Microsome","score_opus":0.06540106714075897,"score_gpt":0.40402326957454904,"score_spread":0.33862220243379004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319656047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800127,0.0025724971,0.010291775,0.0005162292,0.000094065945,0.00002822005,0.0016990806,0.00009546693,0.0046899654],"genre_scores_gemma":[0.9676467,0.0023854473,0.018072098,0.0003967714,0.00006807035,0.00006529714,0.0052653877,0.000098787474,0.006001293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988997,0.000022791288,0.0000054587777,0.000024753115,0.000027596141,0.000029313838],"domain_scores_gemma":[0.9996427,0.000064138396,0.00006127651,0.000034956014,0.00009694376,0.00009985582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036905537,0.0003881769,0.00019737934,0.00044260285,0.00052855595,0.00013733369,0.0004350813,0.0004292572,0.0026630915],"category_scores_gemma":[0.00046521792,0.00018152989,0.00023968982,0.00067896396,0.00035716823,0.00028035583,0.00017162456,0.0006287504,0.0003130071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007555779,0.0000523374,0.0012286084,0.00011381869,0.000033565742,0.00033852964,0.00009765873,0.0010207288,0.98756415,0.00036440394,0.0010065017,0.0074241376],"study_design_scores_gemma":[0.00012523028,0.00070457725,0.021164231,0.000037448248,0.000117566924,0.0015242806,0.00015101419,0.010017181,0.95099896,0.00042769202,0.0146827595,0.00004897232],"about_ca_topic_score_codex":0.0034263134,"about_ca_topic_score_gemma":0.0035252138,"teacher_disagreement_score":0.0034263134,"about_ca_system_score_codex":0.0004406638,"about_ca_system_score_gemma":0.0005647573,"threshold_uncertainty_score":0.008908987},"labels":[],"label_agreement":null},{"id":"W4321764998","doi":"10.1101/2023.02.23.529697","title":"Signatures of co-evolution and co-regulation in the CYP3A and CYP4F genes in humans","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Montreal Heart Institute; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Genetics; Gene; Epistasis; Gene cluster; CYP3A; Linkage disequilibrium; Population; Single-nucleotide polymorphism; Computational biology; Evolutionary biology; Haplotype; Allele; Genotype","score_opus":0.07105387842394927,"score_gpt":0.3655496045629635,"score_spread":0.2944957261390142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321764998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981275,0.00035947733,0.0006430811,0.00007601685,0.00000414342,0.000003397118,0.00035586223,0.000010360542,0.0004201145],"genre_scores_gemma":[0.99896574,0.000075955555,0.00040707624,0.000029303534,0.000010445986,0.0000049488067,0.00026215825,0.000009242318,0.00023504849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995333,0.0001283164,0.000017933122,0.00021657244,0.000060440823,0.00004340857],"domain_scores_gemma":[0.9996117,0.00015834237,0.00009973213,0.000043441665,0.000032680593,0.00005419649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002847562,0.00016756341,0.0003385975,0.00090968196,0.00027875157,0.00030133,0.00014132023,0.00034222522,0.0021413043],"category_scores_gemma":[0.0007711819,0.0001171784,0.00022698406,0.00080244406,0.0003424839,0.000112441805,0.00021058167,0.0002830488,0.00019373154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014503234,0.00006649401,0.87150383,0.00006282942,0.00041856398,0.0011452428,0.00064276095,0.000405038,0.09608662,0.0007091213,0.0007534533,0.026755745],"study_design_scores_gemma":[0.000013309547,0.00006303311,0.9955857,0.000004446777,0.000030362426,0.0013999928,0.00009701588,0.0003210046,0.0015123527,0.00025318688,0.0007121567,0.000007463972],"about_ca_topic_score_codex":0.0009839166,"about_ca_topic_score_gemma":0.0007868085,"teacher_disagreement_score":0.0021413043,"about_ca_system_score_codex":0.00014357481,"about_ca_system_score_gemma":0.00008550747,"threshold_uncertainty_score":0.007163346},"labels":[],"label_agreement":null},{"id":"W4322623465","doi":"10.1515/dmpt-2022-0194","title":"A review of pharmacogenetic studies in the Bangladeshi population","year":2023,"lang":"en","type":"review","venue":"Drug Metabolism and Personalized Therapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenetics; Population; Medicine; Biology; Genetics; Environmental health; Genotype","score_opus":0.4195277884471696,"score_gpt":0.5550168823125288,"score_spread":0.13548909386535918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322623465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021083147,0.9992387,0.00005168752,0.00012511907,0.000046687277,0.00001365855,0.00009609913,0.0000020377738,0.00021515343],"genre_scores_gemma":[0.0012900163,0.99832696,0.00012769634,0.00011480593,0.000024986604,0.000013364739,0.000053442644,7.9590046e-7,0.00004795998],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99868125,0.00027771,0.00053684856,0.0001604533,0.00029497358,0.000048806436],"domain_scores_gemma":[0.99405247,0.004524316,0.0007459553,0.00008529428,0.0005376528,0.000054359865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002607424,0.00092363765,0.0028050095,0.006827944,0.00033810883,0.0010826817,0.001169029,0.00088911457,0.0042823423],"category_scores_gemma":[0.006789405,0.0004776296,0.002506052,0.008843045,0.00036776517,0.0010192149,0.0006899205,0.0007035124,0.00044783548],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017271456,0.000041850937,0.0015227124,0.5614061,0.0026807494,0.00044261356,0.00026707212,0.00025121533,0.00076673983,0.0008545223,0.008631802,0.42296198],"study_design_scores_gemma":[0.00012382945,0.00035549683,0.016734976,0.51659495,0.02310855,0.0041682795,0.00050953345,0.00016193633,0.0010684355,0.0012560392,0.43583116,0.00008683904],"about_ca_topic_score_codex":0.004754327,"about_ca_topic_score_gemma":0.008336942,"teacher_disagreement_score":0.006827944,"about_ca_system_score_codex":0.0011366605,"about_ca_system_score_gemma":0.003940884,"threshold_uncertainty_score":0.014325917},"labels":[],"label_agreement":null},{"id":"W4322771077","doi":"10.3390/ijms24054776","title":"Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"MEDLINE; Medicine; Scopus; Mental illness; Pharmacogenomics; Population; Clinical trial; Standardization; Intensive care medicine; Psychiatry; Mental health; Pharmacology; Pathology; Environmental health; Biology; Computer science","score_opus":0.23180612150393992,"score_gpt":0.5683719450807853,"score_spread":0.33656582357684534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037653465,0.9991726,0.000049415896,0.000080489066,0.000033896587,0.00006937506,0.00010476391,0.0000032325581,0.00010971481],"genre_scores_gemma":[0.007887121,0.9912736,0.00027036003,0.00018346956,0.000055809243,0.00015725689,0.00011745131,0.000002277235,0.00005266953],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961047,0.0012716749,0.0013740141,0.00032964422,0.0008009831,0.00011903201],"domain_scores_gemma":[0.9802588,0.015231475,0.0029874141,0.000214402,0.0011487287,0.00015917982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049149604,0.0013342656,0.0072651263,0.0059587974,0.00046492644,0.0020950045,0.0015459985,0.0015958059,0.0042306273],"category_scores_gemma":[0.024009041,0.0006504829,0.0063678655,0.007911261,0.0006033737,0.0015224419,0.0010367419,0.001008553,0.0002908635],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002458511,0.000028004888,0.0010346781,0.9332944,0.007876331,0.000079344645,0.00009306847,0.00010308875,0.00008144593,0.00020468475,0.0015361578,0.05542287],"study_design_scores_gemma":[0.0003805839,0.00035598152,0.010842354,0.85644543,0.10488398,0.000578956,0.00020564989,0.0001815543,0.00017825066,0.0004356098,0.02545237,0.000059327456],"about_ca_topic_score_codex":0.0058857794,"about_ca_topic_score_gemma":0.014860704,"teacher_disagreement_score":0.0072651263,"about_ca_system_score_codex":0.0021506206,"about_ca_system_score_gemma":0.0070555457,"threshold_uncertainty_score":0.02599305},"labels":[],"label_agreement":null},{"id":"W4323035103","doi":"10.1111/cts.13497","title":"Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Université de Montréal","keywords":"Metoprolol; Allopurinol; Medicine; Gout; Internal medicine; Dosing; Bisoprolol; Pharmacology; Adverse effect; Physiology; Heart failure","score_opus":0.3109674915822188,"score_gpt":0.5002438537530536,"score_spread":0.18927636217083477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323035103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943857,0.0016351948,0.00046811264,0.00012503067,0.000028465287,0.000016760505,0.0014140786,0.000013716533,0.001913013],"genre_scores_gemma":[0.99847347,0.00020843536,0.00022573223,0.000071109505,0.000028278582,0.000010693718,0.0003519075,0.000004926713,0.00062538334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996735,0.00009636583,0.00003325306,0.00007672308,0.00007312964,0.00004699152],"domain_scores_gemma":[0.99894196,0.0001679747,0.00066342903,0.00007248027,0.00008352284,0.0000707501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004991362,0.00025879082,0.0002200035,0.00041157886,0.00020760123,0.0004766508,0.0001602349,0.00018180617,0.008223978],"category_scores_gemma":[0.0011304498,0.00013515532,0.0004589969,0.00040176473,0.000107398715,0.00018980916,0.00020902553,0.00025241647,0.0005328097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018130378,0.000019263616,0.99464417,0.00002950203,0.00014486304,0.000058038542,0.0000415914,0.000016252716,0.0010916378,0.00003257512,0.00020158866,0.003539287],"study_design_scores_gemma":[0.000004624019,0.00006503278,0.9988165,0.0000065826257,0.000035094698,0.00030670938,0.00006808744,0.00004685601,0.00017398663,0.000020761812,0.00045418018,0.000001673347],"about_ca_topic_score_codex":0.0017259693,"about_ca_topic_score_gemma":0.001690511,"teacher_disagreement_score":0.008223978,"about_ca_system_score_codex":0.00009830233,"about_ca_system_score_gemma":0.00012743469,"threshold_uncertainty_score":0.027511954},"labels":[],"label_agreement":null},{"id":"W4323049184","doi":"10.1101/2023.02.27.530342","title":"Haplotype phasing of <i>CYP2D6</i> : an allelic ratio method using Agena MassARRAY data","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Women and Children’s Health Research Institute; Alberta Hospital Edmonton; University of Alberta","funders":"Alberta Innovates; European Commission; Alberta Precision Laboratories","keywords":"Pharmacogenomics; Haplotype; CYP2D6; Concordance; Biology; Computational biology; Genetics; Data mining; Computer science; Allele; Gene; Genotype","score_opus":0.27911776992344267,"score_gpt":0.44847408559571494,"score_spread":0.16935631567227227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323049184","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078998305,0.00060638034,0.90250915,0.0002389237,0.00023778739,0.000862684,0.0059108227,0.0066769975,0.003958943],"genre_scores_gemma":[0.105781876,0.00018860858,0.8849752,0.00030324853,0.00008496627,0.0007290517,0.00543471,0.00073278655,0.0017695823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949763,0.0014689495,0.00057925575,0.0017070683,0.0010145542,0.00025386678],"domain_scores_gemma":[0.9913817,0.0035020583,0.0010831199,0.00210114,0.0016953715,0.00023667542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042594317,0.00092841795,0.0009755219,0.0032329515,0.0007461122,0.0014842638,0.0009921541,0.0010596965,0.0053720716],"category_scores_gemma":[0.014587334,0.0007722044,0.0013011347,0.0018813718,0.00064126845,0.00073861826,0.0011552987,0.0019194018,0.004198853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013391243,0.00032834342,0.028836861,0.00082572893,0.00065496936,0.0014174829,0.0011469912,0.008815283,0.6761305,0.0055710603,0.008067748,0.266866],"study_design_scores_gemma":[0.0002357868,0.0007223193,0.052242022,0.00012383865,0.00047746056,0.0031908376,0.00030171202,0.1245647,0.7579852,0.0057951333,0.053967495,0.00039361097],"about_ca_topic_score_codex":0.0012729998,"about_ca_topic_score_gemma":0.0027457846,"teacher_disagreement_score":0.0053720716,"about_ca_system_score_codex":0.00036734086,"about_ca_system_score_gemma":0.00077072415,"threshold_uncertainty_score":0.022526324},"labels":[],"label_agreement":null},{"id":"W4361213412","doi":"10.1016/j.rpth.2023.100137","title":"Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review","year":2023,"lang":"en","type":"review","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Drug; Medicine; Intensive care medicine; Pharmacology","score_opus":0.738607884384061,"score_gpt":0.6859977651049778,"score_spread":0.05261011927908321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361213412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015012803,0.99723756,0.00010318774,0.00022733616,0.000075229924,0.00017496153,0.00047982341,0.0000056166787,0.00019491433],"genre_scores_gemma":[0.02162244,0.9762296,0.00049428764,0.00058210694,0.00012745042,0.00043085916,0.00038110695,0.000005057379,0.00012720295],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941958,0.001729976,0.002412337,0.00044709758,0.0010531833,0.00016164775],"domain_scores_gemma":[0.9689159,0.022236435,0.0059841876,0.00029430212,0.0023188093,0.00025038555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057381657,0.0012543846,0.007132992,0.008348899,0.00051781535,0.0018943642,0.0015450596,0.0015710202,0.004772735],"category_scores_gemma":[0.030198222,0.00080863823,0.006711622,0.010398657,0.000610238,0.001597847,0.001058857,0.0008309433,0.00028577828],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018271145,0.000015135983,0.00202799,0.9598221,0.016293952,0.00012723336,0.000102228856,0.000087529574,0.00008675611,0.0001099386,0.0015431261,0.019601371],"study_design_scores_gemma":[0.00043592034,0.0002996965,0.0136033865,0.76672614,0.19907321,0.0007689202,0.00024647237,0.00018027231,0.00021819837,0.00038179485,0.018008405,0.000057557696],"about_ca_topic_score_codex":0.005679317,"about_ca_topic_score_gemma":0.016849471,"teacher_disagreement_score":0.008348899,"about_ca_system_score_codex":0.0023968834,"about_ca_system_score_gemma":0.0073284693,"threshold_uncertainty_score":0.030346692},"labels":[],"label_agreement":null},{"id":"W4362735831","doi":"10.1002/cpt.2903","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":403,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health; Patient-Centered Outcomes Research Institute","keywords":"CYP2C19; Pharmacogenetics; Serotonin reuptake inhibitor; Medicine; CYP2B6; CYP2D6; Guideline; Internal medicine; Genotype; Serotonin; CYP3A4; Biology; Genetics; Cytochrome P450","score_opus":0.260799143689104,"score_gpt":0.5708299925254577,"score_spread":0.31003084883635373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735831","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007226702,0.046934087,0.1123848,0.3577135,0.016887588,0.0098652765,0.030929364,0.007087969,0.41097072],"genre_scores_gemma":[0.060442742,0.062185902,0.20617987,0.44570345,0.009284412,0.01713522,0.07320195,0.0024455194,0.123420954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9750597,0.009213463,0.0054024896,0.001127296,0.007992034,0.0012049618],"domain_scores_gemma":[0.9531451,0.01487858,0.004371776,0.0019484845,0.02320146,0.0024545176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016612774,0.000892085,0.0016774526,0.002293568,0.0010746794,0.003255442,0.0041791094,0.008797057,0.017785354],"category_scores_gemma":[0.053329006,0.00078351196,0.0035591437,0.0024371848,0.0012160491,0.0018407431,0.0026217054,0.008102245,0.009264271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014166097,0.00020785895,0.0016423321,0.0012544569,0.00008685019,0.0005092226,0.00028770283,0.00059199554,0.0007492058,0.008903202,0.8382323,0.14739312],"study_design_scores_gemma":[0.00034508988,0.0001358418,0.0039719283,0.0042301537,0.00020269323,0.000981889,0.00015573982,0.0007562956,0.00072048185,0.0057668276,0.98266995,0.0000630586],"about_ca_topic_score_codex":0.02220118,"about_ca_topic_score_gemma":0.03128536,"teacher_disagreement_score":0.02220118,"about_ca_system_score_codex":0.0032927918,"about_ca_system_score_gemma":0.019314576,"threshold_uncertainty_score":0.08785778},"labels":[],"label_agreement":null},{"id":"W4375815274","doi":"10.1007/978-3-030-42825-9_130-1","title":"Pharmacogenomics and Precision Psychiatry","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Drug reaction; Medicine; Psychiatry; Data science; Machine learning; Computer science; Artificial intelligence; Psychology; Drug; Pharmacology; Biology","score_opus":0.14946949354012568,"score_gpt":0.429653680193629,"score_spread":0.2801841866535033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375815274","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046967776,0.20953037,0.032741494,0.012916392,0.005544402,0.000053186428,0.0003196949,0.0004830507,0.73794186],"genre_scores_gemma":[0.0050218776,0.07651452,0.011071192,0.0065209405,0.0025703846,0.00007078676,0.00019199897,0.00023146381,0.8978068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971646,0.000076607495,0.000008870651,0.00003340745,0.000149012,0.000015673906],"domain_scores_gemma":[0.9996679,0.00022463113,0.000011054885,0.000030692354,0.00004899724,0.000016773283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005482582,0.0009924661,0.00076182256,0.001437563,0.0006010592,0.0026173524,0.0007179316,0.001814518,0.03895138],"category_scores_gemma":[0.0010373134,0.00041576856,0.0003348457,0.0014561913,0.001584716,0.0025259133,0.0011888389,0.0028741853,0.022908954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015789545,0.000031959215,0.00006232868,0.0002984396,0.000013610141,0.00009482387,0.00019194273,0.00073321076,0.0005159269,0.26259243,0.42026353,0.31518605],"study_design_scores_gemma":[0.0000032987657,0.00000887891,0.00011531653,0.00018643645,0.000004783335,0.00024588453,0.000047386144,0.00028601335,0.00017214112,0.13351475,0.8654076,0.0000074807213],"about_ca_topic_score_codex":0.0019133065,"about_ca_topic_score_gemma":0.0059189447,"teacher_disagreement_score":0.03895138,"about_ca_system_score_codex":0.0012934709,"about_ca_system_score_gemma":0.0010411151,"threshold_uncertainty_score":0.13030529},"labels":[],"label_agreement":null},{"id":"W4376629962","doi":"10.1503/jpn.230048-l","title":"Response to: “Consistent terminology for medication-related problems in pharmacogenomic cases”","year":2023,"lang":"en","type":"letter","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lakeshore General Hospital; McGill University; Douglas Mental Health University Institute; Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Terminology; Drug response; Psychosis; Psychiatry; Medicine; Psychology; Pharmacology; Drug; Biology; Genetics; Genotype; Philosophy","score_opus":0.13966962000009234,"score_gpt":0.43376094413887295,"score_spread":0.2940913241387806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376629962","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029766795,0.00044206093,0.000098298835,0.9877586,0.009974613,0.000020792198,0.0000466876,0.00004411601,0.0013171185],"genre_scores_gemma":[0.0040825675,0.00037689583,0.00028814646,0.97480154,0.017777052,0.00004718122,0.000032674056,0.000027405375,0.0025666018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729437,0.0008332864,0.00042913607,0.00045389734,0.0005882908,0.0004010544],"domain_scores_gemma":[0.9920082,0.0033801494,0.0006292137,0.00029076738,0.0022334831,0.0014580524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028244643,0.0009675061,0.0016550148,0.0010392141,0.0036071576,0.0030609958,0.0026659907,0.050712157,0.010114998],"category_scores_gemma":[0.031734753,0.00077472883,0.0011258621,0.0009771888,0.0033508008,0.004822535,0.0019332902,0.041276414,0.009551506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062232,0.000021467913,0.0007012996,0.00005931518,0.000008199672,0.004638772,0.0001768212,0.00007025216,0.0001169958,0.0013052794,0.98848337,0.004356001],"study_design_scores_gemma":[0.00016653907,0.00009769109,0.0029004505,0.0008596148,0.00003201944,0.020134766,0.0012977544,0.0010659613,0.00035336538,0.009993203,0.9629164,0.00018222645],"about_ca_topic_score_codex":0.005225752,"about_ca_topic_score_gemma":0.007878901,"teacher_disagreement_score":0.050712157,"about_ca_system_score_codex":0.0041250223,"about_ca_system_score_gemma":0.0033761489,"threshold_uncertainty_score":0.033838034},"labels":[],"label_agreement":null},{"id":"W4376631075","doi":"10.1503/jpn.230022-l","title":"Consistent terminology for medication-related problems in pharmacogenomic cases","year":2023,"lang":"en","type":"letter","venue":"Journal of Psychiatry and Neuroscience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; CYP2D6; Pharmacogenetics; Adverse effect; Terminology; Medicine; Psychiatry; MEDLINE; Psychology; Pharmacology; Internal medicine; Genetics; Biology; Cytochrome P450; Philosophy; Genotype","score_opus":0.16456838910427543,"score_gpt":0.4321141501341668,"score_spread":0.26754576102989136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376631075","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007629811,0.03864756,0.016221076,0.850378,0.04672695,0.00022327596,0.0003986319,0.0004682235,0.039306488],"genre_scores_gemma":[0.1474467,0.03033327,0.024566712,0.5931788,0.19506817,0.00076150073,0.00055632996,0.00058177294,0.007506731],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851667,0.0063149077,0.0036813722,0.0013053913,0.0021119448,0.0014195492],"domain_scores_gemma":[0.95655155,0.026444467,0.0048869285,0.0018377657,0.007927448,0.00235175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007856762,0.0015050991,0.0021776345,0.0049908604,0.0041407836,0.004582839,0.005316808,0.018788345,0.0040122042],"category_scores_gemma":[0.061758924,0.00078556186,0.0017719959,0.0034727363,0.010860941,0.0075028227,0.0058251573,0.026477301,0.0058016106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000160071,0.00012629635,0.009261584,0.0015788365,0.00007082678,0.20533511,0.0033944168,0.0005281763,0.0011504258,0.09807196,0.6436983,0.03662409],"study_design_scores_gemma":[0.00009502668,0.00007782717,0.0025116443,0.0036711243,0.00006827733,0.63397,0.0028600453,0.0014317837,0.0005386951,0.060673885,0.29391932,0.00018228171],"about_ca_topic_score_codex":0.0015323827,"about_ca_topic_score_gemma":0.0016251868,"teacher_disagreement_score":0.018788345,"about_ca_system_score_codex":0.003941934,"about_ca_system_score_gemma":0.002832321,"threshold_uncertainty_score":0.041550994},"labels":[],"label_agreement":null},{"id":"W4377019502","doi":"10.1101/2023.05.15.540828","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-a]pyrimidines Toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Gillings School of Public Health; Genentech; Pharmaron; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Dosing; Pharmacology; Enzyme; Covalent bond; Combinatorial chemistry; Biochemistry; Medicine; Biology; Organic chemistry","score_opus":0.09888589641764382,"score_gpt":0.35888334109182574,"score_spread":0.2599974446741819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377019502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93476707,0.005589608,0.039421607,0.0006980094,0.00016016587,0.0005419975,0.0041454365,0.00059948984,0.014076638],"genre_scores_gemma":[0.9660622,0.0030332785,0.021162776,0.00015376443,0.000020182686,0.00019641056,0.0017559781,0.00007504422,0.007540399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985373,0.000025296029,0.000007840477,0.00003512642,0.000046019646,0.000031900145],"domain_scores_gemma":[0.9999219,0.000012050015,0.000025530182,0.0000098167375,0.000015698433,0.000015001637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037956977,0.0004303456,0.00022475106,0.00019700591,0.00012397827,0.0002315773,0.0002508826,0.00027301745,0.0035498582],"category_scores_gemma":[0.0002025112,0.00012880983,0.00020418872,0.00021064974,0.0001396125,0.00020567415,0.00014360453,0.0005145415,0.0009431487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017291898,0.00005654732,0.00008847888,0.00014884872,0.000008803108,0.00004969989,0.000016465108,0.0009995998,0.9925303,0.00037928086,0.00043407205,0.0051150527],"study_design_scores_gemma":[0.00003372084,0.0004915266,0.00037829948,0.0000067775923,0.000009181108,0.000052532123,0.000006117756,0.0010446333,0.99296135,0.00005259273,0.004955112,0.000008009019],"about_ca_topic_score_codex":0.00048865296,"about_ca_topic_score_gemma":0.0016543721,"teacher_disagreement_score":0.0035498582,"about_ca_system_score_codex":0.00033413075,"about_ca_system_score_gemma":0.00030167119,"threshold_uncertainty_score":0.011875391},"labels":[],"label_agreement":null},{"id":"W4377138764","doi":"10.1186/s13063-023-07361-6","title":"The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care","year":2023,"lang":"en","type":"article","venue":"Trials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Future Fund","keywords":"Medicine; Depression (economics); Patient Health Questionnaire; Randomized controlled trial; Pharmacogenomics; Antidepressant; Clinical trial; Major depressive disorder; Psychiatry; Quality of life (healthcare); Physical therapy; Internal medicine; Anxiety; Depressive symptoms; Mood; Pharmacology","score_opus":0.12379675085023355,"score_gpt":0.43405438778251443,"score_spread":0.31025763693228087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377138764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967226,0.004861315,0.0011000751,0.0017512034,0.0011401863,0.018233571,0.0016265656,0.00019090805,0.0038701785],"genre_scores_gemma":[0.94835687,0.0036086852,0.0052893907,0.0025737358,0.0015160956,0.032204084,0.0015299396,0.000030491954,0.004890818],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971746,0.0018579379,0.00017597256,0.00038124592,0.00022663714,0.0001835948],"domain_scores_gemma":[0.9975478,0.0008021569,0.0007411395,0.00022575083,0.00015511796,0.0005281482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032601696,0.0023961095,0.0041744644,0.00060572225,0.0006830159,0.0012541919,0.0010457131,0.0031150468,0.010400331],"category_scores_gemma":[0.005375392,0.0009599202,0.002190114,0.00045907084,0.0017219621,0.0016065984,0.0009663168,0.0036275457,0.0011967226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9885898,0.0035739322,0.00033006203,0.0008153112,0.0006605646,0.000024913164,0.000049702863,0.00013159684,0.00055952667,0.000117951626,0.00044753618,0.004699051],"study_design_scores_gemma":[0.97765976,0.02078457,0.00067481026,0.00003932931,0.00032522983,0.000011921922,0.000010056197,0.00012420925,0.00006390562,0.00010299343,0.000197115,0.0000060637344],"about_ca_topic_score_codex":0.0011658098,"about_ca_topic_score_gemma":0.0022228812,"teacher_disagreement_score":0.010400331,"about_ca_system_score_codex":0.0008240073,"about_ca_system_score_gemma":0.0016271074,"threshold_uncertainty_score":0.034792542},"labels":[],"label_agreement":null},{"id":"W4378624996","doi":"","title":"Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Acute coronary syndrome; Test (biology); Medicine; Population; Internal medicine; Genetics; Biology; Genotype; Environmental health","score_opus":0.4066049649316228,"score_gpt":0.5819580487747488,"score_spread":0.17535308384312598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378624996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962962,0.000029925617,0.0011308278,0.00051875476,0.00001679695,0.00026002692,0.00027292018,0.00000469775,0.0014698892],"genre_scores_gemma":[0.99694556,0.000042257227,0.0016520157,0.00032624858,0.000011329816,0.00033786747,0.00020339992,0.0000015128868,0.00047986407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889675,0.009140972,0.00027199418,0.0005791062,0.00050572044,0.00053476216],"domain_scores_gemma":[0.9619027,0.03070458,0.0033241098,0.001311647,0.0010113401,0.0017456242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011939303,0.00057113305,0.00061055797,0.00037040195,0.0006392261,0.0020872678,0.000558776,0.0024044341,0.0064119906],"category_scores_gemma":[0.03545047,0.00027928068,0.0010715139,0.00036317835,0.0013108748,0.0008740241,0.001000749,0.0020404942,0.0006497438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039087117,0.04027541,0.75228274,0.00069647026,0.0021311766,0.0021359746,0.010103336,0.07087325,0.0068901,0.012581926,0.006185176,0.056757387],"study_design_scores_gemma":[0.0067134197,0.07028695,0.5092586,0.00053311005,0.0010501802,0.0019231895,0.024883514,0.3390519,0.0056760344,0.029644143,0.010142904,0.00083601946],"about_ca_topic_score_codex":0.003147409,"about_ca_topic_score_gemma":0.0029832714,"teacher_disagreement_score":0.011939303,"about_ca_system_score_codex":0.0016769312,"about_ca_system_score_gemma":0.0008441866,"threshold_uncertainty_score":0.06314182},"labels":[],"label_agreement":null},{"id":"W4379422197","doi":"10.51731/cjht.2023.664","title":"An Overview of Pharmacogenomic Testing for Psychiatric Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Generalizability theory; Medicine; Guideline; Genetic testing; Health care; Personalized medicine; Test (biology); Psychiatry; Psychology; Bioinformatics; Pharmacology","score_opus":0.32274797548898837,"score_gpt":0.507439021635251,"score_spread":0.18469104614626264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379422197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041426954,0.9615468,0.0061140954,0.01690218,0.0013888981,0.00014129655,0.00064708845,0.00026104914,0.01258435],"genre_scores_gemma":[0.0021432352,0.9780612,0.007405498,0.006678657,0.0023788027,0.00014130898,0.00065677287,0.000048317295,0.0024861854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975304,0.00079650315,0.00045543368,0.00028759698,0.00079876656,0.00013132587],"domain_scores_gemma":[0.9893607,0.0073523032,0.0007178146,0.00022465884,0.0019303465,0.0004142681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042926874,0.0012636207,0.0012597007,0.007062575,0.00050149276,0.0018843919,0.0013666912,0.0027404088,0.010898178],"category_scores_gemma":[0.009353009,0.0006486134,0.002070019,0.00446673,0.0009204228,0.0027949375,0.0012978733,0.004151766,0.0047786636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010824185,0.0000975367,0.0011850139,0.011175602,0.00017504762,0.0004576707,0.00010410053,0.00046765097,0.0007772289,0.007884245,0.10766212,0.8699055],"study_design_scores_gemma":[0.00004317489,0.00019726744,0.0034436472,0.01684245,0.00025659916,0.003268064,0.000079136335,0.0004709644,0.00047194597,0.010152468,0.96471137,0.00006299937],"about_ca_topic_score_codex":0.006838915,"about_ca_topic_score_gemma":0.012926659,"teacher_disagreement_score":0.010898178,"about_ca_system_score_codex":0.0026633095,"about_ca_system_score_gemma":0.0044332286,"threshold_uncertainty_score":0.036458015},"labels":[],"label_agreement":null},{"id":"W4380422510","doi":"10.1002/psp4.12980","title":"Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism","year":2023,"lang":"en","type":"review","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ethnic group; Mechanism (biology); Medicine; Drug; Markov chain Monte Carlo; Pharmacology; Statistics; Monte Carlo method","score_opus":0.4743222873254233,"score_gpt":0.5033028148323203,"score_spread":0.028980527506897003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016731845,0.96447986,0.015650937,0.0007809608,0.00040052665,0.0002041087,0.0011817627,0.00013696037,0.00043297923],"genre_scores_gemma":[0.65115696,0.3259391,0.015763318,0.0016833658,0.00059374113,0.00093688775,0.0029866316,0.0001544965,0.00078557205],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.985858,0.01040259,0.0013898914,0.0013660959,0.0008075596,0.0001758013],"domain_scores_gemma":[0.9734234,0.023060756,0.0014076605,0.001318881,0.0006608114,0.00012832876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027462177,0.0025649983,0.008155524,0.0034814337,0.00040943513,0.0021728396,0.0017310295,0.0013394641,0.0018791426],"category_scores_gemma":[0.03714403,0.0008094357,0.02756053,0.004391942,0.0003798847,0.0013061514,0.00090972095,0.0018201016,0.00022805462],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023396164,0.000032154312,0.021625217,0.028878056,0.9091127,0.00017599537,0.00004477786,0.0064980113,0.00042938173,0.0006098844,0.0009445127,0.029309738],"study_design_scores_gemma":[0.00044418755,0.00024039234,0.0115130395,0.0017575409,0.97385806,0.00019820525,0.00003411977,0.0059042037,0.00038431957,0.0024145797,0.0032182105,0.000033084238],"about_ca_topic_score_codex":0.0034187378,"about_ca_topic_score_gemma":0.005000536,"teacher_disagreement_score":0.027462177,"about_ca_system_score_codex":0.0010651626,"about_ca_system_score_gemma":0.001610266,"threshold_uncertainty_score":0.1452356},"labels":[],"label_agreement":null},{"id":"W4381599207","doi":"10.1080/17425255.2023.2228680","title":"The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Drug; Drug metabolism; CYP3A4; Cytochrome P450; Coronavirus disease 2019 (COVID-19); Virology; Biology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pharmacology; Medicine; Metabolism; Infectious disease (medical specialty); Disease; Internal medicine; Biochemistry","score_opus":0.07521101245961502,"score_gpt":0.46952742211583703,"score_spread":0.394316409656222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381599207","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016189938,0.084976904,0.0004314279,0.09768957,0.81032854,0.000043941312,0.0002560012,0.00009981039,0.006011928],"genre_scores_gemma":[0.0014399384,0.068989575,0.00028452804,0.04717416,0.8682749,0.000028782168,0.00017745791,0.00006207694,0.013568631],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980724,0.00036877557,0.00019992107,0.0002521863,0.00097555044,0.00013127735],"domain_scores_gemma":[0.99238175,0.0030137643,0.0004555661,0.0001420823,0.0032904842,0.0007163911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034133857,0.0010835531,0.0018555208,0.0009822976,0.0009135907,0.0029956973,0.001981372,0.0081636,0.012941349],"category_scores_gemma":[0.011407864,0.00043294334,0.0013538819,0.00057590957,0.0010198113,0.0024882888,0.0008577625,0.009430604,0.009853861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046296795,0.0000070393,0.000027467111,0.0004952757,0.00002404344,0.000116685755,0.000012903322,0.000021502019,0.000116389674,0.00048088463,0.97826743,0.020383991],"study_design_scores_gemma":[0.00005415326,0.000044294306,0.00018341331,0.00062812,0.00006156668,0.00038387362,0.000022677817,0.00007872531,0.00013985163,0.0010804533,0.99730957,0.00001319643],"about_ca_topic_score_codex":0.001096343,"about_ca_topic_score_gemma":0.002813481,"teacher_disagreement_score":0.012941349,"about_ca_system_score_codex":0.0015341049,"about_ca_system_score_gemma":0.0016526356,"threshold_uncertainty_score":0.043293178},"labels":[],"label_agreement":null},{"id":"W4383070034","doi":"10.3389/fonc.2023.1199741","title":"Computational pharmacogenotype extraction from clinical next-generation sequencing","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Genotyping; Pharmacogenomics; DNA sequencing; 1000 Genomes Project; Reference genome; DPYD; Genetics; Exome sequencing; Whole genome sequencing; Biology; Computational biology; Genotype; Genome; Single-nucleotide polymorphism; Pharmacogenetics; Gene; Mutation","score_opus":0.4059619616281072,"score_gpt":0.5253191977642967,"score_spread":0.11935723613618948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383070034","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14156674,0.0013097344,0.8141651,0.0017579718,0.00016297847,0.0004991781,0.023799833,0.012582759,0.004155708],"genre_scores_gemma":[0.3997609,0.00062487967,0.5550108,0.0012722175,0.00013578241,0.0007654901,0.03965555,0.0009802633,0.0017941946],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993278,0.00024755823,0.00006421684,0.00018583317,0.00013191602,0.0000427338],"domain_scores_gemma":[0.996847,0.0024683233,0.00014592469,0.00027177617,0.00021567814,0.000051246276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001819496,0.0010242015,0.0011184445,0.0018210079,0.00041582383,0.0015069821,0.0011958287,0.000926843,0.0029700215],"category_scores_gemma":[0.00932915,0.0006964304,0.0019399804,0.0011939843,0.0003765099,0.0005280318,0.0011174094,0.0010313655,0.00091824605],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009332322,0.00016331296,0.03689057,0.0007291903,0.0009537737,0.0014401539,0.00020316642,0.744954,0.0066061155,0.0064993817,0.019885372,0.18074171],"study_design_scores_gemma":[0.00012159217,0.000052360716,0.0028218597,0.000041150637,0.00015561252,0.0003612483,0.000040374,0.974512,0.002551825,0.012942038,0.0063743326,0.000025570514],"about_ca_topic_score_codex":0.0062158736,"about_ca_topic_score_gemma":0.00734712,"teacher_disagreement_score":0.0062158736,"about_ca_system_score_codex":0.0006005129,"about_ca_system_score_gemma":0.002086664,"threshold_uncertainty_score":0.012359381},"labels":[],"label_agreement":null},{"id":"W4383874757","doi":"10.20944/preprints202307.0703.v1","title":"Association of CYP2C9*2 Allele with Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"King Saud University","keywords":"Sulfonylurea; Pharmacogenetics; Allele; CYP2C9; Population; Hypoglycemia; Type 2 Diabetes Mellitus; Medicine; Allele frequency; Internal medicine; CYP2C19; Genetics; Pharmacology; Diabetes mellitus; Genotype; Biology; Endocrinology; Gene; Environmental health","score_opus":0.2005716952847194,"score_gpt":0.446049235203789,"score_spread":0.24547753991906957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996675,0.00006645567,0.000038138813,0.000015025578,0.000002436736,0.000007790062,0.000060048576,5.976172e-7,0.0001421059],"genre_scores_gemma":[0.99966156,0.000069944916,0.00006440574,0.000019227811,0.000006177526,0.000005401114,0.000091574475,5.282731e-7,0.000081146114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973863,0.000052932908,0.000030298092,0.00008073529,0.00005787085,0.000039438382],"domain_scores_gemma":[0.9995078,0.000092241375,0.00020605902,0.0000362464,0.00004700323,0.000110712666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032113667,0.0003124293,0.00038775787,0.0005992531,0.00070453185,0.0004506649,0.00022224105,0.00044835533,0.0012982275],"category_scores_gemma":[0.0008142522,0.00039773656,0.000396838,0.00087271386,0.0002481681,0.00028835644,0.00022500084,0.00051302137,0.00014186717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012709163,0.00006419172,0.9979506,0.000008635384,0.000032567816,0.00053000695,0.00017813989,0.000017592509,0.0003347301,0.00001101288,0.000036406353,0.0007090705],"study_design_scores_gemma":[0.000012959383,0.00021226627,0.9975914,0.0000046238915,0.000024785399,0.0015824616,0.00026834453,0.00013362936,0.00006148877,0.000018425233,0.000085829444,0.000003936375],"about_ca_topic_score_codex":0.0051092333,"about_ca_topic_score_gemma":0.004535944,"teacher_disagreement_score":0.0051092333,"about_ca_system_score_codex":0.00021037838,"about_ca_system_score_gemma":0.00021504759,"threshold_uncertainty_score":0.010158956},"labels":[],"label_agreement":null},{"id":"W4385237423","doi":"10.3389/fphar.2023.1252030","title":"Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research","year":2023,"lang":"en","type":"editorial","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacokinetics; Clinical pharmacology; Pharmacology; Medicine; Drug development; Drug","score_opus":0.22519592954582393,"score_gpt":0.6051608834136852,"score_spread":0.37996495386786133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385237423","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020985239,0.0025971713,0.0001417687,0.020496655,0.9749375,0.000015974383,0.000058799687,0.000068027395,0.001663095],"genre_scores_gemma":[0.00034892806,0.0021153316,0.00013286479,0.012910481,0.97400576,0.000017321872,0.00003636505,0.00004647884,0.010386579],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955165,0.0008298806,0.0005147787,0.0006066917,0.0022463219,0.00028591012],"domain_scores_gemma":[0.9759567,0.00842062,0.0014068208,0.00064911024,0.009885269,0.0036815198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075356485,0.004405765,0.003443143,0.0033273913,0.0033572628,0.0062518944,0.0033223238,0.011437911,0.029883645],"category_scores_gemma":[0.025540084,0.00104559,0.0025455507,0.0012051637,0.0023095214,0.004544597,0.0013838547,0.015900467,0.028020686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030205929,0.000007083442,0.00001171845,0.00010347412,0.000007968284,0.000051484585,0.000005065283,0.000018787225,0.00003282884,0.00019382182,0.9964096,0.003127911],"study_design_scores_gemma":[0.0000754061,0.00003058854,0.00020211727,0.00034369522,0.00004082136,0.00031727267,0.000028668679,0.00018527737,0.00014334286,0.0016280932,0.99698526,0.000019464613],"about_ca_topic_score_codex":0.0010129546,"about_ca_topic_score_gemma":0.002940722,"teacher_disagreement_score":0.029883645,"about_ca_system_score_codex":0.0025277475,"about_ca_system_score_gemma":0.0030217136,"threshold_uncertainty_score":0.09997076},"labels":[],"label_agreement":null},{"id":"W4385955318","doi":"10.3390/biomedicines11082282","title":"Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population","year":2023,"lang":"en","type":"article","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"King Saud University","keywords":"CYP2C9; Pharmacogenetics; Allele; Type 2 Diabetes Mellitus; Internal medicine; Population; Medicine; Allele frequency; Genotype; Biology; Diabetes mellitus; Pharmacology; Genetics; Endocrinology; Gene","score_opus":0.05939322768167714,"score_gpt":0.39923071904395196,"score_spread":0.3398374913622748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385955318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996768,0.000067852765,0.000039516694,0.000014903996,0.0000026203504,0.000008586262,0.000055466713,5.927521e-7,0.00013375188],"genre_scores_gemma":[0.9996686,0.00007507433,0.000060937753,0.00001849019,0.000007023099,0.000005953144,0.00008267365,5.5751576e-7,0.0000807064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996934,0.000065347864,0.00003264489,0.00009885082,0.00006308546,0.00004668149],"domain_scores_gemma":[0.9995065,0.00009451609,0.00019761597,0.00003560659,0.000047075937,0.00011864507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036281307,0.00036830388,0.00042713864,0.0006720892,0.00079953147,0.00048592294,0.00024890056,0.0005149495,0.0013732604],"category_scores_gemma":[0.00085799914,0.00045666663,0.0004470424,0.0009681383,0.0003269098,0.0003424715,0.00025487613,0.0005198001,0.0001627448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015084712,0.000070628106,0.9978302,0.000009232287,0.000040989777,0.0005120388,0.00021208316,0.000018582907,0.0003655118,0.000012107926,0.00003916886,0.00073861965],"study_design_scores_gemma":[0.000015634312,0.00019156064,0.99793506,0.0000045331826,0.000028238277,0.0012699097,0.00026590718,0.00013207772,0.00005374836,0.000017232303,0.00008181364,0.0000042743013],"about_ca_topic_score_codex":0.005758922,"about_ca_topic_score_gemma":0.0050639897,"teacher_disagreement_score":0.005758922,"about_ca_system_score_codex":0.00023345905,"about_ca_system_score_gemma":0.00024002166,"threshold_uncertainty_score":0.0114507675},"labels":[],"label_agreement":null},{"id":"W4385997350","doi":"10.1007/s40273-023-01309-z","title":"Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Warfarin; Apixaban; Rivaroxaban; Medicine; Pharmacogenomics; Atrial fibrillation; Quality-adjusted life year; Cost-effectiveness analysis; Cost effectiveness; Internal medicine; Pharmacology; Risk analysis (engineering)","score_opus":0.17157161540634408,"score_gpt":0.43830788094396717,"score_spread":0.2667362655376231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385997350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766285,0.008474613,0.00042373186,0.0025089881,0.00009165793,0.0008130711,0.0058177463,0.000032847434,0.005208836],"genre_scores_gemma":[0.9951486,0.0018714162,0.00046871597,0.0003315564,0.000028349557,0.000098921744,0.0011492384,0.0000048365914,0.0008982515],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975618,0.00084328634,0.00018439884,0.00018447766,0.00061066105,0.00061529095],"domain_scores_gemma":[0.99558985,0.0012618614,0.0009118961,0.00007891965,0.0009769149,0.0011806306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016558542,0.0006504652,0.0012165693,0.0009333743,0.00084207166,0.0014857817,0.0015086677,0.00084279047,0.0032005585],"category_scores_gemma":[0.008176092,0.0005793196,0.0026341898,0.0023564748,0.00075580995,0.0004649211,0.0008276417,0.0010936445,0.00009028797],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10525284,0.0042562513,0.6014078,0.0060028434,0.016016848,0.0011928827,0.0008327782,0.1253584,0.0019839946,0.0059551606,0.02659756,0.10514255],"study_design_scores_gemma":[0.021821752,0.0069437665,0.8697716,0.0010007634,0.01054728,0.00047995037,0.0013754482,0.08010866,0.0005277743,0.0008217489,0.006384769,0.00021640176],"about_ca_topic_score_codex":0.9809729,"about_ca_topic_score_gemma":0.9848769,"teacher_disagreement_score":0.103855684,"about_ca_system_score_codex":0.103855684,"about_ca_system_score_gemma":0.06776657,"threshold_uncertainty_score":0.75352925},"labels":[],"label_agreement":null},{"id":"W4386116271","doi":"10.2217/pgs-2023-0097","title":"Effects of <i>CYP3A4</i> and <i>CYP2C9</i> Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226","year":2023,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; American Association of Colleges of Pharmacy; Breast Cancer Research Foundation","keywords":"Anastrozole; Fulvestrant; Oncology; CYP2C9; Genotype; Internal medicine; Medicine; CYP3A4; Pharmacology; Dosing; Endocrine system; Tamoxifen; Breast cancer; Cancer; Hormone; Biology; Genetics; Gene","score_opus":0.05199140185514887,"score_gpt":0.3800571171164778,"score_spread":0.32806571526132894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386116271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808455,0.00044993902,0.00026359368,0.00006661782,0.000015046977,0.000025961706,0.00054423104,0.000008415327,0.00054173043],"genre_scores_gemma":[0.99841046,0.00007961485,0.00028331665,0.0000922567,0.000014367724,0.00004718833,0.000538688,0.000009646549,0.00052436104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998914,0.0006257144,0.00007080509,0.0002273425,0.00008952395,0.000072508934],"domain_scores_gemma":[0.99794394,0.00094625214,0.0006990784,0.00016632912,0.000100691665,0.00014375872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021662968,0.00044306027,0.0004779072,0.0001699526,0.00022465271,0.00043605975,0.00023706228,0.00044359337,0.0036460212],"category_scores_gemma":[0.002889147,0.0002096321,0.0013963757,0.00036761706,0.00032812316,0.00027666704,0.0002597148,0.00061381696,0.00039853322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055175964,0.00035945087,0.9181567,0.00019704604,0.002674555,0.0001677429,0.00014625593,0.0007102427,0.00680031,0.0001377621,0.0009933672,0.014480683],"study_design_scores_gemma":[0.0024209924,0.010680069,0.97601366,0.000055403,0.0033543443,0.00055703317,0.00012098405,0.0015470481,0.0025688012,0.00032572122,0.0023322501,0.000023729524],"about_ca_topic_score_codex":0.0010010717,"about_ca_topic_score_gemma":0.0016672456,"teacher_disagreement_score":0.0036460212,"about_ca_system_score_codex":0.00019749982,"about_ca_system_score_gemma":0.00026011822,"threshold_uncertainty_score":0.012197137},"labels":[],"label_agreement":null},{"id":"W4386171477","doi":"10.1016/j.xphs.2023.08.018","title":"A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec","funders":"","keywords":"Volume of distribution; Mechanism (biology); Steady state (chemistry); Computer science; Pharmacology; Biological system; Chemistry; Medicine; Pharmacokinetics; Biology","score_opus":0.09912042181857075,"score_gpt":0.41415640236038753,"score_spread":0.3150359805418168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386171477","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022513397,0.00072480016,0.9722992,0.0004962732,0.00019880236,0.0000641706,0.00042143048,0.00065468025,0.0026271385],"genre_scores_gemma":[0.788798,0.0016032433,0.19015393,0.0011656315,0.00045440518,0.00063650974,0.0011004858,0.000902331,0.015185558],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997658,0.00005592453,0.000014882115,0.00006351589,0.00006686553,0.000033047276],"domain_scores_gemma":[0.9993199,0.00035254253,0.00006129119,0.00005502014,0.00015464782,0.000056676225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008846043,0.0009533964,0.001582183,0.0004803302,0.000474757,0.0012313131,0.002530164,0.0023133613,0.0023459028],"category_scores_gemma":[0.002231891,0.000641875,0.0014282287,0.0005461044,0.00053231453,0.0016469534,0.0008122834,0.0014337186,0.0007736849],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005288657,0.0000430437,0.00041324354,0.000046711462,0.00005628581,0.0000873586,0.000015413725,0.9830034,0.0033465677,0.0030370855,0.0007407756,0.00915726],"study_design_scores_gemma":[0.000003954117,0.0000049322116,0.00003863303,0.0000013382416,0.0000066782036,0.000010743649,7.2547476e-7,0.99886847,0.00017958481,0.00069744285,0.00018437467,0.0000031681877],"about_ca_topic_score_codex":0.012229957,"about_ca_topic_score_gemma":0.00767732,"teacher_disagreement_score":0.012229957,"about_ca_system_score_codex":0.0009959784,"about_ca_system_score_gemma":0.0017859235,"threshold_uncertainty_score":0.024317503},"labels":[],"label_agreement":null},{"id":"W4386237249","doi":"10.1007/978-3-031-35205-8_14","title":"Bioactive Natural Products from Medicinal Plants","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg","funders":"","keywords":"Natural product; Phytochemical; Drug discovery; Chemistry; Natural Product Research; Traditional medicine; Biology; Biochemistry; Biological activity; Medicine; Pharmacognosy; In vitro","score_opus":0.17425675327775234,"score_gpt":0.42276422176436446,"score_spread":0.24850746848661212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386237249","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003621246,0.20390083,0.011909723,0.00131036,0.0023634555,0.00008903533,0.00056339236,0.0002378441,0.77600414],"genre_scores_gemma":[0.01774404,0.13214827,0.008629523,0.0014465332,0.0013028451,0.00008323398,0.0006421628,0.0001618216,0.8378416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999567,0.0000044090493,0.0000016795284,0.0000079316205,0.000025487572,0.0000038053502],"domain_scores_gemma":[0.99997854,0.000010821623,0.0000019747563,0.0000025670338,0.0000036689728,0.000002355526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000957801,0.00068503193,0.0003508158,0.0009943628,0.00031307008,0.0010393314,0.00034740492,0.00045259707,0.026559116],"category_scores_gemma":[0.00010879551,0.00021224446,0.00025394422,0.00090549875,0.00042968354,0.0011248774,0.0006577834,0.0012166579,0.014595775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007028533,0.00011985562,0.000059832753,0.0019762546,0.000012445119,0.00045636395,0.00027258508,0.0009120557,0.04700288,0.09517416,0.09933405,0.75460917],"study_design_scores_gemma":[0.000005131549,0.000041118474,0.0001562423,0.00021052548,0.0000057046664,0.00039280846,0.000026484586,0.00010175271,0.0049811644,0.016149234,0.97792417,0.0000057207058],"about_ca_topic_score_codex":0.00029811956,"about_ca_topic_score_gemma":0.0010157456,"teacher_disagreement_score":0.026559116,"about_ca_system_score_codex":0.00027911883,"about_ca_system_score_gemma":0.0002191464,"threshold_uncertainty_score":0.08884907},"labels":[],"label_agreement":null},{"id":"W4386374956","doi":"10.1016/j.bioorg.2023.106820","title":"4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamide salts: Novel hydrosoluble prodrugs of antimitotics selectively bioactivated by the cytochrome P450 1A1 in breast cancer cells","year":2023,"lang":"en","type":"article","venue":"Bioorganic Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Hôpital Saint-François d'Assise","funders":"","keywords":"Chemistry; Prodrug; HaCaT; Cancer cell; Stereochemistry; Cytochrome P450; Alkyl; Lipophilicity; Mechanism of action; Biochemistry; Cancer; In vitro; Enzyme; Organic chemistry","score_opus":0.053035989475981496,"score_gpt":0.3659227316207345,"score_spread":0.31288674214475304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386374956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769668,0.004858759,0.00874802,0.00015941204,0.00008436658,0.00009516169,0.00027007036,0.00032758396,0.00848979],"genre_scores_gemma":[0.98817784,0.0022512837,0.003109525,0.000057986577,0.00001721245,0.000047291127,0.00019356105,0.000023307108,0.0061219614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999467,0.000011209517,0.000004324647,0.000008374972,0.0000127415615,0.000016650365],"domain_scores_gemma":[0.9999664,0.0000048736388,0.000010596893,0.000002833328,0.0000055564083,0.000009689005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010920597,0.00027233944,0.00024920164,0.00010717824,0.00007955784,0.00011900099,0.00021220339,0.0001746349,0.0011316808],"category_scores_gemma":[0.000070536276,0.00010924867,0.00009123446,0.00009955282,0.000113721966,0.00013319666,0.00017450622,0.00024326834,0.00047534067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013892584,0.000020551193,0.00005981135,0.0000735876,0.0000030401081,0.00007481426,0.000027706501,0.00015821331,0.99480236,0.0002583864,0.00011269983,0.004269998],"study_design_scores_gemma":[0.000059441434,0.00068420876,0.0010934203,0.000007207145,0.00001107284,0.00020957293,0.000017948088,0.00055853074,0.99195236,0.00003201699,0.005368581,0.00000547966],"about_ca_topic_score_codex":0.0006215465,"about_ca_topic_score_gemma":0.0014496378,"teacher_disagreement_score":0.0011316808,"about_ca_system_score_codex":0.00020510073,"about_ca_system_score_gemma":0.00021001641,"threshold_uncertainty_score":0.0037858486},"labels":[],"label_agreement":null},{"id":"W4386378387","doi":"10.1136/military-2023-002447","title":"Evaluating the prospective utility of pharmacogenetics reporting among Canadian Armed Forces personnel receiving pharmacotherapy: a preliminary assessment towards precision psychiatric care","year":2023,"lang":"en","type":"review","venue":"BMJ Military Health","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Glycemic Index Laboratories; Defence Research and Development Canada; Public Health Ontario; University of Toronto; St Joseph's Health Care","funders":"","keywords":"Pharmacogenetics; Pharmacotherapy; Medicine; Psychiatry; Population; Genotype; Genetics; Environmental health","score_opus":0.3796208073157095,"score_gpt":0.6049190133848275,"score_spread":0.22529820606911793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386378387","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637635,0.0015095689,0.003188454,0.0020830103,0.000069832044,0.0027315114,0.0054071597,0.00006144177,0.008572566],"genre_scores_gemma":[0.989023,0.00065407204,0.006951362,0.00046445613,0.000039885774,0.00087875326,0.0012572035,0.000013508847,0.0007178115],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9712601,0.010432701,0.0030405426,0.0017530838,0.011094644,0.0024189278],"domain_scores_gemma":[0.92229795,0.017506601,0.018535838,0.0050614197,0.03371077,0.0028873817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038459543,0.00076521974,0.0005609655,0.0023788828,0.004201671,0.002844524,0.0027220685,0.0008381527,0.0022914035],"category_scores_gemma":[0.09527044,0.0005470502,0.001180169,0.0045650257,0.0017873062,0.0011081869,0.0019727487,0.0010431255,0.00025909723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028052312,0.00012968283,0.97861004,0.00020970315,0.00013586173,0.000043176,0.0027439601,0.00019810887,0.00017217844,0.000290387,0.0008286497,0.016357778],"study_design_scores_gemma":[0.000040734703,0.00039146643,0.9927053,0.00018301648,0.0001277755,0.000070267364,0.002361142,0.0010830868,0.00044802218,0.00008191079,0.0024666272,0.00004063375],"about_ca_topic_score_codex":0.92048186,"about_ca_topic_score_gemma":0.941548,"teacher_disagreement_score":0.9815679,"about_ca_system_score_codex":0.018432105,"about_ca_system_score_gemma":0.050547503,"threshold_uncertainty_score":0.2033959},"labels":[],"label_agreement":null},{"id":"W4386462042","doi":"10.1002/cpt.3044","title":"PharmVar Tutorial on <i>CYP2D6</i> Structural Variation Testing and Recommendations on Reporting","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Calgary","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; National Institutes of Health","keywords":"Variation (astronomy); CYP2D6; Medical physics; Medicine; Internal medicine; Physics","score_opus":0.6853737617081412,"score_gpt":0.635492340409372,"score_spread":0.04988142129876927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386462042","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060252484,0.7616306,0.015051656,0.047434915,0.020527188,0.00092647196,0.009691456,0.0027054483,0.1414297],"genre_scores_gemma":[0.0019403108,0.8018709,0.01602814,0.03655855,0.012053346,0.00097247906,0.009861016,0.0005475346,0.12016775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985771,0.00037220496,0.00022262328,0.000103804276,0.0006348985,0.000089283116],"domain_scores_gemma":[0.9951597,0.0022050845,0.0006537145,0.00012593283,0.001567752,0.0002879315],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032730913,0.000926046,0.0015238263,0.0034445517,0.00037266576,0.0021892784,0.001993699,0.0018595805,0.08446253],"category_scores_gemma":[0.008787943,0.00046342207,0.0014776861,0.0037209077,0.00042005331,0.0032654945,0.0015204201,0.003169876,0.06732206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039688002,0.000034772762,0.00005476767,0.0043606455,0.000019594387,0.00008558012,0.000037495483,0.00013790508,0.00059146597,0.0027010345,0.7088762,0.28306088],"study_design_scores_gemma":[0.0000074545796,0.000016670856,0.00011316436,0.0013625536,0.000009609581,0.00017337932,0.0000088038705,0.00002221256,0.00012111575,0.0005953584,0.99756324,0.0000064019046],"about_ca_topic_score_codex":0.0018891654,"about_ca_topic_score_gemma":0.0025902758,"teacher_disagreement_score":0.99672693,"about_ca_system_score_codex":0.0011765565,"about_ca_system_score_gemma":0.00227912,"threshold_uncertainty_score":0.28255528},"labels":[],"label_agreement":null},{"id":"W4386529157","doi":"10.1080/03602532.2023.2254525","title":"Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models","year":2023,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Arsenic; Cytochrome P450; Xenobiotic; Enzyme; Biochemistry; Biology; Chemistry","score_opus":0.2563365913839806,"score_gpt":0.5178157993822631,"score_spread":0.26147920799828245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386529157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031825195,0.98935914,0.0012682074,0.00040034892,0.00023784196,0.000035275265,0.00038551513,0.00005179993,0.0050792964],"genre_scores_gemma":[0.010956099,0.98375875,0.0012964447,0.00033259942,0.00013698965,0.000057645953,0.0005477292,0.000011151373,0.0029025378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997534,0.00006795809,0.000033772783,0.00004843037,0.00007766508,0.000018734212],"domain_scores_gemma":[0.9997855,0.00009840569,0.000033545926,0.000012041571,0.000058737023,0.000011825931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043281796,0.00048338505,0.0007864097,0.0011060444,0.00012502799,0.00057522545,0.00046051742,0.0005079117,0.003203823],"category_scores_gemma":[0.00052559684,0.00014419357,0.00053441845,0.0011138561,0.000191768,0.00044041942,0.00025685015,0.00068100105,0.0014383045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048065733,0.00024142892,0.0010962451,0.03984548,0.00049608253,0.0006617717,0.00012739503,0.000608292,0.050199468,0.0038195122,0.026897863,0.8755259],"study_design_scores_gemma":[0.00007144183,0.00076747854,0.004484391,0.003067528,0.00075944664,0.0031818186,0.00008296071,0.00020650408,0.022998013,0.0019861395,0.962343,0.00005136069],"about_ca_topic_score_codex":0.00051029003,"about_ca_topic_score_gemma":0.0012196132,"teacher_disagreement_score":0.003203823,"about_ca_system_score_codex":0.00028152255,"about_ca_system_score_gemma":0.00039386065,"threshold_uncertainty_score":0.010717809},"labels":[],"label_agreement":null},{"id":"W4386592972","doi":"10.1097/fpc.0000000000000507","title":"Annual Scientific Meeting of the Pharmacogenomics Global Research Network (PGRN) June 12-13, 2023 Memphis, TN, USA","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memphis; Pharmacogenomics; Pharmacogenetics; Biology; Genetics; Genotype","score_opus":0.17590150158555848,"score_gpt":0.4591286800394171,"score_spread":0.2832271784538586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386592972","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055848854,0.020610135,0.004945641,0.20142606,0.17947204,0.0015980513,0.01765059,0.0010389668,0.5676737],"genre_scores_gemma":[0.007082114,0.0060687293,0.0027371547,0.01598905,0.012615731,0.0005398358,0.006733496,0.0003558897,0.94787794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846727,0.00033110238,0.000048439982,0.0003062579,0.0005548174,0.00029211157],"domain_scores_gemma":[0.9979735,0.00013380403,0.000091593676,0.00004983415,0.0007607361,0.0009906316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038452516,0.0015039329,0.00050996593,0.0006232953,0.0017271454,0.0032847326,0.0011669947,0.0029993327,0.28448784],"category_scores_gemma":[0.0028095385,0.00035464676,0.0005385864,0.00042307153,0.00060738524,0.0014291833,0.0022724452,0.003908362,0.09735235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011591101,0.000032852415,0.0002216165,0.00007262351,0.000005930686,0.00006981664,0.000025518935,0.000051489184,0.00046372454,0.0007093432,0.97958815,0.018643033],"study_design_scores_gemma":[0.000023879871,0.00004157513,0.0012959931,0.00010605976,0.0000032809296,0.00004025083,0.000078689314,0.00008928657,0.00013856382,0.00040101557,0.99777526,0.0000061161304],"about_ca_topic_score_codex":0.0063339523,"about_ca_topic_score_gemma":0.020497529,"teacher_disagreement_score":0.28448784,"about_ca_system_score_codex":0.0027664234,"about_ca_system_score_gemma":0.006626504,"threshold_uncertainty_score":0.95170665},"labels":[],"label_agreement":null},{"id":"W4386898192","doi":"10.1016/j.tem.2023.08.016","title":"Disentangling the nonmetabolic roles of metabolites: lactate as a case study","year":2023,"lang":"en","type":"article","venue":"Trends in Endocrinology and Metabolism","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Computational biology; Covalent bond; Biochemistry; Chemistry; Pharmacology; Biology","score_opus":0.11360307909307416,"score_gpt":0.4553452717993028,"score_spread":0.34174219270622863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386898192","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651805,0.010255121,0.011261371,0.008119117,0.00024750445,0.00019598342,0.00031094943,0.00006451209,0.013027246],"genre_scores_gemma":[0.9887044,0.003935101,0.0042925137,0.00087415206,0.00026914908,0.000022271732,0.00009833376,0.000039388517,0.0017646044],"study_design_codex":"case_report","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9992354,0.00019636264,0.000094337025,0.00012725803,0.00014293904,0.00020365995],"domain_scores_gemma":[0.9970361,0.0015496411,0.00043106405,0.00019477351,0.00029424566,0.0004941213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012850845,0.00087770115,0.0006740845,0.0025690175,0.0017276478,0.002332337,0.0010153353,0.0022208465,0.002392706],"category_scores_gemma":[0.005458819,0.00041057507,0.00082563626,0.0016827255,0.0020243735,0.0020585966,0.002320039,0.0022632645,0.00047076066],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006044427,0.00032353535,0.099100016,0.000202776,0.000059513728,0.8612518,0.0028202427,0.00034698777,0.0026155554,0.0042896783,0.0010245125,0.027360931],"study_design_scores_gemma":[0.00004198073,0.0003036142,0.019346487,0.00030945486,0.000115530995,0.95389163,0.006825833,0.0019276582,0.0034102618,0.0053697857,0.008392156,0.00006568485],"about_ca_topic_score_codex":0.0047105695,"about_ca_topic_score_gemma":0.0058397115,"teacher_disagreement_score":0.0047105695,"about_ca_system_score_codex":0.0010846746,"about_ca_system_score_gemma":0.0015129204,"threshold_uncertainty_score":0.009366274},"labels":[],"label_agreement":null},{"id":"W4386910959","doi":"10.1002/prp2.1137","title":"Impact of amiodarone use on metoprolol concentrations, <scp>α‐OH</scp>‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation Institut de Cardiologie de Montréal","keywords":"Metoprolol; Amiodarone; Medicine; Antiarrhythmic agent; Bisoprolol; Pharmacokinetics; CYP2D6; Heart rate; Regimen; Pharmacology; Internal medicine; Anesthesia; Atrial fibrillation; Cardiology; Heart failure; Heart disease; Blood pressure; Cytochrome P450","score_opus":0.25031480168469356,"score_gpt":0.5557490032381033,"score_spread":0.3054342015534097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386910959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846625,0.00047432992,0.0000851159,0.000040268642,0.000008886822,0.00001894863,0.0004953943,0.000005354257,0.0004053769],"genre_scores_gemma":[0.99914825,0.000111930225,0.00009443573,0.000039887193,0.000015552685,0.000014165475,0.0003721237,0.0000026523246,0.0002009101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991466,0.00034959047,0.000061411905,0.00018616732,0.00014999034,0.00010620481],"domain_scores_gemma":[0.996915,0.000757756,0.0008667266,0.0003153755,0.00045159666,0.00069352216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013364218,0.00031084512,0.00041401092,0.00048218624,0.00040175958,0.00087726803,0.00044096907,0.0006507765,0.0014153004],"category_scores_gemma":[0.0032590772,0.0004623913,0.0006969064,0.0006819087,0.00025529982,0.00047209553,0.0003494809,0.00062987086,0.0002542291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029848734,0.00006193687,0.9986669,0.000006515964,0.00018086983,0.00002396105,0.0000332013,0.000013925109,0.00016467208,0.0000059726417,0.00004447527,0.00049900013],"study_design_scores_gemma":[0.000009642472,0.00016761362,0.99954104,0.0000019319768,0.000053465148,0.00004053195,0.000021959782,0.000069863294,0.000027875723,0.0000024386195,0.000061723505,0.0000019809756],"about_ca_topic_score_codex":0.018980974,"about_ca_topic_score_gemma":0.017685654,"teacher_disagreement_score":0.018980974,"about_ca_system_score_codex":0.0005213055,"about_ca_system_score_gemma":0.0005266756,"threshold_uncertainty_score":0.037741005},"labels":[],"label_agreement":null},{"id":"W4387020481","doi":"10.20944/preprints202309.1566.v1","title":"CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; CYP2C19; Genetic testing; CYP2D6; Selection (genetic algorithm); Dosing; Allele; Pharmacogenetics; Standardization; Medicine; Genetics; Biology; Computer science; Genotype; Pharmacology; Gene; Machine learning","score_opus":0.4911112998570809,"score_gpt":0.48410311898694713,"score_spread":0.007008180870133773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387020481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934366,0.0008651307,0.0005850711,0.00044129934,0.00000874071,0.000025941348,0.0014323893,0.000013851942,0.0031909957],"genre_scores_gemma":[0.99747986,0.0002626315,0.0008272027,0.00015037497,0.000004043404,0.000011387158,0.0005885745,0.000012018638,0.0006640036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774593,0.000660064,0.00023665643,0.00053763064,0.00057619595,0.00024352712],"domain_scores_gemma":[0.9967338,0.0008550206,0.00091665605,0.00021300852,0.00087974186,0.00040180126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019570692,0.000120348595,0.00020458376,0.00074861024,0.0004342822,0.00078408624,0.00032909465,0.00022936823,0.0016993767],"category_scores_gemma":[0.009549075,0.0002522952,0.000210981,0.001086235,0.00036562711,0.0003776417,0.0010706104,0.00040086245,0.00021134099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016628248,0.0000317726,0.93671304,0.00016233625,0.00008605455,0.0005902579,0.00453384,0.00041163672,0.0038981198,0.0005258937,0.0027977752,0.05008303],"study_design_scores_gemma":[0.0000047526855,0.00005335586,0.99257857,0.00008904596,0.000034358443,0.0008846561,0.00092853175,0.0006793776,0.00042269612,0.00016132493,0.0041506654,0.000012703379],"about_ca_topic_score_codex":0.16000073,"about_ca_topic_score_gemma":0.21444805,"teacher_disagreement_score":0.16000073,"about_ca_system_score_codex":0.001441137,"about_ca_system_score_gemma":0.0019366866,"threshold_uncertainty_score":0.31813884},"labels":[],"label_agreement":null},{"id":"W4387099129","doi":"10.22541/au.169581272.28215116/v1","title":"In vitro drug-drug interactions in rat liver between oxycodone and commonly co-consumed drugs","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Canada Research Chairs; University of Toronto; University of New Brunswick","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Oxymorphone; Pharmacology; Chemistry; Diazepam; Oxycodone; Triazolam; Drug; Drug interaction; Dextromethorphan; Opioid; Benzodiazepine; Medicine; Biochemistry; Receptor","score_opus":0.16136379018777028,"score_gpt":0.4597759441883765,"score_spread":0.29841215400060617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387099129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805202,0.0071882964,0.008915893,0.00011333702,0.00008025455,0.00012597271,0.0010085639,0.00019105032,0.001856346],"genre_scores_gemma":[0.98585004,0.0025095681,0.0063686953,0.00007183347,0.0000464341,0.00012464663,0.0019366177,0.00004725578,0.0030449352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962544,0.00011963925,0.000031292588,0.00008678436,0.00007378109,0.00006296026],"domain_scores_gemma":[0.99966335,0.00009113346,0.0000894209,0.000052282754,0.00007615349,0.000027694965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045243595,0.0006652986,0.0004319845,0.00023943082,0.00032949148,0.0003776959,0.00027624745,0.00036776657,0.00212394],"category_scores_gemma":[0.00042062855,0.00030893864,0.00061653246,0.00033080683,0.0002817164,0.0003611379,0.00023481435,0.00057991955,0.0009849764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024019182,0.0003309317,0.004663778,0.00040488102,0.00015493116,0.00027446458,0.00009868247,0.000804352,0.98231035,0.00016340756,0.00024329803,0.008148987],"study_design_scores_gemma":[0.00006200599,0.0039177686,0.011346817,0.000019500687,0.00024451353,0.00059400365,0.00007062348,0.0026524032,0.9783412,0.00007645911,0.0026583176,0.00001626133],"about_ca_topic_score_codex":0.0027155327,"about_ca_topic_score_gemma":0.0032756266,"teacher_disagreement_score":0.0027155327,"about_ca_system_score_codex":0.0005242839,"about_ca_system_score_gemma":0.000619193,"threshold_uncertainty_score":0.0071053505},"labels":[],"label_agreement":null},{"id":"W4387128352","doi":"10.21203/rs.3.rs-3359484/v1","title":"Pharmacogenomic Insights in Psychiatric Care: Uncovering Novel Actionability, Allele-Specific CYP2D6 Copy Number Variation, and Phenoconversion in 15,000 Patients","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; CYP2D6; CYP2C19; Medicine; Pharmacogenetics; Allele; Haplotype; Psychiatry; Bioinformatics; Genetics; Pharmacology; Biology; Internal medicine; Genotype; Gene","score_opus":0.16290618877574106,"score_gpt":0.47780534826788684,"score_spread":0.31489915949214575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387128352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980444,0.00034044942,0.00024647333,0.00012824383,0.000005009193,0.000010046846,0.00094461476,0.000009837969,0.00027096632],"genre_scores_gemma":[0.9989962,0.00014425162,0.00024420462,0.00007393815,0.000011076543,0.000008636356,0.00045056178,0.0000034891302,0.00006759468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992042,0.000189997,0.00013319537,0.00026722826,0.00013141218,0.00007403301],"domain_scores_gemma":[0.99803513,0.0004980481,0.0009382867,0.00017604145,0.00015352706,0.00019901081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075748167,0.00022196575,0.00032431926,0.0008247701,0.00045135926,0.0007368606,0.00030696247,0.00047530077,0.0013561758],"category_scores_gemma":[0.0036814916,0.0003103678,0.000417748,0.0012259299,0.00029690444,0.00043795042,0.0005929495,0.00061795174,0.00024553447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051656192,0.00001091624,0.99765646,0.000007574392,0.00003548264,0.00007704211,0.000052536503,0.000039868686,0.00024351037,0.000019240093,0.00013284353,0.0016728842],"study_design_scores_gemma":[0.000008061404,0.000051369323,0.9983223,0.000005968566,0.00003160393,0.0006695285,0.00008891081,0.00041143064,0.00013971742,0.000048460028,0.00021903357,0.0000036842525],"about_ca_topic_score_codex":0.0033088117,"about_ca_topic_score_gemma":0.0039200876,"teacher_disagreement_score":0.0033088117,"about_ca_system_score_codex":0.0003798393,"about_ca_system_score_gemma":0.00020896936,"threshold_uncertainty_score":0.006579101},"labels":[],"label_agreement":null},{"id":"W4387157765","doi":"10.1017/s0033291723002817","title":"The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review","year":2023,"lang":"en","type":"review","venue":"Psychological Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Tolerability; Pharmacogenomics; Psychiatry; Precision medicine; Personalized medicine; Medicine; Population; Major depressive disorder; Dosing; Psychology; Bioinformatics; Pharmacology; Adverse effect; Biology; Mood","score_opus":0.24564556537310583,"score_gpt":0.5923748923089253,"score_spread":0.3467293269358194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001176313,0.99774444,0.00019798453,0.0012278616,0.00017309359,0.0000066199514,0.000022319613,0.000005070603,0.00050490675],"genre_scores_gemma":[0.0010855283,0.9976814,0.00030508003,0.000613796,0.00018339248,0.000008694493,0.000018696277,0.0000016618229,0.000101758764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903476,0.00033440322,0.0001939137,0.00012243989,0.00026265986,0.000051939867],"domain_scores_gemma":[0.9933868,0.005162196,0.00067021215,0.00008453765,0.00059260236,0.00010362008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023462253,0.00066857616,0.0012564001,0.0025696394,0.00033252724,0.002288241,0.0008084826,0.0015235461,0.0022612798],"category_scores_gemma":[0.006433303,0.0002857516,0.0010495461,0.0032589673,0.0007439882,0.0021865957,0.00097412086,0.001847264,0.00054156984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110079614,0.00003898099,0.00070091116,0.1377292,0.00045368006,0.0005221462,0.00047095944,0.000501465,0.0006977592,0.017176332,0.031159574,0.8104389],"study_design_scores_gemma":[0.000017495418,0.00012539852,0.0018122538,0.10189167,0.001114594,0.0021247845,0.00042041315,0.00027945114,0.00031703428,0.0072541856,0.88460255,0.00004025572],"about_ca_topic_score_codex":0.0018216945,"about_ca_topic_score_gemma":0.0034453326,"teacher_disagreement_score":0.0025696394,"about_ca_system_score_codex":0.0012853605,"about_ca_system_score_gemma":0.004533908,"threshold_uncertainty_score":0.012408197},"labels":[],"label_agreement":null},{"id":"W4387429401","doi":"10.21203/rs.3.rs-3399061/v1","title":"A Call for Increased Inclusivity and Global Representation in Pharmacogenetic Testing","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children","keywords":"Representation (politics); Pharmacogenetics; Political science; Computer science; Law; Genetics; Biology; Genotype","score_opus":0.4768760798581836,"score_gpt":0.6027504125227185,"score_spread":0.12587433266453496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387429401","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012187261,0.003474252,0.9485175,0.016647395,0.0009738328,0.00012248252,0.0011789453,0.004256662,0.012641773],"genre_scores_gemma":[0.2637783,0.003368271,0.70627356,0.009698608,0.0029991553,0.00039971125,0.0026745407,0.002845149,0.007962758],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.94971806,0.0330865,0.00354021,0.0075240512,0.0053389394,0.00079230266],"domain_scores_gemma":[0.6729746,0.17236911,0.010995775,0.125133,0.0144896135,0.0040379064],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.057267915,0.0016813123,0.0032002481,0.003300364,0.00091551954,0.009881894,0.004461303,0.004074905,0.010025386],"category_scores_gemma":[0.20713316,0.001580851,0.0028719134,0.004077654,0.005242292,0.018679915,0.010516093,0.007746845,0.0034981354],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014860821,0.0002829246,0.02102443,0.0010724028,0.0010522621,0.00040274326,0.0019381751,0.02711425,0.0042976346,0.2716967,0.02374795,0.6458844],"study_design_scores_gemma":[0.00016835991,0.0002731649,0.005397952,0.000730111,0.00059237826,0.0012433405,0.00040067144,0.05088378,0.004693332,0.8170858,0.1183516,0.00017957063],"about_ca_topic_score_codex":0.0014067328,"about_ca_topic_score_gemma":0.0009841252,"teacher_disagreement_score":0.9427321,"about_ca_system_score_codex":0.0015004234,"about_ca_system_score_gemma":0.0024010877,"threshold_uncertainty_score":0.30286533},"labels":[],"label_agreement":null},{"id":"W4387476844","doi":"10.1016/j.euroneuro.2023.08.005","title":"ISSUES IN IMPLEMENTATION AND COST-BENEFIT OF PHARMACOGENETIC TESTING FOR DEPRESSION","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Reimbursement; Pharmacogenomics; Stakeholder; Commercialization; Genetic testing; Medicine; Health care; Business; Political science; Public relations; Pharmacology; Marketing","score_opus":0.1473397772594919,"score_gpt":0.4862785579953165,"score_spread":0.3389387807358246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387476844","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018046103,0.019459635,0.05241545,0.87904835,0.0034911544,0.00082390103,0.0012954775,0.0005096979,0.024910267],"genre_scores_gemma":[0.5701801,0.020697592,0.13412325,0.25162134,0.015291126,0.0018772888,0.0012707412,0.00036133564,0.004577223],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8977603,0.0728742,0.007332135,0.004563554,0.014190715,0.0032791242],"domain_scores_gemma":[0.55268997,0.3783594,0.014398939,0.010331644,0.034535363,0.00968474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12828869,0.0012926944,0.0023707424,0.0027842724,0.0010345052,0.008158537,0.007980849,0.013354653,0.0142043065],"category_scores_gemma":[0.31455407,0.0011553103,0.0031779094,0.0029271992,0.006014148,0.009239903,0.0045102807,0.013333965,0.0019540808],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019552754,0.0009447388,0.036435496,0.002652551,0.000880952,0.0011818693,0.0011664203,0.016644418,0.001408097,0.09332276,0.11282616,0.7305813],"study_design_scores_gemma":[0.0033143833,0.0063442374,0.14669546,0.027492128,0.003347807,0.006684042,0.0052211955,0.06934135,0.004142519,0.3447594,0.38176873,0.0008887369],"about_ca_topic_score_codex":0.029368317,"about_ca_topic_score_gemma":0.02555922,"teacher_disagreement_score":0.12828869,"about_ca_system_score_codex":0.0077272556,"about_ca_system_score_gemma":0.026451245,"threshold_uncertainty_score":0.6784635},"labels":[],"label_agreement":null},{"id":"W4387492877","doi":"10.1021/acsomega.3c05377","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5- <i>a</i> ]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"article","venue":"ACS Omega","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Common Fund; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Oncology; Genentech; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Enzyme; Covalent bond; Pharmacology; Combinatorial chemistry; Biochemistry; Stereochemistry; Organic chemistry; Medicine; Biology","score_opus":0.11611231560955293,"score_gpt":0.4087436076058137,"score_spread":0.29263129199626076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387492877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542404,0.0010655419,0.039484188,0.0001776957,0.000032323227,0.000368045,0.00046783153,0.0002978032,0.003866116],"genre_scores_gemma":[0.9499392,0.0013222292,0.042408004,0.000079255864,0.000011828694,0.00030402746,0.0006105963,0.00009206211,0.005232908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997949,0.00003973822,0.0000134942675,0.000059546997,0.00005671993,0.00003563287],"domain_scores_gemma":[0.9998698,0.000025775467,0.000048069618,0.000013418291,0.000022067983,0.000020903093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035913457,0.00040513385,0.00018702564,0.00016228131,0.00016551383,0.00025426838,0.00028604543,0.00029734607,0.0016078004],"category_scores_gemma":[0.00021194213,0.00021074215,0.00017389299,0.00014055756,0.00023831462,0.00021496747,0.00013952707,0.0003431557,0.0004490806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036945425,0.000008824841,0.000026076119,0.000014429208,0.0000011824656,0.000011219841,0.000005598459,0.00010619213,0.99905866,0.000046766956,0.000020148063,0.00066395785],"study_design_scores_gemma":[0.0000069410007,0.00014817857,0.00022838362,9.060039e-7,0.000002214579,0.000030823998,0.000003807764,0.00042771545,0.99837494,0.000007918999,0.00076588464,0.0000022694521],"about_ca_topic_score_codex":0.0007189692,"about_ca_topic_score_gemma":0.0023716094,"teacher_disagreement_score":0.0016078004,"about_ca_system_score_codex":0.00039610156,"about_ca_system_score_gemma":0.00028297218,"threshold_uncertainty_score":0.0053786635},"labels":[],"label_agreement":null},{"id":"W4387501476","doi":"10.1016/j.euroneuro.2023.08.002","title":"EDUCATION DAY: PHARMACOGENETICS TESTING","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Context (archaeology); Pharmacogenomics; Medicine; Psychiatry; Clinical trial; Clinical Practice; Genetic testing; Randomized controlled trial; Family medicine; Pharmacology","score_opus":0.1472888560881657,"score_gpt":0.4462916695570566,"score_spread":0.2990028134688909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387501476","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066118427,0.011031473,0.01094182,0.71556354,0.12234918,0.000587691,0.0012259547,0.0030008936,0.12868764],"genre_scores_gemma":[0.05284985,0.011933491,0.013390334,0.40971282,0.15424955,0.0005589009,0.0017953896,0.0010635417,0.35444617],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984515,0.00032690313,0.00013687329,0.0001806993,0.0005395575,0.0003644598],"domain_scores_gemma":[0.9893701,0.0019349764,0.00038484993,0.00079568004,0.0020544305,0.005459962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028308723,0.0009245697,0.0010215022,0.00097439,0.0015544803,0.0024114088,0.0012790905,0.0102837235,0.122738026],"category_scores_gemma":[0.010356353,0.0005163835,0.0013359574,0.00029751082,0.00076086784,0.0019842328,0.0032446077,0.009978571,0.0555287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105459476,0.00041111477,0.0012973321,0.000067462206,0.000007569757,0.0017759785,0.000029601262,0.00008150536,0.0004029396,0.00054359506,0.90659654,0.08868098],"study_design_scores_gemma":[0.0002653605,0.00048592276,0.012672004,0.00048792837,0.000020294396,0.0064122267,0.0002571945,0.00044863982,0.00084637804,0.013403719,0.9646396,0.000060810384],"about_ca_topic_score_codex":0.001633428,"about_ca_topic_score_gemma":0.00400613,"teacher_disagreement_score":0.122738026,"about_ca_system_score_codex":0.0013169403,"about_ca_system_score_gemma":0.004239928,"threshold_uncertainty_score":0.41059965},"labels":[],"label_agreement":null},{"id":"W4387502285","doi":"10.1016/j.euroneuro.2023.08.003","title":"PHARMACOGENETIC INFORMED PRESCRIBING FOR MAJOR DEPRESSIVE DISORDER","year":2023,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tolerability; Major depressive disorder; Medicine; Pharmacogenetics; Pharmacogenomics; Psychiatry; Intensive care medicine; Pharmacotherapy; Population; Precision medicine; Pharmacology; Cognition; Adverse effect","score_opus":0.09736212529367805,"score_gpt":0.4229185710199656,"score_spread":0.32555644572628756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387502285","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42682475,0.06340282,0.030163804,0.22805458,0.0039937785,0.00055941584,0.01232703,0.00064073753,0.23403306],"genre_scores_gemma":[0.9444897,0.012639191,0.013902189,0.020094866,0.0015586931,0.00012481371,0.0016442315,0.00004260328,0.0055035977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991591,0.0004951162,0.00012379688,0.000056488723,0.00012820672,0.00003741019],"domain_scores_gemma":[0.99701095,0.0019498075,0.00047276646,0.00019261443,0.00022847521,0.00014536722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084362045,0.00014940639,0.00028193888,0.00056306,0.00025424777,0.0006388111,0.00034260572,0.00090829923,0.0043878662],"category_scores_gemma":[0.0076043685,0.00013827531,0.0003171687,0.0004475035,0.00016335376,0.00024648604,0.00025856344,0.0010159662,0.0006856707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022731929,0.00094503927,0.17049752,0.0011699948,0.00077708607,0.0030835122,0.0006149799,0.00534871,0.0059175803,0.021085195,0.10470497,0.68358225],"study_design_scores_gemma":[0.0023392232,0.0010453396,0.44737205,0.008454655,0.002137581,0.012672816,0.0008258142,0.030534796,0.011076595,0.142872,0.34047684,0.00019229022],"about_ca_topic_score_codex":0.0024384882,"about_ca_topic_score_gemma":0.0046987957,"teacher_disagreement_score":0.0043878662,"about_ca_system_score_codex":0.0005548873,"about_ca_system_score_gemma":0.0012986028,"threshold_uncertainty_score":0.014678836},"labels":[],"label_agreement":null},{"id":"W4387608768","doi":"10.1124/dmd.123.001517","title":"Canadian Content in the Pages of Drug Metabolism and Disposition: A Comprehensive Historical Analysis","year":2023,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"University of Toronto; American Society for Pharmacology and Experimental Therapeutics","keywords":"Disposition; Excellence; Realm; Political science; Government (linguistics); Law; Psychology","score_opus":0.08036230862281062,"score_gpt":0.35549424069077196,"score_spread":0.2751319320679613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387608768","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022070135,0.6929452,0.0019853567,0.07606236,0.04163806,0.00007954904,0.0042819157,0.00020015094,0.18060048],"genre_scores_gemma":[0.023894079,0.82062453,0.003808726,0.019254653,0.01392866,0.000042314656,0.0015863352,0.00023369923,0.116627],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99731654,0.00024218071,0.00016377034,0.00020765983,0.0017367475,0.0003330776],"domain_scores_gemma":[0.99268204,0.0008763641,0.00029669714,0.0001647882,0.005479042,0.000501141],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.002510772,0.0009997993,0.00091985683,0.013740963,0.004110421,0.0056826784,0.0012025412,0.001768541,0.02015644],"category_scores_gemma":[0.009133078,0.0004189007,0.00056196057,0.0304116,0.0042467196,0.0022376538,0.0012859072,0.0031046353,0.0039793113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007685897,0.000030298068,0.0011971252,0.0010996748,0.000021950014,0.00019890103,0.0006279873,0.00034260924,0.00025942476,0.048818115,0.7904634,0.15686369],"study_design_scores_gemma":[0.0000026361047,0.000004911529,0.0016060366,0.0004140891,0.000011485035,0.00008491927,0.00014214929,0.000031062256,0.00007412274,0.0009791241,0.99663675,0.000012691467],"about_ca_topic_score_codex":0.8566997,"about_ca_topic_score_gemma":0.89778244,"teacher_disagreement_score":0.9974892,"about_ca_system_score_codex":0.03904086,"about_ca_system_score_gemma":0.073168986,"threshold_uncertainty_score":0.2882884},"labels":[],"label_agreement":null},{"id":"W4387668743","doi":"10.3390/genes14101945","title":"CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia","year":2023,"lang":"en","type":"article","venue":"Genes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenomics; CYP2D6; Antidepressant; Biology; Medicine; Genetics; Biotechnology; Genotype; Psychiatry; Gene","score_opus":0.2312887317903889,"score_gpt":0.4308645587577955,"score_spread":0.1995758269674066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387668743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572146,0.00064795045,0.00051470747,0.00033653958,0.0000058074447,0.00002811632,0.0005471729,0.000009218269,0.0021888774],"genre_scores_gemma":[0.9986027,0.00015655944,0.0006543205,0.00012259181,0.0000025797399,0.000009135833,0.00018279528,0.0000053226067,0.0002640801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971245,0.00091311627,0.00035189657,0.00056912727,0.00076824665,0.0002731231],"domain_scores_gemma":[0.9957287,0.0011219971,0.0012855115,0.00024295803,0.0011312183,0.00048959174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022003078,0.00011884915,0.00021469337,0.00079588575,0.00048025785,0.000748571,0.00039597778,0.00022695008,0.0011603406],"category_scores_gemma":[0.008953126,0.00026047337,0.00020951979,0.0010737983,0.0004009364,0.00037159474,0.0009481916,0.00041806832,0.00012615888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115598385,0.000029423816,0.9574392,0.00009981297,0.00007070682,0.0004749087,0.0028754731,0.00028608067,0.0033623409,0.00027789833,0.00093480165,0.034033976],"study_design_scores_gemma":[0.000004154851,0.000070672184,0.99501944,0.000060298844,0.000031049396,0.0008993438,0.0007356107,0.00067517784,0.00034098624,0.000100970385,0.002051643,0.000010510575],"about_ca_topic_score_codex":0.14414886,"about_ca_topic_score_gemma":0.21925934,"teacher_disagreement_score":0.14414886,"about_ca_system_score_codex":0.001582223,"about_ca_system_score_gemma":0.0017935308,"threshold_uncertainty_score":0.2866196},"labels":[],"label_agreement":null},{"id":"W4387910477","doi":"10.1016/j.ejpb.2023.10.016","title":"Pharmacokinetics of cycloheximide in rats and evaluation of its effect as a blocker of intestinal lymph formation","year":2023,"lang":"en","type":"article","venue":"European Journal of Pharmaceutics and Biopharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Lymph; Chemistry; Cmax; Oral administration; Medicine; Pathology","score_opus":0.13794898727040145,"score_gpt":0.4454693812962794,"score_spread":0.30752039402587794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387910477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949411,0.0014634088,0.0017001227,0.000120815595,0.000041328585,0.000070307055,0.0005879051,0.00011382841,0.00096117373],"genre_scores_gemma":[0.99096465,0.001976525,0.002092073,0.00007921858,0.000037615566,0.00012618762,0.0007368515,0.000040748724,0.0039462456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998503,0.00002812675,0.000007925318,0.000037589758,0.00003060771,0.00004548825],"domain_scores_gemma":[0.999676,0.000057668618,0.000092722265,0.00004699554,0.000042555926,0.000084066894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024539357,0.00056473474,0.0003788009,0.0004790659,0.00020020484,0.0002864376,0.00022205486,0.00037900102,0.0011852849],"category_scores_gemma":[0.00033167965,0.00025271217,0.0003292955,0.00030194654,0.00039414215,0.00039967042,0.00011061266,0.0009845879,0.000313839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008940767,0.0009837005,0.002726313,0.00008499115,0.000040576233,0.00010691841,0.00009473422,0.0004438076,0.97558063,0.00015322295,0.0002413871,0.010602857],"study_design_scores_gemma":[0.00025349716,0.02294417,0.019375032,0.000013650579,0.00011088907,0.00022471073,0.00009708271,0.0022704657,0.95147985,0.00010829575,0.0030932755,0.000028989005],"about_ca_topic_score_codex":0.0020220832,"about_ca_topic_score_gemma":0.0025903462,"teacher_disagreement_score":0.0020220832,"about_ca_system_score_codex":0.0005523949,"about_ca_system_score_gemma":0.00059621286,"threshold_uncertainty_score":0.0040206313},"labels":[],"label_agreement":null},{"id":"W4388669934","doi":"10.1503/cmaj.221785","title":"Cost-effectiveness of pharmacogenomic-guided treatment for major depression","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Positive Living North; Fraser Health; University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Pharmacogenomics; Major depressive disorder; Quality-adjusted life year; Quality of life (healthcare); Medical prescription; Population; Health care; Cost effectiveness; Cohort; Economic evaluation; Psychiatry; Intensive care medicine; Internal medicine; Pharmacology; Environmental health; Mood","score_opus":0.15563632723205795,"score_gpt":0.46473867866936075,"score_spread":0.3091023514373028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388669934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87717426,0.013966756,0.06499341,0.014848186,0.00020311541,0.0012769699,0.009498834,0.00044221498,0.017596154],"genre_scores_gemma":[0.99362093,0.0011315744,0.003346804,0.0003918552,0.000015376127,0.00012590404,0.00069019047,0.00000922825,0.00066816685],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9979241,0.0014806062,0.000073345764,0.00014685746,0.00017017011,0.0002048949],"domain_scores_gemma":[0.9960205,0.0028594485,0.00056275923,0.000108340544,0.00023246453,0.00021641354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003331084,0.00075051206,0.0009272113,0.0008171947,0.00028280038,0.0013644249,0.0009966418,0.0009951115,0.002859676],"category_scores_gemma":[0.015130813,0.00047989632,0.001499243,0.0009962593,0.0005333707,0.0007888313,0.00078996306,0.00097639085,0.00014744907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014707211,0.00018053708,0.027148653,0.000517395,0.0017202516,0.0001462172,0.000046231664,0.9280909,0.0002691673,0.0067232465,0.0021383066,0.03154833],"study_design_scores_gemma":[0.0011037806,0.0011768186,0.029980127,0.0006011261,0.0030167138,0.00038469868,0.00015503584,0.94317377,0.0006726459,0.015369035,0.004290969,0.00007523652],"about_ca_topic_score_codex":0.10888455,"about_ca_topic_score_gemma":0.063982606,"teacher_disagreement_score":0.10888455,"about_ca_system_score_codex":0.01040311,"about_ca_system_score_gemma":0.007354618,"threshold_uncertainty_score":0.21650153},"labels":[],"label_agreement":null},{"id":"W4388831231","doi":"10.3390/pharmacy11060180","title":"The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics","year":2023,"lang":"en","type":"editorial","venue":"Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Pharmacogenomics; Medicine; Pharmacology","score_opus":0.1557937624307845,"score_gpt":0.5578813258797378,"score_spread":0.40208756344895336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388831231","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032320033,0.013875859,0.00028292526,0.16628759,0.8171259,0.000024936999,0.000041708598,0.000075096745,0.0022537222],"genre_scores_gemma":[0.0005593865,0.009741473,0.0002944276,0.10384847,0.87939143,0.00003172158,0.000023242246,0.000039660637,0.0060702483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98410136,0.004971931,0.0016756362,0.0012068786,0.0073521915,0.0006920944],"domain_scores_gemma":[0.8992885,0.068554915,0.0025655027,0.0015232417,0.02077108,0.0072967503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026619358,0.0028831805,0.0030038701,0.0022370652,0.00409389,0.010461931,0.0052629514,0.031043753,0.008354107],"category_scores_gemma":[0.078691386,0.0013384178,0.003326163,0.0014603643,0.0053992276,0.009022624,0.0024769232,0.049359504,0.007431801],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002273787,0.000008381597,0.000019153616,0.0001762895,0.000017271472,0.00007982287,0.000020307105,0.000035342837,0.000024606798,0.0009206783,0.9923505,0.006324903],"study_design_scores_gemma":[0.00010522737,0.000040313877,0.00026185412,0.00083216425,0.00005311884,0.00025503003,0.000071326474,0.00029310948,0.00009138843,0.005202384,0.9927533,0.000040712635],"about_ca_topic_score_codex":0.004262594,"about_ca_topic_score_gemma":0.011580938,"teacher_disagreement_score":0.031043753,"about_ca_system_score_codex":0.0050733653,"about_ca_system_score_gemma":0.010296369,"threshold_uncertainty_score":0.1407783},"labels":[],"label_agreement":null},{"id":"W4389322814","doi":"10.1002/cpt.3124","title":"Characterization of <i>CYP2B6</i> and <i>CYP2A6</i> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institutes of Health; Medical Research Council; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Haplotype; CYP2A6; Genetics; Biology; Allele frequency; Genotype; Evolutionary biology; Gene; Single-nucleotide polymorphism","score_opus":0.21288528920082814,"score_gpt":0.4750250815627104,"score_spread":0.26213979236188223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389322814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930155,0.0006422539,0.00114664,0.00008772075,0.0000062403533,0.000015811322,0.004318275,0.000016897391,0.0007506719],"genre_scores_gemma":[0.9914452,0.0006418761,0.0019404944,0.00007938968,0.000017283763,0.000030806055,0.0054986468,0.000024703648,0.00032161624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997211,0.00007709795,0.000029360559,0.00009405734,0.00004301432,0.000035356203],"domain_scores_gemma":[0.9995782,0.00009644379,0.00018983045,0.000054068452,0.000044094424,0.000037356276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037582516,0.00020097102,0.00029309635,0.00082902814,0.00032388422,0.0004607133,0.00016821478,0.00023989285,0.0023843742],"category_scores_gemma":[0.0011780305,0.00010355675,0.00042513802,0.0019506643,0.00019846784,0.00019971121,0.0003538899,0.00028543247,0.00031282988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007817246,0.000040924377,0.92345977,0.00021474538,0.00047251786,0.000622065,0.0011817588,0.0007646318,0.029110856,0.00070681685,0.0018254794,0.04081873],"study_design_scores_gemma":[0.000024937926,0.00006629983,0.98979133,0.00004602601,0.00010619547,0.0009936685,0.0003558502,0.00068118976,0.001646481,0.0003586019,0.0059201317,0.00000928308],"about_ca_topic_score_codex":0.0023385421,"about_ca_topic_score_gemma":0.0027914203,"teacher_disagreement_score":0.0023843742,"about_ca_system_score_codex":0.00012962897,"about_ca_system_score_gemma":0.00013206061,"threshold_uncertainty_score":0.007976472},"labels":[],"label_agreement":null},{"id":"W4390176255","doi":"10.3390/jpm14010022","title":"User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients","year":2023,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Medicine; Psychiatry; Psychology; Pharmacology","score_opus":0.11460016882536611,"score_gpt":0.44199853347815776,"score_spread":0.32739836465279165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390176255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580586,0.00042093432,0.00045638354,0.001579612,0.00003845787,0.00003744503,0.00007539293,0.000011126292,0.0015746966],"genre_scores_gemma":[0.99753547,0.0004286894,0.00035231482,0.0008560034,0.00002257514,0.000048680286,0.000029196071,0.000009815543,0.00071726914],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9908573,0.0066336077,0.00031429098,0.00029384735,0.000856303,0.0010446406],"domain_scores_gemma":[0.97895,0.015101547,0.0015249229,0.0002928321,0.0015336091,0.0025971099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008469155,0.0004571039,0.0006596819,0.0009144826,0.003368906,0.0032393408,0.00088301563,0.0018092868,0.0029576526],"category_scores_gemma":[0.021928743,0.0005353596,0.00058715197,0.00068039674,0.003562421,0.0025321685,0.004184443,0.0020872927,0.0003658897],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014620191,0.00006127536,0.017385561,0.00017915954,0.000015674956,0.0008781218,0.97292626,0.00005130697,0.00085283176,0.0002705956,0.0005765248,0.0066564516],"study_design_scores_gemma":[0.000011532134,0.00023278639,0.0056821597,0.00011779794,0.000013174834,0.00073493796,0.9887736,0.0001472275,0.00021638854,0.000106369225,0.003926443,0.0000375839],"about_ca_topic_score_codex":0.005455612,"about_ca_topic_score_gemma":0.0062206704,"teacher_disagreement_score":0.008469155,"about_ca_system_score_codex":0.0020341645,"about_ca_system_score_gemma":0.0015992366,"threshold_uncertainty_score":0.044789672},"labels":[],"label_agreement":null},{"id":"W4390426604","doi":"10.59931/rcp.23.0003","title":"Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB","year":2023,"lang":"en","type":"article","venue":"Research in Clinical Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Food and Drug Safety","keywords":"Pharmacogenetics; Allele; Allele frequency; Genetics; Computer science; Medicine; Information retrieval; Biology; Genotype; Gene","score_opus":0.461898859138493,"score_gpt":0.6147177162906688,"score_spread":0.15281885715217586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390426604","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016429838,0.004870703,0.011978575,0.0010070544,0.00017163795,0.0024124598,0.9510477,0.004381169,0.007700731],"genre_scores_gemma":[0.023270825,0.004102053,0.06875706,0.00044073263,0.00012355426,0.0032087998,0.89813876,0.00032863714,0.0016295862],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956204,0.00058623793,0.0022146753,0.0008025293,0.0005960877,0.00018004127],"domain_scores_gemma":[0.98140335,0.006755495,0.004478176,0.001769107,0.004199663,0.0013942706],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0056497813,0.0013203463,0.00234847,0.04738819,0.0009673859,0.0035361315,0.00286621,0.0015262876,0.01979364],"category_scores_gemma":[0.021949401,0.00095452525,0.0019219093,0.03485684,0.00040923667,0.0033282058,0.002540363,0.0013941634,0.010475139],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002117407,0.0006898539,0.087464705,0.042170472,0.0017719603,0.006369428,0.0015987699,0.0060880417,0.009348637,0.009519488,0.39253134,0.44032985],"study_design_scores_gemma":[0.00085459044,0.0003695108,0.092744835,0.004196899,0.002285776,0.004070337,0.00096356444,0.0060653044,0.005023938,0.0038141746,0.87927085,0.00034018178],"about_ca_topic_score_codex":0.010065094,"about_ca_topic_score_gemma":0.008398919,"teacher_disagreement_score":0.9943502,"about_ca_system_score_codex":0.001894209,"about_ca_system_score_gemma":0.009973993,"threshold_uncertainty_score":0.06621629},"labels":[],"label_agreement":null},{"id":"W4390477239","doi":"10.1016/j.ejps.2023.106689","title":"Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation","year":2024,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Oxymorphone; Oxycodone; Pharmacology; Pharmacokinetics; CYP2D6; UGT2B7; CYP3A4; Physiologically based pharmacokinetic modelling; Active metabolite; Opioid; Drug interaction; Chemistry; Medicine; Internal medicine; Glucuronidation; Receptor; Cytochrome P450; Metabolism; In vitro","score_opus":0.3695771790641956,"score_gpt":0.48213048425642424,"score_spread":0.11255330519222861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390477239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74664557,0.0038092611,0.22750525,0.0012090657,0.0001123462,0.0003616367,0.004088957,0.000592653,0.015675178],"genre_scores_gemma":[0.9720339,0.00149439,0.020764116,0.00023168564,0.000020021416,0.00029849997,0.0012794299,0.00006159266,0.0038162966],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973184,0.00010024831,0.000016521337,0.00005017655,0.00006379613,0.00003739799],"domain_scores_gemma":[0.9988393,0.00085475785,0.00012309011,0.0000354534,0.00012116213,0.000026121736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072103215,0.00064704823,0.0008543741,0.0004289228,0.00025299544,0.00086458307,0.0005890353,0.0009273253,0.0020606706],"category_scores_gemma":[0.0025250656,0.00044032515,0.0014137796,0.00041561955,0.00028703845,0.0004594248,0.00037846738,0.00080257363,0.00038318455],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006503943,0.000046406247,0.003318889,0.00008759586,0.00006652443,0.00012936647,0.000017308232,0.9899368,0.0013114093,0.00092855695,0.00026102457,0.0038309973],"study_design_scores_gemma":[0.00003636812,0.00009121295,0.0012076264,0.000014513637,0.00005985075,0.000057500238,0.000012743725,0.9953257,0.001254254,0.0006978139,0.001229906,0.000012416114],"about_ca_topic_score_codex":0.028642565,"about_ca_topic_score_gemma":0.01105351,"teacher_disagreement_score":0.028642565,"about_ca_system_score_codex":0.0008728777,"about_ca_system_score_gemma":0.0019171634,"threshold_uncertainty_score":0.0569517},"labels":[],"label_agreement":null},{"id":"W4390572203","doi":"10.3389/fgene.2023.1295963","title":"Moving towards the implementation of pharmacogenetic testing in Quebec","year":2024,"lang":"en","type":"review","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Pharmacogenetics; Computer science; Data science; Genotype; Biology","score_opus":0.19186639285994792,"score_gpt":0.49436024732789835,"score_spread":0.3024938544679504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390572203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014457989,0.9823496,0.00063869223,0.009432717,0.000440639,0.000036181686,0.00018444292,0.00003521431,0.005436757],"genre_scores_gemma":[0.028236335,0.96173805,0.0019875618,0.0047108917,0.00015247619,0.000033540637,0.0002707647,0.000009019053,0.0028613468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988637,0.00030817877,0.00007548825,0.00010512779,0.00045598895,0.00019163871],"domain_scores_gemma":[0.9959006,0.0009940586,0.00027271864,0.000067926485,0.0023964045,0.00036841305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003974723,0.00043418928,0.00061389385,0.0016993913,0.00061140937,0.0017233891,0.0012828697,0.0011565071,0.003587521],"category_scores_gemma":[0.004265874,0.00016031116,0.0005884806,0.0022434304,0.0008532542,0.00075459044,0.0006768178,0.0016188495,0.0003787056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011064697,0.00006396901,0.0029882293,0.01147131,0.00014583243,0.0003881458,0.00033980457,0.0013157647,0.0010013492,0.017658578,0.056877002,0.9076393],"study_design_scores_gemma":[0.00005946393,0.00010414839,0.015455886,0.013688574,0.00021499669,0.00050978584,0.00031416817,0.00075808493,0.0006962768,0.0016708602,0.9664856,0.000042160736],"about_ca_topic_score_codex":0.8798987,"about_ca_topic_score_gemma":0.89825314,"teacher_disagreement_score":0.12010127,"about_ca_system_score_codex":0.028137878,"about_ca_system_score_gemma":0.06690891,"threshold_uncertainty_score":0.24161708},"labels":[],"label_agreement":null},{"id":"W4390599050","doi":"10.1002/cpdd.1364","title":"Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP3A; CYP3A4; Tacrolimus; Pharmacology; Medicine; Pharmacokinetics; Drug interaction; CYP3A5; Calcineurin; Crossover study; P-glycoprotein; Pharmacokinetic interaction; Cmax; Inducer; Cytochrome P450; Internal medicine; Metabolism; Chemistry; Transplantation; Antibiotics; Biochemistry","score_opus":0.07446660461163242,"score_gpt":0.4725914293935504,"score_spread":0.398124824781918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998185,0.0011822442,0.00014159075,0.00002343,0.000041252944,0.00005385481,0.00006929063,0.000015891086,0.0002874979],"genre_scores_gemma":[0.9988105,0.0004019854,0.00023237636,0.000038235128,0.000056585726,0.0000458205,0.000089514855,0.0000072395887,0.00031784107],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99926406,0.00033129362,0.0000731702,0.00013328061,0.00012172359,0.00007641912],"domain_scores_gemma":[0.998955,0.0004644291,0.0002731781,0.000078932244,0.00006569481,0.0001627189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076361315,0.00038847048,0.00096275995,0.00016925785,0.00012484964,0.00040974104,0.0002211322,0.0005298137,0.0017239855],"category_scores_gemma":[0.0019511061,0.00019758513,0.0005752035,0.00021654322,0.00028243283,0.00036196117,0.00012599802,0.0005936159,0.00030392926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5711684,0.008583002,0.004641489,0.0006172893,0.0008962883,0.00018962023,0.0001306981,0.0008130812,0.32946268,0.00009533649,0.00042613113,0.08297601],"study_design_scores_gemma":[0.026121475,0.7310467,0.090825364,0.00005582637,0.0016968973,0.00069694745,0.000081547594,0.0038453434,0.14328238,0.0000753328,0.002188061,0.000084142695],"about_ca_topic_score_codex":0.00022263487,"about_ca_topic_score_gemma":0.00023107864,"teacher_disagreement_score":0.0017239855,"about_ca_system_score_codex":0.00016029098,"about_ca_system_score_gemma":0.00015991941,"threshold_uncertainty_score":0.005767286},"labels":[],"label_agreement":null},{"id":"W4390734338","doi":"10.1093/gbe/evad236","title":"Signatures of Co-evolution and Co-regulation in the CYP3A and CYP4F Genes in Humans","year":2024,"lang":"en","type":"article","venue":"Genome Biology and Evolution","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal; Mila - Quebec Artificial Intelligence Institute; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Alliance de recherche numérique du Canada; Fondation Institut de Cardiologie de Montréal; Université de Montréal; Institut de Cardiologie de Montréal; Canada Foundation for Innovation","keywords":"Biology; Gene; Evolutionary biology; Genetics; Computational biology","score_opus":0.056756904403381464,"score_gpt":0.41228698556459875,"score_spread":0.3555300811612173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390734338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973149,0.00066607754,0.0010954429,0.00006849471,0.0000041241346,0.0000052407468,0.00030002574,0.000013838388,0.00053179945],"genre_scores_gemma":[0.9988587,0.00011922527,0.0005906944,0.000031528823,0.000008272993,0.0000053086296,0.00021533368,0.000008877895,0.00016221394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994247,0.00013976143,0.00002512796,0.0002807985,0.00008088308,0.00004877188],"domain_scores_gemma":[0.9996086,0.0001490202,0.00010841275,0.000044217933,0.00003753733,0.000052260748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026820754,0.00015399717,0.000371748,0.0009198218,0.0002800299,0.00025830916,0.00014277085,0.00029147646,0.0016565922],"category_scores_gemma":[0.00084348745,0.00011376491,0.00027950923,0.0008032653,0.00034609702,0.000115089766,0.00023030791,0.00026812626,0.00014664592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011327019,0.00006430167,0.778671,0.00009359104,0.0005834821,0.0012805654,0.0007702629,0.00041168596,0.17311464,0.00093141134,0.00045556773,0.042490825],"study_design_scores_gemma":[0.000011433662,0.00005923642,0.9947842,0.0000045447055,0.000044856133,0.001524894,0.00007502209,0.00035771483,0.002017059,0.00023924834,0.00087282364,0.000008975557],"about_ca_topic_score_codex":0.00112546,"about_ca_topic_score_gemma":0.0010824775,"teacher_disagreement_score":0.0016565922,"about_ca_system_score_codex":0.00017457281,"about_ca_system_score_gemma":0.00011734601,"threshold_uncertainty_score":0.005541861},"labels":[],"label_agreement":null},{"id":"W4391223294","doi":"10.1002/hsr2.1844","title":"Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review","year":2024,"lang":"en","type":"review","venue":"Health Science Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba","funders":"","keywords":"Pharmacogenomics; Pharmacy; Clinical pharmacy; Medicine; Pharmacy practice; Perception; Medical education; Family medicine; MEDLINE; Health care; Pharmacist; Psychology; Nursing; Pharmacology; Political science","score_opus":0.2646831729790185,"score_gpt":0.5970368052841961,"score_spread":0.3323536323051776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391223294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007920126,0.99007213,0.00019083335,0.0003873679,0.000074309624,0.00040014714,0.00048187343,0.000005784549,0.0004674272],"genre_scores_gemma":[0.048806738,0.94908637,0.00065834355,0.00042818973,0.000062850704,0.00062669266,0.00024857963,0.0000024581575,0.00007989058],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99152464,0.002450715,0.00320732,0.00057271146,0.0020246096,0.00021998225],"domain_scores_gemma":[0.95956844,0.029901426,0.0066807633,0.0003948959,0.002990024,0.00046433296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007430398,0.0009180698,0.0053128474,0.0077695483,0.000652517,0.0023688967,0.001460463,0.0018930841,0.002321375],"category_scores_gemma":[0.0394117,0.0008099396,0.0047751702,0.008792729,0.00073405536,0.0023099137,0.001278212,0.0010089691,0.0001793579],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001733793,0.00004893374,0.0046358546,0.93758965,0.00825344,0.00022342891,0.0007604161,0.00007038124,0.00013469458,0.00011427434,0.00088765466,0.047107916],"study_design_scores_gemma":[0.00022813534,0.00039450292,0.021869527,0.8985228,0.062593244,0.0011429153,0.0016001584,0.00011425171,0.00025900523,0.00021507498,0.013003683,0.000056630208],"about_ca_topic_score_codex":0.005810154,"about_ca_topic_score_gemma":0.015781444,"teacher_disagreement_score":0.0077695483,"about_ca_system_score_codex":0.0023253607,"about_ca_system_score_gemma":0.011507134,"threshold_uncertainty_score":0.03929621},"labels":[],"label_agreement":null},{"id":"W4391482464","doi":"10.3389/fphar.2024.1232595","title":"Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study","year":2024,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Warren Y. Soper Charitable Trust; Jewish General Hospital; Fonds de Recherche du Québec - Santé; Fondation De Famille Alvin Segal; Genome Canada; Faculty of Medicine, McGill University; McGill University","keywords":"CYP1A2; CYP3A4; Pharmacology; Medicine; Cohort; CYP2C19; Cytochrome P450; Bioinformatics; Biology; Internal medicine; Metabolism","score_opus":0.09208448011742877,"score_gpt":0.39002576583360976,"score_spread":0.297941285716181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391482464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951357,0.00021752098,0.0029200944,0.00005822926,0.000028645281,0.00046753712,0.0004255472,0.00003825333,0.00070855883],"genre_scores_gemma":[0.99310255,0.00020269102,0.0033114275,0.00020720565,0.00008087798,0.0005674804,0.0008630017,0.000027992724,0.0016368041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986411,0.0004568748,0.000060648083,0.00042901046,0.00031281263,0.00009960775],"domain_scores_gemma":[0.998703,0.0002207687,0.00013117152,0.0003008361,0.0003598728,0.00028426258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019547383,0.0010784952,0.0008745402,0.00064946106,0.0013865867,0.0006999086,0.00059504795,0.00095761457,0.002073938],"category_scores_gemma":[0.0022909194,0.000453856,0.0008898765,0.0004509481,0.0007111626,0.00040965376,0.00072695327,0.001123754,0.0009713096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009376157,0.010151622,0.8725258,0.00028407745,0.0010015435,0.0033672852,0.0050132917,0.00042499683,0.057677925,0.0003168069,0.0017633952,0.038097046],"study_design_scores_gemma":[0.00069894135,0.0419797,0.9384638,0.00003595473,0.00072715495,0.005491825,0.0014190947,0.0012656983,0.0054474454,0.00025977183,0.004133434,0.00007723332],"about_ca_topic_score_codex":0.0026308105,"about_ca_topic_score_gemma":0.002315503,"teacher_disagreement_score":0.0026308105,"about_ca_system_score_codex":0.00033980713,"about_ca_system_score_gemma":0.00049766223,"threshold_uncertainty_score":0.01033777},"labels":[],"label_agreement":null},{"id":"W4391487769","doi":"10.1177/23743735241229384","title":"Patients’ Experiences of a Precision Medicine Clinic","year":2024,"lang":"en","type":"article","venue":"Journal of Patient Experience","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Feeling; Family medicine; Health care; Psychology","score_opus":0.11201083667860304,"score_gpt":0.4807917054613771,"score_spread":0.36878086878277405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391487769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894022,0.0010851878,0.00053482683,0.00355604,0.00008485415,0.000021378268,0.00007743511,0.00002470631,0.0052134963],"genre_scores_gemma":[0.9978491,0.00041187304,0.00022023648,0.0008788263,0.000028005614,0.0000127668145,0.000025459989,0.000006228959,0.00056765263],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99292165,0.0048023774,0.0003035886,0.00025657244,0.0008026699,0.00091317715],"domain_scores_gemma":[0.9881882,0.0049884478,0.0017314352,0.00021165246,0.0010080257,0.003872292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032034456,0.00026972438,0.00046121946,0.00051517854,0.0034591374,0.003208657,0.0007496407,0.0013683719,0.004350368],"category_scores_gemma":[0.012786166,0.00035573472,0.00044167414,0.00053253403,0.0021605561,0.0020277954,0.0031026923,0.0021563135,0.00032957754],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007551961,0.0007454773,0.16092838,0.00074488245,0.00023753873,0.008442963,0.7414618,0.00080084655,0.003347066,0.00296136,0.0125399465,0.06703448],"study_design_scores_gemma":[0.000055900593,0.0015852932,0.049024045,0.0003478706,0.00009099827,0.012486695,0.89877254,0.0005845911,0.00060226745,0.00072921155,0.03555823,0.00016239547],"about_ca_topic_score_codex":0.002158227,"about_ca_topic_score_gemma":0.0032205135,"teacher_disagreement_score":0.004350368,"about_ca_system_score_codex":0.0011744603,"about_ca_system_score_gemma":0.001462394,"threshold_uncertainty_score":0.016941667},"labels":[],"label_agreement":null},{"id":"W4391751786","doi":"10.1038/s41398-024-02809-y","title":"Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data","year":2024,"lang":"en","type":"article","venue":"Translational Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Women and Children’s Health Research Institute; Alberta Hospital Edmonton; University of Alberta","funders":"Alberta Innovates; Canada Foundation for Innovation; Alberta Precision Laboratories","keywords":"Haplotype; Allele; CYP2D6; Genetics; Biology; Genotype; Gene","score_opus":0.37549385761937176,"score_gpt":0.5610005516089334,"score_spread":0.1855066939895616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391751786","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05049,0.00061562186,0.9343222,0.00018740809,0.0002151353,0.000712201,0.005436918,0.0051237606,0.0028967625],"genre_scores_gemma":[0.0675717,0.00024611366,0.922864,0.00022586253,0.00008683057,0.0008063141,0.0060572233,0.0005657727,0.0015761734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946273,0.0015285304,0.0005917979,0.001918703,0.0010727057,0.00026095702],"domain_scores_gemma":[0.9921415,0.0031945496,0.0008833958,0.0019477739,0.0016261296,0.00020670664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049045724,0.0009597351,0.0011356605,0.0037223594,0.0007259228,0.0015925119,0.0012062852,0.0010653203,0.0057628253],"category_scores_gemma":[0.018325387,0.00084542297,0.0014763683,0.0024257263,0.0005640327,0.0009027446,0.0013454343,0.002089649,0.0047587804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014507589,0.00039667898,0.036228467,0.0010186681,0.0008330551,0.0016407833,0.0016228821,0.013266962,0.49641445,0.0078062196,0.011556268,0.4277648],"study_design_scores_gemma":[0.00042532597,0.0010896727,0.07781417,0.0002003525,0.0007951457,0.0050880495,0.00048439554,0.21153736,0.58434755,0.013967857,0.10366552,0.0005846635],"about_ca_topic_score_codex":0.0012710643,"about_ca_topic_score_gemma":0.0029349227,"teacher_disagreement_score":0.0057628253,"about_ca_system_score_codex":0.0003676707,"about_ca_system_score_gemma":0.00087637367,"threshold_uncertainty_score":0.025938153},"labels":[],"label_agreement":null},{"id":"W4391838815","doi":"10.1097/fpc.0000000000000523","title":"Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Genotyping; Pharmacogenomics; Genetics; Allele; Biology; Computational biology; Genome; Pharmacogenetics; Genome-wide association study; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.09909228692229773,"score_gpt":0.41518326556243795,"score_spread":0.31609097864014024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391838815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732587,0.0017954502,0.012288817,0.00022934581,0.000014360259,0.00003794695,0.0073393355,0.00023626183,0.004799809],"genre_scores_gemma":[0.98489755,0.00036866983,0.0076825414,0.00011781991,0.000017434893,0.0000669788,0.006137373,0.0000810748,0.0006305174],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99270093,0.0031448866,0.000497188,0.0016355041,0.0016582087,0.00036328993],"domain_scores_gemma":[0.9822863,0.012239551,0.00195395,0.001687917,0.0016457305,0.0001866403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005202799,0.0002655686,0.00051642535,0.0027081063,0.00025925983,0.0010834958,0.00037217457,0.00048365217,0.0023778637],"category_scores_gemma":[0.018136974,0.00025386747,0.0010209841,0.0030800223,0.000357796,0.00057131896,0.00087295705,0.00034348498,0.00047831162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001990816,0.000044081942,0.84053564,0.00041704814,0.0023301307,0.00031287275,0.0013876689,0.0033008952,0.05331534,0.0013316032,0.0018111944,0.093222715],"study_design_scores_gemma":[0.000018718247,0.0001888042,0.97965014,0.00003446407,0.0005691224,0.0007259061,0.00030712888,0.0037406324,0.009659195,0.00045509383,0.00462601,0.000024806968],"about_ca_topic_score_codex":0.0020127248,"about_ca_topic_score_gemma":0.0023943502,"teacher_disagreement_score":0.005202799,"about_ca_system_score_codex":0.00032561398,"about_ca_system_score_gemma":0.00027387048,"threshold_uncertainty_score":0.027515352},"labels":[],"label_agreement":null},{"id":"W4391878438","doi":"10.3389/jpps.2024.12671","title":"Revolutionizing pharmacokinetics: the dawn of AI-powered analysis","year":2024,"lang":"en","type":"editorial","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Computer science; Drug discovery; Data science; Engineering ethics; Artificial intelligence; Pharmacology; Medicine; Engineering; Bioinformatics; Biology","score_opus":0.12183269623071001,"score_gpt":0.508050274395433,"score_spread":0.386217578164723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391878438","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008334867,0.032663252,0.0014943245,0.12280874,0.84046316,0.000017604902,0.000047039888,0.00011773602,0.002304789],"genre_scores_gemma":[0.0009579331,0.019934397,0.0008905544,0.036773477,0.93660384,0.000016369315,0.000020325155,0.000071476345,0.0047316663],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99331635,0.0016806495,0.00070751127,0.0005926804,0.0035202114,0.00018266396],"domain_scores_gemma":[0.9480721,0.034703024,0.0012295287,0.0011358655,0.012052406,0.002807064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009299042,0.0017741784,0.001596245,0.0024807681,0.001953812,0.0067755436,0.0021597492,0.009500429,0.004928047],"category_scores_gemma":[0.042979717,0.000618416,0.0020365443,0.0011640027,0.0041720886,0.0052652657,0.0015770032,0.020138798,0.0045368467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038705082,0.000013212706,0.00004548476,0.00036107015,0.0000279416,0.00011378584,0.000049903338,0.000101212776,0.00009265292,0.0032862818,0.97060186,0.025267864],"study_design_scores_gemma":[0.000027101985,0.00002497769,0.000114245064,0.000490872,0.000029462364,0.00026795297,0.000058439276,0.00028723234,0.000112170725,0.009114351,0.9894512,0.000021971187],"about_ca_topic_score_codex":0.00093274086,"about_ca_topic_score_gemma":0.0023730553,"teacher_disagreement_score":0.009500429,"about_ca_system_score_codex":0.0020948648,"about_ca_system_score_gemma":0.0033754266,"threshold_uncertainty_score":0.0491786},"labels":[],"label_agreement":null},{"id":"W4392003043","doi":"10.3389/fninf.2023.1244336","title":"Comparing feature selection and machine learning approaches for predicting CYP2D6 methylation from genetic variation","year":2024,"lang":"en","type":"article","venue":"Frontiers in Neuroinformatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Ministry of Health, British Columbia; Agency for Science, Technology and Research; National Research Foundation","keywords":"Single-nucleotide polymorphism; Genome-wide association study; Computational biology; Biology; DNA methylation; Feature selection; CpG site; Genetics; Heritability; Elastic net regularization; Genetic association; Computer science; Gene; Artificial intelligence; Genotype; Gene expression","score_opus":0.09958599240446081,"score_gpt":0.3419818027543144,"score_spread":0.24239581034985358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392003043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7356329,0.0050955843,0.24938305,0.002475409,0.00035861027,0.00045782625,0.002174935,0.0018617014,0.0025600982],"genre_scores_gemma":[0.9507477,0.0005370963,0.04441965,0.00032490146,0.0001419654,0.0002860907,0.001870615,0.00007721389,0.0015946255],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974993,0.0015668973,0.00016212469,0.0003727041,0.00021624142,0.000182679],"domain_scores_gemma":[0.9906786,0.007829416,0.00032792546,0.00037360901,0.0005925433,0.00019783292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010585286,0.0017924178,0.0014384956,0.0021493072,0.0004968553,0.001081179,0.0011633858,0.0013592746,0.0019102104],"category_scores_gemma":[0.009986832,0.00037620944,0.0020725627,0.0011217005,0.00046116076,0.0010177299,0.0010791108,0.0016999244,0.000580155],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036987695,0.00077282236,0.06867307,0.00033386657,0.0016561083,0.00017639936,0.00010616052,0.71154714,0.0014908678,0.0009920738,0.0035215633,0.20703119],"study_design_scores_gemma":[0.000056378834,0.00037798833,0.0049615363,0.000030928102,0.00009054015,0.00003891707,0.000030796007,0.99245363,0.00044873098,0.0012547727,0.00023877526,0.000017011324],"about_ca_topic_score_codex":0.0072765774,"about_ca_topic_score_gemma":0.004300586,"teacher_disagreement_score":0.010585286,"about_ca_system_score_codex":0.00094914605,"about_ca_system_score_gemma":0.0010159183,"threshold_uncertainty_score":0.05598104},"labels":[],"label_agreement":null},{"id":"W4392004785","doi":"10.3390/ijms25052522","title":"Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is l-Norfenfluramine a Better Follow-Up Compound to Racemic-Fenfluramine?","year":2024,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Hebrew University of Jerusalem","keywords":"Fenfluramine; Pharmacology; Chemistry; Medicine; Biochemistry","score_opus":0.05030341087919062,"score_gpt":0.4247452365154824,"score_spread":0.3744418256362918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392004785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937504,0.002530011,0.0017320133,0.000112281086,0.00002759513,0.000043872056,0.0005365542,0.000053257903,0.0012139902],"genre_scores_gemma":[0.9914757,0.0026324005,0.0024001813,0.00015455723,0.000023953697,0.00006394175,0.0010412885,0.00002817796,0.0021797812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998733,0.000026788412,0.000012924697,0.000030850155,0.000023873645,0.000032321776],"domain_scores_gemma":[0.99986887,0.000014293318,0.00004752359,0.000017179205,0.000023728722,0.000028382938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019078588,0.00044720928,0.00041348595,0.00038259107,0.00016369665,0.00020123064,0.00026471695,0.00033342303,0.001054127],"category_scores_gemma":[0.00018831312,0.00014004744,0.00028892222,0.00017406784,0.00022162888,0.00039304918,0.000085802334,0.00045842276,0.00030442953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005010744,0.00005491878,0.00049619476,0.000031036656,0.000013006379,0.0000513994,0.000015129853,0.000028781706,0.99619734,0.000042393363,0.000031415027,0.0025373707],"study_design_scores_gemma":[0.00004110345,0.0027044443,0.00908306,0.0000069201587,0.000043374253,0.0003728179,0.00005483108,0.00032252152,0.9853543,0.000033543824,0.001973597,0.0000094882425],"about_ca_topic_score_codex":0.0009997574,"about_ca_topic_score_gemma":0.0016848119,"teacher_disagreement_score":0.001054127,"about_ca_system_score_codex":0.00024965513,"about_ca_system_score_gemma":0.00019138733,"threshold_uncertainty_score":0.0035264492},"labels":[],"label_agreement":null},{"id":"W4392037327","doi":"10.1038/s41525-024-00403-1","title":"A call for increased inclusivity and global representation in pharmacogenetic testing","year":2024,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ted Rogers Centre for Heart Research; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Sick Kids Foundation","keywords":"Pharmacogenetics; Genetic testing; Dosing; Cohort; Genetic variation; Genetics; Medicine; Adverse effect; Biology; Gene; Genotype; Internal medicine","score_opus":0.18311857179338334,"score_gpt":0.4958389406991425,"score_spread":0.31272036890575916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392037327","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66449827,0.009450748,0.2325369,0.049656585,0.0015446199,0.000484683,0.0047589038,0.0016119827,0.035457328],"genre_scores_gemma":[0.8877519,0.0017723348,0.0894566,0.013440692,0.0016586881,0.00042146412,0.0022356538,0.0006129744,0.0026497596],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9187999,0.05627998,0.002909836,0.012216654,0.008173561,0.0016201253],"domain_scores_gemma":[0.67847633,0.22898144,0.017724253,0.05511234,0.01691514,0.002790514],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.097607285,0.0007389629,0.0017062324,0.003420067,0.0006671056,0.0050239405,0.0025746906,0.002418391,0.0033802523],"category_scores_gemma":[0.16911277,0.0008247729,0.0016375444,0.0037771983,0.0037578694,0.0042320816,0.0047874614,0.0038127548,0.00063489954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019883837,0.00012506796,0.62721324,0.00091866066,0.0026003348,0.0007455283,0.0048882384,0.007400745,0.011512251,0.015986485,0.013755804,0.31286538],"study_design_scores_gemma":[0.00023761427,0.0010795613,0.8103378,0.0008525642,0.00092812505,0.007014694,0.002225621,0.02483113,0.00911162,0.05513679,0.087979026,0.0002654323],"about_ca_topic_score_codex":0.0020868012,"about_ca_topic_score_gemma":0.0033693977,"teacher_disagreement_score":0.9974253,"about_ca_system_score_codex":0.0011996569,"about_ca_system_score_gemma":0.00089103257,"threshold_uncertainty_score":0.5162028},"labels":[],"label_agreement":null},{"id":"W4392659185","doi":"10.3390/genes15030352","title":"A New Cloud-Native Tool for Pharmacogenetic Analysis","year":2024,"lang":"en","type":"article","venue":"Genes","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Computer science; Pipeline (software); Cloud computing; Workflow; Genomics; Data science; Computational biology; Data mining; Genome; Biology; Database; Gene; Genetics","score_opus":0.11050324154634676,"score_gpt":0.4666755262621332,"score_spread":0.35617228471578644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392659185","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048640724,0.00094536686,0.52878326,0.0013089287,0.00038023345,0.0007485699,0.043491095,0.41353485,0.005943619],"genre_scores_gemma":[0.11582688,0.0015789061,0.67715716,0.0043051136,0.00045022575,0.0023469229,0.13232805,0.058963906,0.0070428974],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977646,0.00045777037,0.00033498512,0.00061756844,0.0006267764,0.00019825663],"domain_scores_gemma":[0.9944324,0.0023581572,0.00045671238,0.0015611624,0.0006096006,0.0005819185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038687808,0.0024521262,0.0012252867,0.0027552026,0.0007933952,0.0038434912,0.0034075542,0.0014679541,0.02322981],"category_scores_gemma":[0.012173915,0.0010504253,0.0024621976,0.002740968,0.0008160438,0.0032390098,0.0058286325,0.0022402809,0.012840632],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046789804,0.0005140994,0.01704145,0.0026199173,0.0009396647,0.0028265493,0.0009509679,0.02962088,0.015127051,0.036946986,0.45183,0.43690345],"study_design_scores_gemma":[0.0022630547,0.00028809032,0.010690224,0.0007460482,0.00030920317,0.0021686386,0.00026968558,0.3496213,0.031847466,0.12594938,0.47536704,0.00047995348],"about_ca_topic_score_codex":0.004267748,"about_ca_topic_score_gemma":0.002916256,"teacher_disagreement_score":0.02322981,"about_ca_system_score_codex":0.0013221998,"about_ca_system_score_gemma":0.0030421084,"threshold_uncertainty_score":0.07771146},"labels":[],"label_agreement":null},{"id":"W4392700120","doi":"10.1097/fpc.0000000000000526","title":"Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Odds ratio; Internal medicine; Pharmacogenetics; Univariate analysis; Medicine; Vitamin K epoxide reductase; Logistic regression; Genotype; Single-nucleotide polymorphism; Biology; Multivariate analysis; Genetics; Gene; Atrial fibrillation","score_opus":0.03598974033285063,"score_gpt":0.3694414487508352,"score_spread":0.33345170841798455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392700120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991171,0.00039108147,0.000055695262,0.000047162273,0.000003969279,0.0000058693586,0.000112429334,0.000001427446,0.00026521075],"genre_scores_gemma":[0.9996414,0.00008962947,0.000050050625,0.000016570793,0.000007275454,0.0000043231657,0.00009497542,6.8313625e-7,0.00009514603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968886,0.00005957533,0.000042561223,0.00009324239,0.00006788738,0.000047855745],"domain_scores_gemma":[0.9995927,0.00009203199,0.00015096333,0.00004658047,0.000052866566,0.0000647946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005828053,0.00026172952,0.00036101413,0.00045261258,0.00044117536,0.000280153,0.00024410314,0.00028919752,0.0014516106],"category_scores_gemma":[0.0010024738,0.00014921534,0.00065272505,0.00091426563,0.00022259307,0.00013554379,0.00016140738,0.000247569,0.0000869623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038822353,0.000030686224,0.9956838,0.00003348265,0.00030455046,0.00020257912,0.00008603834,0.00009727531,0.0009136009,0.000052538035,0.00007909898,0.0021280851],"study_design_scores_gemma":[0.000030643914,0.000097818796,0.99854916,0.0000063865546,0.00024978,0.000216696,0.000054364566,0.0003915977,0.00018677548,0.00005085984,0.00016145845,0.0000044180524],"about_ca_topic_score_codex":0.010459408,"about_ca_topic_score_gemma":0.01116679,"teacher_disagreement_score":0.010459408,"about_ca_system_score_codex":0.00033836273,"about_ca_system_score_gemma":0.00057835184,"threshold_uncertainty_score":0.020797074},"labels":[],"label_agreement":null},{"id":"W4392711372","doi":"10.1515/jbcpp-2023-0250","title":"Maternal separation influences hepatic drug-metabolizing CYP450 gene expression without pathological changes in adult mice","year":2024,"lang":"en","type":"article","venue":"Journal of Basic and Clinical Physiology and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Al-Zaytoonah University of Jordan; University of Jordan","keywords":"Pathological; Gene expression; Gene; Drug; Biology; Pharmacology; Medicine; Cell biology; Endocrinology; Internal medicine; Genetics","score_opus":0.07965093412923616,"score_gpt":0.4734750038522279,"score_spread":0.3938240697229918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392711372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950846,0.0014751849,0.0021781414,0.00010765442,0.000037303922,0.000019605963,0.00039571984,0.00008277381,0.0006191467],"genre_scores_gemma":[0.99302423,0.00096735824,0.0019326105,0.00012386737,0.000027829828,0.000071660776,0.00051165855,0.0000434669,0.0032972728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972445,0.00004739209,0.00002404937,0.00008024833,0.00007322311,0.00005060624],"domain_scores_gemma":[0.99953616,0.00004498302,0.00022120503,0.00005280986,0.00004548155,0.00009936472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018197822,0.0004792844,0.00033050703,0.00048063247,0.00016530517,0.00031317127,0.00019734602,0.00025064303,0.0015707503],"category_scores_gemma":[0.0002211805,0.00020631643,0.00028901425,0.00014124492,0.00040006818,0.00020800564,0.0002374054,0.0007810437,0.0003062451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074516004,0.000055643668,0.00096705917,0.000031348467,0.000010432327,0.000093779985,0.000030596006,0.000017079501,0.99598455,0.000042746073,0.000029263432,0.0019923316],"study_design_scores_gemma":[0.000042645643,0.0021711881,0.03508898,0.0000150752,0.00006181674,0.00039045658,0.00016809528,0.00034975677,0.95959216,0.000068005946,0.002040442,0.00001142163],"about_ca_topic_score_codex":0.0004645105,"about_ca_topic_score_gemma":0.0009369624,"teacher_disagreement_score":0.0015707503,"about_ca_system_score_codex":0.00024841784,"about_ca_system_score_gemma":0.00021024201,"threshold_uncertainty_score":0.0052547455},"labels":[],"label_agreement":null},{"id":"W4392895297","doi":"10.1080/15622975.2024.2321553","title":"Frequencies of <i>CYP2C19</i> and <i>CYP2D6</i> gene variants in a German inpatient sample with mood and anxiety disorders","year":2024,"lang":"en","type":"article","venue":"The World Journal of Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"CYP2C19; German; Anxiety; CYP2D6; Mood; Cohort; Affect (linguistics); Pharmacogenomics; Gene; Medicine; Sample (material); Mood disorders; Psychology; Psychiatry; Clinical psychology; Genotype; Genetics; Internal medicine; Pharmacology; Biology; Chemistry","score_opus":0.043176747399623905,"score_gpt":0.37076151614059666,"score_spread":0.32758476874097275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392895297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960357,0.000049760227,0.000025672574,0.0000113165315,0.0000012362714,0.0000035456967,0.00016479133,0.000001688597,0.00013854592],"genre_scores_gemma":[0.999498,0.00006254852,0.000049463204,0.00001686688,0.000002860698,0.000004621128,0.00029937975,0.0000012124907,0.00006507405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996755,0.00006656073,0.000045585864,0.00007811979,0.00007358459,0.000060612903],"domain_scores_gemma":[0.99950707,0.00007968026,0.00025422292,0.00004105224,0.00004890683,0.00006912641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025339326,0.00023823646,0.00026371662,0.0008660182,0.00026823825,0.0003802465,0.00023210366,0.00026909634,0.001823328],"category_scores_gemma":[0.0012252633,0.00019133184,0.00023247174,0.0007601927,0.00024942533,0.00013890302,0.00032468743,0.0001925208,0.00026161227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006276377,0.000021639875,0.99780685,0.000009372896,0.000033787583,0.00017463154,0.00010322862,0.000022142807,0.0005011787,0.000015100702,0.00012917405,0.0011201889],"study_design_scores_gemma":[0.0000035057228,0.000027944343,0.99935514,0.0000024554965,0.000015792833,0.00034537868,0.00008612324,0.000046265504,0.000054705743,0.00000589297,0.000055481818,0.0000012810486],"about_ca_topic_score_codex":0.008311545,"about_ca_topic_score_gemma":0.0074769775,"teacher_disagreement_score":0.008311545,"about_ca_system_score_codex":0.00029227984,"about_ca_system_score_gemma":0.00018143852,"threshold_uncertainty_score":0.016526341},"labels":[],"label_agreement":null},{"id":"W4393073512","doi":"10.1038/s41467-024-46559-3","title":"Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligands","year":2024,"lang":"en","type":"article","venue":"Nature Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Natural Sciences and Engineering Research Council of Canada; University of Illinois at Urbana-Champaign; Canadian Institutes of Health Research; American Cancer Society; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Government of Canada; Agence Nationale de la Recherche","keywords":"Nuclear receptor; Microbiome; Biology; Human microbiome; Computational biology; Function (biology); Bacteria; Receptor; Host (biology); Gene; Cell biology; Genetics; Transcription factor","score_opus":0.11939479922796875,"score_gpt":0.4313304683252504,"score_spread":0.31193566909728165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246474,0.009907156,0.010132767,0.00023846424,0.000053801476,0.000055969664,0.00050549785,0.0001360494,0.0065055764],"genre_scores_gemma":[0.9864547,0.0029909927,0.006661007,0.00017774342,0.00001593313,0.000043881028,0.0004564148,0.000021334776,0.003178013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999001,0.000028735692,0.000005582735,0.000018645178,0.000028090113,0.00001877223],"domain_scores_gemma":[0.9999261,0.000017910765,0.000023599161,0.000008511391,0.000008716465,0.00001517056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015374231,0.00019397053,0.00013200131,0.00014477331,0.000079112084,0.00016689641,0.00016663497,0.00017900339,0.0014881075],"category_scores_gemma":[0.00011582499,0.000083304854,0.00014954565,0.00006709884,0.00013938532,0.0001257558,0.00014842692,0.00027451015,0.00041987156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008347972,0.000010001668,0.0001770091,0.000040679683,0.0000038006458,0.000036329173,0.000007854353,0.000038727896,0.9973062,0.00010927806,0.000035770037,0.002150791],"study_design_scores_gemma":[0.000010296549,0.000371359,0.0019733093,0.00000581027,0.000007245356,0.00030457185,0.000026232472,0.00028399946,0.9928237,0.000041560357,0.004147994,0.0000038761627],"about_ca_topic_score_codex":0.00015572971,"about_ca_topic_score_gemma":0.00055446936,"teacher_disagreement_score":0.0014881075,"about_ca_system_score_codex":0.00018352015,"about_ca_system_score_gemma":0.00009436682,"threshold_uncertainty_score":0.0049782395},"labels":[],"label_agreement":null},{"id":"W4393311212","doi":"10.1021/acscatal.4c00086","title":"Choose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants","year":2024,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Government of Canada","keywords":"Catalysis; Cytochrome P450; Chemistry; Database; Combinatorial chemistry; Computer science; Organic chemistry; Enzyme","score_opus":0.0872332195924262,"score_gpt":0.42037099045078896,"score_spread":0.33313777085836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393311212","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036887832,0.046074454,0.024887709,0.0016487429,0.00064323546,0.0004454538,0.82577217,0.024666075,0.038974345],"genre_scores_gemma":[0.04243394,0.022615025,0.035394646,0.001096926,0.00018697059,0.00024626608,0.8846501,0.0022360855,0.0111400625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995036,0.00006701363,0.000113355614,0.000094981886,0.0001729281,0.000048130438],"domain_scores_gemma":[0.9986885,0.0003381646,0.000280676,0.00020963102,0.000286729,0.00019627108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069171225,0.0011979383,0.0012368207,0.0030805846,0.00040007982,0.0017603977,0.0017485598,0.0010822631,0.026761936],"category_scores_gemma":[0.0029434452,0.00051646814,0.00086377905,0.0046863398,0.0002067658,0.0017743162,0.0012000466,0.0013659585,0.020117844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00268448,0.0004762379,0.014867669,0.014261022,0.0006494265,0.002175575,0.00039316528,0.0026690015,0.042513084,0.008272618,0.5739541,0.33708373],"study_design_scores_gemma":[0.00019326477,0.00020321867,0.008885391,0.0006845441,0.00033567814,0.0015272073,0.00009060921,0.0012508631,0.012502556,0.0029595736,0.971274,0.00009299957],"about_ca_topic_score_codex":0.001589088,"about_ca_topic_score_gemma":0.0031117438,"teacher_disagreement_score":0.026761936,"about_ca_system_score_codex":0.00044966274,"about_ca_system_score_gemma":0.0010416906,"threshold_uncertainty_score":0.08952767},"labels":[],"label_agreement":null},{"id":"W4394128195","doi":"10.6084/m9.figshare.20164657","title":"Additional file 3 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Computational biology; Stereochemistry; Computational chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.11617462400845852,"score_gpt":0.3352030744840913,"score_spread":0.2190284504756328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394128195","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009640331,0.000038383027,0.00007049695,0.00003395758,0.0000087966055,0.000014015332,0.9993605,0.00016459326,0.00021283588],"genre_scores_gemma":[0.0014053839,0.00006987628,0.0006902227,0.0001079061,0.000010506437,0.0001995062,0.9965419,0.00013305628,0.0008416308],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993124,0.00012771979,0.00008596997,0.00024094577,0.0001348105,0.00009806578],"domain_scores_gemma":[0.9955974,0.0030466276,0.00026758714,0.00045704405,0.00045449173,0.00017681943],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014615245,0.0023854238,0.0020087336,0.0016721579,0.0007165559,0.002234931,0.0027845826,0.0025037597,0.448024],"category_scores_gemma":[0.009970048,0.00068350433,0.001955293,0.002622991,0.0004248755,0.0012504476,0.0012566467,0.0017992483,0.1229696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028948154,0.00010324176,0.0024974202,0.0042856373,0.00016112704,0.000052916515,0.000024263432,0.0022543976,0.0002912716,0.00073492044,0.9843886,0.004916786],"study_design_scores_gemma":[0.003933323,0.0002334702,0.009185075,0.001392786,0.0003731014,0.00019677418,0.00008777036,0.004262685,0.0012645158,0.006487996,0.9724954,0.000087201006],"about_ca_topic_score_codex":0.00947613,"about_ca_topic_score_gemma":0.02069344,"teacher_disagreement_score":0.448024,"about_ca_system_score_codex":0.0013277764,"about_ca_system_score_gemma":0.0021650593,"threshold_uncertainty_score":0.78732675},"labels":[],"label_agreement":null},{"id":"W4394206967","doi":"10.6084/m9.figshare.20164660","title":"Additional file 4 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Stereochemistry; Biochemistry; Organic chemistry","score_opus":0.11682425758372002,"score_gpt":0.3355695517308271,"score_spread":0.21874529414710708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394206967","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010065498,0.000041703603,0.000072684255,0.000035331574,0.000009064176,0.000014454941,0.99934584,0.00016510273,0.00021510036],"genre_scores_gemma":[0.0015306835,0.0000766176,0.0007342342,0.00010931104,0.000011161503,0.000207154,0.9963237,0.00013342712,0.00087366684],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999302,0.00013195214,0.00008773492,0.00024328525,0.00013569587,0.0000993673],"domain_scores_gemma":[0.99539423,0.003205353,0.00027659567,0.00048071102,0.00046599266,0.0001771783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014873927,0.0023783399,0.0020236145,0.0017363473,0.0006965472,0.0022247275,0.0028233768,0.002513825,0.44814092],"category_scores_gemma":[0.010243123,0.0006934878,0.0019815888,0.002668388,0.0004145674,0.0012533487,0.0012227684,0.0017968606,0.1213013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029966258,0.00010856237,0.002665606,0.004487912,0.00017338344,0.000054371096,0.000024361569,0.0024066798,0.00029531427,0.0007508602,0.9834057,0.005327642],"study_design_scores_gemma":[0.0039051855,0.0002424505,0.009835905,0.0014226321,0.00039526995,0.00020220631,0.00008844875,0.0045242035,0.0012690808,0.0066179703,0.9714049,0.00009177904],"about_ca_topic_score_codex":0.009318149,"about_ca_topic_score_gemma":0.020230297,"teacher_disagreement_score":0.44814092,"about_ca_system_score_codex":0.001338486,"about_ca_system_score_gemma":0.0021689073,"threshold_uncertainty_score":0.78716},"labels":[],"label_agreement":null},{"id":"W4394301895","doi":"10.6084/m9.figshare.20164663","title":"Additional file 5 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Quantitative structure–activity relationship; Group (periodic table); Molecule; Chemistry; Small molecule; Computational biology; Stereochemistry; Computational chemistry; Biology; Biochemistry; Organic chemistry","score_opus":0.11616798793691223,"score_gpt":0.3353219944772633,"score_spread":0.21915400654035105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394301895","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101561716,0.000043130603,0.000072597424,0.000036227557,0.000009042149,0.000014395492,0.99933976,0.00016452206,0.00021876473],"genre_scores_gemma":[0.0015385482,0.00007741158,0.00073194935,0.000110912035,0.000010848394,0.00020216439,0.99633163,0.00012965311,0.0008668686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992926,0.0001368476,0.00008987394,0.0002452556,0.00013682997,0.00009856667],"domain_scores_gemma":[0.9952924,0.0032976703,0.0002811049,0.00048025363,0.00047053548,0.00017808488],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015025288,0.0023206032,0.0020094556,0.0017173298,0.0006943816,0.002213042,0.002721587,0.0024739066,0.44237787],"category_scores_gemma":[0.010338598,0.00069215073,0.0019288072,0.0026478097,0.00040253298,0.0012425581,0.0012089405,0.0017605929,0.11709062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002955103,0.00010837626,0.0026394017,0.0046455376,0.00017608122,0.000055462875,0.000024901663,0.002387641,0.0002923169,0.00077437406,0.983189,0.005411413],"study_design_scores_gemma":[0.003783184,0.00023718434,0.009937061,0.0014704728,0.00038856166,0.00020104404,0.00008885308,0.004388928,0.0012386832,0.006593889,0.97158134,0.00009077766],"about_ca_topic_score_codex":0.009166019,"about_ca_topic_score_gemma":0.020033076,"teacher_disagreement_score":0.44237787,"about_ca_system_score_codex":0.0013238129,"about_ca_system_score_gemma":0.0021416864,"threshold_uncertainty_score":0.7953803},"labels":[],"label_agreement":null},{"id":"W4394553871","doi":"10.6084/m9.figshare.20164654","title":"Additional file 2 of Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Alberta","funders":"","keywords":"Group (periodic table); Quantitative structure–activity relationship; Small molecule; Molecule; Chemistry; Stereochemistry; Computational biology; Biology; Biochemistry","score_opus":0.1147917583116876,"score_gpt":0.33508067717374357,"score_spread":0.22028891886205598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394553871","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000931797,0.00003758945,0.00006849796,0.00003361835,0.000008512405,0.00001421358,0.9993864,0.00014948721,0.00020841735],"genre_scores_gemma":[0.0014025983,0.0000701626,0.00070519774,0.000109732195,0.00001063315,0.00020877557,0.9965216,0.0001285719,0.0008427638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993063,0.00012859202,0.00008781951,0.00024673884,0.00013344166,0.000097151074],"domain_scores_gemma":[0.9953591,0.0032158522,0.0002817064,0.0004869976,0.00046922397,0.00018711062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014819348,0.002305701,0.0019683375,0.001702934,0.00070923904,0.0022463612,0.0027248,0.0024999613,0.45446658],"category_scores_gemma":[0.010352434,0.00069034967,0.0018522561,0.002713638,0.0004329199,0.0012599726,0.0012406866,0.0018182383,0.1246856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027703514,0.000102817176,0.0024078044,0.004160906,0.00014755547,0.000051141327,0.000023302846,0.002137355,0.0002666867,0.0007352681,0.9847772,0.004912973],"study_design_scores_gemma":[0.0037779233,0.00022773215,0.008868592,0.0013610268,0.0003510238,0.00019772505,0.00008551935,0.003976868,0.0011568916,0.0062622963,0.97365063,0.00008370202],"about_ca_topic_score_codex":0.008859962,"about_ca_topic_score_gemma":0.01924212,"teacher_disagreement_score":0.45446658,"about_ca_system_score_codex":0.0013000427,"about_ca_system_score_gemma":0.002229345,"threshold_uncertainty_score":0.7781372},"labels":[],"label_agreement":null},{"id":"W4394579813","doi":"10.1007/s12687-024-00705-y","title":"Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study","year":2024,"lang":"en","type":"article","venue":"Journal of Community Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Canada Research Chairs; McMaster University; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Pharmacogenomics; Equity (law); Health care; Medicine; Major depressive disorder; Family medicine; Psychiatry; Pharmacology; Political science","score_opus":0.2515052777096751,"score_gpt":0.4823314612768248,"score_spread":0.23082618356714968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394579813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736225,0.00074243854,0.0010187537,0.020205393,0.00013879886,0.0002951071,0.00047245945,0.000017293305,0.003487249],"genre_scores_gemma":[0.9901243,0.0005827249,0.00095254177,0.0071372334,0.00003837929,0.00033568122,0.00011421533,0.00001871285,0.00069623516],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.95961875,0.031229967,0.0020145539,0.0010637216,0.0019703307,0.0041026664],"domain_scores_gemma":[0.8551815,0.111760825,0.008827137,0.0017083788,0.0080428235,0.014479326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029224787,0.0003861753,0.00086030783,0.0013124502,0.010473345,0.006134742,0.0018895279,0.0033189573,0.0046355184],"category_scores_gemma":[0.07560027,0.0010782753,0.00085766654,0.0016677378,0.0059669265,0.004708585,0.00875143,0.006965626,0.0003908888],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007639784,0.00022482856,0.02866051,0.00034596014,0.00003173648,0.00068547,0.9619547,0.000056693218,0.00025190075,0.0010160449,0.0016299556,0.0050658],"study_design_scores_gemma":[0.000021917353,0.00012219856,0.005563585,0.00036876195,0.000014757816,0.00031544303,0.9891999,0.00009379954,0.00010902896,0.00029194308,0.0038624553,0.000036138365],"about_ca_topic_score_codex":0.030132575,"about_ca_topic_score_gemma":0.04103004,"teacher_disagreement_score":0.030132575,"about_ca_system_score_codex":0.014297864,"about_ca_system_score_gemma":0.020226752,"threshold_uncertainty_score":0.15455729},"labels":[],"label_agreement":null},{"id":"W4394783108","doi":"10.1007/978-3-030-73317-9_66-1","title":"Metabolism Pharmacology","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Pharmacology; Medicine; Pharmacodynamics; Pharmacokinetics","score_opus":0.12427546743698595,"score_gpt":0.4375534331231647,"score_spread":0.3132779656861787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394783108","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037978758,0.040062185,0.0076949648,0.0027860042,0.002883613,0.00011663769,0.0006561997,0.00077397824,0.9446466],"genre_scores_gemma":[0.0010255987,0.011643783,0.0016156343,0.0012281764,0.0004778159,0.00003907345,0.00029209413,0.000085039435,0.98359275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996836,0.00004420683,0.000010622993,0.00005589519,0.0001803932,0.000025289988],"domain_scores_gemma":[0.99979466,0.00004360241,0.0000118363305,0.000038975817,0.00007930784,0.000031770112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037351495,0.0011944518,0.0008770428,0.0013386416,0.0007756811,0.0022819366,0.000943474,0.0013959283,0.2095854],"category_scores_gemma":[0.000706681,0.0005016314,0.0004429479,0.0013860903,0.00048270455,0.0012799912,0.0015957488,0.0025812653,0.20583294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042074502,0.00008800043,0.000065344444,0.00041100028,0.0000072379207,0.000121090416,0.000074614305,0.00025077013,0.002865658,0.019258484,0.5219466,0.4548691],"study_design_scores_gemma":[0.0000041845124,0.000018731464,0.00008726901,0.00009280015,0.000003192779,0.0001901176,0.000013272175,0.00007365352,0.00041847897,0.0038303274,0.9952644,0.00000358104],"about_ca_topic_score_codex":0.0013828079,"about_ca_topic_score_gemma":0.0035646036,"teacher_disagreement_score":0.2095854,"about_ca_system_score_codex":0.0008807195,"about_ca_system_score_gemma":0.0010687521,"threshold_uncertainty_score":0.701133},"labels":[],"label_agreement":null},{"id":"W4394795767","doi":"10.1134/s1061934824040026","title":"Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma","year":2024,"lang":"en","type":"article","venue":"Journal of Analytical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Chemistry; Chromatography; Prodrug; Biochemistry","score_opus":0.15895684766263257,"score_gpt":0.46532161059816324,"score_spread":0.30636476293553067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394795767","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53926784,0.007632872,0.43751577,0.0005851613,0.00016485689,0.000853036,0.0022738506,0.0065830634,0.0051236097],"genre_scores_gemma":[0.6383951,0.0049356096,0.3405962,0.00089715153,0.00009164481,0.0019865793,0.002571727,0.0002774893,0.010248563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924374,0.00018593913,0.0000409801,0.00018486024,0.00029639067,0.000048178812],"domain_scores_gemma":[0.9996754,0.00008993958,0.00008445497,0.000026089578,0.000081039194,0.000043068954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007849232,0.0011461049,0.0003673375,0.0008705586,0.0003584498,0.00033378688,0.00044697296,0.0007503322,0.0012766673],"category_scores_gemma":[0.00081869075,0.00043566877,0.00031985887,0.00040638863,0.0003681719,0.00030457205,0.0003632327,0.0007996312,0.0012069846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058282556,0.000027956918,0.0003806583,0.000056423327,0.0000118325115,0.000019933848,0.000017677618,0.000086169064,0.9943363,0.00005714513,0.0000918522,0.0048557776],"study_design_scores_gemma":[0.000027505317,0.0003495662,0.0030339384,0.000012341266,0.00003017672,0.0003749396,0.000020510199,0.0024609952,0.9910981,0.000059313716,0.0025145984,0.000018000344],"about_ca_topic_score_codex":0.00089303876,"about_ca_topic_score_gemma":0.0013974028,"teacher_disagreement_score":0.0012766673,"about_ca_system_score_codex":0.00042113988,"about_ca_system_score_gemma":0.000839722,"threshold_uncertainty_score":0.004270911},"labels":[],"label_agreement":null},{"id":"W4395022322","doi":"10.1093/ajhp/zxae110","title":"Recommendations for pharmacogenetic testing in clinical practice guidelines in the US","year":2024,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Pharmacogenetics; Clinical Practice; Medical physics; Medicine; Psychology; Engineering ethics; Family medicine; Engineering; Biology; Genetics; Genotype","score_opus":0.5804898949683032,"score_gpt":0.6605198470699329,"score_spread":0.08002995210162978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395022322","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055436613,0.11625646,0.041737616,0.7468223,0.011844688,0.0071084434,0.0060682935,0.0018547055,0.062763885],"genre_scores_gemma":[0.06256427,0.11262316,0.4401632,0.34395775,0.0050074616,0.015509857,0.010157401,0.0006737332,0.009343197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.87467825,0.070617594,0.033733733,0.003087622,0.015401067,0.0024817218],"domain_scores_gemma":[0.6283624,0.18319058,0.035839304,0.007901067,0.13715158,0.0075550824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08433182,0.0011531931,0.0019043103,0.008903549,0.0026944883,0.006271537,0.005302383,0.011157084,0.009643725],"category_scores_gemma":[0.3254468,0.0013718101,0.005125283,0.008523049,0.0031193618,0.006358513,0.004527108,0.011779664,0.0040991],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015269287,0.00027006504,0.0065463907,0.015413923,0.00037743206,0.0007101383,0.0029926023,0.0013478626,0.0005728692,0.017149497,0.62924045,0.32522616],"study_design_scores_gemma":[0.00068985095,0.00021083113,0.0091136,0.14745633,0.0010202184,0.0010514518,0.0037000866,0.0017437575,0.00090748485,0.032898933,0.8008967,0.00031077507],"about_ca_topic_score_codex":0.026184097,"about_ca_topic_score_gemma":0.03779753,"teacher_disagreement_score":0.08433182,"about_ca_system_score_codex":0.007916653,"about_ca_system_score_gemma":0.048476644,"threshold_uncertainty_score":0.44599462},"labels":[],"label_agreement":null},{"id":"W4395034505","doi":"10.1055/s-0044-1779566","title":"Pharmacogenetics in Psychiatry: Precision medicine or ‘mystic, magic, and mysterious’?","year":2024,"lang":"en","type":"article","venue":"Pharmacopsychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Pharmacogenetics; MAGIC (telescope); Mysticism; Precision medicine; Medicine; Psychiatry; Psychology; Computer science; Philosophy; Physics; Theology; Biology; Astronomy; Genetics","score_opus":0.10913207041235133,"score_gpt":0.4850029080486718,"score_spread":0.37587083763632045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395034505","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002000478,0.4707061,0.028771607,0.48733315,0.0050729117,0.00005189652,0.00021650645,0.00020627877,0.0056410856],"genre_scores_gemma":[0.12721147,0.56533027,0.054832403,0.21824296,0.031140627,0.00019078494,0.0002899567,0.00012259216,0.0026388965],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9817266,0.012256493,0.0013192601,0.0014266833,0.0028909328,0.00038005016],"domain_scores_gemma":[0.9092931,0.07453031,0.0043928623,0.0060460586,0.004704034,0.0010336398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046808008,0.00090332504,0.003371669,0.0027269516,0.0014154877,0.006131542,0.0022805778,0.004730966,0.002925445],"category_scores_gemma":[0.060379937,0.0006580123,0.0013978201,0.002382968,0.016622031,0.011697485,0.0036742107,0.009448974,0.0010015024],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040594823,0.00011881712,0.009271906,0.0067657814,0.001141202,0.00071650016,0.0018490197,0.0013712302,0.0011660153,0.18723668,0.09199505,0.6979619],"study_design_scores_gemma":[0.00013851168,0.0003306557,0.0072741415,0.013277456,0.0006017666,0.0020753753,0.0015597827,0.0014646607,0.00080058264,0.72373784,0.24853462,0.00020457566],"about_ca_topic_score_codex":0.0030174272,"about_ca_topic_score_gemma":0.004191604,"teacher_disagreement_score":0.046808008,"about_ca_system_score_codex":0.003029979,"about_ca_system_score_gemma":0.0064342422,"threshold_uncertainty_score":0.24754733},"labels":[],"label_agreement":null},{"id":"W4396495613","doi":"10.5376/ijccr.2024.14.0007","title":"The Impact of Drug Metabolism Enzyme Gene Polymorphism on Drug Response","year":2024,"lang":"en","type":"article","venue":"International Journal of Clinical Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug metabolism; Drug; Gene; Polymorphism (computer science); Enzyme; Drug response; Genetics; Biology; Pharmacology; Biochemistry; Genotype","score_opus":0.13401931629282618,"score_gpt":0.5416623980489467,"score_spread":0.4076430817561205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396495613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9124532,0.061281644,0.0023893006,0.005128771,0.00017965355,0.000041143794,0.00060606713,0.00006064021,0.017859481],"genre_scores_gemma":[0.9929744,0.005420659,0.00039081447,0.00040416422,0.00007447537,0.0000063285534,0.000121808946,0.0000133676185,0.0005940331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990289,0.00042296437,0.00011348388,0.00013389917,0.00019956322,0.00010109303],"domain_scores_gemma":[0.99784243,0.001326504,0.0004893789,0.00008013133,0.0001570852,0.00010436952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058179937,0.00014943033,0.00047915103,0.00037954858,0.0001840334,0.000562344,0.00018204573,0.00042742846,0.0021585084],"category_scores_gemma":[0.004630241,0.000064280175,0.0004087971,0.0006283051,0.00035072083,0.00031126564,0.00019657098,0.0006188768,0.0003230593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019528328,0.00022986854,0.759322,0.0005713747,0.00065295503,0.024525993,0.00044147702,0.0013080171,0.016919285,0.003064867,0.002779181,0.18823218],"study_design_scores_gemma":[0.000046445904,0.0006704306,0.91340846,0.00021383195,0.00065696944,0.048843574,0.0005303702,0.0017942535,0.0062876674,0.004010933,0.023485335,0.00005172908],"about_ca_topic_score_codex":0.0009560497,"about_ca_topic_score_gemma":0.0006019587,"teacher_disagreement_score":0.0021585084,"about_ca_system_score_codex":0.0004532704,"about_ca_system_score_gemma":0.00026383883,"threshold_uncertainty_score":0.0072209835},"labels":[],"label_agreement":null},{"id":"W4396946152","doi":"10.1016/s0140-6736(24)00709-8","title":"Totality of evidence refutes neoplasm risk with fezolinetant","year":2024,"lang":"en","type":"letter","venue":"The Lancet","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Astellas Pharma","keywords":"Philosophy","score_opus":0.31758362272187646,"score_gpt":0.4642884210715953,"score_spread":0.14670479834971883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396946152","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009529586,0.0036131998,0.00021378622,0.9707271,0.012955084,0.000014734488,0.00024373464,0.00003681949,0.011242635],"genre_scores_gemma":[0.013954961,0.0016325344,0.00043024184,0.94247985,0.036150593,0.000026161733,0.00013168145,0.000036290807,0.005157745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.986257,0.0043625613,0.0022139994,0.0015095314,0.0041374494,0.0015194691],"domain_scores_gemma":[0.88516724,0.09013321,0.0056244954,0.0034688874,0.009452508,0.0061536273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01569259,0.00080814713,0.0026501755,0.0020689454,0.0032247028,0.0056291497,0.004250555,0.08681461,0.008419926],"category_scores_gemma":[0.096852764,0.0010965336,0.0031298227,0.0019282902,0.005492993,0.0026684033,0.0022090687,0.03975874,0.00839252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007008482,0.000050299437,0.004479119,0.00048456187,0.00040796414,0.004524535,0.00019764579,0.00017626252,0.0006819622,0.012554287,0.94896644,0.026776105],"study_design_scores_gemma":[0.00090277626,0.00031992752,0.00492325,0.002876562,0.0009824856,0.0058779716,0.0003340784,0.00078700366,0.0014951037,0.053947944,0.9274144,0.0001383948],"about_ca_topic_score_codex":0.007326589,"about_ca_topic_score_gemma":0.013200877,"teacher_disagreement_score":0.08681461,"about_ca_system_score_codex":0.0044971476,"about_ca_system_score_gemma":0.00800123,"threshold_uncertainty_score":0.08299136},"labels":[],"label_agreement":null},{"id":"W4398195102","doi":"10.1007/978-3-030-73317-9_93-1","title":"An Introduction to Safety Pharmacokinetics","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacology","score_opus":0.07881437904304522,"score_gpt":0.4278404040705888,"score_spread":0.3490260250275436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398195102","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095203205,0.15799373,0.08704811,0.011245051,0.011577078,0.00023462,0.0021762312,0.0019963137,0.7267768],"genre_scores_gemma":[0.0034577693,0.05409817,0.01691345,0.0056556705,0.0032305873,0.00015301477,0.00078596873,0.0005637238,0.9151416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958354,0.00007688786,0.000020338584,0.000053027055,0.00024660566,0.000019553065],"domain_scores_gemma":[0.99941075,0.0003454259,0.000028110098,0.000041336236,0.00014877517,0.00002562961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006800642,0.0012562164,0.00093708554,0.0014906845,0.00040389292,0.0016743278,0.0008038365,0.0014999784,0.080118164],"category_scores_gemma":[0.0014752187,0.00052867766,0.0006209497,0.0011450481,0.0005145967,0.0019037792,0.00088884647,0.0029760257,0.05902961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041482977,0.000098152625,0.00006184714,0.00053682114,0.000011429098,0.00014637785,0.00008233928,0.0014274674,0.0018026888,0.042820822,0.48414376,0.4688268],"study_design_scores_gemma":[0.000004387267,0.00003840775,0.00009515978,0.00019676013,0.0000049784653,0.00032759362,0.000012271792,0.00037872835,0.00038685164,0.022610359,0.975935,0.000009494037],"about_ca_topic_score_codex":0.0010291256,"about_ca_topic_score_gemma":0.0019022342,"teacher_disagreement_score":0.080118164,"about_ca_system_score_codex":0.0008758477,"about_ca_system_score_gemma":0.0009078515,"threshold_uncertainty_score":0.26802194},"labels":[],"label_agreement":null},{"id":"W4398251719","doi":"10.1038/s41380-024-02588-4","title":"Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients","year":2024,"lang":"en","type":"article","venue":"Molecular Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; CYP2D6; CYP2C19; Medicine; Pharmacogenetics; Allele; Haplotype; Psychiatry; Genetics; Pharmacology; Biology; Internal medicine; Genotype; Gene","score_opus":0.02195494573506975,"score_gpt":0.3488336787059868,"score_spread":0.3268787329709171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398251719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998628,0.0003018213,0.00025494018,0.00010685285,0.0000035714893,0.000008780389,0.00047130222,0.000006949643,0.0002177556],"genre_scores_gemma":[0.9991283,0.00015178298,0.00025923864,0.00007678903,0.000009309536,0.000007674581,0.00031049683,0.0000026719877,0.000053858115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898666,0.0002649795,0.00014184952,0.0003389466,0.00017555163,0.000092083355],"domain_scores_gemma":[0.99803835,0.00047485405,0.0009348349,0.00018245309,0.00015732505,0.0002123059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082144066,0.00023225129,0.00033901175,0.000884209,0.0004914733,0.00077207305,0.00031033787,0.0004311405,0.0010412158],"category_scores_gemma":[0.003830456,0.00035873798,0.00040121283,0.0013844175,0.00038992675,0.0004473986,0.00069241365,0.0006701889,0.00020025199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040124454,0.000011951352,0.99745995,0.0000062423333,0.00003068827,0.00009067599,0.000062493054,0.00004143045,0.00026121872,0.000017960345,0.000087684166,0.0018896023],"study_design_scores_gemma":[0.000007875389,0.00005048689,0.9982632,0.000005779671,0.00002949526,0.0006846111,0.000100657424,0.00046670015,0.00013523755,0.000052670675,0.0001995436,0.0000038115197],"about_ca_topic_score_codex":0.0047139195,"about_ca_topic_score_gemma":0.0052646045,"teacher_disagreement_score":0.0047139195,"about_ca_system_score_codex":0.0004177827,"about_ca_system_score_gemma":0.00024346233,"threshold_uncertainty_score":0.00937295},"labels":[],"label_agreement":null},{"id":"W4399125390","doi":"10.1080/17425255.2024.2362190","title":"Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Drug; Pharmacogenetics; Medicine; Pharmacology; Epilepsy; Biology; Genetics; Genotype; Psychiatry; Gene","score_opus":0.03801018489628528,"score_gpt":0.40443367718177314,"score_spread":0.3664234922854879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399125390","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008837703,0.09462681,0.00026985712,0.060818553,0.8398614,0.000033191456,0.00018056824,0.00007041356,0.004050834],"genre_scores_gemma":[0.00062919216,0.058823016,0.00017879058,0.035489727,0.896478,0.000022456361,0.00012709746,0.000030730553,0.008221049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838805,0.0003267783,0.00016974146,0.00022367915,0.0007715668,0.00012014476],"domain_scores_gemma":[0.9944818,0.0027113121,0.00040786032,0.00008793796,0.001850249,0.00046093602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025951664,0.0017915018,0.0021006374,0.0014663299,0.00094646314,0.0020804468,0.002335498,0.0071902024,0.015496903],"category_scores_gemma":[0.008299201,0.0005015504,0.0014144166,0.00079587696,0.0009962693,0.002757208,0.00090521795,0.009793314,0.01036345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058628037,0.000009444515,0.00003098285,0.00062899035,0.000023450197,0.00010310119,0.000009898115,0.000016182077,0.00007751163,0.00030657728,0.98065037,0.01808482],"study_design_scores_gemma":[0.000097008844,0.000046645826,0.0003053749,0.0012328717,0.00011253588,0.0005832071,0.000023049839,0.00007368671,0.000099987104,0.0010354149,0.996376,0.000014238375],"about_ca_topic_score_codex":0.0011667797,"about_ca_topic_score_gemma":0.0030500598,"teacher_disagreement_score":0.015496903,"about_ca_system_score_codex":0.0010805597,"about_ca_system_score_gemma":0.0015270959,"threshold_uncertainty_score":0.051842332},"labels":[],"label_agreement":null},{"id":"W4399590993","doi":"10.1002/cpt.3338","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2B6</i> Genotype and Methadone Therapy","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health; National Human Genome Research Institute; Universidad Autónoma de Madrid; National Institute of General Medical Sciences; Canada Research Chairs","keywords":"Methadone; CYP2B6; Pharmacogenetics; Pharmacology; Medicine; Opioid; Context (archaeology); Opioid use disorder; Pharmacokinetics; Anesthesia; Genotype; Internal medicine; Chemistry; Metabolism; CYP3A4; Receptor; Biology; Cytochrome P450","score_opus":0.5190700035271528,"score_gpt":0.6601642049216446,"score_spread":0.1410942013944918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399590993","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053005973,0.047487114,0.11308744,0.34864756,0.012148402,0.014843312,0.025711639,0.0070997137,0.42567423],"genre_scores_gemma":[0.042620823,0.07165114,0.3022635,0.330364,0.010806524,0.04018252,0.06509817,0.0028910975,0.13412231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9737007,0.013226134,0.004976744,0.0010337323,0.0059143202,0.0011482924],"domain_scores_gemma":[0.94705087,0.020861708,0.0045979084,0.0028450675,0.022090912,0.0025535899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02176743,0.0010600651,0.0018065202,0.0024180824,0.0009658645,0.0030029307,0.0049403687,0.008590077,0.024184968],"category_scores_gemma":[0.055284772,0.0008469566,0.0034631768,0.0028589813,0.0010531388,0.0019847096,0.0025305853,0.008654694,0.01972553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020817868,0.0003256319,0.0018618095,0.0012983179,0.000072222414,0.000542314,0.0002745288,0.0005751778,0.00070606533,0.007889532,0.80121315,0.18503311],"study_design_scores_gemma":[0.0005035715,0.00019653024,0.005688714,0.0071152076,0.00014621165,0.0011264116,0.00018157,0.0008089396,0.00075669657,0.007208329,0.97620505,0.00006272456],"about_ca_topic_score_codex":0.011958816,"about_ca_topic_score_gemma":0.014453136,"teacher_disagreement_score":0.024184968,"about_ca_system_score_codex":0.0023164912,"about_ca_system_score_gemma":0.013191161,"threshold_uncertainty_score":0.1151185},"labels":[],"label_agreement":null},{"id":"W4399634301","doi":"10.33552/appr.2020.02.000546","title":"Is Dexamethasone a Substrate, an Inducer, or a Substrate-Inducer of CYP3As?","year":2020,"lang":"en","type":"article","venue":"Archives of Pharmacy & Pharmacology Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Inducer; Substrate (aquarium); Dexamethasone; Chemistry; Biology; Biochemistry; Ecology; Endocrinology","score_opus":0.49554042035332735,"score_gpt":0.5653964294270049,"score_spread":0.0698560090736775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399634301","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036713343,0.91590196,0.005928001,0.026420249,0.002840396,0.000090385,0.0008756093,0.00010240019,0.0111276135],"genre_scores_gemma":[0.2800185,0.6965578,0.0025520923,0.010104445,0.0048062936,0.00008370953,0.00089058926,0.000033153716,0.004953306],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804074,0.000468296,0.00031639988,0.0004091043,0.000594056,0.00017153396],"domain_scores_gemma":[0.99807715,0.00082948635,0.0005672634,0.00011657979,0.0002765805,0.00013279846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016153429,0.0005669006,0.0016379062,0.0008514755,0.00041509117,0.002590378,0.0010065007,0.0030200032,0.0023946385],"category_scores_gemma":[0.0031443317,0.0002803577,0.000838261,0.0016965171,0.0020682141,0.001708044,0.0004599015,0.001262975,0.0013403422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003320238,0.0004385191,0.075947925,0.025083944,0.0010719178,0.020901537,0.000698212,0.00047424855,0.08759445,0.029154953,0.025116187,0.7301979],"study_design_scores_gemma":[0.0002831964,0.002691161,0.08018235,0.0028162498,0.0015941787,0.061727695,0.0025985183,0.00049374334,0.09790133,0.02068756,0.7288011,0.0002229495],"about_ca_topic_score_codex":0.0015134268,"about_ca_topic_score_gemma":0.0012719157,"teacher_disagreement_score":0.0030200032,"about_ca_system_score_codex":0.001216257,"about_ca_system_score_gemma":0.0011899337,"threshold_uncertainty_score":0.0088246465},"labels":[],"label_agreement":null},{"id":"W4399643619","doi":"10.1080/10408444.2024.2353174","title":"Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Syngenta (Canada)","funders":"","keywords":"Toxicodynamics; Extrapolation; Toxicokinetics; In vivo; Biology; Pharmacology; Computational biology; Statistics; Pharmacokinetics; Mathematics; Biotechnology","score_opus":0.6152899435320234,"score_gpt":0.616036910959938,"score_spread":0.0007469674279145799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399643619","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25861463,0.026727613,0.6268923,0.0018968321,0.0007487103,0.002460464,0.037650988,0.0031803548,0.041828066],"genre_scores_gemma":[0.7585271,0.006584077,0.2089824,0.0013988784,0.000092373964,0.0018264172,0.017375851,0.00080062915,0.004412208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98679745,0.006333313,0.0013526429,0.0017673817,0.0034700118,0.00027915704],"domain_scores_gemma":[0.96284115,0.021382106,0.0051737865,0.0033420615,0.006988703,0.00027216814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027003983,0.001466719,0.0009805678,0.002327128,0.0004989057,0.0017884354,0.0010869581,0.0012069448,0.0036868611],"category_scores_gemma":[0.044919703,0.00045120393,0.0031296501,0.0016876358,0.00059753127,0.0011217261,0.0013366076,0.002105057,0.0011995632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007923899,0.00074750575,0.16382463,0.007568612,0.0038306327,0.0013308299,0.0012501841,0.118365474,0.03595181,0.01973032,0.023817113,0.61565906],"study_design_scores_gemma":[0.0006595776,0.012145247,0.22471303,0.005523753,0.0041851467,0.008206657,0.0017242851,0.114391,0.16527502,0.03943265,0.42259276,0.0011508324],"about_ca_topic_score_codex":0.005053806,"about_ca_topic_score_gemma":0.0048568896,"teacher_disagreement_score":0.027003983,"about_ca_system_score_codex":0.0014963249,"about_ca_system_score_gemma":0.0018854629,"threshold_uncertainty_score":0.14281243},"labels":[],"label_agreement":null},{"id":"W4399670224","doi":"10.1124/pharmrev.124.001017","title":"Pharmacology and Precision Medicine—Preparing for the Next Era in Clinical Medicine—Editorial","year":2024,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Honor; Privilege (computing); Engineering ethics; Medicine; Political science; Law; Computer science; Engineering","score_opus":0.5457612831235339,"score_gpt":0.6281871811351069,"score_spread":0.08242589801157296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670224","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110823246,0.49110273,0.0005038386,0.034606863,0.47077048,0.000034752862,0.00009442195,0.00008223464,0.0026938717],"genre_scores_gemma":[0.0011001561,0.4417187,0.00049601187,0.037336674,0.51121294,0.000036041143,0.00013964345,0.00003157671,0.007928292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869317,0.00032402677,0.0001445951,0.00013791467,0.00059692806,0.00010329904],"domain_scores_gemma":[0.9957675,0.0015939448,0.0003820983,0.00010045548,0.0015771217,0.0005788565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024110314,0.0013742094,0.002132218,0.0019085766,0.00052825554,0.0030248351,0.0015622823,0.003304696,0.0076737422],"category_scores_gemma":[0.005909932,0.0003104675,0.00087836717,0.0012070714,0.00074695126,0.0030598713,0.00129104,0.005222256,0.0053129587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074533076,0.000023295028,0.000033845194,0.0018528489,0.000044651377,0.00009360094,0.000013873862,0.00004571623,0.00020368777,0.0010236414,0.92244595,0.0741444],"study_design_scores_gemma":[0.000049667542,0.00004463819,0.00023246818,0.0017985374,0.000069117865,0.0003907605,0.000024170735,0.00007923578,0.00009243621,0.0015475275,0.99565816,0.0000132114055],"about_ca_topic_score_codex":0.0005379615,"about_ca_topic_score_gemma":0.001594249,"teacher_disagreement_score":0.0076737422,"about_ca_system_score_codex":0.00093926623,"about_ca_system_score_gemma":0.0025586344,"threshold_uncertainty_score":0.025671244},"labels":[],"label_agreement":null},{"id":"W4399805744","doi":"10.1038/s41574-024-01011-w","title":"Mind the (human-based new approach methodology) gap!","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science; Psychology; Cognitive science","score_opus":0.5687607096110431,"score_gpt":0.5905776517575271,"score_spread":0.021816942146483997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399805744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030770482,0.8687214,0.017465439,0.07812093,0.019587347,0.0000478454,0.0002747442,0.00045281084,0.015021736],"genre_scores_gemma":[0.00708002,0.8291766,0.023736885,0.100294225,0.016478367,0.00018392381,0.00045620018,0.00042243153,0.022171373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973322,0.0011295499,0.0001674507,0.00031798263,0.0008835328,0.00016941068],"domain_scores_gemma":[0.9937038,0.0040682266,0.00028055505,0.0005833862,0.0010116867,0.00035241342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011518732,0.0011920035,0.0022641832,0.0013662018,0.00065162434,0.0053963866,0.0026741705,0.0060077147,0.022020904],"category_scores_gemma":[0.006870529,0.0005072675,0.0015328104,0.0010882989,0.004939459,0.0106849745,0.0042934334,0.011407552,0.0154269505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023436212,0.00013577666,0.00022504889,0.009099425,0.00018290397,0.00029501348,0.0003111797,0.00034567327,0.0025639748,0.16769509,0.29051536,0.5283962],"study_design_scores_gemma":[0.000023675368,0.00008147063,0.00015703576,0.0014715653,0.00004340027,0.00028062516,0.00009412334,0.00007179891,0.0004036885,0.034147363,0.96320146,0.000023722649],"about_ca_topic_score_codex":0.0014599735,"about_ca_topic_score_gemma":0.0017779049,"teacher_disagreement_score":0.022020904,"about_ca_system_score_codex":0.0014165046,"about_ca_system_score_gemma":0.004223552,"threshold_uncertainty_score":0.07366729},"labels":[],"label_agreement":null},{"id":"W4399903684","doi":"10.3399/bjgp24x737901","title":"Pharmacogenomics in primary care: a quality improvement project at Alconbury and Brampton surgeries 2019–2023","year":2024,"lang":"en","type":"article","venue":"British Journal of General Practice","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Medical prescription; Primary care; Pharmacogenetics; Adverse effect; Genetic testing; CYP2C19; Intensive care medicine; Drug; Pediatrics; Internal medicine; Family medicine; Psychiatry; Pharmacology; Genotype","score_opus":0.07444806620528673,"score_gpt":0.442867335041007,"score_spread":0.3684192688357203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399903684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5383971,0.019402005,0.013015563,0.3282483,0.0021360102,0.008730224,0.03417199,0.0025911622,0.05330766],"genre_scores_gemma":[0.7683118,0.015723329,0.08316794,0.048770048,0.001633937,0.0058465684,0.032271694,0.0007106443,0.04356399],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98164314,0.0065775644,0.0008801846,0.0014392275,0.0068657575,0.0025940447],"domain_scores_gemma":[0.8950795,0.008461221,0.006864743,0.0038502428,0.024989348,0.060754947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023054624,0.00043317457,0.00054410123,0.001746161,0.003038592,0.004549289,0.0024212294,0.0015098347,0.01247047],"category_scores_gemma":[0.026098322,0.00063212274,0.0006402688,0.003814626,0.0018715122,0.0018080736,0.0054596397,0.0024373946,0.0016045131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016595909,0.0027349754,0.30975917,0.0015794352,0.00035433148,0.0010217361,0.0049053817,0.0011117953,0.003992339,0.0022307832,0.22327878,0.44737166],"study_design_scores_gemma":[0.0009919549,0.001390659,0.91207623,0.0006388944,0.00008566077,0.00031744086,0.0025696482,0.0014337671,0.00047469093,0.0003613411,0.07960637,0.00005325829],"about_ca_topic_score_codex":0.39066708,"about_ca_topic_score_gemma":0.44062313,"teacher_disagreement_score":0.39066708,"about_ca_system_score_codex":0.02679664,"about_ca_system_score_gemma":0.11591196,"threshold_uncertainty_score":0.7767863},"labels":[],"label_agreement":null},{"id":"W4399940744","doi":"10.1080/15622975.2024.2366235","title":"Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics","year":2024,"lang":"en","type":"review","venue":"The World Journal of Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Janssen Biotech; Japan Society for the Promotion of Science; Italfarmaco; H. Lundbeck A/S; Angelini Pharma; Boehringer Ingelheim; ZonMw; Takeda Pharmaceutical Company; AbbVie; GlaxoSmithKline; Servier; Sanofi-Aventis Deutschland; Pfizer; Astellas Pharma; Abbott Fund","keywords":"Pharmacogenetics; Pharmacotherapy; Psychiatry; Medicine; Drug; Schizophrenia (object-oriented programming); Drug response; Antipsychotic drug; Psychology; Antipsychotic; Pharmacology; Biology; Genotype","score_opus":0.12974375704468197,"score_gpt":0.48533450961602626,"score_spread":0.3555907525713443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399940744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018051527,0.9605097,0.008062241,0.022563947,0.0004940377,0.000045888137,0.00014551572,0.0001302557,0.006243182],"genre_scores_gemma":[0.02986501,0.9459678,0.014006667,0.006489786,0.0018125705,0.00006904563,0.00018189229,0.00004806538,0.0015591691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981171,0.0009049592,0.00022963092,0.00023563828,0.00044382477,0.000068900445],"domain_scores_gemma":[0.9952242,0.0029349746,0.0006283555,0.00012576766,0.0009150068,0.00017179274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033646422,0.00083473034,0.0014327611,0.0016291195,0.00021587223,0.0014433098,0.00063169363,0.001225065,0.0022768702],"category_scores_gemma":[0.0053653135,0.00021123361,0.0008078796,0.0012402004,0.00089755916,0.0018847676,0.00085186877,0.0022742017,0.0010731636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015046926,0.00009123289,0.0027625812,0.009565585,0.00028083145,0.00041750865,0.00012644092,0.0009915981,0.002172923,0.007080927,0.023769384,0.95259047],"study_design_scores_gemma":[0.00012630841,0.0006715401,0.024118304,0.021618003,0.0009728892,0.006575767,0.00044488817,0.002123058,0.003685965,0.040049396,0.899465,0.00014883536],"about_ca_topic_score_codex":0.0017638995,"about_ca_topic_score_gemma":0.0030182537,"teacher_disagreement_score":0.0033646422,"about_ca_system_score_codex":0.0013808997,"about_ca_system_score_gemma":0.0025646712,"threshold_uncertainty_score":0.017794132},"labels":[],"label_agreement":null},{"id":"W4399996207","doi":"10.1097/fpc.0000000000000541","title":"Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Health care; Pharmacogenetics; Test (biology); Clinical Practice; Family medicine; Clinical decision support system; Medicine","score_opus":0.15340570376545057,"score_gpt":0.5266863950790736,"score_spread":0.37328069131362296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399996207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971199,0.0014287418,0.0011377704,0.01815981,0.000065064676,0.000048617007,0.000122036545,0.000015997242,0.007823027],"genre_scores_gemma":[0.9968663,0.0006552828,0.0006665063,0.0015419848,0.00004040599,0.000020673804,0.000034818724,0.000003897027,0.00017001177],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.97526634,0.019681202,0.0011261042,0.0005490531,0.0022481747,0.0011291744],"domain_scores_gemma":[0.9584263,0.024833968,0.010144172,0.00050128077,0.0030203983,0.0030738653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010872586,0.00015353048,0.00021863486,0.00046666965,0.001018749,0.0021558735,0.0003365645,0.0010861326,0.003147424],"category_scores_gemma":[0.03861932,0.00025279724,0.00038329654,0.00034501974,0.00093128235,0.0015014324,0.0015197861,0.0010852184,0.00028566006],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006075071,0.00065994984,0.6502338,0.0010752825,0.00023980203,0.0026246586,0.21413706,0.000517765,0.003177023,0.0017230301,0.006589622,0.11841443],"study_design_scores_gemma":[0.00016231791,0.0020102079,0.51283926,0.0017788,0.00019776,0.0051918826,0.43843392,0.0019268232,0.0017820549,0.0014319884,0.034067035,0.00017796815],"about_ca_topic_score_codex":0.0037321155,"about_ca_topic_score_gemma":0.0029610277,"teacher_disagreement_score":0.010872586,"about_ca_system_score_codex":0.0013946015,"about_ca_system_score_gemma":0.0027516165,"threshold_uncertainty_score":0.057500422},"labels":[],"label_agreement":null},{"id":"W4400167090","doi":"10.1248/yakushi.23-00204","title":"Evaluation of Sources of Drug Interaction Information for Nirmatrelvir/ritonavir","year":2024,"lang":"en","type":"article","venue":"YAKUGAKU ZASSHI","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Consistency (knowledge bases); Package insert; Drug; Ritonavir; Extended release; Family medicine; Pharmacology; Human immunodeficiency virus (HIV); Computer science; Antiretroviral therapy; Viral load","score_opus":0.15626776307171508,"score_gpt":0.4933173106341657,"score_spread":0.3370495475624506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400167090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67855585,0.018896267,0.013760156,0.0020448295,0.00021860683,0.0006684477,0.27725968,0.0020139224,0.0065821903],"genre_scores_gemma":[0.55241317,0.0029132382,0.028027551,0.00036322107,0.00015171285,0.00031568483,0.4148871,0.00020520916,0.00072317885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9822826,0.006455483,0.0034540237,0.0029202725,0.004392293,0.00049534935],"domain_scores_gemma":[0.87528545,0.09227398,0.013481969,0.0072777914,0.010551777,0.0011290058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01797407,0.0014415166,0.0014969619,0.021890853,0.00077084097,0.0028433152,0.0017566727,0.0017066468,0.0017806361],"category_scores_gemma":[0.07348853,0.000491671,0.0022811354,0.0131537225,0.00046676732,0.0035259689,0.002461056,0.0010556771,0.00070752064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040349523,0.0008871407,0.7730703,0.0089672785,0.0050186184,0.0014764366,0.0011634507,0.016364224,0.0022259846,0.0022617385,0.024857964,0.1596719],"study_design_scores_gemma":[0.0011068395,0.0013803785,0.7196944,0.005314074,0.0078116413,0.0039178985,0.0027802815,0.13975853,0.014544801,0.004308006,0.098907374,0.0004758338],"about_ca_topic_score_codex":0.008400202,"about_ca_topic_score_gemma":0.006377815,"teacher_disagreement_score":0.021890853,"about_ca_system_score_codex":0.0014098703,"about_ca_system_score_gemma":0.0026187706,"threshold_uncertainty_score":0.09505707},"labels":[],"label_agreement":null},{"id":"W4400255781","doi":"10.2147/tacg.s463965","title":"The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine","year":2024,"lang":"en","type":"article","venue":"The Application of Clinical Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Mahidol University; Rangsit University; Thailand Center of Excellence for Life Sciences","keywords":"CYP2C19; Diversity (politics); Precision medicine; Korean population; Genetics; Medicine; Biology; Genotype; Internal medicine; Gene; Sociology; Anthropology","score_opus":0.3070593084405237,"score_gpt":0.5653913490503782,"score_spread":0.25833204060985454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400255781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898976,0.0048746695,0.0019378368,0.0007419673,0.000040151623,0.000025610723,0.00051846856,0.000013612122,0.0019501989],"genre_scores_gemma":[0.99788696,0.001047633,0.0005140787,0.000086666245,0.00006603408,0.000014540193,0.0002296176,0.0000038025541,0.00015058115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932504,0.00024798338,0.000067223555,0.00018239064,0.00012377364,0.00005365748],"domain_scores_gemma":[0.99852437,0.00049818435,0.0006164017,0.000083387655,0.00014733999,0.00013030937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009137153,0.00027161933,0.00036660582,0.0007025074,0.0004543235,0.0009620091,0.0002528447,0.00027776547,0.002058909],"category_scores_gemma":[0.0020022038,0.0001517435,0.00031388566,0.0016685439,0.0005723002,0.00047278235,0.00030847802,0.00038721357,0.00012249492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019912036,0.000041144453,0.9721175,0.00012745404,0.00021475641,0.0013116928,0.0008189195,0.00032928577,0.0021152555,0.00040294233,0.00057500385,0.021746855],"study_design_scores_gemma":[0.00002750311,0.0001953588,0.9885417,0.00009288118,0.00019013992,0.0041202176,0.0011126217,0.0012369002,0.000543519,0.0016355899,0.0022781035,0.000025294585],"about_ca_topic_score_codex":0.002822919,"about_ca_topic_score_gemma":0.0020202508,"teacher_disagreement_score":0.002822919,"about_ca_system_score_codex":0.000214389,"about_ca_system_score_gemma":0.0003346957,"threshold_uncertainty_score":0.0068877935},"labels":[],"label_agreement":null},{"id":"W4400391710","doi":"10.1016/j.vascn.2024.107536","title":"Effects of species of origin and mode of induction of microsomes on carbamazepine-induced cell toxicity","year":2024,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Toxicity; In vitro; Microsome; Cytotoxicity; Carbamazepine; Clofibrate; Chemistry; Biology; Biochemistry","score_opus":0.14554465809443098,"score_gpt":0.5017164650487971,"score_spread":0.3561718069543661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400391710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857856,0.0029642605,0.0039665527,0.0001881934,0.00007893301,0.000120022836,0.0008276965,0.00012626107,0.003149527],"genre_scores_gemma":[0.992652,0.0015882981,0.0025525352,0.000076522425,0.000015951086,0.00007872955,0.00103631,0.000035024463,0.001964673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994561,0.00021265373,0.000071554154,0.00009117315,0.00011772853,0.000050696017],"domain_scores_gemma":[0.9995198,0.00015864645,0.00009381249,0.00010043421,0.00008762409,0.000039749728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038765845,0.00034179146,0.00029066586,0.00032190455,0.00018077902,0.00040544814,0.00014827285,0.0002308736,0.0013772793],"category_scores_gemma":[0.00070366455,0.00014573481,0.0002787412,0.00024241072,0.00025707603,0.00023922704,0.0003028322,0.0005239427,0.00036320175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051009114,0.000075010044,0.000834169,0.000047663372,0.00002433151,0.00010642548,0.000043564236,0.00005469993,0.9960996,0.000054577995,0.00006508544,0.0020847146],"study_design_scores_gemma":[0.000014514916,0.0009477636,0.007891289,0.000008987008,0.000059210885,0.00032678203,0.000056019497,0.00018161607,0.9886376,0.00003231208,0.0018354909,0.000008533986],"about_ca_topic_score_codex":0.0010358118,"about_ca_topic_score_gemma":0.0016769366,"teacher_disagreement_score":0.0013772793,"about_ca_system_score_codex":0.00023539018,"about_ca_system_score_gemma":0.0002385765,"threshold_uncertainty_score":0.0046074986},"labels":[],"label_agreement":null},{"id":"W4400440181","doi":"10.1016/j.abb.2024.110088","title":"Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib)","year":2024,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Ponatinib; Tofacitinib; Aryl hydrocarbon receptor; Pharmacology; Chemistry; Tyrosine kinase; Transcription factor; Cancer research; Signal transduction; Biology; Biochemistry; Dasatinib; Immunology; Rheumatoid arthritis","score_opus":0.026463369011650067,"score_gpt":0.3387403461492126,"score_spread":0.31227697713756253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400440181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443347,0.010326136,0.029176936,0.0004325295,0.00008693214,0.00006738095,0.0009545575,0.00041872932,0.014202155],"genre_scores_gemma":[0.99185103,0.0028336237,0.0034682394,0.000050639897,0.0000071875816,0.00003953423,0.00039298707,0.00001686303,0.0013398334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992883,0.000010119987,0.000003140331,0.000014086113,0.000023640427,0.000020217796],"domain_scores_gemma":[0.99998224,0.000005053601,0.0000059100107,0.0000015554085,0.0000023019345,0.0000028908296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077179,0.00025569712,0.00032079153,0.00008037813,0.00015420008,0.00026967732,0.000348055,0.00027707964,0.0019163167],"category_scores_gemma":[0.000129981,0.00010532828,0.00037567204,0.00016148327,0.00014457892,0.00030322451,0.00023037006,0.00031368106,0.00032717138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012019334,0.00042937664,0.0061247204,0.0017139707,0.0003128094,0.0010226405,0.000109052475,0.4326515,0.45706674,0.010987498,0.0036114287,0.0847684],"study_design_scores_gemma":[0.00071474037,0.0029034188,0.0063821725,0.00005436958,0.00025297503,0.0011152616,0.00018646148,0.62852764,0.30688876,0.005159433,0.04771994,0.00009489541],"about_ca_topic_score_codex":0.0016823009,"about_ca_topic_score_gemma":0.0013527077,"teacher_disagreement_score":0.0019163167,"about_ca_system_score_codex":0.00025458957,"about_ca_system_score_gemma":0.00034377276,"threshold_uncertainty_score":0.006410718},"labels":[],"label_agreement":null},{"id":"W4400643063","doi":"10.3390/biom14070850","title":"Hepatic Gene Expression and Metabolite Profiles of Androstenone and Skatole Relative to Plasma Estrone Sulfate Levels in Boars","year":2024,"lang":"en","type":"article","venue":"Biomolecules","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canada First Research Excellence Fund","keywords":"Androstenone; Estrone sulfate; Estrone; Metabolite; Skatole; Internal medicine; Endocrinology; Chemistry; Biology; Estrogen; Biochemistry; Medicine","score_opus":0.06719651469228174,"score_gpt":0.3978443840954117,"score_spread":0.33064786940312996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400643063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957171,0.0010093193,0.0011325923,0.000051227653,0.000017924041,0.000013651427,0.0013036673,0.000025988802,0.0007284702],"genre_scores_gemma":[0.9857428,0.0012120715,0.0017813349,0.0001267238,0.000019992302,0.00007645699,0.0023168565,0.000035443678,0.008688374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984384,0.00001666913,0.000008387491,0.00006588909,0.00002918014,0.00003604208],"domain_scores_gemma":[0.9998388,0.000028961447,0.000045960413,0.0000129839345,0.00003737785,0.00003571398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118896976,0.00019843152,0.00025093686,0.0005429749,0.00020111362,0.00037992743,0.0000743887,0.0002445532,0.0017023571],"category_scores_gemma":[0.00013632812,0.00022845091,0.00031276964,0.00031403112,0.000292795,0.00014925774,0.0001070519,0.0004079527,0.00043839336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006865918,0.000023938172,0.009113976,0.000052907297,0.000027556056,0.000055176504,0.00011341974,0.000052288713,0.9882897,0.000033191558,0.000052935105,0.0014983005],"study_design_scores_gemma":[0.000027104808,0.0014131988,0.63869464,0.000018964298,0.00016427117,0.0003936172,0.0008281485,0.00083207194,0.3550942,0.00007468121,0.0024340288,0.000025014164],"about_ca_topic_score_codex":0.0017495222,"about_ca_topic_score_gemma":0.0040959474,"teacher_disagreement_score":0.0017495222,"about_ca_system_score_codex":0.0002441618,"about_ca_system_score_gemma":0.00016546634,"threshold_uncertainty_score":0.0056949854},"labels":[],"label_agreement":null},{"id":"W4400930961","doi":"10.1002/cpt.3380","title":"Solanidine Metabolites as Diet‐Derived Biomarkers of <scp>CYP2D6</scp>‐Mediated Tamoxifen Metabolism in Breast Cancer Patients","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Internal medicine; Endocrinology; Metabolite; CYP2D6; Medicine; Chemistry; Breast cancer; Metabolism; Cancer; Cytochrome P450","score_opus":0.1032164564343435,"score_gpt":0.46476276253494675,"score_spread":0.36154630610060323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400930961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982889,0.0007356853,0.00009207768,0.000026465645,0.0000049019027,0.0000081779635,0.00045947256,0.000006277658,0.00037800192],"genre_scores_gemma":[0.9990404,0.00016144794,0.000120839606,0.000027834249,0.00000951217,0.000008164095,0.00043732708,0.0000026920093,0.00019174979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968207,0.00007980632,0.000042091404,0.00008425345,0.00007571397,0.000036123303],"domain_scores_gemma":[0.9993549,0.000118846874,0.00030944822,0.000052166335,0.000087604705,0.00007702614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036885132,0.00022792962,0.00041626705,0.0006919875,0.00026445283,0.0006024641,0.00020577438,0.00041634584,0.001056637],"category_scores_gemma":[0.0011011118,0.00021860984,0.000437403,0.001102881,0.00015138077,0.0002712495,0.0002672697,0.00045188077,0.00026433184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051960215,0.000030376601,0.996136,0.000011712608,0.00007502201,0.00009579269,0.00002745999,0.000040736515,0.001299359,0.000011074605,0.00006817979,0.0016845942],"study_design_scores_gemma":[0.000014229252,0.00017370524,0.9981944,0.0000034632658,0.0000635881,0.0005344419,0.000043309552,0.00028430836,0.00040577372,0.000018533045,0.00026120347,0.0000030629712],"about_ca_topic_score_codex":0.0012698312,"about_ca_topic_score_gemma":0.0013725399,"teacher_disagreement_score":0.0012698312,"about_ca_system_score_codex":0.00020462064,"about_ca_system_score_gemma":0.00013643334,"threshold_uncertainty_score":0.0035347939},"labels":[],"label_agreement":null},{"id":"W4400982324","doi":"10.1002/cpt.3387","title":"PharmVar GeneFocus: <i>CYP2A6</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2A6; Allele; Genetics; Biology; Genetic variation; Gene; Phenotype; Genotype; Locus (genetics); Computational biology; Genotype-phenotype distinction; Bioinformatics","score_opus":0.5594046779091968,"score_gpt":0.6417700626406821,"score_spread":0.08236538473148536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400982324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089534756,0.8994175,0.0035420428,0.0060952306,0.005566308,0.00022117447,0.0052667083,0.0011872893,0.0778084],"genre_scores_gemma":[0.004413918,0.91199106,0.005516138,0.006124929,0.003401106,0.00020365197,0.010322938,0.00036220747,0.05766415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966276,0.00006072791,0.000045269975,0.000055613393,0.00012977222,0.00004579775],"domain_scores_gemma":[0.9993368,0.00020336716,0.00012153443,0.000037634964,0.00019264553,0.00010802035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062895333,0.00092196895,0.0011389414,0.003212165,0.00026933145,0.0016064552,0.0011557615,0.0011497183,0.03594747],"category_scores_gemma":[0.0011694507,0.00016659478,0.0006857622,0.004261412,0.00052099006,0.0014751757,0.0011070443,0.0019001622,0.040595368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108814376,0.00003710073,0.00019429644,0.008298022,0.000042746604,0.00019129692,0.000040009243,0.0001143424,0.0026847578,0.004666996,0.23805983,0.7455618],"study_design_scores_gemma":[0.0000067907827,0.00002042985,0.00031076596,0.0006441649,0.000014343521,0.00043104475,0.0000065702693,0.000017639484,0.00031134472,0.0005346861,0.9976967,0.0000055766304],"about_ca_topic_score_codex":0.0010637612,"about_ca_topic_score_gemma":0.001345274,"teacher_disagreement_score":0.03594747,"about_ca_system_score_codex":0.0005655934,"about_ca_system_score_gemma":0.0011889951,"threshold_uncertainty_score":0.120256245},"labels":[],"label_agreement":null},{"id":"W4401009397","doi":"10.1016/j.pnpbp.2024.111108","title":"Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response","year":2024,"lang":"en","type":"article","venue":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; University of Toronto; National Institute on Drug Abuse; Canada Research Chairs","keywords":"Estrous cycle; Genetically modified mouse; Transgene; Biology; Drug response; Drug; Neuroscience; Internal medicine; Endocrinology; Andrology; Cell biology; Pharmacology; Medicine; Genetics; Gene","score_opus":0.06406262244914894,"score_gpt":0.45304790466819855,"score_spread":0.3889852822190496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401009397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918826,0.00063399615,0.0027529178,0.00037986872,0.00008989756,0.000017373903,0.0028199004,0.0002459101,0.0011775206],"genre_scores_gemma":[0.9850042,0.0008077113,0.0022870249,0.00024483554,0.000025911027,0.0000894451,0.0020553146,0.00047654056,0.009008892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997296,0.000022030237,0.000019559857,0.00010328176,0.00006425105,0.000061374],"domain_scores_gemma":[0.99959177,0.000048019916,0.00019136003,0.00003436778,0.00003217341,0.00010234328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014339502,0.0004890064,0.00038447586,0.0012698566,0.00035869592,0.0005405201,0.00036217272,0.00057793746,0.0050650686],"category_scores_gemma":[0.00026264667,0.00047026438,0.00045514753,0.00039171882,0.00078777364,0.00035284724,0.00024331149,0.001469317,0.00069034175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060330227,0.00006711677,0.00095819705,0.000018201454,0.000022286897,0.00020088379,0.000057416073,0.000052465828,0.99616987,0.00016415119,0.00016522122,0.0015208828],"study_design_scores_gemma":[0.00014888828,0.00049012515,0.07578204,0.000022915698,0.00020699856,0.0026178577,0.00046405886,0.0014759945,0.91349787,0.0007719742,0.004474547,0.000046690457],"about_ca_topic_score_codex":0.0024459288,"about_ca_topic_score_gemma":0.0042480933,"teacher_disagreement_score":0.0050650686,"about_ca_system_score_codex":0.0005837351,"about_ca_system_score_gemma":0.00028109128,"threshold_uncertainty_score":0.01694429},"labels":[],"label_agreement":null},{"id":"W4401388296","doi":"10.1211/pj.2024.1.325201","title":"Closing the ethnicity gap in pharmacogenomics","year":2024,"lang":"en","type":"article","venue":"Pharmaceutical journal/˜The œpharmaceutical journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Closing (real estate); Pharmacogenomics; Ethnic group; Medicine; Political science; Sociology; Pharmacology; Anthropology; Law","score_opus":0.24461595433399475,"score_gpt":0.5072910514976905,"score_spread":0.26267509716369575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401388296","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028955124,0.09654035,0.006369576,0.84135085,0.0047264253,0.000026471873,0.00299542,0.00007724159,0.01895858],"genre_scores_gemma":[0.3240797,0.1472841,0.008590353,0.49088567,0.02104689,0.00019697467,0.0034021107,0.00031170927,0.0042024804],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98463655,0.009912022,0.00091564487,0.0015072093,0.0022886724,0.0007399634],"domain_scores_gemma":[0.90827,0.07183778,0.003761094,0.0042126495,0.007828312,0.004090127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03575219,0.0004052733,0.001216702,0.0034790256,0.001318111,0.0047876183,0.0010002357,0.0026923595,0.008502563],"category_scores_gemma":[0.085349,0.0003939076,0.000651199,0.0056652646,0.003833587,0.007460431,0.006280012,0.007219648,0.0015089586],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005499026,0.00025180736,0.094922185,0.0018009424,0.0011365379,0.0008067224,0.005671567,0.00060203095,0.00085215794,0.12592158,0.23869814,0.52878636],"study_design_scores_gemma":[0.00015467561,0.00018715321,0.100694284,0.0074896887,0.00045398262,0.0012814433,0.006520594,0.0010952537,0.0006722687,0.27603853,0.6052554,0.00015673201],"about_ca_topic_score_codex":0.010801938,"about_ca_topic_score_gemma":0.011526808,"teacher_disagreement_score":0.03575219,"about_ca_system_score_codex":0.0019895649,"about_ca_system_score_gemma":0.005856523,"threshold_uncertainty_score":0.18907791},"labels":[],"label_agreement":null},{"id":"W4401449137","doi":"10.1124/pharmrev.123.000750","title":"Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test","year":2024,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Pharmacogenetics; Test (biology); Genome-wide association study; Genetic association; Association (psychology); Medicine; Computational biology; Biology; Genetics; Bioinformatics; Genotype; Single-nucleotide polymorphism; Psychology; Gene; Ecology","score_opus":0.33494227886665684,"score_gpt":0.5308978687206324,"score_spread":0.19595558985397554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401449137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085661704,0.99813074,0.0004260514,0.00058458984,0.00024036359,0.0000030981491,0.00002397625,0.000010243621,0.00049536384],"genre_scores_gemma":[0.0009931361,0.99669445,0.0006420209,0.00082564895,0.00046926885,0.0000074232894,0.00004005945,0.0000038061614,0.00032421944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994716,0.00018011479,0.00005714538,0.00011289811,0.00014839157,0.000029886422],"domain_scores_gemma":[0.9978352,0.0017254885,0.000118836586,0.00005395333,0.00020364628,0.00006287855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019542351,0.00095383206,0.0022425512,0.001862563,0.00015016092,0.001201108,0.0010979003,0.0014516064,0.0033423891],"category_scores_gemma":[0.0029841808,0.00031404282,0.000910517,0.0014459133,0.00063410366,0.0009786488,0.000795235,0.0024271067,0.0012523719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014453036,0.000061419596,0.0003620653,0.00851691,0.00023733708,0.00024111895,0.000036011257,0.00038589427,0.0010190086,0.006719572,0.022667939,0.9596083],"study_design_scores_gemma":[0.00012370474,0.00022430453,0.0017328787,0.008894475,0.00060088513,0.0019318472,0.00006564785,0.00030980454,0.00090925506,0.010982888,0.9741669,0.00005738377],"about_ca_topic_score_codex":0.0010123193,"about_ca_topic_score_gemma":0.0014934273,"teacher_disagreement_score":0.0033423891,"about_ca_system_score_codex":0.00057974074,"about_ca_system_score_gemma":0.0012447828,"threshold_uncertainty_score":0.011181414},"labels":[],"label_agreement":null},{"id":"W4401534435","doi":"10.3390/biomedicines12081843","title":"Upholding or Breaking the Law of Superposition in Pharmacokinetics","year":2024,"lang":"en","type":"review","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mitacs","keywords":"Superposition principle; ADME; Pharmacokinetics; Dosing; Pharmacology; Law; Drug; Drug development; Saturation (graph theory); Medicine; Computer science; Mathematics; Political science","score_opus":0.33663019281589995,"score_gpt":0.5600501622615701,"score_spread":0.22341996944567016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401534435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009085576,0.97799915,0.008894454,0.0025363432,0.001154968,0.000021619808,0.00004566249,0.00006422872,0.008375064],"genre_scores_gemma":[0.012334958,0.9745471,0.00539661,0.0024387199,0.0010697921,0.000041598312,0.000067501795,0.000031486205,0.0040722755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989837,0.0003156179,0.00009441189,0.00016586483,0.00038287207,0.00005754548],"domain_scores_gemma":[0.9987883,0.00088043563,0.00010309668,0.00007906008,0.00011438621,0.000034724835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020041028,0.0006909121,0.0015764026,0.0012847718,0.0003741106,0.0017686102,0.0012689233,0.0015888497,0.0031561537],"category_scores_gemma":[0.002495511,0.0004611656,0.0008520258,0.0014182491,0.002864737,0.0036731546,0.0015062217,0.0044161766,0.0020962409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085423926,0.00007443151,0.0002441754,0.017653028,0.00017658992,0.00042759202,0.00037237772,0.0021338963,0.0060471157,0.1964639,0.022998126,0.75332326],"study_design_scores_gemma":[0.000018903658,0.00013609273,0.00041925086,0.0022941895,0.00008524444,0.0010694191,0.000085107895,0.0007237759,0.0024877226,0.06442139,0.92820734,0.000051583884],"about_ca_topic_score_codex":0.0009931973,"about_ca_topic_score_gemma":0.0012642087,"teacher_disagreement_score":0.0031561537,"about_ca_system_score_codex":0.00086524687,"about_ca_system_score_gemma":0.0013211413,"threshold_uncertainty_score":0.010598838},"labels":[],"label_agreement":null},{"id":"W4401553233","doi":"10.1002/cpt.3405","title":"<scp>PharmVar GeneFocus</scp>: <i>CYP4F2</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute on Drug Abuse; National Institute of General Medical Sciences; Österreichische Forschungsförderungsgesellschaft; National Human Genome Research Institute; Universidad Autónoma de Madrid","keywords":"Chemistry","score_opus":0.44551167257493557,"score_gpt":0.5966109123631308,"score_spread":0.15109923978819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401553233","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016974894,0.082499176,0.0062159393,0.01551459,0.0029064172,0.00083184923,0.54318297,0.014333821,0.3328178],"genre_scores_gemma":[0.0107406415,0.11672722,0.017512424,0.013701739,0.0024657096,0.0010528746,0.6418362,0.0060836505,0.18987957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996388,0.000050001072,0.000052311694,0.000052645915,0.00016342284,0.00004282034],"domain_scores_gemma":[0.9985098,0.0004733973,0.00021931803,0.00012398882,0.000489214,0.00018423327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007468011,0.0007142383,0.0012455389,0.0030858682,0.00027984948,0.0017702052,0.0016641795,0.0011738926,0.29865134],"category_scores_gemma":[0.0026177731,0.00025609112,0.0006032466,0.006230208,0.00028361852,0.0014470835,0.0013103037,0.0010281835,0.20429403],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007962659,0.000018127994,0.0001312887,0.004517868,0.000029342726,0.0001196848,0.000035082896,0.00008449017,0.0015627061,0.0021176971,0.8030403,0.18826391],"study_design_scores_gemma":[0.000014047111,0.0000065591566,0.00034013324,0.00035969264,0.0000098974315,0.000089909954,0.000006218263,0.00001953519,0.0003809039,0.00044131346,0.99832684,0.0000049813657],"about_ca_topic_score_codex":0.0033539028,"about_ca_topic_score_gemma":0.0044805272,"teacher_disagreement_score":0.29865134,"about_ca_system_score_codex":0.00078913657,"about_ca_system_score_gemma":0.0020208545,"threshold_uncertainty_score":0.9990882},"labels":[],"label_agreement":null},{"id":"W4401667571","doi":"10.1111/cts.70007","title":"Dose‐dependent induction of <scp>CYP3A</scp> activity by St. John's wort alone and in combination with rifampin","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacology; Midazolam; CYP3A4; Inducer; CYP3A; Enzyme inducer; Pregnane X receptor; Oral administration; Drug interaction; Medicine; Hyperforin; Chemistry; Hypericum perforatum; Cytochrome P450; Pharmacokinetics; Metabolism; Enzyme; Internal medicine; Biochemistry; Nuclear receptor","score_opus":0.10897468422640176,"score_gpt":0.4498997666936486,"score_spread":0.34092508246724684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401667571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985927,0.00059230445,0.00038042548,0.000042286614,0.000013438754,0.000020118454,0.00006793178,0.000024463021,0.00026645744],"genre_scores_gemma":[0.99793833,0.00028448572,0.00081403874,0.000025320849,0.000022179946,0.00002055669,0.00016235902,0.0000073498577,0.0007253369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997092,0.00010162,0.000023804007,0.0000543523,0.000055942914,0.000055099397],"domain_scores_gemma":[0.9997886,0.00004609633,0.00006475373,0.000035993857,0.000022406884,0.000042213804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022691977,0.00030998333,0.0004285431,0.00018069647,0.00013826291,0.00022594913,0.00009151878,0.00019889067,0.0010686402],"category_scores_gemma":[0.00031820062,0.00021787324,0.0003263032,0.00016055869,0.000261277,0.00010581523,0.00015291816,0.00044670736,0.0002886934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021765288,0.00011895673,0.0019258213,0.000037955648,0.000020877425,0.00008694301,0.000024492036,0.000055416225,0.9912156,0.000011473024,0.00005238783,0.0042734654],"study_design_scores_gemma":[0.00018277597,0.013361098,0.051800255,0.000005663007,0.00007922336,0.00070340256,0.000047012163,0.0010225095,0.9317638,0.000024602361,0.0009980762,0.000011606622],"about_ca_topic_score_codex":0.00066122087,"about_ca_topic_score_gemma":0.001481369,"teacher_disagreement_score":0.0010686402,"about_ca_system_score_codex":0.00019005255,"about_ca_system_score_gemma":0.00021192619,"threshold_uncertainty_score":0.0035749674},"labels":[],"label_agreement":null},{"id":"W4401673332","doi":"10.1080/03602532.2024.2385928","title":"Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions","year":2024,"lang":"en","type":"review","venue":"Drug Metabolism Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenetics; Drug; Pharmacogenomics; Genetic variation; Genotyping; Biology; Gene; Genetics; Pharmacology; Computational biology; Medicine; Genotype","score_opus":0.14274760694577707,"score_gpt":0.47772526060447207,"score_spread":0.33497765365869503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401673332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005021459,0.992454,0.0022288223,0.0023696474,0.00055824866,0.000010281747,0.00006392632,0.000029798752,0.0017831454],"genre_scores_gemma":[0.0032042617,0.99260426,0.0012382532,0.0012899819,0.00066213467,0.0000136813605,0.00008327256,0.000007843578,0.000896195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940753,0.0001940288,0.00006581997,0.000101704594,0.00018362569,0.000047413138],"domain_scores_gemma":[0.99847156,0.0011073815,0.0001288048,0.000043527398,0.00019516185,0.000053467156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012186104,0.0009726487,0.0016380589,0.0020746952,0.00024777564,0.0015655742,0.000649644,0.0011659579,0.0041811676],"category_scores_gemma":[0.0017917439,0.00030591158,0.0009030475,0.0017742435,0.0008058981,0.0019366329,0.00077823247,0.0022991947,0.0015229094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012673842,0.00009847475,0.0014113818,0.018914683,0.00044713856,0.000872669,0.0002596628,0.0013657467,0.00640625,0.020900551,0.037357073,0.9118396],"study_design_scores_gemma":[0.000013683348,0.00017426364,0.0018960778,0.0026755193,0.00030269386,0.002887445,0.00013160043,0.00036910473,0.0016016735,0.012517188,0.9773917,0.00003912932],"about_ca_topic_score_codex":0.00075290137,"about_ca_topic_score_gemma":0.0013926054,"teacher_disagreement_score":0.0041811676,"about_ca_system_score_codex":0.0008114541,"about_ca_system_score_gemma":0.0014551086,"threshold_uncertainty_score":0.013987422},"labels":[],"label_agreement":null},{"id":"W4401928844","doi":"10.3389/fpls.2024.1451298","title":"Parallel evolution of methyltransferases leads to vobasine biosynthesis in Tabernaemontana elegans and Catharanthus roseus","year":2024,"lang":"en","type":"article","venue":"Frontiers in Plant Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"Natural Sciences and Engineering Research Council of Canada; Alliance de recherche numérique du Canada; Ministry of Education, India","keywords":"Catharanthus roseus; Biology; Methyltransferase; Apocynaceae; Ajmaline; Methylation; Genetics; Biochemistry; Botany; Gene","score_opus":0.0398448446355752,"score_gpt":0.36308861965299966,"score_spread":0.32324377501742446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401928844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986203,0.00014379388,0.0005164915,0.000021852416,0.0000033962842,0.0000069125995,0.00010795886,0.000033262346,0.0005459755],"genre_scores_gemma":[0.9953661,0.00022891592,0.0020264974,0.000030028235,0.0000027052874,0.000014645568,0.00063676416,0.000019210338,0.0016750346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996495,0.0000032633445,0.0000026866896,0.000013345839,0.0000073821393,0.000008300302],"domain_scores_gemma":[0.99994016,0.000009493727,0.000017014767,0.000006399905,0.000008206778,0.000018687706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008258776,0.00016889512,0.00010131313,0.00031104227,0.00018623749,0.00016372021,0.00014454655,0.00018282747,0.00044307503],"category_scores_gemma":[0.00014121529,0.00010831551,0.00020955915,0.00013673966,0.00010972433,0.000096495896,0.00027062773,0.0002876176,0.00015476573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009300343,0.000013889548,0.004402197,0.00002062357,0.0000071110003,0.00013985508,0.00006438775,0.00013961295,0.990998,0.00014727683,0.000020517775,0.0039535826],"study_design_scores_gemma":[0.000059560934,0.00079699093,0.6086011,0.00005607342,0.00010399794,0.0020857865,0.0005127395,0.011210298,0.36264688,0.00061974046,0.013240859,0.00006603315],"about_ca_topic_score_codex":0.0026295597,"about_ca_topic_score_gemma":0.004524835,"teacher_disagreement_score":0.0026295597,"about_ca_system_score_codex":0.00023651212,"about_ca_system_score_gemma":0.00018070111,"threshold_uncertainty_score":0.0052285194},"labels":[],"label_agreement":null},{"id":"W4402220180","doi":"10.1007/978-3-030-51366-5_130","title":"Pharmacogenomics and Precision Psychiatry","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenomics; Psychiatry; Psychology; Medicine; Pharmacology","score_opus":0.09730162313094975,"score_gpt":0.42209901100645597,"score_spread":0.3247973878755062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402220180","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004797041,0.19916053,0.032776337,0.013213288,0.00535058,0.00005423536,0.00032630778,0.00048204613,0.74815696],"genre_scores_gemma":[0.0049968455,0.070911534,0.010790542,0.00634907,0.0024379264,0.000070209564,0.0001886065,0.0002289426,0.90402627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997011,0.00008187834,0.000008936456,0.000034519293,0.00015695005,0.000016545142],"domain_scores_gemma":[0.9996636,0.00022686097,0.000011048219,0.000031274714,0.00004998124,0.000017249515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005606985,0.0009900928,0.0007606945,0.0014251602,0.00061168475,0.0026424783,0.0007431241,0.0018111945,0.041174844],"category_scores_gemma":[0.0010650195,0.0004200247,0.00033217648,0.001445437,0.0015939882,0.0025602474,0.0012065064,0.0028654088,0.02363064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016110318,0.000032930428,0.00006308196,0.0002922583,0.000013622799,0.00008989814,0.00019370501,0.00071113283,0.00052355975,0.27027482,0.417607,0.31018192],"study_design_scores_gemma":[0.0000033266876,0.00000892244,0.00011471689,0.00018184677,0.000004870822,0.00022592575,0.00004805661,0.0002794809,0.00017616792,0.13657108,0.86237836,0.000007326684],"about_ca_topic_score_codex":0.0018831035,"about_ca_topic_score_gemma":0.005831869,"teacher_disagreement_score":0.041174844,"about_ca_system_score_codex":0.0013165383,"about_ca_system_score_gemma":0.001060849,"threshold_uncertainty_score":0.13774365},"labels":[],"label_agreement":null},{"id":"W4402330563","doi":"10.2196/57705","title":"Design and Implementation of a Dashboard for Drug Interactions Mediated by Cytochromes Using a Health Care Data Warehouse in a University Hospital Center: Development Study","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dashboard; Preprint; Data warehouse; Health care; Computer science; Medicine; Data science; Medical emergency; World Wide Web; Database; Political science","score_opus":0.10868641297336078,"score_gpt":0.4858274659126044,"score_spread":0.3771410529392436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402330563","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5446571,0.000318541,0.38659233,0.00084799906,0.00016621202,0.0073392265,0.004312201,0.05078068,0.004985674],"genre_scores_gemma":[0.3184165,0.00026831115,0.6670646,0.00029736434,0.000027311626,0.0020049224,0.007938672,0.0012886503,0.0026935758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961761,0.0013447311,0.00054064725,0.0007974558,0.00083344936,0.000307566],"domain_scores_gemma":[0.98710656,0.0065337894,0.0007905241,0.0017346268,0.0024296553,0.0014048248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009744553,0.001715699,0.0009976759,0.0017533988,0.000659192,0.0035816159,0.003087199,0.0012252482,0.0038577302],"category_scores_gemma":[0.011880121,0.00097445364,0.0012295926,0.0012867331,0.00048617032,0.0029991742,0.0022453684,0.0012929561,0.0010039442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006369277,0.011514007,0.08558442,0.0037543972,0.0010445524,0.005865175,0.0099843135,0.06310678,0.10819093,0.006670494,0.024472002,0.6734437],"study_design_scores_gemma":[0.0028300313,0.01054076,0.072129294,0.0013446584,0.0010425525,0.0021450408,0.007049932,0.66389817,0.13045713,0.0039516785,0.10393622,0.0006745099],"about_ca_topic_score_codex":0.003125077,"about_ca_topic_score_gemma":0.0019008939,"teacher_disagreement_score":0.009744553,"about_ca_system_score_codex":0.0010446183,"about_ca_system_score_gemma":0.0024504904,"threshold_uncertainty_score":0.051534772},"labels":[],"label_agreement":null},{"id":"W4402481221","doi":"10.1097/ftd.0000000000001243","title":"Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Test (biology); Medical physics","score_opus":0.3247910157054581,"score_gpt":0.5892996101861243,"score_spread":0.2645085944806662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402481221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015952082,0.9803064,0.0048630694,0.00491202,0.0006567123,0.0043486203,0.0003419618,0.00006482989,0.0029111237],"genre_scores_gemma":[0.018600201,0.9566469,0.01572552,0.0014414262,0.00019954533,0.006699557,0.0003619907,0.00002899849,0.00029583983],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.87283033,0.07678643,0.029469203,0.0028429073,0.016399596,0.0016715976],"domain_scores_gemma":[0.6352291,0.2905438,0.027959686,0.005607791,0.039063334,0.0015962818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15784828,0.0025208185,0.005228482,0.024642032,0.0022752676,0.008569659,0.004837417,0.0041082627,0.0034018818],"category_scores_gemma":[0.318318,0.0018292075,0.009186569,0.02279629,0.0024140647,0.00887156,0.004940249,0.0032652572,0.0006864553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012571891,0.00011679744,0.0015989656,0.6286604,0.0023625898,0.00013683514,0.0027170172,0.0008280556,0.0001604454,0.005056659,0.005892527,0.35234398],"study_design_scores_gemma":[0.000045493765,0.00008299387,0.0009524651,0.9649889,0.0039371015,0.000079818616,0.0011676898,0.00026613212,0.00018896571,0.0009676847,0.02729328,0.000029560477],"about_ca_topic_score_codex":0.017319465,"about_ca_topic_score_gemma":0.025392562,"teacher_disagreement_score":0.15784828,"about_ca_system_score_codex":0.01788604,"about_ca_system_score_gemma":0.06666825,"threshold_uncertainty_score":0.8347915},"labels":[],"label_agreement":null},{"id":"W4402567628","doi":"10.1002/cpt.3404","title":"Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?","year":2024,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics","score_opus":0.17465712181962192,"score_gpt":0.5086332172790551,"score_spread":0.3339760954594332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402567628","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003980702,0.07499126,0.010397812,0.8826244,0.005989274,0.00006271218,0.0009904149,0.0002796208,0.020683741],"genre_scores_gemma":[0.17239833,0.34636688,0.046027403,0.38025513,0.04187886,0.0003634019,0.0030408264,0.0005985596,0.009070642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99061525,0.0050101415,0.00073352025,0.0009578466,0.002237472,0.0004457115],"domain_scores_gemma":[0.9565521,0.023731558,0.0047889645,0.0028225104,0.007225327,0.0048796753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017125066,0.00064655166,0.0012777117,0.0023751413,0.0011903277,0.004857203,0.0015127308,0.003941129,0.015990281],"category_scores_gemma":[0.07632241,0.0003843758,0.00065524,0.0034827292,0.0042466833,0.009221544,0.0043770825,0.0067755347,0.0055460213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023447677,0.00017032586,0.022814108,0.0010184856,0.00014743343,0.00036566152,0.0005750006,0.00047588506,0.00047905568,0.045611586,0.2677467,0.6603613],"study_design_scores_gemma":[0.00009231307,0.00022280478,0.023729356,0.0076239356,0.00022254293,0.0017483053,0.0014263646,0.0012796377,0.0007273932,0.11174495,0.8510333,0.00014904166],"about_ca_topic_score_codex":0.005435448,"about_ca_topic_score_gemma":0.0046020015,"teacher_disagreement_score":0.017125066,"about_ca_system_score_codex":0.002362489,"about_ca_system_score_gemma":0.0067692255,"threshold_uncertainty_score":0.09056711},"labels":[],"label_agreement":null},{"id":"W4403071576","doi":"10.1093/clinchem/hvae106.646","title":"B-289 Assessing the Shift in Positivity Rates of Cocaine and Its Metabolites in a Community Based Population: A Transition from utilization of Cutoff Concentrations to Qualitative Structure Identification","year":2024,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Cutoff; Identification (biology); Transition (genetics); Population; Qualitative analysis; Qualitative research; Medicine; Psychology; Chemistry; Sociology; Biology; Environmental health; Physics; Biochemistry; Social science","score_opus":0.27457477545100567,"score_gpt":0.5788821163032498,"score_spread":0.30430734085224415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403071576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941307,0.00020435949,0.00167022,0.00007378245,0.00002112931,0.00008475527,0.0013136765,0.00005288283,0.0024485828],"genre_scores_gemma":[0.9953902,0.000088152694,0.0025402652,0.000062224244,0.000009320646,0.000066791516,0.000935718,0.000009793762,0.0008974149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980876,0.000632501,0.00016013037,0.0003842872,0.00059530896,0.00014023542],"domain_scores_gemma":[0.99737585,0.000632703,0.0006086805,0.00017014184,0.00094788236,0.0002648506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018255485,0.0003127482,0.00030717324,0.0013906778,0.0004945476,0.0008776225,0.00040077724,0.0005598443,0.002984209],"category_scores_gemma":[0.0029871203,0.0002362804,0.00036045138,0.0010579877,0.00041694418,0.00030634497,0.0005947613,0.00041855764,0.001238379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003727365,0.00015254844,0.9817038,0.000042251668,0.000051913623,0.00010216848,0.0001131817,0.0001425265,0.007853629,0.000038924176,0.00031532414,0.009111074],"study_design_scores_gemma":[0.0000112197185,0.0008139576,0.9929629,0.000018070074,0.00003130085,0.0004396484,0.00038803497,0.0012621161,0.0033668163,0.00007133146,0.00062614505,0.000008491668],"about_ca_topic_score_codex":0.007308957,"about_ca_topic_score_gemma":0.0073131146,"teacher_disagreement_score":0.007308957,"about_ca_system_score_codex":0.00047692508,"about_ca_system_score_gemma":0.0005429113,"threshold_uncertainty_score":0.0145328045},"labels":[],"label_agreement":null},{"id":"W4403233605","doi":"10.1002/pds.70014","title":"The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia","year":2024,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft; McGill University","keywords":"Medicine; Warfarin; Hypoglycemia; Sulfonylurea; Hazard ratio; Concomitant; Pharmacoepidemiology; Drug interaction; Internal medicine; Propensity score matching; Drug; Drug-drug interaction; Medical prescription; Pharmacology; Confidence interval; Insulin; Atrial fibrillation","score_opus":0.14236780409675806,"score_gpt":0.4376447361769628,"score_spread":0.2952769320802048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403233605","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83536744,0.0076319557,0.14205547,0.003212021,0.0014426648,0.004111032,0.0014041731,0.00017779459,0.004597345],"genre_scores_gemma":[0.9638248,0.00058988505,0.031475194,0.0010641033,0.00033770583,0.0018119611,0.00029380992,0.000022554821,0.0005800089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8076223,0.17325665,0.008230094,0.0059360457,0.0041591506,0.0007958791],"domain_scores_gemma":[0.8236473,0.10772821,0.029373383,0.028380696,0.0075718975,0.0032985327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1135476,0.0010080626,0.0016326949,0.0015285661,0.0013981016,0.0022953104,0.002104238,0.0023491804,0.0030875206],"category_scores_gemma":[0.15346701,0.0008101043,0.0048448346,0.0014954859,0.0015208747,0.0013735683,0.0021762652,0.0019368145,0.0003596338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051394384,0.0021713583,0.8062369,0.0026165668,0.02545644,0.00077816786,0.0013831833,0.007179995,0.0022336883,0.017679155,0.0026975614,0.08017259],"study_design_scores_gemma":[0.029152699,0.0808272,0.56422657,0.0020432163,0.04577387,0.005268338,0.0019057823,0.15426265,0.009019061,0.07539937,0.031342532,0.0007788178],"about_ca_topic_score_codex":0.0013742507,"about_ca_topic_score_gemma":0.0017303927,"teacher_disagreement_score":0.1135476,"about_ca_system_score_codex":0.00084543956,"about_ca_system_score_gemma":0.0014887736,"threshold_uncertainty_score":0.6005043},"labels":[],"label_agreement":null},{"id":"W4403423749","doi":"10.1186/s12916-024-03700-9","title":"Common pitfalls in drug target Mendelian randomization and how to avoid them","year":2024,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"NIHR Cambridge Biomedical Research Centre; Medical Research Council; Fonds de Recherche du Québec - Santé; National Institute for Health and Care Research; Wellcome Trust","keywords":"Mendelian randomization; Medicine; Mendelian inheritance; Drug; Drug trial; Drug development; Clinical trial; Risk analysis (engineering); Intensive care medicine; Genetic variants; Pharmacology; Genetics; Pathology; Biology","score_opus":0.20920286024555193,"score_gpt":0.4820214774620004,"score_spread":0.2728186172164485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403423749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014313799,0.60500145,0.14140204,0.23248497,0.011470653,0.0003051529,0.00035008648,0.0005648698,0.006989457],"genre_scores_gemma":[0.060694028,0.48606107,0.23507445,0.1889501,0.022006638,0.0017197609,0.00032159177,0.00058287865,0.0045895693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9108309,0.06337992,0.008579964,0.0046389704,0.011972885,0.0005973351],"domain_scores_gemma":[0.7522108,0.22319376,0.008927915,0.0075295856,0.0071563907,0.0009815182],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09864223,0.0012433385,0.0036733132,0.0019936592,0.0011360564,0.003947497,0.0041824784,0.0058434834,0.0035892378],"category_scores_gemma":[0.19743653,0.00080792804,0.0019661093,0.0027758083,0.016231475,0.0066352454,0.0034916473,0.013900634,0.00159704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003939074,0.000060202343,0.0022410448,0.013034944,0.0009740102,0.0013832008,0.0021926623,0.0014998203,0.00045967076,0.30691913,0.09997465,0.5708668],"study_design_scores_gemma":[0.00019293326,0.00014791987,0.0011467359,0.015642233,0.00040736195,0.0039865966,0.0006949331,0.0014407295,0.0007263207,0.59147674,0.38394907,0.00018843771],"about_ca_topic_score_codex":0.0017045692,"about_ca_topic_score_gemma":0.0025221212,"teacher_disagreement_score":0.90135777,"about_ca_system_score_codex":0.0026925337,"about_ca_system_score_gemma":0.0067668855,"threshold_uncertainty_score":0.5216762},"labels":[],"label_agreement":null},{"id":"W4403604981","doi":"10.1007/978-3-031-35529-5_93","title":"An Introduction to Safety Pharmacokinetics","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"Pharmacokinetics; Medicine; Computer science; Pharmacology","score_opus":0.07881437904304522,"score_gpt":0.4278404040705888,"score_spread":0.3490260250275436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604981","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095203205,0.15799373,0.08704811,0.011245051,0.011577078,0.00023462,0.0021762312,0.0019963137,0.7267768],"genre_scores_gemma":[0.0034577693,0.05409817,0.01691345,0.0056556705,0.0032305873,0.00015301477,0.00078596873,0.0005637238,0.9151416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958354,0.00007688786,0.000020338584,0.000053027055,0.00024660566,0.000019553065],"domain_scores_gemma":[0.99941075,0.0003454259,0.000028110098,0.000041336236,0.00014877517,0.00002562961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006800642,0.0012562164,0.00093708554,0.0014906845,0.00040389292,0.0016743278,0.0008038365,0.0014999784,0.080118164],"category_scores_gemma":[0.0014752187,0.00052867766,0.0006209497,0.0011450481,0.0005145967,0.0019037792,0.00088884647,0.0029760257,0.05902961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041482977,0.000098152625,0.00006184714,0.00053682114,0.000011429098,0.00014637785,0.00008233928,0.0014274674,0.0018026888,0.042820822,0.48414376,0.4688268],"study_design_scores_gemma":[0.000004387267,0.00003840775,0.00009515978,0.00019676013,0.0000049784653,0.00032759362,0.000012271792,0.00037872835,0.00038685164,0.022610359,0.975935,0.000009494037],"about_ca_topic_score_codex":0.0010291256,"about_ca_topic_score_gemma":0.0019022342,"teacher_disagreement_score":0.080118164,"about_ca_system_score_codex":0.0008758477,"about_ca_system_score_gemma":0.0009078515,"threshold_uncertainty_score":0.26802194},"labels":[],"label_agreement":null},{"id":"W4403616501","doi":"10.1007/s10549-024-07519-z","title":"CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Genomic Health; Foundation Medicine; Veracyte; Genentech; Max-Planck-Gesellschaft; Eisai; Puma Biotechnology; Natera; National Institutes of Health; ECOG-ACRIN Cancer Research Group; BeiGene; Susan G. Komen; Sanofi Genzyme; Pfizer; Incyte; American College of Radiology Imaging Network; National Cancer Institute; Gilead Sciences; Sanofi; Johns Hopkins University; Susan G. Komen for the Cure; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Internal medicine; Mammary gland; Antiestrogen","score_opus":0.14977172718728982,"score_gpt":0.44882049944701197,"score_spread":0.29904877225972215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403616501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641824,0.0013746339,0.00009030468,0.00011873383,0.000014150851,0.00003452456,0.001266737,0.000013229349,0.00066941074],"genre_scores_gemma":[0.9958269,0.0006850538,0.00014654046,0.00013702245,0.000045412962,0.000025987998,0.0025781149,0.0000066068,0.0005482409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995925,0.00014272962,0.000030696006,0.000093977,0.00008887192,0.00005123152],"domain_scores_gemma":[0.99930394,0.00016515281,0.00024285987,0.00006038778,0.00008564682,0.00014201914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006718433,0.0006069202,0.0010185485,0.00043738403,0.00020247645,0.00054302334,0.0003217514,0.0006237431,0.0009276086],"category_scores_gemma":[0.0012058428,0.00022785661,0.001069084,0.0008157219,0.00022671759,0.00039138345,0.00028015647,0.00069603795,0.00028854236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059712723,0.0010021364,0.895538,0.00012097319,0.0020841488,0.00037637266,0.000107486674,0.0006797631,0.0076224813,0.000041528347,0.0011397703,0.031574715],"study_design_scores_gemma":[0.0029249657,0.0065799304,0.986016,0.000011821265,0.001180176,0.0005676031,0.00007279138,0.0005022428,0.0009496928,0.00004877828,0.0011278898,0.000018167864],"about_ca_topic_score_codex":0.0025786024,"about_ca_topic_score_gemma":0.0036343252,"teacher_disagreement_score":0.0025786024,"about_ca_system_score_codex":0.00047424066,"about_ca_system_score_gemma":0.00030561048,"threshold_uncertainty_score":0.0051271915},"labels":[],"label_agreement":null},{"id":"W4403859485","doi":"10.1124/dmd.124.001893","title":"Uncovering the impact of COVID-19–mediated bidirectional dysregulation of cytochrome P450 3A4 on systemic and pulmonary drug concentrations using physiologically based pharmacokinetic modeling","year":2024,"lang":"en","type":"article","venue":"Drug Metabolism and Disposition","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tobacco Research Unit; College of Physicians and Surgeons of Ontario","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacokinetics; CYP3A4; Drug; Coronavirus disease 2019 (COVID-19); Pharmacology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Chemistry; Computational biology; Biology; Medicine; Cytochrome P450; Enzyme; Disease; Biochemistry; Infectious disease (medical specialty); Internal medicine","score_opus":0.06550685127745885,"score_gpt":0.40176460207453585,"score_spread":0.336257750797077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403859485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360232,0.0009879036,0.05947302,0.00032211313,0.00006646213,0.00005115954,0.0006835146,0.00022225361,0.0021702747],"genre_scores_gemma":[0.9939482,0.00046437455,0.0047012954,0.000048697115,0.0000059194963,0.000020418513,0.00025976563,0.00002469964,0.0005265791],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998267,0.000039558297,0.000009669109,0.000044908087,0.00004707651,0.000032145486],"domain_scores_gemma":[0.9998634,0.000047164747,0.000036272304,0.000023289844,0.000017774844,0.000012134738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033847633,0.00043755685,0.00040275292,0.00017473701,0.00015896389,0.0007351314,0.00034785632,0.0003182537,0.0008858716],"category_scores_gemma":[0.0005896526,0.00020651205,0.000578563,0.00014744935,0.0002784368,0.0003984242,0.00038792385,0.0007948293,0.00020574535],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012238484,0.00033870165,0.018607374,0.0001673416,0.00029488505,0.0006000276,0.00005480631,0.07867513,0.8608277,0.007885335,0.0006306805,0.030694209],"study_design_scores_gemma":[0.00007308903,0.0009045093,0.02180342,0.000019742369,0.00025685763,0.00065241504,0.000094484894,0.58454627,0.38236547,0.004631401,0.0046058274,0.000046614132],"about_ca_topic_score_codex":0.002573682,"about_ca_topic_score_gemma":0.0023829443,"teacher_disagreement_score":0.002573682,"about_ca_system_score_codex":0.00061712303,"about_ca_system_score_gemma":0.0008387871,"threshold_uncertainty_score":0.005117357},"labels":[],"label_agreement":null},{"id":"W4403922127","doi":"10.21203/rs.3.rs-5262235/v1","title":"Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Science and Technology Council; Academia Sinica; Taiwan Biobank","keywords":"Pharmacogenetics; Cohort; Medicine; Internal medicine; Genetics; Genotype; Biology; Gene","score_opus":0.19713075590552875,"score_gpt":0.6173031579643765,"score_spread":0.42017240205884776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403922127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979279,0.0002667661,0.00016597832,0.00012214931,0.000019716963,0.000009073467,0.0007630463,0.000010120813,0.00071517355],"genre_scores_gemma":[0.9982691,0.00015307235,0.0001291899,0.000058714646,0.00002970591,0.000009704825,0.00054362405,0.000010178545,0.0007965754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994012,0.00012163051,0.000037216825,0.00026847422,0.0000737407,0.00009781184],"domain_scores_gemma":[0.9992884,0.00016067551,0.00013724824,0.00017059738,0.00007049791,0.00017266496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079703593,0.0006795427,0.0006038898,0.00091417285,0.0010650124,0.0008259549,0.0005636162,0.00058160065,0.003913821],"category_scores_gemma":[0.0020372304,0.00045952396,0.00084620283,0.00156177,0.0005557879,0.00036700233,0.0005379535,0.0006336853,0.00047863042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012813655,0.00009580455,0.9864007,0.000030547795,0.00070427236,0.0019180481,0.00046290935,0.00016010921,0.0033540896,0.00029228587,0.0008855113,0.0044143414],"study_design_scores_gemma":[0.000054914086,0.000109719345,0.99706453,0.0000071443583,0.00040155335,0.000825047,0.00023333555,0.00033404495,0.00019772907,0.00021681028,0.00053983735,0.000015376048],"about_ca_topic_score_codex":0.01773688,"about_ca_topic_score_gemma":0.0113947345,"teacher_disagreement_score":0.01773688,"about_ca_system_score_codex":0.00042423056,"about_ca_system_score_gemma":0.00070997246,"threshold_uncertainty_score":0.035267293},"labels":[],"label_agreement":null},{"id":"W4403968392","doi":"10.1097/fpc.0000000000000547","title":"The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation","year":2024,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; University of North Carolina at Chapel Hill; University of California, Davis; University of Montana; University of Pennsylvania Health System; University of Illinois at Urbana-Champaign; National Institutes of Health; Univerza v Ljubljani; Rijksuniversiteit Groningen; St. Jude Children's Research Hospital; University of Minnesota; University of Pennsylvania; Moffitt Cancer Center; U.S. Department of Veterans Affairs","keywords":"Pharmacogenetics; Pharmacogenomics; Workflow; Dosing; Drug response; Medicine; Drug; Computer science; Pharmacology; Biology; Genotype; Genetics","score_opus":0.12556258059787465,"score_gpt":0.5459056649859957,"score_spread":0.42034308438812107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403968392","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017336562,0.0067099794,0.062812574,0.83253473,0.015802905,0.010103168,0.0022951323,0.0012884629,0.051116508],"genre_scores_gemma":[0.14538437,0.0090412665,0.44411826,0.28949538,0.006401428,0.02222458,0.011893488,0.0018573905,0.06958383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.889677,0.07540366,0.004384473,0.003938557,0.01308286,0.013513443],"domain_scores_gemma":[0.7443926,0.04605609,0.012849535,0.016434725,0.046244964,0.13402222],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22735943,0.0023920212,0.0015352827,0.0024922667,0.005173063,0.011674394,0.0071734446,0.012399651,0.020401243],"category_scores_gemma":[0.10670673,0.0012949113,0.0024436645,0.002604601,0.0042799963,0.010155911,0.03898713,0.015772194,0.0066847564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096881395,0.0026335143,0.027304647,0.0025067248,0.0004168357,0.0008040823,0.0072855856,0.0022304915,0.0030983498,0.03324856,0.49122798,0.42827445],"study_design_scores_gemma":[0.0014462472,0.0019759976,0.020053117,0.0037529154,0.00020059374,0.0004900719,0.008082275,0.0019153471,0.0024809157,0.025380094,0.93405306,0.00016940439],"about_ca_topic_score_codex":0.0075741117,"about_ca_topic_score_gemma":0.0070570353,"teacher_disagreement_score":0.22735943,"about_ca_system_score_codex":0.0070469356,"about_ca_system_score_gemma":0.19241092,"threshold_uncertainty_score":0.9528034},"labels":[],"label_agreement":null},{"id":"W4404104523","doi":"10.1007/s10571-024-01504-2","title":"Synergistic Epistasis and Systems Biology Approaches to Uncover a Pharmacogenomic Map Linked to Pain, Anti-Inflammatory and Immunomodulating Agents (PAIma) in a Healthy Cohort","year":2024,"lang":"en","type":"article","venue":"Cellular and Molecular Neurobiology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Isfahan; Guilan University of Medical Sciences","keywords":"Pharmacogenomics; Oxycodone; Medicine; Pharmacogenetics; Addiction; Cohort; Opioid; Pharmacology; Bioinformatics; Psychiatry; Genetics; Biology; Gene; Genotype; Internal medicine","score_opus":0.11228683517720484,"score_gpt":0.3577869469488756,"score_spread":0.24550011177167075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404104523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274384,0.0011213493,0.066441394,0.00095840346,0.000048949896,0.00018103649,0.0024327866,0.00035204052,0.0010255829],"genre_scores_gemma":[0.9570115,0.00052829745,0.039906517,0.00023611562,0.0000327647,0.00022330941,0.0013227328,0.000057093897,0.0006816339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982875,0.0009149558,0.00006206149,0.0004822957,0.00010599486,0.00014706753],"domain_scores_gemma":[0.9983,0.001112083,0.00019214967,0.00017908066,0.00008712891,0.0001295952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025630668,0.00083254266,0.00095674547,0.002366151,0.00098714,0.0010798635,0.0005927006,0.0004943167,0.0035869326],"category_scores_gemma":[0.0043845135,0.00038961167,0.0038990465,0.0021866695,0.0006189092,0.00042978124,0.0012507584,0.001106214,0.00022437787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017167487,0.00066321203,0.7860926,0.000564446,0.010934279,0.002578045,0.0018057775,0.02002542,0.060590316,0.011425449,0.0031524964,0.100451246],"study_design_scores_gemma":[0.00017524762,0.0011292367,0.830271,0.000056768455,0.0034534445,0.0015488641,0.001144723,0.1377502,0.0024432917,0.017479438,0.0044271145,0.000120706725],"about_ca_topic_score_codex":0.009484118,"about_ca_topic_score_gemma":0.008355123,"teacher_disagreement_score":0.009484118,"about_ca_system_score_codex":0.0007916058,"about_ca_system_score_gemma":0.0012431176,"threshold_uncertainty_score":0.018857837},"labels":[],"label_agreement":null},{"id":"W4404373822","doi":"10.1016/j.encep.2024.09.003","title":"CYP2D6 and CYP2C19 ultrarapid metabolisms are associated with suicide attempts in schizophrenia","year":2024,"lang":"en","type":"article","venue":"L Encéphale","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"CYP2C19; Schizophrenia (object-oriented programming); Medicine; Psychiatry; Psychology; Internal medicine; Cytochrome P450","score_opus":0.0831350508802647,"score_gpt":0.3982467273946035,"score_spread":0.3151116765143388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404373822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929774,0.0003140553,0.000047505688,0.000031809243,0.0000033412043,0.000004200027,0.00011365827,0.000002642082,0.00018494994],"genre_scores_gemma":[0.999527,0.0001617049,0.00005149482,0.000009544288,0.0000047853355,0.0000025396553,0.00010742785,0.0000011861808,0.00013440178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996973,0.00007240556,0.00005291356,0.000049541293,0.000078052755,0.000049791954],"domain_scores_gemma":[0.9987538,0.00012999482,0.0006937499,0.00007721156,0.000100813646,0.00024441045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003590591,0.0003180329,0.00039175543,0.00075607933,0.00041356162,0.00046011616,0.00021048792,0.0002927883,0.0024889673],"category_scores_gemma":[0.0012752855,0.00030533553,0.0007445832,0.0008855926,0.00022082565,0.00018868515,0.0003712658,0.00061006326,0.00022193824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010887026,0.000014002521,0.99828327,0.000007197021,0.00005037868,0.00014192522,0.000036048477,0.000013168812,0.0003817728,0.000010484284,0.000029048755,0.0009238955],"study_design_scores_gemma":[0.000003824304,0.000031732285,0.99934834,0.000002980266,0.000020857215,0.00040355333,0.000045524597,0.000051593648,0.000040436582,0.00001162116,0.000037866135,0.0000015975204],"about_ca_topic_score_codex":0.004609765,"about_ca_topic_score_gemma":0.005631424,"teacher_disagreement_score":0.004609765,"about_ca_system_score_codex":0.00025428366,"about_ca_system_score_gemma":0.00024759426,"threshold_uncertainty_score":0.009165883},"labels":[],"label_agreement":null},{"id":"W4404871083","doi":"10.1016/b978-0-323-98808-7.00005-9","title":"Pharmacogenetic clinical implementation","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada)","funders":"","keywords":"Pharmacogenetics; Medicine; Medical physics; Biology; Genotype; Genetics","score_opus":0.15808417665270968,"score_gpt":0.5031369954639489,"score_spread":0.34505281881123917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404871083","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015286998,0.015229042,0.04785193,0.065553375,0.0044505163,0.00035506557,0.00068574026,0.0010615297,0.86328405],"genre_scores_gemma":[0.034050107,0.028827341,0.06884732,0.047912225,0.0048503336,0.00059738173,0.0015304221,0.0006097045,0.8127752],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9985091,0.0007327306,0.000089048546,0.00018861145,0.00037886782,0.000101562495],"domain_scores_gemma":[0.99752027,0.0009979693,0.00011106543,0.0004945875,0.0005430506,0.0003329538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004396292,0.0006018127,0.00039155473,0.0010847182,0.00053022034,0.0028368374,0.0011058158,0.0021154175,0.11047012],"category_scores_gemma":[0.0073265405,0.00041432085,0.00040885888,0.0008091612,0.0014921387,0.0016123074,0.0028190368,0.0036565964,0.035774585],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004684797,0.00011435967,0.0005352215,0.00014704267,0.000006720573,0.00028214438,0.00012782954,0.00027158024,0.0004979812,0.11555453,0.22913882,0.6532769],"study_design_scores_gemma":[0.00002389362,0.000034968107,0.0006167431,0.0002888203,0.000005793969,0.0007507921,0.00007395791,0.00027314617,0.0002929271,0.0340211,0.96361125,0.0000066256976],"about_ca_topic_score_codex":0.0021182096,"about_ca_topic_score_gemma":0.0026300862,"teacher_disagreement_score":0.11047012,"about_ca_system_score_codex":0.0011713409,"about_ca_system_score_gemma":0.004278757,"threshold_uncertainty_score":0.36955935},"labels":[],"label_agreement":null},{"id":"W4405476348","doi":"10.1002/cpt.3534","title":"Prevalence Estimates of Cytochrome <scp>P450</scp> Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenetics; Medicine; Pharmacotherapy; CYP2D6; CYP2B6; Pharmacology; CYP3A4; Internal medicine; Cytochrome P450; Genotype; Biology; Genetics; Gene","score_opus":0.21507940728317868,"score_gpt":0.5323083967818297,"score_spread":0.3172289894986511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405476348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981229,0.00034468566,0.00035784632,0.000035811343,0.0000042867987,0.00001782919,0.00082730316,0.000010816148,0.0002785632],"genre_scores_gemma":[0.99877185,0.00022094611,0.00027465945,0.00002360249,0.0000058325736,0.000014115187,0.0005917481,0.0000025170323,0.00009463325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906105,0.00029028684,0.00012800112,0.00021299745,0.00018728247,0.000120356526],"domain_scores_gemma":[0.9966203,0.00058224937,0.001972735,0.00018843859,0.00040241505,0.00023378097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014389402,0.00022761125,0.00027845858,0.0012620391,0.0002791247,0.0004348151,0.0002788898,0.00030163839,0.0010148436],"category_scores_gemma":[0.003275703,0.00026168136,0.000528463,0.0010235036,0.00023286173,0.00032715485,0.0004083996,0.0005014751,0.00021809334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012506674,0.000005504356,0.9988776,0.000004546864,0.000012882259,0.000010681162,0.00003811602,0.000014760459,0.000045167817,0.000007788978,0.000037309626,0.0009331442],"study_design_scores_gemma":[9.4457175e-7,0.000026632128,0.9996393,0.0000053057806,0.00000939129,0.00008526491,0.00006075811,0.00007354866,0.000037019643,0.000006365389,0.000054541753,9.466432e-7],"about_ca_topic_score_codex":0.01802287,"about_ca_topic_score_gemma":0.016507292,"teacher_disagreement_score":0.01802287,"about_ca_system_score_codex":0.00038427117,"about_ca_system_score_gemma":0.00022151247,"threshold_uncertainty_score":0.03583592},"labels":[],"label_agreement":null},{"id":"W4405915226","doi":"10.21037/tlcr-24-662","title":"Fuel for thought: targeting metabolism in lung cancer","year":2024,"lang":"en","type":"review","venue":"Translational Lung Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; OPKO Health; National Cancer Institute; A Breath of Hope Lung Foundation; Gilead Sciences","keywords":"Medicine; Lung cancer; Bioinformatics; Cancer; Intensive care medicine; Cancer research; Oncology; Internal medicine; Biology","score_opus":0.3340065270848984,"score_gpt":0.6206894767633551,"score_spread":0.28668294967845664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405915226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089678964,0.99717605,0.00023244057,0.0010411959,0.00037584174,0.00000378226,0.00002010327,0.000015468182,0.0010453602],"genre_scores_gemma":[0.00075435353,0.99737823,0.00022461046,0.0006750033,0.00033428837,0.0000074793074,0.000025872372,0.0000034904992,0.0005966392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999798,0.00004472387,0.000024189985,0.00003970486,0.000071978815,0.000021359969],"domain_scores_gemma":[0.99956614,0.0002365511,0.000037130074,0.000016685999,0.00010721752,0.00003619221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074835704,0.0005989359,0.00092023687,0.0016628935,0.0002888093,0.0011682705,0.0006999353,0.001323913,0.0029385276],"category_scores_gemma":[0.0009510751,0.00022213258,0.00054879277,0.00156082,0.00066141813,0.0020289102,0.00075760373,0.0029407877,0.0021320537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008412852,0.00006836326,0.0001662328,0.011975561,0.000076480545,0.00015138586,0.000088087014,0.00043447025,0.0019554703,0.010974867,0.050081935,0.92394304],"study_design_scores_gemma":[0.000011299,0.00006549156,0.00031410385,0.0017878435,0.000043941323,0.00044431596,0.000041407355,0.000089511304,0.0004010821,0.0043943655,0.99239445,0.000012214757],"about_ca_topic_score_codex":0.0009958151,"about_ca_topic_score_gemma":0.0016788554,"teacher_disagreement_score":0.0029385276,"about_ca_system_score_codex":0.00079816725,"about_ca_system_score_gemma":0.001277602,"threshold_uncertainty_score":0.009830415},"labels":[],"label_agreement":null},{"id":"W4405985381","doi":"10.1016/s0026-895x(24)12330-9","title":"Heterogeneous Nuclear Ribonucleoprotein A1 and Regulation of the Xenobiotic-Inducible Gene Cyp2a5","year":2002,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Xenobiotic; Gene; Ribonucleoprotein; Chemistry; Cell biology; Computational biology; Biology; Genetics; Biochemistry; RNA; Enzyme","score_opus":0.056557291679361237,"score_gpt":0.3442259826809943,"score_spread":0.28766869100163306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405985381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490614,0.0044104676,0.00454295,0.0004641677,0.000065569664,0.000016349511,0.0004493469,0.00013603775,0.005009047],"genre_scores_gemma":[0.99564964,0.00042955874,0.00070687785,0.00006846406,0.000013257574,0.000007613315,0.00051856984,0.00002739031,0.0025785647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984646,0.000039630217,0.0000071100376,0.00004180017,0.000029512192,0.000035358204],"domain_scores_gemma":[0.99981314,0.000058977264,0.000049431404,0.000021942331,0.000020753534,0.000035822693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016355015,0.00022409609,0.00017769956,0.0004950164,0.00029891162,0.0004995403,0.00020566848,0.0002860896,0.0016151513],"category_scores_gemma":[0.0002751647,0.00019370456,0.00030949313,0.00016330097,0.00036905834,0.00019935926,0.0002581883,0.0003329415,0.0003734576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034796845,0.000032341057,0.0013790188,0.000019989304,0.00001680309,0.00012931277,0.000050290495,0.00016308938,0.9932928,0.0013941049,0.0001967513,0.0029775926],"study_design_scores_gemma":[0.000054667496,0.00032445113,0.087614246,0.000019973468,0.00004575767,0.000652579,0.00023048495,0.003928618,0.9003252,0.0011734542,0.0056048054,0.00002586618],"about_ca_topic_score_codex":0.0024102447,"about_ca_topic_score_gemma":0.0032556155,"teacher_disagreement_score":0.0024102447,"about_ca_system_score_codex":0.0006635895,"about_ca_system_score_gemma":0.00020993433,"threshold_uncertainty_score":0.005403161},"labels":[],"label_agreement":null},{"id":"W4405993801","doi":"10.1016/s0026-895x(24)23106-0","title":"Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking","year":2000,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Genotyping; CYP2A6; Identification (biology); Genetics; Gene; In vivo; Biology; Computational biology; Genotype; In vitro","score_opus":0.029895145519548284,"score_gpt":0.38029568406195907,"score_spread":0.35040053854241077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405993801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645555,0.0004880739,0.0018917075,0.0001446878,0.000021430047,0.000026473886,0.00048392714,0.000058119178,0.0004301396],"genre_scores_gemma":[0.99636495,0.00046701214,0.0011137227,0.000071901784,0.000017808452,0.0000363239,0.00060003676,0.00008608176,0.0012419932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990902,0.0003015618,0.00009885733,0.00021006081,0.00018272483,0.00011667987],"domain_scores_gemma":[0.99846953,0.00075981964,0.00031666536,0.00016917301,0.00005033765,0.00023447176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032777173,0.0007907599,0.00075829454,0.0015039293,0.00036865607,0.0003119415,0.00042876802,0.0011008474,0.0032369476],"category_scores_gemma":[0.0013169427,0.0005542643,0.0008347152,0.0006737949,0.0011732789,0.00028878398,0.00057297375,0.0010723681,0.00046037545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028835079,0.00039930816,0.010172818,0.00006733559,0.00018420741,0.003828286,0.00013959101,0.00063099526,0.9734101,0.00045684262,0.00022891515,0.0075981617],"study_design_scores_gemma":[0.00042666792,0.0030455452,0.15269694,0.000040672614,0.0006528358,0.05224395,0.0003174837,0.0038027859,0.7824265,0.00069196714,0.0035781665,0.00007658087],"about_ca_topic_score_codex":0.0014508228,"about_ca_topic_score_gemma":0.0013100617,"teacher_disagreement_score":0.0032369476,"about_ca_system_score_codex":0.00039090132,"about_ca_system_score_gemma":0.0002956635,"threshold_uncertainty_score":0.010828674},"labels":[],"label_agreement":null},{"id":"W4406465021","doi":"10.1016/s0000-0000(11)55107-1","title":"10.1016/s0000-0000(11)55107-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.04497348627129081,"score_gpt":0.33544096773399723,"score_spread":0.2904674814627064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406465021","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004054416,0.00035839653,0.00060290104,0.0006368608,0.00036607572,0.0001035555,0.0006685762,0.0009061628,0.9959521],"genre_scores_gemma":[0.0006390752,0.00011762022,0.00039699572,0.00023836512,0.00007795143,0.000050498365,0.00034970057,0.0001540033,0.9979759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933124,0.00005486483,0.000055214936,0.00021629978,0.00018239055,0.00016005551],"domain_scores_gemma":[0.9971419,0.0006005281,0.00018960702,0.00030288802,0.0005394598,0.0012256629],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011452017,0.0018318231,0.0013553797,0.002428955,0.0019884335,0.0028866122,0.0025400792,0.0050136843,0.98770255],"category_scores_gemma":[0.0022890246,0.0007255964,0.0012510784,0.0017438893,0.0015533394,0.0032479668,0.0035859887,0.00203611,0.9926443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028942863,0.00017514917,0.0009659682,0.00034759036,0.000020884221,0.00020652247,0.00008132254,0.00032570213,0.001229833,0.004665937,0.31792492,0.67376673],"study_design_scores_gemma":[0.000043599273,0.00009425385,0.000822858,0.00025966213,0.000007588739,0.0003456489,0.00007557139,0.00019487395,0.00022240751,0.00066068827,0.9972554,0.000017443957],"about_ca_topic_score_codex":0.0025304349,"about_ca_topic_score_gemma":0.0023114153,"teacher_disagreement_score":0.0122974515,"about_ca_system_score_codex":0.0011295634,"about_ca_system_score_gemma":0.0011769185,"threshold_uncertainty_score":0.017540812},"labels":[],"label_agreement":null},{"id":"W4406517188","doi":"10.1016/s0029-7437(11)70029-5","title":"10.1016/s0029-7437(11)70029-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Metabolism; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.043614038191269924,"score_gpt":0.333657006754359,"score_spread":0.2900429685630891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406517188","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032850125,0.0005436915,0.0007467636,0.0003982243,0.0003870458,0.00009767756,0.00066649873,0.0007108689,0.99612087],"genre_scores_gemma":[0.00043520672,0.00021358735,0.00032864208,0.00015425637,0.000088635985,0.00005086384,0.00031599053,0.00013452234,0.99827826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925774,0.000047432713,0.00005695618,0.00027820017,0.00020353384,0.00015610868],"domain_scores_gemma":[0.99723214,0.00074666005,0.00019338503,0.00027160312,0.0005241042,0.0010320395],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013304721,0.0032534932,0.0024014749,0.003431081,0.0029478832,0.0047403225,0.004335658,0.006626768,0.98901397],"category_scores_gemma":[0.0020422651,0.001260852,0.0019605397,0.0030785159,0.0026051458,0.0054566166,0.0036891163,0.0032042312,0.9931799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039418365,0.00023622141,0.00063629786,0.0007317837,0.00004502517,0.00027638293,0.00012001239,0.00050943234,0.0023804088,0.006567654,0.31666738,0.6714352],"study_design_scores_gemma":[0.000052257827,0.00012431093,0.0005877187,0.00032190615,0.000013353141,0.00029410803,0.00009672079,0.0001988672,0.00034417203,0.00063802645,0.99730456,0.000023945051],"about_ca_topic_score_codex":0.0038813984,"about_ca_topic_score_gemma":0.0029602763,"teacher_disagreement_score":0.01098603,"about_ca_system_score_codex":0.0013863313,"about_ca_system_score_gemma":0.0015591541,"threshold_uncertainty_score":0.01567024},"labels":[],"label_agreement":null},{"id":"W4406521198","doi":"10.1016/s0029-7437(05)70521-8","title":"10.1016/s0029-7437(05)70521-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Key (lock); Fentanyl; Gene; Medicine; Computational biology; Neuroscience; Biology; Genetics; Pharmacology; Computer science; Computer security","score_opus":0.04495290016387798,"score_gpt":0.33603763648975504,"score_spread":0.29108473632587706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406521198","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032104208,0.00049316185,0.0006723712,0.00044002323,0.00035098472,0.000093598115,0.00065682636,0.0007506027,0.99622154],"genre_scores_gemma":[0.0004083708,0.00017837559,0.00028157854,0.00015254827,0.000076633914,0.00004426412,0.00029776632,0.00012959387,0.9984308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993511,0.000042808588,0.00005111092,0.00023192965,0.00018302145,0.00014007723],"domain_scores_gemma":[0.99710697,0.00075340364,0.00020303378,0.0002840287,0.0006292624,0.0010232646],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001266255,0.0029280542,0.0022430473,0.003223008,0.0027713622,0.0045020944,0.0038902892,0.006216053,0.98919106],"category_scores_gemma":[0.0020768899,0.0011107959,0.0017428054,0.0029014824,0.0023624923,0.0051212455,0.0032995106,0.0030575825,0.99326044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003132908,0.00020971058,0.00060628325,0.0006265688,0.000037186273,0.00022349511,0.00010727643,0.00041316228,0.0020976162,0.006372557,0.33800307,0.6509898],"study_design_scores_gemma":[0.00004499806,0.00010373452,0.00059433194,0.00029220807,0.000011676301,0.00024960842,0.00009084337,0.00017962372,0.0003184464,0.00059783173,0.99749595,0.000020636831],"about_ca_topic_score_codex":0.004431295,"about_ca_topic_score_gemma":0.0031783022,"teacher_disagreement_score":0.010808945,"about_ca_system_score_codex":0.0013519563,"about_ca_system_score_gemma":0.001556313,"threshold_uncertainty_score":0.015417576},"labels":[],"label_agreement":null},{"id":"W4406555704","doi":"10.1016/s1634-6939(21)49710-3","title":"10.1016/s1634-6939(21)49710-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine","score_opus":0.045133677221794836,"score_gpt":0.3381398435766605,"score_spread":0.29300616635486565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555704","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029948007,0.00045904974,0.0005508187,0.0004206608,0.00038010493,0.00009168945,0.0006852314,0.000787568,0.99632543],"genre_scores_gemma":[0.0003959783,0.00020291371,0.0003247367,0.00023058223,0.000102022954,0.000046400724,0.000351373,0.0001279674,0.998218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936956,0.000038191603,0.000055375738,0.00020573777,0.00019969982,0.00013145246],"domain_scores_gemma":[0.99752444,0.0005781616,0.00016024771,0.00026249702,0.00051207386,0.0009625084],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010822673,0.002650705,0.0017312082,0.002863031,0.0024375303,0.0038011721,0.0032796816,0.0056275716,0.9898099],"category_scores_gemma":[0.0019920073,0.0009777523,0.0017047939,0.0023820514,0.001714387,0.0048740273,0.003590795,0.0027950516,0.9931225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032005375,0.00021886989,0.0006491416,0.0005060865,0.00003007004,0.00020741086,0.00007602132,0.00034826397,0.001562289,0.004075278,0.3772834,0.61472315],"study_design_scores_gemma":[0.000053401902,0.00009373138,0.00060879,0.00024960187,0.000010418324,0.00029397022,0.000068831214,0.00013238883,0.00026203867,0.00051249156,0.99769336,0.000020875801],"about_ca_topic_score_codex":0.0043030595,"about_ca_topic_score_gemma":0.0036028016,"teacher_disagreement_score":0.010190129,"about_ca_system_score_codex":0.0011880107,"about_ca_system_score_gemma":0.0013192194,"threshold_uncertainty_score":0.014534891},"labels":[],"label_agreement":null},{"id":"W4406560968","doi":"10.1016/s2211-9698(23)47771-0","title":"10.1016/s2211-9698(23)47771-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mathematics","score_opus":0.04634207960470298,"score_gpt":0.3401207311691029,"score_spread":0.2937786515643999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406560968","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002453133,0.00036017585,0.00053812773,0.0003378612,0.00034061694,0.000083481646,0.0005471877,0.0007797715,0.9967673],"genre_scores_gemma":[0.0002990448,0.00015991609,0.00025688836,0.00016177337,0.00006995097,0.000034987577,0.0002601394,0.00011653265,0.9986407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942744,0.000037413098,0.00004663423,0.00018580562,0.00018530394,0.00011755092],"domain_scores_gemma":[0.99784374,0.00046607407,0.00013001406,0.0002502984,0.0004556769,0.00085420965],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010134928,0.0022503533,0.0015089321,0.0025719714,0.0021375979,0.0038650925,0.002905508,0.00445053,0.98979235],"category_scores_gemma":[0.0018417861,0.00091523834,0.0014983524,0.0021898013,0.0014392341,0.004146267,0.0032628928,0.0022688003,0.9924665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024538292,0.00017242318,0.00051099993,0.00041882118,0.000025280799,0.00016265616,0.000069166315,0.00029028484,0.0014520534,0.003908596,0.38675368,0.60599077],"study_design_scores_gemma":[0.000032279826,0.00006000124,0.00046325472,0.00018750575,0.00000798735,0.00019015998,0.000058879723,0.00009512665,0.00020214778,0.00035500823,0.9983328,0.000014763077],"about_ca_topic_score_codex":0.004412654,"about_ca_topic_score_gemma":0.0038439422,"teacher_disagreement_score":0.010207653,"about_ca_system_score_codex":0.0011006482,"about_ca_system_score_gemma":0.001190194,"threshold_uncertainty_score":0.014559865},"labels":[],"label_agreement":null},{"id":"W4406570226","doi":"10.1016/j.cnur.2024.12.006","title":"The Use of Pharmacogenomics in Mental Health","year":2025,"lang":"en","type":"review","venue":"Nursing Clinics of North America","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Mental health; MEDLINE; Psychiatry; Pharmacology","score_opus":0.2981826777562113,"score_gpt":0.5514604454402324,"score_spread":0.2532777676840211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406570226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041585798,0.99911505,0.000082266495,0.00032879028,0.00009638561,0.000001990214,0.000011107481,0.000002631752,0.0003200505],"genre_scores_gemma":[0.00044057466,0.998697,0.00019782118,0.00036359823,0.00018713764,0.0000027467972,0.0000119042315,7.711863e-7,0.000098454766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921954,0.0002816978,0.00011883871,0.00012518969,0.00021179412,0.000042925054],"domain_scores_gemma":[0.99527407,0.0034832952,0.0005230831,0.00007951119,0.0005107583,0.00012922098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028273785,0.0009881482,0.0018652802,0.0045683943,0.00024749702,0.0017609977,0.00093064504,0.0017620391,0.004319642],"category_scores_gemma":[0.0041722707,0.00040043943,0.0013711295,0.004762718,0.0008377754,0.0017407434,0.0012981837,0.0025652412,0.0009173799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006163627,0.000056007375,0.0005457076,0.019975122,0.00025902316,0.000120169985,0.00005213004,0.00026996146,0.00032180172,0.0039097047,0.013188743,0.96124],"study_design_scores_gemma":[0.000087156106,0.00024425035,0.0069639296,0.038958214,0.001195198,0.0016742226,0.00021801468,0.00040902986,0.0003985215,0.006032949,0.9437459,0.00007249536],"about_ca_topic_score_codex":0.0030494626,"about_ca_topic_score_gemma":0.0072763325,"teacher_disagreement_score":0.0045683943,"about_ca_system_score_codex":0.0010113742,"about_ca_system_score_gemma":0.002468361,"threshold_uncertainty_score":0.014952779},"labels":[],"label_agreement":null},{"id":"W4406583238","doi":"10.1016/s1155-1976(02)00048-7","title":"10.1016/s1155-1976(02)00048-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Disposition; Psychology; Social psychology","score_opus":0.04572781173066551,"score_gpt":0.3391572638153699,"score_spread":0.2934294520847044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583238","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003182973,0.00045844144,0.0005619846,0.00040369347,0.00034254434,0.000103956554,0.0007022497,0.0008660349,0.9962429],"genre_scores_gemma":[0.0003929236,0.00017483393,0.0003572402,0.0001977628,0.00007098783,0.00004678787,0.00034628145,0.00014118436,0.9982718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992569,0.000050064977,0.000066260014,0.00025333292,0.0002043827,0.00016904893],"domain_scores_gemma":[0.99763036,0.00052480266,0.00014927506,0.00028515808,0.0005338786,0.00087650033],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012575645,0.0030373484,0.0019777326,0.0031664548,0.0029307115,0.004048006,0.0038807145,0.006731857,0.9916037],"category_scores_gemma":[0.001995889,0.0011512751,0.0019847343,0.0026878654,0.002154366,0.0050734906,0.0036520113,0.0030183813,0.9944782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040747618,0.00023512846,0.0007744387,0.000590074,0.00003482856,0.00023893405,0.0001093074,0.00041459556,0.0016510247,0.0056641134,0.35349467,0.63638544],"study_design_scores_gemma":[0.000051678428,0.00009741583,0.00055553106,0.00029331874,0.0000121021385,0.0003163258,0.000096912576,0.00014882884,0.00028330556,0.00055814965,0.9975635,0.000022857383],"about_ca_topic_score_codex":0.005532323,"about_ca_topic_score_gemma":0.004665384,"teacher_disagreement_score":0.0083963275,"about_ca_system_score_codex":0.0014216575,"about_ca_system_score_gemma":0.0014181574,"threshold_uncertainty_score":0.011976361},"labels":[],"label_agreement":null},{"id":"W4406666103","doi":"10.1016/b978-0-323-08475-8.00060-8","title":"10.1016/b978-0-323-08475-8.00060-8","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.05311223364517546,"score_gpt":0.31992495093562995,"score_spread":0.26681271729045447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406666103","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001743268,0.0006394488,0.001009423,0.0003250517,0.00019235969,0.000049170565,0.00072681514,0.0010535191,0.99583],"genre_scores_gemma":[0.00039815533,0.00028544286,0.00037132623,0.00010996786,0.00003799203,0.000030421403,0.0003958662,0.00020230855,0.9981686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961036,0.000022280592,0.000023135206,0.00013797422,0.00013594633,0.000070345035],"domain_scores_gemma":[0.9984517,0.00049114675,0.000115269446,0.00020183841,0.0002552097,0.00048492503],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00083609234,0.0021981136,0.0014791349,0.001759214,0.0012643472,0.0043808077,0.002957222,0.0039074207,0.98074776],"category_scores_gemma":[0.0015788835,0.00075647724,0.0009575671,0.0018597604,0.0010941583,0.003830649,0.0031663026,0.0021163598,0.9913544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015505859,0.0001109793,0.00026102795,0.0003847749,0.00001650545,0.000107176136,0.000066687324,0.00032065323,0.0021724394,0.0060584615,0.33017662,0.6601697],"study_design_scores_gemma":[0.000021346825,0.000047869937,0.0004290831,0.00027473393,0.000007622849,0.00019990254,0.000061919956,0.000118005286,0.00030286657,0.0012339364,0.99729013,0.000012633084],"about_ca_topic_score_codex":0.0027742498,"about_ca_topic_score_gemma":0.0024104775,"teacher_disagreement_score":0.01925224,"about_ca_system_score_codex":0.00083722477,"about_ca_system_score_gemma":0.0007934663,"threshold_uncertainty_score":0.027460992},"labels":[],"label_agreement":null},{"id":"W4407147371","doi":"10.2174/011573403x334668241227074314","title":"Pharmacogenomics and its Role in Cardiovascular Diseases: A Narrative Literature Review","year":2025,"lang":"en","type":"review","venue":"Current Cardiology Reviews","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Pharmacogenomics; Medicine; Intensive care medicine; Pharmacogenetics; Personalized medicine; Adverse effect; Precision medicine; Bioinformatics; Pharmacology; Pathology","score_opus":0.1272630510619573,"score_gpt":0.4792411730001591,"score_spread":0.3519781219382018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407147371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096202515,0.998779,0.00009300865,0.00040049056,0.00011322094,0.0000047221524,0.000024773453,0.0000045228808,0.00048391958],"genre_scores_gemma":[0.0007894925,0.9984939,0.00013932373,0.0002211696,0.00017548293,0.000005867085,0.00002776151,0.0000011572538,0.00014584191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954623,0.00011031799,0.00010806206,0.000074600975,0.00012784584,0.00003295518],"domain_scores_gemma":[0.997472,0.0018502016,0.0002871942,0.00004253814,0.0002839723,0.00006410357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011948296,0.00082095707,0.0015238872,0.0038699682,0.0003694461,0.001650582,0.0008262588,0.0012543406,0.005830984],"category_scores_gemma":[0.0033183598,0.00027539066,0.0012947669,0.0043433574,0.0004938248,0.0014411748,0.0008155004,0.0013682774,0.0010943849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013702984,0.00008160574,0.0007253318,0.10579348,0.00045147867,0.00042425483,0.00018213419,0.0004037886,0.0005971261,0.005945421,0.02889804,0.8563604],"study_design_scores_gemma":[0.000036743022,0.00016206942,0.0039662677,0.09157313,0.0021944311,0.0043581063,0.0002542981,0.0002719596,0.00039206145,0.004962769,0.89177704,0.00005113021],"about_ca_topic_score_codex":0.0019860873,"about_ca_topic_score_gemma":0.0033563694,"teacher_disagreement_score":0.005830984,"about_ca_system_score_codex":0.0008611977,"about_ca_system_score_gemma":0.0033960636,"threshold_uncertainty_score":0.019506574},"labels":[],"label_agreement":null},{"id":"W4407366891","doi":"10.3390/pharmaceutics17020233","title":"Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models","year":2025,"lang":"en","type":"article","venue":"Pharmaceutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Hôpital Saint-François d'Assise","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Réseau Québécois de Recherche sur les Médicaments; Canadian Institutes of Health Research; Université Laval","keywords":"Prodrug; Pharmacology; Medicine; Paclitaxel; Toxicity; Chemotherapy; Internal medicine","score_opus":0.1307785560044418,"score_gpt":0.4282220137369749,"score_spread":0.2974434577325331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407366891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946131,0.0015970522,0.0018211214,0.00006168958,0.00001576819,0.00003634871,0.00048632128,0.00009620941,0.0012722997],"genre_scores_gemma":[0.9905509,0.0017797694,0.0016646081,0.00003912139,0.000010801654,0.00006238781,0.0008813275,0.000025987596,0.004985107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999262,0.000011958391,0.0000054062652,0.0000147891915,0.000019143126,0.000022527158],"domain_scores_gemma":[0.9999244,0.0000108231525,0.000031060456,0.000006779813,0.000011266873,0.000015479827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015189941,0.00040276907,0.0001982286,0.0002891992,0.00008686583,0.00013077602,0.00017038404,0.00026099043,0.001012602],"category_scores_gemma":[0.000075202224,0.000109451175,0.00019186603,0.00015446232,0.00014447545,0.00018558445,0.000053475673,0.00045741684,0.00021504986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044069238,0.00013195371,0.0002510833,0.000033841945,0.0000061796554,0.000028155238,0.0000153948,0.00018214683,0.99606663,0.000066831104,0.000068589274,0.002708549],"study_design_scores_gemma":[0.00002261164,0.003052224,0.0015461983,0.000003121792,0.000020847654,0.000102372265,0.000009679577,0.0005729235,0.9937878,0.000016494463,0.0008626353,0.0000029747637],"about_ca_topic_score_codex":0.00048452592,"about_ca_topic_score_gemma":0.0006643178,"teacher_disagreement_score":0.001012602,"about_ca_system_score_codex":0.00017142257,"about_ca_system_score_gemma":0.00013426936,"threshold_uncertainty_score":0.0033874512},"labels":[],"label_agreement":null},{"id":"W4407599227","doi":"10.1016/j.drup.2025.101213","title":"Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"H2020 Marie Skłodowska-Curie Actions; FP7 People: Marie-Curie Actions; National Institutes of Health; Universidad de Zaragoza; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; European Commission; Horizon 2020 Framework Programme","keywords":"Antibiotics; Medicine; Lactam; Tuberculosis; Microbiology; Chemistry; Biology; Pathology","score_opus":0.0657759882485501,"score_gpt":0.4339001372049818,"score_spread":0.36812414895643164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407599227","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75479645,0.21354946,0.00809202,0.0009820522,0.00068811915,0.000444331,0.0010830901,0.00044493587,0.019919414],"genre_scores_gemma":[0.9171098,0.06642874,0.006888859,0.00062259636,0.0002770834,0.000112630216,0.0010197461,0.000027277083,0.0075133373],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999224,0.000012356102,0.0000065571335,0.000014662882,0.00003208577,0.000011990297],"domain_scores_gemma":[0.9999558,0.0000078904495,0.000015330808,0.0000033739843,0.0000075675607,0.0000101266505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009669449,0.00029679944,0.00032495311,0.0003175751,0.0001790908,0.00024661512,0.00024607373,0.00031053557,0.0018200531],"category_scores_gemma":[0.00013971853,0.00009426447,0.00024932998,0.00019429317,0.00019470543,0.00018785564,0.00023342343,0.0004941139,0.0005187451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009548524,0.00047540158,0.0015457341,0.0010676669,0.000040967836,0.000848194,0.0000542523,0.00026136692,0.82800746,0.00045109366,0.00164729,0.16464572],"study_design_scores_gemma":[0.0005032494,0.010986057,0.012580024,0.00025213815,0.00021105641,0.0073842867,0.000097891694,0.001278353,0.82953024,0.0002662843,0.13685913,0.000051251405],"about_ca_topic_score_codex":0.00029092262,"about_ca_topic_score_gemma":0.0006605309,"teacher_disagreement_score":0.0018200531,"about_ca_system_score_codex":0.00013875184,"about_ca_system_score_gemma":0.00020791362,"threshold_uncertainty_score":0.006088674},"labels":[],"label_agreement":null},{"id":"W4407700137","doi":"10.1200/jco.2025.43.5_suppl.538","title":"Efficacy outcomes with belzutifan versus everolimus by baseline disease characteristics and burden subgroups in the phase 3 LITESPARK-005 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Everolimus; Internal medicine; Baseline (sea); Oncology; Disease","score_opus":0.20794132234252433,"score_gpt":0.574952022184666,"score_spread":0.3670106998421417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465704,0.0019081172,0.00019070573,0.00019970282,0.000037826725,0.00041293385,0.0014978219,0.000027990323,0.001067931],"genre_scores_gemma":[0.9945879,0.00034015594,0.00031992228,0.0004751408,0.00005054207,0.0004623104,0.0032357136,0.0000103246275,0.00051797717],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899215,0.00056306197,0.0000574972,0.00013031448,0.00010320154,0.00015374771],"domain_scores_gemma":[0.9989513,0.00017737871,0.00031967805,0.000061596904,0.00004717532,0.000442947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003981597,0.0008111634,0.0011809535,0.00028740705,0.00030307367,0.000838406,0.000569818,0.00079043786,0.002429187],"category_scores_gemma":[0.0013458859,0.00031870368,0.0020077436,0.0003262768,0.0003888354,0.0006393233,0.00040164738,0.0014013621,0.0004381314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9004259,0.006479434,0.05783393,0.0003207907,0.0035964602,0.0000970846,0.000114387614,0.0010250424,0.0053288513,0.000116475196,0.0028784743,0.021783086],"study_design_scores_gemma":[0.37155384,0.24937616,0.36594564,0.00008682684,0.0037948377,0.00038164412,0.0001555935,0.0025840637,0.0020286806,0.00037295232,0.003642884,0.000076820805],"about_ca_topic_score_codex":0.0010014323,"about_ca_topic_score_gemma":0.0031628308,"teacher_disagreement_score":0.003981597,"about_ca_system_score_codex":0.00070620805,"about_ca_system_score_gemma":0.0011770726,"threshold_uncertainty_score":0.02105689},"labels":[],"label_agreement":null},{"id":"W4407945358","doi":"10.1002/bcp.70014","title":"Investigation of a broad‐spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient–drug interactions","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Calgary Foundation","keywords":"Micronutrient; Pharmacology; Pharmacokinetics; Cmax; CYP3A4; Dextromethorphan; Chemistry; Medicine; CYP3A; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.09333039578855917,"score_gpt":0.4792569214368342,"score_spread":0.385926525648275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407945358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977329,0.0010676628,0.00048517447,0.000052872474,0.000011780265,0.00014615247,0.000029758274,0.000010039429,0.0004637656],"genre_scores_gemma":[0.99731535,0.00037646355,0.0016793244,0.00008135255,0.000015512434,0.000047545745,0.00004299978,0.0000037888249,0.00043757333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946517,0.00022470533,0.000037140348,0.00007717524,0.0001596848,0.00003618193],"domain_scores_gemma":[0.9989949,0.0003378553,0.00041610966,0.000062531944,0.00012265553,0.00006592721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011415955,0.0002762943,0.00052186183,0.00023350983,0.00022568107,0.00042529183,0.00026768947,0.00040723718,0.0015579225],"category_scores_gemma":[0.0015643053,0.00019310415,0.00034357616,0.0001730151,0.00027753625,0.00027740502,0.00028428665,0.00043583574,0.00016356604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050940905,0.007935671,0.20647648,0.0016047145,0.00080232776,0.002039791,0.00061302027,0.0010733671,0.55685747,0.00045395247,0.0006414614,0.17056082],"study_design_scores_gemma":[0.0020703343,0.24079104,0.3956199,0.00013858773,0.0012706057,0.0035722482,0.00066011446,0.00673564,0.3412544,0.00037910836,0.007463693,0.000044316785],"about_ca_topic_score_codex":0.00046694177,"about_ca_topic_score_gemma":0.001027473,"teacher_disagreement_score":0.0015579225,"about_ca_system_score_codex":0.00036677276,"about_ca_system_score_gemma":0.00040090046,"threshold_uncertainty_score":0.006037414},"labels":[],"label_agreement":null},{"id":"W4408045789","doi":"10.1016/b978-0-443-23848-2.00013-9","title":"Journey from lab to shelf: Amoxicillin, Alprazolam, Penicillin, Acetaminophen, Metformin","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Amoxicillin; Penicillin; Medicine; Metformin; Acetaminophen; Pharmacology; Internal medicine; Microbiology; Antibiotics; Biology","score_opus":0.07715100299753948,"score_gpt":0.38302237178648146,"score_spread":0.305871368788942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408045789","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001618065,0.5843393,0.0049061133,0.02339467,0.010591677,0.00004418077,0.00044387355,0.00067589944,0.3739862],"genre_scores_gemma":[0.0038713026,0.21438336,0.007428079,0.009756643,0.0034180647,0.00004212539,0.00044644385,0.00030044038,0.76035357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978524,0.00002253926,0.000014774717,0.000030063971,0.0001333537,0.000014068544],"domain_scores_gemma":[0.9998097,0.00005930503,0.000017760673,0.000013288639,0.0000536221,0.000046407567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039192502,0.00085812877,0.00051803776,0.0012446702,0.0005425618,0.0037137065,0.00061404455,0.0017106273,0.06511738],"category_scores_gemma":[0.00073223154,0.00033469888,0.00037951878,0.0012842647,0.000528182,0.0031854815,0.0013649279,0.00281688,0.052484434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003350088,0.000049830505,0.000104154635,0.0003494236,0.0000055478854,0.00015414754,0.00019430406,0.000080180704,0.0016198816,0.0090598585,0.43898,0.54936916],"study_design_scores_gemma":[0.0000023291416,0.000020569556,0.00015567453,0.00028802644,0.000002715633,0.00037090175,0.00008374369,0.000032059514,0.00016130201,0.0019525171,0.9969254,0.0000046077002],"about_ca_topic_score_codex":0.0014240355,"about_ca_topic_score_gemma":0.0049287486,"teacher_disagreement_score":0.06511738,"about_ca_system_score_codex":0.00067416416,"about_ca_system_score_gemma":0.0009503768,"threshold_uncertainty_score":0.21783936},"labels":[],"label_agreement":null},{"id":"W4408131915","doi":"10.3390/jpm15030101","title":"Implementation of Pharmacogenomics Testing in Daily Clinical Practice: Perspectives of Prescribers from Two Canadian Armed Forces Medical Clinics","year":2025,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; Canadian Armed Forces; Defence Research and Development Canada","funders":"Innovation, Science and Economic Development Canada","keywords":"Workflow; Medicine; Observational study; Stakeholder; Test (biology); Pharmacogenomics; Qualitative research; Population; Health care; Variety (cybernetics); Medical education; Family medicine; Computer science; Public relations","score_opus":0.14388016907494117,"score_gpt":0.5696804310817613,"score_spread":0.4258002620068201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408131915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903425,0.0005379386,0.0003696921,0.006474138,0.000031575637,0.00013012094,0.000058632377,0.000008857544,0.0020466163],"genre_scores_gemma":[0.99336666,0.00079042226,0.0010500144,0.003271927,0.000028614846,0.000084099775,0.00004199036,0.000012510156,0.0013536008],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9847173,0.0074380096,0.0006099347,0.0008571185,0.0030487315,0.0033287765],"domain_scores_gemma":[0.95699865,0.01910221,0.0058168136,0.0006149676,0.0056794076,0.011787976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010947355,0.00032181124,0.0005718755,0.001125512,0.017441195,0.0052890475,0.002092417,0.0025345434,0.0032212806],"category_scores_gemma":[0.025135128,0.0008752571,0.00038807464,0.0016327229,0.0071512344,0.0016064208,0.0029882805,0.004141163,0.00027511906],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008723416,0.00024857573,0.038818248,0.0002431934,0.000015115816,0.0017165799,0.94448024,0.00010760511,0.00098468,0.000420802,0.0017541955,0.011123486],"study_design_scores_gemma":[0.000028943256,0.000214136,0.02835946,0.0002091516,0.00001591602,0.00051034364,0.962993,0.00021037087,0.0002580649,0.00009150953,0.007060823,0.000048251848],"about_ca_topic_score_codex":0.4926581,"about_ca_topic_score_gemma":0.6459335,"teacher_disagreement_score":0.4926581,"about_ca_system_score_codex":0.034052327,"about_ca_system_score_gemma":0.055781033,"threshold_uncertainty_score":0.97958106},"labels":[],"label_agreement":null},{"id":"W4408154106","doi":"10.1016/j.psc.2025.01.004","title":"Psychiatric Pharmacogenomic Testing","year":2025,"lang":"en","type":"review","venue":"Psychiatric Clinics of North America","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Mental Health Research Canada; Alberta Children's Hospital; Centre for Addiction and Mental Health; Ontario Brain Institute","funders":"","keywords":"Psychology; Psychiatry; Medicine","score_opus":0.17479296492407626,"score_gpt":0.500747854779213,"score_spread":0.32595488985513676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408154106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007217196,0.9819389,0.0016581733,0.0013005679,0.00045465396,0.000054265933,0.0005044768,0.00006910093,0.013298015],"genre_scores_gemma":[0.008403884,0.98001,0.0025420962,0.0015352682,0.000635943,0.000050737806,0.0009093284,0.000010562062,0.0059022484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997366,0.000082792656,0.000026550875,0.0000507188,0.00008325656,0.00002002297],"domain_scores_gemma":[0.99947363,0.00027785188,0.000074229945,0.000027998558,0.00011273857,0.000033542274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008547015,0.00071990024,0.0008436406,0.0021156399,0.00015815411,0.00061528943,0.00051147945,0.0005682427,0.0076597794],"category_scores_gemma":[0.0014804221,0.00012972568,0.0006216837,0.0015927212,0.00024456228,0.00031094352,0.00052814477,0.0009874767,0.0019439814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063899795,0.000056972352,0.00077742833,0.002958362,0.00010223133,0.00019046722,0.000010977515,0.00011462694,0.0006408553,0.0013834675,0.029653814,0.964047],"study_design_scores_gemma":[0.00014195249,0.00020047626,0.010445324,0.007621567,0.000604426,0.004132578,0.000068394125,0.00029654562,0.0017723793,0.004642458,0.9700375,0.000036458783],"about_ca_topic_score_codex":0.0020559565,"about_ca_topic_score_gemma":0.0049099675,"teacher_disagreement_score":0.0076597794,"about_ca_system_score_codex":0.00033677457,"about_ca_system_score_gemma":0.0010884284,"threshold_uncertainty_score":0.025624573},"labels":[],"label_agreement":null},{"id":"W4408244566","doi":"10.1111/hae.70021","title":"Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling","year":2025,"lang":"en","type":"article","venue":"Haemophilia","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Waterloo","funders":"Sick Kids Foundation","keywords":"Reagent; Medicine; Dosing; Population; Pharmacokinetics; Statistics; Mathematics; Pharmacology; Chemistry; Environmental health","score_opus":0.25381826807796604,"score_gpt":0.4784073528578552,"score_spread":0.22458908477988915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408244566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92619294,0.008709593,0.05601227,0.00068436057,0.00008870505,0.00034212708,0.0024127401,0.0004986812,0.005058741],"genre_scores_gemma":[0.9788739,0.0015902856,0.017022958,0.00030693616,0.000049001665,0.00008866779,0.001373594,0.00012862904,0.0005660078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9829888,0.00937317,0.00083920575,0.0017137381,0.0046845363,0.00040052764],"domain_scores_gemma":[0.94917905,0.038165335,0.007223362,0.002453815,0.0026421833,0.00033631455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02265084,0.00076248427,0.00074579444,0.0013192075,0.00023578126,0.0024341817,0.00078249123,0.0006007703,0.0015005642],"category_scores_gemma":[0.04944679,0.00034890516,0.0012752266,0.001650722,0.0006432732,0.0012005583,0.00088213466,0.0008974168,0.0005733955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007549387,0.00067232206,0.60785806,0.0012889435,0.0024709145,0.000741116,0.00072187773,0.038489647,0.049743485,0.002179591,0.002144478,0.2861402],"study_design_scores_gemma":[0.00031452274,0.012893484,0.54897374,0.0004904792,0.004309128,0.0039359294,0.00041944627,0.12598363,0.25133944,0.005515087,0.045507792,0.00031735163],"about_ca_topic_score_codex":0.0015805155,"about_ca_topic_score_gemma":0.0009620457,"teacher_disagreement_score":0.02265084,"about_ca_system_score_codex":0.0013863932,"about_ca_system_score_gemma":0.0013397391,"threshold_uncertainty_score":0.119790494},"labels":[],"label_agreement":null},{"id":"W4408679963","doi":"10.1007/s00228-025-03817-7","title":"Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacokinetics; Jadad scale; Pharmacodynamics; Pharmacology; Observational study; Drug; Meta-analysis; Internal medicine","score_opus":0.14036840201208808,"score_gpt":0.5251490608771655,"score_spread":0.3847806588650774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408679963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023095617,0.9969585,0.00007105038,0.00012276323,0.00004976728,0.00012701482,0.00020195002,0.0000036281697,0.0001557731],"genre_scores_gemma":[0.032781314,0.965963,0.00038712352,0.0003012254,0.000059408154,0.0002615001,0.00016684867,0.0000031513016,0.00007641963],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99393,0.0021371657,0.002234838,0.000461757,0.0010684835,0.00016770398],"domain_scores_gemma":[0.9697374,0.02290687,0.0051382114,0.00035904328,0.0016267867,0.00023161931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005954116,0.0010717808,0.007121034,0.00606753,0.00050760974,0.0019423205,0.001341471,0.001695708,0.0034456884],"category_scores_gemma":[0.028916905,0.00088768563,0.0076909917,0.008471466,0.0008037611,0.0016566411,0.0009450178,0.00085300626,0.00020446109],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035815104,0.000025448862,0.0029483018,0.9456321,0.019672837,0.00013823163,0.00014940147,0.00010310949,0.0001397059,0.0001273995,0.00072099705,0.029984238],"study_design_scores_gemma":[0.0005246809,0.00050125935,0.022195851,0.7425686,0.21735948,0.00081869436,0.00033482283,0.00020667404,0.00036201478,0.00029778012,0.014767555,0.00006255928],"about_ca_topic_score_codex":0.008859942,"about_ca_topic_score_gemma":0.022352442,"teacher_disagreement_score":0.008859942,"about_ca_system_score_codex":0.0025402894,"about_ca_system_score_gemma":0.007419448,"threshold_uncertainty_score":0.031488776},"labels":[],"label_agreement":null},{"id":"W4408726292","doi":"10.1016/j.bidere.2025.100011","title":"Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives","year":2025,"lang":"en","type":"article","venue":"BioDesign Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bioproduction; Pharmacology; Computer science; Chemistry; Medicine; Biochemistry","score_opus":0.3702322680400097,"score_gpt":0.5794538830619878,"score_spread":0.20922161502197806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408726292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852515,0.0034738628,0.0935154,0.00048551205,0.0003132687,0.00037164384,0.0021257158,0.0005580498,0.013904968],"genre_scores_gemma":[0.962609,0.0015586293,0.027578365,0.000087765125,0.000019426076,0.00013186182,0.0013235947,0.00008191196,0.006609475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.000027006407,0.000019165427,0.00004396325,0.00004857909,0.000036226593],"domain_scores_gemma":[0.9998816,0.000014562062,0.00003086189,0.000025241548,0.0000342724,0.000013300663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020858477,0.0005405654,0.00022211902,0.00022945332,0.000137866,0.00017253454,0.0002639347,0.00029079226,0.0014570805],"category_scores_gemma":[0.00029055894,0.00012529222,0.0002959952,0.00022985753,0.00015371563,0.00023384846,0.00028341738,0.0004980825,0.0009639591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003262156,0.00002355047,0.00010192484,0.000055381122,0.000008320596,0.00008711378,0.000021581181,0.000075947355,0.99522,0.00023672303,0.000076682576,0.0040601906],"study_design_scores_gemma":[0.0000011192986,0.000067676425,0.0001689095,0.0000022828074,0.000004146454,0.000048181777,0.000004527116,0.000097415206,0.998089,0.000026105325,0.001488584,0.0000019570928],"about_ca_topic_score_codex":0.00038991094,"about_ca_topic_score_gemma":0.0008171931,"teacher_disagreement_score":0.0014570805,"about_ca_system_score_codex":0.00020459233,"about_ca_system_score_gemma":0.0002841008,"threshold_uncertainty_score":0.004874468},"labels":[],"label_agreement":null},{"id":"W4409279342","doi":"10.3390/scipharm93020018","title":"Polygenic Risk Scores for Personalized Cardiovascular Pharmacogenomics―A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Scientia Pharmaceutica","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Polygenic risk score; Medicine; Personalized medicine; Bioinformatics; Pharmacology; Biology; Genetics; Genotype; Single-nucleotide polymorphism","score_opus":0.12530812981169875,"score_gpt":0.48443829794383114,"score_spread":0.3591301681321324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409279342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022827499,0.9953329,0.001214835,0.0012460509,0.00032223572,0.00044073098,0.00037248828,0.000024057206,0.000818517],"genre_scores_gemma":[0.0034555607,0.99150604,0.003023383,0.0006066369,0.00021166571,0.00073566503,0.00032064127,0.00001133668,0.00012917488],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9868766,0.005585911,0.0043606176,0.0007585223,0.0021856204,0.00023277938],"domain_scores_gemma":[0.91148573,0.07368922,0.0063813496,0.0016714076,0.006394689,0.00037765363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023613557,0.001606329,0.0063555194,0.02078994,0.0009274525,0.005165194,0.0027021577,0.002821168,0.008161712],"category_scores_gemma":[0.102444686,0.0012975433,0.009562352,0.016142191,0.0012194256,0.0043425635,0.0034744956,0.0025810748,0.0009369427],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106281375,0.00004313352,0.00080821157,0.6198405,0.006977675,0.000120033554,0.00038952785,0.0006441922,0.00015916882,0.0045947614,0.011269561,0.35504702],"study_design_scores_gemma":[0.000051491395,0.000058596543,0.0013418288,0.90367043,0.013520242,0.00018889616,0.00016082525,0.00033714357,0.00008651044,0.003359914,0.07717604,0.00004808918],"about_ca_topic_score_codex":0.010727681,"about_ca_topic_score_gemma":0.014363826,"teacher_disagreement_score":0.023613557,"about_ca_system_score_codex":0.0050944695,"about_ca_system_score_gemma":0.01836356,"threshold_uncertainty_score":0.12488192},"labels":[],"label_agreement":null},{"id":"W4409680632","doi":"10.1186/s13293-025-00708-5","title":"Sexual dimorphism in metabolomic and phenotypic spectra of UGT deficiency: findings from the Canadian Longitudinal Study on Aging","year":2025,"lang":"en","type":"article","venue":"Biology of Sex Differences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Metabolome; Metabolomics; Metabolite; Phenotype; Gene; Biology; Glucuronidation; Genetics; Metabolic pathway; Glucuronosyltransferase; Genome; Medicine; Internal medicine; Bioinformatics; Endocrinology","score_opus":0.1399421760155425,"score_gpt":0.41327330861236417,"score_spread":0.2733311325968216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409680632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936459,0.00081465614,0.00020520895,0.00022581812,0.000010009982,0.000022516855,0.0036394922,0.00000851465,0.0014277924],"genre_scores_gemma":[0.99801433,0.0002758232,0.00021585266,0.000056493463,0.0000039251904,0.0000062023173,0.0011629586,0.0000050813574,0.00025930992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994186,0.00005201605,0.000029604205,0.00014539761,0.0002280116,0.00012638714],"domain_scores_gemma":[0.9984925,0.00009891321,0.0003385838,0.0001321534,0.0006543119,0.00028351668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009824426,0.00040584858,0.00038720507,0.001357435,0.0015489557,0.00055512745,0.0006475448,0.00036831424,0.0012711212],"category_scores_gemma":[0.0021880006,0.00016590142,0.00042715107,0.0023516852,0.00049016613,0.00016393844,0.00062696607,0.00043901018,0.00009968762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489751,0.000010331438,0.994706,0.000015337628,0.000106108775,0.00013159376,0.00041384125,0.00003869908,0.00086828275,0.000094236864,0.00038023156,0.0030863164],"study_design_scores_gemma":[0.0000013338984,0.0000066976777,0.9995425,0.0000030999695,0.00001360112,0.000067204404,0.00010673824,0.00003795405,0.000032036165,0.000015901365,0.00016984393,0.0000031761872],"about_ca_topic_score_codex":0.88002205,"about_ca_topic_score_gemma":0.9022684,"teacher_disagreement_score":0.11997795,"about_ca_system_score_codex":0.003188837,"about_ca_system_score_gemma":0.00445973,"threshold_uncertainty_score":0.24136901},"labels":[],"label_agreement":null},{"id":"W4409852902","doi":"10.1002/cpt.3697","title":"Estimating the Frequency of False‐Negative Pharmacogenetic Test Results by Self‐Reported Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"Alberta Innovates; Alberta Children's Hospital Foundation; American College Health Foundation; Children's Hospital Foundation","keywords":"Pharmacogenetics; Statistics; Test (biology); Medicine; Genetics; Biology; Mathematics; Genotype; Gene","score_opus":0.2090136641616907,"score_gpt":0.5244458290443401,"score_spread":0.3154321648826494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95383185,0.0031150526,0.036650248,0.00040366017,0.0001336719,0.00048731707,0.00095199374,0.00014361294,0.0042825313],"genre_scores_gemma":[0.9876396,0.0003526963,0.010073057,0.00038084935,0.000054381722,0.00023672904,0.00055902486,0.000029274832,0.0006743214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9433099,0.03732987,0.0050180666,0.00599889,0.007212845,0.0011304376],"domain_scores_gemma":[0.8978041,0.066251494,0.020875877,0.010531184,0.004063472,0.0004739722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043447766,0.00072755694,0.00089069427,0.0018606563,0.00054108223,0.0011064579,0.001176998,0.0013848282,0.0009162762],"category_scores_gemma":[0.099623404,0.0005655246,0.0014266553,0.0012995253,0.0013913275,0.0010454396,0.0012684707,0.0011194556,0.00033866207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025068488,0.000036477755,0.990542,0.00004523157,0.00040649448,0.00012642017,0.00028147115,0.00033105115,0.0004367538,0.000268287,0.00027434167,0.007000801],"study_design_scores_gemma":[0.000050694955,0.00047541552,0.9798007,0.00011119824,0.0005860189,0.002487251,0.00030066675,0.010316854,0.0030225303,0.0011180647,0.0016972467,0.000033377735],"about_ca_topic_score_codex":0.003681327,"about_ca_topic_score_gemma":0.0033721593,"teacher_disagreement_score":0.9565522,"about_ca_system_score_codex":0.00042439788,"about_ca_system_score_gemma":0.00030995882,"threshold_uncertainty_score":0.2297765},"labels":[],"label_agreement":null},{"id":"W4409952685","doi":"10.1038/s41467-025-59132-3","title":"Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Agency for Medical Research and Development; Takeda Science Foundation","keywords":"Affect (linguistics); Phenotype; Drug reaction; Gene; Chemistry; Drug; Genetics; Biology; Medicine; Pharmacology; Psychology","score_opus":0.055298746755027724,"score_gpt":0.43291506440470917,"score_spread":0.37761631764968145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409952685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505734,0.0007113938,0.0024607205,0.000051177307,0.000009371543,0.000010499473,0.000670565,0.000081767066,0.00094709184],"genre_scores_gemma":[0.99786204,0.00016688586,0.0009506988,0.00002640996,0.0000055392825,0.00000941045,0.00043753439,0.000014467298,0.00052693486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998636,0.000032168664,0.000007351464,0.00004344959,0.000033856137,0.000019503654],"domain_scores_gemma":[0.9997676,0.00007458392,0.00007154643,0.000034598583,0.000026595084,0.000025117362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096645264,0.00013284874,0.00017261156,0.00031348554,0.000106631225,0.00019623745,0.000059153575,0.0001262401,0.0018692449],"category_scores_gemma":[0.0002884249,0.000112984155,0.00019522966,0.00019233898,0.00014570604,0.00005431697,0.00013100094,0.00016639777,0.00031113895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005126851,0.000023646786,0.02971091,0.000033680957,0.000034930024,0.00020521588,0.000046931014,0.00027275842,0.961857,0.00014045234,0.00007537248,0.007086423],"study_design_scores_gemma":[0.000019267804,0.00037054316,0.59412795,0.000008099614,0.00007047077,0.0014829779,0.000121320256,0.0013468997,0.4004816,0.00036164108,0.0015902793,0.000018964165],"about_ca_topic_score_codex":0.0005128647,"about_ca_topic_score_gemma":0.00092938804,"teacher_disagreement_score":0.0018692449,"about_ca_system_score_codex":0.00013437658,"about_ca_system_score_gemma":0.00008155695,"threshold_uncertainty_score":0.006253183},"labels":[],"label_agreement":null},{"id":"W4409956483","doi":"10.1002/cpt.3693","title":"Impaired Drug Metabolism Caused by Compound Heterozygous Loss‐of‐Function Variants in <i>CYP3A4</i>: A Case Report","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"CYP3A4; Pharmacogenetics; Medicine; Drug; Pharmacology; Population; Drug metabolism; Internal medicine; Metabolism; Biology; Genetics; Genotype; Gene","score_opus":0.11761001336131921,"score_gpt":0.47329417444472477,"score_spread":0.35568416108340556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409956483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613393,0.0064166393,0.010167883,0.0068191555,0.0005264206,0.00025934802,0.0005100037,0.0005837146,0.013377468],"genre_scores_gemma":[0.9921874,0.0016522463,0.0027507623,0.0012636773,0.0008096479,0.000023484754,0.00010996828,0.000064204454,0.0011385195],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99888915,0.00015402182,0.00011506179,0.00033917977,0.0001805459,0.00032216683],"domain_scores_gemma":[0.9973859,0.000896567,0.00068621564,0.00018166039,0.0001140894,0.0007355275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005373975,0.0029493694,0.0015270129,0.0029396329,0.0020754356,0.002092882,0.0013167472,0.0058960887,0.0022550058],"category_scores_gemma":[0.0028964502,0.0016512264,0.0015116257,0.0014638166,0.0027632602,0.0018290379,0.002050924,0.004873421,0.0011078971],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001534396,0.00001557381,0.0025861482,0.000012056403,0.0000062591894,0.9959216,0.00007323357,0.00004100203,0.00039194696,0.000117893826,0.00021943865,0.0005993941],"study_design_scores_gemma":[0.000002832466,0.000016397787,0.0006771274,0.000004300344,0.0000061912783,0.99878556,0.000021460744,0.00007263816,0.00020713104,0.00004523349,0.00015704529,0.0000040101277],"about_ca_topic_score_codex":0.002901375,"about_ca_topic_score_gemma":0.0022760353,"teacher_disagreement_score":0.0058960887,"about_ca_system_score_codex":0.0014098181,"about_ca_system_score_gemma":0.00079990976,"threshold_uncertainty_score":0.0102289915},"labels":[],"label_agreement":null},{"id":"W4409975278","doi":"10.3389/fgene.2025.1435416","title":"Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives","year":2025,"lang":"en","type":"review","venue":"Frontiers in Genetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Computer science; Genotyping; Data science; Identification (biology); DNA sequencing; Computational biology; Bioinformatics; Biology; Genetics","score_opus":0.19453360944736553,"score_gpt":0.4504044710312519,"score_spread":0.2558708615838864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409975278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021540189,0.9957743,0.0010706101,0.0011035452,0.00029381225,0.000008880377,0.000041577234,0.000020869495,0.0014709971],"genre_scores_gemma":[0.0012047392,0.99586934,0.0012896701,0.00064796384,0.00023393163,0.00001314306,0.00006818331,0.0000053127983,0.00066757586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928254,0.0002161719,0.00007428444,0.00010697786,0.00025513626,0.000064850276],"domain_scores_gemma":[0.99788034,0.0014111446,0.00016431704,0.000059034213,0.0004035784,0.00008166658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026525056,0.00070165034,0.0012846012,0.0019548035,0.00021024121,0.0015653342,0.0010703197,0.0015902921,0.0040115505],"category_scores_gemma":[0.0024788845,0.00030139578,0.00092606095,0.0021116391,0.0007005802,0.002204577,0.00081159873,0.0024892006,0.0023176377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007209604,0.00006230295,0.00029732203,0.018128421,0.00012600985,0.0002868156,0.00008814188,0.00065201084,0.0038912673,0.009981552,0.01751382,0.9489002],"study_design_scores_gemma":[0.000019548836,0.00014675716,0.00088194554,0.0046831,0.00015814706,0.0012360584,0.00009575826,0.000369412,0.0016251308,0.007226083,0.98351616,0.000041862015],"about_ca_topic_score_codex":0.0012606508,"about_ca_topic_score_gemma":0.0024501826,"teacher_disagreement_score":0.0040115505,"about_ca_system_score_codex":0.0006094388,"about_ca_system_score_gemma":0.0017112879,"threshold_uncertainty_score":0.014028013},"labels":[],"label_agreement":null},{"id":"W4409984050","doi":"10.1002/cpt.3702","title":"Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Institute on Aging; National Health and Medical Research Council; Monash University; National Cancer Institute; National Institutes of Health; Australian Government; Commonwealth Scientific and Industrial Research Organisation; Medical Research Council","keywords":"Polypharmacy; Pharmacogenetics; Medicine; Genotype; Pharmacogenomics; Internal medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.15653193806827218,"score_gpt":0.4792447535376588,"score_spread":0.32271281546938657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409984050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993111,0.0002073549,0.000032659897,0.000029207124,0.0000022313923,0.0000056773715,0.00022572647,0.0000014102449,0.00018469119],"genre_scores_gemma":[0.9995295,0.00012309202,0.000055953347,0.000033710974,0.000007158668,0.0000058958763,0.00017749373,7.583573e-7,0.00006653362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992387,0.00020527597,0.00014782893,0.00014299106,0.00018688611,0.00007825085],"domain_scores_gemma":[0.9977336,0.00029434173,0.0014551748,0.0001570802,0.00016455728,0.00019511435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009761964,0.00020165798,0.00034670634,0.0007771216,0.0003011789,0.0004999621,0.00023274052,0.0005226068,0.00074747147],"category_scores_gemma":[0.0028358314,0.00026618663,0.00034818792,0.0010167602,0.00021205269,0.00050803035,0.00042285057,0.00040886996,0.000121476194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005704342,0.00002222431,0.9988385,0.0000065996796,0.00003186526,0.000018797924,0.000044089622,0.000011260606,0.000092566515,0.0000060058164,0.00003961874,0.0008314382],"study_design_scores_gemma":[0.0000038215994,0.000047512764,0.9996973,0.0000036553208,0.000012398193,0.00007319082,0.000049114944,0.000050891085,0.000016832604,0.000009468096,0.000034251414,0.0000016500697],"about_ca_topic_score_codex":0.0055578966,"about_ca_topic_score_gemma":0.008689547,"teacher_disagreement_score":0.0055578966,"about_ca_system_score_codex":0.0001722193,"about_ca_system_score_gemma":0.000171574,"threshold_uncertainty_score":0.011051059},"labels":[],"label_agreement":null},{"id":"W4410587725","doi":"10.1097/01.hjh.0001116692.69387.54","title":"ROLE OF CYTOCHROME P450 GENE RS1126742 POLYMORPHISM AND RISK OF HYPERTENSION","year":2025,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Genetics; Gene; Polymorphism (computer science); Cytochrome P450; Internal medicine; Allele; Metabolism","score_opus":0.06701860276290747,"score_gpt":0.35216861903650093,"score_spread":0.2851500162735935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410587725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5449761,0.44542286,0.0018889207,0.002215743,0.00042964728,0.00014995426,0.0020919186,0.00004566021,0.0027791734],"genre_scores_gemma":[0.97416073,0.02363813,0.0006761247,0.00024808137,0.00033844865,0.00006652086,0.00053799537,0.000010158839,0.00032383233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979546,0.0007793747,0.00036229912,0.00044344625,0.00033742917,0.00012286678],"domain_scores_gemma":[0.9942808,0.0036198352,0.0014958673,0.00017211837,0.0002688647,0.00016262646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019827508,0.0004799899,0.001243539,0.0012521269,0.0002603105,0.00094478566,0.00048889476,0.0008061124,0.0028415637],"category_scores_gemma":[0.007712211,0.00025989438,0.0026976126,0.0026886323,0.00034483528,0.0005024306,0.00031229173,0.0006649706,0.00012920433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050747083,0.00008399597,0.91017973,0.013132736,0.023971178,0.0015106174,0.0002109032,0.00045922064,0.0016800772,0.00044641545,0.0016361834,0.04161415],"study_design_scores_gemma":[0.00057170924,0.00047107734,0.951446,0.0026896643,0.035450924,0.0024467937,0.0001526249,0.0013830536,0.00071400986,0.0012187307,0.0034196677,0.000035733294],"about_ca_topic_score_codex":0.002072195,"about_ca_topic_score_gemma":0.001659218,"teacher_disagreement_score":0.0028415637,"about_ca_system_score_codex":0.00026152324,"about_ca_system_score_gemma":0.0005927173,"threshold_uncertainty_score":0.0104858875},"labels":[],"label_agreement":null},{"id":"W4410618198","doi":"10.1016/j.xphs.2025.103827","title":"Which unbound fraction should we use in the well-stirred model for more accurately predicting hepatic clearance of drugs for humans?","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec","funders":"","keywords":"Fraction (chemistry); Chemistry; Metabolic clearance rate; Liver circulation; Pharmacology; Chromatography; Biological system; Medicine; Pharmacokinetics; Internal medicine; Biology","score_opus":0.36731491034039404,"score_gpt":0.5433098460654809,"score_spread":0.1759949357250869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410618198","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15631804,0.008001167,0.81957483,0.007489722,0.0006391458,0.00014320583,0.0013516053,0.0019127745,0.0045695533],"genre_scores_gemma":[0.8896375,0.0045295195,0.09836432,0.0020152153,0.0003015064,0.00014430519,0.0008042299,0.00051009434,0.0036933671],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99930584,0.00030217745,0.00004636326,0.00017850637,0.00008913474,0.00007806759],"domain_scores_gemma":[0.99836046,0.00083485484,0.00025191047,0.00018152999,0.00026435134,0.00010688658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017396641,0.0015717279,0.0035529144,0.000590128,0.00047406123,0.0035317773,0.001751651,0.0028059084,0.0015344269],"category_scores_gemma":[0.0071060914,0.00050567894,0.0017460687,0.0004680447,0.00068735087,0.0040236134,0.00053453003,0.001840738,0.0012695603],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004005383,0.0006678421,0.025172401,0.0011231815,0.001143967,0.0009042967,0.00020310405,0.67012334,0.083522215,0.018756209,0.007196181,0.18718185],"study_design_scores_gemma":[0.00015283556,0.00057363836,0.003000698,0.00012835479,0.00042945115,0.0004486705,0.000072761395,0.95287734,0.019231863,0.017384589,0.0055282814,0.00017149549],"about_ca_topic_score_codex":0.01033211,"about_ca_topic_score_gemma":0.007715306,"teacher_disagreement_score":0.01033211,"about_ca_system_score_codex":0.0010681831,"about_ca_system_score_gemma":0.0017071457,"threshold_uncertainty_score":0.020543933},"labels":[],"label_agreement":null},{"id":"W4410822690","doi":"10.1200/jco.2025.43.16_suppl.e15561","title":"Deciphering colorectal cancer progression through integrative epigenomic analysis for precision therapeutics.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epigenomics; Colorectal cancer; Cancer; Precision medicine; Oncology; Internal medicine; Bioinformatics; Pathology; DNA methylation; Genetics; Biology","score_opus":0.3445006426527239,"score_gpt":0.6433972210706295,"score_spread":0.29889657841790557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75465053,0.026868887,0.17879851,0.0016932795,0.00016543773,0.00025838014,0.027399788,0.0020723338,0.008092796],"genre_scores_gemma":[0.88455236,0.00862954,0.08787759,0.00043374032,0.000046310786,0.00019204461,0.015740983,0.00027219817,0.0022552747],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983823,0.000029826642,0.000010357179,0.000050543746,0.00005048941,0.000020415308],"domain_scores_gemma":[0.99963856,0.00013208471,0.00010897867,0.000039432744,0.000048405826,0.00003245716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075198826,0.0003003133,0.0005276778,0.0009893681,0.00017942562,0.00057278597,0.00033219706,0.00036037475,0.002345066],"category_scores_gemma":[0.0007236759,0.00024546005,0.00050628424,0.0009902366,0.00027185405,0.00049649435,0.0006659422,0.00058373116,0.00041157374],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011172201,0.00010482393,0.090390176,0.0019905758,0.00046606277,0.0006824683,0.00045983001,0.018500827,0.69165635,0.00543019,0.0063625854,0.18283889],"study_design_scores_gemma":[0.00012434469,0.00075505476,0.47354403,0.00045615126,0.0009183449,0.0030594158,0.00091835536,0.123918176,0.27262127,0.014176477,0.10936731,0.00014106245],"about_ca_topic_score_codex":0.0011771529,"about_ca_topic_score_gemma":0.0035542771,"teacher_disagreement_score":0.002345066,"about_ca_system_score_codex":0.00042082588,"about_ca_system_score_gemma":0.00044222016,"threshold_uncertainty_score":0.0078449845},"labels":[],"label_agreement":null},{"id":"W4410953553","doi":"10.3390/bioengineering12060595","title":"Graph Representation Learning for the Prediction of Medication Usage in the UK Biobank Based on Pharmacogenetic Variants","year":2025,"lang":"en","type":"article","venue":"Bioengineering","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Biobank; Pharmacogenetics; Representation (politics); Graph; Computer science; Computational biology; Medicine; Data science; Bioinformatics; Biology; Genotype; Genetics; Gene; Theoretical computer science; Political science","score_opus":0.083822643326512,"score_gpt":0.40743610165880645,"score_spread":0.32361345833229443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410953553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8884296,0.0016698651,0.097679816,0.0027650213,0.00008732787,0.00009657403,0.005857959,0.0014835922,0.0019301531],"genre_scores_gemma":[0.96694815,0.00027869552,0.025543274,0.00019393727,0.00003103982,0.000048881742,0.0060619395,0.000037670718,0.00085642457],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994153,0.00027856528,0.000032194246,0.00016887122,0.000052318308,0.00005278822],"domain_scores_gemma":[0.9932601,0.005389685,0.00054308044,0.00035508402,0.00033472464,0.000117214004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015067883,0.0004920231,0.00048812997,0.0017063064,0.00029715762,0.00059784856,0.0005992722,0.00080435263,0.0014543418],"category_scores_gemma":[0.011744529,0.000336114,0.00078184425,0.0014349519,0.00035025823,0.001178122,0.00053909153,0.0010133871,0.0003790057],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010412711,0.000411333,0.14429885,0.00028298472,0.0004623879,0.00047727133,0.00025935617,0.67128974,0.0023080974,0.004884574,0.0105704,0.16371374],"study_design_scores_gemma":[0.000032573436,0.000060772487,0.010732329,0.00001737384,0.000043449083,0.00004146273,0.00003338971,0.98110145,0.0004253755,0.006701989,0.0007983869,0.000011492107],"about_ca_topic_score_codex":0.0358324,"about_ca_topic_score_gemma":0.040549595,"teacher_disagreement_score":0.0358324,"about_ca_system_score_codex":0.0018132188,"about_ca_system_score_gemma":0.00082375767,"threshold_uncertainty_score":0.0712477},"labels":[],"label_agreement":null},{"id":"W4410972074","doi":"10.26434/chemrxiv-2025-vfkd9","title":"Giving an Enzyme Scissors: Serotonin Derivatives as Potent Organocatalytic Switches of DNA Repair Enzyme OGG1","year":2025,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agencia Estatal de Investigación; Novo Nordisk Fonden; Science for Life Laboratory; Vetenskapsrådet; Kungliga Tekniska Högskolan; Karolinska Institutet; European Commission; Ministerio de Ciencia, Innovación y Universidades; Leverhulme Trust; Stockholms Universitet; Centro de Biología Molecular Severo Ochoa; Cancerfonden; Diamond Light Source; Novo Nordisk; European Federation of Pharmaceutical Industries and Associations; McGill University; Åke Wiberg Stiftelse","keywords":"Enzyme; Chemistry; DNA; Biochemistry; Serotonin; DNA repair","score_opus":0.09559389812020229,"score_gpt":0.41285020647945375,"score_spread":0.31725630835925145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410972074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654528,0.0072160196,0.013543314,0.00046154825,0.00011977418,0.00010083583,0.0006986503,0.00022734563,0.012179716],"genre_scores_gemma":[0.9907141,0.002514884,0.0034099552,0.00009042654,0.000012823278,0.000021844482,0.00023715546,0.000019602006,0.0029791496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993455,0.000013075894,0.0000036697493,0.000014814287,0.000016399092,0.00001742348],"domain_scores_gemma":[0.99995387,0.000009424145,0.000014586326,0.0000061761684,0.0000063435295,0.0000096590475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009332081,0.00020307853,0.00012592043,0.000069602436,0.000076773074,0.0002415343,0.00019035976,0.00023172774,0.001401776],"category_scores_gemma":[0.00013137322,0.00007248898,0.00015124788,0.00010235645,0.00016016403,0.00020566866,0.00019530674,0.0003779318,0.00034497486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005684479,0.00006280955,0.0004083766,0.00032536863,0.000041984153,0.00033000365,0.00008712062,0.0021410969,0.9738903,0.0030748474,0.000951066,0.018118601],"study_design_scores_gemma":[0.00006402655,0.00092723727,0.0004820538,0.000013350688,0.000025848696,0.00018597719,0.000021735048,0.00202644,0.98573583,0.00024024423,0.010263234,0.000014008705],"about_ca_topic_score_codex":0.000653462,"about_ca_topic_score_gemma":0.0010208772,"teacher_disagreement_score":0.001401776,"about_ca_system_score_codex":0.00020056346,"about_ca_system_score_gemma":0.00013921967,"threshold_uncertainty_score":0.004689455},"labels":[],"label_agreement":null},{"id":"W4410995022","doi":"10.1016/j.dmpk.2025.101159","title":"Intra-patient variation in CYP2D6 activity over time assessed using the dietary biomarker solanidine in breast cancer patients on tamoxifen","year":2025,"lang":"en","type":"article","venue":"Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Biomarker; Oncology; CYP2D6; Internal medicine; Endocrinology; Cancer; Biology; Metabolism; Genetics","score_opus":0.041734982363930105,"score_gpt":0.38359745841927795,"score_spread":0.34186247605534786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410995022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987109,0.00035956825,0.00017993017,0.000040464005,0.000009012851,0.000004443693,0.00029103205,0.000008284565,0.00039632272],"genre_scores_gemma":[0.9993585,0.000080953425,0.00010835958,0.000025792328,0.0000068071163,0.0000042277716,0.00021047963,0.0000035754588,0.00020132931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992906,0.00022013982,0.00008918456,0.0002257761,0.00012625445,0.000047965594],"domain_scores_gemma":[0.998755,0.00042989966,0.0004658455,0.0001400984,0.00013378129,0.0000752987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055024255,0.00021009693,0.00044851715,0.00047743798,0.00024072433,0.0004925531,0.00020660304,0.00053398317,0.00073566154],"category_scores_gemma":[0.0019397349,0.00018298547,0.00035209907,0.00090583396,0.00016791352,0.00026779514,0.0002479893,0.00043763738,0.00018145997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012741435,0.000055111617,0.98857075,0.000021965605,0.00035792077,0.00015056819,0.00022577969,0.00020118526,0.00263051,0.0000412208,0.00017839382,0.006292415],"study_design_scores_gemma":[0.000014859119,0.00029690505,0.99679404,0.0000042265815,0.00011077753,0.0005377248,0.00013491456,0.0007276655,0.0007991053,0.00004838266,0.0005232713,0.000008097266],"about_ca_topic_score_codex":0.0016737961,"about_ca_topic_score_gemma":0.0027784493,"teacher_disagreement_score":0.0016737961,"about_ca_system_score_codex":0.00028027565,"about_ca_system_score_gemma":0.00013242454,"threshold_uncertainty_score":0.0033281446},"labels":[],"label_agreement":null},{"id":"W4410996209","doi":"10.1016/j.dmpk.2025.101162","title":"Solanidine metabolites as dietary CYP2D6 biomarkers of tamoxifen metabolism","year":2025,"lang":"en","type":"article","venue":"Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"CYP2D6; Tamoxifen; Metabolism; Pharmacology; Chemistry; Medicine; Internal medicine; Biochemistry; Cytochrome P450; Cancer; Breast cancer","score_opus":0.04519431671995172,"score_gpt":0.39185814562178606,"score_spread":0.34666382890183434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410996209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873011,0.006879377,0.0018095908,0.00017274986,0.000049143873,0.000048072758,0.0012177287,0.0000859513,0.0024362113],"genre_scores_gemma":[0.99484044,0.00086898834,0.0016693377,0.000109771514,0.00002527045,0.000029490382,0.00051641645,0.000017788328,0.0019224618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955875,0.00021316737,0.00002700475,0.000072523784,0.00011023009,0.000018268685],"domain_scores_gemma":[0.99942565,0.00013693866,0.00022131689,0.0000631403,0.00010386395,0.000048991118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038915416,0.000417042,0.00046386558,0.00081528863,0.00023298697,0.0005176364,0.00016449683,0.0006457548,0.0016940517],"category_scores_gemma":[0.0012928729,0.00021523674,0.0003330393,0.00067560875,0.00022332776,0.00025914985,0.00024296352,0.00037763576,0.00033580186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018448925,0.00055053114,0.63457954,0.00056316593,0.0016674172,0.0004791626,0.0003182971,0.0008414845,0.24950185,0.00039859544,0.0011008119,0.09155015],"study_design_scores_gemma":[0.00037972958,0.0063785613,0.81598234,0.000089922025,0.0012122104,0.0026731906,0.00029833883,0.004563394,0.15515558,0.0006712035,0.012542125,0.000053363587],"about_ca_topic_score_codex":0.0007994309,"about_ca_topic_score_gemma":0.0020933263,"teacher_disagreement_score":0.0016940517,"about_ca_system_score_codex":0.0003167049,"about_ca_system_score_gemma":0.00018962663,"threshold_uncertainty_score":0.00566715},"labels":[],"label_agreement":null},{"id":"W4411111155","doi":"10.63995/zxpk7782","title":"Gene Variation: The Key to Understanding Pharmacogenomics and Drug Response Variability","year":2020,"lang":"en","type":"article","venue":"Fusion of Multidisciplinary Research An International Journal","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Drug response; Variation (astronomy); Key (lock); Drug; Genetic variation; Pharmacogenetics; Computational biology; Biology; Pharmacology; Gene; Genetics; Genotype; Ecology","score_opus":0.33735732841915406,"score_gpt":0.5174235326278225,"score_spread":0.18006620420866842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411111155","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10982501,0.18003961,0.578223,0.10342852,0.0023533427,0.0003465146,0.004201561,0.0010174204,0.020565115],"genre_scores_gemma":[0.68818164,0.0935986,0.18234754,0.025170935,0.0043044193,0.0003706929,0.0016640538,0.00040013253,0.00396203],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9960192,0.0016467363,0.0002578273,0.00094944995,0.00095916336,0.00016771322],"domain_scores_gemma":[0.99100155,0.0065278406,0.0008352851,0.00083667395,0.0006048457,0.00019380044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006064649,0.00058347057,0.0019787785,0.0010951348,0.00044076465,0.0025972629,0.00096049876,0.0020192463,0.0019896347],"category_scores_gemma":[0.0127033405,0.00032289734,0.0011254926,0.0017056284,0.0026790649,0.0026152546,0.0011891876,0.0038569116,0.0005454474],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005643798,0.00026779686,0.13888222,0.0023953542,0.0022933825,0.002137639,0.0017297729,0.009993968,0.041702848,0.20542645,0.01269206,0.5819141],"study_design_scores_gemma":[0.000075924014,0.00054769346,0.11318398,0.001226109,0.0011270648,0.0051090796,0.0010971543,0.012843552,0.009658158,0.6896848,0.16514446,0.000301952],"about_ca_topic_score_codex":0.0026889455,"about_ca_topic_score_gemma":0.0015664846,"teacher_disagreement_score":0.006064649,"about_ca_system_score_codex":0.0009924117,"about_ca_system_score_gemma":0.0016834266,"threshold_uncertainty_score":0.03207332},"labels":[],"label_agreement":null},{"id":"W4412011715","doi":"10.1016/j.jaccas.2025.103881","title":"Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem","year":2025,"lang":"en","type":"article","venue":"JACC Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health; Alberta Health Services","funders":"","keywords":"Diltiazem; Cardiology; Internal medicine; Tachycardia; Medicine; Cardiomyopathy; Enzalutamide; Heart failure; Calcium; Androgen receptor","score_opus":0.05821791193063771,"score_gpt":0.4297481678029917,"score_spread":0.371530255872354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412011715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95746344,0.0049884985,0.006227861,0.011273748,0.00063563115,0.0002043615,0.00013909502,0.00033429332,0.018733097],"genre_scores_gemma":[0.9945174,0.00062927156,0.00058673497,0.0020246042,0.00049170636,0.000017826698,0.0000509999,0.000026527627,0.0016550448],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992505,0.00012989585,0.00008319958,0.00012872422,0.00016971628,0.00023799564],"domain_scores_gemma":[0.997162,0.0008767036,0.00090665894,0.00024224943,0.00012277284,0.0006896544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006869815,0.0008447398,0.0008273295,0.0012695048,0.0010274275,0.0009847536,0.0010024136,0.0029405598,0.0017787928],"category_scores_gemma":[0.003694341,0.00042802052,0.0011237925,0.00067539926,0.001053624,0.0009397782,0.00080929423,0.004006912,0.0004546779],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010362668,0.00006204755,0.009350042,0.000020244674,0.000019829113,0.98665106,0.0001187568,0.000108949,0.0007290186,0.00029060798,0.00037287537,0.002172987],"study_design_scores_gemma":[0.00003394473,0.00014988733,0.008624479,0.000019880123,0.000028835153,0.9889628,0.000057140394,0.00061374676,0.0006119248,0.00018321705,0.00070439634,0.000009881353],"about_ca_topic_score_codex":0.0015590577,"about_ca_topic_score_gemma":0.0018347498,"teacher_disagreement_score":0.0029405598,"about_ca_system_score_codex":0.001851002,"about_ca_system_score_gemma":0.00075374136,"threshold_uncertainty_score":0.013430059},"labels":[],"label_agreement":null},{"id":"W4412187638","doi":"10.1002/prp2.70121","title":"Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region","year":2025,"lang":"en","type":"review","venue":"Pharmacology Research & Perspectives","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacogenomics; Curriculum; CINAHL; Medical education; Pharmacy; Health care; MEDLINE; Medicine; Psychology; Family medicine; Political science; Nursing; Psychological intervention; Pedagogy; Pharmacology","score_opus":0.4932962013590145,"score_gpt":0.5932413751997943,"score_spread":0.09994517384077978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412187638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010474006,0.9978168,0.000075667536,0.00037992897,0.00007656197,0.00009285244,0.00007941976,0.0000021130486,0.00042912015],"genre_scores_gemma":[0.0091489395,0.9899296,0.00032881886,0.00023944792,0.000038646886,0.00018890946,0.00007610361,0.000001922523,0.000047681777],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9919418,0.0026716213,0.0030369381,0.0005203428,0.0014550317,0.0003741771],"domain_scores_gemma":[0.93899083,0.05037825,0.005767629,0.00044651548,0.003951242,0.00046555832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014793439,0.0011058827,0.0037879378,0.017635515,0.0010758415,0.003776823,0.0017442044,0.0020897684,0.0028194017],"category_scores_gemma":[0.05698316,0.00090828235,0.003378778,0.019182442,0.0012124059,0.003494027,0.0022570333,0.0013566932,0.00024296099],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115119976,0.00007388963,0.0024310127,0.7428227,0.0014807214,0.0001872699,0.0017883313,0.00018250852,0.0001428639,0.00080451235,0.0020324427,0.24793847],"study_design_scores_gemma":[0.000023526345,0.000057955363,0.0048621995,0.9693479,0.003663112,0.00019674149,0.0010496977,0.00005144059,0.000099861696,0.00017068599,0.020461796,0.000015136563],"about_ca_topic_score_codex":0.022157703,"about_ca_topic_score_gemma":0.035941586,"teacher_disagreement_score":0.022157703,"about_ca_system_score_codex":0.00478805,"about_ca_system_score_gemma":0.022918621,"threshold_uncertainty_score":0.0782361},"labels":[],"label_agreement":null},{"id":"W4412617735","doi":"10.3390/biomedicines13081797","title":"Correction: Yousef et al. Upholding or Breaking the Law of Superposition in Pharmacokinetics. Biomedicines 2024, 12, 1843","year":2025,"lang":"en","type":"erratum","venue":"Biomedicines","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Superposition principle; Engineering ethics; Library science; Philosophy; Political science; Computer science; Medicine; Physics; Engineering","score_opus":0.09033562033081427,"score_gpt":0.4428682889242324,"score_spread":0.35253266859341814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412617735","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006938355,0.0011823152,0.0003499084,0.051517013,0.94462943,0.000019578072,0.00056863506,0.0001404786,0.0015232384],"genre_scores_gemma":[0.011782033,0.013561895,0.004217259,0.17737438,0.64222246,0.0002618371,0.0022394834,0.001114855,0.14722583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528897,0.00078280823,0.0008735043,0.0006448051,0.0020220228,0.00038798965],"domain_scores_gemma":[0.9774169,0.0068038376,0.001251844,0.0012016265,0.012309577,0.0010162047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005280084,0.0029141174,0.002137835,0.003794117,0.0038260573,0.0043617277,0.0036149982,0.009484499,0.037388038],"category_scores_gemma":[0.08525644,0.0012548221,0.002313247,0.002176115,0.003677782,0.0024197337,0.0024838983,0.01516414,0.027145322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016082631,0.0000024226367,0.000026816337,0.00006628599,0.0000079719575,0.00017502715,0.000021771877,0.000015947024,0.000012882323,0.00051736424,0.9966569,0.0024804843],"study_design_scores_gemma":[0.000050134124,0.000013798656,0.00041905628,0.00040948633,0.0000421452,0.00078829,0.00007012865,0.00015339255,0.00016224723,0.001419502,0.99643743,0.00003439473],"about_ca_topic_score_codex":0.022948619,"about_ca_topic_score_gemma":0.020907186,"teacher_disagreement_score":0.037388038,"about_ca_system_score_codex":0.0046313577,"about_ca_system_score_gemma":0.0066410904,"threshold_uncertainty_score":0.1250754},"labels":[],"label_agreement":null},{"id":"W4412711389","doi":"10.1007/s13318-025-00960-5","title":"Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?","year":2025,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; McGill University Health Centre; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Affect (linguistics); Sample size determination; Sample (material); Pharmacokinetics; Population; Statistics; Medicine; Computer science; Psychology; Internal medicine; Mathematics; Chemistry; Chromatography; Environmental health","score_opus":0.0685641862903685,"score_gpt":0.42004607954738077,"score_spread":0.3514818932570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412711389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952467,0.002028314,0.088818416,0.0054036714,0.00047408155,0.00074861554,0.004059537,0.0007167312,0.002504027],"genre_scores_gemma":[0.97109467,0.00018282233,0.0247985,0.00077804446,0.000071364935,0.00029094337,0.0024272976,0.000051139617,0.00030523218],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9910636,0.007401195,0.0003178652,0.0007307309,0.00036119384,0.00012555726],"domain_scores_gemma":[0.889363,0.103297465,0.0016438228,0.0030810307,0.0019110477,0.00070364523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029256444,0.0007871137,0.0012503851,0.0004898268,0.00039453234,0.0014117298,0.001423504,0.0018442413,0.0019446162],"category_scores_gemma":[0.09091636,0.0004317095,0.0012976459,0.000343355,0.00073568575,0.0018074859,0.0008059864,0.0018638826,0.00030125558],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015784696,0.0030877746,0.11761168,0.0010226246,0.0039952467,0.00069852284,0.0002772821,0.70869845,0.003298297,0.003675851,0.020517474,0.12133205],"study_design_scores_gemma":[0.0016459902,0.0016001681,0.013160509,0.00013697479,0.0006724042,0.00030229113,0.00015438384,0.9707173,0.0021387173,0.0069356035,0.0024727508,0.00006288963],"about_ca_topic_score_codex":0.002969056,"about_ca_topic_score_gemma":0.0029298423,"teacher_disagreement_score":0.029256444,"about_ca_system_score_codex":0.0006957216,"about_ca_system_score_gemma":0.0014745136,"threshold_uncertainty_score":0.15472472},"labels":[],"label_agreement":null},{"id":"W4412765612","doi":"10.3389/fmed.2025.1572921","title":"A roadmap for personalized medicine: the findings of the IC2PerMed project","year":2025,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"European Commission","keywords":"Business; Interoperability; European union; Action plan; Health care; Sustainability; Delphi method; Harmonization; Member state; Knowledge management; Process management; Political science; Member states; Management; Computer science","score_opus":0.08790889478428382,"score_gpt":0.4574754429727955,"score_spread":0.3695665481885117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412765612","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18203866,0.014534054,0.07325055,0.36251485,0.0029735141,0.010638753,0.012642841,0.0012721651,0.34013462],"genre_scores_gemma":[0.699892,0.010451497,0.1913622,0.036267623,0.0004509007,0.014960651,0.013591918,0.00062811567,0.032395143],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9397158,0.04237211,0.0015447835,0.0019533872,0.008832005,0.00558193],"domain_scores_gemma":[0.92889404,0.035888344,0.0018185081,0.0042475658,0.014558863,0.014592759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10075202,0.0009448198,0.00065674796,0.0037862542,0.004999373,0.009715993,0.0023839786,0.0044393023,0.010078386],"category_scores_gemma":[0.06042107,0.00044657793,0.001242083,0.005169894,0.0062668696,0.0066430857,0.020187706,0.004696105,0.0015884889],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006323183,0.0009943885,0.029791934,0.0062803784,0.00014335719,0.0012516358,0.056683995,0.0044164476,0.0014964034,0.25877526,0.20716423,0.43236968],"study_design_scores_gemma":[0.00023177294,0.00066398014,0.026515063,0.006539421,0.00012372286,0.00053241674,0.075891465,0.0035230508,0.0019872787,0.041834425,0.84202874,0.0001286578],"about_ca_topic_score_codex":0.022622276,"about_ca_topic_score_gemma":0.015194843,"teacher_disagreement_score":0.10075202,"about_ca_system_score_codex":0.019203749,"about_ca_system_score_gemma":0.09415636,"threshold_uncertainty_score":0.53283393},"labels":[],"label_agreement":null},{"id":"W4412883513","doi":"10.1080/14622416.2025.2541402","title":"Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review","year":2025,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Shores Centre for Mental Health Sciences; University of Toronto; Centre for Addiction and Mental Health; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Antidepressant; Medicine; Pharmacology; Psychology; Psychiatry; Biology; Genetics; Genotype; Anxiety; Gene","score_opus":0.6277444561261495,"score_gpt":0.5615282100637023,"score_spread":0.06621624606244714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412883513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005396598,0.9942625,0.0005573454,0.0014597619,0.00036676574,0.00087030174,0.0009095638,0.000022973698,0.0010110612],"genre_scores_gemma":[0.0222163,0.9688173,0.0023729887,0.0026569206,0.00040357697,0.002234913,0.0008366685,0.000016435142,0.0004448915],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9905667,0.003587134,0.0029089681,0.0008290859,0.0018001447,0.00030789105],"domain_scores_gemma":[0.96623355,0.024989406,0.0048870505,0.0006307477,0.0028917063,0.00036757663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103401495,0.0016845962,0.008939834,0.00577786,0.0007218124,0.0035418742,0.0028464547,0.003458797,0.018503333],"category_scores_gemma":[0.04988608,0.0009276019,0.009344116,0.0064510326,0.0013480071,0.0031729196,0.0016133046,0.0025059101,0.0014613973],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023853098,0.000010073042,0.0006061012,0.9590866,0.0076548797,0.000086352404,0.0000399634,0.00010560933,0.0001596767,0.0005063626,0.0025872623,0.028918566],"study_design_scores_gemma":[0.00050377933,0.0001169941,0.0029476113,0.90767944,0.063962765,0.00028354497,0.000074177355,0.00015255983,0.0001756571,0.0014341426,0.022642555,0.000026751692],"about_ca_topic_score_codex":0.006473372,"about_ca_topic_score_gemma":0.012078664,"teacher_disagreement_score":0.018503333,"about_ca_system_score_codex":0.0045623374,"about_ca_system_score_gemma":0.012227278,"threshold_uncertainty_score":0.06189984},"labels":[],"label_agreement":null},{"id":"W4413260718","doi":"10.1016/j.psycr.2025.100274","title":"Retraction notice to “Pharmacogenetic testing utility in psychiatry: A case report of serotonin syndrome” [Psychiatry Research Case Reports Volume 2, Issue 1, June 2023, 100128]","year":2025,"lang":"en","type":"article","venue":"Psychiatry Research Case Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of Saskatchewan; Alberta Children's Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Notice; Psychiatry; Serotonin syndrome; Pharmacogenetics; Medicine; Psychology; Serotonin; Political science; Biology; Genetics; Internal medicine; Serotonergic; Gene","score_opus":0.16847433260936817,"score_gpt":0.5158027804543307,"score_spread":0.34732844784496253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413260718","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021724496,0.0033881683,0.00075154065,0.6109421,0.3667844,0.00007503858,0.00042632123,0.00029562856,0.015164342],"genre_scores_gemma":[0.020153845,0.004637536,0.0017327224,0.44916108,0.4831869,0.00017121738,0.000807467,0.00023964222,0.039909493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778074,0.00035464752,0.0005065968,0.00025808977,0.0007279095,0.0003720069],"domain_scores_gemma":[0.99023247,0.0046122647,0.0010898266,0.0004002146,0.0024953836,0.001169899],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018974411,0.0017562379,0.0014374377,0.0021478545,0.0022191827,0.0023892135,0.0032359755,0.024761125,0.012938729],"category_scores_gemma":[0.032684505,0.0008521695,0.0017260737,0.001070568,0.002325571,0.0021894064,0.0020866413,0.016471196,0.009685393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025739157,0.000011073378,0.00044217732,0.00007857635,0.000013408478,0.021012353,0.00008539166,0.000054784192,0.00019174883,0.0011085001,0.9721476,0.00482862],"study_design_scores_gemma":[0.00010000093,0.000059514194,0.0042991783,0.0009463128,0.00007582991,0.040449977,0.00030888143,0.00047404316,0.00033515692,0.0026955847,0.95018387,0.00007167316],"about_ca_topic_score_codex":0.0054837246,"about_ca_topic_score_gemma":0.0061531407,"teacher_disagreement_score":0.97523886,"about_ca_system_score_codex":0.0023003665,"about_ca_system_score_gemma":0.0033175636,"threshold_uncertainty_score":0.043284416},"labels":[],"label_agreement":null},{"id":"W4413676345","doi":"10.20944/preprints202508.1747.v1","title":"Hepatic and Biliary Glucuronidation of Bisphenol A in Mice: A Reaction Catalyzed by the UDP-Glucuronosyltransferase (Ugt2b)1 and Ugt2b34 Enzymes","year":2025,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glucuronidation; Enzyme; Chemistry; Bisphenol A; Glucuronosyltransferase; Liver enzyme; Biochemistry; Internal medicine; Medicine; Organic chemistry; Microsome","score_opus":0.13037230434538866,"score_gpt":0.4306293772723793,"score_spread":0.30025707292699066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413676345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653466,0.0024244213,0.0073663923,0.00033053983,0.00007389013,0.00011136262,0.0014762152,0.00037470539,0.0013077849],"genre_scores_gemma":[0.9705438,0.0037020217,0.008090424,0.00034264138,0.000057543286,0.00043059318,0.003523341,0.0001928758,0.013116817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934894,0.00010718503,0.000052592313,0.00020006856,0.00014046195,0.00015075979],"domain_scores_gemma":[0.9996592,0.000022077942,0.000115207724,0.000053874763,0.00003738425,0.0001121773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044543555,0.0012824733,0.0006856086,0.0016939098,0.00040272588,0.0006585484,0.00034538851,0.0009041525,0.0018632954],"category_scores_gemma":[0.00022489339,0.0009881133,0.0011733789,0.0005565653,0.0005973877,0.00075874524,0.0003449987,0.0016621772,0.0010724646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017450773,0.00035325452,0.0013327331,0.000053134925,0.000032260283,0.00009060424,0.000055408615,0.00012569476,0.99338454,0.00016044945,0.00015721814,0.0025096734],"study_design_scores_gemma":[0.00017919118,0.0043542427,0.013348184,0.000020724732,0.0001333967,0.0006397548,0.00008307138,0.0016952542,0.9748964,0.00014817453,0.0044712005,0.000030380554],"about_ca_topic_score_codex":0.0013890979,"about_ca_topic_score_gemma":0.0012272216,"teacher_disagreement_score":0.0018632954,"about_ca_system_score_codex":0.0007529943,"about_ca_system_score_gemma":0.0004492152,"threshold_uncertainty_score":0.0062333345},"labels":[],"label_agreement":null},{"id":"W4413778921","doi":"10.1136/bmjopen-2024-091562","title":"Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; McMaster University; Hamilton Health Sciences","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Medicine; Pharmacogenomics; Primary care; Family medicine; Key (lock); Qualitative research; Alternative medicine; Data science; Pharmacology","score_opus":0.26493740017807804,"score_gpt":0.4990448851646785,"score_spread":0.23410748498660044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413778921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679528,0.0018676014,0.0026482174,0.013146371,0.00016887157,0.0009308705,0.00081883447,0.000029768398,0.012436714],"genre_scores_gemma":[0.9866412,0.0016461528,0.0015686413,0.0031945852,0.000030469078,0.0006816743,0.00019512944,0.000034762685,0.0060073556],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98803526,0.0066873757,0.00042222728,0.0008181207,0.0012555325,0.0027814843],"domain_scores_gemma":[0.96891195,0.019306472,0.0015989644,0.00047947915,0.005043435,0.0046597375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014547311,0.000780771,0.00082581484,0.0020383932,0.022794833,0.0056196977,0.0023354993,0.0023187867,0.0044350955],"category_scores_gemma":[0.01873703,0.00077609916,0.00059807167,0.0034460253,0.0158728,0.002841884,0.0057690167,0.0033418587,0.00030439382],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017661652,0.000012938879,0.0018615461,0.00010910077,0.0000019128631,0.00043863704,0.9950826,0.000026120384,0.0002374183,0.00058302167,0.0005109879,0.0011180796],"study_design_scores_gemma":[0.0000034569753,0.000013660716,0.0012172617,0.00016226518,0.0000029566033,0.0000586191,0.9917778,0.00004419619,0.0000656146,0.00009321544,0.006550813,0.000010166247],"about_ca_topic_score_codex":0.8692094,"about_ca_topic_score_gemma":0.9159328,"teacher_disagreement_score":0.13079059,"about_ca_system_score_codex":0.10060829,"about_ca_system_score_gemma":0.096381634,"threshold_uncertainty_score":0.72996765},"labels":[],"label_agreement":null},{"id":"W4413802936","doi":"10.1017/cts.2026.10592","title":"448 A systematic review of real-world evidence on the clinical relevance, characterization, and utility of CYP2D6 biomarker testing","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; CYP2D6; Biomarker; Pharmacogenetics; Medicine; Precision medicine; Relevance (law); Personalized medicine; Drug response; Drug; Bioinformatics; Pharmacology; Internal medicine; Biology; Pathology","score_opus":0.5539761840844515,"score_gpt":0.6081250858641786,"score_spread":0.05414890177972709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413802936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003669297,0.9861988,0.001014683,0.001559504,0.000413214,0.002560649,0.0026254412,0.000029738969,0.0019287143],"genre_scores_gemma":[0.05472833,0.93126804,0.0041590254,0.002903628,0.00025866652,0.0045542507,0.0015479771,0.00003014117,0.0005499815],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96340907,0.013948653,0.014322227,0.0018688926,0.0057830946,0.0006679855],"domain_scores_gemma":[0.8758669,0.09618178,0.015559971,0.002252746,0.009595225,0.0005434191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027402988,0.0016757437,0.0061362768,0.013866583,0.0010533901,0.00407357,0.002040675,0.0023988364,0.008342892],"category_scores_gemma":[0.14346232,0.0012451321,0.009069361,0.013690722,0.0013836161,0.0034861632,0.0022527827,0.00153359,0.0009781161],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002107911,0.000012275167,0.00107899,0.9650474,0.008064641,0.000106524945,0.0002501085,0.00008620979,0.0001584575,0.00029356938,0.0019903956,0.022700744],"study_design_scores_gemma":[0.00022870192,0.00011054906,0.0024771001,0.93849707,0.043784186,0.00020324883,0.0002804248,0.000063122694,0.00018820619,0.00032184392,0.013818778,0.000026782076],"about_ca_topic_score_codex":0.007837843,"about_ca_topic_score_gemma":0.029563364,"teacher_disagreement_score":0.027402988,"about_ca_system_score_codex":0.0062892996,"about_ca_system_score_gemma":0.023226352,"threshold_uncertainty_score":0.14492255},"labels":[],"label_agreement":null},{"id":"W4414024538","doi":"10.1002/cpt.70059","title":"<scp>GenoStaR</scp> : An R Package for Genotype to Star Allele Conversion for Major Cytochrome <scp>P450</scp> Family of Genes","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Myriad Genetics; Assurex Health","keywords":"Pharmacogenomics; Genotyping; Genotype; CYP2D6; Genetics; Allele; CYP2C19; Pharmacogenetics; Biology; CYP2C9; Haplotype; Computational biology; Gene","score_opus":0.1804791213810116,"score_gpt":0.4970048930810093,"score_spread":0.31652577169999774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414024538","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013163854,0.0017538273,0.25908738,0.001236919,0.00052933884,0.00084659766,0.28569692,0.43186268,0.005822525],"genre_scores_gemma":[0.11529045,0.0022668988,0.39833286,0.003209379,0.0003870082,0.008436576,0.23123823,0.22964616,0.011192379],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757284,0.0010324011,0.00021798529,0.0005773455,0.00041082333,0.00018856312],"domain_scores_gemma":[0.98980623,0.0072894446,0.0010383709,0.00088030595,0.0007183029,0.00026733967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004289126,0.0032178373,0.0023572429,0.0017356442,0.00046280157,0.0019953183,0.0024301163,0.0009659629,0.058164563],"category_scores_gemma":[0.020038856,0.001402135,0.0029630233,0.001657856,0.0008770261,0.0015032156,0.0026613798,0.0029142033,0.030766133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016093545,0.00013333361,0.02095114,0.0046458608,0.0028705308,0.001070152,0.0005716929,0.015012684,0.005694926,0.010434049,0.8463829,0.09062337],"study_design_scores_gemma":[0.0021970544,0.0005984316,0.033017155,0.0011514245,0.0014612345,0.0019825576,0.00024044527,0.13610488,0.016976586,0.047847357,0.7578787,0.000544164],"about_ca_topic_score_codex":0.004448371,"about_ca_topic_score_gemma":0.0049677175,"teacher_disagreement_score":0.058164563,"about_ca_system_score_codex":0.0006891737,"about_ca_system_score_gemma":0.0026226393,"threshold_uncertainty_score":0.19457984},"labels":[],"label_agreement":null},{"id":"W4414135359","doi":"10.63946/aubiomed/16743","title":"Pharmacogenomics Applications in Clinical Practice: Revolutionizing Patient Care","year":2025,"lang":"en","type":"article","venue":"Australian Journal of Biomedical Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Pharmacogenomics; Health care; Pharmacy; Personalized medicine; Precision medicine; Clinical Practice; Healthcare system; Patient care","score_opus":0.29672700016251796,"score_gpt":0.6262425940166643,"score_spread":0.3295155938541463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414135359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017422665,0.5310845,0.027548485,0.37060797,0.005559597,0.0007175905,0.00065572513,0.0004730437,0.06161084],"genre_scores_gemma":[0.058866166,0.6915714,0.09075818,0.13975632,0.010108808,0.0014510383,0.00064260606,0.00026668308,0.0065787043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9529044,0.033806965,0.0037315271,0.0016721757,0.007286131,0.00059883716],"domain_scores_gemma":[0.8303192,0.13549358,0.010517489,0.005541424,0.0154485665,0.002679724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03944895,0.0007086935,0.0012802137,0.0050827633,0.0011725042,0.007641259,0.0020986702,0.0062868325,0.0150526725],"category_scores_gemma":[0.108430535,0.00058412383,0.0025294155,0.005528213,0.0050005545,0.010009218,0.00579686,0.0065063927,0.0047720326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010011873,0.000099772544,0.0012449173,0.038956936,0.00033615157,0.0005084713,0.0028323624,0.00053192966,0.0005347969,0.09140554,0.15184149,0.7116076],"study_design_scores_gemma":[0.0000868825,0.00009924828,0.0018277714,0.08453694,0.00023371901,0.0009644532,0.0020902788,0.00041624487,0.0005628587,0.09291562,0.81620437,0.00006166793],"about_ca_topic_score_codex":0.0031289612,"about_ca_topic_score_gemma":0.004203681,"teacher_disagreement_score":0.03944895,"about_ca_system_score_codex":0.0052692858,"about_ca_system_score_gemma":0.019616557,"threshold_uncertainty_score":0.20862848},"labels":[],"label_agreement":null},{"id":"W4414154142","doi":"10.1016/j.bioorg.2025.108979","title":"Metabolite profiling in human and mouse liver microsomes of the aminosteroid RM-581, a new orally active anticancer agent","year":2025,"lang":"en","type":"article","venue":"Bioorganic Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Metabolite; Pyrrolidine; Active metabolite; Microsome; Primary metabolite; Proline; Human liver; Steroid; Amino acid","score_opus":0.054088246087837036,"score_gpt":0.38471022886079875,"score_spread":0.33062198277296173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414154142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683155,0.0034365482,0.004021364,0.0001157356,0.000032540785,0.00006613744,0.002893001,0.00017070034,0.0024323615],"genre_scores_gemma":[0.9848341,0.0016412254,0.0027700937,0.00007042225,0.000014405216,0.000053045787,0.0041224533,0.00005066513,0.0064435177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999923,0.000020523315,0.0000042311517,0.000026626578,0.000014786042,0.00001091815],"domain_scores_gemma":[0.9999484,0.000010619019,0.000011694186,0.0000068075883,0.000013583202,0.000008860152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012993377,0.00027259556,0.00014480148,0.00033704276,0.0001460148,0.00016192101,0.000086051106,0.00025863494,0.0018543792],"category_scores_gemma":[0.00019947429,0.00018278703,0.00024517163,0.00021977541,0.00010954535,0.00013768837,0.00010824333,0.00023394616,0.00066886935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014981271,0.000045558867,0.0015146572,0.00006183898,0.00003884023,0.00009488549,0.00004108136,0.00011984301,0.99018425,0.000055015367,0.00015497912,0.0061909496],"study_design_scores_gemma":[0.000049426155,0.001372996,0.013686792,0.000009405355,0.000118333126,0.00071557827,0.000049211776,0.0006044997,0.9796326,0.000038995673,0.0037127642,0.000009419859],"about_ca_topic_score_codex":0.0014353127,"about_ca_topic_score_gemma":0.0014953997,"teacher_disagreement_score":0.0018543792,"about_ca_system_score_codex":0.00013413104,"about_ca_system_score_gemma":0.00022922395,"threshold_uncertainty_score":0.006203532},"labels":[],"label_agreement":null},{"id":"W4415093753","doi":"10.1021/acs.jmedchem.5c01467","title":"Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery","year":2025,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Wellcome Trust","keywords":"Drug discovery; Hydroxylation; Chemical synthesis; Enzyme; Metabolic stability; High-throughput screening; Drug; Biocatalysis","score_opus":0.104177169566298,"score_gpt":0.4332439196006316,"score_spread":0.3290667500343336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415093753","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3744116,0.005621657,0.5913386,0.0010307609,0.00021263846,0.00053347653,0.0037334785,0.005135811,0.01798208],"genre_scores_gemma":[0.63932705,0.0053456496,0.33051705,0.00035344702,0.00013790154,0.00038357516,0.005016441,0.0005172625,0.018401558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963343,0.000083666775,0.000022077267,0.00008439411,0.000140353,0.00003605189],"domain_scores_gemma":[0.999701,0.0001127254,0.00005172332,0.000059615326,0.000051273448,0.000023706216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005853391,0.0007114856,0.00031896326,0.00050004025,0.00023595778,0.0005818881,0.00040143644,0.00038917307,0.0044901916],"category_scores_gemma":[0.00049524364,0.00029098697,0.00037915134,0.00035389443,0.0002879419,0.000545015,0.000371091,0.0008456213,0.0022156686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006841945,0.00001813649,0.00018607559,0.00006770712,0.0000103542625,0.00006837229,0.000011649372,0.000104615436,0.985885,0.0002880223,0.00035530562,0.0129362205],"study_design_scores_gemma":[0.000011326206,0.00016303618,0.00096615276,0.0000038919766,0.000011089684,0.0002473372,0.0000057928205,0.0011277823,0.99129313,0.00011695065,0.0060448935,0.000008542713],"about_ca_topic_score_codex":0.0003520828,"about_ca_topic_score_gemma":0.00072499644,"teacher_disagreement_score":0.0044901916,"about_ca_system_score_codex":0.00022093873,"about_ca_system_score_gemma":0.0002737668,"threshold_uncertainty_score":0.015021205},"labels":[],"label_agreement":null},{"id":"W4415170017","doi":"10.1080/14622416.2025.2571387","title":"Characterizing models for delivery of pharmacogenomic testing: a scoping review","year":2025,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Genome British Columbia","keywords":"Pharmacogenomics; Healthcare delivery; Service delivery framework; Work (physics); Health care; Selection (genetic algorithm); Health care delivery","score_opus":0.412099249233429,"score_gpt":0.5263678696704787,"score_spread":0.11426862043704966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415170017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075092755,0.9920407,0.002238576,0.001361282,0.00021646098,0.0007881513,0.00021255684,0.00002043838,0.0023707547],"genre_scores_gemma":[0.0060349316,0.9884073,0.003912835,0.00037021868,0.000049012455,0.00080989226,0.00018627646,0.000009471841,0.00022000115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98084784,0.0088524185,0.0053465227,0.0010580983,0.0034711794,0.00042387168],"domain_scores_gemma":[0.8999139,0.08237024,0.0068644034,0.0018151775,0.008610268,0.00042596203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033430148,0.001695574,0.0033400692,0.016096575,0.0012126733,0.006173706,0.0027793148,0.002660419,0.0031476829],"category_scores_gemma":[0.1043816,0.0013556457,0.0049100607,0.0168308,0.001436737,0.006156451,0.0027475501,0.0024366248,0.00080425333],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010642026,0.000066129345,0.001122899,0.5290636,0.0017118695,0.00019721582,0.0016983574,0.0011458213,0.00041028683,0.011824215,0.0062864227,0.44636676],"study_design_scores_gemma":[0.000035294106,0.00009377429,0.0011602101,0.8807752,0.0044415276,0.00028871902,0.0012808787,0.00043186572,0.00040774854,0.0027155369,0.108327866,0.000041368465],"about_ca_topic_score_codex":0.014131491,"about_ca_topic_score_gemma":0.024465747,"teacher_disagreement_score":0.033430148,"about_ca_system_score_codex":0.0074567115,"about_ca_system_score_gemma":0.030987483,"threshold_uncertainty_score":0.17679763},"labels":[],"label_agreement":null},{"id":"W4415567623","doi":"10.1007/s40261-025-01489-w","title":"Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia","year":2025,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Melbourne; International Society of Oncology Pharmacy Practitioners","keywords":"Reimbursement; DPYD; Genotyping; Standard of care; Pharmacotherapy; Health care; Pharmacogenetics; Health economics","score_opus":0.21893161215604237,"score_gpt":0.5177472132587021,"score_spread":0.2988156011026597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415567623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779047,0.002343016,0.0038134789,0.0020463478,0.00003729978,0.0002853938,0.0009001531,0.00004316727,0.0027406192],"genre_scores_gemma":[0.99804074,0.00031628195,0.00094524986,0.00014491506,0.0000059821296,0.000056114626,0.00021317923,0.000003578455,0.00027398558],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9968202,0.0023595009,0.00012793417,0.0002890987,0.0001729202,0.00023033006],"domain_scores_gemma":[0.99076664,0.0070237746,0.0011131204,0.0001877865,0.0004472592,0.00046135092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059727435,0.0005402633,0.0012303976,0.000533283,0.00024892212,0.0012650453,0.0010765725,0.00085312413,0.0026861492],"category_scores_gemma":[0.02799405,0.0004589969,0.0024786675,0.0004740926,0.00063931633,0.001060658,0.001329807,0.0012289259,0.00011401894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008617868,0.00066829333,0.10603195,0.0009182942,0.0017195428,0.0004149985,0.00024230934,0.83745956,0.00048468873,0.003853353,0.0013076266,0.038281474],"study_design_scores_gemma":[0.0018081375,0.0060818745,0.08015993,0.0005688885,0.0018936348,0.00033168384,0.00027282527,0.90111566,0.0007571921,0.005554424,0.0013736971,0.00008208412],"about_ca_topic_score_codex":0.075976886,"about_ca_topic_score_gemma":0.034215223,"teacher_disagreement_score":0.075976886,"about_ca_system_score_codex":0.0073882565,"about_ca_system_score_gemma":0.004585666,"threshold_uncertainty_score":0.15106928},"labels":[],"label_agreement":null},{"id":"W4415782400","doi":"10.1097/fpc.0000000000000579","title":"Pharmacogenetic testing coverage by Canadian insurance providers","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Dalhousie University","funders":"","keywords":"Reimbursement; Test (biology); Genetic testing; Quality (philosophy); Pharmacogenetics","score_opus":0.06169952826165205,"score_gpt":0.3837315103934607,"score_spread":0.32203198213180867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415782400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8057958,0.017143281,0.0029442247,0.018026063,0.0001587878,0.00064285647,0.06471527,0.00022854217,0.09034531],"genre_scores_gemma":[0.97786194,0.005209362,0.0027545688,0.0029415935,0.0000401213,0.00012098195,0.008143546,0.000031863845,0.0028960947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990507,0.00095400255,0.0006782607,0.00082445744,0.0056338757,0.0014024172],"domain_scores_gemma":[0.98118687,0.0045042676,0.004436931,0.0007628027,0.0069065336,0.0022026838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051481905,0.00029613718,0.00029243538,0.0039292215,0.0026653593,0.0015314587,0.0013038452,0.00046160366,0.0044583604],"category_scores_gemma":[0.024639321,0.00029644,0.0007109494,0.0066922833,0.0008106163,0.0005601881,0.0013001845,0.0006302732,0.00020188346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019666669,0.000042357206,0.8471399,0.00062339817,0.00019554456,0.00046051925,0.003066778,0.0006360107,0.0005649325,0.00448026,0.041834664,0.100759],"study_design_scores_gemma":[0.000038637772,0.000038386257,0.9343279,0.00092545827,0.00018120796,0.00063407107,0.0024619463,0.0015149987,0.00047919885,0.00051058334,0.05882522,0.00006243577],"about_ca_topic_score_codex":0.98506224,"about_ca_topic_score_gemma":0.9871062,"teacher_disagreement_score":0.038673338,"about_ca_system_score_codex":0.038673338,"about_ca_system_score_gemma":0.07593715,"threshold_uncertainty_score":0.28059602},"labels":[],"label_agreement":null},{"id":"W4416038602","doi":"10.1101/2025.11.06.687066","title":"A <i>De Novo</i> Algorithm for Allele Reconstruction from Oxford Nanopore Amplicon Reads, with Application to <i>CYP2D6</i>","year":2025,"lang":"","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Royal Columbian Hospital; University of British Columbia Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Nanopore sequencing; Amplicon; Allele; Sequence (biology); Genotyping; Indel; Gene; Genomics; Reference genome","score_opus":0.02589207618818109,"score_gpt":0.31166156853584176,"score_spread":0.2857694923476607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416038602","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067776046,0.000095399184,0.9787775,0.00010007888,0.0000444941,0.00010341341,0.00040495634,0.013307658,0.00038884225],"genre_scores_gemma":[0.031463217,0.000040592877,0.9653548,0.00011193419,0.000018136314,0.00020100307,0.001045292,0.0009925743,0.00077247596],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990115,0.00018004116,0.00010776001,0.00032861574,0.0002899299,0.00008199637],"domain_scores_gemma":[0.9973833,0.0013215304,0.0003891145,0.0003279973,0.0004650919,0.00011293018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002406193,0.0015010701,0.00094878045,0.0014102658,0.0008001842,0.0020372595,0.0022522532,0.0016729151,0.005358399],"category_scores_gemma":[0.006999187,0.00114585,0.0015151933,0.00096187164,0.0008509435,0.00076544506,0.0018492198,0.0029993653,0.0039000707],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014688753,0.00035225417,0.011718829,0.0012198474,0.000775766,0.0010922638,0.00065805856,0.17316815,0.1699153,0.013146238,0.025904981,0.60057944],"study_design_scores_gemma":[0.00009378595,0.00010207308,0.0018516692,0.00004289385,0.000047092297,0.0003182807,0.00008886914,0.93167126,0.051193632,0.0064524724,0.008063488,0.00007437087],"about_ca_topic_score_codex":0.0036524346,"about_ca_topic_score_gemma":0.0057144864,"teacher_disagreement_score":0.005358399,"about_ca_system_score_codex":0.00084782747,"about_ca_system_score_gemma":0.0015361658,"threshold_uncertainty_score":0.01792562},"labels":[],"label_agreement":null},{"id":"W4416274157","doi":"10.1080/17425255.2025.2592133","title":"The clinical implication of inflammation-driven regulation of drug-metabolizing enzymes","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Enzyme; Disease; Glycolysis; Immune system","score_opus":0.08362478333396023,"score_gpt":0.4659520106390106,"score_spread":0.38232722730505037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416274157","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00848415,0.81355786,0.010512804,0.14274983,0.009647077,0.000056903915,0.00087749085,0.00021721578,0.013896661],"genre_scores_gemma":[0.12574892,0.78962135,0.0057600867,0.03991975,0.030319553,0.00011170521,0.000758229,0.00006750124,0.007692882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989899,0.00029429415,0.000063622334,0.00016413885,0.00036350638,0.00012457266],"domain_scores_gemma":[0.9980702,0.00087820744,0.0002736093,0.00006267308,0.00053981267,0.00017554953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016015527,0.00045716536,0.0009887057,0.00030156277,0.00018714675,0.0015397897,0.00065480836,0.0020793492,0.0049727145],"category_scores_gemma":[0.0028414542,0.00011655468,0.0005442773,0.00021432544,0.00079841836,0.0010613868,0.00056716055,0.0030612054,0.0023151273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013073751,0.0002450447,0.005407529,0.0051685926,0.0003375972,0.0019692497,0.00016914577,0.0013010697,0.033964824,0.037843216,0.24376948,0.6685168],"study_design_scores_gemma":[0.00040560396,0.0013792526,0.0090974225,0.0024638246,0.00040857116,0.004322592,0.00032292077,0.0020744088,0.012092394,0.050769255,0.9165773,0.00008647724],"about_ca_topic_score_codex":0.0004944267,"about_ca_topic_score_gemma":0.00088226836,"teacher_disagreement_score":0.0049727145,"about_ca_system_score_codex":0.0006469138,"about_ca_system_score_gemma":0.001053043,"threshold_uncertainty_score":0.016635418},"labels":[],"label_agreement":null},{"id":"W4416364121","doi":"10.24926/iip.v16i3.6347","title":"Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training","year":2025,"lang":"en","type":"article","venue":"INNOVATIONS in pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; AXYS Technologies (Canada)","funders":"","keywords":"Pharmacy; Clinical decision support system; Health care; Pharmacy practice; Decision support system; Quality (philosophy); Clinical pharmacy; Intervention (counseling); Qualitative research","score_opus":0.4021849442830466,"score_gpt":0.6064238514067891,"score_spread":0.20423890712374254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416364121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975586,0.000011767148,0.0002918354,0.00006382352,0.000009473448,0.0017529649,0.00004243263,0.0000066829252,0.00026235406],"genre_scores_gemma":[0.9908799,0.00008433098,0.0034895386,0.00025244837,0.000027545246,0.0047438373,0.00010699751,0.000004914451,0.00041046072],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99213046,0.003918131,0.00048444423,0.00070337544,0.0010987238,0.0016648142],"domain_scores_gemma":[0.9881543,0.00393847,0.0014052374,0.0007444357,0.001995474,0.0037621094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014642361,0.0008460589,0.0008039672,0.0010947869,0.0019442961,0.0020049307,0.001086822,0.001357808,0.0032180455],"category_scores_gemma":[0.01938958,0.0010973827,0.00090823136,0.0005527886,0.0011314842,0.0017808024,0.0020094984,0.001743622,0.0007919616],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01126432,0.4061657,0.4096404,0.0009492214,0.0002117768,0.0011430545,0.05171394,0.0010799669,0.0085796,0.000427493,0.0013897268,0.10743486],"study_design_scores_gemma":[0.009146252,0.4214496,0.49734107,0.0002789629,0.00023136025,0.0007826403,0.05243173,0.0053140824,0.0063988604,0.00037879086,0.0060355114,0.00021110287],"about_ca_topic_score_codex":0.0018023528,"about_ca_topic_score_gemma":0.003110114,"teacher_disagreement_score":0.014642361,"about_ca_system_score_codex":0.0017905639,"about_ca_system_score_gemma":0.005379488,"threshold_uncertainty_score":0.0774371},"labels":[],"label_agreement":null},{"id":"W4416416572","doi":"10.1016/j.steroids.2025.109720","title":"In vitro metabolic profiling of 6-chloro-testosterone and 6-ene-testosterone by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-time of flight (GC-TOF) mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Steroids","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hydroxylation; Mass spectrometry; Metabolism; Chlorine; Double bond; Metabolic pathway; Microsome; Incubation; In vitro","score_opus":0.018150434789968906,"score_gpt":0.32305036269700343,"score_spread":0.3048999279070345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416416572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94138455,0.01001159,0.03554066,0.00022341646,0.00022578587,0.00020575848,0.006879415,0.0005137491,0.0050151176],"genre_scores_gemma":[0.9551542,0.0041517266,0.022749739,0.00024126859,0.000076824275,0.00020730354,0.0074945805,0.000092899245,0.009831421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995616,0.00008101237,0.000037945007,0.00008085822,0.00016032679,0.000078237994],"domain_scores_gemma":[0.9997454,0.000049859354,0.00003619104,0.000028170134,0.00009139561,0.000048938375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036628268,0.00067038665,0.00041484926,0.00061320333,0.00051113684,0.00055256346,0.0003192194,0.0003772576,0.0010154659],"category_scores_gemma":[0.00029377,0.0002448733,0.00047288398,0.00065002986,0.00033189793,0.00026738286,0.00020205852,0.00049907836,0.0006808599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033145965,0.00004332895,0.0005593673,0.000030001038,0.000021917685,0.00006177007,0.000020765006,0.00020284884,0.99733186,0.00006225086,0.000038832488,0.0012957229],"study_design_scores_gemma":[0.000015333573,0.0002734239,0.0035380058,0.0000028490947,0.00002585867,0.000106155196,0.000027815633,0.00083753694,0.9937215,0.00003589857,0.0014063226,0.000009446606],"about_ca_topic_score_codex":0.0043599866,"about_ca_topic_score_gemma":0.008670661,"teacher_disagreement_score":0.0043599866,"about_ca_system_score_codex":0.00047009546,"about_ca_system_score_gemma":0.00073057786,"threshold_uncertainty_score":0.008669198},"labels":[],"label_agreement":null},{"id":"W4416454402","doi":"10.1007/978-3-031-93616-6_3","title":"Pharmacogenomics","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Pharmacogenomics; Adverse effect; Drug; Pharmacogenetics; Drug response; MEDLINE; Precision medicine","score_opus":0.13499341856451516,"score_gpt":0.4394437847789956,"score_spread":0.3044503662144804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416454402","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007391261,0.06694363,0.0802882,0.011895815,0.004239668,0.00017507424,0.0024792154,0.0020048304,0.8312344],"genre_scores_gemma":[0.0042399857,0.038501825,0.025552811,0.0059143533,0.001895606,0.00012839492,0.001838577,0.0004401124,0.92148834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994941,0.00010725837,0.000016067404,0.000088603294,0.00026913907,0.000024818182],"domain_scores_gemma":[0.9996387,0.00016176107,0.000016223157,0.00007183172,0.000085486325,0.0000260437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088292843,0.0011366593,0.00093534443,0.0012512351,0.00042131657,0.0024010546,0.00090863515,0.0013693627,0.09265237],"category_scores_gemma":[0.0013390827,0.00045224474,0.0005261239,0.0014339637,0.0007753544,0.0014484747,0.0014926206,0.0025055287,0.07558668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024426254,0.00004434761,0.0001452824,0.0003849775,0.00002455635,0.000085716296,0.00006450361,0.0005981868,0.0022262428,0.07452316,0.4368935,0.48498493],"study_design_scores_gemma":[0.0000032890246,0.000012729228,0.0001696274,0.000115190036,0.0000070050587,0.00019646258,0.00001617376,0.00026881153,0.0006243926,0.03343936,0.9651411,0.0000059203117],"about_ca_topic_score_codex":0.0013083577,"about_ca_topic_score_gemma":0.0024470938,"teacher_disagreement_score":0.09265237,"about_ca_system_score_codex":0.0008807569,"about_ca_system_score_gemma":0.0011315446,"threshold_uncertainty_score":0.3099531},"labels":[],"label_agreement":null},{"id":"W4416526318","doi":"10.1016/b978-0-443-29025-1.00016-3","title":"How STOPP/START and American Geriatrics Society criteria medications are metabolized by the P450 enzyme system and medication metabolism varies by genome","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oracle (Canada); University of Calgary","funders":"","keywords":"Geriatrics; Odds ratio; Cytochrome P450; Pharmacogenetics; CYP2D6; Polypharmacy; Odds; MEDLINE","score_opus":0.03285428611762365,"score_gpt":0.335121174674793,"score_spread":0.3022668885571694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416526318","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024922969,0.22685784,0.013292313,0.035969786,0.0034145883,0.00009016731,0.0037790153,0.0009782702,0.690695],"genre_scores_gemma":[0.06913858,0.17021194,0.012044414,0.015943944,0.0022464811,0.00010798752,0.002554729,0.00048233813,0.7272696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987125,0.000026037067,0.000007249952,0.000022633092,0.000061096005,0.00001169538],"domain_scores_gemma":[0.999882,0.00005870036,0.000013575617,0.0000066399884,0.000022752385,0.00001634898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024426822,0.00033639994,0.00030799932,0.00055784127,0.00014906884,0.0016367862,0.0002065853,0.00080763013,0.021266019],"category_scores_gemma":[0.0004918102,0.00017815185,0.00036434736,0.00060860475,0.00027463294,0.0008116578,0.00023699425,0.0010745524,0.009635285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121570236,0.00007277486,0.003262733,0.00032024042,0.000052452426,0.00037792695,0.00022056566,0.0002889753,0.0053277216,0.020226315,0.17483225,0.7948964],"study_design_scores_gemma":[0.00002875405,0.00014937243,0.016961746,0.00032406204,0.000057902158,0.0028537116,0.00016242918,0.00042512533,0.0024559977,0.014806076,0.9617438,0.000031091728],"about_ca_topic_score_codex":0.002481403,"about_ca_topic_score_gemma":0.0055242693,"teacher_disagreement_score":0.021266019,"about_ca_system_score_codex":0.0004111383,"about_ca_system_score_gemma":0.00051581237,"threshold_uncertainty_score":0.0711419},"labels":[],"label_agreement":null},{"id":"W4416605728","doi":"10.5256/f1000research.9367.r14596","title":"Referee report. For: Assessment of pharmacogenomic agreement [version 1; referees: 2 approved]","year":2016,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Higher Education Discipline Innovation Project; Government of Ontario; National Natural Science Foundation of China; Pershing Square Sohn Cancer Research Alliance; National Supercomputer Centre in Guangzhou; National Aeronautics and Space Administration; Cancer Research Society; National Heart, Lung, and Blood Institute; WorldQuant Foundation; Vallee Foundation; Canadian Cancer Society Research Institute; National Institutes of Health; Yale University","keywords":"Measure (data warehouse); Set (abstract data type); Selection (genetic algorithm); Context (archaeology)","score_opus":0.24427002342645424,"score_gpt":0.5282931489550033,"score_spread":0.28402312552854914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416605728","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015243192,0.0020624981,0.013898741,0.29747435,0.32156438,0.008954654,0.12685978,0.00920109,0.21846013],"genre_scores_gemma":[0.01403728,0.0019019307,0.016826501,0.16549155,0.0395212,0.010626885,0.040520772,0.0063300785,0.70474374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9740209,0.0054625575,0.0037564167,0.0024416093,0.012853102,0.00146538],"domain_scores_gemma":[0.58605874,0.083783716,0.0058596004,0.021856047,0.29580468,0.0066372612],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02662884,0.0011420992,0.0020343647,0.005404798,0.006085714,0.006321076,0.0046831514,0.011641418,0.55551076],"category_scores_gemma":[0.3380469,0.0009064953,0.0022062948,0.004746414,0.0014966384,0.004154533,0.005153762,0.007936628,0.28832006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018030372,0.000009498467,0.00003894219,0.000088624445,0.0000051295933,0.00003161337,0.000033495147,0.000009999885,0.00007013699,0.00037678756,0.9965771,0.002740631],"study_design_scores_gemma":[0.0001159127,0.000030065221,0.0014457135,0.00053449767,0.0000365754,0.000112520785,0.000285847,0.0001559016,0.00049264,0.002776605,0.9939401,0.000073655545],"about_ca_topic_score_codex":0.019805176,"about_ca_topic_score_gemma":0.024096102,"teacher_disagreement_score":0.97337115,"about_ca_system_score_codex":0.0056471676,"about_ca_system_score_gemma":0.011302762,"threshold_uncertainty_score":0.63400996},"labels":[],"label_agreement":null},{"id":"W4416619207","doi":"10.5256/f1000research.10354.r22599","title":"Referee report. For: Revisiting inconsistency in large pharmacogenomic studies [version 1; referees: 1 approved, 1 approved with reservations, 1 not approved]","year":2017,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Higher Education Discipline Innovation Project; National Natural Science Foundation of China; Government of Ontario; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; National Supercomputer Centre in Guangzhou; National Cancer Institute; Yale University","keywords":"MEDLINE; Precision medicine; Matching (statistics); Pharmacogenomics; Set (abstract data type)","score_opus":0.3215265235399312,"score_gpt":0.5278834465567952,"score_spread":0.20635692301686398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416619207","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039623707,0.0037951719,0.0077136955,0.3021674,0.61675096,0.004134705,0.03607959,0.0046579624,0.024304314],"genre_scores_gemma":[0.009808712,0.005640324,0.025133613,0.5188871,0.20497224,0.013983381,0.027644891,0.006981256,0.18694848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9528597,0.0119667845,0.012041724,0.0040998473,0.017177204,0.0018547409],"domain_scores_gemma":[0.36964002,0.16782929,0.01986023,0.030299034,0.40509483,0.007276645],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05051766,0.0021716417,0.0031629964,0.009000115,0.0061231614,0.006955241,0.007391719,0.0152020855,0.29348567],"category_scores_gemma":[0.55543774,0.001598056,0.004230629,0.007488682,0.0024471867,0.004807813,0.006608155,0.011184705,0.13968663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014429966,0.0000051649154,0.00004251282,0.00019712473,0.000010869377,0.000033332817,0.000030838135,0.000008171621,0.000042204272,0.00014493635,0.9969952,0.0024752347],"study_design_scores_gemma":[0.00029158217,0.000035701603,0.002107685,0.0023385233,0.00012215682,0.0002598312,0.00029561576,0.00019090027,0.00041681627,0.0031094179,0.9906839,0.00014784715],"about_ca_topic_score_codex":0.025442716,"about_ca_topic_score_gemma":0.029849153,"teacher_disagreement_score":0.9494823,"about_ca_system_score_codex":0.007574137,"about_ca_system_score_gemma":0.013100609,"threshold_uncertainty_score":0.98180735},"labels":[],"label_agreement":null},{"id":"W4416674688","doi":"10.3390/ph18121789","title":"Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively","year":2025,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"CYP3A4; Gene isoform; Cytochrome P450; Isozyme; Microsome; In vitro; Human liver; Enzyme","score_opus":0.19957581549359965,"score_gpt":0.47821498722673283,"score_spread":0.2786391717331332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416674688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9293668,0.010013511,0.049613494,0.0005476872,0.000112554866,0.00016382197,0.0056348382,0.0005903407,0.0039569302],"genre_scores_gemma":[0.93360054,0.006322342,0.045274626,0.0002897577,0.00008972817,0.00031618853,0.0072481656,0.00010192951,0.006756761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942076,0.000073091556,0.000052819476,0.00019517979,0.00020809242,0.000050101895],"domain_scores_gemma":[0.99976414,0.000035129808,0.00007158597,0.000027035478,0.0000861589,0.000015858923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005651079,0.0006619261,0.00033138538,0.00086288486,0.00031569443,0.00057284924,0.00022358003,0.0004836229,0.0015850246],"category_scores_gemma":[0.00050820666,0.0002241822,0.00045077814,0.0008801315,0.00034334633,0.00030106722,0.0002574145,0.0005411779,0.00065015967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012807782,0.000020759138,0.0027137243,0.00015507058,0.000043468786,0.000058661404,0.000028329572,0.000072035466,0.99178195,0.000054490207,0.00012188031,0.0048215766],"study_design_scores_gemma":[0.000010975835,0.0002052249,0.046644673,0.000023826322,0.00011363412,0.00081019616,0.00005528043,0.0013584754,0.94702893,0.00010094845,0.0036328502,0.000014983399],"about_ca_topic_score_codex":0.00079605787,"about_ca_topic_score_gemma":0.0009771014,"teacher_disagreement_score":0.0015850246,"about_ca_system_score_codex":0.0003521004,"about_ca_system_score_gemma":0.000277658,"threshold_uncertainty_score":0.005302489},"labels":[],"label_agreement":null},{"id":"W4416694888","doi":"10.1038/s41598-025-26258-9","title":"Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Medical Research Council; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Scottish Government","keywords":"Shetland; Pharmacogenomics; Genetic variation; Variation (astronomy); Pharmacogenetics; 1000 Genomes Project; Allele frequency; Allele; Precision medicine","score_opus":0.05349752720516733,"score_gpt":0.40223606292014275,"score_spread":0.34873853571497543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416694888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992998,0.00046963434,0.00031063115,0.00027210123,0.000014365452,0.000020802814,0.0046785315,0.000010918388,0.0012251133],"genre_scores_gemma":[0.99310887,0.00040737455,0.00052311615,0.0002268486,0.000019024945,0.000048352358,0.0048529534,0.000018890902,0.0007945028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877673,0.00025340758,0.000117958574,0.00035503824,0.0002504168,0.00024637958],"domain_scores_gemma":[0.998743,0.00035319908,0.00042156933,0.00012383542,0.00020240257,0.00015600788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010392333,0.00039604175,0.0006420855,0.001942779,0.00063583115,0.0010626612,0.00061961653,0.00044579702,0.0038762542],"category_scores_gemma":[0.003235228,0.00022831351,0.0006478791,0.0027836068,0.00079473876,0.0003576526,0.0014641916,0.0003270326,0.00033679945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073085603,0.000044745553,0.95074534,0.00031355524,0.00053624326,0.0031165618,0.0064155627,0.0005988868,0.0050027035,0.0008273032,0.0033001567,0.028367955],"study_design_scores_gemma":[0.000051052648,0.00006644736,0.99325764,0.00006364964,0.00006401935,0.0004492404,0.00200898,0.0001680861,0.0001332007,0.000105882755,0.003614245,0.000017595234],"about_ca_topic_score_codex":0.12675138,"about_ca_topic_score_gemma":0.1573511,"teacher_disagreement_score":0.12675138,"about_ca_system_score_codex":0.0010257395,"about_ca_system_score_gemma":0.0012677442,"threshold_uncertainty_score":0.25202715},"labels":[],"label_agreement":null},{"id":"W4416705609","doi":"10.1055/s-0043-1777159","title":"Givinostat in DMD: Results of the EPIDYS Study with Particular Attention to NSAA","year":2023,"lang":"en","type":"article","venue":"Neuropediatrics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Public health; MEDLINE; Quality of Life Research; Urban park","score_opus":0.09727768270867634,"score_gpt":0.4076726689381504,"score_spread":0.31039498622947403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416705609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922386,0.0028146484,0.00038973647,0.0005025552,0.000019569025,0.000030646435,0.0013265827,0.000016663036,0.002661107],"genre_scores_gemma":[0.9949992,0.0015069955,0.00046560608,0.0001815045,0.000047706664,0.000017332159,0.0016098183,0.000012739301,0.0011592091],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996824,0.00009167242,0.000033100474,0.000063355845,0.00008971559,0.00003967794],"domain_scores_gemma":[0.9996679,0.0001173115,0.000050110124,0.000025181269,0.00006182218,0.0000777366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062959024,0.00061402906,0.0006400223,0.0006522627,0.00030479196,0.0005163466,0.00030391043,0.00059868273,0.0009987663],"category_scores_gemma":[0.0008132085,0.00014046444,0.0006570178,0.00078570633,0.00031498825,0.00036721563,0.00032545696,0.00050726626,0.0002783872],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016019043,0.00074085215,0.8750257,0.000108408356,0.0012746191,0.007950424,0.0005095203,0.001205275,0.028270425,0.0003476698,0.0016468493,0.06690121],"study_design_scores_gemma":[0.00033668499,0.002936053,0.9820541,0.000028652317,0.0010141253,0.0035875393,0.00036549265,0.0006733032,0.0039977813,0.0001751492,0.0048102336,0.000020812608],"about_ca_topic_score_codex":0.0062369956,"about_ca_topic_score_gemma":0.004298651,"teacher_disagreement_score":0.0062369956,"about_ca_system_score_codex":0.0004977557,"about_ca_system_score_gemma":0.00047861377,"threshold_uncertainty_score":0.012401402},"labels":[],"label_agreement":null},{"id":"W4416850271","doi":"10.1002/cpt.70153","title":"An Update to the Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) <i>SLCO1B1</i> Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub‐Saharan African Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Allele; Table (database); 1000 Genomes Project; Perspective (graphical); MEDLINE; Precision medicine","score_opus":0.3652053681126602,"score_gpt":0.5602017774771113,"score_spread":0.19499640936445112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416850271","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021339463,0.03328944,0.07941298,0.45296052,0.037109207,0.0059749084,0.12124678,0.014022617,0.23464409],"genre_scores_gemma":[0.07985601,0.039723538,0.28649443,0.300675,0.022591682,0.00837049,0.17379665,0.0050938604,0.08339829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9706993,0.00943024,0.007839306,0.0012563649,0.009587746,0.0011869081],"domain_scores_gemma":[0.7896733,0.088872135,0.016226036,0.0092640985,0.08395915,0.012005293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035012465,0.0006450265,0.0014149493,0.0053477203,0.0013082891,0.005649436,0.0025809864,0.004059164,0.018337185],"category_scores_gemma":[0.12502286,0.00076451636,0.0017123944,0.005948387,0.0011191282,0.0032559263,0.0028420044,0.0061900117,0.007944588],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024375432,0.00016030621,0.00657721,0.0010864683,0.000102768616,0.00029920624,0.00026796563,0.00039745128,0.00055974675,0.0067473995,0.80605966,0.17749804],"study_design_scores_gemma":[0.00022163003,0.00015230014,0.011675881,0.0023787525,0.0002057575,0.00044698824,0.00018447342,0.00043068387,0.0008529924,0.004320618,0.9790419,0.000088009234],"about_ca_topic_score_codex":0.01602604,"about_ca_topic_score_gemma":0.024971772,"teacher_disagreement_score":0.035012465,"about_ca_system_score_codex":0.0030162297,"about_ca_system_score_gemma":0.025140643,"threshold_uncertainty_score":0.18516582},"labels":[],"label_agreement":null},{"id":"W4417342758","doi":"10.1097/fpc.0000000000000590","title":"NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine","year":2025,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"CYP2D6; Tamoxifen; Metabolism; Affect (linguistics); Pharmacogenetics; Metabolite; Genetic variation","score_opus":0.07339022960160214,"score_gpt":0.4154692999812545,"score_spread":0.34207907037965235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978155,0.00051066023,0.0002497703,0.000053941974,0.00001759298,0.000011065382,0.0005384858,0.0000114056875,0.00079152937],"genre_scores_gemma":[0.99920624,0.000049615373,0.00011448243,0.000032020074,0.0000067426563,0.00000954972,0.0003133863,0.0000076093297,0.00026040018],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966466,0.00006370029,0.000047826754,0.00012526923,0.00005664978,0.00004201035],"domain_scores_gemma":[0.99961996,0.000102890495,0.00014386262,0.00005757812,0.000028143344,0.000047622812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020006592,0.0003201923,0.00041488168,0.00024276275,0.00027992445,0.00026263014,0.00021497914,0.0004964411,0.006141409],"category_scores_gemma":[0.00102013,0.000104137034,0.0006195153,0.0003020845,0.00023732372,0.00011573004,0.00011893771,0.00024484788,0.00054753723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025311595,0.0005077483,0.5316029,0.0003039597,0.002958979,0.004701366,0.00039361708,0.00082667376,0.3977007,0.0004772461,0.0018523335,0.03336282],"study_design_scores_gemma":[0.00075954216,0.002053065,0.95864856,0.000046023302,0.0015110463,0.009643648,0.00012358763,0.0014516639,0.019218259,0.00042957085,0.0060872585,0.000027936436],"about_ca_topic_score_codex":0.0024856725,"about_ca_topic_score_gemma":0.002749252,"teacher_disagreement_score":0.006141409,"about_ca_system_score_codex":0.0002714896,"about_ca_system_score_gemma":0.00014812758,"threshold_uncertainty_score":0.020545006},"labels":[],"label_agreement":null},{"id":"W4417500693","doi":"10.1021/acscatal.5c06523","title":"Indigo Formation as a Predictor of Non-Native Aromatic Hydroxylation in Cytochrome P450 BM3","year":2025,"lang":"en","type":"article","venue":"ACS Catalysis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Cegep Edouard Montpetit; Université de Montréal; PROTEO; Centre in Green Chemistry and Catalysis","funders":"Fonds de recherche du Québec; Hydro-Québec; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Hydroxylation; Cytochrome P450; Substrate (aquarium); Indole test; Enzyme; Mutagenesis; Reactivity (psychology); Active site","score_opus":0.037600080198854774,"score_gpt":0.4065164021075998,"score_spread":0.368916321908745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417500693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980343,0.00018750549,0.0013925668,0.000013784361,0.0000015628391,0.000004786097,0.000118399505,0.00003114196,0.00021593504],"genre_scores_gemma":[0.9988399,0.00004749008,0.0007724856,0.000005299971,8.6546055e-7,0.0000025072516,0.0002158982,0.0000044912713,0.000111140376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997795,0.00005298629,0.000014628608,0.000049402217,0.00007181327,0.00003154959],"domain_scores_gemma":[0.9995116,0.0001394583,0.00018644787,0.000047617832,0.00006835761,0.000046404173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031990066,0.00032239102,0.00024994786,0.00039564987,0.0001224154,0.00040836417,0.00014354155,0.00027210507,0.0005459168],"category_scores_gemma":[0.00082704535,0.00013914867,0.00027326745,0.0003226173,0.00022438298,0.00016580828,0.00023483268,0.0003879812,0.00018310171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003921396,0.00008643204,0.101673305,0.00005564683,0.00007413809,0.00015876695,0.00005572187,0.0026636873,0.8893035,0.00010034193,0.000071147115,0.0053651985],"study_design_scores_gemma":[0.000016390346,0.0006345958,0.35314366,0.00000992839,0.000098525314,0.0011449204,0.00013416307,0.029066857,0.6145927,0.00025399728,0.0008798755,0.000024409434],"about_ca_topic_score_codex":0.0008309611,"about_ca_topic_score_gemma":0.0007789804,"teacher_disagreement_score":0.0008309611,"about_ca_system_score_codex":0.00018668339,"about_ca_system_score_gemma":0.000077219265,"threshold_uncertainty_score":0.0018262863},"labels":[],"label_agreement":null},{"id":"W56588887","doi":"10.1385/0-89603-519-0:147","title":"Spectrophotometric Analysis of Human CY P2El -Catalyzed pNitrophenol Hydroxylation","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences","keywords":"Hydroxylation; Chemistry; CYP2E1; Trichloroacetic acid; Cytochrome P450; Catalysis; Microsome; Enzyme; Organic chemistry; Biochemistry; Chromatography","score_opus":0.20157877951981568,"score_gpt":0.4473165896919867,"score_spread":0.245737810172171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W56588887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7182822,0.007523201,0.24313328,0.0003931813,0.00045617332,0.0006151731,0.004283744,0.002074072,0.02323897],"genre_scores_gemma":[0.8098044,0.0059762807,0.13776042,0.00038954394,0.00015288069,0.0013574136,0.01015613,0.00047772686,0.033925254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984864,0.00045025023,0.000053448326,0.00036075403,0.000518708,0.00013044616],"domain_scores_gemma":[0.9992495,0.00016730095,0.00010098323,0.0000961781,0.00029774263,0.000088151995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010093143,0.0017206396,0.0004916656,0.0011058615,0.0005262857,0.0005013401,0.0007217839,0.0009788334,0.0034074169],"category_scores_gemma":[0.0009859839,0.0003607047,0.00041752172,0.0012950456,0.00043767763,0.0003716617,0.0005706145,0.0015126854,0.0017268445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019886535,0.00010072942,0.00059191155,0.00010781665,0.000036265566,0.00005545111,0.00009875279,0.00025753552,0.9932783,0.00031840356,0.0002507625,0.0047052447],"study_design_scores_gemma":[0.000016235292,0.00024005432,0.0018673782,0.000008288935,0.00002104133,0.000082071565,0.000027391217,0.0018419608,0.99372464,0.000078457284,0.0020828564,0.000009611013],"about_ca_topic_score_codex":0.0015312699,"about_ca_topic_score_gemma":0.0018317604,"teacher_disagreement_score":0.0034074169,"about_ca_system_score_codex":0.0007531558,"about_ca_system_score_gemma":0.0006668713,"threshold_uncertainty_score":0.011398971},"labels":[],"label_agreement":null},{"id":"W571182331","doi":"10.71781/31269","title":"Étude pharmacogénomique de la warfarine et de l'activité physique","year":2014,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Philosophy","score_opus":0.017101765336010075,"score_gpt":0.29696530216026557,"score_spread":0.27986353682425547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571182331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8698338,0.0979698,0.008533863,0.0027734875,0.00028807856,0.0004622818,0.006560976,0.00008032296,0.013497415],"genre_scores_gemma":[0.9630787,0.020038508,0.003334682,0.0009964721,0.000296944,0.00048366835,0.0023479129,0.000025684552,0.009397493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591595,0.0015298288,0.00035490343,0.0006298116,0.0013719429,0.0001975725],"domain_scores_gemma":[0.99305457,0.0024758643,0.0022685016,0.00042895184,0.0015073185,0.0002647352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044111726,0.0005418331,0.0008670676,0.0014397866,0.00047828566,0.0016035875,0.00048689195,0.00071850553,0.0032772804],"category_scores_gemma":[0.011326476,0.0003029881,0.0013154743,0.0031293714,0.000523065,0.0006004233,0.0003640613,0.0007053336,0.0004765822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018977284,0.00025300187,0.88936275,0.0012734605,0.002765366,0.00014898722,0.0007544443,0.00037343107,0.0019614084,0.00076214335,0.0013713434,0.099075936],"study_design_scores_gemma":[0.00012925178,0.0007591762,0.9873497,0.00020839213,0.0009990457,0.0004061497,0.00016000668,0.00055323547,0.0007636871,0.0002569079,0.008384846,0.000029763964],"about_ca_topic_score_codex":0.047859713,"about_ca_topic_score_gemma":0.0447356,"teacher_disagreement_score":0.047859713,"about_ca_system_score_codex":0.0019182565,"about_ca_system_score_gemma":0.0033745,"threshold_uncertainty_score":0.09516233},"labels":[],"label_agreement":null},{"id":"W574556610","doi":"10.2174/1872312809666150602151213","title":"Ontogeny of Human Conjugating Enzymes","year":2015,"lang":"en","type":"review","venue":"Drug Metabolism Letters","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Glucuronidation; Ontogeny; Enzyme; Sulfation; Biology; Fetus; Xenobiotic; Biochemistry; Pharmacology; Pregnancy; Genetics; Microsome","score_opus":0.22655051534464452,"score_gpt":0.4933616011427294,"score_spread":0.2668110857980849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W574556610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013261473,0.9426618,0.005162971,0.0024625002,0.00040986072,0.00004612094,0.0006571604,0.00007290315,0.03526528],"genre_scores_gemma":[0.07626368,0.8993908,0.0040610726,0.0010477959,0.00031953838,0.00006711821,0.00085621024,0.00002487586,0.017968899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982065,0.000034240686,0.000017856946,0.00005173,0.00005120799,0.000024229139],"domain_scores_gemma":[0.9998062,0.00004463059,0.000039127804,0.000017998971,0.00006738086,0.00002471071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043121757,0.00031942036,0.0004511431,0.0007069282,0.00017443852,0.0009582608,0.00032087165,0.0006686179,0.0042667594],"category_scores_gemma":[0.00048652178,0.0002223979,0.00032755898,0.00060537166,0.0005116999,0.0007728526,0.0005020595,0.0010095095,0.0024559726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002668095,0.00006983614,0.0038163925,0.003527059,0.00008705981,0.001260476,0.00029623276,0.000682546,0.032312807,0.036355503,0.009716763,0.9116085],"study_design_scores_gemma":[0.000010599787,0.0001190206,0.0072231037,0.00053701224,0.00004183642,0.0036953064,0.00008647867,0.00011594649,0.010152639,0.0056357114,0.9723626,0.000019716063],"about_ca_topic_score_codex":0.0012385891,"about_ca_topic_score_gemma":0.0006884778,"teacher_disagreement_score":0.0042667594,"about_ca_system_score_codex":0.00051707233,"about_ca_system_score_gemma":0.00086296373,"threshold_uncertainty_score":0.014273763},"labels":[],"label_agreement":null},{"id":"W611003191","doi":"10.1017/cbo9780511543944.005","title":"Statistical approaches in psychopharmacogenetics","year":2002,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Trait; Single-nucleotide polymorphism; Genetic architecture; Pharmacogenetics; Computational biology; Genetic association; Biology; Genetics; Quantitative trait locus; Computer science; Gene; Genotype","score_opus":0.2035239594911129,"score_gpt":0.3487263016566087,"score_spread":0.14520234216549577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W611003191","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010991731,0.086320214,0.86900043,0.010631294,0.0019695815,0.00018880694,0.00046483788,0.0009435212,0.029382113],"genre_scores_gemma":[0.06654429,0.07779466,0.81397796,0.0065933745,0.009499636,0.0019420456,0.0009787703,0.0009460353,0.02172315],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9852013,0.010821985,0.0006723401,0.0008728161,0.0022291455,0.00020235305],"domain_scores_gemma":[0.92537504,0.068597786,0.00084674766,0.0023734043,0.0024428966,0.0003641299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018793643,0.0020265866,0.0025955292,0.005292468,0.0010346707,0.004272387,0.0027828233,0.0032059983,0.008966206],"category_scores_gemma":[0.0424467,0.00095015136,0.0014564402,0.005919144,0.006105928,0.003641223,0.0023091512,0.0061848075,0.0036264495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033662353,0.000058751593,0.00086634106,0.0009150913,0.00028745923,0.0002797294,0.00057230855,0.01019743,0.00026770495,0.78390884,0.04210473,0.16050787],"study_design_scores_gemma":[0.00001411012,0.000024709443,0.00039847638,0.00019148657,0.000022666918,0.00012888196,0.00010531315,0.009438913,0.00008881375,0.93468124,0.05487933,0.000026087573],"about_ca_topic_score_codex":0.0030674913,"about_ca_topic_score_gemma":0.002469923,"teacher_disagreement_score":0.018793643,"about_ca_system_score_codex":0.0025509365,"about_ca_system_score_gemma":0.0026475566,"threshold_uncertainty_score":0.09939146},"labels":[],"label_agreement":null},{"id":"W611917486","doi":"10.71781/4546","title":"Étude pharmacogénomique sur l’utilisation de la warfarine en pratique clinique réelle","year":2010,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.08924771524499857,"score_gpt":0.4716146445027049,"score_spread":0.3823669292577063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W611917486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36932692,0.3086284,0.24436156,0.035352495,0.0016391672,0.0020804375,0.0075641363,0.00090831524,0.03013854],"genre_scores_gemma":[0.78313863,0.078821376,0.12004542,0.006222601,0.001372344,0.0015477636,0.0034372513,0.0002380743,0.0051765107],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96914196,0.018482216,0.0028423404,0.0032165865,0.0059529985,0.0003639892],"domain_scores_gemma":[0.8587032,0.1037131,0.0127516985,0.0062436718,0.017772857,0.00081549905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04913841,0.0011543642,0.0025124683,0.0029806572,0.00070135447,0.00536737,0.001626872,0.0018385383,0.0040444187],"category_scores_gemma":[0.15029538,0.000637013,0.0030962832,0.0048010186,0.0015081778,0.0027109578,0.0011987071,0.0024175316,0.0010955011],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037726527,0.00027555932,0.3720165,0.006290546,0.0060144253,0.00024567585,0.001305776,0.021447105,0.001813546,0.010301639,0.0071138614,0.5694027],"study_design_scores_gemma":[0.0016470716,0.006067654,0.6447624,0.018019026,0.014450946,0.0038053184,0.0013706825,0.092090674,0.011665299,0.025793888,0.17974232,0.0005846463],"about_ca_topic_score_codex":0.028531125,"about_ca_topic_score_gemma":0.019979708,"teacher_disagreement_score":0.04913841,"about_ca_system_score_codex":0.0041121356,"about_ca_system_score_gemma":0.009786237,"threshold_uncertainty_score":0.25987184},"labels":[],"label_agreement":null},{"id":"W648966041","doi":"10.71781/4597","title":"Characterizing the Expression of Cytochrome P450s in Breast Cancer Cells","year":2011,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal","keywords":"Cytochrome; Breast cancer; Cancer research; Cancer; Biology; Internal medicine; Medicine; Biochemistry","score_opus":0.1315405015179271,"score_gpt":0.45612494128732184,"score_spread":0.3245844397693948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W648966041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550344,0.0018419739,0.008303899,0.00018072911,0.00003774271,0.000046078647,0.001249998,0.00007532308,0.0027608168],"genre_scores_gemma":[0.9575158,0.0030636115,0.01906464,0.00022062116,0.00002989615,0.00023292883,0.0051556006,0.00005666571,0.014660226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975413,0.000026042162,0.000021498117,0.00005937791,0.00009797954,0.000041017924],"domain_scores_gemma":[0.99983084,0.00005790915,0.000019898527,0.00002892172,0.000045570516,0.000016906868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020251024,0.0001313791,0.00024346067,0.0002907579,0.0003235799,0.0003969489,0.00011110994,0.0002623661,0.0011593733],"category_scores_gemma":[0.00023786035,0.00014760465,0.00025888387,0.00070651935,0.00018966479,0.00020819849,0.00012940321,0.00051725743,0.00064333086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050358645,0.000012573019,0.0010974386,0.000020022842,0.0000037132047,0.000030954547,0.00006671297,0.000043449763,0.9969921,0.000049495706,0.00004026468,0.0015928573],"study_design_scores_gemma":[0.00000858725,0.00027617693,0.035170667,0.0000069993175,0.000027721675,0.00028304543,0.00020899382,0.0012194171,0.9558003,0.000099534125,0.006890472,0.000008156743],"about_ca_topic_score_codex":0.0015582511,"about_ca_topic_score_gemma":0.0020811132,"teacher_disagreement_score":0.0015582511,"about_ca_system_score_codex":0.00033098253,"about_ca_system_score_gemma":0.00021081029,"threshold_uncertainty_score":0.0038784742},"labels":[],"label_agreement":null},{"id":"W650154501","doi":"10.71781/31425","title":"Études in vitro et in vivo évaluant le rôle du métabolisme des médicaments par les CYP450s comme facteurs de variabilité interindividuelle dans la réponse aux médicaments","year":2008,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Medicine; Pharmacology","score_opus":0.17144212613222945,"score_gpt":0.45604347448578786,"score_spread":0.28460134835355844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W650154501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9388388,0.035343222,0.010815086,0.0006081096,0.00019175792,0.00049349264,0.0016138344,0.00008745206,0.012008324],"genre_scores_gemma":[0.9357376,0.022568693,0.010152371,0.00030269037,0.00015255265,0.00030152668,0.0017609523,0.000043972213,0.028979627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947387,0.0002274209,0.000027688182,0.00009919737,0.00009603048,0.00007584923],"domain_scores_gemma":[0.9993824,0.00029104837,0.0000913018,0.000054445536,0.00013982043,0.000040958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011170374,0.00041448083,0.0005745854,0.00034020937,0.0003503402,0.0006295573,0.0001931802,0.00041374227,0.0044653136],"category_scores_gemma":[0.001105792,0.00028466526,0.00058326876,0.00040637545,0.00030917878,0.00028213518,0.00012376283,0.0006800418,0.0007882591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016623011,0.00057461264,0.0028659576,0.00041555866,0.00014058898,0.00013016586,0.00023709294,0.00026628745,0.9586506,0.00017882333,0.0005828013,0.03429519],"study_design_scores_gemma":[0.00049940805,0.018571349,0.04282716,0.00007417497,0.0007704163,0.000727264,0.00033434716,0.00090437545,0.919017,0.00016035506,0.016071867,0.00004237146],"about_ca_topic_score_codex":0.0051935273,"about_ca_topic_score_gemma":0.008672496,"teacher_disagreement_score":0.0051935273,"about_ca_system_score_codex":0.00036293766,"about_ca_system_score_gemma":0.00058257894,"threshold_uncertainty_score":0.014937937},"labels":[],"label_agreement":null},{"id":"W6889128256","doi":"10.25384/sage.17032680.v1","title":"sj-pdf-1-cpa-10.1177_07067437211058847 - Supplemental material for Encountering Pharmacogenetic Test Results in the Psychiatric Clinic","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Test (biology); Psychiatric diagnosis; Schizophrenia (object-oriented programming); Affect (linguistics)","score_opus":0.14667932358405203,"score_gpt":0.45087167488473284,"score_spread":0.3041923513006808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889128256","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073836785,0.0005022814,0.0036905683,0.0039991555,0.0022239618,0.0010068584,0.5763012,0.022007233,0.38953042],"genre_scores_gemma":[0.010253378,0.001128678,0.009327953,0.006194949,0.0017566789,0.0011956767,0.31447738,0.01622188,0.6394434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998852,0.00015827699,0.00011676168,0.00016464874,0.0004783368,0.00022997496],"domain_scores_gemma":[0.98746234,0.005134415,0.00070793385,0.0010332316,0.003086723,0.002575433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018664667,0.0009788866,0.0010392423,0.0027072334,0.0013199602,0.003366803,0.002795937,0.003988088,0.9690646],"category_scores_gemma":[0.01501735,0.0012163387,0.0010094759,0.0025634689,0.00046910907,0.0024939552,0.002350435,0.0018938694,0.87979865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065985805,0.000046968653,0.00016385433,0.00009725386,0.0000037412099,0.00002825537,0.000008199627,0.00003232526,0.000084554216,0.00027252844,0.9863629,0.012833397],"study_design_scores_gemma":[0.00032579942,0.000078691424,0.0029059171,0.00029803807,0.000013318138,0.00024358816,0.00005182791,0.00021313006,0.00051491836,0.0015808828,0.9937318,0.00004206733],"about_ca_topic_score_codex":0.010964458,"about_ca_topic_score_gemma":0.01968041,"teacher_disagreement_score":0.9690646,"about_ca_system_score_codex":0.0019391296,"about_ca_system_score_gemma":0.0024771802,"threshold_uncertainty_score":0.044125497},"labels":[],"label_agreement":null},{"id":"W6889143631","doi":"10.25402/pgs.25442359","title":"Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada","year":2024,"lang":"en","type":"other","venue":"Future Science Group","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Perception; Qualitative research; Pharmacy practice","score_opus":0.043550220072360965,"score_gpt":0.3820029152545616,"score_spread":0.3384526951822006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889143631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558997,0.0013368011,0.00010078244,0.012970278,0.000048385653,0.00013112681,0.0072885347,0.000014290337,0.02220998],"genre_scores_gemma":[0.98667115,0.0025030894,0.00031704665,0.0026818938,0.000022680817,0.00006242256,0.0011632568,0.000009434432,0.006569105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984762,0.00018266532,0.00010090537,0.00010192203,0.00072901166,0.00040919712],"domain_scores_gemma":[0.99067384,0.0014855146,0.0012272851,0.000086511325,0.0033534998,0.003173421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013375513,0.00016192271,0.00026889093,0.0012826774,0.00360043,0.0022928733,0.0008127417,0.00061194424,0.009067664],"category_scores_gemma":[0.008381381,0.00028114382,0.0003492957,0.003413421,0.0009225031,0.00073136674,0.001204708,0.001086986,0.00043322516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010119846,0.00014772758,0.954744,0.00018490336,0.00006021114,0.00040014443,0.009885601,0.00014253764,0.00024421193,0.0003486848,0.014371644,0.019369146],"study_design_scores_gemma":[0.000027994289,0.000057663332,0.9517529,0.00038794734,0.0000406773,0.00016601695,0.03781374,0.00026609987,0.00010854192,0.000094151525,0.009250786,0.000033506505],"about_ca_topic_score_codex":0.99270344,"about_ca_topic_score_gemma":0.99605703,"teacher_disagreement_score":0.021937247,"about_ca_system_score_codex":0.021937247,"about_ca_system_score_gemma":0.08879224,"threshold_uncertainty_score":0.15916663},"labels":[],"label_agreement":null},{"id":"W6901480414","doi":"10.60692/8c7kc-66w24","title":"Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Genotyping; CYP2D6; Allele; Context (archaeology); Pharmacogenetics; Allele frequency; Genotype; Gene","score_opus":0.11508791568029686,"score_gpt":0.33519760910665297,"score_spread":0.2201096934263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901480414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980185,0.0003575708,0.0006805819,0.0000631548,0.0000039629485,0.000012993437,0.00042690046,0.0000039657652,0.00043232806],"genre_scores_gemma":[0.9983918,0.00029002377,0.0007874399,0.00003854671,0.0000049239616,0.000016606156,0.00028799934,0.0000045801744,0.00017804468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971193,0.00009674626,0.00002576722,0.00008380559,0.00004597619,0.00003572021],"domain_scores_gemma":[0.9997552,0.00007822458,0.00008352294,0.000027107291,0.000037168702,0.000018773198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005151893,0.00021258676,0.00021203572,0.0006743502,0.00038550055,0.0003391501,0.00015448028,0.00019473773,0.00172675],"category_scores_gemma":[0.0015052826,0.00010039374,0.0001796886,0.00091605657,0.00019786926,0.00015060272,0.0002932417,0.00021009713,0.00016295737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004291248,0.000051581355,0.9313832,0.0000980378,0.0002113025,0.0010108346,0.0030604603,0.00036342826,0.021120606,0.0006615782,0.0005855319,0.04102434],"study_design_scores_gemma":[0.00001676289,0.00009025752,0.9901523,0.00004090205,0.000077942685,0.0015527947,0.001168286,0.0007499414,0.0020110167,0.0003387323,0.003790009,0.000010996822],"about_ca_topic_score_codex":0.0024476186,"about_ca_topic_score_gemma":0.0032008719,"teacher_disagreement_score":0.0024476186,"about_ca_system_score_codex":0.00012586424,"about_ca_system_score_gemma":0.00013920348,"threshold_uncertainty_score":0.0057765245},"labels":[],"label_agreement":null},{"id":"W6901879103","doi":"10.6084/m9.figshare.18864868.v1","title":"Additional file 1 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; In vivo; In vitro; Detoxification (alternative medicine); Drug; Inhibitory postsynaptic potential; Transplantation; Cell","score_opus":0.05827887287607926,"score_gpt":0.3335455240895678,"score_spread":0.27526665121348853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901879103","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003603703,0.000052382442,0.00040704454,0.00015607414,0.000017897613,0.000038359463,0.9972299,0.0003587376,0.0013792817],"genre_scores_gemma":[0.021830184,0.0003670978,0.0054687606,0.0008851943,0.0000886927,0.00083144935,0.95750004,0.0009863793,0.012042224],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996635,0.00007607394,0.00003682683,0.00008843907,0.00008642359,0.000048759204],"domain_scores_gemma":[0.99212873,0.0064193686,0.00034444375,0.0002451966,0.00072785694,0.0001344978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001106438,0.0009004845,0.00092087017,0.0010058307,0.00045564026,0.0011928668,0.00143437,0.0012971392,0.807935],"category_scores_gemma":[0.012031789,0.0004256295,0.0010724922,0.0015906646,0.00018800114,0.0013094023,0.0005984207,0.00067698135,0.15727404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048067476,0.00013951675,0.0054134843,0.005217056,0.00012439137,0.00016124082,0.00004711999,0.0035381727,0.00030678776,0.0018750172,0.96970034,0.012996172],"study_design_scores_gemma":[0.005070418,0.00037866726,0.016939677,0.0031896748,0.00044411063,0.0005755682,0.00023624042,0.011545298,0.001834669,0.017017398,0.9426257,0.00014265522],"about_ca_topic_score_codex":0.006587775,"about_ca_topic_score_gemma":0.011189284,"teacher_disagreement_score":0.807935,"about_ca_system_score_codex":0.0008314062,"about_ca_system_score_gemma":0.0013910892,"threshold_uncertainty_score":0.2739573},"labels":[],"label_agreement":null},{"id":"W6902018336","doi":"10.6084/m9.figshare.18864892.v1","title":"Additional file 8 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Identification (biology); Transplantation; Virtual screening; Cofactor; Stevia rebaudiana; Detoxification (alternative medicine)","score_opus":0.057475225775953966,"score_gpt":0.33328348761627896,"score_spread":0.275808261840325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902018336","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039314775,0.00007503049,0.00040152177,0.00021005266,0.00004307784,0.000043433924,0.9963236,0.0008992233,0.0016108592],"genre_scores_gemma":[0.0139716,0.0003384098,0.004619122,0.0006814394,0.000084554864,0.00061807083,0.96789485,0.0014482383,0.010343767],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996294,0.000058601974,0.00004355452,0.00009596431,0.00010815374,0.00006437242],"domain_scores_gemma":[0.99500185,0.0036434717,0.00029910618,0.00023306279,0.00066156365,0.00016098756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009022085,0.001296331,0.001289144,0.001087318,0.0006948751,0.0016252348,0.0018353392,0.00163136,0.8388913],"category_scores_gemma":[0.011190919,0.00053439254,0.0013174152,0.0014762501,0.00023171866,0.001483074,0.00086481136,0.00087892386,0.19525988],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042351653,0.0001153933,0.0028091776,0.0040611275,0.0000907633,0.0001790544,0.00004551078,0.0014764918,0.0003168183,0.0011560958,0.9812413,0.008084701],"study_design_scores_gemma":[0.004670531,0.00027734728,0.011593006,0.0033013246,0.0003465134,0.0006470719,0.00023145671,0.0068810172,0.0019673875,0.012894503,0.95704365,0.00014629847],"about_ca_topic_score_codex":0.0067867367,"about_ca_topic_score_gemma":0.013149241,"teacher_disagreement_score":0.8388913,"about_ca_system_score_codex":0.0009755489,"about_ca_system_score_gemma":0.0017463239,"threshold_uncertainty_score":0.22980195},"labels":[],"label_agreement":null},{"id":"W6902045106","doi":"10.6084/m9.figshare.18864877","title":"Additional file 4 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; AutoDock; Docking (animal); Detoxification (alternative medicine); Transplantation; Ligand (biochemistry); Hematopoietic stem cell transplantation","score_opus":0.05780838960482853,"score_gpt":0.33353113093136527,"score_spread":0.27572274132653674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045106","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064889406,0.00006429981,0.0007242106,0.00023223078,0.000047943646,0.000060534243,0.995673,0.0009678946,0.0015808721],"genre_scores_gemma":[0.02358865,0.0003021414,0.006777163,0.00081862404,0.00012091609,0.0008242204,0.9545496,0.0017313511,0.011287292],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997143,0.00004823507,0.000034479053,0.00007200328,0.00007760629,0.000053443928],"domain_scores_gemma":[0.9954294,0.0033940717,0.0002700657,0.00020976711,0.0005346868,0.00016202251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000914493,0.0011707223,0.0011423511,0.0009005488,0.00060571684,0.0013610492,0.0017652753,0.0014923406,0.8441397],"category_scores_gemma":[0.009078974,0.00049139035,0.0012143395,0.0011458615,0.000211788,0.0012612969,0.00069959485,0.00081032625,0.15971848],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007249874,0.00018524991,0.00399277,0.004317743,0.00011874982,0.00026752826,0.000055099325,0.0032795288,0.00046128005,0.0016103666,0.97219807,0.012788657],"study_design_scores_gemma":[0.008076683,0.0005666831,0.016779039,0.0031779436,0.0005088316,0.0010988353,0.00027555184,0.017999597,0.003589936,0.019776974,0.9279381,0.00021175986],"about_ca_topic_score_codex":0.006103194,"about_ca_topic_score_gemma":0.010125693,"teacher_disagreement_score":0.8441397,"about_ca_system_score_codex":0.00093201065,"about_ca_system_score_gemma":0.0016234824,"threshold_uncertainty_score":0.22231573},"labels":[],"label_agreement":null},{"id":"W6902045470","doi":"10.6084/m9.figshare.16900743.v1","title":"Additional file 2 of Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Degree (music); Airflow; Statistical analysis; Post hoc","score_opus":0.26837214078498695,"score_gpt":0.4103348117906738,"score_spread":0.14196267100568688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045470","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011373756,0.00009580445,0.0005957811,0.00033096425,0.00007282714,0.001428289,0.99218494,0.0003166811,0.0038374625],"genre_scores_gemma":[0.10083712,0.0006370784,0.016291915,0.0038661058,0.00078861025,0.060951013,0.7362184,0.0017305156,0.078679204],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99808,0.00060937984,0.00035863344,0.0002881091,0.00038385045,0.00028001613],"domain_scores_gemma":[0.9492534,0.038966585,0.0047906437,0.0023452155,0.0037777363,0.00086653454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003930739,0.0010379436,0.0016080061,0.001237539,0.0008612596,0.0014346172,0.0016327656,0.0013608043,0.8346915],"category_scores_gemma":[0.04945534,0.00057483744,0.001587878,0.0018922806,0.00031069937,0.0015969488,0.0007261224,0.0010793349,0.06702882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011412446,0.0004663799,0.004899934,0.011663659,0.00060316443,0.00015510262,0.00012060044,0.0010444701,0.00018112405,0.0019917986,0.9447659,0.022695396],"study_design_scores_gemma":[0.19924541,0.005671596,0.08959771,0.015082577,0.0030292869,0.0013376195,0.0006287978,0.00747664,0.0019031506,0.026128462,0.64953166,0.00036709892],"about_ca_topic_score_codex":0.003405542,"about_ca_topic_score_gemma":0.008315735,"teacher_disagreement_score":0.8346915,"about_ca_system_score_codex":0.0011927071,"about_ca_system_score_gemma":0.0022921339,"threshold_uncertainty_score":0.2357924},"labels":[],"label_agreement":null},{"id":"W6902045540","doi":"10.6084/m9.figshare.18864883","title":"Additional file 6 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Docking (animal); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis","score_opus":0.0574577716503202,"score_gpt":0.3332532209878559,"score_spread":0.27579544933753575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902045540","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071892736,0.00009603779,0.00054450665,0.00024921118,0.000043661723,0.000052244875,0.9951148,0.0011024305,0.0020781239],"genre_scores_gemma":[0.02433355,0.00042786275,0.0056566284,0.00080898975,0.000085325795,0.0008305428,0.9547875,0.0017015967,0.011367998],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997317,0.00005031359,0.000031711632,0.00006044348,0.000076420394,0.000049476705],"domain_scores_gemma":[0.99630827,0.0026914072,0.00023228212,0.00015799621,0.0004960731,0.0001138499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076723134,0.0012228511,0.0012148578,0.0008517141,0.0004938045,0.0013353449,0.0015183216,0.0013217283,0.80714583],"category_scores_gemma":[0.008388207,0.0004497821,0.0012350644,0.0012786527,0.00018645336,0.0010946722,0.0006600202,0.000840826,0.13091193],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005603455,0.00015386372,0.0034046748,0.004746462,0.00014447916,0.0001827724,0.000047736816,0.0032133958,0.00040094097,0.001505302,0.97499645,0.010643487],"study_design_scores_gemma":[0.008348106,0.0005018421,0.015981566,0.0031299666,0.0005735723,0.00067913876,0.00029855114,0.016931511,0.0033752436,0.018752199,0.93123204,0.00019627098],"about_ca_topic_score_codex":0.006284926,"about_ca_topic_score_gemma":0.012873953,"teacher_disagreement_score":0.80714583,"about_ca_system_score_codex":0.00081301166,"about_ca_system_score_gemma":0.0013799565,"threshold_uncertainty_score":0.275083},"labels":[],"label_agreement":null},{"id":"W6902060760","doi":"10.6084/m9.figshare.18864862","title":"Additional file 10 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Workflow; Docking (animal); Hematopoietic stem cell transplantation; Transplantation","score_opus":0.058926112205234624,"score_gpt":0.3351414189359377,"score_spread":0.27621530673070305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902060760","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059905177,0.00007188504,0.0006800246,0.00022209279,0.0000390732,0.000059976006,0.99529546,0.0014248057,0.0016076822],"genre_scores_gemma":[0.020718621,0.0003356333,0.0076097515,0.00089510065,0.00009500853,0.000970409,0.9549891,0.0025436347,0.011842691],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996829,0.00005664136,0.000040193783,0.00007630249,0.0000930899,0.000050975985],"domain_scores_gemma":[0.9950918,0.003694602,0.00027574215,0.00019373538,0.0006089542,0.00013513898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009018827,0.0012823585,0.001223587,0.0010205616,0.0005486738,0.0014666658,0.0015517384,0.001483748,0.788804],"category_scores_gemma":[0.009448224,0.0005122906,0.0013675707,0.001303037,0.00022052118,0.0011840493,0.00079049316,0.0008557433,0.14486349],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113565,0.00016359685,0.004036464,0.0040977728,0.00013411437,0.00022586252,0.000048998616,0.003511947,0.00047571296,0.0016231315,0.9734036,0.011567547],"study_design_scores_gemma":[0.0078094113,0.00042994585,0.017235603,0.002664598,0.00044742803,0.0006268985,0.0002564862,0.017229471,0.0039641554,0.020850781,0.92826754,0.0002177173],"about_ca_topic_score_codex":0.006666269,"about_ca_topic_score_gemma":0.012301116,"teacher_disagreement_score":0.788804,"about_ca_system_score_codex":0.00089763914,"about_ca_system_score_gemma":0.0014595641,"threshold_uncertainty_score":0.30124545},"labels":[],"label_agreement":null},{"id":"W6902069077","doi":"10.6084/m9.figshare.18864895","title":"Additional file 9 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Haematopoiesis; Cytotoxicity; Cell","score_opus":0.05748542301556154,"score_gpt":0.33329291555187474,"score_spread":0.2758074925363132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902069077","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006810285,0.00007192251,0.00045021396,0.00020995029,0.00003162791,0.000042007636,0.99663216,0.0005486149,0.0013325388],"genre_scores_gemma":[0.028727178,0.00030008107,0.0061862404,0.00093197665,0.00009402707,0.0007129233,0.9498931,0.00107917,0.012075209],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99962425,0.00007362953,0.00004094764,0.00010259776,0.0000946462,0.000063851585],"domain_scores_gemma":[0.9940393,0.0047122324,0.00031692008,0.00021995498,0.0005746745,0.00013693963],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010599868,0.0011070463,0.0010896968,0.000948221,0.0005454565,0.0013945164,0.001455681,0.0014768111,0.7636864],"category_scores_gemma":[0.011431998,0.00043259293,0.0013721876,0.0012549583,0.00018986399,0.0011672176,0.0006702205,0.00065888395,0.12223881],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007756349,0.0002029632,0.009571238,0.0068122107,0.00023533212,0.0002925347,0.000073334755,0.0041983104,0.0005181923,0.0019271779,0.9599766,0.015416424],"study_design_scores_gemma":[0.007823512,0.00048098253,0.02803266,0.0045997268,0.00070323754,0.0008012964,0.00033895322,0.01485811,0.002595091,0.01849266,0.9210723,0.00020152245],"about_ca_topic_score_codex":0.00728056,"about_ca_topic_score_gemma":0.01389521,"teacher_disagreement_score":0.7636864,"about_ca_system_score_codex":0.00083204894,"about_ca_system_score_gemma":0.0014477383,"threshold_uncertainty_score":0.3370726},"labels":[],"label_agreement":null},{"id":"W6902078429","doi":"10.6084/m9.figshare.18864883.v1","title":"Additional file 6 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Docking (animal); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis","score_opus":0.0574577716503202,"score_gpt":0.3332532209878559,"score_spread":0.27579544933753575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902078429","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071892736,0.00009603779,0.00054450665,0.00024921118,0.000043661723,0.000052244875,0.9951148,0.0011024305,0.0020781239],"genre_scores_gemma":[0.02433355,0.00042786275,0.0056566284,0.00080898975,0.000085325795,0.0008305428,0.9547875,0.0017015967,0.011367998],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997317,0.00005031359,0.000031711632,0.00006044348,0.000076420394,0.000049476705],"domain_scores_gemma":[0.99630827,0.0026914072,0.00023228212,0.00015799621,0.0004960731,0.0001138499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076723134,0.0012228511,0.0012148578,0.0008517141,0.0004938045,0.0013353449,0.0015183216,0.0013217283,0.80714583],"category_scores_gemma":[0.008388207,0.0004497821,0.0012350644,0.0012786527,0.00018645336,0.0010946722,0.0006600202,0.000840826,0.13091193],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005603455,0.00015386372,0.0034046748,0.004746462,0.00014447916,0.0001827724,0.000047736816,0.0032133958,0.00040094097,0.001505302,0.97499645,0.010643487],"study_design_scores_gemma":[0.008348106,0.0005018421,0.015981566,0.0031299666,0.0005735723,0.00067913876,0.00029855114,0.016931511,0.0033752436,0.018752199,0.93123204,0.00019627098],"about_ca_topic_score_codex":0.006284926,"about_ca_topic_score_gemma":0.012873953,"teacher_disagreement_score":0.80714583,"about_ca_system_score_codex":0.00081301166,"about_ca_system_score_gemma":0.0013799565,"threshold_uncertainty_score":0.275083},"labels":[],"label_agreement":null},{"id":"W6907820508","doi":"10.25384/sage.11865390","title":"Supplemental Material, Table_S1_FINAL - Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; MEDLINE; Alternative medicine; Genetic testing; Mental illness","score_opus":0.21256082625237918,"score_gpt":0.4366587941689166,"score_spread":0.22409796791653744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6907820508","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000510815,0.0005981728,0.0008227128,0.00416279,0.0011462556,0.0005639548,0.9241532,0.0010359592,0.067006156],"genre_scores_gemma":[0.013908897,0.0032705266,0.0076779355,0.014780031,0.0013817957,0.0015332969,0.7388012,0.002142393,0.21650392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982672,0.00018587154,0.00023241258,0.00019439458,0.0008124607,0.00030768383],"domain_scores_gemma":[0.9726585,0.008445204,0.0010791897,0.0008046828,0.015037032,0.0019753356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001999317,0.00085853686,0.001003295,0.0035487032,0.0024667203,0.0026821285,0.0018654304,0.0019898186,0.7746423],"category_scores_gemma":[0.037281815,0.00078748213,0.0009656846,0.0058748247,0.00048913696,0.001340586,0.0011554115,0.0016601131,0.23172858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023949548,0.000020373827,0.00038691243,0.00017242474,0.0000042167608,0.000020332523,0.000010990981,0.000039380906,0.000020811518,0.00025147895,0.99375266,0.005296481],"study_design_scores_gemma":[0.00035509953,0.000041687126,0.015365879,0.00106233,0.00004421937,0.00030279465,0.00022638123,0.00027538787,0.00028228626,0.0028239533,0.9791533,0.00006676498],"about_ca_topic_score_codex":0.51817816,"about_ca_topic_score_gemma":0.6354333,"teacher_disagreement_score":0.7746423,"about_ca_system_score_codex":0.0077737654,"about_ca_system_score_gemma":0.024800679,"threshold_uncertainty_score":0.96931875},"labels":[],"label_agreement":null},{"id":"W6912556675","doi":"10.5281/zenodo.5787002","title":"GDSC2","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Metadata; Software; Certification; Research data; Zhàng; Pharmacogenomics","score_opus":0.1550131002636586,"score_gpt":0.39878633716837814,"score_spread":0.24377323690471953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6912556675","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025799049,0.0028302544,0.02015787,0.0043784366,0.0019898966,0.00047697866,0.59500647,0.10793971,0.26464042],"genre_scores_gemma":[0.0069242073,0.001393319,0.011877931,0.0031884252,0.00023167334,0.00065818016,0.82163674,0.03741379,0.11667571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690115,0.00040683855,0.00023511656,0.0007474925,0.0013176164,0.00039187493],"domain_scores_gemma":[0.9964994,0.00050364493,0.00016627918,0.0011954793,0.0011491298,0.0004860597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026085307,0.0018037981,0.0018722267,0.0034252293,0.0022694492,0.0067589064,0.0057265856,0.0028276178,0.39929217],"category_scores_gemma":[0.009547434,0.0014593676,0.0018434866,0.005125623,0.0007961565,0.0037886666,0.0056020725,0.0031243048,0.5083776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019790207,0.000024506759,0.0003295252,0.00037082707,0.00002847164,0.0000610414,0.00006477541,0.00017376512,0.001475082,0.0037046405,0.97409296,0.019476512],"study_design_scores_gemma":[0.00004736444,0.000016170683,0.0002924481,0.000068018955,0.000017620787,0.00011006409,0.000025106026,0.00019891278,0.0011316568,0.0019628466,0.9961099,0.000019957904],"about_ca_topic_score_codex":0.009711251,"about_ca_topic_score_gemma":0.011170534,"teacher_disagreement_score":0.6007078,"about_ca_system_score_codex":0.0023550168,"about_ca_system_score_gemma":0.004666624,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W6920527541","doi":"10.60692/s3mhf-93n23","title":"The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"ADME; 1000 Genomes Project; Pharmacogenomics; Genetic variation; Gene; Population; Genome; Human genetics; Variation (astronomy)","score_opus":0.12294017799973875,"score_gpt":0.36941099452855947,"score_spread":0.24647081652882072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920527541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655837,0.001245228,0.00074303895,0.00014961908,0.0000074520367,0.000009682717,0.0005136752,0.000006594776,0.0007663879],"genre_scores_gemma":[0.99853253,0.0003761736,0.0007286688,0.00004742171,0.000009816374,0.000007002451,0.00022401573,0.0000045230677,0.00007000465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930894,0.00026253687,0.000054706135,0.00019742415,0.000097790406,0.00007864772],"domain_scores_gemma":[0.9988385,0.00053180463,0.00039225174,0.000089524015,0.00008002519,0.00006802903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011317256,0.00029607845,0.0003137313,0.0010324494,0.00042813332,0.00064950506,0.00029774322,0.00033807885,0.0021557617],"category_scores_gemma":[0.0024434752,0.00014932109,0.0002488844,0.0016668838,0.00056289387,0.00035165428,0.00045402392,0.00031499544,0.00015731591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042589544,0.0000319509,0.95228183,0.00015451618,0.00052249926,0.0008488249,0.0011808927,0.00057742634,0.0132799335,0.0006286462,0.0003338726,0.029733656],"study_design_scores_gemma":[0.000015087089,0.00006895674,0.9927046,0.00007704427,0.00013146104,0.001455722,0.0005446106,0.00048371483,0.0013703653,0.00072756474,0.0024094956,0.000011445026],"about_ca_topic_score_codex":0.0017919223,"about_ca_topic_score_gemma":0.0019096641,"teacher_disagreement_score":0.0021557617,"about_ca_system_score_codex":0.00020591,"about_ca_system_score_gemma":0.00018652502,"threshold_uncertainty_score":0.007211685},"labels":[],"label_agreement":null},{"id":"W6920560985","doi":"10.60692/zmrpv-b4703","title":"Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Allele frequency; CYP2A6; Genetic variation; Genome; Human genetic variation","score_opus":0.12961946722350667,"score_gpt":0.3467793525055919,"score_spread":0.2171598852820852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920560985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914677,0.0013514392,0.0017906042,0.00012401656,0.000008860778,0.000017132681,0.00451837,0.000029745186,0.00069215655],"genre_scores_gemma":[0.9904856,0.00101726,0.0026425228,0.00007720649,0.000017940461,0.0000358371,0.005408076,0.000034170313,0.0002813247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996123,0.00012387405,0.000039945775,0.0001275615,0.000055123015,0.00004127771],"domain_scores_gemma":[0.99963963,0.00012433017,0.00012532226,0.000043850046,0.00003883943,0.00002799015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060106575,0.00024206338,0.00036413624,0.00088051276,0.00037035797,0.00046844708,0.00018018497,0.00024652036,0.0025222804],"category_scores_gemma":[0.0017803328,0.00013394187,0.00046228396,0.0018626738,0.00018856017,0.00022538626,0.000379475,0.0003192024,0.00030757062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092554506,0.000049540926,0.92192584,0.00026012777,0.0007047977,0.0008445736,0.0013512553,0.0016070482,0.014028994,0.00075996085,0.002629506,0.054912798],"study_design_scores_gemma":[0.000059690574,0.00008042025,0.98073786,0.000089253415,0.00025672241,0.0016539046,0.0005900852,0.0028554818,0.0018369596,0.0007937754,0.011026815,0.000019059831],"about_ca_topic_score_codex":0.002590659,"about_ca_topic_score_gemma":0.0033410313,"teacher_disagreement_score":0.002590659,"about_ca_system_score_codex":0.0001241999,"about_ca_system_score_gemma":0.00016059834,"threshold_uncertainty_score":0.008437872},"labels":[],"label_agreement":null},{"id":"W6920575832","doi":"10.60692/271rm-kbs87","title":"Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Genotyping; CYP2D6; Allele; Context (archaeology); Pharmacogenetics; Allele frequency; Genotype; Gene","score_opus":0.11508791568029686,"score_gpt":0.33519760910665297,"score_spread":0.2201096934263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920575832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980185,0.0003575708,0.0006805819,0.0000631548,0.0000039629485,0.000012993437,0.00042690046,0.0000039657652,0.00043232806],"genre_scores_gemma":[0.9983918,0.00029002377,0.0007874399,0.00003854671,0.0000049239616,0.000016606156,0.00028799934,0.0000045801744,0.00017804468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971193,0.00009674626,0.00002576722,0.00008380559,0.00004597619,0.00003572021],"domain_scores_gemma":[0.9997552,0.00007822458,0.00008352294,0.000027107291,0.000037168702,0.000018773198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005151893,0.00021258676,0.00021203572,0.0006743502,0.00038550055,0.0003391501,0.00015448028,0.00019473773,0.00172675],"category_scores_gemma":[0.0015052826,0.00010039374,0.0001796886,0.00091605657,0.00019786926,0.00015060272,0.0002932417,0.00021009713,0.00016295737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004291248,0.000051581355,0.9313832,0.0000980378,0.0002113025,0.0010108346,0.0030604603,0.00036342826,0.021120606,0.0006615782,0.0005855319,0.04102434],"study_design_scores_gemma":[0.00001676289,0.00009025752,0.9901523,0.00004090205,0.000077942685,0.0015527947,0.001168286,0.0007499414,0.0020110167,0.0003387323,0.003790009,0.000010996822],"about_ca_topic_score_codex":0.0024476186,"about_ca_topic_score_gemma":0.0032008719,"teacher_disagreement_score":0.0024476186,"about_ca_system_score_codex":0.00012586424,"about_ca_system_score_gemma":0.00013920348,"threshold_uncertainty_score":0.0057765245},"labels":[],"label_agreement":null},{"id":"W6920995309","doi":"10.6084/m9.figshare.18864874.v1","title":"Additional file 3 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Transplantation; Stem cell; Cell","score_opus":0.05745782231110878,"score_gpt":0.3331591838111815,"score_spread":0.2757013615000727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920995309","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045078032,0.000068082285,0.00031855117,0.00013801089,0.000027523294,0.000028243569,0.99729615,0.00066266395,0.001010068],"genre_scores_gemma":[0.012206255,0.00024913132,0.0031410756,0.0004922814,0.000055664044,0.0004183919,0.9774155,0.00096741616,0.005054209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995951,0.00006379033,0.000046683796,0.00011000852,0.000115982126,0.00006850331],"domain_scores_gemma":[0.9950706,0.0036528497,0.0003148767,0.00020503452,0.0006057073,0.00015099638],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009007114,0.0015512737,0.0014500716,0.0011620297,0.0007523811,0.0017179014,0.0015850397,0.001746712,0.74029315],"category_scores_gemma":[0.010183001,0.00050491485,0.0014935397,0.001748429,0.00026413685,0.001376355,0.0008481673,0.0010360719,0.145259],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006101949,0.00013539923,0.005232948,0.00516122,0.00017791628,0.00022844228,0.0000730996,0.0022692138,0.0004922697,0.0014348746,0.9761486,0.008035852],"study_design_scores_gemma":[0.006660968,0.00038201542,0.019396828,0.0034747012,0.0007091751,0.0008499155,0.00029248322,0.010079549,0.003008414,0.016945254,0.9379977,0.00020306726],"about_ca_topic_score_codex":0.009025494,"about_ca_topic_score_gemma":0.017865162,"teacher_disagreement_score":0.74029315,"about_ca_system_score_codex":0.001038231,"about_ca_system_score_gemma":0.0019361242,"threshold_uncertainty_score":0.3704403},"labels":[],"label_agreement":null},{"id":"W6921119853","doi":"10.6084/m9.figshare.18864892","title":"Additional file 8 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Identification (biology); Transplantation; Virtual screening; Cofactor; Stevia rebaudiana; Detoxification (alternative medicine)","score_opus":0.057475225775953966,"score_gpt":0.33328348761627896,"score_spread":0.275808261840325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921119853","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039314775,0.00007503049,0.00040152177,0.00021005266,0.00004307784,0.000043433924,0.9963236,0.0008992233,0.0016108592],"genre_scores_gemma":[0.0139716,0.0003384098,0.004619122,0.0006814394,0.000084554864,0.00061807083,0.96789485,0.0014482383,0.010343767],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996294,0.000058601974,0.00004355452,0.00009596431,0.00010815374,0.00006437242],"domain_scores_gemma":[0.99500185,0.0036434717,0.00029910618,0.00023306279,0.00066156365,0.00016098756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009022085,0.001296331,0.001289144,0.001087318,0.0006948751,0.0016252348,0.0018353392,0.00163136,0.8388913],"category_scores_gemma":[0.011190919,0.00053439254,0.0013174152,0.0014762501,0.00023171866,0.001483074,0.00086481136,0.00087892386,0.19525988],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042351653,0.0001153933,0.0028091776,0.0040611275,0.0000907633,0.0001790544,0.00004551078,0.0014764918,0.0003168183,0.0011560958,0.9812413,0.008084701],"study_design_scores_gemma":[0.004670531,0.00027734728,0.011593006,0.0033013246,0.0003465134,0.0006470719,0.00023145671,0.0068810172,0.0019673875,0.012894503,0.95704365,0.00014629847],"about_ca_topic_score_codex":0.0067867367,"about_ca_topic_score_gemma":0.013149241,"teacher_disagreement_score":0.8388913,"about_ca_system_score_codex":0.0009755489,"about_ca_system_score_gemma":0.0017463239,"threshold_uncertainty_score":0.22980195},"labels":[],"label_agreement":null},{"id":"W6921559714","doi":"10.6084/m9.figshare.28637103","title":"Additional file 17 of Micro-CT imaging of live insects using carbon dioxide gas-induced hypoxia as anesthetic with minimal impact on certain subsequent life history traits","year":2025,"lang":"en","type":"other","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; Western University","funders":"","keywords":"Anesthetic; Life history; Hypoxia (environmental); Carbon dioxide; Life saving; Voxel","score_opus":0.0869362611013834,"score_gpt":0.35324300689001814,"score_spread":0.2663067457886347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921559714","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022958839,0.000029055522,0.0009116997,0.000091123766,0.000044235774,0.000078093995,0.9947377,0.0021712605,0.0017073492],"genre_scores_gemma":[0.00526697,0.00014504162,0.007961288,0.00033752373,0.00008308857,0.0011512807,0.9722233,0.0036881268,0.009143458],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959284,0.00003862917,0.000053230928,0.000088984496,0.0001575097,0.00006872872],"domain_scores_gemma":[0.99460804,0.0037904903,0.00030543134,0.00039143185,0.000671463,0.0002331944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001195861,0.0017177067,0.0013913222,0.0018432357,0.00087340135,0.0016444777,0.0021685378,0.0015740104,0.8871146],"category_scores_gemma":[0.008563382,0.0008608629,0.0008702696,0.0018445757,0.0003443847,0.0018809332,0.0013653908,0.0010093191,0.29729745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031860307,0.0001296032,0.0011559603,0.0023811313,0.00004184415,0.00017672863,0.000056494748,0.00056001724,0.0009168613,0.0007218226,0.98103964,0.012501307],"study_design_scores_gemma":[0.0024139981,0.00022192742,0.017845597,0.0017381067,0.00011870755,0.00097120646,0.00020710978,0.0026658187,0.0045187594,0.007983603,0.9611398,0.00017535473],"about_ca_topic_score_codex":0.0043452443,"about_ca_topic_score_gemma":0.011489851,"teacher_disagreement_score":0.8871146,"about_ca_system_score_codex":0.00079369015,"about_ca_system_score_gemma":0.0011464129,"threshold_uncertainty_score":0.16101736},"labels":[],"label_agreement":null},{"id":"W6926951016","doi":"10.25384/sage.21637974","title":"sj-pdf-1-cpa-10.1177_07067437221140383 - Supplemental material for Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders","year":2022,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Lived experience; Qualitative research; Perception; Pharmacogenomics; Qualitative analysis; Qualitative property","score_opus":0.3409892197344091,"score_gpt":0.5092634791460722,"score_spread":0.16827425941166307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6926951016","genre_codex":"other","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016670195,0.0004867153,0.004031652,0.014685963,0.0020356595,0.0017869935,0.0841743,0.0038344963,0.872294],"genre_scores_gemma":[0.05003471,0.0009126993,0.007850226,0.006217024,0.00030498198,0.0034139722,0.021976553,0.0034646501,0.9058252],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99912983,0.0003299602,0.000034735684,0.000052003994,0.00032565265,0.00012776698],"domain_scores_gemma":[0.9857572,0.009389964,0.00022959153,0.0004032727,0.0021125556,0.0021074845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024949494,0.00025198556,0.0002599764,0.00084370206,0.0024456077,0.0022959874,0.0011110563,0.0012306267,0.8266466],"category_scores_gemma":[0.009514852,0.0002682165,0.00018480765,0.0019678543,0.00077832886,0.0024165348,0.002312218,0.001514028,0.42200705],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032231615,0.0001287661,0.0003313546,0.00013744374,6.250324e-7,0.00008762431,0.0025236825,0.000020294056,0.0002736995,0.0007736532,0.97231156,0.023379015],"study_design_scores_gemma":[0.00003810622,0.00007098888,0.0028933506,0.00025243606,0.0000014794562,0.0001377689,0.009826788,0.00007662081,0.0002419996,0.0007602433,0.98567814,0.000022085867],"about_ca_topic_score_codex":0.014250102,"about_ca_topic_score_gemma":0.032827273,"teacher_disagreement_score":0.8266466,"about_ca_system_score_codex":0.0020166258,"about_ca_system_score_gemma":0.0032461472,"threshold_uncertainty_score":0.24726754},"labels":[],"label_agreement":null},{"id":"W6929994867","doi":"10.5281/zenodo.11677387","title":"là où je me terre pdf gratuit","year":2024,"lang":"fr","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clan; Girl; Family life","score_opus":0.08867230062619322,"score_gpt":0.3661057492253912,"score_spread":0.27743344859919794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929994867","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046817985,0.0008638288,0.0006392453,0.00126498,0.0033038396,0.000121317324,0.0044573112,0.004239765,0.9846415],"genre_scores_gemma":[0.0010182981,0.00039316964,0.00026983782,0.00034878604,0.0003066096,0.000025809208,0.0012351031,0.0009969,0.99540544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958986,0.000021468588,0.0000144895275,0.000053199103,0.00025904618,0.0000618892],"domain_scores_gemma":[0.9984371,0.0001519742,0.00004940213,0.00016671693,0.0008373422,0.00035745546],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038990242,0.0011934753,0.0008892023,0.0017825357,0.0016073793,0.006236266,0.0014563743,0.0019492399,0.92956394],"category_scores_gemma":[0.002813192,0.0005660669,0.0008022047,0.0015191329,0.0005571948,0.0038681268,0.002263326,0.0019918487,0.88987947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032833574,0.000017529603,0.00003742267,0.0001035539,0.0000016059923,0.00006903198,0.000029704675,0.000029438901,0.00046375682,0.0009298779,0.9661045,0.03218069],"study_design_scores_gemma":[0.000008716635,0.000015705602,0.00021558795,0.00004509665,0.0000013514403,0.00008695783,0.000042318872,0.000021447451,0.0002176021,0.00023819003,0.99910104,0.000006011482],"about_ca_topic_score_codex":0.0037066683,"about_ca_topic_score_gemma":0.0072154524,"teacher_disagreement_score":0.07043606,"about_ca_system_score_codex":0.0010207639,"about_ca_system_score_gemma":0.000995111,"threshold_uncertainty_score":0.10046852},"labels":[],"label_agreement":null},{"id":"W6930089775","doi":"10.5281/zenodo.10630689","title":"INSTAR's Kick-off meeting insights and aspirations: Discover how INSTAR aims to shape international standards for advanced technologies.","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Commission","keywords":"Instar; Event (particle physics); Focus (optics); Key (lock); Information technology","score_opus":0.08846094087110204,"score_gpt":0.38221848164146854,"score_spread":0.29375754077036653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930089775","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018598584,0.025396757,0.015767546,0.45385873,0.018956544,0.00019406532,0.003514332,0.0025722047,0.4611413],"genre_scores_gemma":[0.34932086,0.011795091,0.030326618,0.09022692,0.003921057,0.00036568823,0.0059432844,0.0033539364,0.50474656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898491,0.0023752376,0.00019752217,0.0005896293,0.004474382,0.002514051],"domain_scores_gemma":[0.99002296,0.001699201,0.00066199113,0.0005279938,0.0022794358,0.0048083933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016911259,0.0009913386,0.00040390796,0.001425087,0.0037312256,0.017187208,0.0015673917,0.007315545,0.027412895],"category_scores_gemma":[0.0147173535,0.00048020616,0.00076027313,0.0013459411,0.0027831318,0.008904105,0.0076717273,0.00843861,0.016241774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026528368,0.00013856492,0.0011891434,0.00013862016,0.000020282057,0.0002796104,0.0009208064,0.00030786358,0.001863632,0.12751888,0.81738585,0.04997145],"study_design_scores_gemma":[0.000017564771,0.000101557926,0.0014018997,0.00011030413,0.0000075139824,0.000124357,0.00081529643,0.00022647361,0.001332546,0.012680936,0.98314846,0.00003308818],"about_ca_topic_score_codex":0.008830085,"about_ca_topic_score_gemma":0.016465109,"teacher_disagreement_score":0.027412895,"about_ca_system_score_codex":0.006111646,"about_ca_system_score_gemma":0.014471908,"threshold_uncertainty_score":0.09170526},"labels":[],"label_agreement":null},{"id":"W6930320364","doi":"10.5281/zenodo.13243946","title":"Anaspis (Anaspis) flavipennis Haldeman 1848","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"West virginia; Alien; Selection (genetic algorithm); Key (lock); Identification (biology)","score_opus":0.13645602111645913,"score_gpt":0.4053636163069848,"score_spread":0.26890759519052565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930320364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4852994,0.0427359,0.008613387,0.0016373348,0.0009469743,0.0006799427,0.015876113,0.0013189696,0.44289196],"genre_scores_gemma":[0.9221185,0.01134219,0.0061749863,0.0009187366,0.00022299554,0.00015295215,0.0065081646,0.000033847704,0.052527547],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99988186,0.000007727234,0.000007363583,0.00003021226,0.00005872555,0.000014054628],"domain_scores_gemma":[0.99985194,0.000020050275,0.000031628784,0.0000062581266,0.000073194955,0.000016929847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013030377,0.0005347841,0.00022329456,0.0009031894,0.0010600424,0.0003306778,0.00043519394,0.0002507807,0.003772382],"category_scores_gemma":[0.00017606828,0.00011788075,0.00011088745,0.0006111617,0.00023119169,0.0004975285,0.00034734845,0.00036602802,0.002121848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025768977,0.00015872158,0.07021,0.00058687996,0.00010629553,0.0015251149,0.00085943384,0.00086232286,0.043203674,0.002938592,0.057552077,0.8217393],"study_design_scores_gemma":[0.00010008189,0.00026824267,0.45162752,0.00032916103,0.00010120418,0.0030699465,0.001443912,0.00081713445,0.0054322407,0.002455524,0.53432226,0.00003272847],"about_ca_topic_score_codex":0.045222946,"about_ca_topic_score_gemma":0.091932416,"teacher_disagreement_score":0.045222946,"about_ca_system_score_codex":0.0008700519,"about_ca_system_score_gemma":0.00040549706,"threshold_uncertainty_score":0.08991945},"labels":[],"label_agreement":null},{"id":"W6930370647","doi":"10.5281/zenodo.12141046","title":"Tausch und tausch dimensionen pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"History of medicine; Metabolic disease; Squire","score_opus":0.09182865612725744,"score_gpt":0.38098016651307776,"score_spread":0.2891515103858203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930370647","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049299593,0.009185175,0.0008596878,0.005625701,0.0014802302,0.000043882603,0.0038093757,0.00027134488,0.97379464],"genre_scores_gemma":[0.09970606,0.016550487,0.0022274784,0.0025025436,0.0011173121,0.00016604654,0.0050262627,0.0005265738,0.8721772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917346,0.00014854793,0.00004295137,0.00012992213,0.0003425249,0.00016244281],"domain_scores_gemma":[0.99923134,0.00020757991,0.00006030524,0.000095719566,0.00022171343,0.00018343897],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00088685,0.0007556695,0.0004098895,0.0035078097,0.002377324,0.0059131514,0.00045882916,0.0013024483,0.34396806],"category_scores_gemma":[0.002647598,0.00042653183,0.0003525969,0.004777294,0.0022903571,0.0057693343,0.0032283864,0.0021526497,0.08740543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083468636,0.000036944435,0.0010591251,0.00021554483,0.000011350894,0.000077689656,0.0016123784,0.00009959334,0.00025418325,0.281534,0.5792875,0.13572818],"study_design_scores_gemma":[0.0000096140275,0.000009882838,0.0023301179,0.00016733416,0.000004140648,0.00012224019,0.00087165524,0.000041866788,0.00016038316,0.026165854,0.9701052,0.000011707743],"about_ca_topic_score_codex":0.0066847405,"about_ca_topic_score_gemma":0.0090268245,"teacher_disagreement_score":0.65603197,"about_ca_system_score_codex":0.0037348967,"about_ca_system_score_gemma":0.00205868,"threshold_uncertainty_score":0.93574995},"labels":[],"label_agreement":null},{"id":"W6930750427","doi":"10.5281/zenodo.14981155","title":"Fig. 129 in A revision of the genus Sclerocoelus Marshall (Diptera: Sphaeroceridae)","year":2025,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Paratype; Aedeagus; Holotype; Genus; Male genitalia; Subgenus","score_opus":0.07647498326034988,"score_gpt":0.35450834241347623,"score_spread":0.2780333591531263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930750427","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03110396,0.029644527,0.029998224,0.004254247,0.015817635,0.0010157563,0.024499808,0.006172097,0.8574938],"genre_scores_gemma":[0.17093377,0.02402137,0.06294411,0.0024737413,0.0044742175,0.00091189763,0.04009752,0.0017660058,0.6923774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998771,0.000026733998,0.0000138974065,0.000030128616,0.000036152163,0.000016012851],"domain_scores_gemma":[0.9998698,0.000024627068,0.00002109625,0.000019906838,0.000036805955,0.000027734572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002903958,0.0007552814,0.00024253236,0.002165623,0.0006767472,0.00054960354,0.00065357477,0.00051582465,0.059065267],"category_scores_gemma":[0.0005605617,0.00018690298,0.00024690002,0.001142978,0.0008182489,0.0008621977,0.0006821433,0.0007493322,0.020239227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014960312,0.000042530894,0.002723408,0.0007410933,0.00002776468,0.00044875397,0.00046353572,0.00022429193,0.0056946045,0.0138659105,0.39552277,0.5800957],"study_design_scores_gemma":[0.000008572492,0.000023098784,0.00656132,0.00011412672,0.000014188022,0.00046617127,0.00007794011,0.00009006392,0.00035155582,0.0007080797,0.9915768,0.0000080161635],"about_ca_topic_score_codex":0.0050592567,"about_ca_topic_score_gemma":0.009383021,"teacher_disagreement_score":0.059065267,"about_ca_system_score_codex":0.00042064418,"about_ca_system_score_gemma":0.0004927236,"threshold_uncertainty_score":0.19759303},"labels":[],"label_agreement":null},{"id":"W6930896907","doi":"10.5281/zenodo.13335766","title":"♥╣[-_-]╠♥ +91-8094774404 ♥╣[-_-]╠♥ How To Win Back Your Ex Husband After Divorce","year":2024,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wife; Miracle; Caster; MAGIC (telescope); Happening","score_opus":0.12665139063124448,"score_gpt":0.3906243698042958,"score_spread":0.26397297917305135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930896907","genre_codex":"other","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012717455,0.00043275233,0.0004097119,0.0015193905,0.0013977964,0.00012933879,0.0014763639,0.0019356364,0.9914274],"genre_scores_gemma":[0.0018863445,0.00040840468,0.0002642218,0.00045197053,0.00013637704,0.000035645902,0.00058923144,0.00040634078,0.9958215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970645,0.000039658462,0.000012499528,0.000049718383,0.00010324964,0.00008839321],"domain_scores_gemma":[0.9985378,0.00011865981,0.000055516277,0.0000809151,0.00035701998,0.0008502192],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037914971,0.0007447288,0.0005480625,0.00072926277,0.0022050373,0.0031895163,0.0006257864,0.0011108245,0.9370449],"category_scores_gemma":[0.0014979751,0.00036360518,0.0004491146,0.0007515588,0.00029865067,0.0020320727,0.0023005798,0.00139249,0.8966425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029189285,0.000052566425,0.0002039676,0.000065675515,0.0000012284706,0.00004263748,0.000054174885,0.0000140946495,0.00020927245,0.00040029897,0.93604314,0.06288367],"study_design_scores_gemma":[0.0000098814635,0.000033418648,0.00071200985,0.00007563448,0.00000204121,0.000089208566,0.00021484312,0.000024702565,0.000167607,0.0001358009,0.99852777,0.0000069727835],"about_ca_topic_score_codex":0.0018533488,"about_ca_topic_score_gemma":0.00593434,"teacher_disagreement_score":0.06295508,"about_ca_system_score_codex":0.0005047671,"about_ca_system_score_gemma":0.0007278121,"threshold_uncertainty_score":0.089797795},"labels":[],"label_agreement":null},{"id":"W6930957896","doi":"10.5281/zenodo.16750179","title":"Express Entry and Economic Migration Pathways to Canada: Opportunities and Barriers for South Asian Women","year":2020,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Family reunification; Context (archaeology); Human migration; South asia; Multiculturalism; Immigration policy; Economic restructuring","score_opus":0.12578631030112475,"score_gpt":0.3111413746716094,"score_spread":0.18535506437048466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930957896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212298,0.0018788057,0.00019755648,0.0398176,0.000102009144,0.00007485002,0.0002498706,0.000010782151,0.036438778],"genre_scores_gemma":[0.9813998,0.0027886706,0.0003753918,0.0030711018,0.000021008054,0.00004102287,0.00011255418,0.000012451717,0.0121779395],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99798834,0.00035450788,0.000048337486,0.00010196457,0.0003298442,0.0011769806],"domain_scores_gemma":[0.99670994,0.00065211754,0.00032836935,0.000059890106,0.0006352616,0.0016143218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018442544,0.00022538303,0.00025088928,0.00100523,0.019523716,0.004330725,0.0013429231,0.0008958662,0.007149941],"category_scores_gemma":[0.0038161613,0.00023242741,0.00025153597,0.0025882046,0.00466406,0.0012106899,0.004624397,0.0019869967,0.00028824346],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021931072,0.00015047197,0.20735978,0.0004268028,0.000024742014,0.004684071,0.6121846,0.00025786506,0.0014984796,0.030095384,0.02111396,0.12198457],"study_design_scores_gemma":[0.0000079963875,0.00003737265,0.079754,0.00030768607,0.000012802061,0.00043792065,0.87161857,0.00012736466,0.00018905384,0.0011178441,0.04634448,0.000044864373],"about_ca_topic_score_codex":0.97221607,"about_ca_topic_score_gemma":0.9911124,"teacher_disagreement_score":0.034778226,"about_ca_system_score_codex":0.034778226,"about_ca_system_score_gemma":0.11744061,"threshold_uncertainty_score":0.25233483},"labels":[],"label_agreement":null},{"id":"W6930972461","doi":"10.5281/zenodo.4298156","title":"Fig. 9 in The 'red-tailed' Lasioglossum (Dialictus) (Hymenoptera: Halictidae) of the western Nearctic","year":2020,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Nearctic ecozone; Scale (ratio); Dorsum; Taxonomy (biology)","score_opus":0.09487586672941159,"score_gpt":0.3551369093175219,"score_spread":0.26026104258811034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930972461","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40137622,0.0062738643,0.0062302137,0.0015744712,0.0009221944,0.00024207667,0.036507897,0.0020069587,0.54486614],"genre_scores_gemma":[0.7679532,0.001884724,0.0071789823,0.0004446458,0.00010150416,0.0001145048,0.021424351,0.00020589784,0.20069218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999249,0.000007799443,0.0000038669664,0.00002930561,0.000016343103,0.000017879496],"domain_scores_gemma":[0.9999547,0.000004327689,0.000014364746,0.000003949774,0.000009293862,0.000013317756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000090760244,0.00026360876,0.00011768734,0.0011904071,0.0006540318,0.0004597343,0.00028553998,0.0002565677,0.03734982],"category_scores_gemma":[0.00011889415,0.00007784712,0.00016666867,0.00081582373,0.0004196499,0.00028864937,0.00045080864,0.00034862023,0.010788174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007340638,0.00012197402,0.113689214,0.00081340864,0.00007914008,0.002573746,0.0029012596,0.00039749546,0.056534346,0.005033281,0.15945518,0.65766686],"study_design_scores_gemma":[0.000025953332,0.00010461228,0.36551785,0.00011535611,0.00006770605,0.0022622051,0.0018349069,0.00027021897,0.0026689174,0.0006401538,0.62647146,0.000020695095],"about_ca_topic_score_codex":0.017184028,"about_ca_topic_score_gemma":0.057735387,"teacher_disagreement_score":0.9626502,"about_ca_system_score_codex":0.00039762736,"about_ca_system_score_gemma":0.00022134546,"threshold_uncertainty_score":0.12494761},"labels":[],"label_agreement":null},{"id":"W6931566317","doi":"10.5281/zenodo.5068635","title":"Working# Download Justin Bieber Purpose mp3","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleofection; Dysgeusia; Gestational period; Pretext; Hyporeflexia; TSG101","score_opus":0.15908524404698252,"score_gpt":0.38405640113003475,"score_spread":0.22497115708305224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931566317","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038880954,0.00033269823,0.0012842718,0.00029216526,0.0005325832,0.00018335812,0.01647697,0.019361954,0.9611473],"genre_scores_gemma":[0.0016406168,0.00029687016,0.00074574875,0.0002365174,0.00017886415,0.00012910603,0.011676453,0.012255136,0.9728407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961334,0.000023945593,0.000016694685,0.00008216808,0.00018123836,0.00008265142],"domain_scores_gemma":[0.9984837,0.00013374751,0.000043118405,0.0002871348,0.00061826763,0.0004340703],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040822793,0.0014862516,0.0010275445,0.0021456399,0.0018101515,0.005337797,0.0015802732,0.0012253299,0.9468953],"category_scores_gemma":[0.0027605323,0.0008182045,0.0008273516,0.0021421472,0.00037401414,0.0043357774,0.004092953,0.0013214665,0.9510626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029084747,0.000013589432,0.00005814201,0.00009022627,0.0000016892129,0.00002350566,0.00003972609,0.000013426883,0.00025819032,0.0003517978,0.96921533,0.029905286],"study_design_scores_gemma":[0.000010907481,0.000012222162,0.00046179435,0.000058441896,0.0000020894124,0.00004252821,0.000048815178,0.000031700787,0.00024165415,0.00021671079,0.99886394,0.000009242292],"about_ca_topic_score_codex":0.005181482,"about_ca_topic_score_gemma":0.009523196,"teacher_disagreement_score":0.0531047,"about_ca_system_score_codex":0.00077664555,"about_ca_system_score_gemma":0.0007182231,"threshold_uncertainty_score":0.07574743},"labels":[],"label_agreement":null},{"id":"W6931892810","doi":"10.5683/sp3/frjdhe","title":"Machine Learning Based Rapid Self-Assessment and Understanding of COVID-19 Disease Progression to Support Public Policy Decisions","year":2022,"lang":"en","type":"dataset","venue":"Borealis","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University of Edmonton","funders":"Concordia University of Edmonton","keywords":"Action (physics); Big data; Public policy; Measure (data warehouse); Public health policy; Public health; Mental health","score_opus":0.1908353607798446,"score_gpt":0.4916216577200588,"score_spread":0.3007862969402142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931892810","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022285376,0.0012380809,0.004874385,0.0031569437,0.00039066118,0.00014374281,0.9580507,0.0026699265,0.007190109],"genre_scores_gemma":[0.04524561,0.00033747818,0.007543486,0.0005332991,0.000060743325,0.00014269298,0.9430893,0.0000691914,0.0029781326],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99919206,0.0002498474,0.00007116007,0.00023030415,0.00015096358,0.000105797495],"domain_scores_gemma":[0.99845755,0.0005165428,0.00018832996,0.00038224625,0.00031025909,0.00014509082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018102309,0.001178759,0.0006424635,0.0018449208,0.00043599115,0.0010266345,0.0015157126,0.0019344111,0.0058393767],"category_scores_gemma":[0.0058583193,0.00025618883,0.0010864602,0.0013663664,0.00032308948,0.0010101397,0.0013690105,0.0016340782,0.0071954057],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005589973,0.0004750183,0.07862575,0.0008896029,0.00031005553,0.0003244336,0.000119440985,0.02293044,0.0011107221,0.0035615994,0.84033245,0.05076147],"study_design_scores_gemma":[0.00047903697,0.0003979132,0.10581459,0.0008529949,0.00026503016,0.00058079127,0.0007076178,0.15410818,0.0044499333,0.022500353,0.70965105,0.0001923742],"about_ca_topic_score_codex":0.03748033,"about_ca_topic_score_gemma":0.101603895,"teacher_disagreement_score":0.03748033,"about_ca_system_score_codex":0.0018419728,"about_ca_system_score_gemma":0.0013680278,"threshold_uncertainty_score":0.07452434},"labels":[],"label_agreement":null},{"id":"W6939349684","doi":"10.60692/ph6mz-d1132","title":"Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Allele frequency; CYP2A6; Genetic variation; Genome; Human genetic variation","score_opus":0.12961946722350667,"score_gpt":0.3467793525055919,"score_spread":0.2171598852820852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939349684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914677,0.0013514392,0.0017906042,0.00012401656,0.000008860778,0.000017132681,0.00451837,0.000029745186,0.00069215655],"genre_scores_gemma":[0.9904856,0.00101726,0.0026425228,0.00007720649,0.000017940461,0.0000358371,0.005408076,0.000034170313,0.0002813247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996123,0.00012387405,0.000039945775,0.0001275615,0.000055123015,0.00004127771],"domain_scores_gemma":[0.99963963,0.00012433017,0.00012532226,0.000043850046,0.00003883943,0.00002799015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060106575,0.00024206338,0.00036413624,0.00088051276,0.00037035797,0.00046844708,0.00018018497,0.00024652036,0.0025222804],"category_scores_gemma":[0.0017803328,0.00013394187,0.00046228396,0.0018626738,0.00018856017,0.00022538626,0.000379475,0.0003192024,0.00030757062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092554506,0.000049540926,0.92192584,0.00026012777,0.0007047977,0.0008445736,0.0013512553,0.0016070482,0.014028994,0.00075996085,0.002629506,0.054912798],"study_design_scores_gemma":[0.000059690574,0.00008042025,0.98073786,0.000089253415,0.00025672241,0.0016539046,0.0005900852,0.0028554818,0.0018369596,0.0007937754,0.011026815,0.000019059831],"about_ca_topic_score_codex":0.002590659,"about_ca_topic_score_gemma":0.0033410313,"teacher_disagreement_score":0.002590659,"about_ca_system_score_codex":0.0001241999,"about_ca_system_score_gemma":0.00016059834,"threshold_uncertainty_score":0.008437872},"labels":[],"label_agreement":null},{"id":"W6939497478","doi":"10.6084/m9.figshare.18864886","title":"Additional file 7 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Amino acid; Detoxification (alternative medicine); Transplantation; Cell; Hematopoietic stem cell transplantation; Stem cell; Calcineurin","score_opus":0.057514645755624115,"score_gpt":0.33331185138226527,"score_spread":0.2757972056266412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939497478","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062055775,0.000068095585,0.00044955607,0.00021741081,0.000029308698,0.000048086593,0.9961125,0.0006410024,0.001813526],"genre_scores_gemma":[0.030062897,0.0003536825,0.0057041245,0.0009345414,0.00009778258,0.0007965833,0.9452664,0.0013249692,0.015459056],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99969625,0.000060938397,0.000031904885,0.000073177,0.00008482336,0.000052877185],"domain_scores_gemma":[0.99501836,0.003907803,0.00024488522,0.00016685236,0.00056026806,0.000101760066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086004834,0.0010507636,0.0009986684,0.0008203326,0.00044379427,0.0012529447,0.0013298874,0.0013388162,0.8148005],"category_scores_gemma":[0.009853638,0.00041023426,0.0011773697,0.0011237721,0.00016793769,0.0011364991,0.0006197651,0.0006532562,0.14429772],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060499995,0.00017143364,0.005944354,0.0059102853,0.00015872599,0.00021548392,0.00005572449,0.0044035693,0.00035539543,0.0018059006,0.9668578,0.0135163255],"study_design_scores_gemma":[0.0065296334,0.00041230922,0.017209623,0.0033350138,0.00048467415,0.0006252969,0.00028140278,0.016184287,0.0022734609,0.017075961,0.93543357,0.00015475242],"about_ca_topic_score_codex":0.007583712,"about_ca_topic_score_gemma":0.014544078,"teacher_disagreement_score":0.8148005,"about_ca_system_score_codex":0.0008434179,"about_ca_system_score_gemma":0.0012296366,"threshold_uncertainty_score":0.2641645},"labels":[],"label_agreement":null},{"id":"W6939556771","doi":"10.6084/m9.figshare.18864880","title":"Additional file 5 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Stem cell","score_opus":0.05746518789926553,"score_gpt":0.3332821852662203,"score_spread":0.27581699736695475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939556771","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006159347,0.00011742921,0.00052391953,0.00024988453,0.00004041845,0.000053287065,0.9955869,0.0008675698,0.0019446716],"genre_scores_gemma":[0.023469357,0.00048599546,0.005144046,0.0008874669,0.00009640581,0.00086016033,0.9562038,0.0014019626,0.011450832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969375,0.000061846076,0.000039604594,0.00006822365,0.00008153878,0.000055074957],"domain_scores_gemma":[0.9949693,0.0037735591,0.00031344494,0.00020444665,0.00060451525,0.00013471267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087160565,0.0012920431,0.0013710499,0.0009621328,0.000556433,0.0015631856,0.0015385528,0.0015102101,0.8101727],"category_scores_gemma":[0.009772846,0.0004740895,0.0014283907,0.0014678003,0.0002091675,0.0012010976,0.00070366357,0.0008484457,0.13650516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083079125,0.00018121013,0.0037144176,0.006751371,0.00018696376,0.00022917573,0.000052233776,0.0033355656,0.0005068534,0.002109748,0.9697733,0.012328347],"study_design_scores_gemma":[0.008725127,0.0005440268,0.014061593,0.0034992443,0.00064189744,0.00063212,0.00026792614,0.011740617,0.003098388,0.020340016,0.93626475,0.0001842585],"about_ca_topic_score_codex":0.0062096757,"about_ca_topic_score_gemma":0.011495339,"teacher_disagreement_score":0.8101727,"about_ca_system_score_codex":0.000878337,"about_ca_system_score_gemma":0.0014827274,"threshold_uncertainty_score":0.27076554},"labels":[],"label_agreement":null},{"id":"W6939788826","doi":"10.6084/m9.figshare.18864895.v1","title":"Additional file 9 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Haematopoiesis; Cytotoxicity; Cell","score_opus":0.05748542301556154,"score_gpt":0.33329291555187474,"score_spread":0.2758074925363132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939788826","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006810285,0.00007192251,0.00045021373,0.00020995029,0.00003162791,0.000042007636,0.99663216,0.00054861564,0.0013325381],"genre_scores_gemma":[0.028727159,0.0003000811,0.0061862385,0.00093197677,0.000094027266,0.00071292307,0.94989324,0.0010791713,0.012075194],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99962425,0.00007362959,0.000040947718,0.00010259776,0.00009464629,0.00006385165],"domain_scores_gemma":[0.9940393,0.0047122343,0.00031692008,0.00021995517,0.0005746748,0.00013693963],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010599873,0.0011070474,0.0010896974,0.00094822235,0.00054545724,0.0013945178,0.0014556824,0.0014768111,0.7636864],"category_scores_gemma":[0.011432009,0.00043259357,0.001372189,0.0012549601,0.00018986418,0.0011672188,0.0006702205,0.00065888424,0.12223893],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007756349,0.0002029632,0.009571243,0.0068122107,0.00023533212,0.000292535,0.000073334755,0.0041983146,0.0005181925,0.001927177,0.9599766,0.0154164145],"study_design_scores_gemma":[0.007823514,0.0004809827,0.028032675,0.004599726,0.0007032381,0.0008012969,0.00033895316,0.014858112,0.002595093,0.018492674,0.9210721,0.00020152278],"about_ca_topic_score_codex":0.0072805565,"about_ca_topic_score_gemma":0.01389521,"teacher_disagreement_score":0.7636864,"about_ca_system_score_codex":0.0008320481,"about_ca_system_score_gemma":0.0014477397,"threshold_uncertainty_score":0.3370726},"labels":[],"label_agreement":null},{"id":"W6939929994","doi":"10.6084/m9.figshare.18864862.v1","title":"Additional file 10 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Workflow; Docking (animal); Hematopoietic stem cell transplantation; Transplantation","score_opus":0.058926112205234624,"score_gpt":0.3351414189359377,"score_spread":0.27621530673070305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939929994","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059905177,0.00007188504,0.0006800246,0.00022209279,0.0000390732,0.000059976006,0.99529546,0.0014248057,0.0016076822],"genre_scores_gemma":[0.020718621,0.0003356333,0.0076097515,0.00089510065,0.00009500853,0.000970409,0.9549891,0.0025436347,0.011842691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996829,0.00005664136,0.000040193783,0.00007630249,0.0000930899,0.000050975985],"domain_scores_gemma":[0.9950918,0.003694602,0.00027574215,0.00019373538,0.0006089542,0.00013513898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009018827,0.0012823585,0.001223587,0.0010205616,0.0005486738,0.0014666658,0.0015517384,0.001483748,0.788804],"category_scores_gemma":[0.009448224,0.0005122906,0.0013675707,0.001303037,0.00022052118,0.0011840493,0.00079049316,0.0008557433,0.14486349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113565,0.00016359685,0.004036464,0.0040977728,0.00013411437,0.00022586252,0.000048998616,0.003511947,0.00047571296,0.0016231315,0.9734036,0.011567547],"study_design_scores_gemma":[0.0078094113,0.00042994585,0.017235603,0.002664598,0.00044742803,0.0006268985,0.0002564862,0.017229471,0.0039641554,0.020850781,0.92826754,0.0002177173],"about_ca_topic_score_codex":0.006666269,"about_ca_topic_score_gemma":0.012301116,"teacher_disagreement_score":0.788804,"about_ca_system_score_codex":0.00089763914,"about_ca_system_score_gemma":0.0014595641,"threshold_uncertainty_score":0.30124545},"labels":[],"label_agreement":null},{"id":"W6945142356","doi":"10.25384/sage.11865390.v1","title":"Supplemental Material, Table_S1_FINAL - Pharmacogenetic Testing Options Relevant to Psychiatry in Canada","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; MEDLINE; Alternative medicine; Genetic testing; Mental illness","score_opus":0.17160782194296742,"score_gpt":0.3928213312580935,"score_spread":0.22121350931512607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945142356","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042969247,0.0007554636,0.0012762634,0.004067523,0.001402387,0.0006222488,0.8865144,0.00204533,0.10288668],"genre_scores_gemma":[0.014057596,0.0037087144,0.0104082525,0.012118238,0.0014771997,0.0013828742,0.6425391,0.003659766,0.31064832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987878,0.00013479307,0.00012716878,0.0001562272,0.00055812823,0.00023586588],"domain_scores_gemma":[0.9821377,0.0063269488,0.00072114624,0.00066657574,0.008553147,0.0015945543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016766606,0.0010043312,0.0010279596,0.0031963775,0.0024248322,0.0030233962,0.0019839138,0.0021549505,0.86126673],"category_scores_gemma":[0.02739013,0.0008242111,0.0011539349,0.005018042,0.0005394606,0.0015288965,0.0012067597,0.0015412318,0.34410313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018388124,0.000014089391,0.00021734231,0.00014318427,0.000003472948,0.000018403933,0.000008960101,0.000039878785,0.000017777345,0.00029803425,0.9937382,0.0054821833],"study_design_scores_gemma":[0.0002778099,0.000029687108,0.008849841,0.0007895616,0.00003233495,0.00027907893,0.0001343935,0.0002772998,0.0002203445,0.0032705388,0.9857848,0.000054279593],"about_ca_topic_score_codex":0.38202047,"about_ca_topic_score_gemma":0.5141797,"teacher_disagreement_score":0.86126673,"about_ca_system_score_codex":0.006699137,"about_ca_system_score_gemma":0.017697189,"threshold_uncertainty_score":0.7595937},"labels":[],"label_agreement":null},{"id":"W6949599471","doi":"10.5281/zenodo.14583873","title":"Pharmacogenetics in Oncology: Transforming Cancer Treatment - A review","year":2025,"lang":"en","type":"preprint","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Drug response; Drug; Personalized medicine; Precision medicine; Pharmacogenomics; Genetic testing; Cancer treatment","score_opus":0.22038495646921685,"score_gpt":0.4738355759385335,"score_spread":0.25345061946931663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949599471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010417825,0.99557316,0.0002871734,0.0021564355,0.0006752727,0.000007709323,0.000023313156,0.000009832842,0.0011629041],"genre_scores_gemma":[0.0006418147,0.9977731,0.00024655936,0.0006074332,0.00051393535,0.0000057587918,0.000023738816,0.0000019077502,0.00018579692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994167,0.00016458085,0.00009339426,0.00008516386,0.00019988128,0.0000402459],"domain_scores_gemma":[0.99784505,0.0013813162,0.00017938166,0.000042576212,0.00045303497,0.00009858434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013558833,0.0006894837,0.0011205198,0.0026160707,0.0003745038,0.0018253198,0.0007281288,0.0015886356,0.003970116],"category_scores_gemma":[0.0021758873,0.00027773264,0.0008510014,0.0029441507,0.0007194822,0.0020277451,0.000911282,0.002465384,0.0015781942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054305867,0.00006616733,0.0004745497,0.024598956,0.00011802218,0.00022933679,0.00011102977,0.00047478508,0.0004838157,0.008801722,0.046905175,0.91768205],"study_design_scores_gemma":[0.000013034328,0.00009921305,0.0013201217,0.021460116,0.00018561904,0.0015791323,0.00013245254,0.00022910422,0.00019445231,0.005539368,0.9692211,0.00002625329],"about_ca_topic_score_codex":0.0016061348,"about_ca_topic_score_gemma":0.0023697566,"teacher_disagreement_score":0.003970116,"about_ca_system_score_codex":0.0010406803,"about_ca_system_score_gemma":0.0026273835,"threshold_uncertainty_score":0.013281345},"labels":[],"label_agreement":null},{"id":"W6955155473","doi":"10.58066/shah-cx78","title":"Rocky Mountain bighorn sheep 01","year":2021,"lang":"en","type":"other","venue":"UVic’s Research and Learning Repository (University of Victoria)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovis canadensis; Wildlife refuge; Limpet; Current (fluid); Myotis lucifugus","score_opus":0.0803954990209709,"score_gpt":0.3843862036270558,"score_spread":0.3039907046060849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6955155473","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1653341,0.0014851175,0.0011808049,0.0015769326,0.00045672848,0.00019940635,0.0073427637,0.0013039095,0.82112026],"genre_scores_gemma":[0.0959002,0.0006427039,0.002554819,0.0006995426,0.00006544903,0.000049664563,0.007698782,0.00017496305,0.8922138],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998851,0.00000857046,0.0000031691563,0.00003147787,0.000038445203,0.000033137825],"domain_scores_gemma":[0.9997819,0.000018511024,0.000007918822,0.000013266414,0.000052347084,0.00012613187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022436696,0.00025465147,0.0001920791,0.00052050536,0.00093943265,0.0007615177,0.00051384384,0.00082750607,0.12447755],"category_scores_gemma":[0.00019456068,0.0001577711,0.0001653698,0.00039005093,0.00024292899,0.0002132998,0.0005891353,0.00045732094,0.04050949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010498345,0.00048428646,0.05050459,0.00037553464,0.00005788789,0.0056037623,0.0016989058,0.00025252943,0.02860537,0.007638298,0.4189653,0.48476365],"study_design_scores_gemma":[0.00006151928,0.00021053871,0.08343968,0.00015256705,0.00001720529,0.0015311074,0.0010119582,0.00021647806,0.0015873257,0.0006297135,0.9111248,0.000017147106],"about_ca_topic_score_codex":0.06346806,"about_ca_topic_score_gemma":0.2284328,"teacher_disagreement_score":0.12447755,"about_ca_system_score_codex":0.0005812232,"about_ca_system_score_gemma":0.00087013684,"threshold_uncertainty_score":0.4164189},"labels":[],"label_agreement":null},{"id":"W6957995327","doi":"10.6084/m9.figshare.18864874","title":"Additional file 3 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Hematopoietic stem cell transplantation; Transplantation; Stem cell; Cell","score_opus":0.05745782231110878,"score_gpt":0.3331591838111815,"score_spread":0.2757013615000727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957995327","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045078032,0.000068082285,0.00031855117,0.00013801089,0.000027523294,0.000028243569,0.99729615,0.00066266395,0.001010068],"genre_scores_gemma":[0.012206255,0.00024913132,0.0031410756,0.0004922814,0.000055664044,0.0004183919,0.9774155,0.00096741616,0.005054209],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995951,0.00006379033,0.000046683796,0.00011000852,0.000115982126,0.00006850331],"domain_scores_gemma":[0.9950706,0.0036528497,0.0003148767,0.00020503452,0.0006057073,0.00015099638],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009007114,0.0015512737,0.0014500716,0.0011620297,0.0007523811,0.0017179014,0.0015850397,0.001746712,0.74029315],"category_scores_gemma":[0.010183001,0.00050491485,0.0014935397,0.001748429,0.00026413685,0.001376355,0.0008481673,0.0010360719,0.145259],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006101949,0.00013539923,0.005232948,0.00516122,0.00017791628,0.00022844228,0.0000730996,0.0022692138,0.0004922697,0.0014348746,0.9761486,0.008035852],"study_design_scores_gemma":[0.006660968,0.00038201542,0.019396828,0.0034747012,0.0007091751,0.0008499155,0.00029248322,0.010079549,0.003008414,0.016945254,0.9379977,0.00020306726],"about_ca_topic_score_codex":0.009025494,"about_ca_topic_score_gemma":0.017865162,"teacher_disagreement_score":0.74029315,"about_ca_system_score_codex":0.001038231,"about_ca_system_score_gemma":0.0019361242,"threshold_uncertainty_score":0.3704403},"labels":[],"label_agreement":null},{"id":"W6958121567","doi":"10.6084/m9.figshare.18864871.v1","title":"Additional file 2 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Ramachandran plot; Detoxification (alternative medicine); Haematopoiesis; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.05670521650674531,"score_gpt":0.3330324615019495,"score_spread":0.27632724499520417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958121567","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037055893,0.000053672753,0.00041031512,0.00019212962,0.000034676348,0.000040711733,0.9971529,0.0006293289,0.0011155697],"genre_scores_gemma":[0.014641827,0.00024018296,0.004901599,0.0008044573,0.000089599045,0.0007029863,0.96888185,0.0016030188,0.008134569],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994666,0.00009757888,0.00006737364,0.00015364171,0.00013936068,0.00007545498],"domain_scores_gemma":[0.9906723,0.0071971104,0.0004772934,0.00041938876,0.0010078244,0.00022595972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014305109,0.0012592258,0.0013183835,0.0012212156,0.000744705,0.001859595,0.001771856,0.0015640841,0.8272836],"category_scores_gemma":[0.017389186,0.0005338503,0.0013975984,0.0017344564,0.00025911772,0.0015723641,0.0007965113,0.0010545457,0.1734042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000565973,0.00012223891,0.0038113382,0.00457296,0.00013232665,0.00015843862,0.000053568452,0.00204301,0.00027035442,0.0015558031,0.97746664,0.009247295],"study_design_scores_gemma":[0.0073352875,0.0003837669,0.015727451,0.0041719745,0.0005797534,0.00072691066,0.0002620347,0.010058247,0.0023975358,0.020758266,0.93739194,0.00020680611],"about_ca_topic_score_codex":0.0059570465,"about_ca_topic_score_gemma":0.010702993,"teacher_disagreement_score":0.8272836,"about_ca_system_score_codex":0.0009923332,"about_ca_system_score_gemma":0.0020180908,"threshold_uncertainty_score":0.24635887},"labels":[],"label_agreement":null},{"id":"W6968371761","doi":"10.5281/zenodo.15269494","title":"Megaselia nivizona Brown & Hartop & Wong 2022, New Species","year":2022,"lang":"de","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Holotype; Table (database); White (mutation); Range (aeronautics); Taxonomy (biology)","score_opus":0.11186373525043031,"score_gpt":0.3457574219271254,"score_spread":0.23389368667669508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6968371761","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44378063,0.025140192,0.010298578,0.0014689013,0.00096850964,0.00040751148,0.004601276,0.000986899,0.5123475],"genre_scores_gemma":[0.92771155,0.006777825,0.0050792187,0.00068280887,0.00019567019,0.00020019789,0.0024536024,0.000073428884,0.056825716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99992216,0.0000072401785,0.000007877434,0.000027863385,0.000022768256,0.00001204903],"domain_scores_gemma":[0.999925,0.00001812405,0.000018390423,0.0000073627207,0.000015858932,0.000015234728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011872421,0.00049499236,0.00025413846,0.0011156976,0.0012065172,0.0003826611,0.00052366365,0.0004928384,0.010125182],"category_scores_gemma":[0.00025980247,0.00018518319,0.00012043205,0.0007168654,0.00051588466,0.0011908041,0.00075460516,0.0005852531,0.0035154615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067333033,0.00008045129,0.028728254,0.0007973809,0.00009167056,0.0054895566,0.0030948834,0.0012015034,0.03621343,0.008025841,0.035308495,0.8802952],"study_design_scores_gemma":[0.00011358829,0.00028818185,0.25951168,0.001227961,0.0002137303,0.014672177,0.0033336082,0.0013312811,0.0032202923,0.006067195,0.70993614,0.00008415597],"about_ca_topic_score_codex":0.0065507432,"about_ca_topic_score_gemma":0.02600646,"teacher_disagreement_score":0.010125182,"about_ca_system_score_codex":0.00040568167,"about_ca_system_score_gemma":0.00034771324,"threshold_uncertainty_score":0.033872128},"labels":[],"label_agreement":null},{"id":"W6969520278","doi":"10.5441/001/1.f01v7r80/2","title":"Canadian Ringed Plover geolocation tracking, Bylot Island, Canada (data from Leandri-Breton et al. 2019)-tracks","year":2019,"lang":"en","type":"dataset","venue":"Movebank","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flyway; Geolocation; Plover; Circumpolar star; Nearctic ecozone; Charadriiformes; Arctic; Charadrius; Glacier","score_opus":0.11811082296141487,"score_gpt":0.4131444478906195,"score_spread":0.2950336249292046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969520278","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13039401,0.0028370263,0.0057254084,0.00081580563,0.00039939248,0.0005758153,0.74839956,0.0009023826,0.10995058],"genre_scores_gemma":[0.31417716,0.0027909803,0.023043228,0.0007787584,0.000048040063,0.000741029,0.530415,0.00043519097,0.1275705],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993747,0.000035468613,0.000031382246,0.00013391921,0.00029271992,0.00013187919],"domain_scores_gemma":[0.9954847,0.0001201016,0.00023628252,0.00020978076,0.003585146,0.0003639597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008455894,0.00056798063,0.0003889309,0.0021577259,0.0023386134,0.0014232254,0.0011672209,0.00035766265,0.021734891],"category_scores_gemma":[0.0016893937,0.00035384484,0.00039477143,0.0037312752,0.00037569547,0.00053182465,0.0007146526,0.0005693283,0.005052912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067499804,0.00016416272,0.39184514,0.00079670176,0.0002688152,0.00022674534,0.0013313073,0.0012465453,0.0040264083,0.0022368806,0.42860776,0.16857462],"study_design_scores_gemma":[0.00010028731,0.00008208177,0.6640736,0.00034324857,0.00014942465,0.00011087039,0.0012364005,0.0017868814,0.002006632,0.00023357625,0.32977134,0.00010567468],"about_ca_topic_score_codex":0.99160904,"about_ca_topic_score_gemma":0.99741554,"teacher_disagreement_score":0.021734891,"about_ca_system_score_codex":0.008932128,"about_ca_system_score_gemma":0.023769138,"threshold_uncertainty_score":0.072710454},"labels":[],"label_agreement":null},{"id":"W6976764132","doi":"10.6084/m9.figshare.18864865","title":"Additional file 11 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Docking (animal); Homology modeling; Sequence homology; Transplantation; Hematopoietic stem cell transplantation; Homology (biology); Detoxification (alternative medicine)","score_opus":0.058767790910192436,"score_gpt":0.3344986646976627,"score_spread":0.2757308737874703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976764132","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043645204,0.000058484584,0.00043672582,0.00019111161,0.00003736508,0.00005648478,0.99651635,0.0008708666,0.0013961785],"genre_scores_gemma":[0.015859395,0.00030119225,0.005308228,0.0008253499,0.00009860999,0.0009835247,0.96332973,0.0016661804,0.011627761],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99968326,0.000053485608,0.00004256492,0.000073568175,0.00009122831,0.000055818895],"domain_scores_gemma":[0.99416226,0.0042876964,0.0003479537,0.00023374855,0.0007890677,0.00017922773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008891124,0.001208243,0.001284748,0.0011773283,0.0006781081,0.001438088,0.0017967375,0.0014864759,0.83075917],"category_scores_gemma":[0.010360518,0.0005054662,0.0014055409,0.0015889988,0.00021341005,0.001347048,0.0008197345,0.0008922376,0.15381284],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006555544,0.00016159289,0.0034050785,0.004361571,0.00011266176,0.0001907412,0.00004556885,0.0019903562,0.00033817015,0.0012383909,0.97700113,0.010499123],"study_design_scores_gemma":[0.00784748,0.000455636,0.020591848,0.0038114334,0.000455772,0.0007085946,0.00030074973,0.010991221,0.0030955693,0.017866397,0.9336505,0.00022494889],"about_ca_topic_score_codex":0.0074754953,"about_ca_topic_score_gemma":0.013243968,"teacher_disagreement_score":0.83075917,"about_ca_system_score_codex":0.0010051971,"about_ca_system_score_gemma":0.0016303967,"threshold_uncertainty_score":0.24140143},"labels":[],"label_agreement":null},{"id":"W6976769252","doi":"10.6084/m9.figshare.18864880.v1","title":"Additional file 5 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; Detoxification (alternative medicine); Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Stem cell","score_opus":0.05746518789926553,"score_gpt":0.3332821852662203,"score_spread":0.27581699736695475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976769252","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006159347,0.00011742921,0.00052391953,0.00024988453,0.00004041845,0.000053287065,0.9955869,0.0008675698,0.0019446716],"genre_scores_gemma":[0.023469357,0.00048599546,0.005144046,0.0008874669,0.00009640581,0.00086016033,0.9562038,0.0014019626,0.011450832],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99969375,0.000061846076,0.000039604594,0.00006822365,0.00008153878,0.000055074957],"domain_scores_gemma":[0.9949693,0.0037735591,0.00031344494,0.00020444665,0.00060451525,0.00013471267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087160565,0.0012920431,0.0013710499,0.0009621328,0.000556433,0.0015631856,0.0015385528,0.0015102101,0.8101727],"category_scores_gemma":[0.009772846,0.0004740895,0.0014283907,0.0014678003,0.0002091675,0.0012010976,0.00070366357,0.0008484457,0.13650516],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083079125,0.00018121013,0.0037144176,0.006751371,0.00018696376,0.00022917573,0.000052233776,0.0033355656,0.0005068534,0.002109748,0.9697733,0.012328347],"study_design_scores_gemma":[0.008725127,0.0005440268,0.014061593,0.0034992443,0.00064189744,0.00063212,0.00026792614,0.011740617,0.003098388,0.020340016,0.93626475,0.0001842585],"about_ca_topic_score_codex":0.0062096757,"about_ca_topic_score_gemma":0.011495339,"teacher_disagreement_score":0.8101727,"about_ca_system_score_codex":0.000878337,"about_ca_system_score_gemma":0.0014827274,"threshold_uncertainty_score":0.27076554},"labels":[],"label_agreement":null},{"id":"W6976814512","doi":"10.60692/2xy6e-k3h39","title":"The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"ADME; 1000 Genomes Project; Pharmacogenomics; Genetic variation; Gene; Population; Genome; Human genetics; Variation (astronomy)","score_opus":0.12294017799973875,"score_gpt":0.36941099452855947,"score_spread":0.24647081652882072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976814512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655837,0.001245228,0.00074303895,0.00014961908,0.0000074520367,0.000009682717,0.0005136752,0.000006594776,0.0007663879],"genre_scores_gemma":[0.99853253,0.0003761736,0.0007286688,0.00004742171,0.000009816374,0.000007002451,0.00022401573,0.0000045230677,0.00007000465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930894,0.00026253687,0.000054706135,0.00019742415,0.000097790406,0.00007864772],"domain_scores_gemma":[0.9988385,0.00053180463,0.00039225174,0.000089524015,0.00008002519,0.00006802903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011317256,0.00029607845,0.0003137313,0.0010324494,0.00042813332,0.00064950506,0.00029774322,0.00033807885,0.0021557617],"category_scores_gemma":[0.0024434752,0.00014932109,0.0002488844,0.0016668838,0.00056289387,0.00035165428,0.00045402392,0.00031499544,0.00015731591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042589544,0.0000319509,0.95228183,0.00015451618,0.00052249926,0.0008488249,0.0011808927,0.00057742634,0.0132799335,0.0006286462,0.0003338726,0.029733656],"study_design_scores_gemma":[0.000015087089,0.00006895674,0.9927046,0.00007704427,0.00013146104,0.001455722,0.0005446106,0.00048371483,0.0013703653,0.00072756474,0.0024094956,0.000011445026],"about_ca_topic_score_codex":0.0017919223,"about_ca_topic_score_gemma":0.0019096641,"teacher_disagreement_score":0.0021557617,"about_ca_system_score_codex":0.00020591,"about_ca_system_score_gemma":0.00018652502,"threshold_uncertainty_score":0.007211685},"labels":[],"label_agreement":null},{"id":"W6977113418","doi":"10.6084/m9.figshare.16900743","title":"Additional file 2 of Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Degree (music); Airflow; Statistical analysis; Post hoc","score_opus":0.26837214078498695,"score_gpt":0.4103348117906738,"score_spread":0.14196267100568688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977113418","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011373756,0.00009580445,0.0005957811,0.00033096425,0.00007282714,0.001428289,0.99218494,0.0003166811,0.0038374625],"genre_scores_gemma":[0.10083712,0.0006370784,0.016291915,0.0038661058,0.00078861025,0.060951013,0.7362184,0.0017305156,0.078679204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808,0.00060937984,0.00035863344,0.0002881091,0.00038385045,0.00028001613],"domain_scores_gemma":[0.9492534,0.038966585,0.0047906437,0.0023452155,0.0037777363,0.00086653454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003930739,0.0010379436,0.0016080061,0.001237539,0.0008612596,0.0014346172,0.0016327656,0.0013608043,0.8346915],"category_scores_gemma":[0.04945534,0.00057483744,0.001587878,0.0018922806,0.00031069937,0.0015969488,0.0007261224,0.0010793349,0.06702882],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011412446,0.0004663799,0.004899934,0.011663659,0.00060316443,0.00015510262,0.00012060044,0.0010444701,0.00018112405,0.0019917986,0.9447659,0.022695396],"study_design_scores_gemma":[0.19924541,0.005671596,0.08959771,0.015082577,0.0030292869,0.0013376195,0.0006287978,0.00747664,0.0019031506,0.026128462,0.64953166,0.00036709892],"about_ca_topic_score_codex":0.003405542,"about_ca_topic_score_gemma":0.008315735,"teacher_disagreement_score":0.8346915,"about_ca_system_score_codex":0.0011927071,"about_ca_system_score_gemma":0.0022921339,"threshold_uncertainty_score":0.2357924},"labels":[],"label_agreement":null},{"id":"W6977255997","doi":"10.6084/m9.figshare.18864877.v1","title":"Additional file 4 of A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"In silico; AutoDock; Docking (animal); Detoxification (alternative medicine); Transplantation; Ligand (biochemistry); Hematopoietic stem cell transplantation","score_opus":0.05780838960482853,"score_gpt":0.33353113093136527,"score_spread":0.27572274132653674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977255997","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000648895,0.00006429988,0.0007242113,0.00023223055,0.000047943646,0.00006053418,0.995673,0.0009678955,0.0015808728],"genre_scores_gemma":[0.023588685,0.00030214165,0.006777166,0.000818624,0.000120916084,0.00082421995,0.95454955,0.0017313518,0.011287286],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997143,0.00004823498,0.000034479053,0.000072003204,0.00007760621,0.000053443928],"domain_scores_gemma":[0.9954294,0.003394067,0.0002700657,0.00020976711,0.0005346873,0.00016202236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009144926,0.0011707223,0.0011423511,0.00090054964,0.00060571684,0.0013610492,0.0017652746,0.0014923399,0.84413946],"category_scores_gemma":[0.009078974,0.00049139035,0.0012143389,0.0011458615,0.00021178779,0.0012612969,0.00069959485,0.00081032625,0.15971841],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007249874,0.00018524991,0.0039927755,0.0043177465,0.00011874993,0.00026752875,0.00005509938,0.003279535,0.00046128075,0.0016103697,0.97219807,0.012788664],"study_design_scores_gemma":[0.008076678,0.0005666831,0.016779052,0.0031779462,0.00050883205,0.0010988372,0.00027555236,0.017999617,0.003589941,0.019776987,0.92793804,0.00021175985],"about_ca_topic_score_codex":0.0061032,"about_ca_topic_score_gemma":0.010125693,"teacher_disagreement_score":0.84413946,"about_ca_system_score_codex":0.00093201065,"about_ca_system_score_gemma":0.0016234808,"threshold_uncertainty_score":0.22231609},"labels":[],"label_agreement":null},{"id":"W6979735805","doi":"","title":"Active site crowding of P450 3A4 as a strategy to alter its selectivity","year":2016,"lang":"en","type":"article","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de recherche du Québec – Nature et technologies; Centre in Green Chemistry and Catalysis; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Selectivity; Allosteric regulation; Macromolecular crowding; Ligand (biochemistry); Cell","score_opus":0.08266731052872751,"score_gpt":0.3883305993972025,"score_spread":0.305663288868475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6979735805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719895,0.0007792904,0.018184166,0.00043818908,0.00021571253,0.0000706722,0.00017958994,0.0003330867,0.0078096245],"genre_scores_gemma":[0.9913167,0.00025583353,0.0039646514,0.00020395794,0.00004653506,0.000023016715,0.00012713857,0.00006112102,0.0040010144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999764,0.00004015636,0.000013700428,0.000065448665,0.00005825723,0.00005843429],"domain_scores_gemma":[0.9998221,0.000050759285,0.000033807846,0.00002565498,0.000026273567,0.00004142315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029567763,0.00025061553,0.0002896117,0.00020179918,0.00033225215,0.00034555615,0.00039187568,0.00031186893,0.0046714083],"category_scores_gemma":[0.00044768144,0.00016810384,0.00031828435,0.0001691678,0.00021900979,0.00025346238,0.00038833535,0.0007104851,0.0007692406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051123183,0.0001039629,0.00031577752,0.000051767558,0.00003256459,0.00011972197,0.000051941282,0.0020028006,0.98384315,0.0015067676,0.0006466078,0.010813556],"study_design_scores_gemma":[0.0000371661,0.0003576389,0.00037789906,0.0000059438653,0.000021215092,0.000111538764,0.00002032165,0.0050362856,0.9885041,0.00022595422,0.0052838945,0.000018140347],"about_ca_topic_score_codex":0.0010932913,"about_ca_topic_score_gemma":0.0014010853,"teacher_disagreement_score":0.0046714083,"about_ca_system_score_codex":0.00027993167,"about_ca_system_score_gemma":0.00027250306,"threshold_uncertainty_score":0.015627384},"labels":[],"label_agreement":null},{"id":"W6981676723","doi":"","title":"E.valdžios taikymas valstybės sienos apsaugoje","year":2006,"lang":"en","type":"dissertation","venue":"Laba (Lietuvos akademinių bibliotekų direktorių asociacija)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lithuanian; Work (physics); Government (linguistics); Politics; State (computer science); Subject (documents); Eu countries","score_opus":0.08601158229851781,"score_gpt":0.45152594653239264,"score_spread":0.36551436423387484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981676723","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17190172,0.20355223,0.012278992,0.03861511,0.010361103,0.0001937072,0.0015257595,0.0007361196,0.56083524],"genre_scores_gemma":[0.408809,0.11225561,0.0072970656,0.0022996818,0.0017729528,0.00016080606,0.00068044744,0.00024827206,0.46647614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997749,0.000043953703,0.000018212491,0.00006236021,0.000065845044,0.00003479821],"domain_scores_gemma":[0.9998147,0.000038991875,0.000020782858,0.000014428784,0.000060982708,0.00005020608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004068982,0.0004554839,0.0005495632,0.0012487693,0.001061846,0.0028003664,0.00021617253,0.0006307464,0.018133136],"category_scores_gemma":[0.0007358067,0.00021450862,0.0003005963,0.00089046557,0.00065529806,0.0013439244,0.001316875,0.0014767163,0.009136402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005509936,0.000511311,0.0074169263,0.002656049,0.000081968064,0.0018153344,0.01292171,0.0012984906,0.011972196,0.23939256,0.16854145,0.55284095],"study_design_scores_gemma":[0.000021950462,0.00014874616,0.010506677,0.000767876,0.000045191086,0.0021349853,0.003525277,0.0004355974,0.0046789283,0.016492454,0.9612188,0.000023645838],"about_ca_topic_score_codex":0.0004838698,"about_ca_topic_score_gemma":0.00062294875,"teacher_disagreement_score":0.018133136,"about_ca_system_score_codex":0.0007837102,"about_ca_system_score_gemma":0.0014042077,"threshold_uncertainty_score":0.060661376},"labels":[],"label_agreement":null},{"id":"W6981902823","doi":"","title":"Fuktindekser som hjelpemiddel i fuktprosjektering","year":2022,"lang":"no","type":"dissertation","venue":"Duo Research Archive (University of Oslo)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Product (mathematics); Work (physics); Gender relations","score_opus":0.1333754070085403,"score_gpt":0.42648433160736904,"score_spread":0.29310892459882876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981902823","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24663526,0.02205101,0.0302045,0.0131674055,0.0032870201,0.00061757216,0.022486042,0.0040254733,0.6575258],"genre_scores_gemma":[0.2911375,0.014661522,0.026557565,0.0016788834,0.00034828865,0.00023125797,0.019493673,0.0021909124,0.64370036],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975273,0.0001113308,0.00011287283,0.00044729904,0.00143336,0.0003678897],"domain_scores_gemma":[0.9982907,0.0001355782,0.00014574439,0.00016697364,0.0009572892,0.0003036728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017803523,0.0010805118,0.0006811315,0.0014539543,0.0027716085,0.0052069663,0.0013657113,0.0015877949,0.05922639],"category_scores_gemma":[0.0022658198,0.0006211655,0.0010686646,0.0019065058,0.0010671513,0.0019587276,0.0025315494,0.0016161336,0.025293859],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010921876,0.00047430498,0.03723572,0.0027961717,0.00022284374,0.0018926604,0.007152707,0.004910658,0.050409183,0.019039145,0.22883713,0.64593726],"study_design_scores_gemma":[0.00002280766,0.00010376773,0.023803858,0.00033441524,0.000059979804,0.00023821517,0.0023710744,0.00050239055,0.009488871,0.0013925156,0.96160406,0.00007811211],"about_ca_topic_score_codex":0.16409306,"about_ca_topic_score_gemma":0.257307,"teacher_disagreement_score":0.16409306,"about_ca_system_score_codex":0.006108559,"about_ca_system_score_gemma":0.010031861,"threshold_uncertainty_score":0.3262759},"labels":[],"label_agreement":null},{"id":"W69827073","doi":"10.1007/978-1-4419-0840-7_28","title":"Drug–Drug Interactions: What Have We Learned and Where Are We Going?","year":2009,"lang":"en","type":"book-chapter","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Drug; Pharmacology; Drug repositioning; Medicine; Business; Risk analysis (engineering)","score_opus":0.12456421838485118,"score_gpt":0.41891046925073394,"score_spread":0.29434625086588273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W69827073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030444562,0.91887176,0.0036808883,0.051506244,0.007163728,0.00002058269,0.000100049045,0.00013857738,0.018213818],"genre_scores_gemma":[0.003956305,0.90803313,0.009542804,0.03811477,0.00992854,0.00005198426,0.0001454911,0.0000896992,0.030137343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895763,0.00040646677,0.000076320895,0.00011015791,0.0003901677,0.000059317026],"domain_scores_gemma":[0.99667203,0.002222576,0.00014616565,0.00010501864,0.0006487277,0.00020551652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039867666,0.0015415861,0.0023285323,0.0013773666,0.0005079892,0.0037856859,0.0016561088,0.003319874,0.012605931],"category_scores_gemma":[0.004185063,0.00048683072,0.0010469027,0.0015214339,0.0027346746,0.008674317,0.0011969997,0.006046184,0.006676273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004585173,0.0000812056,0.0002774321,0.0028770138,0.000075295604,0.00018091853,0.00018978135,0.0005852078,0.00034725163,0.026660558,0.33598945,0.63269],"study_design_scores_gemma":[0.000021179065,0.00005672565,0.0005694889,0.0025691763,0.00006241929,0.0008426122,0.00017967472,0.00044396654,0.0002191333,0.041789245,0.95320314,0.00004321662],"about_ca_topic_score_codex":0.0038371668,"about_ca_topic_score_gemma":0.009623063,"teacher_disagreement_score":0.012605931,"about_ca_system_score_codex":0.002168702,"about_ca_system_score_gemma":0.0035000676,"threshold_uncertainty_score":0.04217106},"labels":[],"label_agreement":null},{"id":"W6990769860","doi":"","title":"The effects of paper structure on electrophotography /","year":2002,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Dielectric; Electric field; Coupling (piping); Field (mathematics); Permittivity; Finite element method; Constant (computer programming)","score_opus":0.022723538232751566,"score_gpt":0.32605421326598555,"score_spread":0.30333067503323397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990769860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565847,0.00059721625,0.011337638,0.00012137766,0.000021836096,0.000012499215,0.000060125054,0.000105813786,0.0020849626],"genre_scores_gemma":[0.99633265,0.00027956374,0.0027426803,0.000027676046,0.0000070686233,0.0000053171916,0.000035690704,0.00001790528,0.0005514163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988234,0.000023790608,0.0000049179043,0.00002636574,0.000040190454,0.000022469805],"domain_scores_gemma":[0.99908876,0.00059874327,0.00013004972,0.000053409774,0.000068673035,0.000060325743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026362436,0.00026665477,0.0001587892,0.00018155879,0.00020245348,0.00049027754,0.0002530736,0.00036695687,0.001972993],"category_scores_gemma":[0.0012282454,0.00014992287,0.00018516078,0.00018723404,0.00030299535,0.0006970815,0.0002628679,0.00045714856,0.00028533887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024954526,0.00005079649,0.0013716113,0.00006778031,0.000013871436,0.00032520373,0.00006508021,0.011903641,0.9730515,0.00053601287,0.000076386445,0.012288585],"study_design_scores_gemma":[0.000029985624,0.00074084377,0.010648772,0.000013438822,0.000025565716,0.00041788974,0.00006754485,0.058949538,0.92743194,0.0009418889,0.00070866063,0.000023925531],"about_ca_topic_score_codex":0.0003808598,"about_ca_topic_score_gemma":0.00035367688,"teacher_disagreement_score":0.001972993,"about_ca_system_score_codex":0.00024625938,"about_ca_system_score_gemma":0.00010764273,"threshold_uncertainty_score":0.00660038},"labels":[],"label_agreement":null},{"id":"W6991141598","doi":"","title":"Exploring the potential impact of collaborative medicines optimisation involving pharmacogenomic testing and general practice pharmacists in primary care in Ireland","year":2024,"lang":"en","type":"dissertation","venue":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Polypharmacy; Pharmacogenomics; Psychological intervention; Population; Dosing; Health care; Pharmacotherapy; MEDLINE; Primary care; Precision medicine","score_opus":0.33353114083260177,"score_gpt":0.5318883995148753,"score_spread":0.19835725868227355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6991141598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7873234,0.14007166,0.00298043,0.038830943,0.0005845895,0.005817123,0.0026755463,0.00015108254,0.02156515],"genre_scores_gemma":[0.97144055,0.015371212,0.005666213,0.0058996133,0.00012509851,0.0009711977,0.0002468332,0.000010172955,0.00026914882],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.957636,0.031059211,0.0038756651,0.0017692862,0.0032410633,0.0024187092],"domain_scores_gemma":[0.9160064,0.04628364,0.018385287,0.0022589588,0.008849951,0.008215735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032442596,0.00032675895,0.0012844213,0.001976595,0.0008313298,0.0027386085,0.0016492523,0.0015676969,0.002384431],"category_scores_gemma":[0.08456703,0.00058600894,0.0026944897,0.0023000676,0.00094085286,0.0020824326,0.0045254016,0.00142102,0.00017494473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053834305,0.0023355503,0.3469851,0.12294417,0.007092039,0.0028731567,0.013689977,0.002732924,0.00095392915,0.002393382,0.011603089,0.48101327],"study_design_scores_gemma":[0.010299799,0.019953819,0.7060072,0.13463601,0.017521977,0.0034439063,0.030548163,0.0054441397,0.0011011071,0.0031035542,0.0674533,0.00048699064],"about_ca_topic_score_codex":0.07126841,"about_ca_topic_score_gemma":0.12974493,"teacher_disagreement_score":0.07126841,"about_ca_system_score_codex":0.0117598465,"about_ca_system_score_gemma":0.05506753,"threshold_uncertainty_score":0.17157489},"labels":[],"label_agreement":null},{"id":"W6995700058","doi":"","title":"Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pace; Identification (biology); Public health; Precision medicine; Personalized medicine; Health care","score_opus":0.6265854639128405,"score_gpt":0.6788041960556664,"score_spread":0.05221873214282591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995700058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014832463,0.9966883,0.00030058794,0.0018906657,0.00023352195,0.0001178457,0.000112692316,0.000007275376,0.00050081534],"genre_scores_gemma":[0.0020857635,0.9955987,0.0010493947,0.00077225134,0.00010616937,0.00022377138,0.00009589298,0.0000036128902,0.00006450734],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98369414,0.0065739118,0.0054404247,0.00071536563,0.0031738589,0.0004023011],"domain_scores_gemma":[0.8650411,0.11234464,0.007617048,0.0015195145,0.012854737,0.0006229729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030603798,0.0015672343,0.0051745973,0.027505327,0.0012707858,0.006148943,0.002768183,0.0038433853,0.004006174],"category_scores_gemma":[0.08855537,0.0010657092,0.004822604,0.028083825,0.0019950012,0.0074948976,0.0032839132,0.003124703,0.0007192454],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012145048,0.000035703142,0.00095157087,0.60414743,0.0017376706,0.00029193392,0.0013133099,0.00039518328,0.00026599396,0.0080051515,0.015627902,0.3671067],"study_design_scores_gemma":[0.000019432176,0.000032957665,0.001112949,0.9180378,0.0021469016,0.00017718537,0.000708951,0.000107785,0.000074144,0.0018532829,0.075705454,0.000023073599],"about_ca_topic_score_codex":0.010895152,"about_ca_topic_score_gemma":0.021540076,"teacher_disagreement_score":0.030603798,"about_ca_system_score_codex":0.007628881,"about_ca_system_score_gemma":0.029031826,"threshold_uncertainty_score":0.16185027},"labels":[],"label_agreement":null},{"id":"W6996405248","doi":"","title":"Seçici serotonin gerialım inhibitörü kullanan hastalarda cyp2c19 polimorfizmleri ile advers ilaç reaksiyonu ve hasta uyuncu ilişkisi","year":2013,"lang":"tr","type":"other","venue":"Dspace Repository (Marmara Üniversitesi)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Adverse effect; Hasta; Drug withdrawal","score_opus":0.03375035339542334,"score_gpt":0.3287204149397537,"score_spread":0.29497006154433036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6996405248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66812944,0.2032565,0.021756547,0.016411077,0.0026927704,0.001042509,0.0051344247,0.0012214102,0.08035534],"genre_scores_gemma":[0.89391077,0.052625947,0.010043891,0.00274969,0.00068675936,0.00040512855,0.0034312208,0.00013734402,0.036009178],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994128,0.00013938615,0.00007626797,0.000102231315,0.00017017598,0.00009918223],"domain_scores_gemma":[0.9993585,0.00016255394,0.00020009298,0.0000464018,0.00016361807,0.00006885245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006731209,0.0005522259,0.0007466392,0.0004697364,0.00054148777,0.0010475891,0.00037277077,0.00089632283,0.0126110595],"category_scores_gemma":[0.0015393059,0.00026175223,0.0010013584,0.0004816417,0.00048022767,0.00046443962,0.0004885191,0.0013801516,0.0022572728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092886,0.0013430321,0.10119066,0.0046421317,0.0016329632,0.0071416623,0.00086146896,0.0016011619,0.08902852,0.005025549,0.032140516,0.7461038],"study_design_scores_gemma":[0.0014398337,0.011765256,0.38683686,0.0020583894,0.002922538,0.035409592,0.0017579693,0.005962978,0.16681994,0.005208311,0.37952688,0.00029148182],"about_ca_topic_score_codex":0.0061120805,"about_ca_topic_score_gemma":0.006742138,"teacher_disagreement_score":0.0126110595,"about_ca_system_score_codex":0.0011592342,"about_ca_system_score_gemma":0.0012675794,"threshold_uncertainty_score":0.042188227},"labels":[],"label_agreement":null},{"id":"W7008752584","doi":"","title":"CYP2D in the Brain Alters Response to Drugs and Neurotoxins","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canada Research Chairs; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation","keywords":"Genetically modified mouse; Transgene; In vivo; Methamphetamine; Drug; Hypothermia; Human brain","score_opus":0.07343712034392316,"score_gpt":0.47987211672203617,"score_spread":0.406434996378113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008752584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957541,0.0012988392,0.0010843121,0.00014839193,0.000053572978,0.000027762382,0.00036045164,0.00008040707,0.0011922935],"genre_scores_gemma":[0.9907302,0.0018170801,0.0013268102,0.00008289014,0.000022248512,0.000059080034,0.0006201817,0.000019249306,0.0053223404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998857,0.000013033263,0.000008683771,0.00003106796,0.000031147552,0.000030427647],"domain_scores_gemma":[0.9999347,0.0000064962287,0.000020181007,0.000008224699,0.000010484886,0.000019953843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010413624,0.00048201715,0.00036076317,0.00024244656,0.00016768376,0.0002554184,0.0001532384,0.00033457766,0.0016034388],"category_scores_gemma":[0.00009212118,0.00017861584,0.00032657274,0.0001634421,0.00029909378,0.00018740693,0.00011186228,0.00088440237,0.00027109697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045727208,0.00008330121,0.0005071296,0.000032011783,0.000014000327,0.00008166135,0.000015500347,0.000034457837,0.996795,0.00006938855,0.00006918806,0.0018411096],"study_design_scores_gemma":[0.000025700008,0.001281647,0.011638865,0.000004976655,0.00003776482,0.00020177814,0.00003049307,0.00035021862,0.9850375,0.00004432541,0.0013417879,0.0000048875154],"about_ca_topic_score_codex":0.0008217413,"about_ca_topic_score_gemma":0.0019087429,"teacher_disagreement_score":0.0016034388,"about_ca_system_score_codex":0.00032688765,"about_ca_system_score_gemma":0.0003032381,"threshold_uncertainty_score":0.005364001},"labels":[],"label_agreement":null},{"id":"W7010145448","doi":"","title":"How community pharmacy pharmacogenomics testing services around the world can inform their design and delivery in the UK","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacy; Community pharmacy; Pharmacist; Service delivery framework; Service (business); Community pharmacist; Work (physics); Clinical pharmacy","score_opus":0.27101327059000685,"score_gpt":0.4099585461878017,"score_spread":0.13894527559779485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010145448","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06959402,0.24418333,0.03588822,0.48839995,0.005385169,0.0058937613,0.0034048397,0.00086082617,0.14638999],"genre_scores_gemma":[0.548836,0.27148134,0.11225942,0.044979118,0.0010444841,0.005019968,0.002542982,0.0002847038,0.013552023],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9348363,0.046547804,0.0070206085,0.001732078,0.007672725,0.002190527],"domain_scores_gemma":[0.86438817,0.0863252,0.012008567,0.0065137725,0.025291469,0.005472792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04947258,0.00073106115,0.0011061608,0.0060304515,0.0027181532,0.011832864,0.0020322632,0.00410303,0.009436762],"category_scores_gemma":[0.1826749,0.00085775234,0.0011824764,0.0080361515,0.0026264163,0.010271864,0.0075146873,0.0030630266,0.0021316935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002866695,0.00024137988,0.01799828,0.029185405,0.00024991884,0.0025339508,0.04127179,0.0019069072,0.00091168645,0.023757478,0.1125592,0.7690974],"study_design_scores_gemma":[0.0002197892,0.0005331908,0.024486188,0.11199564,0.00041436031,0.0010628783,0.053081337,0.0011742354,0.0008759536,0.020561151,0.7853122,0.0002831439],"about_ca_topic_score_codex":0.06408512,"about_ca_topic_score_gemma":0.08627869,"teacher_disagreement_score":0.06408512,"about_ca_system_score_codex":0.012072668,"about_ca_system_score_gemma":0.041553885,"threshold_uncertainty_score":0.26163918},"labels":[],"label_agreement":null},{"id":"W7010550741","doi":"","title":"Investigations of the biocatalytic activity of human P450 2D6","year":2007,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; McGill University; University of Wisconsin-Madison; Vanderbilt University","keywords":"Enzyme; Limiting; Substrate (aquarium); Cytochrome P450; Drug; Oxygen atom","score_opus":0.09565551814055319,"score_gpt":0.41201519453783064,"score_spread":0.31635967639727747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010550741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244053,0.00847083,0.0032857442,0.00015192393,0.000048824855,0.000040885912,0.0005046257,0.000020602161,0.005036008],"genre_scores_gemma":[0.9864158,0.004479692,0.0024785234,0.000063662636,0.000040312283,0.000022642187,0.0008451268,0.000011110847,0.005643189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997212,0.000054389668,0.00001438121,0.000058592326,0.00009269728,0.00005858171],"domain_scores_gemma":[0.9998878,0.000029648598,0.000017283784,0.000013154528,0.000040513045,0.000011533274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003922616,0.0001727693,0.00016976957,0.00021034345,0.00013719454,0.00022690726,0.00014795763,0.0002105913,0.0010260761],"category_scores_gemma":[0.00035627265,0.00007621178,0.00030085348,0.00037006824,0.000094794865,0.00011561918,0.00009096142,0.0002861608,0.00039786493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030115223,0.0001593681,0.0016137869,0.00014464787,0.000025447514,0.000094028524,0.00007855066,0.00017977049,0.9817618,0.00032390893,0.00027038113,0.0150472205],"study_design_scores_gemma":[0.0000120812365,0.0008379297,0.008038113,0.000007873536,0.000019831401,0.00029102902,0.0000389909,0.00060618814,0.9854033,0.000042770236,0.0046965987,0.000005299357],"about_ca_topic_score_codex":0.001174655,"about_ca_topic_score_gemma":0.0011541613,"teacher_disagreement_score":0.001174655,"about_ca_system_score_codex":0.00021660971,"about_ca_system_score_gemma":0.0001374183,"threshold_uncertainty_score":0.0034325123},"labels":[],"label_agreement":null},{"id":"W7017925180","doi":"","title":"Considerations for the implementation of pharmacogenomic (PGx) testing to guide antidepressant prescribing in primary care in Ontario, Canada","year":2024,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Association of Physicists","funders":"McMaster University; Canadian Institutes of Health Research; Fondation Brocher","keywords":"Pharmacogenomics; Primary care; Equity (law); Genetic testing; Public health; Variety (cybernetics); Health care; MEDLINE; Feeling","score_opus":0.06927141617500784,"score_gpt":0.34479845397119446,"score_spread":0.2755270377961866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7017925180","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20859998,0.11118886,0.0041900547,0.58350015,0.0014755309,0.0029416224,0.0047560465,0.0001845647,0.0831632],"genre_scores_gemma":[0.8815211,0.053007793,0.019333981,0.03971986,0.00019609054,0.0010450924,0.000796417,0.00006338569,0.004316305],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9713291,0.011952211,0.002682649,0.0011539476,0.009210897,0.0036712112],"domain_scores_gemma":[0.8954715,0.040501196,0.0059860568,0.0015267815,0.04347543,0.013038944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02612606,0.0002953218,0.0006810871,0.0017383711,0.011793343,0.0070865345,0.0030072809,0.0021748987,0.0037523],"category_scores_gemma":[0.06985309,0.0006616218,0.0009059276,0.004832718,0.0037219475,0.002275693,0.0031924858,0.0025325576,0.00017368683],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007586317,0.00038870695,0.20672609,0.041826002,0.0009319524,0.003658565,0.19052342,0.003200313,0.0030178258,0.033397708,0.17144682,0.34412402],"study_design_scores_gemma":[0.00053287734,0.00067861564,0.26327604,0.046186306,0.0015351815,0.00067987625,0.2497155,0.002592793,0.0013155846,0.0070438962,0.42594963,0.0004936615],"about_ca_topic_score_codex":0.99325997,"about_ca_topic_score_gemma":0.99741745,"teacher_disagreement_score":0.2608871,"about_ca_system_score_codex":0.2608871,"about_ca_system_score_gemma":0.5948387,"threshold_uncertainty_score":0.8572662},"labels":[],"label_agreement":null},{"id":"W7019888970","doi":"","title":"Inhibition of 17beta-estradiol activation by CYP1A1: Genotype- and regioselective inhibition by St. John's wort and several natural polyphenols","year":2011,"lang":"en","type":"article","venue":"MDC Repository (Max-Delbrueck-Center for Molecular Medicine)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polyphenol; Quercetin; Enzyme; Myricetin; Hydroxytyrosol; Hydroxylation; Flavonols; Resveratrol; Phytoestrogens","score_opus":0.04126108276171334,"score_gpt":0.3254969816386821,"score_spread":0.28423589887696876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7019888970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486816,0.0020707264,0.0008895798,0.00012065741,0.000039118342,0.00003631502,0.00040106566,0.000050072736,0.0015242638],"genre_scores_gemma":[0.993163,0.0020672914,0.00097505783,0.000040860665,0.000029320398,0.000035458404,0.0007328688,0.00003908892,0.002916939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984586,0.000049728922,0.000012227878,0.000022891574,0.00001948468,0.000049739596],"domain_scores_gemma":[0.99988246,0.00003415412,0.000031071177,0.000018401026,0.000009534135,0.00002438279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023846529,0.00044199466,0.0003211826,0.00026567446,0.00014653646,0.00018202212,0.00022525091,0.00013932871,0.003670292],"category_scores_gemma":[0.00028670672,0.00022158344,0.0003857509,0.00024370688,0.00023751275,0.00010266476,0.00014736346,0.00030742286,0.00045270278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003264658,0.00025652064,0.0008637828,0.00011090096,0.000047184265,0.000092625705,0.000050156403,0.0002000101,0.98210484,0.000209197,0.00036394806,0.012436166],"study_design_scores_gemma":[0.00019905077,0.0022298892,0.0080777155,0.000006889854,0.000063547566,0.00030275618,0.000018790572,0.0004014411,0.9865371,0.00004958798,0.002102728,0.000010456464],"about_ca_topic_score_codex":0.0013074931,"about_ca_topic_score_gemma":0.0032020663,"teacher_disagreement_score":0.003670292,"about_ca_system_score_codex":0.00024721355,"about_ca_system_score_gemma":0.0002864712,"threshold_uncertainty_score":0.012278378},"labels":[],"label_agreement":null},{"id":"W7042486716","doi":"","title":"Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pace; Identification (biology); Public health; Precision medicine; Personalized medicine; Health care","score_opus":0.1962153635122578,"score_gpt":0.4787068573117975,"score_spread":0.28249149379953975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042486716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001261661,0.9967435,0.0002903909,0.0018389449,0.00025021064,0.00011839938,0.00011524521,0.000007865223,0.0005093936],"genre_scores_gemma":[0.0016957136,0.9960814,0.0010062482,0.0007363593,0.000104465995,0.00021137838,0.000091296475,0.0000035321316,0.00006969755],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98550147,0.0056659756,0.004877769,0.00063976087,0.0029407213,0.00037434994],"domain_scores_gemma":[0.8875365,0.09138333,0.0068921954,0.0014277032,0.012148985,0.00061131205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028121915,0.0015586199,0.005134988,0.026868377,0.00127831,0.005735789,0.0027311277,0.0039090337,0.004308189],"category_scores_gemma":[0.0772926,0.001033176,0.004873523,0.026883163,0.0019032367,0.0068518952,0.0032262711,0.003057036,0.00078535115],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012271194,0.000036365956,0.0007691881,0.5899582,0.0016094301,0.00027737473,0.0010945773,0.00038632785,0.00028762422,0.008280181,0.01705951,0.38011852],"study_design_scores_gemma":[0.000019071982,0.000035043733,0.0009955,0.9011886,0.0020025016,0.00017027472,0.00057769497,0.00010056072,0.00007916441,0.0017434219,0.093065225,0.00002286838],"about_ca_topic_score_codex":0.011255966,"about_ca_topic_score_gemma":0.021068672,"teacher_disagreement_score":0.028121915,"about_ca_system_score_codex":0.0074132243,"about_ca_system_score_gemma":0.029807633,"threshold_uncertainty_score":0.14872468},"labels":[],"label_agreement":null},{"id":"W7071720833","doi":"","title":"St. John's wort對大鼠腸道及肝臟Cytochrome P450活性之影響","year":2006,"lang":"en","type":"article","venue":"NTUR (臺灣機構典藏)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Process (computing); Identification (biology); Product (mathematics)","score_opus":0.07697392021927119,"score_gpt":0.4204090360956205,"score_spread":0.34343511587634934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071720833","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22473553,0.19675663,0.038621083,0.032656554,0.013319471,0.00102073,0.0064858627,0.0057527716,0.48065135],"genre_scores_gemma":[0.419665,0.055154886,0.01739196,0.004548142,0.0022598426,0.00029660782,0.003006173,0.00035860328,0.49731883],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997694,0.000038337843,0.000021789774,0.000053230888,0.00008767731,0.000029548244],"domain_scores_gemma":[0.999686,0.00010982616,0.00005471759,0.000023195107,0.000059517515,0.00006687058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001774686,0.00061538065,0.0005094359,0.00046161047,0.00032249768,0.0003760065,0.00021547226,0.00066405954,0.072761044],"category_scores_gemma":[0.0010191381,0.00023934682,0.0003760357,0.00030364544,0.0004446469,0.0002566438,0.00036104737,0.0009589416,0.021602547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023804987,0.0003879407,0.0036966566,0.0020440144,0.00017525538,0.003374509,0.00014587231,0.00013541964,0.17482778,0.0033530896,0.13462564,0.6748533],"study_design_scores_gemma":[0.0007840819,0.0048085903,0.04083093,0.00065185607,0.00022379302,0.028763909,0.000223764,0.00061349093,0.093968496,0.0023858147,0.8266631,0.00008213233],"about_ca_topic_score_codex":0.0009091677,"about_ca_topic_score_gemma":0.002740199,"teacher_disagreement_score":0.072761044,"about_ca_system_score_codex":0.00015199867,"about_ca_system_score_gemma":0.00041926667,"threshold_uncertainty_score":0.24340993},"labels":[],"label_agreement":null},{"id":"W7074687273","doi":"","title":"Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape","year":2018,"lang":"en","type":"book","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; ADME; Drug; Bioequivalence; Drug metabolism; Pharmacy; Drug development","score_opus":0.05875969595178177,"score_gpt":0.37317114679606217,"score_spread":0.3144114508442804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7074687273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00100001,0.8825761,0.001543462,0.0547297,0.0064010094,0.000026870212,0.001052989,0.0002937381,0.052376155],"genre_scores_gemma":[0.009731416,0.8858909,0.0030116092,0.013099186,0.005181125,0.000021675716,0.0009882938,0.00014963248,0.08192613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851066,0.00008344912,0.00006514264,0.00012710525,0.001106535,0.00010708348],"domain_scores_gemma":[0.9963626,0.00064238923,0.00014477452,0.00009973188,0.002360552,0.00038995402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018190632,0.00076877006,0.00085340464,0.0027665957,0.0016969638,0.004061341,0.0012794884,0.001816752,0.016924756],"category_scores_gemma":[0.004837185,0.00032817165,0.00045722353,0.007706954,0.0023613148,0.0018543563,0.000972191,0.0024029228,0.0047268793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044274213,0.000020719643,0.0007064108,0.00085001916,0.0000108512295,0.00013475156,0.00018502984,0.00030081352,0.0003499192,0.009910536,0.56193507,0.42555165],"study_design_scores_gemma":[0.0000039438983,0.00001083668,0.0016985093,0.0003545366,0.000010813338,0.00030079202,0.00007792712,0.00012554182,0.00012067518,0.002258892,0.9950204,0.000017127722],"about_ca_topic_score_codex":0.84617436,"about_ca_topic_score_gemma":0.91260463,"teacher_disagreement_score":0.96390295,"about_ca_system_score_codex":0.03609703,"about_ca_system_score_gemma":0.047583763,"threshold_uncertainty_score":0.30946308},"labels":[],"label_agreement":null},{"id":"W7094654196","doi":"","title":"Association of tardive dyskinesia with variation in CYP2D6:Is there a role for active metabolites?","year":2014,"lang":"en","type":"article","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Association (psychology); Tardive dyskinesia; Variation (astronomy); Disease; Action (physics)","score_opus":0.035765183948282486,"score_gpt":0.37283603540500626,"score_spread":0.3370708514567238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7094654196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870291,0.005393576,0.0025361537,0.001967472,0.00017400084,0.000020073447,0.0009308525,0.000072838455,0.0018759541],"genre_scores_gemma":[0.9975581,0.00049878086,0.0007769741,0.00028023665,0.00016071564,0.0000052864402,0.00034298413,0.000023029566,0.0003539177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977258,0.0006472514,0.00040699652,0.0007175552,0.00032326463,0.00017917335],"domain_scores_gemma":[0.99427223,0.0024920402,0.0020038004,0.00061003503,0.00036945756,0.0002525078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016310045,0.0010109878,0.0013834381,0.00092228386,0.00039736612,0.00091657345,0.0011604594,0.0016516895,0.005559895],"category_scores_gemma":[0.006372897,0.00044065266,0.0017735182,0.0015454943,0.00075239,0.00072240323,0.00046684025,0.0014080637,0.0004755904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011589084,0.00006791295,0.9830804,0.000071786766,0.0011840452,0.0021760787,0.00010145419,0.00015975542,0.0036433286,0.00029430437,0.00040792738,0.00765409],"study_design_scores_gemma":[0.00005648545,0.00027773879,0.99111813,0.000034473385,0.0005343507,0.005553759,0.00008218663,0.0007248446,0.0004802069,0.0004697159,0.000646365,0.000021588845],"about_ca_topic_score_codex":0.0028545137,"about_ca_topic_score_gemma":0.002549429,"teacher_disagreement_score":0.005559895,"about_ca_system_score_codex":0.00029446316,"about_ca_system_score_gemma":0.00021542089,"threshold_uncertainty_score":0.018599689},"labels":[],"label_agreement":null},{"id":"W7104262049","doi":"10.71781/4834","title":"Identification de déterminants pharmacogénétiques prédictifs des concentrations des médicaments à l’aide de grandes cohortes observationnelles","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statistical analysis; Negative therapeutic reaction","score_opus":0.043698578052791565,"score_gpt":0.3170707835724838,"score_spread":0.2733722055196922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104262049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535625,0.029823158,0.08755248,0.005469771,0.0010861653,0.00084431097,0.014330362,0.0003987946,0.0069325333],"genre_scores_gemma":[0.9429831,0.007438106,0.0335752,0.0018758795,0.00057041436,0.0012131829,0.0055560707,0.00016615257,0.0066218786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900046,0.0048412243,0.000977488,0.0022616962,0.0014075194,0.0005075021],"domain_scores_gemma":[0.9655196,0.01699606,0.0064229686,0.006612758,0.003739365,0.00070927315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018994618,0.00076185813,0.0013733382,0.0016798474,0.0010162295,0.0030255918,0.0012684381,0.0013725694,0.004705281],"category_scores_gemma":[0.037297625,0.0005196017,0.002931712,0.002353899,0.00079296407,0.0013006222,0.0015134161,0.0016674792,0.00095409836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016208036,0.0002137455,0.9129425,0.0010567652,0.004724053,0.00025456093,0.0012798797,0.00095140486,0.0032886446,0.0019286824,0.0041655465,0.067573436],"study_design_scores_gemma":[0.00022122123,0.0015302431,0.93647045,0.0008621066,0.0056248587,0.0011651205,0.0010830138,0.0049070315,0.0048395344,0.0045977836,0.038571592,0.00012713215],"about_ca_topic_score_codex":0.012783247,"about_ca_topic_score_gemma":0.01575722,"teacher_disagreement_score":0.018994618,"about_ca_system_score_codex":0.0009204965,"about_ca_system_score_gemma":0.0025933157,"threshold_uncertainty_score":0.10045433},"labels":[],"label_agreement":null},{"id":"W7105695419","doi":"10.1136/bmjdhai-2025-000134","title":"Retrospective evaluation of a machine learning model to facilitate pharmacogenetic testing","year":2025,"lang":"en","type":"article","venue":"BMJ Digital Health & AI","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Pharmacogenetics; Logistic regression; Medical prescription; Epidemiology; Retrospective cohort study; Cohort; Gradient boosting","score_opus":0.3195143293878861,"score_gpt":0.5259982311863415,"score_spread":0.20648390179845538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105695419","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3750523,0.0011998926,0.6145654,0.0015858025,0.0001745382,0.00035840934,0.0022934554,0.0018960342,0.0028742312],"genre_scores_gemma":[0.9052494,0.00031825688,0.09027218,0.00022114221,0.000088340676,0.00025437394,0.0023243404,0.00007009007,0.001201872],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99746025,0.0014150244,0.00023142724,0.0004901859,0.00026865545,0.00013448147],"domain_scores_gemma":[0.9864031,0.0099278595,0.0009811298,0.0007720562,0.0017527331,0.00016299661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011550466,0.0010853834,0.0008536279,0.0012138926,0.0003214807,0.0015696671,0.0011693247,0.00094296446,0.0017144906],"category_scores_gemma":[0.024807064,0.0005179086,0.000965496,0.00071512646,0.00039854957,0.0010787828,0.00090171525,0.0013073026,0.00067828974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005919615,0.00022564588,0.109178655,0.00012619777,0.0003165953,0.00029424173,0.0001418954,0.8104613,0.0014560259,0.002941646,0.0025423565,0.07172356],"study_design_scores_gemma":[0.000010723592,0.00008206791,0.0031126097,0.00002039834,0.000024928439,0.00006352697,0.000014394544,0.9949805,0.0004657035,0.0007221044,0.0004936495,0.000009354327],"about_ca_topic_score_codex":0.008522661,"about_ca_topic_score_gemma":0.004628108,"teacher_disagreement_score":0.011550466,"about_ca_system_score_codex":0.001021221,"about_ca_system_score_gemma":0.0012539302,"threshold_uncertainty_score":0.061085463},"labels":[],"label_agreement":null},{"id":"W7106551209","doi":"10.5281/zenodo.17693347","title":"Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Russian Science Foundation; Belarusian Republican Foundation for Fundamental Research","keywords":"Docking (animal); Molecular model; DNA; Genome","score_opus":0.09760576493939019,"score_gpt":0.36710833091511547,"score_spread":0.2695025659757253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7106551209","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3927063,0.014510113,0.040963657,0.0024937817,0.0015385702,0.0005173005,0.49130595,0.0065473504,0.04941701],"genre_scores_gemma":[0.42370167,0.004895275,0.033970498,0.0007612183,0.00013462307,0.00049231737,0.5005264,0.000629639,0.03488838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979573,0.000028894956,0.000017755548,0.000038381586,0.0000785116,0.000040673098],"domain_scores_gemma":[0.99986506,0.000039586073,0.00001977801,0.000014608528,0.000034173856,0.000026770647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024473935,0.0006712811,0.0007170413,0.00040920314,0.00050815335,0.00037866732,0.0005886943,0.0005508229,0.08014541],"category_scores_gemma":[0.0006977235,0.0002320578,0.0005213348,0.0008341033,0.0000857589,0.00022210465,0.0003061555,0.00053330814,0.012847663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031744912,0.00033154312,0.0031646343,0.003411512,0.00019551908,0.000670955,0.00011120989,0.004327968,0.6995311,0.0032569517,0.2414701,0.040353917],"study_design_scores_gemma":[0.0008297162,0.0011861342,0.014538803,0.00021301622,0.00030448427,0.0023899258,0.00013522417,0.01231305,0.59133303,0.0012330479,0.37538514,0.00013858428],"about_ca_topic_score_codex":0.002468611,"about_ca_topic_score_gemma":0.004121985,"teacher_disagreement_score":0.08014541,"about_ca_system_score_codex":0.00060854934,"about_ca_system_score_gemma":0.00064522633,"threshold_uncertainty_score":0.26811314},"labels":[],"label_agreement":null},{"id":"W7106572479","doi":"10.5281/zenodo.17693346","title":"Diverse Ligands for Mycobacterial CYP124 Identified from Plant and Marine Compounds","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Russian Science Foundation; Belarusian Republican Foundation for Fundamental Research","keywords":"Docking (animal); Molecular model; Binding site; Sequence homology; File format","score_opus":0.09760576493939019,"score_gpt":0.36710833091511547,"score_spread":0.2695025659757253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7106572479","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13227102,0.012736219,0.041975047,0.0029964144,0.0028120524,0.000548968,0.7349946,0.009260672,0.06240502],"genre_scores_gemma":[0.16064249,0.004755288,0.033724505,0.0011712916,0.00027415468,0.0005998345,0.7496256,0.00080748316,0.04839942],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972624,0.000045162928,0.00002632246,0.000052063828,0.000098123324,0.00005212911],"domain_scores_gemma":[0.9997003,0.000104025945,0.000044875524,0.000030575724,0.000072060444,0.000048136142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032602367,0.00080977014,0.0008571466,0.0005865864,0.0005008665,0.00046152205,0.0006121531,0.0006052396,0.19382414],"category_scores_gemma":[0.0010130232,0.00027782004,0.0005656759,0.0010347994,0.000087607696,0.00033918148,0.00038685143,0.00057668815,0.0336929],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026074154,0.00032260705,0.002058489,0.003971858,0.00014004094,0.0004960608,0.00007386278,0.0017975764,0.42801568,0.0034380043,0.5032607,0.053817723],"study_design_scores_gemma":[0.0006824237,0.0010847842,0.011634768,0.00030685088,0.00020846695,0.0022102946,0.0000914535,0.005276035,0.27887952,0.0014183372,0.69810385,0.000103165956],"about_ca_topic_score_codex":0.0013429219,"about_ca_topic_score_gemma":0.0023521194,"teacher_disagreement_score":0.19382414,"about_ca_system_score_codex":0.00056089653,"about_ca_system_score_gemma":0.00069272454,"threshold_uncertainty_score":0.6484064},"labels":[],"label_agreement":null},{"id":"W7116127768","doi":"10.5530/gjpb.2025.3.7","title":"Drug Repurposing in Personalized Medicine: Translational Pathways and Recommendations","year":2025,"lang":"en","type":"article","venue":"German Journal of Pharmaceuticals and Biomaterials","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"","keywords":"Repurposing; Drug repositioning; Personalized medicine; Translational medicine; Precision medicine; Translational research; Drug development; Big data; Psychological intervention","score_opus":0.10874218594624126,"score_gpt":0.4791589097608413,"score_spread":0.37041672381460006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116127768","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064465177,0.46561843,0.011411947,0.49992734,0.009820788,0.00040558053,0.00065380364,0.0003923437,0.011125085],"genre_scores_gemma":[0.012549009,0.7904436,0.037505757,0.14292556,0.010411127,0.00085611583,0.00090249476,0.00012635901,0.004279894],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9874555,0.006631748,0.001584443,0.0011431836,0.0024729364,0.00071221986],"domain_scores_gemma":[0.9205576,0.052124977,0.004079269,0.0034165776,0.01528918,0.0045324024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032414693,0.0017446746,0.002873617,0.003621601,0.0014073579,0.007698211,0.0042443853,0.009685742,0.019311463],"category_scores_gemma":[0.04955374,0.00070392044,0.0029548318,0.0037824828,0.004501163,0.014441282,0.0057105212,0.014675482,0.005955497],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036231286,0.00033369186,0.00084176223,0.026905788,0.00040427825,0.00052131247,0.000558712,0.0023617174,0.00077737996,0.08734339,0.23978907,0.63980067],"study_design_scores_gemma":[0.00017558844,0.0002961517,0.00064592145,0.045611337,0.000451801,0.00045204148,0.0008763955,0.0013249038,0.0005321765,0.13849428,0.81104267,0.00009671185],"about_ca_topic_score_codex":0.0043668887,"about_ca_topic_score_gemma":0.008155635,"teacher_disagreement_score":0.032414693,"about_ca_system_score_codex":0.005460163,"about_ca_system_score_gemma":0.025519732,"threshold_uncertainty_score":0.17142731},"labels":[],"label_agreement":null},{"id":"W7117141376","doi":"10.1111/cts.70458","title":"Tutorial Drug–Drug Interactions","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacodynamics; Population; Categorical variable; Drug; Variation (astronomy); Drug development; Socioeconomic status","score_opus":0.16183317808154946,"score_gpt":0.5523489411735696,"score_spread":0.39051576309202013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117141376","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007724369,0.4619165,0.019209562,0.15330446,0.18493065,0.00030784428,0.002488548,0.00203166,0.17503825],"genre_scores_gemma":[0.01053104,0.32486543,0.018970711,0.1878483,0.26438597,0.0005039551,0.0025038903,0.0010302011,0.18936059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722075,0.0010161169,0.00028049905,0.0003130118,0.0009998579,0.000169664],"domain_scores_gemma":[0.9895047,0.007185253,0.00075305573,0.00037413253,0.0014465834,0.00073627377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031391121,0.0023196738,0.0016265196,0.0042401296,0.0010121048,0.0047221887,0.0021286872,0.006496823,0.08434622],"category_scores_gemma":[0.013924498,0.0005368129,0.0013013106,0.0024922215,0.0021427863,0.0072940853,0.0029189165,0.008410389,0.04912938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005197253,0.00003140261,0.00013088092,0.0014067241,0.000028319566,0.00020675898,0.00009328587,0.00017930292,0.00022216339,0.017781677,0.848039,0.13182843],"study_design_scores_gemma":[0.000005953166,0.000025544896,0.00011855593,0.00042742174,0.0000084861895,0.00056136237,0.000028246188,0.000081747945,0.000048848342,0.0063498495,0.9923355,0.000008489799],"about_ca_topic_score_codex":0.0010878163,"about_ca_topic_score_gemma":0.0018886153,"teacher_disagreement_score":0.08434622,"about_ca_system_score_codex":0.0020101268,"about_ca_system_score_gemma":0.001981057,"threshold_uncertainty_score":0.28216624},"labels":[],"label_agreement":null},{"id":"W7117709703","doi":"10.1016/j.athoracsur.2025.12.018","title":"Toward Personalized Neoadjuvant Strategies: Using Metabolic and Biological Response to Guide Treatment Deescalation or Intensification","year":2025,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"MEDLINE; Risk assessment; Neoadjuvant therapy; Precision medicine","score_opus":0.5424871994095962,"score_gpt":0.5634544153078072,"score_spread":0.020967215898210934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117709703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38391903,0.13545625,0.25739464,0.10839327,0.004346652,0.0013194787,0.0038433697,0.002597815,0.10272948],"genre_scores_gemma":[0.84192556,0.030318884,0.09418021,0.017527146,0.0032556788,0.0005803764,0.002072128,0.00039404238,0.009745967],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990177,0.0003975923,0.00012139938,0.00016618319,0.00021830662,0.00007883984],"domain_scores_gemma":[0.9984162,0.00068212854,0.00037673896,0.00010912542,0.00026665186,0.0001492998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002256622,0.0008751016,0.0013366179,0.0013085809,0.00039087003,0.0029239461,0.0006174316,0.0009590568,0.0027484153],"category_scores_gemma":[0.005185714,0.0002566477,0.00085158716,0.00052948983,0.0005734887,0.001557175,0.0007770949,0.0030334005,0.0013464707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021581259,0.0010049334,0.1532633,0.00076496915,0.00056000217,0.0004823811,0.00024395928,0.018427294,0.015562472,0.005998383,0.02290273,0.77863145],"study_design_scores_gemma":[0.0010518271,0.007901814,0.33890155,0.004529566,0.003070135,0.0051775803,0.0021068866,0.15284316,0.046722088,0.10998286,0.3271388,0.00057368603],"about_ca_topic_score_codex":0.0011491714,"about_ca_topic_score_gemma":0.0035517444,"teacher_disagreement_score":0.0029239461,"about_ca_system_score_codex":0.0010709647,"about_ca_system_score_gemma":0.0013800799,"threshold_uncertainty_score":0.01193428},"labels":[],"label_agreement":null},{"id":"W7128294010","doi":"10.33545/26174693.2024.v8.i7c.7431","title":"mRNA expression changes following drug treatment and pharmacogenomic responses","year":2024,"lang":"","type":"article","venue":"International Journal of Advanced Biochemistry Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Drug; CYP2D6; Gene expression; Drug metabolism; Genotype; Gene; Messenger RNA; Peripheral blood mononuclear cell","score_opus":0.1543513701918684,"score_gpt":0.5402486620865178,"score_spread":0.3858972918946494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128294010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947384,0.0005790888,0.0006922647,0.0000693719,0.000016748645,0.000043011434,0.0026736709,0.000020998454,0.0011665024],"genre_scores_gemma":[0.99402606,0.0004072753,0.00076620164,0.000077512035,0.000014401817,0.00010277709,0.0022738317,0.000008333416,0.0023234957],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997398,0.000051667987,0.000012281132,0.000083816645,0.000058374833,0.000053980173],"domain_scores_gemma":[0.9997336,0.000069369016,0.00006384506,0.000026413056,0.00008195257,0.000024684232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002285082,0.00015048057,0.0002665246,0.00038014102,0.00022200937,0.0003261642,0.000091438,0.00024726352,0.0016512979],"category_scores_gemma":[0.00045241567,0.00010879115,0.00020509234,0.00050613633,0.00022042154,0.000087876106,0.00011086789,0.00023169481,0.00032628703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031130563,0.00011650532,0.10662385,0.000089623834,0.00008515003,0.00022113022,0.000319247,0.000252303,0.87630415,0.00007689466,0.00030574977,0.01249231],"study_design_scores_gemma":[0.000026639214,0.0010201654,0.9201893,0.000005792653,0.000063766514,0.00018319424,0.00031108703,0.0003988605,0.076513834,0.000058112753,0.0012205148,0.000008684564],"about_ca_topic_score_codex":0.0031752628,"about_ca_topic_score_gemma":0.005448957,"teacher_disagreement_score":0.0031752628,"about_ca_system_score_codex":0.00040407278,"about_ca_system_score_gemma":0.00018779743,"threshold_uncertainty_score":0.0063135624},"labels":[],"label_agreement":null},{"id":"W7128309113","doi":"10.1093/jpp/rgaf132","title":"Observed tamoxifen drug interactions are dependent on both CYP2D6 phenotype and inhibitor potency","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"CYP2D6; Tamoxifen; Potency; Drug; Phenotype; Clinical Practice","score_opus":0.09420184754445299,"score_gpt":0.4327028005211361,"score_spread":0.3385009529766831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128309113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913641,0.003335752,0.0015194948,0.00022649909,0.000016911832,0.000039358514,0.0011226349,0.000032566495,0.0023427203],"genre_scores_gemma":[0.99832004,0.0003746855,0.00052422384,0.000055046246,0.00001975781,0.000009983307,0.00045035518,0.000008961978,0.0002369747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974669,0.0007785281,0.00036118343,0.00052195176,0.00073755754,0.00013381596],"domain_scores_gemma":[0.9929427,0.003236317,0.002626195,0.00058411533,0.0004190357,0.00019162698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015322639,0.00028987162,0.0005450238,0.00073848735,0.00025843355,0.00068844075,0.00030375196,0.00030219622,0.004004865],"category_scores_gemma":[0.0067138188,0.00017175896,0.0006099642,0.00090946007,0.00031730757,0.00031310497,0.00030192727,0.00047899832,0.00060726044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034995758,0.000035893147,0.988252,0.000037426154,0.0003189872,0.00016702384,0.000030140234,0.000068428606,0.003172943,0.0000364764,0.000097805256,0.0074329507],"study_design_scores_gemma":[0.000010809325,0.0001952287,0.996207,0.000007407958,0.00010756843,0.0013690055,0.000026915968,0.00015692842,0.0013051293,0.00004895733,0.00056173315,0.0000032897015],"about_ca_topic_score_codex":0.00048047354,"about_ca_topic_score_gemma":0.00078642694,"teacher_disagreement_score":0.004004865,"about_ca_system_score_codex":0.00020227558,"about_ca_system_score_gemma":0.00015938841,"threshold_uncertainty_score":0.013397634},"labels":[],"label_agreement":null},{"id":"W7131959576","doi":"","title":"Pharmacogenetics in practice:Barriers and facilitators. Pharmacists take action in implementing pharmacogenetics","year":2024,"lang":"","type":"article","venue":"Pure Amsterdam UMC","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Pharmacogenetics; Action (physics); MEDLINE; Precision medicine; Genetic testing","score_opus":0.08252785550645766,"score_gpt":0.46974927788764886,"score_spread":0.38722142238119117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7131959576","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038197536,0.015952077,0.0046476717,0.9187875,0.0012002649,0.00024700884,0.00007653203,0.00022918404,0.020662298],"genre_scores_gemma":[0.76862824,0.031628773,0.027977647,0.16289657,0.0013068346,0.0007044666,0.00014310115,0.0001455261,0.0065688533],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.927855,0.04729522,0.0039852876,0.0026509638,0.0131263705,0.0050872033],"domain_scores_gemma":[0.7595429,0.14698972,0.023423428,0.005936965,0.021867625,0.042239416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06186151,0.00042123467,0.00064551143,0.0010182487,0.004501424,0.007024809,0.0017558301,0.005887738,0.005980891],"category_scores_gemma":[0.16613135,0.0007320529,0.0005016764,0.0017373536,0.0041049263,0.0071934336,0.009317043,0.01019253,0.0015015734],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022178768,0.0011818437,0.12262224,0.0032633136,0.00012868161,0.0029619217,0.041919224,0.0006361572,0.001179419,0.012075556,0.14133896,0.67247087],"study_design_scores_gemma":[0.00040021614,0.001606174,0.1930343,0.033610873,0.00026426496,0.009288175,0.18199204,0.0030864212,0.001832766,0.05744726,0.5170095,0.00042802296],"about_ca_topic_score_codex":0.019822031,"about_ca_topic_score_gemma":0.020219672,"teacher_disagreement_score":0.06186151,"about_ca_system_score_codex":0.005346909,"about_ca_system_score_gemma":0.04865306,"threshold_uncertainty_score":0.32715887},"labels":[],"label_agreement":null},{"id":"W7132895060","doi":"","title":"CYP2D in the Brain Impacts Response to Opioids","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Opioid; Oxycodone; Endogeny; Agonist; Hormone; Endogenous opioid","score_opus":0.09348131980174242,"score_gpt":0.517528146086346,"score_spread":0.4240468262846036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132895060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287593,0.002828564,0.00094361475,0.00032113845,0.00003974335,0.000018669929,0.00064684474,0.000028054372,0.0022975313],"genre_scores_gemma":[0.9928398,0.0019691633,0.00062530034,0.000115630224,0.00001849228,0.000029458315,0.00045331527,0.000014682925,0.0039340984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999074,0.000016083095,0.000005222133,0.000025157173,0.000025730167,0.00002036035],"domain_scores_gemma":[0.9999201,0.000011533173,0.000028118578,0.000008901325,0.00001489894,0.000016361038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008465978,0.00018830341,0.00018916774,0.00012579525,0.00016224093,0.00034429622,0.00008577574,0.00020523572,0.0021902618],"category_scores_gemma":[0.00015412451,0.000106118256,0.00021137887,0.00013180284,0.00019781964,0.000109200235,0.00013431252,0.0004276508,0.0002826893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024702998,0.00013302613,0.012303305,0.00013298464,0.00006662864,0.0001679175,0.00006686281,0.00018815557,0.9671852,0.0002860585,0.0005324266,0.016467204],"study_design_scores_gemma":[0.00008494055,0.002701181,0.3741323,0.00003529151,0.00019705549,0.0010631912,0.00027524494,0.00077024696,0.6113234,0.00034098796,0.009058641,0.000017495908],"about_ca_topic_score_codex":0.0011901242,"about_ca_topic_score_gemma":0.002167894,"teacher_disagreement_score":0.0021902618,"about_ca_system_score_codex":0.00033209097,"about_ca_system_score_gemma":0.00022591962,"threshold_uncertainty_score":0.0073271394},"labels":[],"label_agreement":null},{"id":"W7132978064","doi":"","title":"Meta-analysis of the data on differences in the exposure to psychiatric drugs between poor and normal cYP2C19/CYP2D6 metabolizers","year":2022,"lang":"sr","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Psychosis; Significant difference","score_opus":0.24703097666292717,"score_gpt":0.42380895361854004,"score_spread":0.17677797695561287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132978064","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03526069,0.94615275,0.0074283034,0.001046587,0.0012107957,0.0005429301,0.006495321,0.00017570538,0.0016868771],"genre_scores_gemma":[0.72091824,0.25352144,0.010357507,0.0029014419,0.00090157666,0.002064071,0.007024674,0.00026997755,0.0020410882],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9845861,0.008039056,0.003445268,0.0022058717,0.0013332142,0.00039046924],"domain_scores_gemma":[0.97134125,0.021591734,0.0028434054,0.0024951668,0.001457152,0.0002712473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016491879,0.0026269385,0.012942329,0.0040114704,0.00082177494,0.00335028,0.0016621548,0.0018580767,0.005150878],"category_scores_gemma":[0.042747594,0.0012784981,0.052894466,0.0059138355,0.00056965917,0.0014305613,0.0014989133,0.0027826075,0.0005050275],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031992781,0.000023302484,0.012953167,0.0403455,0.93272376,0.00013600237,0.000052695766,0.00064586895,0.00039312706,0.00020419121,0.0010082285,0.008314888],"study_design_scores_gemma":[0.00053692085,0.00021892952,0.011601319,0.0026351637,0.98133284,0.0001334914,0.000031987347,0.00026005568,0.00022748075,0.00051716564,0.0024852967,0.00001937976],"about_ca_topic_score_codex":0.004880609,"about_ca_topic_score_gemma":0.007779281,"teacher_disagreement_score":0.016491879,"about_ca_system_score_codex":0.00154629,"about_ca_system_score_gemma":0.0020652893,"threshold_uncertainty_score":0.087218404},"labels":[],"label_agreement":null},{"id":"W7132979001","doi":"","title":"Effects of human milk and formula on the transcriptional regulation of cytochrome P450 3A4 in HepG2 cells","year":2004,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heritage; Library and Archives Canada","funders":"","keywords":"CYP3A4; Pregnane X receptor; Transfection; Reporter gene; Transcriptional regulation; Caffeine; Messenger RNA; Gene expression","score_opus":0.05376511226784259,"score_gpt":0.42202314672170227,"score_spread":0.3682580344538597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132979001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904869,0.0028786652,0.0016690682,0.0002584417,0.00009933397,0.000055405177,0.0011914577,0.00010675106,0.0032539791],"genre_scores_gemma":[0.985471,0.0015895966,0.0032877845,0.00012926436,0.00002837233,0.000091864735,0.0025968119,0.000044056844,0.0067613125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998161,0.00006440944,0.000017534341,0.000022935885,0.0000406073,0.000038344428],"domain_scores_gemma":[0.9999058,0.00003644437,0.000012027204,0.000018464036,0.000017135726,0.000010085474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019857801,0.00023862472,0.00035745744,0.00015787507,0.00017881914,0.00028900488,0.000105964966,0.00013315615,0.0024256825],"category_scores_gemma":[0.00017057276,0.00011651023,0.00039155828,0.00023195783,0.00015449783,0.00009188894,0.00017839645,0.00029663736,0.00060546544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012453283,0.0001450554,0.00046619456,0.000059732225,0.000014669818,0.000103890896,0.00006171914,0.00009245677,0.99334794,0.000060365248,0.00024283827,0.0041596964],"study_design_scores_gemma":[0.00010900334,0.0010292429,0.0069113444,0.000008863308,0.000028828468,0.0001608788,0.000082275175,0.00089641946,0.986858,0.000034568075,0.0038732397,0.0000072455928],"about_ca_topic_score_codex":0.0022530837,"about_ca_topic_score_gemma":0.002741861,"teacher_disagreement_score":0.0024256825,"about_ca_system_score_codex":0.00024375822,"about_ca_system_score_gemma":0.00024146681,"threshold_uncertainty_score":0.008114696},"labels":[],"label_agreement":null},{"id":"W7132990117","doi":"","title":"The Role of the Estrous Cycle on Human CYP2D6-mediated Harmine Response in CYP2D6-transgenic Mice","year":2022,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Estrous cycle; Harmine; Genetically modified mouse; Drug; Human brain; Menstrual cycle; Ratón; Transgene","score_opus":0.05413023961402391,"score_gpt":0.45801388230224255,"score_spread":0.40388364268821864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132990117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793778,0.004374594,0.005716185,0.00078652776,0.00011065653,0.000111882146,0.0036074845,0.00027439778,0.0056404267],"genre_scores_gemma":[0.95294446,0.0052877925,0.006880431,0.00036717084,0.000045248125,0.00029216628,0.0032285394,0.00017792276,0.030776268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998926,0.000016857004,0.000008553834,0.000030603693,0.00002394856,0.000027344713],"domain_scores_gemma":[0.9998996,0.000014052948,0.000031598665,0.000013637014,0.0000116857,0.000029423521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015634942,0.0002524569,0.00022771477,0.00033758962,0.00017387724,0.00027558688,0.0001868146,0.00029958834,0.0039344225],"category_scores_gemma":[0.000111082496,0.00018226424,0.00030783727,0.00018161073,0.00020841697,0.00018031918,0.00014208906,0.0005943179,0.0006543348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008436761,0.0000778402,0.0005890418,0.000045359604,0.00000753069,0.000080509584,0.000030138937,0.000038123067,0.99394566,0.00016334403,0.00014394906,0.004034798],"study_design_scores_gemma":[0.000104425686,0.0011045866,0.02329204,0.000024457493,0.0000564412,0.00034904198,0.00007755633,0.0004949144,0.9655396,0.00017620366,0.0087673785,0.000013415219],"about_ca_topic_score_codex":0.00067162304,"about_ca_topic_score_gemma":0.0012995475,"teacher_disagreement_score":0.0039344225,"about_ca_system_score_codex":0.00027408256,"about_ca_system_score_gemma":0.0002287229,"threshold_uncertainty_score":0.013161898},"labels":[],"label_agreement":null},{"id":"W7133021441","doi":"","title":"Investigating the Involvement of the Sulfotransferase Pathway in Drug-induced Skin Rash","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Covalent bond; Sulfotransferase; Covalent binding; Reactive intermediate; Drug; Plasma protein binding; Metabolism; Genipin","score_opus":0.09699687243208402,"score_gpt":0.4256327531972027,"score_spread":0.3286358807651186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133021441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937272,0.002914923,0.0017053488,0.00008916839,0.000016999269,0.00007768251,0.00011271533,0.00002489471,0.0013310631],"genre_scores_gemma":[0.99569476,0.0017932863,0.0008731466,0.00007459278,0.00001169423,0.000033659617,0.00024491525,0.0000046810765,0.0012690772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998524,0.00004143946,0.000009141284,0.000021625136,0.00002746412,0.00004789549],"domain_scores_gemma":[0.9998703,0.00002290257,0.000038750004,0.000013083685,0.00002524656,0.000029686275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029038583,0.0002674053,0.00020410502,0.000444885,0.0001271532,0.00020817129,0.00014104923,0.00037160589,0.0018781367],"category_scores_gemma":[0.00022806569,0.00016521929,0.00042727002,0.00024120726,0.00018792658,0.000323908,0.0001627794,0.0004244662,0.00036175418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001479377,0.00048409883,0.03007164,0.00026148395,0.0000845078,0.00093902927,0.00007920902,0.00025719687,0.95515555,0.0002672201,0.00008990173,0.010830691],"study_design_scores_gemma":[0.00012704881,0.00829392,0.18877317,0.000032788234,0.00025408177,0.0040280167,0.0004326718,0.0047022575,0.786687,0.0006312101,0.006014999,0.000022765154],"about_ca_topic_score_codex":0.00037326023,"about_ca_topic_score_gemma":0.000321649,"teacher_disagreement_score":0.0018781367,"about_ca_system_score_codex":0.00019942655,"about_ca_system_score_gemma":0.00019693043,"threshold_uncertainty_score":0.006282985},"labels":[],"label_agreement":null},{"id":"W7133046425","doi":"","title":"Characterizing Genotyping Methods for CYP2A6, Their Impacts on Prediction of Nicotine Metabolism, and Applications for the Discovery of Novel Associations","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Common Fund; National Human Genome Research Institute; National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; NIH Office of the Director; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Alliance de recherche numérique du Canada","keywords":"Genotyping; Genotype; CYP2A6; 1000 Genomes Project; Amplicon; Genome-wide association study; Imputation (statistics); Nicotine","score_opus":0.1399656161753509,"score_gpt":0.5006515224826439,"score_spread":0.360685906307293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133046425","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10121297,0.005414477,0.88437617,0.0013813771,0.00028698466,0.000341966,0.0021923769,0.0013246778,0.00346894],"genre_scores_gemma":[0.25231326,0.0034771613,0.7352486,0.00088444434,0.0002773497,0.0005916765,0.0027230026,0.0004471229,0.0040374314],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98279345,0.0076653133,0.000881635,0.0034896352,0.004899584,0.00027045832],"domain_scores_gemma":[0.9835242,0.007978665,0.0030536193,0.0027801746,0.0024406018,0.00022264133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015679242,0.0009828373,0.00090223085,0.0018849883,0.00050967874,0.0020015237,0.0012242129,0.0015421999,0.0011016562],"category_scores_gemma":[0.028110333,0.0005816111,0.0011668113,0.0021334724,0.00081486,0.0010246953,0.0009942524,0.0019701275,0.0013623798],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049018627,0.00025111614,0.15730147,0.0009912362,0.0011541408,0.00017129548,0.00062290154,0.014015653,0.30824018,0.013177501,0.004745021,0.49883935],"study_design_scores_gemma":[0.00014781475,0.0010776954,0.15947022,0.00046246435,0.001059844,0.0023827464,0.00023054023,0.124113455,0.62787974,0.022267126,0.060561173,0.00034714065],"about_ca_topic_score_codex":0.001404237,"about_ca_topic_score_gemma":0.0026336934,"teacher_disagreement_score":0.015679242,"about_ca_system_score_codex":0.0006188736,"about_ca_system_score_gemma":0.0008732999,"threshold_uncertainty_score":0.08292073},"labels":[],"label_agreement":null},{"id":"W7143507916","doi":"10.71465/ajpp.2268","title":"Impact of Nutraceuticals on Drug Efficacy and Metabolism","year":2022,"lang":"","type":"article","venue":"American Journal Of Pharmacy And Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nutraceutical; Drug; Pharmacodynamics; Clinical efficacy; Pharmacokinetics; Adverse effect; Efficacy; Drug development","score_opus":0.057446695774315173,"score_gpt":0.45070323153565417,"score_spread":0.393256535761339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7143507916","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20755221,0.75285506,0.0051748096,0.004191006,0.0006195937,0.00010922221,0.0012788742,0.0001539995,0.028065223],"genre_scores_gemma":[0.71900916,0.26875445,0.0028299694,0.0018304565,0.0005148928,0.00006890733,0.00066627056,0.000051885716,0.0062739947],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990318,0.0004208317,0.00009829851,0.00012328936,0.000267026,0.000058900103],"domain_scores_gemma":[0.99882287,0.0005833392,0.0002705634,0.000051603714,0.00022346305,0.000048133632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010229562,0.00035387554,0.00065739924,0.00043682713,0.00017298656,0.0009260358,0.00021585883,0.0004995812,0.0035599812],"category_scores_gemma":[0.0024658884,0.00015032124,0.0008113605,0.00036300113,0.00030772193,0.00048507628,0.0004648319,0.00071707513,0.0006067346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051250276,0.000617098,0.030848091,0.009472513,0.0025386228,0.0018354715,0.00023367781,0.002225736,0.15089028,0.0064176153,0.0068849185,0.78291094],"study_design_scores_gemma":[0.00079278357,0.015743192,0.28685004,0.0032445712,0.0075102374,0.013596915,0.00053971086,0.0047225575,0.20631514,0.019019151,0.44144946,0.00021620245],"about_ca_topic_score_codex":0.000656421,"about_ca_topic_score_gemma":0.0007482925,"teacher_disagreement_score":0.0035599812,"about_ca_system_score_codex":0.00048092142,"about_ca_system_score_gemma":0.00039246544,"threshold_uncertainty_score":0.011909306},"labels":[],"label_agreement":null},{"id":"W7162122644","doi":"10.82308/47540","title":"Barriers to personalized medicine in pediatrics: The implementation of a novel pharmacogenomic test for pediatric neuroblastoma","year":2015,"lang":"en","type":"dissertation","venue":"","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Test (biology); Personalized medicine; Pediatric cancer; Palliative care; Deliberation; Genetic testing; Stakeholder","score_opus":0.08543492254270567,"score_gpt":0.47477359066425356,"score_spread":0.3893386681215479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162122644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871142,0.0004357555,0.0021927375,0.0066908016,0.000056082088,0.0009161281,0.000049372524,0.000027983702,0.0025168622],"genre_scores_gemma":[0.9816097,0.00068253523,0.013660738,0.0018885874,0.00002635534,0.0016711951,0.000033295688,0.000012647215,0.00041494434],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9281481,0.05894954,0.0024956986,0.0015357265,0.005027378,0.0038436593],"domain_scores_gemma":[0.87121946,0.09629261,0.015649363,0.00275203,0.00593694,0.008149681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051618498,0.000350391,0.0005316804,0.0006891329,0.00425049,0.0034714958,0.0016356705,0.0019031315,0.0023586259],"category_scores_gemma":[0.1091265,0.0005602361,0.00084411574,0.00061013334,0.0030706555,0.0035162435,0.0064824717,0.0030586175,0.00023927951],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013602761,0.0046220063,0.20126298,0.0031130381,0.00014299026,0.004454191,0.5798731,0.001238098,0.003151401,0.0039397473,0.0039133257,0.19292879],"study_design_scores_gemma":[0.0003692268,0.015423054,0.16329345,0.004108156,0.0003651854,0.0037070606,0.7470501,0.003888708,0.007251285,0.0041629868,0.050126206,0.00025460037],"about_ca_topic_score_codex":0.0028277256,"about_ca_topic_score_gemma":0.0049758274,"teacher_disagreement_score":0.051618498,"about_ca_system_score_codex":0.006661074,"about_ca_system_score_gemma":0.024299376,"threshold_uncertainty_score":0.27298796},"labels":[],"label_agreement":null},{"id":"W7163132718","doi":"10.5281/zenodo.20507805","title":"Pharmacogenomics in Clinical Pharmacy","year":2025,"lang":"","type":"book-chapter","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacy; Accreditation; Precision medicine; Clinical pharmacy; Personalized medicine; Population","score_opus":0.20811212818754102,"score_gpt":0.43721074046860325,"score_spread":0.22909861228106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163132718","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029199687,0.17085323,0.0613048,0.50118554,0.010725315,0.00046189709,0.002606212,0.0020999787,0.24784303],"genre_scores_gemma":[0.16315755,0.34961915,0.10626824,0.25124568,0.038784046,0.0013782085,0.0045769583,0.0013515077,0.083618686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98300236,0.009273256,0.0012053641,0.0017697355,0.004041814,0.0007075362],"domain_scores_gemma":[0.9654219,0.019250968,0.0028534997,0.0034116157,0.00616779,0.0028943145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014829642,0.00088707986,0.0014652964,0.00395333,0.001451952,0.010679235,0.0018621269,0.0066129738,0.030043988],"category_scores_gemma":[0.041082878,0.00054726354,0.0011474512,0.006845609,0.0067649214,0.009049506,0.005933673,0.009470381,0.012405376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006961388,0.00014056946,0.004060871,0.0021646826,0.00010475546,0.0005012073,0.00079901353,0.0010901153,0.00033323583,0.3096123,0.2715575,0.40956616],"study_design_scores_gemma":[0.000028541292,0.000060086393,0.0032008782,0.0029643995,0.00003967826,0.0006494977,0.0005887164,0.0007345763,0.00024309776,0.22263099,0.7688071,0.00005244378],"about_ca_topic_score_codex":0.004321946,"about_ca_topic_score_gemma":0.0026180407,"teacher_disagreement_score":0.030043988,"about_ca_system_score_codex":0.006212713,"about_ca_system_score_gemma":0.012045446,"threshold_uncertainty_score":0.10050714},"labels":[],"label_agreement":null},{"id":"W7163189178","doi":"10.5281/zenodo.20507806","title":"Pharmacogenomics in Clinical Pharmacy","year":2025,"lang":"","type":"book-chapter","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Pharmacy; Accreditation; Precision medicine; Clinical pharmacy; Personalized medicine; Population","score_opus":0.20811212818754102,"score_gpt":0.43721074046860325,"score_spread":0.22909861228106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163189178","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029199687,0.17085323,0.0613048,0.50118554,0.010725315,0.00046189709,0.002606212,0.0020999787,0.24784303],"genre_scores_gemma":[0.16315755,0.34961915,0.10626824,0.25124568,0.038784046,0.0013782085,0.0045769583,0.0013515077,0.083618686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98300236,0.009273256,0.0012053641,0.0017697355,0.004041814,0.0007075362],"domain_scores_gemma":[0.9654219,0.019250968,0.0028534997,0.0034116157,0.00616779,0.0028943145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014829642,0.00088707986,0.0014652964,0.00395333,0.001451952,0.010679235,0.0018621269,0.0066129738,0.030043988],"category_scores_gemma":[0.041082878,0.00054726354,0.0011474512,0.006845609,0.0067649214,0.009049506,0.005933673,0.009470381,0.012405376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006961388,0.00014056946,0.004060871,0.0021646826,0.00010475546,0.0005012073,0.00079901353,0.0010901153,0.00033323583,0.3096123,0.2715575,0.40956616],"study_design_scores_gemma":[0.000028541292,0.000060086393,0.0032008782,0.0029643995,0.00003967826,0.0006494977,0.0005887164,0.0007345763,0.00024309776,0.22263099,0.7688071,0.00005244378],"about_ca_topic_score_codex":0.004321946,"about_ca_topic_score_gemma":0.0026180407,"teacher_disagreement_score":0.030043988,"about_ca_system_score_codex":0.006212713,"about_ca_system_score_gemma":0.012045446,"threshold_uncertainty_score":0.10050714},"labels":[],"label_agreement":null},{"id":"W7165991647","doi":"","title":"Farmakogenetik Testlerin Sağlık Ekonomisi Alanındaki Etkisinin Bibliyometrik Analizi","year":2025,"lang":"tr","type":"article","venue":"DergiPark (Istanbul University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Bibliometrics; Health economics; Inclusion (mineral); Citation; Pharmacogenetics; Scientific literature; Value (mathematics)","score_opus":0.07182002256909965,"score_gpt":0.39090622865080266,"score_spread":0.319086206081703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7165991647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33416235,0.53144795,0.014883212,0.008665692,0.0010371376,0.0015898668,0.04897777,0.00042549006,0.058810607],"genre_scores_gemma":[0.70903635,0.23844601,0.02131895,0.00089948566,0.00087539136,0.0016749031,0.022109384,0.00010173604,0.005537727],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9907459,0.0021234753,0.0028097644,0.0006702145,0.0033972417,0.00025341788],"domain_scores_gemma":[0.94970745,0.033732533,0.00764841,0.0011777622,0.0074678105,0.00026608692],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.013831625,0.000601162,0.001675917,0.034340072,0.0005339093,0.004355028,0.00067158596,0.0007450294,0.010006534],"category_scores_gemma":[0.03661054,0.00028517895,0.0019658746,0.03813601,0.0006375851,0.0023187052,0.00091262325,0.0006707186,0.0019089017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013650266,0.00018391128,0.20371689,0.06688762,0.0041481294,0.0016172262,0.0025056452,0.0018895266,0.0022079588,0.00584467,0.018830344,0.69080305],"study_design_scores_gemma":[0.00031240276,0.00090836646,0.62891984,0.047951255,0.018926239,0.008070489,0.0107730655,0.0041995714,0.008797853,0.0085481135,0.26228863,0.0003042715],"about_ca_topic_score_codex":0.0041858163,"about_ca_topic_score_gemma":0.004535918,"teacher_disagreement_score":0.9656599,"about_ca_system_score_codex":0.001958379,"about_ca_system_score_gemma":0.0039369627,"threshold_uncertainty_score":0.0731495},"labels":[],"label_agreement":null},{"id":"W74495713","doi":"10.1097/00008571-200007000-00001","title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.","year":2000,"lang":"en","type":"review","venue":"Pharmacogenetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":397,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP3A4; Genetic variability; Pharmacology; Biology; Medicine; Internal medicine; Genetics; Cytochrome P450; Genotype; Metabolism","score_opus":0.28824948934828076,"score_gpt":0.5423411700006989,"score_spread":0.25409168065241816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W74495713","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6927025,0.09777287,0.17910449,0.001123856,0.0004988009,0.008855464,0.008937751,0.00068313896,0.010321265],"genre_scores_gemma":[0.90020865,0.009332342,0.08062944,0.0002761105,0.00022769967,0.0043518813,0.002179392,0.00010914536,0.0026853408],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.95448273,0.028187612,0.0045694187,0.004022218,0.008434179,0.0003038261],"domain_scores_gemma":[0.923915,0.040471394,0.02302755,0.0066188597,0.0054176752,0.0005494915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036038674,0.0009387907,0.001671059,0.0101853125,0.00042562748,0.0010055696,0.0009484564,0.000976461,0.002300222],"category_scores_gemma":[0.0716566,0.00030776506,0.0024633736,0.011122795,0.000818773,0.00078759727,0.0012732799,0.0006283907,0.00072100124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052880063,0.00025703825,0.6931657,0.005602489,0.022369612,0.0011135235,0.0013922211,0.001251838,0.016912227,0.0015896958,0.0017221821,0.24933553],"study_design_scores_gemma":[0.0005902951,0.006600235,0.9486039,0.00041687168,0.009160019,0.004934827,0.0004745322,0.0062371646,0.0083050765,0.0018152639,0.012637807,0.00022397556],"about_ca_topic_score_codex":0.0010991498,"about_ca_topic_score_gemma":0.00182041,"teacher_disagreement_score":0.036038674,"about_ca_system_score_codex":0.0006438175,"about_ca_system_score_gemma":0.0008848655,"threshold_uncertainty_score":0.19059306},"labels":[],"label_agreement":null},{"id":"W762497818","doi":"","title":"Advancements in the Field of Cardiovascular Disease Pharmacogenetics","year":2015,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Cisco Systems; Sanofi; Eli Lilly Canada; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacogenetics; Field (mathematics); Disease; Medicine; Data science; Intensive care medicine; Computer science; Internal medicine; Biology; Genetics; Genotype; Mathematics","score_opus":0.059891983149146094,"score_gpt":0.3694268530251954,"score_spread":0.3095348698760493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W762497818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01991504,0.6282059,0.05366568,0.1934224,0.0059210625,0.00023098732,0.0008836731,0.00048392714,0.097271286],"genre_scores_gemma":[0.09374823,0.79412055,0.05138525,0.022523437,0.009028038,0.0001852758,0.00045308092,0.00014534353,0.028410843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978515,0.00086662796,0.0001331374,0.0002898591,0.00072787324,0.00013104705],"domain_scores_gemma":[0.9943494,0.0035781793,0.00027505626,0.00049508334,0.0008816254,0.00042071386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007957699,0.00064529397,0.00062425935,0.0015252176,0.00051019154,0.0027246755,0.0005033034,0.001263611,0.007465486],"category_scores_gemma":[0.007046809,0.00030484542,0.00075351435,0.001716765,0.0017761514,0.0012749982,0.0017151647,0.0042677866,0.0025422897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013289305,0.00018300384,0.004612281,0.0020660865,0.00014351388,0.00020498097,0.0007805286,0.0014000281,0.0059828684,0.07668157,0.04131283,0.86649936],"study_design_scores_gemma":[0.000057798636,0.0003244302,0.011373935,0.0020930704,0.00012261167,0.00089400023,0.00033208125,0.0009141985,0.0045447694,0.06768807,0.91159,0.00006505066],"about_ca_topic_score_codex":0.0018692521,"about_ca_topic_score_gemma":0.0024174568,"teacher_disagreement_score":0.007957699,"about_ca_system_score_codex":0.0019256163,"about_ca_system_score_gemma":0.004715065,"threshold_uncertainty_score":0.042084813},"labels":[],"label_agreement":null},{"id":"W821485509","doi":"10.71781/30250","title":"Les Déterminants Génétiques de la Pharmacocinétique du Busulfan et les Résultats de la Transplantation","year":2012,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation Charles-Bruneau","keywords":"Philosophy","score_opus":0.020539569735155264,"score_gpt":0.3238571767413334,"score_spread":0.30331760700617816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W821485509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985202,0.00061363867,0.000325557,0.000045646873,0.0000032892021,0.0000063672856,0.00011602371,0.000006654353,0.0003625283],"genre_scores_gemma":[0.99893576,0.00024414374,0.00019777849,0.00001739821,0.000004551324,0.000008220057,0.000114138165,0.000003810386,0.0004743116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956053,0.00016624937,0.000023923283,0.00007831085,0.00010811515,0.00006282877],"domain_scores_gemma":[0.99887425,0.0004814513,0.00038174333,0.000049977887,0.00013062333,0.00008193931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000572685,0.00017246809,0.00020032647,0.00036330838,0.00013019882,0.00035994384,0.00009048664,0.00026358062,0.0013583273],"category_scores_gemma":[0.0017486447,0.00011040865,0.00022530182,0.00034901578,0.0002680074,0.00015781441,0.00009499059,0.00029392913,0.00017410102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033171377,0.00020750645,0.8487801,0.00006740334,0.00021039062,0.00051412685,0.00028661845,0.00075117924,0.11439619,0.00021372235,0.00015094315,0.03110464],"study_design_scores_gemma":[0.000013387345,0.0013373916,0.9837891,0.0000070472315,0.000068966096,0.00084473926,0.00006953969,0.00040175024,0.012626867,0.00007854063,0.00075624586,0.0000065855775],"about_ca_topic_score_codex":0.0016932816,"about_ca_topic_score_gemma":0.0010102903,"teacher_disagreement_score":0.0016932816,"about_ca_system_score_codex":0.00031276248,"about_ca_system_score_gemma":0.00034752584,"threshold_uncertainty_score":0.0045440793},"labels":[],"label_agreement":null},{"id":"W9251540","doi":"10.18553/jmcp.2014.20.4.376","title":"Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events","year":2014,"lang":"en","type":"article","venue":"Journal of Managed Care Pharmacy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface","funders":"Ministério da Saúde; Universidade de São Paulo","keywords":"Amiodarone; Medicine; Warfarin; Adverse effect; Odds ratio; CYP2C9; Maintenance dose; VKORC1; Internal medicine; Atrial fibrillation; Prothrombin time; Loading dose; Anesthesia; Gastroenterology","score_opus":0.08974925117754175,"score_gpt":0.3912391506886126,"score_spread":0.30148989951107086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9251540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998278,0.00074894045,0.0001413717,0.000074061434,0.000012630363,0.000006243462,0.00010428104,0.0000068699446,0.00062766264],"genre_scores_gemma":[0.99966586,0.000094428986,0.000079411686,0.000026069183,0.000018664274,0.0000022077193,0.000054909797,0.0000030042597,0.000055386077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861884,0.0003978932,0.00022351586,0.00027245664,0.00034426973,0.00014290793],"domain_scores_gemma":[0.99221605,0.0025225913,0.0037375425,0.00046906722,0.00030489793,0.0007498239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069249317,0.00026373623,0.0005554916,0.00043752414,0.0002790462,0.0006431996,0.0002325471,0.0003976554,0.0026594084],"category_scores_gemma":[0.005899424,0.0001925801,0.0009182758,0.0007429478,0.00035350633,0.00030641453,0.00032937273,0.0005281387,0.0002898639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008722268,0.000054042575,0.99322116,0.000023475932,0.00024737598,0.00015606513,0.000037811402,0.00003069891,0.0013842323,0.00001186222,0.000065035354,0.0038960692],"study_design_scores_gemma":[0.000017091525,0.00026816156,0.9986142,0.0000050245776,0.00012239417,0.0005827078,0.000026199015,0.00011183925,0.00014766499,0.000017194454,0.0000853357,0.000002203799],"about_ca_topic_score_codex":0.0011921678,"about_ca_topic_score_gemma":0.0014322795,"teacher_disagreement_score":0.0026594084,"about_ca_system_score_codex":0.00022410268,"about_ca_system_score_gemma":0.00040824956,"threshold_uncertainty_score":0.008896589},"labels":[],"label_agreement":null},{"id":"W995787599","doi":"10.1007/978-3-319-16009-2","title":"Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450","year":2015,"lang":"en","type":"book","venue":"Advances in experimental medicine and biology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Peroxidase; Chemistry; Monooxygenase; Cytochrome P450; Cytochrome c peroxidase; Biochemistry; Stereochemistry; Enzyme","score_opus":0.17305831116150946,"score_gpt":0.44657006518087206,"score_spread":0.27351175401936256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W995787599","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010795253,0.76618326,0.037577245,0.004191173,0.0049210177,0.0000982441,0.0005353406,0.0003787411,0.17531973],"genre_scores_gemma":[0.03543116,0.42485258,0.020422632,0.0020766049,0.005035134,0.0001426762,0.00067942427,0.00013316525,0.51122665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994195,0.000005385026,0.0000025308673,0.000015144275,0.00003112285,0.0000038835597],"domain_scores_gemma":[0.9999552,0.000021915981,0.00000346868,0.000004368544,0.0000102071,0.000004853047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016404166,0.00054758624,0.00037239143,0.00045768794,0.00017497358,0.00058511784,0.00038715822,0.000406708,0.0054906723],"category_scores_gemma":[0.00018242956,0.00021387693,0.00025163934,0.0006507371,0.00047530397,0.0013407673,0.00030393564,0.0012876458,0.0031511323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013973507,0.00009804951,0.00023728154,0.001466992,0.00001959106,0.0003105117,0.00021336517,0.0008769087,0.08201557,0.10422256,0.12791438,0.68248516],"study_design_scores_gemma":[0.0000146249085,0.00012471866,0.0011034461,0.00012534813,0.000017123886,0.0015675386,0.000036670335,0.0006370696,0.011529719,0.06458982,0.9202321,0.000021841046],"about_ca_topic_score_codex":0.00030296735,"about_ca_topic_score_gemma":0.000545464,"teacher_disagreement_score":0.0054906723,"about_ca_system_score_codex":0.00031384584,"about_ca_system_score_gemma":0.00028260468,"threshold_uncertainty_score":0.018368065},"labels":[],"label_agreement":null}]}